data_2lck_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lck _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.961 0.41 . . . . 0.0 110.632 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.611 ' CG2' ' H ' ' A' ' 16' ' ' LYS . 13.4 p -167.07 -178.98 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.898 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.611 ' H ' ' CG2' ' A' ' 15' ' ' VAL . 23.7 mtpp -64.32 -41.81 96.63 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.699 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -63.73 -41.5 98.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.279 0.561 . . . . 0.0 112.077 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 12.9 tp -79.97 -26.0 40.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.046 -179.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.455 ' O ' ' OG1' ' A' ' 22' ' ' THR . . . -66.04 -41.3 95.24 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 107.601 -2.199 . . . . 0.0 107.601 177.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.47 -32.01 67.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 124.886 2.279 . . . . 0.0 107.332 176.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.76 -42.51 98.55 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-N 108.454 -3.975 . . . . 0.0 108.292 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 19' ' ' GLY . 28.3 p -70.61 -27.48 64.11 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.541 0.686 . . . . 0.0 109.436 178.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.76 -49.7 67.43 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.166 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.98 -35.19 77.76 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 118.816 -1.154 . . . . 0.0 112.375 -177.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.47 ' SG ' ' OE1' ' A' ' 89' ' ' GLN . 75.7 m -63.35 -53.79 47.11 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -177.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -65.89 -38.09 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -177.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.493 ' O ' ' OG1' ' A' ' 31' ' ' THR . . . -63.64 -41.59 98.23 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -173.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 29' ' ' LEU . 20.0 p30 -77.6 -27.0 51.13 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 120.893 1.678 . . . . 0.0 109.93 -175.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.501 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 11.2 tp -59.8 -55.39 34.82 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 119.93 1.241 . . . . 0.0 112.148 -178.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.1 pt -75.45 -3.91 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-O 121.376 0.608 . . . . 0.0 112.61 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.493 ' OG1' ' O ' ' A' ' 27' ' ' ALA . 7.1 m -109.3 -16.85 13.95 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.751 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.47 ' N ' ' CD ' ' A' ' 33' ' ' PRO . 1.8 t80 -68.53 -44.33 33.51 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 121.411 1.914 . . . . 0.0 110.93 -178.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.47 ' CD ' ' N ' ' A' ' 32' ' ' PHE . 36.8 Cg_exo -59.36 -15.8 31.52 Favored 'Trans proline' 0 N--CA 1.501 1.964 0 C-N-CA 121.554 1.502 . . . . 0.0 112.701 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.466 ' CD1' ' OG ' ' A' ' 282' ' ' SER . 81.6 mt -67.62 -35.36 78.79 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 114.787 1.402 . . . . 0.0 114.787 -177.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 36' ' ' THR . 45.3 p-10 -64.27 -40.53 96.16 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -177.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.53 ' N ' ' OD1' ' A' ' 35' ' ' ASP . 44.1 p -58.27 -35.28 71.54 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.939 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.86 -39.19 83.8 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 119.755 -0.778 . . . . 0.0 112.015 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.498 ' NZ ' ' CB ' ' A' ' 38' ' ' LYS . 8.7 mtmp? -62.12 -49.36 76.21 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 119.239 -0.984 . . . . 0.0 111.187 -176.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.1 m -64.25 -40.6 89.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -176.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.599 ' NH1' HE21 ' A' ' 44' ' ' GLN . 10.2 tpp180 -61.69 -41.87 98.16 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 119.378 -0.929 . . . . 0.0 110.08 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.54 39.06 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.768 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.517 ' C ' ' H ' ' A' ' 44' ' ' GLN . 60.2 tt0 -125.73 152.78 44.87 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.989 0.424 . . . . 0.0 110.942 -179.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.414 HD13 HG21 ' A' ' 43' ' ' ILE . 73.0 mt -63.11 0.78 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.004 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.599 HE21 ' NH1' ' A' ' 40' ' ' ARG . 46.0 mt-30 64.13 78.98 0.27 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.525 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.17 -5.68 3.45 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.467 ' H ' ' C ' ' A' ' 44' ' ' GLN . 96.8 mt-10 -56.22 -42.83 77.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.912 0.387 . . . . 0.0 109.992 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.549 ' C ' ' H ' ' A' ' 49' ' ' GLY . 4.7 t 37.71 30.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.699 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.406 ' N ' ' O ' ' A' ' 46' ' ' GLU . 85.9 mt-30 -58.05 -2.8 0.19 Allowed 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.121 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.549 ' H ' ' C ' ' A' ' 47' ' ' SER . . . 87.44 -8.62 76.5 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -177.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -66.35 -37.3 85.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.665 0.745 . . . . 0.0 109.237 177.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.1 p -60.76 -44.12 96.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.149 -178.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.9 mmp_? -64.56 -35.14 80.02 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 119.816 -0.754 . . . . 0.0 112.31 -177.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.5 t -68.95 -38.0 79.18 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 119.24 -0.984 . . . . 0.0 108.758 177.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -138.29 97.93 3.49 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 114.798 -1.092 . . . . 0.0 108.39 178.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -80.65 9.0 6.73 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -177.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.525 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 18.7 m -125.69 -140.99 0.28 Allowed 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 56' ' ' SER . . . 97.87 12.74 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 O-C-N 124.127 0.892 . . . . 0.0 111.863 178.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 41.7 tp60 -178.24 84.59 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.704 0.288 . . . . 0.0 110.36 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -63.78 163.06 12.31 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.063 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.413 ' O ' ' C ' ' A' ' 61' ' ' GLY . 78.4 mtm-85 -49.84 -36.85 28.3 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 60' ' ' ARG . . . -28.57 102.58 0.01 OUTLIER Glycine 0 CA--C 1.526 0.764 0 CA-C-N 114.955 -1.021 . . . . 0.0 112.703 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.1 m -67.32 -34.37 68.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 118.41 -0.805 . . . . 0.0 109.663 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -60.48 -32.5 71.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 121.077 1.762 . . . . 0.0 109.615 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.67 -49.32 64.81 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-N 114.623 -1.171 . . . . 0.0 114.781 -176.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.7 p -61.98 -46.48 89.05 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 -178.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 8.8 tt -59.8 -36.19 64.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.21 -35.73 81.75 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 120.303 1.411 . . . . 0.0 111.913 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.473 ' O ' ' OG1' ' A' ' 72' ' ' THR . 98.1 m -63.56 -40.88 98.12 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.312 -1.313 . . . . 0.0 111.085 -175.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 7.3 ptm -60.59 -39.46 88.18 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -175.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.2 p -69.02 -40.01 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 119.532 -0.867 . . . . 0.0 113.05 -177.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 -77.78 -13.08 60.0 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.999 0.904 . . . . 0.0 112.6 -178.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' A' ' 68' ' ' THR . 19.7 m -62.45 -54.65 37.08 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.025 -1.443 . . . . 0.0 111.272 179.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 28.2 mp0 -107.01 -57.76 2.02 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 178.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.42 ' O ' ' CB ' ' A' ' 77' ' ' SER . . . 159.36 165.49 16.46 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -56.84 -35.46 98.26 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 121.487 1.458 . . . . 0.0 111.376 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.64 -11.34 11.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.802 0.811 . . . . 0.0 110.691 175.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 74' ' ' GLY . 5.6 t -77.9 -32.49 51.8 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.098 -1.41 . . . . 0.0 110.905 -178.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 27.5 mt -75.45 -33.48 60.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.116 0.484 . . . . 0.0 110.61 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -92.29 -4.59 53.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 122.798 1.285 . . . . 0.0 113.243 -177.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -95.28 116.25 28.52 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 112.29 -2.232 . . . . 0.0 107.016 175.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.48 -11.38 54.16 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -177.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.461 ' CD1' ' C ' ' A' ' 82' ' ' LEU . 0.3 OUTLIER -59.24 -34.42 72.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 113.94 -1.13 . . . . 0.0 110.489 -179.328 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.1 m -70.49 -27.0 29.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.087 -0.961 . . . . 0.0 109.369 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.95 -31.92 61.61 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.675 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.92 -40.11 89.18 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 119.544 -1.312 . . . . 0.0 111.223 -177.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.0 mp -62.46 -40.1 95.56 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 122.29 1.043 . . . . 0.0 112.574 -177.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -60.57 -27.44 67.69 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 113.106 -1.861 . . . . 0.0 109.613 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 58.2 ttp85 -57.83 -53.55 56.97 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 173.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.47 ' OE1' ' SG ' ' A' ' 25' ' ' CYS . 10.3 tt0 -67.22 -29.9 69.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 112.318 -2.219 . . . . 0.0 112.512 -178.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 38.4 ttm -61.14 -40.66 94.65 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.497 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 38.2 t -74.32 -34.13 63.37 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 119.556 -0.858 . . . . 0.0 111.718 -176.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -57.75 -43.99 85.8 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 120.584 1.538 . . . . 0.0 112.308 -176.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.53 -32.85 64.44 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 119.321 -0.952 . . . . 0.0 111.015 -178.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.469 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 48.8 m -64.35 -41.82 96.55 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.472 ' C ' ' H ' ' A' ' 97' ' ' ILE . 7.2 p -68.42 -28.41 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.221 177.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 16.9 mtp-105 -77.46 10.33 2.65 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -177.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.472 ' H ' ' C ' ' A' ' 95' ' ' VAL . 9.6 tp -86.87 -15.33 9.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 177.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.427 ' O ' ' OG ' ' A' ' 102' ' ' SER . . . -140.05 -48.0 0.06 OUTLIER Glycine 0 CA--C 1.539 1.571 0 CA-C-N 114.23 -1.35 . . . . 0.0 114.383 -177.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.4 tp -70.75 -13.48 62.07 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.183 1.491 . . . . 0.0 113.37 -177.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.473 ' O ' ' HB2' ' A' ' 104' ' ' LYS . 20.6 t80 -81.21 -51.67 8.17 Favored 'General case' 0 C--O 1.211 -0.945 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.957 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.488 ' O ' ' HG3' ' A' ' 105' ' ' GLN . 9.3 p-10 -69.99 -32.73 71.07 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 123.631 1.682 . . . . 0.0 111.83 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 98' ' ' GLY . 49.0 m -68.83 -52.72 26.98 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 110.81 -2.904 . . . . 0.0 116.99 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 69.2 t -74.99 -26.9 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 CA-C-N 121.121 1.782 . . . . 0.0 110.8 176.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 100' ' ' TYR . 0.4 OUTLIER -69.54 -41.53 75.84 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 110.831 -2.895 . . . . 0.0 112.974 -179.259 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.488 ' HG3' ' O ' ' A' ' 101' ' ' ASP . 88.1 mt-30 -78.65 -13.75 59.66 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 123.614 1.673 . . . . 0.0 111.025 178.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.06 -22.74 41.95 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 112.785 -2.007 . . . . 0.0 110.9 178.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -109.87 -30.62 7.75 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.833 0.742 . . . . 0.0 112.212 -175.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 50.1 m -98.46 9.06 44.01 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 118.219 -1.393 . . . . 0.0 112.579 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.444 ' O ' ' C ' ' A' ' 110' ' ' GLY . 35.3 ttmt -53.74 121.11 7.2 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.495 ' O ' ' CB ' ' A' ' 111' ' ' SER . . . -23.59 -78.79 0.01 OUTLIER Glycine 0 N--CA 1.48 1.59 0 CA-C-N 117.81 0.277 . . . . 0.0 113.12 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.498 ' O ' ' HB2' ' A' ' 112' ' ' GLU . 1.4 t 91.96 -87.26 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 177.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.498 ' HB2' ' O ' ' A' ' 111' ' ' SER . 82.7 tt0 171.64 -34.36 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 120.541 1.519 . . . . 0.0 113.915 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.472 ' O ' ' CB ' ' A' ' 114' ' ' ALA . 0.3 OUTLIER 156.87 42.46 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.201 0.524 . . . . 0.0 109.896 -179.214 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.472 ' CB ' ' O ' ' A' ' 113' ' ' HIS . . . 160.45 -162.41 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 178.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.42 ' O ' ' OG ' ' A' ' 118' ' ' SER . . . 102.78 15.23 25.01 Favored Glycine 0 CA--C 1.507 -0.428 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.49 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 12.6 tt -60.43 -40.54 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.68 -40.17 95.71 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-O 121.791 0.661 . . . . 0.0 111.685 175.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.42 ' OG ' ' O ' ' A' ' 115' ' ' GLY . 10.1 p -58.65 -42.97 89.58 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 176.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 76.3 mtm180 -63.71 -37.01 85.74 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.849 -177.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 70.9 mt -63.53 -45.63 89.7 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 177.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 39.4 mt -66.52 -44.82 81.46 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 118.762 -1.175 . . . . 0.0 110.06 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.98 -45.4 89.24 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 120.22 1.373 . . . . 0.0 110.602 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -66.04 -44.16 92.0 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 120.172 -1.014 . . . . 0.0 111.289 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 59.0 m -64.14 -43.82 94.04 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.43 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 20.6 m -69.34 -48.27 61.91 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 119.365 -0.934 . . . . 0.0 111.943 177.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.434 ' CG2' ' N ' ' A' ' 127' ' ' GLY . 4.8 t -65.23 -42.46 93.37 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -173.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.434 ' N ' ' CG2' ' A' ' 126' ' ' THR . . . -63.89 -44.53 95.95 Favored Glycine 0 CA--C 1.521 0.423 0 CA-C-O 122.912 1.284 . . . . 0.0 113.196 -177.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.12 -41.21 96.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 112.029 -2.085 . . . . 0.0 106.714 177.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.98 -41.9 97.39 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.3 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -62.9 -39.98 96.17 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -177.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.5 m -61.04 -26.12 38.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 122.628 1.204 . . . . 0.0 109.513 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -58.31 -44.45 88.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 112.607 -2.088 . . . . 0.0 111.736 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 61.5 t -78.6 -49.02 21.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.941 -178.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -112.38 131.64 55.43 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.746 0.308 . . . . 0.0 110.805 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.519 ' N ' ' CD ' ' A' ' 136' ' ' PRO . 3.4 tt0 -175.51 -41.79 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.82 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.519 ' CD ' ' N ' ' A' ' 135' ' ' GLN . 52.6 Cg_exo -52.78 -34.52 65.35 Favored 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 121.819 1.679 . . . . 0.0 113.437 -178.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 98.6 m -67.54 -42.01 83.4 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 118.029 -1.468 . . . . 0.0 108.594 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -65.51 -43.01 91.43 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 118.159 -1.416 . . . . 0.0 112.788 -177.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.3 p -64.76 -44.22 96.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.455 ' O ' ' N ' ' A' ' 144' ' ' PHE . 21.8 m -65.26 -37.93 81.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -178.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -61.41 -40.72 95.44 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -176.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.453 ' CG1' ' N ' ' A' ' 143' ' ' ARG . 3.9 p -69.61 -44.7 79.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 119.399 -0.92 . . . . 0.0 108.94 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.453 ' N ' ' CG1' ' A' ' 142' ' ' VAL . 65.8 mtt180 -64.24 -35.71 81.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.701 178.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.455 ' N ' ' O ' ' A' ' 140' ' ' VAL . 85.1 t80 -65.71 -40.56 92.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.239 -178.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -64.14 -38.63 91.74 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -64.88 -35.02 79.79 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -178.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -59.75 111.18 1.35 Allowed 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 177.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -106.6 -173.12 2.22 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 117.686 2.476 . . . . 0.0 117.686 -171.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 59.0 61.13 2.21 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 110.035 -3.257 . . . . 0.0 110.899 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . 46.59 -114.79 0.54 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.806 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 170.74 113.88 0.3 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.979 -0.849 . . . . 0.0 110.979 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.708 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 179.963 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.412 ' CD1' ' O ' ' A' ' 156' ' ' TYR . 28.1 p90 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.752 0.311 . . . . 0.0 110.516 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -54.48 175.73 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.662 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 20.5 p -157.0 -178.36 7.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.657 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.433 ' CG2' ' N ' ' A' ' 160' ' ' VAL . 13.7 t -64.1 -46.47 84.06 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.663 -177.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.433 ' N ' ' CG2' ' A' ' 159' ' ' THR . 6.3 p -64.51 -45.43 95.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 119.06 -1.056 . . . . 0.0 109.674 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -66.65 -38.34 86.67 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.162 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.49 ' O ' ' CD1' ' A' ' 166' ' ' ILE . . . -60.97 -44.58 97.12 Favored 'General case' 0 C--O 1.21 -0.981 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -177.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.448 ' CD1' ' C ' ' A' ' 163' ' ' TYR . 20.6 t80 -61.5 -47.84 83.79 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.527 0.565 . . . . 0.0 112.527 -178.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -67.89 -45.39 74.57 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 117.881 2.549 . . . . 0.0 117.881 -172.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 41.7 p -63.38 -45.44 91.11 Favored 'General case' 0 CA--C 1.557 1.227 0 N-CA-C 117.294 2.331 . . . . 0.0 117.294 -175.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.562 ' H ' ' CD1' ' A' ' 166' ' ' ILE . 0.1 OUTLIER -64.68 -37.12 79.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 CA-C-O 121.655 0.741 . . . . 0.0 109.281 176.483 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.454 ' H ' HD13 ' A' ' 166' ' ' ILE . . . -59.07 -36.53 75.24 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 176.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 18.5 tpt85 -62.21 -50.09 73.16 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 122.998 2.635 . . . . 0.0 111.201 -176.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -74.77 -51.08 15.1 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 123.457 0.703 . . . . 0.0 109.593 177.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -78.24 -36.7 46.62 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 116.037 1.866 . . . . 0.0 116.037 -173.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 93.41 -168.21 29.36 Favored Glycine 0 N--CA 1.47 0.957 0 CA-C-N 118.674 0.67 . . . . 0.0 112.623 177.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 10.0 pt -73.52 -41.45 56.12 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.112 0 CA-C-O 121.944 0.878 . . . . 0.0 110.716 -179.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -58.47 -32.98 69.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 113.708 -1.587 . . . . 0.0 110.658 -176.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -60.33 -39.97 96.85 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 119.209 -1.472 . . . . 0.0 109.89 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 5.8 tp -69.49 -33.73 73.29 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 117.056 2.243 . . . . 0.0 117.056 -177.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 9.7 m0 -78.14 -7.62 57.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 111.244 -2.707 . . . . 0.0 109.826 -178.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -43.32 -47.86 6.77 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.327 -176.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -95.7 -36.33 5.35 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 123.936 0.779 . . . . 0.0 111.763 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.463 ' CG2' ' N ' ' A' ' 180' ' ' SER . 0.6 OUTLIER -45.4 -51.23 11.61 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -179.385 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' SER . . . . . 0.463 ' N ' ' CG2' ' A' ' 179' ' ' THR . 0.4 OUTLIER -62.9 -50.89 75.0 Favored Pre-proline 0 N--CA 1.473 0.687 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -176.666 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 180' ' ' SER . 32.6 Cg_endo -64.8 -28.42 59.38 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 121.683 1.588 . . . . 0.0 111.992 177.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -63.73 -39.87 95.35 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 120.266 -0.574 . . . . 0.0 109.967 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 75.6 t -63.45 -42.43 96.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.89 -39.04 90.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.216 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.25 -41.55 93.46 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.898 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -61.61 -42.87 99.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.732 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.32 -44.27 92.06 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 -178.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 3.5 tp -63.95 -45.18 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.882 -178.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.523 ' O ' ' N ' ' A' ' 193' ' ' GLU . 15.5 m -59.83 -45.86 94.39 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.362 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.436 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -62.39 -42.62 99.57 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.843 0.83 . . . . 0.0 109.915 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' CYS . . . . . . . . . . . . . 41.4 t -61.71 -45.8 92.4 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.384 -1.28 . . . . 0.0 109.249 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -63.86 -39.61 94.61 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 113.097 -1.865 . . . . 0.0 108.501 175.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 189' ' ' VAL . 36.6 tp10 -61.01 -46.28 91.4 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.962 -178.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.89 -39.64 93.84 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 118.844 -1.143 . . . . 0.0 110.225 -175.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 2.7 p -64.83 -46.43 91.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 116.693 -2.003 . . . . 0.0 107.853 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 96.3 m -64.11 -45.93 86.41 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.58 0.955 . . . . 0.0 113.58 -178.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -55.43 -37.99 68.4 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.716 1.606 . . . . 0.0 112.275 -176.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -55.86 -43.48 77.14 Favored 'General case' 0 C--N 1.312 -1.04 0 O-C-N 121.594 -0.691 . . . . 0.0 109.606 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 19.3 mt -61.31 -39.79 91.78 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -176.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.3 pt -63.49 -41.2 91.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-N 118.461 0.573 . . . . 0.0 111.304 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 10.3 mtpp -57.92 -37.58 74.33 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.935 1.694 . . . . 0.0 113.013 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -63.73 -38.59 91.67 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.889 -0.725 . . . . 0.0 111.039 -177.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.15 128.63 47.15 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 122.184 0.992 . . . . 0.0 111.579 -178.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 6.4 tp 67.18 3.9 3.41 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 113.233 -1.803 . . . . 0.0 111.726 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -125.11 26.97 6.8 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.488 0.661 . . . . 0.0 111.234 -178.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.25 -21.58 59.71 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.527 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.476 ' O ' ' O ' ' A' ' 208' ' ' ASN . . . -163.44 33.06 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.197 -1.365 . . . . 0.0 109.078 178.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' ASN . . . . . 0.476 ' O ' ' O ' ' A' ' 207' ' ' ALA . 12.3 p30 40.54 117.93 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 177.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.473 ' O ' ' O ' ' A' ' 208' ' ' ASN . 9.0 tp . . . . . 0 N--CA 1.473 0.689 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.292 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . 0.502 ' O ' ' SG ' ' A' ' 216' ' ' CYS . 14.9 m-20 . . . . . 0 N--CA 1.462 0.129 0 CA-C-O 120.945 0.402 . . . . 0.0 110.696 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.492 ' O ' ' ND1' ' A' ' 217' ' ' HIS . 13.6 mt -61.39 -44.13 91.68 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 214' ' ' LEU . 29.8 Cg_endo -61.34 -32.28 89.46 Favored 'Trans proline' 0 N--CA 1.501 1.954 0 CA-C-N 120.741 1.301 . . . . 0.0 112.406 -179.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' CYS . . . . . 0.525 ' SG ' ' N ' ' A' ' 217' ' ' HIS . 1.1 p -63.92 -42.44 97.39 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 113.827 -1.533 . . . . 0.0 111.824 -177.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' HIS . . . . . 0.622 ' CE1' ' CE2' ' A' ' 218' ' ' PHE . 3.5 p-80 -66.77 -37.43 84.58 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.425 -0.51 . . . . 0.0 112.163 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' PHE . . . . . 0.622 ' CE2' ' CE1' ' A' ' 217' ' ' HIS . 25.6 m-85 -63.08 -46.88 85.35 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.069 -178.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 10.1 m -60.14 -37.46 80.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 118.271 0.487 . . . . 0.0 110.709 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 217' ' ' HIS . 54.1 p -59.57 -41.56 90.48 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . 0.605 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.4 -41.63 98.76 Favored 'General case' 0 C--O 1.222 -0.381 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -177.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -61.73 -46.73 88.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 122.056 0.931 . . . . 0.0 113.031 -175.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -60.28 -41.98 98.58 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 107.237 -2.345 . . . . 0.0 107.237 177.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -63.06 -36.99 85.41 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 113.898 -1.151 . . . . 0.0 108.975 176.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . 0.605 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -61.03 -41.67 99.53 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-N 114.062 -1.426 . . . . 0.0 111.472 -176.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' PHE . . . . . 0.441 ' O ' ' OG1' ' A' ' 229' ' ' THR . 60.9 t80 -66.78 -38.26 86.19 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.347 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 94.4 m -63.27 -42.27 99.11 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -62.46 -39.74 94.36 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 120.813 0.339 . . . . 0.0 111.542 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' A' ' 226' ' ' PHE . 17.0 p -58.04 -38.8 76.95 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.068 -177.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 99.0 t -59.87 -40.78 83.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 119.224 -0.99 . . . . 0.0 108.635 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . 0.582 ' O ' ' HD2' ' A' ' 234' ' ' PRO . 1.3 mp -61.32 -39.69 83.56 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.573 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 176.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -61.39 -37.5 83.66 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.257 1.423 . . . . 0.0 114.331 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.468 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 1.4 m -56.31 -38.2 65.79 Favored Pre-proline 0 N--CA 1.48 1.053 0 N-CA-C 116.519 2.044 . . . . 0.0 116.519 -173.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . 0.582 ' HD2' ' O ' ' A' ' 231' ' ' ILE . 31.5 Cg_exo -57.97 -38.69 91.1 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 C-N-CA 122.739 2.293 . . . . 0.0 114.051 -175.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.4 m -63.02 -36.77 77.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 116.795 -1.962 . . . . 0.0 108.846 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -65.88 -40.71 91.84 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -64.9 -44.38 96.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -175.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 91.9 t . . . . . 0 C--N 1.319 -0.76 0 O-C-N 121.885 -0.51 . . . . 0.0 111.97 -177.526 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 60.0 p . . . . . 0 N--CA 1.462 0.159 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' MET . . . . . 0.464 ' SD ' ' C ' ' A' ' 260' ' ' MET . 1.9 tmt? -60.45 -43.86 96.45 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -176.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 33.2 tp -62.21 -46.42 88.98 Favored 'General case' 0 C--N 1.322 -0.624 0 O-C-N 122.029 -0.419 . . . . 0.0 110.413 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 5.2 tpm_? -66.11 -54.0 30.94 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.49 -178.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . 0.443 ' O ' ' O ' ' A' ' 260' ' ' MET . 23.0 pttm -115.36 162.86 16.54 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.114 0.483 . . . . 0.0 111.526 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . 0.498 ' O ' ' O ' ' A' ' 265' ' ' GLY . 70.0 mm-40 56.5 85.06 0.08 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.679 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . 0.498 ' O ' ' O ' ' A' ' 264' ' ' GLU . . . -43.28 177.36 0.01 OUTLIER Glycine 0 CA--C 1.532 1.12 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -68.17 -8.79 23.83 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.301 2.001 . . . . 0.0 111.216 177.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 34.6 ptt-85 -69.72 -26.81 64.52 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 122.978 0.511 . . . . 0.0 111.853 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -58.55 -32.44 68.89 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.711 -0.796 . . . . 0.0 109.287 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -62.06 -41.55 98.27 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.157 177.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -65.66 -37.31 86.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.433 -178.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.446 ' O ' ' O ' ' A' ' 272' ' ' GLY . 54.5 tttp -82.78 171.98 13.36 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 177.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 271' ' ' LYS . . . 48.76 99.44 0.01 OUTLIER Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -171.42 12.09 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.055 0.455 . . . . 0.0 110.496 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' MET . . . . . 0.592 ' SD ' ' N ' ' A' ' 275' ' ' PRO 0.25 0.0 OUTLIER -63.49 -40.36 57.66 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.81 179.372 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' PRO . . . . . 0.592 ' N ' ' SD ' ' A' ' 274' ' ' MET . 16.6 Cg_exo -63.55 -46.38 9.43 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 121.453 1.435 . . . . 0.0 111.197 -176.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 3.1 m -60.43 -39.88 89.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.657 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -61.99 -42.96 99.72 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 123.079 1.418 . . . . 0.0 112.145 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 84.8 mt -62.28 -38.68 90.28 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 111.59 -2.55 . . . . 0.0 108.151 174.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 -63.01 -39.45 94.8 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.314 0.578 . . . . 0.0 110.527 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 1.1 tt -61.76 -36.88 82.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.028 -0.987 . . . . 0.0 112.489 -177.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -68.3 -51.51 32.08 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' SER . . . . . 0.466 ' OG ' ' CD1' ' A' ' 34' ' ' LEU . 5.6 t -63.35 -44.5 94.67 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 123.566 0.747 . . . . 0.0 110.349 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' TRP . . . . . . . . . . . . . 79.4 t90 -59.9 -37.82 80.51 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.922 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . 0.472 ' C ' ' ND2' ' A' ' 284' ' ' ASN . 0.4 OUTLIER -61.47 -37.94 85.47 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.18 -179.313 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -60.86 -37.69 77.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 O-C-N 121.95 -0.468 . . . . 0.0 111.778 -179.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -61.93 -41.14 89.72 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.661 -177.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -61.78 -38.16 87.0 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 121.488 -0.758 . . . . 0.0 109.757 178.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -58.49 -40.62 83.28 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.265 -0.88 . . . . 0.0 112.982 -178.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 27.0 m -60.76 -38.53 79.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 119.974 -0.69 . . . . 0.0 110.984 -178.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 16.8 m -62.54 -40.25 96.21 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -60.85 -38.84 86.93 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 177.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.45 -40.49 82.73 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 117.706 -1.597 . . . . 0.0 109.527 -176.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' GLN . . . . . 0.473 ' O ' ' O ' ' A' ' 296' ' ' ARG . 56.9 tt0 -60.45 -42.9 97.08 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 122.595 1.188 . . . . 0.0 110.971 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 10.3 mp -60.32 -40.65 91.34 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 113.119 -1.855 . . . . 0.0 108.79 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -63.27 -45.91 89.25 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.322 178.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' ARG . . . . . 0.473 ' O ' ' O ' ' A' ' 293' ' ' GLN . 27.6 mmm-85 -123.03 116.16 23.06 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -121.41 -164.09 1.1 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.022 0.439 . . . . 0.0 112.179 -178.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.537 ' CD1' ' H ' ' A' ' 298' ' ' LEU . 0.0 OUTLIER -64.77 -173.96 0.12 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 177.276 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 9.2 ttt -169.15 66.99 0.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 119.236 -0.986 . . . . 0.0 112.832 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.59 100.86 0.07 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.825 0.821 . . . . 0.0 110.534 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -64.08 -46.2 85.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.107 -1.406 . . . . 0.0 113.479 -176.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . 0.525 ' CD2' ' OE1' ' A' ' 306' ' ' GLU . 49.0 t80 -58.8 -39.94 82.62 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 119.706 -0.798 . . . . 0.0 109.563 -178.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -65.26 -46.88 78.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.219 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' SER . . . . . 0.446 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 38.9 t -66.58 -37.67 85.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.796 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 -61.67 -42.8 99.42 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . 0.525 ' OE1' ' CD2' ' A' ' 302' ' ' TYR . 41.4 mt-10 -64.87 -37.08 86.42 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -177.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -60.06 -53.01 69.36 Favored Pre-proline 0 CA--C 1.544 0.743 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -176.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' PRO . . . . . 0.446 ' CD ' ' O ' ' A' ' 304' ' ' SER . 73.6 Cg_endo -75.15 0.17 9.29 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.283 1.988 . . . . 0.0 111.948 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 55.0 t80 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.574 -179.894 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.7 p . . . . . 0 C--O 1.233 0.185 0 CA-C-O 120.639 0.257 . . . . 0.0 110.4 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.483 ' CG2' ' H ' ' A' ' 16' ' ' LYS . 12.4 p -148.37 171.44 2.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.002 0.43 . . . . 0.0 110.64 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.483 ' H ' ' CG2' ' A' ' 15' ' ' VAL . 4.6 mtmp? -64.29 -41.41 96.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.972 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -63.43 -41.56 98.68 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -178.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 57.5 tp -79.9 -26.33 40.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.148 0.499 . . . . 0.0 111.932 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.452 ' O ' ' OG1' ' A' ' 22' ' ' THR . . . -66.07 -41.33 95.16 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 107.595 -2.202 . . . . 0.0 107.595 177.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.47 -32.24 68.06 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 124.803 2.239 . . . . 0.0 107.54 176.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.5 -42.49 98.93 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-N 108.51 -3.95 . . . . 0.0 108.243 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' A' ' 19' ' ' GLY . 22.2 p -70.63 -27.41 64.04 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.503 0.668 . . . . 0.0 109.248 177.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.51 -50.05 64.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.676 -1.147 . . . . 0.0 112.128 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.78 -35.96 79.66 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 118.529 -1.268 . . . . 0.0 111.241 -177.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 68.5 m -63.64 -53.69 47.52 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.24 -178.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.4 pt -65.47 -39.63 85.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -177.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.11 -42.04 97.02 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 119.78 -0.768 . . . . 0.0 112.79 -173.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 32' ' ' PHE . 3.2 m-20 -77.89 -27.28 49.57 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 118.068 -1.453 . . . . 0.0 109.407 -176.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 15.7 mt -60.41 -56.22 24.12 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 120.159 1.345 . . . . 0.0 111.703 -178.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.489 ' CD1' ' N ' ' A' ' 30' ' ' ILE . 2.5 mp -76.23 -5.09 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 120.076 -0.649 . . . . 0.0 112.293 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 26.3 m -110.33 -17.98 13.37 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 117.656 -1.164 . . . . 0.0 109.71 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.517 ' N ' ' O ' ' A' ' 28' ' ' ASP . 11.4 t80 -67.88 -43.44 37.63 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 122.379 2.354 . . . . 0.0 110.009 -177.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.457 ' CD ' ' N ' ' A' ' 32' ' ' PHE . 38.1 Cg_exo -58.55 -14.68 22.0 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 121.239 1.293 . . . . 0.0 110.949 177.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.5 tp -66.92 -35.59 80.35 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -177.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -64.42 -40.65 96.17 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -177.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.401 ' CG2' ' O ' ' A' ' 33' ' ' PRO . 0.3 OUTLIER -58.39 -33.78 70.0 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.13 -38.77 86.12 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.455 ' NZ ' ' CB ' ' A' ' 38' ' ' LYS . 0.1 OUTLIER -61.67 -47.54 84.87 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 119.415 -0.914 . . . . 0.0 111.734 -176.768 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.2 t -62.2 -38.37 80.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -175.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.554 ' C ' ' H ' ' A' ' 42' ' ' GLN . 45.5 mtp85 -59.5 -41.08 89.05 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 119.236 -0.985 . . . . 0.0 110.049 -179.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -62.38 38.67 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.066 178.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.554 ' H ' ' C ' ' A' ' 40' ' ' ARG . 0.7 OUTLIER -94.57 5.11 52.81 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 121.959 -0.463 . . . . 0.0 111.187 -179.437 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.425 ' O ' ' O ' ' A' ' 42' ' ' GLN . 7.6 mm 60.28 147.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -53.14 105.25 0.12 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.873 0.368 . . . . 0.0 110.438 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.92 50.88 0.37 Allowed Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.981 -0.847 . . . . 0.0 110.981 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.47 ' H ' ' CG2' ' A' ' 51' ' ' VAL . 72.1 mm-40 -73.1 -8.68 56.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.778 0.323 . . . . 0.0 110.674 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.54 ' C ' ' H ' ' A' ' 49' ' ' GLY . 3.6 m 61.42 -159.57 0.32 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.723 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 38.7 tp60 66.4 -7.39 0.43 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.142 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.54 ' H ' ' C ' ' A' ' 47' ' ' SER . . . 84.17 3.53 88.84 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -178.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.463 ' O ' ' OG1' ' A' ' 53' ' ' THR . 0.2 OUTLIER -66.61 -38.12 86.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.538 0.685 . . . . 0.0 109.769 178.487 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.47 ' CG2' ' H ' ' A' ' 46' ' ' GLU . 54.6 t -60.74 -44.97 98.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.319 -178.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.96 -34.72 79.09 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.275 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' A' ' 50' ' ' LEU . 19.6 p -68.68 -38.25 80.2 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.115 0.483 . . . . 0.0 110.052 178.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -92.88 -159.77 0.7 Allowed 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.868 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -169.78 -40.19 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.171 -0.611 . . . . 0.0 111.831 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.525 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 87.6 p -126.91 -139.58 0.26 Allowed 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 56' ' ' SER . . . 92.87 14.64 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 O-C-N 123.813 0.696 . . . . 0.0 111.81 178.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 90.6 mm-40 -155.45 52.43 0.59 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -41.39 145.43 0.26 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.381 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.418 ' O ' ' C ' ' A' ' 61' ' ' GLY . 62.7 ttp180 -49.8 -44.62 49.23 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 60' ' ' ARG . . . -28.52 101.54 0.01 OUTLIER Glycine 0 CA--C 1.53 0.995 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.7 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.5 p -67.54 -33.97 65.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.34 176.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.25 -32.37 71.08 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 121.165 1.802 . . . . 0.0 109.436 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.32 -49.22 67.14 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 114.832 -1.077 . . . . 0.0 115.062 -176.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 94.6 m -61.9 -46.32 89.87 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 33.7 mm -59.57 -35.49 59.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 76.8 mt -63.19 -35.82 81.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 121.028 1.74 . . . . 0.0 111.506 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.437 ' O ' ' OG1' ' A' ' 72' ' ' THR . 99.4 m -62.47 -38.8 91.24 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 113.219 -1.81 . . . . 0.0 111.053 -177.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 27.8 ttt -60.73 -40.02 90.79 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 -177.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.1 m -69.07 -39.81 80.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 119.612 -0.835 . . . . 0.0 112.375 -178.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -77.42 -12.76 59.99 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 122.182 0.991 . . . . 0.0 113.217 -177.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.437 ' OG1' ' O ' ' A' ' 68' ' ' THR . 33.5 m -62.5 -55.12 30.47 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 113.927 -1.488 . . . . 0.0 112.762 -179.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -113.6 5.24 16.47 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 123.036 1.398 . . . . 0.0 109.466 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.443 ' O ' ' OG ' ' A' ' 77' ' ' SER . . . 96.46 170.92 34.67 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-N 111.598 -2.546 . . . . 0.0 110.783 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -56.4 -34.47 94.47 Favored 'Trans proline' 0 N--CA 1.5 1.909 0 C-N-CA 122.518 2.145 . . . . 0.0 111.682 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.425 ' O ' ' CB ' ' A' ' 80' ' ' ASN . 1.7 mpt_? -61.01 -10.53 6.03 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.796 0.807 . . . . 0.0 111.093 176.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 74' ' ' GLY . 81.3 p -77.24 -32.35 55.71 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.168 -1.378 . . . . 0.0 111.231 -177.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.2 tt -75.9 -34.15 59.94 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.297 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -93.76 -5.98 47.1 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 122.022 0.915 . . . . 0.0 113.013 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.425 ' CB ' ' O ' ' A' ' 76' ' ' ARG . 4.2 t30 -81.23 124.69 29.51 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 113.802 -1.545 . . . . 0.0 107.625 176.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.99 0.67 71.12 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 109.696 -1.361 . . . . 0.0 109.696 -178.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 45.3 tp -59.43 -35.33 73.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 113.477 -1.361 . . . . 0.0 110.955 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.8 p -70.76 -26.99 29.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.563 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.8 -31.65 61.79 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.512 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -68.14 -40.79 87.97 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 119.489 -1.338 . . . . 0.0 111.389 -177.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.532 ' O ' ' SD ' ' A' ' 90' ' ' MET . 75.7 mt -62.59 -40.53 97.2 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 122.311 1.053 . . . . 0.0 112.587 -176.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -59.51 -26.22 65.13 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 113.324 -1.762 . . . . 0.0 108.944 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 18.3 ttm180 -57.06 -52.88 63.53 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 113.335 -1.757 . . . . 0.0 106.645 173.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.402 HE22 ' CG ' ' A' ' 28' ' ' ASP . 9.8 tp-100 -67.39 -30.19 69.9 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 112.857 -1.974 . . . . 0.0 113.247 -177.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.552 ' N ' ' SD ' ' A' ' 90' ' ' MET . 0.0 OUTLIER -61.02 -40.9 95.33 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.357 -179.489 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 68.7 p -74.53 -34.5 63.02 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 119.382 -0.927 . . . . 0.0 111.409 -176.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -57.86 -44.41 86.59 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-N 121.041 1.746 . . . . 0.0 111.616 -176.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.76 -33.17 64.16 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.691 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.48 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 24.3 p -64.18 -42.07 96.84 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.455 ' C ' ' H ' ' A' ' 97' ' ' ILE . 34.5 m -68.16 -27.74 38.3 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.839 177.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.444 ' O ' ' CD1' ' A' ' 100' ' ' TYR . 49.1 ttm-85 -77.21 9.24 3.23 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 -177.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.48 ' CG2' ' O ' ' A' ' 94' ' ' SER . 11.0 tt -87.12 -15.58 9.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 178.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -140.61 -48.03 0.05 OUTLIER Glycine 0 CA--C 1.538 1.499 0 N-CA-C 115.653 1.021 . . . . 0.0 115.653 -176.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.481 ' CD1' ' N ' ' A' ' 99' ' ' LEU . 9.4 mp -71.18 -12.7 61.62 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.927 1.363 . . . . 0.0 112.521 -178.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.597 ' CD1' ' N ' ' A' ' 101' ' ' ASP . 0.1 OUTLIER -80.46 -50.76 9.64 Favored 'General case' 0 C--O 1.214 -0.792 0 CA-C-N 114.382 -1.281 . . . . 0.0 111.563 -179.623 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 1.072 ' OD1' ' NE2' ' A' ' 105' ' ' GLN . 28.5 t70 -68.14 -31.2 70.61 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 122.857 1.313 . . . . 0.0 109.446 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.2 t -68.61 -53.42 22.8 Favored 'General case' 0 CA--C 1.554 1.134 0 CA-C-N 112.227 -2.26 . . . . 0.0 113.393 176.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -75.59 -28.22 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 CA-C-N 123.34 2.791 . . . . 0.0 115.708 -178.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.436 ' HZ1' ' HB2' ' A' ' 100' ' ' TYR . 18.8 mttt -69.33 -42.3 75.52 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 111.169 -2.741 . . . . 0.0 112.888 -178.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 1.072 ' NE2' ' OD1' ' A' ' 101' ' ' ASP . 88.1 mt-30 -78.97 -10.11 59.73 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 124.225 1.964 . . . . 0.0 111.063 177.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -78.97 -22.45 45.6 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 112.273 -2.24 . . . . 0.0 111.358 177.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.467 ' CZ ' ' OD1' ' A' ' 190' ' ' ASN . 27.5 m-85 -109.3 -30.84 7.8 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 119.637 1.108 . . . . 0.0 111.995 -175.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.9 t -98.66 9.27 43.66 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 117.275 -1.77 . . . . 0.0 112.796 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.512 ' O ' ' C ' ' A' ' 110' ' ' GLY . 0.0 OUTLIER -50.49 122.06 6.58 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 118.395 -0.812 . . . . 0.0 110.948 -179.733 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.518 ' O ' ' CB ' ' A' ' 111' ' ' SER . . . -22.5 -78.83 0.01 OUTLIER Glycine 0 N--CA 1.487 2.066 0 CA-C-N 119.124 0.875 . . . . 0.0 111.73 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 110' ' ' GLY . 5.9 p 94.33 -156.36 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 175.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.431 ' C ' ' H ' ' A' ' 114' ' ' ALA . 76.6 mt-10 -120.45 172.55 7.74 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 114.398 -1.274 . . . . 0.0 111.556 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.453 ' O ' ' CB ' ' A' ' 114' ' ' ALA . 45.1 p-80 -63.81 48.59 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.498 -179.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.453 ' CB ' ' O ' ' A' ' 113' ' ' HIS . . . 159.06 -162.2 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.2 14.98 27.0 Favored Glycine 0 N--CA 1.464 0.514 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.298 177.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 24.0 mm -60.72 -40.45 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.08 -39.41 96.29 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 122.066 0.814 . . . . 0.0 111.67 176.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 7.6 t -58.08 -42.09 84.82 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 177.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.657 HH12 ' HZ1' ' A' ' 201' ' ' LYS . 99.5 mtt180 -63.17 -37.23 86.41 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.227 -177.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 92.5 mt -63.59 -46.01 87.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.256 0.551 . . . . 0.0 109.823 178.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 56.2 mt -66.82 -44.79 80.24 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.391 178.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.11 -45.16 89.85 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 119.876 1.216 . . . . 0.0 110.257 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -65.75 -44.07 92.95 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 120.184 -1.008 . . . . 0.0 111.299 -179.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.4 t -63.93 -43.85 94.63 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.692 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 19.1 m -69.34 -48.32 61.72 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 119.118 -1.033 . . . . 0.0 112.075 177.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.427 ' CG2' ' N ' ' A' ' 127' ' ' GLY . 5.5 t -65.57 -42.74 91.45 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 -174.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.427 ' N ' ' CG2' ' A' ' 126' ' ' THR . . . -64.19 -44.48 95.58 Favored Glycine 0 CA--C 1.52 0.396 0 CA-C-O 122.73 1.183 . . . . 0.0 112.95 -177.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.405 ' O ' ' CG1' ' A' ' 131' ' ' VAL . . . -60.81 -41.35 95.53 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 112.178 -2.011 . . . . 0.0 106.492 177.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 15.1 tp -64.44 -42.25 96.09 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.773 178.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.11 -39.92 96.1 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -177.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.405 ' CG1' ' O ' ' A' ' 128' ' ' ALA . 3.3 p -60.9 -24.81 33.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 122.577 1.18 . . . . 0.0 109.265 178.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -57.74 -44.85 86.36 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 112.709 -2.041 . . . . 0.0 111.727 -178.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.485 ' CG1' ' N ' ' A' ' 134' ' ' ALA . 3.0 p -79.17 -48.98 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.13 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.485 ' N ' ' CG1' ' A' ' 133' ' ' VAL . . . -103.29 128.78 50.23 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.257 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.474 ' N ' ' HD2' ' A' ' 136' ' ' PRO . 27.3 tt0 -179.58 -50.32 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.718 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 135' ' ' GLN . 11.2 Cg_endo -51.79 -33.89 52.38 Favored 'Trans proline' 0 N--CA 1.499 1.849 0 C-N-CA 121.545 1.497 . . . . 0.0 114.221 -177.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 41.4 p -67.36 -41.71 84.67 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 118.183 -1.407 . . . . 0.0 108.42 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -64.43 -42.26 96.11 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.104 -1.038 . . . . 0.0 111.053 -178.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 88.5 t -63.57 -43.43 98.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.176 0.513 . . . . 0.0 111.07 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 53.8 t -64.32 -38.44 82.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.807 -178.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -61.55 -40.58 95.2 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.206 -0.598 . . . . 0.0 111.854 -177.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 97.6 t -69.52 -44.86 79.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.307 0.575 . . . . 0.0 109.66 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.4 -35.74 81.9 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.545 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -66.13 -40.76 90.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 112.166 -177.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 4.0 tm0? -64.67 -39.52 93.82 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.08 -1.048 . . . . 0.0 109.841 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.08 -34.93 79.59 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -177.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.419 ' C ' ' OE1' ' A' ' 147' ' ' GLN . 0.0 OUTLIER -59.36 111.41 1.36 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.417 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -96.42 -62.18 1.31 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 117.777 -1.106 . . . . 0.0 113.828 -176.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -62.02 126.7 28.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 122.481 2.4 . . . . 0.0 110.474 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -55.92 -49.43 73.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.664 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 152.94 155.32 7.07 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.666 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -179.963 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.423 ' O ' ' O ' ' A' ' 157' ' ' GLN . 11.0 t80 . . . . . 0 N--CA 1.463 0.196 0 CA-C-O 120.735 0.302 . . . . 0.0 111.01 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.423 ' O ' ' O ' ' A' ' 156' ' ' TYR . 34.3 mt-30 49.67 176.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.992 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 25.7 t -157.05 -177.66 6.78 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.307 0.575 . . . . 0.0 110.883 -179.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 9.2 t -63.98 -45.86 87.2 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.675 -177.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 87.2 t -63.81 -45.17 97.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 119.063 -1.055 . . . . 0.0 108.721 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -67.28 -39.16 85.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.725 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -61.67 -45.87 92.16 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -177.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.438 ' CD1' ' C ' ' A' ' 163' ' ' TYR . 12.5 t80 -62.47 -50.12 72.69 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.06 -179.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -68.2 -45.51 73.16 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -175.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 18.8 m -62.65 -44.73 95.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 119.433 1.015 . . . . 0.0 113.142 -177.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 47.3 mm -64.63 -38.63 83.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-O 121.968 0.89 . . . . 0.0 109.6 176.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.7 -36.31 76.24 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 113.787 -1.551 . . . . 0.0 108.059 176.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 32.2 mmm-85 -62.13 -50.31 72.42 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 122.2 2.273 . . . . 0.0 111.97 -175.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -75.05 -50.92 14.89 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 123.471 0.708 . . . . 0.0 109.113 177.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -78.07 -36.51 48.19 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 -173.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 91.28 -167.32 31.36 Favored Glycine 0 N--CA 1.469 0.836 0 CA-C-N 118.29 0.496 . . . . 0.0 111.945 177.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 6.3 pt -72.83 -43.26 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 CA-C-O 121.643 0.735 . . . . 0.0 110.414 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -58.88 -33.65 70.73 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.336 -1.302 . . . . 0.0 111.143 -177.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -60.96 -40.64 98.72 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 118.528 -1.796 . . . . 0.0 109.396 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.72 -34.14 71.59 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 111.134 -2.533 . . . . 0.0 117.065 -177.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . 0.528 ' CE2' ' OG ' ' A' ' 180' ' ' SER . 55.7 t90 -78.08 -8.77 58.65 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 111.779 -2.464 . . . . 0.0 110.949 -176.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -44.57 -48.96 10.33 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 114.679 1.362 . . . . 0.0 114.679 -175.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -102.99 -37.96 3.02 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 124.206 0.908 . . . . 0.0 113.528 -177.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.446 ' CG2' ' N ' ' A' ' 180' ' ' SER . 0.9 OUTLIER -45.19 -50.98 11.1 Favored 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -178.925 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' SER . . . . . 0.528 ' OG ' ' CE2' ' A' ' 176' ' ' TRP . 0.0 OUTLIER -62.64 -50.43 78.26 Favored Pre-proline 0 N--CA 1.48 1.026 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -177.0 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.428 ' HD2' ' N ' ' A' ' 180' ' ' SER . 25.8 Cg_endo -63.83 -26.97 67.46 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.196 1.931 . . . . 0.0 111.265 177.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 18.0 t30 -62.7 -38.08 89.04 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 39.8 t -62.08 -41.34 90.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.12 -38.69 87.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.746 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 60.3 ttt85 -60.23 -41.15 92.51 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.717 -0.393 . . . . 0.0 109.944 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -60.92 -42.23 97.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.248 0.547 . . . . 0.0 110.463 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . 0.452 ' O ' ' SG ' ' A' ' 191' ' ' CYS . . . -63.8 -42.93 97.61 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.433 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 96.4 mt -62.85 -44.85 99.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -177.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 6.1 m -59.66 -45.8 93.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 119.854 -0.738 . . . . 0.0 110.875 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . 0.467 ' OD1' ' CZ ' ' A' ' 107' ' ' TYR . 53.1 t30 -62.08 -43.55 98.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 122.069 0.937 . . . . 0.0 109.892 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' CYS . . . . . 0.452 ' SG ' ' O ' ' A' ' 187' ' ' ALA . 79.3 m -62.59 -47.02 85.62 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 113.902 -1.499 . . . . 0.0 110.625 178.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.31 -40.69 96.42 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 114.018 -1.446 . . . . 0.0 109.929 177.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -61.1 -45.49 94.51 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.337 -1.302 . . . . 0.0 112.611 -178.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 1.4 tt -63.22 -37.4 87.09 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 118.676 -1.21 . . . . 0.0 108.262 -175.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 66.1 t -62.74 -46.19 96.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 C-N-CA 117.391 -1.723 . . . . 0.0 107.076 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 14.7 m -64.27 -46.37 84.0 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 113.712 1.005 . . . . 0.0 113.712 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -57.36 -39.16 75.4 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.639 1.176 . . . . 0.0 113.27 -177.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -55.63 -44.64 77.29 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -178.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 8.8 mp -61.46 -39.23 90.12 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.881 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 1.7 mp -63.38 -43.64 98.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-O 118.333 -0.842 . . . . 0.0 111.366 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . 0.657 ' HZ1' HH12 ' A' ' 119' ' ' ARG . 53.4 mtmt -60.59 -41.3 94.41 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 121.154 1.797 . . . . 0.0 111.237 177.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -65.33 -36.67 84.73 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 113.11 -1.859 . . . . 0.0 110.965 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 54.7 m -101.92 129.91 48.28 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.691 0.758 . . . . 0.0 111.892 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 68.37 5.19 4.61 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 114.615 -1.175 . . . . 0.0 112.192 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.518 ' O ' ' O ' ' A' ' 201' ' ' LYS . 1.7 tt -148.05 74.1 1.28 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.656 0.741 . . . . 0.0 110.523 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.35 -17.97 17.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.083 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.569 ' O ' ' CG ' ' A' ' 208' ' ' ASN . . . -170.72 18.98 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.573 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' ASN . . . . . 0.572 ' OD1' ' N ' ' A' ' 209' ' ' LEU . 44.3 p30 115.46 -140.24 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.093 0 O-C-N 125.636 1.835 . . . . 0.0 109.679 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.572 ' N ' ' OD1' ' A' ' 208' ' ' ASN . 13.6 tp . . . . . 0 C--N 1.331 -0.223 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 . . . . . 0 N--CA 1.459 -0.017 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.442 ' N ' ' CD ' ' A' ' 215' ' ' PRO . 3.3 mt -61.14 -43.74 91.53 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.158 -178.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 214' ' ' LEU . 32.3 Cg_exo -60.5 -32.97 94.29 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 121.21 1.273 . . . . 0.0 111.469 -179.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 76.2 m -64.05 -42.0 97.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 113.322 -1.763 . . . . 0.0 111.611 -178.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' HIS . . . . . 0.422 ' O ' ' OG ' ' A' ' 220' ' ' SER . 8.3 t-160 -66.53 -37.89 85.98 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.4 -0.52 . . . . 0.0 111.987 -178.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -63.42 -46.93 84.05 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.803 -178.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 1.5 t -60.13 -37.49 80.24 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 118.94 0.791 . . . . 0.0 111.064 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' A' ' 217' ' ' HIS . 82.5 p -59.38 -41.28 88.98 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.42 -41.6 98.7 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -177.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -61.46 -46.97 87.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 122.133 0.968 . . . . 0.0 112.387 -176.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -60.5 -41.65 98.76 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 107.361 -2.296 . . . . 0.0 107.361 177.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -62.72 -38.33 90.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.45 -0.875 . . . . 0.0 108.717 177.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -62.04 -42.45 99.73 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -178.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -66.9 -38.36 86.11 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 63.5 m -63.24 -41.28 99.07 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.179 177.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' THR . . . . . 0.462 ' OG1' ' O ' ' A' ' 225' ' ' GLY . 53.2 p -61.89 -40.17 94.51 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.494 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 39.5 m -59.58 -40.46 87.47 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.644 -177.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 95.3 t -61.58 -42.73 95.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 119.245 -0.982 . . . . 0.0 112.318 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . 0.493 ' O ' ' HD2' ' A' ' 234' ' ' PRO . 12.8 pt -62.67 -40.65 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 119.895 -0.722 . . . . 0.0 109.383 177.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -62.78 -39.35 93.92 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.472 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 0.0 OUTLIER -58.44 -42.45 94.7 Favored Pre-proline 0 N--CA 1.481 1.094 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -173.327 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . 0.493 ' HD2' ' O ' ' A' ' 231' ' ' ILE . 32.5 Cg_exo -58.77 -41.05 66.99 Favored 'Trans proline' 0 C--N 1.294 -2.304 0 C-N-CA 122.059 1.84 . . . . 0.0 113.654 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 6.9 m -65.99 -37.42 79.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 118.507 -1.277 . . . . 0.0 111.149 178.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -65.54 -41.45 93.05 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -178.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 16.1 m -65.24 -44.86 95.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -176.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 60.3 t . . . . . 0 C--N 1.327 -0.403 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.268 -177.334 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 70.0 p . . . . . 0 N--CA 1.466 0.34 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' MET . . . . . 0.56 ' SD ' ' N ' ' A' ' 261' ' ' LEU . 0.0 OUTLIER -62.47 -43.85 97.83 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.232 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.56 ' N ' ' SD ' ' A' ' 260' ' ' MET . 7.0 tp -62.13 -46.57 88.44 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 122.792 0.437 . . . . 0.0 111.093 -178.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 13.6 tpp85 -66.0 -53.81 34.06 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.868 -178.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -91.16 -122.07 0.07 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.735 0.303 . . . . 0.0 111.595 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . 0.494 ' O ' ' O ' ' A' ' 265' ' ' GLY . 58.0 mt-10 -30.57 107.45 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -178.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 264' ' ' GLU . . . -41.38 175.07 0.01 OUTLIER Glycine 0 CA--C 1.533 1.173 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 178.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -68.73 -9.1 25.22 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 122.835 2.357 . . . . 0.0 111.483 177.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 82.6 mtt85 -69.43 -26.61 64.7 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.122 0.569 . . . . 0.0 112.087 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -58.31 -32.07 68.12 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.392 -179.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -61.99 -41.9 98.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.245 0.545 . . . . 0.0 110.547 177.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -66.15 -37.89 86.77 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.194 -178.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.444 ' O ' ' O ' ' A' ' 272' ' ' GLY . 62.7 mmtt -73.17 -173.75 1.39 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 271' ' ' LYS . . . 48.69 103.87 0.01 OUTLIER Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -170.46 1.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.449 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' MET . . . . . 0.568 ' N ' ' CD ' ' A' ' 275' ' ' PRO . 0.5 OUTLIER -63.97 -44.53 78.7 Favored Pre-proline 0 CA--C 1.532 0.268 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.869 -179.555 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 274' ' ' MET . 21.5 Cg_exo -64.68 -46.67 6.47 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.44 2.093 . . . . 0.0 110.947 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 51.0 m -60.76 -39.51 89.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.287 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -61.75 -42.76 99.4 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 122.878 1.323 . . . . 0.0 112.814 -178.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 8.5 tp -62.29 -38.79 90.73 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 111.853 -2.43 . . . . 0.0 108.138 174.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 16.2 mmm180 -62.73 -39.49 94.24 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.438 0.637 . . . . 0.0 110.326 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 22.3 tp -61.97 -36.61 81.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.974 -1.012 . . . . 0.0 113.028 -177.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -68.24 -51.34 33.34 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 14.0 p -63.07 -44.43 95.81 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.268 0.627 . . . . 0.0 109.883 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' TRP . . . . . . . . . . . . . 62.7 t90 -60.06 -37.99 81.52 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -61.83 -37.41 84.36 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.587 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -59.88 -37.45 71.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.222 -178.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -61.86 -40.02 85.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 120.234 -0.587 . . . . 0.0 109.755 -179.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 16.6 mmt -61.51 -39.59 91.55 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.849 0.357 . . . . 0.0 110.66 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -59.63 -41.95 91.62 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -178.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 3.1 p -61.82 -38.62 80.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 O-C-N 121.854 -0.529 . . . . 0.0 111.279 -178.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 10.3 m -62.58 -40.73 97.83 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -61.27 -38.85 88.25 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 176.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -58.28 -40.45 81.95 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 117.867 -1.533 . . . . 0.0 109.616 -176.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' GLN . . . . . 0.48 ' O ' ' O ' ' A' ' 296' ' ' ARG . 75.7 mt-30 -60.75 -43.13 98.37 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 122.554 1.169 . . . . 0.0 111.293 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 9.3 mp -60.8 -40.66 93.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 113.382 -1.736 . . . . 0.0 109.1 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -63.39 -45.96 88.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.047 178.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' ARG . . . . . 0.48 ' O ' ' O ' ' A' ' 293' ' ' GLN . 16.4 tpp180 -123.22 116.02 22.7 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.299 -0.864 . . . . 0.0 108.873 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -122.24 -163.5 1.08 Allowed 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -178.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.517 ' CD2' ' N ' ' A' ' 298' ' ' LEU . 3.3 mm? -63.54 -175.65 0.13 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 176.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 21.8 ttt -166.55 64.47 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 119.614 -0.835 . . . . 0.0 112.371 -178.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . 0.428 ' CB ' ' OE1' ' A' ' 303' ' ' GLN . . . -175.6 100.85 0.07 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 122.079 0.943 . . . . 0.0 110.52 -178.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -64.18 -46.34 84.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 113.545 -1.661 . . . . 0.0 113.351 -176.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -58.57 -39.62 80.82 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.014 -177.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' GLN . . . . . 0.428 ' OE1' ' CB ' ' A' ' 300' ' ' ALA . 47.0 mt-30 -64.9 -46.93 79.65 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.71 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' SER . . . . . 0.433 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 15.5 m -66.79 -38.05 85.77 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.064 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 65.2 mtt-85 -61.81 -42.61 99.23 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.017 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 10.6 tm-20 -64.75 -36.9 85.81 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -177.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -60.12 -53.12 68.2 Favored Pre-proline 0 CA--C 1.544 0.717 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -176.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' PRO . . . . . 0.433 ' CD ' ' O ' ' A' ' 304' ' ' SER . 73.7 Cg_endo -75.35 0.25 9.27 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.199 1.933 . . . . 0.0 111.955 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 54.2 t80 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.558 -179.841 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.5 m . . . . . 0 C--O 1.23 0.042 0 CA-C-O 120.773 0.32 . . . . 0.0 110.617 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.501 ' CG2' ' H ' ' A' ' 16' ' ' LYS . 8.0 p -156.54 175.45 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.404 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.501 ' H ' ' CG2' ' A' ' 15' ' ' VAL . 54.3 tttp -64.3 -41.34 96.91 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.951 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -63.58 -41.77 98.34 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 44.5 tp -79.8 -26.48 40.54 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.921 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.46 ' O ' ' OG1' ' A' ' 22' ' ' THR . . . -66.32 -41.26 94.68 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 107.615 -2.194 . . . . 0.0 107.615 177.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.39 -32.22 68.19 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 124.811 2.243 . . . . 0.0 107.467 176.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.55 -42.38 98.9 Favored Glycine 0 CA--C 1.528 0.845 1 CA-C-N 108.399 -4.001 . . . . 0.0 108.242 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.46 ' OG1' ' O ' ' A' ' 19' ' ' GLY . 22.2 p -70.68 -27.55 64.09 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.54 0.686 . . . . 0.0 109.225 177.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.48 -50.1 64.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.875 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.79 -35.98 79.76 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 118.46 -1.296 . . . . 0.0 111.253 -177.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 79.2 m -63.9 -53.77 45.25 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.339 -178.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.8 tt -65.64 -39.59 85.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 -177.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.92 -41.93 97.53 Favored 'General case' 0 C--O 1.224 -0.273 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -173.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 28' ' ' ASP . 3.8 t70 -77.78 -26.94 50.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 120.345 1.429 . . . . 0.0 110.078 -175.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 45.6 mt -59.86 -55.12 38.1 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 119.841 1.201 . . . . 0.0 112.332 -178.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.0 pt -75.47 -4.31 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -109.68 -17.59 13.66 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 118.54 -1.264 . . . . 0.0 110.253 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -68.08 -44.33 38.39 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 122.046 2.203 . . . . 0.0 110.779 -177.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -59.16 -15.63 29.47 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 CA-C-N 120.836 1.334 . . . . 0.0 111.31 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.8 -35.74 80.77 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.165 -0.925 . . . . 0.0 113.296 -177.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -64.44 -40.56 95.98 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.149 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 79.6 p -58.12 -34.87 70.69 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.34 -38.64 85.17 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 119.907 -0.717 . . . . 0.0 112.62 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.446 ' CG ' ' N ' ' A' ' 39' ' ' VAL . 12.0 pttp -61.54 -48.1 82.55 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 119.421 -0.912 . . . . 0.0 111.478 -176.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.446 ' N ' ' CG ' ' A' ' 38' ' ' LYS . 7.2 m -62.92 -38.81 82.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -176.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.555 ' C ' ' H ' ' A' ' 42' ' ' GLN . 61.7 mtp85 -59.86 -41.01 90.55 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 119.356 -0.938 . . . . 0.0 110.175 -178.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -62.59 38.75 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.866 177.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.555 ' H ' ' C ' ' A' ' 40' ' ' ARG . 15.7 pt20 -91.03 149.08 21.97 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.823 -0.548 . . . . 0.0 111.168 -179.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 7.5 mt -96.49 44.59 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.054 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 21.5 mm100 46.62 -165.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.52 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 160.49 -72.02 0.22 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.548 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 2.6 pm0 -44.54 -24.8 0.21 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.859 0.361 . . . . 0.0 110.53 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.9 m 56.78 71.06 0.59 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.761 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -62.03 -27.96 69.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.184 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.77 -14.09 61.04 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 109.009 -1.636 . . . . 0.0 109.009 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.1 mp -65.76 -37.48 86.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.65 -0.775 . . . . 0.0 109.176 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 20.0 m -60.87 -44.4 97.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.965 -178.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 -64.67 -35.44 81.05 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 119.779 -0.768 . . . . 0.0 112.35 -177.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 t -68.89 -38.01 79.37 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 119.383 -0.927 . . . . 0.0 108.778 177.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -130.63 94.39 3.63 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.571 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.21 -2.21 18.0 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -177.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.524 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 24.3 p -125.21 -141.74 0.29 Allowed 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 56' ' ' SER . . . 97.66 13.69 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 O-C-N 124.159 0.912 . . . . 0.0 111.928 178.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.445 ' O ' ' O ' ' A' ' 59' ' ' TYR . 25.0 pt20 -163.26 -39.4 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.369 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.445 ' O ' ' O ' ' A' ' 58' ' ' GLN . 39.5 m-85 54.35 166.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.979 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.408 ' O ' ' C ' ' A' ' 61' ' ' GLY . 65.3 mtm180 -57.54 -41.56 81.2 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 60' ' ' ARG . . . -29.98 102.47 0.01 OUTLIER Glycine 0 CA--C 1.527 0.833 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.567 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.3 p -67.26 -33.75 64.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 118.378 -0.82 . . . . 0.0 109.864 176.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -60.18 -32.27 70.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 121.144 1.793 . . . . 0.0 109.674 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.68 -49.4 64.32 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 115.022 -0.99 . . . . 0.0 114.564 -176.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.4 p -62.28 -46.69 87.67 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.5 tp -60.02 -35.38 60.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.2 tt -63.21 -35.51 80.55 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 121.291 1.86 . . . . 0.0 110.848 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 99.9 m -62.63 -38.26 89.55 Favored 'General case' 0 C--O 1.246 0.884 0 CA-C-N 113.049 -1.887 . . . . 0.0 111.069 -175.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.512 ' O ' ' OG1' ' A' ' 72' ' ' THR . 0.4 OUTLIER -60.37 -39.14 86.17 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 120.322 -1.486 . . . . 0.0 114.283 -177.075 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.7 m -69.49 -40.25 79.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 119.186 -1.005 . . . . 0.0 113.054 -178.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -78.4 -13.3 59.9 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -178.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.512 ' OG1' ' O ' ' A' ' 69' ' ' MET . 2.5 p -62.86 -54.61 36.07 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.707 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.515 ' N ' ' OE1' ' A' ' 73' ' ' GLU . 54.8 mp0 -107.36 -58.17 1.99 Allowed 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 155.45 164.19 12.89 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -56.59 -35.36 97.04 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 121.714 1.609 . . . . 0.0 111.925 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -61.65 -12.33 15.66 Favored 'General case' 0 C--O 1.226 -0.144 0 CA-C-O 121.751 0.786 . . . . 0.0 110.887 176.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.3 t -78.24 -32.9 49.95 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.247 -1.342 . . . . 0.0 110.805 -178.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 14.6 tp -75.94 -33.28 59.83 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.833 0.349 . . . . 0.0 110.963 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -92.3 -5.01 53.12 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 122.802 1.287 . . . . 0.0 112.767 -178.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -93.92 117.45 30.12 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 112.224 -2.262 . . . . 0.0 107.071 175.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.84 -10.39 57.24 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 -177.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 56.4 tp -59.05 -34.74 72.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 113.281 -1.46 . . . . 0.0 110.687 -179.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 38.2 t -70.44 -26.36 28.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.794 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.64 -31.17 61.89 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.908 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.8 -40.51 89.63 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 119.693 -1.241 . . . . 0.0 111.619 -177.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.408 ' N ' ' CD2' ' A' ' 86' ' ' LEU . 3.7 mm? -62.43 -40.36 96.32 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 122.351 1.072 . . . . 0.0 112.434 -177.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -60.32 -26.91 66.92 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 113.131 -1.85 . . . . 0.0 108.984 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 16.5 ttm-85 -57.73 -53.42 58.36 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 173.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 53.2 tp60 -67.32 -30.02 69.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 112.606 -2.088 . . . . 0.0 112.151 -178.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 11.9 tpt -61.15 -41.35 96.6 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.018 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 40.4 m -74.8 -34.86 62.47 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 119.455 -0.898 . . . . 0.0 111.304 -177.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -57.9 -44.12 86.56 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 120.966 1.712 . . . . 0.0 111.966 -176.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.48 -33.12 64.68 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.551 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.1 m -64.51 -41.69 96.26 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.451 ' C ' ' H ' ' A' ' 97' ' ' ILE . 86.0 t -68.22 -28.45 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.885 177.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.498 ' NH2' ' CE2' ' A' ' 100' ' ' TYR . 54.4 ttt-85 -77.78 9.5 3.45 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -176.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.451 ' H ' ' C ' ' A' ' 95' ' ' VAL . 98.3 mt -86.8 -14.71 10.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -139.99 -48.38 0.06 OUTLIER Glycine 0 CA--C 1.543 1.809 0 N-CA-C 116.059 1.184 . . . . 0.0 116.059 -177.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 95.2 mt -71.72 -12.48 61.34 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 119.899 1.849 . . . . 0.0 113.792 -178.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.498 ' CE2' ' NH2' ' A' ' 96' ' ' ARG . 2.5 t80 -80.12 -51.47 8.95 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.326 -1.306 . . . . 0.0 111.384 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -69.97 -32.35 70.53 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 123.619 1.676 . . . . 0.0 110.925 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.0 t -68.21 -51.07 49.66 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 110.455 -3.066 . . . . 0.0 113.301 177.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -73.51 -26.41 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.359 0 CA-C-N 121.337 1.881 . . . . 0.0 111.24 179.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 63.8 mttt -69.44 -41.74 75.88 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 112.385 -2.189 . . . . 0.0 112.533 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -80.16 -12.9 59.61 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 122.613 1.197 . . . . 0.0 111.047 -178.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -80.08 -23.19 41.49 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.24 178.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -109.97 -28.54 8.68 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 119.53 1.059 . . . . 0.0 112.881 -175.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.11 9.38 41.06 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 116.765 -1.974 . . . . 0.0 113.962 -175.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.544 ' C ' ' H ' ' A' ' 111' ' ' SER . 62.0 mttp -45.97 130.11 9.75 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.512 1.051 . . . . 0.0 108.699 176.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -63.04 38.98 0.07 OUTLIER Glycine 0 CA--C 1.544 1.903 0 CA-C-N 119.179 0.9 . . . . 0.0 114.166 -178.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.544 ' H ' ' C ' ' A' ' 109' ' ' LYS . 10.6 m -5.29 -81.77 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 116.488 2.033 . . . . 0.0 116.488 -178.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.625 ' O ' ' CG ' ' A' ' 113' ' ' HIS . 2.9 tt0 165.79 -33.24 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 120.456 1.48 . . . . 0.0 113.446 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.625 ' CG ' ' O ' ' A' ' 112' ' ' GLU . 3.9 m-70 160.37 38.01 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.344 0.592 . . . . 0.0 109.931 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.479 ' CB ' ' O ' ' A' ' 113' ' ' HIS . . . 160.37 -162.7 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.855 0.836 . . . . 0.0 109.15 177.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.44 ' O ' ' OG ' ' A' ' 118' ' ' SER . . . 103.08 15.45 23.79 Favored Glycine 0 C--N 1.335 0.495 0 CA-C-N 114.104 -1.407 . . . . 0.0 110.512 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.494 ' CD1' HH21 ' A' ' 119' ' ' ARG . 8.7 tp -60.66 -40.36 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 C-N-CA 119.726 -0.79 . . . . 0.0 109.069 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.404 ' N ' ' CG2' ' A' ' 116' ' ' ILE . . . -65.99 -40.84 95.44 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-O 121.509 0.505 . . . . 0.0 111.885 175.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.606 ' HG ' ' N ' ' A' ' 119' ' ' ARG . 42.0 p -59.11 -43.16 91.9 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 176.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.606 ' N ' ' HG ' ' A' ' 118' ' ' SER . 9.9 ttp-105 -64.05 -36.98 85.79 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.64 -178.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 18.3 tp -63.43 -45.73 89.61 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 36.5 mt -66.08 -44.58 84.03 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.491 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.407 ' O ' ' OG1' ' A' ' 126' ' ' THR . . . -63.8 -45.23 90.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 119.691 1.132 . . . . 0.0 110.27 178.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -66.01 -44.32 91.78 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.129 -1.034 . . . . 0.0 111.318 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 69.3 m -64.04 -44.12 93.46 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.277 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 96.7 m -69.32 -48.19 62.26 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 119.339 -0.944 . . . . 0.0 111.945 177.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 122' ' ' ALA . 25.3 p -65.36 -42.68 92.52 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -174.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -64.11 -44.53 95.63 Favored Glycine 0 CA--C 1.521 0.424 0 CA-C-O 122.969 1.316 . . . . 0.0 112.904 -177.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.35 -41.54 97.23 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 111.878 -2.161 . . . . 0.0 107.296 177.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 35.9 tp -64.04 -42.03 97.19 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.801 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.0 -40.03 96.55 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 113.205 0.816 . . . . 0.0 113.205 -177.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.5 m -61.07 -26.05 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 122.687 1.232 . . . . 0.0 109.989 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -58.35 -45.09 88.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 112.399 -2.182 . . . . 0.0 110.909 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 49.1 t -79.25 -49.08 20.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.449 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -97.96 135.05 40.23 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.478 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.579 ' N ' ' CD ' ' A' ' 136' ' ' PRO . 2.2 tp-100 -177.77 -39.6 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.871 179.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 135' ' ' GLN . 73.8 Cg_exo -52.45 -33.55 57.55 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 122.143 1.896 . . . . 0.0 112.46 -179.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 66.6 p -67.53 -42.69 82.31 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 118.725 -1.19 . . . . 0.0 109.879 -178.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -66.24 -42.81 88.11 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 119.303 -0.959 . . . . 0.0 112.136 -178.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 89.6 t -64.11 -44.28 97.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 34.5 m -65.07 -39.49 85.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -176.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -63.08 -42.3 99.61 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 118.668 -1.213 . . . . 0.0 111.657 -178.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 3.8 p -71.4 -46.45 64.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.678 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 14.4 tpp180 -65.9 -38.09 87.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.693 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -68.11 -42.44 80.24 Favored 'General case' 0 C--O 1.226 -0.165 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -177.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -66.23 -40.83 90.55 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 118.819 -1.153 . . . . 0.0 110.133 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.48 -35.18 80.13 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 -178.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.466 ' O ' ' CG ' ' A' ' 147' ' ' GLN . 6.4 pt20 -59.94 111.1 1.35 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 177.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -95.19 -63.84 1.12 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 117.62 -1.181 . . . . 0.0 112.696 -177.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.462 ' O ' ' N ' ' A' ' 151' ' ' GLY . 16.2 mmm180 -77.76 0.12 24.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 122.675 2.489 . . . . 0.0 109.725 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . 62.02 -75.23 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.619 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 149' ' ' ARG . . . 157.56 -115.66 0.67 Allowed Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.679 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 179.962 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 1.7 t80 . . . . . 0 CA--C 1.531 0.23 0 CA-C-O 120.712 0.291 . . . . 0.0 110.43 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -88.21 153.69 21.03 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.946 0.403 . . . . 0.0 111.047 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.653 ' H ' ' CG ' ' A' ' 161' ' ' GLU . 19.5 m -157.12 -178.77 7.61 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 121.309 0.576 . . . . 0.0 111.007 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 10.2 t -64.78 -46.32 82.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.442 -178.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.4 m -64.53 -45.78 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 C-N-CA 119.354 -0.939 . . . . 0.0 110.674 -178.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.653 ' CG ' ' H ' ' A' ' 158' ' ' SER . 3.1 pp20? -67.59 -38.6 84.27 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.545 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.49 ' N ' ' CD ' ' A' ' 161' ' ' GLU . . . -61.58 -45.68 93.08 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -62.37 -49.69 74.54 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.389 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -68.45 -45.53 72.24 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 -176.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 14.5 m -62.85 -44.7 95.44 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -177.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 2.6 pp -64.71 -38.37 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 121.955 0.884 . . . . 0.0 109.345 176.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.58 -36.19 75.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 113.786 -1.552 . . . . 0.0 107.486 176.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 11.3 tpp85 -61.98 -49.8 74.64 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 122.266 2.303 . . . . 0.0 111.71 -175.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -74.62 -50.82 16.39 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 123.442 0.697 . . . . 0.0 109.51 177.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -77.85 -36.43 49.99 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 116.997 2.221 . . . . 0.0 116.997 -172.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 90.33 -166.16 31.82 Favored Glycine 0 N--CA 1.471 0.994 0 CA-C-N 118.779 0.718 . . . . 0.0 112.109 177.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.511 ' CD1' ' N ' ' A' ' 172' ' ' ILE . 2.0 mp -73.1 -44.11 56.93 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 CA-C-O 121.978 0.894 . . . . 0.0 110.251 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 -58.61 -33.47 70.06 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.632 -176.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -60.74 -40.54 98.25 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 118.896 -1.621 . . . . 0.0 110.23 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 52.4 tp -69.93 -33.94 72.8 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 116.646 2.091 . . . . 0.0 116.646 -177.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -78.41 -7.97 57.95 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 111.437 -2.62 . . . . 0.0 109.794 -178.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 38.1 tptt -43.42 -48.39 7.13 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.792 -176.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -86.02 -39.88 7.8 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.237 0.922 . . . . 0.0 110.845 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.6 m -45.44 -51.44 11.47 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' SER . . . . . 0.416 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 2.7 m -63.19 -50.92 73.05 Favored Pre-proline 0 N--CA 1.474 0.739 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -176.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 180' ' ' SER . 33.6 Cg_endo -65.02 -27.32 57.9 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.278 1.985 . . . . 0.0 112.353 177.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -63.0 -38.63 91.96 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 121.228 -0.189 . . . . 0.0 111.102 -178.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.449 ' O ' ' OD1' ' A' ' 186' ' ' ASN . 1.9 p -62.47 -42.02 94.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.372 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.41 ' N ' ' CG1' ' A' ' 183' ' ' VAL . . . -62.22 -39.54 93.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.95 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 72.3 ttp85 -61.08 -42.06 97.81 Favored 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.793 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . 0.557 ' ND2' ' N ' ' A' ' 187' ' ' ALA . 0.1 OUTLIER -62.13 -42.67 99.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.964 0.411 . . . . 0.0 111.348 179.695 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . 0.557 ' N ' ' ND2' ' A' ' 186' ' ' ASN . . . -63.8 -44.24 93.9 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -177.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 7.4 tt -63.98 -45.23 97.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -178.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 12.9 m -60.18 -46.61 94.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 119.679 -0.808 . . . . 0.0 111.807 -178.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . 0.501 ' ND2' ' N ' ' A' ' 191' ' ' CYS . 0.1 OUTLIER -62.41 -43.0 99.86 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 122.274 1.035 . . . . 0.0 109.602 179.414 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' CYS . . . . . 0.501 ' N ' ' ND2' ' A' ' 190' ' ' ASN . 45.9 t -62.36 -47.19 85.3 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 113.538 -1.664 . . . . 0.0 111.004 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.89 -41.17 95.84 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.083 177.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 0.408 ' O ' ' OG1' ' A' ' 196' ' ' THR . 55.4 mt-10 -61.09 -45.09 96.13 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.366 -1.288 . . . . 0.0 112.087 -178.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.592 ' CD2' ' HE ' ' A' ' 119' ' ' ARG . 17.5 mt -63.21 -37.0 85.53 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 119.228 -0.989 . . . . 0.0 108.705 -175.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 92.7 t -62.69 -45.98 97.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 C-N-CA 117.074 -1.85 . . . . 0.0 107.101 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' A' ' 193' ' ' GLU . 59.9 p -64.46 -45.95 85.2 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -178.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -56.92 -38.91 73.52 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.018 1.327 . . . . 0.0 113.209 -177.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -55.37 -44.12 75.76 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 10.1 mp -60.84 -38.22 84.74 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.624 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 57.9 mt -61.37 -42.01 92.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.19 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 19.4 mmtp -59.68 -38.22 80.92 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.609 1.564 . . . . 0.0 113.329 177.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -63.27 -39.96 96.06 Favored 'General case' 0 C--N 1.316 -0.862 0 O-C-N 121.941 -0.474 . . . . 0.0 111.027 -177.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.4 t -101.26 129.04 47.14 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 122.041 0.924 . . . . 0.0 112.621 -178.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 2.2 tp 67.73 4.25 3.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 113.788 -1.551 . . . . 0.0 111.976 178.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 2.3 mt -126.71 28.78 5.82 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.718 0.771 . . . . 0.0 112.014 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 18.1 mtpp -73.86 -23.68 59.64 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.258 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -162.99 34.17 0.1 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.658 -1.155 . . . . 0.0 108.316 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 2.4 m120 42.42 54.31 4.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.354 -1.294 . . . . 0.0 113.663 177.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.577 ' CD1' ' H ' ' A' ' 209' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.463 0.18 0 CA-C-N 114.777 -1.101 . . . . 0.0 108.745 178.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 . . . . . 0 CA--C 1.521 -0.172 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.467 ' N ' ' CD ' ' A' ' 215' ' ' PRO . 3.4 mt -61.07 -43.48 90.96 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.871 -177.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' A' ' 214' ' ' LEU . 26.4 Cg_exo -61.2 -33.33 90.6 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 120.716 0.944 . . . . 0.0 110.701 -179.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 86.9 m -65.62 -43.58 89.13 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.161 -1.381 . . . . 0.0 112.579 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 38.0 t-80 -67.7 -39.29 84.42 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -177.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -64.12 -46.83 82.43 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.217 -179.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 28.6 p -60.34 -37.84 81.93 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 118.894 0.77 . . . . 0.0 110.239 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 70.7 m -59.76 -41.72 91.68 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . 0.556 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.99 -41.67 97.44 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -177.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -62.02 -47.27 85.5 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.896 0.855 . . . . 0.0 113.111 -176.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -60.98 -42.25 99.7 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 108.0 -2.04 . . . . 0.0 108.0 177.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -63.22 -37.79 88.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.05 -1.075 . . . . 0.0 109.275 176.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -61.33 -41.78 99.61 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 114.172 -1.376 . . . . 0.0 111.59 -176.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -66.08 -38.91 89.45 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 118.168 -1.413 . . . . 0.0 107.949 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 83.6 m -64.01 -41.6 97.41 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.466 0.65 . . . . 0.0 109.778 176.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -61.81 -39.59 92.3 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.321 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 31.3 m -57.85 -39.23 77.24 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.15 -176.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 98.1 t -60.17 -40.87 84.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 118.804 -1.158 . . . . 0.0 108.302 178.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . 0.529 ' O ' ' HD2' ' A' ' 234' ' ' PRO . 0.2 OUTLIER -61.81 -40.8 88.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 177.444 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -62.59 -38.98 92.27 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 115.686 1.736 . . . . 0.0 115.686 -178.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.449 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 0.2 OUTLIER -57.68 -40.82 86.77 Favored Pre-proline 0 N--CA 1.476 0.863 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 -172.721 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . 0.529 ' HD2' ' O ' ' A' ' 231' ' ' ILE . 38.4 Cg_exo -58.62 -40.46 73.5 Favored 'Trans proline' 0 C--N 1.293 -2.343 0 C-N-CA 121.666 1.577 . . . . 0.0 113.78 -177.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.3 m -64.51 -37.44 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 118.395 -1.322 . . . . 0.0 109.336 178.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -65.94 -40.64 91.53 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.05 178.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 55.9 t -64.79 -45.07 96.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 115.295 -0.866 . . . . 0.0 113.073 -177.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 15.5 m . . . . . 0 C--N 1.324 -0.533 0 C-N-CA 119.749 -0.781 . . . . 0.0 111.299 -177.718 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' THR . . . . . 0.499 ' HG1' ' N ' ' A' ' 260' ' ' MET . 74.7 p . . . . . 0 N--CA 1.467 0.423 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' MET . . . . . 0.499 ' N ' ' HG1' ' A' ' 259' ' ' THR . 2.9 ptm -60.77 -43.48 98.0 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 121.013 -0.275 . . . . 0.0 111.505 -177.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 12.2 mt -62.53 -47.29 84.56 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 59.6 ttt85 -67.11 -54.11 24.46 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.549 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 28.1 mmtp -70.13 -156.42 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.929 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . 0.513 ' OE2' ' N ' ' A' ' 265' ' ' GLY . 1.0 OUTLIER -38.8 133.55 1.08 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.025 -179.702 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . 0.552 ' C ' ' H ' ' A' ' 267' ' ' ARG . . . -47.98 169.97 0.07 OUTLIER Glycine 0 CA--C 1.533 1.179 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -55.54 -0.67 0.17 Allowed 'Trans proline' 0 N--CA 1.5 1.869 0 C-N-CA 121.978 1.786 . . . . 0.0 112.326 178.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . 0.552 ' H ' ' C ' ' A' ' 265' ' ' GLY . 91.1 mtt180 -69.77 -26.79 64.45 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.13 0.572 . . . . 0.0 112.3 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -58.37 -32.33 68.48 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.1 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -62.42 -41.34 98.63 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.138 0.494 . . . . 0.0 111.186 177.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -65.74 -37.82 87.42 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -177.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.457 ' O ' ' O ' ' A' ' 272' ' ' GLY . 14.8 mptt -56.39 -172.33 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 271' ' ' LYS . . . 45.82 103.11 0.01 OUTLIER Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.501 -0.64 . . . . 0.0 111.501 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -158.62 -12.91 0.07 Allowed 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.346 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' MET . . . . . 0.51 ' N ' ' HD2' ' A' ' 275' ' ' PRO . 2.1 tpt -64.07 -45.16 79.67 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 120.39 -0.524 . . . . 0.0 111.429 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 274' ' ' MET . 36.9 Cg_endo -64.84 -45.76 7.76 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.362 1.375 . . . . 0.0 111.57 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' SER . . . . . 0.409 ' HG ' ' N ' ' A' ' 277' ' ' PHE . 78.5 p -59.67 -38.88 82.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.746 -178.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . 0.409 ' N ' ' HG ' ' A' ' 276' ' ' SER . 46.8 t80 -61.0 -42.55 98.65 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 122.629 1.204 . . . . 0.0 112.017 -178.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 9.4 mp -62.02 -38.45 88.69 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 112.298 -2.228 . . . . 0.0 107.678 174.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 9.9 mtm180 -62.71 -39.23 93.37 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.21 0.529 . . . . 0.0 110.184 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 6.8 tp -61.97 -36.96 83.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.885 -177.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -67.95 -51.23 35.65 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 36.3 m -62.92 -44.36 96.29 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' TRP . . . . . . . . . . . . . 91.5 t90 -60.05 -38.17 81.99 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.674 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -62.77 -38.62 91.34 Favored 'General case' 0 C--N 1.317 -0.814 0 O-C-N 122.068 -0.395 . . . . 0.0 111.181 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.98 -39.36 81.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -177.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 6.5 m -62.91 -40.08 87.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 119.98 -0.688 . . . . 0.0 109.941 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' MET . . . . . 0.405 ' O ' ' OG1' ' A' ' 290' ' ' THR . 10.0 tpt -60.49 -38.95 85.98 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.162 0.506 . . . . 0.0 109.695 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -58.81 -40.18 83.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.542 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.71 -38.72 79.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.365 -177.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.405 ' OG1' ' O ' ' A' ' 287' ' ' MET . 39.4 p -62.71 -40.62 97.74 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 177.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -61.56 -39.05 89.72 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 176.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -58.72 -40.96 85.25 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 117.921 -1.512 . . . . 0.0 109.506 -176.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' GLN . . . . . 0.45 ' O ' ' O ' ' A' ' 296' ' ' ARG . 88.4 mt-30 -60.78 -42.78 98.19 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 122.825 1.298 . . . . 0.0 110.623 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.41 -40.68 91.87 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 112.583 -2.099 . . . . 0.0 109.091 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 1.8 mmmm -63.48 -45.8 89.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.34 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' ARG . . . . . 0.45 ' O ' ' O ' ' A' ' 293' ' ' GLN . 0.5 OUTLIER -122.96 116.23 23.22 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.364 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -116.25 -95.0 0.48 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.381 0.61 . . . . 0.0 110.767 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 3.5 pp -136.65 -166.66 1.93 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.288 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 12.5 ttt -170.81 66.36 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.288 -0.565 . . . . 0.0 111.489 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.6 101.01 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.849 0.833 . . . . 0.0 110.697 -178.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -64.05 -46.13 85.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 113.895 -1.502 . . . . 0.0 113.534 -176.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . 0.534 ' CD2' ' OE2' ' A' ' 306' ' ' GLU . 19.9 t80 -58.66 -39.82 81.72 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.643 -178.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -64.84 -46.53 81.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.072 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' SER . . . . . 0.42 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 37.8 m -66.15 -37.17 85.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.539 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -61.12 -42.48 98.61 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.186 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . 0.534 ' OE2' ' CD2' ' A' ' 302' ' ' TYR . 52.1 mt-10 -64.66 -36.83 85.52 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 -177.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -59.88 -53.0 69.68 Favored Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -176.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' PRO . . . . . 0.491 ' O ' ' CG ' ' A' ' 309' ' ' PHE . 74.1 Cg_endo -75.13 0.25 9.18 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.109 1.873 . . . . 0.0 111.785 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' PHE . . . . . 0.491 ' CG ' ' O ' ' A' ' 308' ' ' PRO . 56.6 m-85 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.35 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.431 0 CA-C-O 120.771 0.319 . . . . 0.0 111.164 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.6 m -114.2 178.47 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 178.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.433 ' CD ' ' N ' ' A' ' 16' ' ' LYS . 3.8 mptp? -64.53 -41.52 96.32 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.189 -0.46 . . . . 0.0 112.066 -178.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -62.94 -42.13 99.71 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -178.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.462 ' C ' ' CD1' ' A' ' 18' ' ' LEU . 1.1 pp -80.59 -24.17 39.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.428 0.632 . . . . 0.0 112.564 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.07 -40.43 96.99 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 107.241 -2.344 . . . . 0.0 107.241 177.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.423 ' CB ' ' NH2' ' A' ' 96' ' ' ARG . . . -71.17 -31.34 67.55 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 124.515 2.103 . . . . 0.0 107.485 176.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.78 -42.62 98.49 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-N 108.781 -3.827 . . . . 0.0 110.315 -178.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.4 t -70.92 -26.6 63.27 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.8 -50.6 64.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.711 -178.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.08 -36.1 80.68 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 118.308 -1.357 . . . . 0.0 111.016 -177.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.9 t -63.97 -53.63 47.11 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.849 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.43 HG23 HD13 ' A' ' 26' ' ' ILE . 74.3 mt -65.49 -39.88 86.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -177.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.39 -42.43 96.11 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 119.516 -0.873 . . . . 0.0 112.701 -174.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -78.13 -27.05 48.17 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 120.718 1.599 . . . . 0.0 110.111 -175.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.2 tt -59.43 -55.54 33.37 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 120.033 1.288 . . . . 0.0 111.933 -177.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.43 HG21 HD12 ' A' ' 30' ' ' ILE . 0.4 OUTLIER -75.19 -3.56 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -179.24 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -109.5 -17.2 13.81 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.302 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.438 ' O ' ' OD1' ' A' ' 35' ' ' ASP . 1.6 t80 -67.95 -44.62 40.79 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 116.474 -2.09 . . . . 0.0 109.984 -177.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.421 ' CD ' ' N ' ' A' ' 32' ' ' PHE . 35.2 Cg_exo -59.45 -15.68 31.46 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 121.252 1.301 . . . . 0.0 112.291 176.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.96 -35.23 79.51 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -177.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 36' ' ' THR . 27.7 p-10 -64.53 -40.33 95.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.763 -177.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.543 ' N ' ' OD1' ' A' ' 35' ' ' ASP . 31.6 p -58.19 -34.66 70.6 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -179.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.11 -38.78 86.22 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.3 pttp -62.23 -48.3 80.58 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 118.877 -1.129 . . . . 0.0 111.4 -177.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.0 m -63.41 -38.23 81.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 O-C-N 122.135 -0.353 . . . . 0.0 111.927 -178.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.528 ' C ' ' H ' ' A' ' 42' ' ' GLN . 5.5 mmp_? -59.35 -40.03 85.08 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.514 -178.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.46 38.86 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.528 ' H ' ' C ' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -114.09 -177.2 3.07 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.407 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.568 ' CG2' ' H ' ' A' ' 44' ' ' GLN . 13.1 tt -63.12 -62.08 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.364 -0.535 . . . . 0.0 109.81 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.568 ' H ' ' CG2' ' A' ' 43' ' ' ILE . 3.3 mt-30 169.55 5.95 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 54.34 37.46 59.88 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.364 -1.095 . . . . 0.0 110.364 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.443 ' O ' ' CB ' ' A' ' 47' ' ' SER . 2.9 pt-20 -93.17 -95.26 0.15 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.617 0.246 . . . . 0.0 110.515 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.548 ' C ' ' H ' ' A' ' 49' ' ' GLY . 0.9 OUTLIER 82.13 -31.09 0.1 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.82 -179.833 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -65.01 8.43 0.13 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.854 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.548 ' H ' ' C ' ' A' ' 47' ' ' SER . . . 80.85 16.38 75.27 Favored Glycine 0 CA--C 1.535 1.299 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -177.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.7 tt -61.44 -36.38 80.22 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 114.875 -0.662 . . . . 0.0 110.386 -176.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.3 p -59.82 -44.64 94.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 C-N-CA 120.191 -0.603 . . . . 0.0 112.2 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.9 ttp180 -65.33 -35.95 82.54 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 119.451 -0.899 . . . . 0.0 112.793 -178.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 t -69.56 -38.48 77.46 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.628 0.728 . . . . 0.0 109.662 178.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -152.68 123.26 7.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.193 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.407 ' O ' ' OG ' ' A' ' 56' ' ' SER . . . -99.3 176.66 5.45 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -177.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.526 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 45.7 p 53.9 -141.34 0.87 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 113.993 -1.458 . . . . 0.0 108.923 -178.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 56' ' ' SER . . . 95.7 14.23 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.893 178.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 11.9 tp-100 -167.29 73.25 0.12 Allowed 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.547 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -61.05 142.34 56.72 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.433 ' O ' ' C ' ' A' ' 61' ' ' GLY . 84.1 mtp180 -39.41 -37.07 0.42 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.955 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 60' ' ' ARG . . . -28.8 101.44 0.01 OUTLIER Glycine 0 CA--C 1.531 1.064 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.28 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 56.2 t -66.97 -33.79 65.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 118.121 -0.943 . . . . 0.0 109.687 176.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 43.9 mt -60.56 -32.43 71.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 121.489 1.949 . . . . 0.0 111.213 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.6 -49.01 66.84 Favored Glycine 0 CA--C 1.532 1.138 0 N-CA-C 115.246 0.859 . . . . 0.0 115.246 -176.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.99 -45.97 91.27 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.465 0.542 . . . . 0.0 112.465 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 25.0 pt -59.75 -36.03 63.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 118.365 -0.826 . . . . 0.0 108.845 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 78.3 mt -63.84 -35.72 81.55 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 121.137 1.789 . . . . 0.0 111.749 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.445 ' O ' ' OG1' ' A' ' 72' ' ' THR . 97.9 m -62.91 -39.11 93.51 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 113.506 -1.679 . . . . 0.0 111.008 -175.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.457 ' C ' ' SD ' ' A' ' 69' ' ' MET . 0.0 OUTLIER -60.29 -40.39 90.31 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 120.775 -1.203 . . . . 0.0 113.835 -176.427 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.6 p -69.66 -40.56 79.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 119.211 -0.996 . . . . 0.0 113.176 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 67.9 ttp85 -78.42 -13.27 59.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.709 0.766 . . . . 0.0 112.823 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 68' ' ' THR . 61.0 m -62.55 -54.82 34.06 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.111 179.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -110.18 -54.17 2.6 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 157.03 164.11 13.22 Favored Glycine 0 CA--C 1.539 1.56 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -56.42 -35.47 96.41 Favored 'Trans proline' 0 N--CA 1.503 2.058 0 CA-C-N 119.493 1.646 . . . . 0.0 112.395 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -61.09 -11.47 8.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 122.102 0.953 . . . . 0.0 111.135 176.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.472 ' O ' ' OD1' ' A' ' 80' ' ' ASN . 3.6 t -77.72 -32.26 52.74 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 113.716 -1.583 . . . . 0.0 110.727 -178.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.422 ' N ' ' CD2' ' A' ' 78' ' ' LEU . 4.1 mm? -75.65 -32.5 60.23 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 122.089 -0.382 . . . . 0.0 110.843 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -91.37 -4.35 55.83 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -176.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.472 ' OD1' ' O ' ' A' ' 77' ' ' SER . 35.1 p30 -95.72 26.88 3.74 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 112.189 -2.278 . . . . 0.0 107.648 175.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -159.05 -19.72 0.03 OUTLIER Glycine 0 CA--C 1.53 1.001 0 CA-C-N 114.28 -1.327 . . . . 0.0 112.417 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.65 -35.16 73.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.263 -0.968 . . . . 0.0 110.502 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.9 p -70.87 -27.44 30.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.525 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.86 -31.33 61.6 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.349 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.91 -40.54 89.15 Favored Glycine 0 C--O 1.223 -0.573 0 C-N-CA 119.69 -1.243 . . . . 0.0 111.148 -178.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 50.5 mt -62.37 -40.25 95.84 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 122.476 1.132 . . . . 0.0 112.67 -177.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -60.03 -27.01 66.55 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 112.986 -1.915 . . . . 0.0 109.025 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 36.2 ttp180 -57.31 -52.55 64.89 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 173.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -67.53 -30.32 69.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 112.853 -1.976 . . . . 0.0 112.329 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 11.8 tmm? -61.01 -41.99 97.61 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.551 -0.749 . . . . 0.0 112.484 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 21.8 t -74.81 -34.33 62.35 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.533 -176.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -57.69 -44.08 85.59 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 120.231 1.378 . . . . 0.0 111.9 -176.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.56 -32.87 64.39 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 119.402 -0.919 . . . . 0.0 110.732 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.496 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 58.4 p -64.51 -42.2 95.96 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.486 ' C ' ' H ' ' A' ' 97' ' ' ILE . 7.1 p -68.39 -28.32 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 177.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.483 ' CG ' ' O ' ' A' ' 96' ' ' ARG . 35.3 ttt-85 -77.36 9.71 3.02 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 -176.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.496 ' CG2' ' O ' ' A' ' 94' ' ' SER . 3.4 tp -86.92 -15.39 9.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 177.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.498 ' O ' ' OD1' ' A' ' 101' ' ' ASP . . . -140.24 -48.17 0.06 OUTLIER Glycine 0 CA--C 1.544 1.872 0 N-CA-C 116.018 1.167 . . . . 0.0 116.018 -177.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.51 ' CD1' ' N ' ' A' ' 99' ' ' LEU . 8.6 mp -72.06 -13.06 61.49 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 120.111 1.955 . . . . 0.0 113.669 -178.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.498 ' O ' ' CG ' ' A' ' 104' ' ' LYS . 48.7 t80 -80.48 -51.85 8.32 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 114.551 -1.204 . . . . 0.0 113.025 -178.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.498 ' OD1' ' O ' ' A' ' 98' ' ' GLY . 30.9 p-10 -70.32 -32.36 70.07 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 123.663 1.696 . . . . 0.0 110.821 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.456 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 24.1 p -68.19 -51.34 46.7 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 110.284 -3.144 . . . . 0.0 112.641 176.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 59.1 t -73.51 -26.47 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 CA-C-N 121.254 1.843 . . . . 0.0 112.106 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.498 ' CG ' ' O ' ' A' ' 100' ' ' TYR . 22.7 mmtm -68.89 -41.75 77.85 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 111.914 -2.403 . . . . 0.0 110.757 178.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.446 ' HG3' ' O ' ' A' ' 101' ' ' ASP . 88.1 mt-30 -78.26 -14.64 59.35 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-O 122.772 1.272 . . . . 0.0 111.045 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -79.76 -23.16 42.41 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 114.672 -1.149 . . . . 0.0 112.462 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.622 ' CZ ' ' ND2' ' A' ' 190' ' ' ASN . 32.9 m-85 -109.66 -29.95 8.12 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 119.39 0.995 . . . . 0.0 111.735 -175.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.9 p -97.56 9.33 42.74 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 117.028 -1.869 . . . . 0.0 112.675 -178.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.532 ' O ' ' C ' ' A' ' 110' ' ' GLY . 6.1 pttp -48.06 124.41 7.58 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 117.792 -1.099 . . . . 0.0 109.835 177.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.533 ' O ' ' CB ' ' A' ' 111' ' ' SER . . . -26.46 -77.52 0.01 OUTLIER Glycine 0 N--CA 1.488 2.134 0 CA-C-N 120.46 1.482 . . . . 0.0 111.515 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 110' ' ' GLY . 24.0 p 103.35 -159.68 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 176.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.563 ' O ' ' N ' ' A' ' 114' ' ' ALA . 94.8 mt-10 -128.76 96.8 4.47 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.254 -0.885 . . . . 0.0 112.649 -178.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.459 ' C ' ' O ' ' A' ' 112' ' ' GLU . 76.8 m-70 12.63 51.11 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 O-C-N 124.245 0.965 . . . . 0.0 113.138 178.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.563 ' N ' ' O ' ' A' ' 112' ' ' GLU . . . 159.41 -161.79 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.43 ' O ' ' OG ' ' A' ' 118' ' ' SER . . . 102.36 14.97 26.65 Favored Glycine 0 C--N 1.338 0.687 0 CA-C-N 114.999 -1.0 . . . . 0.0 113.227 176.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 13.0 tt -60.91 -40.35 85.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 119.167 -1.013 . . . . 0.0 109.438 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.49 -39.56 95.72 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 122.047 0.804 . . . . 0.0 111.4 176.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.43 ' OG ' ' O ' ' A' ' 115' ' ' GLY . 9.6 p -57.81 -42.11 83.59 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 177.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -63.42 -37.18 86.3 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.975 -178.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 30.8 tp -64.03 -46.98 82.04 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.354 0.597 . . . . 0.0 109.778 178.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 42.8 mt -67.06 -44.83 79.12 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.848 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.78 -44.7 92.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 119.281 0.946 . . . . 0.0 109.36 178.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -65.94 -44.16 92.28 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 119.691 -1.242 . . . . 0.0 111.665 -179.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 67.1 m -63.72 -43.91 95.15 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.384 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 20.9 m -69.44 -48.53 60.65 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 119.082 -1.047 . . . . 0.0 112.023 177.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 41.5 p -65.54 -43.0 91.3 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 -174.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -64.46 -44.85 94.65 Favored Glycine 0 CA--C 1.521 0.407 0 CA-C-N 114.734 -1.121 . . . . 0.0 112.918 -177.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.83 -41.66 98.08 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 112.395 -1.903 . . . . 0.0 107.451 177.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 24.9 tp -64.67 -42.6 95.26 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.218 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.63 -40.16 96.17 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -177.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.7 p -61.27 -26.46 39.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 123.363 1.554 . . . . 0.0 109.942 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.528 ' O ' ' NE2' ' A' ' 135' ' ' GLN . . . -58.78 -45.68 89.25 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 110.787 -2.915 . . . . 0.0 112.372 -178.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.557 ' C ' HE22 ' A' ' 135' ' ' GLN . 2.5 p -79.79 -48.65 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -178.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -102.5 86.12 2.73 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -177.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.648 ' H ' ' CD ' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -126.77 -22.99 0.04 OUTLIER Pre-proline 0 CA--C 1.551 0.983 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 177.6 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.648 ' CD ' ' H ' ' A' ' 135' ' ' GLN . 6.8 Cg_endo -54.98 -33.13 81.82 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 CA-C-N 121.554 1.591 . . . . 0.0 112.214 -178.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.513 ' O ' ' NZ ' ' A' ' 141' ' ' LYS . 73.3 p -68.22 -42.87 79.14 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 117.828 -1.549 . . . . 0.0 112.286 -175.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -67.46 -44.37 78.78 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 118.438 -1.305 . . . . 0.0 113.373 -178.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.9 m -65.45 -44.76 94.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -178.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 75.2 t -65.48 -40.29 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -176.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.513 ' NZ ' ' O ' ' A' ' 137' ' ' THR . 29.3 mtmm -63.18 -41.53 99.22 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.118 -178.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 3.5 p -71.1 -45.57 71.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.833 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.574 HH21 ' CG2' ' A' ' 166' ' ' ILE . 61.1 mtp180 -64.73 -37.34 87.28 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.161 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.611 ' CD1' ' NE2' ' A' ' 147' ' ' GLN . 76.2 t80 -67.27 -41.76 84.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.451 -178.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 18.0 tm0? -65.92 -40.73 91.71 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.518 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -64.84 -35.96 82.81 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -176.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.611 ' NE2' ' CD1' ' A' ' 144' ' ' PHE . 5.7 pt20 -59.3 111.12 1.24 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 177.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -102.49 -174.87 2.67 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 117.469 2.396 . . . . 0.0 117.469 -171.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 90.9 mtt-85 56.02 105.39 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 110.601 -2.999 . . . . 0.0 110.376 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -44.41 -77.45 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.786 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 46.07 81.95 0.04 OUTLIER Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.622 0 N-CA-C 110.829 -0.909 . . . . 0.0 110.829 179.898 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.489 ' O ' ' CD2' ' A' ' 156' ' ' TYR . 74.1 t80 . . . . . 0 C--O 1.23 0.044 0 CA-C-O 120.347 0.118 . . . . 0.0 111.059 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.448 ' O ' ' O ' ' A' ' 156' ' ' TYR . 51.0 mt-30 58.45 144.03 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.316 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.593 ' H ' ' CG ' ' A' ' 161' ' ' GLU . 3.5 m -156.97 -178.91 7.72 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.779 0.799 . . . . 0.0 112.23 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 26.4 p -64.87 -46.48 81.61 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 114.234 -1.348 . . . . 0.0 113.063 -177.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 42.4 t -64.28 -45.48 96.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.281 -177.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.593 ' CG ' ' H ' ' A' ' 158' ' ' SER . 8.3 pt-20 -67.99 -38.89 83.21 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -61.56 -45.72 92.96 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -177.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.451 ' CG ' ' N ' ' A' ' 164' ' ' LYS . 0.1 OUTLIER -62.45 -48.77 78.18 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.041 -179.424 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.451 ' N ' ' CG ' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -67.54 -45.08 76.74 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -174.793 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 40.6 p -62.77 -44.79 95.26 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 119.738 1.154 . . . . 0.0 113.706 -177.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.574 ' CG2' HH21 ' A' ' 143' ' ' ARG . 18.5 tt -64.94 -38.51 82.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-O 121.933 0.873 . . . . 0.0 109.454 176.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.78 -36.56 76.96 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 113.825 -1.534 . . . . 0.0 108.042 176.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -62.1 -50.03 73.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 122.708 2.504 . . . . 0.0 111.51 -175.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -74.75 -51.0 15.34 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 177.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -78.18 -36.51 47.38 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 116.25 1.944 . . . . 0.0 116.25 -173.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 91.78 -167.29 30.72 Favored Glycine 0 N--CA 1.468 0.779 0 CA-C-N 118.553 0.615 . . . . 0.0 112.095 177.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 8.5 pt -72.69 -42.74 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-O 121.845 0.831 . . . . 0.0 110.551 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 53.5 ttt85 -58.94 -33.54 70.73 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 114.381 -1.282 . . . . 0.0 110.838 -177.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -61.12 -40.69 98.89 Favored Glycine 0 CA--C 1.522 0.479 0 C-N-CA 118.503 -1.808 . . . . 0.0 109.592 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.429 ' CD1' ' NH1' ' A' ' 143' ' ' ARG . 7.4 tt -70.42 -33.78 71.74 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 111.688 -2.256 . . . . 0.0 116.701 -177.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 10.1 m0 -78.21 -7.86 57.62 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 111.713 -2.494 . . . . 0.0 109.909 -177.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 16.9 tptm -43.52 -48.3 7.38 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.192 -176.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -91.05 -34.99 7.3 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.449 1.023 . . . . 0.0 111.492 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.3 m -46.29 -51.94 13.6 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.24 -50.83 73.15 Favored Pre-proline 0 N--CA 1.477 0.903 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -176.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -64.06 -28.21 65.7 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 121.666 1.577 . . . . 0.0 111.44 175.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -63.79 -38.8 92.45 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.79 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.419 ' CG1' ' N ' ' A' ' 184' ' ' ALA . 0.8 OUTLIER -62.39 -42.12 94.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.722 -178.648 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.419 ' N ' ' CG1' ' A' ' 183' ' ' VAL . . . -61.96 -39.41 92.02 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.341 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 57.3 ttp85 -60.76 -41.97 96.51 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.093 -179.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -61.58 -43.23 99.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.26 0.552 . . . . 0.0 110.596 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.37 -43.05 95.74 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.741 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.437 ' O ' ' SG ' ' A' ' 191' ' ' CYS . 78.1 mt -62.96 -45.02 99.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -176.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.518 ' O ' ' N ' ' A' ' 193' ' ' GLU . 5.9 m -59.44 -46.34 92.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 119.546 -0.861 . . . . 0.0 111.395 -178.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . 0.622 ' ND2' ' CZ ' ' A' ' 107' ' ' TYR . 26.6 t-20 -63.08 -42.98 99.76 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 122.045 0.926 . . . . 0.0 110.908 178.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' CYS . . . . . 0.591 ' SG ' ' N ' ' A' ' 192' ' ' ALA . 0.5 OUTLIER -61.6 -45.41 94.2 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.014 -1.448 . . . . 0.0 108.867 179.049 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . 0.591 ' N ' ' SG ' ' A' ' 191' ' ' CYS . . . -63.76 -39.2 93.69 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 112.584 -2.098 . . . . 0.0 109.149 175.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 189' ' ' VAL . 44.0 tp10 -60.31 -46.38 90.09 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.004 0.922 . . . . 0.0 112.706 -176.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 75.2 mt -65.61 -37.64 87.19 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.671 -175.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 2.5 p -64.26 -46.28 93.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 117.089 -1.845 . . . . 0.0 109.569 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 2.2 t -64.48 -45.36 87.71 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -177.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -57.41 -39.45 76.19 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 114.58 -1.191 . . . . 0.0 112.305 -178.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -56.07 -44.7 79.19 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 47.3 mt -61.83 -39.42 91.73 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.891 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 42.5 mm -63.47 -43.36 98.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 118.813 -0.613 . . . . 0.0 111.257 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . 0.482 ' O ' ' O ' ' A' ' 205' ' ' LEU . 49.9 mtmt -60.27 -40.51 90.63 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 120.171 1.35 . . . . 0.0 111.613 177.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -64.81 -38.23 90.27 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 113.867 -1.515 . . . . 0.0 110.982 -176.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 13.3 t -101.89 129.16 48.07 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.706 0.765 . . . . 0.0 112.413 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 68.14 5.63 4.75 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 114.323 -1.308 . . . . 0.0 112.489 178.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.482 ' O ' ' O ' ' A' ' 201' ' ' LYS . 0.4 OUTLIER -141.78 79.88 1.7 Allowed 'General case' 0 N--CA 1.472 0.643 0 O-C-N 122.136 -0.352 . . . . 0.0 110.214 -178.652 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.539 ' O ' ' CB ' ' A' ' 207' ' ' ALA . 3.2 mtmp? -112.03 49.3 0.92 Allowed 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.079 -1.013 . . . . 0.0 110.826 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.539 ' CB ' ' O ' ' A' ' 206' ' ' LYS . . . 122.44 34.09 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.491 1.116 . . . . 0.0 110.007 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' ASN . . . . . 0.537 ' CB ' ' O ' ' A' ' 207' ' ' ALA . 9.0 t-20 102.36 -138.17 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 O-C-N 125.05 1.469 . . . . 0.0 108.95 -177.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.516 ' H ' ' CG ' ' A' ' 208' ' ' ASN . 0.3 OUTLIER . . . . . 0 N--CA 1.465 0.303 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . 0.409 ' O ' ' OD2' ' A' ' 213' ' ' ASP . 5.6 p-10 . . . . . 0 N--CA 1.465 0.278 0 CA-C-O 120.964 0.411 . . . . 0.0 110.455 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.431 ' N ' ' CD ' ' A' ' 215' ' ' PRO . 3.8 mt -61.58 -43.53 88.84 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -178.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 214' ' ' LEU . 31.0 Cg_exo -60.97 -33.51 92.22 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 CA-C-O 122.811 1.088 . . . . 0.0 111.02 -178.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 77.6 m -64.7 -41.79 95.77 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 112.352 -2.204 . . . . 0.0 110.997 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' HIS . . . . . 0.496 ' O ' ' ND1' ' A' ' 217' ' ' HIS . 1.1 t60 -66.28 -37.52 85.63 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.514 -178.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -63.08 -48.13 79.93 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.199 -178.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 78.8 p -60.82 -38.46 85.53 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 119.79 1.177 . . . . 0.0 110.484 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 64.2 m -59.79 -42.01 92.44 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . 0.529 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.98 -42.29 97.27 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -62.78 -48.14 80.45 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -176.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -61.88 -42.89 99.79 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 108.466 -1.854 . . . . 0.0 108.466 177.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . 0.518 ' O ' ' SG ' ' A' ' 227' ' ' CYS . . . -63.43 -38.64 91.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.112 -1.044 . . . . 0.0 109.183 177.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -62.37 -43.31 99.24 Favored Glycine 0 CA--C 1.521 0.435 0 CA-C-N 114.685 -1.143 . . . . 0.0 111.07 -177.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' PHE . . . . . 0.45 ' O ' ' OG1' ' A' ' 229' ' ' THR . 72.7 t80 -67.48 -39.85 85.24 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 119.274 -0.971 . . . . 0.0 109.849 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . 0.529 ' SG ' ' N ' ' A' ' 228' ' ' THR . 1.5 p -64.5 -41.82 96.2 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.766 0.794 . . . . 0.0 109.238 176.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' THR . . . . . 0.529 ' N ' ' SG ' ' A' ' 227' ' ' CYS . 91.3 m -62.35 -40.58 96.88 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 114.041 -1.436 . . . . 0.0 111.914 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 226' ' ' PHE . 5.4 p -58.73 -39.99 82.45 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.633 -176.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 58.9 t -61.05 -41.98 91.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 118.423 -1.311 . . . . 0.0 108.449 178.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . 0.503 ' O ' ' HD2' ' A' ' 234' ' ' PRO . 47.8 mt -62.48 -41.41 91.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.485 0.659 . . . . 0.0 110.158 177.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.06 -39.37 94.53 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 115.891 1.811 . . . . 0.0 115.891 -178.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.444 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 0.1 OUTLIER -57.95 -41.94 92.62 Favored Pre-proline 0 N--CA 1.475 0.809 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -172.512 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . 0.503 ' HD2' ' O ' ' A' ' 231' ' ' ILE . 30.7 Cg_exo -59.77 -41.13 57.65 Favored 'Trans proline' 0 C--N 1.295 -2.259 0 C-N-CA 121.209 1.272 . . . . 0.0 112.894 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -65.69 -37.03 79.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 118.639 -1.224 . . . . 0.0 109.246 177.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -66.01 -41.71 90.64 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.437 ' CG1' ' N ' ' A' ' 238' ' ' VAL . 1.6 p -65.88 -46.41 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -176.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.437 ' N ' ' CG1' ' A' ' 237' ' ' VAL . 9.9 p . . . . . 0 C--N 1.33 -0.247 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.971 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 29.7 p . . . . . 0 CA--C 1.532 0.279 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' MET . . . . . . . . . . . . . 10.1 ptm -62.78 -44.13 96.99 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -178.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.23 -47.01 86.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.858 0.361 . . . . 0.0 110.041 -178.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -66.49 -53.69 32.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.547 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 54.1 mttp -80.57 -124.92 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -48.92 117.21 1.97 Allowed 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . 0.489 ' C ' ' H ' ' A' ' 267' ' ' ARG . . . -47.94 175.67 0.02 OUTLIER Glycine 0 CA--C 1.53 1.029 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 179.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.6 0.73 0.69 Allowed 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 122.237 1.958 . . . . 0.0 111.87 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . 0.489 ' H ' ' C ' ' A' ' 265' ' ' GLY . 77.4 mtt85 -68.79 -25.92 64.94 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.195 0.598 . . . . 0.0 111.875 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -57.82 -31.97 67.14 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.127 -178.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -62.07 -42.13 98.88 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.1 0.476 . . . . 0.0 110.78 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -66.39 -38.09 86.73 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -177.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.47 ' CG ' ' N ' ' A' ' 272' ' ' GLY . 53.2 tttp -80.85 173.08 12.96 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . 0.47 ' N ' ' CG ' ' A' ' 271' ' ' LYS . . . 62.38 100.37 0.01 OUTLIER Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -173.85 5.67 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.53 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' MET . . . . . 0.578 ' N ' ' CD ' ' A' ' 275' ' ' PRO . 0.7 OUTLIER -64.03 -44.21 77.27 Favored Pre-proline 0 CA--C 1.531 0.229 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.04 -179.879 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 274' ' ' MET . 21.5 Cg_exo -64.38 -46.46 7.51 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.516 2.144 . . . . 0.0 111.253 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 20.0 m -60.41 -39.44 87.41 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.25 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -61.48 -42.59 99.02 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 122.583 1.182 . . . . 0.0 112.737 -178.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.96 -38.76 89.71 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 112.262 -2.244 . . . . 0.0 107.778 174.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 41.7 mmm-85 -62.68 -39.32 93.58 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.32 0.581 . . . . 0.0 110.511 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.66 -36.23 80.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.13 -0.941 . . . . 0.0 113.011 -177.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -67.75 -50.73 40.04 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -178.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 47.8 p -62.74 -43.94 97.5 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' TRP . . . . . . . . . . . . . 75.3 t90 -59.9 -37.94 80.85 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.524 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . 0.405 ' ND2' ' N ' ' A' ' 285' ' ' VAL . 0.0 OUTLIER -61.56 -37.82 85.21 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.559 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . 0.405 ' N ' ' ND2' ' A' ' 284' ' ' ASN . 94.6 t -59.76 -38.3 75.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.576 -0.283 . . . . 0.0 110.397 -179.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 10.8 t -62.58 -41.07 90.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.845 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -61.36 -39.25 89.92 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.22 0.533 . . . . 0.0 110.378 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -59.5 -41.05 88.99 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -178.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.435 ' O ' ' OE1' ' A' ' 293' ' ' GLN . 0.7 OUTLIER -61.36 -40.14 85.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -175.914 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.21 -39.41 94.55 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -60.48 -38.5 84.47 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 176.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 32.9 tp10 -57.94 -40.27 80.11 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 118.157 -1.417 . . . . 0.0 109.417 -176.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' GLN . . . . . 0.435 ' OE1' ' O ' ' A' ' 289' ' ' VAL . 5.2 mp0 -60.35 -42.23 95.3 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 122.827 1.299 . . . . 0.0 110.032 179.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 78.4 mt -60.27 -39.26 86.19 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 112.268 -2.242 . . . . 0.0 109.564 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -62.3 -45.2 94.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.582 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' ARG . . . . . 0.433 ' O ' ' O ' ' A' ' 293' ' ' GLN . 9.0 tpm_? -122.44 116.07 23.34 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -114.22 -163.84 0.89 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.223 0.535 . . . . 0.0 112.113 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 20.1 tp -72.22 114.4 10.29 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 176.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 41.7 ttp -95.93 61.9 2.2 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.527 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.75 101.04 0.07 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.937 0.875 . . . . 0.0 111.071 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -63.94 -46.05 86.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 113.814 -1.539 . . . . 0.0 113.293 -176.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -58.14 -38.9 77.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.739 -177.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 45.3 tp60 -63.75 -46.49 85.09 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.423 -178.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' SER . . . . . 0.438 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 3.4 t -66.0 -37.56 86.23 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.105 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -61.78 -42.94 99.63 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.97 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 11.7 tm-20 -64.94 -37.03 86.29 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -177.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -60.07 -52.87 70.38 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -176.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' PRO . . . . . 0.438 ' CD ' ' O ' ' A' ' 304' ' ' SER . 73.7 Cg_endo -75.4 0.49 9.01 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.166 1.911 . . . . 0.0 112.157 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.588 -179.852 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.9 m . . . . . 0 N--CA 1.46 0.031 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.621 ' CG2' ' H ' ' A' ' 16' ' ' LYS . 10.8 p -88.32 -178.6 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.28 -178.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.621 ' H ' ' CG2' ' A' ' 15' ' ' VAL . 12.6 mptt -63.96 -40.88 97.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.99 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -63.54 -41.26 98.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.79 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.0 tp -79.96 -26.61 39.95 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.804 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.441 ' O ' ' OG1' ' A' ' 22' ' ' THR . . . -66.56 -41.53 94.05 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 107.215 -2.354 . . . . 0.0 107.215 176.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.18 -31.78 68.06 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 124.917 2.294 . . . . 0.0 107.286 176.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.45 -42.78 98.92 Favored Glycine 0 CA--C 1.527 0.825 1 CA-C-N 108.32 -4.037 . . . . 0.0 108.234 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.501 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 28.9 p -70.65 -28.01 64.49 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.529 0.681 . . . . 0.0 109.345 177.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.2 -50.16 64.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.866 -178.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.443 ' O ' ' OD2' ' A' ' 28' ' ' ASP . . . -62.04 -35.74 79.49 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 118.404 -1.318 . . . . 0.0 111.322 -177.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.638 ' SG ' ' N ' ' A' ' 26' ' ' ILE . 5.4 p -64.1 -53.48 48.93 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.538 -179.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.638 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 11.2 tp -65.59 -39.79 86.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -177.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.02 -41.78 97.32 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 119.775 -0.77 . . . . 0.0 112.967 -173.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.484 ' CG ' ' NE2' ' A' ' 89' ' ' GLN . 1.7 p30 -77.64 -27.14 50.95 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 118.329 -1.348 . . . . 0.0 109.636 -176.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 10.9 tp -60.16 -55.92 27.95 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 119.65 1.114 . . . . 0.0 111.929 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.8 tt -75.58 -4.63 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-O 121.382 0.61 . . . . 0.0 112.274 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 53.5 m -109.41 -16.72 13.95 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.013 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.457 ' N ' ' HD2' ' A' ' 33' ' ' PRO . 84.2 t80 -68.46 -45.89 36.72 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 121.879 2.127 . . . . 0.0 112.011 -177.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 32' ' ' PHE . 27.7 Cg_endo -60.35 -16.1 39.28 Favored 'Trans proline' 0 N--CA 1.5 1.862 0 CA-C-N 121.27 1.489 . . . . 0.0 112.858 177.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 80.5 mt -67.08 -35.18 79.25 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.518 0.932 . . . . 0.0 113.518 -177.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -64.45 -40.07 95.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.236 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.8 m -58.33 -35.0 71.24 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.922 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.65 -37.92 83.1 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.124 -0.63 . . . . 0.0 111.615 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -61.4 -49.09 78.31 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.631 -176.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -63.28 -39.09 83.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 119.193 0.906 . . . . 0.0 112.248 -177.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.599 ' NH2' HE22 ' A' ' 58' ' ' GLN . 0.0 OUTLIER -60.36 -40.7 91.7 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.698 -179.485 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.82 39.02 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.946 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.477 ' H ' ' C ' ' A' ' 40' ' ' ARG . 21.3 pt20 -81.11 147.11 30.24 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.748 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 14.7 mt -82.67 53.19 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.987 0.422 . . . . 0.0 110.246 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 45.01 74.83 0.12 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.742 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.52 59.95 0.31 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.405 ' O ' ' OG ' ' A' ' 47' ' ' SER . 28.3 tp10 -71.21 -7.18 45.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.836 0.35 . . . . 0.0 110.388 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' A' ' 46' ' ' GLU . 23.8 p 57.47 50.02 11.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.492 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -143.77 -18.43 0.6 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.674 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.15 -10.15 74.13 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.0 tp -65.28 -38.11 89.25 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.691 0.281 . . . . 0.0 111.554 -178.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.416 ' CG2' ' N ' ' A' ' 52' ' ' ARG . 14.7 m -60.88 -44.81 98.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.495 -178.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.416 ' N ' ' CG2' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -64.92 -33.43 76.02 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.208 -179.644 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 79.7 m -67.77 -38.23 83.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.969 0.414 . . . . 0.0 110.522 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -86.82 -153.84 0.22 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.77 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -162.42 -53.38 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.89 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.528 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 8.4 t -128.32 -139.1 0.24 Allowed 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 56' ' ' SER . . . 93.82 14.63 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.659 0.6 . . . . 0.0 111.592 178.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.599 HE22 ' NH2' ' A' ' 40' ' ' ARG . 6.4 pt20 175.89 122.74 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.946 0.403 . . . . 0.0 109.915 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -105.83 159.46 15.99 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.402 ' O ' ' C ' ' A' ' 61' ' ' GLY . 36.2 ptt180 -43.44 -32.35 0.86 Allowed 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.505 -0.478 . . . . 0.0 109.808 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 60' ' ' ARG . . . -31.37 102.75 0.01 OUTLIER Glycine 0 CA--C 1.526 0.733 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.01 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.7 p -67.08 -33.71 64.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 118.232 -0.889 . . . . 0.0 109.639 176.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -60.32 -32.63 71.42 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 121.442 1.928 . . . . 0.0 110.288 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.49 -49.0 67.54 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-N 115.377 -0.829 . . . . 0.0 114.352 -176.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 14.1 m -61.73 -46.02 91.44 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.201 -0.5 . . . . 0.0 112.057 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 72.1 mt -59.09 -36.23 61.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 74.4 mt -63.63 -34.97 79.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 120.439 1.472 . . . . 0.0 112.602 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.443 ' O ' ' OG1' ' A' ' 72' ' ' THR . 98.9 m -63.47 -41.59 98.6 Favored 'General case' 0 C--O 1.254 1.308 0 C-N-CA 125.433 1.493 . . . . 0.0 110.983 -174.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 6.5 ptp -60.36 -38.92 85.39 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 120.018 -1.676 . . . . 0.0 113.842 -176.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.3 m -68.55 -40.77 82.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 119.025 -1.07 . . . . 0.0 113.627 -176.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 61.5 ttp85 -77.92 -13.55 59.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 122.028 0.918 . . . . 0.0 112.305 -178.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 68' ' ' THR . 70.4 m -62.92 -55.05 29.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.335 -1.302 . . . . 0.0 111.775 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -108.68 -58.22 2.04 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.794 178.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.32 164.62 13.58 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -56.59 -35.16 96.87 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 121.966 1.777 . . . . 0.0 111.775 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.465 ' O ' ' OD1' ' A' ' 80' ' ' ASN . 96.5 mtt180 -60.93 -11.19 7.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.928 0.87 . . . . 0.0 110.925 176.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.505 ' O ' ' OD1' ' A' ' 80' ' ' ASN . 7.4 t -77.64 -32.21 53.23 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 113.275 -1.784 . . . . 0.0 110.265 -178.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.9 mp -75.54 -29.34 59.37 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.224 1.01 . . . . 0.0 111.59 177.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -87.4 -2.62 58.75 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 122.896 1.331 . . . . 0.0 113.417 -172.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.505 ' OD1' ' O ' ' A' ' 77' ' ' SER . 11.9 p-10 -117.67 135.14 54.21 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 112.104 -2.316 . . . . 0.0 108.207 176.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.8 -25.9 25.89 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 -177.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.14 -34.44 72.06 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 113.834 -1.183 . . . . 0.0 110.283 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.6 p -70.83 -27.12 29.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.917 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.88 -31.86 61.7 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.408 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.8 -40.13 89.74 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 119.984 -1.103 . . . . 0.0 111.205 -177.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 86.2 mt -62.55 -40.25 96.21 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 122.285 1.04 . . . . 0.0 112.871 -176.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -60.67 -27.5 67.88 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 113.149 -1.841 . . . . 0.0 109.865 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 14.9 mmt85 -57.93 -53.32 59.54 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 173.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.484 ' NE2' ' CG ' ' A' ' 28' ' ' ASP . 60.7 mt-30 -66.83 -29.74 69.74 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 112.418 -2.174 . . . . 0.0 111.776 -177.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 33.9 ttm -61.37 -40.89 95.97 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.067 -0.97 . . . . 0.0 112.429 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.9 m -74.59 -34.65 62.91 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.453 -176.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -57.63 -43.67 84.99 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 120.794 1.633 . . . . 0.0 112.123 -176.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.47 -32.6 64.42 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 119.602 -0.839 . . . . 0.0 111.228 -178.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 38.7 t -64.11 -41.57 97.21 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.434 ' C ' ' H ' ' A' ' 97' ' ' ILE . 30.6 m -67.8 -27.94 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.005 177.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.473 ' CG ' ' O ' ' A' ' 96' ' ' ARG . 6.7 ttt85 -77.61 9.28 3.49 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -176.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.434 ' H ' ' C ' ' A' ' 95' ' ' VAL . 0.3 OUTLIER -87.02 -15.95 9.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 176.538 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -140.49 -48.46 0.05 OUTLIER Glycine 0 CA--C 1.544 1.891 0 N-CA-C 115.569 0.987 . . . . 0.0 115.569 -177.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 14.9 mt -71.17 -13.12 61.83 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.2 1.5 . . . . 0.0 112.644 -177.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.446 ' O ' ' HB2' ' A' ' 104' ' ' LYS . 1.9 m-85 -81.0 -50.34 9.81 Favored 'General case' 0 C--O 1.214 -0.785 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.008 178.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.922 ' OD2' ' NE2' ' A' ' 105' ' ' GLN . 19.4 t70 -68.55 -31.82 71.31 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 114.059 -1.428 . . . . 0.0 110.12 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.0 t -69.33 -53.16 21.01 Favored 'General case' 0 CA--C 1.554 1.107 0 CA-C-N 112.203 -2.272 . . . . 0.0 114.544 177.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.1 t -74.9 -27.64 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 CA-C-N 122.487 2.403 . . . . 0.0 113.437 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.446 ' HB2' ' O ' ' A' ' 100' ' ' TYR . 13.4 tttp -70.16 -40.99 74.41 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 112.004 -2.362 . . . . 0.0 111.548 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.922 ' NE2' ' OD2' ' A' ' 101' ' ' ASP . 88.1 mt-30 -79.62 -13.17 59.69 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.742 0.782 . . . . 0.0 111.071 -178.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -78.79 -22.92 45.58 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.876 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 6.4 m-30 -109.04 -30.11 8.23 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 119.341 0.973 . . . . 0.0 112.068 -174.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.2 m -97.49 9.25 42.91 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 117.926 -1.509 . . . . 0.0 113.233 -178.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.466 ' O ' ' C ' ' A' ' 110' ' ' GLY . 18.7 mmtt -52.77 121.51 7.37 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-N 119.025 0.83 . . . . 0.0 111.715 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.517 ' O ' ' CB ' ' A' ' 111' ' ' SER . . . -22.91 -82.35 0.01 OUTLIER Glycine 0 N--CA 1.485 1.91 0 CA-C-N 118.665 0.666 . . . . 0.0 113.171 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.517 ' CB ' ' O ' ' A' ' 110' ' ' GLY . 1.4 m 96.53 -90.26 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 178.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.513 ' O ' ' CG ' ' A' ' 113' ' ' HIS . 0.3 OUTLIER 168.83 -35.75 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 120.725 1.602 . . . . 0.0 114.215 179.308 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.513 ' CG ' ' O ' ' A' ' 112' ' ' GLU . 1.1 p-80 155.61 46.07 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 121.103 0.477 . . . . 0.0 110.841 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.484 ' CB ' ' O ' ' A' ' 113' ' ' HIS . . . 159.91 -162.9 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.15 15.25 26.4 Favored Glycine 0 C--N 1.337 0.587 0 CA-C-N 114.114 -1.403 . . . . 0.0 111.2 178.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.413 HD13 HG21 ' A' ' 116' ' ' ILE . 31.6 mm -60.66 -41.07 86.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 C-N-CA 120.065 -0.654 . . . . 0.0 109.278 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.54 -40.12 95.94 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 121.91 0.728 . . . . 0.0 111.858 175.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 35.6 t -57.78 -41.81 82.79 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 177.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 9.5 ttm-85 -63.23 -36.78 84.78 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.984 -177.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 58.5 mt -63.73 -46.33 85.84 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.255 0.55 . . . . 0.0 109.805 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 41.5 mt -66.65 -44.77 81.02 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 119.112 -1.035 . . . . 0.0 110.459 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.69 -44.83 92.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 119.625 1.102 . . . . 0.0 109.932 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -65.73 -44.2 92.79 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 119.801 -1.19 . . . . 0.0 111.126 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 77.9 p -64.5 -44.44 90.96 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.829 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 97.2 m -69.47 -48.4 60.86 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 119.453 -0.899 . . . . 0.0 111.916 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.439 ' CG2' ' N ' ' A' ' 127' ' ' GLY . 6.2 t -65.26 -42.41 93.3 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -174.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.439 ' N ' ' CG2' ' A' ' 126' ' ' THR . . . -64.07 -44.78 95.33 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-O 122.704 1.169 . . . . 0.0 113.518 -177.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.406 ' O ' ' CG2' ' A' ' 131' ' ' VAL . . . -61.58 -41.62 97.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 112.358 -1.921 . . . . 0.0 107.141 177.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -64.66 -42.08 95.65 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.725 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.22 -39.94 96.05 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -177.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.524 ' O ' ' NE2' ' A' ' 135' ' ' GLN . 15.3 m -61.27 -25.75 37.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 123.005 1.383 . . . . 0.0 109.902 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -58.31 -44.93 88.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 111.906 -2.406 . . . . 0.0 112.621 -178.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.476 ' CG1' ' N ' ' A' ' 134' ' ' ALA . 3.5 p -78.95 -48.72 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 C-N-CA 120.712 -0.395 . . . . 0.0 112.006 -178.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.476 ' N ' ' CG1' ' A' ' 133' ' ' VAL . . . -122.95 135.92 54.67 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.994 0.426 . . . . 0.0 111.575 -178.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.698 ' H ' ' CD ' ' A' ' 136' ' ' PRO . 24.4 pt20 177.99 -24.61 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.703 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.717 178.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.698 ' CD ' ' H ' ' A' ' 135' ' ' GLN . 52.9 Cg_exo -53.14 -33.42 63.99 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 121.437 1.425 . . . . 0.0 112.691 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 11.1 t -66.54 -41.76 88.21 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 119.234 -0.986 . . . . 0.0 109.523 -178.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -64.93 -42.59 94.56 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 117.876 -1.53 . . . . 0.0 111.566 -178.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 15.1 t -64.64 -44.9 96.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.0 p -65.38 -37.08 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -178.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.44 ' O ' ' OE1' ' A' ' 145' ' ' GLN . 14.0 mptt -60.42 -40.2 90.19 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.713 -176.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 70.5 t -68.54 -44.52 82.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.523 ' NH2' ' O ' ' A' ' 174' ' ' GLY . 65.6 mtt-85 -64.34 -36.09 83.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.066 178.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.414 ' CD1' ' C ' ' A' ' 144' ' ' PHE . 36.0 t80 -66.46 -41.56 88.85 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -177.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.44 ' OE1' ' O ' ' A' ' 141' ' ' LYS . 4.8 mp0 -64.83 -39.5 93.68 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 118.941 -1.104 . . . . 0.0 108.087 178.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.39 -34.59 78.66 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.686 HE22 HE21 ' A' ' 157' ' ' GLN . 32.9 tt0 -60.54 110.3 1.24 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 175.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.487 ' C ' ' H ' ' A' ' 150' ' ' ALA . . . -106.1 -55.18 2.36 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 -175.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -77.24 21.47 0.24 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 122.327 2.33 . . . . 0.0 110.417 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.487 ' H ' ' C ' ' A' ' 148' ' ' ALA . . . 51.24 -94.72 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.659 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -162.78 -37.91 0.02 OUTLIER Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.638 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 179.913 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 74.3 t80 . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.772 0.32 . . . . 0.0 110.467 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.686 HE21 HE22 ' A' ' 147' ' ' GLN . 19.0 tt0 -71.54 164.8 25.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.455 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.441 ' OG ' ' N ' ' A' ' 159' ' ' THR . 29.7 t -156.94 -177.94 7.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.878 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.441 ' N ' ' OG ' ' A' ' 158' ' ' SER . 69.5 p -63.79 -45.96 87.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.65 -177.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 77.0 t -64.04 -45.37 96.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 119.067 -1.053 . . . . 0.0 109.165 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -66.89 -38.44 86.29 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.527 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.496 ' O ' ' CD1' ' A' ' 166' ' ' ILE . . . -61.33 -44.27 97.48 Favored 'General case' 0 C--O 1.211 -0.969 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -177.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -61.32 -47.85 84.04 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.67 0.747 . . . . 0.0 112.151 -177.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 17.8 tptp -68.19 -45.33 73.69 Favored 'General case' 0 CA--C 1.554 1.129 0 N-CA-C 117.841 2.534 . . . . 0.0 117.841 -172.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 17.6 m -63.1 -45.48 91.86 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 117.344 2.35 . . . . 0.0 117.344 -174.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.573 ' H ' ' CD1' ' A' ' 166' ' ' ILE . 0.1 OUTLIER -64.62 -37.36 79.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-O 121.524 0.678 . . . . 0.0 109.271 176.925 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.464 ' H ' HD13 ' A' ' 166' ' ' ILE . . . -59.18 -37.02 76.38 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 176.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -62.57 -50.32 71.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 122.992 2.633 . . . . 0.0 111.465 -177.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -75.15 -51.24 13.91 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 123.539 0.736 . . . . 0.0 109.409 177.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -78.27 -36.8 46.32 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 115.775 1.768 . . . . 0.0 115.775 -174.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 93.71 -168.44 29.12 Favored Glycine 0 N--CA 1.468 0.788 0 CA-C-N 118.472 0.578 . . . . 0.0 112.615 177.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.6 mt -73.56 -41.62 55.78 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.067 0 CA-C-O 122.252 1.025 . . . . 0.0 110.62 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 60.5 ttt85 -58.31 -32.77 68.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 113.448 -1.706 . . . . 0.0 111.027 -176.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.523 ' O ' ' NH2' ' A' ' 143' ' ' ARG . . . -59.83 -39.37 95.33 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 119.292 -1.432 . . . . 0.0 109.579 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 5.5 tp -69.44 -33.39 72.88 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 117.085 2.254 . . . . 0.0 117.085 -177.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 67.3 m95 -77.58 -7.46 56.37 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 111.254 -2.703 . . . . 0.0 109.843 -177.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -43.28 -48.02 6.66 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.556 -177.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -111.24 -29.61 3.41 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.065 0.84 . . . . 0.0 112.046 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 3.9 m -46.26 -52.14 13.15 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.31 -49.75 77.83 Favored Pre-proline 0 N--CA 1.481 1.118 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -177.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -62.2 -27.87 78.88 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 121.973 1.782 . . . . 0.0 111.766 175.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -63.41 -39.04 93.44 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 178.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 97.0 t -63.21 -42.0 94.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.251 178.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.53 -39.21 90.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.237 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.53 -41.52 94.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.035 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -60.97 -42.38 98.22 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.265 0.555 . . . . 0.0 110.051 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.68 -43.1 97.64 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.166 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 5.6 mm -63.14 -44.78 99.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -177.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.401 ' O ' ' CD ' ' A' ' 193' ' ' GLU . 6.9 m -59.69 -45.7 94.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 120.328 -0.549 . . . . 0.0 111.472 -178.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . 0.5 ' OD1' ' N ' ' A' ' 191' ' ' CYS . 2.0 p30 -61.84 -42.52 99.13 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 122.259 1.028 . . . . 0.0 108.91 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' CYS . . . . . 0.5 ' N ' ' OD1' ' A' ' 190' ' ' ASN . 52.2 t -62.15 -46.56 88.44 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 113.294 -1.775 . . . . 0.0 110.922 179.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.35 -40.61 96.2 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 114.296 -1.32 . . . . 0.0 109.529 176.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 0.515 ' OE1' ' N ' ' A' ' 193' ' ' GLU . 0.0 OUTLIER -61.52 -45.4 94.37 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.768 -178.701 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 4.1 tt -64.01 -39.52 94.3 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 118.331 -1.348 . . . . 0.0 110.18 -174.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 8.2 m -64.59 -45.86 94.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 116.909 -1.916 . . . . 0.0 107.775 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 98.4 m -64.16 -46.33 84.53 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -177.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -57.92 -40.11 79.61 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -178.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -56.48 -44.98 81.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.573 0.701 . . . . 0.0 109.317 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.515 ' CD2' ' N ' ' A' ' 199' ' ' LEU . 1.5 mm? -61.92 -39.89 93.6 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.51 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 45.6 mm -64.03 -43.54 97.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 118.575 -0.726 . . . . 0.0 112.893 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -59.63 -40.95 89.29 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 120.588 1.54 . . . . 0.0 110.839 178.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -66.22 -38.46 88.01 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 112.939 -1.937 . . . . 0.0 111.027 -177.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 43.8 m -102.26 130.3 48.91 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.367 -0.833 . . . . 0.0 112.446 -178.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 20.9 mt 68.08 5.58 4.7 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 114.777 -1.101 . . . . 0.0 113.402 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.403 ' CD2' ' O ' ' A' ' 205' ' ' LEU . 2.3 tt -137.37 49.58 2.0 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 178.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 4.3 tppt? -74.11 -23.55 59.33 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.718 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.483 ' O ' ' CB ' ' A' ' 208' ' ' ASN . . . -130.04 -40.22 1.34 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.776 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' ASN . . . . . 0.483 ' CB ' ' O ' ' A' ' 207' ' ' ALA . 41.2 p-10 130.34 76.1 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.247 1.419 . . . . 0.0 108.007 -178.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 3.1 tp . . . . . 0 N--CA 1.474 0.772 0 N-CA-C 118.276 2.695 . . . . 0.0 118.276 178.261 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . 0.491 ' OD1' ' SG ' ' A' ' 216' ' ' CYS . 32.9 t70 . . . . . 0 C--O 1.232 0.141 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -61.31 -43.72 90.68 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -177.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -60.86 -34.07 91.8 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 CA-C-N 120.778 1.313 . . . . 0.0 111.514 -177.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' CYS . . . . . 0.491 ' SG ' ' OD1' ' A' ' 213' ' ' ASP . 62.4 m -66.56 -42.69 86.69 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 113.089 -1.869 . . . . 0.0 111.862 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 13.2 t-160 -66.59 -37.54 85.12 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.081 -1.418 . . . . 0.0 114.425 -176.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -62.92 -48.33 79.39 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 118.775 -0.631 . . . . 0.0 110.775 -178.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 12.9 m -61.26 -39.09 89.07 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 120.028 1.285 . . . . 0.0 110.013 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 39.5 t -59.97 -41.71 92.56 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 177.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . 0.564 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.53 -41.79 98.45 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -177.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -61.55 -46.86 88.13 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 122.162 0.982 . . . . 0.0 112.822 -175.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -60.88 -42.11 99.51 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 107.458 -2.257 . . . . 0.0 107.458 176.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . 0.515 ' O ' ' SG ' ' A' ' 227' ' ' CYS . . . -63.03 -37.21 86.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 113.869 -1.166 . . . . 0.0 108.934 176.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -61.06 -42.51 99.82 Favored Glycine 0 CA--C 1.52 0.383 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.626 -176.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' PHE . . . . . 0.419 ' O ' ' OG1' ' A' ' 229' ' ' THR . 67.3 t80 -66.88 -38.87 87.11 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 118.782 -1.167 . . . . 0.0 108.4 178.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . 0.515 ' SG ' ' O ' ' A' ' 224' ' ' ALA . 0.5 OUTLIER -63.89 -41.18 97.79 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.165 0.507 . . . . 0.0 110.251 177.445 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' THR . . . . . 0.477 ' HG1' ' N ' ' A' ' 229' ' ' THR . 78.5 p -61.58 -40.3 94.28 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.465 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.477 ' N ' ' HG1' ' A' ' 228' ' ' THR . 23.8 p -59.34 -40.26 85.77 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 119.802 -0.759 . . . . 0.0 111.567 -176.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 92.7 t -61.47 -43.17 96.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 118.588 -1.245 . . . . 0.0 111.919 -178.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 3.4 tp -63.08 -40.86 90.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 121.711 0.767 . . . . 0.0 109.148 176.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -62.58 -39.39 93.56 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 114.331 -1.304 . . . . 0.0 113.924 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.488 ' N ' ' HD2' ' A' ' 234' ' ' PRO . 8.0 t -58.34 -42.39 94.49 Favored Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 116.04 1.867 . . . . 0.0 116.04 -174.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 233' ' ' SER . 17.9 Cg_endo -58.93 -40.9 67.34 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 CA-C-N 121.352 1.519 . . . . 0.0 113.457 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 2.8 p -65.52 -37.63 80.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 118.357 -1.337 . . . . 0.0 110.914 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -66.42 -42.0 88.4 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 15.6 m -65.59 -45.66 91.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -176.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 12.9 p . . . . . 0 C--N 1.323 -0.58 0 C-N-CA 119.116 -1.034 . . . . 0.0 112.047 -177.683 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 67.0 p . . . . . 0 CA--C 1.529 0.137 0 CA-C-O 121.634 0.73 . . . . 0.0 109.222 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' MET . . . . . . . . . . . . . 39.1 ttp -58.71 -41.6 86.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.625 -1.17 . . . . 0.0 110.066 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 15.3 tp -61.06 -45.86 93.02 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.745 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 40.5 ttt-85 -65.77 -54.07 32.05 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 120.434 -0.506 . . . . 0.0 112.029 -177.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 3.4 pttt -75.34 -52.99 9.49 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 119.877 -0.729 . . . . 0.0 111.46 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' A' ' 265' ' ' GLY . 22.9 mt-10 -84.36 112.55 20.43 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.356 -179.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 264' ' ' GLU . . . -39.65 170.51 0.01 OUTLIER Glycine 0 CA--C 1.532 1.097 0 CA-C-N 115.718 -0.673 . . . . 0.0 112.564 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.3 -2.36 5.83 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.492 2.128 . . . . 0.0 112.515 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . 0.407 ' HD3' ' H ' ' A' ' 268' ' ' ALA . 0.0 OUTLIER -69.77 -26.42 64.28 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 179.476 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . 0.407 ' H ' ' HD3' ' A' ' 267' ' ' ARG . . . -58.37 -32.5 68.63 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.241 -178.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -62.5 -41.46 98.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.4 0.619 . . . . 0.0 110.96 177.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -65.86 -37.18 85.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.338 -178.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.78 164.04 13.85 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 60.45 106.16 0.01 OUTLIER Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -174.68 12.32 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.441 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' MET . . . . . 0.45 ' N ' ' HD2' ' A' ' 275' ' ' PRO . 17.1 mtt -63.84 -44.93 80.91 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' A' ' 274' ' ' MET . 38.0 Cg_endo -64.93 -47.39 4.97 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 CA-C-N 120.586 1.245 . . . . 0.0 112.436 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' SER . . . . . 0.521 ' HG ' ' N ' ' A' ' 277' ' ' PHE . 89.7 p -61.32 -40.57 94.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.754 0.787 . . . . 0.0 109.926 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . 0.521 ' N ' ' HG ' ' A' ' 276' ' ' SER . 59.1 t80 -62.05 -41.85 98.56 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 123.597 1.665 . . . . 0.0 112.264 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 29.4 mt -62.0 -38.5 88.87 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 110.272 -3.149 . . . . 0.0 108.513 174.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -62.67 -40.88 98.46 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.475 0.655 . . . . 0.0 110.465 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.454 ' CD1' ' C ' ' A' ' 280' ' ' LEU . 0.1 OUTLIER -62.43 -36.56 82.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.326 -177.585 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -68.04 -51.14 35.64 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -178.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 7.5 t -63.09 -45.04 93.99 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.226 0.61 . . . . 0.0 110.506 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' TRP . . . . . . . . . . . . . 16.3 t90 -60.77 -38.22 84.51 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.698 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . 0.446 ' OD1' ' CD1' ' A' ' 280' ' ' LEU . 2.2 m120 -61.96 -37.72 85.8 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.43 0.529 . . . . 0.0 112.43 -178.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -59.95 -37.67 73.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -177.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -61.95 -40.11 86.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.942 -178.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 4.5 ptm -60.58 -38.77 85.7 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -58.65 -40.04 82.31 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.444 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 86.0 t -60.73 -39.37 81.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.522 -178.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 71.0 m -63.03 -40.56 98.09 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 119.654 -0.819 . . . . 0.0 109.039 177.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -60.92 -38.94 87.52 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 177.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -58.34 -40.21 81.56 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 117.756 -1.578 . . . . 0.0 109.847 -176.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' GLN . . . . . 0.459 ' O ' ' O ' ' A' ' 296' ' ' ARG . 76.6 mt-30 -60.32 -42.67 96.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 122.893 1.33 . . . . 0.0 110.874 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 9.4 mp -60.29 -39.75 88.02 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 112.487 -2.142 . . . . 0.0 109.226 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 26.7 mmtt -62.9 -45.47 92.39 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.055 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' ARG . . . . . 0.459 ' O ' ' O ' ' A' ' 293' ' ' GLN . 41.4 ttm180 -122.83 116.38 23.57 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -116.97 -162.69 0.87 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.311 0.577 . . . . 0.0 112.356 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 1.9 mt -69.55 116.14 9.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.504 177.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 2.5 tpt -99.5 60.4 1.14 Allowed 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -177.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.66 100.78 0.07 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.651 0.739 . . . . 0.0 110.551 -178.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -63.96 -46.21 85.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.345 -1.298 . . . . 0.0 114.029 -176.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -58.77 -39.9 82.4 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.185 -178.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' GLN . . . . . 0.528 ' N ' ' OE1' ' A' ' 303' ' ' GLN . 11.0 mp0 -65.0 -46.76 80.05 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.413 -179.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' SER . . . . . 0.439 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 78.1 p -66.69 -37.68 85.23 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.508 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -61.83 -43.15 99.42 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -179.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -65.11 -37.09 86.37 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 -176.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -60.17 -52.98 69.45 Favored Pre-proline 0 CA--C 1.544 0.738 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 -176.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' PRO . . . . . 0.439 ' CD ' ' O ' ' A' ' 304' ' ' SER . 74.2 Cg_endo -75.29 0.3 9.18 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.147 1.898 . . . . 0.0 111.929 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 86.0 t80 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.547 -179.965 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.9 m . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.779 0.324 . . . . 0.0 110.455 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.0 t -147.57 158.92 8.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.518 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.437 ' NZ ' ' CB ' ' A' ' 16' ' ' LYS . 0.3 OUTLIER -64.41 -41.55 96.57 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.582 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.404 ' N ' ' CG ' ' A' ' 16' ' ' LYS . 4.4 t80 -63.95 -41.6 97.53 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.501 ' N ' ' CD2' ' A' ' 18' ' ' LEU . 3.3 mm? -79.58 -26.73 41.24 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.803 -178.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.442 ' O ' ' OG1' ' A' ' 22' ' ' THR . . . -66.2 -41.29 94.91 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 107.486 -2.245 . . . . 0.0 107.486 177.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.73 -32.21 67.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 124.79 2.233 . . . . 0.0 107.705 176.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.47 -42.4 99.01 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-N 108.501 -3.954 . . . . 0.0 108.091 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.498 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 34.4 p -70.55 -27.34 64.07 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 177.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.39 -50.09 64.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.879 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.0 -36.17 80.72 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 118.621 -1.232 . . . . 0.0 111.502 -177.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.625 ' SG ' ' N ' ' A' ' 26' ' ' ILE . 8.7 p -63.88 -53.21 54.07 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.382 -178.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.625 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -64.84 -38.98 84.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -176.505 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.73 -41.2 98.09 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -173.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.524 ' OD1' ' NE2' ' A' ' 89' ' ' GLN . 6.7 m-20 -77.18 -27.24 53.57 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 120.976 1.717 . . . . 0.0 111.714 -174.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.98 -54.09 50.12 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 121.29 1.859 . . . . 0.0 112.894 -178.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.5 tt -75.34 -4.2 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -179.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 34.2 p -109.03 -16.03 14.22 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 119.369 -0.932 . . . . 0.0 109.315 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.463 ' N ' ' HD2' ' A' ' 33' ' ' PRO . 88.1 t80 -68.18 -45.77 39.86 Favored Pre-proline 0 CA--C 1.546 0.826 0 CA-C-N 121.821 2.1 . . . . 0.0 111.488 -178.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 32' ' ' PHE . 26.3 Cg_endo -60.33 -15.72 36.89 Favored 'Trans proline' 0 N--CA 1.504 2.122 0 CA-C-N 121.299 1.5 . . . . 0.0 113.195 176.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.409 ' N ' ' CD2' ' A' ' 34' ' ' LEU . 3.9 mm? -66.62 -34.94 79.0 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -177.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -64.18 -40.17 95.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.345 -178.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.3 m -58.3 -35.14 71.37 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.253 -0.43 . . . . 0.0 112.048 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.53 -38.5 84.32 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 119.926 -0.71 . . . . 0.0 111.981 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.637 ' HZ2' HH12 ' A' ' 279' ' ' ARG . 27.2 ttpt -61.25 -48.44 81.42 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 119.614 -0.835 . . . . 0.0 110.938 -176.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.3 t -62.9 -38.91 83.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -177.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.548 ' C ' ' H ' ' A' ' 42' ' ' GLN . 5.8 mmm180 -59.83 -41.1 90.62 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 119.806 -0.758 . . . . 0.0 109.948 -179.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -62.19 38.62 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.157 178.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.548 ' H ' ' C ' ' A' ' 40' ' ' ARG . 45.3 tt0 -87.18 147.87 25.41 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 121.89 -0.506 . . . . 0.0 110.972 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 29.1 pt -81.42 -177.07 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.431 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -74.48 135.48 42.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.714 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 46' ' ' GLU . . . 168.99 -114.27 0.55 Allowed Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.406 ' O ' ' O ' ' A' ' 45' ' ' GLY . 38.0 tt0 60.62 131.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.831 0.348 . . . . 0.0 110.845 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 69.5 m -74.1 -34.08 63.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.072 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -52.15 -38.88 58.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.351 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.92 9.44 85.36 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -178.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.437 ' O ' ' OG1' ' A' ' 53' ' ' THR . 0.2 OUTLIER -66.62 -38.42 86.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.294 0.569 . . . . 0.0 110.241 179.004 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.432 ' O ' ' O ' ' A' ' 54' ' ' ALA . 97.2 t -60.95 -45.26 98.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.095 -177.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -65.32 -34.16 77.69 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.787 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.437 ' OG1' ' O ' ' A' ' 50' ' ' LEU . 23.3 p -68.4 -38.18 81.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.907 0.384 . . . . 0.0 110.345 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' A' ' 51' ' ' VAL . . . -95.83 122.02 38.18 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.127 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.97 -43.0 12.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.723 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.443 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 10.4 m -131.05 -137.94 0.21 Allowed 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.443 ' CB ' ' O ' ' A' ' 56' ' ' SER . . . 80.1 -27.04 0.15 Allowed 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 176.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -120.82 38.81 3.94 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.528 ' O ' ' NH2' ' A' ' 40' ' ' ARG . 16.2 m-85 -37.51 151.62 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.81 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.42 ' O ' ' C ' ' A' ' 61' ' ' GLY . 31.9 mtm105 -46.4 -33.68 4.08 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 60' ' ' ARG . . . -30.51 101.95 0.01 OUTLIER Glycine 0 CA--C 1.527 0.795 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.89 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.2 p -66.95 -33.94 66.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 118.155 -0.926 . . . . 0.0 109.44 176.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.52 -33.01 72.01 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 121.263 1.847 . . . . 0.0 110.343 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.94 -49.5 62.59 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-N 115.518 -0.765 . . . . 0.0 114.575 -176.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.488 ' OG1' ' NH2' ' A' ' 40' ' ' ARG . 4.6 m -62.18 -46.36 89.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.005 -0.598 . . . . 0.0 112.498 -178.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 11.2 tt -59.78 -35.79 62.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.87 -35.77 81.74 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 120.597 1.544 . . . . 0.0 111.488 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.44 ' O ' ' OG1' ' A' ' 72' ' ' THR . 99.5 m -63.08 -39.3 94.32 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 113.595 -1.639 . . . . 0.0 111.064 -175.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.492 ' SD ' ' O ' ' A' ' 69' ' ' MET . 0.0 OUTLIER -60.59 -39.99 90.12 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 120.835 -1.166 . . . . 0.0 113.912 -176.548 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.1 p -69.33 -40.34 80.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 119.256 -0.978 . . . . 0.0 112.726 -178.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -78.3 -13.37 59.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.334 0.588 . . . . 0.0 112.585 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 68' ' ' THR . 90.8 m -62.88 -55.02 29.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.136 179.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -108.01 -56.93 2.17 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 157.84 164.39 13.87 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -56.29 -34.96 95.18 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.009 1.806 . . . . 0.0 111.673 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 72.4 mtp85 -61.23 -11.55 9.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.609 0.719 . . . . 0.0 111.463 176.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.9 p -78.28 -33.07 49.76 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.853 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.443 ' CD1' ' N ' ' A' ' 78' ' ' LEU . 8.9 mp -76.13 -32.12 58.98 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 122.309 -0.244 . . . . 0.0 111.45 179.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -90.7 -3.83 57.19 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 123.485 1.612 . . . . 0.0 112.531 -176.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.674 HD21 ' HH ' ' A' ' 156' ' ' TYR . 28.0 t30 -94.24 37.36 1.11 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 110.748 -2.933 . . . . 0.0 108.732 176.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -168.45 -15.37 0.02 OUTLIER Glycine 0 CA--C 1.533 1.209 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.842 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 59.9 mt -59.97 -34.92 73.94 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 119.163 -1.015 . . . . 0.0 111.861 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.9 p -70.54 -27.67 32.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.846 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.7 -31.62 61.93 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.541 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -68.37 -40.57 86.98 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 119.472 -1.347 . . . . 0.0 111.601 -177.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 27.1 mt -63.01 -41.21 99.51 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -176.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -60.9 -26.78 67.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.405 -1.271 . . . . 0.0 108.925 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 18.7 ttm105 -57.47 -53.46 57.87 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 173.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.524 ' NE2' ' OD1' ' A' ' 28' ' ' ASP . 10.7 mm100 -67.05 -29.58 69.42 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 112.557 -2.11 . . . . 0.0 112.089 -178.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 34.4 ttm -61.19 -40.4 93.77 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.951 -1.022 . . . . 0.0 112.682 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 78.2 p -74.22 -34.31 63.65 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 118.491 -0.766 . . . . 0.0 111.058 -176.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -57.8 -44.36 86.29 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 120.609 1.55 . . . . 0.0 110.746 -177.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.63 -33.47 64.56 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 119.075 -1.05 . . . . 0.0 110.744 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.3 p -64.82 -42.85 94.65 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.461 ' C ' ' H ' ' A' ' 97' ' ' ILE . 11.7 p -68.52 -27.91 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.666 178.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.06 9.84 2.74 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 -176.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.461 ' H ' ' C ' ' A' ' 95' ' ' VAL . 99.2 mt -87.23 -15.11 9.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 177.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -140.39 -47.9 0.06 OUTLIER Glycine 0 CA--C 1.538 1.504 0 N-CA-C 115.846 1.098 . . . . 0.0 115.846 -175.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.531 ' CD2' ' N ' ' A' ' 99' ' ' LEU . 3.3 mm? -70.9 -12.62 61.65 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.109 1.454 . . . . 0.0 112.02 -178.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -79.78 -50.43 10.57 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.0 -1.454 . . . . 0.0 109.609 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -67.71 -32.35 72.92 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 113.768 -1.56 . . . . 0.0 109.264 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.2 p -69.84 -53.96 15.74 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 112.661 -2.063 . . . . 0.0 112.874 175.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.411 ' CG2' ' HH ' ' A' ' 107' ' ' TYR . 0.3 OUTLIER -75.15 -27.63 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-N 122.088 2.222 . . . . 0.0 116.182 -176.835 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.514 ' NZ ' ' CB ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -69.54 -43.5 72.85 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 112.409 -2.178 . . . . 0.0 113.412 -177.723 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.421 ' N ' ' HG3' ' A' ' 104' ' ' LYS . 88.1 mt-30 -78.27 -10.97 59.89 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 124.345 2.021 . . . . 0.0 111.039 178.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -79.23 -22.69 44.47 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 112.055 -2.339 . . . . 0.0 111.512 178.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.411 ' HH ' ' CG2' ' A' ' 103' ' ' VAL . 28.2 m-85 -109.38 -30.74 7.83 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 119.155 0.889 . . . . 0.0 110.831 -177.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.3 m -97.75 8.85 43.98 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 117.918 -1.513 . . . . 0.0 113.157 -178.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.494 ' O ' ' C ' ' A' ' 110' ' ' GLY . 35.4 ttpt -48.74 125.75 10.7 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 117.908 -1.044 . . . . 0.0 109.541 177.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' A' ' 111' ' ' SER . . . -29.39 -74.45 0.04 OUTLIER Glycine 0 N--CA 1.485 1.962 0 CA-C-N 120.231 1.378 . . . . 0.0 111.6 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.531 ' CB ' ' O ' ' A' ' 110' ' ' GLY . 2.7 m 104.23 -161.67 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 177.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.618 ' O ' ' N ' ' A' ' 114' ' ' ALA . 79.6 tt0 -129.95 102.3 6.22 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -178.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.464 ' O ' ' CB ' ' A' ' 114' ' ' ALA . 88.0 m-70 13.51 46.75 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 O-C-N 124.411 1.069 . . . . 0.0 113.135 178.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.618 ' N ' ' O ' ' A' ' 112' ' ' GLU . . . 159.09 -161.7 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.16 15.02 26.98 Favored Glycine 0 C--N 1.337 0.626 0 CA-C-N 115.141 -0.936 . . . . 0.0 113.038 176.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 50.0 mt -60.73 -40.72 85.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 C-N-CA 119.133 -1.027 . . . . 0.0 108.576 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.6 -40.09 95.81 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 122.01 0.783 . . . . 0.0 111.362 175.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 19.4 m -58.18 -42.53 86.24 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 177.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -63.72 -37.42 87.3 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.009 -0.676 . . . . 0.0 111.058 -178.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 97.2 mt -64.16 -46.56 83.5 Favored 'General case' 0 N--CA 1.457 -0.11 0 CA-C-O 121.481 0.657 . . . . 0.0 109.352 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.4 tt -66.67 -44.59 81.39 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.933 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.36 -44.69 94.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 119.457 1.026 . . . . 0.0 108.853 177.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -65.83 -44.03 92.81 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 120.034 -1.079 . . . . 0.0 111.584 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 63.9 m -64.27 -44.51 91.52 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 13.9 t -70.16 -48.02 59.11 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 118.885 -1.126 . . . . 0.0 112.077 177.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.413 ' CG2' ' N ' ' A' ' 127' ' ' GLY . 9.4 t -65.66 -42.69 91.05 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 -174.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.413 ' N ' ' CG2' ' A' ' 126' ' ' THR . . . -64.23 -44.71 95.19 Favored Glycine 0 C--N 1.33 0.206 0 CA-C-N 114.416 -1.265 . . . . 0.0 112.253 -178.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.01 -41.58 96.81 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 112.302 -1.949 . . . . 0.0 106.287 177.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 31.3 mt -64.91 -42.36 94.8 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.841 177.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.24 -40.01 96.23 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -177.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.459 ' O ' ' O ' ' A' ' 134' ' ' ALA . 4.0 p -61.22 -24.84 34.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 122.932 1.348 . . . . 0.0 109.042 178.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -57.64 -44.55 85.68 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 112.188 -2.278 . . . . 0.0 111.343 -178.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.9 p -78.81 -48.74 21.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.229 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.459 ' O ' ' O ' ' A' ' 131' ' ' VAL . . . -92.06 138.18 31.75 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.712 0.291 . . . . 0.0 111.064 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.497 ' N ' ' CD ' ' A' ' 136' ' ' PRO . 1.2 tt0 -179.69 -47.19 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.815 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 135' ' ' GLN . 55.3 Cg_exo -52.11 -33.5 53.96 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 122.326 2.017 . . . . 0.0 112.302 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 32.2 p -67.69 -42.78 81.53 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 117.941 -1.504 . . . . 0.0 109.786 -179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -66.24 -42.96 87.88 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 119.317 -0.953 . . . . 0.0 112.098 -178.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 62.5 t -64.08 -43.72 97.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -179.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 72.4 t -64.89 -39.34 85.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -177.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 31.3 mttp -62.83 -42.01 99.56 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 118.754 -1.179 . . . . 0.0 111.325 -178.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 11.8 m -71.24 -46.33 66.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.87 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 12.8 tpp85 -65.59 -37.37 86.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.895 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -67.34 -42.0 84.26 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -177.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.3 -40.49 90.03 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 119.173 -1.011 . . . . 0.0 111.232 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.32 -35.46 81.08 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 -177.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -60.62 111.27 1.54 Allowed 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 176.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -106.12 -52.44 2.8 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.872 1.804 . . . . 0.0 115.872 -174.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.426 ' C ' ' H ' ' A' ' 151' ' ' GLY . 10.9 mmt180 -86.9 12.14 11.78 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 121.68 2.036 . . . . 0.0 110.544 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . 72.62 -45.72 0.63 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.667 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.426 ' H ' ' C ' ' A' ' 149' ' ' ARG . . . 103.16 169.71 26.0 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.636 0 N-CA-C 111.094 -0.803 . . . . 0.0 111.094 -179.93 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.674 ' HH ' HD21 ' A' ' 80' ' ' ASN . 0.7 OUTLIER . . . . . 0 CA--C 1.534 0.348 0 CA-C-O 120.907 0.384 . . . . 0.0 110.751 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.516 ' H ' ' NE2' ' A' ' 157' ' ' GLN . 4.1 mp0 -62.65 164.17 8.07 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.42 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.403 ' OG ' ' N ' ' A' ' 159' ' ' THR . 47.6 t -157.16 -178.02 7.05 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.457 0.646 . . . . 0.0 111.273 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.437 ' CG2' ' N ' ' A' ' 160' ' ' VAL . 15.1 t -63.78 -45.89 87.72 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.66 -177.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.437 ' N ' ' CG2' ' A' ' 159' ' ' THR . 94.9 t -63.95 -45.26 97.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 119.251 -0.98 . . . . 0.0 109.096 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 38.6 tp10 -67.01 -38.37 85.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.663 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.485 ' O ' ' CD1' ' A' ' 166' ' ' ILE . . . -60.96 -44.41 97.37 Favored 'General case' 0 C--O 1.211 -0.952 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -176.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.434 ' CD1' ' C ' ' A' ' 163' ' ' TYR . 14.8 t80 -61.25 -47.62 85.19 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.662 0.744 . . . . 0.0 112.204 -177.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.402 ' NZ ' ' CB ' ' A' ' 164' ' ' LYS . 2.3 ttmp? -68.39 -45.41 72.77 Favored 'General case' 0 CA--C 1.555 1.169 0 N-CA-C 118.17 2.656 . . . . 0.0 118.17 -173.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 63.8 p -63.49 -45.51 90.39 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 117.381 2.363 . . . . 0.0 117.381 -175.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.57 ' H ' ' CD1' ' A' ' 166' ' ' ILE . 0.2 OUTLIER -64.59 -37.14 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-O 121.635 0.731 . . . . 0.0 109.233 177.082 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.436 ' H ' HD12 ' A' ' 166' ' ' ILE . . . -58.93 -36.97 75.64 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 117.177 -1.392 . . . . 0.0 107.628 177.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 77.5 ttt-85 -62.75 -50.7 70.02 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 123.393 2.815 . . . . 0.0 111.835 -176.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -75.34 -51.22 13.69 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 123.584 0.754 . . . . 0.0 109.5 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -78.15 -36.54 47.54 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -174.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 91.9 -169.09 32.03 Favored Glycine 0 N--CA 1.464 0.509 0 N-CA-C 111.707 -0.557 . . . . 0.0 111.707 178.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.416 ' CG1' ' N ' ' A' ' 173' ' ' ARG . 7.5 pt -71.51 -42.04 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-O 121.454 0.645 . . . . 0.0 110.61 -179.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.416 ' N ' ' CG1' ' A' ' 172' ' ' ILE . 25.4 mmt180 -59.24 -34.09 71.8 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.595 -177.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -60.91 -40.67 98.68 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 118.514 -1.803 . . . . 0.0 109.035 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.55 -33.48 71.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 111.239 -2.48 . . . . 0.0 116.771 -177.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . 0.486 ' CD2' ' OG1' ' A' ' 179' ' ' THR . 33.5 t-105 -77.93 -7.63 57.02 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 111.694 -2.503 . . . . 0.0 110.563 -177.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 51.4 mttm -43.55 -48.41 7.49 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -176.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -99.31 -25.65 9.29 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.099 0.857 . . . . 0.0 112.601 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.486 ' OG1' ' CD2' ' A' ' 176' ' ' TRP . 69.2 p -46.3 -51.9 13.71 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.99 -50.41 76.94 Favored Pre-proline 0 N--CA 1.48 1.038 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -175.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -63.34 -28.35 71.85 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 121.628 1.552 . . . . 0.0 111.42 176.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -63.88 -39.0 93.18 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.245 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 71.1 t -62.69 -42.14 94.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.0 0.429 . . . . 0.0 110.009 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.72 -38.99 89.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.347 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -60.4 -41.97 94.99 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.71 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -61.55 -43.2 99.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.366 0.603 . . . . 0.0 110.169 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.34 -43.13 95.58 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.167 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 1.4 mp -63.04 -45.07 99.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.2 -177.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.42 ' O ' ' OE1' ' A' ' 193' ' ' GLU . 11.8 m -60.44 -47.06 94.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 119.409 -0.916 . . . . 0.0 112.431 -178.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -62.68 -43.19 99.44 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 122.586 1.184 . . . . 0.0 109.868 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' CYS . . . . . . . . . . . . . 31.2 m -62.34 -46.22 89.68 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 112.565 -2.107 . . . . 0.0 110.479 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.11 -40.13 95.53 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 114.037 -1.438 . . . . 0.0 109.659 176.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 0.492 ' OE1' ' N ' ' A' ' 193' ' ' GLU . 0.0 OUTLIER -61.01 -45.64 94.0 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.63 -178.381 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 67.2 tp -64.21 -39.14 93.37 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 118.637 -1.225 . . . . 0.0 110.053 -175.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 6.9 m -64.45 -45.88 94.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 C-N-CA 116.891 -1.924 . . . . 0.0 107.907 178.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 23.4 m -63.98 -45.95 86.78 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -178.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -57.16 -39.08 74.55 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.862 0.865 . . . . 0.0 112.56 -178.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -55.86 -44.29 77.92 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.467 ' CD2' ' N ' ' A' ' 199' ' ' LEU . 3.8 mm? -61.34 -38.79 88.19 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 41.8 mm -62.0 -42.41 94.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 26.1 mmtm -59.57 -38.71 81.86 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.876 1.27 . . . . 0.0 113.183 178.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -67.79 -37.12 81.6 Favored 'General case' 0 C--O 1.256 1.42 0 C-N-CA 118.511 -1.276 . . . . 0.0 111.028 -175.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 5.8 t -100.96 128.82 46.82 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 121.308 1.867 . . . . 0.0 111.895 -178.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . 0.508 ' CD2' ' CE1' ' A' ' 217' ' ' HIS . 6.9 mp 66.82 3.74 3.16 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 113.342 -1.754 . . . . 0.0 110.576 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 2.3 mt -126.59 29.78 5.66 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.882 0.849 . . . . 0.0 110.628 -179.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -68.78 -25.8 64.89 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.482 -1.235 . . . . 0.0 109.848 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.528 ' O ' ' ND2' ' A' ' 208' ' ' ASN . . . -161.93 39.62 0.13 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 114.363 -1.29 . . . . 0.0 109.563 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' ASN . . . . . 0.528 ' ND2' ' O ' ' A' ' 207' ' ' ALA . 0.4 OUTLIER 87.93 -18.38 0.27 Allowed 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 175.979 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.504 ' CB ' ' O ' ' A' ' 208' ' ' ASN . 1.0 OUTLIER . . . . . 0 N--CA 1.477 0.907 0 CA-C-N 119.742 1.155 . . . . 0.0 109.524 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 . . . . . 0 N--CA 1.465 0.307 0 CA-C-O 121.308 0.575 . . . . 0.0 109.683 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.412 ' N ' ' CD ' ' A' ' 215' ' ' PRO . 2.5 mm? -61.24 -43.89 91.55 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.921 -178.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 214' ' ' LEU . 27.3 Cg_exo -60.7 -34.45 91.92 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 CA-C-N 120.263 1.129 . . . . 0.0 111.16 -178.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 7.9 t -65.24 -42.43 93.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 113.085 -1.871 . . . . 0.0 111.231 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' HIS . . . . . 0.522 ' O ' ' ND1' ' A' ' 217' ' ' HIS . 1.8 t60 -66.78 -37.41 84.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.446 -0.797 . . . . 0.0 113.064 -178.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -62.95 -47.62 82.42 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.096 -177.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 33.5 p -60.53 -38.1 83.34 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 119.097 0.862 . . . . 0.0 110.986 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 217' ' ' HIS . 66.0 p -59.64 -41.78 91.28 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . 0.574 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.89 -41.84 97.62 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -178.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -62.63 -47.82 82.08 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -176.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -61.06 -42.27 99.74 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 107.811 -2.116 . . . . 0.0 107.811 177.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -63.31 -37.78 88.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 113.817 -1.191 . . . . 0.0 109.009 176.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . 0.574 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -61.67 -42.38 99.75 Favored Glycine 0 CA--C 1.522 0.51 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.827 -176.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' PHE . . . . . 0.436 ' O ' ' OG1' ' A' ' 229' ' ' THR . 0.9 OUTLIER -66.55 -38.58 87.44 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 118.28 1.04 . . . . 0.0 108.27 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 96.6 m -63.54 -41.88 98.43 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.09 0.471 . . . . 0.0 110.265 177.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' THR . . . . . 0.436 ' HG1' ' N ' ' A' ' 229' ' ' THR . 80.1 p -62.5 -40.48 96.87 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.896 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 226' ' ' PHE . 18.6 p -58.8 -39.73 81.99 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.097 -176.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 98.3 t -60.61 -41.91 89.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 118.521 -1.271 . . . . 0.0 108.839 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . 0.454 ' CD1' ' N ' ' A' ' 231' ' ' ILE . 1.3 mp -62.13 -41.29 90.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-O 121.418 0.628 . . . . 0.0 109.393 176.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -62.99 -40.09 96.7 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 -178.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.442 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 0.0 OUTLIER -59.11 -43.39 97.15 Favored Pre-proline 0 N--CA 1.476 0.84 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -173.255 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . 0.452 ' HD2' ' O ' ' A' ' 231' ' ' ILE . 39.4 Cg_exo -60.0 -41.72 50.49 Favored 'Trans proline' 0 C--N 1.296 -2.189 0 C-N-CA 121.576 1.517 . . . . 0.0 113.781 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 13.6 m -66.34 -37.55 79.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 119.131 -1.028 . . . . 0.0 111.303 178.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -66.0 -41.7 90.72 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -178.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 3.0 p -65.68 -45.72 91.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -177.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 8.5 p . . . . . 0 C--N 1.327 -0.406 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.323 -178.627 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 73.4 p . . . . . 0 N--CA 1.465 0.302 0 CA-C-O 120.936 0.398 . . . . 0.0 111.93 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' MET . . . . . . . . . . . . . 51.9 ttp -60.31 -44.44 95.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.011 -176.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.17 -46.5 88.65 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 69.1 mmt-85 -66.41 -53.78 31.83 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.666 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -142.62 158.73 43.36 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.687 0.28 . . . . 0.0 111.23 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . 0.448 ' O ' ' O ' ' A' ' 265' ' ' GLY . 18.3 tp10 76.25 68.31 0.06 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.285 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 264' ' ' GLU . . . -32.09 156.59 0.01 OUTLIER Glycine 0 CA--C 1.536 1.379 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.667 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -62.82 -3.11 4.17 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 122.246 1.964 . . . . 0.0 111.836 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . 0.417 ' H ' ' C ' ' A' ' 265' ' ' GLY . 80.5 mtt85 -70.0 -27.05 64.37 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 123.053 0.541 . . . . 0.0 111.805 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . 0.441 ' O ' ' O ' ' A' ' 271' ' ' LYS . . . -58.8 -32.47 69.38 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 119.824 -0.75 . . . . 0.0 109.948 -179.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -62.45 -41.72 98.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.412 0.625 . . . . 0.0 110.836 178.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -66.0 -37.7 86.59 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 114.9 -1.046 . . . . 0.0 112.363 -178.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 268' ' ' ALA . 17.6 ttpp -110.65 134.37 52.49 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.73 0.3 . . . . 0.0 110.616 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 108.47 55.77 0.58 Allowed Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -147.95 29.58 0.9 Allowed 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 120.836 0.35 . . . . 0.0 110.69 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' MET . . . . . 0.588 ' N ' ' CD ' ' A' ' 275' ' ' PRO . 0.3 OUTLIER -63.74 -43.88 78.21 Favored Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.238 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 274' ' ' MET . 23.4 Cg_exo -63.69 -45.87 10.19 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.776 2.317 . . . . 0.0 111.908 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' SER . . . . . 0.567 ' HG ' ' N ' ' A' ' 277' ' ' PHE . 86.1 p -59.72 -39.13 83.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.061 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . 0.567 ' N ' ' HG ' ' A' ' 276' ' ' SER . 71.1 t80 -61.21 -41.86 97.59 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 122.884 1.326 . . . . 0.0 111.85 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -61.87 -38.31 87.81 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 111.829 -2.441 . . . . 0.0 107.78 174.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . 0.637 HH12 ' HZ2' ' A' ' 38' ' ' LYS . 48.4 mtp180 -62.88 -39.33 94.15 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.304 0.573 . . . . 0.0 110.26 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 30.7 tp -61.85 -36.46 81.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.121 -0.945 . . . . 0.0 112.869 -177.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -68.12 -51.18 34.94 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -178.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 76.4 p -63.09 -44.41 95.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.422 0.63 . . . . 0.0 110.072 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' TRP . . . . . . . . . . . . . 75.5 t90 -60.76 -38.75 86.27 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.604 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -62.58 -39.69 94.52 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -178.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 3.7 p -61.32 -37.89 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.093 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 95.0 t -62.02 -40.6 87.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 120.311 -0.556 . . . . 0.0 109.526 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' MET . . . . . 0.459 ' C ' ' SD ' ' A' ' 287' ' ' MET . 0.0 OUTLIER -61.15 -38.55 86.81 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.342 0.591 . . . . 0.0 109.893 178.606 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -58.51 -39.4 80.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.168 -0.923 . . . . 0.0 112.604 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 1.3 p -59.85 -38.13 74.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 113.213 0.819 . . . . 0.0 113.213 -175.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 2.1 t -62.35 -40.54 96.73 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 118.892 -1.123 . . . . 0.0 109.135 178.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -60.82 -38.86 86.88 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 177.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -58.35 -40.25 81.7 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 117.664 -1.614 . . . . 0.0 109.913 -175.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' GLN . . . . . 0.496 ' O ' ' O ' ' A' ' 296' ' ' ARG . 56.5 tt0 -60.46 -43.3 97.02 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 122.6 1.191 . . . . 0.0 111.443 -179.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 11.0 mp -60.95 -40.39 93.11 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 113.313 -1.767 . . . . 0.0 109.671 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -62.68 -45.76 91.3 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.36 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' ARG . . . . . 0.496 ' O ' ' O ' ' A' ' 293' ' ' GLN . 43.5 ttm180 -122.53 116.33 23.72 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -119.16 -160.8 0.82 Allowed 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -178.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 33.6 tp -71.42 114.82 9.88 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 177.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 28.1 ttp -96.7 64.71 2.13 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -177.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.58 101.04 0.07 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 122.047 0.927 . . . . 0.0 110.721 -178.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -64.15 -46.27 84.82 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 113.505 -1.68 . . . . 0.0 113.452 -176.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -58.73 -39.64 81.48 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.617 -0.433 . . . . 0.0 109.957 -178.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -64.68 -46.76 81.04 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.027 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' SER . . . . . 0.435 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 3.0 m -66.34 -38.1 86.85 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.404 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 59.7 mmt-85 -61.88 -42.86 99.57 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.721 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -64.94 -36.8 85.56 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -177.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -60.02 -52.92 70.03 Favored Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -176.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' PRO . . . . . 0.435 ' CD ' ' O ' ' A' ' 304' ' ' SER . 73.9 Cg_endo -75.21 0.33 9.12 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.109 1.873 . . . . 0.0 111.816 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 50.4 t80 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.51 179.992 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 48.5 m . . . . . 0 N--CA 1.465 0.308 0 CA-C-O 120.824 0.345 . . . . 0.0 110.399 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.8 t -87.05 164.19 2.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.336 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm -64.37 -42.03 96.41 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -63.77 -41.62 97.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.386 0.612 . . . . 0.0 111.428 179.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.5 tp -79.81 -26.11 40.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.236 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.45 -41.43 94.33 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 107.472 -2.251 . . . . 0.0 107.472 177.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.47 -32.29 68.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 124.838 2.256 . . . . 0.0 107.061 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.56 -42.47 98.86 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-N 108.516 -3.947 . . . . 0.0 107.759 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.0 m -70.7 -27.87 64.32 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.462 0.648 . . . . 0.0 109.591 177.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.95 -49.83 66.52 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.981 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.05 -35.16 77.77 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 118.693 -1.203 . . . . 0.0 112.206 -177.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 78.2 m -63.29 -53.85 46.4 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -177.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -66.06 -38.16 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -177.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.37 -41.9 98.83 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-O 118.175 -0.917 . . . . 0.0 113.316 -172.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -77.58 -26.78 51.07 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 120.914 1.688 . . . . 0.0 110.51 -175.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.3 mp -59.56 -54.56 45.15 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 119.686 1.13 . . . . 0.0 112.27 -178.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.9 tp -74.78 -3.44 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 CA-C-O 121.692 0.758 . . . . 0.0 112.711 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -109.06 -16.19 14.17 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.39 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.465 ' N ' ' HD2' ' A' ' 33' ' ' PRO . 27.0 t80 -68.5 -46.08 36.28 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 116.654 -2.018 . . . . 0.0 111.829 -177.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 32' ' ' PHE . 24.0 Cg_endo -60.26 -15.89 37.47 Favored 'Trans proline' 0 N--CA 1.499 1.824 0 CA-C-N 120.988 1.389 . . . . 0.0 113.238 177.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.5 mp -67.36 -35.7 79.9 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -177.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -64.64 -40.4 95.39 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.618 -178.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.9 p -58.22 -34.8 70.81 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.812 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.43 -38.85 85.2 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 119.862 -0.735 . . . . 0.0 112.231 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.629 ' HZ1' ' NH2' ' A' ' 279' ' ' ARG . 52.7 mtpt -62.64 -49.86 73.49 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 119.106 -1.037 . . . . 0.0 111.296 -177.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 65.6 t -64.96 -40.19 88.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -177.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.51 ' C ' ' H ' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -61.05 -41.09 95.95 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.752 -178.457 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.6 tp -62.03 38.79 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.967 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.51 ' H ' ' C ' ' A' ' 40' ' ' ARG . 6.3 pt20 -95.51 154.63 17.11 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.82 0.343 . . . . 0.0 110.603 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.507 ' CD1' ' N ' ' A' ' 43' ' ' ILE . 1.9 mp -69.22 -11.92 15.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.289 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 55.29 -175.71 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.374 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 57.83 38.81 90.06 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.999 -0.841 . . . . 0.0 110.999 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.422 ' O ' ' OG ' ' A' ' 47' ' ' SER . 14.7 pt-20 -61.65 -35.03 76.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.793 0.33 . . . . 0.0 110.408 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' A' ' 46' ' ' GLU . 69.1 m -168.58 -15.88 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.677 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -64.59 -40.78 96.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.655 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.51 9.57 84.61 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -177.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.457 ' O ' ' OG1' ' A' ' 53' ' ' THR . 12.1 tp -64.62 -36.8 85.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.313 -0.944 . . . . 0.0 109.929 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 95.3 t -59.69 -44.2 93.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.397 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 93.1 mtm-85 -64.46 -34.19 77.62 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.201 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.457 ' OG1' ' O ' ' A' ' 50' ' ' LEU . 59.7 p -68.44 -38.09 80.83 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 178.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -134.51 93.36 3.04 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.803 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.52 -13.38 52.17 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -178.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.533 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 90.5 p -126.33 -140.06 0.27 Allowed 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.533 ' CB ' ' O ' ' A' ' 56' ' ' SER . . . 98.01 12.88 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 O-C-N 124.245 0.965 . . . . 0.0 112.04 178.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.421 ' OE1' ' O ' ' A' ' 59' ' ' TYR . 1.3 tm0? -173.59 84.17 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.562 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.421 ' O ' ' OE1' ' A' ' 58' ' ' GLN . 5.4 m-85 -65.5 148.55 51.53 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -40.23 -36.71 0.55 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.023 0.44 . . . . 0.0 110.255 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -31.85 103.38 0.01 OUTLIER Glycine 0 CA--C 1.529 0.926 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.334 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.3 p -67.14 -33.53 63.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 118.205 -0.902 . . . . 0.0 109.626 176.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -60.02 -32.3 70.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 121.397 1.908 . . . . 0.0 109.958 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.51 -48.96 67.84 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 115.262 -0.881 . . . . 0.0 114.555 -176.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.2 m -61.87 -46.3 90.03 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -178.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 28.9 mm -59.49 -36.27 63.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 40.0 tp -64.04 -35.82 81.97 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 120.252 1.387 . . . . 0.0 112.511 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.44 ' O ' ' OG1' ' A' ' 72' ' ' THR . 98.6 m -63.3 -40.7 98.08 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.069 -175.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 31.7 ttp -60.15 -40.19 88.97 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 114.406 1.262 . . . . 0.0 114.406 -175.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.41 ' CG1' ' N ' ' A' ' 71' ' ' ARG . 3.0 p -69.46 -40.93 80.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 119.218 -0.993 . . . . 0.0 113.16 -177.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.41 ' N ' ' CG1' ' A' ' 70' ' ' VAL . 68.1 ttt-85 -78.75 -12.92 60.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.697 0.76 . . . . 0.0 112.991 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 68' ' ' THR . 56.8 m -61.63 -54.85 37.33 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.682 -1.144 . . . . 0.0 111.094 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.451 ' CD ' ' H ' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -117.32 -40.81 3.03 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 118.754 -0.641 . . . . 0.0 110.472 178.064 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 155.15 159.58 9.39 Favored Glycine 0 CA--C 1.549 2.158 0 CA-C-N 120.192 1.36 . . . . 0.0 111.34 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -56.53 -34.58 95.48 Favored 'Trans proline' 0 N--CA 1.511 2.531 0 C-N-CA 122.269 1.98 . . . . 0.0 114.032 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.5 mmp_? -60.23 -10.55 4.7 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 178.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.568 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 1.2 p -77.28 -31.79 55.09 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.642 -178.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 43.5 tp -74.91 -31.94 61.68 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 122.039 -0.413 . . . . 0.0 110.626 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -90.88 -3.86 57.01 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 122.851 1.31 . . . . 0.0 114.091 -176.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.568 ' ND2' ' O ' ' A' ' 77' ' ' SER . 0.0 OUTLIER -104.17 123.64 47.66 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 111.986 -2.37 . . . . 0.0 107.738 175.337 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.24 -16.29 49.59 Favored Glycine 0 N--CA 1.467 0.746 0 N-CA-C 108.389 -1.885 . . . . 0.0 108.389 -177.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.503 ' CD1' ' N ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -59.34 -34.37 72.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 113.859 -1.17 . . . . 0.0 110.559 -179.601 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.503 ' N ' ' CD1' ' A' ' 82' ' ' LEU . 7.5 p -70.7 -27.36 30.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.322 177.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.96 -31.96 61.6 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 119.199 -0.429 . . . . 0.0 111.35 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.84 -40.01 89.6 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 119.533 -1.317 . . . . 0.0 110.832 -177.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.4 tt -62.45 -40.54 96.94 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 122.261 1.029 . . . . 0.0 113.335 -176.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -60.55 -27.48 67.69 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 113.541 -1.663 . . . . 0.0 109.815 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 64.2 mtm180 -57.81 -53.25 60.34 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 173.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 70.7 tp60 -67.06 -29.68 69.53 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 112.505 -2.134 . . . . 0.0 111.921 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.446 ' SD ' ' C ' ' A' ' 90' ' ' MET . 11.5 tmm? -61.27 -40.89 95.79 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.044 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 77.7 p -74.24 -34.5 63.66 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 119.362 -0.935 . . . . 0.0 111.402 -176.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -57.84 -44.19 86.32 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 120.951 1.705 . . . . 0.0 111.857 -177.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.38 -33.16 64.89 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 119.546 -0.862 . . . . 0.0 111.094 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.493 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 25.3 m -64.2 -41.78 96.92 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.475 ' C ' ' H ' ' A' ' 97' ' ' ILE . 72.9 t -68.37 -28.71 41.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.485 178.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 29.6 ttp180 -77.61 10.4 2.69 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -177.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.493 ' CG2' ' O ' ' A' ' 94' ' ' SER . 10.9 tt -86.96 -15.0 9.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.859 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.429 ' O ' ' OG ' ' A' ' 102' ' ' SER . . . -140.3 -49.0 0.05 OUTLIER Glycine 0 CA--C 1.541 1.711 0 N-CA-C 117.103 1.601 . . . . 0.0 117.103 -176.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.431 ' CD1' ' C ' ' A' ' 99' ' ' LEU . 3.1 pp -73.28 -12.77 60.97 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 120.558 2.179 . . . . 0.0 114.515 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.541 ' O ' ' HB2' ' A' ' 104' ' ' LYS . 46.6 t80 -79.16 -53.04 7.38 Favored 'General case' 0 C--O 1.214 -0.797 0 C-N-CA 118.777 -1.169 . . . . 0.0 113.073 -176.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.451 ' OD1' ' NE2' ' A' ' 105' ' ' GLN . 6.0 t70 -72.3 -33.18 67.22 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 124.26 1.981 . . . . 0.0 112.403 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 98' ' ' GLY . 67.0 m -65.47 -48.98 70.78 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 109.317 -3.583 . . . . 0.0 115.034 -178.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 19.1 m -72.29 -23.83 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.368 0 CA-C-O 123.945 1.831 . . . . 0.0 109.437 175.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.541 ' HB2' ' O ' ' A' ' 100' ' ' TYR . 0.0 OUTLIER -68.03 -42.61 80.35 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 109.943 -3.299 . . . . 0.0 113.675 -179.058 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.451 ' NE2' ' OD1' ' A' ' 101' ' ' ASP . 88.1 mt-30 -76.56 -13.33 60.09 Favored 'General case' 0 C--O 1.211 -0.948 0 CA-C-O 125.468 2.556 . . . . 0.0 111.102 177.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.484 ' O ' ' NZ ' ' A' ' 109' ' ' LYS . 1.9 t80 -80.15 -22.08 42.42 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 109.378 -3.555 . . . . 0.0 110.711 177.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.438 ' OH ' ' O ' ' A' ' 119' ' ' ARG . 0.3 OUTLIER -109.68 -28.72 8.69 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.607 0.763 . . . . 0.0 112.404 -174.137 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.799 ' C ' ' H ' ' A' ' 110' ' ' GLY . 0.8 OUTLIER -94.91 12.99 26.32 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -174.723 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.484 ' NZ ' ' O ' ' A' ' 106' ' ' PHE . 7.2 ptpp? -56.58 18.73 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 119.602 1.092 . . . . 0.0 110.825 177.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.799 ' H ' ' C ' ' A' ' 108' ' ' THR . . . 57.8 19.2 35.3 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-N 113.956 -1.475 . . . . 0.0 109.773 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.431 ' O ' ' O ' ' A' ' 110' ' ' GLY . 36.2 m 31.19 -160.73 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 112.47 -1.865 . . . . 0.0 114.333 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.623 ' O ' ' N ' ' A' ' 114' ' ' ALA . 39.8 tt0 -134.12 92.99 3.02 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 114.144 1.165 . . . . 0.0 114.144 -176.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.421 ' O ' ' CB ' ' A' ' 114' ' ' ALA . 89.4 m-70 30.63 28.68 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.082 178.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.623 ' N ' ' O ' ' A' ' 112' ' ' GLU . . . 159.97 -161.97 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.99 15.46 23.94 Favored Glycine 0 N--CA 1.464 0.556 0 C-N-CA 120.035 -1.079 . . . . 0.0 111.647 178.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.478 ' CD1' ' H ' ' A' ' 116' ' ' ILE . 2.0 mp -60.34 -40.37 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 C-N-CA 119.237 -0.985 . . . . 0.0 108.713 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.91 -41.01 95.66 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.021 175.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 38.3 t -59.33 -43.64 92.69 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 176.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.438 ' O ' ' OH ' ' A' ' 107' ' ' TYR . 64.5 mtm180 -64.15 -37.13 86.33 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.677 -178.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.4 tt -63.2 -45.5 91.41 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 62.3 mt -66.33 -44.62 82.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.406 -1.27 . . . . 0.0 110.129 178.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.09 -45.01 90.57 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 120.074 1.307 . . . . 0.0 110.82 178.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -65.96 -44.44 91.68 Favored Glycine 0 N--CA 1.458 0.155 0 C-N-CA 119.588 -1.291 . . . . 0.0 111.371 -178.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.2 m -63.99 -43.75 94.77 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.949 0.404 . . . . 0.0 110.804 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 21.2 m -69.57 -48.7 59.39 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 119.201 -1.0 . . . . 0.0 112.333 177.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 13.8 m -65.93 -42.79 89.62 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 114.868 1.433 . . . . 0.0 114.868 -175.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.435 ' O ' ' OD1' ' A' ' 186' ' ' ASN . . . -64.73 -44.81 94.33 Favored Glycine 0 CA--C 1.521 0.413 0 CA-C-N 114.512 -1.222 . . . . 0.0 113.236 -177.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.32 -41.45 97.04 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 112.457 -1.871 . . . . 0.0 107.196 177.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -64.07 -42.03 97.14 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.173 -0.922 . . . . 0.0 110.207 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -62.6 -38.88 91.9 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.58 0.229 . . . . 0.0 111.053 -178.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.418 ' O ' ' O ' ' A' ' 134' ' ' ALA . 85.6 t -60.58 -25.37 34.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 122.262 1.03 . . . . 0.0 109.516 178.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -57.94 -44.86 87.21 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 113.281 -1.781 . . . . 0.0 111.988 -178.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.487 ' CG1' ' N ' ' A' ' 134' ' ' ALA . 2.7 p -79.04 -48.87 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.536 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.487 ' N ' ' CG1' ' A' ' 133' ' ' VAL . . . -93.2 139.82 30.19 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.905 0.383 . . . . 0.0 111.23 -179.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.513 ' N ' ' CD ' ' A' ' 136' ' ' PRO . 1.2 tt0 178.45 -46.71 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.416 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.513 ' CD ' ' N ' ' A' ' 135' ' ' GLN . 54.3 Cg_exo -52.31 -33.45 55.75 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 122.501 2.134 . . . . 0.0 112.462 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 37.9 p -67.65 -42.39 82.29 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 118.255 -1.378 . . . . 0.0 109.394 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -66.67 -43.58 84.11 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 118.351 -1.34 . . . . 0.0 111.912 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 52.9 t -64.75 -44.89 96.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -178.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.4 p -65.48 -39.09 84.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -177.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -62.46 -41.67 98.93 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.715 -177.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 13.2 m -70.47 -45.58 74.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.108 -0.637 . . . . 0.0 110.516 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 9.6 mmt85 -65.08 -37.06 86.3 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.585 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.538 ' CD1' ' NE2' ' A' ' 147' ' ' GLN . 76.9 t80 -67.21 -42.1 84.66 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -177.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 23.8 mm100 -65.85 -40.14 91.43 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 119.203 -0.999 . . . . 0.0 110.103 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.22 -34.89 79.43 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 -178.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.538 ' NE2' ' CD1' ' A' ' 144' ' ' PHE . 6.5 pt20 -59.89 111.07 1.33 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 177.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -100.39 -59.01 1.78 Allowed 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -175.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -96.46 60.69 1.92 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 122.125 2.239 . . . . 0.0 110.17 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . 54.97 -94.98 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.321 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 161.97 58.24 0.02 OUTLIER Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.716 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.911 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.743 0.306 . . . . 0.0 110.622 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -72.25 179.64 3.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.544 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.429 ' OG ' ' N ' ' A' ' 159' ' ' THR . 40.3 t -157.05 -178.14 7.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.293 0.568 . . . . 0.0 110.978 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.429 ' N ' ' OG ' ' A' ' 158' ' ' SER . 72.5 p -64.04 -46.22 85.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.591 -177.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.461 ' CG1' ' N ' ' A' ' 161' ' ' GLU . 10.3 p -64.43 -45.3 96.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 118.995 -1.082 . . . . 0.0 109.418 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.461 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 60.6 mt-10 -67.23 -39.13 86.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.961 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -61.58 -46.0 91.75 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -177.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.478 ' CD1' ' C ' ' A' ' 163' ' ' TYR . 0.3 OUTLIER -62.77 -49.97 72.87 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 119.901 -0.719 . . . . 0.0 110.122 -179.577 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.6 mmtt -67.79 -45.62 74.29 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -174.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 19.7 m -62.82 -44.87 95.01 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 119.557 1.072 . . . . 0.0 113.385 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.512 ' CD1' ' N ' ' A' ' 166' ' ' ILE . 1.3 mp -64.86 -38.73 83.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 121.967 0.889 . . . . 0.0 109.165 176.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.78 -36.43 76.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 113.651 -1.613 . . . . 0.0 108.287 176.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 22.5 tpt85 -62.53 -50.88 69.61 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 122.301 2.319 . . . . 0.0 112.075 -175.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -75.29 -51.36 13.43 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 123.587 0.755 . . . . 0.0 109.231 176.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -78.57 -36.76 44.04 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 -174.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 92.89 -168.48 30.26 Favored Glycine 0 N--CA 1.468 0.81 0 O-C-N 121.995 -0.441 . . . . 0.0 112.427 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.448 ' CG2' ' N ' ' A' ' 173' ' ' ARG . 10.3 tp -72.99 -41.94 59.79 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.14 0 CA-C-O 121.916 0.865 . . . . 0.0 110.783 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.448 ' N ' ' CG2' ' A' ' 172' ' ' ILE . 36.2 ttm180 -58.69 -33.34 70.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 113.969 -1.469 . . . . 0.0 110.88 -176.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -60.76 -40.43 98.11 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 118.942 -1.599 . . . . 0.0 110.071 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 7.0 tt -70.37 -33.57 71.58 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 111.58 -2.31 . . . . 0.0 117.129 -177.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 4.9 m0 -77.88 -7.39 56.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 111.771 -2.468 . . . . 0.0 109.961 -176.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 24.8 ttpp -43.22 -48.03 6.51 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.434 -176.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -95.16 -36.29 5.5 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 124.142 0.877 . . . . 0.0 111.495 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.446 ' CG2' ' N ' ' A' ' 180' ' ' SER . 0.6 OUTLIER -45.4 -51.05 11.84 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' SER . . . . . 0.446 ' N ' ' CG2' ' A' ' 179' ' ' THR . 3.7 m -62.41 -50.13 80.52 Favored Pre-proline 0 N--CA 1.475 0.801 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -176.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.411 ' HD2' ' N ' ' A' ' 180' ' ' SER . 22.8 Cg_endo -63.95 -27.61 66.53 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 121.533 1.489 . . . . 0.0 111.652 177.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -63.43 -39.26 94.02 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 60.4 t -63.17 -42.46 96.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.067 0.461 . . . . 0.0 109.878 178.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.03 -38.98 90.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.57 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -60.23 -41.54 93.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.753 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 127' ' ' GLY . 0.5 OUTLIER -61.21 -42.99 99.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.983 0.42 . . . . 0.0 111.211 -179.471 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.73 -44.12 91.18 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.506 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 36.6 mm -64.0 -45.8 95.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.533 ' O ' ' N ' ' A' ' 193' ' ' GLU . 30.8 m -60.34 -46.11 95.48 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.373 0 C-N-CA 119.882 -0.727 . . . . 0.0 111.155 -178.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -62.62 -42.87 99.83 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.501 0.667 . . . . 0.0 110.241 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' CYS . . . . . . . . . . . . . 16.1 t -62.09 -46.09 90.62 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.365 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -63.89 -39.5 94.34 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 113.011 -1.904 . . . . 0.0 109.192 176.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 189' ' ' VAL . 49.4 tp10 -60.18 -46.49 89.53 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.065 -0.97 . . . . 0.0 111.97 -176.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -65.26 -38.49 90.48 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 118.17 -1.412 . . . . 0.0 110.866 -176.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . 0.437 ' O ' ' CD2' ' A' ' 199' ' ' LEU . 0.3 OUTLIER -63.89 -47.02 92.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 116.345 -2.142 . . . . 0.0 107.347 -179.691 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 9.4 p -65.16 -46.54 80.43 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -179.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -57.34 -39.15 75.32 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.121 1.368 . . . . 0.0 113.473 -177.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -55.59 -44.19 76.7 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.517 ' H ' ' CD2' ' A' ' 199' ' ' LEU . 2.5 mm? -61.4 -39.54 91.09 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 80.0 mt -63.18 -43.78 99.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 118.485 -0.769 . . . . 0.0 111.464 -178.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 17.8 mmmt -60.52 -40.13 90.33 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 120.551 1.523 . . . . 0.0 109.511 175.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -64.34 -35.45 80.91 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 112.885 -1.961 . . . . 0.0 111.026 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' A' ' 199' ' ' LEU . 0.2 OUTLIER -101.55 128.35 47.84 Favored 'General case' 0 C--N 1.357 0.894 0 O-C-N 121.0 -1.063 . . . . 0.0 111.239 -179.268 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 10.4 mp 66.23 4.91 3.35 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.202 177.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 2.4 mt -129.38 35.8 4.2 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.465 0.65 . . . . 0.0 112.258 -177.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -73.83 -23.33 59.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.728 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.624 ' C ' HD21 ' A' ' 208' ' ' ASN . . . -131.17 -45.36 1.01 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.95 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' ASN . . . . . 0.948 ' ND2' ' H ' ' A' ' 209' ' ' LEU . 0.0 OUTLIER 127.2 -72.4 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.198 1.799 . . . . 0.0 108.388 -178.207 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.948 ' H ' ' ND2' ' A' ' 208' ' ' ASN . 0.3 OUTLIER . . . . . 0 C--N 1.327 -0.406 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 . . . . . 0 N--CA 1.465 0.29 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.436 ' N ' ' CD ' ' A' ' 215' ' ' PRO . 4.1 mt -61.41 -43.52 89.56 Favored Pre-proline 0 C--N 1.33 -0.255 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 214' ' ' LEU . 26.7 Cg_exo -61.09 -33.58 91.2 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 CA-C-N 119.978 1.028 . . . . 0.0 111.107 -178.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 90.4 m -64.78 -42.46 95.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 113.269 -1.787 . . . . 0.0 111.807 -178.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' HIS . . . . . 0.441 ' O ' ' ND1' ' A' ' 217' ' ' HIS . 1.9 t60 -66.83 -38.32 86.2 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -177.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -63.35 -47.23 82.99 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.73 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 30.5 p -60.17 -37.86 81.43 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 118.943 0.792 . . . . 0.0 111.054 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 11.4 t -59.15 -41.16 87.7 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.3 -41.48 98.96 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -177.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -61.25 -46.98 88.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 122.172 0.987 . . . . 0.0 112.467 -176.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -60.43 -41.61 98.64 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 107.418 -2.273 . . . . 0.0 107.418 176.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . 0.519 ' O ' ' SG ' ' A' ' 227' ' ' CYS . . . -62.52 -37.73 87.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.255 -0.972 . . . . 0.0 108.479 176.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -61.65 -42.22 99.72 Favored Glycine 0 CA--C 1.525 0.679 0 CA-C-N 114.757 -1.111 . . . . 0.0 110.586 -178.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -66.62 -38.5 87.09 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.166 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . 0.519 ' SG ' ' O ' ' A' ' 224' ' ' ALA . 0.5 OUTLIER -63.11 -40.48 97.75 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.236 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' THR . . . . . 0.467 ' N ' ' SG ' ' A' ' 227' ' ' CYS . 0.3 OUTLIER -61.29 -39.69 91.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.254 179.473 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 20.1 m -58.39 -39.43 79.63 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 -178.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 92.8 t -60.25 -40.84 84.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 119.339 -0.944 . . . . 0.0 108.497 178.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . 0.553 ' O ' ' HD2' ' A' ' 234' ' ' PRO . 24.8 mm -61.29 -40.09 84.85 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.362 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -62.17 -38.4 88.92 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -178.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.451 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 0.3 OUTLIER -57.24 -40.19 82.89 Favored Pre-proline 0 N--CA 1.48 1.054 0 N-CA-C 116.107 1.891 . . . . 0.0 116.107 -173.052 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . 0.553 ' HD2' ' O ' ' A' ' 231' ' ' ILE . 33.0 Cg_exo -58.76 -40.52 71.98 Favored 'Trans proline' 0 C--N 1.298 -2.088 0 C-N-CA 122.008 1.805 . . . . 0.0 113.516 -177.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 4.6 m -64.66 -36.0 76.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 119.071 -1.051 . . . . 0.0 110.243 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -64.79 -40.71 95.7 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 -177.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 6.3 m -64.79 -45.48 94.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -176.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 5.7 p . . . . . 0 C--N 1.324 -0.519 0 C-N-CA 119.888 -0.725 . . . . 0.0 110.038 -179.851 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 96.8 m . . . . . 0 CA--C 1.534 0.348 0 CA-C-O 121.152 0.501 . . . . 0.0 109.879 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' MET . . . . . 0.595 ' O ' ' N ' ' A' ' 264' ' ' GLU . 0.0 OUTLIER -60.5 -41.58 94.59 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.894 -178.972 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 8.8 tp -61.2 -47.68 85.0 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 29.1 mtp85 -67.28 -53.86 26.06 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 43.6 tttp -66.51 -69.89 0.28 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.42 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . 0.595 ' N ' ' O ' ' A' ' 260' ' ' MET . 43.6 tp10 -88.32 110.77 21.03 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.835 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . 0.529 ' C ' ' H ' ' A' ' 267' ' ' ARG . . . -34.45 155.9 0.01 OUTLIER Glycine 0 CA--C 1.539 1.558 0 CA-C-N 116.3 -0.409 . . . . 0.0 112.11 -179.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -56.03 3.23 0.08 OUTLIER 'Trans proline' 0 N--CA 1.503 2.048 0 C-N-CA 122.131 1.888 . . . . 0.0 113.086 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . 0.529 ' H ' ' C ' ' A' ' 265' ' ' GLY . 99.6 mtt180 -68.95 -27.0 65.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.436 0.16 . . . . 0.0 110.768 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -58.78 -32.7 69.54 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.57 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' PHE . . . . . 0.408 ' CE2' ' CE ' ' A' ' 260' ' ' MET . 51.1 m-85 -62.47 -42.47 99.5 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.554 0.693 . . . . 0.0 110.683 178.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -66.62 -37.46 84.92 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.668 -1.151 . . . . 0.0 113.17 -178.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 272' ' ' GLY . 68.4 mttm -77.59 171.89 14.22 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 271' ' ' LYS . . . 53.69 111.79 0.01 OUTLIER Glycine 0 CA--C 1.528 0.874 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -172.25 3.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.616 -0.433 . . . . 0.0 111.144 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' MET . . . . . 0.559 ' N ' ' CD ' ' A' ' 275' ' ' PRO . 1.4 ttt -64.01 -44.13 77.12 Favored Pre-proline 0 C--N 1.329 -0.324 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.615 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' A' ' 274' ' ' MET . 19.5 Cg_exo -64.71 -47.9 4.76 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 121.852 1.701 . . . . 0.0 112.107 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 44.6 t -61.52 -40.74 95.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.664 0.745 . . . . 0.0 110.743 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -62.33 -42.62 99.53 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 123.491 1.615 . . . . 0.0 113.541 -178.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 9.2 tp -62.78 -39.24 93.6 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 110.607 -2.997 . . . . 0.0 108.887 174.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . 0.629 ' NH2' ' HZ1' ' A' ' 38' ' ' LYS . 71.5 mtp180 -63.04 -40.54 98.04 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.561 0.696 . . . . 0.0 110.713 179.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.457 ' CD1' ' C ' ' A' ' 280' ' ' LEU . 0.1 OUTLIER -62.26 -36.22 81.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.609 -1.178 . . . . 0.0 112.211 -177.446 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -68.14 -51.16 34.94 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 71.1 m -63.19 -44.68 94.68 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 123.087 0.555 . . . . 0.0 109.84 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' TRP . . . . . . . . . . . . . 80.3 t90 -60.46 -38.0 82.8 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.851 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -61.75 -37.96 86.19 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.718 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -60.2 -37.44 73.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 111.567 0.21 . . . . 0.0 111.567 -178.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -61.75 -40.15 85.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 120.505 -0.478 . . . . 0.0 109.986 -178.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 8.4 tpt -60.91 -39.11 88.11 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.245 0.545 . . . . 0.0 109.721 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -59.05 -41.05 86.98 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.856 -178.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 8.1 p -61.28 -38.53 80.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 O-C-N 121.855 -0.528 . . . . 0.0 112.091 -177.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.551 ' HG1' ' N ' ' A' ' 291' ' ' TYR . 19.4 p -62.53 -40.98 98.5 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 119.18 -1.008 . . . . 0.0 108.379 177.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' TYR . . . . . 0.551 ' N ' ' HG1' ' A' ' 290' ' ' THR . 3.1 m-85 -60.89 -38.55 86.06 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 177.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 14.9 tm-20 -57.53 -39.58 76.92 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 118.138 -1.425 . . . . 0.0 109.535 -176.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' GLN . . . . . 0.439 ' O ' ' O ' ' A' ' 296' ' ' ARG . 0.0 OUTLIER -60.17 -41.63 93.25 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 122.968 1.366 . . . . 0.0 110.11 179.197 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 65.0 mt -60.25 -39.32 86.31 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 112.206 -2.27 . . . . 0.0 109.557 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -62.16 -45.26 94.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.088 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' ARG . . . . . 0.439 ' O ' ' O ' ' A' ' 293' ' ' GLN . 62.3 ttm-85 -122.58 116.06 23.22 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -109.72 -169.82 1.54 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.402 0.62 . . . . 0.0 111.76 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.596 ' CD1' ' H ' ' A' ' 298' ' ' LEU . 0.0 OUTLIER -68.24 -8.83 42.66 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.977 -1.011 . . . . 0.0 111.471 -178.663 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' MET . . . . . 0.403 ' C ' ' O ' ' A' ' 298' ' ' LEU . 74.1 mtp 28.1 62.41 0.11 Allowed 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 177.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.62 100.81 0.07 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.812 0.815 . . . . 0.0 110.896 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -63.93 -46.3 85.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.131 -1.395 . . . . 0.0 113.386 -176.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . 0.527 ' CD2' ' OE2' ' A' ' 306' ' ' GLU . 32.8 t80 -58.68 -40.13 82.68 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.023 -0.671 . . . . 0.0 109.539 -178.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' GLN . . . . . 0.485 ' N ' ' OE1' ' A' ' 303' ' ' GLN . 1.3 mp0 -65.0 -46.83 79.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.186 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' SER . . . . . 0.446 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 77.8 p -66.23 -37.4 85.45 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.553 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -61.43 -42.82 99.35 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.057 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . 0.527 ' OE2' ' CD2' ' A' ' 302' ' ' TYR . 41.7 mt-10 -64.71 -36.99 86.08 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.228 1.195 . . . . 0.0 114.228 -177.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -60.02 -52.95 69.88 Favored Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -176.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' PRO . . . . . 0.446 ' CD ' ' O ' ' A' ' 304' ' ' SER . 74.0 Cg_endo -75.26 0.27 9.21 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.193 1.929 . . . . 0.0 111.908 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 91.9 t80 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.609 -179.981 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.5 m . . . . . 0 C--O 1.23 0.06 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.9 t -147.23 143.85 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 121.129 0.49 . . . . 0.0 111.085 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -64.21 -40.82 96.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.679 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -63.49 -41.39 98.57 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.175 -0.921 . . . . 0.0 113.208 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 50.9 tp -79.77 -26.48 40.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.177 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.449 ' O ' ' OG1' ' A' ' 22' ' ' THR . . . -66.43 -41.44 94.37 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 107.363 -2.295 . . . . 0.0 107.363 176.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.26 -31.75 67.89 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 124.84 2.257 . . . . 0.0 107.316 176.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.46 -42.72 98.93 Favored Glycine 0 CA--C 1.528 0.867 1 CA-C-N 108.364 -4.016 . . . . 0.0 108.307 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' A' ' 19' ' ' GLY . 35.6 p -70.71 -27.95 64.37 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.576 0.703 . . . . 0.0 109.314 177.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.38 -50.18 64.34 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.946 -178.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.82 -35.82 79.33 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 118.671 -1.212 . . . . 0.0 111.2 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 75.6 m -63.71 -53.63 48.16 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.343 -178.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.9 pt -65.47 -39.77 86.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 -177.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.05 -42.02 97.19 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 119.763 -0.775 . . . . 0.0 112.845 -173.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 28' ' ' ASP . 43.1 t0 -77.71 -27.36 50.63 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 118.249 -1.38 . . . . 0.0 109.544 -176.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.1 tp -60.29 -55.67 30.86 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.714 1.143 . . . . 0.0 111.729 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.0 pt -75.4 -4.0 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 121.306 0.574 . . . . 0.0 112.368 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.1 m -109.12 -16.8 14.02 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.254 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -69.02 -44.69 29.29 Favored Pre-proline 0 CA--C 1.544 0.731 0 CA-C-N 121.868 2.122 . . . . 0.0 111.926 -178.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -59.64 -16.25 35.67 Favored 'Trans proline' 0 N--CA 1.504 2.088 0 CA-C-N 120.897 1.356 . . . . 0.0 112.857 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 62.2 mt -67.54 -35.15 78.51 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -177.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.43 ' CB ' ' HZ3' ' A' ' 38' ' ' LYS . 1.1 m-20 -64.23 -40.52 96.2 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.128 -177.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 87.0 m -58.2 -34.84 70.81 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.14 -38.97 86.43 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 119.691 -0.804 . . . . 0.0 113.048 -179.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.43 ' HZ3' ' CB ' ' A' ' 35' ' ' ASP . 9.2 pttm -62.14 -47.55 84.07 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 118.995 -1.082 . . . . 0.0 111.656 -177.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.6 t -62.83 -38.72 82.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -177.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.561 ' C ' ' H ' ' A' ' 42' ' ' GLN . 7.9 tpm_? -59.45 -41.25 89.22 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 119.266 -0.974 . . . . 0.0 109.706 -178.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.516 ' C ' ' H ' ' A' ' 43' ' ' ILE . 9.4 mp -62.69 38.83 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.59 177.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.57 ' O ' ' N ' ' A' ' 44' ' ' GLN . 25.1 tp60 -72.71 23.96 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 O-C-N 121.947 -0.471 . . . . 0.0 111.385 -178.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.516 ' H ' ' C ' ' A' ' 41' ' ' LEU . 9.2 tp 28.98 34.03 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 121.404 0.621 . . . . 0.0 111.534 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.57 ' N ' ' O ' ' A' ' 42' ' ' GLN . 3.1 mp0 53.79 98.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.566 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -169.19 31.74 0.17 Allowed Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -70.57 -28.68 65.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.828 0.347 . . . . 0.0 110.684 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 17.7 t 59.38 42.2 18.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.998 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -98.99 -19.64 17.18 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.1 0.476 . . . . 0.0 110.05 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.16 -23.28 30.29 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.1 -38.26 87.79 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.3 p -61.04 -44.5 98.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.151 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.24 -33.58 76.15 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.714 -178.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -67.93 -38.05 82.41 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -93.18 -146.25 0.23 Allowed 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.847 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -176.11 -32.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.084 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.524 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 7.9 t -128.08 -138.83 0.24 Allowed 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 56' ' ' SER . . . 99.25 12.56 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.6 0 O-C-N 124.165 0.916 . . . . 0.0 111.277 178.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.439 ' CG ' ' O ' ' A' ' 58' ' ' GLN . 4.3 pt20 -174.24 121.1 0.28 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -85.76 151.41 23.85 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 87.9 mtt180 -45.43 -33.02 2.39 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 122.453 1.121 . . . . 0.0 108.096 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -41.89 114.37 0.67 Allowed Glycine 0 CA--C 1.526 0.723 0 CA-C-N 112.86 -1.973 . . . . 0.0 113.195 -178.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.6 p -66.75 -33.02 60.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 118.124 -0.941 . . . . 0.0 108.862 176.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -60.18 -32.3 70.94 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 121.747 2.067 . . . . 0.0 110.868 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.59 -49.07 66.59 Favored Glycine 0 CA--C 1.532 1.121 0 N-CA-C 114.965 0.746 . . . . 0.0 114.965 -176.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.6 t -62.04 -45.57 93.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.178 -0.511 . . . . 0.0 111.933 -179.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 35.2 mm -59.25 -36.25 62.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -63.91 -35.84 81.97 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 120.764 1.62 . . . . 0.0 112.148 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.447 ' O ' ' OG1' ' A' ' 72' ' ' THR . 97.9 m -63.0 -39.82 95.89 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 114.002 -1.454 . . . . 0.0 111.04 -175.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.463 ' O ' ' OG1' ' A' ' 72' ' ' THR . 0.1 OUTLIER -60.03 -39.61 86.48 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -176.023 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.6 p -69.91 -40.5 78.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 113.934 1.086 . . . . 0.0 113.934 -178.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -78.3 -13.56 59.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.8 0.809 . . . . 0.0 112.883 -178.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' A' ' 69' ' ' MET . 0.0 OUTLIER -63.2 -54.62 34.61 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.069 -1.423 . . . . 0.0 111.002 178.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -107.79 -57.76 2.06 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.805 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 157.99 163.49 12.81 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -56.51 -35.15 96.53 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 121.987 1.792 . . . . 0.0 111.683 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.433 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 91.7 mtt-85 -61.39 -11.65 11.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.654 0.74 . . . . 0.0 111.022 176.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.9 t -77.69 -32.42 53.04 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.089 -1.414 . . . . 0.0 111.038 -177.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.433 ' N ' ' CD1' ' A' ' 78' ' ' LEU . 10.2 mp -75.5 -33.09 60.74 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 122.126 -0.359 . . . . 0.0 110.783 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -91.91 -4.58 54.54 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 122.796 1.284 . . . . 0.0 113.142 -178.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.433 ' ND2' ' O ' ' A' ' 76' ' ' ARG . 0.9 OUTLIER -97.47 117.65 32.21 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 112.025 -2.352 . . . . 0.0 107.168 174.903 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.9 -13.5 56.17 Favored Glycine 0 N--CA 1.469 0.866 0 N-CA-C 108.255 -1.938 . . . . 0.0 108.255 -177.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 12.3 tp -58.85 -34.71 71.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 113.305 -1.448 . . . . 0.0 110.249 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.8 p -70.54 -26.78 29.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.364 178.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.81 -31.61 61.76 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.796 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.86 -40.42 89.4 Favored Glycine 0 N--CA 1.463 0.492 0 C-N-CA 119.677 -1.249 . . . . 0.0 111.223 -177.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.3 mp -62.34 -40.08 95.21 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 122.364 1.078 . . . . 0.0 112.5 -177.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -60.44 -27.24 67.35 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 113.071 -1.877 . . . . 0.0 109.34 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 49.4 ttp180 -57.91 -53.48 57.77 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 173.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.404 HE21 ' HB2' ' A' ' 28' ' ' ASP . 9.8 tp-100 -67.44 -29.89 69.48 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 112.56 -2.109 . . . . 0.0 112.428 -178.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 12.2 tpt -61.02 -40.98 95.63 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.352 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 78.2 p -74.35 -34.34 63.38 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 119.509 -0.877 . . . . 0.0 111.401 -176.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -58.04 -44.48 87.43 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 120.6 1.545 . . . . 0.0 111.789 -176.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.33 -33.59 65.21 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.49 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.1 t -64.48 -41.8 96.25 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.411 ' C ' ' H ' ' A' ' 97' ' ' ILE . 93.3 t -68.41 -28.6 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.841 177.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.568 ' NH2' ' CE2' ' A' ' 100' ' ' TYR . 59.9 ttt-85 -78.05 8.79 4.29 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -177.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.426 HG23 HD11 ' A' ' 97' ' ' ILE . 0.3 OUTLIER -87.49 -14.95 9.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.086 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -140.09 -48.13 0.06 OUTLIER Glycine 0 CA--C 1.54 1.631 0 N-CA-C 115.864 1.106 . . . . 0.0 115.864 -176.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.7 mt -71.08 -12.56 61.58 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 119.586 1.693 . . . . 0.0 112.817 -178.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.568 ' CE2' ' NH2' ' A' ' 96' ' ' ARG . 4.3 t80 -80.22 -51.32 9.08 Favored 'General case' 0 C--O 1.214 -0.778 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.438 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 1.162 ' OD1' ' NE2' ' A' ' 105' ' ' GLN . 12.7 t70 -69.48 -32.73 71.81 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 123.45 1.595 . . . . 0.0 110.561 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 31.1 m -68.82 -52.47 29.77 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 111.023 -2.808 . . . . 0.0 114.466 177.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.532 ' O ' ' CD2' ' A' ' 107' ' ' TYR . 1.1 p -74.97 -27.82 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 CA-C-N 121.942 2.156 . . . . 0.0 112.479 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -69.99 -41.74 73.98 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 110.849 -2.887 . . . . 0.0 112.801 -179.636 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 1.162 ' NE2' ' OD1' ' A' ' 101' ' ' ASP . 88.1 mt-30 -78.88 -11.43 60.0 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 122.972 1.368 . . . . 0.0 111.043 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.47 -21.94 48.27 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 113.924 -1.489 . . . . 0.0 111.086 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.532 ' CD2' ' O ' ' A' ' 103' ' ' VAL . 47.5 m-85 -108.36 -30.57 8.25 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 120.005 1.275 . . . . 0.0 111.614 -175.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.1 p -98.27 9.68 42.44 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 117.972 -1.491 . . . . 0.0 112.047 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.47 ' O ' ' C ' ' A' ' 110' ' ' GLY . 16.0 ttmm -54.19 118.17 3.85 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.619 0.645 . . . . 0.0 112.453 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.511 ' O ' ' O ' ' A' ' 111' ' ' SER . . . -17.24 -89.09 0.01 OUTLIER Glycine 0 N--CA 1.48 1.585 0 CA-C-O 119.81 -0.439 . . . . 0.0 113.155 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.703 ' O ' ' O ' ' A' ' 112' ' ' GLU . 5.9 t 45.44 111.54 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 117.252 0.526 . . . . 0.0 111.797 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.703 ' O ' ' O ' ' A' ' 111' ' ' SER . 17.1 pt-20 -9.57 -148.26 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 126.481 1.913 . . . . 0.0 115.929 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.466 ' CG ' ' O ' ' A' ' 113' ' ' HIS . 0.0 OUTLIER -105.92 73.35 0.99 Allowed 'General case' 0 C--N 1.343 0.303 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -177.257 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.445 ' CB ' ' O ' ' A' ' 113' ' ' HIS . . . 160.14 -164.38 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 122.35 1.072 . . . . 0.0 108.963 175.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.418 ' O ' ' OG ' ' A' ' 118' ' ' SER . . . 102.03 15.6 25.72 Favored Glycine 0 C--N 1.342 0.863 0 CA-C-N 113.015 -1.902 . . . . 0.0 111.487 178.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 13.3 tt -60.71 -40.33 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 C-N-CA 119.609 -0.837 . . . . 0.0 111.015 -178.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.56 -40.39 96.05 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-O 121.716 0.62 . . . . 0.0 112.098 176.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 115' ' ' GLY . 26.0 p -58.41 -42.57 87.48 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 176.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.1 tpp180 -63.55 -37.24 86.55 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 119.824 -0.75 . . . . 0.0 110.927 -177.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.407 ' N ' HD23 ' A' ' 120' ' ' LEU . 2.6 mm? -63.35 -46.1 88.11 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 20.9 mt -66.51 -44.76 81.66 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 118.896 -1.122 . . . . 0.0 109.847 178.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.1 -45.21 89.67 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 119.964 1.256 . . . . 0.0 110.452 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -65.81 -44.42 92.14 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.191 -1.004 . . . . 0.0 111.262 -178.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 42.5 m -64.17 -43.75 94.2 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.742 0.306 . . . . 0.0 111.418 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 19.7 m -69.5 -48.27 61.11 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 119.346 -0.942 . . . . 0.0 112.337 177.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.424 ' CG2' ' N ' ' A' ' 127' ' ' GLY . 6.0 t -65.68 -42.75 90.9 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 -174.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.424 ' N ' ' CG2' ' A' ' 126' ' ' THR . . . -64.48 -44.96 94.46 Favored Glycine 0 CA--C 1.52 0.401 0 CA-C-N 114.632 -1.167 . . . . 0.0 113.138 -177.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.81 -41.71 98.1 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 112.719 -1.741 . . . . 0.0 107.207 177.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 54.6 tp -64.7 -42.62 95.15 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.09 178.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.34 -40.09 96.33 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.099 0.778 . . . . 0.0 113.099 -177.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.3 m -61.17 -26.55 39.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 123.521 1.629 . . . . 0.0 109.639 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -59.29 -45.49 91.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 110.835 -2.893 . . . . 0.0 112.673 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.6 p -79.65 -49.03 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 -178.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -121.79 136.39 54.93 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.823 0.344 . . . . 0.0 111.667 -178.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.672 ' H ' ' CD ' ' A' ' 136' ' ' PRO . 0.0 OUTLIER 170.33 -21.36 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.723 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.79 178.669 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.672 ' CD ' ' H ' ' A' ' 135' ' ' GLN . 53.0 Cg_exo -52.84 -34.68 66.74 Favored 'Trans proline' 0 N--CA 1.499 1.85 0 CA-C-N 121.174 1.455 . . . . 0.0 113.268 -178.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 11.5 t -67.28 -41.59 85.22 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 119.07 -1.052 . . . . 0.0 108.613 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -64.68 -42.24 95.49 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 118.857 -1.137 . . . . 0.0 111.34 -178.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 55.3 t -63.85 -44.48 98.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 32.1 m -65.33 -38.17 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -177.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -61.73 -40.65 95.84 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -176.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.443 ' CG2' ' N ' ' A' ' 143' ' ' ARG . 1.5 m -69.41 -44.24 80.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.028 -0.669 . . . . 0.0 109.343 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.528 ' NH2' ' O ' ' A' ' 174' ' ' GLY . 94.8 mtt-85 -63.86 -35.41 80.56 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.288 178.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -65.89 -40.21 91.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.92 -177.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 23.8 tm0? -63.98 -39.31 93.83 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 119.335 -0.946 . . . . 0.0 108.861 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.14 -35.16 80.24 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 113.267 0.839 . . . . 0.0 113.267 -178.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.52 110.78 1.19 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 177.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -99.41 -60.58 1.5 Allowed 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -175.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -98.35 117.51 32.93 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 122.107 2.23 . . . . 0.0 109.968 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -68.14 -15.0 63.4 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.666 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 71.08 -173.85 41.68 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.692 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 179.827 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.428 ' O ' ' O ' ' A' ' 157' ' ' GLN . 79.4 t80 . . . . . 0 N--CA 1.466 0.349 0 CA-C-O 120.712 0.291 . . . . 0.0 110.979 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.428 ' O ' ' O ' ' A' ' 156' ' ' TYR . 18.1 mm100 59.4 145.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.338 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 70.5 m -157.07 -177.73 6.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.383 0.611 . . . . 0.0 111.201 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 96.8 m -63.92 -45.97 86.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.551 -177.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.457 ' CG2' ' N ' ' A' ' 161' ' ' GLU . 8.2 m -64.01 -44.9 97.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 118.913 -1.115 . . . . 0.0 109.008 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.457 ' N ' ' CG2' ' A' ' 160' ' ' VAL . 94.6 mt-10 -66.94 -39.04 87.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.859 0.361 . . . . 0.0 111.459 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -61.76 -45.62 93.14 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -177.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.42 ' HH ' ' CD2' ' A' ' 175' ' ' LEU . 28.4 t80 -62.38 -49.66 74.65 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.509 -178.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 65.7 mmtt -68.44 -45.43 72.53 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 -175.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 35.6 p -62.79 -44.66 95.58 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 120.78 -1.2 . . . . 0.0 113.921 -177.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 2.4 pp -64.64 -37.78 80.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 121.825 0.822 . . . . 0.0 109.632 176.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -58.64 -35.87 73.2 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 113.741 -1.572 . . . . 0.0 107.829 177.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 7.8 tpm_? -61.94 -50.47 71.99 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 121.706 2.048 . . . . 0.0 112.726 -175.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -75.25 -51.21 13.83 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 123.684 0.793 . . . . 0.0 111.199 178.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -78.14 -36.24 48.01 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 116.169 1.914 . . . . 0.0 116.169 -172.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 93.03 -167.42 29.28 Favored Glycine 0 N--CA 1.47 0.951 0 N-CA-C 111.872 -0.491 . . . . 0.0 111.872 177.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.559 ' CD1' ' H ' ' A' ' 172' ' ' ILE . 0.0 OUTLIER -73.37 -44.48 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 CA-C-O 121.796 0.808 . . . . 0.0 109.871 -179.827 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -59.03 -33.9 71.28 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 114.442 -1.254 . . . . 0.0 111.424 -177.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.528 ' O ' ' NH2' ' A' ' 143' ' ' ARG . . . -61.05 -40.41 98.47 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 118.575 -1.774 . . . . 0.0 109.3 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.42 ' CD2' ' HH ' ' A' ' 163' ' ' TYR . 1.2 tp -70.54 -33.71 71.45 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 111.459 -2.371 . . . . 0.0 116.995 -177.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 6.4 m95 -77.84 -7.56 56.83 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 111.991 -2.368 . . . . 0.0 109.796 -177.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 48.1 tttp -43.39 -48.29 7.04 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.575 -176.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -95.1 -40.03 4.39 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.3 0.953 . . . . 0.0 112.109 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 11.5 p -45.46 -51.44 11.57 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' SER . . . . . 0.432 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 2.6 m -62.72 -50.69 76.7 Favored Pre-proline 0 N--CA 1.472 0.659 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -176.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 180' ' ' SER . 30.1 Cg_endo -64.5 -27.58 62.07 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 121.986 1.791 . . . . 0.0 111.928 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -63.35 -39.09 93.58 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 120.588 -0.445 . . . . 0.0 109.939 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.451 ' O ' ' OD1' ' A' ' 186' ' ' ASN . 85.2 t -62.84 -42.3 95.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.051 0.453 . . . . 0.0 109.975 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.88 -39.51 92.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.095 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 46.2 ttp85 -60.44 -40.83 92.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.923 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . 0.49 ' C ' ' ND2' ' A' ' 186' ' ' ASN . 0.0 OUTLIER -60.34 -41.67 94.08 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.136 0.493 . . . . 0.0 110.34 -179.667 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.2 -43.19 98.87 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.79 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.512 ' O ' ' SG ' ' A' ' 191' ' ' CYS . 42.9 mm -63.01 -44.8 99.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 6.3 m -59.37 -45.67 93.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 119.816 -0.754 . . . . 0.0 111.276 -178.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . 0.406 ' OD1' ' N ' ' A' ' 191' ' ' CYS . 0.9 OUTLIER -61.8 -42.51 99.1 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.876 0.846 . . . . 0.0 109.419 179.302 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' CYS . . . . . 0.551 ' SG ' ' N ' ' A' ' 192' ' ' ALA . 0.5 OUTLIER -62.0 -45.94 91.41 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.013 -1.449 . . . . 0.0 110.828 179.666 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . 0.551 ' N ' ' SG ' ' A' ' 191' ' ' CYS . . . -63.71 -40.4 96.68 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 114.463 -1.244 . . . . 0.0 109.433 177.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -60.74 -44.72 96.33 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.702 -1.136 . . . . 0.0 112.579 -178.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.446 ' HG ' ' N ' ' A' ' 195' ' ' VAL . 2.5 pp -63.0 -37.83 88.74 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 118.862 -1.135 . . . . 0.0 109.75 -174.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . 0.446 ' N ' ' HG ' ' A' ' 194' ' ' LEU . 0.6 OUTLIER -63.99 -46.15 94.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 C-N-CA 117.206 -1.798 . . . . 0.0 107.464 179.074 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 19.2 m -63.98 -46.52 84.24 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -176.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -56.8 -39.12 73.57 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.694 0.798 . . . . 0.0 111.222 -178.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -56.06 -43.93 78.41 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 7.7 mt -61.21 -39.39 90.06 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.599 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.1 mm -62.94 -42.04 95.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 1.8 mmmm -59.27 -38.77 80.95 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.744 1.618 . . . . 0.0 114.911 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -64.27 -42.24 96.53 Favored 'General case' 0 C--O 1.245 0.849 0 O-C-N 121.087 -1.008 . . . . 0.0 111.063 -176.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 4.0 m -102.5 129.19 48.95 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -176.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . 0.61 ' O ' ' O ' ' A' ' 208' ' ' ASN . 3.6 mm? 66.52 3.32 2.83 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 113.717 -1.583 . . . . 0.0 111.299 177.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -122.1 24.53 9.46 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 -178.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -79.33 -18.11 53.18 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.502 0.668 . . . . 0.0 110.382 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.463 ' O ' ' CB ' ' A' ' 208' ' ' ASN . . . -167.1 25.96 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.204 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' ASN . . . . . 0.61 ' O ' ' O ' ' A' ' 204' ' ' LEU . 0.7 OUTLIER 93.53 -130.83 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.39 0.676 . . . . 0.0 109.81 -178.729 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.465 ' O ' ' CD2' ' A' ' 209' ' ' LEU . 6.5 tt . . . . . 0 CA--C 1.505 -0.757 0 N-CA-C 106.719 -1.585 . . . . 0.0 106.719 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 213' ' ' ASP . 34.8 p30 . . . . . 0 N--CA 1.464 0.249 0 CA-C-O 120.963 0.411 . . . . 0.0 110.444 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.422 ' N ' ' HD2' ' A' ' 215' ' ' PRO . 2.0 pt? -61.11 -42.07 84.3 Favored Pre-proline 0 CA--C 1.548 0.877 0 N-CA-C 113.828 1.048 . . . . 0.0 113.828 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.422 ' HD2' ' N ' ' A' ' 214' ' ' LEU . 37.5 Cg_endo -60.13 -32.19 94.27 Favored 'Trans proline' 0 N--CA 1.502 2.01 0 CA-C-N 122.419 1.9 . . . . 0.0 111.458 -178.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 9.9 t -63.51 -42.13 98.5 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 113.48 -1.691 . . . . 0.0 111.713 -177.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' HIS . . . . . 0.43 ' O ' ' OG ' ' A' ' 220' ' ' SER . 54.8 t60 -66.64 -37.75 85.46 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.348 -0.541 . . . . 0.0 111.933 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -63.28 -47.04 84.0 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.515 -178.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 1.5 t -60.22 -37.51 80.54 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 118.845 0.748 . . . . 0.0 111.032 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' SER . . . . . 0.502 ' HG ' ' N ' ' A' ' 221' ' ' ALA . 78.7 p -59.51 -41.71 90.54 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . 0.544 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.68 -41.61 98.13 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -177.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -61.66 -47.04 87.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 122.007 0.908 . . . . 0.0 112.71 -176.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -60.42 -41.73 98.67 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 107.544 -2.223 . . . . 0.0 107.544 177.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . 0.418 ' O ' ' OG1' ' A' ' 228' ' ' THR . . . -62.95 -38.05 89.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.33 -0.935 . . . . 0.0 109.043 177.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -61.94 -42.1 99.71 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.192 -178.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -66.16 -38.4 88.0 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 97.5 m -63.1 -40.8 98.69 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 176.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 224' ' ' ALA . 11.2 m -61.59 -40.1 93.59 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.263 -1.335 . . . . 0.0 110.997 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 92.4 m -58.4 -39.13 78.86 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.371 -177.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 97.1 t -59.68 -40.46 82.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . 0.556 ' O ' ' HD2' ' A' ' 234' ' ' PRO . 23.0 mm -60.97 -40.11 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 177.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -62.32 -38.63 90.17 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.47 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 0.1 OUTLIER -57.25 -40.87 87.82 Favored Pre-proline 0 N--CA 1.482 1.173 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 -172.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . 0.556 ' HD2' ' O ' ' A' ' 231' ' ' ILE . 31.6 Cg_exo -57.87 -39.22 88.53 Favored 'Trans proline' 0 C--N 1.292 -2.404 0 C-N-CA 122.021 1.814 . . . . 0.0 112.491 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 31.0 t -63.52 -36.32 75.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 118.802 -1.159 . . . . 0.0 109.398 178.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . 0.451 ' OD2' ' O ' ' A' ' 233' ' ' SER . 0.0 OUTLIER -65.23 -40.11 93.62 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.174 179.634 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 96.7 t -64.29 -45.63 95.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -176.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 25.6 m . . . . . 0 C--N 1.325 -0.478 0 C-N-CA 119.756 -0.777 . . . . 0.0 110.533 -179.044 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 31.6 m . . . . . 0 C--O 1.228 -0.069 0 CA-C-O 121.177 0.513 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' MET . . . . . 0.426 ' O ' ' O ' ' A' ' 264' ' ' GLU . 32.2 mtt -62.1 -43.58 98.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.945 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 11.8 tp -62.21 -46.26 89.68 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 122.685 0.394 . . . . 0.0 111.068 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 69.6 ttp85 -65.92 -53.8 34.68 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.906 -178.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . 0.426 ' O ' ' N ' ' A' ' 265' ' ' GLY . 0.1 OUTLIER -102.73 -107.35 0.26 Allowed 'General case' 0 N--CA 1.472 0.659 0 O-C-N 122.249 -0.282 . . . . 0.0 111.208 179.562 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . 0.443 ' O ' ' O ' ' A' ' 265' ' ' GLY . 71.2 mm-40 -33.47 91.92 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . 0.443 ' O ' ' O ' ' A' ' 264' ' ' GLU . . . -38.51 166.11 0.01 OUTLIER Glycine 0 CA--C 1.534 1.251 0 CA-C-O 121.623 0.568 . . . . 0.0 111.712 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -63.21 -3.81 5.53 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 122.807 2.338 . . . . 0.0 111.628 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 27.8 mtp180 -69.08 -25.8 64.62 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 123.043 0.537 . . . . 0.0 111.671 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -57.88 -31.84 67.12 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.253 -178.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -62.34 -41.24 98.42 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.18 0.514 . . . . 0.0 110.987 177.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -66.17 -38.37 87.88 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -176.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.439 ' O ' ' O ' ' A' ' 272' ' ' GLY . 14.5 pttm -72.09 -172.43 0.88 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 271' ' ' LYS . . . 47.05 99.23 0.01 OUTLIER Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -158.74 0.94 0.09 Allowed 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.248 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' MET . . . . . 0.522 ' N ' ' HD2' ' A' ' 275' ' ' PRO . 6.2 mmt -63.55 -45.44 83.2 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.581 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 274' ' ' MET . 31.9 Cg_endo -64.9 -45.9 7.35 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 121.133 1.222 . . . . 0.0 110.574 177.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 1.4 m -60.36 -39.78 88.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.246 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . 0.404 ' O ' ' HG ' ' A' ' 280' ' ' LEU . 34.3 t80 -61.65 -43.03 99.63 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 124.438 2.066 . . . . 0.0 112.175 -178.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.11 -38.81 92.67 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 110.568 -3.015 . . . . 0.0 109.569 175.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 11.3 mmm180 -63.2 -41.8 99.23 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.51 0.929 . . . . 0.0 113.51 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.427 HD12 ' N ' ' A' ' 281' ' ' GLY . 3.0 pp -63.12 -35.34 79.94 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -178.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . 0.427 ' N ' HD12 ' A' ' 280' ' ' LEU . . . -67.83 -50.88 38.51 Favored Glycine 0 CA--C 1.521 0.413 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -177.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 9.5 t -62.49 -43.89 97.72 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.642 0.777 . . . . 0.0 109.387 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' TRP . . . . . . . . . . . . . 83.0 t90 -59.54 -37.68 79.04 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 281' ' ' GLY . 0.1 OUTLIER -61.49 -37.2 82.77 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.665 -179.845 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.3 -39.0 79.54 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 O-C-N 121.505 -0.747 . . . . 0.0 112.184 -177.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -63.41 -41.94 94.49 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 119.902 -0.719 . . . . 0.0 112.585 -178.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 6.8 ptm -61.78 -38.47 88.18 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.192 0.52 . . . . 0.0 109.808 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -58.2 -40.31 81.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.937 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 91.5 t -60.87 -39.41 81.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.591 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 10.8 m -63.21 -40.45 97.5 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -61.21 -38.73 87.63 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 176.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -57.94 -40.17 79.87 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 118.143 -1.423 . . . . 0.0 109.272 -176.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' GLN . . . . . 0.446 ' O ' ' O ' ' A' ' 296' ' ' ARG . 73.9 mt-30 -60.29 -41.96 94.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 123.126 1.441 . . . . 0.0 109.764 179.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.41 -39.66 88.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 111.717 -2.492 . . . . 0.0 109.342 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -62.72 -45.31 93.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.537 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' ARG . . . . . 0.446 ' O ' ' O ' ' A' ' 293' ' ' GLN . 44.7 ttm180 -122.53 116.18 23.45 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -113.55 -164.83 0.95 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.269 0.557 . . . . 0.0 112.162 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 14.1 mt -72.74 114.89 11.38 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 79.0 mmm -97.93 63.86 1.68 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -178.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.66 100.96 0.07 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.868 0.842 . . . . 0.0 110.716 -178.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -63.95 -46.22 85.66 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 113.962 -1.472 . . . . 0.0 113.528 -176.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -58.59 -39.21 79.72 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -178.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -64.13 -46.15 85.39 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.539 -179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' SER . . . . . 0.432 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 40.5 t -66.19 -37.72 86.29 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.764 -0.375 . . . . 0.0 110.999 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -61.76 -43.28 99.17 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -179.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -65.19 -36.63 84.8 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.344 1.238 . . . . 0.0 114.344 -177.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -60.02 -52.82 70.8 Favored Pre-proline 0 CA--C 1.544 0.738 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -176.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' PRO . . . . . 0.472 ' O ' ' CG ' ' A' ' 309' ' ' PHE . 74.2 Cg_endo -75.12 0.21 9.23 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.069 1.846 . . . . 0.0 111.808 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' PHE . . . . . 0.472 ' CG ' ' O ' ' A' ' 308' ' ' PRO . 69.4 m-85 . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.546 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.467 0.391 0 CA-C-O 120.786 0.326 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.3 m -83.15 150.61 4.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.266 0.555 . . . . 0.0 110.982 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.55 -40.74 96.14 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.241 -0.89 . . . . 0.0 112.088 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -63.32 -41.83 98.95 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -177.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.475 ' C ' ' CD1' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -80.06 -26.36 39.69 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.092 0.472 . . . . 0.0 111.568 -179.298 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.24 -41.54 94.7 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 107.594 -2.202 . . . . 0.0 107.594 177.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.55 -32.5 68.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 124.818 2.247 . . . . 0.0 107.602 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.25 -42.26 99.36 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-N 108.502 -3.954 . . . . 0.0 107.626 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.7 m -70.49 -27.68 64.39 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.57 -49.8 65.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.842 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.93 -35.97 79.99 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 118.077 -1.449 . . . . 0.0 111.054 -177.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 77.4 m -63.84 -53.93 42.87 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.496 -178.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.2 pp -65.79 -39.43 84.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -177.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.415 ' O ' ' OG1' ' A' ' 31' ' ' THR . . . -64.11 -41.96 97.05 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -174.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.519 ' OD1' ' NH2' ' A' ' 88' ' ' ARG . 10.0 t70 -77.64 -27.39 51.05 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 120.594 1.543 . . . . 0.0 109.809 -175.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 43.5 mt -60.0 -55.28 35.97 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 119.724 1.147 . . . . 0.0 112.097 -178.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.8 tp -75.42 -3.87 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-O 121.743 0.783 . . . . 0.0 112.335 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 27' ' ' ALA . 29.7 m -108.96 -16.39 14.15 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 117.491 -1.242 . . . . 0.0 110.305 -178.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.441 ' O ' ' OD1' ' A' ' 35' ' ' ASP . 14.5 t80 -69.01 -44.3 28.25 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-N 122.784 2.538 . . . . 0.0 111.758 -177.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' A' ' 32' ' ' PHE . 32.1 Cg_exo -59.6 -15.72 32.52 Favored 'Trans proline' 0 N--CA 1.504 2.107 0 C-N-CA 121.298 1.332 . . . . 0.0 113.245 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.8 mp -67.18 -35.5 79.78 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -177.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 36' ' ' THR . 15.8 p30 -64.86 -40.53 95.3 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -178.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.538 ' N ' ' OD1' ' A' ' 35' ' ' ASP . 43.3 p -58.4 -34.99 71.35 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.59 -38.37 83.93 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 119.948 -0.701 . . . . 0.0 111.84 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -61.66 -49.09 77.94 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 119.625 -0.83 . . . . 0.0 111.266 -176.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.5 m -63.69 -39.75 86.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 118.31 0.504 . . . . 0.0 111.913 -177.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.521 ' NH2' ' OE1' ' A' ' 42' ' ' GLN . 7.6 tpm_? -60.78 -40.99 94.66 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.411 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.0 38.85 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.589 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.521 ' OE1' ' NH2' ' A' ' 40' ' ' ARG . 2.6 pt20 -85.82 61.73 7.03 Favored 'General case' 0 N--CA 1.463 0.188 0 O-C-N 121.965 -0.459 . . . . 0.0 110.971 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.408 ' C ' ' O ' ' A' ' 42' ' ' GLN . 22.2 pt 32.06 -125.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.861 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -158.15 100.62 1.71 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.649 0.262 . . . . 0.0 110.334 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.547 ' C ' ' H ' ' A' ' 47' ' ' SER . . . -176.31 -118.59 0.54 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.089 -0.805 . . . . 0.0 111.089 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 69.22 -16.9 0.23 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.704 0.288 . . . . 0.0 110.786 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.547 ' H ' ' C ' ' A' ' 45' ' ' GLY . 29.0 t 53.66 26.41 5.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.919 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.519 ' O ' ' NE2' ' A' ' 48' ' ' GLN . 0.0 OUTLIER -44.16 -28.39 0.5 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.674 0.75 . . . . 0.0 109.789 179.727 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.72 -36.71 3.66 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -178.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.419 ' N ' ' CD2' ' A' ' 50' ' ' LEU . 3.6 mm? -66.73 -38.03 85.85 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.448 0.642 . . . . 0.0 109.311 177.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 96.2 t -60.68 -44.55 97.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 114.919 -1.037 . . . . 0.0 112.604 -177.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -64.19 -33.54 76.02 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.938 -178.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.5 m -67.92 -38.06 82.45 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 177.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.439 ' C ' ' H ' ' A' ' 56' ' ' SER . . . -127.93 78.6 1.84 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.177 -0.919 . . . . 0.0 108.801 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.38 -3.42 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.635 -0.712 . . . . 0.0 112.813 -178.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.532 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 94.9 p -126.58 -140.04 0.27 Allowed 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.532 ' CB ' ' O ' ' A' ' 56' ' ' SER . . . 99.2 11.77 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 O-C-N 124.12 0.888 . . . . 0.0 111.878 178.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 177.52 70.78 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -41.12 -83.78 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.054 0.454 . . . . 0.0 110.633 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.415 ' O ' ' C ' ' A' ' 61' ' ' GLY . 30.0 ttm180 -161.01 -34.36 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.591 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 60' ' ' ARG . . . -28.61 102.74 0.01 OUTLIER Glycine 0 CA--C 1.527 0.807 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.641 -179.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 90.3 t -67.41 -34.6 69.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 118.451 -0.785 . . . . 0.0 109.685 176.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.488 ' CD2' ' N ' ' A' ' 63' ' ' LEU . 3.6 mm? -60.79 -32.65 71.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 121.011 1.732 . . . . 0.0 109.726 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.61 -49.31 65.18 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-N 114.905 -1.043 . . . . 0.0 114.398 -176.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.3 m -62.1 -46.36 89.41 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 70.6 mt -59.43 -35.95 61.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.94 -35.76 81.72 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 120.919 1.69 . . . . 0.0 112.156 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.46 ' O ' ' OG1' ' A' ' 72' ' ' THR . 99.2 m -63.22 -40.73 98.29 Favored 'General case' 0 C--O 1.246 0.906 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.003 -174.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.402 ' C ' ' SD ' ' A' ' 69' ' ' MET . 3.2 ppp? -59.67 -40.05 86.51 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -175.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.2 p -69.49 -40.78 80.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 119.096 -1.042 . . . . 0.0 112.563 -178.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 75.0 ttt-85 -78.54 -13.3 59.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.769 0.795 . . . . 0.0 112.534 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.46 ' OG1' ' O ' ' A' ' 68' ' ' THR . 54.5 m -62.81 -54.65 35.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.643 178.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -107.44 -56.47 2.21 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.276 178.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 157.3 165.89 15.87 Favored Glycine 0 CA--C 1.535 1.325 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -56.27 -35.47 95.76 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 CA-C-N 119.508 1.654 . . . . 0.0 111.893 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.41 ' O ' ' CB ' ' A' ' 80' ' ' ASN . 12.1 tpp180 -61.42 -12.27 13.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.756 0.789 . . . . 0.0 111.007 176.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.471 ' HG ' ' N ' ' A' ' 78' ' ' LEU . 10.4 p -78.55 -33.0 48.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.968 -178.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.471 ' N ' ' HG ' ' A' ' 77' ' ' SER . 1.0 OUTLIER -75.94 -33.64 59.84 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.116 0.484 . . . . 0.0 110.535 179.754 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -92.74 -5.15 51.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 122.335 1.064 . . . . 0.0 113.202 -178.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.41 ' CB ' ' O ' ' A' ' 76' ' ' ARG . 4.7 t30 -90.01 118.85 29.88 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 112.812 -1.995 . . . . 0.0 107.502 175.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.71 -7.25 57.55 Favored Glycine 0 N--CA 1.468 0.782 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 -177.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.505 ' CD1' ' N ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -59.42 -34.59 72.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 113.603 -1.298 . . . . 0.0 110.834 -179.687 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.505 ' N ' ' CD1' ' A' ' 82' ' ' LEU . 4.8 p -70.61 -26.79 29.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.94 -31.62 61.55 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.576 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -68.17 -40.34 88.01 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 119.344 -1.407 . . . . 0.0 111.206 -177.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.3 mp -62.66 -40.54 97.38 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.978 0.894 . . . . 0.0 113.099 -176.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -60.62 -27.17 67.56 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 113.799 -1.546 . . . . 0.0 109.306 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.725 ' HE ' HE22 ' A' ' 89' ' ' GLN . 37.3 ttp180 -57.89 -53.76 54.58 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 173.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.725 HE22 ' HE ' ' A' ' 88' ' ' ARG . 0.9 OUTLIER -67.1 -29.86 69.73 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 112.325 -2.216 . . . . 0.0 111.84 -178.17 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 33.4 tpp -61.35 -40.82 95.66 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.493 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 37.1 m -74.44 -34.6 63.24 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 118.099 -0.953 . . . . 0.0 111.302 -177.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -57.66 -43.88 85.29 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 121.324 1.874 . . . . 0.0 112.262 -176.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.56 -32.84 64.39 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.127 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.8 p -64.09 -41.31 97.34 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.428 ' C ' ' H ' ' A' ' 97' ' ' ILE . 7.9 p -68.27 -28.23 39.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.022 177.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.403 ' NH2' ' CE2' ' A' ' 100' ' ' TYR . 51.0 ttt-85 -77.44 9.22 3.42 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -176.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.428 ' H ' ' C ' ' A' ' 95' ' ' VAL . 0.3 OUTLIER -87.3 -14.93 9.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.833 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -139.98 -48.2 0.06 OUTLIER Glycine 0 CA--C 1.543 1.781 0 N-CA-C 116.087 1.195 . . . . 0.0 116.087 -176.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 16.6 mt -71.14 -12.76 61.67 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 119.84 1.82 . . . . 0.0 113.05 -178.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.499 ' O ' ' CG ' ' A' ' 104' ' ' LYS . 26.2 t80 -80.57 -51.19 9.04 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 114.48 -1.236 . . . . 0.0 111.868 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 1.051 ' OD2' ' NE2' ' A' ' 105' ' ' GLN . 9.7 t70 -69.46 -32.29 71.11 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 123.175 1.464 . . . . 0.0 110.043 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 11.4 t -68.74 -52.54 29.48 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 111.158 -2.746 . . . . 0.0 111.89 175.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 52.3 t -74.28 -27.79 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-N 121.697 2.044 . . . . 0.0 114.131 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.499 ' CG ' ' O ' ' A' ' 100' ' ' TYR . 3.2 mmpt? -69.69 -41.68 75.12 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 112.131 -2.304 . . . . 0.0 111.518 179.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 1.051 ' NE2' ' OD2' ' A' ' 101' ' ' ASP . 88.1 mt-30 -79.69 -12.95 59.78 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 122.638 1.209 . . . . 0.0 111.011 -178.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -79.93 -22.8 42.28 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.21 178.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.619 ' CZ ' ' ND2' ' A' ' 190' ' ' ASN . 35.4 m-85 -109.81 -29.45 8.3 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 119.532 1.06 . . . . 0.0 112.721 -175.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.6 p -96.78 9.11 42.71 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 117.144 -1.823 . . . . 0.0 113.135 -177.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.402 ' HG2' ' H ' ' A' ' 110' ' ' GLY . 12.4 ttpp -96.87 -154.82 0.46 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 177.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.402 ' H ' ' HG2' ' A' ' 109' ' ' LYS . . . 140.42 134.58 3.11 Favored Glycine 0 N--CA 1.475 1.245 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 76.2 p -90.19 -40.29 12.29 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -177.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -116.28 174.41 6.07 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 112.899 -1.955 . . . . 0.0 113.485 -176.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.437 ' O ' ' CB ' ' A' ' 114' ' ' ALA . 85.9 m-70 -86.47 77.08 9.51 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.759 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.437 ' CB ' ' O ' ' A' ' 113' ' ' HIS . . . 159.6 -161.39 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.05 14.82 27.77 Favored Glycine 0 C--N 1.335 0.499 0 CA-C-N 115.449 -0.796 . . . . 0.0 113.213 176.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.422 HG21 HD12 ' A' ' 116' ' ' ILE . 22.6 mm -60.89 -40.83 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.0 -39.29 96.34 Favored Glycine 0 CA--C 1.525 0.713 0 CA-C-O 122.253 0.918 . . . . 0.0 110.982 175.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 5.8 t -57.93 -42.17 84.27 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 177.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 59.7 mtm180 -63.58 -37.47 87.44 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.278 -178.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 8.0 mp -64.15 -46.51 83.76 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 76.9 mt -66.83 -44.83 80.07 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 114.926 -1.033 . . . . 0.0 110.494 178.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.91 -44.77 91.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 119.532 1.06 . . . . 0.0 109.869 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -66.01 -44.1 92.21 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 119.73 -1.224 . . . . 0.0 111.295 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 71.0 m -64.07 -43.95 93.9 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.784 -0.367 . . . . 0.0 111.538 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 21.1 p -69.35 -48.43 61.36 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 119.333 -0.947 . . . . 0.0 111.954 177.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 24.0 p -65.37 -42.41 92.75 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 -174.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -63.95 -44.54 95.84 Favored Glycine 0 CA--C 1.521 0.463 0 CA-C-O 122.967 1.315 . . . . 0.0 112.916 -177.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.35 -41.6 97.33 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 111.903 -2.148 . . . . 0.0 107.25 177.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 17.3 mt -64.41 -42.15 96.24 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.221 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.0 -39.77 95.74 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -177.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 18.9 m -60.96 -26.03 37.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 122.829 1.3 . . . . 0.0 109.572 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -58.63 -44.83 90.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 112.251 -2.25 . . . . 0.0 111.876 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 5.1 m -79.0 -48.63 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -126.7 135.75 51.54 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.695 0.283 . . . . 0.0 111.451 -178.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.685 ' H ' ' CD ' ' A' ' 136' ' ' PRO . 2.1 pt20 175.2 -23.59 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.828 0 CA-C-N 115.47 -0.786 . . . . 0.0 113.069 178.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.685 ' CD ' ' H ' ' A' ' 135' ' ' GLN . 54.3 Cg_exo -53.03 -34.17 66.39 Favored 'Trans proline' 0 N--CA 1.5 1.894 0 CA-C-N 120.955 1.377 . . . . 0.0 113.275 -178.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.43 -41.58 84.55 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 119.064 -1.055 . . . . 0.0 110.667 -178.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -64.38 -42.44 96.16 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 119.238 -0.985 . . . . 0.0 111.777 -177.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 14.6 m -63.6 -42.71 97.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.879 0.371 . . . . 0.0 110.977 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.423 ' O ' ' N ' ' A' ' 144' ' ' PHE . 25.3 t -63.97 -38.54 82.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.437 ' NZ ' ' CB ' ' A' ' 141' ' ' LYS . 8.8 mtmp? -62.0 -40.93 97.33 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 119.556 -0.858 . . . . 0.0 111.895 -177.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.4 p -69.56 -44.81 79.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 119.992 -0.683 . . . . 0.0 109.23 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -64.36 -35.9 82.39 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.468 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.423 ' N ' ' O ' ' A' ' 140' ' ' VAL . 93.9 t80 -66.14 -40.76 90.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.249 -177.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -64.4 -39.53 94.03 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 118.844 -1.142 . . . . 0.0 109.709 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.22 -35.03 79.79 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.413 ' O ' ' CG ' ' A' ' 147' ' ' GLN . 0.0 OUTLIER -59.85 111.35 1.43 Allowed 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 177.981 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -94.49 -64.39 1.08 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 117.396 -1.288 . . . . 0.0 112.615 -177.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -91.06 110.68 21.96 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 122.862 2.574 . . . . 0.0 110.121 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -81.41 68.69 7.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.648 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 43.28 59.37 3.52 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.697 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -179.816 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.449 ' CE2' ' O ' ' A' ' 157' ' ' GLN . 85.1 t80 . . . . . 0 N--CA 1.467 0.388 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.449 ' O ' ' CE2' ' A' ' 156' ' ' TYR . 19.7 mp0 -109.67 -155.24 0.55 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -178.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 83.4 p -157.22 -176.25 5.86 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 123.256 1.503 . . . . 0.0 112.936 -177.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 8.4 m -62.89 -43.53 98.56 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 111.26 -2.7 . . . . 0.0 112.002 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.5 t -61.05 -42.76 94.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -178.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.45 ' OE2' ' OG1' ' A' ' 165' ' ' THR . 0.7 OUTLIER -65.47 -38.33 89.48 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.066 179.877 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -61.4 -45.67 93.35 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -178.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.436 ' CD1' ' C ' ' A' ' 163' ' ' TYR . 13.7 t80 -62.62 -49.21 76.09 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.278 -178.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -67.83 -45.36 74.88 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -174.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.45 ' OG1' ' OE2' ' A' ' 161' ' ' GLU . 1.9 p -63.0 -43.86 97.63 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -176.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 15.0 pt -64.26 -37.93 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 CA-C-O 121.746 0.784 . . . . 0.0 109.133 177.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.89 -37.07 78.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.17 -1.377 . . . . 0.0 107.37 175.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -62.46 -50.44 71.46 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 122.211 2.278 . . . . 0.0 111.849 -176.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.524 ' N ' ' OE1' ' A' ' 169' ' ' GLU . 0.2 OUTLIER -74.93 -50.99 14.91 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.523 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -78.09 -36.28 48.32 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 116.594 2.072 . . . . 0.0 116.594 -173.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 91.14 -166.61 31.03 Favored Glycine 0 C--N 1.337 0.628 0 CA-C-N 118.841 0.746 . . . . 0.0 112.263 177.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.579 ' CD1' ' H ' ' A' ' 172' ' ' ILE . 0.0 OUTLIER -72.64 -38.58 59.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.903 0.859 . . . . 0.0 109.175 -179.576 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 68.1 mtp180 -58.5 -33.74 70.15 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 113.852 -1.522 . . . . 0.0 111.103 -177.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -61.48 -41.24 99.51 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 118.672 -1.728 . . . . 0.0 111.425 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.464 ' CD1' ' N ' ' A' ' 175' ' ' LEU . 7.8 mp -71.33 -34.35 70.47 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 117.717 2.488 . . . . 0.0 117.717 -177.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . 0.493 ' CD1' ' O ' ' A' ' 172' ' ' ILE . 63.7 m95 -78.18 -7.09 56.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 112.995 -1.912 . . . . 0.0 109.589 -177.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 16.8 ttmm -43.63 -48.64 7.75 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -175.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -90.11 -32.23 10.01 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.39 0.995 . . . . 0.0 111.815 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 90.1 m -45.31 -50.66 11.81 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.96 -50.47 80.78 Favored Pre-proline 0 N--CA 1.472 0.627 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -175.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -64.64 -27.98 60.81 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 121.17 1.247 . . . . 0.0 111.704 176.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -64.06 -39.33 93.85 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 1.6 p -62.91 -41.71 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.855 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.48 -39.28 90.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.961 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.57 HH12 ' CG1' ' A' ' 235' ' ' VAL . 48.8 ttt85 -60.6 -42.13 96.14 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 119.922 -0.711 . . . . 0.0 110.344 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -61.67 -43.86 98.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.183 0.516 . . . . 0.0 110.679 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -65.28 -44.2 88.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.617 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 24.3 mm -63.81 -45.89 95.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -177.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.503 ' O ' ' N ' ' A' ' 193' ' ' GLU . 5.9 p -60.72 -47.31 93.62 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.339 0 C-N-CA 119.237 -0.985 . . . . 0.0 111.729 -178.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . 0.619 ' ND2' ' CZ ' ' A' ' 107' ' ' TYR . 12.2 t-20 -63.54 -42.94 98.37 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 122.282 1.039 . . . . 0.0 110.868 178.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' CYS . . . . . . . . . . . . . 31.3 m -61.39 -45.53 93.98 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 113.348 -1.751 . . . . 0.0 108.389 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.27 -40.4 95.91 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 112.662 -2.063 . . . . 0.0 109.672 175.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 0.503 ' N ' ' O ' ' A' ' 189' ' ' VAL . 0.7 OUTLIER -60.81 -46.54 90.12 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.001 0.92 . . . . 0.0 113.086 -176.884 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 2.8 pp -64.31 -36.73 85.08 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 119.231 -0.988 . . . . 0.0 109.528 -175.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 1.4 m -63.18 -45.74 97.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 C-N-CA 117.01 -1.876 . . . . 0.0 107.389 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 30.3 p -64.35 -46.11 84.88 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -177.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -57.67 -39.87 78.1 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.133 -0.939 . . . . 0.0 113.338 -177.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -56.4 -44.46 80.32 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 9.7 mt -61.66 -39.45 91.41 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.803 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 1.6 mp -63.12 -42.79 97.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 118.813 -0.613 . . . . 0.0 110.115 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -59.99 -40.42 89.12 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 120.224 1.374 . . . . 0.0 111.897 178.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -66.96 -38.43 86.08 Favored 'General case' 0 C--O 1.25 1.104 0 CA-C-N 114.682 -1.145 . . . . 0.0 111.003 -176.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -101.96 128.89 48.17 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 120.804 -1.185 . . . . 0.0 112.455 -178.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 4.1 tp 67.46 4.45 3.8 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 114.275 -1.33 . . . . 0.0 112.082 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.74 38.11 4.0 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -74.52 -21.57 59.47 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.527 0.68 . . . . 0.0 111.455 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.427 ' O ' ' CB ' ' A' ' 208' ' ' ASN . . . -130.86 -40.45 1.19 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.54 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' ASN . . . . . 0.427 ' CB ' ' O ' ' A' ' 207' ' ' ALA . 6.4 p30 152.13 124.43 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 -178.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.433 ' CD1' ' O ' ' A' ' 209' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.484 1.266 0 CA-C-N 110.41 -3.086 . . . . 0.0 111.954 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 . . . . . 0 N--CA 1.469 0.482 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.4 ' N ' ' CD ' ' A' ' 215' ' ' PRO . 4.4 mm? -61.28 -43.74 90.87 Favored Pre-proline 0 CA--C 1.537 0.481 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 214' ' ' LEU . 25.9 Cg_exo -60.88 -34.07 91.71 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 CA-C-N 120.59 1.246 . . . . 0.0 111.039 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 82.3 m -64.77 -42.53 95.05 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 113.173 -1.83 . . . . 0.0 111.771 -178.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' HIS . . . . . 0.416 ' O ' ' OG ' ' A' ' 220' ' ' SER . 4.0 t60 -66.83 -38.13 85.82 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -178.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -63.44 -47.37 82.15 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.941 -178.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 27.1 p -60.65 -38.24 84.17 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 119.102 0.864 . . . . 0.0 110.465 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 217' ' ' HIS . 47.8 p -59.67 -41.88 91.61 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . 0.568 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.91 -41.82 97.58 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -177.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -62.11 -47.15 85.89 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -176.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -60.74 -42.09 99.28 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 107.464 -2.254 . . . . 0.0 107.464 177.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -63.1 -37.93 89.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.211 -0.995 . . . . 0.0 108.977 176.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -61.66 -42.28 99.73 Favored Glycine 0 CA--C 1.521 0.412 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.811 -177.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -66.57 -38.34 86.87 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 96.3 m -63.22 -41.11 99.08 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.012 0.434 . . . . 0.0 110.387 177.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 225' ' ' GLY . 55.9 p -61.99 -39.95 93.96 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.759 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -58.17 -38.73 77.23 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -176.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 1.7 p -59.57 -40.53 82.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 119.004 -1.078 . . . . 0.0 110.02 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . 0.495 ' O ' ' HD2' ' A' ' 234' ' ' PRO . 0.3 OUTLIER -61.45 -40.16 85.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 177.615 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -62.78 -39.47 94.29 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 115.683 1.735 . . . . 0.0 115.683 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.488 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 0.2 OUTLIER -57.99 -41.72 91.39 Favored Pre-proline 0 N--CA 1.484 1.244 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 -173.525 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . 0.495 ' HD2' ' O ' ' A' ' 231' ' ' ILE . 32.3 Cg_exo -57.7 -39.56 86.67 Favored 'Trans proline' 0 C--N 1.291 -2.461 0 C-N-CA 122.495 2.13 . . . . 0.0 113.128 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . 0.57 ' CG1' HH12 ' A' ' 185' ' ' ARG . 59.3 t -63.69 -37.22 79.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 C-N-CA 117.8 -1.56 . . . . 0.0 108.799 178.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . 0.526 ' OD2' ' CE3' ' A' ' 283' ' ' TRP . 53.1 t0 -65.77 -40.37 91.94 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.266 178.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 59.2 t -64.6 -45.22 96.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 -176.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 84.4 t . . . . . 0 C--N 1.32 -0.693 0 C-N-CA 120.028 -0.669 . . . . 0.0 111.737 -178.064 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 19.7 m . . . . . 0 N--CA 1.467 0.403 0 N-CA-C 113.863 1.061 . . . . 0.0 113.863 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' MET . . . . . 0.459 ' SD ' ' N ' ' A' ' 261' ' ' LEU . 0.0 OUTLIER -61.75 -44.37 97.03 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -176.817 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.459 ' N ' ' SD ' ' A' ' 260' ' ' MET . 11.7 tp -62.36 -47.08 85.77 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 121.92 -0.487 . . . . 0.0 109.766 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 70.0 mtp180 -66.77 -53.64 30.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.976 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . 0.455 ' O ' ' O ' ' A' ' 260' ' ' MET . 9.6 mtpm? -130.59 179.17 6.1 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.881 0.372 . . . . 0.0 111.258 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . 0.456 ' O ' ' O ' ' A' ' 265' ' ' GLY . 95.1 mt-10 56.43 67.78 0.95 Allowed 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.609 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 264' ' ' GLU . . . -33.34 159.81 0.01 OUTLIER Glycine 0 CA--C 1.533 1.158 0 CA-C-O 121.789 0.661 . . . . 0.0 112.304 -179.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -64.91 -5.34 10.48 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.076 1.851 . . . . 0.0 111.355 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -69.73 -26.28 64.25 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.536 0.734 . . . . 0.0 111.362 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -58.02 -32.28 67.8 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.532 -178.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -62.39 -41.15 98.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.347 177.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -65.79 -37.9 87.55 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.387 -177.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.506 ' CB ' ' HZ2' ' A' ' 271' ' ' LYS . 0.0 OUTLIER -95.97 165.54 12.21 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 178.448 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 69.03 86.64 0.1 Allowed Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.614 -0.995 . . . . 0.0 110.614 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -168.74 22.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 121.064 -0.255 . . . . 0.0 110.784 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' MET . . . . . 0.568 ' N ' ' CD ' ' A' ' 275' ' ' PRO . 1.0 OUTLIER -63.7 -44.1 79.16 Favored Pre-proline 0 C--N 1.33 -0.254 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.219 -179.792 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 274' ' ' MET . 21.3 Cg_exo -64.38 -46.61 7.21 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.43 2.087 . . . . 0.0 111.54 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 1.5 p -60.66 -40.11 90.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.038 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . 0.411 ' CD1' ' C ' ' A' ' 277' ' ' PHE . 36.4 t80 -61.89 -42.92 99.65 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 123.289 1.519 . . . . 0.0 111.936 -178.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 12.0 tp -62.12 -38.73 90.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 111.037 -2.801 . . . . 0.0 108.159 174.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . 0.408 ' HA ' ' HE ' ' A' ' 279' ' ' ARG . 0.5 OUTLIER -62.62 -40.2 96.24 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.072 179.215 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.446 ' CD1' ' C ' ' A' ' 280' ' ' LEU . 0.2 OUTLIER -61.97 -36.31 81.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.145 -0.934 . . . . 0.0 113.1 -177.255 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -67.7 -50.89 39.19 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 109.146 -1.581 . . . . 0.0 109.146 -178.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 78.0 p -61.92 -43.63 98.44 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.694 0.798 . . . . 0.0 109.538 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' TRP . . . . . 0.526 ' CE3' ' OD2' ' A' ' 236' ' ' ASP . 1.3 m95 -59.5 -38.09 79.99 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . 0.422 ' ND2' ' CD1' ' A' ' 280' ' ' LEU . 85.2 m-20 -61.76 -38.95 89.92 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -178.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 23.0 m -61.46 -37.26 77.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 O-C-N 121.354 -0.841 . . . . 0.0 111.339 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.406 ' O ' ' CG2' ' A' ' 289' ' ' VAL . 26.8 t -62.14 -41.63 92.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -177.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' MET . . . . . 0.42 ' O ' ' OG1' ' A' ' 290' ' ' THR . 11.5 ptm -62.34 -38.32 89.05 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 121.305 -0.872 . . . . 0.0 109.608 178.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -58.47 -41.22 84.73 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.13 -0.941 . . . . 0.0 113.303 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.406 ' CG2' ' O ' ' A' ' 286' ' ' VAL . 2.7 m -61.33 -38.68 80.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 121.693 -0.63 . . . . 0.0 110.846 -178.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 287' ' ' MET . 75.7 p -62.22 -40.43 96.1 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 177.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -61.24 -38.44 86.65 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 176.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -58.31 -40.71 82.72 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 117.915 -1.514 . . . . 0.0 109.283 -176.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' GLN . . . . . 0.451 ' O ' ' O ' ' A' ' 296' ' ' ARG . 83.3 mm-40 -60.72 -43.13 98.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 122.577 1.18 . . . . 0.0 110.784 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 73.5 mt -60.47 -40.52 91.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 113.027 -1.897 . . . . 0.0 109.219 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -63.18 -46.15 88.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.982 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' ARG . . . . . 0.451 ' O ' ' O ' ' A' ' 293' ' ' GLN . 20.1 tpt85 -123.07 116.19 23.08 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.009 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -115.52 -96.11 0.46 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.177 0.513 . . . . 0.0 110.522 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 38.9 tp -139.3 120.87 15.17 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.683 179.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 30.2 ttm -92.69 64.32 4.11 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 121.202 -0.199 . . . . 0.0 111.271 -179.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.71 101.22 0.07 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.976 0.893 . . . . 0.0 111.227 -178.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -64.12 -46.2 85.19 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 113.47 -1.695 . . . . 0.0 112.936 -176.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -58.48 -39.29 79.58 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.498 -0.481 . . . . 0.0 109.789 -178.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' GLN . . . . . 0.432 ' O ' ' OE2' ' A' ' 306' ' ' GLU . 86.3 mt-30 -64.56 -46.49 82.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.224 -179.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' SER . . . . . 0.439 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 74.2 p -67.09 -38.64 86.05 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.454 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -62.5 -43.87 97.75 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -178.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . 0.473 ' CD ' ' N ' ' A' ' 307' ' ' ALA . 2.7 pp20? -65.72 -36.76 84.51 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -177.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . 0.473 ' N ' ' CD ' ' A' ' 306' ' ' GLU . . . -59.84 -52.6 72.57 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -176.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' PRO . . . . . 0.439 ' CD ' ' O ' ' A' ' 304' ' ' SER . 73.1 Cg_endo -74.96 0.3 9.05 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.954 1.769 . . . . 0.0 111.604 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 82.5 t80 . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.459 179.881 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.7 m . . . . . 0 N--CA 1.465 0.294 0 CA-C-O 120.829 0.347 . . . . 0.0 110.111 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.504 ' CG2' ' H ' ' A' ' 16' ' ' LYS . 7.2 p -91.79 176.58 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.318 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.504 ' H ' ' CG2' ' A' ' 15' ' ' VAL . 35.0 mtmm -64.21 -41.37 97.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.517 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -63.61 -41.42 98.3 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 31.3 tp -79.85 -26.42 40.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.079 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.444 ' O ' ' OG1' ' A' ' 22' ' ' THR . . . -66.26 -41.39 94.74 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 107.451 -2.259 . . . . 0.0 107.451 177.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.427 ' CB ' HH12 ' A' ' 96' ' ' ARG . . . -71.37 -32.0 67.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 124.77 2.224 . . . . 0.0 107.314 176.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.45 -42.57 98.98 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-N 108.469 -3.969 . . . . 0.0 108.095 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.499 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 33.6 p -70.75 -28.0 64.37 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.28 -50.23 64.39 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.745 -178.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.406 ' O ' ' OE1' ' A' ' 89' ' ' GLN . . . -61.95 -35.96 79.98 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 118.504 -1.278 . . . . 0.0 111.234 -177.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.632 ' SG ' ' N ' ' A' ' 26' ' ' ILE . 5.8 p -64.15 -53.47 48.88 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.027 -179.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.632 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 16.0 pt -65.68 -39.68 85.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -178.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.498 ' O ' ' OG1' ' A' ' 31' ' ' THR . . . -63.68 -42.18 98.06 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 119.686 -0.806 . . . . 0.0 112.738 -173.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.532 ' CG ' HE22 ' A' ' 89' ' ' GLN . 1.5 m-20 -77.09 -27.13 54.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 120.739 1.608 . . . . 0.0 109.941 -174.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.42 -54.26 47.71 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 118.922 0.783 . . . . 0.0 112.222 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.4 pp -72.86 -1.0 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-O 122.501 1.144 . . . . 0.0 111.906 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.498 ' OG1' ' O ' ' A' ' 27' ' ' ALA . 97.8 m -106.72 -12.58 15.5 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 112.588 -2.096 . . . . 0.0 112.051 -174.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.439 ' N ' ' CD ' ' A' ' 33' ' ' PRO . 8.4 t80 -70.74 -44.87 16.63 Favored Pre-proline 0 CA--C 1.551 1.011 0 CA-C-N 121.935 2.152 . . . . 0.0 113.765 -178.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.439 ' CD ' ' N ' ' A' ' 32' ' ' PHE . 33.5 Cg_exo -60.54 -17.75 50.33 Favored 'Trans proline' 0 N--CA 1.52 3.047 0 N-CA-C 119.363 2.793 . . . . 0.0 119.363 -175.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.651 ' CD1' ' H ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -69.11 -35.47 76.47 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 120.342 1.428 . . . . 0.0 114.067 -179.071 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -65.02 -41.73 95.02 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -175.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.5 p -58.33 -36.0 72.75 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 119.551 -0.86 . . . . 0.0 111.348 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.96 -38.81 83.21 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 119.782 -0.767 . . . . 0.0 111.731 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.4 ' CG ' ' N ' ' A' ' 39' ' ' VAL . 8.2 pttp -61.37 -48.24 82.18 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.28 -176.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.4 ' N ' ' CG ' ' A' ' 38' ' ' LYS . 82.2 t -63.48 -41.05 91.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 119.667 -0.813 . . . . 0.0 111.565 -176.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.524 ' C ' ' H ' ' A' ' 42' ' ' GLN . 67.9 mmt-85 -61.94 -42.09 98.7 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 119.252 -0.979 . . . . 0.0 110.064 178.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -62.81 38.85 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.685 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.524 ' H ' ' C ' ' A' ' 40' ' ' ARG . 8.1 tp-100 -128.41 -76.43 0.56 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.909 0.385 . . . . 0.0 110.01 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 21.0 tt -168.46 121.45 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.885 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -71.69 57.57 0.29 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.889 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -167.24 165.87 38.87 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.137 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.6 mp0 -147.11 -160.12 1.12 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.134 -0.533 . . . . 0.0 109.574 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.7 m -81.94 -6.22 58.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.033 0.444 . . . . 0.0 110.106 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -59.42 -30.49 68.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.729 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.71 1.17 87.5 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -178.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.3 tp -64.03 -36.03 82.66 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.361 -0.92 . . . . 0.0 109.532 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.428 ' O ' ' O ' ' A' ' 54' ' ' ALA . 8.6 p -58.95 -43.05 87.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.067 -178.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.413 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 22.3 ptt85 -63.06 -33.07 74.65 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 119.734 -0.787 . . . . 0.0 109.658 -178.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -67.7 -37.81 82.8 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 51' ' ' VAL . . . -132.26 111.3 11.27 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.469 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.61 -8.77 59.59 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -178.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.515 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 29.4 p -130.55 -138.15 0.21 Allowed 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.515 ' CB ' ' O ' ' A' ' 56' ' ' SER . . . 91.84 -30.96 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 176.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.468 ' O ' ' N ' ' A' ' 60' ' ' ARG . 68.8 mt-30 -139.55 8.05 2.37 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.565 ' O ' ' CD2' ' A' ' 59' ' ' TYR . 20.9 p90 -46.3 87.03 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.555 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.477 ' O ' ' O ' ' A' ' 59' ' ' TYR . 75.9 mtt180 51.33 165.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.021 0.439 . . . . 0.0 110.419 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 120.01 83.87 0.82 Allowed Glycine 0 CA--C 1.519 0.298 0 N-CA-C 104.441 -3.463 . . . . 0.0 104.441 -175.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.6 p -67.79 -36.11 74.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 118.631 -0.699 . . . . 0.0 110.86 178.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.75 -33.02 73.32 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 117.687 -1.605 . . . . 0.0 109.24 178.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.89 -49.9 60.85 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 113.559 -1.655 . . . . 0.0 115.126 -176.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.0 m -62.37 -46.92 86.48 Favored 'General case' 0 C--N 1.334 -0.1 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -178.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 12.0 tt -59.98 -36.04 64.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 38.6 tp -63.88 -35.57 81.07 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 120.82 1.645 . . . . 0.0 111.607 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 98.4 m -63.28 -40.13 96.52 Favored 'General case' 0 C--O 1.249 1.058 0 CA-C-N 113.729 -1.578 . . . . 0.0 111.042 -174.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 3.2 ptt? -60.63 -39.99 90.29 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 120.328 -1.482 . . . . 0.0 114.628 -175.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.8 m -69.52 -40.31 79.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 119.213 -0.995 . . . . 0.0 112.86 -178.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 62.8 ttp85 -78.78 -13.21 59.93 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.499 ' CG2' ' N ' ' A' ' 73' ' ' GLU . 0.6 OUTLIER -62.57 -54.42 40.04 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.667 179.194 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.499 ' N ' ' CG2' ' A' ' 72' ' ' THR . 19.2 mt-10 -105.24 -54.8 2.42 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.437 ' O ' ' OG ' ' A' ' 77' ' ' SER . . . 155.7 166.94 16.45 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -56.37 -35.14 95.85 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 121.329 1.352 . . . . 0.0 111.106 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.2 tpp180 -61.32 -11.93 11.77 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-O 121.985 0.897 . . . . 0.0 110.543 176.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.452 ' O ' ' OD1' ' A' ' 80' ' ' ASN . 28.9 p -77.59 -32.05 53.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 113.858 -1.519 . . . . 0.0 110.611 -177.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.424 ' N ' ' HG ' ' A' ' 77' ' ' SER . 7.0 tt -75.88 -33.93 59.98 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.539 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.519 ' C ' ' H ' ' A' ' 81' ' ' GLY . 26.2 m-85 -93.33 -5.25 50.07 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 115.003 1.482 . . . . 0.0 115.003 -178.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.452 ' OD1' ' O ' ' A' ' 77' ' ' SER . 50.1 p30 -84.13 32.59 0.49 Allowed 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 114.272 -1.331 . . . . 0.0 107.734 175.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.519 ' H ' ' C ' ' A' ' 79' ' ' TYR . . . -171.93 -9.46 0.02 OUTLIER Glycine 0 CA--C 1.525 0.67 0 CA-C-N 114.503 -1.226 . . . . 0.0 112.376 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 35.9 tp -59.13 -34.85 72.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 113.998 -1.101 . . . . 0.0 110.279 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.7 p -70.8 -27.16 29.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.284 178.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.69 -31.39 61.88 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.574 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.85 -40.03 89.54 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 119.442 -1.361 . . . . 0.0 111.051 -177.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 45.2 mt -62.21 -40.24 95.45 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 122.371 1.081 . . . . 0.0 113.179 -177.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -60.22 -26.72 66.62 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 112.993 -1.912 . . . . 0.0 108.979 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 -57.68 -53.45 58.05 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 172.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.532 HE22 ' CG ' ' A' ' 28' ' ' ASP . 1.4 tp-100 -67.95 -30.28 69.54 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 112.596 -2.093 . . . . 0.0 113.74 -177.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.53 -40.17 93.67 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 78.2 p -74.31 -34.5 63.51 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 118.409 -0.805 . . . . 0.0 111.192 -176.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -57.48 -44.05 84.58 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 120.842 1.656 . . . . 0.0 111.621 -176.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.51 -33.03 64.57 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 119.456 -0.898 . . . . 0.0 111.117 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.476 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 38.8 t -64.08 -41.94 97.14 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.468 ' C ' ' H ' ' A' ' 97' ' ' ILE . 1.4 p -67.51 -27.47 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.755 179.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.499 ' CG ' ' O ' ' A' ' 96' ' ' ARG . 15.0 ttt180 -77.01 9.61 2.85 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -177.034 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.476 ' CG2' ' O ' ' A' ' 94' ' ' SER . 10.2 tp -86.6 -16.3 9.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 177.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -140.98 -49.0 0.05 OUTLIER Glycine 0 CA--C 1.541 1.662 0 N-CA-C 115.952 1.141 . . . . 0.0 115.952 -177.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.406 ' N ' ' CD1' ' A' ' 99' ' ' LEU . 10.7 mp -71.8 -13.45 61.7 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 119.453 1.627 . . . . 0.0 112.682 -177.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.479 ' O ' ' CG ' ' A' ' 104' ' ' LYS . 2.6 m-85 -80.77 -51.06 9.07 Favored 'General case' 0 C--O 1.211 -0.938 0 CA-C-N 114.293 -1.321 . . . . 0.0 110.809 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.936 ' OD2' ' NE2' ' A' ' 105' ' ' GLN . 18.3 t70 -69.18 -32.34 71.58 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 123.391 1.567 . . . . 0.0 110.071 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.5 t -68.96 -52.71 26.18 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 110.953 -2.839 . . . . 0.0 113.526 176.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 10.0 p -74.69 -27.66 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 CA-C-N 122.211 2.278 . . . . 0.0 113.146 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.479 ' CG ' ' O ' ' A' ' 100' ' ' TYR . 47.6 mtpt -69.48 -42.13 75.25 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 111.47 -2.605 . . . . 0.0 111.805 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.936 ' NE2' ' OD2' ' A' ' 101' ' ' ASP . 88.1 mt-30 -75.05 -16.37 60.59 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 122.997 1.38 . . . . 0.0 111.05 176.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -78.7 -22.65 46.36 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 112.614 -2.085 . . . . 0.0 112.044 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.486 ' OH ' ' ND2' ' A' ' 190' ' ' ASN . 16.7 m-85 -109.54 -30.83 7.74 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 119.369 0.986 . . . . 0.0 111.269 -175.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.4 m -98.1 9.06 43.78 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 118.029 -1.468 . . . . 0.0 112.105 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.521 ' O ' ' C ' ' A' ' 110' ' ' GLY . 51.4 tttm -51.97 120.8 5.74 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 118.129 -0.939 . . . . 0.0 111.564 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.544 ' O ' ' CB ' ' A' ' 111' ' ' SER . . . -20.87 -82.86 0.01 OUTLIER Glycine 0 N--CA 1.488 2.14 0 CA-C-N 119.474 1.034 . . . . 0.0 112.076 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.544 ' CB ' ' O ' ' A' ' 110' ' ' GLY . 24.2 p 103.67 -161.19 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 176.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.621 ' O ' ' N ' ' A' ' 114' ' ' ALA . 18.9 tp10 -131.49 101.56 5.57 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -177.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.478 ' CG ' ' O ' ' A' ' 113' ' ' HIS . 81.3 t60 17.36 42.41 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.924 178.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.621 ' N ' ' O ' ' A' ' 112' ' ' GLU . . . 159.33 -161.48 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.437 ' O ' ' OG ' ' A' ' 118' ' ' SER . . . 102.51 14.9 26.53 Favored Glycine 0 C--N 1.337 0.614 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.991 177.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 48.6 mt -60.83 -40.5 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.0 -39.51 96.49 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-O 122.078 0.821 . . . . 0.0 111.559 175.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 115' ' ' GLY . 8.6 p -57.57 -42.09 82.37 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 177.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -63.42 -37.23 86.47 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.099 -0.64 . . . . 0.0 111.377 -178.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 29.0 mt -64.18 -46.68 82.91 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.351 0.596 . . . . 0.0 110.018 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.4 tt -66.63 -44.88 80.8 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.983 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.89 -44.99 91.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 119.222 0.919 . . . . 0.0 109.907 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -65.73 -44.04 93.08 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.568 -0.825 . . . . 0.0 111.83 -178.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 78.1 p -63.64 -43.27 97.26 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 18.9 m -68.84 -48.03 64.51 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 119.281 -0.968 . . . . 0.0 112.012 177.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 21.6 p -65.49 -42.63 91.95 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 -173.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -64.01 -44.79 95.39 Favored Glycine 0 CA--C 1.521 0.46 0 CA-C-O 122.586 1.103 . . . . 0.0 113.092 -177.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.402 ' O ' ' CG2' ' A' ' 131' ' ' VAL . . . -61.1 -41.3 96.41 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 112.54 -1.83 . . . . 0.0 106.818 177.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 51.9 mt -63.93 -41.75 97.54 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.308 178.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -62.64 -40.09 95.92 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -177.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.402 ' CG2' ' O ' ' A' ' 128' ' ' ALA . 5.0 m -61.22 -25.64 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 122.696 1.236 . . . . 0.0 109.5 178.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -57.87 -44.8 86.86 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 112.49 -2.141 . . . . 0.0 111.626 -178.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 3.6 m -78.97 -48.73 21.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.711 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -103.59 133.19 49.03 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.786 0.326 . . . . 0.0 111.468 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.551 ' H ' ' CD ' ' A' ' 136' ' ' PRO . 33.8 tp60 -175.88 -39.41 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.552 178.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.551 ' CD ' ' H ' ' A' ' 135' ' ' GLN . 52.9 Cg_exo -52.75 -33.56 60.66 Favored 'Trans proline' 0 N--CA 1.498 1.775 0 C-N-CA 122.009 1.806 . . . . 0.0 112.548 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 58.7 p -67.3 -41.88 84.63 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 118.309 -1.356 . . . . 0.0 109.65 -178.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -65.88 -42.48 90.26 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 118.796 -1.162 . . . . 0.0 111.903 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 59.1 t -64.04 -44.14 97.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 33.2 m -65.08 -38.76 83.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -177.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 14.8 mtpp -62.29 -41.86 98.86 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 119.269 -0.973 . . . . 0.0 111.823 -177.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 12.7 m -70.44 -45.64 74.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.237 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.492 ' NH2' ' O ' ' A' ' 174' ' ' GLY . 17.6 mmt85 -65.06 -37.09 86.41 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.566 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -66.98 -42.11 85.66 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -177.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -65.52 -40.39 92.9 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 118.853 -1.139 . . . . 0.0 109.572 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.64 -35.34 80.52 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -178.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.597 ' NE2' ' NE2' ' A' ' 157' ' ' GLN . 46.3 tt0 -60.2 110.51 1.24 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 176.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -98.83 -61.06 1.42 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 117.617 -1.182 . . . . 0.0 113.266 -177.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 70.8 mtp85 -71.29 -172.58 0.75 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 122.633 2.47 . . . . 0.0 110.259 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -160.79 18.61 0.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.647 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 57.57 -130.86 51.62 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.678 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -179.96 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.516 ' O ' ' CD2' ' A' ' 156' ' ' TYR . 60.8 t80 . . . . . 0 N--CA 1.463 0.185 0 CA-C-O 120.755 0.312 . . . . 0.0 110.63 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.597 ' NE2' ' NE2' ' A' ' 147' ' ' GLN . 27.6 tt0 58.85 146.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.811 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 88.8 p -157.06 -178.19 7.18 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.472 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 97.8 m -64.31 -45.88 86.0 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.805 -177.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 85.0 t -64.04 -45.35 96.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 119.016 -1.074 . . . . 0.0 108.898 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 -66.72 -39.55 88.05 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.833 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -62.16 -45.61 92.67 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -179.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.429 ' CD1' ' C ' ' A' ' 163' ' ' TYR . 19.3 t80 -62.4 -50.05 73.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.293 0.568 . . . . 0.0 111.075 -178.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -68.44 -45.21 73.14 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -175.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.403 ' O ' ' OE1' ' A' ' 169' ' ' GLU . 19.0 m -62.44 -44.6 96.01 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 -176.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 11.9 pt -64.6 -38.45 82.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-O 121.777 0.799 . . . . 0.0 109.651 176.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.91 -36.8 77.76 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 175.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 16.2 tpt85 -62.12 -49.86 74.19 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 122.095 2.225 . . . . 0.0 111.232 -176.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.403 ' OE1' ' O ' ' A' ' 165' ' ' THR . 16.4 mp0 -74.7 -51.13 15.14 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 123.561 0.744 . . . . 0.0 109.855 177.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -78.32 -36.75 45.98 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 117.033 2.235 . . . . 0.0 117.033 -172.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 91.77 -167.43 30.85 Favored Glycine 0 N--CA 1.472 1.036 0 CA-C-N 119.136 0.88 . . . . 0.0 112.597 177.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 9.0 pt -73.37 -41.91 57.07 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-O 122.098 0.951 . . . . 0.0 110.552 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -58.63 -32.94 69.5 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 113.661 -1.609 . . . . 0.0 110.473 -177.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.492 ' O ' ' NH2' ' A' ' 143' ' ' ARG . . . -60.45 -40.16 97.28 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 118.994 -1.574 . . . . 0.0 109.586 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.6 tt -69.46 -34.16 73.98 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 111.883 -2.159 . . . . 0.0 116.261 -176.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . 0.404 ' CD1' ' N ' ' A' ' 176' ' ' TRP . 39.2 m0 -78.36 -7.86 57.78 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 111.071 -2.786 . . . . 0.0 110.227 -178.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 37.6 tptt -43.45 -48.18 7.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.925 -176.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -83.75 -34.42 18.98 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 93.0 m -45.39 -51.49 11.22 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 1.6 t -62.9 -50.91 74.92 Favored Pre-proline 0 N--CA 1.473 0.71 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -176.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -64.81 -28.73 59.19 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.296 1.331 . . . . 0.0 111.901 177.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.526 ' CG ' HE22 ' A' ' 135' ' ' GLN . 14.8 t-20 -64.22 -39.74 94.61 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.637 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 94.5 t -63.28 -42.97 98.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.189 -0.459 . . . . 0.0 109.907 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.45 -39.89 94.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.014 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 65.2 ttt180 -61.1 -42.19 98.06 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.13 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -62.24 -44.0 97.55 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.169 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -65.65 -45.95 81.03 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -178.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 10.0 tp -65.38 -46.28 90.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.423 ' O ' ' N ' ' A' ' 193' ' ' GLU . 29.6 m -60.83 -46.85 95.51 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 C-N-CA 119.837 -0.745 . . . . 0.0 111.648 -178.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . 0.486 ' ND2' ' OH ' ' A' ' 107' ' ' TYR . 19.6 t-20 -62.28 -43.46 98.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 122.169 0.985 . . . . 0.0 109.876 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' CYS . . . . . . . . . . . . . 28.2 t -62.7 -47.38 83.88 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 113.554 -1.657 . . . . 0.0 110.862 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -65.01 -41.19 95.58 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.253 177.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 0.423 ' N ' ' O ' ' A' ' 189' ' ' VAL . 48.1 mt-10 -61.37 -45.75 93.08 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 114.335 -1.302 . . . . 0.0 111.999 -178.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.56 -38.1 89.83 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 -176.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . 0.438 ' O ' ' CD2' ' A' ' 199' ' ' LEU . 72.1 t -63.44 -46.48 95.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 C-N-CA 117.648 -1.621 . . . . 0.0 107.603 178.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 19.2 m -64.35 -45.74 86.49 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -178.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -56.78 -38.69 72.86 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.487 1.115 . . . . 0.0 112.497 -177.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -55.48 -44.13 76.18 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.531 ' H ' ' CD2' ' A' ' 199' ' ' LEU . 2.5 mm? -61.24 -39.95 92.24 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 40.2 mt -63.86 -44.24 98.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-O 118.65 -0.691 . . . . 0.0 112.037 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -61.13 -41.04 96.01 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 120.415 1.462 . . . . 0.0 112.182 177.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -67.32 -37.63 83.63 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.235 -1.348 . . . . 0.0 111.061 -177.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 3.4 m -101.94 129.9 48.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.269 0.557 . . . . 0.0 111.939 -177.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 22.9 mt 68.12 4.97 4.36 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 114.384 -1.28 . . . . 0.0 113.082 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.74 44.12 2.53 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.202 0.525 . . . . 0.0 110.889 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.55 ' O ' ' CB ' ' A' ' 207' ' ' ALA . 56.8 pttt -88.03 49.67 1.84 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.835 -178.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.55 ' CB ' ' O ' ' A' ' 206' ' ' LYS . . . 119.96 17.83 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.155 0 O-C-N 124.494 1.121 . . . . 0.0 109.474 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' A' ' 207' ' ' ALA . 0.0 OUTLIER 77.57 116.33 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 102.31 -3.219 . . . . 0.0 102.31 -171.492 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 2.0 tt . . . . . 0 N--CA 1.465 0.299 0 CA-C-O 120.965 0.412 . . . . 0.0 111.418 -178.843 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 . . . . . 0 N--CA 1.462 0.165 0 CA-C-O 121.03 0.443 . . . . 0.0 110.712 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.487 ' N ' ' CD ' ' A' ' 215' ' ' PRO . 1.9 mt -61.34 -43.42 89.55 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.263 -178.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.487 ' CD ' ' N ' ' A' ' 214' ' ' LEU . 33.5 Cg_exo -60.17 -32.58 94.69 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 121.602 1.534 . . . . 0.0 111.89 -178.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 97.7 m -64.08 -42.01 97.11 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 113.456 -1.702 . . . . 0.0 111.148 -179.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -66.34 -38.35 87.43 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.855 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -63.47 -46.92 84.0 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.285 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 32.7 p -59.97 -37.39 79.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 118.222 0.464 . . . . 0.0 110.785 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 14.0 t -59.29 -41.37 88.81 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.21 -41.49 99.14 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -177.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -61.46 -46.86 88.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 122.1 0.952 . . . . 0.0 112.59 -176.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -60.69 -41.79 99.1 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 107.725 -2.15 . . . . 0.0 107.725 176.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -62.7 -37.87 88.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.163 -1.018 . . . . 0.0 109.218 177.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -61.41 -41.91 99.65 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.993 -177.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -66.37 -38.16 86.92 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 119.316 -0.954 . . . . 0.0 108.574 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 96.4 m -63.03 -41.23 99.47 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.081 0.467 . . . . 0.0 110.306 177.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' A' ' 225' ' ' GLY . 60.4 p -61.85 -39.4 91.74 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.575 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 19.5 m -58.15 -39.22 78.25 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.72 -176.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 1.5 p -59.66 -40.19 81.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 118.709 -1.197 . . . . 0.0 108.442 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . 0.547 ' O ' ' HD2' ' A' ' 234' ' ' PRO . 26.7 mt -60.88 -40.23 84.59 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.449 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 177.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -61.95 -38.35 88.17 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 115.454 1.649 . . . . 0.0 115.454 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.466 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 0.9 OUTLIER -56.89 -39.65 79.44 Favored Pre-proline 0 N--CA 1.481 1.093 0 N-CA-C 116.276 1.954 . . . . 0.0 116.276 -172.972 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . 0.547 ' HD2' ' O ' ' A' ' 231' ' ' ILE . 38.1 Cg_exo -59.06 -39.94 75.35 Favored 'Trans proline' 0 C--N 1.29 -2.54 0 C-N-CA 122.097 1.865 . . . . 0.0 114.246 -176.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.8 m -64.2 -37.62 80.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 118.435 -1.306 . . . . 0.0 111.369 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . 0.441 ' CG ' ' O ' ' A' ' 233' ' ' SER . 0.3 OUTLIER -66.28 -40.09 89.85 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 179.003 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 99.0 t -64.54 -44.97 96.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -175.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 10.0 p . . . . . 0 C--N 1.325 -0.492 0 C-N-CA 119.423 -0.911 . . . . 0.0 110.865 -178.177 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 19.4 m . . . . . 0 CA--C 1.537 0.454 0 CA-C-O 121.25 0.548 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' MET . . . . . 0.575 ' O ' ' N ' ' A' ' 264' ' ' GLU . 0.0 OUTLIER -59.48 -40.87 88.36 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.074 -178.517 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 9.6 tp -59.81 -46.36 89.48 Favored 'General case' 0 C--N 1.32 -0.681 0 O-C-N 121.887 -0.508 . . . . 0.0 110.098 -177.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' ARG . . . . . 0.424 ' HG3' ' H ' ' A' ' 263' ' ' LYS . 9.4 ptm180 -66.36 -52.95 41.66 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 119.056 -1.058 . . . . 0.0 110.304 178.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . 0.424 ' H ' ' HG3' ' A' ' 262' ' ' ARG . 2.7 ptmm? -88.29 -55.45 3.73 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . 0.575 ' N ' ' O ' ' A' ' 260' ' ' MET . 25.0 mt-10 -90.25 102.16 14.88 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 119.673 1.124 . . . . 0.0 111.473 -179.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . 0.534 ' C ' ' H ' ' A' ' 267' ' ' ARG . . . -36.91 159.44 0.01 OUTLIER Glycine 0 CA--C 1.536 1.377 0 N-CA-C 111.424 -0.67 . . . . 0.0 111.424 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -56.96 1.13 0.16 Allowed 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 121.952 1.768 . . . . 0.0 112.412 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . 0.534 ' H ' ' C ' ' A' ' 265' ' ' GLY . 20.8 mmt85 -69.12 -27.33 65.47 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 110.627 -0.138 . . . . 0.0 110.627 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -59.05 -32.63 69.93 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 119.615 -0.834 . . . . 0.0 109.626 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -62.58 -42.66 99.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.172 178.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -66.94 -36.88 83.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.845 -1.07 . . . . 0.0 112.73 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.428 ' O ' ' O ' ' A' ' 272' ' ' GLY . 98.3 mttt -75.1 174.61 9.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.317 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 271' ' ' LYS . . . 47.69 101.79 0.01 OUTLIER Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -164.65 7.35 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.167 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' MET . . . . . 0.49 ' N ' ' HD2' ' A' ' 275' ' ' PRO . 65.1 mtp -63.79 -44.67 80.39 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 274' ' ' MET . 34.6 Cg_endo -64.53 -46.34 7.42 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 120.969 1.113 . . . . 0.0 112.554 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 17.4 t -60.7 -40.65 93.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.062 0.458 . . . . 0.0 111.044 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -62.05 -42.5 99.25 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 123.668 1.699 . . . . 0.0 110.445 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 7.2 mp -62.52 -38.29 89.39 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 110.288 -3.142 . . . . 0.0 108.192 174.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 17.5 tpt85 -62.62 -40.96 98.64 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.605 0.717 . . . . 0.0 110.613 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 9.7 mt -62.29 -36.15 81.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.586 -1.188 . . . . 0.0 112.834 -177.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -67.78 -50.73 39.85 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -178.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 78.0 p -62.88 -44.7 95.39 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.164 0.507 . . . . 0.0 109.817 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' TRP . . . . . . . . . . . . . 37.8 t90 -61.32 -39.02 88.98 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.743 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -62.86 -39.73 95.31 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -178.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 9.5 m -61.12 -37.37 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.337 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 96.9 t -61.83 -40.52 87.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 29.5 ttp -60.99 -39.18 88.68 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.453 0.645 . . . . 0.0 109.472 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -58.87 -39.52 81.62 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.906 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.16 -38.31 76.63 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -176.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -62.65 -40.19 96.25 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 119.137 -1.025 . . . . 0.0 108.642 177.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -61.23 -39.07 88.94 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 176.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -58.57 -40.59 83.53 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 117.748 -1.581 . . . . 0.0 109.737 -176.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' GLN . . . . . 0.445 ' O ' ' O ' ' A' ' 296' ' ' ARG . 21.9 mm100 -60.43 -42.86 96.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 122.506 1.146 . . . . 0.0 110.944 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 10.5 mt -60.2 -40.76 91.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 113.029 -1.896 . . . . 0.0 109.305 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 21.8 mtpt -63.24 -45.82 89.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.271 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' ARG . . . . . 0.445 ' O ' ' O ' ' A' ' 293' ' ' GLN . 80.6 mtm180 -123.02 116.51 23.65 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.443 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -117.22 -94.68 0.49 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.3 0.571 . . . . 0.0 110.862 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.98 -166.45 1.87 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.032 178.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 5.7 ptm -171.57 66.48 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.343 -0.543 . . . . 0.0 111.747 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.53 101.12 0.07 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.983 0.897 . . . . 0.0 110.343 -178.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -64.14 -46.23 85.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 113.789 -1.55 . . . . 0.0 113.436 -176.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -58.96 -40.06 83.56 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.177 -0.609 . . . . 0.0 109.613 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -64.83 -46.66 81.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.689 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' SER . . . . . 0.435 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 75.9 p -66.66 -37.37 84.65 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.882 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -61.55 -43.14 99.41 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -65.21 -36.73 85.07 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -177.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -59.92 -52.88 70.51 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -176.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' PRO . . . . . 0.435 ' CD ' ' O ' ' A' ' 304' ' ' SER . 74.4 Cg_endo -75.26 0.37 9.09 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.048 1.832 . . . . 0.0 111.874 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 82.3 t80 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.614 179.925 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.1 t . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.748 0.309 . . . . 0.0 110.84 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.4 ' CG1' ' N ' ' A' ' 16' ' ' LYS . 42.1 t -135.8 164.33 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 121.031 0.443 . . . . 0.0 110.302 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.4 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 14.2 ptpt -64.52 -41.68 96.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.434 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.535 ' CE2' ' NH1' ' A' ' 96' ' ' ARG . 32.4 t80 -63.41 -41.89 98.73 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -178.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.2 pp -80.1 -25.59 39.92 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.185 0.517 . . . . 0.0 112.351 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.452 ' O ' ' OG1' ' A' ' 22' ' ' THR . . . -66.14 -41.21 95.09 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 107.667 -2.173 . . . . 0.0 107.667 177.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.5 -32.07 67.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 124.787 2.232 . . . . 0.0 107.193 176.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.6 -42.43 98.81 Favored Glycine 0 CA--C 1.527 0.837 1 CA-C-N 108.389 -4.005 . . . . 0.0 108.19 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' A' ' 19' ' ' GLY . 22.4 p -70.65 -27.74 64.27 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.48 -50.02 64.66 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.814 -179.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.94 -36.06 80.27 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 118.161 -1.416 . . . . 0.0 110.931 -177.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.2 t -63.99 -53.87 43.38 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.616 -0.433 . . . . 0.0 111.326 -179.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.1 tp -65.82 -39.75 85.68 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -177.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.408 ' O ' ' CG2' ' A' ' 31' ' ' THR . . . -63.9 -41.93 97.57 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 119.736 -0.786 . . . . 0.0 112.924 -173.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -77.69 -27.24 50.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 120.439 1.472 . . . . 0.0 109.886 -176.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.0 tp -59.86 -55.71 30.84 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 119.802 1.183 . . . . 0.0 112.553 -178.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.4 tp -75.75 -4.63 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.408 ' CG2' ' O ' ' A' ' 27' ' ' ALA . 28.3 p -109.84 -17.27 13.69 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 118.7 -1.2 . . . . 0.0 110.41 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.414 ' N ' ' CD ' ' A' ' 33' ' ' PRO . 66.3 t80 -67.86 -43.65 38.53 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 122.461 2.391 . . . . 0.0 110.583 -178.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 32' ' ' PHE . 37.6 Cg_exo -58.94 -15.32 26.72 Favored 'Trans proline' 0 N--CA 1.503 2.06 0 C-N-CA 121.343 1.362 . . . . 0.0 112.341 178.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.466 ' CD1' HH21 ' A' ' 279' ' ' ARG . 88.8 mt -67.15 -34.43 77.55 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -178.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -64.09 -40.64 96.67 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -177.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 75.7 p -58.29 -34.79 70.93 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.04 -38.91 86.7 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -178.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.496 ' NZ ' ' CB ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -61.17 -47.06 87.91 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 119.378 -0.929 . . . . 0.0 111.723 -176.173 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 95.0 t -62.39 -38.06 80.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 O-C-N 122.287 -0.258 . . . . 0.0 111.264 -178.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.507 ' C ' ' H ' ' A' ' 42' ' ' GLN . 25.9 mmt180 -59.58 -40.16 86.47 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.367 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 84.2 mt -61.19 38.93 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.507 ' H ' ' C ' ' A' ' 40' ' ' ARG . 2.7 pt20 -172.29 55.32 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 O-C-N 122.074 -0.391 . . . . 0.0 110.739 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.428 ' CG1' ' H ' ' A' ' 44' ' ' GLN . 0.1 OUTLIER 26.68 -117.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.959 179.622 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.428 ' H ' ' CG1' ' A' ' 43' ' ' ILE . 95.9 mm-40 -129.89 102.51 6.33 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.366 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -81.47 73.6 2.58 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -156.56 163.62 39.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.878 0.37 . . . . 0.0 110.45 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 63.6 p -82.18 67.21 8.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.645 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.642 HE21 ' N ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -118.34 -47.39 2.56 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.825 179.805 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.02 13.09 81.76 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -177.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.642 ' N ' HE21 ' A' ' 48' ' ' GLN . 0.2 OUTLIER -65.82 -38.12 88.07 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.435 0.636 . . . . 0.0 109.319 178.978 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.415 ' O ' ' O ' ' A' ' 54' ' ' ALA . 12.5 p -60.24 -44.5 95.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.859 -178.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 52.5 ttp180 -64.31 -33.59 76.19 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.183 -0.607 . . . . 0.0 109.474 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 95.8 m -67.71 -38.21 83.32 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.415 ' O ' ' O ' ' A' ' 51' ' ' VAL . . . -89.76 124.52 34.71 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.706 179.107 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -87.62 -7.08 57.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.949 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.462 ' C ' ' H ' ' A' ' 58' ' ' GLN . 88.1 p -174.43 -125.89 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 65.27 -19.72 0.09 Allowed 'General case' 0 N--CA 1.461 0.092 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 176.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.462 ' H ' ' C ' ' A' ' 56' ' ' SER . 7.6 mm100 -126.01 38.76 4.08 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 177.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.427 ' O ' ' O ' ' A' ' 58' ' ' GLN . 75.2 m-85 -37.53 -98.37 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.132 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.428 ' O ' ' C ' ' A' ' 61' ' ' GLY . 34.4 ttm180 -154.51 -31.63 0.11 Allowed 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.442 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 60' ' ' ARG . . . -29.03 102.27 0.01 OUTLIER Glycine 0 C--N 1.34 0.774 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.914 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.1 t -66.77 -34.46 70.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 118.31 -0.852 . . . . 0.0 109.14 176.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.7 tp -60.93 -33.01 72.5 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 121.495 1.952 . . . . 0.0 111.365 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -65.05 -49.43 62.42 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 115.223 0.849 . . . . 0.0 115.223 -176.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -45.57 92.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.958 -0.621 . . . . 0.0 111.714 -179.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 66' ' ' ILE . 94.5 mt -59.66 -36.37 65.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -179.081 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.92 -36.41 83.86 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 120.561 1.528 . . . . 0.0 111.343 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.473 ' O ' ' OG1' ' A' ' 72' ' ' THR . 98.3 m -62.52 -39.35 93.24 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 113.215 -1.812 . . . . 0.0 111.084 -176.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 28.7 ttt -60.52 -39.46 87.9 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -177.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.8 t -68.92 -40.38 81.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 119.473 -0.891 . . . . 0.0 112.851 -177.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -77.71 -13.25 59.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.679 0.752 . . . . 0.0 112.947 -178.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' A' ' 68' ' ' THR . 16.1 m -62.96 -55.06 29.15 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.947 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 31.9 mp0 -108.39 -58.85 1.94 Allowed 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.438 ' O ' ' OG ' ' A' ' 77' ' ' SER . . . 158.75 164.54 14.45 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -56.49 -35.14 96.39 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.762 1.642 . . . . 0.0 111.546 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.428 ' O ' ' OD1' ' A' ' 80' ' ' ASN . 48.4 ttm-85 -60.97 -11.01 6.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 122.211 1.005 . . . . 0.0 111.003 176.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.531 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 36.2 p -77.59 -32.19 53.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 113.285 -1.779 . . . . 0.0 110.205 -179.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 85.7 mt -74.8 -28.93 60.92 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.486 1.114 . . . . 0.0 111.477 178.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -86.64 -2.45 58.52 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 122.678 1.228 . . . . 0.0 113.041 -172.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.531 ' ND2' ' O ' ' A' ' 77' ' ' SER . 0.4 OUTLIER -116.33 138.23 51.5 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 112.376 -2.193 . . . . 0.0 108.542 176.847 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.8 -28.09 17.37 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -178.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 69.5 mt -59.34 -34.87 72.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.148 -1.026 . . . . 0.0 110.573 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.3 t -70.85 -27.47 30.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.293 -0.867 . . . . 0.0 108.969 178.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.01 -31.93 61.5 Favored 'General case' 0 C--O 1.226 -0.15 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.331 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.64 -40.33 90.42 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 119.463 -1.351 . . . . 0.0 110.802 -178.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.5 tp -62.22 -40.27 95.56 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 122.343 1.068 . . . . 0.0 113.243 -176.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -60.17 -27.04 66.78 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 113.285 -1.78 . . . . 0.0 109.307 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.584 HH22 HE21 ' A' ' 145' ' ' GLN . 77.0 mtt180 -57.93 -53.41 58.59 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 172.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 11.5 tm0? -67.65 -30.65 70.26 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 112.061 -2.336 . . . . 0.0 113.794 -177.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 2.7 ptm -61.72 -40.09 93.83 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.925 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.5 m -74.1 -34.31 63.91 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 119.191 -1.004 . . . . 0.0 111.048 -176.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -58.0 -43.92 86.94 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 120.899 1.681 . . . . 0.0 112.416 -176.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.1 -33.07 65.36 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.921 -177.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 85.9 p -63.69 -40.74 97.56 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.454 ' C ' ' H ' ' A' ' 97' ' ' ILE . 18.7 m -67.89 -28.77 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.535 ' NH1' ' CE2' ' A' ' 17' ' ' PHE . 5.0 ptm180 -77.61 12.0 1.82 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -177.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.454 ' H ' ' C ' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -86.63 -15.35 9.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 179.07 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.503 ' O ' ' OD1' ' A' ' 101' ' ' ASP . . . -140.26 -47.84 0.06 OUTLIER Glycine 0 CA--C 1.536 1.344 0 CA-C-N 114.265 -1.334 . . . . 0.0 114.553 -177.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.4 tp -71.65 -13.52 61.77 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 119.453 1.626 . . . . 0.0 113.443 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -81.18 -52.16 7.66 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 114.595 -1.184 . . . . 0.0 112.189 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.579 ' O ' ' HG3' ' A' ' 105' ' ' GLN . 41.5 p-10 -70.15 -32.47 70.47 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 124.061 1.886 . . . . 0.0 110.591 -179.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.524 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 28.7 t -67.49 -50.74 57.6 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 109.695 -3.411 . . . . 0.0 111.936 176.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -73.25 -26.42 22.58 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.185 0 CA-C-N 121.446 1.93 . . . . 0.0 111.492 178.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -69.29 -41.44 76.8 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 112.524 -2.126 . . . . 0.0 110.955 178.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.579 ' HG3' ' O ' ' A' ' 101' ' ' ASP . 88.1 mt-30 -76.64 -16.98 59.41 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.591 0.71 . . . . 0.0 111.073 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -79.33 -22.95 43.83 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.17 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -109.34 -29.35 8.5 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 119.669 1.122 . . . . 0.0 112.855 -174.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 59.3 p -95.99 9.42 40.79 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 117.07 -1.852 . . . . 0.0 113.208 -176.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.0 mmmt -47.55 122.64 4.96 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.258 0.935 . . . . 0.0 108.661 176.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -119.29 85.83 0.39 Allowed Glycine 0 N--CA 1.476 1.33 0 CA-C-N 120.216 1.371 . . . . 0.0 111.624 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 34.3 t -94.55 -61.37 1.52 Allowed 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 -176.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -123.29 -176.83 3.53 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 112.749 -2.023 . . . . 0.0 111.971 -177.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.501 ' O ' ' ND1' ' A' ' 113' ' ' HIS . 0.0 OUTLIER -91.25 72.5 6.21 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -178.51 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.468 ' CB ' ' O ' ' A' ' 113' ' ' HIS . . . 159.77 -162.96 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 176.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.22 15.27 26.17 Favored Glycine 0 C--N 1.343 0.958 0 CA-C-N 114.471 -1.241 . . . . 0.0 113.15 177.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 15.0 tt -60.87 -40.29 84.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 118.053 0.927 . . . . 0.0 110.215 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.1 -39.68 96.44 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-O 122.029 0.794 . . . . 0.0 111.837 176.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 36.2 m -57.2 -41.68 79.85 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -63.2 -36.71 84.53 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.181 -0.607 . . . . 0.0 111.509 -178.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.44 ' CD1' ' C ' ' A' ' 120' ' ' LEU . 0.1 OUTLIER -63.91 -45.78 87.77 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.087 0.47 . . . . 0.0 110.407 178.387 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.9 tp -65.7 -44.05 87.3 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 119.405 -0.918 . . . . 0.0 109.821 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.69 -44.38 96.38 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 118.922 0.783 . . . . 0.0 110.496 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -65.72 -44.23 92.76 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 119.561 -1.304 . . . . 0.0 112.021 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 10.9 t -64.15 -44.76 91.16 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 119.985 -0.686 . . . . 0.0 111.631 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 21.3 m -69.73 -48.89 57.85 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 119.07 -1.052 . . . . 0.0 112.194 177.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 24.5 m -65.49 -42.81 91.78 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 -174.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -64.22 -44.65 95.3 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-O 122.802 1.223 . . . . 0.0 113.342 -177.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.426 ' O ' ' CG2' ' A' ' 131' ' ' VAL . . . -60.96 -41.31 96.09 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 112.073 -2.063 . . . . 0.0 107.075 177.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -64.3 -42.02 96.57 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.438 178.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.18 -39.86 95.85 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -177.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.426 ' CG2' ' O ' ' A' ' 128' ' ' ALA . 7.0 m -61.15 -25.76 37.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 122.753 1.264 . . . . 0.0 109.544 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -58.55 -44.94 89.83 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 112.364 -2.198 . . . . 0.0 111.673 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.0 p -79.07 -48.82 20.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -102.73 129.15 49.27 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.826 0.346 . . . . 0.0 111.122 -179.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.571 ' H ' ' CD ' ' A' ' 136' ' ' PRO . 8.1 tp-100 -173.15 -38.5 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.25 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.934 179.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.571 ' CD ' ' H ' ' A' ' 135' ' ' GLN . 63.3 Cg_exo -52.88 -34.17 64.77 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.467 1.444 . . . . 0.0 112.002 -179.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 11.2 m -68.35 -42.92 78.55 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 118.082 -1.447 . . . . 0.0 110.919 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -66.91 -43.97 82.0 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 118.26 -1.376 . . . . 0.0 112.853 -178.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.6 m -64.96 -44.6 96.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -179.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.6 p -65.33 -38.69 83.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -177.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -62.16 -41.08 97.96 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -176.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.449 ' CG1' ' N ' ' A' ' 143' ' ' ARG . 2.4 p -70.39 -44.78 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.072 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.52 ' NH2' ' O ' ' A' ' 175' ' ' LEU . 81.5 mtt85 -64.26 -36.28 83.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.468 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -66.42 -41.23 89.52 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.769 -0.373 . . . . 0.0 111.572 -177.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.584 HE21 HH22 ' A' ' 88' ' ' ARG . 76.5 mm-40 -64.92 -39.56 93.7 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 119.526 -0.87 . . . . 0.0 109.083 178.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.31 -34.84 79.28 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -179.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -60.27 110.47 1.24 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 176.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -100.91 -58.26 1.93 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 117.226 -1.368 . . . . 0.0 113.836 -176.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.528 ' O ' ' N ' ' A' ' 151' ' ' GLY . 28.9 ptt-85 -133.66 17.67 3.92 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 122.641 2.473 . . . . 0.0 110.03 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . 49.95 -86.5 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.724 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 149' ' ' ARG . . . -157.28 42.56 0.53 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.712 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 179.941 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.765 0.317 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -80.39 -164.68 0.73 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.545 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 56.7 m -156.97 -178.1 7.12 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.156 0.503 . . . . 0.0 110.843 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 98.7 m -64.25 -46.31 84.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.983 -177.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 34.0 m -64.35 -45.36 96.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 118.946 -1.102 . . . . 0.0 109.239 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -67.36 -39.27 85.69 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.665 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -61.68 -45.99 91.65 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -177.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -62.73 -49.66 74.16 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.422 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -68.36 -45.41 72.87 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 -175.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.441 ' CG2' ' N ' ' A' ' 166' ' ' ILE . 14.1 t -62.82 -44.88 94.99 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.519 1.054 . . . . 0.0 113.689 -177.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.441 ' N ' ' CG2' ' A' ' 165' ' ' THR . 2.5 pp -64.84 -38.3 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 121.906 0.86 . . . . 0.0 109.337 176.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.25 -35.6 73.97 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 113.992 -1.458 . . . . 0.0 107.788 176.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.6 -49.78 75.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 122.401 2.364 . . . . 0.0 111.449 -175.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -74.57 -50.99 15.86 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 123.446 0.698 . . . . 0.0 109.63 177.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.487 ' CD ' ' N ' ' A' ' 170' ' ' GLU . 2.2 mp0 -77.98 -36.6 48.76 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 116.637 2.088 . . . . 0.0 116.637 -173.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 91.49 -167.23 31.03 Favored Glycine 0 N--CA 1.47 0.935 0 CA-C-N 118.842 0.746 . . . . 0.0 112.007 177.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.466 ' CG2' ' N ' ' A' ' 173' ' ' ARG . 19.8 tt -73.45 -42.55 56.5 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.07 0 CA-C-O 121.963 0.887 . . . . 0.0 110.885 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.466 ' N ' ' CG2' ' A' ' 172' ' ' ILE . 3.9 tpt180 -58.79 -33.49 70.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 113.993 -1.458 . . . . 0.0 111.261 -176.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -60.7 -40.24 97.76 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 118.965 -1.588 . . . . 0.0 110.006 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.52 ' O ' ' NH2' ' A' ' 143' ' ' ARG . 3.7 mm? -70.61 -33.27 70.86 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 111.673 -2.264 . . . . 0.0 116.922 -177.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 19.5 m0 -78.06 -7.65 57.2 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 112.076 -2.329 . . . . 0.0 109.845 -177.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -43.22 -47.97 6.49 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.405 -176.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . 0.482 ' H ' HH22 ' A' ' 143' ' ' ARG . . . -91.9 -32.06 8.79 Favored Glycine 0 CA--C 1.533 1.217 0 N-CA-C 111.329 -0.708 . . . . 0.0 111.329 178.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 34.8 m -45.36 -51.52 11.09 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' SER . . . . . 0.412 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 2.8 m -62.47 -50.8 77.21 Favored Pre-proline 0 N--CA 1.471 0.581 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -176.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.412 ' HD2' ' N ' ' A' ' 180' ' ' SER . 28.2 Cg_endo -64.84 -28.38 59.08 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 121.482 1.455 . . . . 0.0 111.782 176.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.528 ' ND2' ' OE1' ' A' ' 135' ' ' GLN . 45.5 t30 -63.92 -39.53 94.38 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.454 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 70.9 t -63.09 -42.59 97.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.14 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.2 -39.49 92.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.048 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 33.0 ttm105 -60.59 -41.67 95.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.842 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -61.34 -42.92 99.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.063 0.459 . . . . 0.0 110.805 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.44 -43.82 93.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.092 -179.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 33.0 mm -63.56 -45.25 98.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -177.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.46 ' O ' ' N ' ' A' ' 193' ' ' GLU . 3.0 p -60.09 -46.79 93.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 119.679 -0.808 . . . . 0.0 112.027 -177.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 191' ' ' CYS . 2.6 p30 -63.13 -42.64 99.55 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 122.089 0.947 . . . . 0.0 109.983 179.103 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' CYS . . . . . 0.524 ' N ' ' OD1' ' A' ' 190' ' ' ASN . 27.2 m -61.2 -45.66 93.69 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 113.94 -1.482 . . . . 0.0 109.317 179.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -63.76 -39.56 94.56 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 112.99 -1.913 . . . . 0.0 108.638 175.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 0.46 ' N ' ' O ' ' A' ' 189' ' ' VAL . 74.6 tt0 -61.33 -46.96 88.07 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.868 -177.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 53.4 mt -65.15 -39.26 92.75 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 118.547 -1.261 . . . . 0.0 110.493 -175.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 7.0 m -63.97 -45.74 95.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 C-N-CA 117.078 -1.849 . . . . 0.0 107.297 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 19.9 m -63.75 -45.7 88.64 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -178.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -56.49 -38.34 71.62 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.296 1.038 . . . . 0.0 112.29 -178.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.44 -44.0 75.91 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.473 ' CD2' ' N ' ' A' ' 199' ' ' LEU . 2.9 mm? -61.18 -39.15 89.1 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 41.3 mm -62.78 -42.99 98.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.029 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -60.24 -39.55 87.13 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.758 1.223 . . . . 0.0 111.852 177.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -63.06 -38.53 91.56 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.119 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 35.9 m -101.56 128.19 47.93 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.855 0.835 . . . . 0.0 111.987 -179.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 3.7 tp 66.84 4.73 3.61 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 114.186 -1.37 . . . . 0.0 112.147 177.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -125.55 29.93 5.88 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.35 0.595 . . . . 0.0 112.487 -177.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -71.55 -24.65 61.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.806 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.547 ' O ' ' O ' ' A' ' 208' ' ' ASN . . . -165.05 33.04 0.06 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.362 179.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' ASN . . . . . 0.547 ' O ' ' O ' ' A' ' 207' ' ' ALA . 1.6 m-20 40.0 123.22 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 177.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.501 ' C ' ' O ' ' A' ' 208' ' ' ASN . 43.4 tp . . . . . 0 N--CA 1.48 1.073 0 CA-C-N 115.015 -0.993 . . . . 0.0 112.559 179.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . 0.407 ' O ' ' OD1' ' A' ' 213' ' ' ASP . 2.5 p30 . . . . . 0 N--CA 1.464 0.24 0 CA-C-O 121.078 0.466 . . . . 0.0 110.514 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.436 ' N ' ' CD ' ' A' ' 215' ' ' PRO . 6.0 mt -61.41 -43.27 88.71 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 113.118 0.785 . . . . 0.0 113.118 -178.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 214' ' ' LEU . 27.1 Cg_exo -60.74 -33.73 92.69 Favored 'Trans proline' 0 N--CA 1.5 1.884 0 CA-C-N 120.051 1.054 . . . . 0.0 111.555 -177.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 84.1 m -64.01 -41.79 97.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 112.767 -2.015 . . . . 0.0 111.213 -178.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -66.18 -37.08 84.76 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.241 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -62.96 -47.41 83.31 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.252 -178.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 1.4 t -60.58 -37.94 82.97 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 119.395 0.998 . . . . 0.0 110.87 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 71.1 m -59.68 -41.89 91.71 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.9 -41.94 97.57 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -62.39 -47.5 83.86 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 119.755 -0.778 . . . . 0.0 112.953 -176.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -61.27 -42.48 99.79 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 108.199 -1.961 . . . . 0.0 108.199 177.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . 0.495 ' O ' ' SG ' ' A' ' 227' ' ' CYS . . . -63.25 -39.14 93.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.497 -0.851 . . . . 0.0 109.02 177.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -62.93 -43.05 99.49 Favored Glycine 0 CA--C 1.52 0.354 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.607 -178.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' PHE . . . . . 0.442 ' O ' ' OG1' ' A' ' 229' ' ' THR . 75.3 t80 -66.91 -38.95 87.19 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 119.659 -0.816 . . . . 0.0 108.855 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 224' ' ' ALA . 0.5 OUTLIER -63.41 -41.06 98.71 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 176.847 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' THR . . . . . 0.466 ' N ' ' SG ' ' A' ' 227' ' ' CYS . 26.8 m -62.7 -41.54 99.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.839 179.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' A' ' 226' ' ' PHE . 16.1 p -59.99 -40.32 88.75 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -176.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 3.3 m -60.66 -40.27 84.2 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.381 0 C-N-CA 118.455 -1.298 . . . . 0.0 108.953 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . 0.459 ' O ' ' HD2' ' A' ' 234' ' ' PRO . 1.7 mp -61.0 -40.85 86.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 176.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.01 -39.98 96.39 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.48 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 0.5 OUTLIER -58.47 -42.18 93.2 Favored Pre-proline 0 N--CA 1.483 1.214 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 -173.858 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 233' ' ' SER . 31.3 Cg_exo -57.97 -39.75 83.64 Favored 'Trans proline' 0 C--N 1.293 -2.378 0 C-N-CA 122.536 2.157 . . . . 0.0 113.276 179.081 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 46.5 t -63.95 -37.26 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 118.055 -1.458 . . . . 0.0 108.922 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -65.88 -40.62 91.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.75 178.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 53.2 t -64.79 -45.51 94.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -176.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 27.6 m . . . . . 0 C--N 1.322 -0.613 0 C-N-CA 119.224 -0.991 . . . . 0.0 111.732 -178.159 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 85.8 m . . . . . 0 N--CA 1.456 -0.135 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' MET . . . . . 0.447 ' SD ' ' C ' ' A' ' 260' ' ' MET . 13.6 tmm? -61.62 -45.04 95.76 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -177.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.17 -47.5 82.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.102 0.477 . . . . 0.0 110.26 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' ARG . . . . . 0.463 ' O ' ' O ' ' A' ' 263' ' ' LYS . 61.5 ttt85 -66.66 -53.84 29.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.463 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 262' ' ' ARG . 28.0 tttp -57.81 -138.99 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.9 0.381 . . . . 0.0 111.369 -178.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -63.91 149.52 46.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.997 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . 0.602 ' C ' ' H ' ' A' ' 267' ' ' ARG . . . -44.04 160.19 0.1 OUTLIER Glycine 0 CA--C 1.535 1.283 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -50.85 0.07 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 122.018 1.812 . . . . 0.0 112.945 178.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . 0.602 ' H ' ' C ' ' A' ' 265' ' ' GLY . 89.4 mtt-85 -69.5 -26.95 64.79 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 122.696 0.398 . . . . 0.0 111.817 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -58.83 -32.63 69.57 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.404 -178.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -62.51 -41.55 98.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.376 0.608 . . . . 0.0 110.89 178.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -66.05 -37.46 85.91 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.284 -178.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.434 ' O ' ' O ' ' A' ' 272' ' ' GLY . 95.8 mttt -80.65 -179.72 7.37 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . 0.434 ' O ' ' O ' ' A' ' 271' ' ' LYS . . . 52.3 109.29 0.01 OUTLIER Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.694 -0.563 . . . . 0.0 111.694 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -178.31 8.27 0.01 OUTLIER 'General case' 0 C--O 1.232 0.151 0 C-N-CA 121.166 -0.214 . . . . 0.0 111.325 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 274' ' ' MET . . . . . 0.549 ' N ' ' CD ' ' A' ' 275' ' ' PRO . 0.1 OUTLIER -63.91 -44.53 79.11 Favored Pre-proline 0 CA--C 1.533 0.291 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.898 -179.148 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 275' ' ' PRO . . . . . 0.549 ' CD ' ' N ' ' A' ' 274' ' ' MET . 22.1 Cg_exo -64.46 -46.86 6.58 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 122.353 2.035 . . . . 0.0 111.471 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 49.2 m -60.78 -39.71 89.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.749 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . 0.403 ' CD1' ' C ' ' A' ' 277' ' ' PHE . 41.0 t80 -61.64 -42.67 99.21 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 122.738 1.256 . . . . 0.0 112.969 -178.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.29 -38.78 90.65 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 112.11 -2.314 . . . . 0.0 107.815 174.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . 0.466 HH21 ' CD1' ' A' ' 34' ' ' LEU . 4.4 mtp180 -62.81 -39.71 95.14 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.375 0.607 . . . . 0.0 110.283 178.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -62.07 -36.55 82.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.508 -178.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -68.08 -51.2 35.06 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -178.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 74.8 m -63.0 -44.36 96.24 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 123.109 0.564 . . . . 0.0 109.91 179.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 283' ' ' TRP . . . . . . . . . . . . . 48.7 t-105 -59.7 -38.36 81.39 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -62.2 -37.37 85.06 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.363 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -59.88 -37.73 73.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.143 -178.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -61.61 -40.28 86.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.724 -179.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 30.9 mtm -60.95 -38.85 87.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.098 0.475 . . . . 0.0 110.453 178.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -58.69 -40.13 82.7 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.83 -178.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.434 ' O ' ' CG ' ' A' ' 292' ' ' GLU . 1.0 OUTLIER -60.31 -38.91 79.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 120.981 0.419 . . . . 0.0 110.91 -177.576 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 12.5 m -64.27 -40.04 95.17 Favored 'General case' 0 CA--C 1.549 0.925 0 O-C-N 121.574 -0.704 . . . . 0.0 111.729 177.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -61.01 -40.4 93.39 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-O 118.652 -0.69 . . . . 0.0 109.165 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . 0.434 ' CG ' ' O ' ' A' ' 289' ' ' VAL . 4.4 pt-20 -59.39 -39.42 83.33 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 116.552 -2.059 . . . . 0.0 109.781 -176.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 293' ' ' GLN . . . . . 0.471 ' O ' ' O ' ' A' ' 296' ' ' ARG . 57.4 tt0 -59.51 -42.83 93.11 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 122.38 1.086 . . . . 0.0 111.306 -178.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -60.52 -40.74 92.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 113.61 -1.632 . . . . 0.0 108.574 178.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -63.22 -45.97 89.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.263 178.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 296' ' ' ARG . . . . . 0.471 ' O ' ' O ' ' A' ' 293' ' ' GLN . 11.9 tpp85 -123.03 116.25 23.21 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -121.01 -163.38 1.02 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.236 0.541 . . . . 0.0 112.413 -178.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.526 ' CD2' ' N ' ' A' ' 298' ' ' LEU . 3.2 mm? -67.21 116.94 8.56 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 26.4 ttm -96.77 62.64 1.94 Allowed 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -178.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.65 100.84 0.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.976 0.893 . . . . 0.0 110.834 -178.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -64.1 -46.4 84.39 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 113.746 -1.57 . . . . 0.0 113.434 -176.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -58.6 -39.67 81.07 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.39 -0.524 . . . . 0.0 109.897 -178.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -64.9 -46.77 80.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.871 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 304' ' ' SER . . . . . 0.445 ' HG ' ' NH1' ' A' ' 305' ' ' ARG . 78.0 p -66.66 -38.04 86.04 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.711 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 305' ' ' ARG . . . . . 0.445 ' NH1' ' HG ' ' A' ' 304' ' ' SER . 0.0 OUTLIER -62.04 -42.73 99.49 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.544 179.354 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 12.7 tm-20 -64.74 -37.12 86.53 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -177.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -60.01 -52.94 69.96 Favored Pre-proline 0 CA--C 1.544 0.716 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -176.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 308' ' ' PRO . . . . . 0.426 ' CD ' ' O ' ' A' ' 304' ' ' SER . 74.5 Cg_endo -75.36 0.32 9.18 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.255 1.97 . . . . 0.0 112.106 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 78.7 t80 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.519 -179.895 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.3 m . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.774 0.321 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.479 ' CG2' ' N ' ' A' ' 16' ' ' LYS . 4.3 p -160.67 166.53 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.235 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.479 ' N ' ' CG2' ' A' ' 15' ' ' VAL . 30.2 mmtp -64.38 -41.65 96.58 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -178.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -63.54 -41.15 98.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.228 0.537 . . . . 0.0 112.438 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.418 ' H ' HG11 ' A' ' 15' ' ' VAL . 9.8 tp -79.78 -25.96 40.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.276 -0.874 . . . . 0.0 112.617 -178.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.32 -41.41 94.6 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 107.768 -2.133 . . . . 0.0 107.768 177.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.53 -32.08 67.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 124.873 2.273 . . . . 0.0 107.18 176.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.35 -42.38 99.18 Favored Glycine 0 CA--C 1.527 0.818 1 CA-C-N 108.393 -4.003 . . . . 0.0 107.804 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 92.8 m -70.54 -27.97 64.56 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.498 0.666 . . . . 0.0 109.262 177.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.39 -49.94 65.13 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.851 -179.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.96 -35.89 79.8 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 118.144 -1.422 . . . . 0.0 110.979 -177.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 77.5 m -63.8 -54.08 40.77 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.616 -178.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.6 pp -65.73 -39.39 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -176.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.453 ' O ' ' OG1' ' A' ' 31' ' ' THR . . . -64.12 -41.9 97.06 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 119.831 -0.748 . . . . 0.0 112.706 -173.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.464 ' O ' ' N ' ' A' ' 32' ' ' PHE . 29.9 m-20 -77.78 -27.35 50.22 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 117.823 -1.551 . . . . 0.0 109.52 -176.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.4 mp -60.23 -55.92 27.81 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 120.129 1.331 . . . . 0.0 111.731 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.1 tp -75.68 -4.79 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 121.659 0.742 . . . . 0.0 112.034 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 27' ' ' ALA . 16.6 m -109.83 -16.48 13.87 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 114.454 -1.248 . . . . 0.0 110.202 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.507 ' N ' ' CD ' ' A' ' 33' ' ' PRO . 0.2 OUTLIER -68.28 -44.92 38.19 Favored Pre-proline 0 C--N 1.325 -0.463 0 C-N-CA 116.156 -2.218 . . . . 0.0 109.452 -178.231 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 32' ' ' PHE . 34.0 Cg_exo -59.95 -16.67 39.99 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 121.32 1.346 . . . . 0.0 112.573 177.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.6 mp -67.7 -35.41 78.74 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -178.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 36' ' ' THR . 1.9 p30 -64.44 -40.47 95.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.948 -177.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.545 ' N ' ' OD1' ' A' ' 35' ' ' ASP . 47.5 p -58.44 -34.97 71.41 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 120.41 -0.516 . . . . 0.0 112.176 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.52 -39.55 85.11 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 119.547 -0.861 . . . . 0.0 112.902 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.455 ' CB ' ' NH2' ' A' ' 279' ' ' ARG . 10.0 ptmt -63.09 -48.68 77.57 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 118.854 -1.138 . . . . 0.0 111.246 -177.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 66.4 t -63.55 -39.81 86.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -177.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.518 ' C ' ' H ' ' A' ' 42' ' ' GLN . 8.6 tpm_? -60.82 -41.39 95.62 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 119.19 -1.004 . . . . 0.0 109.718 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.49 38.81 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.58 178.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.518 ' H ' ' C ' ' A' ' 40' ' ' ARG . 45.1 tt0 -88.7 -112.64 0.06 Allowed 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.646 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.1 tp -154.3 8.93 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.158 0.504 . . . . 0.0 109.794 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.519 ' NE2' ' OE1' ' A' ' 58' ' ' GLN . 14.7 mm100 56.97 26.04 11.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.55 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -118.65 141.17 15.84 Favored Glycine 0 N--CA 1.466 0.683 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -149.4 -84.26 0.1 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 86.4 p -172.04 70.49 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.782 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 -156.01 -27.63 0.1 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.085 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.98 17.67 74.15 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 108.577 -1.809 . . . . 0.0 108.577 -177.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.535 HD13 ' H ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -63.92 -35.52 80.93 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.081 -1.06 . . . . 0.0 111.031 -179.089 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.535 ' H ' HD13 ' A' ' 50' ' ' LEU . 83.9 t -59.4 -43.81 91.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.217 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 71.0 ttp85 -64.01 -33.86 76.69 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.99 -38.13 82.32 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.279 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -136.36 95.39 3.17 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.236 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.92 -19.83 64.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.3 -178.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.7 ' HG ' ' H ' ' A' ' 57' ' ' ALA . 7.9 t -125.67 -141.02 0.28 Allowed 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.7 ' H ' ' HG ' ' A' ' 56' ' ' SER . . . 99.38 12.42 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 O-C-N 124.132 0.895 . . . . 0.0 112.616 178.349 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.519 ' OE1' ' NE2' ' A' ' 44' ' ' GLN . 10.7 pt20 178.36 101.72 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.995 0.426 . . . . 0.0 111.052 179.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -84.88 166.95 16.43 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.44 ' O ' ' C ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER -52.29 -35.07 49.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.233 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.44 ' C ' ' O ' ' A' ' 60' ' ' ARG . . . -28.23 100.21 0.01 OUTLIER Glycine 0 CA--C 1.53 1.011 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.241 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 24.6 m -67.21 -33.99 66.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.072 176.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -60.26 -32.4 71.13 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 121.31 1.868 . . . . 0.0 109.731 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.51 -48.99 67.52 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-N 114.934 -1.03 . . . . 0.0 114.459 -176.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.8 p -62.14 -46.13 90.37 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 97.0 mt -59.68 -35.99 62.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 118.119 -0.943 . . . . 0.0 108.94 -178.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.425 ' CD1' ' C ' ' A' ' 67' ' ' LEU . 0.3 OUTLIER -63.84 -35.28 80.12 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 121.422 1.919 . . . . 0.0 111.993 179.525 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 98.3 m -62.19 -38.34 88.74 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 113.4 -1.727 . . . . 0.0 110.99 -176.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 58.0 mmm -59.79 -40.04 86.95 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 121.048 -1.032 . . . . 0.0 113.425 -177.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 93.3 t -69.71 -41.14 79.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 118.967 -1.093 . . . . 0.0 113.82 -177.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 36.5 mmm-85 -78.97 -13.06 60.02 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -178.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.521 ' CG2' ' N ' ' A' ' 73' ' ' GLU . 0.7 OUTLIER -62.27 -54.65 37.6 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.633 -179.215 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.521 ' N ' ' CG2' ' A' ' 72' ' ' THR . 35.2 mt-10 -106.88 -53.93 2.54 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.417 ' O ' ' CB ' ' A' ' 77' ' ' SER . . . 155.77 166.23 15.52 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -56.43 -35.32 96.32 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 121.281 1.32 . . . . 0.0 110.971 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -61.43 -12.0 12.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.983 0.897 . . . . 0.0 110.723 175.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.617 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 6.5 t -77.91 -32.36 51.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 113.911 -1.495 . . . . 0.0 110.454 -178.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 15.3 tp -75.95 -33.41 59.82 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 121.761 -0.587 . . . . 0.0 110.823 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.464 ' C ' ' H ' ' A' ' 81' ' ' GLY . 53.5 m-85 -92.75 -5.09 51.96 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 -177.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.617 ' ND2' ' O ' ' A' ' 77' ' ' SER . 0.0 OUTLIER -92.52 26.05 2.79 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 174.55 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.464 ' H ' ' C ' ' A' ' 79' ' ' TYR . . . -160.07 -19.62 0.03 OUTLIER Glycine 0 CA--C 1.526 0.732 0 CA-C-N 112.942 -1.935 . . . . 0.0 112.036 -178.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 42.6 tp -59.06 -35.0 72.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.091 -1.054 . . . . 0.0 110.406 -179.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.4 t -70.67 -27.01 29.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.29 178.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.67 -31.32 61.88 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.717 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.42 -40.06 91.43 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 119.645 -1.264 . . . . 0.0 111.46 -177.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -62.37 -39.92 94.75 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 122.192 0.996 . . . . 0.0 113.655 -176.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -59.68 -26.12 65.32 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 113.348 -1.751 . . . . 0.0 109.615 -179.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.662 ' NE ' ' HZ1' ' A' ' 141' ' ' LYS . 7.4 mmm180 -56.44 -52.35 64.99 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 173.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -67.6 -29.9 69.36 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 113.475 -1.693 . . . . 0.0 112.692 -178.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 24.8 mmt -61.08 -42.06 97.8 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 78.1 p -74.7 -34.84 62.71 Favored 'General case' 0 C--N 1.338 0.102 0 C-N-CA 119.301 -0.959 . . . . 0.0 111.864 -176.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -57.96 -43.55 86.5 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 120.496 1.498 . . . . 0.0 112.279 -176.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.41 -32.65 64.54 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 119.78 -0.768 . . . . 0.0 111.292 -178.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.48 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 50.5 m -63.96 -41.53 97.55 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.48 ' C ' ' H ' ' A' ' 97' ' ' ILE . 24.2 m -68.12 -28.48 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.493 178.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 64.4 mtp180 -77.42 10.41 2.57 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -177.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.48 ' CG2' ' O ' ' A' ' 94' ' ' SER . 12.0 tt -86.78 -15.62 9.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.446 ' O ' ' OG ' ' A' ' 102' ' ' SER . . . -141.0 -48.85 0.05 OUTLIER Glycine 0 CA--C 1.534 1.252 0 CA-C-N 114.917 -1.038 . . . . 0.0 114.77 -178.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 60.5 mt -72.53 -14.29 61.61 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.096 1.448 . . . . 0.0 113.985 -177.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.521 ' O ' ' CD ' ' A' ' 104' ' ' LYS . 46.6 t80 -81.84 -53.12 6.44 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 114.653 -1.158 . . . . 0.0 112.542 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -72.6 -33.57 66.81 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 123.799 1.761 . . . . 0.0 114.136 -179.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.446 ' OG ' ' O ' ' A' ' 98' ' ' GLY . 79.3 p -66.5 -50.6 62.71 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 110.244 -3.162 . . . . 0.0 117.068 -177.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.45 ' O ' ' CD2' ' A' ' 107' ' ' TYR . 1.5 t -73.32 -23.37 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 CA-C-O 124.327 2.013 . . . . 0.0 109.94 175.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.521 ' CD ' ' O ' ' A' ' 100' ' ' TYR . 0.0 OUTLIER -66.8 -41.22 87.92 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 109.677 -3.42 . . . . 0.0 112.194 -178.02 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -78.81 -11.08 59.97 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 125.143 2.401 . . . . 0.0 111.05 178.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -79.63 -21.88 44.32 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 110.712 -2.949 . . . . 0.0 110.538 177.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.45 ' CD2' ' O ' ' A' ' 103' ' ' VAL . 41.1 m-85 -109.5 -28.67 8.79 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -175.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.811 ' C ' ' H ' ' A' ' 110' ' ' GLY . 66.4 p -95.55 12.07 30.84 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 -174.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.435 ' O ' ' N ' ' A' ' 111' ' ' SER . 15.2 ttpp -54.71 22.31 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.055 0 CA-C-N 119.472 1.033 . . . . 0.0 111.239 177.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.811 ' H ' ' C ' ' A' ' 108' ' ' THR . . . 65.24 -57.06 0.11 Allowed Glycine 0 N--CA 1.472 1.053 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.544 ' CB ' ' O ' ' A' ' 110' ' ' GLY . 6.9 t 106.35 -164.67 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 177.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.537 ' OE1' ' N ' ' A' ' 112' ' ' GLU . 35.4 mp0 -120.55 -40.28 2.68 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 -175.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.497 ' ND1' ' N ' ' A' ' 113' ' ' HIS . 0.0 OUTLIER 165.05 29.97 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.503 0.668 . . . . 0.0 109.366 -179.318 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.44 ' CB ' ' O ' ' A' ' 113' ' ' HIS . . . 160.31 -161.21 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.86 14.87 25.8 Favored Glycine 0 CA--C 1.507 -0.429 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.441 ' CG2' ' N ' ' A' ' 117' ' ' GLY . 3.0 tp -60.77 -40.22 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.441 ' N ' ' CG2' ' A' ' 116' ' ' ILE . . . -65.69 -39.87 95.54 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 110.946 -0.861 . . . . 0.0 110.946 174.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 6.8 t -58.85 -43.06 90.67 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 176.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 25.9 mmm-85 -63.65 -37.48 87.49 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 119.849 -0.741 . . . . 0.0 110.38 -177.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.69 -45.91 87.89 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 6.3 tp -67.14 -45.29 77.54 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.729 178.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.433 ' O ' ' OG1' ' A' ' 126' ' ' THR . . . -64.29 -44.97 90.03 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 119.918 1.235 . . . . 0.0 109.803 178.079 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -65.85 -44.48 91.92 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 119.222 -1.466 . . . . 0.0 110.614 -178.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 65.7 m -64.48 -44.61 90.45 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.309 -0.556 . . . . 0.0 111.095 178.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 19.5 m -69.9 -49.03 56.14 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 119.419 -0.912 . . . . 0.0 112.433 177.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' A' ' 122' ' ' ALA . 42.3 p -65.82 -42.16 90.95 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 120.149 1.34 . . . . 0.0 113.775 -175.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.619 ' CA ' HD22 ' A' ' 186' ' ' ASN . . . -64.03 -44.33 96.03 Favored Glycine 0 CA--C 1.518 0.254 0 CA-C-O 122.983 1.324 . . . . 0.0 112.162 -178.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.417 ' O ' ' CG2' ' A' ' 131' ' ' VAL . . . -61.48 -41.45 97.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 111.386 -2.407 . . . . 0.0 107.247 177.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.5 -42.33 95.89 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.25 178.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.23 -40.08 96.45 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -177.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.417 ' CG2' ' O ' ' A' ' 128' ' ' ALA . 5.8 m -61.15 -25.98 37.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 122.482 1.134 . . . . 0.0 109.942 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -58.29 -44.98 88.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 112.755 -2.02 . . . . 0.0 112.425 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.48 ' CG1' ' N ' ' A' ' 134' ' ' ALA . 2.7 p -79.09 -48.89 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.295 -179.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.48 ' N ' ' CG1' ' A' ' 133' ' ' VAL . . . -106.55 138.76 42.13 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.707 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.524 ' H ' ' HD2' ' A' ' 136' ' ' PRO . 7.8 pt20 172.23 -38.48 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.797 0 CA-C-O 118.279 -0.867 . . . . 0.0 113.132 179.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.524 ' HD2' ' H ' ' A' ' 135' ' ' GLN . 13.1 Cg_endo -52.66 -34.37 63.52 Favored 'Trans proline' 0 N--CA 1.498 1.785 0 CA-C-N 122.257 1.842 . . . . 0.0 112.544 -178.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 85.1 m -67.85 -42.6 81.14 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 118.683 -1.207 . . . . 0.0 110.184 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -65.82 -43.08 89.65 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 118.054 -1.458 . . . . 0.0 112.776 -177.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 24.4 m -64.47 -44.05 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 12.7 p -64.63 -37.48 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -177.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.662 ' HZ1' ' NE ' ' A' ' 88' ' ' ARG . 48.5 mttm -60.98 -40.55 93.88 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.16 -177.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 82.1 t -69.89 -44.95 78.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.57 -36.33 83.87 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.934 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -66.39 -40.69 89.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.06 -177.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 65.6 tp60 -64.35 -39.08 93.18 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 119.486 -0.886 . . . . 0.0 109.28 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.2 -35.0 79.7 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.446 ' O ' ' CG ' ' A' ' 147' ' ' GLN . 3.0 pt20 -60.31 111.06 1.4 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 177.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -102.5 8.81 39.87 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.246 -177.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 60.7 ttm-85 -143.71 135.99 26.85 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.848 0.356 . . . . 0.0 110.696 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -82.52 -56.36 3.92 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.617 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 168.03 -51.65 0.23 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.615 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -179.982 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 46.7 t80 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.865 0.364 . . . . 0.0 110.462 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -56.98 154.63 9.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.453 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.41 ' OG ' ' N ' ' A' ' 159' ' ' THR . 43.7 t -157.07 -178.28 7.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.211 0.529 . . . . 0.0 111.015 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.41 ' N ' ' OG ' ' A' ' 158' ' ' SER . 65.1 p -64.32 -46.1 84.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.737 -177.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 86.3 t -64.22 -45.59 95.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 119.132 -1.027 . . . . 0.0 109.438 -179.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.522 ' N ' ' OE1' ' A' ' 161' ' ' GLU . 15.1 mp0 -66.75 -39.04 87.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.873 0.368 . . . . 0.0 111.198 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -61.8 -45.54 93.41 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -178.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -62.59 -50.33 71.73 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 120.372 -0.531 . . . . 0.0 110.617 -178.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 30.5 mmtm -68.84 -45.57 70.78 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 -175.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.417 ' CG2' ' N ' ' A' ' 166' ' ' ILE . 15.3 t -62.95 -44.73 95.27 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.198 1.185 . . . . 0.0 114.198 -177.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.417 ' N ' ' CG2' ' A' ' 165' ' ' THR . 10.0 pt -64.51 -38.44 82.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 122.032 0.92 . . . . 0.0 109.505 177.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.53 -36.47 76.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 113.709 -1.587 . . . . 0.0 108.074 176.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -62.54 -50.39 71.54 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 122.436 2.38 . . . . 0.0 112.164 -175.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -75.05 -51.03 14.55 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 123.903 0.881 . . . . 0.0 109.641 177.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -77.96 -36.46 49.08 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 -173.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 90.99 -167.71 32.06 Favored Glycine 0 N--CA 1.467 0.714 0 N-CA-C 111.792 -0.523 . . . . 0.0 111.792 177.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 25.2 mm -72.18 -44.72 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-O 121.679 0.752 . . . . 0.0 110.652 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -59.0 -33.96 71.32 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 114.371 -1.286 . . . . 0.0 111.529 -177.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -60.75 -40.37 98.02 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 118.783 -1.675 . . . . 0.0 109.272 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.34 -33.43 71.47 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 111.477 -2.362 . . . . 0.0 116.72 -177.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . 0.428 ' O ' ' OG1' ' A' ' 179' ' ' THR . 2.3 m95 -77.89 -7.39 56.66 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 111.564 -2.562 . . . . 0.0 109.909 -177.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 16.3 ttmm -43.24 -47.93 6.55 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.354 -176.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -92.04 -27.43 16.25 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 123.981 0.8 . . . . 0.0 112.216 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' A' ' 176' ' ' TRP . 39.7 p -45.3 -51.17 11.3 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' SER . . . . . 0.427 ' N ' ' HG1' ' A' ' 179' ' ' THR . 3.3 m -62.4 -50.82 77.44 Favored Pre-proline 0 N--CA 1.47 0.57 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -176.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -64.87 -28.61 58.68 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 121.212 1.275 . . . . 0.0 111.63 176.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -64.27 -39.73 94.52 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 120.363 -0.535 . . . . 0.0 109.809 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 82.0 t -63.32 -42.85 97.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.201 0.524 . . . . 0.0 110.026 179.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.32 -39.39 92.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.091 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 44.1 ttt85 -60.74 -42.19 96.86 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.928 -179.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . 0.619 HD22 ' CA ' ' A' ' 127' ' ' GLY . 40.5 t30 -61.9 -43.89 97.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.107 0.48 . . . . 0.0 110.705 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -65.31 -44.31 88.26 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.805 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 87.4 mt -63.86 -46.04 95.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -177.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 6.9 p -60.64 -46.96 94.88 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 C-N-CA 119.403 -0.919 . . . . 0.0 111.267 -178.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -62.63 -42.62 99.7 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 122.204 1.002 . . . . 0.0 109.779 178.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' CYS . . . . . . . . . . . . . 41.9 t -61.63 -46.08 91.32 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 113.647 -1.615 . . . . 0.0 109.979 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.25 -40.2 95.52 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 113.317 -1.765 . . . . 0.0 109.719 176.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.81 -45.7 93.4 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.278 -177.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 21.1 tp -64.77 -38.89 92.51 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 118.785 -1.166 . . . . 0.0 110.972 -174.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 6.3 m -64.57 -45.97 93.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 117.275 -1.77 . . . . 0.0 108.536 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 29.0 p -63.91 -45.33 89.77 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -56.44 -38.77 72.07 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.641 0.776 . . . . 0.0 111.417 -178.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -55.95 -44.0 77.99 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.17 -38.69 87.38 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 37.2 mt -62.4 -41.87 93.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 15.4 mtpt -59.19 -38.2 79.24 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.958 1.303 . . . . 0.0 113.477 178.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -63.06 -42.58 99.71 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.692 -0.63 . . . . 0.0 110.986 -176.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.42 128.36 47.65 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 121.062 -1.024 . . . . 0.0 112.822 -176.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . 0.524 ' CD2' ' CD2' ' A' ' 217' ' ' HIS . 11.1 mp 66.24 4.67 3.26 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 113.601 -1.636 . . . . 0.0 112.49 176.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 16.1 tp -137.1 72.02 1.41 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.117 0.484 . . . . 0.0 109.793 -178.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -112.36 -13.58 13.4 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -162.1 36.6 0.12 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.728 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' ASN . . . . . 0.443 ' O ' ' O ' ' A' ' 209' ' ' LEU . 50.2 t30 54.66 79.38 0.14 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 175.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.443 ' O ' ' O ' ' A' ' 208' ' ' ASN . 16.7 mt . . . . . 0 C--O 1.231 0.131 0 CA-C-N 115.252 -0.885 . . . . 0.0 108.795 -178.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 . . . . . 0 N--CA 1.464 0.265 0 CA-C-O 120.835 0.35 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.458 ' N ' ' CD ' ' A' ' 215' ' ' PRO . 0.4 OUTLIER -61.43 -41.53 79.75 Favored Pre-proline 0 CA--C 1.538 0.487 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -179.241 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.458 ' CD ' ' N ' ' A' ' 214' ' ' LEU . 25.0 Cg_exo -61.35 -33.3 89.3 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 120.951 1.101 . . . . 0.0 112.342 -175.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 35.5 t -63.31 -40.27 96.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 113.085 -1.87 . . . . 0.0 108.809 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' HIS . . . . . 0.524 ' CD2' ' CD2' ' A' ' 204' ' ' LEU . 2.0 t-160 -64.94 -34.37 78.25 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.658 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.11 -46.97 86.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.908 -177.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -60.18 -37.1 79.2 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 119.132 0.878 . . . . 0.0 111.044 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 67.0 m -59.59 -41.62 90.7 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.7 -41.71 98.08 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -177.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . 0.481 ' CZ ' ' CE1' ' A' ' 226' ' ' PHE . 38.4 t80 -62.21 -47.48 84.27 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -176.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -60.91 -42.17 99.57 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 107.962 -2.055 . . . . 0.0 107.962 177.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . 0.451 ' O ' ' OG1' ' A' ' 228' ' ' THR . . . -63.16 -38.18 90.14 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.068 -1.066 . . . . 0.0 109.377 177.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -62.05 -42.21 99.72 Favored Glycine 0 CA--C 1.522 0.491 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.513 -177.168 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' PHE . . . . . 0.481 ' CE1' ' CZ ' ' A' ' 222' ' ' PHE . 3.0 m-85 -66.65 -38.38 86.75 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 99.9 m -63.24 -40.65 98.04 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 176.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 224' ' ' ALA . 15.1 m -61.61 -40.09 93.57 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 114.604 -1.18 . . . . 0.0 112.371 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -58.34 -39.13 78.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.749 -176.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -59.94 -40.38 82.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 118.907 -1.117 . . . . 0.0 109.146 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . 0.51 ' O ' ' HD2' ' A' ' 234' ' ' PRO . 97.2 mt -61.39 -40.72 87.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-O 121.134 0.492 . . . . 0.0 109.783 177.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -62.81 -39.43 94.28 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.485 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 0.0 OUTLIER -57.97 -41.54 90.49 Favored Pre-proline 0 N--CA 1.483 1.187 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -173.542 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . 0.51 ' HD2' ' O ' ' A' ' 231' ' ' ILE . 31.8 Cg_exo -57.87 -39.58 85.55 Favored 'Trans proline' 0 C--N 1.292 -2.431 0 C-N-CA 122.357 2.038 . . . . 0.0 113.551 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 83.9 t -64.08 -37.33 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 117.514 -1.674 . . . . 0.0 109.191 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . 0.525 ' OD2' ' CZ2' ' A' ' 283' ' ' TRP . 94.7 m-20 -66.21 -41.09 90.61 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.41 ' CG1' ' N ' ' A' ' 238' ' ' VAL . 0.5 OUTLIER -65.37 -45.23 93.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -176.448 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.41 ' N ' ' CG1' ' A' ' 237' ' ' VAL . 94.9 t . . . . . 0 C--N 1.322 -0.595 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.441 -178.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' THR . . . . . 0.433 ' CG2' ' N ' ' A' ' 260' ' ' MET . 2.1 t . . . . . 0 N--CA 1.466 0.371 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' MET . . . . . 0.433 ' N ' ' CG2' ' A' ' 259' ' ' THR . 15.2 mmt -61.61 -44.19 97.46 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.106 -0.497 . . . . 0.0 112.051 -178.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 11.9 tp -62.6 -47.81 82.17 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 121.23 -0.188 . . . . 0.0 110.74 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 78.5 mtm180 -67.4 -54.03 24.05 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.078 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -76.66 -141.57 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.899 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . 0.541 ' CD ' ' H ' ' A' ' 264' ' ' GLU . 0.7 OUTLIER -39.87 128.47 2.1 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.083 0.468 . . . . 0.0 110.603 -179.659 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . 0.554 ' C ' ' H ' ' A' ' 267' ' ' ARG . . . -46.33 167.12 0.06 OUTLIER Glycine 0 CA--C 1.533 1.173 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 -179.137 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -53.79 -1.11 0.1 Allowed 'Trans proline' 0 N--CA 1.5 1.887 0 C-N-CA 122.093 1.862 . . . . 0.0 112.509 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . 0.554 ' H ' ' C ' ' A' ' 265' ' ' GLY . 5.1 ptp180 -69.89 -26.94 64.42 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 122.838 0.455 . . . . 0.0 111.511 178.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -58.67 -32.5 69.17 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 119.695 -0.802 . . . . 0.0 109.934 -178.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -62.47 -41.25 98.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.127 177.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 270' ' ' TYR . . . . . 0.428 ' O ' ' O ' ' A' ' 271' ' ' LYS . 36.7 t80 -65.87 -37.6 86.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.924 -1.035 . . . . 0.0 112.633 -178.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.478 ' O ' ' O ' ' A' ' 272' ' ' GLY . 54.8 mtpt -51.31 -175.36 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 271' ' ' LYS . . . 57.38 126.34 0.01 OUTLIER Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -169.37 -26.14 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 119.453 -0.899 . . . . 0.0 112.828 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 274' ' ' MET . . . . . 0.526 ' N ' ' CD ' ' A' ' 275' ' ' PRO . 1.0 OUTLIER -64.16 -45.31 79.16 Favored Pre-proline 0 CA--C 1.529 0.169 0 C-N-CA 119.274 -0.97 . . . . 0.0 110.635 -178.661 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 275' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' A' ' 274' ' ' MET . 19.7 Cg_exo -65.44 -47.78 3.94 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 121.837 1.692 . . . . 0.0 111.966 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 5.0 m -61.42 -40.22 93.61 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.018 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -61.82 -42.8 99.48 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 123.6 1.667 . . . . 0.0 113.486 -177.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 75.5 mt -62.54 -39.06 92.39 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 110.355 -3.111 . . . . 0.0 109.625 175.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . 0.455 ' NH2' ' CB ' ' A' ' 38' ' ' LYS . 28.7 mmt-85 -62.8 -40.67 98.08 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.099 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.453 ' CD1' ' C ' ' A' ' 280' ' ' LEU . 0.1 OUTLIER -62.2 -36.78 82.97 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.235 -0.893 . . . . 0.0 113.195 -177.495 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -68.01 -51.04 36.38 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -178.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 16.4 m -62.79 -44.3 96.54 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.247 0.619 . . . . 0.0 109.68 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 283' ' ' TRP . . . . . 0.525 ' CZ2' ' OD2' ' A' ' 236' ' ' ASP . 83.5 t90 -59.94 -38.24 81.87 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -62.78 -38.4 90.5 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.695 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.82 -38.69 79.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -177.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 6.8 m -62.53 -39.52 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 120.105 -0.638 . . . . 0.0 109.674 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 287' ' ' MET . . . . . 0.426 ' O ' ' OG1' ' A' ' 290' ' ' THR . 76.0 mmm -60.62 -38.6 85.28 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -59.02 -41.53 87.98 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 29.4 m -61.61 -37.99 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 120.269 -0.572 . . . . 0.0 111.16 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 287' ' ' MET . 82.8 p -62.41 -40.43 96.49 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -60.83 -38.81 86.75 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 177.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -58.07 -40.14 80.29 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 117.77 -1.572 . . . . 0.0 109.169 -177.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 293' ' ' GLN . . . . . 0.477 ' O ' ' O ' ' A' ' 296' ' ' ARG . 14.3 mm100 -60.46 -42.42 96.15 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 123.121 1.439 . . . . 0.0 110.258 179.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 77.1 mt -60.43 -39.48 87.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 112.079 -2.328 . . . . 0.0 109.305 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -61.95 -45.03 95.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.41 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 296' ' ' ARG . . . . . 0.477 ' O ' ' O ' ' A' ' 293' ' ' GLN . 36.0 ttm180 -122.27 115.86 23.09 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -111.28 -163.5 0.85 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.694 0.759 . . . . 0.0 112.845 -177.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.481 ' CD1' ' H ' ' A' ' 298' ' ' LEU . 10.0 mp -32.98 -71.27 0.06 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.406 -1.27 . . . . 0.0 112.902 -178.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 299' ' ' MET . . . . . 0.526 ' SD ' ' O ' ' A' ' 299' ' ' MET . 0.0 OUTLIER 88.16 32.06 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 113.895 -1.502 . . . . 0.0 110.869 179.464 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.69 101.01 0.07 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 122.472 1.129 . . . . 0.0 111.182 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -64.34 -46.36 83.82 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 112.952 -1.931 . . . . 0.0 113.142 -176.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -58.67 -38.9 79.19 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 -177.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -64.29 -46.46 83.52 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 304' ' ' SER . . . . . 0.411 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 1.9 t -66.46 -38.18 86.78 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.672 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 -61.86 -42.64 99.3 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.919 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -64.71 -36.78 85.38 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -177.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -60.04 -52.98 69.64 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -176.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 308' ' ' PRO . . . . . 0.411 ' CD ' ' O ' ' A' ' 304' ' ' SER . 74.3 Cg_endo -75.21 0.23 9.24 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.046 1.831 . . . . 0.0 111.862 179.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 29.8 t80 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.586 -179.812 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.7 p . . . . . 0 N--CA 1.462 0.133 0 CA-C-O 120.825 0.345 . . . . 0.0 110.628 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.2 t -83.43 166.44 2.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.573 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.441 ' CD ' ' N ' ' A' ' 16' ' ' LYS . 1.1 mptm? -64.25 -41.8 96.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.095 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -63.75 -41.6 97.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.411 0.624 . . . . 0.0 111.905 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.83 -26.19 40.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.977 -1.011 . . . . 0.0 111.165 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.59 -40.69 96.16 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 106.75 -2.54 . . . . 0.0 106.75 176.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.61 -31.26 68.17 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 124.44 2.067 . . . . 0.0 107.41 176.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.38 -43.19 97.17 Favored Glycine 0 CA--C 1.532 1.115 0 CA-C-N 109.112 -3.676 . . . . 0.0 110.726 -177.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.5 t -71.23 -27.3 63.37 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 117.567 0.684 . . . . 0.0 109.279 178.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.75 -50.64 64.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.69 -178.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.15 -35.88 80.13 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 118.109 -1.437 . . . . 0.0 110.943 -177.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 73.2 m -63.98 -54.11 39.65 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.579 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.6 pp -65.74 -39.59 85.3 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -177.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.94 -41.8 97.52 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 119.733 -0.787 . . . . 0.0 112.861 -173.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -77.63 -27.07 51.01 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 120.325 1.42 . . . . 0.0 109.918 -175.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 10.8 tp -59.81 -55.83 29.41 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 119.835 1.198 . . . . 0.0 112.806 -178.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.9 pt -76.11 -4.55 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.3 p -109.71 -17.08 13.77 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 118.941 -1.104 . . . . 0.0 109.549 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.479 ' N ' ' CD ' ' A' ' 33' ' ' PRO . 4.3 t80 -67.3 -44.0 45.79 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 122.296 2.316 . . . . 0.0 109.164 -178.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 32' ' ' PHE . 30.7 Cg_exo -59.62 -15.85 33.39 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 121.0 1.134 . . . . 0.0 111.556 177.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 26.9 tp -66.99 -35.47 80.03 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -177.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 36' ' ' THR . 2.0 p30 -64.61 -40.29 95.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.36 -0.837 . . . . 0.0 112.401 -177.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.532 ' N ' ' OD1' ' A' ' 35' ' ' ASP . 67.4 p -58.17 -35.01 70.95 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.03 -38.09 85.27 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.627 ' HZ1' ' NH2' ' A' ' 279' ' ' ARG . 11.5 ptmt -60.58 -46.99 88.18 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 120.119 -0.632 . . . . 0.0 111.855 -175.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.443 ' N ' ' CG ' ' A' ' 38' ' ' LYS . 93.0 t -62.16 -38.42 80.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -176.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.549 ' C ' ' H ' ' A' ' 42' ' ' GLN . 6.8 mmp_? -59.37 -40.47 86.57 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 119.345 -0.942 . . . . 0.0 109.611 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.58 38.96 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.3 179.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.549 ' H ' ' C ' ' A' ' 40' ' ' ARG . 3.1 pt20 -67.89 -159.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 O-C-N 122.136 -0.352 . . . . 0.0 110.936 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.0 mp -132.07 47.81 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.562 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 46.72 29.11 0.9 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.855 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 46' ' ' GLU . . . -64.82 -116.32 0.01 OUTLIER Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.427 ' O ' ' O ' ' A' ' 45' ' ' GLY . 41.7 tt0 59.35 132.29 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.889 0.376 . . . . 0.0 110.839 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 66.9 m -115.71 -12.79 11.48 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.544 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -42.63 -27.08 0.15 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.648 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.46 -10.05 73.21 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -178.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 45.5 tp -65.89 -38.01 87.64 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.373 -0.413 . . . . 0.0 110.585 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.6 p -60.74 -44.81 98.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.734 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 -64.86 -33.65 76.52 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.881 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 98.0 m -67.86 -38.16 82.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.186 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.74 -152.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.207 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -166.9 -24.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.069 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.533 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 57.8 p -166.74 -127.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 179.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.533 ' CB ' ' O ' ' A' ' 56' ' ' SER . . . 94.33 13.8 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 177.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.497 ' N ' ' CD ' ' A' ' 58' ' ' GLN . 2.2 pm0 -175.29 176.81 1.97 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.867 0.365 . . . . 0.0 110.162 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.461 ' CD1' ' C ' ' A' ' 58' ' ' GLN . 84.7 m-85 -157.07 159.22 37.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.646 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 34.1 ptt-85 -48.16 -33.01 7.74 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -31.33 103.51 0.01 OUTLIER Glycine 0 CA--C 1.526 0.762 0 CA-C-N 114.875 -1.057 . . . . 0.0 112.221 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.6 m -66.91 -33.61 64.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 118.229 -0.891 . . . . 0.0 109.194 176.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -60.09 -32.32 70.86 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 121.25 1.841 . . . . 0.0 110.359 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -65.02 -49.3 63.2 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-N 115.243 -0.889 . . . . 0.0 114.609 -177.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.556 ' HG1' ' N ' ' A' ' 66' ' ' ILE . 6.8 p -62.15 -46.38 89.24 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -178.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.556 ' N ' ' HG1' ' A' ' 65' ' ' THR . 2.3 pp -58.99 -35.0 54.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -178.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.8 tp -63.03 -35.29 79.73 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 120.36 1.437 . . . . 0.0 113.116 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 98.6 m -61.47 -41.52 97.37 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-N 114.316 -1.311 . . . . 0.0 111.011 -177.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 50.4 mmm -59.3 -39.31 82.61 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -176.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.7 t -68.99 -41.04 81.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 118.968 -1.093 . . . . 0.0 113.646 -177.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 23.0 ttp-105 -78.26 -13.54 59.81 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.503 ' CG2' ' N ' ' A' ' 73' ' ' GLU . 0.5 OUTLIER -62.85 -54.95 30.9 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 114.639 -1.164 . . . . 0.0 112.391 -179.297 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.503 ' N ' ' CG2' ' A' ' 72' ' ' THR . 13.6 tp10 -110.61 -57.36 2.23 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.283 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.41 163.21 12.08 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -56.57 -34.92 96.44 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 122.107 1.871 . . . . 0.0 112.198 -179.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.4 tpp180 -61.25 -11.84 10.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.887 0.851 . . . . 0.0 111.132 176.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.6 p -78.28 -32.86 49.69 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 113.868 -1.514 . . . . 0.0 110.95 -178.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.3 mp -75.58 -31.65 60.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.017 0.437 . . . . 0.0 110.449 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -90.15 -3.69 57.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 123.644 1.688 . . . . 0.0 112.549 -176.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 -106.7 121.21 43.91 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 110.619 -2.991 . . . . 0.0 107.654 175.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.46 -18.6 50.57 Favored Glycine 0 N--CA 1.469 0.893 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 -177.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.544 ' CD1' ' N ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -58.91 -33.69 70.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 113.905 -1.148 . . . . 0.0 110.332 -179.096 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.544 ' N ' ' CD1' ' A' ' 82' ' ' LEU . 7.1 p -70.44 -26.28 28.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.265 177.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.14 -31.95 61.2 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 119.11 -0.471 . . . . 0.0 111.837 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.93 -40.0 89.18 Favored Glycine 0 N--CA 1.466 0.679 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.891 -178.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -62.48 -40.25 96.07 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 122.15 0.976 . . . . 0.0 112.842 -176.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.431 ' O ' ' OE1' ' A' ' 87' ' ' GLN . 0.1 OUTLIER -60.83 -28.29 68.7 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 113.431 -1.713 . . . . 0.0 110.378 -179.267 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 62.5 mtt85 -58.53 -53.7 55.36 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 173.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -66.67 -29.36 69.35 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 112.035 -2.348 . . . . 0.0 111.847 -177.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 12.3 tpt -61.27 -40.14 92.99 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.425 179.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 33.8 t -74.37 -34.19 63.29 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 119.366 -0.934 . . . . 0.0 111.456 -177.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -57.87 -43.84 86.26 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 121.04 1.745 . . . . 0.0 112.615 -176.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.49 -32.85 64.51 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 119.484 -0.886 . . . . 0.0 110.748 -178.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.488 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 70.2 p -64.1 -41.43 97.28 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.472 ' C ' ' H ' ' A' ' 97' ' ' ILE . 29.8 m -68.79 -28.28 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.44 177.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 55.3 ttp85 -77.15 9.22 3.2 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -176.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.488 ' CG2' ' O ' ' A' ' 94' ' ' SER . 11.0 tt -86.96 -14.68 10.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.412 ' O ' ' OG ' ' A' ' 102' ' ' SER . . . -139.98 -48.14 0.06 OUTLIER Glycine 0 CA--C 1.544 1.867 0 N-CA-C 115.772 1.069 . . . . 0.0 115.772 -177.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.541 ' CD2' ' N ' ' A' ' 99' ' ' LEU . 3.4 mm? -71.79 -13.4 61.68 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 119.841 1.82 . . . . 0.0 113.925 -177.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.49 ' CZ ' ' NZ ' ' A' ' 104' ' ' LYS . 9.6 t80 -80.84 -51.94 8.05 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 114.63 -1.168 . . . . 0.0 112.795 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.498 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 0.4 OUTLIER -70.42 -32.23 69.74 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 124.056 1.884 . . . . 0.0 110.686 -179.738 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' A' ' 98' ' ' GLY . 67.3 m -67.32 -50.88 58.3 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 109.609 -3.451 . . . . 0.0 113.492 178.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 10.0 p -73.83 -26.66 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 CA-C-N 121.27 1.85 . . . . 0.0 111.79 177.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.49 ' NZ ' ' CZ ' ' A' ' 100' ' ' TYR . 39.0 mttp -69.51 -41.86 75.47 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 111.621 -2.536 . . . . 0.0 113.284 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -76.27 -14.69 60.11 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 123.63 1.681 . . . . 0.0 111.029 178.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -79.27 -22.47 44.67 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 112.518 -2.128 . . . . 0.0 111.95 178.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.582 ' HH ' HD22 ' A' ' 190' ' ' ASN . 15.4 m-85 -109.79 -27.73 9.16 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.231 1.012 . . . . 0.0 113.299 -173.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.807 ' C ' ' H ' ' A' ' 110' ' ' GLY . 14.4 t -94.53 12.68 26.54 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 -173.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -54.69 19.11 0.0 OUTLIER 'General case' 0 CA--C 1.57 1.747 0 CA-C-N 119.885 1.221 . . . . 0.0 110.726 177.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.807 ' H ' ' C ' ' A' ' 108' ' ' THR . . . 59.18 20.52 50.4 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.542 ' OG ' ' NH2' ' A' ' 119' ' ' ARG . 1.4 m 33.02 -163.23 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 113.23 -1.485 . . . . 0.0 113.385 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.62 ' C ' ' H ' ' A' ' 114' ' ' ALA . 3.3 tt0 -141.14 -157.3 0.75 Allowed 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 118.807 -1.157 . . . . 0.0 113.424 -177.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.537 ' CG ' ' O ' ' A' ' 113' ' ' HIS . 37.5 t60 -61.12 9.24 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 114.814 -1.085 . . . . 0.0 111.312 -179.104 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.62 ' H ' ' C ' ' A' ' 112' ' ' GLU . . . 160.42 -161.01 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.26 14.58 25.74 Favored Glycine 0 N--CA 1.459 0.221 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 -179.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.43 HD13 HG22 ' A' ' 116' ' ' ILE . 25.6 mm -60.91 -39.98 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.08 -39.49 96.35 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.92 175.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 6.0 t -58.85 -43.23 90.74 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 176.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.542 ' NH2' ' OG ' ' A' ' 111' ' ' SER . 18.6 mmt85 -63.75 -37.37 87.1 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.658 -178.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 30.5 tp -63.58 -45.71 89.17 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 42.1 mt -66.92 -44.97 79.33 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.518 178.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.75 -45.1 87.84 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 119.903 1.229 . . . . 0.0 110.955 178.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -65.59 -44.39 92.84 Favored Glycine 0 CA--C 1.517 0.2 0 C-N-CA 119.777 -1.201 . . . . 0.0 111.148 -177.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 79.9 p -64.16 -43.07 96.32 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.83 0.348 . . . . 0.0 111.007 178.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 96.6 m -69.5 -48.82 59.39 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 119.192 -1.003 . . . . 0.0 112.687 177.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.441 ' CG2' ' N ' ' A' ' 127' ' ' GLY . 6.3 t -66.17 -42.7 88.56 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 115.197 1.555 . . . . 0.0 115.197 -174.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.441 ' N ' ' CG2' ' A' ' 126' ' ' THR . . . -64.74 -44.83 94.28 Favored Glycine 0 C--O 1.228 -0.233 0 CA-C-N 114.238 -1.347 . . . . 0.0 112.748 -177.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.57 -41.78 97.9 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 112.482 -1.859 . . . . 0.0 107.259 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.403 ' O ' ' CB ' ' A' ' 132' ' ' ALA . 0.2 OUTLIER -64.85 -42.81 94.58 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.169 178.118 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.13 -39.67 95.36 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.894 -0.504 . . . . 0.0 111.817 -178.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 94.5 t -60.98 -26.25 38.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 123.342 1.544 . . . . 0.0 109.298 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.403 ' CB ' ' O ' ' A' ' 129' ' ' LEU . . . -58.93 -44.67 91.38 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 110.971 -2.832 . . . . 0.0 112.386 -178.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 61.4 t -79.07 -49.18 20.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -177.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.517 ' O ' ' CB ' ' A' ' 135' ' ' GLN . . . -107.36 -169.12 1.48 Allowed 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -177.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.527 ' N ' ' CD ' ' A' ' 136' ' ' PRO . 3.4 tt0 105.15 -23.28 0.0 OUTLIER Pre-proline 0 CA--C 1.552 1.051 0 O-C-N 124.676 1.235 . . . . 0.0 114.051 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.527 ' CD ' ' N ' ' A' ' 135' ' ' GLN . 5.2 Cg_exo -52.68 -34.64 64.93 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 CA-C-N 122.025 1.759 . . . . 0.0 112.803 -178.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 12.6 m -66.75 -40.72 88.39 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -64.52 -42.16 95.94 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 118.965 -1.094 . . . . 0.0 112.424 -177.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.89 -42.93 97.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -179.198 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 19.7 m -63.92 -37.3 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -177.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 16.5 mtpp -60.82 -40.13 91.61 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.981 -177.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 90.4 t -69.83 -45.11 78.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.28 0.562 . . . . 0.0 109.694 178.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.64 -36.11 83.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.508 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -66.28 -40.4 90.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.899 -0.592 . . . . 0.0 112.312 -177.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -64.06 -39.07 93.28 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 119.884 -0.726 . . . . 0.0 110.185 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.16 -35.06 79.9 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.521 ' NE2' ' O ' ' A' ' 149' ' ' ARG . 0.0 OUTLIER -59.66 110.73 1.2 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 177.584 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 150' ' ' ALA . . . -43.17 93.03 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 117.33 -1.319 . . . . 0.0 111.531 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.521 ' O ' ' NE2' ' A' ' 147' ' ' GLN . 78.8 mtm180 53.81 -89.44 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 122.64 2.473 . . . . 0.0 111.055 178.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 148' ' ' ALA . . . -154.37 -149.7 0.29 Allowed 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.405 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -158.44 31.57 0.48 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.664 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 179.98 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.514 ' CE2' ' O ' ' A' ' 157' ' ' GLN . 92.0 t80 . . . . . 0 N--CA 1.464 0.241 0 CA-C-O 120.875 0.369 . . . . 0.0 110.677 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.514 ' O ' ' CE2' ' A' ' 156' ' ' TYR . 84.1 mt-30 -81.07 166.49 20.7 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.34 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.655 ' H ' ' CG ' ' A' ' 161' ' ' GLU . 20.7 p -157.04 -178.56 7.46 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.565 0.698 . . . . 0.0 111.602 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 25.4 p -64.77 -46.64 81.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.113 -0.948 . . . . 0.0 112.335 -178.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.416 ' CG1' ' N ' ' A' ' 161' ' ' GLU . 14.9 p -65.02 -45.98 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 119.241 -0.984 . . . . 0.0 110.896 -178.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.655 ' CG ' ' H ' ' A' ' 158' ' ' SER . 2.1 pp20? -68.14 -38.54 82.27 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.921 0.391 . . . . 0.0 111.843 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.426 ' N ' ' CD ' ' A' ' 161' ' ' GLU . . . -61.14 -45.68 93.67 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -177.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -62.54 -50.15 72.47 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.137 -179.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -68.68 -45.68 71.05 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 -175.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.42 ' CG2' ' N ' ' A' ' 166' ' ' ILE . 15.3 t -63.27 -45.1 93.05 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -177.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.42 ' N ' ' CG2' ' A' ' 165' ' ' THR . 8.4 pt -64.83 -39.08 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 CA-C-O 122.043 0.925 . . . . 0.0 108.964 177.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.404 ' N ' ' CG1' ' A' ' 166' ' ' ILE . . . -60.41 -37.62 81.44 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 113.704 -1.589 . . . . 0.0 109.145 177.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 13.4 tpp85 -63.47 -51.35 65.99 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 123.715 2.962 . . . . 0.0 112.821 -175.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -75.7 -51.4 12.82 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 123.287 0.635 . . . . 0.0 109.515 177.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.526 ' OE2' ' N ' ' A' ' 174' ' ' GLY . 0.0 OUTLIER -78.96 -37.19 40.17 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 119.602 1.092 . . . . 0.0 113.784 -176.204 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . 0.47 ' O ' ' OE2' ' A' ' 170' ' ' GLU . . . 98.31 -171.73 25.8 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 120.776 -0.726 . . . . 0.0 113.366 179.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 20.8 tt -75.12 -37.84 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -177.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 7.3 tpp180 -58.22 -34.1 70.05 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 114.298 -1.319 . . . . 0.0 112.938 -173.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.526 ' N ' ' OE2' ' A' ' 170' ' ' GLU . . . -60.56 -38.87 95.64 Favored Glycine 0 N--CA 1.464 0.51 0 CA-C-O 123.726 1.737 . . . . 0.0 111.995 -178.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.541 ' CD1' ' N ' ' A' ' 175' ' ' LEU . 5.2 mp -70.2 -34.24 72.69 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 110.153 -3.024 . . . . 0.0 116.425 -176.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 11.0 m95 -78.72 -7.72 58.02 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 113.481 -1.691 . . . . 0.0 109.653 -178.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -44.06 -49.28 8.86 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.756 0.651 . . . . 0.0 112.756 -175.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -87.99 -36.6 8.27 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 124.548 1.071 . . . . 0.0 111.754 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 40.3 p -45.24 -51.39 10.81 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' SER . . . . . 0.408 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 1.5 t -62.92 -50.93 74.72 Favored Pre-proline 0 N--CA 1.472 0.667 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -176.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.408 ' HD2' ' N ' ' A' ' 180' ' ' SER . 32.3 Cg_endo -65.06 -28.15 57.24 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.676 1.584 . . . . 0.0 111.257 176.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.426 ' CB ' ' OE1' ' A' ' 135' ' ' GLN . 24.5 t-20 -63.41 -39.19 93.82 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 71.8 t -62.91 -42.79 97.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.63 -39.99 95.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.18 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -60.99 -41.94 97.47 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.084 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -61.61 -43.24 99.24 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.033 0.444 . . . . 0.0 110.124 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . 0.508 ' O ' ' SG ' ' A' ' 191' ' ' CYS . . . -64.24 -43.87 93.56 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.24 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 25.2 mm -63.32 -45.17 98.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.864 -0.335 . . . . 0.0 111.309 -178.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 89.3 t -60.42 -47.22 93.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 120.265 -0.574 . . . . 0.0 111.765 -178.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . 0.582 HD22 ' HH ' ' A' ' 107' ' ' TYR . 16.6 t30 -62.61 -43.27 99.22 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 122.663 1.22 . . . . 0.0 109.873 179.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' CYS . . . . . 0.508 ' SG ' ' O ' ' A' ' 187' ' ' ALA . 94.5 m -62.43 -46.49 88.3 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 112.46 -2.155 . . . . 0.0 110.752 179.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.41 -40.29 95.5 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.479 176.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -61.54 -45.57 93.6 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.879 -178.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 7.9 tt -64.16 -38.95 92.88 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 118.623 -1.231 . . . . 0.0 110.071 -174.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 6.1 m -64.5 -45.48 95.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 116.762 -1.975 . . . . 0.0 107.808 178.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 19.8 m -63.89 -45.87 87.43 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -178.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -56.48 -38.35 71.61 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.34 1.056 . . . . 0.0 112.09 -178.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -55.19 -43.09 74.05 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 24.5 mt -60.79 -39.51 89.17 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.422 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 1.3 mp -62.98 -42.45 96.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -59.59 -38.67 81.85 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.505 1.522 . . . . 0.0 113.193 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -62.9 -40.04 96.36 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.027 -178.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 90.5 m -100.66 129.37 46.56 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.797 0.808 . . . . 0.0 111.839 -177.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 4.6 tp 68.02 4.38 4.03 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 114.221 -1.354 . . . . 0.0 111.954 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -128.42 28.81 5.41 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -177.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -72.84 -25.06 60.98 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.263 -178.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.46 ' O ' ' CG ' ' A' ' 208' ' ' ASN . . . -131.09 -38.88 1.21 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.547 0.689 . . . . 0.0 110.219 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' ASN . . . . . 0.64 ' CG ' ' H ' ' A' ' 209' ' ' LEU . 13.9 p30 141.25 -92.84 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 113.138 -1.846 . . . . 0.0 106.846 -177.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.64 ' H ' ' CG ' ' A' ' 208' ' ' ASN . 4.3 tt . . . . . 0 N--CA 1.463 0.185 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 177.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . 0.51 ' N ' ' OD1' ' A' ' 213' ' ' ASP . 11.5 p-10 . . . . . 0 N--CA 1.46 0.051 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.491 ' N ' ' CD ' ' A' ' 215' ' ' PRO . 4.3 mm? -60.88 -42.63 88.12 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.215 -178.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.491 ' CD ' ' N ' ' A' ' 214' ' ' LEU . 35.1 Cg_exo -59.89 -32.34 95.1 Favored 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 121.58 1.52 . . . . 0.0 112.337 -177.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' CYS . . . . . 0.527 ' SG ' ' N ' ' A' ' 217' ' ' HIS . 1.6 p -63.98 -42.23 97.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 113.714 -1.584 . . . . 0.0 111.422 -177.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' HIS . . . . . 0.527 ' N ' ' SG ' ' A' ' 216' ' ' CYS . 77.3 m80 -66.5 -37.32 84.81 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.332 0.587 . . . . 0.0 110.766 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -63.47 -46.77 84.66 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.804 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 20.8 p -60.2 -37.79 81.32 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 118.81 0.732 . . . . 0.0 110.44 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 217' ' ' HIS . 49.7 p -59.45 -41.63 90.09 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 178.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . 0.566 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.74 -41.81 97.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -177.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -62.19 -47.67 83.45 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -175.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -61.15 -42.4 99.78 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 107.994 -2.042 . . . . 0.0 107.994 177.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . 0.504 ' O ' ' SG ' ' A' ' 227' ' ' CYS . . . -63.48 -37.34 86.91 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 113.839 -1.18 . . . . 0.0 109.622 177.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -61.15 -41.96 99.64 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-N 114.364 -1.289 . . . . 0.0 112.529 -175.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' PHE . . . . . 0.457 ' O ' ' OG1' ' A' ' 229' ' ' THR . 55.1 m-85 -66.24 -38.79 88.74 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 118.767 1.283 . . . . 0.0 110.014 -178.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . 0.504 ' SG ' ' O ' ' A' ' 224' ' ' ALA . 1.8 p -63.69 -41.91 98.07 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 119.74 -0.784 . . . . 0.0 109.873 177.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' THR . . . . . 0.495 ' N ' ' SG ' ' A' ' 227' ' ' CYS . 67.6 p -62.56 -40.93 98.42 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.412 179.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.457 ' OG1' ' O ' ' A' ' 226' ' ' PHE . 13.1 p -59.19 -39.46 82.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.266 -177.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 92.8 t -60.35 -41.26 86.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 C-N-CA 118.91 -1.116 . . . . 0.0 108.524 178.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . 0.472 ' O ' ' HD2' ' A' ' 234' ' ' PRO . 30.4 mm -62.08 -41.18 90.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 121.345 0.593 . . . . 0.0 109.727 176.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.1 -39.9 96.06 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 116.16 1.911 . . . . 0.0 116.16 -179.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.48 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 0.1 OUTLIER -58.1 -41.91 92.27 Favored Pre-proline 0 N--CA 1.481 1.098 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -173.271 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 233' ' ' SER . 35.5 Cg_exo -58.39 -40.08 78.3 Favored 'Trans proline' 0 C--N 1.291 -2.483 0 C-N-CA 121.915 1.744 . . . . 0.0 112.503 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 58.9 t -64.38 -37.29 79.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 C-N-CA 118.591 -1.244 . . . . 0.0 109.004 178.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -66.22 -40.98 90.67 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-N 115.351 -0.841 . . . . 0.0 112.182 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 74.1 t -65.63 -45.28 92.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -176.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 C--N 1.328 -0.367 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -176.412 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 21.9 m . . . . . 0 N--CA 1.466 0.342 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' MET . . . . . 0.419 ' CG ' ' N ' ' A' ' 261' ' ' LEU . 17.0 ptt? -61.57 -44.45 97.01 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -177.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.419 ' N ' ' CG ' ' A' ' 260' ' ' MET . 11.6 tp -63.25 -48.12 79.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.787 0.327 . . . . 0.0 110.467 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 50.1 ttt85 -67.4 -54.14 23.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.582 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 3.8 ttmm -68.29 -148.45 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.954 0.407 . . . . 0.0 111.484 -178.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -51.45 136.4 25.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.399 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . 0.446 ' C ' ' H ' ' A' ' 267' ' ' ARG . . . -41.37 166.63 0.01 OUTLIER Glycine 0 CA--C 1.527 0.834 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.809 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -60.23 -2.97 2.07 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.625 2.217 . . . . 0.0 111.7 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . 0.446 ' H ' ' C ' ' A' ' 265' ' ' GLY . 37.7 ttm180 -69.98 -27.01 64.36 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.193 0.597 . . . . 0.0 111.739 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -58.76 -32.31 69.16 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.006 -179.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -62.39 -41.19 98.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.915 177.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -65.67 -37.55 86.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.909 -1.042 . . . . 0.0 112.146 -178.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.455 ' O ' ' O ' ' A' ' 272' ' ' GLY . 42.3 mmtm -65.42 -176.7 0.35 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 271' ' ' LYS . . . 47.72 104.13 0.01 OUTLIER Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -165.26 4.26 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.611 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 274' ' ' MET . . . . . 0.583 ' N ' ' CD ' ' A' ' 275' ' ' PRO . 2.9 ttm -63.57 -44.15 80.26 Favored Pre-proline 0 C--N 1.329 -0.304 0 C-N-CA 120.268 -0.573 . . . . 0.0 109.646 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 275' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 274' ' ' MET . 22.8 Cg_exo -64.33 -46.12 8.26 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.732 2.288 . . . . 0.0 111.334 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 38.7 t -60.1 -40.04 88.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.514 -179.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . 0.464 ' O ' ' CD1' ' A' ' 280' ' ' LEU . 3.4 m-85 -61.59 -42.76 99.32 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 124.3 2.0 . . . . 0.0 111.809 -178.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 11.5 tp -62.87 -38.98 93.01 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 110.385 -3.098 . . . . 0.0 109.892 175.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . 0.627 ' NH2' ' HZ1' ' A' ' 38' ' ' LYS . 56.6 mtt-85 -63.03 -41.49 99.53 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.464 ' CD1' ' O ' ' A' ' 277' ' ' PHE . 1.3 pp -62.7 -35.37 79.49 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -177.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . 0.436 ' O ' ' OD1' ' A' ' 284' ' ' ASN . . . -67.67 -50.98 38.7 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -177.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 66.4 m -62.49 -43.89 97.72 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.477 0.711 . . . . 0.0 109.689 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 283' ' ' TRP . . . . . . . . . . . . . 85.0 t90 -59.61 -38.16 80.55 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' A' ' 285' ' ' VAL . 0.2 OUTLIER -62.52 -38.37 89.7 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.295 179.549 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . 0.531 ' N ' ' OD1' ' A' ' 284' ' ' ASN . 0.3 OUTLIER -61.01 -39.91 83.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -177.52 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 10.2 m -63.31 -40.07 87.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.051 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 287' ' ' MET . . . . . 0.461 ' SD ' ' CE1' ' A' ' 291' ' ' TYR . 0.0 OUTLIER -60.83 -38.41 85.37 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.656 179.919 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -58.44 -40.1 81.63 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.846 -178.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -60.53 -38.24 77.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 -177.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 41.8 p -62.42 -40.91 98.09 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 119.558 -0.857 . . . . 0.0 108.834 177.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 291' ' ' TYR . . . . . 0.461 ' CE1' ' SD ' ' A' ' 287' ' ' MET . 16.2 m-85 -60.98 -38.34 85.6 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 177.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 -57.27 -39.35 75.5 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 118.163 -1.415 . . . . 0.0 109.261 -176.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 293' ' ' GLN . . . . . 0.468 ' O ' ' O ' ' A' ' 296' ' ' ARG . 17.9 mm100 -60.24 -42.08 94.53 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 122.904 1.335 . . . . 0.0 110.58 178.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -60.8 -39.41 88.8 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 112.404 -2.18 . . . . 0.0 110.02 178.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 45.2 mttp -61.83 -44.67 96.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.226 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 296' ' ' ARG . . . . . 0.468 ' O ' ' O ' ' A' ' 293' ' ' GLN . 89.1 mtm180 -121.89 115.7 23.06 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -112.13 -163.24 0.84 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.349 0.595 . . . . 0.0 112.276 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.426 ' CD1' ' N ' ' A' ' 298' ' ' LEU . 9.9 mp -74.79 109.72 8.49 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 176.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 299' ' ' MET . . . . . 0.5 ' SD ' ' O ' ' A' ' 299' ' ' MET . 0.1 OUTLIER -94.59 63.97 2.97 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.755 0.312 . . . . 0.0 111.651 -178.302 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.49 100.86 0.08 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 122.233 1.016 . . . . 0.0 110.647 -178.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -64.2 -46.47 83.8 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 113.16 -1.837 . . . . 0.0 113.265 -176.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -59.06 -39.92 83.56 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.161 -177.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -65.01 -47.0 79.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.846 0.355 . . . . 0.0 110.351 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 304' ' ' SER . . . . . 0.453 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 39.2 t -67.11 -38.33 85.44 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.776 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 34.7 mmm-85 -62.25 -43.76 98.09 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -179.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -65.35 -36.82 85.18 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -177.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -60.13 -52.87 70.26 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -176.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 308' ' ' PRO . . . . . 0.49 ' O ' ' C ' ' A' ' 309' ' ' PHE . 72.5 Cg_endo -75.07 0.38 9.0 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.374 2.049 . . . . 0.0 112.995 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 309' ' ' PHE . . . . . 0.49 ' C ' ' O ' ' A' ' 308' ' ' PRO . 36.3 p90 . . . . . 0 N--CA 1.481 1.078 0 O-C-N 123.894 0.746 . . . . 0.0 112.923 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.2 p . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.842 0.353 . . . . 0.0 110.516 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.6 t -84.36 155.8 3.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.846 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -64.51 -41.7 96.26 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.287 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -63.67 -41.74 98.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.497 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 45.3 tp -79.6 -26.44 41.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.089 -178.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.26 -41.25 94.81 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 107.714 -2.154 . . . . 0.0 107.714 177.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.66 -32.15 67.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 124.856 2.265 . . . . 0.0 107.625 176.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.43 -42.24 99.11 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-N 108.492 -3.958 . . . . 0.0 108.092 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -70.52 -27.62 64.31 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.098 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.46 -49.97 64.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.965 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.02 -35.87 79.88 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 118.157 -1.417 . . . . 0.0 110.995 -177.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 78.7 m -63.85 -53.94 42.69 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.245 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.7 pp -65.54 -39.58 85.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -177.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.92 -41.65 97.6 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -173.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 32' ' ' PHE . 8.4 p-10 -77.67 -27.11 50.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 120.464 1.483 . . . . 0.0 109.89 -176.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -60.33 -55.71 30.3 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 119.531 1.06 . . . . 0.0 111.77 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.6 pt -75.89 -4.84 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 121.188 0.518 . . . . 0.0 112.363 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 53.5 m -109.91 -17.02 13.72 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 117.319 -1.324 . . . . 0.0 109.95 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.443 ' N ' ' O ' ' A' ' 28' ' ' ASP . 10.3 t80 -68.38 -44.88 36.95 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-N 122.67 2.486 . . . . 0.0 110.977 -177.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -60.21 -16.69 41.88 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 CA-C-N 121.05 1.411 . . . . 0.0 112.74 177.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 82.9 mt -67.65 -35.08 78.22 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -177.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.62 ' CB ' ' HZ2' ' A' ' 38' ' ' LYS . 5.3 p30 -63.98 -39.56 94.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.133 -178.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.532 ' N ' ' OD1' ' A' ' 35' ' ' ASP . 44.4 p -58.11 -34.02 69.75 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.29 -38.76 85.58 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.62 ' HZ2' ' CB ' ' A' ' 35' ' ' ASP . 12.1 pttm -62.0 -47.7 83.61 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 119.049 -1.06 . . . . 0.0 111.93 -177.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.9 m -62.8 -38.98 83.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -176.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.555 ' C ' ' H ' ' A' ' 42' ' ' GLN . 13.0 mmp_? -60.24 -41.08 92.41 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 118.986 -1.085 . . . . 0.0 109.909 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 12.8 tp -62.48 38.98 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.236 178.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.583 HE22 ' CA ' ' A' ' 44' ' ' GLN . 5.1 pp0? -53.0 176.02 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.078 0.466 . . . . 0.0 111.436 -178.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 90.9 mt -45.29 -84.01 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.688 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.583 ' CA ' HE22 ' A' ' 42' ' ' GLN . 10.6 tm0? -150.64 -33.93 0.16 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.439 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -163.69 155.61 27.05 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.412 ' OE1' ' CG1' ' A' ' 51' ' ' VAL . 16.8 mp0 -87.27 168.8 12.87 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.815 0.34 . . . . 0.0 110.532 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.5 t -91.26 1.18 57.29 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -63.34 -25.49 68.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.436 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.03 -6.05 84.04 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.02 -1.632 . . . . 0.0 109.02 -177.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.3 tt -65.31 -37.66 87.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.583 -0.809 . . . . 0.0 109.638 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.412 ' CG1' ' OE1' ' A' ' 46' ' ' GLU . 16.5 m -60.38 -44.04 95.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.411 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 23.7 ttm105 -64.16 -34.04 77.15 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 19.3 m -67.97 -38.26 82.52 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -131.5 78.82 1.85 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.227 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -48.13 -14.91 0.06 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.39 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.526 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 23.1 t -126.23 -140.54 0.28 Allowed 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 56' ' ' SER . . . 96.66 13.96 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.706 0 O-C-N 124.062 0.851 . . . . 0.0 111.909 178.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -175.32 69.99 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.653 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -52.36 155.44 2.07 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.402 ' O ' ' C ' ' A' ' 61' ' ' GLY . 75.4 mtp180 -45.35 -37.0 4.54 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 60' ' ' ARG . . . -30.33 103.05 0.01 OUTLIER Glycine 0 CA--C 1.529 0.95 0 CA-C-N 114.993 -1.003 . . . . 0.0 112.478 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 31.0 m -67.42 -33.79 64.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 118.268 -0.872 . . . . 0.0 109.888 176.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.0 mp -60.27 -32.28 71.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 121.239 1.836 . . . . 0.0 109.881 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.42 -49.2 66.74 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 114.975 -1.011 . . . . 0.0 114.671 -176.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.6 m -62.1 -46.41 89.19 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -178.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 29.0 pt -59.89 -35.97 63.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.3 tt -63.84 -35.83 81.92 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 121.04 1.745 . . . . 0.0 111.651 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.458 ' O ' ' OG1' ' A' ' 72' ' ' THR . 98.6 m -62.79 -39.47 94.31 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-N 113.674 -1.603 . . . . 0.0 111.049 -175.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 7.6 ptt? -60.39 -39.8 88.6 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 120.648 -1.283 . . . . 0.0 113.819 -176.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.2 p -69.36 -40.7 80.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 119.244 -0.982 . . . . 0.0 113.015 -178.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 55.6 ttm-85 -77.86 -13.44 59.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.979 0.895 . . . . 0.0 112.173 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.458 ' OG1' ' O ' ' A' ' 68' ' ' THR . 71.3 m -63.14 -54.77 32.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.137 -1.392 . . . . 0.0 111.154 178.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -106.29 -59.85 1.73 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.473 178.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 160.98 166.34 19.51 Favored Glycine 0 CA--C 1.535 1.34 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -56.17 -35.15 94.9 Favored 'Trans proline' 0 N--CA 1.5 1.91 0 CA-C-N 119.33 1.565 . . . . 0.0 111.721 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -61.36 -11.15 8.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.739 0.78 . . . . 0.0 111.071 176.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.8 t -77.79 -32.77 52.67 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.248 -1.342 . . . . 0.0 110.876 -178.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.431 ' CD1' ' N ' ' A' ' 78' ' ' LEU . 9.6 mp -75.86 -33.64 60.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 118.271 0.487 . . . . 0.0 110.958 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -92.53 -4.95 52.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 122.796 1.284 . . . . 0.0 112.76 -178.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -90.69 118.31 30.02 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 112.487 -2.142 . . . . 0.0 107.228 175.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.89 -7.58 57.42 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -178.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.46 ' CD1' ' C ' ' A' ' 82' ' ' LEU . 0.4 OUTLIER -59.25 -34.51 72.32 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 113.949 -1.125 . . . . 0.0 110.541 -179.092 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.1 p -70.46 -26.67 29.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.525 178.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.73 -31.58 61.87 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.748 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.427 ' O ' ' OE1' ' A' ' 89' ' ' GLN . . . -67.84 -40.26 89.52 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 119.701 -1.238 . . . . 0.0 111.241 -177.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.3 mp -62.0 -40.05 94.34 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 122.598 1.189 . . . . 0.0 112.203 -177.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 49.9 tp60 -60.41 -26.99 67.1 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 112.657 -2.065 . . . . 0.0 108.992 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 46.8 ttt180 -57.56 -53.41 58.42 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 173.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.427 ' OE1' ' O ' ' A' ' 85' ' ' GLY . 13.7 mp0 -67.82 -29.8 69.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 113.437 -1.71 . . . . 0.0 112.196 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 8.8 tpt -60.94 -41.97 97.28 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.044 -179.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.429 ' O ' ' OG ' ' A' ' 94' ' ' SER . 77.9 p -74.9 -35.08 62.25 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 119.225 -0.99 . . . . 0.0 111.729 -177.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -57.93 -43.4 86.24 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 121.293 1.861 . . . . 0.0 113.051 -176.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.41 -32.42 64.42 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.322 -177.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 91' ' ' SER . 97.1 p -63.68 -40.55 97.11 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 179.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.458 ' C ' ' H ' ' A' ' 97' ' ' ILE . 18.4 m -67.94 -28.3 40.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.829 177.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -77.63 10.12 2.9 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -177.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.458 ' H ' ' C ' ' A' ' 95' ' ' VAL . 38.8 mm -86.69 -15.39 9.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 177.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.433 ' O ' ' OG ' ' A' ' 102' ' ' SER . . . -140.45 -48.0 0.05 OUTLIER Glycine 0 CA--C 1.537 1.415 0 CA-C-N 114.569 -1.196 . . . . 0.0 114.267 -177.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.489 ' CD1' ' N ' ' A' ' 99' ' ' LEU . 8.5 mp -70.76 -13.26 61.99 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 118.586 1.193 . . . . 0.0 112.776 -177.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.486 ' O ' ' CG ' ' A' ' 104' ' ' LYS . 91.8 t80 -81.53 -51.19 8.52 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.234 178.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 1.159 ' OD2' ' NE2' ' A' ' 105' ' ' GLN . 18.4 t70 -69.4 -31.55 69.99 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 113.332 -1.758 . . . . 0.0 111.512 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 98' ' ' GLY . 51.2 m -68.17 -52.48 34.13 Favored 'General case' 0 CA--C 1.556 1.185 0 CA-C-N 111.138 -2.755 . . . . 0.0 115.918 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.505 ' O ' ' CD2' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -74.66 -26.26 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-N 122.015 2.189 . . . . 0.0 111.505 177.547 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.486 ' CG ' ' O ' ' A' ' 100' ' ' TYR . 16.7 mmtt -68.8 -42.17 77.67 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 111.875 -2.42 . . . . 0.0 112.334 -179.11 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 1.159 ' NE2' ' OD2' ' A' ' 101' ' ' ASP . 88.1 mt-30 -76.74 -15.95 59.62 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 122.677 1.227 . . . . 0.0 111.056 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -79.44 -23.43 43.15 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 114.105 -1.407 . . . . 0.0 112.202 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.505 ' CD2' ' O ' ' A' ' 103' ' ' VAL . 45.2 m-85 -110.22 -30.27 7.8 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 119.871 1.214 . . . . 0.0 113.278 -175.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.0 t -97.77 9.35 42.84 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 117.257 -1.777 . . . . 0.0 112.844 -178.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.518 ' O ' ' C ' ' A' ' 110' ' ' GLY . 0.0 OUTLIER -52.13 124.2 12.43 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 117.827 -1.082 . . . . 0.0 110.497 179.054 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.549 ' O ' ' CB ' ' A' ' 111' ' ' SER . . . -21.04 -83.33 0.01 OUTLIER Glycine 0 N--CA 1.491 2.352 0 CA-C-N 119.79 1.177 . . . . 0.0 111.699 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.549 ' CB ' ' O ' ' A' ' 110' ' ' GLY . 7.2 t 106.35 -162.28 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 115.424 1.638 . . . . 0.0 115.424 176.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.542 ' O ' ' CG ' ' A' ' 113' ' ' HIS . 33.4 tp10 -108.97 -46.12 3.66 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -176.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.542 ' CG ' ' O ' ' A' ' 112' ' ' GLU . 0.3 OUTLIER 150.44 51.07 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -179.611 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.451 ' CB ' ' O ' ' A' ' 113' ' ' HIS . . . 159.57 -161.36 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 179.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.15 14.79 27.62 Favored Glycine 0 C--O 1.227 -0.314 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.733 177.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 59.9 mt -60.47 -40.56 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.54 -39.97 95.86 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 175.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 34.6 t -58.78 -42.89 90.07 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 176.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.514 HH22 ' CD ' ' A' ' 109' ' ' LYS . 2.4 mpt_? -63.75 -37.3 86.86 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.249 -178.009 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 62.5 tp -63.49 -46.27 86.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.587 0.708 . . . . 0.0 109.145 178.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 59.8 mt -66.83 -44.7 80.43 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.342 178.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.96 -44.94 91.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 119.433 1.015 . . . . 0.0 109.434 177.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -66.15 -44.26 91.51 Favored Glycine 0 CA--C 1.517 0.172 0 C-N-CA 119.806 -1.187 . . . . 0.0 111.244 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 14.6 t -64.05 -44.0 93.8 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.875 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 21.7 p -69.53 -48.53 60.14 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 119.22 -0.992 . . . . 0.0 112.054 177.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 25.3 m -65.53 -42.72 91.66 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -174.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -64.19 -44.38 95.73 Favored Glycine 0 N--CA 1.461 0.365 0 CA-C-O 122.945 1.303 . . . . 0.0 112.975 -177.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.413 ' O ' ' CG1' ' A' ' 131' ' ' VAL . . . -60.8 -40.93 94.48 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 111.763 -2.219 . . . . 0.0 106.627 177.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -64.24 -42.23 96.61 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.538 178.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.19 -39.92 96.02 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -177.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.427 ' O ' ' O ' ' A' ' 134' ' ' ALA . 2.4 p -60.88 -24.74 33.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 122.383 1.087 . . . . 0.0 109.366 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -57.32 -44.49 84.25 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 113.096 -1.866 . . . . 0.0 111.685 -178.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.492 ' CG1' ' N ' ' A' ' 134' ' ' ALA . 2.6 p -78.91 -48.68 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.785 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.492 ' N ' ' CG1' ' A' ' 133' ' ' VAL . . . -86.52 126.07 34.2 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.527 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.439 ' N ' ' HD2' ' A' ' 136' ' ' PRO . 12.0 tp-100 -171.29 -53.25 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.686 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 135' ' ' GLN . 10.9 Cg_endo -51.67 -32.9 46.95 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 121.706 1.604 . . . . 0.0 111.852 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.408 ' CG2' ' NZ ' ' A' ' 141' ' ' LYS . 12.2 m -67.46 -42.44 83.04 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 117.759 -1.576 . . . . 0.0 109.736 -179.067 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -66.89 -43.57 83.11 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -178.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.2 m -64.73 -44.22 96.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -178.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 31.6 m -65.16 -39.03 84.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -177.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.408 ' NZ ' ' CG2' ' A' ' 137' ' ' THR . 33.0 mttp -62.53 -42.15 99.33 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 119.38 -0.928 . . . . 0.0 111.98 -177.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 14.4 m -70.42 -45.41 75.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 120.104 -0.638 . . . . 0.0 110.036 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.02 -36.84 85.68 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.624 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -66.91 -42.02 86.14 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -177.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 24.6 mm100 -65.67 -40.03 91.97 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 118.987 -1.085 . . . . 0.0 110.093 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.32 -34.98 79.61 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -178.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.507 ' NE2' ' O ' ' A' ' 147' ' ' GLN . 2.0 pp0? -59.89 111.1 1.34 Allowed 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 177.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -98.62 -60.88 1.46 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 117.6 -1.191 . . . . 0.0 113.919 -175.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 96.6 mtt-85 -90.67 130.42 36.68 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 122.476 2.398 . . . . 0.0 110.357 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -65.21 -14.21 60.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.436 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 72.41 23.95 77.09 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.691 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 -179.878 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.428 ' CD2' ' O ' ' A' ' 157' ' ' GLN . 49.8 t80 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.888 0.375 . . . . 0.0 110.627 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.428 ' O ' ' CD2' ' A' ' 156' ' ' TYR . 26.4 mt-30 -84.3 172.37 11.87 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.954 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.623 ' H ' ' CG ' ' A' ' 161' ' ' GLU . 37.0 m -157.05 -178.52 7.43 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.253 0.549 . . . . 0.0 111.054 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 9.4 p -64.88 -46.55 81.33 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 120.149 -0.62 . . . . 0.0 112.39 -178.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 8.3 p -64.72 -45.92 93.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 119.305 -0.958 . . . . 0.0 110.777 -178.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.623 ' CG ' ' H ' ' A' ' 158' ' ' SER . 1.5 pp20? -67.55 -38.74 84.58 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.219 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.527 ' N ' ' OE2' ' A' ' 161' ' ' GLU . . . -61.36 -45.65 93.51 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -178.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.4 ' CD1' ' C ' ' A' ' 163' ' ' TYR . 21.4 t80 -62.5 -50.19 72.36 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.286 -179.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 4.7 mtpm? -69.15 -45.48 69.96 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 -176.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.439 ' CG2' ' N ' ' A' ' 166' ' ' ILE . 14.4 t -62.69 -44.64 95.72 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -176.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.439 ' N ' ' CG2' ' A' ' 165' ' ' THR . 20.9 tt -64.65 -38.36 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-O 121.997 0.904 . . . . 0.0 109.559 176.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.73 -36.54 76.78 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 113.834 -1.53 . . . . 0.0 107.821 176.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 13.1 tpp85 -62.26 -50.25 72.47 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 122.393 2.36 . . . . 0.0 111.89 -175.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -74.9 -51.06 14.82 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 123.486 0.715 . . . . 0.0 109.392 177.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -78.1 -36.42 48.06 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 -173.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 91.52 -166.91 30.75 Favored Glycine 0 N--CA 1.468 0.767 0 O-C-N 121.704 -0.622 . . . . 0.0 112.088 177.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 2.5 pp -72.97 -43.67 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-O 121.908 0.861 . . . . 0.0 110.469 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 24.9 tpt85 -58.89 -33.86 70.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.199 -1.364 . . . . 0.0 111.0 -177.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -60.9 -40.64 98.61 Favored Glycine 0 CA--C 1.522 0.511 0 C-N-CA 118.619 -1.753 . . . . 0.0 109.646 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 17.8 tp -70.34 -33.77 71.88 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 111.319 -2.44 . . . . 0.0 116.803 -177.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 7.3 m0 -78.01 -7.44 56.88 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 111.845 -2.434 . . . . 0.0 109.783 -177.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -43.39 -47.99 6.99 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.529 -0.759 . . . . 0.0 112.521 -176.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -91.51 -34.31 7.5 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 123.978 0.799 . . . . 0.0 111.81 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 44.7 p -45.19 -51.21 10.85 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 1.6 t -62.44 -50.8 77.33 Favored Pre-proline 0 N--CA 1.47 0.562 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -176.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -64.96 -28.32 57.99 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.402 1.402 . . . . 0.0 111.377 176.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -63.95 -39.13 93.43 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 56.4 t -63.01 -43.15 98.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.219 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.75 -40.01 95.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.762 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 9.1 tmm_? -61.31 -42.39 98.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.422 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -61.81 -43.69 98.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.081 0.467 . . . . 0.0 110.53 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.62 -43.84 92.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.952 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 79.4 mt -63.35 -45.35 98.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.856 -178.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 84.7 t -60.09 -47.4 92.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 119.465 -0.894 . . . . 0.0 111.033 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -62.91 -42.99 99.98 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 122.311 1.053 . . . . 0.0 110.194 178.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' CYS . . . . . . . . . . . . . 37.5 t -61.86 -45.63 92.93 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 113.422 -1.717 . . . . 0.0 109.685 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -63.91 -39.57 94.48 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 113.193 -1.822 . . . . 0.0 109.94 176.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.5 -44.95 92.97 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.557 0.743 . . . . 0.0 111.522 -176.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 37.6 tp -64.87 -38.23 90.28 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.971 -176.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 92.1 t -64.47 -47.43 89.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 117.893 -1.523 . . . . 0.0 110.508 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 3.1 t -64.55 -44.24 91.41 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.057 0.943 . . . . 0.0 113.172 -177.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -54.75 -38.28 66.99 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.821 0.848 . . . . 0.0 111.372 -176.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -56.42 -44.09 80.04 Favored 'General case' 0 C--N 1.313 -0.997 0 O-C-N 121.739 -0.6 . . . . 0.0 110.451 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.557 ' H ' ' CD2' ' A' ' 199' ' ' LEU . 2.8 mm? -61.71 -41.09 97.15 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -177.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 6.3 pt -64.23 -40.61 89.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.68 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -57.66 -38.54 75.27 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.461 1.904 . . . . 0.0 113.846 -178.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -65.43 -38.9 91.28 Favored 'General case' 0 C--O 1.245 0.861 0 C-N-CA 117.932 -1.507 . . . . 0.0 111.105 -177.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 55.1 m -102.61 128.9 49.09 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 122.369 1.081 . . . . 0.0 112.736 -178.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 1.2 mt 67.27 2.65 2.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 112.945 -1.934 . . . . 0.0 112.048 178.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.79 24.03 11.31 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.817 ' O ' ' N ' ' A' ' 208' ' ' ASN . 57.4 pttt -96.78 173.38 7.34 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 178.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . 48.91 -67.15 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 O-C-N 126.116 2.135 . . . . 0.0 110.658 -178.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' ASN . . . . . 0.817 ' N ' ' O ' ' A' ' 206' ' ' LYS . 9.6 p-10 164.92 109.71 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 111.976 -2.374 . . . . 0.0 106.229 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.483 ' CG ' ' O ' ' A' ' 209' ' ' LEU . 13.4 tp . . . . . 0 N--CA 1.489 1.497 0 CA-C-N 108.846 -3.797 . . . . 0.0 112.564 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.785 0.326 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.455 ' N ' ' HD2' ' A' ' 215' ' ' PRO . 12.4 mt -61.28 -44.48 93.36 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.455 ' HD2' ' N ' ' A' ' 214' ' ' LEU . 23.0 Cg_endo -61.43 -33.31 88.65 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 CA-C-N 120.944 1.373 . . . . 0.0 111.052 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 85.8 m -64.6 -42.47 95.54 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 113.487 -1.688 . . . . 0.0 111.969 -178.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' HIS . . . . . 0.628 ' NE2' ' CD2' ' A' ' 218' ' ' PHE . 1.8 p-80 -66.78 -37.9 85.49 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' PHE . . . . . 0.628 ' CD2' ' NE2' ' A' ' 217' ' ' HIS . 1.4 m-85 -63.14 -47.29 83.37 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.322 -178.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 89.7 m -60.13 -37.8 81.16 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 118.73 0.696 . . . . 0.0 110.925 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 67.9 m -59.35 -41.42 89.17 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . 0.569 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.62 -41.4 98.29 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -177.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -61.43 -46.8 88.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 122.077 0.942 . . . . 0.0 112.786 -176.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -60.1 -41.66 98.17 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 107.164 -2.374 . . . . 0.0 107.164 177.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -62.77 -37.78 87.99 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 176.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -61.82 -42.38 99.74 Favored Glycine 0 CA--C 1.523 0.584 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.843 -178.225 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' PHE . . . . . 0.432 ' O ' ' OG1' ' A' ' 229' ' ' THR . 55.5 t80 -66.39 -38.3 87.2 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 15.7 t -62.84 -40.7 98.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.532 0.682 . . . . 0.0 109.248 176.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -61.43 -40.09 93.19 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.589 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' A' ' 226' ' ' PHE . 19.7 p -59.36 -39.63 83.88 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.85 -177.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 92.6 t -60.82 -42.61 93.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 119.006 -1.078 . . . . 0.0 111.969 -178.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 3.8 tp -62.4 -40.22 87.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 176.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -62.1 -39.77 93.63 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.483 ' N ' ' HD2' ' A' ' 234' ' ' PRO . 66.2 m -58.71 -42.81 96.27 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 115.768 1.766 . . . . 0.0 115.768 -175.017 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 233' ' ' SER . 21.0 Cg_endo -59.89 -40.72 60.24 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 CA-C-N 121.051 1.411 . . . . 0.0 113.9 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 11.1 m -65.14 -36.5 77.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.008 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -64.96 -41.24 95.64 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -178.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 5.7 m -65.64 -45.58 91.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -177.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 57.3 t . . . . . 0 C--N 1.33 -0.243 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -177.116 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 24.8 p . . . . . 0 CA--C 1.532 0.27 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' MET . . . . . 0.601 ' SD ' ' N ' ' A' ' 261' ' ' LEU . 0.0 OUTLIER -61.8 -44.37 97.0 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.214 -0.594 . . . . 0.0 112.47 -177.273 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.601 ' N ' ' SD ' ' A' ' 260' ' ' MET . 12.5 tp -62.62 -46.67 87.2 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.607 0.242 . . . . 0.0 110.444 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 52.5 ttp180 -66.14 -53.76 33.71 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.805 -178.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . 0.581 ' CB ' ' HZ3' ' A' ' 263' ' ' LYS . 0.0 OUTLIER -123.33 160.95 25.64 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 120.938 0.399 . . . . 0.0 111.044 179.272 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . 0.464 ' O ' ' O ' ' A' ' 265' ' ' GLY . 72.6 mt-10 57.83 88.71 0.06 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.278 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 264' ' ' GLU . . . -38.04 166.07 0.01 OUTLIER Glycine 0 CA--C 1.531 1.058 0 N-CA-C 111.669 -0.572 . . . . 0.0 111.669 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -63.4 -5.07 7.63 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 122.817 2.344 . . . . 0.0 111.596 179.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 18.3 ptp180 -69.63 -26.58 64.49 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 123.086 0.554 . . . . 0.0 111.685 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -58.52 -32.49 68.88 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.895 -179.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -62.53 -41.87 99.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.237 0.541 . . . . 0.0 110.753 177.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -65.93 -37.77 86.92 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.84 -178.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp -77.99 -175.16 3.91 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 44.45 84.85 0.01 OUTLIER Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.371 -1.091 . . . . 0.0 110.371 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -152.78 6.79 0.4 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.558 0.218 . . . . 0.0 110.769 -179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 274' ' ' MET . . . . . 0.587 ' N ' ' CD ' ' A' ' 275' ' ' PRO . 1.9 tpt -63.66 -43.92 78.86 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 275' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 274' ' ' MET . 23.0 Cg_exo -64.12 -46.72 7.54 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.343 2.029 . . . . 0.0 111.205 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 37.4 t -61.0 -40.67 94.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.23 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -62.41 -43.44 98.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 122.88 1.324 . . . . 0.0 113.163 -178.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 8.0 tt -62.01 -38.57 89.14 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 111.897 -2.411 . . . . 0.0 107.072 174.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.69 -40.32 96.75 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.843 178.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 8.2 tp -62.32 -37.24 84.82 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -178.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -67.95 -50.6 39.75 Favored Glycine 0 CA--C 1.52 0.399 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 -178.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.14 -44.38 96.76 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 283' ' ' TRP . . . . . . . . . . . . . 57.1 t-105 -60.26 -38.67 84.2 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -63.18 -38.5 91.44 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.725 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 54.8 t -61.11 -39.24 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 -178.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 6.9 m -62.6 -39.99 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 119.848 -0.741 . . . . 0.0 110.574 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 287' ' ' MET . . . . . 0.456 ' C ' ' SD ' ' A' ' 287' ' ' MET . 0.0 OUTLIER -60.94 -38.87 87.35 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 122.128 -0.357 . . . . 0.0 110.503 179.758 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -59.32 -41.61 89.51 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -178.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 7.4 p -61.52 -37.72 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.027 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.416 ' OG1' ' O ' ' A' ' 287' ' ' MET . 51.2 p -61.67 -39.43 91.37 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 177.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -60.37 -38.49 84.05 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 177.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.99 -39.93 79.45 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 117.948 -1.501 . . . . 0.0 109.488 -176.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 293' ' ' GLN . . . . . 0.45 ' O ' ' O ' ' A' ' 296' ' ' ARG . 80.3 mt-30 -60.37 -42.47 95.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 122.678 1.228 . . . . 0.0 110.641 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 8.9 mp -60.43 -40.26 90.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 112.632 -2.076 . . . . 0.0 109.003 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 17.9 tptp -63.02 -45.84 90.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.266 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 296' ' ' ARG . . . . . 0.45 ' O ' ' O ' ' A' ' 293' ' ' GLN . 64.0 ttm-85 -123.06 116.37 23.38 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.264 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -116.82 -93.2 0.51 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.125 0.488 . . . . 0.0 111.318 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.54 ' CD1' ' N ' ' A' ' 298' ' ' LEU . 0.0 OUTLIER -137.39 -170.89 2.84 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.394 178.4 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 299' ' ' MET . . . . . 0.506 ' N ' ' CD2' ' A' ' 298' ' ' LEU . 34.8 ttm -169.32 65.91 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.625 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.68 101.04 0.07 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.928 0.871 . . . . 0.0 110.583 -178.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -64.0 -46.26 85.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 113.822 -1.536 . . . . 0.0 113.331 -176.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -58.65 -39.89 81.89 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.119 -0.633 . . . . 0.0 109.791 -178.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 6.6 tm0? -65.01 -47.0 79.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.487 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 304' ' ' SER . . . . . 0.429 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 50.0 m -66.71 -37.83 85.51 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.509 -0.477 . . . . 0.0 110.581 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -61.7 -43.22 99.28 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -65.04 -36.97 86.08 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -176.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -60.02 -52.94 69.89 Favored Pre-proline 0 CA--C 1.545 0.76 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 -176.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 308' ' ' PRO . . . . . 0.429 ' CD ' ' O ' ' A' ' 304' ' ' SER . 74.0 Cg_endo -75.23 0.21 9.27 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.053 1.835 . . . . 0.0 111.793 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 52.4 t80 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.499 -179.996 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.9 m . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.768 0.318 . . . . 0.0 110.496 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.4 t -137.97 150.08 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.495 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.1 mmmm -64.41 -41.87 96.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.905 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -63.61 -41.34 98.31 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.4 tt -79.59 -26.23 41.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.443 -178.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.452 ' O ' ' OG1' ' A' ' 22' ' ' THR . . . -66.18 -41.42 94.88 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 107.761 -2.135 . . . . 0.0 107.761 177.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.6 -32.25 67.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 124.889 2.281 . . . . 0.0 107.657 176.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.29 -42.26 99.3 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-N 108.448 -3.978 . . . . 0.0 108.165 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' A' ' 19' ' ' GLY . 32.6 p -70.62 -27.32 63.99 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 177.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.51 -50.04 64.55 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.775 -1.102 . . . . 0.0 112.194 -179.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.97 -35.89 79.83 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 118.482 -1.287 . . . . 0.0 111.204 -177.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.0 t -63.78 -53.39 51.64 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.847 -178.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 71.2 mt -65.43 -39.74 86.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 -177.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.441 ' O ' ' OG1' ' A' ' 31' ' ' THR . . . -64.57 -42.19 95.81 Favored 'General case' 0 C--N 1.333 -0.109 0 C-N-CA 119.84 -0.744 . . . . 0.0 112.946 -174.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.459 ' CB ' ' OE1' ' A' ' 89' ' ' GLN . 16.7 m-20 -78.24 -27.49 47.66 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 117.964 -1.495 . . . . 0.0 109.084 -177.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.5 tp -59.98 -56.05 26.46 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 118.546 -1.262 . . . . 0.0 111.113 -178.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.2 pp -75.73 -5.24 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' A' ' 27' ' ' ALA . 19.1 m -110.17 -17.96 13.42 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 118.811 -1.155 . . . . 0.0 109.941 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.478 ' N ' ' HD2' ' A' ' 33' ' ' PRO . 72.7 t80 -68.27 -45.22 38.55 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 121.308 1.867 . . . . 0.0 112.235 -177.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 32' ' ' PHE . 20.8 Cg_endo -59.42 -14.73 26.49 Favored 'Trans proline' 0 N--CA 1.5 1.872 0 CA-C-N 121.147 1.445 . . . . 0.0 111.147 176.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.31 -35.41 80.3 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 114.686 -1.143 . . . . 0.0 113.086 -177.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -64.69 -40.55 95.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.278 -178.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 52.1 p -58.39 -34.9 71.23 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.3 -38.27 84.73 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.72 -0.792 . . . . 0.0 112.534 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.446 ' CG ' ' N ' ' A' ' 39' ' ' VAL . 10.7 pttp -62.01 -48.93 78.12 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 119.576 -0.85 . . . . 0.0 111.69 -176.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.446 ' N ' ' CG ' ' A' ' 38' ' ' LYS . 8.8 p -64.8 -39.89 87.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -177.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.526 ' C ' ' H ' ' A' ' 42' ' ' GLN . 6.4 tpm_? -61.04 -42.86 99.28 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -177.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.423 ' CD1' ' O ' ' A' ' 38' ' ' LYS . 2.4 pp -63.15 38.73 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.799 178.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.526 ' H ' ' C ' ' A' ' 40' ' ' ARG . 42.7 tt0 -145.25 165.68 27.69 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.901 0.382 . . . . 0.0 111.273 -178.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.495 ' CD1' ' H ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -73.57 79.17 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.62 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -44.89 135.99 4.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.857 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.99 135.88 0.24 Allowed Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.502 ' O ' ' N ' ' A' ' 48' ' ' GLN . 11.1 pt-20 -94.16 150.51 20.25 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.71 0.291 . . . . 0.0 110.564 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 49.9 m 57.45 -80.55 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.571 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.502 ' N ' ' O ' ' A' ' 46' ' ' GLU . 63.7 mt-30 55.0 178.54 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.212 0.53 . . . . 0.0 111.049 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -153.3 -22.66 0.05 OUTLIER Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.523 ' CD2' ' N ' ' A' ' 50' ' ' LEU . 3.5 mm? -66.63 -38.5 87.05 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 20.5 m -61.15 -44.28 98.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.992 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 33.4 mtm-85 -64.31 -33.64 76.3 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.357 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 19.1 m -67.6 -38.32 83.81 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.471 ' O ' ' CB ' ' A' ' 55' ' ' ALA . . . -95.44 -122.1 0.11 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.195 178.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.471 ' CB ' ' O ' ' A' ' 54' ' ' ALA . . . 162.87 -22.71 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 121.191 -0.203 . . . . 0.0 110.842 179.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.52 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 4.6 m -128.53 -138.31 0.24 Allowed 'General case' 0 C--N 1.334 -0.107 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.52 ' CB ' ' O ' ' A' ' 56' ' ' SER . . . 93.59 14.99 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 O-C-N 123.883 0.74 . . . . 0.0 111.937 178.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.521 HE22 HH22 ' A' ' 40' ' ' ARG . 27.7 mt-30 -152.92 55.99 0.78 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -41.91 132.8 3.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.187 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 63.3 mtm-85 -41.02 -42.92 2.03 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.34 0.59 . . . . 0.0 109.921 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -31.95 104.22 0.01 OUTLIER Glycine 0 CA--C 1.527 0.834 0 CA-C-N 114.853 -1.067 . . . . 0.0 112.476 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 26.2 m -67.11 -33.58 64.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 118.262 -0.875 . . . . 0.0 109.046 176.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -60.0 -32.32 70.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 121.061 1.755 . . . . 0.0 109.785 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -65.1 -49.59 61.45 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-N 115.393 -0.821 . . . . 0.0 114.534 -177.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.3 m -62.57 -46.88 86.3 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -178.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.8 pp -60.27 -35.18 60.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.35 -35.56 80.81 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 120.853 1.66 . . . . 0.0 110.948 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.469 ' O ' ' OG1' ' A' ' 72' ' ' THR . 98.8 m -61.77 -39.19 90.78 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 113.168 -1.833 . . . . 0.0 111.034 -176.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 15.5 tpt -60.51 -39.47 87.91 Favored 'General case' 0 C--N 1.332 -0.179 0 O-C-N 121.135 -0.978 . . . . 0.0 113.531 -177.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.5 t -68.98 -40.42 80.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 119.192 -1.003 . . . . 0.0 112.652 -177.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 56.9 ttt-85 -77.63 -13.39 59.92 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.94 0.876 . . . . 0.0 112.736 -178.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.469 ' OG1' ' O ' ' A' ' 68' ' ' THR . 49.3 m -62.87 -55.12 28.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.17 -1.377 . . . . 0.0 112.338 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -108.74 -58.78 1.97 Allowed 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 159.37 163.81 13.78 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -56.51 -34.89 96.08 Favored 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 122.229 1.953 . . . . 0.0 111.605 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 12.3 tpp180 -61.16 -11.22 8.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.908 0.861 . . . . 0.0 111.056 176.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.5 t -77.36 -32.1 54.79 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 113.953 -1.476 . . . . 0.0 110.994 -177.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 19.3 mt -75.61 -33.66 60.54 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.286 -0.566 . . . . 0.0 111.156 179.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.472 ' C ' ' H ' ' A' ' 81' ' ' GLY . 61.6 m-85 -92.81 -5.33 51.32 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 122.305 1.05 . . . . 0.0 113.386 -178.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.433 ' CG ' ' O ' ' A' ' 80' ' ' ASN . 21.5 t30 -86.25 33.9 0.62 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 112.957 -1.929 . . . . 0.0 107.393 175.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.472 ' H ' ' C ' ' A' ' 79' ' ' TYR . . . -172.9 -9.78 0.02 OUTLIER Glycine 0 CA--C 1.526 0.747 0 CA-C-N 114.485 -1.234 . . . . 0.0 112.535 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 61.2 tp -59.48 -35.07 73.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.469 -0.866 . . . . 0.0 110.963 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.2 m -70.74 -26.84 28.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.799 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.63 -31.45 61.99 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.793 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.8 -40.18 89.73 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 119.893 -1.146 . . . . 0.0 111.751 -177.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -62.63 -40.28 96.5 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 122.16 0.981 . . . . 0.0 113.094 -176.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 20.2 tm0? -60.39 -27.44 67.44 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 113.349 -1.751 . . . . 0.0 109.456 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 72.7 mtt-85 -58.07 -53.46 57.96 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 173.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.459 ' OE1' ' CB ' ' A' ' 28' ' ' ASP . 23.6 mm100 -67.15 -29.97 69.83 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 112.08 -2.327 . . . . 0.0 112.373 -177.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 10.4 tpp -61.2 -40.46 94.04 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.078 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 68.3 m -74.64 -34.16 62.69 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 118.346 -0.835 . . . . 0.0 111.339 -176.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -57.58 -44.11 85.1 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 120.701 1.591 . . . . 0.0 112.044 -176.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.48 -33.0 64.61 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.466 -0.893 . . . . 0.0 111.025 -178.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 59.6 p -64.03 -41.87 97.28 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.449 ' C ' ' H ' ' A' ' 97' ' ' ILE . 34.3 m -68.18 -27.81 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.988 177.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 47.6 ttp85 -77.21 8.54 3.9 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -176.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.449 ' H ' ' C ' ' A' ' 95' ' ' VAL . 46.3 mm -87.71 -15.08 9.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 177.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.423 ' O ' ' OG ' ' A' ' 102' ' ' SER . . . -140.25 -48.3 0.05 OUTLIER Glycine 0 CA--C 1.538 1.53 0 N-CA-C 115.902 1.121 . . . . 0.0 115.902 -175.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.0 tp -71.1 -13.23 61.89 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 119.249 1.524 . . . . 0.0 112.244 -177.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.521 ' O ' ' CG ' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -80.86 -51.28 8.76 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 114.688 -1.142 . . . . 0.0 111.834 179.71 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.468 ' O ' ' HG3' ' A' ' 105' ' ' GLN . 2.4 p30 -69.23 -32.48 71.75 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 123.768 1.747 . . . . 0.0 110.47 -178.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 98' ' ' GLY . 25.8 m -68.17 -51.79 41.83 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 110.234 -3.167 . . . . 0.0 113.327 177.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 47.0 t -73.63 -26.28 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 CA-C-N 121.405 1.911 . . . . 0.0 111.257 178.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.521 ' CG ' ' O ' ' A' ' 100' ' ' TYR . 20.7 mmtp -69.32 -41.61 76.48 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 112.523 -2.126 . . . . 0.0 111.582 179.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.468 ' HG3' ' O ' ' A' ' 101' ' ' ASP . 88.1 mt-30 -80.1 -15.66 56.66 Favored 'General case' 0 C--O 1.245 0.847 0 CA-C-O 122.065 0.936 . . . . 0.0 110.998 -178.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -80.48 -22.29 41.17 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 121.741 -0.6 . . . . 0.0 112.109 179.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.414 ' O ' ' NE ' ' A' ' 119' ' ' ARG . 13.8 m-85 -109.07 -28.62 8.97 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.692 0.797 . . . . 0.0 111.794 -174.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.2 m -96.12 9.49 40.73 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 116.752 -1.979 . . . . 0.0 113.639 -176.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -46.46 124.7 6.1 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.997 1.271 . . . . 0.0 109.49 176.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -131.55 40.91 1.57 Allowed Glycine 0 N--CA 1.479 1.549 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 178.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 14.8 m -67.5 -37.63 83.12 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 -176.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -125.43 162.41 24.91 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 120.759 0.314 . . . . 0.0 111.084 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.447 ' O ' ' CB ' ' A' ' 114' ' ' ALA . 6.7 p-80 -77.03 67.33 3.0 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -178.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.447 ' CB ' ' O ' ' A' ' 113' ' ' HIS . . . 159.06 -163.06 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 176.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 101.57 15.33 27.5 Favored Glycine 0 C--N 1.343 0.949 0 CA-C-N 113.873 -1.512 . . . . 0.0 113.238 175.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.41 HG23 HD12 ' A' ' 116' ' ' ILE . 25.4 mm -61.1 -40.99 87.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 CA-C-N 118.416 1.108 . . . . 0.0 110.31 -179.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.33 -39.96 96.22 Favored Glycine 0 C--N 1.346 1.095 0 CA-C-O 122.237 0.909 . . . . 0.0 111.361 176.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.1 t -57.48 -41.72 81.23 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 177.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.414 ' NE ' ' O ' ' A' ' 107' ' ' TYR . 26.9 ttm180 -63.18 -37.54 87.61 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.474 -0.491 . . . . 0.0 111.249 -177.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -64.32 -46.28 84.23 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 177.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 31.5 mt -66.64 -45.1 80.09 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 118.978 -1.089 . . . . 0.0 110.145 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.97 -45.18 90.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 119.813 1.188 . . . . 0.0 110.315 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.413 ' CA ' ' CZ ' ' A' ' 107' ' ' TYR . . . -65.79 -44.28 92.48 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.766 -178.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 59.0 m -63.83 -43.66 95.52 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 19.1 m -69.06 -48.01 63.86 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 119.526 -0.87 . . . . 0.0 112.416 177.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.42 ' CG2' ' N ' ' A' ' 127' ' ' GLY . 5.7 t -65.47 -42.51 92.2 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 -173.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.542 ' C ' HD22 ' A' ' 186' ' ' ASN . . . -64.46 -44.73 94.84 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-O 122.543 1.08 . . . . 0.0 113.736 -177.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.03 -40.8 94.98 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 112.689 -1.756 . . . . 0.0 107.204 178.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.84 -41.22 99.26 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 114.86 -1.063 . . . . 0.0 109.576 178.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -61.82 -38.44 88.17 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.74 -0.209 . . . . 0.0 111.38 -178.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 79.1 t -60.63 -25.91 36.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.742 0.782 . . . . 0.0 109.836 179.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -57.9 -44.41 86.73 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.236 -1.347 . . . . 0.0 111.215 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 43.1 t -78.73 -49.15 20.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.563 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -99.89 124.52 45.29 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 110.248 -0.278 . . . . 0.0 110.248 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.439 ' N ' ' HD2' ' A' ' 136' ' ' PRO . 33.2 tt0 -176.62 -54.49 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 135' ' ' GLN . 11.2 Cg_endo -52.3 -34.81 61.67 Favored 'Trans proline' 0 N--CA 1.5 1.885 0 C-N-CA 121.389 1.393 . . . . 0.0 113.902 -177.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 81.0 p -67.54 -41.77 83.77 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 118.491 -1.284 . . . . 0.0 109.369 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -64.58 -42.43 95.63 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 118.977 -1.089 . . . . 0.0 112.746 -176.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 17.2 m -63.81 -43.35 97.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 54.3 t -64.53 -38.47 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -178.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -61.47 -40.33 94.14 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 119.978 -0.689 . . . . 0.0 112.106 -176.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.3 p -69.39 -44.42 80.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.529 ' NH2' ' OE1' ' A' ' 170' ' ' GLU . 12.4 tpt85 -63.98 -35.83 81.99 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.951 179.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.488 ' CD2' ' OE1' ' A' ' 147' ' ' GLN . 40.9 t80 -65.96 -40.22 91.09 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.975 -177.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -63.72 -38.91 92.88 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.358 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -64.86 -34.76 79.15 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -178.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.488 ' OE1' ' CD2' ' A' ' 144' ' ' PHE . 5.0 pt20 -59.48 111.1 1.27 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 178.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -97.55 -61.61 1.37 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 117.523 -1.227 . . . . 0.0 113.951 -176.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 14.1 mtp-105 -101.4 135.52 42.75 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 122.273 2.306 . . . . 0.0 109.903 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -75.35 -113.37 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.519 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 175.19 131.47 1.44 Allowed Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.638 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 179.96 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.501 ' CD2' ' O ' ' A' ' 157' ' ' GLN . 91.8 t80 . . . . . 0 N--CA 1.466 0.356 0 CA-C-O 120.72 0.295 . . . . 0.0 110.368 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.501 ' O ' ' CD2' ' A' ' 156' ' ' TYR . 24.0 mt-30 -49.51 170.46 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.552 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 45.2 p -156.94 -178.25 7.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.954 0.407 . . . . 0.0 110.789 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.408 ' CG2' ' N ' ' A' ' 160' ' ' VAL . 11.7 t -64.5 -46.36 83.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.792 -177.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.461 ' CG1' ' N ' ' A' ' 161' ' ' GLU . 12.7 p -64.63 -45.52 95.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 118.898 -1.121 . . . . 0.0 109.077 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.461 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 74.6 tt0 -66.99 -38.95 86.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.996 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -61.41 -45.78 92.91 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -177.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -62.85 -50.42 71.02 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.923 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -68.77 -45.42 71.4 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 115.162 1.541 . . . . 0.0 115.162 -175.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 10.0 m -63.24 -44.44 95.19 Favored 'General case' 0 C--N 1.321 -0.658 0 O-C-N 121.137 -0.977 . . . . 0.0 113.25 -178.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -64.64 -38.72 83.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 122.199 0.999 . . . . 0.0 109.156 177.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.94 -36.64 77.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 113.201 -1.818 . . . . 0.0 109.137 177.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -62.62 -51.0 69.02 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 122.5 2.409 . . . . 0.0 112.713 -174.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -75.38 -51.07 14.01 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 177.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.529 ' OE1' ' NH2' ' A' ' 143' ' ' ARG . 16.3 tt0 -78.67 -36.42 43.79 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -175.016 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 95.62 -169.03 26.95 Favored Glycine 0 N--CA 1.467 0.764 0 CA-C-N 118.13 0.423 . . . . 0.0 112.57 177.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.408 HD11 HG22 ' A' ' 172' ' ' ILE . 6.0 pt -72.92 -40.71 60.11 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.129 0 CA-C-O 121.978 0.894 . . . . 0.0 110.396 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 9.1 tpp85 -58.68 -33.63 70.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 113.859 -1.519 . . . . 0.0 110.952 -177.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -60.91 -40.82 98.88 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 118.676 -1.726 . . . . 0.0 110.244 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 6.8 mt -70.84 -33.64 70.87 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 111.286 -2.457 . . . . 0.0 116.975 -177.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 11.1 m0 -78.35 -7.76 57.66 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 112.456 -2.156 . . . . 0.0 109.752 -176.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -43.47 -48.49 7.27 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.535 -0.466 . . . . 0.0 112.154 -175.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . 0.412 ' O ' ' HD2' ' A' ' 181' ' ' PRO . . . -79.11 -13.63 82.74 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 124.444 1.021 . . . . 0.0 111.933 178.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.422 ' O ' ' OD1' ' A' ' 182' ' ' ASN . 84.6 m -46.33 -51.44 14.71 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.86 -50.95 74.9 Favored Pre-proline 0 N--CA 1.475 0.789 0 N-CA-C 114.287 1.218 . . . . 0.0 114.287 -174.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.412 ' HD2' ' O ' ' A' ' 178' ' ' GLY . 29.1 Cg_exo -64.52 -29.96 61.58 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 CA-C-N 120.678 1.278 . . . . 0.0 113.279 177.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 179' ' ' THR . 0.0 OUTLIER -65.53 -40.85 93.42 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 119.366 -0.934 . . . . 0.0 109.896 178.876 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 54.9 t -64.35 -43.12 97.07 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.166 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.083 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.66 -39.79 95.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.178 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.616 HH21 ' CG1' ' A' ' 189' ' ' VAL . 0.7 OUTLIER -60.88 -43.55 98.31 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 119.789 -0.764 . . . . 0.0 110.885 -178.704 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . 0.542 HD22 ' C ' ' A' ' 127' ' ' GLY . 35.3 t30 -63.36 -45.43 91.22 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.744 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -66.59 -45.86 77.82 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.07 -46.25 91.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -177.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.616 ' CG1' HH21 ' A' ' 185' ' ' ARG . 35.6 m -60.86 -47.81 91.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 119.224 -0.99 . . . . 0.0 111.899 -177.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -62.43 -44.22 96.94 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.609 0.718 . . . . 0.0 110.047 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' CYS . . . . . . . . . . . . . 21.9 t -63.24 -47.61 81.75 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.031 178.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.8 -39.77 94.13 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 113.742 -1.572 . . . . 0.0 110.037 177.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 0.494 ' N ' ' O ' ' A' ' 189' ' ' VAL . 3.8 tm-20 -59.63 -45.75 91.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.252 -1.34 . . . . 0.0 111.803 -176.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.04 -37.64 88.26 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 118.544 -1.262 . . . . 0.0 111.229 -175.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 94.8 t -64.21 -47.34 90.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 117.172 -1.811 . . . . 0.0 109.414 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 3.0 t -65.48 -45.68 82.71 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 122.075 0.94 . . . . 0.0 112.743 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -57.99 -39.8 79.12 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 113.611 -1.631 . . . . 0.0 113.07 -178.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -56.41 -44.85 80.75 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 16.4 mt -62.12 -39.64 93.22 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.185 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 80.6 mt -63.6 -42.9 97.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-O 119.252 -0.404 . . . . 0.0 111.021 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . 0.496 ' O ' ' CD1' ' A' ' 205' ' ' LEU . 0.0 OUTLIER -59.63 -37.46 78.71 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.774 2.03 . . . . 0.0 112.272 177.19 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -58.98 -34.97 72.44 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 114.135 -1.393 . . . . 0.0 110.996 -175.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.2 t -98.78 130.67 45.24 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 121.745 0.784 . . . . 0.0 111.383 -177.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . 0.478 ' CD2' ' CE1' ' A' ' 217' ' ' HIS . 9.7 mp 70.02 6.96 6.01 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 113.417 -1.72 . . . . 0.0 115.61 -178.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.608 ' O ' ' CD2' ' A' ' 205' ' ' LEU . 0.0 OUTLIER -109.71 21.0 17.47 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 120.091 1.314 . . . . 0.0 112.954 179.345 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -60.44 -32.85 71.77 Favored 'General case' 0 C--N 1.332 -0.185 0 O-C-N 120.047 -1.658 . . . . 0.0 113.045 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.492 ' O ' ' CB ' ' A' ' 208' ' ' ASN . . . -165.86 32.83 0.05 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.003 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' ASN . . . . . 0.492 ' CB ' ' O ' ' A' ' 207' ' ' ALA . 0.3 OUTLIER 93.19 -126.44 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 O-C-N 123.882 0.739 . . . . 0.0 110.371 -179.574 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 6.6 tp . . . . . 0 C--N 1.33 -0.271 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.966 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . 0.514 ' O ' ' SG ' ' A' ' 216' ' ' CYS . 71.0 m-20 . . . . . 0 N--CA 1.462 0.13 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.468 ' N ' ' CD ' ' A' ' 215' ' ' PRO . 1.8 mt -61.21 -43.39 90.01 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.63 -0.713 . . . . 0.0 112.504 -178.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.468 ' CD ' ' N ' ' A' ' 214' ' ' LEU . 35.4 Cg_exo -60.29 -33.45 94.55 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 120.966 1.111 . . . . 0.0 111.715 -178.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' CYS . . . . . 0.514 ' SG ' ' O ' ' A' ' 213' ' ' ASP . 0.8 OUTLIER -64.69 -42.04 95.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 113.427 -1.715 . . . . 0.0 111.543 -178.164 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' HIS . . . . . 0.513 ' N ' ' SG ' ' A' ' 216' ' ' CYS . 11.6 t-160 -66.08 -37.13 85.03 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.575 -177.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -62.98 -47.94 80.99 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.051 -178.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 8.4 m -61.11 -38.81 87.66 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 120.211 1.369 . . . . 0.0 110.255 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' A' ' 217' ' ' HIS . 20.7 p -58.97 -40.94 86.28 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -62.71 -41.26 99.06 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -176.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -60.25 -46.59 89.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 122.66 1.219 . . . . 0.0 111.873 -176.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -60.9 -41.77 99.41 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-N 112.364 -2.198 . . . . 0.0 107.771 176.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . 0.524 ' O ' ' SG ' ' A' ' 227' ' ' CYS . . . -62.37 -37.3 85.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.067 -1.067 . . . . 0.0 108.555 177.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -60.97 -41.99 99.59 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 -177.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -66.77 -38.54 86.76 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 119.294 -0.962 . . . . 0.0 108.799 178.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . 0.524 ' SG ' ' O ' ' A' ' 224' ' ' ALA . 0.5 OUTLIER -63.38 -40.53 97.5 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.503 0.668 . . . . 0.0 110.295 177.617 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' THR . . . . . 0.48 ' OG1' ' O ' ' A' ' 225' ' ' GLY . 75.8 p -61.34 -38.06 85.55 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 114.839 -1.073 . . . . 0.0 112.533 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 71.6 p -56.7 -38.86 72.86 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.486 -0.485 . . . . 0.0 111.229 -174.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 3.8 p -59.79 -40.81 83.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 118.026 -1.47 . . . . 0.0 108.318 178.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 24.7 mt -61.54 -40.67 87.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 176.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -62.15 -39.2 91.81 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 114.539 -1.209 . . . . 0.0 113.8 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.44 ' N ' ' HD2' ' A' ' 234' ' ' PRO . 8.2 t -58.74 -43.24 97.58 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 -174.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 233' ' ' SER . 20.0 Cg_endo -60.14 -41.5 51.18 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 CA-C-N 121.947 1.731 . . . . 0.0 112.705 179.065 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 2.9 p -65.97 -37.7 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 117.972 -1.491 . . . . 0.0 109.237 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -66.69 -42.0 87.14 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 -179.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 15.4 m -65.7 -45.43 91.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -176.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 C--N 1.324 -0.515 0 C-N-CA 119.444 -0.902 . . . . 0.0 111.818 -177.878 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 94.0 m . . . . . 0 N--CA 1.466 0.355 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' MET . . . . . 0.566 ' SD ' ' N ' ' A' ' 261' ' ' LEU . 0.1 OUTLIER -61.33 -43.86 98.16 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 120.134 -0.626 . . . . 0.0 110.851 -178.317 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.566 ' N ' ' SD ' ' A' ' 260' ' ' MET . 63.7 tp -63.18 -48.29 79.0 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' ARG . . . . . 0.447 ' O ' ' O ' ' A' ' 263' ' ' LYS . 8.6 tpt180 -67.68 -53.94 23.57 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.765 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . 0.447 ' O ' ' O ' ' A' ' 262' ' ' ARG . 5.4 ttpm? -56.25 -126.49 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.778 -178.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -85.89 143.11 28.4 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 121.094 0.473 . . . . 0.0 111.122 -178.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . 0.563 ' C ' ' H ' ' A' ' 267' ' ' ARG . . . -42.22 160.84 0.04 OUTLIER Glycine 0 CA--C 1.529 0.968 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.382 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -55.98 0.21 0.17 Allowed 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 121.798 1.666 . . . . 0.0 111.909 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . 0.563 ' H ' ' C ' ' A' ' 265' ' ' GLY . 82.9 mtt85 -70.25 -26.46 63.84 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.753 0.821 . . . . 0.0 112.225 178.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -57.98 -32.06 67.51 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.849 -178.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -62.1 -41.02 97.79 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.674 177.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -65.28 -37.98 88.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.372 -177.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.472 ' O ' ' O ' ' A' ' 272' ' ' GLY . 37.0 mmtm -67.33 -176.8 0.61 Allowed 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 178.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 271' ' ' LYS . . . 37.11 99.3 0.01 OUTLIER Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -156.63 -0.58 0.12 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.019 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 274' ' ' MET . . . . . 0.574 ' N ' ' CD ' ' A' ' 275' ' ' PRO . 0.1 OUTLIER -63.77 -44.62 80.39 Favored Pre-proline 0 C--N 1.328 -0.35 0 C-N-CA 120.247 -0.581 . . . . 0.0 109.565 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 275' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 274' ' ' MET . 20.9 Cg_exo -64.7 -47.22 5.58 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.093 1.862 . . . . 0.0 111.651 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 19.7 m -61.03 -40.03 92.05 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.701 0.762 . . . . 0.0 110.434 179.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -62.14 -41.85 98.67 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 123.528 1.633 . . . . 0.0 112.138 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 1.4 mp -62.05 -38.85 90.32 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 110.617 -2.992 . . . . 0.0 108.549 174.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 13.5 mmt85 -62.76 -40.65 97.94 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.291 0.567 . . . . 0.0 109.751 178.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.07 -37.2 86.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.099 -179.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -67.81 -50.93 38.24 Favored Glycine 0 CA--C 1.519 0.297 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -177.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 77.8 p -61.63 -44.32 97.21 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 283' ' ' TRP . . . . . . . . . . . . . 87.6 t90 -61.26 -39.72 91.41 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.637 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -64.31 -40.66 96.38 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 5.3 m -62.28 -38.18 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 27.1 m -62.02 -38.83 81.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 121.094 -0.242 . . . . 0.0 111.041 -178.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 287' ' ' MET . . . . . 0.453 ' C ' ' SD ' ' A' ' 287' ' ' MET . 0.0 OUTLIER -59.33 -37.31 77.49 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.643 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -57.95 -40.07 79.66 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.003 -179.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 1.2 m -60.46 -38.16 77.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 O-C-N 121.766 -0.584 . . . . 0.0 111.018 -178.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 287' ' ' MET . 75.1 p -61.81 -38.93 89.96 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 177.199 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -60.64 -38.34 84.52 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 177.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -58.22 -40.71 82.36 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 118.089 -1.445 . . . . 0.0 109.421 -176.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 293' ' ' GLN . . . . . 0.453 ' O ' ' O ' ' A' ' 296' ' ' ARG . 36.5 tp60 -60.72 -42.74 97.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 122.823 1.296 . . . . 0.0 110.468 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 35.9 tp -60.29 -40.15 89.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 112.497 -2.138 . . . . 0.0 109.157 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -63.05 -45.71 90.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.335 179.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 296' ' ' ARG . . . . . 0.453 ' O ' ' O ' ' A' ' 293' ' ' GLN . 44.8 ttm180 -123.03 116.39 23.45 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.047 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -114.41 -97.25 0.44 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.069 0.461 . . . . 0.0 110.682 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 36.8 tp -140.7 121.06 14.0 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.009 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 24.3 ttt -95.59 66.15 2.73 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -178.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.52 100.82 0.07 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 122.149 0.976 . . . . 0.0 110.805 -178.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -64.28 -46.31 84.21 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 113.393 -1.73 . . . . 0.0 113.362 -176.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -58.92 -39.75 82.48 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.085 -177.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 303' ' ' GLN . . . . . 0.423 ' O ' ' OE1' ' A' ' 303' ' ' GLN . 0.3 OUTLIER -64.51 -46.73 81.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.003 -179.61 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 304' ' ' SER . . . . . 0.44 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 15.1 m -66.56 -37.42 84.93 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.61 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -61.66 -43.25 99.22 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -178.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -65.17 -36.88 85.6 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -177.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -59.86 -52.7 71.85 Favored Pre-proline 0 CA--C 1.543 0.675 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -176.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 308' ' ' PRO . . . . . 0.44 ' CD ' ' O ' ' A' ' 304' ' ' SER . 73.1 Cg_endo -75.2 0.39 9.04 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.038 1.825 . . . . 0.0 111.862 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 39.8 t80 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.501 179.914 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.59 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.55 168.41 17.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.632 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.611 ' CG2' ' H ' ' A' ' 16' ' ' LYS . 13.4 p -167.07 -178.98 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.898 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.611 ' H ' ' CG2' ' A' ' 15' ' ' VAL . 23.7 mtpp -64.32 -41.81 96.63 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.699 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -63.73 -41.5 98.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.279 0.561 . . . . 0.0 112.077 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 12.9 tp -79.97 -26.0 40.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.046 -179.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.455 ' O ' ' OG1' ' A' ' 22' ' ' THR . . . -66.04 -41.3 95.24 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 107.601 -2.199 . . . . 0.0 107.601 177.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.47 -32.01 67.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 124.886 2.279 . . . . 0.0 107.332 176.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.76 -42.51 98.55 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-N 108.454 -3.975 . . . . 0.0 108.292 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 19' ' ' GLY . 28.3 p -70.61 -27.48 64.11 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.541 0.686 . . . . 0.0 109.436 178.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.76 -49.7 67.43 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.166 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.98 -35.19 77.76 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 118.816 -1.154 . . . . 0.0 112.375 -177.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.47 ' SG ' ' OE1' ' A' ' 89' ' ' GLN . 75.7 m -63.35 -53.79 47.11 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -177.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -65.89 -38.09 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -177.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.493 ' O ' ' OG1' ' A' ' 31' ' ' THR . . . -63.64 -41.59 98.23 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -173.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 29' ' ' LEU . 20.0 p30 -77.6 -27.0 51.13 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 120.893 1.678 . . . . 0.0 109.93 -175.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.501 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 11.2 tp -59.8 -55.39 34.82 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 119.93 1.241 . . . . 0.0 112.148 -178.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.1 pt -75.45 -3.91 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-O 121.376 0.608 . . . . 0.0 112.61 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.493 ' OG1' ' O ' ' A' ' 27' ' ' ALA . 7.1 m -109.3 -16.85 13.95 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.751 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.47 ' N ' ' CD ' ' A' ' 33' ' ' PRO . 1.8 t80 -68.53 -44.33 33.51 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 121.411 1.914 . . . . 0.0 110.93 -178.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.47 ' CD ' ' N ' ' A' ' 32' ' ' PHE . 36.8 Cg_exo -59.36 -15.8 31.52 Favored 'Trans proline' 0 N--CA 1.501 1.964 0 C-N-CA 121.554 1.502 . . . . 0.0 112.701 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.466 ' CD1' ' OG ' ' A' ' 282' ' ' SER . 81.6 mt -67.62 -35.36 78.79 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 114.787 1.402 . . . . 0.0 114.787 -177.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 36' ' ' THR . 45.3 p-10 -64.27 -40.53 96.16 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -177.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.53 ' N ' ' OD1' ' A' ' 35' ' ' ASP . 44.1 p -58.27 -35.28 71.54 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.939 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.86 -39.19 83.8 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 119.755 -0.778 . . . . 0.0 112.015 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.498 ' NZ ' ' CB ' ' A' ' 38' ' ' LYS . 8.7 mtmp? -62.12 -49.36 76.21 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 119.239 -0.984 . . . . 0.0 111.187 -176.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.1 m -64.25 -40.6 89.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -176.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.599 ' NH1' HE21 ' A' ' 44' ' ' GLN . 10.2 tpp180 -61.69 -41.87 98.16 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 119.378 -0.929 . . . . 0.0 110.08 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.54 39.06 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.768 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.517 ' C ' ' H ' ' A' ' 44' ' ' GLN . 60.2 tt0 -125.73 152.78 44.87 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.989 0.424 . . . . 0.0 110.942 -179.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.414 HD13 HG21 ' A' ' 43' ' ' ILE . 73.0 mt -63.11 0.78 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.004 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.599 HE21 ' NH1' ' A' ' 40' ' ' ARG . 46.0 mt-30 64.13 78.98 0.27 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.525 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.17 -5.68 3.45 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.467 ' H ' ' C ' ' A' ' 44' ' ' GLN . 96.8 mt-10 -56.22 -42.83 77.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.912 0.387 . . . . 0.0 109.992 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.549 ' C ' ' H ' ' A' ' 49' ' ' GLY . 4.7 t 37.71 30.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.699 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.406 ' N ' ' O ' ' A' ' 46' ' ' GLU . 85.9 mt-30 -58.05 -2.8 0.19 Allowed 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.121 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.549 ' H ' ' C ' ' A' ' 47' ' ' SER . . . 87.44 -8.62 76.5 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -177.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -66.35 -37.3 85.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.665 0.745 . . . . 0.0 109.237 177.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.1 p -60.76 -44.12 96.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.149 -178.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.9 mmp_? -64.56 -35.14 80.02 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 119.816 -0.754 . . . . 0.0 112.31 -177.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.5 t -68.95 -38.0 79.18 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 119.24 -0.984 . . . . 0.0 108.758 177.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -138.29 97.93 3.49 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 114.798 -1.092 . . . . 0.0 108.39 178.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -80.65 9.0 6.73 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -177.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.525 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 18.7 m -125.69 -140.99 0.28 Allowed 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 56' ' ' SER . . . 97.87 12.74 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 O-C-N 124.127 0.892 . . . . 0.0 111.863 178.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 41.7 tp60 -178.24 84.59 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.704 0.288 . . . . 0.0 110.36 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -63.78 163.06 12.31 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.063 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.413 ' O ' ' C ' ' A' ' 61' ' ' GLY . 78.4 mtm-85 -49.84 -36.85 28.3 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 60' ' ' ARG . . . -28.57 102.58 0.01 OUTLIER Glycine 0 CA--C 1.526 0.764 0 CA-C-N 114.955 -1.021 . . . . 0.0 112.703 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.1 m -67.32 -34.37 68.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 118.41 -0.805 . . . . 0.0 109.663 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -60.48 -32.5 71.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 121.077 1.762 . . . . 0.0 109.615 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.67 -49.32 64.81 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-N 114.623 -1.171 . . . . 0.0 114.781 -176.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.7 p -61.98 -46.48 89.05 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 -178.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 8.8 tt -59.8 -36.19 64.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.21 -35.73 81.75 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 120.303 1.411 . . . . 0.0 111.913 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.473 ' O ' ' OG1' ' A' ' 72' ' ' THR . 98.1 m -63.56 -40.88 98.12 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.312 -1.313 . . . . 0.0 111.085 -175.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 7.3 ptm -60.59 -39.46 88.18 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -175.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.2 p -69.02 -40.01 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 119.532 -0.867 . . . . 0.0 113.05 -177.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 -77.78 -13.08 60.0 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.999 0.904 . . . . 0.0 112.6 -178.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' A' ' 68' ' ' THR . 19.7 m -62.45 -54.65 37.08 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.025 -1.443 . . . . 0.0 111.272 179.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 28.2 mp0 -107.01 -57.76 2.02 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 178.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.42 ' O ' ' CB ' ' A' ' 77' ' ' SER . . . 159.36 165.49 16.46 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -56.84 -35.46 98.26 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 121.487 1.458 . . . . 0.0 111.376 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.64 -11.34 11.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.802 0.811 . . . . 0.0 110.691 175.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 74' ' ' GLY . 5.6 t -77.9 -32.49 51.8 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.098 -1.41 . . . . 0.0 110.905 -178.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 27.5 mt -75.45 -33.48 60.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.116 0.484 . . . . 0.0 110.61 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -92.29 -4.59 53.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 122.798 1.285 . . . . 0.0 113.243 -177.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -95.28 116.25 28.52 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 112.29 -2.232 . . . . 0.0 107.016 175.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.48 -11.38 54.16 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -177.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.461 ' CD1' ' C ' ' A' ' 82' ' ' LEU . 0.3 OUTLIER -59.24 -34.42 72.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 113.94 -1.13 . . . . 0.0 110.489 -179.328 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.1 m -70.49 -27.0 29.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.087 -0.961 . . . . 0.0 109.369 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.95 -31.92 61.61 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.675 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.92 -40.11 89.18 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 119.544 -1.312 . . . . 0.0 111.223 -177.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.0 mp -62.46 -40.1 95.56 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 122.29 1.043 . . . . 0.0 112.574 -177.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -60.57 -27.44 67.69 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 113.106 -1.861 . . . . 0.0 109.613 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 58.2 ttp85 -57.83 -53.55 56.97 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 173.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.47 ' OE1' ' SG ' ' A' ' 25' ' ' CYS . 10.3 tt0 -67.22 -29.9 69.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 112.318 -2.219 . . . . 0.0 112.512 -178.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 38.4 ttm -61.14 -40.66 94.65 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.497 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 38.2 t -74.32 -34.13 63.37 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 119.556 -0.858 . . . . 0.0 111.718 -176.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -57.75 -43.99 85.8 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 120.584 1.538 . . . . 0.0 112.308 -176.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.53 -32.85 64.44 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 119.321 -0.952 . . . . 0.0 111.015 -178.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.469 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 48.8 m -64.35 -41.82 96.55 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.472 ' C ' ' H ' ' A' ' 97' ' ' ILE . 7.2 p -68.42 -28.41 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.221 177.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 16.9 mtp-105 -77.46 10.33 2.65 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -177.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.472 ' H ' ' C ' ' A' ' 95' ' ' VAL . 9.6 tp -86.87 -15.33 9.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 177.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.427 ' O ' ' OG ' ' A' ' 102' ' ' SER . . . -140.05 -48.0 0.06 OUTLIER Glycine 0 CA--C 1.539 1.571 0 CA-C-N 114.23 -1.35 . . . . 0.0 114.383 -177.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.4 tp -70.75 -13.48 62.07 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.183 1.491 . . . . 0.0 113.37 -177.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.473 ' O ' ' HB2' ' A' ' 104' ' ' LYS . 20.6 t80 -81.21 -51.67 8.17 Favored 'General case' 0 C--O 1.211 -0.945 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.957 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.488 ' O ' ' HG3' ' A' ' 105' ' ' GLN . 9.3 p-10 -69.99 -32.73 71.07 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 123.631 1.682 . . . . 0.0 111.83 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 98' ' ' GLY . 49.0 m -68.83 -52.72 26.98 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 110.81 -2.904 . . . . 0.0 116.99 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 69.2 t -74.99 -26.9 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 CA-C-N 121.121 1.782 . . . . 0.0 110.8 176.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 100' ' ' TYR . 0.4 OUTLIER -69.54 -41.53 75.84 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 110.831 -2.895 . . . . 0.0 112.974 -179.259 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.488 ' HG3' ' O ' ' A' ' 101' ' ' ASP . 88.1 mt-30 -78.65 -13.75 59.66 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 123.614 1.673 . . . . 0.0 111.025 178.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.06 -22.74 41.95 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 112.785 -2.007 . . . . 0.0 110.9 178.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -109.87 -30.62 7.75 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.833 0.742 . . . . 0.0 112.212 -175.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 50.1 m -98.46 9.06 44.01 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 118.219 -1.393 . . . . 0.0 112.579 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.444 ' O ' ' C ' ' A' ' 110' ' ' GLY . 35.3 ttmt -53.74 121.11 7.2 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.495 ' O ' ' CB ' ' A' ' 111' ' ' SER . . . -23.59 -78.79 0.01 OUTLIER Glycine 0 N--CA 1.48 1.59 0 CA-C-N 117.81 0.277 . . . . 0.0 113.12 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.498 ' O ' ' HB2' ' A' ' 112' ' ' GLU . 1.4 t 91.96 -87.26 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 177.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.498 ' HB2' ' O ' ' A' ' 111' ' ' SER . 82.7 tt0 171.64 -34.36 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 120.541 1.519 . . . . 0.0 113.915 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.472 ' O ' ' CB ' ' A' ' 114' ' ' ALA . 0.3 OUTLIER 156.87 42.46 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.201 0.524 . . . . 0.0 109.896 -179.214 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.472 ' CB ' ' O ' ' A' ' 113' ' ' HIS . . . 160.45 -162.41 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 178.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.42 ' O ' ' OG ' ' A' ' 118' ' ' SER . . . 102.78 15.23 25.01 Favored Glycine 0 CA--C 1.507 -0.428 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.49 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 12.6 tt -60.43 -40.54 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.68 -40.17 95.71 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-O 121.791 0.661 . . . . 0.0 111.685 175.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.42 ' OG ' ' O ' ' A' ' 115' ' ' GLY . 10.1 p -58.65 -42.97 89.58 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 176.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 76.3 mtm180 -63.71 -37.01 85.74 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.849 -177.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 70.9 mt -63.53 -45.63 89.7 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 177.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 39.4 mt -66.52 -44.82 81.46 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 118.762 -1.175 . . . . 0.0 110.06 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.98 -45.4 89.24 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 120.22 1.373 . . . . 0.0 110.602 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -66.04 -44.16 92.0 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 120.172 -1.014 . . . . 0.0 111.289 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 59.0 m -64.14 -43.82 94.04 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.43 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 20.6 m -69.34 -48.27 61.91 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 119.365 -0.934 . . . . 0.0 111.943 177.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.434 ' CG2' ' N ' ' A' ' 127' ' ' GLY . 4.8 t -65.23 -42.46 93.37 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -173.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.434 ' N ' ' CG2' ' A' ' 126' ' ' THR . . . -63.89 -44.53 95.95 Favored Glycine 0 CA--C 1.521 0.423 0 CA-C-O 122.912 1.284 . . . . 0.0 113.196 -177.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.12 -41.21 96.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 112.029 -2.085 . . . . 0.0 106.714 177.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.98 -41.9 97.39 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.3 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -62.9 -39.98 96.17 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -177.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.5 m -61.04 -26.12 38.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 122.628 1.204 . . . . 0.0 109.513 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -58.31 -44.45 88.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 112.607 -2.088 . . . . 0.0 111.736 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 61.5 t -78.6 -49.02 21.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.941 -178.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -112.38 131.64 55.43 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.746 0.308 . . . . 0.0 110.805 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.519 ' N ' ' CD ' ' A' ' 136' ' ' PRO . 3.4 tt0 -175.51 -41.79 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.82 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.519 ' CD ' ' N ' ' A' ' 135' ' ' GLN . 52.6 Cg_exo -52.78 -34.52 65.35 Favored 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 121.819 1.679 . . . . 0.0 113.437 -178.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 98.6 m -67.54 -42.01 83.4 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 118.029 -1.468 . . . . 0.0 108.594 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -65.51 -43.01 91.43 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 118.159 -1.416 . . . . 0.0 112.788 -177.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.3 p -64.76 -44.22 96.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.455 ' O ' ' N ' ' A' ' 144' ' ' PHE . 21.8 m -65.26 -37.93 81.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -178.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -61.41 -40.72 95.44 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -176.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.453 ' CG1' ' N ' ' A' ' 143' ' ' ARG . 3.9 p -69.61 -44.7 79.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 119.399 -0.92 . . . . 0.0 108.94 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.453 ' N ' ' CG1' ' A' ' 142' ' ' VAL . 65.8 mtt180 -64.24 -35.71 81.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.701 178.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.455 ' N ' ' O ' ' A' ' 140' ' ' VAL . 85.1 t80 -65.71 -40.56 92.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.239 -178.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -64.14 -38.63 91.74 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -64.88 -35.02 79.79 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -178.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -59.75 111.18 1.35 Allowed 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 177.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -106.6 -173.12 2.22 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 117.686 2.476 . . . . 0.0 117.686 -171.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 59.0 61.13 2.21 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 110.035 -3.257 . . . . 0.0 110.899 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . 46.59 -114.79 0.54 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.806 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 170.74 113.88 0.3 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.979 -0.849 . . . . 0.0 110.979 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -99.56 -156.89 28.66 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 155' ' ' ARG . . . 81.66 56.47 2.94 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 77.8 mtp85 41.76 -90.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.733 0.301 . . . . 0.0 110.94 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.52 ' N ' ' O ' ' A' ' 153' ' ' GLY . 25.7 ttm105 -64.49 128.75 37.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.417 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.412 ' CD1' ' O ' ' A' ' 156' ' ' TYR . 28.1 p90 -70.7 132.06 44.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.516 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -54.48 175.73 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.662 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 20.5 p -157.0 -178.36 7.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.657 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.433 ' CG2' ' N ' ' A' ' 160' ' ' VAL . 13.7 t -64.1 -46.47 84.06 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.663 -177.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.433 ' N ' ' CG2' ' A' ' 159' ' ' THR . 6.3 p -64.51 -45.43 95.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 119.06 -1.056 . . . . 0.0 109.674 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -66.65 -38.34 86.67 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.162 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.49 ' O ' ' CD1' ' A' ' 166' ' ' ILE . . . -60.97 -44.58 97.12 Favored 'General case' 0 C--O 1.21 -0.981 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -177.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.448 ' CD1' ' C ' ' A' ' 163' ' ' TYR . 20.6 t80 -61.5 -47.84 83.79 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.527 0.565 . . . . 0.0 112.527 -178.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -67.89 -45.39 74.57 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 117.881 2.549 . . . . 0.0 117.881 -172.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 41.7 p -63.38 -45.44 91.11 Favored 'General case' 0 CA--C 1.557 1.227 0 N-CA-C 117.294 2.331 . . . . 0.0 117.294 -175.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.562 ' H ' ' CD1' ' A' ' 166' ' ' ILE . 0.1 OUTLIER -64.68 -37.12 79.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 CA-C-O 121.655 0.741 . . . . 0.0 109.281 176.483 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.454 ' H ' HD13 ' A' ' 166' ' ' ILE . . . -59.07 -36.53 75.24 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 176.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 18.5 tpt85 -62.21 -50.09 73.16 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 122.998 2.635 . . . . 0.0 111.201 -176.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -74.77 -51.08 15.1 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 123.457 0.703 . . . . 0.0 109.593 177.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -78.24 -36.7 46.62 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 116.037 1.866 . . . . 0.0 116.037 -173.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 93.41 -168.21 29.36 Favored Glycine 0 N--CA 1.47 0.957 0 CA-C-N 118.674 0.67 . . . . 0.0 112.623 177.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 10.0 pt -73.52 -41.45 56.12 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.112 0 CA-C-O 121.944 0.878 . . . . 0.0 110.716 -179.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -58.47 -32.98 69.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 113.708 -1.587 . . . . 0.0 110.658 -176.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -60.33 -39.97 96.85 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 119.209 -1.472 . . . . 0.0 109.89 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 5.8 tp -69.49 -33.73 73.29 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 117.056 2.243 . . . . 0.0 117.056 -177.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 9.7 m0 -78.14 -7.62 57.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 111.244 -2.707 . . . . 0.0 109.826 -178.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -43.32 -47.86 6.77 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.327 -176.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -95.7 -36.33 5.35 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 123.936 0.779 . . . . 0.0 111.763 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.463 ' CG2' ' N ' ' A' ' 180' ' ' SER . 0.6 OUTLIER -45.4 -51.23 11.61 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -179.385 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.463 ' N ' ' CG2' ' A' ' 179' ' ' THR . 0.4 OUTLIER -62.9 -50.89 75.0 Favored Pre-proline 0 N--CA 1.473 0.687 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -176.666 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 180' ' ' SER . 32.6 Cg_endo -64.8 -28.42 59.38 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 121.683 1.588 . . . . 0.0 111.992 177.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -63.73 -39.87 95.35 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 120.266 -0.574 . . . . 0.0 109.967 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 75.6 t -63.45 -42.43 96.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.89 -39.04 90.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.216 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.25 -41.55 93.46 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.898 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -61.61 -42.87 99.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.732 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.32 -44.27 92.06 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 -178.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 3.5 tp -63.95 -45.18 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.882 -178.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.523 ' O ' ' N ' ' A' ' 193' ' ' GLU . 15.5 m -59.83 -45.86 94.39 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.362 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.436 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -62.39 -42.62 99.57 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.843 0.83 . . . . 0.0 109.915 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' CYS . . . . . . . . . . . . . 41.4 t -61.71 -45.8 92.4 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.384 -1.28 . . . . 0.0 109.249 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -63.86 -39.61 94.61 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 113.097 -1.865 . . . . 0.0 108.501 175.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 189' ' ' VAL . 36.6 tp10 -61.01 -46.28 91.4 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.962 -178.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.89 -39.64 93.84 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 118.844 -1.143 . . . . 0.0 110.225 -175.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 2.7 p -64.83 -46.43 91.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 116.693 -2.003 . . . . 0.0 107.853 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 96.3 m -64.11 -45.93 86.41 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.58 0.955 . . . . 0.0 113.58 -178.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -55.43 -37.99 68.4 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.716 1.606 . . . . 0.0 112.275 -176.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -55.86 -43.48 77.14 Favored 'General case' 0 C--N 1.312 -1.04 0 O-C-N 121.594 -0.691 . . . . 0.0 109.606 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 19.3 mt -61.31 -39.79 91.78 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -176.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.3 pt -63.49 -41.2 91.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-N 118.461 0.573 . . . . 0.0 111.304 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 10.3 mtpp -57.92 -37.58 74.33 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.935 1.694 . . . . 0.0 113.013 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -63.73 -38.59 91.67 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.889 -0.725 . . . . 0.0 111.039 -177.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.15 128.63 47.15 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 122.184 0.992 . . . . 0.0 111.579 -178.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 6.4 tp 67.18 3.9 3.41 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 113.233 -1.803 . . . . 0.0 111.726 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -125.11 26.97 6.8 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.488 0.661 . . . . 0.0 111.234 -178.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.25 -21.58 59.71 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.527 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.476 ' O ' ' O ' ' A' ' 208' ' ' ASN . . . -163.44 33.06 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.197 -1.365 . . . . 0.0 109.078 178.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . 0.476 ' O ' ' O ' ' A' ' 207' ' ' ALA . 12.3 p30 40.54 117.93 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 177.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.473 ' O ' ' O ' ' A' ' 208' ' ' ASN . 9.0 tp 26.35 102.83 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.292 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 34.3 mtt -146.73 51.32 1.11 Allowed 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 177.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 4.2 m -158.09 142.77 16.29 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.359 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -83.68 -14.83 50.85 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.196 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.502 ' O ' ' SG ' ' A' ' 216' ' ' CYS . 14.9 m-20 -83.4 73.71 10.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.945 0.402 . . . . 0.0 110.696 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.492 ' O ' ' ND1' ' A' ' 217' ' ' HIS . 13.6 mt -61.39 -44.13 91.68 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 214' ' ' LEU . 29.8 Cg_endo -61.34 -32.28 89.46 Favored 'Trans proline' 0 N--CA 1.501 1.954 0 CA-C-N 120.741 1.301 . . . . 0.0 112.406 -179.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' CYS . . . . . 0.525 ' SG ' ' N ' ' A' ' 217' ' ' HIS . 1.1 p -63.92 -42.44 97.39 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 113.827 -1.533 . . . . 0.0 111.824 -177.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' HIS . . . . . 0.622 ' CE1' ' CE2' ' A' ' 218' ' ' PHE . 3.5 p-80 -66.77 -37.43 84.58 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.425 -0.51 . . . . 0.0 112.163 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' PHE . . . . . 0.622 ' CE2' ' CE1' ' A' ' 217' ' ' HIS . 25.6 m-85 -63.08 -46.88 85.35 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.069 -178.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 10.1 m -60.14 -37.46 80.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 118.271 0.487 . . . . 0.0 110.709 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 217' ' ' HIS . 54.1 p -59.57 -41.56 90.48 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . 0.605 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.4 -41.63 98.76 Favored 'General case' 0 C--O 1.222 -0.381 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -177.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -61.73 -46.73 88.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 122.056 0.931 . . . . 0.0 113.031 -175.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -60.28 -41.98 98.58 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 107.237 -2.345 . . . . 0.0 107.237 177.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -63.06 -36.99 85.41 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 113.898 -1.151 . . . . 0.0 108.975 176.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . 0.605 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -61.03 -41.67 99.53 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-N 114.062 -1.426 . . . . 0.0 111.472 -176.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' PHE . . . . . 0.441 ' O ' ' OG1' ' A' ' 229' ' ' THR . 60.9 t80 -66.78 -38.26 86.19 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.347 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 94.4 m -63.27 -42.27 99.11 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -62.46 -39.74 94.36 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 120.813 0.339 . . . . 0.0 111.542 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' A' ' 226' ' ' PHE . 17.0 p -58.04 -38.8 76.95 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.068 -177.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 99.0 t -59.87 -40.78 83.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 119.224 -0.99 . . . . 0.0 108.635 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . 0.582 ' O ' ' HD2' ' A' ' 234' ' ' PRO . 1.3 mp -61.32 -39.69 83.56 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.573 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 176.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -61.39 -37.5 83.66 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.257 1.423 . . . . 0.0 114.331 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.468 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 1.4 m -56.31 -38.2 65.79 Favored Pre-proline 0 N--CA 1.48 1.053 0 N-CA-C 116.519 2.044 . . . . 0.0 116.519 -173.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.582 ' HD2' ' O ' ' A' ' 231' ' ' ILE . 31.5 Cg_exo -57.97 -38.69 91.1 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 C-N-CA 122.739 2.293 . . . . 0.0 114.051 -175.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.4 m -63.02 -36.77 77.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 116.795 -1.962 . . . . 0.0 108.846 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -65.88 -40.71 91.84 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -64.9 -44.38 96.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -175.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 91.9 t -62.52 -36.46 75.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 O-C-N 121.885 -0.51 . . . . 0.0 111.97 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 22.6 mmtp -59.91 -44.14 94.47 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -177.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.3 -41.91 97.77 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -178.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.404 ' O ' ' ND2' ' A' ' 244' ' ' ASN . 5.0 mmm180 -45.56 -45.58 13.63 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.168 0.509 . . . . 0.0 111.146 -179.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.612 ' O ' ' N ' ' A' ' 244' ' ' ASN . 20.4 t80 -37.34 -57.71 0.88 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.961 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' MET . . . . . 0.538 ' O ' ' N ' ' A' ' 245' ' ' SER . 6.9 mmt -25.82 -34.22 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . 0.612 ' N ' ' O ' ' A' ' 242' ' ' TYR . 20.5 p30 -41.0 -20.17 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.957 0.408 . . . . 0.0 110.699 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' SER . . . . . 0.538 ' N ' ' O ' ' A' ' 243' ' ' MET . 80.3 p -167.77 177.58 5.7 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.528 0.68 . . . . 0.0 112.76 -178.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -159.24 123.61 3.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.04 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 12.5 mt 63.2 150.09 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.041 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 163.8 -115.93 0.68 Allowed Glycine 0 CA--C 1.527 0.816 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -128.89 54.99 1.75 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.304 0.573 . . . . 0.0 109.984 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -106.9 97.43 7.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.649 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 40.9 t60 -66.39 -51.68 54.56 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -177.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 16.6 p -147.37 -173.59 4.3 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -178.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -60.09 -44.02 95.11 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -55.52 -35.17 61.05 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.167 1.365 . . . . 0.0 111.655 -171.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -57.03 -33.19 66.96 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 117.44 -1.704 . . . . 0.0 111.042 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' CYS . . . . . . . . . . . . . 1.5 t -60.98 -44.7 97.0 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 120.838 -1.164 . . . . 0.0 111.333 179.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -60.26 -45.46 93.21 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -177.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.75 -43.4 84.24 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 120.064 -0.654 . . . . 0.0 110.132 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 60.0 p -62.99 -45.36 92.78 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.257 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' MET . . . . . 0.464 ' SD ' ' C ' ' A' ' 260' ' ' MET . 1.9 tmt? -60.45 -43.86 96.45 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -176.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 33.2 tp -62.21 -46.42 88.98 Favored 'General case' 0 C--N 1.322 -0.624 0 O-C-N 122.029 -0.419 . . . . 0.0 110.413 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 5.2 tpm_? -66.11 -54.0 30.94 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.49 -178.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . 0.443 ' O ' ' O ' ' A' ' 260' ' ' MET . 23.0 pttm -115.36 162.86 16.54 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.114 0.483 . . . . 0.0 111.526 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . 0.498 ' O ' ' O ' ' A' ' 265' ' ' GLY . 70.0 mm-40 56.5 85.06 0.08 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.679 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . 0.498 ' O ' ' O ' ' A' ' 264' ' ' GLU . . . -43.28 177.36 0.01 OUTLIER Glycine 0 CA--C 1.532 1.12 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -68.17 -8.79 23.83 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.301 2.001 . . . . 0.0 111.216 177.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 34.6 ptt-85 -69.72 -26.81 64.52 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 122.978 0.511 . . . . 0.0 111.853 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -58.55 -32.44 68.89 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.711 -0.796 . . . . 0.0 109.287 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -62.06 -41.55 98.27 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.157 177.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -65.66 -37.31 86.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.433 -178.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.446 ' O ' ' O ' ' A' ' 272' ' ' GLY . 54.5 tttp -82.78 171.98 13.36 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 177.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 271' ' ' LYS . . . 48.76 99.44 0.01 OUTLIER Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -171.42 12.09 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.055 0.455 . . . . 0.0 110.496 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' MET . . . . . 0.592 ' SD ' ' N ' ' A' ' 275' ' ' PRO 0.25 0.0 OUTLIER -63.49 -40.36 57.66 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.81 179.372 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' PRO . . . . . 0.592 ' N ' ' SD ' ' A' ' 274' ' ' MET . 16.6 Cg_exo -63.55 -46.38 9.43 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 121.453 1.435 . . . . 0.0 111.197 -176.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 3.1 m -60.43 -39.88 89.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.657 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -61.99 -42.96 99.72 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 123.079 1.418 . . . . 0.0 112.145 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 84.8 mt -62.28 -38.68 90.28 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 111.59 -2.55 . . . . 0.0 108.151 174.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 -63.01 -39.45 94.8 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.314 0.578 . . . . 0.0 110.527 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 1.1 tt -61.76 -36.88 82.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.028 -0.987 . . . . 0.0 112.489 -177.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -68.3 -51.51 32.08 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' SER . . . . . 0.466 ' OG ' ' CD1' ' A' ' 34' ' ' LEU . 5.6 t -63.35 -44.5 94.67 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 123.566 0.747 . . . . 0.0 110.349 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' TRP . . . . . . . . . . . . . 79.4 t90 -59.9 -37.82 80.51 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.922 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . 0.472 ' C ' ' ND2' ' A' ' 284' ' ' ASN . 0.4 OUTLIER -61.47 -37.94 85.47 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.18 -179.313 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -60.86 -37.69 77.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 O-C-N 121.95 -0.468 . . . . 0.0 111.778 -179.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -61.93 -41.14 89.72 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.661 -177.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -61.78 -38.16 87.0 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 121.488 -0.758 . . . . 0.0 109.757 178.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -58.49 -40.62 83.28 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.265 -0.88 . . . . 0.0 112.982 -178.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 27.0 m -60.76 -38.53 79.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 119.974 -0.69 . . . . 0.0 110.984 -178.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 16.8 m -62.54 -40.25 96.21 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -60.85 -38.84 86.93 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 177.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.45 -40.49 82.73 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 117.706 -1.597 . . . . 0.0 109.527 -176.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' GLN . . . . . 0.473 ' O ' ' O ' ' A' ' 296' ' ' ARG . 56.9 tt0 -60.45 -42.9 97.08 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 122.595 1.188 . . . . 0.0 110.971 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 10.3 mp -60.32 -40.65 91.34 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 113.119 -1.855 . . . . 0.0 108.79 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -63.27 -45.91 89.25 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.322 178.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' ARG . . . . . 0.473 ' O ' ' O ' ' A' ' 293' ' ' GLN . 27.6 mmm-85 -123.03 116.16 23.06 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -121.41 -164.09 1.1 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.022 0.439 . . . . 0.0 112.179 -178.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.537 ' CD1' ' H ' ' A' ' 298' ' ' LEU . 0.0 OUTLIER -64.77 -173.96 0.12 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 177.276 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 9.2 ttt -169.15 66.99 0.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 119.236 -0.986 . . . . 0.0 112.832 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.59 100.86 0.07 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.825 0.821 . . . . 0.0 110.534 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -64.08 -46.2 85.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.107 -1.406 . . . . 0.0 113.479 -176.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . 0.525 ' CD2' ' OE1' ' A' ' 306' ' ' GLU . 49.0 t80 -58.8 -39.94 82.62 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 119.706 -0.798 . . . . 0.0 109.563 -178.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -65.26 -46.88 78.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.219 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' SER . . . . . 0.446 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 38.9 t -66.58 -37.67 85.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.796 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 -61.67 -42.8 99.42 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.525 ' OE1' ' CD2' ' A' ' 302' ' ' TYR . 41.4 mt-10 -64.87 -37.08 86.42 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -177.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -60.06 -53.01 69.36 Favored Pre-proline 0 CA--C 1.544 0.743 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -176.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' PRO . . . . . 0.446 ' CD ' ' O ' ' A' ' 304' ' ' SER . 73.6 Cg_endo -75.15 0.17 9.29 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.283 1.988 . . . . 0.0 111.948 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 55.0 t80 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.574 -179.894 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.588 ' N ' ' SD ' ' A' ' 13' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.7 p 45.61 93.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.4 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.483 ' CG2' ' H ' ' A' ' 16' ' ' LYS . 12.4 p -148.37 171.44 2.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.002 0.43 . . . . 0.0 110.64 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.483 ' H ' ' CG2' ' A' ' 15' ' ' VAL . 4.6 mtmp? -64.29 -41.41 96.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.972 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -63.43 -41.56 98.68 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -178.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 57.5 tp -79.9 -26.33 40.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.148 0.499 . . . . 0.0 111.932 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.452 ' O ' ' OG1' ' A' ' 22' ' ' THR . . . -66.07 -41.33 95.16 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 107.595 -2.202 . . . . 0.0 107.595 177.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.47 -32.24 68.06 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 124.803 2.239 . . . . 0.0 107.54 176.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.5 -42.49 98.93 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-N 108.51 -3.95 . . . . 0.0 108.243 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' A' ' 19' ' ' GLY . 22.2 p -70.63 -27.41 64.04 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.503 0.668 . . . . 0.0 109.248 177.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.51 -50.05 64.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.676 -1.147 . . . . 0.0 112.128 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.78 -35.96 79.66 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 118.529 -1.268 . . . . 0.0 111.241 -177.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 68.5 m -63.64 -53.69 47.52 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.24 -178.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.4 pt -65.47 -39.63 85.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -177.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.11 -42.04 97.02 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 119.78 -0.768 . . . . 0.0 112.79 -173.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 32' ' ' PHE . 3.2 m-20 -77.89 -27.28 49.57 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 118.068 -1.453 . . . . 0.0 109.407 -176.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 15.7 mt -60.41 -56.22 24.12 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 120.159 1.345 . . . . 0.0 111.703 -178.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.489 ' CD1' ' N ' ' A' ' 30' ' ' ILE . 2.5 mp -76.23 -5.09 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 120.076 -0.649 . . . . 0.0 112.293 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 26.3 m -110.33 -17.98 13.37 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 117.656 -1.164 . . . . 0.0 109.71 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.517 ' N ' ' O ' ' A' ' 28' ' ' ASP . 11.4 t80 -67.88 -43.44 37.63 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 122.379 2.354 . . . . 0.0 110.009 -177.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.457 ' CD ' ' N ' ' A' ' 32' ' ' PHE . 38.1 Cg_exo -58.55 -14.68 22.0 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 121.239 1.293 . . . . 0.0 110.949 177.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.5 tp -66.92 -35.59 80.35 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -177.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -64.42 -40.65 96.17 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -177.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.401 ' CG2' ' O ' ' A' ' 33' ' ' PRO . 0.3 OUTLIER -58.39 -33.78 70.0 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.13 -38.77 86.12 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.455 ' NZ ' ' CB ' ' A' ' 38' ' ' LYS . 0.1 OUTLIER -61.67 -47.54 84.87 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 119.415 -0.914 . . . . 0.0 111.734 -176.768 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.2 t -62.2 -38.37 80.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -175.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.554 ' C ' ' H ' ' A' ' 42' ' ' GLN . 45.5 mtp85 -59.5 -41.08 89.05 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 119.236 -0.985 . . . . 0.0 110.049 -179.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -62.38 38.67 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.066 178.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.554 ' H ' ' C ' ' A' ' 40' ' ' ARG . 0.7 OUTLIER -94.57 5.11 52.81 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 121.959 -0.463 . . . . 0.0 111.187 -179.437 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.425 ' O ' ' O ' ' A' ' 42' ' ' GLN . 7.6 mm 60.28 147.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -53.14 105.25 0.12 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.873 0.368 . . . . 0.0 110.438 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.92 50.88 0.37 Allowed Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.981 -0.847 . . . . 0.0 110.981 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.47 ' H ' ' CG2' ' A' ' 51' ' ' VAL . 72.1 mm-40 -73.1 -8.68 56.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.778 0.323 . . . . 0.0 110.674 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.54 ' C ' ' H ' ' A' ' 49' ' ' GLY . 3.6 m 61.42 -159.57 0.32 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.723 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 38.7 tp60 66.4 -7.39 0.43 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.142 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.54 ' H ' ' C ' ' A' ' 47' ' ' SER . . . 84.17 3.53 88.84 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -178.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.463 ' O ' ' OG1' ' A' ' 53' ' ' THR . 0.2 OUTLIER -66.61 -38.12 86.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.538 0.685 . . . . 0.0 109.769 178.487 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.47 ' CG2' ' H ' ' A' ' 46' ' ' GLU . 54.6 t -60.74 -44.97 98.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.319 -178.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.96 -34.72 79.09 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.275 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' A' ' 50' ' ' LEU . 19.6 p -68.68 -38.25 80.2 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.115 0.483 . . . . 0.0 110.052 178.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -92.88 -159.77 0.7 Allowed 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.868 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -169.78 -40.19 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.171 -0.611 . . . . 0.0 111.831 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.525 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 87.6 p -126.91 -139.58 0.26 Allowed 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 56' ' ' SER . . . 92.87 14.64 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 O-C-N 123.813 0.696 . . . . 0.0 111.81 178.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 90.6 mm-40 -155.45 52.43 0.59 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -41.39 145.43 0.26 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.381 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.418 ' O ' ' C ' ' A' ' 61' ' ' GLY . 62.7 ttp180 -49.8 -44.62 49.23 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 60' ' ' ARG . . . -28.52 101.54 0.01 OUTLIER Glycine 0 CA--C 1.53 0.995 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.7 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.5 p -67.54 -33.97 65.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.34 176.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.25 -32.37 71.08 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 121.165 1.802 . . . . 0.0 109.436 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.32 -49.22 67.14 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 114.832 -1.077 . . . . 0.0 115.062 -176.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 94.6 m -61.9 -46.32 89.87 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 33.7 mm -59.57 -35.49 59.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 76.8 mt -63.19 -35.82 81.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 121.028 1.74 . . . . 0.0 111.506 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.437 ' O ' ' OG1' ' A' ' 72' ' ' THR . 99.4 m -62.47 -38.8 91.24 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 113.219 -1.81 . . . . 0.0 111.053 -177.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 27.8 ttt -60.73 -40.02 90.79 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 -177.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.1 m -69.07 -39.81 80.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 119.612 -0.835 . . . . 0.0 112.375 -178.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -77.42 -12.76 59.99 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 122.182 0.991 . . . . 0.0 113.217 -177.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.437 ' OG1' ' O ' ' A' ' 68' ' ' THR . 33.5 m -62.5 -55.12 30.47 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 113.927 -1.488 . . . . 0.0 112.762 -179.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -113.6 5.24 16.47 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 123.036 1.398 . . . . 0.0 109.466 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.443 ' O ' ' OG ' ' A' ' 77' ' ' SER . . . 96.46 170.92 34.67 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-N 111.598 -2.546 . . . . 0.0 110.783 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -56.4 -34.47 94.47 Favored 'Trans proline' 0 N--CA 1.5 1.909 0 C-N-CA 122.518 2.145 . . . . 0.0 111.682 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.425 ' O ' ' CB ' ' A' ' 80' ' ' ASN . 1.7 mpt_? -61.01 -10.53 6.03 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.796 0.807 . . . . 0.0 111.093 176.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 74' ' ' GLY . 81.3 p -77.24 -32.35 55.71 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.168 -1.378 . . . . 0.0 111.231 -177.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.2 tt -75.9 -34.15 59.94 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.297 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -93.76 -5.98 47.1 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 122.022 0.915 . . . . 0.0 113.013 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.425 ' CB ' ' O ' ' A' ' 76' ' ' ARG . 4.2 t30 -81.23 124.69 29.51 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 113.802 -1.545 . . . . 0.0 107.625 176.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.99 0.67 71.12 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 109.696 -1.361 . . . . 0.0 109.696 -178.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 45.3 tp -59.43 -35.33 73.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 113.477 -1.361 . . . . 0.0 110.955 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.8 p -70.76 -26.99 29.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.563 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.8 -31.65 61.79 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.512 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -68.14 -40.79 87.97 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 119.489 -1.338 . . . . 0.0 111.389 -177.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.532 ' O ' ' SD ' ' A' ' 90' ' ' MET . 75.7 mt -62.59 -40.53 97.2 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 122.311 1.053 . . . . 0.0 112.587 -176.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -59.51 -26.22 65.13 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 113.324 -1.762 . . . . 0.0 108.944 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 18.3 ttm180 -57.06 -52.88 63.53 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 113.335 -1.757 . . . . 0.0 106.645 173.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.402 HE22 ' CG ' ' A' ' 28' ' ' ASP . 9.8 tp-100 -67.39 -30.19 69.9 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 112.857 -1.974 . . . . 0.0 113.247 -177.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.552 ' N ' ' SD ' ' A' ' 90' ' ' MET . 0.0 OUTLIER -61.02 -40.9 95.33 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.357 -179.489 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 68.7 p -74.53 -34.5 63.02 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 119.382 -0.927 . . . . 0.0 111.409 -176.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -57.86 -44.41 86.59 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-N 121.041 1.746 . . . . 0.0 111.616 -176.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.76 -33.17 64.16 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.691 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.48 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 24.3 p -64.18 -42.07 96.84 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.455 ' C ' ' H ' ' A' ' 97' ' ' ILE . 34.5 m -68.16 -27.74 38.3 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.839 177.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.444 ' O ' ' CD1' ' A' ' 100' ' ' TYR . 49.1 ttm-85 -77.21 9.24 3.23 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 -177.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.48 ' CG2' ' O ' ' A' ' 94' ' ' SER . 11.0 tt -87.12 -15.58 9.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 178.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -140.61 -48.03 0.05 OUTLIER Glycine 0 CA--C 1.538 1.499 0 N-CA-C 115.653 1.021 . . . . 0.0 115.653 -176.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.481 ' CD1' ' N ' ' A' ' 99' ' ' LEU . 9.4 mp -71.18 -12.7 61.62 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.927 1.363 . . . . 0.0 112.521 -178.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.597 ' CD1' ' N ' ' A' ' 101' ' ' ASP . 0.1 OUTLIER -80.46 -50.76 9.64 Favored 'General case' 0 C--O 1.214 -0.792 0 CA-C-N 114.382 -1.281 . . . . 0.0 111.563 -179.623 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 1.072 ' OD1' ' NE2' ' A' ' 105' ' ' GLN . 28.5 t70 -68.14 -31.2 70.61 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 122.857 1.313 . . . . 0.0 109.446 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.2 t -68.61 -53.42 22.8 Favored 'General case' 0 CA--C 1.554 1.134 0 CA-C-N 112.227 -2.26 . . . . 0.0 113.393 176.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -75.59 -28.22 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 CA-C-N 123.34 2.791 . . . . 0.0 115.708 -178.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.436 ' HZ1' ' HB2' ' A' ' 100' ' ' TYR . 18.8 mttt -69.33 -42.3 75.52 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 111.169 -2.741 . . . . 0.0 112.888 -178.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 1.072 ' NE2' ' OD1' ' A' ' 101' ' ' ASP . 88.1 mt-30 -78.97 -10.11 59.73 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 124.225 1.964 . . . . 0.0 111.063 177.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -78.97 -22.45 45.6 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 112.273 -2.24 . . . . 0.0 111.358 177.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.467 ' CZ ' ' OD1' ' A' ' 190' ' ' ASN . 27.5 m-85 -109.3 -30.84 7.8 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 119.637 1.108 . . . . 0.0 111.995 -175.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.9 t -98.66 9.27 43.66 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 117.275 -1.77 . . . . 0.0 112.796 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.512 ' O ' ' C ' ' A' ' 110' ' ' GLY . 0.0 OUTLIER -50.49 122.06 6.58 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 118.395 -0.812 . . . . 0.0 110.948 -179.733 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.518 ' O ' ' CB ' ' A' ' 111' ' ' SER . . . -22.5 -78.83 0.01 OUTLIER Glycine 0 N--CA 1.487 2.066 0 CA-C-N 119.124 0.875 . . . . 0.0 111.73 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 110' ' ' GLY . 5.9 p 94.33 -156.36 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 175.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.431 ' C ' ' H ' ' A' ' 114' ' ' ALA . 76.6 mt-10 -120.45 172.55 7.74 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 114.398 -1.274 . . . . 0.0 111.556 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.453 ' O ' ' CB ' ' A' ' 114' ' ' ALA . 45.1 p-80 -63.81 48.59 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.498 -179.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.453 ' CB ' ' O ' ' A' ' 113' ' ' HIS . . . 159.06 -162.2 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.2 14.98 27.0 Favored Glycine 0 N--CA 1.464 0.514 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.298 177.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 24.0 mm -60.72 -40.45 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.08 -39.41 96.29 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 122.066 0.814 . . . . 0.0 111.67 176.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 7.6 t -58.08 -42.09 84.82 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 177.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.657 HH12 ' HZ1' ' A' ' 201' ' ' LYS . 99.5 mtt180 -63.17 -37.23 86.41 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.227 -177.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 92.5 mt -63.59 -46.01 87.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.256 0.551 . . . . 0.0 109.823 178.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 56.2 mt -66.82 -44.79 80.24 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.391 178.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.11 -45.16 89.85 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 119.876 1.216 . . . . 0.0 110.257 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -65.75 -44.07 92.95 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 120.184 -1.008 . . . . 0.0 111.299 -179.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.4 t -63.93 -43.85 94.63 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.692 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 19.1 m -69.34 -48.32 61.72 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 119.118 -1.033 . . . . 0.0 112.075 177.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.427 ' CG2' ' N ' ' A' ' 127' ' ' GLY . 5.5 t -65.57 -42.74 91.45 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 -174.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.427 ' N ' ' CG2' ' A' ' 126' ' ' THR . . . -64.19 -44.48 95.58 Favored Glycine 0 CA--C 1.52 0.396 0 CA-C-O 122.73 1.183 . . . . 0.0 112.95 -177.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.405 ' O ' ' CG1' ' A' ' 131' ' ' VAL . . . -60.81 -41.35 95.53 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 112.178 -2.011 . . . . 0.0 106.492 177.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 15.1 tp -64.44 -42.25 96.09 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.773 178.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.11 -39.92 96.1 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -177.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.405 ' CG1' ' O ' ' A' ' 128' ' ' ALA . 3.3 p -60.9 -24.81 33.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 122.577 1.18 . . . . 0.0 109.265 178.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -57.74 -44.85 86.36 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 112.709 -2.041 . . . . 0.0 111.727 -178.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.485 ' CG1' ' N ' ' A' ' 134' ' ' ALA . 3.0 p -79.17 -48.98 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.13 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.485 ' N ' ' CG1' ' A' ' 133' ' ' VAL . . . -103.29 128.78 50.23 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.257 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.474 ' N ' ' HD2' ' A' ' 136' ' ' PRO . 27.3 tt0 -179.58 -50.32 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.718 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 135' ' ' GLN . 11.2 Cg_endo -51.79 -33.89 52.38 Favored 'Trans proline' 0 N--CA 1.499 1.849 0 C-N-CA 121.545 1.497 . . . . 0.0 114.221 -177.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 41.4 p -67.36 -41.71 84.67 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 118.183 -1.407 . . . . 0.0 108.42 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -64.43 -42.26 96.11 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.104 -1.038 . . . . 0.0 111.053 -178.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 88.5 t -63.57 -43.43 98.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.176 0.513 . . . . 0.0 111.07 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 53.8 t -64.32 -38.44 82.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.807 -178.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -61.55 -40.58 95.2 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.206 -0.598 . . . . 0.0 111.854 -177.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 97.6 t -69.52 -44.86 79.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.307 0.575 . . . . 0.0 109.66 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.4 -35.74 81.9 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.545 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -66.13 -40.76 90.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 112.166 -177.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 4.0 tm0? -64.67 -39.52 93.82 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.08 -1.048 . . . . 0.0 109.841 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.08 -34.93 79.59 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -177.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.419 ' C ' ' OE1' ' A' ' 147' ' ' GLN . 0.0 OUTLIER -59.36 111.41 1.36 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.417 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -96.42 -62.18 1.31 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 117.777 -1.106 . . . . 0.0 113.828 -176.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -62.02 126.7 28.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 122.481 2.4 . . . . 0.0 110.474 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -55.92 -49.43 73.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.664 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.482 ' C ' ' H ' ' A' ' 153' ' ' GLY . . . 152.94 155.32 7.07 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -76.73 27.54 1.6 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.482 ' H ' ' C ' ' A' ' 151' ' ' GLY . . . -159.78 156.5 27.69 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 45.8 ttp180 -71.91 1.58 6.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.115 0.483 . . . . 0.0 110.086 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.505 ' NH1' ' OE2' ' A' ' 161' ' ' GLU . 0.0 OUTLIER -52.88 -35.59 58.1 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.021 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.423 ' O ' ' O ' ' A' ' 157' ' ' GLN . 11.0 t80 76.08 -9.32 1.47 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.01 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.423 ' O ' ' O ' ' A' ' 156' ' ' TYR . 34.3 mt-30 49.67 176.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.992 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 25.7 t -157.05 -177.66 6.78 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.307 0.575 . . . . 0.0 110.883 -179.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 9.2 t -63.98 -45.86 87.2 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.675 -177.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 87.2 t -63.81 -45.17 97.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 119.063 -1.055 . . . . 0.0 108.721 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.505 ' OE2' ' NH1' ' A' ' 155' ' ' ARG . 92.1 mt-10 -67.28 -39.16 85.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.725 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -61.67 -45.87 92.16 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -177.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.438 ' CD1' ' C ' ' A' ' 163' ' ' TYR . 12.5 t80 -62.47 -50.12 72.69 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.06 -179.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -68.2 -45.51 73.16 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -175.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 18.8 m -62.65 -44.73 95.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 119.433 1.015 . . . . 0.0 113.142 -177.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 47.3 mm -64.63 -38.63 83.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-O 121.968 0.89 . . . . 0.0 109.6 176.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.7 -36.31 76.24 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 113.787 -1.551 . . . . 0.0 108.059 176.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 32.2 mmm-85 -62.13 -50.31 72.42 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 122.2 2.273 . . . . 0.0 111.97 -175.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -75.05 -50.92 14.89 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 123.471 0.708 . . . . 0.0 109.113 177.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -78.07 -36.51 48.19 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 -173.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 91.28 -167.32 31.36 Favored Glycine 0 N--CA 1.469 0.836 0 CA-C-N 118.29 0.496 . . . . 0.0 111.945 177.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 6.3 pt -72.83 -43.26 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 CA-C-O 121.643 0.735 . . . . 0.0 110.414 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -58.88 -33.65 70.73 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.336 -1.302 . . . . 0.0 111.143 -177.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -60.96 -40.64 98.72 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 118.528 -1.796 . . . . 0.0 109.396 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.72 -34.14 71.59 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 111.134 -2.533 . . . . 0.0 117.065 -177.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . 0.528 ' CE2' ' OG ' ' A' ' 180' ' ' SER . 55.7 t90 -78.08 -8.77 58.65 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 111.779 -2.464 . . . . 0.0 110.949 -176.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -44.57 -48.96 10.33 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 114.679 1.362 . . . . 0.0 114.679 -175.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -102.99 -37.96 3.02 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 124.206 0.908 . . . . 0.0 113.528 -177.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.446 ' CG2' ' N ' ' A' ' 180' ' ' SER . 0.9 OUTLIER -45.19 -50.98 11.1 Favored 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -178.925 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.528 ' OG ' ' CE2' ' A' ' 176' ' ' TRP . 0.0 OUTLIER -62.64 -50.43 78.26 Favored Pre-proline 0 N--CA 1.48 1.026 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -177.0 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.428 ' HD2' ' N ' ' A' ' 180' ' ' SER . 25.8 Cg_endo -63.83 -26.97 67.46 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.196 1.931 . . . . 0.0 111.265 177.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 18.0 t30 -62.7 -38.08 89.04 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 39.8 t -62.08 -41.34 90.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.12 -38.69 87.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.746 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 60.3 ttt85 -60.23 -41.15 92.51 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.717 -0.393 . . . . 0.0 109.944 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -60.92 -42.23 97.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.248 0.547 . . . . 0.0 110.463 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . 0.452 ' O ' ' SG ' ' A' ' 191' ' ' CYS . . . -63.8 -42.93 97.61 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.433 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 96.4 mt -62.85 -44.85 99.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -177.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 6.1 m -59.66 -45.8 93.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 119.854 -0.738 . . . . 0.0 110.875 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . 0.467 ' OD1' ' CZ ' ' A' ' 107' ' ' TYR . 53.1 t30 -62.08 -43.55 98.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 122.069 0.937 . . . . 0.0 109.892 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' CYS . . . . . 0.452 ' SG ' ' O ' ' A' ' 187' ' ' ALA . 79.3 m -62.59 -47.02 85.62 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 113.902 -1.499 . . . . 0.0 110.625 178.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.31 -40.69 96.42 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 114.018 -1.446 . . . . 0.0 109.929 177.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -61.1 -45.49 94.51 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.337 -1.302 . . . . 0.0 112.611 -178.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 1.4 tt -63.22 -37.4 87.09 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 118.676 -1.21 . . . . 0.0 108.262 -175.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 66.1 t -62.74 -46.19 96.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 C-N-CA 117.391 -1.723 . . . . 0.0 107.076 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 14.7 m -64.27 -46.37 84.0 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 113.712 1.005 . . . . 0.0 113.712 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -57.36 -39.16 75.4 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.639 1.176 . . . . 0.0 113.27 -177.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -55.63 -44.64 77.29 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -178.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 8.8 mp -61.46 -39.23 90.12 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.881 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 1.7 mp -63.38 -43.64 98.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-O 118.333 -0.842 . . . . 0.0 111.366 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . 0.657 ' HZ1' HH12 ' A' ' 119' ' ' ARG . 53.4 mtmt -60.59 -41.3 94.41 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 121.154 1.797 . . . . 0.0 111.237 177.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -65.33 -36.67 84.73 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 113.11 -1.859 . . . . 0.0 110.965 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 54.7 m -101.92 129.91 48.28 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.691 0.758 . . . . 0.0 111.892 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 68.37 5.19 4.61 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 114.615 -1.175 . . . . 0.0 112.192 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.518 ' O ' ' O ' ' A' ' 201' ' ' LYS . 1.7 tt -148.05 74.1 1.28 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.656 0.741 . . . . 0.0 110.523 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.35 -17.97 17.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.083 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.569 ' O ' ' CG ' ' A' ' 208' ' ' ASN . . . -170.72 18.98 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.573 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . 0.572 ' OD1' ' N ' ' A' ' 209' ' ' LEU . 44.3 p30 115.46 -140.24 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.093 0 O-C-N 125.636 1.835 . . . . 0.0 109.679 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.572 ' N ' ' OD1' ' A' ' 208' ' ' ASN . 13.6 tp -176.07 53.94 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 60.9 mtm -72.42 -13.67 61.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.491 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 16.9 m -56.39 152.92 10.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.911 0.386 . . . . 0.0 111.065 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -83.86 -141.22 0.07 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.574 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 53.11 57.41 6.33 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.442 ' N ' ' CD ' ' A' ' 215' ' ' PRO . 3.3 mt -61.14 -43.74 91.53 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.158 -178.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 214' ' ' LEU . 32.3 Cg_exo -60.5 -32.97 94.29 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 121.21 1.273 . . . . 0.0 111.469 -179.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 76.2 m -64.05 -42.0 97.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 113.322 -1.763 . . . . 0.0 111.611 -178.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' HIS . . . . . 0.422 ' O ' ' OG ' ' A' ' 220' ' ' SER . 8.3 t-160 -66.53 -37.89 85.98 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.4 -0.52 . . . . 0.0 111.987 -178.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -63.42 -46.93 84.05 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.803 -178.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 1.5 t -60.13 -37.49 80.24 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 118.94 0.791 . . . . 0.0 111.064 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' A' ' 217' ' ' HIS . 82.5 p -59.38 -41.28 88.98 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.42 -41.6 98.7 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -177.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -61.46 -46.97 87.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 122.133 0.968 . . . . 0.0 112.387 -176.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -60.5 -41.65 98.76 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 107.361 -2.296 . . . . 0.0 107.361 177.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -62.72 -38.33 90.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.45 -0.875 . . . . 0.0 108.717 177.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -62.04 -42.45 99.73 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -178.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -66.9 -38.36 86.11 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 63.5 m -63.24 -41.28 99.07 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.179 177.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' THR . . . . . 0.462 ' OG1' ' O ' ' A' ' 225' ' ' GLY . 53.2 p -61.89 -40.17 94.51 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.494 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 39.5 m -59.58 -40.46 87.47 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.644 -177.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 95.3 t -61.58 -42.73 95.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 119.245 -0.982 . . . . 0.0 112.318 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . 0.493 ' O ' ' HD2' ' A' ' 234' ' ' PRO . 12.8 pt -62.67 -40.65 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 119.895 -0.722 . . . . 0.0 109.383 177.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -62.78 -39.35 93.92 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.472 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 0.0 OUTLIER -58.44 -42.45 94.7 Favored Pre-proline 0 N--CA 1.481 1.094 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -173.327 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.493 ' HD2' ' O ' ' A' ' 231' ' ' ILE . 32.5 Cg_exo -58.77 -41.05 66.99 Favored 'Trans proline' 0 C--N 1.294 -2.304 0 C-N-CA 122.059 1.84 . . . . 0.0 113.654 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 6.9 m -65.99 -37.42 79.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 118.507 -1.277 . . . . 0.0 111.149 178.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -65.54 -41.45 93.05 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -178.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.442 ' O ' ' OG1' ' A' ' 240' ' ' THR . 16.1 m -65.24 -44.86 95.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -176.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 60.3 t -62.8 -37.3 78.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.268 -177.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -60.63 -43.97 96.9 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.486 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' A' ' 237' ' ' VAL . 31.3 p -61.26 -41.72 97.4 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.238 -0.437 . . . . 0.0 112.156 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.518 ' O ' ' CB ' ' A' ' 242' ' ' TYR . 54.7 ttt-85 -39.76 142.06 0.36 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.757 -179.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.518 ' CB ' ' O ' ' A' ' 241' ' ' ARG . 0.9 OUTLIER 153.88 120.6 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 O-C-N 123.357 0.411 . . . . 0.0 111.109 179.238 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' MET . . . . . 0.435 ' O ' ' O ' ' A' ' 244' ' ' ASN . 12.1 ptp -178.56 -154.67 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . 0.497 ' O ' ' OG ' ' A' ' 245' ' ' SER . 12.1 t-20 57.2 113.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.709 -0.397 . . . . 0.0 110.874 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' SER . . . . . 0.497 ' OG ' ' O ' ' A' ' 244' ' ' ASN . 92.6 p 61.94 -127.84 0.73 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.647 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -178.87 -103.78 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.651 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 5.5 mt -70.41 121.67 18.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.749 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -173.3 145.66 8.47 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.962 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.588 ' HB3' ' CE1' ' A' ' 255' ' ' HIS . 96.2 mm-40 51.05 -99.63 0.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.815 0.341 . . . . 0.0 110.633 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER 63.24 140.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.862 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 175.72 -46.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.633 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' SER . . . . . 0.656 ' O ' ' N ' ' A' ' 255' ' ' HIS . 30.8 t -178.98 130.49 0.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.632 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.603 ' C ' ' O ' ' A' ' 252' ' ' SER . . . -17.69 -56.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.241 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 252' ' ' SER . . . -42.19 -34.73 1.58 Allowed Glycine 0 N--CA 1.468 0.817 0 CA-C-O 119.394 -0.67 . . . . 0.0 112.773 178.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' HIS . . . . . 0.737 ' ND1' HG22 ' A' ' 259' ' ' THR . 64.7 t-80 -54.32 -36.69 64.02 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 117.545 -1.662 . . . . 0.0 111.066 -179.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' CYS . . . . . . . . . . . . . 17.3 t -60.59 -45.05 95.42 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 119.912 -0.715 . . . . 0.0 112.008 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -60.62 -45.66 93.2 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.446 -0.502 . . . . 0.0 112.303 -177.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.83 -44.58 76.9 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.356 -0.937 . . . . 0.0 110.452 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' THR . . . . . 0.737 HG22 ' ND1' ' A' ' 255' ' ' HIS . 70.0 p -64.03 -47.63 79.47 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -178.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' MET . . . . . 0.56 ' SD ' ' N ' ' A' ' 261' ' ' LEU . 0.0 OUTLIER -62.47 -43.85 97.83 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.232 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.56 ' N ' ' SD ' ' A' ' 260' ' ' MET . 7.0 tp -62.13 -46.57 88.44 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 122.792 0.437 . . . . 0.0 111.093 -178.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 13.6 tpp85 -66.0 -53.81 34.06 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.868 -178.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -91.16 -122.07 0.07 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.735 0.303 . . . . 0.0 111.595 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . 0.494 ' O ' ' O ' ' A' ' 265' ' ' GLY . 58.0 mt-10 -30.57 107.45 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -178.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 264' ' ' GLU . . . -41.38 175.07 0.01 OUTLIER Glycine 0 CA--C 1.533 1.173 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 178.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -68.73 -9.1 25.22 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 122.835 2.357 . . . . 0.0 111.483 177.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 82.6 mtt85 -69.43 -26.61 64.7 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.122 0.569 . . . . 0.0 112.087 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -58.31 -32.07 68.12 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.392 -179.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -61.99 -41.9 98.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.245 0.545 . . . . 0.0 110.547 177.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -66.15 -37.89 86.77 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.194 -178.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.444 ' O ' ' O ' ' A' ' 272' ' ' GLY . 62.7 mmtt -73.17 -173.75 1.39 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 271' ' ' LYS . . . 48.69 103.87 0.01 OUTLIER Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -170.46 1.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.449 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' MET . . . . . 0.568 ' N ' ' CD ' ' A' ' 275' ' ' PRO . 0.5 OUTLIER -63.97 -44.53 78.7 Favored Pre-proline 0 CA--C 1.532 0.268 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.869 -179.555 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 274' ' ' MET . 21.5 Cg_exo -64.68 -46.67 6.47 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.44 2.093 . . . . 0.0 110.947 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 51.0 m -60.76 -39.51 89.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.287 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -61.75 -42.76 99.4 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 122.878 1.323 . . . . 0.0 112.814 -178.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 8.5 tp -62.29 -38.79 90.73 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 111.853 -2.43 . . . . 0.0 108.138 174.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 16.2 mmm180 -62.73 -39.49 94.24 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.438 0.637 . . . . 0.0 110.326 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 22.3 tp -61.97 -36.61 81.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.974 -1.012 . . . . 0.0 113.028 -177.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -68.24 -51.34 33.34 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 14.0 p -63.07 -44.43 95.81 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.268 0.627 . . . . 0.0 109.883 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' TRP . . . . . . . . . . . . . 62.7 t90 -60.06 -37.99 81.52 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -61.83 -37.41 84.36 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.587 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -59.88 -37.45 71.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.222 -178.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -61.86 -40.02 85.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 120.234 -0.587 . . . . 0.0 109.755 -179.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 16.6 mmt -61.51 -39.59 91.55 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.849 0.357 . . . . 0.0 110.66 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -59.63 -41.95 91.62 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -178.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 3.1 p -61.82 -38.62 80.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 O-C-N 121.854 -0.529 . . . . 0.0 111.279 -178.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 10.3 m -62.58 -40.73 97.83 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -61.27 -38.85 88.25 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 176.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -58.28 -40.45 81.95 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 117.867 -1.533 . . . . 0.0 109.616 -176.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' GLN . . . . . 0.48 ' O ' ' O ' ' A' ' 296' ' ' ARG . 75.7 mt-30 -60.75 -43.13 98.37 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 122.554 1.169 . . . . 0.0 111.293 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 9.3 mp -60.8 -40.66 93.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 113.382 -1.736 . . . . 0.0 109.1 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -63.39 -45.96 88.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.047 178.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' ARG . . . . . 0.48 ' O ' ' O ' ' A' ' 293' ' ' GLN . 16.4 tpp180 -123.22 116.02 22.7 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.299 -0.864 . . . . 0.0 108.873 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -122.24 -163.5 1.08 Allowed 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -178.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.517 ' CD2' ' N ' ' A' ' 298' ' ' LEU . 3.3 mm? -63.54 -175.65 0.13 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 176.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 21.8 ttt -166.55 64.47 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 119.614 -0.835 . . . . 0.0 112.371 -178.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . 0.428 ' CB ' ' OE1' ' A' ' 303' ' ' GLN . . . -175.6 100.85 0.07 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 122.079 0.943 . . . . 0.0 110.52 -178.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -64.18 -46.34 84.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 113.545 -1.661 . . . . 0.0 113.351 -176.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -58.57 -39.62 80.82 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.014 -177.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . 0.428 ' OE1' ' CB ' ' A' ' 300' ' ' ALA . 47.0 mt-30 -64.9 -46.93 79.65 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.71 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' SER . . . . . 0.433 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 15.5 m -66.79 -38.05 85.77 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.064 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 65.2 mtt-85 -61.81 -42.61 99.23 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.017 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 10.6 tm-20 -64.75 -36.9 85.81 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -177.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -60.12 -53.12 68.2 Favored Pre-proline 0 CA--C 1.544 0.717 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -176.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' PRO . . . . . 0.433 ' CD ' ' O ' ' A' ' 304' ' ' SER . 73.7 Cg_endo -75.35 0.25 9.27 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.199 1.933 . . . . 0.0 111.955 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 54.2 t80 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.558 -179.841 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 14.5 ptt? . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.5 m 44.61 85.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.617 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.501 ' CG2' ' H ' ' A' ' 16' ' ' LYS . 8.0 p -156.54 175.45 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.404 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.501 ' H ' ' CG2' ' A' ' 15' ' ' VAL . 54.3 tttp -64.3 -41.34 96.91 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.951 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -63.58 -41.77 98.34 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 44.5 tp -79.8 -26.48 40.54 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.921 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.46 ' O ' ' OG1' ' A' ' 22' ' ' THR . . . -66.32 -41.26 94.68 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 107.615 -2.194 . . . . 0.0 107.615 177.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.39 -32.22 68.19 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 124.811 2.243 . . . . 0.0 107.467 176.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.55 -42.38 98.9 Favored Glycine 0 CA--C 1.528 0.845 1 CA-C-N 108.399 -4.001 . . . . 0.0 108.242 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.46 ' OG1' ' O ' ' A' ' 19' ' ' GLY . 22.2 p -70.68 -27.55 64.09 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.54 0.686 . . . . 0.0 109.225 177.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.48 -50.1 64.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.875 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.79 -35.98 79.76 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 118.46 -1.296 . . . . 0.0 111.253 -177.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 79.2 m -63.9 -53.77 45.25 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.339 -178.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.8 tt -65.64 -39.59 85.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 -177.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.92 -41.93 97.53 Favored 'General case' 0 C--O 1.224 -0.273 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -173.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 28' ' ' ASP . 3.8 t70 -77.78 -26.94 50.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 120.345 1.429 . . . . 0.0 110.078 -175.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 45.6 mt -59.86 -55.12 38.1 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 119.841 1.201 . . . . 0.0 112.332 -178.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.0 pt -75.47 -4.31 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -109.68 -17.59 13.66 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 118.54 -1.264 . . . . 0.0 110.253 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -68.08 -44.33 38.39 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 122.046 2.203 . . . . 0.0 110.779 -177.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -59.16 -15.63 29.47 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 CA-C-N 120.836 1.334 . . . . 0.0 111.31 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.8 -35.74 80.77 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.165 -0.925 . . . . 0.0 113.296 -177.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -64.44 -40.56 95.98 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.149 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 79.6 p -58.12 -34.87 70.69 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.34 -38.64 85.17 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 119.907 -0.717 . . . . 0.0 112.62 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.446 ' CG ' ' N ' ' A' ' 39' ' ' VAL . 12.0 pttp -61.54 -48.1 82.55 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 119.421 -0.912 . . . . 0.0 111.478 -176.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.446 ' N ' ' CG ' ' A' ' 38' ' ' LYS . 7.2 m -62.92 -38.81 82.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -176.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.555 ' C ' ' H ' ' A' ' 42' ' ' GLN . 61.7 mtp85 -59.86 -41.01 90.55 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 119.356 -0.938 . . . . 0.0 110.175 -178.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -62.59 38.75 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.866 177.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.555 ' H ' ' C ' ' A' ' 40' ' ' ARG . 15.7 pt20 -91.03 149.08 21.97 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.823 -0.548 . . . . 0.0 111.168 -179.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 7.5 mt -96.49 44.59 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.054 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 21.5 mm100 46.62 -165.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.52 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 160.49 -72.02 0.22 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.548 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 2.6 pm0 -44.54 -24.8 0.21 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.859 0.361 . . . . 0.0 110.53 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.9 m 56.78 71.06 0.59 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.761 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -62.03 -27.96 69.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.184 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.77 -14.09 61.04 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 109.009 -1.636 . . . . 0.0 109.009 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.1 mp -65.76 -37.48 86.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.65 -0.775 . . . . 0.0 109.176 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 20.0 m -60.87 -44.4 97.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.965 -178.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 -64.67 -35.44 81.05 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 119.779 -0.768 . . . . 0.0 112.35 -177.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 t -68.89 -38.01 79.37 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 119.383 -0.927 . . . . 0.0 108.778 177.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -130.63 94.39 3.63 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.571 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.21 -2.21 18.0 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -177.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.524 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 24.3 p -125.21 -141.74 0.29 Allowed 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 56' ' ' SER . . . 97.66 13.69 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 O-C-N 124.159 0.912 . . . . 0.0 111.928 178.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.445 ' O ' ' O ' ' A' ' 59' ' ' TYR . 25.0 pt20 -163.26 -39.4 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.369 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.445 ' O ' ' O ' ' A' ' 58' ' ' GLN . 39.5 m-85 54.35 166.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.979 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.408 ' O ' ' C ' ' A' ' 61' ' ' GLY . 65.3 mtm180 -57.54 -41.56 81.2 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 60' ' ' ARG . . . -29.98 102.47 0.01 OUTLIER Glycine 0 CA--C 1.527 0.833 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.567 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.3 p -67.26 -33.75 64.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 118.378 -0.82 . . . . 0.0 109.864 176.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -60.18 -32.27 70.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 121.144 1.793 . . . . 0.0 109.674 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.68 -49.4 64.32 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 115.022 -0.99 . . . . 0.0 114.564 -176.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.4 p -62.28 -46.69 87.67 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.5 tp -60.02 -35.38 60.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.2 tt -63.21 -35.51 80.55 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 121.291 1.86 . . . . 0.0 110.848 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 99.9 m -62.63 -38.26 89.55 Favored 'General case' 0 C--O 1.246 0.884 0 CA-C-N 113.049 -1.887 . . . . 0.0 111.069 -175.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.512 ' O ' ' OG1' ' A' ' 72' ' ' THR . 0.4 OUTLIER -60.37 -39.14 86.17 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 120.322 -1.486 . . . . 0.0 114.283 -177.075 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.7 m -69.49 -40.25 79.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 119.186 -1.005 . . . . 0.0 113.054 -178.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -78.4 -13.3 59.9 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -178.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.512 ' OG1' ' O ' ' A' ' 69' ' ' MET . 2.5 p -62.86 -54.61 36.07 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.707 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.515 ' N ' ' OE1' ' A' ' 73' ' ' GLU . 54.8 mp0 -107.36 -58.17 1.99 Allowed 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 155.45 164.19 12.89 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -56.59 -35.36 97.04 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 121.714 1.609 . . . . 0.0 111.925 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -61.65 -12.33 15.66 Favored 'General case' 0 C--O 1.226 -0.144 0 CA-C-O 121.751 0.786 . . . . 0.0 110.887 176.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.3 t -78.24 -32.9 49.95 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.247 -1.342 . . . . 0.0 110.805 -178.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 14.6 tp -75.94 -33.28 59.83 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.833 0.349 . . . . 0.0 110.963 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -92.3 -5.01 53.12 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 122.802 1.287 . . . . 0.0 112.767 -178.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -93.92 117.45 30.12 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 112.224 -2.262 . . . . 0.0 107.071 175.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.84 -10.39 57.24 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 -177.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 56.4 tp -59.05 -34.74 72.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 113.281 -1.46 . . . . 0.0 110.687 -179.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 38.2 t -70.44 -26.36 28.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.794 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.64 -31.17 61.89 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.908 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.8 -40.51 89.63 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 119.693 -1.241 . . . . 0.0 111.619 -177.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.408 ' N ' ' CD2' ' A' ' 86' ' ' LEU . 3.7 mm? -62.43 -40.36 96.32 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 122.351 1.072 . . . . 0.0 112.434 -177.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -60.32 -26.91 66.92 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 113.131 -1.85 . . . . 0.0 108.984 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 16.5 ttm-85 -57.73 -53.42 58.36 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 173.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 53.2 tp60 -67.32 -30.02 69.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 112.606 -2.088 . . . . 0.0 112.151 -178.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 11.9 tpt -61.15 -41.35 96.6 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.018 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 40.4 m -74.8 -34.86 62.47 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 119.455 -0.898 . . . . 0.0 111.304 -177.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -57.9 -44.12 86.56 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 120.966 1.712 . . . . 0.0 111.966 -176.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.48 -33.12 64.68 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.551 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.1 m -64.51 -41.69 96.26 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.451 ' C ' ' H ' ' A' ' 97' ' ' ILE . 86.0 t -68.22 -28.45 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.885 177.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.498 ' NH2' ' CE2' ' A' ' 100' ' ' TYR . 54.4 ttt-85 -77.78 9.5 3.45 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -176.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.451 ' H ' ' C ' ' A' ' 95' ' ' VAL . 98.3 mt -86.8 -14.71 10.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -139.99 -48.38 0.06 OUTLIER Glycine 0 CA--C 1.543 1.809 0 N-CA-C 116.059 1.184 . . . . 0.0 116.059 -177.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 95.2 mt -71.72 -12.48 61.34 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 119.899 1.849 . . . . 0.0 113.792 -178.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.498 ' CE2' ' NH2' ' A' ' 96' ' ' ARG . 2.5 t80 -80.12 -51.47 8.95 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.326 -1.306 . . . . 0.0 111.384 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -69.97 -32.35 70.53 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 123.619 1.676 . . . . 0.0 110.925 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.0 t -68.21 -51.07 49.66 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 110.455 -3.066 . . . . 0.0 113.301 177.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -73.51 -26.41 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.359 0 CA-C-N 121.337 1.881 . . . . 0.0 111.24 179.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 63.8 mttt -69.44 -41.74 75.88 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 112.385 -2.189 . . . . 0.0 112.533 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -80.16 -12.9 59.61 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 122.613 1.197 . . . . 0.0 111.047 -178.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -80.08 -23.19 41.49 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.24 178.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -109.97 -28.54 8.68 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 119.53 1.059 . . . . 0.0 112.881 -175.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.11 9.38 41.06 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 116.765 -1.974 . . . . 0.0 113.962 -175.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.544 ' C ' ' H ' ' A' ' 111' ' ' SER . 62.0 mttp -45.97 130.11 9.75 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.512 1.051 . . . . 0.0 108.699 176.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -63.04 38.98 0.07 OUTLIER Glycine 0 CA--C 1.544 1.903 0 CA-C-N 119.179 0.9 . . . . 0.0 114.166 -178.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.544 ' H ' ' C ' ' A' ' 109' ' ' LYS . 10.6 m -5.29 -81.77 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 116.488 2.033 . . . . 0.0 116.488 -178.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.625 ' O ' ' CG ' ' A' ' 113' ' ' HIS . 2.9 tt0 165.79 -33.24 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 120.456 1.48 . . . . 0.0 113.446 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.625 ' CG ' ' O ' ' A' ' 112' ' ' GLU . 3.9 m-70 160.37 38.01 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.344 0.592 . . . . 0.0 109.931 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.479 ' CB ' ' O ' ' A' ' 113' ' ' HIS . . . 160.37 -162.7 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.855 0.836 . . . . 0.0 109.15 177.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.44 ' O ' ' OG ' ' A' ' 118' ' ' SER . . . 103.08 15.45 23.79 Favored Glycine 0 C--N 1.335 0.495 0 CA-C-N 114.104 -1.407 . . . . 0.0 110.512 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.494 ' CD1' HH21 ' A' ' 119' ' ' ARG . 8.7 tp -60.66 -40.36 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 C-N-CA 119.726 -0.79 . . . . 0.0 109.069 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.404 ' N ' ' CG2' ' A' ' 116' ' ' ILE . . . -65.99 -40.84 95.44 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-O 121.509 0.505 . . . . 0.0 111.885 175.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.606 ' HG ' ' N ' ' A' ' 119' ' ' ARG . 42.0 p -59.11 -43.16 91.9 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 176.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.606 ' N ' ' HG ' ' A' ' 118' ' ' SER . 9.9 ttp-105 -64.05 -36.98 85.79 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.64 -178.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 18.3 tp -63.43 -45.73 89.61 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 36.5 mt -66.08 -44.58 84.03 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.491 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.407 ' O ' ' OG1' ' A' ' 126' ' ' THR . . . -63.8 -45.23 90.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 119.691 1.132 . . . . 0.0 110.27 178.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -66.01 -44.32 91.78 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.129 -1.034 . . . . 0.0 111.318 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 69.3 m -64.04 -44.12 93.46 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.277 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 96.7 m -69.32 -48.19 62.26 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 119.339 -0.944 . . . . 0.0 111.945 177.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 122' ' ' ALA . 25.3 p -65.36 -42.68 92.52 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -174.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -64.11 -44.53 95.63 Favored Glycine 0 CA--C 1.521 0.424 0 CA-C-O 122.969 1.316 . . . . 0.0 112.904 -177.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.35 -41.54 97.23 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 111.878 -2.161 . . . . 0.0 107.296 177.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 35.9 tp -64.04 -42.03 97.19 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.801 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.0 -40.03 96.55 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 113.205 0.816 . . . . 0.0 113.205 -177.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.5 m -61.07 -26.05 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 122.687 1.232 . . . . 0.0 109.989 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -58.35 -45.09 88.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 112.399 -2.182 . . . . 0.0 110.909 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 49.1 t -79.25 -49.08 20.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.449 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -97.96 135.05 40.23 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.478 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.579 ' N ' ' CD ' ' A' ' 136' ' ' PRO . 2.2 tp-100 -177.77 -39.6 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.871 179.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 135' ' ' GLN . 73.8 Cg_exo -52.45 -33.55 57.55 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 122.143 1.896 . . . . 0.0 112.46 -179.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 66.6 p -67.53 -42.69 82.31 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 118.725 -1.19 . . . . 0.0 109.879 -178.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -66.24 -42.81 88.11 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 119.303 -0.959 . . . . 0.0 112.136 -178.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 89.6 t -64.11 -44.28 97.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 34.5 m -65.07 -39.49 85.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -176.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -63.08 -42.3 99.61 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 118.668 -1.213 . . . . 0.0 111.657 -178.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 3.8 p -71.4 -46.45 64.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.678 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 14.4 tpp180 -65.9 -38.09 87.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.693 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -68.11 -42.44 80.24 Favored 'General case' 0 C--O 1.226 -0.165 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -177.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -66.23 -40.83 90.55 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 118.819 -1.153 . . . . 0.0 110.133 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.48 -35.18 80.13 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 -178.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.466 ' O ' ' CG ' ' A' ' 147' ' ' GLN . 6.4 pt20 -59.94 111.1 1.35 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 177.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -95.19 -63.84 1.12 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 117.62 -1.181 . . . . 0.0 112.696 -177.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.462 ' O ' ' N ' ' A' ' 151' ' ' GLY . 16.2 mmm180 -77.76 0.12 24.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 122.675 2.489 . . . . 0.0 109.725 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . 62.02 -75.23 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.619 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 149' ' ' ARG . . . 157.56 -115.66 0.67 Allowed Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.464 ' C ' ' H ' ' A' ' 154' ' ' ARG . . . 165.38 -92.24 0.11 Allowed Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 46.46 15.88 0.16 Allowed Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.483 ' C ' ' H ' ' A' ' 156' ' ' TYR . 22.9 ttm-85 65.99 -177.03 0.19 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 81.6 mtt85 55.45 7.44 0.23 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.778 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.483 ' H ' ' C ' ' A' ' 154' ' ' ARG . 1.7 t80 59.48 159.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.43 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -88.21 153.69 21.03 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.946 0.403 . . . . 0.0 111.047 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.653 ' H ' ' CG ' ' A' ' 161' ' ' GLU . 19.5 m -157.12 -178.77 7.61 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 121.309 0.576 . . . . 0.0 111.007 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 10.2 t -64.78 -46.32 82.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.442 -178.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.4 m -64.53 -45.78 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 C-N-CA 119.354 -0.939 . . . . 0.0 110.674 -178.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.653 ' CG ' ' H ' ' A' ' 158' ' ' SER . 3.1 pp20? -67.59 -38.6 84.27 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.545 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.49 ' N ' ' CD ' ' A' ' 161' ' ' GLU . . . -61.58 -45.68 93.08 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -62.37 -49.69 74.54 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.389 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -68.45 -45.53 72.24 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 -176.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 14.5 m -62.85 -44.7 95.44 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -177.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 2.6 pp -64.71 -38.37 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 121.955 0.884 . . . . 0.0 109.345 176.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.58 -36.19 75.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 113.786 -1.552 . . . . 0.0 107.486 176.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 11.3 tpp85 -61.98 -49.8 74.64 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 122.266 2.303 . . . . 0.0 111.71 -175.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -74.62 -50.82 16.39 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 123.442 0.697 . . . . 0.0 109.51 177.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -77.85 -36.43 49.99 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 116.997 2.221 . . . . 0.0 116.997 -172.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 90.33 -166.16 31.82 Favored Glycine 0 N--CA 1.471 0.994 0 CA-C-N 118.779 0.718 . . . . 0.0 112.109 177.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.511 ' CD1' ' N ' ' A' ' 172' ' ' ILE . 2.0 mp -73.1 -44.11 56.93 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 CA-C-O 121.978 0.894 . . . . 0.0 110.251 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 -58.61 -33.47 70.06 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.632 -176.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -60.74 -40.54 98.25 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 118.896 -1.621 . . . . 0.0 110.23 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 52.4 tp -69.93 -33.94 72.8 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 116.646 2.091 . . . . 0.0 116.646 -177.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -78.41 -7.97 57.95 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 111.437 -2.62 . . . . 0.0 109.794 -178.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 38.1 tptt -43.42 -48.39 7.13 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.792 -176.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -86.02 -39.88 7.8 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.237 0.922 . . . . 0.0 110.845 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.6 m -45.44 -51.44 11.47 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.416 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 2.7 m -63.19 -50.92 73.05 Favored Pre-proline 0 N--CA 1.474 0.739 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -176.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.419 ' CB ' ' OH ' ' A' ' 242' ' ' TYR . 33.6 Cg_endo -65.02 -27.32 57.9 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.278 1.985 . . . . 0.0 112.353 177.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -63.0 -38.63 91.96 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 121.228 -0.189 . . . . 0.0 111.102 -178.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.449 ' O ' ' OD1' ' A' ' 186' ' ' ASN . 1.9 p -62.47 -42.02 94.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.372 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.41 ' N ' ' CG1' ' A' ' 183' ' ' VAL . . . -62.22 -39.54 93.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.95 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 72.3 ttp85 -61.08 -42.06 97.81 Favored 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.793 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . 0.557 ' ND2' ' N ' ' A' ' 187' ' ' ALA . 0.1 OUTLIER -62.13 -42.67 99.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.964 0.411 . . . . 0.0 111.348 179.695 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . 0.557 ' N ' ' ND2' ' A' ' 186' ' ' ASN . . . -63.8 -44.24 93.9 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -177.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 7.4 tt -63.98 -45.23 97.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -178.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 12.9 m -60.18 -46.61 94.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 119.679 -0.808 . . . . 0.0 111.807 -178.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . 0.501 ' ND2' ' N ' ' A' ' 191' ' ' CYS . 0.1 OUTLIER -62.41 -43.0 99.86 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 122.274 1.035 . . . . 0.0 109.602 179.414 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' CYS . . . . . 0.501 ' N ' ' ND2' ' A' ' 190' ' ' ASN . 45.9 t -62.36 -47.19 85.3 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 113.538 -1.664 . . . . 0.0 111.004 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.89 -41.17 95.84 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.083 177.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 0.408 ' O ' ' OG1' ' A' ' 196' ' ' THR . 55.4 mt-10 -61.09 -45.09 96.13 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.366 -1.288 . . . . 0.0 112.087 -178.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.592 ' CD2' ' HE ' ' A' ' 119' ' ' ARG . 17.5 mt -63.21 -37.0 85.53 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 119.228 -0.989 . . . . 0.0 108.705 -175.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 92.7 t -62.69 -45.98 97.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 C-N-CA 117.074 -1.85 . . . . 0.0 107.101 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' A' ' 193' ' ' GLU . 59.9 p -64.46 -45.95 85.2 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -178.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -56.92 -38.91 73.52 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.018 1.327 . . . . 0.0 113.209 -177.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -55.37 -44.12 75.76 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 10.1 mp -60.84 -38.22 84.74 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.624 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 57.9 mt -61.37 -42.01 92.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.19 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 19.4 mmtp -59.68 -38.22 80.92 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.609 1.564 . . . . 0.0 113.329 177.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -63.27 -39.96 96.06 Favored 'General case' 0 C--N 1.316 -0.862 0 O-C-N 121.941 -0.474 . . . . 0.0 111.027 -177.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.4 t -101.26 129.04 47.14 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 122.041 0.924 . . . . 0.0 112.621 -178.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 2.2 tp 67.73 4.25 3.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 113.788 -1.551 . . . . 0.0 111.976 178.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 2.3 mt -126.71 28.78 5.82 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.718 0.771 . . . . 0.0 112.014 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 18.1 mtpp -73.86 -23.68 59.64 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.258 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -162.99 34.17 0.1 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.658 -1.155 . . . . 0.0 108.316 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 2.4 m120 42.42 54.31 4.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.354 -1.294 . . . . 0.0 113.663 177.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.577 ' CD1' ' H ' ' A' ' 209' ' ' LEU . 0.0 OUTLIER -115.97 142.96 46.1 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 114.777 -1.101 . . . . 0.0 108.745 178.234 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' MET . . . . . 0.415 ' O ' ' O ' ' A' ' 211' ' ' THR . 11.0 mmt -127.24 83.8 2.2 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.415 ' O ' ' O ' ' A' ' 210' ' ' MET . 4.4 m -33.16 154.61 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.467 -178.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . 0.405 ' O ' ' OD1' ' A' ' 213' ' ' ASP . 94.3 m-20 -78.09 68.45 4.13 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.04 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 212' ' ' ASP . 25.3 m-20 -159.28 71.82 0.52 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.467 ' N ' ' CD ' ' A' ' 215' ' ' PRO . 3.4 mt -61.07 -43.48 90.96 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.871 -177.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' A' ' 214' ' ' LEU . 26.4 Cg_exo -61.2 -33.33 90.6 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 120.716 0.944 . . . . 0.0 110.701 -179.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 86.9 m -65.62 -43.58 89.13 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.161 -1.381 . . . . 0.0 112.579 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 38.0 t-80 -67.7 -39.29 84.42 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -177.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -64.12 -46.83 82.43 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.217 -179.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 28.6 p -60.34 -37.84 81.93 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 118.894 0.77 . . . . 0.0 110.239 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 70.7 m -59.76 -41.72 91.68 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . 0.556 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.99 -41.67 97.44 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -177.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -62.02 -47.27 85.5 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.896 0.855 . . . . 0.0 113.111 -176.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -60.98 -42.25 99.7 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 108.0 -2.04 . . . . 0.0 108.0 177.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -63.22 -37.79 88.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.05 -1.075 . . . . 0.0 109.275 176.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -61.33 -41.78 99.61 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 114.172 -1.376 . . . . 0.0 111.59 -176.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -66.08 -38.91 89.45 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 118.168 -1.413 . . . . 0.0 107.949 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 83.6 m -64.01 -41.6 97.41 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.466 0.65 . . . . 0.0 109.778 176.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -61.81 -39.59 92.3 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.321 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 31.3 m -57.85 -39.23 77.24 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.15 -176.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 98.1 t -60.17 -40.87 84.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 118.804 -1.158 . . . . 0.0 108.302 178.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . 0.529 ' O ' ' HD2' ' A' ' 234' ' ' PRO . 0.2 OUTLIER -61.81 -40.8 88.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 177.444 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -62.59 -38.98 92.27 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 115.686 1.736 . . . . 0.0 115.686 -178.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.449 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 0.2 OUTLIER -57.68 -40.82 86.77 Favored Pre-proline 0 N--CA 1.476 0.863 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 -172.721 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.529 ' HD2' ' O ' ' A' ' 231' ' ' ILE . 38.4 Cg_exo -58.62 -40.46 73.5 Favored 'Trans proline' 0 C--N 1.293 -2.343 0 C-N-CA 121.666 1.577 . . . . 0.0 113.78 -177.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.3 m -64.51 -37.44 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 118.395 -1.322 . . . . 0.0 109.336 178.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -65.94 -40.64 91.53 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.05 178.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.552 ' CG1' ' NH1' ' A' ' 241' ' ' ARG . 55.9 t -64.79 -45.07 96.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 115.295 -0.866 . . . . 0.0 113.073 -177.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 15.5 m -62.77 -37.28 78.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 119.749 -0.781 . . . . 0.0 111.299 -177.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -60.81 -44.68 96.56 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.399 -0.52 . . . . 0.0 111.532 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' THR . . . . . 0.592 ' HG1' ' CZ ' ' A' ' 279' ' ' ARG . 13.5 m -61.8 -42.3 98.84 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.889 0.376 . . . . 0.0 111.56 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.586 ' O ' ' CD2' ' A' ' 242' ' ' TYR . 24.7 mtt85 -49.19 124.31 8.77 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.999 -178.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.586 ' CD2' ' O ' ' A' ' 241' ' ' ARG . 3.3 m-85 171.26 -64.72 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.6 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' MET . . . . . . . . . . . . . 12.2 mmt -69.84 84.99 0.49 Allowed 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.356 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . 0.449 ' O ' ' OG ' ' A' ' 245' ' ' SER . 4.7 p30 -157.94 99.89 1.7 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -178.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' SER . . . . . 0.463 ' O ' ' OG ' ' A' ' 245' ' ' SER . 11.0 p 66.22 84.89 0.15 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.995 178.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 245' ' ' SER . . . 29.99 -145.0 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.668 178.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.68 -166.27 1.32 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.608 -179.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 172.05 -119.51 0.78 Allowed Glycine 0 CA--C 1.534 1.281 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 1.065 HE21 ' CE1' ' A' ' 255' ' ' HIS . 14.6 mm100 -107.38 133.68 51.54 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 122.679 -0.307 . . . . 0.0 110.761 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.406 ' CD1' ' C ' ' A' ' 249' ' ' GLN . 35.6 m-85 -149.38 34.53 0.72 Allowed 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 118.614 -0.707 . . . . 0.0 111.606 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . 0.441 ' ND1' ' C ' ' A' ' 251' ' ' HIS . 10.8 t-80 -66.4 -54.45 24.22 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 115.915 -2.314 . . . . 0.0 112.166 -176.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 44.2 t -148.74 -175.1 4.81 Favored 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 178.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -62.36 -45.94 90.92 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.852 1.205 . . . . 0.0 110.028 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -58.82 -37.62 90.75 Favored Glycine 0 N--CA 1.475 1.283 0 C-N-CA 124.41 1.005 . . . . 0.0 114.387 -173.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' HIS . . . . . 1.065 ' CE1' HE21 ' A' ' 249' ' ' GLN . 86.4 t60 -59.45 -32.74 70.5 Favored 'General case' 0 C--N 1.367 1.328 0 C-N-CA 116.479 -2.088 . . . . 0.0 111.005 -179.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' CYS . . . . . . . . . . . . . 8.9 t -60.29 -43.93 95.83 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 117.921 0.328 . . . . 0.0 111.138 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -59.16 -44.43 92.13 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.186 -177.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.457 ' CD2' ' N ' ' A' ' 258' ' ' LEU . 3.6 mm? -66.32 -42.99 87.43 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 119.969 -0.692 . . . . 0.0 110.183 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' THR . . . . . 0.499 ' HG1' ' N ' ' A' ' 260' ' ' MET . 74.7 p -62.75 -45.66 91.64 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' MET . . . . . 0.499 ' N ' ' HG1' ' A' ' 259' ' ' THR . 2.9 ptm -60.77 -43.48 98.0 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 121.013 -0.275 . . . . 0.0 111.505 -177.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 12.2 mt -62.53 -47.29 84.56 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 59.6 ttt85 -67.11 -54.11 24.46 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.549 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 28.1 mmtp -70.13 -156.42 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.929 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . 0.513 ' OE2' ' N ' ' A' ' 265' ' ' GLY . 1.0 OUTLIER -38.8 133.55 1.08 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.025 -179.702 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . 0.552 ' C ' ' H ' ' A' ' 267' ' ' ARG . . . -47.98 169.97 0.07 OUTLIER Glycine 0 CA--C 1.533 1.179 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -55.54 -0.67 0.17 Allowed 'Trans proline' 0 N--CA 1.5 1.869 0 C-N-CA 121.978 1.786 . . . . 0.0 112.326 178.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.552 ' H ' ' C ' ' A' ' 265' ' ' GLY . 91.1 mtt180 -69.77 -26.79 64.45 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.13 0.572 . . . . 0.0 112.3 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -58.37 -32.33 68.48 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.1 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . 0.537 ' O ' ' NH2' ' A' ' 241' ' ' ARG . 20.8 m-85 -62.42 -41.34 98.63 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.138 0.494 . . . . 0.0 111.186 177.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -65.74 -37.82 87.42 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -177.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.457 ' O ' ' O ' ' A' ' 272' ' ' GLY . 14.8 mptt -56.39 -172.33 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 271' ' ' LYS . . . 45.82 103.11 0.01 OUTLIER Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.501 -0.64 . . . . 0.0 111.501 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -158.62 -12.91 0.07 Allowed 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.346 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' MET . . . . . 0.51 ' N ' ' HD2' ' A' ' 275' ' ' PRO . 2.1 tpt -64.07 -45.16 79.67 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 120.39 -0.524 . . . . 0.0 111.429 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 274' ' ' MET . 36.9 Cg_endo -64.84 -45.76 7.76 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.362 1.375 . . . . 0.0 111.57 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' SER . . . . . 0.409 ' HG ' ' N ' ' A' ' 277' ' ' PHE . 78.5 p -59.67 -38.88 82.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.746 -178.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . 0.409 ' N ' ' HG ' ' A' ' 276' ' ' SER . 46.8 t80 -61.0 -42.55 98.65 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 122.629 1.204 . . . . 0.0 112.017 -178.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 9.4 mp -62.02 -38.45 88.69 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 112.298 -2.228 . . . . 0.0 107.678 174.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . 0.592 ' CZ ' ' HG1' ' A' ' 240' ' ' THR . 9.9 mtm180 -62.71 -39.23 93.37 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.21 0.529 . . . . 0.0 110.184 178.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 6.8 tp -61.97 -36.96 83.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.885 -177.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -67.95 -51.23 35.65 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 36.3 m -62.92 -44.36 96.29 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' TRP . . . . . . . . . . . . . 91.5 t90 -60.05 -38.17 81.99 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.674 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -62.77 -38.62 91.34 Favored 'General case' 0 C--N 1.317 -0.814 0 O-C-N 122.068 -0.395 . . . . 0.0 111.181 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.98 -39.36 81.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -177.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 6.5 m -62.91 -40.08 87.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 119.98 -0.688 . . . . 0.0 109.941 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' MET . . . . . 0.405 ' O ' ' OG1' ' A' ' 290' ' ' THR . 10.0 tpt -60.49 -38.95 85.98 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.162 0.506 . . . . 0.0 109.695 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -58.81 -40.18 83.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.542 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.71 -38.72 79.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.365 -177.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.405 ' OG1' ' O ' ' A' ' 287' ' ' MET . 39.4 p -62.71 -40.62 97.74 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 177.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -61.56 -39.05 89.72 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 176.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -58.72 -40.96 85.25 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 117.921 -1.512 . . . . 0.0 109.506 -176.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' GLN . . . . . 0.45 ' O ' ' O ' ' A' ' 296' ' ' ARG . 88.4 mt-30 -60.78 -42.78 98.19 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 122.825 1.298 . . . . 0.0 110.623 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.41 -40.68 91.87 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 112.583 -2.099 . . . . 0.0 109.091 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 1.8 mmmm -63.48 -45.8 89.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.34 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' ARG . . . . . 0.45 ' O ' ' O ' ' A' ' 293' ' ' GLN . 0.5 OUTLIER -122.96 116.23 23.22 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.364 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -116.25 -95.0 0.48 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.381 0.61 . . . . 0.0 110.767 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 3.5 pp -136.65 -166.66 1.93 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.288 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 12.5 ttt -170.81 66.36 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.288 -0.565 . . . . 0.0 111.489 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.6 101.01 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.849 0.833 . . . . 0.0 110.697 -178.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -64.05 -46.13 85.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 113.895 -1.502 . . . . 0.0 113.534 -176.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . 0.534 ' CD2' ' OE2' ' A' ' 306' ' ' GLU . 19.9 t80 -58.66 -39.82 81.72 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.643 -178.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -64.84 -46.53 81.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.072 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' SER . . . . . 0.42 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 37.8 m -66.15 -37.17 85.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.539 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -61.12 -42.48 98.61 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.186 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.534 ' OE2' ' CD2' ' A' ' 302' ' ' TYR . 52.1 mt-10 -64.66 -36.83 85.52 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 -177.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -59.88 -53.0 69.68 Favored Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -176.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' PRO . . . . . 0.491 ' O ' ' CG ' ' A' ' 309' ' ' PHE . 74.1 Cg_endo -75.13 0.25 9.18 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.109 1.873 . . . . 0.0 111.785 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' PHE . . . . . 0.491 ' CG ' ' O ' ' A' ' 308' ' ' PRO . 56.6 m-85 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.35 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 13.3 tpp . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.42 111.25 8.78 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.164 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.6 m -114.2 178.47 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 178.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.433 ' CD ' ' N ' ' A' ' 16' ' ' LYS . 3.8 mptp? -64.53 -41.52 96.32 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.189 -0.46 . . . . 0.0 112.066 -178.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -62.94 -42.13 99.71 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -178.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.462 ' C ' ' CD1' ' A' ' 18' ' ' LEU . 1.1 pp -80.59 -24.17 39.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.428 0.632 . . . . 0.0 112.564 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.07 -40.43 96.99 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 107.241 -2.344 . . . . 0.0 107.241 177.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.423 ' CB ' ' NH2' ' A' ' 96' ' ' ARG . . . -71.17 -31.34 67.55 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 124.515 2.103 . . . . 0.0 107.485 176.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.78 -42.62 98.49 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-N 108.781 -3.827 . . . . 0.0 110.315 -178.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.4 t -70.92 -26.6 63.27 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.8 -50.6 64.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.711 -178.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.08 -36.1 80.68 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 118.308 -1.357 . . . . 0.0 111.016 -177.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.9 t -63.97 -53.63 47.11 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.849 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.43 HG23 HD13 ' A' ' 26' ' ' ILE . 74.3 mt -65.49 -39.88 86.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -177.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.39 -42.43 96.11 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 119.516 -0.873 . . . . 0.0 112.701 -174.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -78.13 -27.05 48.17 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 120.718 1.599 . . . . 0.0 110.111 -175.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.2 tt -59.43 -55.54 33.37 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 120.033 1.288 . . . . 0.0 111.933 -177.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.43 HG21 HD12 ' A' ' 30' ' ' ILE . 0.4 OUTLIER -75.19 -3.56 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -179.24 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -109.5 -17.2 13.81 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.302 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.438 ' O ' ' OD1' ' A' ' 35' ' ' ASP . 1.6 t80 -67.95 -44.62 40.79 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 116.474 -2.09 . . . . 0.0 109.984 -177.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.421 ' CD ' ' N ' ' A' ' 32' ' ' PHE . 35.2 Cg_exo -59.45 -15.68 31.46 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 121.252 1.301 . . . . 0.0 112.291 176.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.96 -35.23 79.51 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -177.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 36' ' ' THR . 27.7 p-10 -64.53 -40.33 95.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.763 -177.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.543 ' N ' ' OD1' ' A' ' 35' ' ' ASP . 31.6 p -58.19 -34.66 70.6 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -179.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.11 -38.78 86.22 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.3 pttp -62.23 -48.3 80.58 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 118.877 -1.129 . . . . 0.0 111.4 -177.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.0 m -63.41 -38.23 81.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 O-C-N 122.135 -0.353 . . . . 0.0 111.927 -178.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.528 ' C ' ' H ' ' A' ' 42' ' ' GLN . 5.5 mmp_? -59.35 -40.03 85.08 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.514 -178.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.46 38.86 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.528 ' H ' ' C ' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -114.09 -177.2 3.07 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.407 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.568 ' CG2' ' H ' ' A' ' 44' ' ' GLN . 13.1 tt -63.12 -62.08 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.364 -0.535 . . . . 0.0 109.81 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.568 ' H ' ' CG2' ' A' ' 43' ' ' ILE . 3.3 mt-30 169.55 5.95 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 54.34 37.46 59.88 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.364 -1.095 . . . . 0.0 110.364 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.443 ' O ' ' CB ' ' A' ' 47' ' ' SER . 2.9 pt-20 -93.17 -95.26 0.15 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.617 0.246 . . . . 0.0 110.515 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.548 ' C ' ' H ' ' A' ' 49' ' ' GLY . 0.9 OUTLIER 82.13 -31.09 0.1 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.82 -179.833 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -65.01 8.43 0.13 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.854 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.548 ' H ' ' C ' ' A' ' 47' ' ' SER . . . 80.85 16.38 75.27 Favored Glycine 0 CA--C 1.535 1.299 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -177.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.7 tt -61.44 -36.38 80.22 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 114.875 -0.662 . . . . 0.0 110.386 -176.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.3 p -59.82 -44.64 94.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 C-N-CA 120.191 -0.603 . . . . 0.0 112.2 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.9 ttp180 -65.33 -35.95 82.54 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 119.451 -0.899 . . . . 0.0 112.793 -178.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 t -69.56 -38.48 77.46 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.628 0.728 . . . . 0.0 109.662 178.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -152.68 123.26 7.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.193 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.407 ' O ' ' OG ' ' A' ' 56' ' ' SER . . . -99.3 176.66 5.45 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -177.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.526 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 45.7 p 53.9 -141.34 0.87 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 113.993 -1.458 . . . . 0.0 108.923 -178.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 56' ' ' SER . . . 95.7 14.23 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.893 178.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 11.9 tp-100 -167.29 73.25 0.12 Allowed 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.547 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -61.05 142.34 56.72 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.433 ' O ' ' C ' ' A' ' 61' ' ' GLY . 84.1 mtp180 -39.41 -37.07 0.42 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.955 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 60' ' ' ARG . . . -28.8 101.44 0.01 OUTLIER Glycine 0 CA--C 1.531 1.064 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.28 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 56.2 t -66.97 -33.79 65.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 118.121 -0.943 . . . . 0.0 109.687 176.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 43.9 mt -60.56 -32.43 71.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 121.489 1.949 . . . . 0.0 111.213 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.6 -49.01 66.84 Favored Glycine 0 CA--C 1.532 1.138 0 N-CA-C 115.246 0.859 . . . . 0.0 115.246 -176.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.99 -45.97 91.27 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.465 0.542 . . . . 0.0 112.465 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 25.0 pt -59.75 -36.03 63.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 118.365 -0.826 . . . . 0.0 108.845 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 78.3 mt -63.84 -35.72 81.55 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 121.137 1.789 . . . . 0.0 111.749 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.445 ' O ' ' OG1' ' A' ' 72' ' ' THR . 97.9 m -62.91 -39.11 93.51 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 113.506 -1.679 . . . . 0.0 111.008 -175.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.457 ' C ' ' SD ' ' A' ' 69' ' ' MET . 0.0 OUTLIER -60.29 -40.39 90.31 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 120.775 -1.203 . . . . 0.0 113.835 -176.427 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.6 p -69.66 -40.56 79.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 119.211 -0.996 . . . . 0.0 113.176 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 67.9 ttp85 -78.42 -13.27 59.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.709 0.766 . . . . 0.0 112.823 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 68' ' ' THR . 61.0 m -62.55 -54.82 34.06 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.111 179.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -110.18 -54.17 2.6 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 157.03 164.11 13.22 Favored Glycine 0 CA--C 1.539 1.56 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -56.42 -35.47 96.41 Favored 'Trans proline' 0 N--CA 1.503 2.058 0 CA-C-N 119.493 1.646 . . . . 0.0 112.395 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -61.09 -11.47 8.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 122.102 0.953 . . . . 0.0 111.135 176.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.472 ' O ' ' OD1' ' A' ' 80' ' ' ASN . 3.6 t -77.72 -32.26 52.74 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 113.716 -1.583 . . . . 0.0 110.727 -178.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.422 ' N ' ' CD2' ' A' ' 78' ' ' LEU . 4.1 mm? -75.65 -32.5 60.23 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 122.089 -0.382 . . . . 0.0 110.843 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -91.37 -4.35 55.83 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -176.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.472 ' OD1' ' O ' ' A' ' 77' ' ' SER . 35.1 p30 -95.72 26.88 3.74 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 112.189 -2.278 . . . . 0.0 107.648 175.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -159.05 -19.72 0.03 OUTLIER Glycine 0 CA--C 1.53 1.001 0 CA-C-N 114.28 -1.327 . . . . 0.0 112.417 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.65 -35.16 73.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.263 -0.968 . . . . 0.0 110.502 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.9 p -70.87 -27.44 30.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.525 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.86 -31.33 61.6 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.349 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.91 -40.54 89.15 Favored Glycine 0 C--O 1.223 -0.573 0 C-N-CA 119.69 -1.243 . . . . 0.0 111.148 -178.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 50.5 mt -62.37 -40.25 95.84 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 122.476 1.132 . . . . 0.0 112.67 -177.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -60.03 -27.01 66.55 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 112.986 -1.915 . . . . 0.0 109.025 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 36.2 ttp180 -57.31 -52.55 64.89 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 173.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -67.53 -30.32 69.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 112.853 -1.976 . . . . 0.0 112.329 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 11.8 tmm? -61.01 -41.99 97.61 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.551 -0.749 . . . . 0.0 112.484 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 21.8 t -74.81 -34.33 62.35 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.533 -176.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -57.69 -44.08 85.59 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 120.231 1.378 . . . . 0.0 111.9 -176.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.56 -32.87 64.39 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 119.402 -0.919 . . . . 0.0 110.732 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.496 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 58.4 p -64.51 -42.2 95.96 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.486 ' C ' ' H ' ' A' ' 97' ' ' ILE . 7.1 p -68.39 -28.32 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 177.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.483 ' CG ' ' O ' ' A' ' 96' ' ' ARG . 35.3 ttt-85 -77.36 9.71 3.02 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 -176.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.496 ' CG2' ' O ' ' A' ' 94' ' ' SER . 3.4 tp -86.92 -15.39 9.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 177.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.498 ' O ' ' OD1' ' A' ' 101' ' ' ASP . . . -140.24 -48.17 0.06 OUTLIER Glycine 0 CA--C 1.544 1.872 0 N-CA-C 116.018 1.167 . . . . 0.0 116.018 -177.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.51 ' CD1' ' N ' ' A' ' 99' ' ' LEU . 8.6 mp -72.06 -13.06 61.49 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 120.111 1.955 . . . . 0.0 113.669 -178.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.498 ' O ' ' CG ' ' A' ' 104' ' ' LYS . 48.7 t80 -80.48 -51.85 8.32 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 114.551 -1.204 . . . . 0.0 113.025 -178.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.498 ' OD1' ' O ' ' A' ' 98' ' ' GLY . 30.9 p-10 -70.32 -32.36 70.07 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 123.663 1.696 . . . . 0.0 110.821 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.456 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 24.1 p -68.19 -51.34 46.7 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 110.284 -3.144 . . . . 0.0 112.641 176.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 59.1 t -73.51 -26.47 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 CA-C-N 121.254 1.843 . . . . 0.0 112.106 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.498 ' CG ' ' O ' ' A' ' 100' ' ' TYR . 22.7 mmtm -68.89 -41.75 77.85 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 111.914 -2.403 . . . . 0.0 110.757 178.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.446 ' HG3' ' O ' ' A' ' 101' ' ' ASP . 88.1 mt-30 -78.26 -14.64 59.35 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-O 122.772 1.272 . . . . 0.0 111.045 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -79.76 -23.16 42.41 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 114.672 -1.149 . . . . 0.0 112.462 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.622 ' CZ ' ' ND2' ' A' ' 190' ' ' ASN . 32.9 m-85 -109.66 -29.95 8.12 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 119.39 0.995 . . . . 0.0 111.735 -175.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.9 p -97.56 9.33 42.74 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 117.028 -1.869 . . . . 0.0 112.675 -178.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.532 ' O ' ' C ' ' A' ' 110' ' ' GLY . 6.1 pttp -48.06 124.41 7.58 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 117.792 -1.099 . . . . 0.0 109.835 177.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.533 ' O ' ' CB ' ' A' ' 111' ' ' SER . . . -26.46 -77.52 0.01 OUTLIER Glycine 0 N--CA 1.488 2.134 0 CA-C-N 120.46 1.482 . . . . 0.0 111.515 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 110' ' ' GLY . 24.0 p 103.35 -159.68 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 176.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.563 ' O ' ' N ' ' A' ' 114' ' ' ALA . 94.8 mt-10 -128.76 96.8 4.47 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.254 -0.885 . . . . 0.0 112.649 -178.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.459 ' C ' ' O ' ' A' ' 112' ' ' GLU . 76.8 m-70 12.63 51.11 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 O-C-N 124.245 0.965 . . . . 0.0 113.138 178.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.563 ' N ' ' O ' ' A' ' 112' ' ' GLU . . . 159.41 -161.79 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.43 ' O ' ' OG ' ' A' ' 118' ' ' SER . . . 102.36 14.97 26.65 Favored Glycine 0 C--N 1.338 0.687 0 CA-C-N 114.999 -1.0 . . . . 0.0 113.227 176.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 13.0 tt -60.91 -40.35 85.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 119.167 -1.013 . . . . 0.0 109.438 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.49 -39.56 95.72 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 122.047 0.804 . . . . 0.0 111.4 176.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.43 ' OG ' ' O ' ' A' ' 115' ' ' GLY . 9.6 p -57.81 -42.11 83.59 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 177.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -63.42 -37.18 86.3 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.975 -178.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 30.8 tp -64.03 -46.98 82.04 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.354 0.597 . . . . 0.0 109.778 178.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 42.8 mt -67.06 -44.83 79.12 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.848 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.78 -44.7 92.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 119.281 0.946 . . . . 0.0 109.36 178.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -65.94 -44.16 92.28 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 119.691 -1.242 . . . . 0.0 111.665 -179.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 67.1 m -63.72 -43.91 95.15 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.384 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 20.9 m -69.44 -48.53 60.65 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 119.082 -1.047 . . . . 0.0 112.023 177.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 41.5 p -65.54 -43.0 91.3 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 -174.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -64.46 -44.85 94.65 Favored Glycine 0 CA--C 1.521 0.407 0 CA-C-N 114.734 -1.121 . . . . 0.0 112.918 -177.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.83 -41.66 98.08 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 112.395 -1.903 . . . . 0.0 107.451 177.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 24.9 tp -64.67 -42.6 95.26 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.218 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.63 -40.16 96.17 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -177.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.7 p -61.27 -26.46 39.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 123.363 1.554 . . . . 0.0 109.942 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.528 ' O ' ' NE2' ' A' ' 135' ' ' GLN . . . -58.78 -45.68 89.25 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 110.787 -2.915 . . . . 0.0 112.372 -178.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.557 ' C ' HE22 ' A' ' 135' ' ' GLN . 2.5 p -79.79 -48.65 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -178.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -102.5 86.12 2.73 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -177.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.648 ' H ' ' CD ' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -126.77 -22.99 0.04 OUTLIER Pre-proline 0 CA--C 1.551 0.983 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 177.6 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.648 ' CD ' ' H ' ' A' ' 135' ' ' GLN . 6.8 Cg_endo -54.98 -33.13 81.82 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 CA-C-N 121.554 1.591 . . . . 0.0 112.214 -178.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.513 ' O ' ' NZ ' ' A' ' 141' ' ' LYS . 73.3 p -68.22 -42.87 79.14 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 117.828 -1.549 . . . . 0.0 112.286 -175.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -67.46 -44.37 78.78 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 118.438 -1.305 . . . . 0.0 113.373 -178.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.9 m -65.45 -44.76 94.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -178.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 75.2 t -65.48 -40.29 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -176.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.513 ' NZ ' ' O ' ' A' ' 137' ' ' THR . 29.3 mtmm -63.18 -41.53 99.22 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.118 -178.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 3.5 p -71.1 -45.57 71.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.833 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.574 HH21 ' CG2' ' A' ' 166' ' ' ILE . 61.1 mtp180 -64.73 -37.34 87.28 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.161 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.611 ' CD1' ' NE2' ' A' ' 147' ' ' GLN . 76.2 t80 -67.27 -41.76 84.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.451 -178.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 18.0 tm0? -65.92 -40.73 91.71 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.518 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -64.84 -35.96 82.81 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -176.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.611 ' NE2' ' CD1' ' A' ' 144' ' ' PHE . 5.7 pt20 -59.3 111.12 1.24 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 177.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -102.49 -174.87 2.67 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 117.469 2.396 . . . . 0.0 117.469 -171.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 90.9 mtt-85 56.02 105.39 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 110.601 -2.999 . . . . 0.0 110.376 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -44.41 -77.45 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.786 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.427 ' C ' ' H ' ' A' ' 153' ' ' GLY . . . 46.07 81.95 0.04 OUTLIER Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -75.24 42.2 1.39 Allowed Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.829 -0.909 . . . . 0.0 110.829 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 154' ' ' ARG . . . -66.09 100.08 0.49 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.436 ' O ' ' O ' ' A' ' 153' ' ' GLY . 10.1 tpp85 57.37 156.65 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.745 0.307 . . . . 0.0 110.25 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 15.2 mmt85 48.86 -138.32 0.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.491 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.489 ' O ' ' CD2' ' A' ' 156' ' ' TYR . 74.1 t80 -165.6 6.41 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.059 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.448 ' O ' ' O ' ' A' ' 156' ' ' TYR . 51.0 mt-30 58.45 144.03 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.316 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.593 ' H ' ' CG ' ' A' ' 161' ' ' GLU . 3.5 m -156.97 -178.91 7.72 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.779 0.799 . . . . 0.0 112.23 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 26.4 p -64.87 -46.48 81.61 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 114.234 -1.348 . . . . 0.0 113.063 -177.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 42.4 t -64.28 -45.48 96.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.281 -177.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.593 ' CG ' ' H ' ' A' ' 158' ' ' SER . 8.3 pt-20 -67.99 -38.89 83.21 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -61.56 -45.72 92.96 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -177.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.451 ' CG ' ' N ' ' A' ' 164' ' ' LYS . 0.1 OUTLIER -62.45 -48.77 78.18 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.041 -179.424 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.451 ' N ' ' CG ' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -67.54 -45.08 76.74 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -174.793 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 40.6 p -62.77 -44.79 95.26 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 119.738 1.154 . . . . 0.0 113.706 -177.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.574 ' CG2' HH21 ' A' ' 143' ' ' ARG . 18.5 tt -64.94 -38.51 82.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-O 121.933 0.873 . . . . 0.0 109.454 176.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.78 -36.56 76.96 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 113.825 -1.534 . . . . 0.0 108.042 176.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -62.1 -50.03 73.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 122.708 2.504 . . . . 0.0 111.51 -175.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -74.75 -51.0 15.34 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 177.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -78.18 -36.51 47.38 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 116.25 1.944 . . . . 0.0 116.25 -173.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 91.78 -167.29 30.72 Favored Glycine 0 N--CA 1.468 0.779 0 CA-C-N 118.553 0.615 . . . . 0.0 112.095 177.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 8.5 pt -72.69 -42.74 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-O 121.845 0.831 . . . . 0.0 110.551 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 53.5 ttt85 -58.94 -33.54 70.73 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 114.381 -1.282 . . . . 0.0 110.838 -177.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -61.12 -40.69 98.89 Favored Glycine 0 CA--C 1.522 0.479 0 C-N-CA 118.503 -1.808 . . . . 0.0 109.592 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.429 ' CD1' ' NH1' ' A' ' 143' ' ' ARG . 7.4 tt -70.42 -33.78 71.74 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 111.688 -2.256 . . . . 0.0 116.701 -177.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 10.1 m0 -78.21 -7.86 57.62 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 111.713 -2.494 . . . . 0.0 109.909 -177.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 16.9 tptm -43.52 -48.3 7.38 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.192 -176.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -91.05 -34.99 7.3 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.449 1.023 . . . . 0.0 111.492 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.3 m -46.29 -51.94 13.6 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.24 -50.83 73.15 Favored Pre-proline 0 N--CA 1.477 0.903 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -176.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -64.06 -28.21 65.7 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 121.666 1.577 . . . . 0.0 111.44 175.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -63.79 -38.8 92.45 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.79 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.419 ' CG1' ' N ' ' A' ' 184' ' ' ALA . 0.8 OUTLIER -62.39 -42.12 94.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.722 -178.648 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.419 ' N ' ' CG1' ' A' ' 183' ' ' VAL . . . -61.96 -39.41 92.02 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.341 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 57.3 ttp85 -60.76 -41.97 96.51 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.093 -179.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -61.58 -43.23 99.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.26 0.552 . . . . 0.0 110.596 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.37 -43.05 95.74 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.741 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.437 ' O ' ' SG ' ' A' ' 191' ' ' CYS . 78.1 mt -62.96 -45.02 99.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -176.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.518 ' O ' ' N ' ' A' ' 193' ' ' GLU . 5.9 m -59.44 -46.34 92.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 119.546 -0.861 . . . . 0.0 111.395 -178.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . 0.622 ' ND2' ' CZ ' ' A' ' 107' ' ' TYR . 26.6 t-20 -63.08 -42.98 99.76 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 122.045 0.926 . . . . 0.0 110.908 178.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' CYS . . . . . 0.591 ' SG ' ' N ' ' A' ' 192' ' ' ALA . 0.5 OUTLIER -61.6 -45.41 94.2 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.014 -1.448 . . . . 0.0 108.867 179.049 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . 0.591 ' N ' ' SG ' ' A' ' 191' ' ' CYS . . . -63.76 -39.2 93.69 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 112.584 -2.098 . . . . 0.0 109.149 175.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 189' ' ' VAL . 44.0 tp10 -60.31 -46.38 90.09 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.004 0.922 . . . . 0.0 112.706 -176.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 75.2 mt -65.61 -37.64 87.19 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.671 -175.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 2.5 p -64.26 -46.28 93.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 117.089 -1.845 . . . . 0.0 109.569 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 2.2 t -64.48 -45.36 87.71 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -177.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -57.41 -39.45 76.19 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 114.58 -1.191 . . . . 0.0 112.305 -178.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -56.07 -44.7 79.19 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 47.3 mt -61.83 -39.42 91.73 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.891 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 42.5 mm -63.47 -43.36 98.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 118.813 -0.613 . . . . 0.0 111.257 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . 0.482 ' O ' ' O ' ' A' ' 205' ' ' LEU . 49.9 mtmt -60.27 -40.51 90.63 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 120.171 1.35 . . . . 0.0 111.613 177.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -64.81 -38.23 90.27 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 113.867 -1.515 . . . . 0.0 110.982 -176.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 13.3 t -101.89 129.16 48.07 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.706 0.765 . . . . 0.0 112.413 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 68.14 5.63 4.75 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 114.323 -1.308 . . . . 0.0 112.489 178.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.482 ' O ' ' O ' ' A' ' 201' ' ' LYS . 0.4 OUTLIER -141.78 79.88 1.7 Allowed 'General case' 0 N--CA 1.472 0.643 0 O-C-N 122.136 -0.352 . . . . 0.0 110.214 -178.652 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.539 ' O ' ' CB ' ' A' ' 207' ' ' ALA . 3.2 mtmp? -112.03 49.3 0.92 Allowed 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.079 -1.013 . . . . 0.0 110.826 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.539 ' CB ' ' O ' ' A' ' 206' ' ' LYS . . . 122.44 34.09 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.491 1.116 . . . . 0.0 110.007 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . 0.537 ' CB ' ' O ' ' A' ' 207' ' ' ALA . 9.0 t-20 102.36 -138.17 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 O-C-N 125.05 1.469 . . . . 0.0 108.95 -177.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.516 ' H ' ' CG ' ' A' ' 208' ' ' ASN . 0.3 OUTLIER -176.27 58.68 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.22 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 3.4 tpt -81.52 28.04 0.41 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.549 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 12.0 m -87.09 168.94 12.82 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.997 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . 0.42 ' O ' ' OD1' ' A' ' 213' ' ' ASP . 8.2 m-20 -104.01 -135.99 0.34 Allowed 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.258 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 212' ' ' ASP . 5.6 p-10 44.27 56.97 4.57 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.455 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.431 ' N ' ' CD ' ' A' ' 215' ' ' PRO . 3.8 mt -61.58 -43.53 88.84 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -178.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 214' ' ' LEU . 31.0 Cg_exo -60.97 -33.51 92.22 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 CA-C-O 122.811 1.088 . . . . 0.0 111.02 -178.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 77.6 m -64.7 -41.79 95.77 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 112.352 -2.204 . . . . 0.0 110.997 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' HIS . . . . . 0.496 ' O ' ' ND1' ' A' ' 217' ' ' HIS . 1.1 t60 -66.28 -37.52 85.63 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.514 -178.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -63.08 -48.13 79.93 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.199 -178.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 78.8 p -60.82 -38.46 85.53 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 119.79 1.177 . . . . 0.0 110.484 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 64.2 m -59.79 -42.01 92.44 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . 0.529 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.98 -42.29 97.27 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -62.78 -48.14 80.45 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -176.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -61.88 -42.89 99.79 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 108.466 -1.854 . . . . 0.0 108.466 177.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . 0.518 ' O ' ' SG ' ' A' ' 227' ' ' CYS . . . -63.43 -38.64 91.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.112 -1.044 . . . . 0.0 109.183 177.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -62.37 -43.31 99.24 Favored Glycine 0 CA--C 1.521 0.435 0 CA-C-N 114.685 -1.143 . . . . 0.0 111.07 -177.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' PHE . . . . . 0.45 ' O ' ' OG1' ' A' ' 229' ' ' THR . 72.7 t80 -67.48 -39.85 85.24 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 119.274 -0.971 . . . . 0.0 109.849 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . 0.529 ' SG ' ' N ' ' A' ' 228' ' ' THR . 1.5 p -64.5 -41.82 96.2 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.766 0.794 . . . . 0.0 109.238 176.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' THR . . . . . 0.529 ' N ' ' SG ' ' A' ' 227' ' ' CYS . 91.3 m -62.35 -40.58 96.88 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 114.041 -1.436 . . . . 0.0 111.914 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 226' ' ' PHE . 5.4 p -58.73 -39.99 82.45 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.633 -176.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 58.9 t -61.05 -41.98 91.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 118.423 -1.311 . . . . 0.0 108.449 178.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . 0.503 ' O ' ' HD2' ' A' ' 234' ' ' PRO . 47.8 mt -62.48 -41.41 91.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.485 0.659 . . . . 0.0 110.158 177.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.06 -39.37 94.53 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 115.891 1.811 . . . . 0.0 115.891 -178.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.444 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 0.1 OUTLIER -57.95 -41.94 92.62 Favored Pre-proline 0 N--CA 1.475 0.809 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -172.512 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.503 ' HD2' ' O ' ' A' ' 231' ' ' ILE . 30.7 Cg_exo -59.77 -41.13 57.65 Favored 'Trans proline' 0 C--N 1.295 -2.259 0 C-N-CA 121.209 1.272 . . . . 0.0 112.894 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -65.69 -37.03 79.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 118.639 -1.224 . . . . 0.0 109.246 177.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -66.01 -41.71 90.64 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.437 ' CG1' ' N ' ' A' ' 238' ' ' VAL . 1.6 p -65.88 -46.41 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -176.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.437 ' N ' ' CG1' ' A' ' 237' ' ' VAL . 9.9 p -64.17 -38.13 81.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.971 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp -61.18 -44.33 97.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.968 0.413 . . . . 0.0 111.477 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 9.2 m -61.37 -41.97 97.95 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.436 ' O ' ' HB2' ' A' ' 242' ' ' TYR . 5.6 ptm180 -50.26 145.81 5.75 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.576 -178.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.647 ' CG ' ' N ' ' A' ' 243' ' ' MET . 42.8 t80 160.91 -178.49 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 O-C-N 124.807 1.317 . . . . 0.0 109.383 -179.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' MET . . . . . 0.647 ' N ' ' CG ' ' A' ' 242' ' ' TYR . 4.7 ttt 32.28 102.23 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 O-C-N 123.242 0.339 . . . . 0.0 111.675 179.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . 0.586 ' ND2' ' HG ' ' A' ' 245' ' ' SER . 2.9 t30 -179.59 131.77 0.11 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.874 0.369 . . . . 0.0 111.601 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' SER . . . . . 0.586 ' HG ' ' ND2' ' A' ' 244' ' ' ASN . 3.8 m 55.24 162.57 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.447 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -175.73 67.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.789 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 68.6 mt -101.99 -87.17 0.41 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.795 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 0.416 ' O ' ' C ' ' A' ' 249' ' ' GLN . . . -152.26 -146.42 4.35 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.416 ' C ' ' O ' ' A' ' 248' ' ' GLY . 3.7 pm0 32.54 -145.0 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 122.277 0.231 . . . . 0.0 111.137 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.647 ' CG ' ' O ' ' A' ' 250' ' ' TYR . 0.1 OUTLIER 54.15 75.06 0.3 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 120.686 -0.406 . . . . 0.0 109.949 179.268 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -67.42 -53.85 25.48 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 117.346 -1.742 . . . . 0.0 112.269 -178.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 39.2 m -148.82 -173.35 4.33 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.0 0.92 . . . . 0.0 109.338 -178.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -59.96 -43.8 94.84 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 178.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -55.8 -34.86 61.66 Favored Glycine 0 N--CA 1.464 0.521 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 -174.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -53.5 -36.57 61.85 Favored 'General case' 0 C--O 1.214 -0.777 0 C-N-CA 117.781 -1.567 . . . . 0.0 110.965 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' CYS . . . . . . . . . . . . . 43.0 t -61.31 -44.67 96.81 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.535 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -60.12 -45.91 91.41 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.405 -0.518 . . . . 0.0 112.261 -177.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.444 ' CD2' ' N ' ' A' ' 258' ' ' LEU . 3.6 mm? -67.58 -44.3 78.49 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 119.395 -0.922 . . . . 0.0 111.2 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 29.7 p -64.18 -47.92 77.93 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -178.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' MET . . . . . . . . . . . . . 10.1 ptm -62.78 -44.13 96.99 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -178.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.23 -47.01 86.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.858 0.361 . . . . 0.0 110.041 -178.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -66.49 -53.69 32.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.547 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 54.1 mttp -80.57 -124.92 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -48.92 117.21 1.97 Allowed 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . 0.489 ' C ' ' H ' ' A' ' 267' ' ' ARG . . . -47.94 175.67 0.02 OUTLIER Glycine 0 CA--C 1.53 1.029 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 179.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.6 0.73 0.69 Allowed 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 122.237 1.958 . . . . 0.0 111.87 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.489 ' H ' ' C ' ' A' ' 265' ' ' GLY . 77.4 mtt85 -68.79 -25.92 64.94 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.195 0.598 . . . . 0.0 111.875 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -57.82 -31.97 67.14 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.127 -178.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -62.07 -42.13 98.88 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.1 0.476 . . . . 0.0 110.78 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -66.39 -38.09 86.73 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -177.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.47 ' CG ' ' N ' ' A' ' 272' ' ' GLY . 53.2 tttp -80.85 173.08 12.96 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . 0.47 ' N ' ' CG ' ' A' ' 271' ' ' LYS . . . 62.38 100.37 0.01 OUTLIER Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -173.85 5.67 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.53 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' MET . . . . . 0.578 ' N ' ' CD ' ' A' ' 275' ' ' PRO . 0.7 OUTLIER -64.03 -44.21 77.27 Favored Pre-proline 0 CA--C 1.531 0.229 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.04 -179.879 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 274' ' ' MET . 21.5 Cg_exo -64.38 -46.46 7.51 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.516 2.144 . . . . 0.0 111.253 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 20.0 m -60.41 -39.44 87.41 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.25 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -61.48 -42.59 99.02 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 122.583 1.182 . . . . 0.0 112.737 -178.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.96 -38.76 89.71 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 112.262 -2.244 . . . . 0.0 107.778 174.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 41.7 mmm-85 -62.68 -39.32 93.58 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.32 0.581 . . . . 0.0 110.511 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.66 -36.23 80.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.13 -0.941 . . . . 0.0 113.011 -177.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -67.75 -50.73 40.04 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -178.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 47.8 p -62.74 -43.94 97.5 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' TRP . . . . . . . . . . . . . 75.3 t90 -59.9 -37.94 80.85 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.524 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . 0.405 ' ND2' ' N ' ' A' ' 285' ' ' VAL . 0.0 OUTLIER -61.56 -37.82 85.21 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.559 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . 0.405 ' N ' ' ND2' ' A' ' 284' ' ' ASN . 94.6 t -59.76 -38.3 75.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.576 -0.283 . . . . 0.0 110.397 -179.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 10.8 t -62.58 -41.07 90.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.845 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -61.36 -39.25 89.92 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.22 0.533 . . . . 0.0 110.378 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -59.5 -41.05 88.99 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -178.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.435 ' O ' ' OE1' ' A' ' 293' ' ' GLN . 0.7 OUTLIER -61.36 -40.14 85.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -175.914 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.21 -39.41 94.55 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -60.48 -38.5 84.47 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 176.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 32.9 tp10 -57.94 -40.27 80.11 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 118.157 -1.417 . . . . 0.0 109.417 -176.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' GLN . . . . . 0.435 ' OE1' ' O ' ' A' ' 289' ' ' VAL . 5.2 mp0 -60.35 -42.23 95.3 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 122.827 1.299 . . . . 0.0 110.032 179.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 78.4 mt -60.27 -39.26 86.19 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 112.268 -2.242 . . . . 0.0 109.564 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -62.3 -45.2 94.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.582 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' ARG . . . . . 0.433 ' O ' ' O ' ' A' ' 293' ' ' GLN . 9.0 tpm_? -122.44 116.07 23.34 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -114.22 -163.84 0.89 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.223 0.535 . . . . 0.0 112.113 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 20.1 tp -72.22 114.4 10.29 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 176.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 41.7 ttp -95.93 61.9 2.2 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.527 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.75 101.04 0.07 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.937 0.875 . . . . 0.0 111.071 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -63.94 -46.05 86.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 113.814 -1.539 . . . . 0.0 113.293 -176.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -58.14 -38.9 77.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.739 -177.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 45.3 tp60 -63.75 -46.49 85.09 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.423 -178.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' SER . . . . . 0.438 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 3.4 t -66.0 -37.56 86.23 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.105 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -61.78 -42.94 99.63 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.97 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 11.7 tm-20 -64.94 -37.03 86.29 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -177.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -60.07 -52.87 70.38 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -176.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' PRO . . . . . 0.438 ' CD ' ' O ' ' A' ' 304' ' ' SER . 73.7 Cg_endo -75.4 0.49 9.01 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.166 1.911 . . . . 0.0 112.157 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.588 -179.852 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 10.3 ptt? . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.9 m -153.25 99.11 2.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.789 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.621 ' CG2' ' H ' ' A' ' 16' ' ' LYS . 10.8 p -88.32 -178.6 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.28 -178.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.621 ' H ' ' CG2' ' A' ' 15' ' ' VAL . 12.6 mptt -63.96 -40.88 97.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.99 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -63.54 -41.26 98.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.79 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.0 tp -79.96 -26.61 39.95 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.804 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.441 ' O ' ' OG1' ' A' ' 22' ' ' THR . . . -66.56 -41.53 94.05 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 107.215 -2.354 . . . . 0.0 107.215 176.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.18 -31.78 68.06 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 124.917 2.294 . . . . 0.0 107.286 176.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.45 -42.78 98.92 Favored Glycine 0 CA--C 1.527 0.825 1 CA-C-N 108.32 -4.037 . . . . 0.0 108.234 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.501 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 28.9 p -70.65 -28.01 64.49 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.529 0.681 . . . . 0.0 109.345 177.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.2 -50.16 64.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.866 -178.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.443 ' O ' ' OD2' ' A' ' 28' ' ' ASP . . . -62.04 -35.74 79.49 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 118.404 -1.318 . . . . 0.0 111.322 -177.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.638 ' SG ' ' N ' ' A' ' 26' ' ' ILE . 5.4 p -64.1 -53.48 48.93 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.538 -179.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.638 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 11.2 tp -65.59 -39.79 86.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -177.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.02 -41.78 97.32 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 119.775 -0.77 . . . . 0.0 112.967 -173.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.484 ' CG ' ' NE2' ' A' ' 89' ' ' GLN . 1.7 p30 -77.64 -27.14 50.95 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 118.329 -1.348 . . . . 0.0 109.636 -176.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 10.9 tp -60.16 -55.92 27.95 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 119.65 1.114 . . . . 0.0 111.929 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.8 tt -75.58 -4.63 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-O 121.382 0.61 . . . . 0.0 112.274 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 53.5 m -109.41 -16.72 13.95 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.013 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.457 ' N ' ' HD2' ' A' ' 33' ' ' PRO . 84.2 t80 -68.46 -45.89 36.72 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 121.879 2.127 . . . . 0.0 112.011 -177.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 32' ' ' PHE . 27.7 Cg_endo -60.35 -16.1 39.28 Favored 'Trans proline' 0 N--CA 1.5 1.862 0 CA-C-N 121.27 1.489 . . . . 0.0 112.858 177.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 80.5 mt -67.08 -35.18 79.25 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.518 0.932 . . . . 0.0 113.518 -177.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -64.45 -40.07 95.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.236 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.8 m -58.33 -35.0 71.24 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.922 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.65 -37.92 83.1 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.124 -0.63 . . . . 0.0 111.615 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -61.4 -49.09 78.31 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.631 -176.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -63.28 -39.09 83.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 119.193 0.906 . . . . 0.0 112.248 -177.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.599 ' NH2' HE22 ' A' ' 58' ' ' GLN . 0.0 OUTLIER -60.36 -40.7 91.7 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.698 -179.485 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.82 39.02 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.946 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.477 ' H ' ' C ' ' A' ' 40' ' ' ARG . 21.3 pt20 -81.11 147.11 30.24 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.748 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 14.7 mt -82.67 53.19 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.987 0.422 . . . . 0.0 110.246 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 45.01 74.83 0.12 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.742 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.52 59.95 0.31 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.405 ' O ' ' OG ' ' A' ' 47' ' ' SER . 28.3 tp10 -71.21 -7.18 45.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.836 0.35 . . . . 0.0 110.388 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' A' ' 46' ' ' GLU . 23.8 p 57.47 50.02 11.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.492 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -143.77 -18.43 0.6 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.674 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.15 -10.15 74.13 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.0 tp -65.28 -38.11 89.25 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.691 0.281 . . . . 0.0 111.554 -178.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.416 ' CG2' ' N ' ' A' ' 52' ' ' ARG . 14.7 m -60.88 -44.81 98.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.495 -178.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.416 ' N ' ' CG2' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -64.92 -33.43 76.02 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.208 -179.644 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 79.7 m -67.77 -38.23 83.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.969 0.414 . . . . 0.0 110.522 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -86.82 -153.84 0.22 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.77 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -162.42 -53.38 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.89 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.528 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 8.4 t -128.32 -139.1 0.24 Allowed 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 56' ' ' SER . . . 93.82 14.63 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.659 0.6 . . . . 0.0 111.592 178.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.599 HE22 ' NH2' ' A' ' 40' ' ' ARG . 6.4 pt20 175.89 122.74 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.946 0.403 . . . . 0.0 109.915 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -105.83 159.46 15.99 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.402 ' O ' ' C ' ' A' ' 61' ' ' GLY . 36.2 ptt180 -43.44 -32.35 0.86 Allowed 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.505 -0.478 . . . . 0.0 109.808 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 60' ' ' ARG . . . -31.37 102.75 0.01 OUTLIER Glycine 0 CA--C 1.526 0.733 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.01 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.7 p -67.08 -33.71 64.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 118.232 -0.889 . . . . 0.0 109.639 176.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -60.32 -32.63 71.42 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 121.442 1.928 . . . . 0.0 110.288 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.49 -49.0 67.54 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-N 115.377 -0.829 . . . . 0.0 114.352 -176.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 14.1 m -61.73 -46.02 91.44 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.201 -0.5 . . . . 0.0 112.057 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 72.1 mt -59.09 -36.23 61.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 74.4 mt -63.63 -34.97 79.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 120.439 1.472 . . . . 0.0 112.602 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.443 ' O ' ' OG1' ' A' ' 72' ' ' THR . 98.9 m -63.47 -41.59 98.6 Favored 'General case' 0 C--O 1.254 1.308 0 C-N-CA 125.433 1.493 . . . . 0.0 110.983 -174.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 6.5 ptp -60.36 -38.92 85.39 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 120.018 -1.676 . . . . 0.0 113.842 -176.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.3 m -68.55 -40.77 82.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 119.025 -1.07 . . . . 0.0 113.627 -176.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 61.5 ttp85 -77.92 -13.55 59.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 122.028 0.918 . . . . 0.0 112.305 -178.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 68' ' ' THR . 70.4 m -62.92 -55.05 29.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.335 -1.302 . . . . 0.0 111.775 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -108.68 -58.22 2.04 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.794 178.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.32 164.62 13.58 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -56.59 -35.16 96.87 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 121.966 1.777 . . . . 0.0 111.775 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.465 ' O ' ' OD1' ' A' ' 80' ' ' ASN . 96.5 mtt180 -60.93 -11.19 7.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.928 0.87 . . . . 0.0 110.925 176.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.505 ' O ' ' OD1' ' A' ' 80' ' ' ASN . 7.4 t -77.64 -32.21 53.23 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 113.275 -1.784 . . . . 0.0 110.265 -178.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.9 mp -75.54 -29.34 59.37 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.224 1.01 . . . . 0.0 111.59 177.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -87.4 -2.62 58.75 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 122.896 1.331 . . . . 0.0 113.417 -172.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.505 ' OD1' ' O ' ' A' ' 77' ' ' SER . 11.9 p-10 -117.67 135.14 54.21 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 112.104 -2.316 . . . . 0.0 108.207 176.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.8 -25.9 25.89 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 -177.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.14 -34.44 72.06 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 113.834 -1.183 . . . . 0.0 110.283 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.6 p -70.83 -27.12 29.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.917 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.88 -31.86 61.7 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.408 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.8 -40.13 89.74 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 119.984 -1.103 . . . . 0.0 111.205 -177.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 86.2 mt -62.55 -40.25 96.21 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 122.285 1.04 . . . . 0.0 112.871 -176.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -60.67 -27.5 67.88 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 113.149 -1.841 . . . . 0.0 109.865 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 14.9 mmt85 -57.93 -53.32 59.54 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 173.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.484 ' NE2' ' CG ' ' A' ' 28' ' ' ASP . 60.7 mt-30 -66.83 -29.74 69.74 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 112.418 -2.174 . . . . 0.0 111.776 -177.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 33.9 ttm -61.37 -40.89 95.97 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.067 -0.97 . . . . 0.0 112.429 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.9 m -74.59 -34.65 62.91 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.453 -176.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -57.63 -43.67 84.99 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 120.794 1.633 . . . . 0.0 112.123 -176.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.47 -32.6 64.42 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 119.602 -0.839 . . . . 0.0 111.228 -178.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 38.7 t -64.11 -41.57 97.21 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.434 ' C ' ' H ' ' A' ' 97' ' ' ILE . 30.6 m -67.8 -27.94 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.005 177.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.473 ' CG ' ' O ' ' A' ' 96' ' ' ARG . 6.7 ttt85 -77.61 9.28 3.49 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -176.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.434 ' H ' ' C ' ' A' ' 95' ' ' VAL . 0.3 OUTLIER -87.02 -15.95 9.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 176.538 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -140.49 -48.46 0.05 OUTLIER Glycine 0 CA--C 1.544 1.891 0 N-CA-C 115.569 0.987 . . . . 0.0 115.569 -177.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 14.9 mt -71.17 -13.12 61.83 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.2 1.5 . . . . 0.0 112.644 -177.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.446 ' O ' ' HB2' ' A' ' 104' ' ' LYS . 1.9 m-85 -81.0 -50.34 9.81 Favored 'General case' 0 C--O 1.214 -0.785 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.008 178.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.922 ' OD2' ' NE2' ' A' ' 105' ' ' GLN . 19.4 t70 -68.55 -31.82 71.31 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 114.059 -1.428 . . . . 0.0 110.12 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.0 t -69.33 -53.16 21.01 Favored 'General case' 0 CA--C 1.554 1.107 0 CA-C-N 112.203 -2.272 . . . . 0.0 114.544 177.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.1 t -74.9 -27.64 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 CA-C-N 122.487 2.403 . . . . 0.0 113.437 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.446 ' HB2' ' O ' ' A' ' 100' ' ' TYR . 13.4 tttp -70.16 -40.99 74.41 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 112.004 -2.362 . . . . 0.0 111.548 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.922 ' NE2' ' OD2' ' A' ' 101' ' ' ASP . 88.1 mt-30 -79.62 -13.17 59.69 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.742 0.782 . . . . 0.0 111.071 -178.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -78.79 -22.92 45.58 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.876 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 6.4 m-30 -109.04 -30.11 8.23 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 119.341 0.973 . . . . 0.0 112.068 -174.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.2 m -97.49 9.25 42.91 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 117.926 -1.509 . . . . 0.0 113.233 -178.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.466 ' O ' ' C ' ' A' ' 110' ' ' GLY . 18.7 mmtt -52.77 121.51 7.37 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-N 119.025 0.83 . . . . 0.0 111.715 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.517 ' O ' ' CB ' ' A' ' 111' ' ' SER . . . -22.91 -82.35 0.01 OUTLIER Glycine 0 N--CA 1.485 1.91 0 CA-C-N 118.665 0.666 . . . . 0.0 113.171 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.517 ' CB ' ' O ' ' A' ' 110' ' ' GLY . 1.4 m 96.53 -90.26 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 178.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.513 ' O ' ' CG ' ' A' ' 113' ' ' HIS . 0.3 OUTLIER 168.83 -35.75 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 120.725 1.602 . . . . 0.0 114.215 179.308 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.513 ' CG ' ' O ' ' A' ' 112' ' ' GLU . 1.1 p-80 155.61 46.07 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 121.103 0.477 . . . . 0.0 110.841 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.484 ' CB ' ' O ' ' A' ' 113' ' ' HIS . . . 159.91 -162.9 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.15 15.25 26.4 Favored Glycine 0 C--N 1.337 0.587 0 CA-C-N 114.114 -1.403 . . . . 0.0 111.2 178.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.413 HD13 HG21 ' A' ' 116' ' ' ILE . 31.6 mm -60.66 -41.07 86.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 C-N-CA 120.065 -0.654 . . . . 0.0 109.278 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.54 -40.12 95.94 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 121.91 0.728 . . . . 0.0 111.858 175.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 35.6 t -57.78 -41.81 82.79 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 177.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 9.5 ttm-85 -63.23 -36.78 84.78 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.984 -177.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 58.5 mt -63.73 -46.33 85.84 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.255 0.55 . . . . 0.0 109.805 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 41.5 mt -66.65 -44.77 81.02 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 119.112 -1.035 . . . . 0.0 110.459 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.69 -44.83 92.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 119.625 1.102 . . . . 0.0 109.932 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -65.73 -44.2 92.79 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 119.801 -1.19 . . . . 0.0 111.126 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 77.9 p -64.5 -44.44 90.96 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.829 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 97.2 m -69.47 -48.4 60.86 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 119.453 -0.899 . . . . 0.0 111.916 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.439 ' CG2' ' N ' ' A' ' 127' ' ' GLY . 6.2 t -65.26 -42.41 93.3 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -174.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.439 ' N ' ' CG2' ' A' ' 126' ' ' THR . . . -64.07 -44.78 95.33 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-O 122.704 1.169 . . . . 0.0 113.518 -177.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.406 ' O ' ' CG2' ' A' ' 131' ' ' VAL . . . -61.58 -41.62 97.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 112.358 -1.921 . . . . 0.0 107.141 177.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -64.66 -42.08 95.65 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.725 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.22 -39.94 96.05 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -177.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.524 ' O ' ' NE2' ' A' ' 135' ' ' GLN . 15.3 m -61.27 -25.75 37.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 123.005 1.383 . . . . 0.0 109.902 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -58.31 -44.93 88.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 111.906 -2.406 . . . . 0.0 112.621 -178.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.476 ' CG1' ' N ' ' A' ' 134' ' ' ALA . 3.5 p -78.95 -48.72 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 C-N-CA 120.712 -0.395 . . . . 0.0 112.006 -178.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.476 ' N ' ' CG1' ' A' ' 133' ' ' VAL . . . -122.95 135.92 54.67 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.994 0.426 . . . . 0.0 111.575 -178.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.698 ' H ' ' CD ' ' A' ' 136' ' ' PRO . 24.4 pt20 177.99 -24.61 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.703 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.717 178.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.698 ' CD ' ' H ' ' A' ' 135' ' ' GLN . 52.9 Cg_exo -53.14 -33.42 63.99 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 121.437 1.425 . . . . 0.0 112.691 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 11.1 t -66.54 -41.76 88.21 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 119.234 -0.986 . . . . 0.0 109.523 -178.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -64.93 -42.59 94.56 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 117.876 -1.53 . . . . 0.0 111.566 -178.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 15.1 t -64.64 -44.9 96.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.0 p -65.38 -37.08 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -178.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.44 ' O ' ' OE1' ' A' ' 145' ' ' GLN . 14.0 mptt -60.42 -40.2 90.19 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.713 -176.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 70.5 t -68.54 -44.52 82.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.523 ' NH2' ' O ' ' A' ' 174' ' ' GLY . 65.6 mtt-85 -64.34 -36.09 83.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.066 178.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.414 ' CD1' ' C ' ' A' ' 144' ' ' PHE . 36.0 t80 -66.46 -41.56 88.85 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -177.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.44 ' OE1' ' O ' ' A' ' 141' ' ' LYS . 4.8 mp0 -64.83 -39.5 93.68 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 118.941 -1.104 . . . . 0.0 108.087 178.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.39 -34.59 78.66 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.686 HE22 HE21 ' A' ' 157' ' ' GLN . 32.9 tt0 -60.54 110.3 1.24 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 175.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.487 ' C ' ' H ' ' A' ' 150' ' ' ALA . . . -106.1 -55.18 2.36 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 -175.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -77.24 21.47 0.24 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 122.327 2.33 . . . . 0.0 110.417 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.487 ' H ' ' C ' ' A' ' 148' ' ' ALA . . . 51.24 -94.72 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.659 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -162.78 -37.91 0.02 OUTLIER Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 55.85 -133.96 50.04 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 65.13 28.2 73.25 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 53.1 ttt85 61.74 54.9 2.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.833 0.349 . . . . 0.0 110.409 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -170.1 143.95 2.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.625 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -87.71 109.49 19.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.467 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.686 HE21 HE22 ' A' ' 147' ' ' GLN . 19.0 tt0 -71.54 164.8 25.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.455 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.441 ' OG ' ' N ' ' A' ' 159' ' ' THR . 29.7 t -156.94 -177.94 7.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.878 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.441 ' N ' ' OG ' ' A' ' 158' ' ' SER . 69.5 p -63.79 -45.96 87.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.65 -177.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 77.0 t -64.04 -45.37 96.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 119.067 -1.053 . . . . 0.0 109.165 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -66.89 -38.44 86.29 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.527 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.496 ' O ' ' CD1' ' A' ' 166' ' ' ILE . . . -61.33 -44.27 97.48 Favored 'General case' 0 C--O 1.211 -0.969 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -177.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -61.32 -47.85 84.04 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.67 0.747 . . . . 0.0 112.151 -177.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 17.8 tptp -68.19 -45.33 73.69 Favored 'General case' 0 CA--C 1.554 1.129 0 N-CA-C 117.841 2.534 . . . . 0.0 117.841 -172.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 17.6 m -63.1 -45.48 91.86 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 117.344 2.35 . . . . 0.0 117.344 -174.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.573 ' H ' ' CD1' ' A' ' 166' ' ' ILE . 0.1 OUTLIER -64.62 -37.36 79.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-O 121.524 0.678 . . . . 0.0 109.271 176.925 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.464 ' H ' HD13 ' A' ' 166' ' ' ILE . . . -59.18 -37.02 76.38 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 176.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -62.57 -50.32 71.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 122.992 2.633 . . . . 0.0 111.465 -177.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -75.15 -51.24 13.91 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 123.539 0.736 . . . . 0.0 109.409 177.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -78.27 -36.8 46.32 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 115.775 1.768 . . . . 0.0 115.775 -174.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 93.71 -168.44 29.12 Favored Glycine 0 N--CA 1.468 0.788 0 CA-C-N 118.472 0.578 . . . . 0.0 112.615 177.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.6 mt -73.56 -41.62 55.78 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.067 0 CA-C-O 122.252 1.025 . . . . 0.0 110.62 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 60.5 ttt85 -58.31 -32.77 68.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 113.448 -1.706 . . . . 0.0 111.027 -176.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.523 ' O ' ' NH2' ' A' ' 143' ' ' ARG . . . -59.83 -39.37 95.33 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 119.292 -1.432 . . . . 0.0 109.579 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 5.5 tp -69.44 -33.39 72.88 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 117.085 2.254 . . . . 0.0 117.085 -177.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 67.3 m95 -77.58 -7.46 56.37 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 111.254 -2.703 . . . . 0.0 109.843 -177.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -43.28 -48.02 6.66 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.556 -177.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -111.24 -29.61 3.41 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.065 0.84 . . . . 0.0 112.046 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 3.9 m -46.26 -52.14 13.15 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.31 -49.75 77.83 Favored Pre-proline 0 N--CA 1.481 1.118 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -177.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -62.2 -27.87 78.88 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 121.973 1.782 . . . . 0.0 111.766 175.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -63.41 -39.04 93.44 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 178.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 97.0 t -63.21 -42.0 94.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.251 178.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.53 -39.21 90.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.237 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.53 -41.52 94.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.035 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -60.97 -42.38 98.22 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.265 0.555 . . . . 0.0 110.051 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.68 -43.1 97.64 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.166 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 5.6 mm -63.14 -44.78 99.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -177.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.401 ' O ' ' CD ' ' A' ' 193' ' ' GLU . 6.9 m -59.69 -45.7 94.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 120.328 -0.549 . . . . 0.0 111.472 -178.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . 0.5 ' OD1' ' N ' ' A' ' 191' ' ' CYS . 2.0 p30 -61.84 -42.52 99.13 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 122.259 1.028 . . . . 0.0 108.91 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' CYS . . . . . 0.5 ' N ' ' OD1' ' A' ' 190' ' ' ASN . 52.2 t -62.15 -46.56 88.44 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 113.294 -1.775 . . . . 0.0 110.922 179.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.35 -40.61 96.2 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 114.296 -1.32 . . . . 0.0 109.529 176.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 0.515 ' OE1' ' N ' ' A' ' 193' ' ' GLU . 0.0 OUTLIER -61.52 -45.4 94.37 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.768 -178.701 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 4.1 tt -64.01 -39.52 94.3 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 118.331 -1.348 . . . . 0.0 110.18 -174.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 8.2 m -64.59 -45.86 94.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 116.909 -1.916 . . . . 0.0 107.775 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 98.4 m -64.16 -46.33 84.53 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -177.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -57.92 -40.11 79.61 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -178.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -56.48 -44.98 81.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.573 0.701 . . . . 0.0 109.317 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.515 ' CD2' ' N ' ' A' ' 199' ' ' LEU . 1.5 mm? -61.92 -39.89 93.6 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.51 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 45.6 mm -64.03 -43.54 97.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 118.575 -0.726 . . . . 0.0 112.893 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -59.63 -40.95 89.29 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 120.588 1.54 . . . . 0.0 110.839 178.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -66.22 -38.46 88.01 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 112.939 -1.937 . . . . 0.0 111.027 -177.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 43.8 m -102.26 130.3 48.91 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.367 -0.833 . . . . 0.0 112.446 -178.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 20.9 mt 68.08 5.58 4.7 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 114.777 -1.101 . . . . 0.0 113.402 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.403 ' CD2' ' O ' ' A' ' 205' ' ' LEU . 2.3 tt -137.37 49.58 2.0 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 178.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 4.3 tppt? -74.11 -23.55 59.33 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.718 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.483 ' O ' ' CB ' ' A' ' 208' ' ' ASN . . . -130.04 -40.22 1.34 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.776 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . 0.626 ' O ' ' N ' ' A' ' 210' ' ' MET . 41.2 p-10 130.34 76.1 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.247 1.419 . . . . 0.0 108.007 -178.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 3.1 tp 2.07 38.87 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 118.276 2.695 . . . . 0.0 118.276 178.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' MET . . . . . 0.626 ' N ' ' O ' ' A' ' 208' ' ' ASN . 41.6 ttp -78.17 -56.82 4.16 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 120.583 1.538 . . . . 0.0 112.282 -178.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.403 ' C ' ' O ' ' A' ' 210' ' ' MET . 44.3 p -34.44 126.41 0.48 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.941 0.401 . . . . 0.0 111.88 -179.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -60.86 114.84 3.27 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.733 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.491 ' OD1' ' SG ' ' A' ' 216' ' ' CYS . 32.9 t70 -174.17 30.58 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -61.31 -43.72 90.68 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -177.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -60.86 -34.07 91.8 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 CA-C-N 120.778 1.313 . . . . 0.0 111.514 -177.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' CYS . . . . . 0.491 ' SG ' ' OD1' ' A' ' 213' ' ' ASP . 62.4 m -66.56 -42.69 86.69 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 113.089 -1.869 . . . . 0.0 111.862 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 13.2 t-160 -66.59 -37.54 85.12 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.081 -1.418 . . . . 0.0 114.425 -176.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -62.92 -48.33 79.39 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 118.775 -0.631 . . . . 0.0 110.775 -178.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 12.9 m -61.26 -39.09 89.07 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 120.028 1.285 . . . . 0.0 110.013 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 39.5 t -59.97 -41.71 92.56 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 177.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . 0.564 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.53 -41.79 98.45 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -177.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -61.55 -46.86 88.13 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 122.162 0.982 . . . . 0.0 112.822 -175.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -60.88 -42.11 99.51 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 107.458 -2.257 . . . . 0.0 107.458 176.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . 0.515 ' O ' ' SG ' ' A' ' 227' ' ' CYS . . . -63.03 -37.21 86.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 113.869 -1.166 . . . . 0.0 108.934 176.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -61.06 -42.51 99.82 Favored Glycine 0 CA--C 1.52 0.383 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.626 -176.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' PHE . . . . . 0.419 ' O ' ' OG1' ' A' ' 229' ' ' THR . 67.3 t80 -66.88 -38.87 87.11 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 118.782 -1.167 . . . . 0.0 108.4 178.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . 0.515 ' SG ' ' O ' ' A' ' 224' ' ' ALA . 0.5 OUTLIER -63.89 -41.18 97.79 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.165 0.507 . . . . 0.0 110.251 177.445 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' THR . . . . . 0.477 ' HG1' ' N ' ' A' ' 229' ' ' THR . 78.5 p -61.58 -40.3 94.28 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.465 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.477 ' N ' ' HG1' ' A' ' 228' ' ' THR . 23.8 p -59.34 -40.26 85.77 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 119.802 -0.759 . . . . 0.0 111.567 -176.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 92.7 t -61.47 -43.17 96.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 118.588 -1.245 . . . . 0.0 111.919 -178.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 3.4 tp -63.08 -40.86 90.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 121.711 0.767 . . . . 0.0 109.148 176.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -62.58 -39.39 93.56 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 114.331 -1.304 . . . . 0.0 113.924 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.488 ' N ' ' HD2' ' A' ' 234' ' ' PRO . 8.0 t -58.34 -42.39 94.49 Favored Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 116.04 1.867 . . . . 0.0 116.04 -174.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 233' ' ' SER . 17.9 Cg_endo -58.93 -40.9 67.34 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 CA-C-N 121.352 1.519 . . . . 0.0 113.457 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 2.8 p -65.52 -37.63 80.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 118.357 -1.337 . . . . 0.0 110.914 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -66.42 -42.0 88.4 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 15.6 m -65.59 -45.66 91.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -176.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 12.9 p -63.74 -38.49 82.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 119.116 -1.034 . . . . 0.0 112.047 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -61.57 -45.91 92.11 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 119.94 -0.704 . . . . 0.0 112.591 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' THR . . . . . 0.419 ' O ' ' C ' ' A' ' 241' ' ' ARG . 1.6 t -62.5 -41.69 98.99 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 120.97 0.414 . . . . 0.0 110.864 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.419 ' C ' ' O ' ' A' ' 240' ' ' THR . 29.8 ttp180 -29.38 134.92 0.04 OUTLIER 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.328 -178.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -159.14 -76.53 0.07 Allowed 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' MET . . . . . . . . . . . . . 31.6 mmm -42.17 122.12 2.06 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.875 0.845 . . . . 0.0 112.281 -178.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . 0.827 ' OD1' ' SG ' ' A' ' 256' ' ' CYS . 19.0 p30 -171.46 118.04 0.44 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.32 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' SER . . . . . 0.607 ' HG ' ' HB2' ' A' ' 260' ' ' MET . 15.9 m 63.44 -123.86 0.57 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.086 -177.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . 0.547 ' CB ' ' O ' ' A' ' 245' ' ' SER . . . 153.45 -97.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.295 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.417 ' N ' ' CD2' ' A' ' 247' ' ' LEU . 2.3 mm? -57.97 -161.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.85 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 1.065 ' O ' ' N ' ' A' ' 250' ' ' TYR . . . 73.04 -162.63 54.82 Favored Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 111.695 -0.562 . . . . 0.0 111.695 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.523 ' O ' ' C ' ' A' ' 250' ' ' TYR . 96.2 mm-40 -33.75 61.31 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.816 0.341 . . . . 0.0 110.773 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 1.065 ' N ' ' O ' ' A' ' 248' ' ' GLY . 66.9 t80 -26.8 -68.17 0.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.711 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . 0.572 ' ND1' ' NE2' ' A' ' 255' ' ' HIS . 32.5 m170 39.25 -92.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.866 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' SER . . . . . 0.485 ' N ' ' O ' ' A' ' 250' ' ' TYR . 23.9 m -149.52 140.11 22.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.121 -179.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.499 ' O ' ' SG ' ' A' ' 256' ' ' CYS . . . -32.73 -44.9 0.11 Allowed 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -66.24 -40.92 94.97 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.803 178.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' HIS . . . . . 0.572 ' NE2' ' ND1' ' A' ' 251' ' ' HIS . 86.4 t60 -62.92 -33.08 74.57 Favored 'General case' 0 C--N 1.367 1.332 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.033 -176.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' CYS . . . . . 0.827 ' SG ' ' OD1' ' A' ' 244' ' ' ASN . 3.8 p -60.46 -42.63 96.6 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.556 ' HB1' ' ND2' ' A' ' 244' ' ' ASN . . . -58.81 -43.45 90.56 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.161 -179.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.01 -42.91 94.0 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 256' ' ' CYS . 67.0 p -62.29 -43.59 98.48 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.634 0.73 . . . . 0.0 109.222 177.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' MET . . . . . 0.607 ' HB2' ' HG ' ' A' ' 245' ' ' SER . 39.1 ttp -58.71 -41.6 86.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.625 -1.17 . . . . 0.0 110.066 -179.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 15.3 tp -61.06 -45.86 93.02 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.745 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 40.5 ttt-85 -65.77 -54.07 32.05 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 120.434 -0.506 . . . . 0.0 112.029 -177.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 3.4 pttt -75.34 -52.99 9.49 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 119.877 -0.729 . . . . 0.0 111.46 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' A' ' 265' ' ' GLY . 22.9 mt-10 -84.36 112.55 20.43 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.356 -179.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 264' ' ' GLU . . . -39.65 170.51 0.01 OUTLIER Glycine 0 CA--C 1.532 1.097 0 CA-C-N 115.718 -0.673 . . . . 0.0 112.564 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.3 -2.36 5.83 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.492 2.128 . . . . 0.0 112.515 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.407 ' HD3' ' H ' ' A' ' 268' ' ' ALA . 0.0 OUTLIER -69.77 -26.42 64.28 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 179.476 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . 0.407 ' H ' ' HD3' ' A' ' 267' ' ' ARG . . . -58.37 -32.5 68.63 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.241 -178.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -62.5 -41.46 98.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.4 0.619 . . . . 0.0 110.96 177.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -65.86 -37.18 85.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.338 -178.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.78 164.04 13.85 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 60.45 106.16 0.01 OUTLIER Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -174.68 12.32 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.441 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' MET . . . . . 0.45 ' N ' ' HD2' ' A' ' 275' ' ' PRO . 17.1 mtt -63.84 -44.93 80.91 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' A' ' 274' ' ' MET . 38.0 Cg_endo -64.93 -47.39 4.97 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 CA-C-N 120.586 1.245 . . . . 0.0 112.436 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' SER . . . . . 0.521 ' HG ' ' N ' ' A' ' 277' ' ' PHE . 89.7 p -61.32 -40.57 94.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.754 0.787 . . . . 0.0 109.926 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . 0.521 ' N ' ' HG ' ' A' ' 276' ' ' SER . 59.1 t80 -62.05 -41.85 98.56 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 123.597 1.665 . . . . 0.0 112.264 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 29.4 mt -62.0 -38.5 88.87 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 110.272 -3.149 . . . . 0.0 108.513 174.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -62.67 -40.88 98.46 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.475 0.655 . . . . 0.0 110.465 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.454 ' CD1' ' C ' ' A' ' 280' ' ' LEU . 0.1 OUTLIER -62.43 -36.56 82.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.326 -177.585 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -68.04 -51.14 35.64 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -178.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 7.5 t -63.09 -45.04 93.99 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.226 0.61 . . . . 0.0 110.506 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' TRP . . . . . . . . . . . . . 16.3 t90 -60.77 -38.22 84.51 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.698 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . 0.446 ' OD1' ' CD1' ' A' ' 280' ' ' LEU . 2.2 m120 -61.96 -37.72 85.8 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.43 0.529 . . . . 0.0 112.43 -178.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -59.95 -37.67 73.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -177.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -61.95 -40.11 86.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.942 -178.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 4.5 ptm -60.58 -38.77 85.7 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -58.65 -40.04 82.31 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.444 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 86.0 t -60.73 -39.37 81.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.522 -178.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 71.0 m -63.03 -40.56 98.09 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 119.654 -0.819 . . . . 0.0 109.039 177.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -60.92 -38.94 87.52 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 177.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -58.34 -40.21 81.56 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 117.756 -1.578 . . . . 0.0 109.847 -176.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' GLN . . . . . 0.459 ' O ' ' O ' ' A' ' 296' ' ' ARG . 76.6 mt-30 -60.32 -42.67 96.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 122.893 1.33 . . . . 0.0 110.874 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 9.4 mp -60.29 -39.75 88.02 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 112.487 -2.142 . . . . 0.0 109.226 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 26.7 mmtt -62.9 -45.47 92.39 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.055 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' ARG . . . . . 0.459 ' O ' ' O ' ' A' ' 293' ' ' GLN . 41.4 ttm180 -122.83 116.38 23.57 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -116.97 -162.69 0.87 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.311 0.577 . . . . 0.0 112.356 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 1.9 mt -69.55 116.14 9.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.504 177.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 2.5 tpt -99.5 60.4 1.14 Allowed 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -177.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.66 100.78 0.07 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.651 0.739 . . . . 0.0 110.551 -178.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -63.96 -46.21 85.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.345 -1.298 . . . . 0.0 114.029 -176.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -58.77 -39.9 82.4 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.185 -178.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . 0.528 ' N ' ' OE1' ' A' ' 303' ' ' GLN . 11.0 mp0 -65.0 -46.76 80.05 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.413 -179.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' SER . . . . . 0.439 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 78.1 p -66.69 -37.68 85.23 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.508 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -61.83 -43.15 99.42 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -179.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -65.11 -37.09 86.37 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 -176.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -60.17 -52.98 69.45 Favored Pre-proline 0 CA--C 1.544 0.738 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 -176.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' PRO . . . . . 0.439 ' CD ' ' O ' ' A' ' 304' ' ' SER . 74.2 Cg_endo -75.29 0.3 9.18 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.147 1.898 . . . . 0.0 111.929 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 86.0 t80 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.547 -179.965 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.8 mmt . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.9 m -69.63 126.51 29.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.455 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.0 t -147.57 158.92 8.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.518 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.437 ' NZ ' ' CB ' ' A' ' 16' ' ' LYS . 0.3 OUTLIER -64.41 -41.55 96.57 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.582 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.404 ' N ' ' CG ' ' A' ' 16' ' ' LYS . 4.4 t80 -63.95 -41.6 97.53 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.501 ' N ' ' CD2' ' A' ' 18' ' ' LEU . 3.3 mm? -79.58 -26.73 41.24 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.803 -178.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.442 ' O ' ' OG1' ' A' ' 22' ' ' THR . . . -66.2 -41.29 94.91 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 107.486 -2.245 . . . . 0.0 107.486 177.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.73 -32.21 67.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 124.79 2.233 . . . . 0.0 107.705 176.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.47 -42.4 99.01 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-N 108.501 -3.954 . . . . 0.0 108.091 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.498 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 34.4 p -70.55 -27.34 64.07 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 177.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.39 -50.09 64.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.879 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.0 -36.17 80.72 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 118.621 -1.232 . . . . 0.0 111.502 -177.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.625 ' SG ' ' N ' ' A' ' 26' ' ' ILE . 8.7 p -63.88 -53.21 54.07 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.382 -178.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.625 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -64.84 -38.98 84.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -176.505 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.73 -41.2 98.09 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -173.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.524 ' OD1' ' NE2' ' A' ' 89' ' ' GLN . 6.7 m-20 -77.18 -27.24 53.57 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 120.976 1.717 . . . . 0.0 111.714 -174.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.98 -54.09 50.12 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 121.29 1.859 . . . . 0.0 112.894 -178.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.5 tt -75.34 -4.2 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -179.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 34.2 p -109.03 -16.03 14.22 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 119.369 -0.932 . . . . 0.0 109.315 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.463 ' N ' ' HD2' ' A' ' 33' ' ' PRO . 88.1 t80 -68.18 -45.77 39.86 Favored Pre-proline 0 CA--C 1.546 0.826 0 CA-C-N 121.821 2.1 . . . . 0.0 111.488 -178.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 32' ' ' PHE . 26.3 Cg_endo -60.33 -15.72 36.89 Favored 'Trans proline' 0 N--CA 1.504 2.122 0 CA-C-N 121.299 1.5 . . . . 0.0 113.195 176.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.409 ' N ' ' CD2' ' A' ' 34' ' ' LEU . 3.9 mm? -66.62 -34.94 79.0 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -177.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -64.18 -40.17 95.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.345 -178.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.3 m -58.3 -35.14 71.37 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.253 -0.43 . . . . 0.0 112.048 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.53 -38.5 84.32 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 119.926 -0.71 . . . . 0.0 111.981 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.637 ' HZ2' HH12 ' A' ' 279' ' ' ARG . 27.2 ttpt -61.25 -48.44 81.42 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 119.614 -0.835 . . . . 0.0 110.938 -176.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.3 t -62.9 -38.91 83.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -177.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.548 ' C ' ' H ' ' A' ' 42' ' ' GLN . 5.8 mmm180 -59.83 -41.1 90.62 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 119.806 -0.758 . . . . 0.0 109.948 -179.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -62.19 38.62 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.157 178.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.548 ' H ' ' C ' ' A' ' 40' ' ' ARG . 45.3 tt0 -87.18 147.87 25.41 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 121.89 -0.506 . . . . 0.0 110.972 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 29.1 pt -81.42 -177.07 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.431 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -74.48 135.48 42.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.714 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 46' ' ' GLU . . . 168.99 -114.27 0.55 Allowed Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.406 ' O ' ' O ' ' A' ' 45' ' ' GLY . 38.0 tt0 60.62 131.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.831 0.348 . . . . 0.0 110.845 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 69.5 m -74.1 -34.08 63.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.072 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -52.15 -38.88 58.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.351 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.92 9.44 85.36 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -178.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.437 ' O ' ' OG1' ' A' ' 53' ' ' THR . 0.2 OUTLIER -66.62 -38.42 86.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.294 0.569 . . . . 0.0 110.241 179.004 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.432 ' O ' ' O ' ' A' ' 54' ' ' ALA . 97.2 t -60.95 -45.26 98.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.095 -177.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -65.32 -34.16 77.69 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.787 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.437 ' OG1' ' O ' ' A' ' 50' ' ' LEU . 23.3 p -68.4 -38.18 81.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.907 0.384 . . . . 0.0 110.345 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' A' ' 51' ' ' VAL . . . -95.83 122.02 38.18 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.127 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.97 -43.0 12.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.723 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.443 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 10.4 m -131.05 -137.94 0.21 Allowed 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.443 ' CB ' ' O ' ' A' ' 56' ' ' SER . . . 80.1 -27.04 0.15 Allowed 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 176.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -120.82 38.81 3.94 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.528 ' O ' ' NH2' ' A' ' 40' ' ' ARG . 16.2 m-85 -37.51 151.62 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.81 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.42 ' O ' ' C ' ' A' ' 61' ' ' GLY . 31.9 mtm105 -46.4 -33.68 4.08 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 60' ' ' ARG . . . -30.51 101.95 0.01 OUTLIER Glycine 0 CA--C 1.527 0.795 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.89 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.2 p -66.95 -33.94 66.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 118.155 -0.926 . . . . 0.0 109.44 176.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.52 -33.01 72.01 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 121.263 1.847 . . . . 0.0 110.343 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.94 -49.5 62.59 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-N 115.518 -0.765 . . . . 0.0 114.575 -176.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.488 ' OG1' ' NH2' ' A' ' 40' ' ' ARG . 4.6 m -62.18 -46.36 89.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.005 -0.598 . . . . 0.0 112.498 -178.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 11.2 tt -59.78 -35.79 62.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.87 -35.77 81.74 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 120.597 1.544 . . . . 0.0 111.488 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.44 ' O ' ' OG1' ' A' ' 72' ' ' THR . 99.5 m -63.08 -39.3 94.32 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 113.595 -1.639 . . . . 0.0 111.064 -175.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.492 ' SD ' ' O ' ' A' ' 69' ' ' MET . 0.0 OUTLIER -60.59 -39.99 90.12 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 120.835 -1.166 . . . . 0.0 113.912 -176.548 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.1 p -69.33 -40.34 80.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 119.256 -0.978 . . . . 0.0 112.726 -178.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -78.3 -13.37 59.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.334 0.588 . . . . 0.0 112.585 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 68' ' ' THR . 90.8 m -62.88 -55.02 29.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.136 179.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -108.01 -56.93 2.17 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 157.84 164.39 13.87 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -56.29 -34.96 95.18 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.009 1.806 . . . . 0.0 111.673 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 72.4 mtp85 -61.23 -11.55 9.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.609 0.719 . . . . 0.0 111.463 176.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.9 p -78.28 -33.07 49.76 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.853 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.443 ' CD1' ' N ' ' A' ' 78' ' ' LEU . 8.9 mp -76.13 -32.12 58.98 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 122.309 -0.244 . . . . 0.0 111.45 179.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -90.7 -3.83 57.19 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 123.485 1.612 . . . . 0.0 112.531 -176.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.674 HD21 ' HH ' ' A' ' 156' ' ' TYR . 28.0 t30 -94.24 37.36 1.11 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 110.748 -2.933 . . . . 0.0 108.732 176.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -168.45 -15.37 0.02 OUTLIER Glycine 0 CA--C 1.533 1.209 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.842 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 59.9 mt -59.97 -34.92 73.94 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 119.163 -1.015 . . . . 0.0 111.861 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.9 p -70.54 -27.67 32.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.846 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.7 -31.62 61.93 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.541 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -68.37 -40.57 86.98 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 119.472 -1.347 . . . . 0.0 111.601 -177.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 27.1 mt -63.01 -41.21 99.51 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -176.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -60.9 -26.78 67.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.405 -1.271 . . . . 0.0 108.925 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 18.7 ttm105 -57.47 -53.46 57.87 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 173.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.524 ' NE2' ' OD1' ' A' ' 28' ' ' ASP . 10.7 mm100 -67.05 -29.58 69.42 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 112.557 -2.11 . . . . 0.0 112.089 -178.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 34.4 ttm -61.19 -40.4 93.77 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.951 -1.022 . . . . 0.0 112.682 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 78.2 p -74.22 -34.31 63.65 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 118.491 -0.766 . . . . 0.0 111.058 -176.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -57.8 -44.36 86.29 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 120.609 1.55 . . . . 0.0 110.746 -177.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.63 -33.47 64.56 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 119.075 -1.05 . . . . 0.0 110.744 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.3 p -64.82 -42.85 94.65 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.461 ' C ' ' H ' ' A' ' 97' ' ' ILE . 11.7 p -68.52 -27.91 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.666 178.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.06 9.84 2.74 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 -176.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.461 ' H ' ' C ' ' A' ' 95' ' ' VAL . 99.2 mt -87.23 -15.11 9.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 177.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -140.39 -47.9 0.06 OUTLIER Glycine 0 CA--C 1.538 1.504 0 N-CA-C 115.846 1.098 . . . . 0.0 115.846 -175.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.531 ' CD2' ' N ' ' A' ' 99' ' ' LEU . 3.3 mm? -70.9 -12.62 61.65 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.109 1.454 . . . . 0.0 112.02 -178.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -79.78 -50.43 10.57 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.0 -1.454 . . . . 0.0 109.609 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -67.71 -32.35 72.92 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 113.768 -1.56 . . . . 0.0 109.264 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.2 p -69.84 -53.96 15.74 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 112.661 -2.063 . . . . 0.0 112.874 175.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.411 ' CG2' ' HH ' ' A' ' 107' ' ' TYR . 0.3 OUTLIER -75.15 -27.63 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-N 122.088 2.222 . . . . 0.0 116.182 -176.835 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.514 ' NZ ' ' CB ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -69.54 -43.5 72.85 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 112.409 -2.178 . . . . 0.0 113.412 -177.723 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.421 ' N ' ' HG3' ' A' ' 104' ' ' LYS . 88.1 mt-30 -78.27 -10.97 59.89 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 124.345 2.021 . . . . 0.0 111.039 178.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -79.23 -22.69 44.47 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 112.055 -2.339 . . . . 0.0 111.512 178.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.411 ' HH ' ' CG2' ' A' ' 103' ' ' VAL . 28.2 m-85 -109.38 -30.74 7.83 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 119.155 0.889 . . . . 0.0 110.831 -177.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.3 m -97.75 8.85 43.98 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 117.918 -1.513 . . . . 0.0 113.157 -178.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.494 ' O ' ' C ' ' A' ' 110' ' ' GLY . 35.4 ttpt -48.74 125.75 10.7 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 117.908 -1.044 . . . . 0.0 109.541 177.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' A' ' 111' ' ' SER . . . -29.39 -74.45 0.04 OUTLIER Glycine 0 N--CA 1.485 1.962 0 CA-C-N 120.231 1.378 . . . . 0.0 111.6 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.531 ' CB ' ' O ' ' A' ' 110' ' ' GLY . 2.7 m 104.23 -161.67 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 177.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.618 ' O ' ' N ' ' A' ' 114' ' ' ALA . 79.6 tt0 -129.95 102.3 6.22 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -178.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.464 ' O ' ' CB ' ' A' ' 114' ' ' ALA . 88.0 m-70 13.51 46.75 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 O-C-N 124.411 1.069 . . . . 0.0 113.135 178.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.618 ' N ' ' O ' ' A' ' 112' ' ' GLU . . . 159.09 -161.7 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.16 15.02 26.98 Favored Glycine 0 C--N 1.337 0.626 0 CA-C-N 115.141 -0.936 . . . . 0.0 113.038 176.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 50.0 mt -60.73 -40.72 85.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 C-N-CA 119.133 -1.027 . . . . 0.0 108.576 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.6 -40.09 95.81 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 122.01 0.783 . . . . 0.0 111.362 175.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 19.4 m -58.18 -42.53 86.24 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 177.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -63.72 -37.42 87.3 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.009 -0.676 . . . . 0.0 111.058 -178.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 97.2 mt -64.16 -46.56 83.5 Favored 'General case' 0 N--CA 1.457 -0.11 0 CA-C-O 121.481 0.657 . . . . 0.0 109.352 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.4 tt -66.67 -44.59 81.39 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.933 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.36 -44.69 94.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 119.457 1.026 . . . . 0.0 108.853 177.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -65.83 -44.03 92.81 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 120.034 -1.079 . . . . 0.0 111.584 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 63.9 m -64.27 -44.51 91.52 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 13.9 t -70.16 -48.02 59.11 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 118.885 -1.126 . . . . 0.0 112.077 177.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.413 ' CG2' ' N ' ' A' ' 127' ' ' GLY . 9.4 t -65.66 -42.69 91.05 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 -174.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.413 ' N ' ' CG2' ' A' ' 126' ' ' THR . . . -64.23 -44.71 95.19 Favored Glycine 0 C--N 1.33 0.206 0 CA-C-N 114.416 -1.265 . . . . 0.0 112.253 -178.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.01 -41.58 96.81 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 112.302 -1.949 . . . . 0.0 106.287 177.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 31.3 mt -64.91 -42.36 94.8 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.841 177.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.24 -40.01 96.23 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -177.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.459 ' O ' ' O ' ' A' ' 134' ' ' ALA . 4.0 p -61.22 -24.84 34.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 122.932 1.348 . . . . 0.0 109.042 178.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -57.64 -44.55 85.68 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 112.188 -2.278 . . . . 0.0 111.343 -178.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.9 p -78.81 -48.74 21.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.229 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.459 ' O ' ' O ' ' A' ' 131' ' ' VAL . . . -92.06 138.18 31.75 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.712 0.291 . . . . 0.0 111.064 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.497 ' N ' ' CD ' ' A' ' 136' ' ' PRO . 1.2 tt0 -179.69 -47.19 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.815 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 135' ' ' GLN . 55.3 Cg_exo -52.11 -33.5 53.96 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 122.326 2.017 . . . . 0.0 112.302 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 32.2 p -67.69 -42.78 81.53 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 117.941 -1.504 . . . . 0.0 109.786 -179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -66.24 -42.96 87.88 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 119.317 -0.953 . . . . 0.0 112.098 -178.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 62.5 t -64.08 -43.72 97.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -179.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 72.4 t -64.89 -39.34 85.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -177.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 31.3 mttp -62.83 -42.01 99.56 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 118.754 -1.179 . . . . 0.0 111.325 -178.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 11.8 m -71.24 -46.33 66.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.87 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 12.8 tpp85 -65.59 -37.37 86.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.895 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -67.34 -42.0 84.26 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -177.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.3 -40.49 90.03 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 119.173 -1.011 . . . . 0.0 111.232 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.32 -35.46 81.08 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 -177.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -60.62 111.27 1.54 Allowed 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 176.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -106.12 -52.44 2.8 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.872 1.804 . . . . 0.0 115.872 -174.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.426 ' C ' ' H ' ' A' ' 151' ' ' GLY . 10.9 mmt180 -86.9 12.14 11.78 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 121.68 2.036 . . . . 0.0 110.544 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . 72.62 -45.72 0.63 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.667 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.426 ' H ' ' C ' ' A' ' 149' ' ' ARG . . . 103.16 169.71 26.0 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -70.54 121.46 9.85 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.094 -0.803 . . . . 0.0 111.094 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 152.02 -162.78 29.9 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' A' ' 156' ' ' TYR . 39.4 ttp180 -160.28 -135.14 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.43 ' O ' ' O ' ' A' ' 156' ' ' TYR . 29.9 mmt180 44.89 15.5 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.831 0.348 . . . . 0.0 110.508 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.674 ' HH ' HD21 ' A' ' 80' ' ' ASN . 0.7 OUTLIER 54.29 112.52 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.751 179.758 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.516 ' H ' ' NE2' ' A' ' 157' ' ' GLN . 4.1 mp0 -62.65 164.17 8.07 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.42 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.403 ' OG ' ' N ' ' A' ' 159' ' ' THR . 47.6 t -157.16 -178.02 7.05 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.457 0.646 . . . . 0.0 111.273 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.437 ' CG2' ' N ' ' A' ' 160' ' ' VAL . 15.1 t -63.78 -45.89 87.72 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.66 -177.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.437 ' N ' ' CG2' ' A' ' 159' ' ' THR . 94.9 t -63.95 -45.26 97.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 119.251 -0.98 . . . . 0.0 109.096 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 38.6 tp10 -67.01 -38.37 85.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.663 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.485 ' O ' ' CD1' ' A' ' 166' ' ' ILE . . . -60.96 -44.41 97.37 Favored 'General case' 0 C--O 1.211 -0.952 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -176.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.434 ' CD1' ' C ' ' A' ' 163' ' ' TYR . 14.8 t80 -61.25 -47.62 85.19 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.662 0.744 . . . . 0.0 112.204 -177.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.402 ' NZ ' ' CB ' ' A' ' 164' ' ' LYS . 2.3 ttmp? -68.39 -45.41 72.77 Favored 'General case' 0 CA--C 1.555 1.169 0 N-CA-C 118.17 2.656 . . . . 0.0 118.17 -173.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 63.8 p -63.49 -45.51 90.39 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 117.381 2.363 . . . . 0.0 117.381 -175.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.57 ' H ' ' CD1' ' A' ' 166' ' ' ILE . 0.2 OUTLIER -64.59 -37.14 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-O 121.635 0.731 . . . . 0.0 109.233 177.082 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.436 ' H ' HD12 ' A' ' 166' ' ' ILE . . . -58.93 -36.97 75.64 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 117.177 -1.392 . . . . 0.0 107.628 177.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 77.5 ttt-85 -62.75 -50.7 70.02 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 123.393 2.815 . . . . 0.0 111.835 -176.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -75.34 -51.22 13.69 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 123.584 0.754 . . . . 0.0 109.5 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -78.15 -36.54 47.54 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -174.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 91.9 -169.09 32.03 Favored Glycine 0 N--CA 1.464 0.509 0 N-CA-C 111.707 -0.557 . . . . 0.0 111.707 178.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.416 ' CG1' ' N ' ' A' ' 173' ' ' ARG . 7.5 pt -71.51 -42.04 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-O 121.454 0.645 . . . . 0.0 110.61 -179.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.416 ' N ' ' CG1' ' A' ' 172' ' ' ILE . 25.4 mmt180 -59.24 -34.09 71.8 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.595 -177.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -60.91 -40.67 98.68 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 118.514 -1.803 . . . . 0.0 109.035 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.55 -33.48 71.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 111.239 -2.48 . . . . 0.0 116.771 -177.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . 0.486 ' CD2' ' OG1' ' A' ' 179' ' ' THR . 33.5 t-105 -77.93 -7.63 57.02 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 111.694 -2.503 . . . . 0.0 110.563 -177.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 51.4 mttm -43.55 -48.41 7.49 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -176.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -99.31 -25.65 9.29 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.099 0.857 . . . . 0.0 112.601 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.486 ' OG1' ' CD2' ' A' ' 176' ' ' TRP . 69.2 p -46.3 -51.9 13.71 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.99 -50.41 76.94 Favored Pre-proline 0 N--CA 1.48 1.038 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -175.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -63.34 -28.35 71.85 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 121.628 1.552 . . . . 0.0 111.42 176.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -63.88 -39.0 93.18 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.245 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 71.1 t -62.69 -42.14 94.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.0 0.429 . . . . 0.0 110.009 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.72 -38.99 89.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.347 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.447 ' NH1' ' O ' ' A' ' 239' ' ' LYS . 97.7 mtt180 -60.4 -41.97 94.99 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.71 -179.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -61.55 -43.2 99.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.366 0.603 . . . . 0.0 110.169 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.34 -43.13 95.58 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.167 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 1.4 mp -63.04 -45.07 99.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.2 -177.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.42 ' O ' ' OE1' ' A' ' 193' ' ' GLU . 11.8 m -60.44 -47.06 94.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 119.409 -0.916 . . . . 0.0 112.431 -178.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -62.68 -43.19 99.44 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 122.586 1.184 . . . . 0.0 109.868 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' CYS . . . . . . . . . . . . . 31.2 m -62.34 -46.22 89.68 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 112.565 -2.107 . . . . 0.0 110.479 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.11 -40.13 95.53 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 114.037 -1.438 . . . . 0.0 109.659 176.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 0.492 ' OE1' ' N ' ' A' ' 193' ' ' GLU . 0.0 OUTLIER -61.01 -45.64 94.0 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.63 -178.381 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 67.2 tp -64.21 -39.14 93.37 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 118.637 -1.225 . . . . 0.0 110.053 -175.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 6.9 m -64.45 -45.88 94.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 C-N-CA 116.891 -1.924 . . . . 0.0 107.907 178.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 23.4 m -63.98 -45.95 86.78 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -178.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -57.16 -39.08 74.55 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.862 0.865 . . . . 0.0 112.56 -178.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -55.86 -44.29 77.92 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.467 ' CD2' ' N ' ' A' ' 199' ' ' LEU . 3.8 mm? -61.34 -38.79 88.19 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 41.8 mm -62.0 -42.41 94.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 26.1 mmtm -59.57 -38.71 81.86 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.876 1.27 . . . . 0.0 113.183 178.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -67.79 -37.12 81.6 Favored 'General case' 0 C--O 1.256 1.42 0 C-N-CA 118.511 -1.276 . . . . 0.0 111.028 -175.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 5.8 t -100.96 128.82 46.82 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 121.308 1.867 . . . . 0.0 111.895 -178.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.508 ' CD2' ' CE1' ' A' ' 217' ' ' HIS . 6.9 mp 66.82 3.74 3.16 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 113.342 -1.754 . . . . 0.0 110.576 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 2.3 mt -126.59 29.78 5.66 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.882 0.849 . . . . 0.0 110.628 -179.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -68.78 -25.8 64.89 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.482 -1.235 . . . . 0.0 109.848 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.528 ' O ' ' ND2' ' A' ' 208' ' ' ASN . . . -161.93 39.62 0.13 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 114.363 -1.29 . . . . 0.0 109.563 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . 0.53 HD22 ' CG ' ' A' ' 210' ' ' MET . 0.4 OUTLIER 87.93 -18.38 0.27 Allowed 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 175.979 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.504 ' CB ' ' O ' ' A' ' 208' ' ' ASN . 1.0 OUTLIER 84.85 46.33 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 119.742 1.155 . . . . 0.0 109.524 -179.874 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' MET . . . . . 0.53 ' CG ' HD22 ' A' ' 208' ' ' ASN . 78.1 mtm -53.04 -166.97 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.865 178.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.505 ' OG1' ' N ' ' A' ' 212' ' ' ASP . 4.4 p 61.21 -134.43 0.63 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.927 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . 0.529 ' CG ' ' H ' ' A' ' 213' ' ' ASP . 4.0 p-10 -155.96 -94.12 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.551 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.529 ' H ' ' CG ' ' A' ' 212' ' ' ASP . 4.6 p-10 44.22 42.78 5.36 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.308 0.575 . . . . 0.0 109.683 -178.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.412 ' N ' ' CD ' ' A' ' 215' ' ' PRO . 2.5 mm? -61.24 -43.89 91.55 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.921 -178.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 214' ' ' LEU . 27.3 Cg_exo -60.7 -34.45 91.92 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 CA-C-N 120.263 1.129 . . . . 0.0 111.16 -178.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 7.9 t -65.24 -42.43 93.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 113.085 -1.871 . . . . 0.0 111.231 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' HIS . . . . . 0.522 ' O ' ' ND1' ' A' ' 217' ' ' HIS . 1.8 t60 -66.78 -37.41 84.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.446 -0.797 . . . . 0.0 113.064 -178.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -62.95 -47.62 82.42 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.096 -177.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 33.5 p -60.53 -38.1 83.34 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 119.097 0.862 . . . . 0.0 110.986 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 217' ' ' HIS . 66.0 p -59.64 -41.78 91.28 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . 0.574 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.89 -41.84 97.62 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -178.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -62.63 -47.82 82.08 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -176.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -61.06 -42.27 99.74 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 107.811 -2.116 . . . . 0.0 107.811 177.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -63.31 -37.78 88.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 113.817 -1.191 . . . . 0.0 109.009 176.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . 0.574 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -61.67 -42.38 99.75 Favored Glycine 0 CA--C 1.522 0.51 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.827 -176.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' PHE . . . . . 0.436 ' O ' ' OG1' ' A' ' 229' ' ' THR . 0.9 OUTLIER -66.55 -38.58 87.44 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 118.28 1.04 . . . . 0.0 108.27 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 96.6 m -63.54 -41.88 98.43 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.09 0.471 . . . . 0.0 110.265 177.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' THR . . . . . 0.436 ' HG1' ' N ' ' A' ' 229' ' ' THR . 80.1 p -62.5 -40.48 96.87 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.896 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 226' ' ' PHE . 18.6 p -58.8 -39.73 81.99 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.097 -176.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 98.3 t -60.61 -41.91 89.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 118.521 -1.271 . . . . 0.0 108.839 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . 0.454 ' CD1' ' N ' ' A' ' 231' ' ' ILE . 1.3 mp -62.13 -41.29 90.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-O 121.418 0.628 . . . . 0.0 109.393 176.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -62.99 -40.09 96.7 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 -178.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.442 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 0.0 OUTLIER -59.11 -43.39 97.15 Favored Pre-proline 0 N--CA 1.476 0.84 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -173.255 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.452 ' HD2' ' O ' ' A' ' 231' ' ' ILE . 39.4 Cg_exo -60.0 -41.72 50.49 Favored 'Trans proline' 0 C--N 1.296 -2.189 0 C-N-CA 121.576 1.517 . . . . 0.0 113.781 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 13.6 m -66.34 -37.55 79.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 119.131 -1.028 . . . . 0.0 111.303 178.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -66.0 -41.7 90.72 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -178.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.428 ' O ' ' OG1' ' A' ' 240' ' ' THR . 3.0 p -65.68 -45.72 91.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -177.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 8.5 p -63.2 -37.35 79.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.323 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . 0.447 ' O ' ' NH1' ' A' ' 185' ' ' ARG . 88.6 mttt -60.77 -45.02 95.98 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 119.786 -0.765 . . . . 0.0 110.426 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' A' ' 237' ' ' VAL . 51.8 p -62.24 -42.17 99.08 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.988 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.409 ' N ' ' HG1' ' A' ' 240' ' ' THR . 0.9 OUTLIER -37.57 139.52 0.28 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.533 -178.313 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.55 ' CG ' ' N ' ' A' ' 243' ' ' MET . 0.0 OUTLIER 161.88 -62.88 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 114.964 -1.016 . . . . 0.0 108.74 -179.661 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' MET . . . . . 0.55 ' N ' ' CG ' ' A' ' 242' ' ' TYR . 10.7 tpt -68.44 75.88 0.26 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . 0.449 ' O ' ' OG ' ' A' ' 245' ' ' SER . 34.4 t30 -158.97 109.1 1.99 Allowed 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 244' ' ' ASN . 12.1 p 62.62 -178.16 0.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.857 -178.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -140.36 -70.14 0.39 Allowed 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.403 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 23.9 mt -57.88 136.78 57.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.894 0.378 . . . . 0.0 111.08 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 143.14 158.7 7.65 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.74 ' HG3' ' NE2' ' A' ' 255' ' ' HIS . 16.5 mm100 -44.74 -90.18 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER 71.49 32.81 2.0 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.021 178.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 39.9 t60 -66.83 -53.93 27.65 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 116.431 -2.108 . . . . 0.0 111.773 -177.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 69.1 m -148.53 -173.65 4.39 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -61.15 -44.88 96.63 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -57.66 -36.04 76.73 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 126.12 1.819 . . . . 0.0 115.185 -171.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' HIS . . . . . 0.74 ' NE2' ' HG3' ' A' ' 249' ' ' GLN . 86.4 t60 -57.23 -32.63 66.72 Favored 'General case' 0 C--N 1.365 1.276 0 CA-C-N 120.239 2.019 . . . . 0.0 111.019 -178.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -59.95 -44.8 94.17 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.327 0.512 . . . . 0.0 110.683 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -60.72 -45.41 94.35 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.823 -0.751 . . . . 0.0 111.24 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.427 ' CD1' ' N ' ' A' ' 258' ' ' LEU . 10.2 mp -66.97 -44.01 81.6 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.957 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' THR . . . . . 0.638 HG23 ' CD2' ' A' ' 255' ' ' HIS . 73.4 p -63.36 -45.09 92.79 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.93 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' MET . . . . . . . . . . . . . 51.9 ttp -60.31 -44.44 95.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.011 -176.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.17 -46.5 88.65 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 69.1 mmt-85 -66.41 -53.78 31.83 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.666 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -142.62 158.73 43.36 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.687 0.28 . . . . 0.0 111.23 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . 0.448 ' O ' ' O ' ' A' ' 265' ' ' GLY . 18.3 tp10 76.25 68.31 0.06 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.285 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 264' ' ' GLU . . . -32.09 156.59 0.01 OUTLIER Glycine 0 CA--C 1.536 1.379 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.667 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -62.82 -3.11 4.17 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 122.246 1.964 . . . . 0.0 111.836 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.417 ' H ' ' C ' ' A' ' 265' ' ' GLY . 80.5 mtt85 -70.0 -27.05 64.37 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 123.053 0.541 . . . . 0.0 111.805 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . 0.441 ' O ' ' O ' ' A' ' 271' ' ' LYS . . . -58.8 -32.47 69.38 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 119.824 -0.75 . . . . 0.0 109.948 -179.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -62.45 -41.72 98.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.412 0.625 . . . . 0.0 110.836 178.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -66.0 -37.7 86.59 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 114.9 -1.046 . . . . 0.0 112.363 -178.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 268' ' ' ALA . 17.6 ttpp -110.65 134.37 52.49 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.73 0.3 . . . . 0.0 110.616 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 108.47 55.77 0.58 Allowed Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -147.95 29.58 0.9 Allowed 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 120.836 0.35 . . . . 0.0 110.69 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' MET . . . . . 0.588 ' N ' ' CD ' ' A' ' 275' ' ' PRO . 0.3 OUTLIER -63.74 -43.88 78.21 Favored Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.238 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 274' ' ' MET . 23.4 Cg_exo -63.69 -45.87 10.19 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.776 2.317 . . . . 0.0 111.908 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' SER . . . . . 0.567 ' HG ' ' N ' ' A' ' 277' ' ' PHE . 86.1 p -59.72 -39.13 83.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.061 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . 0.567 ' N ' ' HG ' ' A' ' 276' ' ' SER . 71.1 t80 -61.21 -41.86 97.59 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 122.884 1.326 . . . . 0.0 111.85 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -61.87 -38.31 87.81 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 111.829 -2.441 . . . . 0.0 107.78 174.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . 0.637 HH12 ' HZ2' ' A' ' 38' ' ' LYS . 48.4 mtp180 -62.88 -39.33 94.15 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.304 0.573 . . . . 0.0 110.26 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 30.7 tp -61.85 -36.46 81.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.121 -0.945 . . . . 0.0 112.869 -177.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -68.12 -51.18 34.94 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -178.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 76.4 p -63.09 -44.41 95.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.422 0.63 . . . . 0.0 110.072 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' TRP . . . . . . . . . . . . . 75.5 t90 -60.76 -38.75 86.27 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.604 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -62.58 -39.69 94.52 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -178.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 3.7 p -61.32 -37.89 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.093 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 95.0 t -62.02 -40.6 87.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 120.311 -0.556 . . . . 0.0 109.526 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' MET . . . . . 0.459 ' C ' ' SD ' ' A' ' 287' ' ' MET . 0.0 OUTLIER -61.15 -38.55 86.81 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.342 0.591 . . . . 0.0 109.893 178.606 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -58.51 -39.4 80.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.168 -0.923 . . . . 0.0 112.604 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 1.3 p -59.85 -38.13 74.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 113.213 0.819 . . . . 0.0 113.213 -175.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 2.1 t -62.35 -40.54 96.73 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 118.892 -1.123 . . . . 0.0 109.135 178.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -60.82 -38.86 86.88 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 177.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -58.35 -40.25 81.7 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 117.664 -1.614 . . . . 0.0 109.913 -175.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' GLN . . . . . 0.496 ' O ' ' O ' ' A' ' 296' ' ' ARG . 56.5 tt0 -60.46 -43.3 97.02 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 122.6 1.191 . . . . 0.0 111.443 -179.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 11.0 mp -60.95 -40.39 93.11 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 113.313 -1.767 . . . . 0.0 109.671 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -62.68 -45.76 91.3 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.36 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' ARG . . . . . 0.496 ' O ' ' O ' ' A' ' 293' ' ' GLN . 43.5 ttm180 -122.53 116.33 23.72 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -119.16 -160.8 0.82 Allowed 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -178.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 33.6 tp -71.42 114.82 9.88 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 177.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 28.1 ttp -96.7 64.71 2.13 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -177.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.58 101.04 0.07 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 122.047 0.927 . . . . 0.0 110.721 -178.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -64.15 -46.27 84.82 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 113.505 -1.68 . . . . 0.0 113.452 -176.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -58.73 -39.64 81.48 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.617 -0.433 . . . . 0.0 109.957 -178.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -64.68 -46.76 81.04 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.027 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' SER . . . . . 0.435 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 3.0 m -66.34 -38.1 86.85 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.404 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 59.7 mmt-85 -61.88 -42.86 99.57 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.721 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -64.94 -36.8 85.56 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -177.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -60.02 -52.92 70.03 Favored Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -176.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' PRO . . . . . 0.435 ' CD ' ' O ' ' A' ' 304' ' ' SER . 73.9 Cg_endo -75.21 0.33 9.12 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.109 1.873 . . . . 0.0 111.816 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 50.4 t80 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.51 179.992 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.552 ' N ' ' SD ' ' A' ' 13' ' ' MET . 1.5 mpt? . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 48.5 m -106.21 88.54 2.82 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.399 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.8 t -87.05 164.19 2.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.336 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm -64.37 -42.03 96.41 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -63.77 -41.62 97.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.386 0.612 . . . . 0.0 111.428 179.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.5 tp -79.81 -26.11 40.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.236 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.45 -41.43 94.33 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 107.472 -2.251 . . . . 0.0 107.472 177.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.47 -32.29 68.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 124.838 2.256 . . . . 0.0 107.061 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.56 -42.47 98.86 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-N 108.516 -3.947 . . . . 0.0 107.759 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.0 m -70.7 -27.87 64.32 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.462 0.648 . . . . 0.0 109.591 177.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.95 -49.83 66.52 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.981 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.05 -35.16 77.77 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 118.693 -1.203 . . . . 0.0 112.206 -177.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 78.2 m -63.29 -53.85 46.4 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -177.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -66.06 -38.16 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -177.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.37 -41.9 98.83 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-O 118.175 -0.917 . . . . 0.0 113.316 -172.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -77.58 -26.78 51.07 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 120.914 1.688 . . . . 0.0 110.51 -175.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.3 mp -59.56 -54.56 45.15 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 119.686 1.13 . . . . 0.0 112.27 -178.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.9 tp -74.78 -3.44 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 CA-C-O 121.692 0.758 . . . . 0.0 112.711 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -109.06 -16.19 14.17 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.39 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.465 ' N ' ' HD2' ' A' ' 33' ' ' PRO . 27.0 t80 -68.5 -46.08 36.28 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 116.654 -2.018 . . . . 0.0 111.829 -177.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 32' ' ' PHE . 24.0 Cg_endo -60.26 -15.89 37.47 Favored 'Trans proline' 0 N--CA 1.499 1.824 0 CA-C-N 120.988 1.389 . . . . 0.0 113.238 177.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.5 mp -67.36 -35.7 79.9 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -177.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -64.64 -40.4 95.39 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.618 -178.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.9 p -58.22 -34.8 70.81 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.812 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.43 -38.85 85.2 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 119.862 -0.735 . . . . 0.0 112.231 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.629 ' HZ1' ' NH2' ' A' ' 279' ' ' ARG . 52.7 mtpt -62.64 -49.86 73.49 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 119.106 -1.037 . . . . 0.0 111.296 -177.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 65.6 t -64.96 -40.19 88.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -177.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.51 ' C ' ' H ' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -61.05 -41.09 95.95 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.752 -178.457 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.6 tp -62.03 38.79 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.967 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.51 ' H ' ' C ' ' A' ' 40' ' ' ARG . 6.3 pt20 -95.51 154.63 17.11 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.82 0.343 . . . . 0.0 110.603 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.507 ' CD1' ' N ' ' A' ' 43' ' ' ILE . 1.9 mp -69.22 -11.92 15.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.289 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 55.29 -175.71 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.374 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 57.83 38.81 90.06 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.999 -0.841 . . . . 0.0 110.999 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.422 ' O ' ' OG ' ' A' ' 47' ' ' SER . 14.7 pt-20 -61.65 -35.03 76.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.793 0.33 . . . . 0.0 110.408 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' A' ' 46' ' ' GLU . 69.1 m -168.58 -15.88 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.677 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -64.59 -40.78 96.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.655 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.51 9.57 84.61 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -177.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.457 ' O ' ' OG1' ' A' ' 53' ' ' THR . 12.1 tp -64.62 -36.8 85.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.313 -0.944 . . . . 0.0 109.929 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 95.3 t -59.69 -44.2 93.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.397 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 93.1 mtm-85 -64.46 -34.19 77.62 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.201 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.457 ' OG1' ' O ' ' A' ' 50' ' ' LEU . 59.7 p -68.44 -38.09 80.83 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 178.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -134.51 93.36 3.04 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.803 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.52 -13.38 52.17 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -178.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.533 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 90.5 p -126.33 -140.06 0.27 Allowed 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.533 ' CB ' ' O ' ' A' ' 56' ' ' SER . . . 98.01 12.88 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 O-C-N 124.245 0.965 . . . . 0.0 112.04 178.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.421 ' OE1' ' O ' ' A' ' 59' ' ' TYR . 1.3 tm0? -173.59 84.17 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.562 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.421 ' O ' ' OE1' ' A' ' 58' ' ' GLN . 5.4 m-85 -65.5 148.55 51.53 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -40.23 -36.71 0.55 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.023 0.44 . . . . 0.0 110.255 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -31.85 103.38 0.01 OUTLIER Glycine 0 CA--C 1.529 0.926 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.334 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.3 p -67.14 -33.53 63.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 118.205 -0.902 . . . . 0.0 109.626 176.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -60.02 -32.3 70.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 121.397 1.908 . . . . 0.0 109.958 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.51 -48.96 67.84 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 115.262 -0.881 . . . . 0.0 114.555 -176.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.2 m -61.87 -46.3 90.03 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -178.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 28.9 mm -59.49 -36.27 63.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 40.0 tp -64.04 -35.82 81.97 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 120.252 1.387 . . . . 0.0 112.511 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.44 ' O ' ' OG1' ' A' ' 72' ' ' THR . 98.6 m -63.3 -40.7 98.08 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.069 -175.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 31.7 ttp -60.15 -40.19 88.97 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 114.406 1.262 . . . . 0.0 114.406 -175.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.41 ' CG1' ' N ' ' A' ' 71' ' ' ARG . 3.0 p -69.46 -40.93 80.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 119.218 -0.993 . . . . 0.0 113.16 -177.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.41 ' N ' ' CG1' ' A' ' 70' ' ' VAL . 68.1 ttt-85 -78.75 -12.92 60.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.697 0.76 . . . . 0.0 112.991 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 68' ' ' THR . 56.8 m -61.63 -54.85 37.33 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.682 -1.144 . . . . 0.0 111.094 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.451 ' CD ' ' H ' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -117.32 -40.81 3.03 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 118.754 -0.641 . . . . 0.0 110.472 178.064 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 155.15 159.58 9.39 Favored Glycine 0 CA--C 1.549 2.158 0 CA-C-N 120.192 1.36 . . . . 0.0 111.34 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -56.53 -34.58 95.48 Favored 'Trans proline' 0 N--CA 1.511 2.531 0 C-N-CA 122.269 1.98 . . . . 0.0 114.032 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.5 mmp_? -60.23 -10.55 4.7 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 178.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.568 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 1.2 p -77.28 -31.79 55.09 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.642 -178.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 43.5 tp -74.91 -31.94 61.68 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 122.039 -0.413 . . . . 0.0 110.626 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -90.88 -3.86 57.01 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 122.851 1.31 . . . . 0.0 114.091 -176.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.568 ' ND2' ' O ' ' A' ' 77' ' ' SER . 0.0 OUTLIER -104.17 123.64 47.66 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 111.986 -2.37 . . . . 0.0 107.738 175.337 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.24 -16.29 49.59 Favored Glycine 0 N--CA 1.467 0.746 0 N-CA-C 108.389 -1.885 . . . . 0.0 108.389 -177.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.503 ' CD1' ' N ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -59.34 -34.37 72.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 113.859 -1.17 . . . . 0.0 110.559 -179.601 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.503 ' N ' ' CD1' ' A' ' 82' ' ' LEU . 7.5 p -70.7 -27.36 30.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.322 177.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.96 -31.96 61.6 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 119.199 -0.429 . . . . 0.0 111.35 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.84 -40.01 89.6 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 119.533 -1.317 . . . . 0.0 110.832 -177.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.4 tt -62.45 -40.54 96.94 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 122.261 1.029 . . . . 0.0 113.335 -176.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -60.55 -27.48 67.69 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 113.541 -1.663 . . . . 0.0 109.815 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 64.2 mtm180 -57.81 -53.25 60.34 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 173.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 70.7 tp60 -67.06 -29.68 69.53 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 112.505 -2.134 . . . . 0.0 111.921 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.446 ' SD ' ' C ' ' A' ' 90' ' ' MET . 11.5 tmm? -61.27 -40.89 95.79 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.044 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 77.7 p -74.24 -34.5 63.66 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 119.362 -0.935 . . . . 0.0 111.402 -176.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -57.84 -44.19 86.32 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 120.951 1.705 . . . . 0.0 111.857 -177.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.38 -33.16 64.89 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 119.546 -0.862 . . . . 0.0 111.094 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.493 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 25.3 m -64.2 -41.78 96.92 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.475 ' C ' ' H ' ' A' ' 97' ' ' ILE . 72.9 t -68.37 -28.71 41.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.485 178.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 29.6 ttp180 -77.61 10.4 2.69 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -177.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.493 ' CG2' ' O ' ' A' ' 94' ' ' SER . 10.9 tt -86.96 -15.0 9.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.859 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.429 ' O ' ' OG ' ' A' ' 102' ' ' SER . . . -140.3 -49.0 0.05 OUTLIER Glycine 0 CA--C 1.541 1.711 0 N-CA-C 117.103 1.601 . . . . 0.0 117.103 -176.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.431 ' CD1' ' C ' ' A' ' 99' ' ' LEU . 3.1 pp -73.28 -12.77 60.97 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 120.558 2.179 . . . . 0.0 114.515 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.541 ' O ' ' HB2' ' A' ' 104' ' ' LYS . 46.6 t80 -79.16 -53.04 7.38 Favored 'General case' 0 C--O 1.214 -0.797 0 C-N-CA 118.777 -1.169 . . . . 0.0 113.073 -176.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.451 ' OD1' ' NE2' ' A' ' 105' ' ' GLN . 6.0 t70 -72.3 -33.18 67.22 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 124.26 1.981 . . . . 0.0 112.403 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 98' ' ' GLY . 67.0 m -65.47 -48.98 70.78 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 109.317 -3.583 . . . . 0.0 115.034 -178.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 19.1 m -72.29 -23.83 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.368 0 CA-C-O 123.945 1.831 . . . . 0.0 109.437 175.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.541 ' HB2' ' O ' ' A' ' 100' ' ' TYR . 0.0 OUTLIER -68.03 -42.61 80.35 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 109.943 -3.299 . . . . 0.0 113.675 -179.058 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.451 ' NE2' ' OD1' ' A' ' 101' ' ' ASP . 88.1 mt-30 -76.56 -13.33 60.09 Favored 'General case' 0 C--O 1.211 -0.948 0 CA-C-O 125.468 2.556 . . . . 0.0 111.102 177.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.484 ' O ' ' NZ ' ' A' ' 109' ' ' LYS . 1.9 t80 -80.15 -22.08 42.42 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 109.378 -3.555 . . . . 0.0 110.711 177.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.438 ' OH ' ' O ' ' A' ' 119' ' ' ARG . 0.3 OUTLIER -109.68 -28.72 8.69 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.607 0.763 . . . . 0.0 112.404 -174.137 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.799 ' C ' ' H ' ' A' ' 110' ' ' GLY . 0.8 OUTLIER -94.91 12.99 26.32 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -174.723 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.484 ' NZ ' ' O ' ' A' ' 106' ' ' PHE . 7.2 ptpp? -56.58 18.73 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 119.602 1.092 . . . . 0.0 110.825 177.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.799 ' H ' ' C ' ' A' ' 108' ' ' THR . . . 57.8 19.2 35.3 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-N 113.956 -1.475 . . . . 0.0 109.773 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.431 ' O ' ' O ' ' A' ' 110' ' ' GLY . 36.2 m 31.19 -160.73 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 112.47 -1.865 . . . . 0.0 114.333 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.623 ' O ' ' N ' ' A' ' 114' ' ' ALA . 39.8 tt0 -134.12 92.99 3.02 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 114.144 1.165 . . . . 0.0 114.144 -176.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.421 ' O ' ' CB ' ' A' ' 114' ' ' ALA . 89.4 m-70 30.63 28.68 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.082 178.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.623 ' N ' ' O ' ' A' ' 112' ' ' GLU . . . 159.97 -161.97 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.99 15.46 23.94 Favored Glycine 0 N--CA 1.464 0.556 0 C-N-CA 120.035 -1.079 . . . . 0.0 111.647 178.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.478 ' CD1' ' H ' ' A' ' 116' ' ' ILE . 2.0 mp -60.34 -40.37 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 C-N-CA 119.237 -0.985 . . . . 0.0 108.713 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.91 -41.01 95.66 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.021 175.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 38.3 t -59.33 -43.64 92.69 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 176.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.438 ' O ' ' OH ' ' A' ' 107' ' ' TYR . 64.5 mtm180 -64.15 -37.13 86.33 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.677 -178.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.4 tt -63.2 -45.5 91.41 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 62.3 mt -66.33 -44.62 82.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.406 -1.27 . . . . 0.0 110.129 178.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.09 -45.01 90.57 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 120.074 1.307 . . . . 0.0 110.82 178.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -65.96 -44.44 91.68 Favored Glycine 0 N--CA 1.458 0.155 0 C-N-CA 119.588 -1.291 . . . . 0.0 111.371 -178.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.2 m -63.99 -43.75 94.77 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.949 0.404 . . . . 0.0 110.804 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 21.2 m -69.57 -48.7 59.39 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 119.201 -1.0 . . . . 0.0 112.333 177.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 13.8 m -65.93 -42.79 89.62 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 114.868 1.433 . . . . 0.0 114.868 -175.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.435 ' O ' ' OD1' ' A' ' 186' ' ' ASN . . . -64.73 -44.81 94.33 Favored Glycine 0 CA--C 1.521 0.413 0 CA-C-N 114.512 -1.222 . . . . 0.0 113.236 -177.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.32 -41.45 97.04 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 112.457 -1.871 . . . . 0.0 107.196 177.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -64.07 -42.03 97.14 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.173 -0.922 . . . . 0.0 110.207 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -62.6 -38.88 91.9 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.58 0.229 . . . . 0.0 111.053 -178.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.418 ' O ' ' O ' ' A' ' 134' ' ' ALA . 85.6 t -60.58 -25.37 34.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 122.262 1.03 . . . . 0.0 109.516 178.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -57.94 -44.86 87.21 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 113.281 -1.781 . . . . 0.0 111.988 -178.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.487 ' CG1' ' N ' ' A' ' 134' ' ' ALA . 2.7 p -79.04 -48.87 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.536 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.487 ' N ' ' CG1' ' A' ' 133' ' ' VAL . . . -93.2 139.82 30.19 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.905 0.383 . . . . 0.0 111.23 -179.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.513 ' N ' ' CD ' ' A' ' 136' ' ' PRO . 1.2 tt0 178.45 -46.71 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.416 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.513 ' CD ' ' N ' ' A' ' 135' ' ' GLN . 54.3 Cg_exo -52.31 -33.45 55.75 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 122.501 2.134 . . . . 0.0 112.462 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 37.9 p -67.65 -42.39 82.29 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 118.255 -1.378 . . . . 0.0 109.394 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -66.67 -43.58 84.11 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 118.351 -1.34 . . . . 0.0 111.912 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 52.9 t -64.75 -44.89 96.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -178.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.4 p -65.48 -39.09 84.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -177.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -62.46 -41.67 98.93 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.715 -177.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 13.2 m -70.47 -45.58 74.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.108 -0.637 . . . . 0.0 110.516 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 9.6 mmt85 -65.08 -37.06 86.3 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.585 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.538 ' CD1' ' NE2' ' A' ' 147' ' ' GLN . 76.9 t80 -67.21 -42.1 84.66 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -177.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 23.8 mm100 -65.85 -40.14 91.43 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 119.203 -0.999 . . . . 0.0 110.103 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.22 -34.89 79.43 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 -178.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.538 ' NE2' ' CD1' ' A' ' 144' ' ' PHE . 6.5 pt20 -59.89 111.07 1.33 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 177.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -100.39 -59.01 1.78 Allowed 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -175.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -96.46 60.69 1.92 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 122.125 2.239 . . . . 0.0 110.17 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . 54.97 -94.98 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.321 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 161.97 58.24 0.02 OUTLIER Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 67.32 -80.05 0.15 Allowed Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -56.97 120.74 22.26 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 27.5 ptt-85 -79.4 -129.92 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 121.253 -0.179 . . . . 0.0 110.768 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.43 ' O ' ' O ' ' A' ' 156' ' ' TYR . 72.2 mtt85 57.34 26.31 12.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.739 0.304 . . . . 0.0 110.513 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.43 ' O ' ' O ' ' A' ' 155' ' ' ARG . 67.0 m-85 52.0 104.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.622 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -72.25 179.64 3.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.544 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.429 ' OG ' ' N ' ' A' ' 159' ' ' THR . 40.3 t -157.05 -178.14 7.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.293 0.568 . . . . 0.0 110.978 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.429 ' N ' ' OG ' ' A' ' 158' ' ' SER . 72.5 p -64.04 -46.22 85.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.591 -177.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.461 ' CG1' ' N ' ' A' ' 161' ' ' GLU . 10.3 p -64.43 -45.3 96.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 118.995 -1.082 . . . . 0.0 109.418 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.461 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 60.6 mt-10 -67.23 -39.13 86.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.961 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -61.58 -46.0 91.75 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -177.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.478 ' CD1' ' C ' ' A' ' 163' ' ' TYR . 0.3 OUTLIER -62.77 -49.97 72.87 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 119.901 -0.719 . . . . 0.0 110.122 -179.577 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.6 mmtt -67.79 -45.62 74.29 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -174.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 19.7 m -62.82 -44.87 95.01 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 119.557 1.072 . . . . 0.0 113.385 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.512 ' CD1' ' N ' ' A' ' 166' ' ' ILE . 1.3 mp -64.86 -38.73 83.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 121.967 0.889 . . . . 0.0 109.165 176.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.78 -36.43 76.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 113.651 -1.613 . . . . 0.0 108.287 176.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 22.5 tpt85 -62.53 -50.88 69.61 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 122.301 2.319 . . . . 0.0 112.075 -175.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -75.29 -51.36 13.43 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 123.587 0.755 . . . . 0.0 109.231 176.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -78.57 -36.76 44.04 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 -174.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 92.89 -168.48 30.26 Favored Glycine 0 N--CA 1.468 0.81 0 O-C-N 121.995 -0.441 . . . . 0.0 112.427 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.448 ' CG2' ' N ' ' A' ' 173' ' ' ARG . 10.3 tp -72.99 -41.94 59.79 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.14 0 CA-C-O 121.916 0.865 . . . . 0.0 110.783 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.448 ' N ' ' CG2' ' A' ' 172' ' ' ILE . 36.2 ttm180 -58.69 -33.34 70.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 113.969 -1.469 . . . . 0.0 110.88 -176.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -60.76 -40.43 98.11 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 118.942 -1.599 . . . . 0.0 110.071 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 7.0 tt -70.37 -33.57 71.58 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 111.58 -2.31 . . . . 0.0 117.129 -177.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 4.9 m0 -77.88 -7.39 56.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 111.771 -2.468 . . . . 0.0 109.961 -176.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 24.8 ttpp -43.22 -48.03 6.51 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.434 -176.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -95.16 -36.29 5.5 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 124.142 0.877 . . . . 0.0 111.495 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.446 ' CG2' ' N ' ' A' ' 180' ' ' SER . 0.6 OUTLIER -45.4 -51.05 11.84 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.446 ' N ' ' CG2' ' A' ' 179' ' ' THR . 3.7 m -62.41 -50.13 80.52 Favored Pre-proline 0 N--CA 1.475 0.801 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -176.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.411 ' HD2' ' N ' ' A' ' 180' ' ' SER . 22.8 Cg_endo -63.95 -27.61 66.53 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 121.533 1.489 . . . . 0.0 111.652 177.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -63.43 -39.26 94.02 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 60.4 t -63.17 -42.46 96.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.067 0.461 . . . . 0.0 109.878 178.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.03 -38.98 90.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.57 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -60.23 -41.54 93.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.753 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 127' ' ' GLY . 0.5 OUTLIER -61.21 -42.99 99.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.983 0.42 . . . . 0.0 111.211 -179.471 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.73 -44.12 91.18 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.506 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 36.6 mm -64.0 -45.8 95.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.533 ' O ' ' N ' ' A' ' 193' ' ' GLU . 30.8 m -60.34 -46.11 95.48 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.373 0 C-N-CA 119.882 -0.727 . . . . 0.0 111.155 -178.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -62.62 -42.87 99.83 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.501 0.667 . . . . 0.0 110.241 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' CYS . . . . . . . . . . . . . 16.1 t -62.09 -46.09 90.62 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.365 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -63.89 -39.5 94.34 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 113.011 -1.904 . . . . 0.0 109.192 176.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 189' ' ' VAL . 49.4 tp10 -60.18 -46.49 89.53 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.065 -0.97 . . . . 0.0 111.97 -176.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -65.26 -38.49 90.48 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 118.17 -1.412 . . . . 0.0 110.866 -176.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . 0.437 ' O ' ' CD2' ' A' ' 199' ' ' LEU . 0.3 OUTLIER -63.89 -47.02 92.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 116.345 -2.142 . . . . 0.0 107.347 -179.691 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 9.4 p -65.16 -46.54 80.43 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -179.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -57.34 -39.15 75.32 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.121 1.368 . . . . 0.0 113.473 -177.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -55.59 -44.19 76.7 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.517 ' H ' ' CD2' ' A' ' 199' ' ' LEU . 2.5 mm? -61.4 -39.54 91.09 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 80.0 mt -63.18 -43.78 99.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 118.485 -0.769 . . . . 0.0 111.464 -178.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 17.8 mmmt -60.52 -40.13 90.33 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 120.551 1.523 . . . . 0.0 109.511 175.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -64.34 -35.45 80.91 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 112.885 -1.961 . . . . 0.0 111.026 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' A' ' 199' ' ' LEU . 0.2 OUTLIER -101.55 128.35 47.84 Favored 'General case' 0 C--N 1.357 0.894 0 O-C-N 121.0 -1.063 . . . . 0.0 111.239 -179.268 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 10.4 mp 66.23 4.91 3.35 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.202 177.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 2.4 mt -129.38 35.8 4.2 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.465 0.65 . . . . 0.0 112.258 -177.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -73.83 -23.33 59.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.728 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.624 ' C ' HD21 ' A' ' 208' ' ' ASN . . . -131.17 -45.36 1.01 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.95 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . 0.948 ' ND2' ' H ' ' A' ' 209' ' ' LEU . 0.0 OUTLIER 127.2 -72.4 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.198 1.799 . . . . 0.0 108.388 -178.207 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.948 ' H ' ' ND2' ' A' ' 208' ' ' ASN . 0.3 OUTLIER -160.84 104.16 1.35 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 179.139 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -139.17 29.04 2.26 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.592 ' HG1' ' H ' ' A' ' 212' ' ' ASP . 5.8 t -142.85 -162.77 1.49 Allowed 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.585 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . 0.592 ' H ' ' HG1' ' A' ' 211' ' ' THR . 43.1 m-20 -143.29 -147.2 0.2 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.152 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 63.1 72.89 0.47 Allowed 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.436 ' N ' ' CD ' ' A' ' 215' ' ' PRO . 4.1 mt -61.41 -43.52 89.56 Favored Pre-proline 0 C--N 1.33 -0.255 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 214' ' ' LEU . 26.7 Cg_exo -61.09 -33.58 91.2 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 CA-C-N 119.978 1.028 . . . . 0.0 111.107 -178.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 90.4 m -64.78 -42.46 95.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 113.269 -1.787 . . . . 0.0 111.807 -178.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' HIS . . . . . 0.441 ' O ' ' ND1' ' A' ' 217' ' ' HIS . 1.9 t60 -66.83 -38.32 86.2 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -177.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -63.35 -47.23 82.99 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.73 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 30.5 p -60.17 -37.86 81.43 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 118.943 0.792 . . . . 0.0 111.054 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 11.4 t -59.15 -41.16 87.7 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.3 -41.48 98.96 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -177.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -61.25 -46.98 88.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 122.172 0.987 . . . . 0.0 112.467 -176.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -60.43 -41.61 98.64 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 107.418 -2.273 . . . . 0.0 107.418 176.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . 0.519 ' O ' ' SG ' ' A' ' 227' ' ' CYS . . . -62.52 -37.73 87.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.255 -0.972 . . . . 0.0 108.479 176.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -61.65 -42.22 99.72 Favored Glycine 0 CA--C 1.525 0.679 0 CA-C-N 114.757 -1.111 . . . . 0.0 110.586 -178.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -66.62 -38.5 87.09 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.166 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . 0.519 ' SG ' ' O ' ' A' ' 224' ' ' ALA . 0.5 OUTLIER -63.11 -40.48 97.75 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.236 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' THR . . . . . 0.467 ' N ' ' SG ' ' A' ' 227' ' ' CYS . 0.3 OUTLIER -61.29 -39.69 91.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.254 179.473 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 20.1 m -58.39 -39.43 79.63 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 -178.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 92.8 t -60.25 -40.84 84.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 119.339 -0.944 . . . . 0.0 108.497 178.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . 0.553 ' O ' ' HD2' ' A' ' 234' ' ' PRO . 24.8 mm -61.29 -40.09 84.85 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.362 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -62.17 -38.4 88.92 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -178.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.451 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 0.3 OUTLIER -57.24 -40.19 82.89 Favored Pre-proline 0 N--CA 1.48 1.054 0 N-CA-C 116.107 1.891 . . . . 0.0 116.107 -173.052 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.553 ' HD2' ' O ' ' A' ' 231' ' ' ILE . 33.0 Cg_exo -58.76 -40.52 71.98 Favored 'Trans proline' 0 C--N 1.298 -2.088 0 C-N-CA 122.008 1.805 . . . . 0.0 113.516 -177.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 4.6 m -64.66 -36.0 76.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 119.071 -1.051 . . . . 0.0 110.243 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -64.79 -40.71 95.7 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 -177.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 6.3 m -64.79 -45.48 94.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -176.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 5.7 p -63.36 -36.72 77.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 119.888 -0.725 . . . . 0.0 110.038 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 30.9 mmtm -60.0 -43.66 95.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.552 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -60.59 -41.84 95.53 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -177.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.445 ' NH1' ' CE1' ' A' ' 269' ' ' PHE . 64.3 mtp180 -70.05 134.2 48.0 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.277 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.617 ' CG ' ' O ' ' A' ' 242' ' ' TYR . 22.6 t80 163.76 5.2 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 O-C-N 123.839 0.712 . . . . 0.0 112.535 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' MET . . . . . 0.406 ' O ' ' CB ' ' A' ' 244' ' ' ASN . 21.4 ttm -116.37 161.3 19.27 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.084 -1.01 . . . . 0.0 110.942 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . 0.406 ' CB ' ' O ' ' A' ' 243' ' ' MET . 2.6 m120 81.05 -178.11 0.07 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.281 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 1.7 m 67.05 30.66 7.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.85 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -112.06 45.47 1.26 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.962 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 15.5 mt -97.64 -74.27 0.58 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.798 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 0.446 ' O ' ' CD2' ' A' ' 250' ' ' TYR . . . -171.19 170.09 43.0 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.61 ' O ' ' CG ' ' A' ' 250' ' ' TYR . 23.5 mt-30 65.85 -164.39 0.24 Allowed 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.61 ' CG ' ' O ' ' A' ' 249' ' ' GLN . 23.3 p90 50.52 140.12 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 O-C-N 124.133 0.896 . . . . 0.0 110.941 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . 1.358 ' HD2' ' NE2' ' A' ' 255' ' ' HIS . 53.8 m-70 -65.37 -51.23 61.88 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 118.267 -1.373 . . . . 0.0 108.331 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 55.7 m -149.09 -178.6 6.47 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 121.677 0.751 . . . . 0.0 112.031 175.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -65.13 -43.99 90.1 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.412 -1.267 . . . . 0.0 112.569 177.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -67.21 -43.47 89.16 Favored Glycine 0 N--CA 1.463 0.463 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.814 177.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' HIS . . . . . 1.358 ' NE2' ' HD2' ' A' ' 251' ' ' HIS . 86.4 t60 -63.27 -32.5 73.92 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 112.546 -1.827 . . . . 0.0 110.983 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' CYS . . . . . . . . . . . . . 7.5 t -61.81 -42.34 98.89 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 114.049 -1.432 . . . . 0.0 108.529 175.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -58.06 -42.95 86.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.604 -178.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -64.43 -42.31 96.09 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 96.8 m -62.37 -45.03 95.02 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.879 177.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' MET . . . . . 0.595 ' O ' ' N ' ' A' ' 264' ' ' GLU . 0.0 OUTLIER -60.5 -41.58 94.59 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.894 -178.972 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 8.8 tp -61.2 -47.68 85.0 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 29.1 mtp85 -67.28 -53.86 26.06 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 43.6 tttp -66.51 -69.89 0.28 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.42 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . 0.595 ' N ' ' O ' ' A' ' 260' ' ' MET . 43.6 tp10 -88.32 110.77 21.03 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.835 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . 0.529 ' C ' ' H ' ' A' ' 267' ' ' ARG . . . -34.45 155.9 0.01 OUTLIER Glycine 0 CA--C 1.539 1.558 0 CA-C-N 116.3 -0.409 . . . . 0.0 112.11 -179.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -56.03 3.23 0.08 OUTLIER 'Trans proline' 0 N--CA 1.503 2.048 0 C-N-CA 122.131 1.888 . . . . 0.0 113.086 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.529 ' H ' ' C ' ' A' ' 265' ' ' GLY . 99.6 mtt180 -68.95 -27.0 65.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.436 0.16 . . . . 0.0 110.768 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -58.78 -32.7 69.54 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.57 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . 0.445 ' CE1' ' NH1' ' A' ' 241' ' ' ARG . 51.1 m-85 -62.47 -42.47 99.5 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.554 0.693 . . . . 0.0 110.683 178.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -66.62 -37.46 84.92 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.668 -1.151 . . . . 0.0 113.17 -178.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 272' ' ' GLY . 68.4 mttm -77.59 171.89 14.22 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 271' ' ' LYS . . . 53.69 111.79 0.01 OUTLIER Glycine 0 CA--C 1.528 0.874 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -172.25 3.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.616 -0.433 . . . . 0.0 111.144 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' MET . . . . . 0.559 ' N ' ' CD ' ' A' ' 275' ' ' PRO . 1.4 ttt -64.01 -44.13 77.12 Favored Pre-proline 0 C--N 1.329 -0.324 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.615 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' A' ' 274' ' ' MET . 19.5 Cg_exo -64.71 -47.9 4.76 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 121.852 1.701 . . . . 0.0 112.107 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 44.6 t -61.52 -40.74 95.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.664 0.745 . . . . 0.0 110.743 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -62.33 -42.62 99.53 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 123.491 1.615 . . . . 0.0 113.541 -178.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 9.2 tp -62.78 -39.24 93.6 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 110.607 -2.997 . . . . 0.0 108.887 174.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . 0.629 ' NH2' ' HZ1' ' A' ' 38' ' ' LYS . 71.5 mtp180 -63.04 -40.54 98.04 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.561 0.696 . . . . 0.0 110.713 179.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.457 ' CD1' ' C ' ' A' ' 280' ' ' LEU . 0.1 OUTLIER -62.26 -36.22 81.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.609 -1.178 . . . . 0.0 112.211 -177.446 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -68.14 -51.16 34.94 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 71.1 m -63.19 -44.68 94.68 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 123.087 0.555 . . . . 0.0 109.84 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' TRP . . . . . . . . . . . . . 80.3 t90 -60.46 -38.0 82.8 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.851 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -61.75 -37.96 86.19 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.718 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -60.2 -37.44 73.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 111.567 0.21 . . . . 0.0 111.567 -178.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -61.75 -40.15 85.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 120.505 -0.478 . . . . 0.0 109.986 -178.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 8.4 tpt -60.91 -39.11 88.11 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.245 0.545 . . . . 0.0 109.721 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -59.05 -41.05 86.98 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.856 -178.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 8.1 p -61.28 -38.53 80.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 O-C-N 121.855 -0.528 . . . . 0.0 112.091 -177.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.551 ' HG1' ' N ' ' A' ' 291' ' ' TYR . 19.4 p -62.53 -40.98 98.5 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 119.18 -1.008 . . . . 0.0 108.379 177.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' TYR . . . . . 0.551 ' N ' ' HG1' ' A' ' 290' ' ' THR . 3.1 m-85 -60.89 -38.55 86.06 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 177.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 14.9 tm-20 -57.53 -39.58 76.92 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 118.138 -1.425 . . . . 0.0 109.535 -176.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' GLN . . . . . 0.439 ' O ' ' O ' ' A' ' 296' ' ' ARG . 0.0 OUTLIER -60.17 -41.63 93.25 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 122.968 1.366 . . . . 0.0 110.11 179.197 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 65.0 mt -60.25 -39.32 86.31 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 112.206 -2.27 . . . . 0.0 109.557 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -62.16 -45.26 94.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.088 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' ARG . . . . . 0.439 ' O ' ' O ' ' A' ' 293' ' ' GLN . 62.3 ttm-85 -122.58 116.06 23.22 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -109.72 -169.82 1.54 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.402 0.62 . . . . 0.0 111.76 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.596 ' CD1' ' H ' ' A' ' 298' ' ' LEU . 0.0 OUTLIER -68.24 -8.83 42.66 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.977 -1.011 . . . . 0.0 111.471 -178.663 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' MET . . . . . 0.403 ' C ' ' O ' ' A' ' 298' ' ' LEU . 74.1 mtp 28.1 62.41 0.11 Allowed 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 177.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.62 100.81 0.07 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.812 0.815 . . . . 0.0 110.896 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -63.93 -46.3 85.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.131 -1.395 . . . . 0.0 113.386 -176.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . 0.527 ' CD2' ' OE2' ' A' ' 306' ' ' GLU . 32.8 t80 -58.68 -40.13 82.68 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.023 -0.671 . . . . 0.0 109.539 -178.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . 0.485 ' N ' ' OE1' ' A' ' 303' ' ' GLN . 1.3 mp0 -65.0 -46.83 79.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.186 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' SER . . . . . 0.446 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 77.8 p -66.23 -37.4 85.45 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.553 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -61.43 -42.82 99.35 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.057 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.527 ' OE2' ' CD2' ' A' ' 302' ' ' TYR . 41.7 mt-10 -64.71 -36.99 86.08 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.228 1.195 . . . . 0.0 114.228 -177.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -60.02 -52.95 69.88 Favored Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -176.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' PRO . . . . . 0.446 ' CD ' ' O ' ' A' ' 304' ' ' SER . 74.0 Cg_endo -75.26 0.27 9.21 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.193 1.929 . . . . 0.0 111.908 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 91.9 t80 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.609 -179.981 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 16.6 ptm . . . . . 0 N--CA 1.492 1.651 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.5 m -78.74 119.39 21.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.048 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.9 t -147.23 143.85 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 121.129 0.49 . . . . 0.0 111.085 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -64.21 -40.82 96.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.679 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -63.49 -41.39 98.57 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.175 -0.921 . . . . 0.0 113.208 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 50.9 tp -79.77 -26.48 40.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.177 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.449 ' O ' ' OG1' ' A' ' 22' ' ' THR . . . -66.43 -41.44 94.37 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 107.363 -2.295 . . . . 0.0 107.363 176.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.26 -31.75 67.89 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 124.84 2.257 . . . . 0.0 107.316 176.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.46 -42.72 98.93 Favored Glycine 0 CA--C 1.528 0.867 1 CA-C-N 108.364 -4.016 . . . . 0.0 108.307 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' A' ' 19' ' ' GLY . 35.6 p -70.71 -27.95 64.37 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.576 0.703 . . . . 0.0 109.314 177.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.38 -50.18 64.34 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.946 -178.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.82 -35.82 79.33 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 118.671 -1.212 . . . . 0.0 111.2 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 75.6 m -63.71 -53.63 48.16 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.343 -178.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.9 pt -65.47 -39.77 86.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 -177.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.05 -42.02 97.19 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 119.763 -0.775 . . . . 0.0 112.845 -173.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 28' ' ' ASP . 43.1 t0 -77.71 -27.36 50.63 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 118.249 -1.38 . . . . 0.0 109.544 -176.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.1 tp -60.29 -55.67 30.86 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.714 1.143 . . . . 0.0 111.729 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.0 pt -75.4 -4.0 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 121.306 0.574 . . . . 0.0 112.368 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.1 m -109.12 -16.8 14.02 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.254 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -69.02 -44.69 29.29 Favored Pre-proline 0 CA--C 1.544 0.731 0 CA-C-N 121.868 2.122 . . . . 0.0 111.926 -178.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -59.64 -16.25 35.67 Favored 'Trans proline' 0 N--CA 1.504 2.088 0 CA-C-N 120.897 1.356 . . . . 0.0 112.857 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 62.2 mt -67.54 -35.15 78.51 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -177.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.43 ' CB ' ' HZ3' ' A' ' 38' ' ' LYS . 1.1 m-20 -64.23 -40.52 96.2 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.128 -177.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 87.0 m -58.2 -34.84 70.81 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.14 -38.97 86.43 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 119.691 -0.804 . . . . 0.0 113.048 -179.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.43 ' HZ3' ' CB ' ' A' ' 35' ' ' ASP . 9.2 pttm -62.14 -47.55 84.07 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 118.995 -1.082 . . . . 0.0 111.656 -177.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.6 t -62.83 -38.72 82.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -177.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.561 ' C ' ' H ' ' A' ' 42' ' ' GLN . 7.9 tpm_? -59.45 -41.25 89.22 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 119.266 -0.974 . . . . 0.0 109.706 -178.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.516 ' C ' ' H ' ' A' ' 43' ' ' ILE . 9.4 mp -62.69 38.83 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.59 177.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.57 ' O ' ' N ' ' A' ' 44' ' ' GLN . 25.1 tp60 -72.71 23.96 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 O-C-N 121.947 -0.471 . . . . 0.0 111.385 -178.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.516 ' H ' ' C ' ' A' ' 41' ' ' LEU . 9.2 tp 28.98 34.03 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 121.404 0.621 . . . . 0.0 111.534 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.57 ' N ' ' O ' ' A' ' 42' ' ' GLN . 3.1 mp0 53.79 98.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.566 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -169.19 31.74 0.17 Allowed Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -70.57 -28.68 65.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.828 0.347 . . . . 0.0 110.684 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 17.7 t 59.38 42.2 18.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.998 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -98.99 -19.64 17.18 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.1 0.476 . . . . 0.0 110.05 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.16 -23.28 30.29 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.1 -38.26 87.79 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.3 p -61.04 -44.5 98.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.151 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.24 -33.58 76.15 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.714 -178.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -67.93 -38.05 82.41 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -93.18 -146.25 0.23 Allowed 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.847 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -176.11 -32.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.084 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.524 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 7.9 t -128.08 -138.83 0.24 Allowed 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 56' ' ' SER . . . 99.25 12.56 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.6 0 O-C-N 124.165 0.916 . . . . 0.0 111.277 178.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.439 ' CG ' ' O ' ' A' ' 58' ' ' GLN . 4.3 pt20 -174.24 121.1 0.28 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -85.76 151.41 23.85 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 87.9 mtt180 -45.43 -33.02 2.39 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 122.453 1.121 . . . . 0.0 108.096 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -41.89 114.37 0.67 Allowed Glycine 0 CA--C 1.526 0.723 0 CA-C-N 112.86 -1.973 . . . . 0.0 113.195 -178.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.6 p -66.75 -33.02 60.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 118.124 -0.941 . . . . 0.0 108.862 176.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -60.18 -32.3 70.94 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 121.747 2.067 . . . . 0.0 110.868 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.59 -49.07 66.59 Favored Glycine 0 CA--C 1.532 1.121 0 N-CA-C 114.965 0.746 . . . . 0.0 114.965 -176.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.6 t -62.04 -45.57 93.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.178 -0.511 . . . . 0.0 111.933 -179.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 35.2 mm -59.25 -36.25 62.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -63.91 -35.84 81.97 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 120.764 1.62 . . . . 0.0 112.148 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.447 ' O ' ' OG1' ' A' ' 72' ' ' THR . 97.9 m -63.0 -39.82 95.89 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 114.002 -1.454 . . . . 0.0 111.04 -175.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.463 ' O ' ' OG1' ' A' ' 72' ' ' THR . 0.1 OUTLIER -60.03 -39.61 86.48 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -176.023 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.6 p -69.91 -40.5 78.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 113.934 1.086 . . . . 0.0 113.934 -178.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -78.3 -13.56 59.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.8 0.809 . . . . 0.0 112.883 -178.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' A' ' 69' ' ' MET . 0.0 OUTLIER -63.2 -54.62 34.61 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.069 -1.423 . . . . 0.0 111.002 178.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -107.79 -57.76 2.06 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.805 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 157.99 163.49 12.81 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -56.51 -35.15 96.53 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 121.987 1.792 . . . . 0.0 111.683 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.433 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 91.7 mtt-85 -61.39 -11.65 11.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.654 0.74 . . . . 0.0 111.022 176.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.9 t -77.69 -32.42 53.04 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.089 -1.414 . . . . 0.0 111.038 -177.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.433 ' N ' ' CD1' ' A' ' 78' ' ' LEU . 10.2 mp -75.5 -33.09 60.74 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 122.126 -0.359 . . . . 0.0 110.783 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -91.91 -4.58 54.54 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 122.796 1.284 . . . . 0.0 113.142 -178.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.433 ' ND2' ' O ' ' A' ' 76' ' ' ARG . 0.9 OUTLIER -97.47 117.65 32.21 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 112.025 -2.352 . . . . 0.0 107.168 174.903 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.9 -13.5 56.17 Favored Glycine 0 N--CA 1.469 0.866 0 N-CA-C 108.255 -1.938 . . . . 0.0 108.255 -177.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 12.3 tp -58.85 -34.71 71.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 113.305 -1.448 . . . . 0.0 110.249 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.8 p -70.54 -26.78 29.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.364 178.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.81 -31.61 61.76 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.796 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.86 -40.42 89.4 Favored Glycine 0 N--CA 1.463 0.492 0 C-N-CA 119.677 -1.249 . . . . 0.0 111.223 -177.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.3 mp -62.34 -40.08 95.21 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 122.364 1.078 . . . . 0.0 112.5 -177.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -60.44 -27.24 67.35 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 113.071 -1.877 . . . . 0.0 109.34 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 49.4 ttp180 -57.91 -53.48 57.77 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 173.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.404 HE21 ' HB2' ' A' ' 28' ' ' ASP . 9.8 tp-100 -67.44 -29.89 69.48 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 112.56 -2.109 . . . . 0.0 112.428 -178.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 12.2 tpt -61.02 -40.98 95.63 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.352 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 78.2 p -74.35 -34.34 63.38 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 119.509 -0.877 . . . . 0.0 111.401 -176.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -58.04 -44.48 87.43 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 120.6 1.545 . . . . 0.0 111.789 -176.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.33 -33.59 65.21 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.49 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.1 t -64.48 -41.8 96.25 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.411 ' C ' ' H ' ' A' ' 97' ' ' ILE . 93.3 t -68.41 -28.6 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.841 177.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.568 ' NH2' ' CE2' ' A' ' 100' ' ' TYR . 59.9 ttt-85 -78.05 8.79 4.29 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -177.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.426 HG23 HD11 ' A' ' 97' ' ' ILE . 0.3 OUTLIER -87.49 -14.95 9.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.086 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -140.09 -48.13 0.06 OUTLIER Glycine 0 CA--C 1.54 1.631 0 N-CA-C 115.864 1.106 . . . . 0.0 115.864 -176.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.7 mt -71.08 -12.56 61.58 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 119.586 1.693 . . . . 0.0 112.817 -178.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.568 ' CE2' ' NH2' ' A' ' 96' ' ' ARG . 4.3 t80 -80.22 -51.32 9.08 Favored 'General case' 0 C--O 1.214 -0.778 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.438 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 1.162 ' OD1' ' NE2' ' A' ' 105' ' ' GLN . 12.7 t70 -69.48 -32.73 71.81 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 123.45 1.595 . . . . 0.0 110.561 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 31.1 m -68.82 -52.47 29.77 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 111.023 -2.808 . . . . 0.0 114.466 177.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.532 ' O ' ' CD2' ' A' ' 107' ' ' TYR . 1.1 p -74.97 -27.82 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 CA-C-N 121.942 2.156 . . . . 0.0 112.479 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -69.99 -41.74 73.98 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 110.849 -2.887 . . . . 0.0 112.801 -179.636 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 1.162 ' NE2' ' OD1' ' A' ' 101' ' ' ASP . 88.1 mt-30 -78.88 -11.43 60.0 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 122.972 1.368 . . . . 0.0 111.043 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.47 -21.94 48.27 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 113.924 -1.489 . . . . 0.0 111.086 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.532 ' CD2' ' O ' ' A' ' 103' ' ' VAL . 47.5 m-85 -108.36 -30.57 8.25 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 120.005 1.275 . . . . 0.0 111.614 -175.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.1 p -98.27 9.68 42.44 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 117.972 -1.491 . . . . 0.0 112.047 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.47 ' O ' ' C ' ' A' ' 110' ' ' GLY . 16.0 ttmm -54.19 118.17 3.85 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.619 0.645 . . . . 0.0 112.453 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.511 ' O ' ' O ' ' A' ' 111' ' ' SER . . . -17.24 -89.09 0.01 OUTLIER Glycine 0 N--CA 1.48 1.585 0 CA-C-O 119.81 -0.439 . . . . 0.0 113.155 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.703 ' O ' ' O ' ' A' ' 112' ' ' GLU . 5.9 t 45.44 111.54 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 117.252 0.526 . . . . 0.0 111.797 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.703 ' O ' ' O ' ' A' ' 111' ' ' SER . 17.1 pt-20 -9.57 -148.26 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 126.481 1.913 . . . . 0.0 115.929 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.466 ' CG ' ' O ' ' A' ' 113' ' ' HIS . 0.0 OUTLIER -105.92 73.35 0.99 Allowed 'General case' 0 C--N 1.343 0.303 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -177.257 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.445 ' CB ' ' O ' ' A' ' 113' ' ' HIS . . . 160.14 -164.38 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 122.35 1.072 . . . . 0.0 108.963 175.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.418 ' O ' ' OG ' ' A' ' 118' ' ' SER . . . 102.03 15.6 25.72 Favored Glycine 0 C--N 1.342 0.863 0 CA-C-N 113.015 -1.902 . . . . 0.0 111.487 178.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 13.3 tt -60.71 -40.33 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 C-N-CA 119.609 -0.837 . . . . 0.0 111.015 -178.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.56 -40.39 96.05 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-O 121.716 0.62 . . . . 0.0 112.098 176.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 115' ' ' GLY . 26.0 p -58.41 -42.57 87.48 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 176.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.1 tpp180 -63.55 -37.24 86.55 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 119.824 -0.75 . . . . 0.0 110.927 -177.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.407 ' N ' HD23 ' A' ' 120' ' ' LEU . 2.6 mm? -63.35 -46.1 88.11 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 20.9 mt -66.51 -44.76 81.66 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 118.896 -1.122 . . . . 0.0 109.847 178.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.1 -45.21 89.67 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 119.964 1.256 . . . . 0.0 110.452 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -65.81 -44.42 92.14 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.191 -1.004 . . . . 0.0 111.262 -178.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 42.5 m -64.17 -43.75 94.2 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.742 0.306 . . . . 0.0 111.418 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 19.7 m -69.5 -48.27 61.11 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 119.346 -0.942 . . . . 0.0 112.337 177.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.424 ' CG2' ' N ' ' A' ' 127' ' ' GLY . 6.0 t -65.68 -42.75 90.9 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 -174.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.424 ' N ' ' CG2' ' A' ' 126' ' ' THR . . . -64.48 -44.96 94.46 Favored Glycine 0 CA--C 1.52 0.401 0 CA-C-N 114.632 -1.167 . . . . 0.0 113.138 -177.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.81 -41.71 98.1 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 112.719 -1.741 . . . . 0.0 107.207 177.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 54.6 tp -64.7 -42.62 95.15 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.09 178.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.34 -40.09 96.33 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.099 0.778 . . . . 0.0 113.099 -177.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.3 m -61.17 -26.55 39.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 123.521 1.629 . . . . 0.0 109.639 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -59.29 -45.49 91.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 110.835 -2.893 . . . . 0.0 112.673 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.6 p -79.65 -49.03 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 -178.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -121.79 136.39 54.93 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.823 0.344 . . . . 0.0 111.667 -178.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.672 ' H ' ' CD ' ' A' ' 136' ' ' PRO . 0.0 OUTLIER 170.33 -21.36 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.723 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.79 178.669 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.672 ' CD ' ' H ' ' A' ' 135' ' ' GLN . 53.0 Cg_exo -52.84 -34.68 66.74 Favored 'Trans proline' 0 N--CA 1.499 1.85 0 CA-C-N 121.174 1.455 . . . . 0.0 113.268 -178.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 11.5 t -67.28 -41.59 85.22 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 119.07 -1.052 . . . . 0.0 108.613 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -64.68 -42.24 95.49 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 118.857 -1.137 . . . . 0.0 111.34 -178.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 55.3 t -63.85 -44.48 98.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 32.1 m -65.33 -38.17 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -177.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -61.73 -40.65 95.84 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -176.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.443 ' CG2' ' N ' ' A' ' 143' ' ' ARG . 1.5 m -69.41 -44.24 80.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.028 -0.669 . . . . 0.0 109.343 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.528 ' NH2' ' O ' ' A' ' 174' ' ' GLY . 94.8 mtt-85 -63.86 -35.41 80.56 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.288 178.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -65.89 -40.21 91.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.92 -177.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 23.8 tm0? -63.98 -39.31 93.83 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 119.335 -0.946 . . . . 0.0 108.861 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.14 -35.16 80.24 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 113.267 0.839 . . . . 0.0 113.267 -178.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.52 110.78 1.19 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 177.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -99.41 -60.58 1.5 Allowed 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -175.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -98.35 117.51 32.93 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 122.107 2.23 . . . . 0.0 109.968 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -68.14 -15.0 63.4 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.666 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 71.08 -173.85 41.68 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 153' ' ' GLY . . . -46.37 -94.5 0.01 OUTLIER Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 152' ' ' GLY . . . 48.57 101.83 0.01 OUTLIER Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -59.99 -40.41 89.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.789 0.328 . . . . 0.0 110.373 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -56.78 -169.74 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.344 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.428 ' O ' ' O ' ' A' ' 157' ' ' GLN . 79.4 t80 -108.86 -0.17 19.95 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.979 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.428 ' O ' ' O ' ' A' ' 156' ' ' TYR . 18.1 mm100 59.4 145.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.338 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 70.5 m -157.07 -177.73 6.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.383 0.611 . . . . 0.0 111.201 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 96.8 m -63.92 -45.97 86.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.551 -177.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.457 ' CG2' ' N ' ' A' ' 161' ' ' GLU . 8.2 m -64.01 -44.9 97.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 118.913 -1.115 . . . . 0.0 109.008 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.457 ' N ' ' CG2' ' A' ' 160' ' ' VAL . 94.6 mt-10 -66.94 -39.04 87.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.859 0.361 . . . . 0.0 111.459 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -61.76 -45.62 93.14 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -177.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.42 ' HH ' ' CD2' ' A' ' 175' ' ' LEU . 28.4 t80 -62.38 -49.66 74.65 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.509 -178.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 65.7 mmtt -68.44 -45.43 72.53 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 -175.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 35.6 p -62.79 -44.66 95.58 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 120.78 -1.2 . . . . 0.0 113.921 -177.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 2.4 pp -64.64 -37.78 80.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 121.825 0.822 . . . . 0.0 109.632 176.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -58.64 -35.87 73.2 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 113.741 -1.572 . . . . 0.0 107.829 177.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 7.8 tpm_? -61.94 -50.47 71.99 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 121.706 2.048 . . . . 0.0 112.726 -175.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -75.25 -51.21 13.83 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 123.684 0.793 . . . . 0.0 111.199 178.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -78.14 -36.24 48.01 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 116.169 1.914 . . . . 0.0 116.169 -172.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 93.03 -167.42 29.28 Favored Glycine 0 N--CA 1.47 0.951 0 N-CA-C 111.872 -0.491 . . . . 0.0 111.872 177.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.559 ' CD1' ' H ' ' A' ' 172' ' ' ILE . 0.0 OUTLIER -73.37 -44.48 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 CA-C-O 121.796 0.808 . . . . 0.0 109.871 -179.827 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -59.03 -33.9 71.28 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 114.442 -1.254 . . . . 0.0 111.424 -177.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.528 ' O ' ' NH2' ' A' ' 143' ' ' ARG . . . -61.05 -40.41 98.47 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 118.575 -1.774 . . . . 0.0 109.3 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.42 ' CD2' ' HH ' ' A' ' 163' ' ' TYR . 1.2 tp -70.54 -33.71 71.45 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 111.459 -2.371 . . . . 0.0 116.995 -177.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 6.4 m95 -77.84 -7.56 56.83 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 111.991 -2.368 . . . . 0.0 109.796 -177.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 48.1 tttp -43.39 -48.29 7.04 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.575 -176.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -95.1 -40.03 4.39 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.3 0.953 . . . . 0.0 112.109 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 11.5 p -45.46 -51.44 11.57 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.432 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 2.6 m -62.72 -50.69 76.7 Favored Pre-proline 0 N--CA 1.472 0.659 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -176.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 180' ' ' SER . 30.1 Cg_endo -64.5 -27.58 62.07 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 121.986 1.791 . . . . 0.0 111.928 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -63.35 -39.09 93.58 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 120.588 -0.445 . . . . 0.0 109.939 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.451 ' O ' ' OD1' ' A' ' 186' ' ' ASN . 85.2 t -62.84 -42.3 95.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.051 0.453 . . . . 0.0 109.975 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.88 -39.51 92.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.095 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 46.2 ttp85 -60.44 -40.83 92.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.923 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . 0.49 ' C ' ' ND2' ' A' ' 186' ' ' ASN . 0.0 OUTLIER -60.34 -41.67 94.08 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.136 0.493 . . . . 0.0 110.34 -179.667 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.2 -43.19 98.87 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.79 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.512 ' O ' ' SG ' ' A' ' 191' ' ' CYS . 42.9 mm -63.01 -44.8 99.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 6.3 m -59.37 -45.67 93.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 119.816 -0.754 . . . . 0.0 111.276 -178.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . 0.406 ' OD1' ' N ' ' A' ' 191' ' ' CYS . 0.9 OUTLIER -61.8 -42.51 99.1 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.876 0.846 . . . . 0.0 109.419 179.302 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' CYS . . . . . 0.551 ' SG ' ' N ' ' A' ' 192' ' ' ALA . 0.5 OUTLIER -62.0 -45.94 91.41 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.013 -1.449 . . . . 0.0 110.828 179.666 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . 0.551 ' N ' ' SG ' ' A' ' 191' ' ' CYS . . . -63.71 -40.4 96.68 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 114.463 -1.244 . . . . 0.0 109.433 177.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -60.74 -44.72 96.33 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.702 -1.136 . . . . 0.0 112.579 -178.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.446 ' HG ' ' N ' ' A' ' 195' ' ' VAL . 2.5 pp -63.0 -37.83 88.74 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 118.862 -1.135 . . . . 0.0 109.75 -174.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . 0.446 ' N ' ' HG ' ' A' ' 194' ' ' LEU . 0.6 OUTLIER -63.99 -46.15 94.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 C-N-CA 117.206 -1.798 . . . . 0.0 107.464 179.074 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 19.2 m -63.98 -46.52 84.24 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -176.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -56.8 -39.12 73.57 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.694 0.798 . . . . 0.0 111.222 -178.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -56.06 -43.93 78.41 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 7.7 mt -61.21 -39.39 90.06 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.599 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.1 mm -62.94 -42.04 95.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 1.8 mmmm -59.27 -38.77 80.95 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.744 1.618 . . . . 0.0 114.911 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -64.27 -42.24 96.53 Favored 'General case' 0 C--O 1.245 0.849 0 O-C-N 121.087 -1.008 . . . . 0.0 111.063 -176.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 4.0 m -102.5 129.19 48.95 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -176.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.61 ' O ' ' O ' ' A' ' 208' ' ' ASN . 3.6 mm? 66.52 3.32 2.83 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 113.717 -1.583 . . . . 0.0 111.299 177.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -122.1 24.53 9.46 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 -178.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -79.33 -18.11 53.18 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.502 0.668 . . . . 0.0 110.382 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.463 ' O ' ' CB ' ' A' ' 208' ' ' ASN . . . -167.1 25.96 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.204 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . 0.61 ' O ' ' O ' ' A' ' 204' ' ' LEU . 0.7 OUTLIER 93.53 -130.83 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.39 0.676 . . . . 0.0 109.81 -178.729 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.465 ' O ' ' CD2' ' A' ' 209' ' ' LEU . 6.5 tt -170.21 57.11 0.04 OUTLIER 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 106.719 -1.585 . . . . 0.0 106.719 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 8.5 mmt -99.02 42.95 1.08 Allowed 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 112.833 -1.985 . . . . 0.0 109.217 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 2.6 m -69.48 -130.38 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.984 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -158.57 18.89 0.21 Allowed 'General case' 0 CA--C 1.528 0.118 0 CA-C-O 120.7 0.286 . . . . 0.0 110.885 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 213' ' ' ASP . 34.8 p30 -147.44 81.42 1.52 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.963 0.411 . . . . 0.0 110.444 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.422 ' N ' ' HD2' ' A' ' 215' ' ' PRO . 2.0 pt? -61.11 -42.07 84.3 Favored Pre-proline 0 CA--C 1.548 0.877 0 N-CA-C 113.828 1.048 . . . . 0.0 113.828 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.422 ' HD2' ' N ' ' A' ' 214' ' ' LEU . 37.5 Cg_endo -60.13 -32.19 94.27 Favored 'Trans proline' 0 N--CA 1.502 2.01 0 CA-C-N 122.419 1.9 . . . . 0.0 111.458 -178.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 9.9 t -63.51 -42.13 98.5 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 113.48 -1.691 . . . . 0.0 111.713 -177.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' HIS . . . . . 0.43 ' O ' ' OG ' ' A' ' 220' ' ' SER . 54.8 t60 -66.64 -37.75 85.46 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.348 -0.541 . . . . 0.0 111.933 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -63.28 -47.04 84.0 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.515 -178.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 1.5 t -60.22 -37.51 80.54 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 118.845 0.748 . . . . 0.0 111.032 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' SER . . . . . 0.502 ' HG ' ' N ' ' A' ' 221' ' ' ALA . 78.7 p -59.51 -41.71 90.54 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . 0.544 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.68 -41.61 98.13 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -177.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -61.66 -47.04 87.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 122.007 0.908 . . . . 0.0 112.71 -176.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -60.42 -41.73 98.67 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 107.544 -2.223 . . . . 0.0 107.544 177.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . 0.418 ' O ' ' OG1' ' A' ' 228' ' ' THR . . . -62.95 -38.05 89.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.33 -0.935 . . . . 0.0 109.043 177.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -61.94 -42.1 99.71 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.192 -178.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -66.16 -38.4 88.0 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 97.5 m -63.1 -40.8 98.69 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 176.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 224' ' ' ALA . 11.2 m -61.59 -40.1 93.59 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.263 -1.335 . . . . 0.0 110.997 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 92.4 m -58.4 -39.13 78.86 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.371 -177.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 97.1 t -59.68 -40.46 82.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . 0.556 ' O ' ' HD2' ' A' ' 234' ' ' PRO . 23.0 mm -60.97 -40.11 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 177.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -62.32 -38.63 90.17 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.47 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 0.1 OUTLIER -57.25 -40.87 87.82 Favored Pre-proline 0 N--CA 1.482 1.173 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 -172.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.556 ' HD2' ' O ' ' A' ' 231' ' ' ILE . 31.6 Cg_exo -57.87 -39.22 88.53 Favored 'Trans proline' 0 C--N 1.292 -2.404 0 C-N-CA 122.021 1.814 . . . . 0.0 112.491 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 31.0 t -63.52 -36.32 75.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 118.802 -1.159 . . . . 0.0 109.398 178.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . 0.451 ' OD2' ' O ' ' A' ' 233' ' ' SER . 0.0 OUTLIER -65.23 -40.11 93.62 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.174 179.634 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 96.7 t -64.29 -45.63 95.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -176.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 25.6 m -63.06 -37.15 78.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 119.756 -0.777 . . . . 0.0 110.533 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 18.3 mmmt -60.49 -43.9 96.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.635 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 8.9 m -61.1 -42.2 98.07 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -177.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.463 ' O ' ' HB3' ' A' ' 242' ' ' TYR . 20.9 ptt180 -70.12 131.31 44.09 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.777 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.463 ' HB3' ' O ' ' A' ' 241' ' ' ARG . 0.1 OUTLIER 168.64 9.17 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 O-C-N 123.858 0.724 . . . . 0.0 112.525 178.155 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' MET . . . . . 0.401 ' CE ' ' NE2' ' A' ' 42' ' ' GLN . 11.2 tpt -113.17 61.73 0.64 Allowed 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.758 0.708 . . . . 0.0 111.94 -179.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . 0.435 ' O ' ' OG ' ' A' ' 245' ' ' SER . 4.1 m120 -115.81 -27.57 6.99 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' A' ' 244' ' ' ASN . 51.1 m -171.39 175.83 4.03 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.524 -1.217 . . . . 0.0 112.926 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -165.35 152.16 10.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.215 -1.357 . . . . 0.0 108.89 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 21.7 mt 59.98 79.06 0.25 Allowed 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.304 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 249' ' ' GLN . . . 172.38 -153.05 18.24 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.528 ' CD ' ' H ' ' A' ' 249' ' ' GLN . 3.5 pm0 -56.49 -111.66 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.8 m-30 48.36 67.03 0.91 Allowed 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 17.6 t-80 -67.5 -53.8 25.61 Favored 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 117.694 2.479 . . . . 0.0 117.694 -176.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 22.6 m -148.82 -174.69 4.69 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 118.818 0.735 . . . . 0.0 109.859 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -60.54 -45.11 95.08 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 119.771 -1.831 . . . . 0.0 107.3 178.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -58.64 -36.98 88.26 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-N 118.733 0.697 . . . . 0.0 111.884 -175.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -58.46 -37.02 74.62 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 117.977 -1.489 . . . . 0.0 110.996 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -62.25 -45.52 92.94 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 121.648 -0.657 . . . . 0.0 111.65 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -60.57 -45.17 94.93 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.57 -43.95 83.59 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 119.869 -0.733 . . . . 0.0 110.246 -179.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 31.6 m -63.31 -47.14 83.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.177 0.513 . . . . 0.0 111.091 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' MET . . . . . 0.426 ' O ' ' O ' ' A' ' 264' ' ' GLU . 32.2 mtt -62.1 -43.58 98.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.945 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 11.8 tp -62.21 -46.26 89.68 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 122.685 0.394 . . . . 0.0 111.068 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 69.6 ttp85 -65.92 -53.8 34.68 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.906 -178.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . 0.426 ' O ' ' N ' ' A' ' 265' ' ' GLY . 0.1 OUTLIER -102.73 -107.35 0.26 Allowed 'General case' 0 N--CA 1.472 0.659 0 O-C-N 122.249 -0.282 . . . . 0.0 111.208 179.562 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . 0.443 ' O ' ' O ' ' A' ' 265' ' ' GLY . 71.2 mm-40 -33.47 91.92 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . 0.443 ' O ' ' O ' ' A' ' 264' ' ' GLU . . . -38.51 166.11 0.01 OUTLIER Glycine 0 CA--C 1.534 1.251 0 CA-C-O 121.623 0.568 . . . . 0.0 111.712 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -63.21 -3.81 5.53 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 122.807 2.338 . . . . 0.0 111.628 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 27.8 mtp180 -69.08 -25.8 64.62 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 123.043 0.537 . . . . 0.0 111.671 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -57.88 -31.84 67.12 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.253 -178.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -62.34 -41.24 98.42 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.18 0.514 . . . . 0.0 110.987 177.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -66.17 -38.37 87.88 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -176.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.439 ' O ' ' O ' ' A' ' 272' ' ' GLY . 14.5 pttm -72.09 -172.43 0.88 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 271' ' ' LYS . . . 47.05 99.23 0.01 OUTLIER Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -158.74 0.94 0.09 Allowed 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.248 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' MET . . . . . 0.522 ' N ' ' HD2' ' A' ' 275' ' ' PRO . 6.2 mmt -63.55 -45.44 83.2 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.581 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 274' ' ' MET . 31.9 Cg_endo -64.9 -45.9 7.35 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 121.133 1.222 . . . . 0.0 110.574 177.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 1.4 m -60.36 -39.78 88.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.246 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . 0.404 ' O ' ' HG ' ' A' ' 280' ' ' LEU . 34.3 t80 -61.65 -43.03 99.63 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 124.438 2.066 . . . . 0.0 112.175 -178.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.11 -38.81 92.67 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 110.568 -3.015 . . . . 0.0 109.569 175.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 11.3 mmm180 -63.2 -41.8 99.23 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.51 0.929 . . . . 0.0 113.51 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.427 HD12 ' N ' ' A' ' 281' ' ' GLY . 3.0 pp -63.12 -35.34 79.94 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -178.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . 0.427 ' N ' HD12 ' A' ' 280' ' ' LEU . . . -67.83 -50.88 38.51 Favored Glycine 0 CA--C 1.521 0.413 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -177.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 9.5 t -62.49 -43.89 97.72 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.642 0.777 . . . . 0.0 109.387 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' TRP . . . . . . . . . . . . . 83.0 t90 -59.54 -37.68 79.04 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 281' ' ' GLY . 0.1 OUTLIER -61.49 -37.2 82.77 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.665 -179.845 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.3 -39.0 79.54 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 O-C-N 121.505 -0.747 . . . . 0.0 112.184 -177.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -63.41 -41.94 94.49 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 119.902 -0.719 . . . . 0.0 112.585 -178.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 6.8 ptm -61.78 -38.47 88.18 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.192 0.52 . . . . 0.0 109.808 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -58.2 -40.31 81.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.937 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 91.5 t -60.87 -39.41 81.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.591 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 10.8 m -63.21 -40.45 97.5 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -61.21 -38.73 87.63 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 176.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -57.94 -40.17 79.87 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 118.143 -1.423 . . . . 0.0 109.272 -176.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' GLN . . . . . 0.446 ' O ' ' O ' ' A' ' 296' ' ' ARG . 73.9 mt-30 -60.29 -41.96 94.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 123.126 1.441 . . . . 0.0 109.764 179.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.41 -39.66 88.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 111.717 -2.492 . . . . 0.0 109.342 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -62.72 -45.31 93.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.537 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' ARG . . . . . 0.446 ' O ' ' O ' ' A' ' 293' ' ' GLN . 44.7 ttm180 -122.53 116.18 23.45 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -113.55 -164.83 0.95 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.269 0.557 . . . . 0.0 112.162 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 14.1 mt -72.74 114.89 11.38 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 79.0 mmm -97.93 63.86 1.68 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -178.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.66 100.96 0.07 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.868 0.842 . . . . 0.0 110.716 -178.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -63.95 -46.22 85.66 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 113.962 -1.472 . . . . 0.0 113.528 -176.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -58.59 -39.21 79.72 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -178.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -64.13 -46.15 85.39 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.539 -179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' SER . . . . . 0.432 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 40.5 t -66.19 -37.72 86.29 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.764 -0.375 . . . . 0.0 110.999 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -61.76 -43.28 99.17 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -179.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -65.19 -36.63 84.8 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.344 1.238 . . . . 0.0 114.344 -177.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -60.02 -52.82 70.8 Favored Pre-proline 0 CA--C 1.544 0.738 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -176.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' PRO . . . . . 0.472 ' O ' ' CG ' ' A' ' 309' ' ' PHE . 74.2 Cg_endo -75.12 0.21 9.23 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.069 1.846 . . . . 0.0 111.808 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' PHE . . . . . 0.472 ' CG ' ' O ' ' A' ' 308' ' ' PRO . 69.4 m-85 . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.546 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.537 ' N ' ' SD ' ' A' ' 13' ' ' MET . 1.7 mpt? . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.8 t -125.47 54.96 1.44 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.221 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.3 m -83.15 150.61 4.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.266 0.555 . . . . 0.0 110.982 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.55 -40.74 96.14 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.241 -0.89 . . . . 0.0 112.088 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -63.32 -41.83 98.95 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -177.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.475 ' C ' ' CD1' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -80.06 -26.36 39.69 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.092 0.472 . . . . 0.0 111.568 -179.298 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.24 -41.54 94.7 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 107.594 -2.202 . . . . 0.0 107.594 177.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.55 -32.5 68.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 124.818 2.247 . . . . 0.0 107.602 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.25 -42.26 99.36 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-N 108.502 -3.954 . . . . 0.0 107.626 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.7 m -70.49 -27.68 64.39 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.57 -49.8 65.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.842 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.93 -35.97 79.99 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 118.077 -1.449 . . . . 0.0 111.054 -177.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 77.4 m -63.84 -53.93 42.87 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.496 -178.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.2 pp -65.79 -39.43 84.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -177.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.415 ' O ' ' OG1' ' A' ' 31' ' ' THR . . . -64.11 -41.96 97.05 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -174.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.519 ' OD1' ' NH2' ' A' ' 88' ' ' ARG . 10.0 t70 -77.64 -27.39 51.05 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 120.594 1.543 . . . . 0.0 109.809 -175.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 43.5 mt -60.0 -55.28 35.97 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 119.724 1.147 . . . . 0.0 112.097 -178.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.8 tp -75.42 -3.87 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-O 121.743 0.783 . . . . 0.0 112.335 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 27' ' ' ALA . 29.7 m -108.96 -16.39 14.15 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 117.491 -1.242 . . . . 0.0 110.305 -178.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.441 ' O ' ' OD1' ' A' ' 35' ' ' ASP . 14.5 t80 -69.01 -44.3 28.25 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-N 122.784 2.538 . . . . 0.0 111.758 -177.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' A' ' 32' ' ' PHE . 32.1 Cg_exo -59.6 -15.72 32.52 Favored 'Trans proline' 0 N--CA 1.504 2.107 0 C-N-CA 121.298 1.332 . . . . 0.0 113.245 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.8 mp -67.18 -35.5 79.78 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -177.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 36' ' ' THR . 15.8 p30 -64.86 -40.53 95.3 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -178.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.538 ' N ' ' OD1' ' A' ' 35' ' ' ASP . 43.3 p -58.4 -34.99 71.35 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.59 -38.37 83.93 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 119.948 -0.701 . . . . 0.0 111.84 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -61.66 -49.09 77.94 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 119.625 -0.83 . . . . 0.0 111.266 -176.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.5 m -63.69 -39.75 86.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 118.31 0.504 . . . . 0.0 111.913 -177.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.521 ' NH2' ' OE1' ' A' ' 42' ' ' GLN . 7.6 tpm_? -60.78 -40.99 94.66 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.411 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.0 38.85 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.589 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.521 ' OE1' ' NH2' ' A' ' 40' ' ' ARG . 2.6 pt20 -85.82 61.73 7.03 Favored 'General case' 0 N--CA 1.463 0.188 0 O-C-N 121.965 -0.459 . . . . 0.0 110.971 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.408 ' C ' ' O ' ' A' ' 42' ' ' GLN . 22.2 pt 32.06 -125.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.861 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -158.15 100.62 1.71 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.649 0.262 . . . . 0.0 110.334 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.547 ' C ' ' H ' ' A' ' 47' ' ' SER . . . -176.31 -118.59 0.54 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.089 -0.805 . . . . 0.0 111.089 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 69.22 -16.9 0.23 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.704 0.288 . . . . 0.0 110.786 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.547 ' H ' ' C ' ' A' ' 45' ' ' GLY . 29.0 t 53.66 26.41 5.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.919 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.519 ' O ' ' NE2' ' A' ' 48' ' ' GLN . 0.0 OUTLIER -44.16 -28.39 0.5 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.674 0.75 . . . . 0.0 109.789 179.727 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.72 -36.71 3.66 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -178.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.419 ' N ' ' CD2' ' A' ' 50' ' ' LEU . 3.6 mm? -66.73 -38.03 85.85 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.448 0.642 . . . . 0.0 109.311 177.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 96.2 t -60.68 -44.55 97.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 114.919 -1.037 . . . . 0.0 112.604 -177.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -64.19 -33.54 76.02 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.938 -178.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.5 m -67.92 -38.06 82.45 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 177.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.439 ' C ' ' H ' ' A' ' 56' ' ' SER . . . -127.93 78.6 1.84 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.177 -0.919 . . . . 0.0 108.801 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.38 -3.42 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.635 -0.712 . . . . 0.0 112.813 -178.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.532 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 94.9 p -126.58 -140.04 0.27 Allowed 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.532 ' CB ' ' O ' ' A' ' 56' ' ' SER . . . 99.2 11.77 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 O-C-N 124.12 0.888 . . . . 0.0 111.878 178.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 177.52 70.78 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -41.12 -83.78 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.054 0.454 . . . . 0.0 110.633 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.415 ' O ' ' C ' ' A' ' 61' ' ' GLY . 30.0 ttm180 -161.01 -34.36 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.591 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 60' ' ' ARG . . . -28.61 102.74 0.01 OUTLIER Glycine 0 CA--C 1.527 0.807 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.641 -179.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 90.3 t -67.41 -34.6 69.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 118.451 -0.785 . . . . 0.0 109.685 176.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.488 ' CD2' ' N ' ' A' ' 63' ' ' LEU . 3.6 mm? -60.79 -32.65 71.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 121.011 1.732 . . . . 0.0 109.726 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.61 -49.31 65.18 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-N 114.905 -1.043 . . . . 0.0 114.398 -176.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.3 m -62.1 -46.36 89.41 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 70.6 mt -59.43 -35.95 61.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.94 -35.76 81.72 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 120.919 1.69 . . . . 0.0 112.156 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.46 ' O ' ' OG1' ' A' ' 72' ' ' THR . 99.2 m -63.22 -40.73 98.29 Favored 'General case' 0 C--O 1.246 0.906 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.003 -174.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.402 ' C ' ' SD ' ' A' ' 69' ' ' MET . 3.2 ppp? -59.67 -40.05 86.51 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -175.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.2 p -69.49 -40.78 80.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 119.096 -1.042 . . . . 0.0 112.563 -178.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 75.0 ttt-85 -78.54 -13.3 59.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.769 0.795 . . . . 0.0 112.534 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.46 ' OG1' ' O ' ' A' ' 68' ' ' THR . 54.5 m -62.81 -54.65 35.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.643 178.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -107.44 -56.47 2.21 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.276 178.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 157.3 165.89 15.87 Favored Glycine 0 CA--C 1.535 1.325 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -56.27 -35.47 95.76 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 CA-C-N 119.508 1.654 . . . . 0.0 111.893 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.41 ' O ' ' CB ' ' A' ' 80' ' ' ASN . 12.1 tpp180 -61.42 -12.27 13.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.756 0.789 . . . . 0.0 111.007 176.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.471 ' HG ' ' N ' ' A' ' 78' ' ' LEU . 10.4 p -78.55 -33.0 48.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.968 -178.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.471 ' N ' ' HG ' ' A' ' 77' ' ' SER . 1.0 OUTLIER -75.94 -33.64 59.84 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.116 0.484 . . . . 0.0 110.535 179.754 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -92.74 -5.15 51.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 122.335 1.064 . . . . 0.0 113.202 -178.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.41 ' CB ' ' O ' ' A' ' 76' ' ' ARG . 4.7 t30 -90.01 118.85 29.88 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 112.812 -1.995 . . . . 0.0 107.502 175.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.71 -7.25 57.55 Favored Glycine 0 N--CA 1.468 0.782 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 -177.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.505 ' CD1' ' N ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -59.42 -34.59 72.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 113.603 -1.298 . . . . 0.0 110.834 -179.687 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.505 ' N ' ' CD1' ' A' ' 82' ' ' LEU . 4.8 p -70.61 -26.79 29.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.94 -31.62 61.55 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.576 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -68.17 -40.34 88.01 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 119.344 -1.407 . . . . 0.0 111.206 -177.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.3 mp -62.66 -40.54 97.38 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.978 0.894 . . . . 0.0 113.099 -176.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -60.62 -27.17 67.56 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 113.799 -1.546 . . . . 0.0 109.306 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.725 ' HE ' HE22 ' A' ' 89' ' ' GLN . 37.3 ttp180 -57.89 -53.76 54.58 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 173.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.725 HE22 ' HE ' ' A' ' 88' ' ' ARG . 0.9 OUTLIER -67.1 -29.86 69.73 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 112.325 -2.216 . . . . 0.0 111.84 -178.17 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 33.4 tpp -61.35 -40.82 95.66 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.493 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 37.1 m -74.44 -34.6 63.24 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 118.099 -0.953 . . . . 0.0 111.302 -177.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -57.66 -43.88 85.29 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 121.324 1.874 . . . . 0.0 112.262 -176.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.56 -32.84 64.39 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.127 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.8 p -64.09 -41.31 97.34 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.428 ' C ' ' H ' ' A' ' 97' ' ' ILE . 7.9 p -68.27 -28.23 39.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.022 177.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.403 ' NH2' ' CE2' ' A' ' 100' ' ' TYR . 51.0 ttt-85 -77.44 9.22 3.42 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -176.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.428 ' H ' ' C ' ' A' ' 95' ' ' VAL . 0.3 OUTLIER -87.3 -14.93 9.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.833 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -139.98 -48.2 0.06 OUTLIER Glycine 0 CA--C 1.543 1.781 0 N-CA-C 116.087 1.195 . . . . 0.0 116.087 -176.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 16.6 mt -71.14 -12.76 61.67 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 119.84 1.82 . . . . 0.0 113.05 -178.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.499 ' O ' ' CG ' ' A' ' 104' ' ' LYS . 26.2 t80 -80.57 -51.19 9.04 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 114.48 -1.236 . . . . 0.0 111.868 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 1.051 ' OD2' ' NE2' ' A' ' 105' ' ' GLN . 9.7 t70 -69.46 -32.29 71.11 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 123.175 1.464 . . . . 0.0 110.043 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 11.4 t -68.74 -52.54 29.48 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 111.158 -2.746 . . . . 0.0 111.89 175.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 52.3 t -74.28 -27.79 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-N 121.697 2.044 . . . . 0.0 114.131 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.499 ' CG ' ' O ' ' A' ' 100' ' ' TYR . 3.2 mmpt? -69.69 -41.68 75.12 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 112.131 -2.304 . . . . 0.0 111.518 179.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 1.051 ' NE2' ' OD2' ' A' ' 101' ' ' ASP . 88.1 mt-30 -79.69 -12.95 59.78 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 122.638 1.209 . . . . 0.0 111.011 -178.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -79.93 -22.8 42.28 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.21 178.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.619 ' CZ ' ' ND2' ' A' ' 190' ' ' ASN . 35.4 m-85 -109.81 -29.45 8.3 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 119.532 1.06 . . . . 0.0 112.721 -175.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.6 p -96.78 9.11 42.71 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 117.144 -1.823 . . . . 0.0 113.135 -177.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.402 ' HG2' ' H ' ' A' ' 110' ' ' GLY . 12.4 ttpp -96.87 -154.82 0.46 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 177.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.402 ' H ' ' HG2' ' A' ' 109' ' ' LYS . . . 140.42 134.58 3.11 Favored Glycine 0 N--CA 1.475 1.245 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 76.2 p -90.19 -40.29 12.29 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -177.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -116.28 174.41 6.07 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 112.899 -1.955 . . . . 0.0 113.485 -176.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.437 ' O ' ' CB ' ' A' ' 114' ' ' ALA . 85.9 m-70 -86.47 77.08 9.51 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.759 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.437 ' CB ' ' O ' ' A' ' 113' ' ' HIS . . . 159.6 -161.39 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.05 14.82 27.77 Favored Glycine 0 C--N 1.335 0.499 0 CA-C-N 115.449 -0.796 . . . . 0.0 113.213 176.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.422 HG21 HD12 ' A' ' 116' ' ' ILE . 22.6 mm -60.89 -40.83 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.0 -39.29 96.34 Favored Glycine 0 CA--C 1.525 0.713 0 CA-C-O 122.253 0.918 . . . . 0.0 110.982 175.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 5.8 t -57.93 -42.17 84.27 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 177.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 59.7 mtm180 -63.58 -37.47 87.44 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.278 -178.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 8.0 mp -64.15 -46.51 83.76 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 76.9 mt -66.83 -44.83 80.07 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 114.926 -1.033 . . . . 0.0 110.494 178.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.91 -44.77 91.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 119.532 1.06 . . . . 0.0 109.869 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -66.01 -44.1 92.21 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 119.73 -1.224 . . . . 0.0 111.295 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 71.0 m -64.07 -43.95 93.9 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.784 -0.367 . . . . 0.0 111.538 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 21.1 p -69.35 -48.43 61.36 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 119.333 -0.947 . . . . 0.0 111.954 177.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 24.0 p -65.37 -42.41 92.75 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 -174.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -63.95 -44.54 95.84 Favored Glycine 0 CA--C 1.521 0.463 0 CA-C-O 122.967 1.315 . . . . 0.0 112.916 -177.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.35 -41.6 97.33 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 111.903 -2.148 . . . . 0.0 107.25 177.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 17.3 mt -64.41 -42.15 96.24 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.221 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.0 -39.77 95.74 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -177.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 18.9 m -60.96 -26.03 37.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 122.829 1.3 . . . . 0.0 109.572 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -58.63 -44.83 90.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 112.251 -2.25 . . . . 0.0 111.876 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 5.1 m -79.0 -48.63 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -126.7 135.75 51.54 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.695 0.283 . . . . 0.0 111.451 -178.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.685 ' H ' ' CD ' ' A' ' 136' ' ' PRO . 2.1 pt20 175.2 -23.59 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.828 0 CA-C-N 115.47 -0.786 . . . . 0.0 113.069 178.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.685 ' CD ' ' H ' ' A' ' 135' ' ' GLN . 54.3 Cg_exo -53.03 -34.17 66.39 Favored 'Trans proline' 0 N--CA 1.5 1.894 0 CA-C-N 120.955 1.377 . . . . 0.0 113.275 -178.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.43 -41.58 84.55 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 119.064 -1.055 . . . . 0.0 110.667 -178.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -64.38 -42.44 96.16 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 119.238 -0.985 . . . . 0.0 111.777 -177.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 14.6 m -63.6 -42.71 97.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.879 0.371 . . . . 0.0 110.977 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.423 ' O ' ' N ' ' A' ' 144' ' ' PHE . 25.3 t -63.97 -38.54 82.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.437 ' NZ ' ' CB ' ' A' ' 141' ' ' LYS . 8.8 mtmp? -62.0 -40.93 97.33 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 119.556 -0.858 . . . . 0.0 111.895 -177.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.4 p -69.56 -44.81 79.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 119.992 -0.683 . . . . 0.0 109.23 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -64.36 -35.9 82.39 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.468 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.423 ' N ' ' O ' ' A' ' 140' ' ' VAL . 93.9 t80 -66.14 -40.76 90.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.249 -177.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -64.4 -39.53 94.03 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 118.844 -1.142 . . . . 0.0 109.709 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.22 -35.03 79.79 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.413 ' O ' ' CG ' ' A' ' 147' ' ' GLN . 0.0 OUTLIER -59.85 111.35 1.43 Allowed 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 177.981 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -94.49 -64.39 1.08 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 117.396 -1.288 . . . . 0.0 112.615 -177.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -91.06 110.68 21.96 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 122.862 2.574 . . . . 0.0 110.121 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -81.41 68.69 7.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.648 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 43.28 59.37 3.52 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -56.7 125.8 39.55 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.414 ' O ' ' O ' ' A' ' 154' ' ' ARG . . . 166.19 72.91 0.03 OUTLIER Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.708 HH12 ' HE ' ' A' ' 155' ' ' ARG . 54.3 ttp85 56.08 164.95 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.708 ' HE ' HH12 ' A' ' 154' ' ' ARG . 18.0 mmt85 56.97 177.48 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.881 0.372 . . . . 0.0 110.849 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.449 ' CE2' ' O ' ' A' ' 157' ' ' GLN . 85.1 t80 -138.6 145.26 40.34 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.437 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.449 ' O ' ' CE2' ' A' ' 156' ' ' TYR . 19.7 mp0 -109.67 -155.24 0.55 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -178.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 83.4 p -157.22 -176.25 5.86 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 123.256 1.503 . . . . 0.0 112.936 -177.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 8.4 m -62.89 -43.53 98.56 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 111.26 -2.7 . . . . 0.0 112.002 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.5 t -61.05 -42.76 94.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -178.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.45 ' OE2' ' OG1' ' A' ' 165' ' ' THR . 0.7 OUTLIER -65.47 -38.33 89.48 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.066 179.877 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -61.4 -45.67 93.35 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -178.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.436 ' CD1' ' C ' ' A' ' 163' ' ' TYR . 13.7 t80 -62.62 -49.21 76.09 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.278 -178.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -67.83 -45.36 74.88 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -174.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.45 ' OG1' ' OE2' ' A' ' 161' ' ' GLU . 1.9 p -63.0 -43.86 97.63 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -176.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 15.0 pt -64.26 -37.93 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 CA-C-O 121.746 0.784 . . . . 0.0 109.133 177.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.89 -37.07 78.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.17 -1.377 . . . . 0.0 107.37 175.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -62.46 -50.44 71.46 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 122.211 2.278 . . . . 0.0 111.849 -176.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.524 ' N ' ' OE1' ' A' ' 169' ' ' GLU . 0.2 OUTLIER -74.93 -50.99 14.91 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.523 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -78.09 -36.28 48.32 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 116.594 2.072 . . . . 0.0 116.594 -173.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 91.14 -166.61 31.03 Favored Glycine 0 C--N 1.337 0.628 0 CA-C-N 118.841 0.746 . . . . 0.0 112.263 177.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.579 ' CD1' ' H ' ' A' ' 172' ' ' ILE . 0.0 OUTLIER -72.64 -38.58 59.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.903 0.859 . . . . 0.0 109.175 -179.576 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 68.1 mtp180 -58.5 -33.74 70.15 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 113.852 -1.522 . . . . 0.0 111.103 -177.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -61.48 -41.24 99.51 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 118.672 -1.728 . . . . 0.0 111.425 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.464 ' CD1' ' N ' ' A' ' 175' ' ' LEU . 7.8 mp -71.33 -34.35 70.47 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 117.717 2.488 . . . . 0.0 117.717 -177.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . 0.493 ' CD1' ' O ' ' A' ' 172' ' ' ILE . 63.7 m95 -78.18 -7.09 56.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 112.995 -1.912 . . . . 0.0 109.589 -177.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 16.8 ttmm -43.63 -48.64 7.75 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -175.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -90.11 -32.23 10.01 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.39 0.995 . . . . 0.0 111.815 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 90.1 m -45.31 -50.66 11.81 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.96 -50.47 80.78 Favored Pre-proline 0 N--CA 1.472 0.627 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -175.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -64.64 -27.98 60.81 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 121.17 1.247 . . . . 0.0 111.704 176.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -64.06 -39.33 93.85 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 1.6 p -62.91 -41.71 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.855 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.48 -39.28 90.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.961 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.57 HH12 ' CG1' ' A' ' 235' ' ' VAL . 48.8 ttt85 -60.6 -42.13 96.14 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 119.922 -0.711 . . . . 0.0 110.344 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -61.67 -43.86 98.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.183 0.516 . . . . 0.0 110.679 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -65.28 -44.2 88.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.617 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 24.3 mm -63.81 -45.89 95.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -177.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.503 ' O ' ' N ' ' A' ' 193' ' ' GLU . 5.9 p -60.72 -47.31 93.62 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.339 0 C-N-CA 119.237 -0.985 . . . . 0.0 111.729 -178.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . 0.619 ' ND2' ' CZ ' ' A' ' 107' ' ' TYR . 12.2 t-20 -63.54 -42.94 98.37 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 122.282 1.039 . . . . 0.0 110.868 178.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' CYS . . . . . . . . . . . . . 31.3 m -61.39 -45.53 93.98 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 113.348 -1.751 . . . . 0.0 108.389 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.27 -40.4 95.91 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 112.662 -2.063 . . . . 0.0 109.672 175.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 0.503 ' N ' ' O ' ' A' ' 189' ' ' VAL . 0.7 OUTLIER -60.81 -46.54 90.12 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.001 0.92 . . . . 0.0 113.086 -176.884 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 2.8 pp -64.31 -36.73 85.08 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 119.231 -0.988 . . . . 0.0 109.528 -175.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 1.4 m -63.18 -45.74 97.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 C-N-CA 117.01 -1.876 . . . . 0.0 107.389 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 30.3 p -64.35 -46.11 84.88 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -177.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -57.67 -39.87 78.1 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.133 -0.939 . . . . 0.0 113.338 -177.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -56.4 -44.46 80.32 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 9.7 mt -61.66 -39.45 91.41 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.803 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 1.6 mp -63.12 -42.79 97.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 118.813 -0.613 . . . . 0.0 110.115 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -59.99 -40.42 89.12 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 120.224 1.374 . . . . 0.0 111.897 178.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -66.96 -38.43 86.08 Favored 'General case' 0 C--O 1.25 1.104 0 CA-C-N 114.682 -1.145 . . . . 0.0 111.003 -176.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -101.96 128.89 48.17 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 120.804 -1.185 . . . . 0.0 112.455 -178.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 4.1 tp 67.46 4.45 3.8 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 114.275 -1.33 . . . . 0.0 112.082 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.74 38.11 4.0 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -74.52 -21.57 59.47 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.527 0.68 . . . . 0.0 111.455 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.427 ' O ' ' CB ' ' A' ' 208' ' ' ASN . . . -130.86 -40.45 1.19 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.54 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . 0.691 ' C ' ' H ' ' A' ' 210' ' ' MET . 6.4 p30 152.13 124.43 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 -178.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.433 ' CD1' ' O ' ' A' ' 209' ' ' LEU . 0.2 OUTLIER -50.81 24.63 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 110.41 -3.086 . . . . 0.0 111.954 179.164 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' MET . . . . . 0.691 ' H ' ' C ' ' A' ' 208' ' ' ASN . 35.3 ttp -110.42 75.87 0.95 Allowed 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.789 -0.569 . . . . 0.0 110.614 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 38.4 p -98.0 -154.28 0.45 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.579 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -125.6 3.37 7.56 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.878 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -115.07 66.78 0.69 Allowed 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.4 ' N ' ' CD ' ' A' ' 215' ' ' PRO . 4.4 mm? -61.28 -43.74 90.87 Favored Pre-proline 0 CA--C 1.537 0.481 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 214' ' ' LEU . 25.9 Cg_exo -60.88 -34.07 91.71 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 CA-C-N 120.59 1.246 . . . . 0.0 111.039 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 82.3 m -64.77 -42.53 95.05 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 113.173 -1.83 . . . . 0.0 111.771 -178.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' HIS . . . . . 0.416 ' O ' ' OG ' ' A' ' 220' ' ' SER . 4.0 t60 -66.83 -38.13 85.82 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -178.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -63.44 -47.37 82.15 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.941 -178.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 27.1 p -60.65 -38.24 84.17 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 119.102 0.864 . . . . 0.0 110.465 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 217' ' ' HIS . 47.8 p -59.67 -41.88 91.61 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . 0.568 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.91 -41.82 97.58 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -177.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -62.11 -47.15 85.89 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -176.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -60.74 -42.09 99.28 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 107.464 -2.254 . . . . 0.0 107.464 177.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -63.1 -37.93 89.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.211 -0.995 . . . . 0.0 108.977 176.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -61.66 -42.28 99.73 Favored Glycine 0 CA--C 1.521 0.412 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.811 -177.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -66.57 -38.34 86.87 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 96.3 m -63.22 -41.11 99.08 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.012 0.434 . . . . 0.0 110.387 177.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 225' ' ' GLY . 55.9 p -61.99 -39.95 93.96 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.759 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -58.17 -38.73 77.23 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -176.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 1.7 p -59.57 -40.53 82.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 119.004 -1.078 . . . . 0.0 110.02 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . 0.495 ' O ' ' HD2' ' A' ' 234' ' ' PRO . 0.3 OUTLIER -61.45 -40.16 85.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 177.615 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -62.78 -39.47 94.29 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 115.683 1.735 . . . . 0.0 115.683 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.488 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 0.2 OUTLIER -57.99 -41.72 91.39 Favored Pre-proline 0 N--CA 1.484 1.244 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 -173.525 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.495 ' HD2' ' O ' ' A' ' 231' ' ' ILE . 32.3 Cg_exo -57.7 -39.56 86.67 Favored 'Trans proline' 0 C--N 1.291 -2.461 0 C-N-CA 122.495 2.13 . . . . 0.0 113.128 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . 0.57 ' CG1' HH12 ' A' ' 185' ' ' ARG . 59.3 t -63.69 -37.22 79.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 C-N-CA 117.8 -1.56 . . . . 0.0 108.799 178.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . 0.526 ' OD2' ' CE3' ' A' ' 283' ' ' TRP . 53.1 t0 -65.77 -40.37 91.94 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.266 178.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 59.2 t -64.6 -45.22 96.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 -176.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 84.4 t -62.86 -37.13 78.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 C-N-CA 120.028 -0.669 . . . . 0.0 111.737 -178.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -60.41 -43.98 96.19 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -60.94 -41.89 97.13 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.711 -178.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.596 ' NH1' ' CZ ' ' A' ' 269' ' ' PHE . 15.8 mtt180 -44.61 -41.85 6.92 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 120.974 -0.29 . . . . 0.0 110.7 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.553 ' O ' ' N ' ' A' ' 244' ' ' ASN . 38.4 t80 -36.29 -60.25 0.58 Allowed 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' MET . . . . . 0.53 ' SD ' ' O ' ' A' ' 243' ' ' MET . 0.0 OUTLIER -31.65 -32.27 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 O-C-N 123.788 0.68 . . . . 0.0 110.774 179.716 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . 0.553 ' N ' ' O ' ' A' ' 242' ' ' TYR . 5.5 t-20 -34.21 147.89 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.753 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' SER . . . . . 0.484 ' C ' ' O ' ' A' ' 244' ' ' ASN . 67.1 m 12.41 -79.64 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 O-C-N 124.535 1.147 . . . . 0.0 112.767 179.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 244' ' ' ASN . . . 79.35 78.03 0.05 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.579 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 6.3 tp -173.39 106.56 0.14 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.764 0.316 . . . . 0.0 111.012 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 65.87 170.01 3.1 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.764 -0.534 . . . . 0.0 111.764 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 55.46 -164.18 0.13 Allowed 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 110.638 -0.134 . . . . 0.0 110.638 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 55.97 63.31 2.07 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.795 -0.184 . . . . 0.0 110.526 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 27.0 t60 -66.34 -52.08 50.7 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -177.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 24.5 p -147.93 -174.92 4.69 Favored 'General case' 0 C--O 1.215 -0.721 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -61.9 -45.87 91.86 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 119.774 1.17 . . . . 0.0 110.062 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -56.52 -35.42 66.53 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.705 1.622 . . . . 0.0 113.501 -171.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' HIS . . . . . 0.412 ' O ' ' OG1' ' A' ' 259' ' ' THR . 86.4 t60 -55.91 -34.19 65.34 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 117.159 -1.816 . . . . 0.0 111.041 -179.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -61.93 -44.26 97.14 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 122.03 -0.419 . . . . 0.0 110.732 178.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -59.92 -45.75 91.56 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.82 -178.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.469 ' CD2' ' N ' ' A' ' 258' ' ' LEU . 3.4 mm? -67.71 -44.08 78.54 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.05 178.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' THR . . . . . 0.412 ' OG1' ' O ' ' A' ' 255' ' ' HIS . 19.7 m -63.68 -46.79 83.91 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 113.863 1.061 . . . . 0.0 113.863 -179.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' MET . . . . . 0.459 ' SD ' ' N ' ' A' ' 261' ' ' LEU . 0.0 OUTLIER -61.75 -44.37 97.03 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -176.817 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.459 ' N ' ' SD ' ' A' ' 260' ' ' MET . 11.7 tp -62.36 -47.08 85.77 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 121.92 -0.487 . . . . 0.0 109.766 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 70.0 mtp180 -66.77 -53.64 30.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.976 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . 0.455 ' O ' ' O ' ' A' ' 260' ' ' MET . 9.6 mtpm? -130.59 179.17 6.1 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.881 0.372 . . . . 0.0 111.258 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . 0.456 ' O ' ' O ' ' A' ' 265' ' ' GLY . 95.1 mt-10 56.43 67.78 0.95 Allowed 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.609 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 264' ' ' GLU . . . -33.34 159.81 0.01 OUTLIER Glycine 0 CA--C 1.533 1.158 0 CA-C-O 121.789 0.661 . . . . 0.0 112.304 -179.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -64.91 -5.34 10.48 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.076 1.851 . . . . 0.0 111.355 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -69.73 -26.28 64.25 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.536 0.734 . . . . 0.0 111.362 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -58.02 -32.28 67.8 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.532 -178.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . 0.596 ' CZ ' ' NH1' ' A' ' 241' ' ' ARG . 29.0 m-85 -62.39 -41.15 98.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.347 177.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -65.79 -37.9 87.55 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.387 -177.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.506 ' CB ' ' HZ2' ' A' ' 271' ' ' LYS . 0.0 OUTLIER -95.97 165.54 12.21 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 178.448 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 69.03 86.64 0.1 Allowed Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.614 -0.995 . . . . 0.0 110.614 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -168.74 22.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 121.064 -0.255 . . . . 0.0 110.784 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' MET . . . . . 0.568 ' N ' ' CD ' ' A' ' 275' ' ' PRO . 1.0 OUTLIER -63.7 -44.1 79.16 Favored Pre-proline 0 C--N 1.33 -0.254 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.219 -179.792 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 274' ' ' MET . 21.3 Cg_exo -64.38 -46.61 7.21 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.43 2.087 . . . . 0.0 111.54 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 1.5 p -60.66 -40.11 90.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.038 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . 0.411 ' CD1' ' C ' ' A' ' 277' ' ' PHE . 36.4 t80 -61.89 -42.92 99.65 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 123.289 1.519 . . . . 0.0 111.936 -178.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 12.0 tp -62.12 -38.73 90.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 111.037 -2.801 . . . . 0.0 108.159 174.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . 0.408 ' HA ' ' HE ' ' A' ' 279' ' ' ARG . 0.5 OUTLIER -62.62 -40.2 96.24 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.072 179.215 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.446 ' CD1' ' C ' ' A' ' 280' ' ' LEU . 0.2 OUTLIER -61.97 -36.31 81.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.145 -0.934 . . . . 0.0 113.1 -177.255 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -67.7 -50.89 39.19 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 109.146 -1.581 . . . . 0.0 109.146 -178.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 78.0 p -61.92 -43.63 98.44 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.694 0.798 . . . . 0.0 109.538 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' TRP . . . . . 0.526 ' CE3' ' OD2' ' A' ' 236' ' ' ASP . 1.3 m95 -59.5 -38.09 79.99 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . 0.422 ' ND2' ' CD1' ' A' ' 280' ' ' LEU . 85.2 m-20 -61.76 -38.95 89.92 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -178.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 23.0 m -61.46 -37.26 77.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 O-C-N 121.354 -0.841 . . . . 0.0 111.339 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.406 ' O ' ' CG2' ' A' ' 289' ' ' VAL . 26.8 t -62.14 -41.63 92.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -177.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' MET . . . . . 0.42 ' O ' ' OG1' ' A' ' 290' ' ' THR . 11.5 ptm -62.34 -38.32 89.05 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 121.305 -0.872 . . . . 0.0 109.608 178.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -58.47 -41.22 84.73 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.13 -0.941 . . . . 0.0 113.303 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.406 ' CG2' ' O ' ' A' ' 286' ' ' VAL . 2.7 m -61.33 -38.68 80.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 121.693 -0.63 . . . . 0.0 110.846 -178.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 287' ' ' MET . 75.7 p -62.22 -40.43 96.1 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 177.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -61.24 -38.44 86.65 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 176.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -58.31 -40.71 82.72 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 117.915 -1.514 . . . . 0.0 109.283 -176.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' GLN . . . . . 0.451 ' O ' ' O ' ' A' ' 296' ' ' ARG . 83.3 mm-40 -60.72 -43.13 98.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 122.577 1.18 . . . . 0.0 110.784 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 73.5 mt -60.47 -40.52 91.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 113.027 -1.897 . . . . 0.0 109.219 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -63.18 -46.15 88.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.982 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' ARG . . . . . 0.451 ' O ' ' O ' ' A' ' 293' ' ' GLN . 20.1 tpt85 -123.07 116.19 23.08 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.009 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -115.52 -96.11 0.46 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.177 0.513 . . . . 0.0 110.522 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 38.9 tp -139.3 120.87 15.17 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.683 179.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 30.2 ttm -92.69 64.32 4.11 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 121.202 -0.199 . . . . 0.0 111.271 -179.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.71 101.22 0.07 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.976 0.893 . . . . 0.0 111.227 -178.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -64.12 -46.2 85.19 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 113.47 -1.695 . . . . 0.0 112.936 -176.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -58.48 -39.29 79.58 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.498 -0.481 . . . . 0.0 109.789 -178.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . 0.432 ' O ' ' OE2' ' A' ' 306' ' ' GLU . 86.3 mt-30 -64.56 -46.49 82.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.224 -179.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' SER . . . . . 0.439 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 74.2 p -67.09 -38.64 86.05 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.454 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -62.5 -43.87 97.75 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -178.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.473 ' CD ' ' N ' ' A' ' 307' ' ' ALA . 2.7 pp20? -65.72 -36.76 84.51 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -177.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . 0.473 ' N ' ' CD ' ' A' ' 306' ' ' GLU . . . -59.84 -52.6 72.57 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -176.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' PRO . . . . . 0.439 ' CD ' ' O ' ' A' ' 304' ' ' SER . 73.1 Cg_endo -74.96 0.3 9.05 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.954 1.769 . . . . 0.0 111.604 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 82.5 t80 . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.459 179.881 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.485 ' SD ' ' OG1' ' A' ' 14' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.485 ' OG1' ' SD ' ' A' ' 13' ' ' MET . 39.7 m -131.0 112.5 12.98 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.111 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.504 ' CG2' ' H ' ' A' ' 16' ' ' LYS . 7.2 p -91.79 176.58 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.318 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.504 ' H ' ' CG2' ' A' ' 15' ' ' VAL . 35.0 mtmm -64.21 -41.37 97.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.517 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -63.61 -41.42 98.3 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 31.3 tp -79.85 -26.42 40.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.079 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.444 ' O ' ' OG1' ' A' ' 22' ' ' THR . . . -66.26 -41.39 94.74 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 107.451 -2.259 . . . . 0.0 107.451 177.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.427 ' CB ' HH12 ' A' ' 96' ' ' ARG . . . -71.37 -32.0 67.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 124.77 2.224 . . . . 0.0 107.314 176.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.45 -42.57 98.98 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-N 108.469 -3.969 . . . . 0.0 108.095 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.499 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 33.6 p -70.75 -28.0 64.37 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.28 -50.23 64.39 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.745 -178.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.406 ' O ' ' OE1' ' A' ' 89' ' ' GLN . . . -61.95 -35.96 79.98 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 118.504 -1.278 . . . . 0.0 111.234 -177.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.632 ' SG ' ' N ' ' A' ' 26' ' ' ILE . 5.8 p -64.15 -53.47 48.88 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.027 -179.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.632 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 16.0 pt -65.68 -39.68 85.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -178.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.498 ' O ' ' OG1' ' A' ' 31' ' ' THR . . . -63.68 -42.18 98.06 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 119.686 -0.806 . . . . 0.0 112.738 -173.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.532 ' CG ' HE22 ' A' ' 89' ' ' GLN . 1.5 m-20 -77.09 -27.13 54.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 120.739 1.608 . . . . 0.0 109.941 -174.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.42 -54.26 47.71 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 118.922 0.783 . . . . 0.0 112.222 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.4 pp -72.86 -1.0 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-O 122.501 1.144 . . . . 0.0 111.906 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.498 ' OG1' ' O ' ' A' ' 27' ' ' ALA . 97.8 m -106.72 -12.58 15.5 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 112.588 -2.096 . . . . 0.0 112.051 -174.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.439 ' N ' ' CD ' ' A' ' 33' ' ' PRO . 8.4 t80 -70.74 -44.87 16.63 Favored Pre-proline 0 CA--C 1.551 1.011 0 CA-C-N 121.935 2.152 . . . . 0.0 113.765 -178.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.439 ' CD ' ' N ' ' A' ' 32' ' ' PHE . 33.5 Cg_exo -60.54 -17.75 50.33 Favored 'Trans proline' 0 N--CA 1.52 3.047 0 N-CA-C 119.363 2.793 . . . . 0.0 119.363 -175.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.651 ' CD1' ' H ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -69.11 -35.47 76.47 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 120.342 1.428 . . . . 0.0 114.067 -179.071 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -65.02 -41.73 95.02 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -175.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.5 p -58.33 -36.0 72.75 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 119.551 -0.86 . . . . 0.0 111.348 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.96 -38.81 83.21 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 119.782 -0.767 . . . . 0.0 111.731 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.4 ' CG ' ' N ' ' A' ' 39' ' ' VAL . 8.2 pttp -61.37 -48.24 82.18 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.28 -176.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.4 ' N ' ' CG ' ' A' ' 38' ' ' LYS . 82.2 t -63.48 -41.05 91.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 119.667 -0.813 . . . . 0.0 111.565 -176.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.524 ' C ' ' H ' ' A' ' 42' ' ' GLN . 67.9 mmt-85 -61.94 -42.09 98.7 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 119.252 -0.979 . . . . 0.0 110.064 178.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -62.81 38.85 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.685 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.572 ' NE2' ' SD ' ' A' ' 243' ' ' MET . 8.1 tp-100 -128.41 -76.43 0.56 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.909 0.385 . . . . 0.0 110.01 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 21.0 tt -168.46 121.45 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.885 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -71.69 57.57 0.29 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.889 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -167.24 165.87 38.87 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.137 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.6 mp0 -147.11 -160.12 1.12 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.134 -0.533 . . . . 0.0 109.574 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.7 m -81.94 -6.22 58.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.033 0.444 . . . . 0.0 110.106 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -59.42 -30.49 68.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.729 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.71 1.17 87.5 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -178.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.3 tp -64.03 -36.03 82.66 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.361 -0.92 . . . . 0.0 109.532 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.428 ' O ' ' O ' ' A' ' 54' ' ' ALA . 8.6 p -58.95 -43.05 87.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.067 -178.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.413 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 22.3 ptt85 -63.06 -33.07 74.65 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 119.734 -0.787 . . . . 0.0 109.658 -178.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -67.7 -37.81 82.8 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 51' ' ' VAL . . . -132.26 111.3 11.27 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.469 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.61 -8.77 59.59 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -178.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.515 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 29.4 p -130.55 -138.15 0.21 Allowed 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.515 ' CB ' ' O ' ' A' ' 56' ' ' SER . . . 91.84 -30.96 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 176.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.468 ' O ' ' N ' ' A' ' 60' ' ' ARG . 68.8 mt-30 -139.55 8.05 2.37 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.565 ' O ' ' CD2' ' A' ' 59' ' ' TYR . 20.9 p90 -46.3 87.03 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.555 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.477 ' O ' ' O ' ' A' ' 59' ' ' TYR . 75.9 mtt180 51.33 165.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.021 0.439 . . . . 0.0 110.419 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 120.01 83.87 0.82 Allowed Glycine 0 CA--C 1.519 0.298 0 N-CA-C 104.441 -3.463 . . . . 0.0 104.441 -175.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.6 p -67.79 -36.11 74.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 118.631 -0.699 . . . . 0.0 110.86 178.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.75 -33.02 73.32 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 117.687 -1.605 . . . . 0.0 109.24 178.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.89 -49.9 60.85 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 113.559 -1.655 . . . . 0.0 115.126 -176.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.0 m -62.37 -46.92 86.48 Favored 'General case' 0 C--N 1.334 -0.1 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -178.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 12.0 tt -59.98 -36.04 64.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 38.6 tp -63.88 -35.57 81.07 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 120.82 1.645 . . . . 0.0 111.607 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 98.4 m -63.28 -40.13 96.52 Favored 'General case' 0 C--O 1.249 1.058 0 CA-C-N 113.729 -1.578 . . . . 0.0 111.042 -174.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 3.2 ptt? -60.63 -39.99 90.29 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 120.328 -1.482 . . . . 0.0 114.628 -175.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.8 m -69.52 -40.31 79.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 119.213 -0.995 . . . . 0.0 112.86 -178.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 62.8 ttp85 -78.78 -13.21 59.93 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.499 ' CG2' ' N ' ' A' ' 73' ' ' GLU . 0.6 OUTLIER -62.57 -54.42 40.04 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.667 179.194 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.499 ' N ' ' CG2' ' A' ' 72' ' ' THR . 19.2 mt-10 -105.24 -54.8 2.42 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.437 ' O ' ' OG ' ' A' ' 77' ' ' SER . . . 155.7 166.94 16.45 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -56.37 -35.14 95.85 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 121.329 1.352 . . . . 0.0 111.106 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.2 tpp180 -61.32 -11.93 11.77 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-O 121.985 0.897 . . . . 0.0 110.543 176.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.452 ' O ' ' OD1' ' A' ' 80' ' ' ASN . 28.9 p -77.59 -32.05 53.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 113.858 -1.519 . . . . 0.0 110.611 -177.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.424 ' N ' ' HG ' ' A' ' 77' ' ' SER . 7.0 tt -75.88 -33.93 59.98 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.539 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.519 ' C ' ' H ' ' A' ' 81' ' ' GLY . 26.2 m-85 -93.33 -5.25 50.07 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 115.003 1.482 . . . . 0.0 115.003 -178.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.452 ' OD1' ' O ' ' A' ' 77' ' ' SER . 50.1 p30 -84.13 32.59 0.49 Allowed 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 114.272 -1.331 . . . . 0.0 107.734 175.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.519 ' H ' ' C ' ' A' ' 79' ' ' TYR . . . -171.93 -9.46 0.02 OUTLIER Glycine 0 CA--C 1.525 0.67 0 CA-C-N 114.503 -1.226 . . . . 0.0 112.376 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 35.9 tp -59.13 -34.85 72.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 113.998 -1.101 . . . . 0.0 110.279 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.7 p -70.8 -27.16 29.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.284 178.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.69 -31.39 61.88 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.574 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.85 -40.03 89.54 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 119.442 -1.361 . . . . 0.0 111.051 -177.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 45.2 mt -62.21 -40.24 95.45 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 122.371 1.081 . . . . 0.0 113.179 -177.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -60.22 -26.72 66.62 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 112.993 -1.912 . . . . 0.0 108.979 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 -57.68 -53.45 58.05 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 172.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.532 HE22 ' CG ' ' A' ' 28' ' ' ASP . 1.4 tp-100 -67.95 -30.28 69.54 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 112.596 -2.093 . . . . 0.0 113.74 -177.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.53 -40.17 93.67 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 78.2 p -74.31 -34.5 63.51 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 118.409 -0.805 . . . . 0.0 111.192 -176.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -57.48 -44.05 84.58 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 120.842 1.656 . . . . 0.0 111.621 -176.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.51 -33.03 64.57 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 119.456 -0.898 . . . . 0.0 111.117 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.476 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 38.8 t -64.08 -41.94 97.14 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.468 ' C ' ' H ' ' A' ' 97' ' ' ILE . 1.4 p -67.51 -27.47 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.755 179.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.499 ' CG ' ' O ' ' A' ' 96' ' ' ARG . 15.0 ttt180 -77.01 9.61 2.85 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -177.034 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.476 ' CG2' ' O ' ' A' ' 94' ' ' SER . 10.2 tp -86.6 -16.3 9.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 177.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -140.98 -49.0 0.05 OUTLIER Glycine 0 CA--C 1.541 1.662 0 N-CA-C 115.952 1.141 . . . . 0.0 115.952 -177.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.406 ' N ' ' CD1' ' A' ' 99' ' ' LEU . 10.7 mp -71.8 -13.45 61.7 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 119.453 1.627 . . . . 0.0 112.682 -177.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.479 ' O ' ' CG ' ' A' ' 104' ' ' LYS . 2.6 m-85 -80.77 -51.06 9.07 Favored 'General case' 0 C--O 1.211 -0.938 0 CA-C-N 114.293 -1.321 . . . . 0.0 110.809 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.936 ' OD2' ' NE2' ' A' ' 105' ' ' GLN . 18.3 t70 -69.18 -32.34 71.58 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 123.391 1.567 . . . . 0.0 110.071 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.5 t -68.96 -52.71 26.18 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 110.953 -2.839 . . . . 0.0 113.526 176.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 10.0 p -74.69 -27.66 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 CA-C-N 122.211 2.278 . . . . 0.0 113.146 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.479 ' CG ' ' O ' ' A' ' 100' ' ' TYR . 47.6 mtpt -69.48 -42.13 75.25 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 111.47 -2.605 . . . . 0.0 111.805 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.936 ' NE2' ' OD2' ' A' ' 101' ' ' ASP . 88.1 mt-30 -75.05 -16.37 60.59 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 122.997 1.38 . . . . 0.0 111.05 176.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -78.7 -22.65 46.36 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 112.614 -2.085 . . . . 0.0 112.044 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.486 ' OH ' ' ND2' ' A' ' 190' ' ' ASN . 16.7 m-85 -109.54 -30.83 7.74 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 119.369 0.986 . . . . 0.0 111.269 -175.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.4 m -98.1 9.06 43.78 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 118.029 -1.468 . . . . 0.0 112.105 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.521 ' O ' ' C ' ' A' ' 110' ' ' GLY . 51.4 tttm -51.97 120.8 5.74 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 118.129 -0.939 . . . . 0.0 111.564 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.544 ' O ' ' CB ' ' A' ' 111' ' ' SER . . . -20.87 -82.86 0.01 OUTLIER Glycine 0 N--CA 1.488 2.14 0 CA-C-N 119.474 1.034 . . . . 0.0 112.076 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.544 ' CB ' ' O ' ' A' ' 110' ' ' GLY . 24.2 p 103.67 -161.19 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 176.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.621 ' O ' ' N ' ' A' ' 114' ' ' ALA . 18.9 tp10 -131.49 101.56 5.57 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -177.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.478 ' CG ' ' O ' ' A' ' 113' ' ' HIS . 81.3 t60 17.36 42.41 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.924 178.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.621 ' N ' ' O ' ' A' ' 112' ' ' GLU . . . 159.33 -161.48 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.437 ' O ' ' OG ' ' A' ' 118' ' ' SER . . . 102.51 14.9 26.53 Favored Glycine 0 C--N 1.337 0.614 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.991 177.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 48.6 mt -60.83 -40.5 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.0 -39.51 96.49 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-O 122.078 0.821 . . . . 0.0 111.559 175.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 115' ' ' GLY . 8.6 p -57.57 -42.09 82.37 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 177.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -63.42 -37.23 86.47 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.099 -0.64 . . . . 0.0 111.377 -178.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 29.0 mt -64.18 -46.68 82.91 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.351 0.596 . . . . 0.0 110.018 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.4 tt -66.63 -44.88 80.8 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.983 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.89 -44.99 91.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 119.222 0.919 . . . . 0.0 109.907 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -65.73 -44.04 93.08 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.568 -0.825 . . . . 0.0 111.83 -178.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 78.1 p -63.64 -43.27 97.26 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 18.9 m -68.84 -48.03 64.51 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 119.281 -0.968 . . . . 0.0 112.012 177.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 21.6 p -65.49 -42.63 91.95 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 -173.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -64.01 -44.79 95.39 Favored Glycine 0 CA--C 1.521 0.46 0 CA-C-O 122.586 1.103 . . . . 0.0 113.092 -177.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.402 ' O ' ' CG2' ' A' ' 131' ' ' VAL . . . -61.1 -41.3 96.41 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 112.54 -1.83 . . . . 0.0 106.818 177.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 51.9 mt -63.93 -41.75 97.54 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.308 178.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -62.64 -40.09 95.92 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -177.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.402 ' CG2' ' O ' ' A' ' 128' ' ' ALA . 5.0 m -61.22 -25.64 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 122.696 1.236 . . . . 0.0 109.5 178.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -57.87 -44.8 86.86 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 112.49 -2.141 . . . . 0.0 111.626 -178.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 3.6 m -78.97 -48.73 21.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.711 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -103.59 133.19 49.03 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.786 0.326 . . . . 0.0 111.468 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.551 ' H ' ' CD ' ' A' ' 136' ' ' PRO . 33.8 tp60 -175.88 -39.41 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.552 178.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.551 ' CD ' ' H ' ' A' ' 135' ' ' GLN . 52.9 Cg_exo -52.75 -33.56 60.66 Favored 'Trans proline' 0 N--CA 1.498 1.775 0 C-N-CA 122.009 1.806 . . . . 0.0 112.548 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 58.7 p -67.3 -41.88 84.63 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 118.309 -1.356 . . . . 0.0 109.65 -178.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -65.88 -42.48 90.26 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 118.796 -1.162 . . . . 0.0 111.903 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 59.1 t -64.04 -44.14 97.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 33.2 m -65.08 -38.76 83.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -177.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 14.8 mtpp -62.29 -41.86 98.86 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 119.269 -0.973 . . . . 0.0 111.823 -177.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 12.7 m -70.44 -45.64 74.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.237 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.492 ' NH2' ' O ' ' A' ' 174' ' ' GLY . 17.6 mmt85 -65.06 -37.09 86.41 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.566 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -66.98 -42.11 85.66 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -177.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -65.52 -40.39 92.9 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 118.853 -1.139 . . . . 0.0 109.572 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.64 -35.34 80.52 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -178.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.597 ' NE2' ' NE2' ' A' ' 157' ' ' GLN . 46.3 tt0 -60.2 110.51 1.24 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 176.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -98.83 -61.06 1.42 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 117.617 -1.182 . . . . 0.0 113.266 -177.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 70.8 mtp85 -71.29 -172.58 0.75 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 122.633 2.47 . . . . 0.0 110.259 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -160.79 18.61 0.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.647 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 57.57 -130.86 51.62 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 159.37 126.75 0.87 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 178.63 -150.94 9.98 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -62.13 -41.41 98.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.796 0.331 . . . . 0.0 110.523 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 80.4 mmt-85 -92.06 136.14 33.41 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.421 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.516 ' O ' ' CD2' ' A' ' 156' ' ' TYR . 60.8 t80 -90.96 19.89 5.28 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.63 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.597 ' NE2' ' NE2' ' A' ' 147' ' ' GLN . 27.6 tt0 58.85 146.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.811 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 88.8 p -157.06 -178.19 7.18 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.472 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 97.8 m -64.31 -45.88 86.0 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.805 -177.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 85.0 t -64.04 -45.35 96.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 119.016 -1.074 . . . . 0.0 108.898 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 -66.72 -39.55 88.05 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.833 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -62.16 -45.61 92.67 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -179.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.429 ' CD1' ' C ' ' A' ' 163' ' ' TYR . 19.3 t80 -62.4 -50.05 73.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.293 0.568 . . . . 0.0 111.075 -178.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -68.44 -45.21 73.14 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -175.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.403 ' O ' ' OE1' ' A' ' 169' ' ' GLU . 19.0 m -62.44 -44.6 96.01 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 -176.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 11.9 pt -64.6 -38.45 82.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-O 121.777 0.799 . . . . 0.0 109.651 176.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.91 -36.8 77.76 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 175.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 16.2 tpt85 -62.12 -49.86 74.19 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 122.095 2.225 . . . . 0.0 111.232 -176.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.403 ' OE1' ' O ' ' A' ' 165' ' ' THR . 16.4 mp0 -74.7 -51.13 15.14 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 123.561 0.744 . . . . 0.0 109.855 177.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -78.32 -36.75 45.98 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 117.033 2.235 . . . . 0.0 117.033 -172.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 91.77 -167.43 30.85 Favored Glycine 0 N--CA 1.472 1.036 0 CA-C-N 119.136 0.88 . . . . 0.0 112.597 177.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 9.0 pt -73.37 -41.91 57.07 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-O 122.098 0.951 . . . . 0.0 110.552 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -58.63 -32.94 69.5 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 113.661 -1.609 . . . . 0.0 110.473 -177.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.492 ' O ' ' NH2' ' A' ' 143' ' ' ARG . . . -60.45 -40.16 97.28 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 118.994 -1.574 . . . . 0.0 109.586 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.6 tt -69.46 -34.16 73.98 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 111.883 -2.159 . . . . 0.0 116.261 -176.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . 0.404 ' CD1' ' N ' ' A' ' 176' ' ' TRP . 39.2 m0 -78.36 -7.86 57.78 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 111.071 -2.786 . . . . 0.0 110.227 -178.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 37.6 tptt -43.45 -48.18 7.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.925 -176.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -83.75 -34.42 18.98 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 93.0 m -45.39 -51.49 11.22 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 1.6 t -62.9 -50.91 74.92 Favored Pre-proline 0 N--CA 1.473 0.71 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -176.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -64.81 -28.73 59.19 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.296 1.331 . . . . 0.0 111.901 177.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.526 ' CG ' HE22 ' A' ' 135' ' ' GLN . 14.8 t-20 -64.22 -39.74 94.61 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.637 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 94.5 t -63.28 -42.97 98.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.189 -0.459 . . . . 0.0 109.907 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.45 -39.89 94.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.014 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.636 ' NE ' ' HZ2' ' A' ' 239' ' ' LYS . 65.2 ttt180 -61.1 -42.19 98.06 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.13 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -62.24 -44.0 97.55 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.169 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -65.65 -45.95 81.03 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -178.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 10.0 tp -65.38 -46.28 90.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.423 ' O ' ' N ' ' A' ' 193' ' ' GLU . 29.6 m -60.83 -46.85 95.51 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 C-N-CA 119.837 -0.745 . . . . 0.0 111.648 -178.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . 0.486 ' ND2' ' OH ' ' A' ' 107' ' ' TYR . 19.6 t-20 -62.28 -43.46 98.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 122.169 0.985 . . . . 0.0 109.876 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' CYS . . . . . . . . . . . . . 28.2 t -62.7 -47.38 83.88 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 113.554 -1.657 . . . . 0.0 110.862 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -65.01 -41.19 95.58 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.253 177.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 0.423 ' N ' ' O ' ' A' ' 189' ' ' VAL . 48.1 mt-10 -61.37 -45.75 93.08 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 114.335 -1.302 . . . . 0.0 111.999 -178.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.56 -38.1 89.83 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 -176.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . 0.438 ' O ' ' CD2' ' A' ' 199' ' ' LEU . 72.1 t -63.44 -46.48 95.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 C-N-CA 117.648 -1.621 . . . . 0.0 107.603 178.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 19.2 m -64.35 -45.74 86.49 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -178.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -56.78 -38.69 72.86 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.487 1.115 . . . . 0.0 112.497 -177.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -55.48 -44.13 76.18 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.531 ' H ' ' CD2' ' A' ' 199' ' ' LEU . 2.5 mm? -61.24 -39.95 92.24 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 40.2 mt -63.86 -44.24 98.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-O 118.65 -0.691 . . . . 0.0 112.037 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -61.13 -41.04 96.01 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 120.415 1.462 . . . . 0.0 112.182 177.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -67.32 -37.63 83.63 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.235 -1.348 . . . . 0.0 111.061 -177.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 3.4 m -101.94 129.9 48.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.269 0.557 . . . . 0.0 111.939 -177.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 22.9 mt 68.12 4.97 4.36 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 114.384 -1.28 . . . . 0.0 113.082 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.74 44.12 2.53 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.202 0.525 . . . . 0.0 110.889 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.55 ' O ' ' CB ' ' A' ' 207' ' ' ALA . 56.8 pttt -88.03 49.67 1.84 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.835 -178.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.55 ' CB ' ' O ' ' A' ' 206' ' ' LYS . . . 119.96 17.83 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.155 0 O-C-N 124.494 1.121 . . . . 0.0 109.474 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' A' ' 207' ' ' ALA . 0.0 OUTLIER 77.57 116.33 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 102.31 -3.219 . . . . 0.0 102.31 -171.492 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 2.0 tt -95.48 86.6 4.52 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.965 0.412 . . . . 0.0 111.418 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' MET . . . . . 0.43 ' O ' ' OG1' ' A' ' 211' ' ' THR . 37.2 ttp -135.21 136.43 41.77 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.964 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 210' ' ' MET . 28.0 m -167.93 -66.53 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.501 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . 0.54 ' CG ' ' H ' ' A' ' 213' ' ' ASP . 19.7 t70 -169.44 -163.23 0.38 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.306 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.54 ' H ' ' CG ' ' A' ' 212' ' ' ASP . 6.6 p-10 41.46 65.82 0.78 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.03 0.443 . . . . 0.0 110.712 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.487 ' N ' ' CD ' ' A' ' 215' ' ' PRO . 1.9 mt -61.34 -43.42 89.55 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.263 -178.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.487 ' CD ' ' N ' ' A' ' 214' ' ' LEU . 33.5 Cg_exo -60.17 -32.58 94.69 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 121.602 1.534 . . . . 0.0 111.89 -178.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 97.7 m -64.08 -42.01 97.11 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 113.456 -1.702 . . . . 0.0 111.148 -179.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -66.34 -38.35 87.43 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.855 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -63.47 -46.92 84.0 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.285 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 32.7 p -59.97 -37.39 79.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 118.222 0.464 . . . . 0.0 110.785 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 14.0 t -59.29 -41.37 88.81 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.21 -41.49 99.14 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -177.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -61.46 -46.86 88.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 122.1 0.952 . . . . 0.0 112.59 -176.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -60.69 -41.79 99.1 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 107.725 -2.15 . . . . 0.0 107.725 176.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -62.7 -37.87 88.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.163 -1.018 . . . . 0.0 109.218 177.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -61.41 -41.91 99.65 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.993 -177.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -66.37 -38.16 86.92 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 119.316 -0.954 . . . . 0.0 108.574 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 96.4 m -63.03 -41.23 99.47 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.081 0.467 . . . . 0.0 110.306 177.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' A' ' 225' ' ' GLY . 60.4 p -61.85 -39.4 91.74 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.575 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 19.5 m -58.15 -39.22 78.25 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.72 -176.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 1.5 p -59.66 -40.19 81.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 118.709 -1.197 . . . . 0.0 108.442 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . 0.547 ' O ' ' HD2' ' A' ' 234' ' ' PRO . 26.7 mt -60.88 -40.23 84.59 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.449 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 177.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -61.95 -38.35 88.17 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 115.454 1.649 . . . . 0.0 115.454 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.466 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 0.9 OUTLIER -56.89 -39.65 79.44 Favored Pre-proline 0 N--CA 1.481 1.093 0 N-CA-C 116.276 1.954 . . . . 0.0 116.276 -172.972 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.547 ' HD2' ' O ' ' A' ' 231' ' ' ILE . 38.1 Cg_exo -59.06 -39.94 75.35 Favored 'Trans proline' 0 C--N 1.29 -2.54 0 C-N-CA 122.097 1.865 . . . . 0.0 114.246 -176.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.8 m -64.2 -37.62 80.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 118.435 -1.306 . . . . 0.0 111.369 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . 0.441 ' CG ' ' O ' ' A' ' 233' ' ' SER . 0.3 OUTLIER -66.28 -40.09 89.85 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 179.003 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 99.0 t -64.54 -44.97 96.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -175.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.454 ' CG2' HH21 ' A' ' 241' ' ' ARG . 10.0 p -62.91 -36.94 77.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 119.423 -0.911 . . . . 0.0 110.865 -178.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . 0.636 ' HZ2' ' NE ' ' A' ' 185' ' ' ARG . 3.9 mmmm -60.83 -43.79 97.8 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.06 -42.14 97.93 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 -176.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.48 ' O ' ' CB ' ' A' ' 242' ' ' TYR . 12.9 ptt180 -56.56 135.69 54.58 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 119.774 -0.77 . . . . 0.0 109.727 -178.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.516 ' O ' ' ND2' ' A' ' 244' ' ' ASN . 11.9 t80 153.48 -57.94 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 O-C-N 124.009 0.818 . . . . 0.0 110.834 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' MET . . . . . 0.572 ' SD ' ' NE2' ' A' ' 42' ' ' GLN . 4.7 ttt -52.21 114.95 1.49 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.344 0.593 . . . . 0.0 111.248 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 242' ' ' TYR . 22.6 p30 179.21 -7.12 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' SER . . . . . 0.626 ' OG ' ' CE2' ' A' ' 250' ' ' TYR . 54.0 m -119.05 152.62 36.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 112.661 -2.063 . . . . 0.0 113.157 -177.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . 0.465 ' CB ' ' O ' ' A' ' 245' ' ' SER . . . 157.12 -24.6 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.166 -1.379 . . . . 0.0 109.105 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 7.1 mt -137.86 101.02 4.33 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.271 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 139.81 -161.29 26.26 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 111.536 -0.625 . . . . 0.0 111.536 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.439 ' O ' ' O ' ' A' ' 250' ' ' TYR . 85.5 mm-40 -76.85 -103.34 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.626 ' CE2' ' OG ' ' A' ' 245' ' ' SER . 7.3 t80 57.0 98.67 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 119.111 -1.035 . . . . 0.0 108.934 178.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -65.22 -53.07 50.0 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 116.148 -2.221 . . . . 0.0 107.795 -178.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 2.8 m -151.17 -179.82 7.66 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.361 171.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.484 ' O ' ' SG ' ' A' ' 256' ' ' CYS . . . -67.49 -47.55 69.69 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 177.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -68.23 -43.48 79.75 Favored Glycine 0 N--CA 1.471 1.025 0 CA-C-N 124.051 3.114 . . . . 0.0 113.489 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -65.52 -31.98 73.33 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 111.894 -2.153 . . . . 0.0 111.093 -176.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' CYS . . . . . 0.63 ' SG ' ' N ' ' A' ' 257' ' ' ALA . 2.1 p -64.01 -43.53 95.35 Favored 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 172.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.63 ' N ' ' SG ' ' A' ' 256' ' ' CYS . . . -59.25 -43.95 92.39 Favored 'General case' 0 C--N 1.335 -0.059 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.064 -177.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 22.6 tp -65.25 -42.26 93.49 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 19.4 m -61.96 -43.78 98.13 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.891 -1.049 . . . . 0.0 109.555 177.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' MET . . . . . 0.575 ' O ' ' N ' ' A' ' 264' ' ' GLU . 0.0 OUTLIER -59.48 -40.87 88.36 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.074 -178.517 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 9.6 tp -59.81 -46.36 89.48 Favored 'General case' 0 C--N 1.32 -0.681 0 O-C-N 121.887 -0.508 . . . . 0.0 110.098 -177.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' ARG . . . . . 0.424 ' HG3' ' H ' ' A' ' 263' ' ' LYS . 9.4 ptm180 -66.36 -52.95 41.66 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 119.056 -1.058 . . . . 0.0 110.304 178.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . 0.424 ' H ' ' HG3' ' A' ' 262' ' ' ARG . 2.7 ptmm? -88.29 -55.45 3.73 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . 0.575 ' N ' ' O ' ' A' ' 260' ' ' MET . 25.0 mt-10 -90.25 102.16 14.88 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 119.673 1.124 . . . . 0.0 111.473 -179.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . 0.534 ' C ' ' H ' ' A' ' 267' ' ' ARG . . . -36.91 159.44 0.01 OUTLIER Glycine 0 CA--C 1.536 1.377 0 N-CA-C 111.424 -0.67 . . . . 0.0 111.424 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -56.96 1.13 0.16 Allowed 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 121.952 1.768 . . . . 0.0 112.412 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.534 ' H ' ' C ' ' A' ' 265' ' ' GLY . 20.8 mmt85 -69.12 -27.33 65.47 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 110.627 -0.138 . . . . 0.0 110.627 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -59.05 -32.63 69.93 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 119.615 -0.834 . . . . 0.0 109.626 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -62.58 -42.66 99.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.172 178.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -66.94 -36.88 83.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.845 -1.07 . . . . 0.0 112.73 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.428 ' O ' ' O ' ' A' ' 272' ' ' GLY . 98.3 mttt -75.1 174.61 9.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.317 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 271' ' ' LYS . . . 47.69 101.79 0.01 OUTLIER Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -164.65 7.35 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.167 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' MET . . . . . 0.49 ' N ' ' HD2' ' A' ' 275' ' ' PRO . 65.1 mtp -63.79 -44.67 80.39 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 274' ' ' MET . 34.6 Cg_endo -64.53 -46.34 7.42 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 120.969 1.113 . . . . 0.0 112.554 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 17.4 t -60.7 -40.65 93.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.062 0.458 . . . . 0.0 111.044 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -62.05 -42.5 99.25 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 123.668 1.699 . . . . 0.0 110.445 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 7.2 mp -62.52 -38.29 89.39 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 110.288 -3.142 . . . . 0.0 108.192 174.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 17.5 tpt85 -62.62 -40.96 98.64 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.605 0.717 . . . . 0.0 110.613 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 9.7 mt -62.29 -36.15 81.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.586 -1.188 . . . . 0.0 112.834 -177.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -67.78 -50.73 39.85 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -178.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 78.0 p -62.88 -44.7 95.39 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.164 0.507 . . . . 0.0 109.817 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' TRP . . . . . . . . . . . . . 37.8 t90 -61.32 -39.02 88.98 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.743 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -62.86 -39.73 95.31 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -178.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 9.5 m -61.12 -37.37 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.337 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 96.9 t -61.83 -40.52 87.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 29.5 ttp -60.99 -39.18 88.68 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.453 0.645 . . . . 0.0 109.472 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -58.87 -39.52 81.62 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.906 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.16 -38.31 76.63 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -176.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -62.65 -40.19 96.25 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 119.137 -1.025 . . . . 0.0 108.642 177.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -61.23 -39.07 88.94 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 176.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -58.57 -40.59 83.53 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 117.748 -1.581 . . . . 0.0 109.737 -176.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' GLN . . . . . 0.445 ' O ' ' O ' ' A' ' 296' ' ' ARG . 21.9 mm100 -60.43 -42.86 96.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 122.506 1.146 . . . . 0.0 110.944 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 10.5 mt -60.2 -40.76 91.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 113.029 -1.896 . . . . 0.0 109.305 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 21.8 mtpt -63.24 -45.82 89.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.271 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' ARG . . . . . 0.445 ' O ' ' O ' ' A' ' 293' ' ' GLN . 80.6 mtm180 -123.02 116.51 23.65 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.443 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -117.22 -94.68 0.49 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.3 0.571 . . . . 0.0 110.862 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.98 -166.45 1.87 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.032 178.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 5.7 ptm -171.57 66.48 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.343 -0.543 . . . . 0.0 111.747 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.53 101.12 0.07 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.983 0.897 . . . . 0.0 110.343 -178.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -64.14 -46.23 85.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 113.789 -1.55 . . . . 0.0 113.436 -176.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -58.96 -40.06 83.56 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.177 -0.609 . . . . 0.0 109.613 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . 0.473 ' CD ' ' N ' ' A' ' 13' ' ' MET . 14.9 tt0 -64.83 -46.66 81.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.689 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' SER . . . . . 0.435 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 75.9 p -66.66 -37.37 84.65 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.882 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -61.55 -43.14 99.41 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -65.21 -36.73 85.07 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -177.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -59.92 -52.88 70.51 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -176.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' PRO . . . . . 0.435 ' CD ' ' O ' ' A' ' 304' ' ' SER . 74.4 Cg_endo -75.26 0.37 9.09 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.048 1.832 . . . . 0.0 111.874 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 82.3 t80 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.614 179.925 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.569 ' N ' ' SD ' ' A' ' 13' ' ' MET . 4.6 mpp? . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.1 t -177.08 69.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.84 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.4 ' CG1' ' N ' ' A' ' 16' ' ' LYS . 42.1 t -135.8 164.33 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 121.031 0.443 . . . . 0.0 110.302 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.4 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 14.2 ptpt -64.52 -41.68 96.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.434 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.535 ' CE2' ' NH1' ' A' ' 96' ' ' ARG . 32.4 t80 -63.41 -41.89 98.73 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -178.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.2 pp -80.1 -25.59 39.92 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.185 0.517 . . . . 0.0 112.351 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.452 ' O ' ' OG1' ' A' ' 22' ' ' THR . . . -66.14 -41.21 95.09 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 107.667 -2.173 . . . . 0.0 107.667 177.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.5 -32.07 67.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 124.787 2.232 . . . . 0.0 107.193 176.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.6 -42.43 98.81 Favored Glycine 0 CA--C 1.527 0.837 1 CA-C-N 108.389 -4.005 . . . . 0.0 108.19 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' A' ' 19' ' ' GLY . 22.4 p -70.65 -27.74 64.27 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.48 -50.02 64.66 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.814 -179.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.94 -36.06 80.27 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 118.161 -1.416 . . . . 0.0 110.931 -177.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.2 t -63.99 -53.87 43.38 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.616 -0.433 . . . . 0.0 111.326 -179.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.1 tp -65.82 -39.75 85.68 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -177.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.408 ' O ' ' CG2' ' A' ' 31' ' ' THR . . . -63.9 -41.93 97.57 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 119.736 -0.786 . . . . 0.0 112.924 -173.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -77.69 -27.24 50.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 120.439 1.472 . . . . 0.0 109.886 -176.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.0 tp -59.86 -55.71 30.84 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 119.802 1.183 . . . . 0.0 112.553 -178.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.4 tp -75.75 -4.63 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.408 ' CG2' ' O ' ' A' ' 27' ' ' ALA . 28.3 p -109.84 -17.27 13.69 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 118.7 -1.2 . . . . 0.0 110.41 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.414 ' N ' ' CD ' ' A' ' 33' ' ' PRO . 66.3 t80 -67.86 -43.65 38.53 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 122.461 2.391 . . . . 0.0 110.583 -178.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 32' ' ' PHE . 37.6 Cg_exo -58.94 -15.32 26.72 Favored 'Trans proline' 0 N--CA 1.503 2.06 0 C-N-CA 121.343 1.362 . . . . 0.0 112.341 178.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.466 ' CD1' HH21 ' A' ' 279' ' ' ARG . 88.8 mt -67.15 -34.43 77.55 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -178.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -64.09 -40.64 96.67 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -177.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 75.7 p -58.29 -34.79 70.93 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.04 -38.91 86.7 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -178.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.496 ' NZ ' ' CB ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -61.17 -47.06 87.91 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 119.378 -0.929 . . . . 0.0 111.723 -176.173 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 95.0 t -62.39 -38.06 80.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 O-C-N 122.287 -0.258 . . . . 0.0 111.264 -178.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.507 ' C ' ' H ' ' A' ' 42' ' ' GLN . 25.9 mmt180 -59.58 -40.16 86.47 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.367 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 84.2 mt -61.19 38.93 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.507 ' H ' ' C ' ' A' ' 40' ' ' ARG . 2.7 pt20 -172.29 55.32 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 O-C-N 122.074 -0.391 . . . . 0.0 110.739 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.428 ' CG1' ' H ' ' A' ' 44' ' ' GLN . 0.1 OUTLIER 26.68 -117.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.959 179.622 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.428 ' H ' ' CG1' ' A' ' 43' ' ' ILE . 95.9 mm-40 -129.89 102.51 6.33 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.366 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -81.47 73.6 2.58 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -156.56 163.62 39.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.878 0.37 . . . . 0.0 110.45 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 63.6 p -82.18 67.21 8.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.645 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.642 HE21 ' N ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -118.34 -47.39 2.56 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.825 179.805 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.02 13.09 81.76 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -177.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.642 ' N ' HE21 ' A' ' 48' ' ' GLN . 0.2 OUTLIER -65.82 -38.12 88.07 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.435 0.636 . . . . 0.0 109.319 178.978 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.415 ' O ' ' O ' ' A' ' 54' ' ' ALA . 12.5 p -60.24 -44.5 95.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.859 -178.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 52.5 ttp180 -64.31 -33.59 76.19 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.183 -0.607 . . . . 0.0 109.474 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 95.8 m -67.71 -38.21 83.32 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.415 ' O ' ' O ' ' A' ' 51' ' ' VAL . . . -89.76 124.52 34.71 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.706 179.107 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -87.62 -7.08 57.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.949 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.462 ' C ' ' H ' ' A' ' 58' ' ' GLN . 88.1 p -174.43 -125.89 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 65.27 -19.72 0.09 Allowed 'General case' 0 N--CA 1.461 0.092 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 176.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.462 ' H ' ' C ' ' A' ' 56' ' ' SER . 7.6 mm100 -126.01 38.76 4.08 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 177.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.427 ' O ' ' O ' ' A' ' 58' ' ' GLN . 75.2 m-85 -37.53 -98.37 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.132 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.428 ' O ' ' C ' ' A' ' 61' ' ' GLY . 34.4 ttm180 -154.51 -31.63 0.11 Allowed 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.442 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 60' ' ' ARG . . . -29.03 102.27 0.01 OUTLIER Glycine 0 C--N 1.34 0.774 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.914 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.1 t -66.77 -34.46 70.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 118.31 -0.852 . . . . 0.0 109.14 176.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.7 tp -60.93 -33.01 72.5 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 121.495 1.952 . . . . 0.0 111.365 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -65.05 -49.43 62.42 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 115.223 0.849 . . . . 0.0 115.223 -176.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -45.57 92.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.958 -0.621 . . . . 0.0 111.714 -179.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 66' ' ' ILE . 94.5 mt -59.66 -36.37 65.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -179.081 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.92 -36.41 83.86 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 120.561 1.528 . . . . 0.0 111.343 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.473 ' O ' ' OG1' ' A' ' 72' ' ' THR . 98.3 m -62.52 -39.35 93.24 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 113.215 -1.812 . . . . 0.0 111.084 -176.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 28.7 ttt -60.52 -39.46 87.9 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -177.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.8 t -68.92 -40.38 81.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 119.473 -0.891 . . . . 0.0 112.851 -177.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -77.71 -13.25 59.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.679 0.752 . . . . 0.0 112.947 -178.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' A' ' 68' ' ' THR . 16.1 m -62.96 -55.06 29.15 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.947 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 31.9 mp0 -108.39 -58.85 1.94 Allowed 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.438 ' O ' ' OG ' ' A' ' 77' ' ' SER . . . 158.75 164.54 14.45 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -56.49 -35.14 96.39 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.762 1.642 . . . . 0.0 111.546 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.428 ' O ' ' OD1' ' A' ' 80' ' ' ASN . 48.4 ttm-85 -60.97 -11.01 6.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 122.211 1.005 . . . . 0.0 111.003 176.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.531 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 36.2 p -77.59 -32.19 53.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 113.285 -1.779 . . . . 0.0 110.205 -179.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 85.7 mt -74.8 -28.93 60.92 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.486 1.114 . . . . 0.0 111.477 178.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -86.64 -2.45 58.52 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 122.678 1.228 . . . . 0.0 113.041 -172.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.531 ' ND2' ' O ' ' A' ' 77' ' ' SER . 0.4 OUTLIER -116.33 138.23 51.5 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 112.376 -2.193 . . . . 0.0 108.542 176.847 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.8 -28.09 17.37 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -178.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 69.5 mt -59.34 -34.87 72.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.148 -1.026 . . . . 0.0 110.573 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.3 t -70.85 -27.47 30.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.293 -0.867 . . . . 0.0 108.969 178.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.01 -31.93 61.5 Favored 'General case' 0 C--O 1.226 -0.15 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.331 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.64 -40.33 90.42 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 119.463 -1.351 . . . . 0.0 110.802 -178.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.5 tp -62.22 -40.27 95.56 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 122.343 1.068 . . . . 0.0 113.243 -176.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -60.17 -27.04 66.78 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 113.285 -1.78 . . . . 0.0 109.307 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.584 HH22 HE21 ' A' ' 145' ' ' GLN . 77.0 mtt180 -57.93 -53.41 58.59 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 172.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 11.5 tm0? -67.65 -30.65 70.26 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 112.061 -2.336 . . . . 0.0 113.794 -177.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 2.7 ptm -61.72 -40.09 93.83 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.925 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.5 m -74.1 -34.31 63.91 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 119.191 -1.004 . . . . 0.0 111.048 -176.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -58.0 -43.92 86.94 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 120.899 1.681 . . . . 0.0 112.416 -176.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.1 -33.07 65.36 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.921 -177.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 85.9 p -63.69 -40.74 97.56 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.454 ' C ' ' H ' ' A' ' 97' ' ' ILE . 18.7 m -67.89 -28.77 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.535 ' NH1' ' CE2' ' A' ' 17' ' ' PHE . 5.0 ptm180 -77.61 12.0 1.82 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -177.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.454 ' H ' ' C ' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -86.63 -15.35 9.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 179.07 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.503 ' O ' ' OD1' ' A' ' 101' ' ' ASP . . . -140.26 -47.84 0.06 OUTLIER Glycine 0 CA--C 1.536 1.344 0 CA-C-N 114.265 -1.334 . . . . 0.0 114.553 -177.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.4 tp -71.65 -13.52 61.77 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 119.453 1.626 . . . . 0.0 113.443 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -81.18 -52.16 7.66 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 114.595 -1.184 . . . . 0.0 112.189 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.579 ' O ' ' HG3' ' A' ' 105' ' ' GLN . 41.5 p-10 -70.15 -32.47 70.47 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 124.061 1.886 . . . . 0.0 110.591 -179.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.524 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 28.7 t -67.49 -50.74 57.6 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 109.695 -3.411 . . . . 0.0 111.936 176.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -73.25 -26.42 22.58 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.185 0 CA-C-N 121.446 1.93 . . . . 0.0 111.492 178.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -69.29 -41.44 76.8 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 112.524 -2.126 . . . . 0.0 110.955 178.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.579 ' HG3' ' O ' ' A' ' 101' ' ' ASP . 88.1 mt-30 -76.64 -16.98 59.41 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.591 0.71 . . . . 0.0 111.073 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -79.33 -22.95 43.83 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.17 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -109.34 -29.35 8.5 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 119.669 1.122 . . . . 0.0 112.855 -174.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 59.3 p -95.99 9.42 40.79 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 117.07 -1.852 . . . . 0.0 113.208 -176.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.0 mmmt -47.55 122.64 4.96 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.258 0.935 . . . . 0.0 108.661 176.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -119.29 85.83 0.39 Allowed Glycine 0 N--CA 1.476 1.33 0 CA-C-N 120.216 1.371 . . . . 0.0 111.624 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 34.3 t -94.55 -61.37 1.52 Allowed 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 -176.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -123.29 -176.83 3.53 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 112.749 -2.023 . . . . 0.0 111.971 -177.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.501 ' O ' ' ND1' ' A' ' 113' ' ' HIS . 0.0 OUTLIER -91.25 72.5 6.21 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -178.51 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.468 ' CB ' ' O ' ' A' ' 113' ' ' HIS . . . 159.77 -162.96 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 176.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.22 15.27 26.17 Favored Glycine 0 C--N 1.343 0.958 0 CA-C-N 114.471 -1.241 . . . . 0.0 113.15 177.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 15.0 tt -60.87 -40.29 84.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 118.053 0.927 . . . . 0.0 110.215 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.1 -39.68 96.44 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-O 122.029 0.794 . . . . 0.0 111.837 176.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 36.2 m -57.2 -41.68 79.85 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -63.2 -36.71 84.53 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.181 -0.607 . . . . 0.0 111.509 -178.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.44 ' CD1' ' C ' ' A' ' 120' ' ' LEU . 0.1 OUTLIER -63.91 -45.78 87.77 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.087 0.47 . . . . 0.0 110.407 178.387 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.9 tp -65.7 -44.05 87.3 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 119.405 -0.918 . . . . 0.0 109.821 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.69 -44.38 96.38 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 118.922 0.783 . . . . 0.0 110.496 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -65.72 -44.23 92.76 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 119.561 -1.304 . . . . 0.0 112.021 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 10.9 t -64.15 -44.76 91.16 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 119.985 -0.686 . . . . 0.0 111.631 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 21.3 m -69.73 -48.89 57.85 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 119.07 -1.052 . . . . 0.0 112.194 177.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 24.5 m -65.49 -42.81 91.78 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 -174.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -64.22 -44.65 95.3 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-O 122.802 1.223 . . . . 0.0 113.342 -177.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.426 ' O ' ' CG2' ' A' ' 131' ' ' VAL . . . -60.96 -41.31 96.09 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 112.073 -2.063 . . . . 0.0 107.075 177.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -64.3 -42.02 96.57 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.438 178.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.18 -39.86 95.85 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -177.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.426 ' CG2' ' O ' ' A' ' 128' ' ' ALA . 7.0 m -61.15 -25.76 37.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 122.753 1.264 . . . . 0.0 109.544 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -58.55 -44.94 89.83 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 112.364 -2.198 . . . . 0.0 111.673 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.0 p -79.07 -48.82 20.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -102.73 129.15 49.27 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.826 0.346 . . . . 0.0 111.122 -179.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.571 ' H ' ' CD ' ' A' ' 136' ' ' PRO . 8.1 tp-100 -173.15 -38.5 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.25 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.934 179.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.571 ' CD ' ' H ' ' A' ' 135' ' ' GLN . 63.3 Cg_exo -52.88 -34.17 64.77 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.467 1.444 . . . . 0.0 112.002 -179.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 11.2 m -68.35 -42.92 78.55 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 118.082 -1.447 . . . . 0.0 110.919 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -66.91 -43.97 82.0 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 118.26 -1.376 . . . . 0.0 112.853 -178.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.6 m -64.96 -44.6 96.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -179.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.6 p -65.33 -38.69 83.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -177.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -62.16 -41.08 97.96 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -176.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.449 ' CG1' ' N ' ' A' ' 143' ' ' ARG . 2.4 p -70.39 -44.78 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.072 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.52 ' NH2' ' O ' ' A' ' 175' ' ' LEU . 81.5 mtt85 -64.26 -36.28 83.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.468 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -66.42 -41.23 89.52 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.769 -0.373 . . . . 0.0 111.572 -177.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.584 HE21 HH22 ' A' ' 88' ' ' ARG . 76.5 mm-40 -64.92 -39.56 93.7 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 119.526 -0.87 . . . . 0.0 109.083 178.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.31 -34.84 79.28 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -179.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -60.27 110.47 1.24 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 176.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -100.91 -58.26 1.93 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 117.226 -1.368 . . . . 0.0 113.836 -176.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.528 ' O ' ' N ' ' A' ' 151' ' ' GLY . 28.9 ptt-85 -133.66 17.67 3.92 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 122.641 2.473 . . . . 0.0 110.03 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . 49.95 -86.5 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.724 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 149' ' ' ARG . . . -157.28 42.56 0.53 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 64.3 23.99 68.68 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -60.1 126.01 40.43 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 76.4 mtm-85 -62.21 -44.37 96.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.949 0.404 . . . . 0.0 110.145 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -85.4 130.69 34.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.216 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -64.64 132.43 49.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.662 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -80.39 -164.68 0.73 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.545 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 56.7 m -156.97 -178.1 7.12 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.156 0.503 . . . . 0.0 110.843 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 98.7 m -64.25 -46.31 84.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.983 -177.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 34.0 m -64.35 -45.36 96.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 118.946 -1.102 . . . . 0.0 109.239 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -67.36 -39.27 85.69 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.665 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -61.68 -45.99 91.65 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -177.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -62.73 -49.66 74.16 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.422 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -68.36 -45.41 72.87 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 -175.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.441 ' CG2' ' N ' ' A' ' 166' ' ' ILE . 14.1 t -62.82 -44.88 94.99 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.519 1.054 . . . . 0.0 113.689 -177.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.441 ' N ' ' CG2' ' A' ' 165' ' ' THR . 2.5 pp -64.84 -38.3 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 121.906 0.86 . . . . 0.0 109.337 176.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.25 -35.6 73.97 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 113.992 -1.458 . . . . 0.0 107.788 176.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.6 -49.78 75.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 122.401 2.364 . . . . 0.0 111.449 -175.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -74.57 -50.99 15.86 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 123.446 0.698 . . . . 0.0 109.63 177.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.487 ' CD ' ' N ' ' A' ' 170' ' ' GLU . 2.2 mp0 -77.98 -36.6 48.76 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 116.637 2.088 . . . . 0.0 116.637 -173.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 91.49 -167.23 31.03 Favored Glycine 0 N--CA 1.47 0.935 0 CA-C-N 118.842 0.746 . . . . 0.0 112.007 177.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.466 ' CG2' ' N ' ' A' ' 173' ' ' ARG . 19.8 tt -73.45 -42.55 56.5 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.07 0 CA-C-O 121.963 0.887 . . . . 0.0 110.885 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.466 ' N ' ' CG2' ' A' ' 172' ' ' ILE . 3.9 tpt180 -58.79 -33.49 70.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 113.993 -1.458 . . . . 0.0 111.261 -176.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -60.7 -40.24 97.76 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 118.965 -1.588 . . . . 0.0 110.006 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.52 ' O ' ' NH2' ' A' ' 143' ' ' ARG . 3.7 mm? -70.61 -33.27 70.86 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 111.673 -2.264 . . . . 0.0 116.922 -177.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 19.5 m0 -78.06 -7.65 57.2 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 112.076 -2.329 . . . . 0.0 109.845 -177.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -43.22 -47.97 6.49 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.405 -176.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.482 ' H ' HH22 ' A' ' 143' ' ' ARG . . . -91.9 -32.06 8.79 Favored Glycine 0 CA--C 1.533 1.217 0 N-CA-C 111.329 -0.708 . . . . 0.0 111.329 178.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 34.8 m -45.36 -51.52 11.09 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.412 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 2.8 m -62.47 -50.8 77.21 Favored Pre-proline 0 N--CA 1.471 0.581 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -176.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.412 ' HD2' ' N ' ' A' ' 180' ' ' SER . 28.2 Cg_endo -64.84 -28.38 59.08 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 121.482 1.455 . . . . 0.0 111.782 176.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.528 ' ND2' ' OE1' ' A' ' 135' ' ' GLN . 45.5 t30 -63.92 -39.53 94.38 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.454 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 70.9 t -63.09 -42.59 97.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.14 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.2 -39.49 92.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.048 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.627 ' HE ' ' NZ ' ' A' ' 239' ' ' LYS . 33.0 ttm105 -60.59 -41.67 95.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.842 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -61.34 -42.92 99.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.063 0.459 . . . . 0.0 110.805 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.44 -43.82 93.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.092 -179.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 33.0 mm -63.56 -45.25 98.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -177.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.46 ' O ' ' N ' ' A' ' 193' ' ' GLU . 3.0 p -60.09 -46.79 93.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 119.679 -0.808 . . . . 0.0 112.027 -177.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 191' ' ' CYS . 2.6 p30 -63.13 -42.64 99.55 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 122.089 0.947 . . . . 0.0 109.983 179.103 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' CYS . . . . . 0.524 ' N ' ' OD1' ' A' ' 190' ' ' ASN . 27.2 m -61.2 -45.66 93.69 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 113.94 -1.482 . . . . 0.0 109.317 179.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -63.76 -39.56 94.56 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 112.99 -1.913 . . . . 0.0 108.638 175.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 0.46 ' N ' ' O ' ' A' ' 189' ' ' VAL . 74.6 tt0 -61.33 -46.96 88.07 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.868 -177.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 53.4 mt -65.15 -39.26 92.75 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 118.547 -1.261 . . . . 0.0 110.493 -175.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 7.0 m -63.97 -45.74 95.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 C-N-CA 117.078 -1.849 . . . . 0.0 107.297 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 19.9 m -63.75 -45.7 88.64 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -178.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -56.49 -38.34 71.62 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.296 1.038 . . . . 0.0 112.29 -178.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.44 -44.0 75.91 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.473 ' CD2' ' N ' ' A' ' 199' ' ' LEU . 2.9 mm? -61.18 -39.15 89.1 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 41.3 mm -62.78 -42.99 98.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.029 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -60.24 -39.55 87.13 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.758 1.223 . . . . 0.0 111.852 177.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -63.06 -38.53 91.56 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.119 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 35.9 m -101.56 128.19 47.93 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.855 0.835 . . . . 0.0 111.987 -179.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 3.7 tp 66.84 4.73 3.61 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 114.186 -1.37 . . . . 0.0 112.147 177.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -125.55 29.93 5.88 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.35 0.595 . . . . 0.0 112.487 -177.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -71.55 -24.65 61.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.806 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.547 ' O ' ' O ' ' A' ' 208' ' ' ASN . . . -165.05 33.04 0.06 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.362 179.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . 0.547 ' O ' ' O ' ' A' ' 207' ' ' ALA . 1.6 m-20 40.0 123.22 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 177.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.501 ' C ' ' O ' ' A' ' 208' ' ' ASN . 43.4 tp -1.28 106.32 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 115.015 -0.993 . . . . 0.0 112.559 179.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 5.4 tpt -143.37 25.69 1.68 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.706 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 69.2 p -123.12 -133.21 0.28 Allowed 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.542 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 25.2 p-10 -160.53 -140.47 0.07 Allowed 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.946 -0.301 . . . . 0.0 111.033 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.407 ' O ' ' OD1' ' A' ' 213' ' ' ASP . 2.5 p30 41.74 72.22 0.18 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.078 0.466 . . . . 0.0 110.514 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.436 ' N ' ' CD ' ' A' ' 215' ' ' PRO . 6.0 mt -61.41 -43.27 88.71 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 113.118 0.785 . . . . 0.0 113.118 -178.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 214' ' ' LEU . 27.1 Cg_exo -60.74 -33.73 92.69 Favored 'Trans proline' 0 N--CA 1.5 1.884 0 CA-C-N 120.051 1.054 . . . . 0.0 111.555 -177.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 84.1 m -64.01 -41.79 97.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 112.767 -2.015 . . . . 0.0 111.213 -178.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -66.18 -37.08 84.76 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.241 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -62.96 -47.41 83.31 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.252 -178.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 1.4 t -60.58 -37.94 82.97 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 119.395 0.998 . . . . 0.0 110.87 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 71.1 m -59.68 -41.89 91.71 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.9 -41.94 97.57 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -62.39 -47.5 83.86 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 119.755 -0.778 . . . . 0.0 112.953 -176.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -61.27 -42.48 99.79 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 108.199 -1.961 . . . . 0.0 108.199 177.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . 0.495 ' O ' ' SG ' ' A' ' 227' ' ' CYS . . . -63.25 -39.14 93.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.497 -0.851 . . . . 0.0 109.02 177.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -62.93 -43.05 99.49 Favored Glycine 0 CA--C 1.52 0.354 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.607 -178.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' PHE . . . . . 0.442 ' O ' ' OG1' ' A' ' 229' ' ' THR . 75.3 t80 -66.91 -38.95 87.19 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 119.659 -0.816 . . . . 0.0 108.855 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 224' ' ' ALA . 0.5 OUTLIER -63.41 -41.06 98.71 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 176.847 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' THR . . . . . 0.466 ' N ' ' SG ' ' A' ' 227' ' ' CYS . 26.8 m -62.7 -41.54 99.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.839 179.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' A' ' 226' ' ' PHE . 16.1 p -59.99 -40.32 88.75 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -176.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 3.3 m -60.66 -40.27 84.2 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.381 0 C-N-CA 118.455 -1.298 . . . . 0.0 108.953 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . 0.459 ' O ' ' HD2' ' A' ' 234' ' ' PRO . 1.7 mp -61.0 -40.85 86.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 176.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.01 -39.98 96.39 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.48 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 0.5 OUTLIER -58.47 -42.18 93.2 Favored Pre-proline 0 N--CA 1.483 1.214 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 -173.858 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 233' ' ' SER . 31.3 Cg_exo -57.97 -39.75 83.64 Favored 'Trans proline' 0 C--N 1.293 -2.378 0 C-N-CA 122.536 2.157 . . . . 0.0 113.276 179.081 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 46.5 t -63.95 -37.26 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 118.055 -1.458 . . . . 0.0 108.922 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -65.88 -40.62 91.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.75 178.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 53.2 t -64.79 -45.51 94.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -176.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 27.6 m -63.41 -37.78 80.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 119.224 -0.991 . . . . 0.0 111.732 -178.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . 0.627 ' NZ ' ' HE ' ' A' ' 185' ' ' ARG . 25.0 mtpp -60.98 -45.08 96.21 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -179.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' THR . . . . . 0.412 ' O ' ' C ' ' A' ' 241' ' ' ARG . 1.1 t -61.88 -41.92 98.46 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -178.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.412 ' C ' ' O ' ' A' ' 240' ' ' THR . 27.0 mtp180 -33.51 140.62 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.222 0.534 . . . . 0.0 112.438 -178.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.43 ' O ' ' C ' ' A' ' 243' ' ' MET . 33.7 t80 -130.71 -78.67 0.53 Allowed 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 177.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' MET . . . . . 0.43 ' C ' ' O ' ' A' ' 242' ' ' TYR . 7.1 ptp -30.92 113.58 0.11 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.969 0.414 . . . . 0.0 111.515 -179.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . 0.42 ' N ' HD21 ' A' ' 244' ' ' ASN . 0.1 OUTLIER -151.83 17.54 0.68 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.085 -179.529 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 49.0 p 42.96 67.24 0.65 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.751 0.31 . . . . 0.0 110.547 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -94.18 -99.98 0.15 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.291 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 43.9 mt 62.64 78.73 0.28 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.074 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 96.43 -6.69 65.77 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 111.977 -0.449 . . . . 0.0 111.977 179.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.809 ' HB3' ' HE2' ' A' ' 255' ' ' HIS . 52.9 mt-30 -131.67 107.98 9.18 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.477 ' CD1' ' N ' ' A' ' 250' ' ' TYR . 0.0 OUTLIER -176.27 53.22 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.845 -178.94 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -66.49 -53.25 37.21 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 115.929 1.825 . . . . 0.0 115.929 -175.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 12.4 p -148.56 -173.32 4.31 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -178.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -59.87 -44.21 94.29 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 178.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -57.29 -36.13 74.37 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -174.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' HIS . . . . . 0.809 ' HE2' ' HB3' ' A' ' 249' ' ' GLN . 86.4 t60 -55.59 -36.23 66.69 Favored 'General case' 0 CA--C 1.509 -0.599 0 C-N-CA 117.338 -1.745 . . . . 0.0 111.082 178.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' CYS . . . . . . . . . . . . . 11.7 t -61.87 -45.37 94.08 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.678 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -60.55 -45.22 94.68 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.767 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 11.8 tp -66.53 -43.01 86.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.151 0.501 . . . . 0.0 109.871 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 85.8 m -62.43 -46.28 89.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.868 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' MET . . . . . 0.447 ' SD ' ' C ' ' A' ' 260' ' ' MET . 13.6 tmm? -61.62 -45.04 95.76 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -177.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.17 -47.5 82.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.102 0.477 . . . . 0.0 110.26 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' ARG . . . . . 0.463 ' O ' ' O ' ' A' ' 263' ' ' LYS . 61.5 ttt85 -66.66 -53.84 29.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.463 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 262' ' ' ARG . 28.0 tttp -57.81 -138.99 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.9 0.381 . . . . 0.0 111.369 -178.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -63.91 149.52 46.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.997 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . 0.602 ' C ' ' H ' ' A' ' 267' ' ' ARG . . . -44.04 160.19 0.1 OUTLIER Glycine 0 CA--C 1.535 1.283 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -50.85 0.07 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 122.018 1.812 . . . . 0.0 112.945 178.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.602 ' H ' ' C ' ' A' ' 265' ' ' GLY . 89.4 mtt-85 -69.5 -26.95 64.79 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 122.696 0.398 . . . . 0.0 111.817 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -58.83 -32.63 69.57 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.404 -178.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -62.51 -41.55 98.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.376 0.608 . . . . 0.0 110.89 178.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -66.05 -37.46 85.91 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.284 -178.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.434 ' O ' ' O ' ' A' ' 272' ' ' GLY . 95.8 mttt -80.65 -179.72 7.37 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . 0.434 ' O ' ' O ' ' A' ' 271' ' ' LYS . . . 52.3 109.29 0.01 OUTLIER Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.694 -0.563 . . . . 0.0 111.694 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -178.31 8.27 0.01 OUTLIER 'General case' 0 C--O 1.232 0.151 0 C-N-CA 121.166 -0.214 . . . . 0.0 111.325 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' MET . . . . . 0.549 ' N ' ' CD ' ' A' ' 275' ' ' PRO . 0.1 OUTLIER -63.91 -44.53 79.11 Favored Pre-proline 0 CA--C 1.533 0.291 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.898 -179.148 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' PRO . . . . . 0.549 ' CD ' ' N ' ' A' ' 274' ' ' MET . 22.1 Cg_exo -64.46 -46.86 6.58 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 122.353 2.035 . . . . 0.0 111.471 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 49.2 m -60.78 -39.71 89.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.749 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . 0.403 ' CD1' ' C ' ' A' ' 277' ' ' PHE . 41.0 t80 -61.64 -42.67 99.21 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 122.738 1.256 . . . . 0.0 112.969 -178.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.29 -38.78 90.65 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 112.11 -2.314 . . . . 0.0 107.815 174.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . 0.466 HH21 ' CD1' ' A' ' 34' ' ' LEU . 4.4 mtp180 -62.81 -39.71 95.14 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.375 0.607 . . . . 0.0 110.283 178.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -62.07 -36.55 82.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.508 -178.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -68.08 -51.2 35.06 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -178.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 74.8 m -63.0 -44.36 96.24 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 123.109 0.564 . . . . 0.0 109.91 179.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' TRP . . . . . . . . . . . . . 48.7 t-105 -59.7 -38.36 81.39 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -62.2 -37.37 85.06 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.363 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -59.88 -37.73 73.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.143 -178.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -61.61 -40.28 86.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.724 -179.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 30.9 mtm -60.95 -38.85 87.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.098 0.475 . . . . 0.0 110.453 178.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -58.69 -40.13 82.7 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.83 -178.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.434 ' O ' ' CG ' ' A' ' 292' ' ' GLU . 1.0 OUTLIER -60.31 -38.91 79.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 120.981 0.419 . . . . 0.0 110.91 -177.576 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 12.5 m -64.27 -40.04 95.17 Favored 'General case' 0 CA--C 1.549 0.925 0 O-C-N 121.574 -0.704 . . . . 0.0 111.729 177.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -61.01 -40.4 93.39 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-O 118.652 -0.69 . . . . 0.0 109.165 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . 0.434 ' CG ' ' O ' ' A' ' 289' ' ' VAL . 4.4 pt-20 -59.39 -39.42 83.33 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 116.552 -2.059 . . . . 0.0 109.781 -176.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' GLN . . . . . 0.471 ' O ' ' O ' ' A' ' 296' ' ' ARG . 57.4 tt0 -59.51 -42.83 93.11 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 122.38 1.086 . . . . 0.0 111.306 -178.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -60.52 -40.74 92.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 113.61 -1.632 . . . . 0.0 108.574 178.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -63.22 -45.97 89.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.263 178.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' ARG . . . . . 0.471 ' O ' ' O ' ' A' ' 293' ' ' GLN . 11.9 tpp85 -123.03 116.25 23.21 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -121.01 -163.38 1.02 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.236 0.541 . . . . 0.0 112.413 -178.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.526 ' CD2' ' N ' ' A' ' 298' ' ' LEU . 3.2 mm? -67.21 116.94 8.56 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 26.4 ttm -96.77 62.64 1.94 Allowed 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -178.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.65 100.84 0.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.976 0.893 . . . . 0.0 110.834 -178.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -64.1 -46.4 84.39 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 113.746 -1.57 . . . . 0.0 113.434 -176.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -58.6 -39.67 81.07 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.39 -0.524 . . . . 0.0 109.897 -178.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -64.9 -46.77 80.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.871 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 304' ' ' SER . . . . . 0.445 ' HG ' ' NH1' ' A' ' 305' ' ' ARG . 78.0 p -66.66 -38.04 86.04 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.711 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 305' ' ' ARG . . . . . 0.445 ' NH1' ' HG ' ' A' ' 304' ' ' SER . 0.0 OUTLIER -62.04 -42.73 99.49 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.544 179.354 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 12.7 tm-20 -64.74 -37.12 86.53 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -177.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -60.01 -52.94 69.96 Favored Pre-proline 0 CA--C 1.544 0.716 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -176.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 308' ' ' PRO . . . . . 0.426 ' CD ' ' O ' ' A' ' 304' ' ' SER . 74.5 Cg_endo -75.36 0.32 9.18 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.255 1.97 . . . . 0.0 112.106 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 78.7 t80 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.519 -179.895 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.6 ptm . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.3 m -64.91 129.18 38.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.818 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.479 ' CG2' ' N ' ' A' ' 16' ' ' LYS . 4.3 p -160.67 166.53 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.235 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.479 ' N ' ' CG2' ' A' ' 15' ' ' VAL . 30.2 mmtp -64.38 -41.65 96.58 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -178.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -63.54 -41.15 98.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.228 0.537 . . . . 0.0 112.438 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.418 ' H ' HG11 ' A' ' 15' ' ' VAL . 9.8 tp -79.78 -25.96 40.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.276 -0.874 . . . . 0.0 112.617 -178.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.32 -41.41 94.6 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 107.768 -2.133 . . . . 0.0 107.768 177.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.53 -32.08 67.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 124.873 2.273 . . . . 0.0 107.18 176.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.35 -42.38 99.18 Favored Glycine 0 CA--C 1.527 0.818 1 CA-C-N 108.393 -4.003 . . . . 0.0 107.804 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 92.8 m -70.54 -27.97 64.56 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.498 0.666 . . . . 0.0 109.262 177.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.39 -49.94 65.13 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.851 -179.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.96 -35.89 79.8 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 118.144 -1.422 . . . . 0.0 110.979 -177.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 77.5 m -63.8 -54.08 40.77 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.616 -178.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.6 pp -65.73 -39.39 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -176.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.453 ' O ' ' OG1' ' A' ' 31' ' ' THR . . . -64.12 -41.9 97.06 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 119.831 -0.748 . . . . 0.0 112.706 -173.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.464 ' O ' ' N ' ' A' ' 32' ' ' PHE . 29.9 m-20 -77.78 -27.35 50.22 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 117.823 -1.551 . . . . 0.0 109.52 -176.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.4 mp -60.23 -55.92 27.81 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 120.129 1.331 . . . . 0.0 111.731 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.1 tp -75.68 -4.79 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 121.659 0.742 . . . . 0.0 112.034 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 27' ' ' ALA . 16.6 m -109.83 -16.48 13.87 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 114.454 -1.248 . . . . 0.0 110.202 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.507 ' N ' ' CD ' ' A' ' 33' ' ' PRO . 0.2 OUTLIER -68.28 -44.92 38.19 Favored Pre-proline 0 C--N 1.325 -0.463 0 C-N-CA 116.156 -2.218 . . . . 0.0 109.452 -178.231 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 32' ' ' PHE . 34.0 Cg_exo -59.95 -16.67 39.99 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 121.32 1.346 . . . . 0.0 112.573 177.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.6 mp -67.7 -35.41 78.74 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -178.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 36' ' ' THR . 1.9 p30 -64.44 -40.47 95.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.948 -177.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.545 ' N ' ' OD1' ' A' ' 35' ' ' ASP . 47.5 p -58.44 -34.97 71.41 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 120.41 -0.516 . . . . 0.0 112.176 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.52 -39.55 85.11 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 119.547 -0.861 . . . . 0.0 112.902 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.455 ' CB ' ' NH2' ' A' ' 279' ' ' ARG . 10.0 ptmt -63.09 -48.68 77.57 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 118.854 -1.138 . . . . 0.0 111.246 -177.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 66.4 t -63.55 -39.81 86.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -177.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.518 ' C ' ' H ' ' A' ' 42' ' ' GLN . 8.6 tpm_? -60.82 -41.39 95.62 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 119.19 -1.004 . . . . 0.0 109.718 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.49 38.81 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.58 178.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.518 ' H ' ' C ' ' A' ' 40' ' ' ARG . 45.1 tt0 -88.7 -112.64 0.06 Allowed 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.646 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.1 tp -154.3 8.93 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.158 0.504 . . . . 0.0 109.794 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.519 ' NE2' ' OE1' ' A' ' 58' ' ' GLN . 14.7 mm100 56.97 26.04 11.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.55 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -118.65 141.17 15.84 Favored Glycine 0 N--CA 1.466 0.683 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -149.4 -84.26 0.1 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 86.4 p -172.04 70.49 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.782 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 -156.01 -27.63 0.1 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.085 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.98 17.67 74.15 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 108.577 -1.809 . . . . 0.0 108.577 -177.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.535 HD13 ' H ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -63.92 -35.52 80.93 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.081 -1.06 . . . . 0.0 111.031 -179.089 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.535 ' H ' HD13 ' A' ' 50' ' ' LEU . 83.9 t -59.4 -43.81 91.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.217 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 71.0 ttp85 -64.01 -33.86 76.69 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.99 -38.13 82.32 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.279 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -136.36 95.39 3.17 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.236 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.92 -19.83 64.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.3 -178.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.7 ' HG ' ' H ' ' A' ' 57' ' ' ALA . 7.9 t -125.67 -141.02 0.28 Allowed 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.7 ' H ' ' HG ' ' A' ' 56' ' ' SER . . . 99.38 12.42 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 O-C-N 124.132 0.895 . . . . 0.0 112.616 178.349 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.519 ' OE1' ' NE2' ' A' ' 44' ' ' GLN . 10.7 pt20 178.36 101.72 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.995 0.426 . . . . 0.0 111.052 179.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -84.88 166.95 16.43 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.44 ' O ' ' C ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER -52.29 -35.07 49.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.233 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.44 ' C ' ' O ' ' A' ' 60' ' ' ARG . . . -28.23 100.21 0.01 OUTLIER Glycine 0 CA--C 1.53 1.011 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.241 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 24.6 m -67.21 -33.99 66.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.072 176.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -60.26 -32.4 71.13 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 121.31 1.868 . . . . 0.0 109.731 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.51 -48.99 67.52 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-N 114.934 -1.03 . . . . 0.0 114.459 -176.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.8 p -62.14 -46.13 90.37 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 97.0 mt -59.68 -35.99 62.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 118.119 -0.943 . . . . 0.0 108.94 -178.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.425 ' CD1' ' C ' ' A' ' 67' ' ' LEU . 0.3 OUTLIER -63.84 -35.28 80.12 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 121.422 1.919 . . . . 0.0 111.993 179.525 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 98.3 m -62.19 -38.34 88.74 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 113.4 -1.727 . . . . 0.0 110.99 -176.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 58.0 mmm -59.79 -40.04 86.95 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 121.048 -1.032 . . . . 0.0 113.425 -177.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 93.3 t -69.71 -41.14 79.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 118.967 -1.093 . . . . 0.0 113.82 -177.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 36.5 mmm-85 -78.97 -13.06 60.02 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -178.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.521 ' CG2' ' N ' ' A' ' 73' ' ' GLU . 0.7 OUTLIER -62.27 -54.65 37.6 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.633 -179.215 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.521 ' N ' ' CG2' ' A' ' 72' ' ' THR . 35.2 mt-10 -106.88 -53.93 2.54 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.417 ' O ' ' CB ' ' A' ' 77' ' ' SER . . . 155.77 166.23 15.52 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -56.43 -35.32 96.32 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 121.281 1.32 . . . . 0.0 110.971 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -61.43 -12.0 12.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.983 0.897 . . . . 0.0 110.723 175.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.617 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 6.5 t -77.91 -32.36 51.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 113.911 -1.495 . . . . 0.0 110.454 -178.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 15.3 tp -75.95 -33.41 59.82 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 121.761 -0.587 . . . . 0.0 110.823 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.464 ' C ' ' H ' ' A' ' 81' ' ' GLY . 53.5 m-85 -92.75 -5.09 51.96 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 -177.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.617 ' ND2' ' O ' ' A' ' 77' ' ' SER . 0.0 OUTLIER -92.52 26.05 2.79 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 174.55 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.464 ' H ' ' C ' ' A' ' 79' ' ' TYR . . . -160.07 -19.62 0.03 OUTLIER Glycine 0 CA--C 1.526 0.732 0 CA-C-N 112.942 -1.935 . . . . 0.0 112.036 -178.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 42.6 tp -59.06 -35.0 72.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.091 -1.054 . . . . 0.0 110.406 -179.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.4 t -70.67 -27.01 29.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.29 178.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.67 -31.32 61.88 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.717 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.42 -40.06 91.43 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 119.645 -1.264 . . . . 0.0 111.46 -177.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -62.37 -39.92 94.75 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 122.192 0.996 . . . . 0.0 113.655 -176.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -59.68 -26.12 65.32 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 113.348 -1.751 . . . . 0.0 109.615 -179.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.662 ' NE ' ' HZ1' ' A' ' 141' ' ' LYS . 7.4 mmm180 -56.44 -52.35 64.99 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 173.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -67.6 -29.9 69.36 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 113.475 -1.693 . . . . 0.0 112.692 -178.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 24.8 mmt -61.08 -42.06 97.8 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 78.1 p -74.7 -34.84 62.71 Favored 'General case' 0 C--N 1.338 0.102 0 C-N-CA 119.301 -0.959 . . . . 0.0 111.864 -176.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -57.96 -43.55 86.5 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 120.496 1.498 . . . . 0.0 112.279 -176.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.41 -32.65 64.54 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 119.78 -0.768 . . . . 0.0 111.292 -178.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.48 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 50.5 m -63.96 -41.53 97.55 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.48 ' C ' ' H ' ' A' ' 97' ' ' ILE . 24.2 m -68.12 -28.48 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.493 178.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 64.4 mtp180 -77.42 10.41 2.57 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -177.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.48 ' CG2' ' O ' ' A' ' 94' ' ' SER . 12.0 tt -86.78 -15.62 9.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.446 ' O ' ' OG ' ' A' ' 102' ' ' SER . . . -141.0 -48.85 0.05 OUTLIER Glycine 0 CA--C 1.534 1.252 0 CA-C-N 114.917 -1.038 . . . . 0.0 114.77 -178.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 60.5 mt -72.53 -14.29 61.61 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.096 1.448 . . . . 0.0 113.985 -177.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.521 ' O ' ' CD ' ' A' ' 104' ' ' LYS . 46.6 t80 -81.84 -53.12 6.44 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 114.653 -1.158 . . . . 0.0 112.542 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -72.6 -33.57 66.81 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 123.799 1.761 . . . . 0.0 114.136 -179.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.446 ' OG ' ' O ' ' A' ' 98' ' ' GLY . 79.3 p -66.5 -50.6 62.71 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 110.244 -3.162 . . . . 0.0 117.068 -177.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.45 ' O ' ' CD2' ' A' ' 107' ' ' TYR . 1.5 t -73.32 -23.37 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 CA-C-O 124.327 2.013 . . . . 0.0 109.94 175.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.521 ' CD ' ' O ' ' A' ' 100' ' ' TYR . 0.0 OUTLIER -66.8 -41.22 87.92 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 109.677 -3.42 . . . . 0.0 112.194 -178.02 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -78.81 -11.08 59.97 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 125.143 2.401 . . . . 0.0 111.05 178.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -79.63 -21.88 44.32 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 110.712 -2.949 . . . . 0.0 110.538 177.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.45 ' CD2' ' O ' ' A' ' 103' ' ' VAL . 41.1 m-85 -109.5 -28.67 8.79 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -175.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.811 ' C ' ' H ' ' A' ' 110' ' ' GLY . 66.4 p -95.55 12.07 30.84 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 -174.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.435 ' O ' ' N ' ' A' ' 111' ' ' SER . 15.2 ttpp -54.71 22.31 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.055 0 CA-C-N 119.472 1.033 . . . . 0.0 111.239 177.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.811 ' H ' ' C ' ' A' ' 108' ' ' THR . . . 65.24 -57.06 0.11 Allowed Glycine 0 N--CA 1.472 1.053 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.544 ' CB ' ' O ' ' A' ' 110' ' ' GLY . 6.9 t 106.35 -164.67 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 177.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.537 ' OE1' ' N ' ' A' ' 112' ' ' GLU . 35.4 mp0 -120.55 -40.28 2.68 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 -175.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.497 ' ND1' ' N ' ' A' ' 113' ' ' HIS . 0.0 OUTLIER 165.05 29.97 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.503 0.668 . . . . 0.0 109.366 -179.318 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.44 ' CB ' ' O ' ' A' ' 113' ' ' HIS . . . 160.31 -161.21 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.86 14.87 25.8 Favored Glycine 0 CA--C 1.507 -0.429 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.441 ' CG2' ' N ' ' A' ' 117' ' ' GLY . 3.0 tp -60.77 -40.22 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.441 ' N ' ' CG2' ' A' ' 116' ' ' ILE . . . -65.69 -39.87 95.54 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 110.946 -0.861 . . . . 0.0 110.946 174.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 6.8 t -58.85 -43.06 90.67 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 176.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 25.9 mmm-85 -63.65 -37.48 87.49 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 119.849 -0.741 . . . . 0.0 110.38 -177.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.69 -45.91 87.89 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 6.3 tp -67.14 -45.29 77.54 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.729 178.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.433 ' O ' ' OG1' ' A' ' 126' ' ' THR . . . -64.29 -44.97 90.03 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 119.918 1.235 . . . . 0.0 109.803 178.079 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -65.85 -44.48 91.92 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 119.222 -1.466 . . . . 0.0 110.614 -178.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 65.7 m -64.48 -44.61 90.45 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.309 -0.556 . . . . 0.0 111.095 178.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 19.5 m -69.9 -49.03 56.14 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 119.419 -0.912 . . . . 0.0 112.433 177.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' A' ' 122' ' ' ALA . 42.3 p -65.82 -42.16 90.95 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 120.149 1.34 . . . . 0.0 113.775 -175.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.619 ' CA ' HD22 ' A' ' 186' ' ' ASN . . . -64.03 -44.33 96.03 Favored Glycine 0 CA--C 1.518 0.254 0 CA-C-O 122.983 1.324 . . . . 0.0 112.162 -178.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.417 ' O ' ' CG2' ' A' ' 131' ' ' VAL . . . -61.48 -41.45 97.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 111.386 -2.407 . . . . 0.0 107.247 177.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.5 -42.33 95.89 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.25 178.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.23 -40.08 96.45 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -177.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.417 ' CG2' ' O ' ' A' ' 128' ' ' ALA . 5.8 m -61.15 -25.98 37.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 122.482 1.134 . . . . 0.0 109.942 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -58.29 -44.98 88.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 112.755 -2.02 . . . . 0.0 112.425 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.48 ' CG1' ' N ' ' A' ' 134' ' ' ALA . 2.7 p -79.09 -48.89 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.295 -179.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.48 ' N ' ' CG1' ' A' ' 133' ' ' VAL . . . -106.55 138.76 42.13 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.707 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.524 ' H ' ' HD2' ' A' ' 136' ' ' PRO . 7.8 pt20 172.23 -38.48 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.797 0 CA-C-O 118.279 -0.867 . . . . 0.0 113.132 179.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.524 ' HD2' ' H ' ' A' ' 135' ' ' GLN . 13.1 Cg_endo -52.66 -34.37 63.52 Favored 'Trans proline' 0 N--CA 1.498 1.785 0 CA-C-N 122.257 1.842 . . . . 0.0 112.544 -178.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 85.1 m -67.85 -42.6 81.14 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 118.683 -1.207 . . . . 0.0 110.184 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -65.82 -43.08 89.65 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 118.054 -1.458 . . . . 0.0 112.776 -177.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 24.4 m -64.47 -44.05 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 12.7 p -64.63 -37.48 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -177.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.662 ' HZ1' ' NE ' ' A' ' 88' ' ' ARG . 48.5 mttm -60.98 -40.55 93.88 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.16 -177.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 82.1 t -69.89 -44.95 78.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.57 -36.33 83.87 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.934 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -66.39 -40.69 89.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.06 -177.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 65.6 tp60 -64.35 -39.08 93.18 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 119.486 -0.886 . . . . 0.0 109.28 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.2 -35.0 79.7 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.446 ' O ' ' CG ' ' A' ' 147' ' ' GLN . 3.0 pt20 -60.31 111.06 1.4 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 177.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -102.5 8.81 39.87 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.246 -177.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 60.7 ttm-85 -143.71 135.99 26.85 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.848 0.356 . . . . 0.0 110.696 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -82.52 -56.36 3.92 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.617 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 168.03 -51.65 0.23 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 73.81 65.72 2.15 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -159.0 -79.08 0.03 OUTLIER Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.573 ' NH2' ' HE ' ' A' ' 155' ' ' ARG . 44.9 ttp85 -158.43 167.94 28.3 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.573 ' HE ' ' NH2' ' A' ' 154' ' ' ARG . 1.9 mpt_? 55.96 108.88 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -58.89 128.23 36.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.462 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -56.98 154.63 9.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.453 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.41 ' OG ' ' N ' ' A' ' 159' ' ' THR . 43.7 t -157.07 -178.28 7.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.211 0.529 . . . . 0.0 111.015 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.41 ' N ' ' OG ' ' A' ' 158' ' ' SER . 65.1 p -64.32 -46.1 84.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.737 -177.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 86.3 t -64.22 -45.59 95.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 119.132 -1.027 . . . . 0.0 109.438 -179.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.522 ' N ' ' OE1' ' A' ' 161' ' ' GLU . 15.1 mp0 -66.75 -39.04 87.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.873 0.368 . . . . 0.0 111.198 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -61.8 -45.54 93.41 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -178.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -62.59 -50.33 71.73 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 120.372 -0.531 . . . . 0.0 110.617 -178.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 30.5 mmtm -68.84 -45.57 70.78 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 -175.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.417 ' CG2' ' N ' ' A' ' 166' ' ' ILE . 15.3 t -62.95 -44.73 95.27 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.198 1.185 . . . . 0.0 114.198 -177.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.417 ' N ' ' CG2' ' A' ' 165' ' ' THR . 10.0 pt -64.51 -38.44 82.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 122.032 0.92 . . . . 0.0 109.505 177.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.53 -36.47 76.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 113.709 -1.587 . . . . 0.0 108.074 176.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -62.54 -50.39 71.54 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 122.436 2.38 . . . . 0.0 112.164 -175.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -75.05 -51.03 14.55 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 123.903 0.881 . . . . 0.0 109.641 177.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -77.96 -36.46 49.08 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 -173.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 90.99 -167.71 32.06 Favored Glycine 0 N--CA 1.467 0.714 0 N-CA-C 111.792 -0.523 . . . . 0.0 111.792 177.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 25.2 mm -72.18 -44.72 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-O 121.679 0.752 . . . . 0.0 110.652 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -59.0 -33.96 71.32 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 114.371 -1.286 . . . . 0.0 111.529 -177.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -60.75 -40.37 98.02 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 118.783 -1.675 . . . . 0.0 109.272 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.34 -33.43 71.47 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 111.477 -2.362 . . . . 0.0 116.72 -177.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . 0.428 ' O ' ' OG1' ' A' ' 179' ' ' THR . 2.3 m95 -77.89 -7.39 56.66 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 111.564 -2.562 . . . . 0.0 109.909 -177.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 16.3 ttmm -43.24 -47.93 6.55 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.354 -176.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -92.04 -27.43 16.25 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 123.981 0.8 . . . . 0.0 112.216 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' A' ' 176' ' ' TRP . 39.7 p -45.3 -51.17 11.3 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.427 ' N ' ' HG1' ' A' ' 179' ' ' THR . 3.3 m -62.4 -50.82 77.44 Favored Pre-proline 0 N--CA 1.47 0.57 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -176.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -64.87 -28.61 58.68 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 121.212 1.275 . . . . 0.0 111.63 176.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -64.27 -39.73 94.52 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 120.363 -0.535 . . . . 0.0 109.809 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 82.0 t -63.32 -42.85 97.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.201 0.524 . . . . 0.0 110.026 179.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.32 -39.39 92.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.091 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 44.1 ttt85 -60.74 -42.19 96.86 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.928 -179.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . 0.619 HD22 ' CA ' ' A' ' 127' ' ' GLY . 40.5 t30 -61.9 -43.89 97.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.107 0.48 . . . . 0.0 110.705 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -65.31 -44.31 88.26 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.805 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 87.4 mt -63.86 -46.04 95.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -177.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 6.9 p -60.64 -46.96 94.88 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 C-N-CA 119.403 -0.919 . . . . 0.0 111.267 -178.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -62.63 -42.62 99.7 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 122.204 1.002 . . . . 0.0 109.779 178.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' CYS . . . . . . . . . . . . . 41.9 t -61.63 -46.08 91.32 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 113.647 -1.615 . . . . 0.0 109.979 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.25 -40.2 95.52 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 113.317 -1.765 . . . . 0.0 109.719 176.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.81 -45.7 93.4 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.278 -177.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 21.1 tp -64.77 -38.89 92.51 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 118.785 -1.166 . . . . 0.0 110.972 -174.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 6.3 m -64.57 -45.97 93.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 117.275 -1.77 . . . . 0.0 108.536 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 29.0 p -63.91 -45.33 89.77 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -56.44 -38.77 72.07 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.641 0.776 . . . . 0.0 111.417 -178.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -55.95 -44.0 77.99 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.17 -38.69 87.38 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 37.2 mt -62.4 -41.87 93.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 15.4 mtpt -59.19 -38.2 79.24 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.958 1.303 . . . . 0.0 113.477 178.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -63.06 -42.58 99.71 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.692 -0.63 . . . . 0.0 110.986 -176.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.42 128.36 47.65 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 121.062 -1.024 . . . . 0.0 112.822 -176.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.524 ' CD2' ' CD2' ' A' ' 217' ' ' HIS . 11.1 mp 66.24 4.67 3.26 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 113.601 -1.636 . . . . 0.0 112.49 176.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 16.1 tp -137.1 72.02 1.41 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.117 0.484 . . . . 0.0 109.793 -178.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -112.36 -13.58 13.4 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -162.1 36.6 0.12 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.728 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . 0.443 ' O ' ' O ' ' A' ' 209' ' ' LEU . 50.2 t30 54.66 79.38 0.14 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 175.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.443 ' O ' ' O ' ' A' ' 208' ' ' ASN . 16.7 mt 56.91 110.95 0.01 OUTLIER 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.252 -0.885 . . . . 0.0 108.795 -178.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 20.5 ttp -140.07 15.71 2.45 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.563 ' CG2' ' H ' ' A' ' 212' ' ' ASP . 33.3 m -114.58 179.55 3.92 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.153 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . 0.563 ' H ' ' CG2' ' A' ' 211' ' ' THR . 25.7 t70 -131.84 -57.64 0.98 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.486 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -58.94 74.93 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.835 0.35 . . . . 0.0 110.869 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.531 ' N ' ' O ' ' A' ' 212' ' ' ASP . 0.4 OUTLIER -61.43 -41.53 79.75 Favored Pre-proline 0 CA--C 1.538 0.487 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -179.241 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.458 ' CD ' ' N ' ' A' ' 214' ' ' LEU . 25.0 Cg_exo -61.35 -33.3 89.3 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 120.951 1.101 . . . . 0.0 112.342 -175.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 35.5 t -63.31 -40.27 96.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 113.085 -1.87 . . . . 0.0 108.809 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' HIS . . . . . 0.524 ' CD2' ' CD2' ' A' ' 204' ' ' LEU . 2.0 t-160 -64.94 -34.37 78.25 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.658 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.11 -46.97 86.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.908 -177.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -60.18 -37.1 79.2 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 119.132 0.878 . . . . 0.0 111.044 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 67.0 m -59.59 -41.62 90.7 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.7 -41.71 98.08 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -177.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . 0.481 ' CZ ' ' CE1' ' A' ' 226' ' ' PHE . 38.4 t80 -62.21 -47.48 84.27 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -176.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -60.91 -42.17 99.57 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 107.962 -2.055 . . . . 0.0 107.962 177.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . 0.451 ' O ' ' OG1' ' A' ' 228' ' ' THR . . . -63.16 -38.18 90.14 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.068 -1.066 . . . . 0.0 109.377 177.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -62.05 -42.21 99.72 Favored Glycine 0 CA--C 1.522 0.491 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.513 -177.168 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' PHE . . . . . 0.481 ' CE1' ' CZ ' ' A' ' 222' ' ' PHE . 3.0 m-85 -66.65 -38.38 86.75 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 99.9 m -63.24 -40.65 98.04 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 176.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 224' ' ' ALA . 15.1 m -61.61 -40.09 93.57 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 114.604 -1.18 . . . . 0.0 112.371 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -58.34 -39.13 78.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.749 -176.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -59.94 -40.38 82.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 118.907 -1.117 . . . . 0.0 109.146 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . 0.51 ' O ' ' HD2' ' A' ' 234' ' ' PRO . 97.2 mt -61.39 -40.72 87.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-O 121.134 0.492 . . . . 0.0 109.783 177.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -62.81 -39.43 94.28 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.485 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 0.0 OUTLIER -57.97 -41.54 90.49 Favored Pre-proline 0 N--CA 1.483 1.187 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -173.542 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.51 ' HD2' ' O ' ' A' ' 231' ' ' ILE . 31.8 Cg_exo -57.87 -39.58 85.55 Favored 'Trans proline' 0 C--N 1.292 -2.431 0 C-N-CA 122.357 2.038 . . . . 0.0 113.551 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 83.9 t -64.08 -37.33 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 117.514 -1.674 . . . . 0.0 109.191 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . 0.525 ' OD2' ' CZ2' ' A' ' 283' ' ' TRP . 94.7 m-20 -66.21 -41.09 90.61 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.41 ' CG1' ' N ' ' A' ' 238' ' ' VAL . 0.5 OUTLIER -65.37 -45.23 93.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -176.448 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.41 ' N ' ' CG1' ' A' ' 237' ' ' VAL . 94.9 t -63.22 -37.07 78.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.441 -178.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 10.8 tptp -60.2 -44.48 95.09 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.64 -41.85 98.08 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.424 ' O ' ' CB ' ' A' ' 242' ' ' TYR . 8.8 tpm_? -42.21 129.41 3.76 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 121.326 -0.15 . . . . 0.0 111.166 -178.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.44 ' O ' ' C ' ' A' ' 243' ' ' MET . 19.8 t80 159.96 -58.81 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.813 0 O-C-N 123.865 0.728 . . . . 0.0 111.234 178.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' MET . . . . . 0.44 ' C ' ' O ' ' A' ' 242' ' ' TYR . 24.8 mtt -29.99 97.92 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . 0.854 HD22 ' HH ' ' A' ' 250' ' ' TYR . 50.4 p30 -168.74 -24.47 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 121.126 -0.23 . . . . 0.0 111.327 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' SER . . . . . 0.527 ' N ' ' OD1' ' A' ' 244' ' ' ASN . 5.2 m 150.43 -115.3 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 O-C-N 124.237 0.961 . . . . 0.0 111.679 178.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -179.23 -25.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.817 0.342 . . . . 0.0 110.58 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -77.45 91.08 3.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.65 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 0.44 ' C ' ' OE1' ' A' ' 249' ' ' GLN . . . -164.27 21.97 0.15 Allowed Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.96 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.645 ' O ' ' N ' ' A' ' 251' ' ' HIS . 12.8 mp0 63.76 28.12 14.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.797 0.332 . . . . 0.0 110.82 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.854 ' HH ' HD22 ' A' ' 244' ' ' ASN . 5.6 m-30 -56.1 71.11 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.267 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . 0.645 ' N ' ' O ' ' A' ' 249' ' ' GLN . 19.9 m-70 -75.17 -57.56 3.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.331 -178.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 26.5 t -149.55 -174.72 4.76 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -178.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.552 ' O ' ' SG ' ' A' ' 256' ' ' CYS . . . -62.14 -45.77 91.96 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.224 0.92 . . . . 0.0 110.364 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -57.41 -35.69 73.19 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.894 1.235 . . . . 0.0 112.581 -173.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -54.32 -39.45 67.05 Favored 'General case' 0 C--O 1.215 -0.711 0 CA-C-N 118.912 1.356 . . . . 0.0 111.093 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' CYS . . . . . 0.552 ' SG ' ' O ' ' A' ' 253' ' ' ALA . 0.0 OUTLIER -59.17 -44.97 92.16 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 119.932 -0.707 . . . . 0.0 110.415 -178.022 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -61.31 -46.35 90.66 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 119.622 -0.831 . . . . 0.0 111.725 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 11.2 mp -67.86 -44.58 76.79 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -179.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' THR . . . . . 0.433 ' CG2' ' N ' ' A' ' 260' ' ' MET . 2.1 t -63.42 -46.51 86.02 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -178.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' MET . . . . . 0.433 ' N ' ' CG2' ' A' ' 259' ' ' THR . 15.2 mmt -61.61 -44.19 97.46 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.106 -0.497 . . . . 0.0 112.051 -178.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 11.9 tp -62.6 -47.81 82.17 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 121.23 -0.188 . . . . 0.0 110.74 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 78.5 mtm180 -67.4 -54.03 24.05 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.078 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -76.66 -141.57 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.899 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . 0.541 ' CD ' ' H ' ' A' ' 264' ' ' GLU . 0.7 OUTLIER -39.87 128.47 2.1 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.083 0.468 . . . . 0.0 110.603 -179.659 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . 0.554 ' C ' ' H ' ' A' ' 267' ' ' ARG . . . -46.33 167.12 0.06 OUTLIER Glycine 0 CA--C 1.533 1.173 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 -179.137 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -53.79 -1.11 0.1 Allowed 'Trans proline' 0 N--CA 1.5 1.887 0 C-N-CA 122.093 1.862 . . . . 0.0 112.509 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.554 ' H ' ' C ' ' A' ' 265' ' ' GLY . 5.1 ptp180 -69.89 -26.94 64.42 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 122.838 0.455 . . . . 0.0 111.511 178.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -58.67 -32.5 69.17 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 119.695 -0.802 . . . . 0.0 109.934 -178.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -62.47 -41.25 98.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.127 177.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' TYR . . . . . 0.428 ' O ' ' O ' ' A' ' 271' ' ' LYS . 36.7 t80 -65.87 -37.6 86.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.924 -1.035 . . . . 0.0 112.633 -178.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.478 ' O ' ' O ' ' A' ' 272' ' ' GLY . 54.8 mtpt -51.31 -175.36 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 271' ' ' LYS . . . 57.38 126.34 0.01 OUTLIER Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -169.37 -26.14 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 119.453 -0.899 . . . . 0.0 112.828 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' MET . . . . . 0.526 ' N ' ' CD ' ' A' ' 275' ' ' PRO . 1.0 OUTLIER -64.16 -45.31 79.16 Favored Pre-proline 0 CA--C 1.529 0.169 0 C-N-CA 119.274 -0.97 . . . . 0.0 110.635 -178.661 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' A' ' 274' ' ' MET . 19.7 Cg_exo -65.44 -47.78 3.94 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 121.837 1.692 . . . . 0.0 111.966 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 5.0 m -61.42 -40.22 93.61 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.018 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -61.82 -42.8 99.48 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 123.6 1.667 . . . . 0.0 113.486 -177.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 75.5 mt -62.54 -39.06 92.39 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 110.355 -3.111 . . . . 0.0 109.625 175.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . 0.455 ' NH2' ' CB ' ' A' ' 38' ' ' LYS . 28.7 mmt-85 -62.8 -40.67 98.08 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.099 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.453 ' CD1' ' C ' ' A' ' 280' ' ' LEU . 0.1 OUTLIER -62.2 -36.78 82.97 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.235 -0.893 . . . . 0.0 113.195 -177.495 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -68.01 -51.04 36.38 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -178.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 16.4 m -62.79 -44.3 96.54 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.247 0.619 . . . . 0.0 109.68 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' TRP . . . . . 0.525 ' CZ2' ' OD2' ' A' ' 236' ' ' ASP . 83.5 t90 -59.94 -38.24 81.87 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -62.78 -38.4 90.5 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.695 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.82 -38.69 79.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -177.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 6.8 m -62.53 -39.52 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 120.105 -0.638 . . . . 0.0 109.674 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' MET . . . . . 0.426 ' O ' ' OG1' ' A' ' 290' ' ' THR . 76.0 mmm -60.62 -38.6 85.28 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -59.02 -41.53 87.98 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 29.4 m -61.61 -37.99 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 120.269 -0.572 . . . . 0.0 111.16 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 287' ' ' MET . 82.8 p -62.41 -40.43 96.49 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -60.83 -38.81 86.75 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 177.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -58.07 -40.14 80.29 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 117.77 -1.572 . . . . 0.0 109.169 -177.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' GLN . . . . . 0.477 ' O ' ' O ' ' A' ' 296' ' ' ARG . 14.3 mm100 -60.46 -42.42 96.15 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 123.121 1.439 . . . . 0.0 110.258 179.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 77.1 mt -60.43 -39.48 87.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 112.079 -2.328 . . . . 0.0 109.305 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -61.95 -45.03 95.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.41 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' ARG . . . . . 0.477 ' O ' ' O ' ' A' ' 293' ' ' GLN . 36.0 ttm180 -122.27 115.86 23.09 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -111.28 -163.5 0.85 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.694 0.759 . . . . 0.0 112.845 -177.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.481 ' CD1' ' H ' ' A' ' 298' ' ' LEU . 10.0 mp -32.98 -71.27 0.06 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.406 -1.27 . . . . 0.0 112.902 -178.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 299' ' ' MET . . . . . 0.526 ' SD ' ' O ' ' A' ' 299' ' ' MET . 0.0 OUTLIER 88.16 32.06 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 113.895 -1.502 . . . . 0.0 110.869 179.464 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.69 101.01 0.07 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 122.472 1.129 . . . . 0.0 111.182 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -64.34 -46.36 83.82 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 112.952 -1.931 . . . . 0.0 113.142 -176.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -58.67 -38.9 79.19 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 -177.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -64.29 -46.46 83.52 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 304' ' ' SER . . . . . 0.411 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 1.9 t -66.46 -38.18 86.78 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.672 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 -61.86 -42.64 99.3 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.919 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -64.71 -36.78 85.38 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -177.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -60.04 -52.98 69.64 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -176.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 308' ' ' PRO . . . . . 0.411 ' CD ' ' O ' ' A' ' 304' ' ' SER . 74.3 Cg_endo -75.21 0.23 9.24 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.046 1.831 . . . . 0.0 111.862 179.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 29.8 t80 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.586 -179.812 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.495 ' N ' ' SD ' ' A' ' 13' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.7 p 43.69 73.23 0.15 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.628 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.2 t -83.43 166.44 2.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.573 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.441 ' CD ' ' N ' ' A' ' 16' ' ' LYS . 1.1 mptm? -64.25 -41.8 96.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.095 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -63.75 -41.6 97.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.411 0.624 . . . . 0.0 111.905 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.83 -26.19 40.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.977 -1.011 . . . . 0.0 111.165 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.59 -40.69 96.16 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 106.75 -2.54 . . . . 0.0 106.75 176.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.61 -31.26 68.17 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 124.44 2.067 . . . . 0.0 107.41 176.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.38 -43.19 97.17 Favored Glycine 0 CA--C 1.532 1.115 0 CA-C-N 109.112 -3.676 . . . . 0.0 110.726 -177.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.5 t -71.23 -27.3 63.37 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 117.567 0.684 . . . . 0.0 109.279 178.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.75 -50.64 64.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.69 -178.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.15 -35.88 80.13 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 118.109 -1.437 . . . . 0.0 110.943 -177.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 73.2 m -63.98 -54.11 39.65 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.579 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.6 pp -65.74 -39.59 85.3 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -177.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.94 -41.8 97.52 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 119.733 -0.787 . . . . 0.0 112.861 -173.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -77.63 -27.07 51.01 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 120.325 1.42 . . . . 0.0 109.918 -175.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 10.8 tp -59.81 -55.83 29.41 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 119.835 1.198 . . . . 0.0 112.806 -178.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.9 pt -76.11 -4.55 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.3 p -109.71 -17.08 13.77 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 118.941 -1.104 . . . . 0.0 109.549 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.479 ' N ' ' CD ' ' A' ' 33' ' ' PRO . 4.3 t80 -67.3 -44.0 45.79 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 122.296 2.316 . . . . 0.0 109.164 -178.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 32' ' ' PHE . 30.7 Cg_exo -59.62 -15.85 33.39 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 121.0 1.134 . . . . 0.0 111.556 177.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 26.9 tp -66.99 -35.47 80.03 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -177.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 36' ' ' THR . 2.0 p30 -64.61 -40.29 95.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.36 -0.837 . . . . 0.0 112.401 -177.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.532 ' N ' ' OD1' ' A' ' 35' ' ' ASP . 67.4 p -58.17 -35.01 70.95 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.03 -38.09 85.27 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.627 ' HZ1' ' NH2' ' A' ' 279' ' ' ARG . 11.5 ptmt -60.58 -46.99 88.18 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 120.119 -0.632 . . . . 0.0 111.855 -175.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.443 ' N ' ' CG ' ' A' ' 38' ' ' LYS . 93.0 t -62.16 -38.42 80.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -176.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.549 ' C ' ' H ' ' A' ' 42' ' ' GLN . 6.8 mmp_? -59.37 -40.47 86.57 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 119.345 -0.942 . . . . 0.0 109.611 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.58 38.96 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.3 179.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.549 ' H ' ' C ' ' A' ' 40' ' ' ARG . 3.1 pt20 -67.89 -159.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 O-C-N 122.136 -0.352 . . . . 0.0 110.936 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.0 mp -132.07 47.81 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.562 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 46.72 29.11 0.9 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.855 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 46' ' ' GLU . . . -64.82 -116.32 0.01 OUTLIER Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.427 ' O ' ' O ' ' A' ' 45' ' ' GLY . 41.7 tt0 59.35 132.29 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.889 0.376 . . . . 0.0 110.839 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 66.9 m -115.71 -12.79 11.48 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.544 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -42.63 -27.08 0.15 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.648 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.46 -10.05 73.21 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -178.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 45.5 tp -65.89 -38.01 87.64 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.373 -0.413 . . . . 0.0 110.585 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.6 p -60.74 -44.81 98.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.734 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 -64.86 -33.65 76.52 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.881 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 98.0 m -67.86 -38.16 82.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.186 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.74 -152.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.207 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -166.9 -24.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.069 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.533 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 57.8 p -166.74 -127.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 179.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.533 ' CB ' ' O ' ' A' ' 56' ' ' SER . . . 94.33 13.8 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 177.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.497 ' N ' ' CD ' ' A' ' 58' ' ' GLN . 2.2 pm0 -175.29 176.81 1.97 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.867 0.365 . . . . 0.0 110.162 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.461 ' CD1' ' C ' ' A' ' 58' ' ' GLN . 84.7 m-85 -157.07 159.22 37.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.646 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 34.1 ptt-85 -48.16 -33.01 7.74 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -31.33 103.51 0.01 OUTLIER Glycine 0 CA--C 1.526 0.762 0 CA-C-N 114.875 -1.057 . . . . 0.0 112.221 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.6 m -66.91 -33.61 64.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 118.229 -0.891 . . . . 0.0 109.194 176.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -60.09 -32.32 70.86 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 121.25 1.841 . . . . 0.0 110.359 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -65.02 -49.3 63.2 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-N 115.243 -0.889 . . . . 0.0 114.609 -177.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.556 ' HG1' ' N ' ' A' ' 66' ' ' ILE . 6.8 p -62.15 -46.38 89.24 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -178.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.556 ' N ' ' HG1' ' A' ' 65' ' ' THR . 2.3 pp -58.99 -35.0 54.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -178.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.8 tp -63.03 -35.29 79.73 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 120.36 1.437 . . . . 0.0 113.116 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 98.6 m -61.47 -41.52 97.37 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-N 114.316 -1.311 . . . . 0.0 111.011 -177.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 50.4 mmm -59.3 -39.31 82.61 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -176.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.7 t -68.99 -41.04 81.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 118.968 -1.093 . . . . 0.0 113.646 -177.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 23.0 ttp-105 -78.26 -13.54 59.81 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.503 ' CG2' ' N ' ' A' ' 73' ' ' GLU . 0.5 OUTLIER -62.85 -54.95 30.9 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 114.639 -1.164 . . . . 0.0 112.391 -179.297 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.503 ' N ' ' CG2' ' A' ' 72' ' ' THR . 13.6 tp10 -110.61 -57.36 2.23 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.283 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.41 163.21 12.08 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -56.57 -34.92 96.44 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 122.107 1.871 . . . . 0.0 112.198 -179.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.4 tpp180 -61.25 -11.84 10.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.887 0.851 . . . . 0.0 111.132 176.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.6 p -78.28 -32.86 49.69 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 113.868 -1.514 . . . . 0.0 110.95 -178.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.3 mp -75.58 -31.65 60.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.017 0.437 . . . . 0.0 110.449 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -90.15 -3.69 57.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 123.644 1.688 . . . . 0.0 112.549 -176.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 -106.7 121.21 43.91 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 110.619 -2.991 . . . . 0.0 107.654 175.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.46 -18.6 50.57 Favored Glycine 0 N--CA 1.469 0.893 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 -177.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.544 ' CD1' ' N ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -58.91 -33.69 70.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 113.905 -1.148 . . . . 0.0 110.332 -179.096 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.544 ' N ' ' CD1' ' A' ' 82' ' ' LEU . 7.1 p -70.44 -26.28 28.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.265 177.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.14 -31.95 61.2 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 119.11 -0.471 . . . . 0.0 111.837 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.93 -40.0 89.18 Favored Glycine 0 N--CA 1.466 0.679 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.891 -178.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -62.48 -40.25 96.07 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 122.15 0.976 . . . . 0.0 112.842 -176.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.431 ' O ' ' OE1' ' A' ' 87' ' ' GLN . 0.1 OUTLIER -60.83 -28.29 68.7 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 113.431 -1.713 . . . . 0.0 110.378 -179.267 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 62.5 mtt85 -58.53 -53.7 55.36 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 173.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -66.67 -29.36 69.35 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 112.035 -2.348 . . . . 0.0 111.847 -177.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 12.3 tpt -61.27 -40.14 92.99 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.425 179.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 33.8 t -74.37 -34.19 63.29 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 119.366 -0.934 . . . . 0.0 111.456 -177.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -57.87 -43.84 86.26 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 121.04 1.745 . . . . 0.0 112.615 -176.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.49 -32.85 64.51 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 119.484 -0.886 . . . . 0.0 110.748 -178.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.488 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 70.2 p -64.1 -41.43 97.28 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.472 ' C ' ' H ' ' A' ' 97' ' ' ILE . 29.8 m -68.79 -28.28 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.44 177.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 55.3 ttp85 -77.15 9.22 3.2 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -176.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.488 ' CG2' ' O ' ' A' ' 94' ' ' SER . 11.0 tt -86.96 -14.68 10.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.412 ' O ' ' OG ' ' A' ' 102' ' ' SER . . . -139.98 -48.14 0.06 OUTLIER Glycine 0 CA--C 1.544 1.867 0 N-CA-C 115.772 1.069 . . . . 0.0 115.772 -177.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.541 ' CD2' ' N ' ' A' ' 99' ' ' LEU . 3.4 mm? -71.79 -13.4 61.68 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 119.841 1.82 . . . . 0.0 113.925 -177.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.49 ' CZ ' ' NZ ' ' A' ' 104' ' ' LYS . 9.6 t80 -80.84 -51.94 8.05 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 114.63 -1.168 . . . . 0.0 112.795 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.498 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 0.4 OUTLIER -70.42 -32.23 69.74 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 124.056 1.884 . . . . 0.0 110.686 -179.738 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' A' ' 98' ' ' GLY . 67.3 m -67.32 -50.88 58.3 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 109.609 -3.451 . . . . 0.0 113.492 178.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 10.0 p -73.83 -26.66 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 CA-C-N 121.27 1.85 . . . . 0.0 111.79 177.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.49 ' NZ ' ' CZ ' ' A' ' 100' ' ' TYR . 39.0 mttp -69.51 -41.86 75.47 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 111.621 -2.536 . . . . 0.0 113.284 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -76.27 -14.69 60.11 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 123.63 1.681 . . . . 0.0 111.029 178.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -79.27 -22.47 44.67 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 112.518 -2.128 . . . . 0.0 111.95 178.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.582 ' HH ' HD22 ' A' ' 190' ' ' ASN . 15.4 m-85 -109.79 -27.73 9.16 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.231 1.012 . . . . 0.0 113.299 -173.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.807 ' C ' ' H ' ' A' ' 110' ' ' GLY . 14.4 t -94.53 12.68 26.54 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 -173.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -54.69 19.11 0.0 OUTLIER 'General case' 0 CA--C 1.57 1.747 0 CA-C-N 119.885 1.221 . . . . 0.0 110.726 177.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.807 ' H ' ' C ' ' A' ' 108' ' ' THR . . . 59.18 20.52 50.4 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.542 ' OG ' ' NH2' ' A' ' 119' ' ' ARG . 1.4 m 33.02 -163.23 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 113.23 -1.485 . . . . 0.0 113.385 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.62 ' C ' ' H ' ' A' ' 114' ' ' ALA . 3.3 tt0 -141.14 -157.3 0.75 Allowed 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 118.807 -1.157 . . . . 0.0 113.424 -177.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.537 ' CG ' ' O ' ' A' ' 113' ' ' HIS . 37.5 t60 -61.12 9.24 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 114.814 -1.085 . . . . 0.0 111.312 -179.104 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.62 ' H ' ' C ' ' A' ' 112' ' ' GLU . . . 160.42 -161.01 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.26 14.58 25.74 Favored Glycine 0 N--CA 1.459 0.221 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 -179.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.43 HD13 HG22 ' A' ' 116' ' ' ILE . 25.6 mm -60.91 -39.98 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.08 -39.49 96.35 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.92 175.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 6.0 t -58.85 -43.23 90.74 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 176.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.542 ' NH2' ' OG ' ' A' ' 111' ' ' SER . 18.6 mmt85 -63.75 -37.37 87.1 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.658 -178.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 30.5 tp -63.58 -45.71 89.17 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 42.1 mt -66.92 -44.97 79.33 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.518 178.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.75 -45.1 87.84 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 119.903 1.229 . . . . 0.0 110.955 178.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -65.59 -44.39 92.84 Favored Glycine 0 CA--C 1.517 0.2 0 C-N-CA 119.777 -1.201 . . . . 0.0 111.148 -177.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 79.9 p -64.16 -43.07 96.32 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.83 0.348 . . . . 0.0 111.007 178.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 96.6 m -69.5 -48.82 59.39 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 119.192 -1.003 . . . . 0.0 112.687 177.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.441 ' CG2' ' N ' ' A' ' 127' ' ' GLY . 6.3 t -66.17 -42.7 88.56 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 115.197 1.555 . . . . 0.0 115.197 -174.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.441 ' N ' ' CG2' ' A' ' 126' ' ' THR . . . -64.74 -44.83 94.28 Favored Glycine 0 C--O 1.228 -0.233 0 CA-C-N 114.238 -1.347 . . . . 0.0 112.748 -177.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.57 -41.78 97.9 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 112.482 -1.859 . . . . 0.0 107.259 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.403 ' O ' ' CB ' ' A' ' 132' ' ' ALA . 0.2 OUTLIER -64.85 -42.81 94.58 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.169 178.118 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.13 -39.67 95.36 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.894 -0.504 . . . . 0.0 111.817 -178.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 94.5 t -60.98 -26.25 38.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 123.342 1.544 . . . . 0.0 109.298 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.403 ' CB ' ' O ' ' A' ' 129' ' ' LEU . . . -58.93 -44.67 91.38 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 110.971 -2.832 . . . . 0.0 112.386 -178.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 61.4 t -79.07 -49.18 20.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -177.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.517 ' O ' ' CB ' ' A' ' 135' ' ' GLN . . . -107.36 -169.12 1.48 Allowed 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -177.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.527 ' N ' ' CD ' ' A' ' 136' ' ' PRO . 3.4 tt0 105.15 -23.28 0.0 OUTLIER Pre-proline 0 CA--C 1.552 1.051 0 O-C-N 124.676 1.235 . . . . 0.0 114.051 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.527 ' CD ' ' N ' ' A' ' 135' ' ' GLN . 5.2 Cg_exo -52.68 -34.64 64.93 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 CA-C-N 122.025 1.759 . . . . 0.0 112.803 -178.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 12.6 m -66.75 -40.72 88.39 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -64.52 -42.16 95.94 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 118.965 -1.094 . . . . 0.0 112.424 -177.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.89 -42.93 97.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -179.198 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 19.7 m -63.92 -37.3 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -177.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 16.5 mtpp -60.82 -40.13 91.61 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.981 -177.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 90.4 t -69.83 -45.11 78.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.28 0.562 . . . . 0.0 109.694 178.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.64 -36.11 83.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.508 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -66.28 -40.4 90.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.899 -0.592 . . . . 0.0 112.312 -177.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -64.06 -39.07 93.28 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 119.884 -0.726 . . . . 0.0 110.185 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.16 -35.06 79.9 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.521 ' NE2' ' O ' ' A' ' 149' ' ' ARG . 0.0 OUTLIER -59.66 110.73 1.2 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 177.584 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 150' ' ' ALA . . . -43.17 93.03 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 117.33 -1.319 . . . . 0.0 111.531 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.521 ' O ' ' NE2' ' A' ' 147' ' ' GLN . 78.8 mtm180 53.81 -89.44 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 122.64 2.473 . . . . 0.0 111.055 178.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 148' ' ' ALA . . . -154.37 -149.7 0.29 Allowed 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.405 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -158.44 31.57 0.48 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 155' ' ' ARG . . . -172.95 111.08 0.36 Allowed Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -67.57 -53.12 26.12 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -70.96 -44.89 65.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.702 0.287 . . . . 0.0 110.762 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.406 ' O ' ' O ' ' A' ' 152' ' ' GLY . 37.8 ttm180 -85.77 138.94 31.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.68 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.514 ' CE2' ' O ' ' A' ' 157' ' ' GLN . 92.0 t80 -102.4 126.69 49.5 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.677 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.514 ' O ' ' CE2' ' A' ' 156' ' ' TYR . 84.1 mt-30 -81.07 166.49 20.7 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.34 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.655 ' H ' ' CG ' ' A' ' 161' ' ' GLU . 20.7 p -157.04 -178.56 7.46 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.565 0.698 . . . . 0.0 111.602 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 25.4 p -64.77 -46.64 81.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.113 -0.948 . . . . 0.0 112.335 -178.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.416 ' CG1' ' N ' ' A' ' 161' ' ' GLU . 14.9 p -65.02 -45.98 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 119.241 -0.984 . . . . 0.0 110.896 -178.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.655 ' CG ' ' H ' ' A' ' 158' ' ' SER . 2.1 pp20? -68.14 -38.54 82.27 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.921 0.391 . . . . 0.0 111.843 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.426 ' N ' ' CD ' ' A' ' 161' ' ' GLU . . . -61.14 -45.68 93.67 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -177.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -62.54 -50.15 72.47 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.137 -179.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -68.68 -45.68 71.05 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 -175.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.42 ' CG2' ' N ' ' A' ' 166' ' ' ILE . 15.3 t -63.27 -45.1 93.05 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -177.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.42 ' N ' ' CG2' ' A' ' 165' ' ' THR . 8.4 pt -64.83 -39.08 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 CA-C-O 122.043 0.925 . . . . 0.0 108.964 177.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.404 ' N ' ' CG1' ' A' ' 166' ' ' ILE . . . -60.41 -37.62 81.44 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 113.704 -1.589 . . . . 0.0 109.145 177.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 13.4 tpp85 -63.47 -51.35 65.99 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 123.715 2.962 . . . . 0.0 112.821 -175.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -75.7 -51.4 12.82 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 123.287 0.635 . . . . 0.0 109.515 177.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.526 ' OE2' ' N ' ' A' ' 174' ' ' GLY . 0.0 OUTLIER -78.96 -37.19 40.17 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 119.602 1.092 . . . . 0.0 113.784 -176.204 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . 0.47 ' O ' ' OE2' ' A' ' 170' ' ' GLU . . . 98.31 -171.73 25.8 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 120.776 -0.726 . . . . 0.0 113.366 179.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 20.8 tt -75.12 -37.84 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -177.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 7.3 tpp180 -58.22 -34.1 70.05 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 114.298 -1.319 . . . . 0.0 112.938 -173.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.526 ' N ' ' OE2' ' A' ' 170' ' ' GLU . . . -60.56 -38.87 95.64 Favored Glycine 0 N--CA 1.464 0.51 0 CA-C-O 123.726 1.737 . . . . 0.0 111.995 -178.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.541 ' CD1' ' N ' ' A' ' 175' ' ' LEU . 5.2 mp -70.2 -34.24 72.69 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 110.153 -3.024 . . . . 0.0 116.425 -176.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 11.0 m95 -78.72 -7.72 58.02 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 113.481 -1.691 . . . . 0.0 109.653 -178.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -44.06 -49.28 8.86 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.756 0.651 . . . . 0.0 112.756 -175.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -87.99 -36.6 8.27 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 124.548 1.071 . . . . 0.0 111.754 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 40.3 p -45.24 -51.39 10.81 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.408 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 1.5 t -62.92 -50.93 74.72 Favored Pre-proline 0 N--CA 1.472 0.667 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -176.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.408 ' HD2' ' N ' ' A' ' 180' ' ' SER . 32.3 Cg_endo -65.06 -28.15 57.24 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.676 1.584 . . . . 0.0 111.257 176.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.426 ' CB ' ' OE1' ' A' ' 135' ' ' GLN . 24.5 t-20 -63.41 -39.19 93.82 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 71.8 t -62.91 -42.79 97.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.63 -39.99 95.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.18 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -60.99 -41.94 97.47 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.084 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -61.61 -43.24 99.24 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.033 0.444 . . . . 0.0 110.124 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . 0.508 ' O ' ' SG ' ' A' ' 191' ' ' CYS . . . -64.24 -43.87 93.56 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.24 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 25.2 mm -63.32 -45.17 98.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.864 -0.335 . . . . 0.0 111.309 -178.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 89.3 t -60.42 -47.22 93.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 120.265 -0.574 . . . . 0.0 111.765 -178.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . 0.582 HD22 ' HH ' ' A' ' 107' ' ' TYR . 16.6 t30 -62.61 -43.27 99.22 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 122.663 1.22 . . . . 0.0 109.873 179.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' CYS . . . . . 0.508 ' SG ' ' O ' ' A' ' 187' ' ' ALA . 94.5 m -62.43 -46.49 88.3 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 112.46 -2.155 . . . . 0.0 110.752 179.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.41 -40.29 95.5 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.479 176.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -61.54 -45.57 93.6 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.879 -178.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 7.9 tt -64.16 -38.95 92.88 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 118.623 -1.231 . . . . 0.0 110.071 -174.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 6.1 m -64.5 -45.48 95.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 116.762 -1.975 . . . . 0.0 107.808 178.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 19.8 m -63.89 -45.87 87.43 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -178.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -56.48 -38.35 71.61 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.34 1.056 . . . . 0.0 112.09 -178.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -55.19 -43.09 74.05 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 24.5 mt -60.79 -39.51 89.17 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.422 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 1.3 mp -62.98 -42.45 96.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -59.59 -38.67 81.85 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.505 1.522 . . . . 0.0 113.193 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -62.9 -40.04 96.36 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.027 -178.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 90.5 m -100.66 129.37 46.56 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.797 0.808 . . . . 0.0 111.839 -177.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 4.6 tp 68.02 4.38 4.03 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 114.221 -1.354 . . . . 0.0 111.954 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -128.42 28.81 5.41 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -177.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -72.84 -25.06 60.98 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.263 -178.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.46 ' O ' ' CG ' ' A' ' 208' ' ' ASN . . . -131.09 -38.88 1.21 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.547 0.689 . . . . 0.0 110.219 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . 0.64 ' CG ' ' H ' ' A' ' 209' ' ' LEU . 13.9 p30 141.25 -92.84 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 113.138 -1.846 . . . . 0.0 106.846 -177.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.64 ' H ' ' CG ' ' A' ' 208' ' ' ASN . 4.3 tt -101.12 114.19 27.91 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 177.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 6.6 tpt -158.62 79.61 0.8 Allowed 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 120.281 -0.567 . . . . 0.0 111.692 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 24.3 p -159.42 170.88 20.81 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.627 179.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -133.83 -60.95 0.81 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.61 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.51 ' N ' ' OD1' ' A' ' 213' ' ' ASP . 11.5 p-10 -84.16 94.66 8.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.611 178.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.491 ' N ' ' CD ' ' A' ' 215' ' ' PRO . 4.3 mm? -60.88 -42.63 88.12 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.215 -178.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.491 ' CD ' ' N ' ' A' ' 214' ' ' LEU . 35.1 Cg_exo -59.89 -32.34 95.1 Favored 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 121.58 1.52 . . . . 0.0 112.337 -177.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' CYS . . . . . 0.527 ' SG ' ' N ' ' A' ' 217' ' ' HIS . 1.6 p -63.98 -42.23 97.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 113.714 -1.584 . . . . 0.0 111.422 -177.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' HIS . . . . . 0.527 ' N ' ' SG ' ' A' ' 216' ' ' CYS . 77.3 m80 -66.5 -37.32 84.81 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.332 0.587 . . . . 0.0 110.766 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -63.47 -46.77 84.66 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.804 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 20.8 p -60.2 -37.79 81.32 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 118.81 0.732 . . . . 0.0 110.44 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 217' ' ' HIS . 49.7 p -59.45 -41.63 90.09 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 178.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . 0.566 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.74 -41.81 97.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -177.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -62.19 -47.67 83.45 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -175.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -61.15 -42.4 99.78 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 107.994 -2.042 . . . . 0.0 107.994 177.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . 0.504 ' O ' ' SG ' ' A' ' 227' ' ' CYS . . . -63.48 -37.34 86.91 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 113.839 -1.18 . . . . 0.0 109.622 177.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -61.15 -41.96 99.64 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-N 114.364 -1.289 . . . . 0.0 112.529 -175.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' PHE . . . . . 0.457 ' O ' ' OG1' ' A' ' 229' ' ' THR . 55.1 m-85 -66.24 -38.79 88.74 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 118.767 1.283 . . . . 0.0 110.014 -178.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . 0.504 ' SG ' ' O ' ' A' ' 224' ' ' ALA . 1.8 p -63.69 -41.91 98.07 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 119.74 -0.784 . . . . 0.0 109.873 177.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' THR . . . . . 0.495 ' N ' ' SG ' ' A' ' 227' ' ' CYS . 67.6 p -62.56 -40.93 98.42 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.412 179.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.457 ' OG1' ' O ' ' A' ' 226' ' ' PHE . 13.1 p -59.19 -39.46 82.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.266 -177.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 92.8 t -60.35 -41.26 86.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 C-N-CA 118.91 -1.116 . . . . 0.0 108.524 178.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . 0.472 ' O ' ' HD2' ' A' ' 234' ' ' PRO . 30.4 mm -62.08 -41.18 90.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 121.345 0.593 . . . . 0.0 109.727 176.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.1 -39.9 96.06 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 116.16 1.911 . . . . 0.0 116.16 -179.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.48 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 0.1 OUTLIER -58.1 -41.91 92.27 Favored Pre-proline 0 N--CA 1.481 1.098 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -173.271 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 233' ' ' SER . 35.5 Cg_exo -58.39 -40.08 78.3 Favored 'Trans proline' 0 C--N 1.291 -2.483 0 C-N-CA 121.915 1.744 . . . . 0.0 112.503 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 58.9 t -64.38 -37.29 79.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 C-N-CA 118.591 -1.244 . . . . 0.0 109.004 178.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -66.22 -40.98 90.67 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-N 115.351 -0.841 . . . . 0.0 112.182 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 74.1 t -65.63 -45.28 92.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -176.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.19 -36.9 77.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -176.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 7.3 ptmm? -60.1 -43.56 95.46 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.632 -178.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 1.8 p -61.09 -41.94 97.58 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.509 ' O ' ' CB ' ' A' ' 242' ' ' TYR . 0.0 OUTLIER -40.25 131.56 2.09 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 121.148 -0.221 . . . . 0.0 111.165 -178.462 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.509 ' CB ' ' O ' ' A' ' 241' ' ' ARG . 2.7 t80 153.54 -59.17 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 O-C-N 123.688 0.617 . . . . 0.0 110.292 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' MET . . . . . 0.535 ' O ' ' ND2' ' A' ' 244' ' ' ASN . 79.6 mtp -33.25 144.68 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 O-C-N 123.147 0.279 . . . . 0.0 110.72 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . 0.556 ' OD1' ' N ' ' A' ' 245' ' ' SER . 0.7 OUTLIER 75.07 -175.27 0.13 Allowed 'General case' 0 N--CA 1.468 0.441 0 O-C-N 123.463 0.477 . . . . 0.0 111.259 -179.474 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' SER . . . . . 0.556 ' N ' ' OD1' ' A' ' 244' ' ' ASN . 41.7 t 38.47 -135.33 0.1 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.862 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . 0.495 ' N ' ' OG ' ' A' ' 245' ' ' SER . . . 66.35 51.44 1.2 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.173 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 39.4 mt -128.85 -19.89 3.58 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.675 -0.238 . . . . 0.0 111.149 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 249' ' ' GLN . . . -90.21 -166.81 41.58 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 -179.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.972 ' NE2' ' CE1' ' A' ' 255' ' ' HIS . 6.5 tt0 -46.38 -101.64 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.801 -0.2 . . . . 0.0 110.521 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.558 ' CD1' ' N ' ' A' ' 250' ' ' TYR . 0.8 OUTLIER 71.72 59.97 0.15 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.67 179.082 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -66.7 -51.4 56.47 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 114.374 1.249 . . . . 0.0 114.374 -178.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.52 -173.51 4.29 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -178.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -60.38 -44.9 95.2 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 118.921 0.782 . . . . 0.0 108.914 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -56.0 -34.94 62.58 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 125.225 1.393 . . . . 0.0 111.102 -173.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' HIS . . . . . 0.972 ' CE1' ' NE2' ' A' ' 249' ' ' GLN . 86.4 t60 -55.68 -34.87 65.43 Favored 'General case' 0 C--N 1.361 1.088 0 C-N-CA 116.805 -1.958 . . . . 0.0 110.982 179.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -60.47 -45.04 95.18 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.984 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -60.62 -45.94 92.15 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.6 -179.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 11.5 tp -67.8 -43.72 79.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.054 0.454 . . . . 0.0 111.245 179.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 255' ' ' HIS . 21.9 m -63.11 -46.73 85.96 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -178.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' MET . . . . . 0.419 ' CG ' ' N ' ' A' ' 261' ' ' LEU . 17.0 ptt? -61.57 -44.45 97.01 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -177.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.419 ' N ' ' CG ' ' A' ' 260' ' ' MET . 11.6 tp -63.25 -48.12 79.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.787 0.327 . . . . 0.0 110.467 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 50.1 ttt85 -67.4 -54.14 23.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.582 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 3.8 ttmm -68.29 -148.45 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.954 0.407 . . . . 0.0 111.484 -178.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -51.45 136.4 25.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.399 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . 0.446 ' C ' ' H ' ' A' ' 267' ' ' ARG . . . -41.37 166.63 0.01 OUTLIER Glycine 0 CA--C 1.527 0.834 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.809 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -60.23 -2.97 2.07 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.625 2.217 . . . . 0.0 111.7 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.446 ' H ' ' C ' ' A' ' 265' ' ' GLY . 37.7 ttm180 -69.98 -27.01 64.36 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.193 0.597 . . . . 0.0 111.739 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -58.76 -32.31 69.16 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.006 -179.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -62.39 -41.19 98.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.915 177.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -65.67 -37.55 86.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.909 -1.042 . . . . 0.0 112.146 -178.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.455 ' O ' ' O ' ' A' ' 272' ' ' GLY . 42.3 mmtm -65.42 -176.7 0.35 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 271' ' ' LYS . . . 47.72 104.13 0.01 OUTLIER Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -165.26 4.26 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.611 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' MET . . . . . 0.583 ' N ' ' CD ' ' A' ' 275' ' ' PRO . 2.9 ttm -63.57 -44.15 80.26 Favored Pre-proline 0 C--N 1.329 -0.304 0 C-N-CA 120.268 -0.573 . . . . 0.0 109.646 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 274' ' ' MET . 22.8 Cg_exo -64.33 -46.12 8.26 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.732 2.288 . . . . 0.0 111.334 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 38.7 t -60.1 -40.04 88.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.514 -179.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . 0.464 ' O ' ' CD1' ' A' ' 280' ' ' LEU . 3.4 m-85 -61.59 -42.76 99.32 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 124.3 2.0 . . . . 0.0 111.809 -178.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 11.5 tp -62.87 -38.98 93.01 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 110.385 -3.098 . . . . 0.0 109.892 175.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . 0.627 ' NH2' ' HZ1' ' A' ' 38' ' ' LYS . 56.6 mtt-85 -63.03 -41.49 99.53 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.464 ' CD1' ' O ' ' A' ' 277' ' ' PHE . 1.3 pp -62.7 -35.37 79.49 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -177.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . 0.436 ' O ' ' OD1' ' A' ' 284' ' ' ASN . . . -67.67 -50.98 38.7 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -177.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 66.4 m -62.49 -43.89 97.72 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.477 0.711 . . . . 0.0 109.689 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' TRP . . . . . . . . . . . . . 85.0 t90 -59.61 -38.16 80.55 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' A' ' 285' ' ' VAL . 0.2 OUTLIER -62.52 -38.37 89.7 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.295 179.549 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . 0.531 ' N ' ' OD1' ' A' ' 284' ' ' ASN . 0.3 OUTLIER -61.01 -39.91 83.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -177.52 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 10.2 m -63.31 -40.07 87.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.051 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' MET . . . . . 0.461 ' SD ' ' CE1' ' A' ' 291' ' ' TYR . 0.0 OUTLIER -60.83 -38.41 85.37 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.656 179.919 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -58.44 -40.1 81.63 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.846 -178.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -60.53 -38.24 77.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 -177.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 41.8 p -62.42 -40.91 98.09 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 119.558 -0.857 . . . . 0.0 108.834 177.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' TYR . . . . . 0.461 ' CE1' ' SD ' ' A' ' 287' ' ' MET . 16.2 m-85 -60.98 -38.34 85.6 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 177.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 -57.27 -39.35 75.5 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 118.163 -1.415 . . . . 0.0 109.261 -176.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' GLN . . . . . 0.468 ' O ' ' O ' ' A' ' 296' ' ' ARG . 17.9 mm100 -60.24 -42.08 94.53 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 122.904 1.335 . . . . 0.0 110.58 178.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -60.8 -39.41 88.8 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 112.404 -2.18 . . . . 0.0 110.02 178.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 45.2 mttp -61.83 -44.67 96.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.226 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' ARG . . . . . 0.468 ' O ' ' O ' ' A' ' 293' ' ' GLN . 89.1 mtm180 -121.89 115.7 23.06 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -112.13 -163.24 0.84 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.349 0.595 . . . . 0.0 112.276 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.426 ' CD1' ' N ' ' A' ' 298' ' ' LEU . 9.9 mp -74.79 109.72 8.49 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 176.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 299' ' ' MET . . . . . 0.5 ' SD ' ' O ' ' A' ' 299' ' ' MET . 0.1 OUTLIER -94.59 63.97 2.97 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.755 0.312 . . . . 0.0 111.651 -178.302 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.49 100.86 0.08 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 122.233 1.016 . . . . 0.0 110.647 -178.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -64.2 -46.47 83.8 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 113.16 -1.837 . . . . 0.0 113.265 -176.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -59.06 -39.92 83.56 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.161 -177.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . 0.494 ' OE1' ' SD ' ' A' ' 13' ' ' MET . 9.2 tp-100 -65.01 -47.0 79.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.846 0.355 . . . . 0.0 110.351 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 304' ' ' SER . . . . . 0.453 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 39.2 t -67.11 -38.33 85.44 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.776 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 34.7 mmm-85 -62.25 -43.76 98.09 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -179.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -65.35 -36.82 85.18 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -177.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -60.13 -52.87 70.26 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -176.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 308' ' ' PRO . . . . . 0.49 ' O ' ' C ' ' A' ' 309' ' ' PHE . 72.5 Cg_endo -75.07 0.38 9.0 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.374 2.049 . . . . 0.0 112.995 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 309' ' ' PHE . . . . . 0.49 ' C ' ' O ' ' A' ' 308' ' ' PRO . 36.3 p90 . . . . . 0 N--CA 1.481 1.078 0 O-C-N 123.894 0.746 . . . . 0.0 112.923 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 39.9 ttm . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.2 p -79.65 82.93 5.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.516 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.6 t -84.36 155.8 3.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.846 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -64.51 -41.7 96.26 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.287 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -63.67 -41.74 98.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.497 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 45.3 tp -79.6 -26.44 41.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.089 -178.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.26 -41.25 94.81 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 107.714 -2.154 . . . . 0.0 107.714 177.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.66 -32.15 67.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 124.856 2.265 . . . . 0.0 107.625 176.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.43 -42.24 99.11 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-N 108.492 -3.958 . . . . 0.0 108.092 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -70.52 -27.62 64.31 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.098 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.46 -49.97 64.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.965 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.02 -35.87 79.88 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 118.157 -1.417 . . . . 0.0 110.995 -177.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 78.7 m -63.85 -53.94 42.69 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.245 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.7 pp -65.54 -39.58 85.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -177.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.92 -41.65 97.6 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -173.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 32' ' ' PHE . 8.4 p-10 -77.67 -27.11 50.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 120.464 1.483 . . . . 0.0 109.89 -176.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -60.33 -55.71 30.3 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 119.531 1.06 . . . . 0.0 111.77 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.6 pt -75.89 -4.84 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 121.188 0.518 . . . . 0.0 112.363 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 53.5 m -109.91 -17.02 13.72 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 117.319 -1.324 . . . . 0.0 109.95 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.443 ' N ' ' O ' ' A' ' 28' ' ' ASP . 10.3 t80 -68.38 -44.88 36.95 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-N 122.67 2.486 . . . . 0.0 110.977 -177.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -60.21 -16.69 41.88 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 CA-C-N 121.05 1.411 . . . . 0.0 112.74 177.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 82.9 mt -67.65 -35.08 78.22 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -177.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.62 ' CB ' ' HZ2' ' A' ' 38' ' ' LYS . 5.3 p30 -63.98 -39.56 94.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.133 -178.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.532 ' N ' ' OD1' ' A' ' 35' ' ' ASP . 44.4 p -58.11 -34.02 69.75 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.29 -38.76 85.58 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.62 ' HZ2' ' CB ' ' A' ' 35' ' ' ASP . 12.1 pttm -62.0 -47.7 83.61 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 119.049 -1.06 . . . . 0.0 111.93 -177.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.9 m -62.8 -38.98 83.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -176.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.555 ' C ' ' H ' ' A' ' 42' ' ' GLN . 13.0 mmp_? -60.24 -41.08 92.41 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 118.986 -1.085 . . . . 0.0 109.909 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 12.8 tp -62.48 38.98 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.236 178.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.583 HE22 ' CA ' ' A' ' 44' ' ' GLN . 5.1 pp0? -53.0 176.02 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.078 0.466 . . . . 0.0 111.436 -178.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 90.9 mt -45.29 -84.01 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.688 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.583 ' CA ' HE22 ' A' ' 42' ' ' GLN . 10.6 tm0? -150.64 -33.93 0.16 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.439 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -163.69 155.61 27.05 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.412 ' OE1' ' CG1' ' A' ' 51' ' ' VAL . 16.8 mp0 -87.27 168.8 12.87 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.815 0.34 . . . . 0.0 110.532 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.5 t -91.26 1.18 57.29 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -63.34 -25.49 68.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.436 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.03 -6.05 84.04 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.02 -1.632 . . . . 0.0 109.02 -177.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.3 tt -65.31 -37.66 87.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.583 -0.809 . . . . 0.0 109.638 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.412 ' CG1' ' OE1' ' A' ' 46' ' ' GLU . 16.5 m -60.38 -44.04 95.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.411 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 23.7 ttm105 -64.16 -34.04 77.15 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 19.3 m -67.97 -38.26 82.52 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -131.5 78.82 1.85 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.227 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -48.13 -14.91 0.06 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.39 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.526 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 23.1 t -126.23 -140.54 0.28 Allowed 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 56' ' ' SER . . . 96.66 13.96 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.706 0 O-C-N 124.062 0.851 . . . . 0.0 111.909 178.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -175.32 69.99 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.653 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -52.36 155.44 2.07 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.402 ' O ' ' C ' ' A' ' 61' ' ' GLY . 75.4 mtp180 -45.35 -37.0 4.54 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 60' ' ' ARG . . . -30.33 103.05 0.01 OUTLIER Glycine 0 CA--C 1.529 0.95 0 CA-C-N 114.993 -1.003 . . . . 0.0 112.478 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 31.0 m -67.42 -33.79 64.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 118.268 -0.872 . . . . 0.0 109.888 176.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.0 mp -60.27 -32.28 71.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 121.239 1.836 . . . . 0.0 109.881 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.42 -49.2 66.74 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 114.975 -1.011 . . . . 0.0 114.671 -176.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.6 m -62.1 -46.41 89.19 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -178.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 29.0 pt -59.89 -35.97 63.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.3 tt -63.84 -35.83 81.92 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 121.04 1.745 . . . . 0.0 111.651 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.458 ' O ' ' OG1' ' A' ' 72' ' ' THR . 98.6 m -62.79 -39.47 94.31 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-N 113.674 -1.603 . . . . 0.0 111.049 -175.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 7.6 ptt? -60.39 -39.8 88.6 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 120.648 -1.283 . . . . 0.0 113.819 -176.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.2 p -69.36 -40.7 80.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 119.244 -0.982 . . . . 0.0 113.015 -178.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 55.6 ttm-85 -77.86 -13.44 59.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.979 0.895 . . . . 0.0 112.173 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.458 ' OG1' ' O ' ' A' ' 68' ' ' THR . 71.3 m -63.14 -54.77 32.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.137 -1.392 . . . . 0.0 111.154 178.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -106.29 -59.85 1.73 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.473 178.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 160.98 166.34 19.51 Favored Glycine 0 CA--C 1.535 1.34 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -56.17 -35.15 94.9 Favored 'Trans proline' 0 N--CA 1.5 1.91 0 CA-C-N 119.33 1.565 . . . . 0.0 111.721 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -61.36 -11.15 8.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.739 0.78 . . . . 0.0 111.071 176.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.8 t -77.79 -32.77 52.67 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.248 -1.342 . . . . 0.0 110.876 -178.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.431 ' CD1' ' N ' ' A' ' 78' ' ' LEU . 9.6 mp -75.86 -33.64 60.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 118.271 0.487 . . . . 0.0 110.958 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -92.53 -4.95 52.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 122.796 1.284 . . . . 0.0 112.76 -178.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -90.69 118.31 30.02 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 112.487 -2.142 . . . . 0.0 107.228 175.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.89 -7.58 57.42 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -178.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.46 ' CD1' ' C ' ' A' ' 82' ' ' LEU . 0.4 OUTLIER -59.25 -34.51 72.32 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 113.949 -1.125 . . . . 0.0 110.541 -179.092 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.1 p -70.46 -26.67 29.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.525 178.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.73 -31.58 61.87 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.748 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.427 ' O ' ' OE1' ' A' ' 89' ' ' GLN . . . -67.84 -40.26 89.52 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 119.701 -1.238 . . . . 0.0 111.241 -177.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.3 mp -62.0 -40.05 94.34 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 122.598 1.189 . . . . 0.0 112.203 -177.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 49.9 tp60 -60.41 -26.99 67.1 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 112.657 -2.065 . . . . 0.0 108.992 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 46.8 ttt180 -57.56 -53.41 58.42 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 173.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.427 ' OE1' ' O ' ' A' ' 85' ' ' GLY . 13.7 mp0 -67.82 -29.8 69.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 113.437 -1.71 . . . . 0.0 112.196 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 8.8 tpt -60.94 -41.97 97.28 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.044 -179.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.429 ' O ' ' OG ' ' A' ' 94' ' ' SER . 77.9 p -74.9 -35.08 62.25 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 119.225 -0.99 . . . . 0.0 111.729 -177.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -57.93 -43.4 86.24 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 121.293 1.861 . . . . 0.0 113.051 -176.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.41 -32.42 64.42 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.322 -177.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 91' ' ' SER . 97.1 p -63.68 -40.55 97.11 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 179.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.458 ' C ' ' H ' ' A' ' 97' ' ' ILE . 18.4 m -67.94 -28.3 40.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.829 177.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -77.63 10.12 2.9 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -177.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.458 ' H ' ' C ' ' A' ' 95' ' ' VAL . 38.8 mm -86.69 -15.39 9.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 177.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.433 ' O ' ' OG ' ' A' ' 102' ' ' SER . . . -140.45 -48.0 0.05 OUTLIER Glycine 0 CA--C 1.537 1.415 0 CA-C-N 114.569 -1.196 . . . . 0.0 114.267 -177.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.489 ' CD1' ' N ' ' A' ' 99' ' ' LEU . 8.5 mp -70.76 -13.26 61.99 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 118.586 1.193 . . . . 0.0 112.776 -177.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.486 ' O ' ' CG ' ' A' ' 104' ' ' LYS . 91.8 t80 -81.53 -51.19 8.52 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.234 178.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 1.159 ' OD2' ' NE2' ' A' ' 105' ' ' GLN . 18.4 t70 -69.4 -31.55 69.99 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 113.332 -1.758 . . . . 0.0 111.512 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 98' ' ' GLY . 51.2 m -68.17 -52.48 34.13 Favored 'General case' 0 CA--C 1.556 1.185 0 CA-C-N 111.138 -2.755 . . . . 0.0 115.918 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.505 ' O ' ' CD2' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -74.66 -26.26 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-N 122.015 2.189 . . . . 0.0 111.505 177.547 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.486 ' CG ' ' O ' ' A' ' 100' ' ' TYR . 16.7 mmtt -68.8 -42.17 77.67 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 111.875 -2.42 . . . . 0.0 112.334 -179.11 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 1.159 ' NE2' ' OD2' ' A' ' 101' ' ' ASP . 88.1 mt-30 -76.74 -15.95 59.62 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 122.677 1.227 . . . . 0.0 111.056 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -79.44 -23.43 43.15 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 114.105 -1.407 . . . . 0.0 112.202 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.505 ' CD2' ' O ' ' A' ' 103' ' ' VAL . 45.2 m-85 -110.22 -30.27 7.8 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 119.871 1.214 . . . . 0.0 113.278 -175.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.0 t -97.77 9.35 42.84 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 117.257 -1.777 . . . . 0.0 112.844 -178.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.518 ' O ' ' C ' ' A' ' 110' ' ' GLY . 0.0 OUTLIER -52.13 124.2 12.43 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 117.827 -1.082 . . . . 0.0 110.497 179.054 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.549 ' O ' ' CB ' ' A' ' 111' ' ' SER . . . -21.04 -83.33 0.01 OUTLIER Glycine 0 N--CA 1.491 2.352 0 CA-C-N 119.79 1.177 . . . . 0.0 111.699 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.549 ' CB ' ' O ' ' A' ' 110' ' ' GLY . 7.2 t 106.35 -162.28 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 115.424 1.638 . . . . 0.0 115.424 176.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.542 ' O ' ' CG ' ' A' ' 113' ' ' HIS . 33.4 tp10 -108.97 -46.12 3.66 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -176.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.542 ' CG ' ' O ' ' A' ' 112' ' ' GLU . 0.3 OUTLIER 150.44 51.07 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -179.611 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.451 ' CB ' ' O ' ' A' ' 113' ' ' HIS . . . 159.57 -161.36 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 179.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.15 14.79 27.62 Favored Glycine 0 C--O 1.227 -0.314 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.733 177.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 59.9 mt -60.47 -40.56 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.54 -39.97 95.86 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 175.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 34.6 t -58.78 -42.89 90.07 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 176.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.514 HH22 ' CD ' ' A' ' 109' ' ' LYS . 2.4 mpt_? -63.75 -37.3 86.86 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.249 -178.009 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 62.5 tp -63.49 -46.27 86.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.587 0.708 . . . . 0.0 109.145 178.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 59.8 mt -66.83 -44.7 80.43 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.342 178.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.96 -44.94 91.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 119.433 1.015 . . . . 0.0 109.434 177.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -66.15 -44.26 91.51 Favored Glycine 0 CA--C 1.517 0.172 0 C-N-CA 119.806 -1.187 . . . . 0.0 111.244 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 14.6 t -64.05 -44.0 93.8 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.875 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 21.7 p -69.53 -48.53 60.14 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 119.22 -0.992 . . . . 0.0 112.054 177.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 25.3 m -65.53 -42.72 91.66 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -174.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -64.19 -44.38 95.73 Favored Glycine 0 N--CA 1.461 0.365 0 CA-C-O 122.945 1.303 . . . . 0.0 112.975 -177.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.413 ' O ' ' CG1' ' A' ' 131' ' ' VAL . . . -60.8 -40.93 94.48 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 111.763 -2.219 . . . . 0.0 106.627 177.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -64.24 -42.23 96.61 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.538 178.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.19 -39.92 96.02 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -177.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.427 ' O ' ' O ' ' A' ' 134' ' ' ALA . 2.4 p -60.88 -24.74 33.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 122.383 1.087 . . . . 0.0 109.366 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -57.32 -44.49 84.25 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 113.096 -1.866 . . . . 0.0 111.685 -178.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.492 ' CG1' ' N ' ' A' ' 134' ' ' ALA . 2.6 p -78.91 -48.68 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.785 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.492 ' N ' ' CG1' ' A' ' 133' ' ' VAL . . . -86.52 126.07 34.2 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.527 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.439 ' N ' ' HD2' ' A' ' 136' ' ' PRO . 12.0 tp-100 -171.29 -53.25 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.686 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 135' ' ' GLN . 10.9 Cg_endo -51.67 -32.9 46.95 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 121.706 1.604 . . . . 0.0 111.852 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.408 ' CG2' ' NZ ' ' A' ' 141' ' ' LYS . 12.2 m -67.46 -42.44 83.04 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 117.759 -1.576 . . . . 0.0 109.736 -179.067 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -66.89 -43.57 83.11 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -178.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.2 m -64.73 -44.22 96.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -178.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 31.6 m -65.16 -39.03 84.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -177.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.408 ' NZ ' ' CG2' ' A' ' 137' ' ' THR . 33.0 mttp -62.53 -42.15 99.33 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 119.38 -0.928 . . . . 0.0 111.98 -177.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 14.4 m -70.42 -45.41 75.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 120.104 -0.638 . . . . 0.0 110.036 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.02 -36.84 85.68 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.624 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -66.91 -42.02 86.14 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -177.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 24.6 mm100 -65.67 -40.03 91.97 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 118.987 -1.085 . . . . 0.0 110.093 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.32 -34.98 79.61 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -178.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.507 ' NE2' ' O ' ' A' ' 147' ' ' GLN . 2.0 pp0? -59.89 111.1 1.34 Allowed 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 177.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -98.62 -60.88 1.46 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 117.6 -1.191 . . . . 0.0 113.919 -175.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 96.6 mtt-85 -90.67 130.42 36.68 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 122.476 2.398 . . . . 0.0 110.357 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -65.21 -14.21 60.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.436 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 72.41 23.95 77.09 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.525 ' C ' ' H ' ' A' ' 154' ' ' ARG . . . 80.68 -104.29 2.28 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.583 ' C ' ' H ' ' A' ' 155' ' ' ARG . . . 73.75 -33.79 0.87 Allowed Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.525 ' H ' ' C ' ' A' ' 152' ' ' GLY . 51.0 ttp85 67.01 -28.47 0.13 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.423 0.154 . . . . 0.0 111.387 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.583 ' H ' ' C ' ' A' ' 153' ' ' GLY . 28.8 ttm180 -93.67 8.72 39.82 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.87 0.367 . . . . 0.0 110.391 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.428 ' CD2' ' O ' ' A' ' 157' ' ' GLN . 49.8 t80 60.1 139.86 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.627 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.428 ' O ' ' CD2' ' A' ' 156' ' ' TYR . 26.4 mt-30 -84.3 172.37 11.87 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.954 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.623 ' H ' ' CG ' ' A' ' 161' ' ' GLU . 37.0 m -157.05 -178.52 7.43 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.253 0.549 . . . . 0.0 111.054 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 9.4 p -64.88 -46.55 81.33 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 120.149 -0.62 . . . . 0.0 112.39 -178.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 8.3 p -64.72 -45.92 93.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 119.305 -0.958 . . . . 0.0 110.777 -178.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.623 ' CG ' ' H ' ' A' ' 158' ' ' SER . 1.5 pp20? -67.55 -38.74 84.58 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.219 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.527 ' N ' ' OE2' ' A' ' 161' ' ' GLU . . . -61.36 -45.65 93.51 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -178.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.4 ' CD1' ' C ' ' A' ' 163' ' ' TYR . 21.4 t80 -62.5 -50.19 72.36 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.286 -179.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 4.7 mtpm? -69.15 -45.48 69.96 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 -176.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.439 ' CG2' ' N ' ' A' ' 166' ' ' ILE . 14.4 t -62.69 -44.64 95.72 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -176.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.439 ' N ' ' CG2' ' A' ' 165' ' ' THR . 20.9 tt -64.65 -38.36 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-O 121.997 0.904 . . . . 0.0 109.559 176.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.73 -36.54 76.78 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 113.834 -1.53 . . . . 0.0 107.821 176.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 13.1 tpp85 -62.26 -50.25 72.47 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 122.393 2.36 . . . . 0.0 111.89 -175.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -74.9 -51.06 14.82 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 123.486 0.715 . . . . 0.0 109.392 177.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -78.1 -36.42 48.06 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 -173.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 91.52 -166.91 30.75 Favored Glycine 0 N--CA 1.468 0.767 0 O-C-N 121.704 -0.622 . . . . 0.0 112.088 177.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 2.5 pp -72.97 -43.67 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-O 121.908 0.861 . . . . 0.0 110.469 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 24.9 tpt85 -58.89 -33.86 70.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.199 -1.364 . . . . 0.0 111.0 -177.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -60.9 -40.64 98.61 Favored Glycine 0 CA--C 1.522 0.511 0 C-N-CA 118.619 -1.753 . . . . 0.0 109.646 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 17.8 tp -70.34 -33.77 71.88 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 111.319 -2.44 . . . . 0.0 116.803 -177.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 7.3 m0 -78.01 -7.44 56.88 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 111.845 -2.434 . . . . 0.0 109.783 -177.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -43.39 -47.99 6.99 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.529 -0.759 . . . . 0.0 112.521 -176.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -91.51 -34.31 7.5 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 123.978 0.799 . . . . 0.0 111.81 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 44.7 p -45.19 -51.21 10.85 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 1.6 t -62.44 -50.8 77.33 Favored Pre-proline 0 N--CA 1.47 0.562 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -176.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -64.96 -28.32 57.99 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.402 1.402 . . . . 0.0 111.377 176.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -63.95 -39.13 93.43 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 56.4 t -63.01 -43.15 98.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.219 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.75 -40.01 95.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.762 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 9.1 tmm_? -61.31 -42.39 98.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.422 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -61.81 -43.69 98.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.081 0.467 . . . . 0.0 110.53 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.62 -43.84 92.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.952 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 79.4 mt -63.35 -45.35 98.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.856 -178.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 84.7 t -60.09 -47.4 92.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 119.465 -0.894 . . . . 0.0 111.033 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -62.91 -42.99 99.98 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 122.311 1.053 . . . . 0.0 110.194 178.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' CYS . . . . . . . . . . . . . 37.5 t -61.86 -45.63 92.93 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 113.422 -1.717 . . . . 0.0 109.685 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -63.91 -39.57 94.48 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 113.193 -1.822 . . . . 0.0 109.94 176.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.5 -44.95 92.97 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.557 0.743 . . . . 0.0 111.522 -176.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 37.6 tp -64.87 -38.23 90.28 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.971 -176.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 92.1 t -64.47 -47.43 89.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 117.893 -1.523 . . . . 0.0 110.508 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 3.1 t -64.55 -44.24 91.41 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.057 0.943 . . . . 0.0 113.172 -177.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -54.75 -38.28 66.99 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.821 0.848 . . . . 0.0 111.372 -176.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -56.42 -44.09 80.04 Favored 'General case' 0 C--N 1.313 -0.997 0 O-C-N 121.739 -0.6 . . . . 0.0 110.451 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.557 ' H ' ' CD2' ' A' ' 199' ' ' LEU . 2.8 mm? -61.71 -41.09 97.15 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -177.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 6.3 pt -64.23 -40.61 89.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.68 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -57.66 -38.54 75.27 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.461 1.904 . . . . 0.0 113.846 -178.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -65.43 -38.9 91.28 Favored 'General case' 0 C--O 1.245 0.861 0 C-N-CA 117.932 -1.507 . . . . 0.0 111.105 -177.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 55.1 m -102.61 128.9 49.09 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 122.369 1.081 . . . . 0.0 112.736 -178.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 1.2 mt 67.27 2.65 2.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 112.945 -1.934 . . . . 0.0 112.048 178.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.79 24.03 11.31 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.817 ' O ' ' N ' ' A' ' 208' ' ' ASN . 57.4 pttt -96.78 173.38 7.34 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 178.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . 48.91 -67.15 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 O-C-N 126.116 2.135 . . . . 0.0 110.658 -178.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . 0.817 ' N ' ' O ' ' A' ' 206' ' ' LYS . 9.6 p-10 164.92 109.71 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 111.976 -2.374 . . . . 0.0 106.229 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.483 ' CG ' ' O ' ' A' ' 209' ' ' LEU . 13.4 tp -48.97 17.48 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 108.846 -3.797 . . . . 0.0 112.564 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' MET . . . . . 0.72 ' H ' ' C ' ' A' ' 208' ' ' ASN . 4.3 ptm -119.96 134.02 55.37 Favored 'General case' 0 C--N 1.314 -0.95 0 O-C-N 121.632 -0.668 . . . . 0.0 110.499 178.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 3.9 m -154.7 -127.93 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.694 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -132.37 -35.37 1.17 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.356 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -79.4 68.23 5.36 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.197 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.455 ' N ' ' HD2' ' A' ' 215' ' ' PRO . 12.4 mt -61.28 -44.48 93.36 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.455 ' HD2' ' N ' ' A' ' 214' ' ' LEU . 23.0 Cg_endo -61.43 -33.31 88.65 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 CA-C-N 120.944 1.373 . . . . 0.0 111.052 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 85.8 m -64.6 -42.47 95.54 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 113.487 -1.688 . . . . 0.0 111.969 -178.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' HIS . . . . . 0.628 ' NE2' ' CD2' ' A' ' 218' ' ' PHE . 1.8 p-80 -66.78 -37.9 85.49 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' PHE . . . . . 0.628 ' CD2' ' NE2' ' A' ' 217' ' ' HIS . 1.4 m-85 -63.14 -47.29 83.37 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.322 -178.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 89.7 m -60.13 -37.8 81.16 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 118.73 0.696 . . . . 0.0 110.925 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 67.9 m -59.35 -41.42 89.17 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . 0.569 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.62 -41.4 98.29 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -177.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -61.43 -46.8 88.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 122.077 0.942 . . . . 0.0 112.786 -176.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -60.1 -41.66 98.17 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 107.164 -2.374 . . . . 0.0 107.164 177.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -62.77 -37.78 87.99 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 176.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -61.82 -42.38 99.74 Favored Glycine 0 CA--C 1.523 0.584 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.843 -178.225 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' PHE . . . . . 0.432 ' O ' ' OG1' ' A' ' 229' ' ' THR . 55.5 t80 -66.39 -38.3 87.2 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 15.7 t -62.84 -40.7 98.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.532 0.682 . . . . 0.0 109.248 176.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -61.43 -40.09 93.19 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.589 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' A' ' 226' ' ' PHE . 19.7 p -59.36 -39.63 83.88 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.85 -177.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 92.6 t -60.82 -42.61 93.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 119.006 -1.078 . . . . 0.0 111.969 -178.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 3.8 tp -62.4 -40.22 87.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 176.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -62.1 -39.77 93.63 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.483 ' N ' ' HD2' ' A' ' 234' ' ' PRO . 66.2 m -58.71 -42.81 96.27 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 115.768 1.766 . . . . 0.0 115.768 -175.017 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 233' ' ' SER . 21.0 Cg_endo -59.89 -40.72 60.24 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 CA-C-N 121.051 1.411 . . . . 0.0 113.9 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 11.1 m -65.14 -36.5 77.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.008 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -64.96 -41.24 95.64 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -178.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.406 ' O ' ' OG1' ' A' ' 240' ' ' THR . 5.7 m -65.64 -45.58 91.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -177.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 57.3 t -63.1 -38.19 81.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -177.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 5.1 ptmm? -60.73 -43.23 98.15 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.082 -0.647 . . . . 0.0 111.34 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' THR . . . . . 0.406 ' OG1' ' O ' ' A' ' 237' ' ' VAL . 37.6 p -60.58 -41.87 95.52 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.304 -0.407 . . . . 0.0 112.002 -178.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.592 ' NH1' ' CD1' ' A' ' 269' ' ' PHE . 71.7 ttt180 -46.57 138.19 6.11 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.435 -0.506 . . . . 0.0 109.797 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.628 ' CG ' ' O ' ' A' ' 242' ' ' TYR . 5.0 t80 169.37 8.53 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' MET . . . . . 0.578 ' N ' ' SD ' ' A' ' 243' ' ' MET . 2.0 mpt? -92.86 -24.58 18.43 Favored 'General case' 0 N--CA 1.463 0.19 0 O-C-N 121.726 -0.609 . . . . 0.0 109.632 177.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . 0.492 ' C ' ' O ' ' A' ' 243' ' ' MET . 6.9 p30 -28.18 133.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.734 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' SER . . . . . 0.576 ' O ' ' O ' ' A' ' 246' ' ' ALA . 6.6 t -91.55 -147.93 0.22 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.589 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . 0.629 ' O ' ' C ' ' A' ' 247' ' ' LEU . . . 55.77 126.97 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 -170.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.845 ' CB ' ' HA2' ' A' ' 248' ' ' GLY . 0.3 OUTLIER -21.87 -71.17 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.2 -171.937 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 1.002 ' O ' ' HB2' ' A' ' 249' ' ' GLN . . . -137.84 43.13 1.22 Allowed Glycine 0 N--CA 1.451 -0.358 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 -1.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 1.002 ' HB2' ' O ' ' A' ' 248' ' ' GLY . 3.2 mt-30 102.65 118.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.703 0.287 . . . . 0.0 110.493 -178.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.477 ' CE1' ' CA ' ' A' ' 252' ' ' SER . 6.1 t80 -149.9 136.14 18.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.048 0.451 . . . . 0.0 111.795 -178.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -136.25 -23.67 1.28 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 176.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' SER . . . . . 0.477 ' CA ' ' CE1' ' A' ' 250' ' ' TYR . 9.6 t 179.22 -173.13 0.17 Allowed 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -59.72 -43.44 94.16 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 179.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -55.52 -34.89 60.52 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 125.21 1.386 . . . . 0.0 111.268 -172.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' HIS . . . . . 0.769 ' NE2' HG21 ' A' ' 259' ' ' THR . 86.4 t60 -55.92 -32.11 63.49 Favored 'General case' 0 C--N 1.369 1.441 0 C-N-CA 115.514 -2.474 . . . . 0.0 111.061 178.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' CYS . . . . . . . . . . . . . 7.1 t -60.75 -45.68 93.38 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.116 178.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -61.17 -46.0 92.3 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.194 -0.602 . . . . 0.0 111.532 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 20.2 mt -67.93 -43.97 77.93 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.691 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' THR . . . . . 0.769 HG21 ' NE2' ' A' ' 255' ' ' HIS . 24.8 p -63.48 -46.88 84.14 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 -178.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' MET . . . . . 0.601 ' SD ' ' N ' ' A' ' 261' ' ' LEU . 0.0 OUTLIER -61.8 -44.37 97.0 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.214 -0.594 . . . . 0.0 112.47 -177.273 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.601 ' N ' ' SD ' ' A' ' 260' ' ' MET . 12.5 tp -62.62 -46.67 87.2 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.607 0.242 . . . . 0.0 110.444 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 52.5 ttp180 -66.14 -53.76 33.71 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.805 -178.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . 0.581 ' CB ' ' HZ3' ' A' ' 263' ' ' LYS . 0.0 OUTLIER -123.33 160.95 25.64 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 120.938 0.399 . . . . 0.0 111.044 179.272 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . 0.464 ' O ' ' O ' ' A' ' 265' ' ' GLY . 72.6 mt-10 57.83 88.71 0.06 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.278 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 264' ' ' GLU . . . -38.04 166.07 0.01 OUTLIER Glycine 0 CA--C 1.531 1.058 0 N-CA-C 111.669 -0.572 . . . . 0.0 111.669 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -63.4 -5.07 7.63 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 122.817 2.344 . . . . 0.0 111.596 179.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 18.3 ptp180 -69.63 -26.58 64.49 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 123.086 0.554 . . . . 0.0 111.685 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -58.52 -32.49 68.88 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.895 -179.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . 0.592 ' CD1' ' NH1' ' A' ' 241' ' ' ARG . 57.2 m-85 -62.53 -41.87 99.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.237 0.541 . . . . 0.0 110.753 177.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -65.93 -37.77 86.92 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.84 -178.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp -77.99 -175.16 3.91 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 44.45 84.85 0.01 OUTLIER Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.371 -1.091 . . . . 0.0 110.371 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -152.78 6.79 0.4 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.558 0.218 . . . . 0.0 110.769 -179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' MET . . . . . 0.587 ' N ' ' CD ' ' A' ' 275' ' ' PRO . 1.9 tpt -63.66 -43.92 78.86 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 274' ' ' MET . 23.0 Cg_exo -64.12 -46.72 7.54 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.343 2.029 . . . . 0.0 111.205 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 37.4 t -61.0 -40.67 94.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.23 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -62.41 -43.44 98.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 122.88 1.324 . . . . 0.0 113.163 -178.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 8.0 tt -62.01 -38.57 89.14 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 111.897 -2.411 . . . . 0.0 107.072 174.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.69 -40.32 96.75 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.843 178.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 8.2 tp -62.32 -37.24 84.82 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -178.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -67.95 -50.6 39.75 Favored Glycine 0 CA--C 1.52 0.399 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 -178.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.14 -44.38 96.76 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' TRP . . . . . . . . . . . . . 57.1 t-105 -60.26 -38.67 84.2 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -63.18 -38.5 91.44 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.725 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 54.8 t -61.11 -39.24 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 -178.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 6.9 m -62.6 -39.99 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 119.848 -0.741 . . . . 0.0 110.574 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' MET . . . . . 0.456 ' C ' ' SD ' ' A' ' 287' ' ' MET . 0.0 OUTLIER -60.94 -38.87 87.35 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 122.128 -0.357 . . . . 0.0 110.503 179.758 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -59.32 -41.61 89.51 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -178.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 7.4 p -61.52 -37.72 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.027 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.416 ' OG1' ' O ' ' A' ' 287' ' ' MET . 51.2 p -61.67 -39.43 91.37 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 177.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -60.37 -38.49 84.05 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 177.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.99 -39.93 79.45 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 117.948 -1.501 . . . . 0.0 109.488 -176.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' GLN . . . . . 0.45 ' O ' ' O ' ' A' ' 296' ' ' ARG . 80.3 mt-30 -60.37 -42.47 95.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 122.678 1.228 . . . . 0.0 110.641 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 8.9 mp -60.43 -40.26 90.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 112.632 -2.076 . . . . 0.0 109.003 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 17.9 tptp -63.02 -45.84 90.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.266 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' ARG . . . . . 0.45 ' O ' ' O ' ' A' ' 293' ' ' GLN . 64.0 ttm-85 -123.06 116.37 23.38 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.264 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -116.82 -93.2 0.51 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.125 0.488 . . . . 0.0 111.318 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.54 ' CD1' ' N ' ' A' ' 298' ' ' LEU . 0.0 OUTLIER -137.39 -170.89 2.84 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.394 178.4 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 299' ' ' MET . . . . . 0.506 ' N ' ' CD2' ' A' ' 298' ' ' LEU . 34.8 ttm -169.32 65.91 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.625 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.68 101.04 0.07 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.928 0.871 . . . . 0.0 110.583 -178.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -64.0 -46.26 85.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 113.822 -1.536 . . . . 0.0 113.331 -176.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -58.65 -39.89 81.89 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.119 -0.633 . . . . 0.0 109.791 -178.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 6.6 tm0? -65.01 -47.0 79.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.487 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 304' ' ' SER . . . . . 0.429 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 50.0 m -66.71 -37.83 85.51 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.509 -0.477 . . . . 0.0 110.581 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -61.7 -43.22 99.28 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -65.04 -36.97 86.08 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -176.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -60.02 -52.94 69.89 Favored Pre-proline 0 CA--C 1.545 0.76 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 -176.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 308' ' ' PRO . . . . . 0.429 ' CD ' ' O ' ' A' ' 304' ' ' SER . 74.0 Cg_endo -75.23 0.21 9.27 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.053 1.835 . . . . 0.0 111.793 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 52.4 t80 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.499 -179.996 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.579 ' N ' ' NE2' ' A' ' 303' ' ' GLN . 2.2 mpt? . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.9 m -159.67 104.08 1.57 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.496 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.4 t -137.97 150.08 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.495 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.1 mmmm -64.41 -41.87 96.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.905 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -63.61 -41.34 98.31 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.4 tt -79.59 -26.23 41.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.443 -178.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.452 ' O ' ' OG1' ' A' ' 22' ' ' THR . . . -66.18 -41.42 94.88 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 107.761 -2.135 . . . . 0.0 107.761 177.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.6 -32.25 67.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 124.889 2.281 . . . . 0.0 107.657 176.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.29 -42.26 99.3 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-N 108.448 -3.978 . . . . 0.0 108.165 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' A' ' 19' ' ' GLY . 32.6 p -70.62 -27.32 63.99 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 177.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.51 -50.04 64.55 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.775 -1.102 . . . . 0.0 112.194 -179.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.97 -35.89 79.83 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 118.482 -1.287 . . . . 0.0 111.204 -177.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.0 t -63.78 -53.39 51.64 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.847 -178.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 71.2 mt -65.43 -39.74 86.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 -177.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.441 ' O ' ' OG1' ' A' ' 31' ' ' THR . . . -64.57 -42.19 95.81 Favored 'General case' 0 C--N 1.333 -0.109 0 C-N-CA 119.84 -0.744 . . . . 0.0 112.946 -174.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.459 ' CB ' ' OE1' ' A' ' 89' ' ' GLN . 16.7 m-20 -78.24 -27.49 47.66 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 117.964 -1.495 . . . . 0.0 109.084 -177.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.5 tp -59.98 -56.05 26.46 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 118.546 -1.262 . . . . 0.0 111.113 -178.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.2 pp -75.73 -5.24 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' A' ' 27' ' ' ALA . 19.1 m -110.17 -17.96 13.42 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 118.811 -1.155 . . . . 0.0 109.941 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.478 ' N ' ' HD2' ' A' ' 33' ' ' PRO . 72.7 t80 -68.27 -45.22 38.55 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 121.308 1.867 . . . . 0.0 112.235 -177.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 32' ' ' PHE . 20.8 Cg_endo -59.42 -14.73 26.49 Favored 'Trans proline' 0 N--CA 1.5 1.872 0 CA-C-N 121.147 1.445 . . . . 0.0 111.147 176.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.31 -35.41 80.3 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 114.686 -1.143 . . . . 0.0 113.086 -177.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -64.69 -40.55 95.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.278 -178.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 52.1 p -58.39 -34.9 71.23 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.3 -38.27 84.73 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.72 -0.792 . . . . 0.0 112.534 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.446 ' CG ' ' N ' ' A' ' 39' ' ' VAL . 10.7 pttp -62.01 -48.93 78.12 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 119.576 -0.85 . . . . 0.0 111.69 -176.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.446 ' N ' ' CG ' ' A' ' 38' ' ' LYS . 8.8 p -64.8 -39.89 87.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -177.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.526 ' C ' ' H ' ' A' ' 42' ' ' GLN . 6.4 tpm_? -61.04 -42.86 99.28 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -177.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.423 ' CD1' ' O ' ' A' ' 38' ' ' LYS . 2.4 pp -63.15 38.73 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.799 178.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.526 ' H ' ' C ' ' A' ' 40' ' ' ARG . 42.7 tt0 -145.25 165.68 27.69 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.901 0.382 . . . . 0.0 111.273 -178.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.495 ' CD1' ' H ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -73.57 79.17 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.62 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -44.89 135.99 4.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.857 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.99 135.88 0.24 Allowed Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.502 ' O ' ' N ' ' A' ' 48' ' ' GLN . 11.1 pt-20 -94.16 150.51 20.25 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.71 0.291 . . . . 0.0 110.564 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 49.9 m 57.45 -80.55 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.571 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.502 ' N ' ' O ' ' A' ' 46' ' ' GLU . 63.7 mt-30 55.0 178.54 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.212 0.53 . . . . 0.0 111.049 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -153.3 -22.66 0.05 OUTLIER Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.523 ' CD2' ' N ' ' A' ' 50' ' ' LEU . 3.5 mm? -66.63 -38.5 87.05 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 20.5 m -61.15 -44.28 98.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.992 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 33.4 mtm-85 -64.31 -33.64 76.3 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.357 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 19.1 m -67.6 -38.32 83.81 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.471 ' O ' ' CB ' ' A' ' 55' ' ' ALA . . . -95.44 -122.1 0.11 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.195 178.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.471 ' CB ' ' O ' ' A' ' 54' ' ' ALA . . . 162.87 -22.71 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 121.191 -0.203 . . . . 0.0 110.842 179.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.52 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 4.6 m -128.53 -138.31 0.24 Allowed 'General case' 0 C--N 1.334 -0.107 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.52 ' CB ' ' O ' ' A' ' 56' ' ' SER . . . 93.59 14.99 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 O-C-N 123.883 0.74 . . . . 0.0 111.937 178.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.521 HE22 HH22 ' A' ' 40' ' ' ARG . 27.7 mt-30 -152.92 55.99 0.78 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -41.91 132.8 3.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.187 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 63.3 mtm-85 -41.02 -42.92 2.03 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.34 0.59 . . . . 0.0 109.921 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -31.95 104.22 0.01 OUTLIER Glycine 0 CA--C 1.527 0.834 0 CA-C-N 114.853 -1.067 . . . . 0.0 112.476 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 26.2 m -67.11 -33.58 64.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 118.262 -0.875 . . . . 0.0 109.046 176.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -60.0 -32.32 70.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 121.061 1.755 . . . . 0.0 109.785 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -65.1 -49.59 61.45 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-N 115.393 -0.821 . . . . 0.0 114.534 -177.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.3 m -62.57 -46.88 86.3 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -178.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.8 pp -60.27 -35.18 60.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.35 -35.56 80.81 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 120.853 1.66 . . . . 0.0 110.948 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.469 ' O ' ' OG1' ' A' ' 72' ' ' THR . 98.8 m -61.77 -39.19 90.78 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 113.168 -1.833 . . . . 0.0 111.034 -176.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 15.5 tpt -60.51 -39.47 87.91 Favored 'General case' 0 C--N 1.332 -0.179 0 O-C-N 121.135 -0.978 . . . . 0.0 113.531 -177.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.5 t -68.98 -40.42 80.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 119.192 -1.003 . . . . 0.0 112.652 -177.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 56.9 ttt-85 -77.63 -13.39 59.92 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.94 0.876 . . . . 0.0 112.736 -178.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.469 ' OG1' ' O ' ' A' ' 68' ' ' THR . 49.3 m -62.87 -55.12 28.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.17 -1.377 . . . . 0.0 112.338 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -108.74 -58.78 1.97 Allowed 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 159.37 163.81 13.78 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -56.51 -34.89 96.08 Favored 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 122.229 1.953 . . . . 0.0 111.605 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 12.3 tpp180 -61.16 -11.22 8.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.908 0.861 . . . . 0.0 111.056 176.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.5 t -77.36 -32.1 54.79 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 113.953 -1.476 . . . . 0.0 110.994 -177.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 19.3 mt -75.61 -33.66 60.54 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.286 -0.566 . . . . 0.0 111.156 179.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.472 ' C ' ' H ' ' A' ' 81' ' ' GLY . 61.6 m-85 -92.81 -5.33 51.32 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 122.305 1.05 . . . . 0.0 113.386 -178.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.433 ' CG ' ' O ' ' A' ' 80' ' ' ASN . 21.5 t30 -86.25 33.9 0.62 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 112.957 -1.929 . . . . 0.0 107.393 175.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.472 ' H ' ' C ' ' A' ' 79' ' ' TYR . . . -172.9 -9.78 0.02 OUTLIER Glycine 0 CA--C 1.526 0.747 0 CA-C-N 114.485 -1.234 . . . . 0.0 112.535 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 61.2 tp -59.48 -35.07 73.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.469 -0.866 . . . . 0.0 110.963 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.2 m -70.74 -26.84 28.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.799 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.63 -31.45 61.99 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.793 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.8 -40.18 89.73 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 119.893 -1.146 . . . . 0.0 111.751 -177.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -62.63 -40.28 96.5 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 122.16 0.981 . . . . 0.0 113.094 -176.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 20.2 tm0? -60.39 -27.44 67.44 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 113.349 -1.751 . . . . 0.0 109.456 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 72.7 mtt-85 -58.07 -53.46 57.96 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 173.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.459 ' OE1' ' CB ' ' A' ' 28' ' ' ASP . 23.6 mm100 -67.15 -29.97 69.83 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 112.08 -2.327 . . . . 0.0 112.373 -177.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 10.4 tpp -61.2 -40.46 94.04 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.078 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 68.3 m -74.64 -34.16 62.69 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 118.346 -0.835 . . . . 0.0 111.339 -176.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -57.58 -44.11 85.1 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 120.701 1.591 . . . . 0.0 112.044 -176.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.48 -33.0 64.61 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.466 -0.893 . . . . 0.0 111.025 -178.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 59.6 p -64.03 -41.87 97.28 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.449 ' C ' ' H ' ' A' ' 97' ' ' ILE . 34.3 m -68.18 -27.81 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.988 177.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 47.6 ttp85 -77.21 8.54 3.9 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -176.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.449 ' H ' ' C ' ' A' ' 95' ' ' VAL . 46.3 mm -87.71 -15.08 9.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 177.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.423 ' O ' ' OG ' ' A' ' 102' ' ' SER . . . -140.25 -48.3 0.05 OUTLIER Glycine 0 CA--C 1.538 1.53 0 N-CA-C 115.902 1.121 . . . . 0.0 115.902 -175.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.0 tp -71.1 -13.23 61.89 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 119.249 1.524 . . . . 0.0 112.244 -177.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.521 ' O ' ' CG ' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -80.86 -51.28 8.76 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 114.688 -1.142 . . . . 0.0 111.834 179.71 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.468 ' O ' ' HG3' ' A' ' 105' ' ' GLN . 2.4 p30 -69.23 -32.48 71.75 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 123.768 1.747 . . . . 0.0 110.47 -178.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 98' ' ' GLY . 25.8 m -68.17 -51.79 41.83 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 110.234 -3.167 . . . . 0.0 113.327 177.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 47.0 t -73.63 -26.28 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 CA-C-N 121.405 1.911 . . . . 0.0 111.257 178.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.521 ' CG ' ' O ' ' A' ' 100' ' ' TYR . 20.7 mmtp -69.32 -41.61 76.48 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 112.523 -2.126 . . . . 0.0 111.582 179.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.468 ' HG3' ' O ' ' A' ' 101' ' ' ASP . 88.1 mt-30 -80.1 -15.66 56.66 Favored 'General case' 0 C--O 1.245 0.847 0 CA-C-O 122.065 0.936 . . . . 0.0 110.998 -178.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -80.48 -22.29 41.17 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 121.741 -0.6 . . . . 0.0 112.109 179.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.414 ' O ' ' NE ' ' A' ' 119' ' ' ARG . 13.8 m-85 -109.07 -28.62 8.97 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.692 0.797 . . . . 0.0 111.794 -174.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.2 m -96.12 9.49 40.73 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 116.752 -1.979 . . . . 0.0 113.639 -176.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -46.46 124.7 6.1 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.997 1.271 . . . . 0.0 109.49 176.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -131.55 40.91 1.57 Allowed Glycine 0 N--CA 1.479 1.549 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 178.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 14.8 m -67.5 -37.63 83.12 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 -176.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -125.43 162.41 24.91 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 120.759 0.314 . . . . 0.0 111.084 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.447 ' O ' ' CB ' ' A' ' 114' ' ' ALA . 6.7 p-80 -77.03 67.33 3.0 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -178.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.447 ' CB ' ' O ' ' A' ' 113' ' ' HIS . . . 159.06 -163.06 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 176.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 101.57 15.33 27.5 Favored Glycine 0 C--N 1.343 0.949 0 CA-C-N 113.873 -1.512 . . . . 0.0 113.238 175.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.41 HG23 HD12 ' A' ' 116' ' ' ILE . 25.4 mm -61.1 -40.99 87.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 CA-C-N 118.416 1.108 . . . . 0.0 110.31 -179.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.33 -39.96 96.22 Favored Glycine 0 C--N 1.346 1.095 0 CA-C-O 122.237 0.909 . . . . 0.0 111.361 176.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.1 t -57.48 -41.72 81.23 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 177.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.414 ' NE ' ' O ' ' A' ' 107' ' ' TYR . 26.9 ttm180 -63.18 -37.54 87.61 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.474 -0.491 . . . . 0.0 111.249 -177.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -64.32 -46.28 84.23 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 177.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 31.5 mt -66.64 -45.1 80.09 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 118.978 -1.089 . . . . 0.0 110.145 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.97 -45.18 90.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 119.813 1.188 . . . . 0.0 110.315 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.413 ' CA ' ' CZ ' ' A' ' 107' ' ' TYR . . . -65.79 -44.28 92.48 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.766 -178.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 59.0 m -63.83 -43.66 95.52 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 19.1 m -69.06 -48.01 63.86 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 119.526 -0.87 . . . . 0.0 112.416 177.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.42 ' CG2' ' N ' ' A' ' 127' ' ' GLY . 5.7 t -65.47 -42.51 92.2 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 -173.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.542 ' C ' HD22 ' A' ' 186' ' ' ASN . . . -64.46 -44.73 94.84 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-O 122.543 1.08 . . . . 0.0 113.736 -177.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.03 -40.8 94.98 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 112.689 -1.756 . . . . 0.0 107.204 178.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.84 -41.22 99.26 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 114.86 -1.063 . . . . 0.0 109.576 178.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -61.82 -38.44 88.17 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.74 -0.209 . . . . 0.0 111.38 -178.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 79.1 t -60.63 -25.91 36.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.742 0.782 . . . . 0.0 109.836 179.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -57.9 -44.41 86.73 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.236 -1.347 . . . . 0.0 111.215 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 43.1 t -78.73 -49.15 20.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.563 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -99.89 124.52 45.29 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 110.248 -0.278 . . . . 0.0 110.248 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.439 ' N ' ' HD2' ' A' ' 136' ' ' PRO . 33.2 tt0 -176.62 -54.49 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 135' ' ' GLN . 11.2 Cg_endo -52.3 -34.81 61.67 Favored 'Trans proline' 0 N--CA 1.5 1.885 0 C-N-CA 121.389 1.393 . . . . 0.0 113.902 -177.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 81.0 p -67.54 -41.77 83.77 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 118.491 -1.284 . . . . 0.0 109.369 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -64.58 -42.43 95.63 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 118.977 -1.089 . . . . 0.0 112.746 -176.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 17.2 m -63.81 -43.35 97.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 54.3 t -64.53 -38.47 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -178.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -61.47 -40.33 94.14 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 119.978 -0.689 . . . . 0.0 112.106 -176.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.3 p -69.39 -44.42 80.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.529 ' NH2' ' OE1' ' A' ' 170' ' ' GLU . 12.4 tpt85 -63.98 -35.83 81.99 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.951 179.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.488 ' CD2' ' OE1' ' A' ' 147' ' ' GLN . 40.9 t80 -65.96 -40.22 91.09 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.975 -177.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -63.72 -38.91 92.88 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.358 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -64.86 -34.76 79.15 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -178.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.488 ' OE1' ' CD2' ' A' ' 144' ' ' PHE . 5.0 pt20 -59.48 111.1 1.27 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 178.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -97.55 -61.61 1.37 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 117.523 -1.227 . . . . 0.0 113.951 -176.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 14.1 mtp-105 -101.4 135.52 42.75 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 122.273 2.306 . . . . 0.0 109.903 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -75.35 -113.37 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.519 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 175.19 131.47 1.44 Allowed Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -55.18 126.33 38.57 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 175.82 30.68 0.04 OUTLIER Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 49.0 mmt-85 55.45 172.2 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.786 0.327 . . . . 0.0 110.608 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 83.9 mtt85 54.12 -179.99 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.666 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.501 ' CD2' ' O ' ' A' ' 157' ' ' GLN . 91.8 t80 -123.94 127.22 47.64 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.368 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.501 ' O ' ' CD2' ' A' ' 156' ' ' TYR . 24.0 mt-30 -49.51 170.46 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.552 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 45.2 p -156.94 -178.25 7.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.954 0.407 . . . . 0.0 110.789 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.408 ' CG2' ' N ' ' A' ' 160' ' ' VAL . 11.7 t -64.5 -46.36 83.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.792 -177.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.461 ' CG1' ' N ' ' A' ' 161' ' ' GLU . 12.7 p -64.63 -45.52 95.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 118.898 -1.121 . . . . 0.0 109.077 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.461 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 74.6 tt0 -66.99 -38.95 86.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.996 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -61.41 -45.78 92.91 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -177.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -62.85 -50.42 71.02 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.923 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -68.77 -45.42 71.4 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 115.162 1.541 . . . . 0.0 115.162 -175.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 10.0 m -63.24 -44.44 95.19 Favored 'General case' 0 C--N 1.321 -0.658 0 O-C-N 121.137 -0.977 . . . . 0.0 113.25 -178.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -64.64 -38.72 83.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 122.199 0.999 . . . . 0.0 109.156 177.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.94 -36.64 77.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 113.201 -1.818 . . . . 0.0 109.137 177.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -62.62 -51.0 69.02 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 122.5 2.409 . . . . 0.0 112.713 -174.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -75.38 -51.07 14.01 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 177.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.529 ' OE1' ' NH2' ' A' ' 143' ' ' ARG . 16.3 tt0 -78.67 -36.42 43.79 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -175.016 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 95.62 -169.03 26.95 Favored Glycine 0 N--CA 1.467 0.764 0 CA-C-N 118.13 0.423 . . . . 0.0 112.57 177.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.408 HD11 HG22 ' A' ' 172' ' ' ILE . 6.0 pt -72.92 -40.71 60.11 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.129 0 CA-C-O 121.978 0.894 . . . . 0.0 110.396 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 9.1 tpp85 -58.68 -33.63 70.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 113.859 -1.519 . . . . 0.0 110.952 -177.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -60.91 -40.82 98.88 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 118.676 -1.726 . . . . 0.0 110.244 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 6.8 mt -70.84 -33.64 70.87 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 111.286 -2.457 . . . . 0.0 116.975 -177.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 11.1 m0 -78.35 -7.76 57.66 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 112.456 -2.156 . . . . 0.0 109.752 -176.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -43.47 -48.49 7.27 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.535 -0.466 . . . . 0.0 112.154 -175.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.412 ' O ' ' HD2' ' A' ' 181' ' ' PRO . . . -79.11 -13.63 82.74 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 124.444 1.021 . . . . 0.0 111.933 178.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.422 ' O ' ' OD1' ' A' ' 182' ' ' ASN . 84.6 m -46.33 -51.44 14.71 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.86 -50.95 74.9 Favored Pre-proline 0 N--CA 1.475 0.789 0 N-CA-C 114.287 1.218 . . . . 0.0 114.287 -174.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.412 ' HD2' ' O ' ' A' ' 178' ' ' GLY . 29.1 Cg_exo -64.52 -29.96 61.58 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 CA-C-N 120.678 1.278 . . . . 0.0 113.279 177.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 179' ' ' THR . 0.0 OUTLIER -65.53 -40.85 93.42 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 119.366 -0.934 . . . . 0.0 109.896 178.876 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 54.9 t -64.35 -43.12 97.07 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.166 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.083 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.66 -39.79 95.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.178 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.797 ' HE ' ' HZ1' ' A' ' 239' ' ' LYS . 0.7 OUTLIER -60.88 -43.55 98.31 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 119.789 -0.764 . . . . 0.0 110.885 -178.704 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . 0.542 HD22 ' C ' ' A' ' 127' ' ' GLY . 35.3 t30 -63.36 -45.43 91.22 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.744 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -66.59 -45.86 77.82 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.07 -46.25 91.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -177.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.616 ' CG1' HH21 ' A' ' 185' ' ' ARG . 35.6 m -60.86 -47.81 91.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 119.224 -0.99 . . . . 0.0 111.899 -177.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -62.43 -44.22 96.94 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.609 0.718 . . . . 0.0 110.047 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' CYS . . . . . . . . . . . . . 21.9 t -63.24 -47.61 81.75 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.031 178.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.8 -39.77 94.13 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 113.742 -1.572 . . . . 0.0 110.037 177.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 0.494 ' N ' ' O ' ' A' ' 189' ' ' VAL . 3.8 tm-20 -59.63 -45.75 91.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.252 -1.34 . . . . 0.0 111.803 -176.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.04 -37.64 88.26 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 118.544 -1.262 . . . . 0.0 111.229 -175.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 94.8 t -64.21 -47.34 90.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 117.172 -1.811 . . . . 0.0 109.414 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 3.0 t -65.48 -45.68 82.71 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 122.075 0.94 . . . . 0.0 112.743 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -57.99 -39.8 79.12 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 113.611 -1.631 . . . . 0.0 113.07 -178.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -56.41 -44.85 80.75 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 16.4 mt -62.12 -39.64 93.22 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.185 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 80.6 mt -63.6 -42.9 97.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-O 119.252 -0.404 . . . . 0.0 111.021 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . 0.496 ' O ' ' CD1' ' A' ' 205' ' ' LEU . 0.0 OUTLIER -59.63 -37.46 78.71 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.774 2.03 . . . . 0.0 112.272 177.19 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -58.98 -34.97 72.44 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 114.135 -1.393 . . . . 0.0 110.996 -175.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.2 t -98.78 130.67 45.24 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 121.745 0.784 . . . . 0.0 111.383 -177.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.478 ' CD2' ' CE1' ' A' ' 217' ' ' HIS . 9.7 mp 70.02 6.96 6.01 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 113.417 -1.72 . . . . 0.0 115.61 -178.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.608 ' O ' ' CD2' ' A' ' 205' ' ' LEU . 0.0 OUTLIER -109.71 21.0 17.47 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 120.091 1.314 . . . . 0.0 112.954 179.345 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -60.44 -32.85 71.77 Favored 'General case' 0 C--N 1.332 -0.185 0 O-C-N 120.047 -1.658 . . . . 0.0 113.045 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.492 ' O ' ' CB ' ' A' ' 208' ' ' ASN . . . -165.86 32.83 0.05 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.003 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . 0.492 ' CB ' ' O ' ' A' ' 207' ' ' ALA . 0.3 OUTLIER 93.19 -126.44 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 O-C-N 123.882 0.739 . . . . 0.0 110.371 -179.574 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 6.6 tp -175.85 50.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' MET . . . . . 0.447 ' SD ' ' C ' ' A' ' 210' ' ' MET . 1.5 tmt? -65.96 -21.42 66.42 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.485 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 28.4 p -62.68 -146.27 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.85 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . 0.447 ' CG ' ' N ' ' A' ' 213' ' ' ASP . 35.9 t70 -150.56 -118.0 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.564 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.514 ' O ' ' SG ' ' A' ' 216' ' ' CYS . 71.0 m-20 48.95 44.08 22.19 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.468 ' N ' ' CD ' ' A' ' 215' ' ' PRO . 1.8 mt -61.21 -43.39 90.01 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.63 -0.713 . . . . 0.0 112.504 -178.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.468 ' CD ' ' N ' ' A' ' 214' ' ' LEU . 35.4 Cg_exo -60.29 -33.45 94.55 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 120.966 1.111 . . . . 0.0 111.715 -178.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' CYS . . . . . 0.514 ' SG ' ' O ' ' A' ' 213' ' ' ASP . 0.8 OUTLIER -64.69 -42.04 95.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 113.427 -1.715 . . . . 0.0 111.543 -178.164 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' HIS . . . . . 0.513 ' N ' ' SG ' ' A' ' 216' ' ' CYS . 11.6 t-160 -66.08 -37.13 85.03 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.575 -177.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -62.98 -47.94 80.99 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.051 -178.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 8.4 m -61.11 -38.81 87.66 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 120.211 1.369 . . . . 0.0 110.255 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' A' ' 217' ' ' HIS . 20.7 p -58.97 -40.94 86.28 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -62.71 -41.26 99.06 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -176.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -60.25 -46.59 89.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 122.66 1.219 . . . . 0.0 111.873 -176.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -60.9 -41.77 99.41 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-N 112.364 -2.198 . . . . 0.0 107.771 176.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . 0.524 ' O ' ' SG ' ' A' ' 227' ' ' CYS . . . -62.37 -37.3 85.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.067 -1.067 . . . . 0.0 108.555 177.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -60.97 -41.99 99.59 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 -177.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -66.77 -38.54 86.76 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 119.294 -0.962 . . . . 0.0 108.799 178.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . 0.524 ' SG ' ' O ' ' A' ' 224' ' ' ALA . 0.5 OUTLIER -63.38 -40.53 97.5 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.503 0.668 . . . . 0.0 110.295 177.617 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' THR . . . . . 0.48 ' OG1' ' O ' ' A' ' 225' ' ' GLY . 75.8 p -61.34 -38.06 85.55 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 114.839 -1.073 . . . . 0.0 112.533 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 71.6 p -56.7 -38.86 72.86 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.486 -0.485 . . . . 0.0 111.229 -174.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 3.8 p -59.79 -40.81 83.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 118.026 -1.47 . . . . 0.0 108.318 178.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 24.7 mt -61.54 -40.67 87.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 176.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -62.15 -39.2 91.81 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 114.539 -1.209 . . . . 0.0 113.8 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.44 ' N ' ' HD2' ' A' ' 234' ' ' PRO . 8.2 t -58.74 -43.24 97.58 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 -174.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 233' ' ' SER . 20.0 Cg_endo -60.14 -41.5 51.18 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 CA-C-N 121.947 1.731 . . . . 0.0 112.705 179.065 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 2.9 p -65.97 -37.7 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 117.972 -1.491 . . . . 0.0 109.237 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -66.69 -42.0 87.14 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 -179.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 15.4 m -65.7 -45.43 91.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -176.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 9.9 p -63.54 -37.78 80.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 119.444 -0.902 . . . . 0.0 111.818 -177.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . 0.797 ' HZ1' ' HE ' ' A' ' 185' ' ' ARG . 63.9 mmtt -61.38 -45.72 93.18 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 1.4 t -62.58 -42.14 99.38 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.935 0.398 . . . . 0.0 111.465 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.627 ' NH2' ' CE1' ' A' ' 269' ' ' PHE . 77.1 mtt-85 -54.07 122.41 10.13 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.75 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.606 ' CG ' ' O ' ' A' ' 242' ' ' TYR . 32.7 t80 168.52 6.45 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 O-C-N 123.662 0.602 . . . . 0.0 111.456 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' MET . . . . . . . . . . . . . 16.5 tpt -110.26 125.43 53.1 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . 0.498 ' O ' ' N ' ' A' ' 246' ' ' ALA . 1.5 p30 -179.33 141.13 0.16 Allowed 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.329 -0.548 . . . . 0.0 111.09 -179.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 35.5 p -65.28 68.54 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.739 178.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . 0.498 ' N ' ' O ' ' A' ' 244' ' ' ASN . . . -125.5 -87.59 0.6 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.277 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.401 ' CB ' ' O ' ' A' ' 246' ' ' ALA . 0.2 OUTLIER 76.41 81.64 0.09 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.829 179.783 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 250' ' ' TYR . . . 68.47 -46.47 0.39 Allowed Glycine 0 CA--C 1.526 0.753 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.387 179.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.477 ' HB3' ' CD2' ' A' ' 255' ' ' HIS . 79.7 mt-30 49.96 -89.78 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -178.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.847 ' HB2' ' ND1' ' A' ' 255' ' ' HIS . 5.4 t80 -103.78 -138.95 0.36 Allowed 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.898 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -67.1 -51.9 48.5 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 119.697 3.221 . . . . 0.0 119.697 -174.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 86.9 p -147.92 -170.41 3.57 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 113.267 -1.788 . . . . 0.0 112.175 -172.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -56.72 -39.0 73.14 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 179.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -54.38 -33.99 53.84 Favored Glycine 0 C--N 1.311 -0.825 0 N-CA-C 108.824 -1.711 . . . . 0.0 108.824 -173.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' HIS . . . . . 0.847 ' ND1' ' HB2' ' A' ' 250' ' ' TYR . 86.4 t60 -54.64 -37.66 65.93 Favored 'General case' 0 C--O 1.218 -0.601 0 C-N-CA 118.181 -1.407 . . . . 0.0 110.964 178.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' CYS . . . . . . . . . . . . . 6.7 t -59.4 -44.48 92.82 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.678 -177.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -59.92 -45.26 93.16 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.279 -0.569 . . . . 0.0 110.48 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.43 -43.51 81.0 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 120.134 -0.627 . . . . 0.0 110.118 178.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 94.0 m -62.6 -46.69 87.12 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 -177.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' MET . . . . . 0.566 ' SD ' ' N ' ' A' ' 261' ' ' LEU . 0.1 OUTLIER -61.33 -43.86 98.16 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 120.134 -0.626 . . . . 0.0 110.851 -178.317 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.566 ' N ' ' SD ' ' A' ' 260' ' ' MET . 63.7 tp -63.18 -48.29 79.0 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' ARG . . . . . 0.447 ' O ' ' O ' ' A' ' 263' ' ' LYS . 8.6 tpt180 -67.68 -53.94 23.57 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.765 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . 0.447 ' O ' ' O ' ' A' ' 262' ' ' ARG . 5.4 ttpm? -56.25 -126.49 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.778 -178.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -85.89 143.11 28.4 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 121.094 0.473 . . . . 0.0 111.122 -178.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . 0.563 ' C ' ' H ' ' A' ' 267' ' ' ARG . . . -42.22 160.84 0.04 OUTLIER Glycine 0 CA--C 1.529 0.968 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.382 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -55.98 0.21 0.17 Allowed 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 121.798 1.666 . . . . 0.0 111.909 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.563 ' H ' ' C ' ' A' ' 265' ' ' GLY . 82.9 mtt85 -70.25 -26.46 63.84 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.753 0.821 . . . . 0.0 112.225 178.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -57.98 -32.06 67.51 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.849 -178.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . 0.627 ' CE1' ' NH2' ' A' ' 241' ' ' ARG . 10.5 t80 -62.1 -41.02 97.79 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.674 177.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -65.28 -37.98 88.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.372 -177.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.472 ' O ' ' O ' ' A' ' 272' ' ' GLY . 37.0 mmtm -67.33 -176.8 0.61 Allowed 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 178.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 271' ' ' LYS . . . 37.11 99.3 0.01 OUTLIER Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -156.63 -0.58 0.12 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.019 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' MET . . . . . 0.574 ' N ' ' CD ' ' A' ' 275' ' ' PRO . 0.1 OUTLIER -63.77 -44.62 80.39 Favored Pre-proline 0 C--N 1.328 -0.35 0 C-N-CA 120.247 -0.581 . . . . 0.0 109.565 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 274' ' ' MET . 20.9 Cg_exo -64.7 -47.22 5.58 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.093 1.862 . . . . 0.0 111.651 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 19.7 m -61.03 -40.03 92.05 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.701 0.762 . . . . 0.0 110.434 179.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -62.14 -41.85 98.67 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 123.528 1.633 . . . . 0.0 112.138 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 1.4 mp -62.05 -38.85 90.32 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 110.617 -2.992 . . . . 0.0 108.549 174.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 13.5 mmt85 -62.76 -40.65 97.94 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.291 0.567 . . . . 0.0 109.751 178.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.07 -37.2 86.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.099 -179.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -67.81 -50.93 38.24 Favored Glycine 0 CA--C 1.519 0.297 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -177.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 77.8 p -61.63 -44.32 97.21 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' TRP . . . . . . . . . . . . . 87.6 t90 -61.26 -39.72 91.41 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.637 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -64.31 -40.66 96.38 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 5.3 m -62.28 -38.18 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 27.1 m -62.02 -38.83 81.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 121.094 -0.242 . . . . 0.0 111.041 -178.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' MET . . . . . 0.453 ' C ' ' SD ' ' A' ' 287' ' ' MET . 0.0 OUTLIER -59.33 -37.31 77.49 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.643 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -57.95 -40.07 79.66 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.003 -179.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 1.2 m -60.46 -38.16 77.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 O-C-N 121.766 -0.584 . . . . 0.0 111.018 -178.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 287' ' ' MET . 75.1 p -61.81 -38.93 89.96 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 177.199 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -60.64 -38.34 84.52 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 177.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -58.22 -40.71 82.36 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 118.089 -1.445 . . . . 0.0 109.421 -176.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' GLN . . . . . 0.453 ' O ' ' O ' ' A' ' 296' ' ' ARG . 36.5 tp60 -60.72 -42.74 97.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 122.823 1.296 . . . . 0.0 110.468 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 35.9 tp -60.29 -40.15 89.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 112.497 -2.138 . . . . 0.0 109.157 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -63.05 -45.71 90.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.335 179.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' ARG . . . . . 0.453 ' O ' ' O ' ' A' ' 293' ' ' GLN . 44.8 ttm180 -123.03 116.39 23.45 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.047 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -114.41 -97.25 0.44 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.069 0.461 . . . . 0.0 110.682 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 36.8 tp -140.7 121.06 14.0 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.009 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 24.3 ttt -95.59 66.15 2.73 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -178.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.52 100.82 0.07 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 122.149 0.976 . . . . 0.0 110.805 -178.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -64.28 -46.31 84.21 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 113.393 -1.73 . . . . 0.0 113.362 -176.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -58.92 -39.75 82.48 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.085 -177.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . 0.579 ' NE2' ' N ' ' A' ' 13' ' ' MET . 0.3 OUTLIER -64.51 -46.73 81.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.003 -179.61 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 304' ' ' SER . . . . . 0.44 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 15.1 m -66.56 -37.42 84.93 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.61 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -61.66 -43.25 99.22 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -178.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -65.17 -36.88 85.6 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -177.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -59.86 -52.7 71.85 Favored Pre-proline 0 CA--C 1.543 0.675 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -176.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 308' ' ' PRO . . . . . 0.44 ' CD ' ' O ' ' A' ' 304' ' ' SER . 73.1 Cg_endo -75.2 0.39 9.04 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.038 1.825 . . . . 0.0 111.862 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 39.8 t80 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.501 179.914 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.961 0.41 . . . . 0.0 110.632 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.796 HG22 ' H ' ' A' ' 16' ' ' LYS . 13.4 p -167.07 -178.98 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.898 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.796 ' H ' HG22 ' A' ' 15' ' ' VAL . 23.7 mtpp -64.32 -41.81 96.63 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.699 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -63.73 -41.5 98.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.279 0.561 . . . . 0.0 112.077 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.514 ' H ' HG13 ' A' ' 15' ' ' VAL . 12.9 tp -79.97 -26.0 40.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.046 -179.001 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.04 -41.3 95.24 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 107.601 -2.199 . . . . 0.0 107.601 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -71.47 -32.01 67.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 124.886 2.279 . . . . 0.0 107.332 176.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.76 -42.51 98.55 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-N 108.454 -3.975 . . . . 0.0 108.292 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 28.3 p -70.61 -27.48 64.11 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.541 0.686 . . . . 0.0 109.436 178.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.654 ' O ' HD13 ' A' ' 26' ' ' ILE . . . -65.76 -49.7 67.43 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.166 -178.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.98 -35.19 77.76 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 118.816 -1.154 . . . . 0.0 112.375 -177.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.4 ' HA ' HE22 ' A' ' 89' ' ' GLN . 75.7 m -63.35 -53.79 47.11 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -177.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.654 HD13 ' O ' ' A' ' 23' ' ' ALA . 0.2 OUTLIER -65.89 -38.09 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -177.117 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.449 ' O ' ' OG1' ' A' ' 31' ' ' THR . . . -63.64 -41.59 98.23 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -173.029 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 29' ' ' LEU . 20.0 p30 -77.6 -27.0 51.13 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 120.893 1.678 . . . . 0.0 109.93 -175.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.501 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 11.2 tp -59.8 -55.39 34.82 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 119.93 1.241 . . . . 0.0 112.148 -178.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.1 pt -75.45 -3.91 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-O 121.376 0.608 . . . . 0.0 112.61 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.573 HG23 HD12 ' A' ' 34' ' ' LEU . 7.1 m -109.3 -16.85 13.95 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.751 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.47 ' N ' ' CD ' ' A' ' 33' ' ' PRO . 1.8 t80 -68.53 -44.33 33.51 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 121.411 1.914 . . . . 0.0 110.93 -178.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.47 ' CD ' ' N ' ' A' ' 32' ' ' PHE . 36.8 Cg_exo -59.36 -15.8 31.52 Favored 'Trans proline' 0 N--CA 1.501 1.964 0 C-N-CA 121.554 1.502 . . . . 0.0 112.701 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.573 HD12 HG23 ' A' ' 31' ' ' THR . 81.6 mt -67.62 -35.36 78.79 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 114.787 1.402 . . . . 0.0 114.787 -177.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 36' ' ' THR . 45.3 p-10 -64.27 -40.53 96.16 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -177.071 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.53 ' N ' ' OD1' ' A' ' 35' ' ' ASP . 44.1 p -58.27 -35.28 71.54 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.939 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.86 -39.19 83.8 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 119.755 -0.778 . . . . 0.0 112.015 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.498 ' NZ ' ' CB ' ' A' ' 38' ' ' LYS . 8.7 mtmp? -62.12 -49.36 76.21 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 119.239 -0.984 . . . . 0.0 111.187 -176.407 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.1 m -64.25 -40.6 89.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -176.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.461 ' O ' ' N ' ' A' ' 42' ' ' GLN . 10.2 tpp180 -61.69 -41.87 98.16 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 119.378 -0.929 . . . . 0.0 110.08 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.54 39.06 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.768 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.498 ' C ' ' H ' ' A' ' 44' ' ' GLN . 60.2 tt0 -125.73 152.78 44.87 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.989 0.424 . . . . 0.0 110.942 -179.133 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.538 HG22 ' O ' ' A' ' 43' ' ' ILE . 73.0 mt -63.11 0.78 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.004 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.498 ' H ' ' C ' ' A' ' 42' ' ' GLN . 23.4 mt-30 64.13 78.98 0.27 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.525 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.17 -5.68 3.45 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.427 ' H ' ' C ' ' A' ' 44' ' ' GLN . 96.8 mt-10 -56.22 -42.83 77.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.912 0.387 . . . . 0.0 109.992 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.532 ' C ' ' H ' ' A' ' 49' ' ' GLY . 4.7 t 37.71 30.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.699 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.406 ' N ' ' O ' ' A' ' 46' ' ' GLU . 85.9 mt-30 -58.05 -2.8 0.19 Allowed 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.121 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.532 ' H ' ' C ' ' A' ' 47' ' ' SER . . . 87.44 -8.62 76.5 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -177.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -66.35 -37.3 85.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.665 0.745 . . . . 0.0 109.237 177.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.504 HG13 ' N ' ' A' ' 52' ' ' ARG . 13.1 p -60.76 -44.12 96.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.149 -178.264 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.504 ' N ' HG13 ' A' ' 51' ' ' VAL . 6.9 mmp_? -64.56 -35.14 80.02 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 119.816 -0.754 . . . . 0.0 112.31 -177.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.5 t -68.95 -38.0 79.18 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 119.24 -0.984 . . . . 0.0 108.758 177.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -138.29 97.93 3.49 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 114.798 -1.092 . . . . 0.0 108.39 178.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -80.65 9.0 6.73 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -177.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.608 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 18.7 m -125.69 -140.99 0.28 Allowed 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.608 ' HB3' ' O ' ' A' ' 56' ' ' SER . . . 97.87 12.74 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 O-C-N 124.127 0.892 . . . . 0.0 111.863 178.297 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -178.24 84.59 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.704 0.288 . . . . 0.0 110.36 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -63.78 163.06 12.31 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.063 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.413 ' O ' ' C ' ' A' ' 61' ' ' GLY . 78.4 mtm-85 -49.84 -36.85 28.3 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 60' ' ' ARG . . . -28.57 102.58 0.01 OUTLIER Glycine 0 CA--C 1.526 0.764 0 CA-C-N 114.955 -1.021 . . . . 0.0 112.703 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.416 HG22 ' H ' ' A' ' 62' ' ' VAL . 2.1 m -67.32 -34.37 68.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 118.41 -0.805 . . . . 0.0 109.663 176.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.439 HD22 ' N ' ' A' ' 63' ' ' LEU . 4.4 mm? -60.48 -32.5 71.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 121.077 1.762 . . . . 0.0 109.615 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.67 -49.32 64.81 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-N 114.623 -1.171 . . . . 0.0 114.781 -176.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.7 p -61.98 -46.48 89.05 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 -178.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 8.8 tt -59.8 -36.19 64.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.547 ' O ' HD13 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -64.21 -35.73 81.75 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 120.303 1.411 . . . . 0.0 111.913 179.645 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.466 ' O ' ' OG1' ' A' ' 72' ' ' THR . 98.1 m -63.56 -40.88 98.12 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.312 -1.313 . . . . 0.0 111.085 -175.186 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 7.3 ptm -60.59 -39.46 88.18 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -175.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.43 ' CG2' HD11 ' A' ' 78' ' ' LEU . 5.2 p -69.02 -40.01 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 119.532 -0.867 . . . . 0.0 113.05 -177.514 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.42 ' N ' HG13 ' A' ' 70' ' ' VAL . 56.6 ttp180 -77.78 -13.08 60.0 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.999 0.904 . . . . 0.0 112.6 -178.273 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.466 ' OG1' ' O ' ' A' ' 68' ' ' THR . 19.7 m -62.45 -54.65 37.08 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.025 -1.443 . . . . 0.0 111.272 179.071 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 28.2 mp0 -107.01 -57.76 2.02 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 178.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.42 ' O ' ' CB ' ' A' ' 77' ' ' SER . . . 159.36 165.49 16.46 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -56.84 -35.46 98.26 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 121.487 1.458 . . . . 0.0 111.376 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.64 -11.34 11.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.802 0.811 . . . . 0.0 110.691 175.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 74' ' ' GLY . 5.6 t -77.9 -32.49 51.8 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.098 -1.41 . . . . 0.0 110.905 -178.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.43 HD11 ' CG2' ' A' ' 70' ' ' VAL . 27.5 mt -75.45 -33.48 60.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.116 0.484 . . . . 0.0 110.61 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -92.29 -4.59 53.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 122.798 1.285 . . . . 0.0 113.243 -177.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -95.28 116.25 28.52 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 112.29 -2.232 . . . . 0.0 107.016 175.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.48 -11.38 54.16 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -177.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.674 HD12 ' C ' ' A' ' 82' ' ' LEU . 0.3 OUTLIER -59.24 -34.42 72.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 113.94 -1.13 . . . . 0.0 110.489 -179.328 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.1 m -70.49 -27.0 29.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.087 -0.961 . . . . 0.0 109.369 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.95 -31.92 61.61 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.675 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.92 -40.11 89.18 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 119.544 -1.312 . . . . 0.0 111.223 -177.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.0 mp -62.46 -40.1 95.56 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 122.29 1.043 . . . . 0.0 112.574 -177.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -60.57 -27.44 67.69 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 113.106 -1.861 . . . . 0.0 109.613 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 58.2 ttp85 -57.83 -53.55 56.97 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 173.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.4 HE22 ' HA ' ' A' ' 25' ' ' CYS . 10.3 tt0 -67.22 -29.9 69.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 112.318 -2.219 . . . . 0.0 112.512 -178.137 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 38.4 ttm -61.14 -40.66 94.65 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.497 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 38.2 t -74.32 -34.13 63.37 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 119.556 -0.858 . . . . 0.0 111.718 -176.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -57.75 -43.99 85.8 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 120.584 1.538 . . . . 0.0 112.308 -176.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.53 -32.85 64.44 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 119.321 -0.952 . . . . 0.0 111.015 -178.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.601 ' O ' HG22 ' A' ' 97' ' ' ILE . 48.8 m -64.35 -41.82 96.55 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.438 ' C ' ' H ' ' A' ' 97' ' ' ILE . 7.2 p -68.42 -28.41 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.221 177.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 16.9 mtp-105 -77.46 10.33 2.65 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -177.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.601 HG22 ' O ' ' A' ' 94' ' ' SER . 9.6 tp -86.87 -15.33 9.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 177.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.404 ' O ' ' OD1' ' A' ' 101' ' ' ASP . . . -140.05 -48.0 0.06 OUTLIER Glycine 0 CA--C 1.539 1.571 0 CA-C-N 114.23 -1.35 . . . . 0.0 114.383 -177.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.4 tp -70.75 -13.48 62.07 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.183 1.491 . . . . 0.0 113.37 -177.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.53 ' O ' ' HB2' ' A' ' 104' ' ' LYS . 20.6 t80 -81.21 -51.67 8.17 Favored 'General case' 0 C--O 1.211 -0.945 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.957 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.536 ' O ' ' HG3' ' A' ' 105' ' ' GLN . 9.3 p-10 -69.99 -32.73 71.07 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 123.631 1.682 . . . . 0.0 111.83 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.0 m -68.83 -52.72 26.98 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 110.81 -2.904 . . . . 0.0 116.99 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 69.2 t -74.99 -26.9 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 CA-C-N 121.121 1.782 . . . . 0.0 110.8 176.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.53 ' HB2' ' O ' ' A' ' 100' ' ' TYR . 0.4 OUTLIER -69.54 -41.53 75.84 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 110.831 -2.895 . . . . 0.0 112.974 -179.259 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.536 ' HG3' ' O ' ' A' ' 101' ' ' ASP . 88.1 mt-30 -78.65 -13.75 59.66 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 123.614 1.673 . . . . 0.0 111.025 178.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.06 -22.74 41.95 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 112.785 -2.007 . . . . 0.0 110.9 178.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -109.87 -30.62 7.75 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.833 0.742 . . . . 0.0 112.212 -175.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.646 ' O ' HG22 ' A' ' 108' ' ' THR . 50.1 m -98.46 9.06 44.01 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 118.219 -1.393 . . . . 0.0 112.579 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.444 ' O ' ' C ' ' A' ' 110' ' ' GLY . 35.3 ttmt -53.74 121.11 7.2 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.495 ' O ' ' CB ' ' A' ' 111' ' ' SER . . . -23.59 -78.79 0.01 OUTLIER Glycine 0 N--CA 1.48 1.59 0 CA-C-N 117.81 0.277 . . . . 0.0 113.12 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.525 ' O ' ' HB2' ' A' ' 112' ' ' GLU . 1.4 t 91.96 -87.26 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 177.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.525 ' HB2' ' O ' ' A' ' 111' ' ' SER . 82.7 tt0 171.64 -34.36 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 120.541 1.519 . . . . 0.0 113.915 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.637 ' O ' ' HB2' ' A' ' 114' ' ' ALA . 0.3 OUTLIER 156.87 42.46 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.201 0.524 . . . . 0.0 109.896 -179.214 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.637 ' HB2' ' O ' ' A' ' 113' ' ' HIS . . . 160.45 -162.41 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 178.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.78 15.23 25.01 Favored Glycine 0 CA--C 1.507 -0.428 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.49 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.459 HG23 ' N ' ' A' ' 117' ' ' GLY . 12.6 tt -60.43 -40.54 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.459 ' N ' HG23 ' A' ' 116' ' ' ILE . . . -65.68 -40.17 95.71 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-O 121.791 0.661 . . . . 0.0 111.685 175.079 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 10.1 p -58.65 -42.97 89.58 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 176.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.402 ' NE ' ' HA ' ' A' ' 116' ' ' ILE . 76.3 mtm180 -63.71 -37.01 85.74 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.849 -177.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.46 HD21 HD13 ' A' ' 194' ' ' LEU . 70.9 mt -63.53 -45.63 89.7 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 177.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 39.4 mt -66.52 -44.82 81.46 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 118.762 -1.175 . . . . 0.0 110.06 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.98 -45.4 89.24 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 120.22 1.373 . . . . 0.0 110.602 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -66.04 -44.16 92.0 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 120.172 -1.014 . . . . 0.0 111.289 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 59.0 m -64.14 -43.82 94.04 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.43 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 20.6 m -69.34 -48.27 61.91 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 119.365 -0.934 . . . . 0.0 111.943 177.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.449 HG23 ' N ' ' A' ' 127' ' ' GLY . 4.8 t -65.23 -42.46 93.37 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -173.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.449 ' N ' HG23 ' A' ' 126' ' ' THR . . . -63.89 -44.53 95.95 Favored Glycine 0 CA--C 1.521 0.423 0 CA-C-O 122.912 1.284 . . . . 0.0 113.196 -177.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.449 ' O ' HG22 ' A' ' 131' ' ' VAL . . . -61.12 -41.21 96.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 112.029 -2.085 . . . . 0.0 106.714 177.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.679 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 0.2 OUTLIER -63.98 -41.9 97.39 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.3 178.886 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -62.9 -39.98 96.17 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -177.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.449 HG22 ' O ' ' A' ' 128' ' ' ALA . 12.5 m -61.04 -26.12 38.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 122.628 1.204 . . . . 0.0 109.513 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.679 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . -58.31 -44.45 88.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 112.607 -2.088 . . . . 0.0 111.736 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 61.5 t -78.6 -49.02 21.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.941 -178.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -112.38 131.64 55.43 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.746 0.308 . . . . 0.0 110.805 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.596 ' H ' ' HD2' ' A' ' 136' ' ' PRO . 11.6 tt0 -175.51 -41.79 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.82 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.596 ' HD2' ' H ' ' A' ' 135' ' ' GLN . 52.6 Cg_exo -52.78 -34.52 65.35 Favored 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 121.819 1.679 . . . . 0.0 113.437 -178.074 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 98.6 m -67.54 -42.01 83.4 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 118.029 -1.468 . . . . 0.0 108.594 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -65.51 -43.01 91.43 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 118.159 -1.416 . . . . 0.0 112.788 -177.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.3 p -64.76 -44.22 96.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.455 ' O ' ' N ' ' A' ' 144' ' ' PHE . 21.8 m -65.26 -37.93 81.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -178.253 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -61.41 -40.72 95.44 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -176.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.453 ' CG1' ' N ' ' A' ' 143' ' ' ARG . 3.9 p -69.61 -44.7 79.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 119.399 -0.92 . . . . 0.0 108.94 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.453 ' N ' ' CG1' ' A' ' 142' ' ' VAL . 65.8 mtt180 -64.24 -35.71 81.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.701 178.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.455 ' N ' ' O ' ' A' ' 140' ' ' VAL . 85.1 t80 -65.71 -40.56 92.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.239 -178.204 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -64.14 -38.63 91.74 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -64.88 -35.02 79.79 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -178.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -59.75 111.18 1.35 Allowed 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 177.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -106.6 -173.12 2.22 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 117.686 2.476 . . . . 0.0 117.686 -171.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 59.0 61.13 2.21 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 110.035 -3.257 . . . . 0.0 110.899 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . 46.59 -114.79 0.54 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.806 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 170.74 113.88 0.3 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.979 -0.849 . . . . 0.0 110.979 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.708 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 179.963 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.412 ' CD1' ' O ' ' A' ' 156' ' ' TYR . 28.1 p90 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.752 0.311 . . . . 0.0 110.516 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -54.48 175.73 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.662 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 162' ' ' ALA . 20.5 p -157.0 -178.36 7.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.657 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.57 HG23 ' N ' ' A' ' 160' ' ' VAL . 13.7 t -64.1 -46.47 84.06 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.663 -177.376 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.57 ' N ' HG23 ' A' ' 159' ' ' THR . 6.3 p -64.51 -45.43 95.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 119.06 -1.056 . . . . 0.0 109.674 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.485 ' N ' HG13 ' A' ' 160' ' ' VAL . 50.3 mm-40 -66.65 -38.34 86.67 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.162 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.556 ' O ' HD12 ' A' ' 166' ' ' ILE . . . -60.97 -44.58 97.12 Favored 'General case' 0 C--O 1.21 -0.981 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -177.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.448 ' CD1' ' C ' ' A' ' 163' ' ' TYR . 20.6 t80 -61.5 -47.84 83.79 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.527 0.565 . . . . 0.0 112.527 -178.037 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -67.89 -45.39 74.57 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 117.881 2.549 . . . . 0.0 117.881 -172.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 41.7 p -63.38 -45.44 91.11 Favored 'General case' 0 CA--C 1.557 1.227 0 N-CA-C 117.294 2.331 . . . . 0.0 117.294 -175.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.709 HD13 ' H ' ' A' ' 166' ' ' ILE . 0.1 OUTLIER -64.68 -37.12 79.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 CA-C-O 121.655 0.741 . . . . 0.0 109.281 176.483 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.07 -36.53 75.24 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 176.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 18.5 tpt85 -62.21 -50.09 73.16 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 122.998 2.635 . . . . 0.0 111.201 -176.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -74.77 -51.08 15.1 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 123.457 0.703 . . . . 0.0 109.593 177.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -78.24 -36.7 46.62 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 116.037 1.866 . . . . 0.0 116.037 -173.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 93.41 -168.21 29.36 Favored Glycine 0 N--CA 1.47 0.957 0 CA-C-N 118.674 0.67 . . . . 0.0 112.623 177.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 10.0 pt -73.52 -41.45 56.12 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.112 0 CA-C-O 121.944 0.878 . . . . 0.0 110.716 -179.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -58.47 -32.98 69.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 113.708 -1.587 . . . . 0.0 110.658 -176.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -60.33 -39.97 96.85 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 119.209 -1.472 . . . . 0.0 109.89 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 5.8 tp -69.49 -33.73 73.29 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 117.056 2.243 . . . . 0.0 117.056 -177.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 9.7 m0 -78.14 -7.62 57.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 111.244 -2.707 . . . . 0.0 109.826 -178.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -43.32 -47.86 6.77 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.327 -176.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -95.7 -36.33 5.35 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 123.936 0.779 . . . . 0.0 111.763 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.463 ' CG2' ' N ' ' A' ' 180' ' ' SER . 0.6 OUTLIER -45.4 -51.23 11.61 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -179.385 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 180' ' ' SER . . . . . 0.463 ' N ' ' CG2' ' A' ' 179' ' ' THR . 0.4 OUTLIER -62.9 -50.89 75.0 Favored Pre-proline 0 N--CA 1.473 0.687 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -176.666 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' A' ' 180' ' ' SER . 32.6 Cg_endo -64.8 -28.42 59.38 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 121.683 1.588 . . . . 0.0 111.992 177.326 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -63.73 -39.87 95.35 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 120.266 -0.574 . . . . 0.0 109.967 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 75.6 t -63.45 -42.43 96.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.89 -39.04 90.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.216 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.25 -41.55 93.46 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.898 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -61.61 -42.87 99.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.732 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.32 -44.27 92.06 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 -178.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 3.5 tp -63.95 -45.18 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.882 -178.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.523 ' O ' ' N ' ' A' ' 193' ' ' GLU . 15.5 m -59.83 -45.86 94.39 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.362 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.436 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -62.39 -42.62 99.57 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.843 0.83 . . . . 0.0 109.915 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' CYS . . . . . . . . . . . . . 41.4 t -61.71 -45.8 92.4 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.384 -1.28 . . . . 0.0 109.249 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -63.86 -39.61 94.61 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 113.097 -1.865 . . . . 0.0 108.501 175.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 189' ' ' VAL . 36.6 tp10 -61.01 -46.28 91.4 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.962 -178.107 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.46 HD13 HD21 ' A' ' 120' ' ' LEU . 0.6 OUTLIER -64.89 -39.64 93.84 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 118.844 -1.143 . . . . 0.0 110.225 -175.683 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 2.7 p -64.83 -46.43 91.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 116.693 -2.003 . . . . 0.0 107.853 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 96.3 m -64.11 -45.93 86.41 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.58 0.955 . . . . 0.0 113.58 -178.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -55.43 -37.99 68.4 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.716 1.606 . . . . 0.0 112.275 -176.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -55.86 -43.48 77.14 Favored 'General case' 0 C--N 1.312 -1.04 0 O-C-N 121.594 -0.691 . . . . 0.0 109.606 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 19.3 mt -61.31 -39.79 91.78 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -176.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.3 pt -63.49 -41.2 91.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-N 118.461 0.573 . . . . 0.0 111.304 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 10.3 mtpp -57.92 -37.58 74.33 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.935 1.694 . . . . 0.0 113.013 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -63.73 -38.59 91.67 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.889 -0.725 . . . . 0.0 111.039 -177.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.15 128.63 47.15 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 122.184 0.992 . . . . 0.0 111.579 -178.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.421 ' O ' HD22 ' A' ' 205' ' ' LEU . 6.4 tp 67.18 3.9 3.41 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 113.233 -1.803 . . . . 0.0 111.726 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.421 HD22 ' O ' ' A' ' 204' ' ' LEU . 0.8 OUTLIER -125.11 26.97 6.8 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.488 0.661 . . . . 0.0 111.234 -178.598 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.404 ' HD2' ' H ' ' A' ' 207' ' ' ALA . 0.1 OUTLIER -74.25 -21.58 59.71 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.527 179.658 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.476 ' O ' ' O ' ' A' ' 208' ' ' ASN . . . -163.44 33.06 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.197 -1.365 . . . . 0.0 109.078 178.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' ASN . . . . . 0.476 ' O ' ' O ' ' A' ' 207' ' ' ALA . 12.3 p30 40.54 117.93 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 177.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.473 ' O ' ' O ' ' A' ' 208' ' ' ASN . 9.0 tp . . . . . 0 N--CA 1.473 0.689 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.292 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 0.405 ' O ' ' SG ' ' A' ' 216' ' ' CYS . 14.9 m-20 . . . . . 0 N--CA 1.462 0.129 0 CA-C-O 120.945 0.402 . . . . 0.0 110.696 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.511 ' N ' ' HD2' ' A' ' 215' ' ' PRO . 13.6 mt -61.39 -44.13 91.68 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 214' ' ' LEU . 29.8 Cg_endo -61.34 -32.28 89.46 Favored 'Trans proline' 0 N--CA 1.501 1.954 0 CA-C-N 120.741 1.301 . . . . 0.0 112.406 -179.104 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 216' ' ' CYS . . . . . 0.525 ' SG ' ' N ' ' A' ' 217' ' ' HIS . 1.1 p -63.92 -42.44 97.39 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 113.827 -1.533 . . . . 0.0 111.824 -177.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 217' ' ' HIS . . . . . 0.622 ' CE1' ' CE2' ' A' ' 218' ' ' PHE . 3.5 p-80 -66.77 -37.43 84.58 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.425 -0.51 . . . . 0.0 112.163 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 218' ' ' PHE . . . . . 0.622 ' CE2' ' CE1' ' A' ' 217' ' ' HIS . 25.6 m-85 -63.08 -46.88 85.35 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.069 -178.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 10.1 m -60.14 -37.46 80.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 118.271 0.487 . . . . 0.0 110.709 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 54.1 p -59.57 -41.56 90.48 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' ALA . . . . . 0.605 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.4 -41.63 98.76 Favored 'General case' 0 C--O 1.222 -0.381 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -177.279 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -61.73 -46.73 88.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 122.056 0.931 . . . . 0.0 113.031 -175.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -60.28 -41.98 98.58 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 107.237 -2.345 . . . . 0.0 107.237 177.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -63.06 -36.99 85.41 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 113.898 -1.151 . . . . 0.0 108.975 176.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' GLY . . . . . 0.605 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -61.03 -41.67 99.53 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-N 114.062 -1.426 . . . . 0.0 111.472 -176.39 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 226' ' ' PHE . . . . . 0.44 ' O ' ' OG1' ' A' ' 229' ' ' THR . 60.9 t80 -66.78 -38.26 86.19 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.347 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 94.4 m -63.27 -42.27 99.11 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' THR . . . . . 0.41 HG22 ' H ' ' A' ' 228' ' ' THR . 1.0 OUTLIER -62.46 -39.74 94.36 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 120.813 0.339 . . . . 0.0 111.542 179.623 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 226' ' ' PHE . 17.0 p -58.04 -38.8 76.95 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.068 -177.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 99.0 t -59.87 -40.78 83.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 119.224 -0.99 . . . . 0.0 108.635 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ILE . . . . . 0.64 ' O ' ' HD2' ' A' ' 234' ' ' PRO . 1.3 mp -61.32 -39.69 83.56 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.573 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 176.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 229' ' ' THR . . . -61.39 -37.5 83.66 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.257 1.423 . . . . 0.0 114.331 -179.283 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.468 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 1.4 m -56.31 -38.2 65.79 Favored Pre-proline 0 N--CA 1.48 1.053 0 N-CA-C 116.519 2.044 . . . . 0.0 116.519 -173.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.64 ' HD2' ' O ' ' A' ' 231' ' ' ILE . 31.5 Cg_exo -57.97 -38.69 91.1 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 C-N-CA 122.739 2.293 . . . . 0.0 114.051 -175.111 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.435 ' H ' HG22 ' A' ' 235' ' ' VAL . 3.4 m -63.02 -36.77 77.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 116.795 -1.962 . . . . 0.0 108.846 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -65.88 -40.71 91.84 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -64.9 -44.38 96.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -175.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 91.9 t . . . . . 0 C--N 1.319 -0.76 0 O-C-N 121.885 -0.51 . . . . 0.0 111.97 -177.526 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 60.0 p . . . . . 0 N--CA 1.462 0.159 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 260' ' ' MET . . . . . 0.464 ' SD ' ' C ' ' A' ' 260' ' ' MET . 1.9 tmt? -60.45 -43.86 96.45 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -176.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 33.2 tp -62.21 -46.42 88.98 Favored 'General case' 0 C--N 1.322 -0.624 0 O-C-N 122.029 -0.419 . . . . 0.0 110.413 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 262' ' ' ARG . . . . . 0.413 ' HE ' ' HA ' ' A' ' 262' ' ' ARG . 5.2 tpm_? -66.11 -54.0 30.94 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.49 -178.186 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 263' ' ' LYS . . . . . 0.443 ' O ' ' O ' ' A' ' 260' ' ' MET . 23.0 pttm -115.36 162.86 16.54 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.114 0.483 . . . . 0.0 111.526 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 264' ' ' GLU . . . . . 0.498 ' O ' ' O ' ' A' ' 265' ' ' GLY . 70.0 mm-40 56.5 85.06 0.08 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.679 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 265' ' ' GLY . . . . . 0.498 ' O ' ' O ' ' A' ' 264' ' ' GLU . . . -43.28 177.36 0.01 OUTLIER Glycine 0 CA--C 1.532 1.12 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -68.17 -8.79 23.83 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.301 2.001 . . . . 0.0 111.216 177.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 34.6 ptt-85 -69.72 -26.81 64.52 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 122.978 0.511 . . . . 0.0 111.853 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -58.55 -32.44 68.89 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.711 -0.796 . . . . 0.0 109.287 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -62.06 -41.55 98.27 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.157 177.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -65.66 -37.31 86.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.433 -178.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.446 ' O ' ' O ' ' A' ' 272' ' ' GLY . 54.5 tttp -82.78 171.98 13.36 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 177.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 272' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 271' ' ' LYS . . . 48.76 99.44 0.01 OUTLIER Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -171.42 12.09 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.055 0.455 . . . . 0.0 110.496 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 274' ' ' MET . . . . . 0.592 ' SD ' ' N ' ' A' ' 275' ' ' PRO 0.25 0.0 OUTLIER -63.49 -40.36 57.66 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.81 179.372 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 275' ' ' PRO . . . . . 0.592 ' N ' ' SD ' ' A' ' 274' ' ' MET . 16.6 Cg_exo -63.55 -46.38 9.43 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 121.453 1.435 . . . . 0.0 111.197 -176.284 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 3.1 m -60.43 -39.88 89.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.657 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -61.99 -42.96 99.72 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 123.079 1.418 . . . . 0.0 112.145 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 84.8 mt -62.28 -38.68 90.28 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 111.59 -2.55 . . . . 0.0 108.151 174.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 -63.01 -39.45 94.8 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.314 0.578 . . . . 0.0 110.527 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.652 ' O ' HD23 ' A' ' 280' ' ' LEU . 1.1 tt -61.76 -36.88 82.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.028 -0.987 . . . . 0.0 112.489 -177.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -68.3 -51.51 32.08 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 282' ' ' SER . . . . . 0.533 ' O ' HG22 ' A' ' 285' ' ' VAL . 5.6 t -63.35 -44.5 94.67 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 123.566 0.747 . . . . 0.0 110.349 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 283' ' ' TRP . . . . . 0.406 ' O ' HG22 ' A' ' 286' ' ' VAL . 79.4 t90 -59.9 -37.82 80.51 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.922 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -61.47 -37.94 85.47 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.18 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.533 HG22 ' O ' ' A' ' 282' ' ' SER . 0.9 OUTLIER -60.86 -37.69 77.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 O-C-N 121.95 -0.468 . . . . 0.0 111.778 -179.094 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.735 ' O ' HG22 ' A' ' 289' ' ' VAL . 0.9 OUTLIER -61.93 -41.14 89.72 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.661 -177.623 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -61.78 -38.16 87.0 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 121.488 -0.758 . . . . 0.0 109.757 178.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -58.49 -40.62 83.28 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.265 -0.88 . . . . 0.0 112.982 -178.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.735 HG22 ' O ' ' A' ' 286' ' ' VAL . 27.0 m -60.76 -38.53 79.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 119.974 -0.69 . . . . 0.0 110.984 -178.183 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 16.8 m -62.54 -40.25 96.21 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -60.85 -38.84 86.93 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 177.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.45 -40.49 82.73 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 117.706 -1.597 . . . . 0.0 109.527 -176.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 293' ' ' GLN . . . . . 0.473 ' O ' ' O ' ' A' ' 296' ' ' ARG . 56.9 tt0 -60.45 -42.9 97.08 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 122.595 1.188 . . . . 0.0 110.971 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 10.3 mp -60.32 -40.65 91.34 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 113.119 -1.855 . . . . 0.0 108.79 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -63.27 -45.91 89.25 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.322 178.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 296' ' ' ARG . . . . . 0.473 ' O ' ' O ' ' A' ' 293' ' ' GLN . 27.6 mmm-85 -123.03 116.16 23.06 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -121.41 -164.09 1.1 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.022 0.439 . . . . 0.0 112.179 -178.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.656 ' H ' HD12 ' A' ' 298' ' ' LEU . 0.0 OUTLIER -64.77 -173.96 0.12 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 177.276 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 9.2 ttt -169.15 66.99 0.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 119.236 -0.986 . . . . 0.0 112.832 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.59 100.86 0.07 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.825 0.821 . . . . 0.0 110.534 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -64.08 -46.2 85.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.107 -1.406 . . . . 0.0 113.479 -176.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 302' ' ' TYR . . . . . 0.525 ' CD2' ' OE1' ' A' ' 306' ' ' GLU . 49.0 t80 -58.8 -39.94 82.62 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 119.706 -0.798 . . . . 0.0 109.563 -178.274 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -65.26 -46.88 78.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.219 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 304' ' ' SER . . . . . 0.446 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 38.9 t -66.58 -37.67 85.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.796 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 -61.67 -42.8 99.42 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 306' ' ' GLU . . . . . 0.525 ' OE1' ' CD2' ' A' ' 302' ' ' TYR . 41.4 mt-10 -64.87 -37.08 86.42 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -177.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 307' ' ' ALA . . . . . 0.553 ' HB3' ' HD3' ' A' ' 308' ' ' PRO . . . -60.06 -53.01 69.36 Favored Pre-proline 0 CA--C 1.544 0.743 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -176.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 308' ' ' PRO . . . . . 0.553 ' HD3' ' HB3' ' A' ' 307' ' ' ALA . 73.6 Cg_endo -75.15 0.17 9.29 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.283 1.988 . . . . 0.0 111.948 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 55.0 t80 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.574 -179.894 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.7 p . . . . . 0 C--O 1.233 0.185 0 CA-C-O 120.639 0.257 . . . . 0.0 110.4 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.655 HG22 ' N ' ' A' ' 16' ' ' LYS . 12.4 p -148.37 171.44 2.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.002 0.43 . . . . 0.0 110.64 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.655 ' N ' HG22 ' A' ' 15' ' ' VAL . 4.6 mtmp? -64.29 -41.41 96.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.972 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -63.43 -41.56 98.68 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -178.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.525 ' H ' HG13 ' A' ' 15' ' ' VAL . 57.5 tp -79.9 -26.33 40.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.148 0.499 . . . . 0.0 111.932 -179.015 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.41 ' O ' ' OG1' ' A' ' 22' ' ' THR . . . -66.07 -41.33 95.16 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 107.595 -2.202 . . . . 0.0 107.595 177.259 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.419 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -71.47 -32.24 68.06 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 124.803 2.239 . . . . 0.0 107.54 176.413 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.5 -42.49 98.93 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-N 108.51 -3.95 . . . . 0.0 108.243 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.41 ' OG1' ' O ' ' A' ' 19' ' ' GLY . 22.2 p -70.63 -27.41 64.04 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.503 0.668 . . . . 0.0 109.248 177.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -66.51 -50.05 64.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.676 -1.147 . . . . 0.0 112.128 -179.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.78 -35.96 79.66 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 118.529 -1.268 . . . . 0.0 111.241 -177.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 68.5 m -63.64 -53.69 47.52 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.24 -178.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.4 pt -65.47 -39.63 85.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -177.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.11 -42.04 97.02 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 119.78 -0.768 . . . . 0.0 112.79 -173.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 32' ' ' PHE . 3.2 m-20 -77.89 -27.28 49.57 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 118.068 -1.453 . . . . 0.0 109.407 -176.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 15.7 mt -60.41 -56.22 24.12 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 120.159 1.345 . . . . 0.0 111.703 -178.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.71 HD12 ' N ' ' A' ' 30' ' ' ILE . 2.5 mp -76.23 -5.09 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 120.076 -0.649 . . . . 0.0 112.293 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 26.3 m -110.33 -17.98 13.37 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 117.656 -1.164 . . . . 0.0 109.71 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.517 ' N ' ' O ' ' A' ' 28' ' ' ASP . 11.4 t80 -67.88 -43.44 37.63 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 122.379 2.354 . . . . 0.0 110.009 -177.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.457 ' CD ' ' N ' ' A' ' 32' ' ' PHE . 38.1 Cg_exo -58.55 -14.68 22.0 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 121.239 1.293 . . . . 0.0 110.949 177.273 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.5 tp -66.92 -35.59 80.35 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -177.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -64.42 -40.65 96.17 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -177.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.401 ' CG2' ' O ' ' A' ' 33' ' ' PRO . 0.3 OUTLIER -58.39 -33.78 70.0 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.992 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.13 -38.77 86.12 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.455 ' NZ ' ' CB ' ' A' ' 38' ' ' LYS . 0.1 OUTLIER -61.67 -47.54 84.87 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 119.415 -0.914 . . . . 0.0 111.734 -176.768 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.2 t -62.2 -38.37 80.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -175.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.504 ' O ' ' N ' ' A' ' 42' ' ' GLN . 45.5 mtp85 -59.5 -41.08 89.05 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 119.236 -0.985 . . . . 0.0 110.049 -179.161 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -62.38 38.67 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.066 178.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.504 ' N ' ' O ' ' A' ' 40' ' ' ARG . 0.2 OUTLIER -94.57 5.11 52.81 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 121.959 -0.463 . . . . 0.0 111.187 -179.437 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.425 ' O ' ' O ' ' A' ' 42' ' ' GLN . 7.6 mm 60.28 147.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -53.14 105.25 0.12 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.873 0.368 . . . . 0.0 110.438 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.92 50.88 0.37 Allowed Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.981 -0.847 . . . . 0.0 110.981 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.51 ' H ' ' CG2' ' A' ' 51' ' ' VAL . 72.1 mm-40 -73.1 -8.68 56.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.778 0.323 . . . . 0.0 110.674 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.499 ' C ' ' H ' ' A' ' 49' ' ' GLY . 3.6 m 61.42 -159.57 0.32 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.723 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 38.7 tp60 66.4 -7.39 0.43 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.142 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.499 ' H ' ' C ' ' A' ' 47' ' ' SER . . . 84.17 3.53 88.84 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -178.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.573 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -66.61 -38.12 86.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.538 0.685 . . . . 0.0 109.769 178.487 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.51 ' CG2' ' H ' ' A' ' 46' ' ' GLU . 54.6 t -60.74 -44.97 98.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.319 -178.253 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.96 -34.72 79.09 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.275 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 19.6 p -68.68 -38.25 80.2 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.115 0.483 . . . . 0.0 110.052 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -92.88 -159.77 0.7 Allowed 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.868 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -169.78 -40.19 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.171 -0.611 . . . . 0.0 111.831 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.64 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 87.6 p -126.91 -139.58 0.26 Allowed 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.64 ' HB3' ' O ' ' A' ' 56' ' ' SER . . . 92.87 14.64 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 O-C-N 123.813 0.696 . . . . 0.0 111.81 178.448 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 90.6 mm-40 -155.45 52.43 0.59 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -41.39 145.43 0.26 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.381 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.418 ' O ' ' C ' ' A' ' 61' ' ' GLY . 62.7 ttp180 -49.8 -44.62 49.23 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 60' ' ' ARG . . . -28.52 101.54 0.01 OUTLIER Glycine 0 CA--C 1.53 0.995 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.7 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.5 p -67.54 -33.97 65.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.34 176.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.25 -32.37 71.08 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 121.165 1.802 . . . . 0.0 109.436 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.32 -49.22 67.14 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 114.832 -1.077 . . . . 0.0 115.062 -176.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 94.6 m -61.9 -46.32 89.87 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 33.7 mm -59.57 -35.49 59.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 76.8 mt -63.19 -35.82 81.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 121.028 1.74 . . . . 0.0 111.506 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.408 ' O ' ' OG1' ' A' ' 72' ' ' THR . 99.4 m -62.47 -38.8 91.24 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 113.219 -1.81 . . . . 0.0 111.053 -177.067 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 27.8 ttt -60.73 -40.02 90.79 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 -177.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.1 m -69.07 -39.81 80.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 119.612 -0.835 . . . . 0.0 112.375 -178.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -77.42 -12.76 59.99 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 122.182 0.991 . . . . 0.0 113.217 -177.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' A' ' 68' ' ' THR . 33.5 m -62.5 -55.12 30.47 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 113.927 -1.488 . . . . 0.0 112.762 -179.235 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -113.6 5.24 16.47 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 123.036 1.398 . . . . 0.0 109.466 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 96.46 170.92 34.67 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-N 111.598 -2.546 . . . . 0.0 110.783 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -56.4 -34.47 94.47 Favored 'Trans proline' 0 N--CA 1.5 1.909 0 C-N-CA 122.518 2.145 . . . . 0.0 111.682 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.425 ' O ' ' CB ' ' A' ' 80' ' ' ASN . 1.7 mpt_? -61.01 -10.53 6.03 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.796 0.807 . . . . 0.0 111.093 176.173 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 81.3 p -77.24 -32.35 55.71 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.168 -1.378 . . . . 0.0 111.231 -177.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.2 tt -75.9 -34.15 59.94 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.297 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -93.76 -5.98 47.1 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 122.022 0.915 . . . . 0.0 113.013 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.425 ' CB ' ' O ' ' A' ' 76' ' ' ARG . 4.2 t30 -81.23 124.69 29.51 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 113.802 -1.545 . . . . 0.0 107.625 176.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.99 0.67 71.12 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 109.696 -1.361 . . . . 0.0 109.696 -178.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 45.3 tp -59.43 -35.33 73.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 113.477 -1.361 . . . . 0.0 110.955 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.8 p -70.76 -26.99 29.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.563 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.8 -31.65 61.79 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.512 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -68.14 -40.79 87.97 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 119.489 -1.338 . . . . 0.0 111.389 -177.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.532 ' O ' ' SD ' ' A' ' 90' ' ' MET . 75.7 mt -62.59 -40.53 97.2 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 122.311 1.053 . . . . 0.0 112.587 -176.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -59.51 -26.22 65.13 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 113.324 -1.762 . . . . 0.0 108.944 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 18.3 ttm180 -57.06 -52.88 63.53 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 113.335 -1.757 . . . . 0.0 106.645 173.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -67.39 -30.19 69.9 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 112.857 -1.974 . . . . 0.0 113.247 -177.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.552 ' N ' ' SD ' ' A' ' 90' ' ' MET . 0.0 OUTLIER -61.02 -40.9 95.33 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.357 -179.489 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 68.7 p -74.53 -34.5 63.02 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 119.382 -0.927 . . . . 0.0 111.409 -176.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -57.86 -44.41 86.59 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-N 121.041 1.746 . . . . 0.0 111.616 -176.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.76 -33.17 64.16 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.691 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.609 ' O ' HG22 ' A' ' 97' ' ' ILE . 24.3 p -64.18 -42.07 96.84 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.432 ' C ' ' H ' ' A' ' 97' ' ' ILE . 34.5 m -68.16 -27.74 38.3 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.839 177.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.444 ' O ' ' CD1' ' A' ' 100' ' ' TYR . 49.1 ttm-85 -77.21 9.24 3.23 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 -177.1 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.609 HG22 ' O ' ' A' ' 94' ' ' SER . 11.0 tt -87.12 -15.58 9.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 178.256 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -140.61 -48.03 0.05 OUTLIER Glycine 0 CA--C 1.538 1.499 0 N-CA-C 115.653 1.021 . . . . 0.0 115.653 -176.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.598 ' N ' HD12 ' A' ' 99' ' ' LEU . 9.4 mp -71.18 -12.7 61.62 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.927 1.363 . . . . 0.0 112.521 -178.09 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.597 ' CD1' ' N ' ' A' ' 101' ' ' ASP . 0.1 OUTLIER -80.46 -50.76 9.64 Favored 'General case' 0 C--O 1.214 -0.792 0 CA-C-N 114.382 -1.281 . . . . 0.0 111.563 -179.623 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.941 ' OD1' ' OE1' ' A' ' 105' ' ' GLN . 28.5 t70 -68.14 -31.2 70.61 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 122.857 1.313 . . . . 0.0 109.446 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.2 t -68.61 -53.42 22.8 Favored 'General case' 0 CA--C 1.554 1.134 0 CA-C-N 112.227 -2.26 . . . . 0.0 113.393 176.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -75.59 -28.22 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 CA-C-N 123.34 2.791 . . . . 0.0 115.708 -178.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 100' ' ' TYR . 18.8 mttt -69.33 -42.3 75.52 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 111.169 -2.741 . . . . 0.0 112.888 -178.016 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.941 ' OE1' ' OD1' ' A' ' 101' ' ' ASP . 27.2 mt-30 -78.97 -10.11 59.73 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 124.225 1.964 . . . . 0.0 111.063 177.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -78.97 -22.45 45.6 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 112.273 -2.24 . . . . 0.0 111.358 177.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.467 ' CZ ' ' OD1' ' A' ' 190' ' ' ASN . 27.5 m-85 -109.3 -30.84 7.8 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 119.637 1.108 . . . . 0.0 111.995 -175.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.9 t -98.66 9.27 43.66 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 117.275 -1.77 . . . . 0.0 112.796 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.512 ' O ' ' C ' ' A' ' 110' ' ' GLY . 0.0 OUTLIER -50.49 122.06 6.58 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 118.395 -0.812 . . . . 0.0 110.948 -179.733 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.518 ' O ' ' CB ' ' A' ' 111' ' ' SER . . . -22.5 -78.83 0.01 OUTLIER Glycine 0 N--CA 1.487 2.066 0 CA-C-N 119.124 0.875 . . . . 0.0 111.73 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 110' ' ' GLY . 5.9 p 94.33 -156.36 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 175.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.496 ' O ' ' N ' ' A' ' 114' ' ' ALA . 76.6 mt-10 -120.45 172.55 7.74 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 114.398 -1.274 . . . . 0.0 111.556 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.617 ' O ' ' HB2' ' A' ' 114' ' ' ALA . 45.1 p-80 -63.81 48.59 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.498 -179.163 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' A' ' 113' ' ' HIS . . . 159.06 -162.2 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.2 14.98 27.0 Favored Glycine 0 N--CA 1.464 0.514 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.298 177.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 24.0 mm -60.72 -40.45 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.08 -39.41 96.29 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 122.066 0.814 . . . . 0.0 111.67 176.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 7.6 t -58.08 -42.09 84.82 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 177.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.559 HH12 ' NZ ' ' A' ' 201' ' ' LYS . 99.5 mtt180 -63.17 -37.23 86.41 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.227 -177.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 92.5 mt -63.59 -46.01 87.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.256 0.551 . . . . 0.0 109.823 178.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 56.2 mt -66.82 -44.79 80.24 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.391 178.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.11 -45.16 89.85 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 119.876 1.216 . . . . 0.0 110.257 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -65.75 -44.07 92.95 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 120.184 -1.008 . . . . 0.0 111.299 -179.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.4 t -63.93 -43.85 94.63 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.692 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 19.1 m -69.34 -48.32 61.72 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 119.118 -1.033 . . . . 0.0 112.075 177.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.468 HG23 ' N ' ' A' ' 127' ' ' GLY . 5.5 t -65.57 -42.74 91.45 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 -174.079 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.468 ' N ' HG23 ' A' ' 126' ' ' THR . . . -64.19 -44.48 95.58 Favored Glycine 0 CA--C 1.52 0.396 0 CA-C-O 122.73 1.183 . . . . 0.0 112.95 -177.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.484 ' O ' HG12 ' A' ' 131' ' ' VAL . . . -60.81 -41.35 95.53 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 112.178 -2.011 . . . . 0.0 106.492 177.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.646 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 15.1 tp -64.44 -42.25 96.09 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.773 178.17 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.11 -39.92 96.1 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -177.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.484 HG12 ' O ' ' A' ' 128' ' ' ALA . 3.3 p -60.9 -24.81 33.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 122.577 1.18 . . . . 0.0 109.265 178.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.646 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . -57.74 -44.85 86.36 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 112.709 -2.041 . . . . 0.0 111.727 -178.505 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.485 ' CG1' ' N ' ' A' ' 134' ' ' ALA . 3.0 p -79.17 -48.98 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.13 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.485 ' N ' ' CG1' ' A' ' 133' ' ' VAL . . . -103.29 128.78 50.23 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.257 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.503 ' N ' ' HD2' ' A' ' 136' ' ' PRO . 21.1 tt0 -179.58 -50.32 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.718 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 135' ' ' GLN . 11.2 Cg_endo -51.79 -33.89 52.38 Favored 'Trans proline' 0 N--CA 1.499 1.849 0 C-N-CA 121.545 1.497 . . . . 0.0 114.221 -177.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 41.4 p -67.36 -41.71 84.67 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 118.183 -1.407 . . . . 0.0 108.42 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -64.43 -42.26 96.11 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.104 -1.038 . . . . 0.0 111.053 -178.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 88.5 t -63.57 -43.43 98.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.176 0.513 . . . . 0.0 111.07 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 136' ' ' PRO . 53.8 t -64.32 -38.44 82.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.807 -178.153 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -61.55 -40.58 95.2 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.206 -0.598 . . . . 0.0 111.854 -177.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 97.6 t -69.52 -44.86 79.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.307 0.575 . . . . 0.0 109.66 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.481 HH12 ' HA ' ' A' ' 175' ' ' LEU . 0.3 OUTLIER -64.4 -35.74 81.9 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.545 179.103 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -66.13 -40.76 90.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 112.166 -177.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 4.0 tm0? -64.67 -39.52 93.82 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.08 -1.048 . . . . 0.0 109.841 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.08 -34.93 79.59 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -177.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.419 ' C ' ' OE1' ' A' ' 147' ' ' GLN . 0.0 OUTLIER -59.36 111.41 1.36 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.417 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -96.42 -62.18 1.31 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 117.777 -1.106 . . . . 0.0 113.828 -176.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -62.02 126.7 28.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 122.481 2.4 . . . . 0.0 110.474 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -55.92 -49.43 73.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.664 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 152.94 155.32 7.07 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.666 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -179.963 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.423 ' O ' ' O ' ' A' ' 157' ' ' GLN . 11.0 t80 . . . . . 0 N--CA 1.463 0.196 0 CA-C-O 120.735 0.302 . . . . 0.0 111.01 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.423 ' O ' ' O ' ' A' ' 156' ' ' TYR . 34.3 mt-30 49.67 176.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.992 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 25.7 t -157.05 -177.66 6.78 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.307 0.575 . . . . 0.0 110.883 -179.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.551 HG23 ' N ' ' A' ' 160' ' ' VAL . 9.2 t -63.98 -45.86 87.2 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.675 -177.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.551 ' N ' HG23 ' A' ' 159' ' ' THR . 87.2 t -63.81 -45.17 97.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 119.063 -1.055 . . . . 0.0 108.721 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -67.28 -39.16 85.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.725 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -61.67 -45.87 92.16 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -177.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.438 ' CD1' ' C ' ' A' ' 163' ' ' TYR . 12.5 t80 -62.47 -50.12 72.69 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.06 -179.3 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -68.2 -45.51 73.16 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -175.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 18.8 m -62.65 -44.73 95.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 119.433 1.015 . . . . 0.0 113.142 -177.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 47.3 mm -64.63 -38.63 83.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-O 121.968 0.89 . . . . 0.0 109.6 176.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.7 -36.31 76.24 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 113.787 -1.551 . . . . 0.0 108.059 176.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 32.2 mmm-85 -62.13 -50.31 72.42 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 122.2 2.273 . . . . 0.0 111.97 -175.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -75.05 -50.92 14.89 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 123.471 0.708 . . . . 0.0 109.113 177.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -78.07 -36.51 48.19 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 -173.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 91.28 -167.32 31.36 Favored Glycine 0 N--CA 1.469 0.836 0 CA-C-N 118.29 0.496 . . . . 0.0 111.945 177.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.416 HG12 ' H ' ' A' ' 172' ' ' ILE . 6.3 pt -72.83 -43.26 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 CA-C-O 121.643 0.735 . . . . 0.0 110.414 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -58.88 -33.65 70.73 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.336 -1.302 . . . . 0.0 111.143 -177.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -60.96 -40.64 98.72 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 118.528 -1.796 . . . . 0.0 109.396 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.528 ' O ' HD13 ' A' ' 175' ' ' LEU . 0.1 OUTLIER -70.72 -34.14 71.59 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 111.134 -2.533 . . . . 0.0 117.065 -177.173 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 176' ' ' TRP . . . . . 0.528 ' CE2' ' OG ' ' A' ' 180' ' ' SER . 55.7 t90 -78.08 -8.77 58.65 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 111.779 -2.464 . . . . 0.0 110.949 -176.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.409 ' HB2' HH22 ' A' ' 143' ' ' ARG . 0.5 OUTLIER -44.57 -48.96 10.33 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 114.679 1.362 . . . . 0.0 114.679 -175.866 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -102.99 -37.96 3.02 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 124.206 0.908 . . . . 0.0 113.528 -177.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.446 ' CG2' ' N ' ' A' ' 180' ' ' SER . 0.9 OUTLIER -45.19 -50.98 11.1 Favored 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -178.925 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 180' ' ' SER . . . . . 0.528 ' OG ' ' CE2' ' A' ' 176' ' ' TRP . 0.0 OUTLIER -62.64 -50.43 78.26 Favored Pre-proline 0 N--CA 1.48 1.026 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -177.0 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 180' ' ' SER . 25.8 Cg_endo -63.83 -26.97 67.46 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.196 1.931 . . . . 0.0 111.265 177.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 18.0 t30 -62.7 -38.08 89.04 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 39.8 t -62.08 -41.34 90.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.12 -38.69 87.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.746 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 60.3 ttt85 -60.23 -41.15 92.51 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.717 -0.393 . . . . 0.0 109.944 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -60.92 -42.23 97.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.248 0.547 . . . . 0.0 110.463 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' ALA . . . . . 0.401 ' O ' ' SG ' ' A' ' 191' ' ' CYS . . . -63.8 -42.93 97.61 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.433 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 96.4 mt -62.85 -44.85 99.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -177.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 6.1 m -59.66 -45.8 93.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 119.854 -0.738 . . . . 0.0 110.875 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' ASN . . . . . 0.467 ' OD1' ' CZ ' ' A' ' 107' ' ' TYR . 53.1 t30 -62.08 -43.55 98.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 122.069 0.937 . . . . 0.0 109.892 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 191' ' ' CYS . . . . . 0.401 ' SG ' ' O ' ' A' ' 187' ' ' ALA . 79.3 m -62.59 -47.02 85.62 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 113.902 -1.499 . . . . 0.0 110.625 178.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.31 -40.69 96.42 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 114.018 -1.446 . . . . 0.0 109.929 177.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -61.1 -45.49 94.51 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.337 -1.302 . . . . 0.0 112.611 -178.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 1.4 tt -63.22 -37.4 87.09 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 118.676 -1.21 . . . . 0.0 108.262 -175.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 66.1 t -62.74 -46.19 96.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 C-N-CA 117.391 -1.723 . . . . 0.0 107.076 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 14.7 m -64.27 -46.37 84.0 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 113.712 1.005 . . . . 0.0 113.712 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -57.36 -39.16 75.4 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.639 1.176 . . . . 0.0 113.27 -177.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -55.63 -44.64 77.29 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -178.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.42 HD12 ' N ' ' A' ' 199' ' ' LEU . 8.8 mp -61.46 -39.23 90.12 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.881 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 1.7 mp -63.38 -43.64 98.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-O 118.333 -0.842 . . . . 0.0 111.366 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' LYS . . . . . 0.559 ' NZ ' HH12 ' A' ' 119' ' ' ARG . 53.4 mtmt -60.59 -41.3 94.41 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 121.154 1.797 . . . . 0.0 111.237 177.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -65.33 -36.67 84.73 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 113.11 -1.859 . . . . 0.0 110.965 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 54.7 m -101.92 129.91 48.28 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.691 0.758 . . . . 0.0 111.892 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.453 HD13 HD13 ' A' ' 209' ' ' LEU . 0.3 OUTLIER 68.37 5.19 4.61 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 114.615 -1.175 . . . . 0.0 112.192 179.248 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.518 ' O ' ' O ' ' A' ' 201' ' ' LYS . 1.7 tt -148.05 74.1 1.28 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.656 0.741 . . . . 0.0 110.523 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.35 -17.97 17.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.083 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.569 ' O ' ' CG ' ' A' ' 208' ' ' ASN . . . -170.72 18.98 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.573 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' ASN . . . . . 0.572 ' OD1' ' N ' ' A' ' 209' ' ' LEU . 44.3 p30 115.46 -140.24 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.093 0 O-C-N 125.636 1.835 . . . . 0.0 109.679 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.572 ' N ' ' OD1' ' A' ' 208' ' ' ASN . 13.6 tp . . . . . 0 C--N 1.331 -0.223 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 . . . . . 0 N--CA 1.459 -0.017 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.442 ' N ' ' CD ' ' A' ' 215' ' ' PRO . 3.3 mt -61.14 -43.74 91.53 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.158 -178.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 214' ' ' LEU . 32.3 Cg_exo -60.5 -32.97 94.29 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 121.21 1.273 . . . . 0.0 111.469 -179.155 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 76.2 m -64.05 -42.0 97.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 113.322 -1.763 . . . . 0.0 111.611 -178.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -66.53 -37.89 85.98 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.4 -0.52 . . . . 0.0 111.987 -178.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -63.42 -46.93 84.05 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.803 -178.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 1.5 t -60.13 -37.49 80.24 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 118.94 0.791 . . . . 0.0 111.064 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 82.5 p -59.38 -41.28 88.98 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.42 -41.6 98.7 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -177.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -61.46 -46.97 87.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 122.133 0.968 . . . . 0.0 112.387 -176.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -60.5 -41.65 98.76 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 107.361 -2.296 . . . . 0.0 107.361 177.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' ALA . . . . . 0.644 ' O ' HG23 ' A' ' 228' ' ' THR . . . -62.72 -38.33 90.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.45 -0.875 . . . . 0.0 108.717 177.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 225' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -62.04 -42.45 99.73 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -178.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -66.9 -38.36 86.11 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 63.5 m -63.24 -41.28 99.07 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.179 177.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' THR . . . . . 0.644 HG23 ' O ' ' A' ' 224' ' ' ALA . 53.2 p -61.89 -40.17 94.51 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.494 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 39.5 m -59.58 -40.46 87.47 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.644 -177.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 95.3 t -61.58 -42.73 95.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 119.245 -0.982 . . . . 0.0 112.318 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ILE . . . . . 0.523 ' O ' ' HD2' ' A' ' 234' ' ' PRO . 12.8 pt -62.67 -40.65 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 119.895 -0.722 . . . . 0.0 109.383 177.307 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -62.78 -39.35 93.92 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.472 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 0.0 OUTLIER -58.44 -42.45 94.7 Favored Pre-proline 0 N--CA 1.481 1.094 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -173.327 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.523 ' HD2' ' O ' ' A' ' 231' ' ' ILE . 32.5 Cg_exo -58.77 -41.05 66.99 Favored 'Trans proline' 0 C--N 1.294 -2.304 0 C-N-CA 122.059 1.84 . . . . 0.0 113.654 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.402 HG22 ' H ' ' A' ' 235' ' ' VAL . 6.9 m -65.99 -37.42 79.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 118.507 -1.277 . . . . 0.0 111.149 178.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -65.54 -41.45 93.05 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -178.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 16.1 m -65.24 -44.86 95.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -176.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 60.3 t . . . . . 0 C--N 1.327 -0.403 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.268 -177.334 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 70.0 p . . . . . 0 N--CA 1.466 0.34 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 260' ' ' MET . . . . . 0.56 ' SD ' ' N ' ' A' ' 261' ' ' LEU . 0.0 OUTLIER -62.47 -43.85 97.83 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.232 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.56 ' N ' ' SD ' ' A' ' 260' ' ' MET . 7.0 tp -62.13 -46.57 88.44 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 122.792 0.437 . . . . 0.0 111.093 -178.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 13.6 tpp85 -66.0 -53.81 34.06 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.868 -178.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -91.16 -122.07 0.07 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.735 0.303 . . . . 0.0 111.595 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 264' ' ' GLU . . . . . 0.494 ' O ' ' O ' ' A' ' 265' ' ' GLY . 58.0 mt-10 -30.57 107.45 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -178.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 265' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 264' ' ' GLU . . . -41.38 175.07 0.01 OUTLIER Glycine 0 CA--C 1.533 1.173 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 178.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -68.73 -9.1 25.22 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 122.835 2.357 . . . . 0.0 111.483 177.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 82.6 mtt85 -69.43 -26.61 64.7 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.122 0.569 . . . . 0.0 112.087 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -58.31 -32.07 68.12 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.392 -179.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -61.99 -41.9 98.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.245 0.545 . . . . 0.0 110.547 177.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -66.15 -37.89 86.77 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.194 -178.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.444 ' O ' ' O ' ' A' ' 272' ' ' GLY . 62.7 mmtt -73.17 -173.75 1.39 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.231 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 272' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 271' ' ' LYS . . . 48.69 103.87 0.01 OUTLIER Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 273' ' ' PHE . . . . . 0.401 ' H ' ' H ' ' A' ' 274' ' ' MET . 46.0 p90 -170.46 1.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.449 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 274' ' ' MET . . . . . 0.568 ' N ' ' CD ' ' A' ' 275' ' ' PRO . 0.5 OUTLIER -63.97 -44.53 78.7 Favored Pre-proline 0 CA--C 1.532 0.268 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.869 -179.555 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 275' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 274' ' ' MET . 21.5 Cg_exo -64.68 -46.67 6.47 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.44 2.093 . . . . 0.0 110.947 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 51.0 m -60.76 -39.51 89.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.287 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -61.75 -42.76 99.4 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 122.878 1.323 . . . . 0.0 112.814 -178.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 8.5 tp -62.29 -38.79 90.73 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 111.853 -2.43 . . . . 0.0 108.138 174.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 16.2 mmm180 -62.73 -39.49 94.24 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.438 0.637 . . . . 0.0 110.326 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 22.3 tp -61.97 -36.61 81.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.974 -1.012 . . . . 0.0 113.028 -177.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -68.24 -51.34 33.34 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 282' ' ' SER . . . . . 0.442 ' O ' HG12 ' A' ' 285' ' ' VAL . 14.0 p -63.07 -44.43 95.81 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.268 0.627 . . . . 0.0 109.883 179.27 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 283' ' ' TRP . . . . . 0.421 ' O ' HG22 ' A' ' 286' ' ' VAL . 62.7 t90 -60.06 -37.99 81.52 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -61.83 -37.41 84.36 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.587 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 282' ' ' SER . 0.3 OUTLIER -59.88 -37.45 71.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.222 -178.303 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.568 ' O ' HG12 ' A' ' 289' ' ' VAL . 0.9 OUTLIER -61.86 -40.02 85.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 120.234 -0.587 . . . . 0.0 109.755 -179.27 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 16.6 mmt -61.51 -39.59 91.55 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.849 0.357 . . . . 0.0 110.66 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -59.63 -41.95 91.62 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -178.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.568 HG12 ' O ' ' A' ' 286' ' ' VAL . 3.1 p -61.82 -38.62 80.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 O-C-N 121.854 -0.529 . . . . 0.0 111.279 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 10.3 m -62.58 -40.73 97.83 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -61.27 -38.85 88.25 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 176.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -58.28 -40.45 81.95 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 117.867 -1.533 . . . . 0.0 109.616 -176.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 293' ' ' GLN . . . . . 0.48 ' O ' ' O ' ' A' ' 296' ' ' ARG . 75.7 mt-30 -60.75 -43.13 98.37 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 122.554 1.169 . . . . 0.0 111.293 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 9.3 mp -60.8 -40.66 93.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 113.382 -1.736 . . . . 0.0 109.1 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -63.39 -45.96 88.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.047 178.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 296' ' ' ARG . . . . . 0.48 ' O ' ' O ' ' A' ' 293' ' ' GLN . 16.4 tpp180 -123.22 116.02 22.7 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.299 -0.864 . . . . 0.0 108.873 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -122.24 -163.5 1.08 Allowed 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -178.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.604 HD22 ' N ' ' A' ' 298' ' ' LEU . 3.3 mm? -63.54 -175.65 0.13 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 176.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 21.8 ttt -166.55 64.47 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 119.614 -0.835 . . . . 0.0 112.371 -178.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 300' ' ' ALA . . . . . 0.428 ' CB ' ' OE1' ' A' ' 303' ' ' GLN . . . -175.6 100.85 0.07 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 122.079 0.943 . . . . 0.0 110.52 -178.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.411 ' HB1' ' HE ' ' A' ' 305' ' ' ARG . . . -64.18 -46.34 84.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 113.545 -1.661 . . . . 0.0 113.351 -176.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -58.57 -39.62 80.82 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.014 -177.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 303' ' ' GLN . . . . . 0.428 ' OE1' ' CB ' ' A' ' 300' ' ' ALA . 47.0 mt-30 -64.9 -46.93 79.65 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.71 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 304' ' ' SER . . . . . 0.433 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 15.5 m -66.79 -38.05 85.77 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.064 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 305' ' ' ARG . . . . . 0.411 ' HE ' ' HB1' ' A' ' 301' ' ' ALA . 65.2 mtt-85 -61.81 -42.61 99.23 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.017 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 10.6 tm-20 -64.75 -36.9 85.81 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -177.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 307' ' ' ALA . . . . . 0.54 ' HB3' ' HD3' ' A' ' 308' ' ' PRO . . . -60.12 -53.12 68.2 Favored Pre-proline 0 CA--C 1.544 0.717 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -176.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 308' ' ' PRO . . . . . 0.54 ' HD3' ' HB3' ' A' ' 307' ' ' ALA . 73.7 Cg_endo -75.35 0.25 9.27 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.199 1.933 . . . . 0.0 111.955 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 54.2 t80 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.558 -179.841 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.5 m . . . . . 0 C--O 1.23 0.042 0 CA-C-O 120.773 0.32 . . . . 0.0 110.617 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.684 HG22 ' H ' ' A' ' 16' ' ' LYS . 8.0 p -156.54 175.45 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.404 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.684 ' H ' HG22 ' A' ' 15' ' ' VAL . 54.3 tttp -64.3 -41.34 96.91 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.951 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -63.58 -41.77 98.34 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.519 ' H ' HG13 ' A' ' 15' ' ' VAL . 44.5 tp -79.8 -26.48 40.54 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.921 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.409 ' O ' ' OG1' ' A' ' 22' ' ' THR . . . -66.32 -41.26 94.68 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 107.615 -2.194 . . . . 0.0 107.615 177.175 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.42 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -71.39 -32.22 68.19 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 124.811 2.243 . . . . 0.0 107.467 176.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.55 -42.38 98.9 Favored Glycine 0 CA--C 1.528 0.845 1 CA-C-N 108.399 -4.001 . . . . 0.0 108.242 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 19' ' ' GLY . 22.2 p -70.68 -27.55 64.09 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.54 0.686 . . . . 0.0 109.225 177.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -66.48 -50.1 64.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.875 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.79 -35.98 79.76 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 118.46 -1.296 . . . . 0.0 111.253 -177.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 79.2 m -63.9 -53.77 45.25 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.339 -178.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.8 tt -65.64 -39.59 85.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 -177.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.92 -41.93 97.53 Favored 'General case' 0 C--O 1.224 -0.273 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -173.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 28' ' ' ASP . 3.8 t70 -77.78 -26.94 50.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 120.345 1.429 . . . . 0.0 110.078 -175.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 45.6 mt -59.86 -55.12 38.1 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 119.841 1.201 . . . . 0.0 112.332 -178.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.0 pt -75.47 -4.31 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -109.68 -17.59 13.66 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 118.54 -1.264 . . . . 0.0 110.253 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -68.08 -44.33 38.39 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 122.046 2.203 . . . . 0.0 110.779 -177.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -59.16 -15.63 29.47 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 CA-C-N 120.836 1.334 . . . . 0.0 111.31 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.607 ' O ' HD23 ' A' ' 34' ' ' LEU . 0.9 OUTLIER -66.8 -35.74 80.77 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.165 -0.925 . . . . 0.0 113.296 -177.293 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -64.44 -40.56 95.98 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.149 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 79.6 p -58.12 -34.87 70.69 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.34 -38.64 85.17 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 119.907 -0.717 . . . . 0.0 112.62 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.446 ' CG ' ' N ' ' A' ' 39' ' ' VAL . 12.0 pttp -61.54 -48.1 82.55 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 119.421 -0.912 . . . . 0.0 111.478 -176.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.446 ' N ' ' CG ' ' A' ' 38' ' ' LYS . 7.2 m -62.92 -38.81 82.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -176.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.508 ' O ' ' N ' ' A' ' 42' ' ' GLN . 61.7 mtp85 -59.86 -41.01 90.55 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 119.356 -0.938 . . . . 0.0 110.175 -178.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -62.59 38.75 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.866 177.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.508 ' N ' ' O ' ' A' ' 40' ' ' ARG . 5.2 pt20 -91.03 149.08 21.97 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.823 -0.548 . . . . 0.0 111.168 -179.329 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 7.5 mt -96.49 44.59 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.054 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 69.2 mm-40 46.62 -165.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.52 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 160.49 -72.02 0.22 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.606 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 2.6 pm0 -44.54 -24.8 0.21 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.859 0.361 . . . . 0.0 110.53 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.9 m 56.78 71.06 0.59 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.761 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -62.03 -27.96 69.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.184 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.77 -14.09 61.04 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 109.009 -1.636 . . . . 0.0 109.009 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.1 mp -65.76 -37.48 86.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.65 -0.775 . . . . 0.0 109.176 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.534 HG23 ' N ' ' A' ' 52' ' ' ARG . 20.0 m -60.87 -44.4 97.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.965 -178.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.534 ' N ' HG23 ' A' ' 51' ' ' VAL . 32.3 ttm180 -64.67 -35.44 81.05 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 119.779 -0.768 . . . . 0.0 112.35 -177.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 t -68.89 -38.01 79.37 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 119.383 -0.927 . . . . 0.0 108.778 177.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -130.63 94.39 3.63 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.571 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.21 -2.21 18.0 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -177.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.607 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 24.3 p -125.21 -141.74 0.29 Allowed 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.064 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.607 ' HB3' ' O ' ' A' ' 56' ' ' SER . . . 97.66 13.69 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 O-C-N 124.159 0.912 . . . . 0.0 111.928 178.408 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.445 ' O ' ' O ' ' A' ' 59' ' ' TYR . 25.0 pt20 -163.26 -39.4 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.369 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.445 ' O ' ' O ' ' A' ' 58' ' ' GLN . 39.5 m-85 54.35 166.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.979 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.408 ' O ' ' C ' ' A' ' 61' ' ' GLY . 65.3 mtm180 -57.54 -41.56 81.2 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 60' ' ' ARG . . . -29.98 102.47 0.01 OUTLIER Glycine 0 CA--C 1.527 0.833 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.567 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.3 p -67.26 -33.75 64.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 118.378 -0.82 . . . . 0.0 109.864 176.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -60.18 -32.27 70.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 121.144 1.793 . . . . 0.0 109.674 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.68 -49.4 64.32 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 115.022 -0.99 . . . . 0.0 114.564 -176.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.4 p -62.28 -46.69 87.67 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.5 tp -60.02 -35.38 60.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.606 ' O ' HD23 ' A' ' 67' ' ' LEU . 1.2 tt -63.21 -35.51 80.55 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 121.291 1.86 . . . . 0.0 110.848 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.614 ' O ' HG23 ' A' ' 72' ' ' THR . 99.9 m -62.63 -38.26 89.55 Favored 'General case' 0 C--O 1.246 0.884 0 CA-C-N 113.049 -1.887 . . . . 0.0 111.069 -175.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.512 ' O ' ' OG1' ' A' ' 72' ' ' THR . 0.4 OUTLIER -60.37 -39.14 86.17 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 120.322 -1.486 . . . . 0.0 114.283 -177.075 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.412 HG22 ' H ' ' A' ' 70' ' ' VAL . 5.7 m -69.49 -40.25 79.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 119.186 -1.005 . . . . 0.0 113.054 -178.277 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -78.4 -13.3 59.9 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -178.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.614 HG23 ' O ' ' A' ' 68' ' ' THR . 2.5 p -62.86 -54.61 36.07 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.707 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.515 ' N ' ' OE1' ' A' ' 73' ' ' GLU . 54.8 mp0 -107.36 -58.17 1.99 Allowed 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 155.45 164.19 12.89 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -56.59 -35.36 97.04 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 121.714 1.609 . . . . 0.0 111.925 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -61.65 -12.33 15.66 Favored 'General case' 0 C--O 1.226 -0.144 0 CA-C-O 121.751 0.786 . . . . 0.0 110.887 176.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.3 t -78.24 -32.9 49.95 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.247 -1.342 . . . . 0.0 110.805 -178.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 14.6 tp -75.94 -33.28 59.83 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.833 0.349 . . . . 0.0 110.963 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -92.3 -5.01 53.12 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 122.802 1.287 . . . . 0.0 112.767 -178.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -93.92 117.45 30.12 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 112.224 -2.262 . . . . 0.0 107.071 175.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.84 -10.39 57.24 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 -177.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 56.4 tp -59.05 -34.74 72.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 113.281 -1.46 . . . . 0.0 110.687 -179.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 38.2 t -70.44 -26.36 28.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.794 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.64 -31.17 61.89 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.908 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.8 -40.51 89.63 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 119.693 -1.241 . . . . 0.0 111.619 -177.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.408 ' N ' ' CD2' ' A' ' 86' ' ' LEU . 3.7 mm? -62.43 -40.36 96.32 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 122.351 1.072 . . . . 0.0 112.434 -177.088 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -60.32 -26.91 66.92 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 113.131 -1.85 . . . . 0.0 108.984 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 16.5 ttm-85 -57.73 -53.42 58.36 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 173.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 53.2 tp60 -67.32 -30.02 69.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 112.606 -2.088 . . . . 0.0 112.151 -178.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 11.9 tpt -61.15 -41.35 96.6 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.018 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 40.4 m -74.8 -34.86 62.47 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 119.455 -0.898 . . . . 0.0 111.304 -177.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -57.9 -44.12 86.56 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 120.966 1.712 . . . . 0.0 111.966 -176.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.48 -33.12 64.68 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.551 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.1 m -64.51 -41.69 96.26 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.429 ' CG1' HD12 ' A' ' 99' ' ' LEU . 86.0 t -68.22 -28.45 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.885 177.511 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.498 ' NH2' ' CE2' ' A' ' 100' ' ' TYR . 54.4 ttt-85 -77.78 9.5 3.45 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -176.334 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.454 HG22 ' O ' ' A' ' 97' ' ' ILE . 98.3 mt -86.8 -14.71 10.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.109 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -139.99 -48.38 0.06 OUTLIER Glycine 0 CA--C 1.543 1.809 0 N-CA-C 116.059 1.184 . . . . 0.0 116.059 -177.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.429 HD12 ' CG1' ' A' ' 95' ' ' VAL . 95.2 mt -71.72 -12.48 61.34 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 119.899 1.849 . . . . 0.0 113.792 -178.037 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.514 ' HE2' ' HZ1' ' A' ' 104' ' ' LYS . 2.5 t80 -80.12 -51.47 8.95 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.326 -1.306 . . . . 0.0 111.384 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -69.97 -32.35 70.53 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 123.619 1.676 . . . . 0.0 110.925 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.0 t -68.21 -51.07 49.66 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 110.455 -3.066 . . . . 0.0 113.301 177.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.684 HG22 ' CE2' ' A' ' 107' ' ' TYR . 0.3 OUTLIER -73.51 -26.41 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.359 0 CA-C-N 121.337 1.881 . . . . 0.0 111.24 179.115 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.514 ' HZ1' ' HE2' ' A' ' 100' ' ' TYR . 63.8 mttt -69.44 -41.74 75.88 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 112.385 -2.189 . . . . 0.0 112.533 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -80.16 -12.9 59.61 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 122.613 1.197 . . . . 0.0 111.047 -178.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -80.08 -23.19 41.49 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.24 178.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.684 ' CE2' HG22 ' A' ' 103' ' ' VAL . 21.4 m-85 -109.97 -28.54 8.68 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 119.53 1.059 . . . . 0.0 112.881 -175.103 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.11 9.38 41.06 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 116.765 -1.974 . . . . 0.0 113.962 -175.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.514 ' C ' ' H ' ' A' ' 111' ' ' SER . 62.0 mttp -45.97 130.11 9.75 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.512 1.051 . . . . 0.0 108.699 176.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -63.04 38.98 0.07 OUTLIER Glycine 0 CA--C 1.544 1.903 0 CA-C-N 119.179 0.9 . . . . 0.0 114.166 -178.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.514 ' H ' ' C ' ' A' ' 109' ' ' LYS . 10.6 m -5.29 -81.77 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 116.488 2.033 . . . . 0.0 116.488 -178.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.625 ' O ' ' CG ' ' A' ' 113' ' ' HIS . 2.9 tt0 165.79 -33.24 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 120.456 1.48 . . . . 0.0 113.446 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.655 ' O ' ' HB2' ' A' ' 114' ' ' ALA . 3.9 m-70 160.37 38.01 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.344 0.592 . . . . 0.0 109.931 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.655 ' HB2' ' O ' ' A' ' 113' ' ' HIS . . . 160.37 -162.7 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.855 0.836 . . . . 0.0 109.15 177.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.08 15.45 23.79 Favored Glycine 0 C--N 1.335 0.495 0 CA-C-N 114.104 -1.407 . . . . 0.0 110.512 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.631 HD12 HH21 ' A' ' 119' ' ' ARG . 8.7 tp -60.66 -40.36 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 C-N-CA 119.726 -0.79 . . . . 0.0 109.069 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.508 ' N ' HG23 ' A' ' 116' ' ' ILE . . . -65.99 -40.84 95.44 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-O 121.509 0.505 . . . . 0.0 111.885 175.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 42.0 p -59.11 -43.16 91.9 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 176.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.631 HH21 HD12 ' A' ' 116' ' ' ILE . 9.9 ttp-105 -64.05 -36.98 85.79 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.64 -178.219 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 18.3 tp -63.43 -45.73 89.61 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 36.5 mt -66.08 -44.58 84.03 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.491 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.8 -45.23 90.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 119.691 1.132 . . . . 0.0 110.27 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -66.01 -44.32 91.78 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.129 -1.034 . . . . 0.0 111.318 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 69.3 m -64.04 -44.12 93.46 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.277 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 96.7 m -69.32 -48.19 62.26 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 119.339 -0.944 . . . . 0.0 111.945 177.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 25.3 p -65.36 -42.68 92.52 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -174.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -64.11 -44.53 95.63 Favored Glycine 0 CA--C 1.521 0.424 0 CA-C-O 122.969 1.316 . . . . 0.0 112.904 -177.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.476 ' O ' HG22 ' A' ' 131' ' ' VAL . . . -61.35 -41.54 97.23 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 111.878 -2.161 . . . . 0.0 107.296 177.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.613 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 35.9 tp -64.04 -42.03 97.19 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.801 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.0 -40.03 96.55 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 113.205 0.816 . . . . 0.0 113.205 -177.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.476 HG22 ' O ' ' A' ' 128' ' ' ALA . 15.5 m -61.07 -26.05 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 122.687 1.232 . . . . 0.0 109.989 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.613 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . -58.35 -45.09 88.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 112.399 -2.182 . . . . 0.0 110.909 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 49.1 t -79.25 -49.08 20.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.449 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -97.96 135.05 40.23 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.478 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.641 ' H ' ' HD2' ' A' ' 136' ' ' PRO . 2.2 tp-100 -177.77 -39.6 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.871 179.075 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.641 ' HD2' ' H ' ' A' ' 135' ' ' GLN . 73.8 Cg_exo -52.45 -33.55 57.55 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 122.143 1.896 . . . . 0.0 112.46 -179.401 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 66.6 p -67.53 -42.69 82.31 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 118.725 -1.19 . . . . 0.0 109.879 -178.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -66.24 -42.81 88.11 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 119.303 -0.959 . . . . 0.0 112.136 -178.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 89.6 t -64.11 -44.28 97.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.406 HG13 ' O ' ' A' ' 136' ' ' PRO . 34.5 m -65.07 -39.49 85.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -176.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -63.08 -42.3 99.61 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 118.668 -1.213 . . . . 0.0 111.657 -178.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.421 HG13 ' N ' ' A' ' 143' ' ' ARG . 3.8 p -71.4 -46.45 64.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.678 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.421 ' N ' HG13 ' A' ' 142' ' ' VAL . 14.4 tpp180 -65.9 -38.09 87.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.693 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -68.11 -42.44 80.24 Favored 'General case' 0 C--O 1.226 -0.165 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -177.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -66.23 -40.83 90.55 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 118.819 -1.153 . . . . 0.0 110.133 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.48 -35.18 80.13 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 -178.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.466 ' O ' ' CG ' ' A' ' 147' ' ' GLN . 6.4 pt20 -59.94 111.1 1.35 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 177.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -95.19 -63.84 1.12 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 117.62 -1.181 . . . . 0.0 112.696 -177.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.462 ' O ' ' N ' ' A' ' 151' ' ' GLY . 16.2 mmm180 -77.76 0.12 24.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 122.675 2.489 . . . . 0.0 109.725 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . 62.02 -75.23 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.619 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 149' ' ' ARG . . . 157.56 -115.66 0.67 Allowed Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.679 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 179.962 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 1.7 t80 . . . . . 0 CA--C 1.531 0.23 0 CA-C-O 120.712 0.291 . . . . 0.0 110.43 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -88.21 153.69 21.03 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.946 0.403 . . . . 0.0 111.047 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.711 ' H ' ' CG ' ' A' ' 161' ' ' GLU . 19.5 m -157.12 -178.77 7.61 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 121.309 0.576 . . . . 0.0 111.007 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.548 HG23 ' N ' ' A' ' 160' ' ' VAL . 10.2 t -64.78 -46.32 82.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.442 -178.078 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.55 HG23 ' N ' ' A' ' 161' ' ' GLU . 27.4 m -64.53 -45.78 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 C-N-CA 119.354 -0.939 . . . . 0.0 110.674 -178.332 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.711 ' CG ' ' H ' ' A' ' 158' ' ' SER . 3.1 pp20? -67.59 -38.6 84.27 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.545 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.49 ' N ' ' CD ' ' A' ' 161' ' ' GLU . . . -61.58 -45.68 93.08 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.172 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -62.37 -49.69 74.54 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.389 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -68.45 -45.53 72.24 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 -176.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 14.5 m -62.85 -44.7 95.44 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -177.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.476 HD12 ' N ' ' A' ' 167' ' ' ALA . 2.6 pp -64.71 -38.37 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 121.955 0.884 . . . . 0.0 109.345 176.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.476 ' N ' HD12 ' A' ' 166' ' ' ILE . . . -59.58 -36.19 75.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 113.786 -1.552 . . . . 0.0 107.486 176.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 11.3 tpp85 -61.98 -49.8 74.64 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 122.266 2.303 . . . . 0.0 111.71 -175.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -74.62 -50.82 16.39 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 123.442 0.697 . . . . 0.0 109.51 177.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -77.85 -36.43 49.99 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 116.997 2.221 . . . . 0.0 116.997 -172.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 90.33 -166.16 31.82 Favored Glycine 0 N--CA 1.471 0.994 0 CA-C-N 118.779 0.718 . . . . 0.0 112.109 177.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.703 HD12 ' N ' ' A' ' 172' ' ' ILE . 2.0 mp -73.1 -44.11 56.93 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 CA-C-O 121.978 0.894 . . . . 0.0 110.251 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 -58.61 -33.47 70.06 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.632 -176.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -60.74 -40.54 98.25 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 118.896 -1.621 . . . . 0.0 110.23 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 52.4 tp -69.93 -33.94 72.8 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 116.646 2.091 . . . . 0.0 116.646 -177.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -78.41 -7.97 57.95 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 111.437 -2.62 . . . . 0.0 109.794 -178.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 38.1 tptt -43.42 -48.39 7.13 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.792 -176.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -86.02 -39.88 7.8 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.237 0.922 . . . . 0.0 110.845 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.6 m -45.44 -51.44 11.47 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' SER . . . . . 0.457 ' O ' HG12 ' A' ' 183' ' ' VAL . 2.7 m -63.19 -50.92 73.05 Favored Pre-proline 0 N--CA 1.474 0.739 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -176.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 180' ' ' SER . 33.6 Cg_endo -65.02 -27.32 57.9 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.278 1.985 . . . . 0.0 112.353 177.164 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -63.0 -38.63 91.96 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 121.228 -0.189 . . . . 0.0 111.102 -178.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.457 HG12 ' O ' ' A' ' 180' ' ' SER . 1.9 p -62.47 -42.02 94.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.372 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.41 ' N ' ' CG1' ' A' ' 183' ' ' VAL . . . -62.22 -39.54 93.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.95 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 72.3 ttp85 -61.08 -42.06 97.81 Favored 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.793 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' ASN . . . . . 0.557 ' ND2' ' N ' ' A' ' 187' ' ' ALA . 0.1 OUTLIER -62.13 -42.67 99.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.964 0.411 . . . . 0.0 111.348 179.695 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 187' ' ' ALA . . . . . 0.557 ' N ' ' ND2' ' A' ' 186' ' ' ASN . . . -63.8 -44.24 93.9 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -177.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 7.4 tt -63.98 -45.23 97.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -178.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 12.9 m -60.18 -46.61 94.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 119.679 -0.808 . . . . 0.0 111.807 -178.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' ASN . . . . . 0.425 ' ND2' ' HA ' ' A' ' 187' ' ' ALA . 1.4 p30 -62.41 -43.0 99.86 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 122.274 1.035 . . . . 0.0 109.602 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' CYS . . . . . . . . . . . . . 45.9 t -62.36 -47.19 85.3 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 113.538 -1.664 . . . . 0.0 111.004 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.514 ' O ' HG23 ' A' ' 196' ' ' THR . . . -64.89 -41.17 95.84 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.083 177.229 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -61.09 -45.09 96.13 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.366 -1.288 . . . . 0.0 112.087 -178.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.627 ' CD2' ' HE ' ' A' ' 119' ' ' ARG . 17.5 mt -63.21 -37.0 85.53 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 119.228 -0.989 . . . . 0.0 108.705 -175.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 92.7 t -62.69 -45.98 97.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 C-N-CA 117.074 -1.85 . . . . 0.0 107.101 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' THR . . . . . 0.514 HG23 ' O ' ' A' ' 192' ' ' ALA . 59.9 p -64.46 -45.95 85.2 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -178.01 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -56.92 -38.91 73.52 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.018 1.327 . . . . 0.0 113.209 -177.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -55.37 -44.12 75.76 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.53 HD12 ' N ' ' A' ' 199' ' ' LEU . 10.1 mp -60.84 -38.22 84.74 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.624 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 57.9 mt -61.37 -42.01 92.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.19 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 19.4 mmtp -59.68 -38.22 80.92 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.609 1.564 . . . . 0.0 113.329 177.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -63.27 -39.96 96.06 Favored 'General case' 0 C--N 1.316 -0.862 0 O-C-N 121.941 -0.474 . . . . 0.0 111.027 -177.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.4 t -101.26 129.04 47.14 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 122.041 0.924 . . . . 0.0 112.621 -178.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 2.2 tp 67.73 4.25 3.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 113.788 -1.551 . . . . 0.0 111.976 178.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 2.3 mt -126.71 28.78 5.82 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.718 0.771 . . . . 0.0 112.014 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 18.1 mtpp -73.86 -23.68 59.64 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.258 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -162.99 34.17 0.1 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.658 -1.155 . . . . 0.0 108.316 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 2.4 m120 42.42 54.31 4.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.354 -1.294 . . . . 0.0 113.663 177.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.826 HD13 ' H ' ' A' ' 209' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.463 0.18 0 CA-C-N 114.777 -1.101 . . . . 0.0 108.745 178.234 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 . . . . . 0 CA--C 1.521 -0.172 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.467 ' N ' ' CD ' ' A' ' 215' ' ' PRO . 3.4 mt -61.07 -43.48 90.96 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.871 -177.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' A' ' 214' ' ' LEU . 26.4 Cg_exo -61.2 -33.33 90.6 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 120.716 0.944 . . . . 0.0 110.701 -179.115 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 86.9 m -65.62 -43.58 89.13 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.161 -1.381 . . . . 0.0 112.579 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 38.0 t-80 -67.7 -39.29 84.42 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -177.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -64.12 -46.83 82.43 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.217 -179.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 28.6 p -60.34 -37.84 81.93 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 118.894 0.77 . . . . 0.0 110.239 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 70.7 m -59.76 -41.72 91.68 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' ALA . . . . . 0.556 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.99 -41.67 97.44 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -177.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -62.02 -47.27 85.5 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.896 0.855 . . . . 0.0 113.111 -176.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -60.98 -42.25 99.7 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 108.0 -2.04 . . . . 0.0 108.0 177.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -63.22 -37.79 88.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.05 -1.075 . . . . 0.0 109.275 176.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -61.33 -41.78 99.61 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 114.172 -1.376 . . . . 0.0 111.59 -176.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -66.08 -38.91 89.45 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 118.168 -1.413 . . . . 0.0 107.949 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 83.6 m -64.01 -41.6 97.41 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.466 0.65 . . . . 0.0 109.778 176.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -61.81 -39.59 92.3 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.321 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 31.3 m -57.85 -39.23 77.24 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.15 -176.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 98.1 t -60.17 -40.87 84.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 118.804 -1.158 . . . . 0.0 108.302 178.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ILE . . . . . 0.567 ' O ' ' HD2' ' A' ' 234' ' ' PRO . 0.2 OUTLIER -61.81 -40.8 88.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 177.444 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -62.59 -38.98 92.27 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 115.686 1.736 . . . . 0.0 115.686 -178.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.449 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 0.2 OUTLIER -57.68 -40.82 86.77 Favored Pre-proline 0 N--CA 1.476 0.863 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 -172.721 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.567 ' HD2' ' O ' ' A' ' 231' ' ' ILE . 38.4 Cg_exo -58.62 -40.46 73.5 Favored 'Trans proline' 0 C--N 1.293 -2.343 0 C-N-CA 121.666 1.577 . . . . 0.0 113.78 -177.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.3 m -64.51 -37.44 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 118.395 -1.322 . . . . 0.0 109.336 178.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -65.94 -40.64 91.53 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.05 178.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 233' ' ' SER . 55.9 t -64.79 -45.07 96.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 115.295 -0.866 . . . . 0.0 113.073 -177.027 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 15.5 m . . . . . 0 C--N 1.324 -0.533 0 C-N-CA 119.749 -0.781 . . . . 0.0 111.299 -177.718 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 74.7 p . . . . . 0 N--CA 1.467 0.423 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 260' ' ' MET . . . . . . . . . . . . . 2.9 ptm -60.77 -43.48 98.0 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 121.013 -0.275 . . . . 0.0 111.505 -177.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 12.2 mt -62.53 -47.29 84.56 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 59.6 ttt85 -67.11 -54.11 24.46 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.549 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 28.1 mmtp -70.13 -156.42 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.929 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 264' ' ' GLU . . . . . 0.513 ' OE2' ' N ' ' A' ' 265' ' ' GLY . 1.0 OUTLIER -38.8 133.55 1.08 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.025 -179.702 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 265' ' ' GLY . . . . . 0.513 ' N ' ' OE2' ' A' ' 264' ' ' GLU . . . -47.98 169.97 0.07 OUTLIER Glycine 0 CA--C 1.533 1.179 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -55.54 -0.67 0.17 Allowed 'Trans proline' 0 N--CA 1.5 1.869 0 C-N-CA 121.978 1.786 . . . . 0.0 112.326 178.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 267' ' ' ARG . . . . . 0.492 ' H ' ' C ' ' A' ' 265' ' ' GLY . 91.1 mtt180 -69.77 -26.79 64.45 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.13 0.572 . . . . 0.0 112.3 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -58.37 -32.33 68.48 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.1 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -62.42 -41.34 98.63 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.138 0.494 . . . . 0.0 111.186 177.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -65.74 -37.82 87.42 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -177.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.457 ' O ' ' O ' ' A' ' 272' ' ' GLY . 14.8 mptt -56.39 -172.33 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 272' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 271' ' ' LYS . . . 45.82 103.11 0.01 OUTLIER Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.501 -0.64 . . . . 0.0 111.501 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -158.62 -12.91 0.07 Allowed 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.346 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 274' ' ' MET . . . . . 0.541 ' N ' ' HD2' ' A' ' 275' ' ' PRO . 2.1 tpt -64.07 -45.16 79.67 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 120.39 -0.524 . . . . 0.0 111.429 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 275' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 274' ' ' MET . 36.9 Cg_endo -64.84 -45.76 7.76 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.362 1.375 . . . . 0.0 111.57 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 78.5 p -59.67 -38.88 82.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.746 -178.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -61.0 -42.55 98.65 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 122.629 1.204 . . . . 0.0 112.017 -178.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 9.4 mp -62.02 -38.45 88.69 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 112.298 -2.228 . . . . 0.0 107.678 174.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 9.9 mtm180 -62.71 -39.23 93.37 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.21 0.529 . . . . 0.0 110.184 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 6.8 tp -61.97 -36.96 83.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.885 -177.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -67.95 -51.23 35.65 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 282' ' ' SER . . . . . 0.425 ' O ' HG12 ' A' ' 285' ' ' VAL . 36.3 m -62.92 -44.36 96.29 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 283' ' ' TRP . . . . . 0.471 ' O ' HG22 ' A' ' 286' ' ' VAL . 91.5 t90 -60.05 -38.17 81.99 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.674 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -62.77 -38.62 91.34 Favored 'General case' 0 C--N 1.317 -0.814 0 O-C-N 122.068 -0.395 . . . . 0.0 111.181 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.425 HG12 ' O ' ' A' ' 282' ' ' SER . 0.3 OUTLIER -60.98 -39.36 81.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -177.585 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.471 HG22 ' O ' ' A' ' 283' ' ' TRP . 6.5 m -62.91 -40.08 87.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 119.98 -0.688 . . . . 0.0 109.941 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 287' ' ' MET . . . . . 0.4 ' O ' ' OG1' ' A' ' 290' ' ' THR . 10.0 tpt -60.49 -38.95 85.98 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.162 0.506 . . . . 0.0 109.695 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -58.81 -40.18 83.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.542 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.427 HG12 ' O ' ' A' ' 286' ' ' VAL . 0.3 OUTLIER -60.71 -38.72 79.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.365 -177.645 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.4 ' OG1' ' O ' ' A' ' 287' ' ' MET . 39.4 p -62.71 -40.62 97.74 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 177.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -61.56 -39.05 89.72 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 176.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -58.72 -40.96 85.25 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 117.921 -1.512 . . . . 0.0 109.506 -176.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 293' ' ' GLN . . . . . 0.45 ' O ' ' O ' ' A' ' 296' ' ' ARG . 88.4 mt-30 -60.78 -42.78 98.19 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 122.825 1.298 . . . . 0.0 110.623 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.513 ' O ' HD13 ' A' ' 294' ' ' LEU . 0.2 OUTLIER -60.41 -40.68 91.87 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 112.583 -2.099 . . . . 0.0 109.091 179.507 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 1.8 mmmm -63.48 -45.8 89.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.34 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 296' ' ' ARG . . . . . 0.45 ' O ' ' O ' ' A' ' 293' ' ' GLN . 0.5 OUTLIER -122.96 116.23 23.22 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.364 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -116.25 -95.0 0.48 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.381 0.61 . . . . 0.0 110.767 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.415 ' C ' HD12 ' A' ' 298' ' ' LEU . 3.5 pp -136.65 -166.66 1.93 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.288 178.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 12.5 ttt -170.81 66.36 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.288 -0.565 . . . . 0.0 111.489 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.6 101.01 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.849 0.833 . . . . 0.0 110.697 -178.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -64.05 -46.13 85.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 113.895 -1.502 . . . . 0.0 113.534 -176.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 302' ' ' TYR . . . . . 0.534 ' CD2' ' OE2' ' A' ' 306' ' ' GLU . 19.9 t80 -58.66 -39.82 81.72 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.643 -178.172 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -64.84 -46.53 81.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.072 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 304' ' ' SER . . . . . 0.42 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 37.8 m -66.15 -37.17 85.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.539 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -61.12 -42.48 98.61 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.186 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 306' ' ' GLU . . . . . 0.534 ' OE2' ' CD2' ' A' ' 302' ' ' TYR . 52.1 mt-10 -64.66 -36.83 85.52 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 -177.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 307' ' ' ALA . . . . . 0.542 ' HB3' ' HD3' ' A' ' 308' ' ' PRO . . . -59.88 -53.0 69.68 Favored Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -176.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 308' ' ' PRO . . . . . 0.542 ' HD3' ' HB3' ' A' ' 307' ' ' ALA . 74.1 Cg_endo -75.13 0.25 9.18 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.109 1.873 . . . . 0.0 111.785 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 309' ' ' PHE . . . . . 0.491 ' CG ' ' O ' ' A' ' 308' ' ' PRO . 56.6 m-85 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.35 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.733 ' HA ' HD21 ' A' ' 18' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.431 0 CA-C-O 120.771 0.319 . . . . 0.0 111.164 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.411 ' H ' ' HG ' ' A' ' 18' ' ' LEU . 7.6 m -114.2 178.47 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 178.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.433 ' CD ' ' N ' ' A' ' 16' ' ' LYS . 3.8 mptp? -64.53 -41.52 96.32 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.189 -0.46 . . . . 0.0 112.066 -178.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -62.94 -42.13 99.71 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -178.16 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.738 ' C ' HD12 ' A' ' 18' ' ' LEU . 1.1 pp -80.59 -24.17 39.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.428 0.632 . . . . 0.0 112.564 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.478 ' N ' HD12 ' A' ' 18' ' ' LEU . . . -65.07 -40.43 96.99 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 107.241 -2.344 . . . . 0.0 107.241 177.242 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.452 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -71.17 -31.34 67.55 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 124.515 2.103 . . . . 0.0 107.485 176.336 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.78 -42.62 98.49 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-N 108.781 -3.827 . . . . 0.0 110.315 -178.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.4 t -70.92 -26.6 63.27 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -65.8 -50.6 64.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.711 -178.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.08 -36.1 80.68 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 118.308 -1.357 . . . . 0.0 111.016 -177.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.9 t -63.97 -53.63 47.11 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.849 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 74.3 mt -65.49 -39.88 86.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -177.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.39 -42.43 96.11 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 119.516 -0.873 . . . . 0.0 112.701 -174.107 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.409 ' HA ' HG22 ' A' ' 31' ' ' THR . 11.1 t70 -78.13 -27.05 48.17 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 120.718 1.599 . . . . 0.0 110.111 -175.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.494 ' O ' HD23 ' A' ' 29' ' ' LEU . 1.2 tt -59.43 -55.54 33.37 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 120.033 1.288 . . . . 0.0 111.933 -177.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.432 HD13 ' O ' ' A' ' 30' ' ' ILE . 0.4 OUTLIER -75.19 -3.56 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -179.24 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.409 HG22 ' HA ' ' A' ' 28' ' ' ASP . 0.4 OUTLIER -109.5 -17.2 13.81 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.302 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.438 ' O ' ' OD1' ' A' ' 35' ' ' ASP . 1.6 t80 -67.95 -44.62 40.79 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 116.474 -2.09 . . . . 0.0 109.984 -177.152 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.421 ' CD ' ' N ' ' A' ' 32' ' ' PHE . 35.2 Cg_exo -59.45 -15.68 31.46 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 121.252 1.301 . . . . 0.0 112.291 176.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.96 -35.23 79.51 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -177.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 36' ' ' THR . 27.7 p-10 -64.53 -40.33 95.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.763 -177.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.543 ' N ' ' OD1' ' A' ' 35' ' ' ASP . 31.6 p -58.19 -34.66 70.6 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -179.116 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.11 -38.78 86.22 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.3 pttp -62.23 -48.3 80.58 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 118.877 -1.129 . . . . 0.0 111.4 -177.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.0 m -63.41 -38.23 81.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 O-C-N 122.135 -0.353 . . . . 0.0 111.927 -178.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.524 ' O ' ' NE2' ' A' ' 42' ' ' GLN . 5.5 mmp_? -59.35 -40.03 85.08 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.514 -178.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.46 38.86 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.524 ' NE2' ' O ' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -114.09 -177.2 3.07 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.407 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.786 HG23 ' H ' ' A' ' 44' ' ' GLN . 13.1 tt -63.12 -62.08 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.364 -0.535 . . . . 0.0 109.81 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.786 ' H ' HG23 ' A' ' 43' ' ' ILE . 0.3 OUTLIER 169.55 5.95 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.226 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.456 ' H ' ' H ' ' A' ' 44' ' ' GLN . . . 54.34 37.46 59.88 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.364 -1.095 . . . . 0.0 110.364 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.443 ' O ' ' CB ' ' A' ' 47' ' ' SER . 2.9 pt-20 -93.17 -95.26 0.15 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.617 0.246 . . . . 0.0 110.515 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.524 ' C ' ' H ' ' A' ' 49' ' ' GLY . 0.9 OUTLIER 82.13 -31.09 0.1 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.82 -179.833 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -65.01 8.43 0.13 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.854 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.524 ' H ' ' C ' ' A' ' 47' ' ' SER . . . 80.85 16.38 75.27 Favored Glycine 0 CA--C 1.535 1.299 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -177.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.572 ' O ' HD23 ' A' ' 50' ' ' LEU . 1.7 tt -61.44 -36.38 80.22 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 114.875 -0.662 . . . . 0.0 110.386 -176.469 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.499 HG13 ' N ' ' A' ' 52' ' ' ARG . 7.3 p -59.82 -44.64 94.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 C-N-CA 120.191 -0.603 . . . . 0.0 112.2 -178.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.499 ' N ' HG13 ' A' ' 51' ' ' VAL . 45.9 ttp180 -65.33 -35.95 82.54 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 119.451 -0.899 . . . . 0.0 112.793 -178.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 t -69.56 -38.48 77.46 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.628 0.728 . . . . 0.0 109.662 178.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -152.68 123.26 7.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.193 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -99.3 176.66 5.45 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -177.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.618 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 45.7 p 53.9 -141.34 0.87 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 113.993 -1.458 . . . . 0.0 108.923 -178.141 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.618 ' HB3' ' O ' ' A' ' 56' ' ' SER . . . 95.7 14.23 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.893 178.078 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 11.9 tp-100 -167.29 73.25 0.12 Allowed 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.547 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -61.05 142.34 56.72 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.433 ' O ' ' C ' ' A' ' 61' ' ' GLY . 84.1 mtp180 -39.41 -37.07 0.42 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.955 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 60' ' ' ARG . . . -28.8 101.44 0.01 OUTLIER Glycine 0 CA--C 1.531 1.064 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.28 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 56.2 t -66.97 -33.79 65.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 118.121 -0.943 . . . . 0.0 109.687 176.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 43.9 mt -60.56 -32.43 71.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 121.489 1.949 . . . . 0.0 111.213 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.6 -49.01 66.84 Favored Glycine 0 CA--C 1.532 1.138 0 N-CA-C 115.246 0.859 . . . . 0.0 115.246 -176.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.439 HG22 ' H ' ' A' ' 65' ' ' THR . 0.6 OUTLIER -61.99 -45.97 91.27 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.465 0.542 . . . . 0.0 112.465 -179.082 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 25.0 pt -59.75 -36.03 63.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 118.365 -0.826 . . . . 0.0 108.845 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 78.3 mt -63.84 -35.72 81.55 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 121.137 1.789 . . . . 0.0 111.749 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 97.9 m -62.91 -39.11 93.51 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 113.506 -1.679 . . . . 0.0 111.008 -175.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.457 ' C ' ' SD ' ' A' ' 69' ' ' MET . 0.0 OUTLIER -60.29 -40.39 90.31 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 120.775 -1.203 . . . . 0.0 113.835 -176.427 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.6 p -69.66 -40.56 79.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 119.211 -0.996 . . . . 0.0 113.176 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 67.9 ttp85 -78.42 -13.27 59.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.709 0.766 . . . . 0.0 112.823 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 61.0 m -62.55 -54.82 34.06 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.111 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -110.18 -54.17 2.6 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 157.03 164.11 13.22 Favored Glycine 0 CA--C 1.539 1.56 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -56.42 -35.47 96.41 Favored 'Trans proline' 0 N--CA 1.503 2.058 0 CA-C-N 119.493 1.646 . . . . 0.0 112.395 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -61.09 -11.47 8.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 122.102 0.953 . . . . 0.0 111.135 176.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.472 ' O ' ' OD1' ' A' ' 80' ' ' ASN . 3.6 t -77.72 -32.26 52.74 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 113.716 -1.583 . . . . 0.0 110.727 -178.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.45 HD22 ' N ' ' A' ' 78' ' ' LEU . 4.1 mm? -75.65 -32.5 60.23 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 122.089 -0.382 . . . . 0.0 110.843 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -91.37 -4.35 55.83 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -176.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.472 ' OD1' ' O ' ' A' ' 77' ' ' SER . 35.1 p30 -95.72 26.88 3.74 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 112.189 -2.278 . . . . 0.0 107.648 175.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -159.05 -19.72 0.03 OUTLIER Glycine 0 CA--C 1.53 1.001 0 CA-C-N 114.28 -1.327 . . . . 0.0 112.417 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.589 ' O ' HD13 ' A' ' 82' ' ' LEU . 0.2 OUTLIER -59.65 -35.16 73.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.263 -0.968 . . . . 0.0 110.502 -179.442 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.9 p -70.87 -27.44 30.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.525 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.86 -31.33 61.6 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.349 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.91 -40.54 89.15 Favored Glycine 0 C--O 1.223 -0.573 0 C-N-CA 119.69 -1.243 . . . . 0.0 111.148 -178.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 50.5 mt -62.37 -40.25 95.84 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 122.476 1.132 . . . . 0.0 112.67 -177.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -60.03 -27.01 66.55 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 112.986 -1.915 . . . . 0.0 109.025 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 36.2 ttp180 -57.31 -52.55 64.89 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 173.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -67.53 -30.32 69.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 112.853 -1.976 . . . . 0.0 112.329 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 11.8 tmm? -61.01 -41.99 97.61 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.551 -0.749 . . . . 0.0 112.484 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 21.8 t -74.81 -34.33 62.35 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.533 -176.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -57.69 -44.08 85.59 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 120.231 1.378 . . . . 0.0 111.9 -176.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.56 -32.87 64.39 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 119.402 -0.919 . . . . 0.0 110.732 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.618 ' O ' HG22 ' A' ' 97' ' ' ILE . 58.4 p -64.51 -42.2 95.96 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.457 ' C ' ' H ' ' A' ' 97' ' ' ILE . 7.1 p -68.39 -28.32 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 177.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.483 ' CG ' ' O ' ' A' ' 96' ' ' ARG . 35.3 ttt-85 -77.36 9.71 3.02 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 -176.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.618 HG22 ' O ' ' A' ' 94' ' ' SER . 3.4 tp -86.92 -15.39 9.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 177.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.498 ' O ' ' OD1' ' A' ' 101' ' ' ASP . . . -140.24 -48.17 0.06 OUTLIER Glycine 0 CA--C 1.544 1.872 0 N-CA-C 116.018 1.167 . . . . 0.0 116.018 -177.056 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.601 ' N ' HD12 ' A' ' 99' ' ' LEU . 8.6 mp -72.06 -13.06 61.49 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 120.111 1.955 . . . . 0.0 113.669 -178.219 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.498 ' O ' ' CG ' ' A' ' 104' ' ' LYS . 48.7 t80 -80.48 -51.85 8.32 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 114.551 -1.204 . . . . 0.0 113.025 -178.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.498 ' OD1' ' O ' ' A' ' 98' ' ' GLY . 30.9 p-10 -70.32 -32.36 70.07 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 123.663 1.696 . . . . 0.0 110.821 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.456 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 24.1 p -68.19 -51.34 46.7 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 110.284 -3.144 . . . . 0.0 112.641 176.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 59.1 t -73.51 -26.47 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 CA-C-N 121.254 1.843 . . . . 0.0 112.106 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.498 ' CG ' ' O ' ' A' ' 100' ' ' TYR . 22.7 mmtm -68.89 -41.75 77.85 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 111.914 -2.403 . . . . 0.0 110.757 178.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.487 ' HG3' ' O ' ' A' ' 101' ' ' ASP . 88.1 mt-30 -78.26 -14.64 59.35 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-O 122.772 1.272 . . . . 0.0 111.045 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -79.76 -23.16 42.41 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 114.672 -1.149 . . . . 0.0 112.462 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.463 ' CZ ' ' OD1' ' A' ' 190' ' ' ASN . 32.9 m-85 -109.66 -29.95 8.12 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 119.39 0.995 . . . . 0.0 111.735 -175.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.9 p -97.56 9.33 42.74 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 117.028 -1.869 . . . . 0.0 112.675 -178.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.532 ' O ' ' C ' ' A' ' 110' ' ' GLY . 6.1 pttp -48.06 124.41 7.58 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 117.792 -1.099 . . . . 0.0 109.835 177.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.533 ' O ' ' CB ' ' A' ' 111' ' ' SER . . . -26.46 -77.52 0.01 OUTLIER Glycine 0 N--CA 1.488 2.134 0 CA-C-N 120.46 1.482 . . . . 0.0 111.515 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 110' ' ' GLY . 24.0 p 103.35 -159.68 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 176.125 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.563 ' O ' ' N ' ' A' ' 114' ' ' ALA . 94.8 mt-10 -128.76 96.8 4.47 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.254 -0.885 . . . . 0.0 112.649 -178.178 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.636 ' O ' ' HB2' ' A' ' 114' ' ' ALA . 76.8 m-70 12.63 51.11 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 O-C-N 124.245 0.965 . . . . 0.0 113.138 178.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.636 ' HB2' ' O ' ' A' ' 113' ' ' HIS . . . 159.41 -161.79 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.36 14.97 26.65 Favored Glycine 0 C--N 1.338 0.687 0 CA-C-N 114.999 -1.0 . . . . 0.0 113.227 176.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.462 HG23 ' N ' ' A' ' 117' ' ' GLY . 13.0 tt -60.91 -40.35 85.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 119.167 -1.013 . . . . 0.0 109.438 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.462 ' N ' HG23 ' A' ' 116' ' ' ILE . . . -65.49 -39.56 95.72 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 122.047 0.804 . . . . 0.0 111.4 176.017 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 9.6 p -57.81 -42.11 83.59 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 177.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -63.42 -37.18 86.3 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.975 -178.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 30.8 tp -64.03 -46.98 82.04 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.354 0.597 . . . . 0.0 109.778 178.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 42.8 mt -67.06 -44.83 79.12 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.848 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.78 -44.7 92.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 119.281 0.946 . . . . 0.0 109.36 178.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.472 ' HA3' HD22 ' A' ' 190' ' ' ASN . . . -65.94 -44.16 92.28 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 119.691 -1.242 . . . . 0.0 111.665 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 67.1 m -63.72 -43.91 95.15 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.384 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 20.9 m -69.44 -48.53 60.65 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 119.082 -1.047 . . . . 0.0 112.023 177.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 41.5 p -65.54 -43.0 91.3 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 -174.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -64.46 -44.85 94.65 Favored Glycine 0 CA--C 1.521 0.407 0 CA-C-N 114.734 -1.121 . . . . 0.0 112.918 -177.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.448 ' O ' HG12 ' A' ' 131' ' ' VAL . . . -61.83 -41.66 98.08 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 112.395 -1.903 . . . . 0.0 107.451 177.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.682 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 24.9 tp -64.67 -42.6 95.26 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.218 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.63 -40.16 96.17 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -177.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.448 HG12 ' O ' ' A' ' 128' ' ' ALA . 2.7 p -61.27 -26.46 39.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 123.363 1.554 . . . . 0.0 109.942 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.682 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . -58.78 -45.68 89.25 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 110.787 -2.915 . . . . 0.0 112.372 -178.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.5 p -79.79 -48.65 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -178.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -102.5 86.12 2.73 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -177.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.688 ' H ' ' CD ' ' A' ' 136' ' ' PRO . 5.1 pm0 -126.77 -22.99 0.04 OUTLIER Pre-proline 0 CA--C 1.551 0.983 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 177.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.688 ' CD ' ' H ' ' A' ' 135' ' ' GLN . 6.8 Cg_endo -54.98 -33.13 81.82 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 CA-C-N 121.554 1.591 . . . . 0.0 112.214 -178.409 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.513 ' O ' ' NZ ' ' A' ' 141' ' ' LYS . 73.3 p -68.22 -42.87 79.14 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 117.828 -1.549 . . . . 0.0 112.286 -175.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -67.46 -44.37 78.78 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 118.438 -1.305 . . . . 0.0 113.373 -178.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.452 HG23 ' N ' ' A' ' 140' ' ' VAL . 27.9 m -65.45 -44.76 94.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -178.406 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.452 ' N ' HG23 ' A' ' 139' ' ' VAL . 75.2 t -65.48 -40.29 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -176.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.513 ' NZ ' ' O ' ' A' ' 137' ' ' THR . 29.3 mtmm -63.18 -41.53 99.22 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.118 -178.178 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 3.5 p -71.1 -45.57 71.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.833 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.59 HH21 ' CG2' ' A' ' 166' ' ' ILE . 61.1 mtp180 -64.73 -37.34 87.28 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.161 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.611 ' CD1' ' NE2' ' A' ' 147' ' ' GLN . 76.2 t80 -67.27 -41.76 84.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.451 -178.407 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 18.0 tm0? -65.92 -40.73 91.71 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.518 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -64.84 -35.96 82.81 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -176.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.611 ' NE2' ' CD1' ' A' ' 144' ' ' PHE . 5.7 pt20 -59.3 111.12 1.24 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 177.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -102.49 -174.87 2.67 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 117.469 2.396 . . . . 0.0 117.469 -171.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 90.9 mtt-85 56.02 105.39 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 110.601 -2.999 . . . . 0.0 110.376 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -44.41 -77.45 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.786 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 46.07 81.95 0.04 OUTLIER Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.622 0 N-CA-C 110.829 -0.909 . . . . 0.0 110.829 179.898 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.489 ' O ' ' CD2' ' A' ' 156' ' ' TYR . 74.1 t80 . . . . . 0 C--O 1.23 0.044 0 CA-C-O 120.347 0.118 . . . . 0.0 111.059 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.448 ' O ' ' O ' ' A' ' 156' ' ' TYR . 51.0 mt-30 58.45 144.03 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.316 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.644 ' H ' ' CG ' ' A' ' 161' ' ' GLU . 3.5 m -156.97 -178.91 7.72 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.779 0.799 . . . . 0.0 112.23 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 26.4 p -64.87 -46.48 81.61 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 114.234 -1.348 . . . . 0.0 113.063 -177.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 42.4 t -64.28 -45.48 96.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.281 -177.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.644 ' CG ' ' H ' ' A' ' 158' ' ' SER . 8.3 pt-20 -67.99 -38.89 83.21 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.401 ' O ' HG22 ' A' ' 166' ' ' ILE . . . -61.56 -45.72 92.96 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -177.04 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.451 ' CG ' ' N ' ' A' ' 164' ' ' LYS . 0.1 OUTLIER -62.45 -48.77 78.18 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.041 -179.424 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.451 ' N ' ' CG ' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -67.54 -45.08 76.74 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -174.793 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 40.6 p -62.77 -44.79 95.26 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 119.738 1.154 . . . . 0.0 113.706 -177.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.59 ' CG2' HH21 ' A' ' 143' ' ' ARG . 18.5 tt -64.94 -38.51 82.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-O 121.933 0.873 . . . . 0.0 109.454 176.447 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.441 ' N ' HG23 ' A' ' 166' ' ' ILE . . . -59.78 -36.56 76.96 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 113.825 -1.534 . . . . 0.0 108.042 176.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -62.1 -50.03 73.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 122.708 2.504 . . . . 0.0 111.51 -175.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -74.75 -51.0 15.34 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 177.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -78.18 -36.51 47.38 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 116.25 1.944 . . . . 0.0 116.25 -173.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 91.78 -167.29 30.72 Favored Glycine 0 N--CA 1.468 0.779 0 CA-C-N 118.553 0.615 . . . . 0.0 112.095 177.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 8.5 pt -72.69 -42.74 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-O 121.845 0.831 . . . . 0.0 110.551 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 53.5 ttt85 -58.94 -33.54 70.73 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 114.381 -1.282 . . . . 0.0 110.838 -177.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -61.12 -40.69 98.89 Favored Glycine 0 CA--C 1.522 0.479 0 C-N-CA 118.503 -1.808 . . . . 0.0 109.592 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.429 ' CD1' ' NH1' ' A' ' 143' ' ' ARG . 7.4 tt -70.42 -33.78 71.74 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 111.688 -2.256 . . . . 0.0 116.701 -177.267 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 10.1 m0 -78.21 -7.86 57.62 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 111.713 -2.494 . . . . 0.0 109.909 -177.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 16.9 tptm -43.52 -48.3 7.38 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.192 -176.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -91.05 -34.99 7.3 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.449 1.023 . . . . 0.0 111.492 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.3 m -46.29 -51.94 13.6 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.24 -50.83 73.15 Favored Pre-proline 0 N--CA 1.477 0.903 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -176.085 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -64.06 -28.21 65.7 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 121.666 1.577 . . . . 0.0 111.44 175.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -63.79 -38.8 92.45 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.79 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.419 ' CG1' ' N ' ' A' ' 184' ' ' ALA . 0.8 OUTLIER -62.39 -42.12 94.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.722 -178.648 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.419 ' N ' ' CG1' ' A' ' 183' ' ' VAL . . . -61.96 -39.41 92.02 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.341 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 57.3 ttp85 -60.76 -41.97 96.51 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.093 -179.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -61.58 -43.23 99.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.26 0.552 . . . . 0.0 110.596 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.37 -43.05 95.74 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.741 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 78.1 mt -62.96 -45.02 99.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -176.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.518 ' O ' ' N ' ' A' ' 193' ' ' GLU . 5.9 m -59.44 -46.34 92.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 119.546 -0.861 . . . . 0.0 111.395 -178.237 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' ASN . . . . . 0.472 HD22 ' HA3' ' A' ' 123' ' ' GLY . 6.6 t30 -63.08 -42.98 99.76 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 122.045 0.926 . . . . 0.0 110.908 178.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' CYS . . . . . 0.591 ' SG ' ' N ' ' A' ' 192' ' ' ALA . 0.5 OUTLIER -61.6 -45.41 94.2 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.014 -1.448 . . . . 0.0 108.867 179.049 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.591 ' N ' ' SG ' ' A' ' 191' ' ' CYS . . . -63.76 -39.2 93.69 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 112.584 -2.098 . . . . 0.0 109.149 175.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 189' ' ' VAL . 44.0 tp10 -60.31 -46.38 90.09 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.004 0.922 . . . . 0.0 112.706 -176.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 75.2 mt -65.61 -37.64 87.19 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.671 -175.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 2.5 p -64.26 -46.28 93.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 117.089 -1.845 . . . . 0.0 109.569 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 2.2 t -64.48 -45.36 87.71 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -177.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -57.41 -39.45 76.19 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 114.58 -1.191 . . . . 0.0 112.305 -178.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -56.07 -44.7 79.19 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 47.3 mt -61.83 -39.42 91.73 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.891 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 42.5 mm -63.47 -43.36 98.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 118.813 -0.613 . . . . 0.0 111.257 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' LYS . . . . . 0.482 ' O ' ' O ' ' A' ' 205' ' ' LEU . 49.9 mtmt -60.27 -40.51 90.63 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 120.171 1.35 . . . . 0.0 111.613 177.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -64.81 -38.23 90.27 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 113.867 -1.515 . . . . 0.0 110.982 -176.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.481 ' O ' HG23 ' A' ' 203' ' ' THR . 13.3 t -101.89 129.16 48.07 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.706 0.765 . . . . 0.0 112.413 -178.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.763 ' O ' HD23 ' A' ' 209' ' ' LEU . 0.5 OUTLIER 68.14 5.63 4.75 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 114.323 -1.308 . . . . 0.0 112.489 178.383 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.482 ' O ' ' O ' ' A' ' 201' ' ' LYS . 0.4 OUTLIER -141.78 79.88 1.7 Allowed 'General case' 0 N--CA 1.472 0.643 0 O-C-N 122.136 -0.352 . . . . 0.0 110.214 -178.652 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.539 ' O ' ' CB ' ' A' ' 207' ' ' ALA . 3.2 mtmp? -112.03 49.3 0.92 Allowed 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.079 -1.013 . . . . 0.0 110.826 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.539 ' CB ' ' O ' ' A' ' 206' ' ' LYS . . . 122.44 34.09 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.491 1.116 . . . . 0.0 110.007 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' ASN . . . . . 0.537 ' CB ' ' O ' ' A' ' 207' ' ' ALA . 9.0 t-20 102.36 -138.17 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 O-C-N 125.05 1.469 . . . . 0.0 108.95 -177.265 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.763 HD23 ' O ' ' A' ' 204' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.465 0.303 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 0.409 ' O ' ' OD2' ' A' ' 213' ' ' ASP . 5.6 p-10 . . . . . 0 N--CA 1.465 0.278 0 CA-C-O 120.964 0.411 . . . . 0.0 110.455 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.431 ' N ' ' CD ' ' A' ' 215' ' ' PRO . 3.8 mt -61.58 -43.53 88.84 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -178.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 215' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 214' ' ' LEU . 31.0 Cg_exo -60.97 -33.51 92.22 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 CA-C-O 122.811 1.088 . . . . 0.0 111.02 -178.364 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 77.6 m -64.7 -41.79 95.77 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 112.352 -2.204 . . . . 0.0 110.997 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' HIS . . . . . 0.496 ' O ' ' ND1' ' A' ' 217' ' ' HIS . 1.1 t60 -66.28 -37.52 85.63 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.514 -178.106 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -63.08 -48.13 79.93 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.199 -178.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 78.8 p -60.82 -38.46 85.53 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 119.79 1.177 . . . . 0.0 110.484 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 64.2 m -59.79 -42.01 92.44 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' ALA . . . . . 0.529 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.98 -42.29 97.27 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -62.78 -48.14 80.45 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -176.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -61.88 -42.89 99.79 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 108.466 -1.854 . . . . 0.0 108.466 177.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -63.43 -38.64 91.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.112 -1.044 . . . . 0.0 109.183 177.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -62.37 -43.31 99.24 Favored Glycine 0 CA--C 1.521 0.435 0 CA-C-N 114.685 -1.143 . . . . 0.0 111.07 -177.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 226' ' ' PHE . . . . . 0.45 ' O ' ' OG1' ' A' ' 229' ' ' THR . 72.7 t80 -67.48 -39.85 85.24 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 119.274 -0.971 . . . . 0.0 109.849 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 227' ' ' CYS . . . . . 0.529 ' SG ' ' N ' ' A' ' 228' ' ' THR . 1.5 p -64.5 -41.82 96.2 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.766 0.794 . . . . 0.0 109.238 176.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 228' ' ' THR . . . . . 0.529 ' N ' ' SG ' ' A' ' 227' ' ' CYS . 91.3 m -62.35 -40.58 96.88 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 114.041 -1.436 . . . . 0.0 111.914 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 226' ' ' PHE . 5.4 p -58.73 -39.99 82.45 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.633 -176.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 58.9 t -61.05 -41.98 91.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 118.423 -1.311 . . . . 0.0 108.449 178.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ILE . . . . . 0.538 ' O ' ' HD2' ' A' ' 234' ' ' PRO . 47.8 mt -62.48 -41.41 91.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.485 0.659 . . . . 0.0 110.158 177.053 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.42 ' HB3' ' HA ' ' A' ' 229' ' ' THR . . . -63.06 -39.37 94.53 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 115.891 1.811 . . . . 0.0 115.891 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.444 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 0.1 OUTLIER -57.95 -41.94 92.62 Favored Pre-proline 0 N--CA 1.475 0.809 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -172.512 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.538 ' HD2' ' O ' ' A' ' 231' ' ' ILE . 30.7 Cg_exo -59.77 -41.13 57.65 Favored 'Trans proline' 0 C--N 1.295 -2.259 0 C-N-CA 121.209 1.272 . . . . 0.0 112.894 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -65.69 -37.03 79.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 118.639 -1.224 . . . . 0.0 109.246 177.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -66.01 -41.71 90.64 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.437 ' CG1' ' N ' ' A' ' 238' ' ' VAL . 1.6 p -65.88 -46.41 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -176.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.437 ' N ' ' CG1' ' A' ' 237' ' ' VAL . 9.9 p . . . . . 0 C--N 1.33 -0.247 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.971 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 29.7 p . . . . . 0 CA--C 1.532 0.279 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 260' ' ' MET . . . . . . . . . . . . . 10.1 ptm -62.78 -44.13 96.99 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -178.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.508 HD13 ' O ' ' A' ' 261' ' ' LEU . 0.2 OUTLIER -62.23 -47.01 86.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.858 0.361 . . . . 0.0 110.041 -178.972 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -66.49 -53.69 32.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.547 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 54.1 mttp -80.57 -124.92 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -48.92 117.21 1.97 Allowed 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 265' ' ' GLY . . . . . 0.454 ' C ' ' H ' ' A' ' 267' ' ' ARG . . . -47.94 175.67 0.02 OUTLIER Glycine 0 CA--C 1.53 1.029 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 179.304 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.6 0.73 0.69 Allowed 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 122.237 1.958 . . . . 0.0 111.87 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 267' ' ' ARG . . . . . 0.454 ' H ' ' C ' ' A' ' 265' ' ' GLY . 77.4 mtt85 -68.79 -25.92 64.94 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.195 0.598 . . . . 0.0 111.875 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -57.82 -31.97 67.14 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.127 -178.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -62.07 -42.13 98.88 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.1 0.476 . . . . 0.0 110.78 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -66.39 -38.09 86.73 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -177.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.47 ' CG ' ' N ' ' A' ' 272' ' ' GLY . 53.2 tttp -80.85 173.08 12.96 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 272' ' ' GLY . . . . . 0.47 ' N ' ' CG ' ' A' ' 271' ' ' LYS . . . 62.38 100.37 0.01 OUTLIER Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -173.85 5.67 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.53 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 274' ' ' MET . . . . . 0.578 ' N ' ' CD ' ' A' ' 275' ' ' PRO . 0.7 OUTLIER -64.03 -44.21 77.27 Favored Pre-proline 0 CA--C 1.531 0.229 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.04 -179.879 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 275' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 274' ' ' MET . 21.5 Cg_exo -64.38 -46.46 7.51 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.516 2.144 . . . . 0.0 111.253 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 20.0 m -60.41 -39.44 87.41 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.25 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -61.48 -42.59 99.02 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 122.583 1.182 . . . . 0.0 112.737 -178.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.514 HD13 ' O ' ' A' ' 278' ' ' LEU . 0.2 OUTLIER -61.96 -38.76 89.71 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 112.262 -2.244 . . . . 0.0 107.778 174.501 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 41.7 mmm-85 -62.68 -39.32 93.58 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.32 0.581 . . . . 0.0 110.511 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.66 -36.23 80.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.13 -0.941 . . . . 0.0 113.011 -177.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -67.75 -50.73 40.04 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -178.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 47.8 p -62.74 -43.94 97.5 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 283' ' ' TRP . . . . . . . . . . . . . 75.3 t90 -59.9 -37.94 80.85 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.524 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.56 -37.82 85.21 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 94.6 t -59.76 -38.3 75.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.576 -0.283 . . . . 0.0 110.397 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.438 ' O ' HG12 ' A' ' 289' ' ' VAL . 10.8 t -62.58 -41.07 90.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.845 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -61.36 -39.25 89.92 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.22 0.533 . . . . 0.0 110.378 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -59.5 -41.05 88.99 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -178.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.438 HG12 ' O ' ' A' ' 286' ' ' VAL . 0.7 OUTLIER -61.36 -40.14 85.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -175.914 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.21 -39.41 94.55 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -60.48 -38.5 84.47 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 176.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 32.9 tp10 -57.94 -40.27 80.11 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 118.157 -1.417 . . . . 0.0 109.417 -176.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 293' ' ' GLN . . . . . 0.435 ' OE1' ' O ' ' A' ' 289' ' ' VAL . 5.2 mp0 -60.35 -42.23 95.3 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 122.827 1.299 . . . . 0.0 110.032 179.018 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 78.4 mt -60.27 -39.26 86.19 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 112.268 -2.242 . . . . 0.0 109.564 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -62.3 -45.2 94.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.582 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 296' ' ' ARG . . . . . 0.433 ' O ' ' O ' ' A' ' 293' ' ' GLN . 9.0 tpm_? -122.44 116.07 23.34 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -114.22 -163.84 0.89 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.223 0.535 . . . . 0.0 112.113 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 20.1 tp -72.22 114.4 10.29 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 176.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 41.7 ttp -95.93 61.9 2.2 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.527 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.75 101.04 0.07 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.937 0.875 . . . . 0.0 111.071 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -63.94 -46.05 86.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 113.814 -1.539 . . . . 0.0 113.293 -176.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -58.14 -38.9 77.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.739 -177.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 45.3 tp60 -63.75 -46.49 85.09 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.423 -178.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 304' ' ' SER . . . . . 0.438 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 3.4 t -66.0 -37.56 86.23 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.105 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -61.78 -42.94 99.63 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.97 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 11.7 tm-20 -64.94 -37.03 86.29 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -177.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 307' ' ' ALA . . . . . 0.535 ' HB3' ' HD3' ' A' ' 308' ' ' PRO . . . -60.07 -52.87 70.38 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -176.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 308' ' ' PRO . . . . . 0.535 ' HD3' ' HB3' ' A' ' 307' ' ' ALA . 73.7 Cg_endo -75.4 0.49 9.01 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.166 1.911 . . . . 0.0 112.157 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.588 -179.852 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.562 ' O ' HD13 ' A' ' 298' ' ' LEU . 69.9 m . . . . . 0 N--CA 1.46 0.031 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.83 HG22 ' H ' ' A' ' 16' ' ' LYS . 10.8 p -88.32 -178.6 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.28 -178.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.83 ' H ' HG22 ' A' ' 15' ' ' VAL . 12.6 mptt -63.96 -40.88 97.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.99 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -63.54 -41.26 98.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.79 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.476 ' H ' HG13 ' A' ' 15' ' ' VAL . 55.0 tp -79.96 -26.61 39.95 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.804 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.56 -41.53 94.05 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 107.215 -2.354 . . . . 0.0 107.215 176.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.18 -31.78 68.06 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 124.917 2.294 . . . . 0.0 107.286 176.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.45 -42.78 98.92 Favored Glycine 0 CA--C 1.527 0.825 1 CA-C-N 108.32 -4.037 . . . . 0.0 108.234 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 28.9 p -70.65 -28.01 64.49 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.529 0.681 . . . . 0.0 109.345 177.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.412 ' HB2' ' OE1' ' A' ' 293' ' ' GLN . . . -66.2 -50.16 64.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.866 -178.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.443 ' O ' ' OD2' ' A' ' 28' ' ' ASP . . . -62.04 -35.74 79.49 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 118.404 -1.318 . . . . 0.0 111.322 -177.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.638 ' SG ' ' N ' ' A' ' 26' ' ' ILE . 5.4 p -64.1 -53.48 48.93 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.538 -179.053 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.638 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 11.2 tp -65.59 -39.79 86.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -177.135 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.02 -41.78 97.32 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 119.775 -0.77 . . . . 0.0 112.967 -173.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.484 ' CG ' ' NE2' ' A' ' 89' ' ' GLN . 1.7 p30 -77.64 -27.14 50.95 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 118.329 -1.348 . . . . 0.0 109.636 -176.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 10.9 tp -60.16 -55.92 27.95 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 119.65 1.114 . . . . 0.0 111.929 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.8 tt -75.58 -4.63 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-O 121.382 0.61 . . . . 0.0 112.274 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.444 HG22 ' O ' ' A' ' 31' ' ' THR . 53.5 m -109.41 -16.72 13.95 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.013 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.485 ' N ' ' HD2' ' A' ' 33' ' ' PRO . 84.2 t80 -68.46 -45.89 36.72 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 121.879 2.127 . . . . 0.0 112.011 -177.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 32' ' ' PHE . 27.7 Cg_endo -60.35 -16.1 39.28 Favored 'Trans proline' 0 N--CA 1.5 1.862 0 CA-C-N 121.27 1.489 . . . . 0.0 112.858 177.199 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.643 HD13 ' OG ' ' A' ' 282' ' ' SER . 80.5 mt -67.08 -35.18 79.25 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.518 0.932 . . . . 0.0 113.518 -177.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -64.45 -40.07 95.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.236 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.8 m -58.33 -35.0 71.24 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.922 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.65 -37.92 83.1 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.124 -0.63 . . . . 0.0 111.615 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -61.4 -49.09 78.31 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.631 -176.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -63.28 -39.09 83.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 119.193 0.906 . . . . 0.0 112.248 -177.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.503 ' O ' ' N ' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -60.36 -40.7 91.7 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.698 -179.485 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.82 39.02 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.946 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.503 ' N ' ' O ' ' A' ' 40' ' ' ARG . 21.3 pt20 -81.11 147.11 30.24 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.748 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 14.7 mt -82.67 53.19 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.987 0.422 . . . . 0.0 110.246 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 45.01 74.83 0.12 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.742 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.52 59.95 0.31 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.405 ' O ' ' OG ' ' A' ' 47' ' ' SER . 28.3 tp10 -71.21 -7.18 45.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.836 0.35 . . . . 0.0 110.388 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' A' ' 46' ' ' GLU . 23.8 p 57.47 50.02 11.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.492 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -143.77 -18.43 0.6 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.674 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.15 -10.15 74.13 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.0 tp -65.28 -38.11 89.25 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.691 0.281 . . . . 0.0 111.554 -178.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.554 HG23 ' N ' ' A' ' 52' ' ' ARG . 14.7 m -60.88 -44.81 98.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.495 -178.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.554 ' N ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -64.92 -33.43 76.02 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.208 -179.644 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 79.7 m -67.77 -38.23 83.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.969 0.414 . . . . 0.0 110.522 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -86.82 -153.84 0.22 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.77 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -162.42 -53.38 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.89 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.639 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 8.4 t -128.32 -139.1 0.24 Allowed 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.639 ' HB3' ' O ' ' A' ' 56' ' ' SER . . . 93.82 14.63 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.659 0.6 . . . . 0.0 111.592 178.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.437 ' OE1' ' NH2' ' A' ' 40' ' ' ARG . 16.7 pt20 175.89 122.74 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.946 0.403 . . . . 0.0 109.915 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -105.83 159.46 15.99 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.402 ' O ' ' C ' ' A' ' 61' ' ' GLY . 36.2 ptt180 -43.44 -32.35 0.86 Allowed 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.505 -0.478 . . . . 0.0 109.808 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 60' ' ' ARG . . . -31.37 102.75 0.01 OUTLIER Glycine 0 CA--C 1.526 0.733 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.01 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.7 p -67.08 -33.71 64.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 118.232 -0.889 . . . . 0.0 109.639 176.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -60.32 -32.63 71.42 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 121.442 1.928 . . . . 0.0 110.288 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.49 -49.0 67.54 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-N 115.377 -0.829 . . . . 0.0 114.352 -176.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 14.1 m -61.73 -46.02 91.44 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.201 -0.5 . . . . 0.0 112.057 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 72.1 mt -59.09 -36.23 61.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 74.4 mt -63.63 -34.97 79.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 120.439 1.472 . . . . 0.0 112.602 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.416 ' O ' ' OG1' ' A' ' 72' ' ' THR . 98.9 m -63.47 -41.59 98.6 Favored 'General case' 0 C--O 1.254 1.308 0 C-N-CA 125.433 1.493 . . . . 0.0 110.983 -174.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 6.5 ptp -60.36 -38.92 85.39 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 120.018 -1.676 . . . . 0.0 113.842 -176.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.3 m -68.55 -40.77 82.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 119.025 -1.07 . . . . 0.0 113.627 -176.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 61.5 ttp85 -77.92 -13.55 59.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 122.028 0.918 . . . . 0.0 112.305 -178.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.416 ' OG1' ' O ' ' A' ' 68' ' ' THR . 70.4 m -62.92 -55.05 29.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.335 -1.302 . . . . 0.0 111.775 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -108.68 -58.22 2.04 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.794 178.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.32 164.62 13.58 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -56.59 -35.16 96.87 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 121.966 1.777 . . . . 0.0 111.775 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.465 ' O ' ' OD1' ' A' ' 80' ' ' ASN . 96.5 mtt180 -60.93 -11.19 7.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.928 0.87 . . . . 0.0 110.925 176.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.505 ' O ' ' OD1' ' A' ' 80' ' ' ASN . 7.4 t -77.64 -32.21 53.23 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 113.275 -1.784 . . . . 0.0 110.265 -178.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.9 mp -75.54 -29.34 59.37 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.224 1.01 . . . . 0.0 111.59 177.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -87.4 -2.62 58.75 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 122.896 1.331 . . . . 0.0 113.417 -172.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.505 ' OD1' ' O ' ' A' ' 77' ' ' SER . 11.9 p-10 -117.67 135.14 54.21 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 112.104 -2.316 . . . . 0.0 108.207 176.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.8 -25.9 25.89 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 -177.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.425 ' HG ' ' N ' ' A' ' 83' ' ' VAL . 0.5 OUTLIER -59.14 -34.44 72.06 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 113.834 -1.183 . . . . 0.0 110.283 -179.661 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.425 ' N ' ' HG ' ' A' ' 82' ' ' LEU . 10.6 p -70.83 -27.12 29.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.917 178.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.88 -31.86 61.7 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.408 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.8 -40.13 89.74 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 119.984 -1.103 . . . . 0.0 111.205 -177.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 86.2 mt -62.55 -40.25 96.21 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 122.285 1.04 . . . . 0.0 112.871 -176.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -60.67 -27.5 67.88 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 113.149 -1.841 . . . . 0.0 109.865 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 14.9 mmt85 -57.93 -53.32 59.54 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 173.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.484 ' NE2' ' CG ' ' A' ' 28' ' ' ASP . 60.7 mt-30 -66.83 -29.74 69.74 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 112.418 -2.174 . . . . 0.0 111.776 -177.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 33.9 ttm -61.37 -40.89 95.97 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.067 -0.97 . . . . 0.0 112.429 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.9 m -74.59 -34.65 62.91 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.453 -176.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -57.63 -43.67 84.99 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 120.794 1.633 . . . . 0.0 112.123 -176.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.47 -32.6 64.42 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 119.602 -0.839 . . . . 0.0 111.228 -178.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 38.7 t -64.11 -41.57 97.21 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.401 ' C ' ' H ' ' A' ' 97' ' ' ILE . 30.6 m -67.8 -27.94 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.005 177.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.473 ' CG ' ' O ' ' A' ' 96' ' ' ARG . 6.7 ttt85 -77.61 9.28 3.49 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -176.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.524 HD13 ' O ' ' A' ' 97' ' ' ILE . 0.3 OUTLIER -87.02 -15.95 9.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 176.538 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -140.49 -48.46 0.05 OUTLIER Glycine 0 CA--C 1.544 1.891 0 N-CA-C 115.569 0.987 . . . . 0.0 115.569 -177.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 14.9 mt -71.17 -13.12 61.83 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.2 1.5 . . . . 0.0 112.644 -177.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.494 ' O ' ' HB2' ' A' ' 104' ' ' LYS . 1.9 m-85 -81.0 -50.34 9.81 Favored 'General case' 0 C--O 1.214 -0.785 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.008 178.056 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.773 ' OD2' ' OE1' ' A' ' 105' ' ' GLN . 19.4 t70 -68.55 -31.82 71.31 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 114.059 -1.428 . . . . 0.0 110.12 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.0 t -69.33 -53.16 21.01 Favored 'General case' 0 CA--C 1.554 1.107 0 CA-C-N 112.203 -2.272 . . . . 0.0 114.544 177.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.1 t -74.9 -27.64 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 CA-C-N 122.487 2.403 . . . . 0.0 113.437 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 100' ' ' TYR . 13.4 tttp -70.16 -40.99 74.41 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 112.004 -2.362 . . . . 0.0 111.548 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.773 ' OE1' ' OD2' ' A' ' 101' ' ' ASP . 27.2 mt-30 -79.62 -13.17 59.69 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.742 0.782 . . . . 0.0 111.071 -178.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -78.79 -22.92 45.58 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.876 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 6.4 m-30 -109.04 -30.11 8.23 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 119.341 0.973 . . . . 0.0 112.068 -174.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.2 m -97.49 9.25 42.91 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 117.926 -1.509 . . . . 0.0 113.233 -178.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.466 ' O ' ' C ' ' A' ' 110' ' ' GLY . 18.7 mmtt -52.77 121.51 7.37 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-N 119.025 0.83 . . . . 0.0 111.715 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.517 ' O ' ' CB ' ' A' ' 111' ' ' SER . . . -22.91 -82.35 0.01 OUTLIER Glycine 0 N--CA 1.485 1.91 0 CA-C-N 118.665 0.666 . . . . 0.0 113.171 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.517 ' CB ' ' O ' ' A' ' 110' ' ' GLY . 1.4 m 96.53 -90.26 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 178.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.513 ' O ' ' CG ' ' A' ' 113' ' ' HIS . 0.3 OUTLIER 168.83 -35.75 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 120.725 1.602 . . . . 0.0 114.215 179.308 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.647 ' O ' ' HB2' ' A' ' 114' ' ' ALA . 1.1 p-80 155.61 46.07 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 121.103 0.477 . . . . 0.0 110.841 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.647 ' HB2' ' O ' ' A' ' 113' ' ' HIS . . . 159.91 -162.9 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.15 15.25 26.4 Favored Glycine 0 C--N 1.337 0.587 0 CA-C-N 114.114 -1.403 . . . . 0.0 111.2 178.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.549 HD13 HH21 ' A' ' 119' ' ' ARG . 31.6 mm -60.66 -41.07 86.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 C-N-CA 120.065 -0.654 . . . . 0.0 109.278 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.54 -40.12 95.94 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 121.91 0.728 . . . . 0.0 111.858 175.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 35.6 t -57.78 -41.81 82.79 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 177.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.549 HH21 HD13 ' A' ' 116' ' ' ILE . 9.5 ttm-85 -63.23 -36.78 84.78 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.984 -177.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 58.5 mt -63.73 -46.33 85.84 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.255 0.55 . . . . 0.0 109.805 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 41.5 mt -66.65 -44.77 81.02 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 119.112 -1.035 . . . . 0.0 110.459 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.69 -44.83 92.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 119.625 1.102 . . . . 0.0 109.932 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -65.73 -44.2 92.79 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 119.801 -1.19 . . . . 0.0 111.126 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 77.9 p -64.5 -44.44 90.96 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.829 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 97.2 m -69.47 -48.4 60.86 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 119.453 -0.899 . . . . 0.0 111.916 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.493 HG23 ' N ' ' A' ' 127' ' ' GLY . 6.2 t -65.26 -42.41 93.3 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -174.325 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.493 ' N ' HG23 ' A' ' 126' ' ' THR . . . -64.07 -44.78 95.33 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-O 122.704 1.169 . . . . 0.0 113.518 -177.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.448 ' O ' HG22 ' A' ' 131' ' ' VAL . . . -61.58 -41.62 97.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 112.358 -1.921 . . . . 0.0 107.141 177.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.68 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 1.8 mm? -64.66 -42.08 95.65 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.725 178.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.22 -39.94 96.05 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -177.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.524 ' O ' ' NE2' ' A' ' 135' ' ' GLN . 15.3 m -61.27 -25.75 37.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 123.005 1.383 . . . . 0.0 109.902 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.68 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . -58.31 -44.93 88.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 111.906 -2.406 . . . . 0.0 112.621 -178.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.493 HG13 ' N ' ' A' ' 134' ' ' ALA . 3.5 p -78.95 -48.72 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 C-N-CA 120.712 -0.395 . . . . 0.0 112.006 -178.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.493 ' N ' HG13 ' A' ' 133' ' ' VAL . . . -122.95 135.92 54.67 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.994 0.426 . . . . 0.0 111.575 -178.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.787 ' H ' ' CD ' ' A' ' 136' ' ' PRO . 24.4 pt20 177.99 -24.61 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.703 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.717 178.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.787 ' CD ' ' H ' ' A' ' 135' ' ' GLN . 52.9 Cg_exo -53.14 -33.42 63.99 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 121.437 1.425 . . . . 0.0 112.691 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.494 HG23 ' N ' ' A' ' 138' ' ' ASP . 11.1 t -66.54 -41.76 88.21 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 119.234 -0.986 . . . . 0.0 109.523 -178.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.494 ' N ' HG23 ' A' ' 137' ' ' THR . 4.5 m-20 -64.93 -42.59 94.56 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 117.876 -1.53 . . . . 0.0 111.566 -178.457 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 15.1 t -64.64 -44.9 96.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.0 p -65.38 -37.08 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -178.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.44 ' O ' ' OE1' ' A' ' 145' ' ' GLN . 14.0 mptt -60.42 -40.2 90.19 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.713 -176.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 70.5 t -68.54 -44.52 82.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.523 ' NH2' ' O ' ' A' ' 174' ' ' GLY . 65.6 mtt-85 -64.34 -36.09 83.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.066 178.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.414 ' CD1' ' C ' ' A' ' 144' ' ' PHE . 36.0 t80 -66.46 -41.56 88.85 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -177.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.44 ' OE1' ' O ' ' A' ' 141' ' ' LYS . 4.8 mp0 -64.83 -39.5 93.68 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 118.941 -1.104 . . . . 0.0 108.087 178.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.39 -34.59 78.66 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -60.54 110.3 1.24 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 175.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.468 ' C ' ' H ' ' A' ' 150' ' ' ALA . . . -106.1 -55.18 2.36 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 -175.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -77.24 21.47 0.24 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 122.327 2.33 . . . . 0.0 110.417 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.468 ' H ' ' C ' ' A' ' 148' ' ' ALA . . . 51.24 -94.72 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.659 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -162.78 -37.91 0.02 OUTLIER Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.638 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 179.913 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 74.3 t80 . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.772 0.32 . . . . 0.0 110.467 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -71.54 164.8 25.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.455 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.441 ' OG ' ' N ' ' A' ' 159' ' ' THR . 29.7 t -156.94 -177.94 7.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.878 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.441 ' N ' ' OG ' ' A' ' 158' ' ' SER . 69.5 p -63.79 -45.96 87.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.65 -177.317 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 77.0 t -64.04 -45.37 96.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 119.067 -1.053 . . . . 0.0 109.165 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -66.89 -38.44 86.29 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.527 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.575 ' O ' HD12 ' A' ' 166' ' ' ILE . . . -61.33 -44.27 97.48 Favored 'General case' 0 C--O 1.211 -0.969 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -177.545 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.436 ' O ' HD11 ' A' ' 166' ' ' ILE . 32.3 t80 -61.32 -47.85 84.04 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.67 0.747 . . . . 0.0 112.151 -177.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 17.8 tptp -68.19 -45.33 73.69 Favored 'General case' 0 CA--C 1.554 1.129 0 N-CA-C 117.841 2.534 . . . . 0.0 117.841 -172.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 17.6 m -63.1 -45.48 91.86 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 117.344 2.35 . . . . 0.0 117.344 -174.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.73 HD13 ' H ' ' A' ' 166' ' ' ILE . 0.1 OUTLIER -64.62 -37.36 79.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-O 121.524 0.678 . . . . 0.0 109.271 176.925 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.18 -37.02 76.38 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 176.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -62.57 -50.32 71.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 122.992 2.633 . . . . 0.0 111.465 -177.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -75.15 -51.24 13.91 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 123.539 0.736 . . . . 0.0 109.409 177.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -78.27 -36.8 46.32 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 115.775 1.768 . . . . 0.0 115.775 -174.043 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 93.71 -168.44 29.12 Favored Glycine 0 N--CA 1.468 0.788 0 CA-C-N 118.472 0.578 . . . . 0.0 112.615 177.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.6 mt -73.56 -41.62 55.78 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.067 0 CA-C-O 122.252 1.025 . . . . 0.0 110.62 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 60.5 ttt85 -58.31 -32.77 68.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 113.448 -1.706 . . . . 0.0 111.027 -176.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.523 ' O ' ' NH2' ' A' ' 143' ' ' ARG . . . -59.83 -39.37 95.33 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 119.292 -1.432 . . . . 0.0 109.579 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.403 HD22 ' OH ' ' A' ' 163' ' ' TYR . 5.5 tp -69.44 -33.39 72.88 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 117.085 2.254 . . . . 0.0 117.085 -177.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 67.3 m95 -77.58 -7.46 56.37 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 111.254 -2.703 . . . . 0.0 109.843 -177.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -43.28 -48.02 6.66 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.556 -177.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -111.24 -29.61 3.41 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.065 0.84 . . . . 0.0 112.046 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 3.9 m -46.26 -52.14 13.15 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.31 -49.75 77.83 Favored Pre-proline 0 N--CA 1.481 1.118 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -177.083 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -62.2 -27.87 78.88 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 121.973 1.782 . . . . 0.0 111.766 175.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -63.41 -39.04 93.44 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 178.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.422 HG13 HG21 ' A' ' 131' ' ' VAL . 97.0 t -63.21 -42.0 94.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.251 178.615 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.53 -39.21 90.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.237 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.53 -41.52 94.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.035 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -60.97 -42.38 98.22 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.265 0.555 . . . . 0.0 110.051 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.68 -43.1 97.64 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.166 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 5.6 mm -63.14 -44.78 99.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -177.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.401 ' O ' ' CD ' ' A' ' 193' ' ' GLU . 6.9 m -59.69 -45.7 94.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 120.328 -0.549 . . . . 0.0 111.472 -178.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' ASN . . . . . 0.5 ' OD1' ' N ' ' A' ' 191' ' ' CYS . 2.0 p30 -61.84 -42.52 99.13 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 122.259 1.028 . . . . 0.0 108.91 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' CYS . . . . . 0.5 ' N ' ' OD1' ' A' ' 190' ' ' ASN . 52.2 t -62.15 -46.56 88.44 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 113.294 -1.775 . . . . 0.0 110.922 179.107 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.35 -40.61 96.2 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 114.296 -1.32 . . . . 0.0 109.529 176.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 0.515 ' OE1' ' N ' ' A' ' 193' ' ' GLU . 0.0 OUTLIER -61.52 -45.4 94.37 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.768 -178.701 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 4.1 tt -64.01 -39.52 94.3 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 118.331 -1.348 . . . . 0.0 110.18 -174.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 8.2 m -64.59 -45.86 94.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 116.909 -1.916 . . . . 0.0 107.775 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 98.4 m -64.16 -46.33 84.53 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -177.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -57.92 -40.11 79.61 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -178.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -56.48 -44.98 81.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.573 0.701 . . . . 0.0 109.317 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.515 ' CD2' ' N ' ' A' ' 199' ' ' LEU . 1.5 mm? -61.92 -39.89 93.6 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.51 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 45.6 mm -64.03 -43.54 97.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 118.575 -0.726 . . . . 0.0 112.893 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -59.63 -40.95 89.29 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 120.588 1.54 . . . . 0.0 110.839 178.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -66.22 -38.46 88.01 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 112.939 -1.937 . . . . 0.0 111.027 -177.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 43.8 m -102.26 130.3 48.91 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.367 -0.833 . . . . 0.0 112.446 -178.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 20.9 mt 68.08 5.58 4.7 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 114.777 -1.101 . . . . 0.0 113.402 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.403 ' CD2' ' O ' ' A' ' 205' ' ' LEU . 2.3 tt -137.37 49.58 2.0 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 178.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 4.3 tppt? -74.11 -23.55 59.33 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.718 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.483 ' O ' ' CB ' ' A' ' 208' ' ' ASN . . . -130.04 -40.22 1.34 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.776 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' ASN . . . . . 0.483 ' CB ' ' O ' ' A' ' 207' ' ' ALA . 41.2 p-10 130.34 76.1 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.247 1.419 . . . . 0.0 108.007 -178.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 3.1 tp . . . . . 0 N--CA 1.474 0.772 0 N-CA-C 118.276 2.695 . . . . 0.0 118.276 178.261 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 0.491 ' OD1' ' SG ' ' A' ' 216' ' ' CYS . 32.9 t70 . . . . . 0 C--O 1.232 0.141 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -61.31 -43.72 90.68 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -177.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -60.86 -34.07 91.8 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 CA-C-N 120.778 1.313 . . . . 0.0 111.514 -177.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' CYS . . . . . 0.491 ' SG ' ' OD1' ' A' ' 213' ' ' ASP . 62.4 m -66.56 -42.69 86.69 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 113.089 -1.869 . . . . 0.0 111.862 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 13.2 t-160 -66.59 -37.54 85.12 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.081 -1.418 . . . . 0.0 114.425 -176.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -62.92 -48.33 79.39 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 118.775 -0.631 . . . . 0.0 110.775 -178.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 12.9 m -61.26 -39.09 89.07 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 120.028 1.285 . . . . 0.0 110.013 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 39.5 t -59.97 -41.71 92.56 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 177.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' ALA . . . . . 0.564 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.53 -41.79 98.45 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -177.202 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -61.55 -46.86 88.13 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 122.162 0.982 . . . . 0.0 112.822 -175.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -60.88 -42.11 99.51 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 107.458 -2.257 . . . . 0.0 107.458 176.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' ALA . . . . . 0.913 ' O ' HG23 ' A' ' 228' ' ' THR . . . -63.03 -37.21 86.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 113.869 -1.166 . . . . 0.0 108.934 176.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 225' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -61.06 -42.51 99.82 Favored Glycine 0 CA--C 1.52 0.383 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.626 -176.231 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 226' ' ' PHE . . . . . 0.419 ' O ' ' OG1' ' A' ' 229' ' ' THR . 67.3 t80 -66.88 -38.87 87.11 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 118.782 -1.167 . . . . 0.0 108.4 178.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 227' ' ' CYS . . . . . 0.511 ' SG ' ' O ' ' A' ' 224' ' ' ALA . 0.5 OUTLIER -63.89 -41.18 97.79 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.165 0.507 . . . . 0.0 110.251 177.445 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 228' ' ' THR . . . . . 0.913 HG23 ' O ' ' A' ' 224' ' ' ALA . 78.5 p -61.58 -40.3 94.28 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.465 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 226' ' ' PHE . 23.8 p -59.34 -40.26 85.77 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 119.802 -0.759 . . . . 0.0 111.567 -176.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 92.7 t -61.47 -43.17 96.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 118.588 -1.245 . . . . 0.0 111.919 -178.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 3.4 tp -63.08 -40.86 90.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 121.711 0.767 . . . . 0.0 109.148 176.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.418 ' O ' HG12 ' A' ' 235' ' ' VAL . . . -62.58 -39.39 93.56 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 114.331 -1.304 . . . . 0.0 113.924 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.509 ' N ' ' HD2' ' A' ' 234' ' ' PRO . 8.0 t -58.34 -42.39 94.49 Favored Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 116.04 1.867 . . . . 0.0 116.04 -174.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 233' ' ' SER . 17.9 Cg_endo -58.93 -40.9 67.34 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 CA-C-N 121.352 1.519 . . . . 0.0 113.457 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.418 HG12 ' O ' ' A' ' 232' ' ' ALA . 2.8 p -65.52 -37.63 80.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 118.357 -1.337 . . . . 0.0 110.914 178.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -66.42 -42.0 88.4 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 15.6 m -65.59 -45.66 91.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -176.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 12.9 p . . . . . 0 C--N 1.323 -0.58 0 C-N-CA 119.116 -1.034 . . . . 0.0 112.047 -177.683 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 67.0 p . . . . . 0 CA--C 1.529 0.137 0 CA-C-O 121.634 0.73 . . . . 0.0 109.222 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 260' ' ' MET . . . . . . . . . . . . . 39.1 ttp -58.71 -41.6 86.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.625 -1.17 . . . . 0.0 110.066 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 15.3 tp -61.06 -45.86 93.02 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.745 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 40.5 ttt-85 -65.77 -54.07 32.05 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 120.434 -0.506 . . . . 0.0 112.029 -177.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 3.4 pttt -75.34 -52.99 9.49 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 119.877 -0.729 . . . . 0.0 111.46 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 264' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' A' ' 265' ' ' GLY . 22.9 mt-10 -84.36 112.55 20.43 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.356 -179.136 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 265' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 264' ' ' GLU . . . -39.65 170.51 0.01 OUTLIER Glycine 0 CA--C 1.532 1.097 0 CA-C-N 115.718 -0.673 . . . . 0.0 112.564 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.3 -2.36 5.83 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.492 2.128 . . . . 0.0 112.515 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.77 -26.42 64.28 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -58.37 -32.5 68.63 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.241 -178.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -62.5 -41.46 98.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.4 0.619 . . . . 0.0 110.96 177.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -65.86 -37.18 85.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.338 -178.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.78 164.04 13.85 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.076 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 60.45 106.16 0.01 OUTLIER Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -174.68 12.32 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.441 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 274' ' ' MET . . . . . 0.478 ' N ' ' HD2' ' A' ' 275' ' ' PRO . 17.1 mtt -63.84 -44.93 80.91 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 275' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 274' ' ' MET . 38.0 Cg_endo -64.93 -47.39 4.97 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 CA-C-N 120.586 1.245 . . . . 0.0 112.436 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 89.7 p -61.32 -40.57 94.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.754 0.787 . . . . 0.0 109.926 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -62.05 -41.85 98.56 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 123.597 1.665 . . . . 0.0 112.264 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 29.4 mt -62.0 -38.5 88.87 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 110.272 -3.149 . . . . 0.0 108.513 174.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -62.67 -40.88 98.46 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.475 0.655 . . . . 0.0 110.465 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.8 ' O ' HD12 ' A' ' 280' ' ' LEU . 0.1 OUTLIER -62.43 -36.56 82.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.326 -177.585 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -68.04 -51.14 35.64 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -178.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 282' ' ' SER . . . . . 0.643 ' OG ' HD13 ' A' ' 34' ' ' LEU . 7.5 t -63.09 -45.04 93.99 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.226 0.61 . . . . 0.0 110.506 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 283' ' ' TRP . . . . . 0.433 ' O ' HG22 ' A' ' 286' ' ' VAL . 16.3 t90 -60.77 -38.22 84.51 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.698 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 284' ' ' ASN . . . . . 0.446 ' OD1' ' CD1' ' A' ' 280' ' ' LEU . 2.2 m120 -61.96 -37.72 85.8 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.43 0.529 . . . . 0.0 112.43 -178.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.493 HG22 ' O ' ' A' ' 282' ' ' SER . 1.0 OUTLIER -59.95 -37.67 73.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -177.447 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 283' ' ' TRP . 1.0 OUTLIER -61.95 -40.11 86.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.942 -178.682 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 4.5 ptm -60.58 -38.77 85.7 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -58.65 -40.04 82.31 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.444 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 86.0 t -60.73 -39.37 81.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.522 -178.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 71.0 m -63.03 -40.56 98.09 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 119.654 -0.819 . . . . 0.0 109.039 177.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -60.92 -38.94 87.52 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 177.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -58.34 -40.21 81.56 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 117.756 -1.578 . . . . 0.0 109.847 -176.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 293' ' ' GLN . . . . . 0.459 ' O ' ' O ' ' A' ' 296' ' ' ARG . 34.5 mt-30 -60.32 -42.67 96.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 122.893 1.33 . . . . 0.0 110.874 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 9.4 mp -60.29 -39.75 88.02 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 112.487 -2.142 . . . . 0.0 109.226 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 26.7 mmtt -62.9 -45.47 92.39 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.055 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 296' ' ' ARG . . . . . 0.459 ' O ' ' O ' ' A' ' 293' ' ' GLN . 41.4 ttm180 -122.83 116.38 23.57 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -116.97 -162.69 0.87 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.311 0.577 . . . . 0.0 112.356 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.562 HD13 ' O ' ' A' ' 14' ' ' THR . 1.9 mt -69.55 116.14 9.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.504 177.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 2.5 tpt -99.5 60.4 1.14 Allowed 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -177.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.66 100.78 0.07 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.651 0.739 . . . . 0.0 110.551 -178.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -63.96 -46.21 85.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.345 -1.298 . . . . 0.0 114.029 -176.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -58.77 -39.9 82.4 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.185 -178.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 303' ' ' GLN . . . . . 0.528 ' N ' ' OE1' ' A' ' 303' ' ' GLN . 11.0 mp0 -65.0 -46.76 80.05 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.413 -179.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 304' ' ' SER . . . . . 0.439 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 78.1 p -66.69 -37.68 85.23 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.508 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -61.83 -43.15 99.42 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -179.347 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -65.11 -37.09 86.37 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 -176.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 307' ' ' ALA . . . . . 0.559 ' HB3' ' HD3' ' A' ' 308' ' ' PRO . . . -60.17 -52.98 69.45 Favored Pre-proline 0 CA--C 1.544 0.738 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 -176.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 308' ' ' PRO . . . . . 0.559 ' HD3' ' HB3' ' A' ' 307' ' ' ALA . 74.2 Cg_endo -75.29 0.3 9.18 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.147 1.898 . . . . 0.0 111.929 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 86.0 t80 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.547 -179.965 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.9 m . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.779 0.324 . . . . 0.0 110.455 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.456 HG12 ' N ' ' A' ' 16' ' ' LYS . 24.0 t -147.57 158.92 8.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.518 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.456 ' N ' HG12 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -64.41 -41.55 96.57 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.582 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.404 ' N ' ' CG ' ' A' ' 16' ' ' LYS . 4.4 t80 -63.95 -41.6 97.53 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.523 ' N ' HD22 ' A' ' 18' ' ' LEU . 3.3 mm? -79.58 -26.73 41.24 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.803 -178.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.404 ' O ' ' OG1' ' A' ' 22' ' ' THR . . . -66.2 -41.29 94.91 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 107.486 -2.245 . . . . 0.0 107.486 177.23 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.43 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -71.73 -32.21 67.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 124.79 2.233 . . . . 0.0 107.705 176.407 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.47 -42.4 99.01 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-N 108.501 -3.954 . . . . 0.0 108.091 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 19' ' ' GLY . 34.4 p -70.55 -27.34 64.07 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 177.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -66.39 -50.09 64.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.879 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.0 -36.17 80.72 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 118.621 -1.232 . . . . 0.0 111.502 -177.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.625 ' SG ' ' N ' ' A' ' 26' ' ' ILE . 8.7 p -63.88 -53.21 54.07 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.382 -178.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.625 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -64.84 -38.98 84.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -176.505 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.544 ' O ' HG23 ' A' ' 31' ' ' THR . . . -63.73 -41.2 98.09 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -173.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -77.18 -27.24 53.57 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 120.976 1.717 . . . . 0.0 111.714 -174.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.442 ' H ' ' HG ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -59.98 -54.09 50.12 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 121.29 1.859 . . . . 0.0 112.894 -178.395 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.5 tt -75.34 -4.2 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -179.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.544 HG23 ' O ' ' A' ' 27' ' ' ALA . 34.2 p -109.03 -16.03 14.22 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 119.369 -0.932 . . . . 0.0 109.315 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.49 ' N ' ' HD2' ' A' ' 33' ' ' PRO . 88.1 t80 -68.18 -45.77 39.86 Favored Pre-proline 0 CA--C 1.546 0.826 0 CA-C-N 121.821 2.1 . . . . 0.0 111.488 -178.047 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 32' ' ' PHE . 26.3 Cg_endo -60.33 -15.72 36.89 Favored 'Trans proline' 0 N--CA 1.504 2.122 0 CA-C-N 121.299 1.5 . . . . 0.0 113.195 176.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.414 ' N ' HD22 ' A' ' 34' ' ' LEU . 3.9 mm? -66.62 -34.94 79.0 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -177.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -64.18 -40.17 95.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.345 -178.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.3 m -58.3 -35.14 71.37 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.253 -0.43 . . . . 0.0 112.048 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.53 -38.5 84.32 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 119.926 -0.71 . . . . 0.0 111.981 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.2 ttpt -61.25 -48.44 81.42 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 119.614 -0.835 . . . . 0.0 110.938 -176.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.3 t -62.9 -38.91 83.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -177.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.528 ' NH2' ' O ' ' A' ' 59' ' ' TYR . 5.8 mmm180 -59.83 -41.1 90.62 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 119.806 -0.758 . . . . 0.0 109.948 -179.438 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -62.19 38.62 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.157 178.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.489 ' H ' ' C ' ' A' ' 40' ' ' ARG . 45.3 tt0 -87.18 147.87 25.41 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 121.89 -0.506 . . . . 0.0 110.972 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 29.1 pt -81.42 -177.07 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.431 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -74.48 135.48 42.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.714 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 46' ' ' GLU . . . 168.99 -114.27 0.55 Allowed Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.406 ' O ' ' O ' ' A' ' 45' ' ' GLY . 38.0 tt0 60.62 131.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.831 0.348 . . . . 0.0 110.845 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 69.5 m -74.1 -34.08 63.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.072 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -52.15 -38.88 58.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.351 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.92 9.44 85.36 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -178.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.576 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -66.62 -38.42 86.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.294 0.569 . . . . 0.0 110.241 179.004 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.432 ' O ' ' O ' ' A' ' 54' ' ' ALA . 97.2 t -60.95 -45.26 98.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.095 -177.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -65.32 -34.16 77.69 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.787 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 50' ' ' LEU . 23.3 p -68.4 -38.18 81.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.907 0.384 . . . . 0.0 110.345 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' A' ' 51' ' ' VAL . . . -95.83 122.02 38.18 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.127 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.97 -43.0 12.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.723 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.624 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 10.4 m -131.05 -137.94 0.21 Allowed 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.624 ' HB3' ' O ' ' A' ' 56' ' ' SER . . . 80.1 -27.04 0.15 Allowed 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 176.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -120.82 38.81 3.94 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.528 ' O ' ' NH2' ' A' ' 40' ' ' ARG . 16.2 m-85 -37.51 151.62 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.81 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.42 ' O ' ' C ' ' A' ' 61' ' ' GLY . 31.9 mtm105 -46.4 -33.68 4.08 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 60' ' ' ARG . . . -30.51 101.95 0.01 OUTLIER Glycine 0 CA--C 1.527 0.795 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.89 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.2 p -66.95 -33.94 66.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 118.155 -0.926 . . . . 0.0 109.44 176.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.578 ' O ' HD13 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -60.52 -33.01 72.01 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 121.263 1.847 . . . . 0.0 110.343 -179.689 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.94 -49.5 62.59 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-N 115.518 -0.765 . . . . 0.0 114.575 -176.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.488 ' OG1' ' NH2' ' A' ' 40' ' ' ARG . 4.6 m -62.18 -46.36 89.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.005 -0.598 . . . . 0.0 112.498 -178.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 11.2 tt -59.78 -35.79 62.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.87 -35.77 81.74 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 120.597 1.544 . . . . 0.0 111.488 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 99.5 m -63.08 -39.3 94.32 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 113.595 -1.639 . . . . 0.0 111.064 -175.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.492 ' SD ' ' O ' ' A' ' 69' ' ' MET . 0.0 OUTLIER -60.59 -39.99 90.12 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 120.835 -1.166 . . . . 0.0 113.912 -176.548 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.1 p -69.33 -40.34 80.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 119.256 -0.978 . . . . 0.0 112.726 -178.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -78.3 -13.37 59.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.334 0.588 . . . . 0.0 112.585 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 90.8 m -62.88 -55.02 29.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.136 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -108.01 -56.93 2.17 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 157.84 164.39 13.87 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -56.29 -34.96 95.18 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.009 1.806 . . . . 0.0 111.673 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 72.4 mtp85 -61.23 -11.55 9.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.609 0.719 . . . . 0.0 111.463 176.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.9 p -78.28 -33.07 49.76 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.853 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.485 HD12 ' N ' ' A' ' 78' ' ' LEU . 8.9 mp -76.13 -32.12 58.98 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 122.309 -0.244 . . . . 0.0 111.45 179.087 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -90.7 -3.83 57.19 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 123.485 1.612 . . . . 0.0 112.531 -176.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -94.24 37.36 1.11 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 110.748 -2.933 . . . . 0.0 108.732 176.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -168.45 -15.37 0.02 OUTLIER Glycine 0 CA--C 1.533 1.209 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.842 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 82' ' ' LEU . 59.9 mt -59.97 -34.92 73.94 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 119.163 -1.015 . . . . 0.0 111.861 -179.415 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.9 p -70.54 -27.67 32.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.846 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.7 -31.62 61.93 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.541 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -68.37 -40.57 86.98 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 119.472 -1.347 . . . . 0.0 111.601 -177.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 27.1 mt -63.01 -41.21 99.51 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -176.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.41 ' H ' ' HG2' ' A' ' 87' ' ' GLN . 4.3 pt20 -60.9 -26.78 67.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.405 -1.271 . . . . 0.0 108.925 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 18.7 ttm105 -57.47 -53.46 57.87 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 173.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 66.0 mm-40 -67.05 -29.58 69.42 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 112.557 -2.11 . . . . 0.0 112.089 -178.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 34.4 ttm -61.19 -40.4 93.77 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.951 -1.022 . . . . 0.0 112.682 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 78.2 p -74.22 -34.31 63.65 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 118.491 -0.766 . . . . 0.0 111.058 -176.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -57.8 -44.36 86.29 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 120.609 1.55 . . . . 0.0 110.746 -177.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.63 -33.47 64.56 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 119.075 -1.05 . . . . 0.0 110.744 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.3 p -64.82 -42.85 94.65 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.437 ' C ' ' H ' ' A' ' 97' ' ' ILE . 11.7 p -68.52 -27.91 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.666 178.361 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.06 9.84 2.74 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 -176.452 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.471 HG22 ' O ' ' A' ' 97' ' ' ILE . 99.2 mt -87.23 -15.11 9.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 177.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -140.39 -47.9 0.06 OUTLIER Glycine 0 CA--C 1.538 1.504 0 N-CA-C 115.846 1.098 . . . . 0.0 115.846 -175.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.597 HD22 ' N ' ' A' ' 99' ' ' LEU . 3.3 mm? -70.9 -12.62 61.65 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.109 1.454 . . . . 0.0 112.02 -178.192 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -79.78 -50.43 10.57 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.0 -1.454 . . . . 0.0 109.609 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -67.71 -32.35 72.92 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 113.768 -1.56 . . . . 0.0 109.264 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.2 p -69.84 -53.96 15.74 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 112.661 -2.063 . . . . 0.0 112.874 175.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.723 HG22 ' CE2' ' A' ' 107' ' ' TYR . 0.3 OUTLIER -75.15 -27.63 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-N 122.088 2.222 . . . . 0.0 116.182 -176.835 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.514 ' NZ ' ' CB ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -69.54 -43.5 72.85 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 112.409 -2.178 . . . . 0.0 113.412 -177.723 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.455 ' N ' ' HG3' ' A' ' 104' ' ' LYS . 88.1 mt-30 -78.27 -10.97 59.89 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 124.345 2.021 . . . . 0.0 111.039 178.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -79.23 -22.69 44.47 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 112.055 -2.339 . . . . 0.0 111.512 178.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.723 ' CE2' HG22 ' A' ' 103' ' ' VAL . 28.2 m-85 -109.38 -30.74 7.83 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 119.155 0.889 . . . . 0.0 110.831 -177.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.3 m -97.75 8.85 43.98 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 117.918 -1.513 . . . . 0.0 113.157 -178.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.494 ' O ' ' C ' ' A' ' 110' ' ' GLY . 35.4 ttpt -48.74 125.75 10.7 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 117.908 -1.044 . . . . 0.0 109.541 177.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' A' ' 111' ' ' SER . . . -29.39 -74.45 0.04 OUTLIER Glycine 0 N--CA 1.485 1.962 0 CA-C-N 120.231 1.378 . . . . 0.0 111.6 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.531 ' CB ' ' O ' ' A' ' 110' ' ' GLY . 2.7 m 104.23 -161.67 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 177.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.618 ' O ' ' N ' ' A' ' 114' ' ' ALA . 79.6 tt0 -129.95 102.3 6.22 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -178.104 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.633 ' O ' ' HB2' ' A' ' 114' ' ' ALA . 88.0 m-70 13.51 46.75 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 O-C-N 124.411 1.069 . . . . 0.0 113.135 178.177 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.633 ' HB2' ' O ' ' A' ' 113' ' ' HIS . . . 159.09 -161.7 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.072 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.16 15.02 26.98 Favored Glycine 0 C--N 1.337 0.626 0 CA-C-N 115.141 -0.936 . . . . 0.0 113.038 176.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 50.0 mt -60.73 -40.72 85.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 C-N-CA 119.133 -1.027 . . . . 0.0 108.576 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.6 -40.09 95.81 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 122.01 0.783 . . . . 0.0 111.362 175.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 19.4 m -58.18 -42.53 86.24 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 177.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -63.72 -37.42 87.3 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.009 -0.676 . . . . 0.0 111.058 -178.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 97.2 mt -64.16 -46.56 83.5 Favored 'General case' 0 N--CA 1.457 -0.11 0 CA-C-O 121.481 0.657 . . . . 0.0 109.352 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.568 ' O ' HD23 ' A' ' 121' ' ' LEU . 1.4 tt -66.67 -44.59 81.39 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.933 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.457 ' O ' HG22 ' A' ' 126' ' ' THR . . . -63.36 -44.69 94.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 119.457 1.026 . . . . 0.0 108.853 177.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -65.83 -44.03 92.81 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 120.034 -1.079 . . . . 0.0 111.584 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 63.9 m -64.27 -44.51 91.52 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.508 HG23 ' N ' ' A' ' 126' ' ' THR . 13.9 t -70.16 -48.02 59.11 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 118.885 -1.126 . . . . 0.0 112.077 177.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.508 ' N ' HG23 ' A' ' 125' ' ' THR . 9.4 t -65.66 -42.69 91.05 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 -174.004 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.493 ' N ' HG23 ' A' ' 126' ' ' THR . . . -64.23 -44.71 95.19 Favored Glycine 0 C--N 1.33 0.206 0 CA-C-N 114.416 -1.265 . . . . 0.0 112.253 -178.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.477 ' O ' HG12 ' A' ' 131' ' ' VAL . . . -61.01 -41.58 96.81 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 112.302 -1.949 . . . . 0.0 106.287 177.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.677 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 31.3 mt -64.91 -42.36 94.8 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.841 177.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.24 -40.01 96.23 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -177.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 128' ' ' ALA . 4.0 p -61.22 -24.84 34.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 122.932 1.348 . . . . 0.0 109.042 178.574 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.677 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . -57.64 -44.55 85.68 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 112.188 -2.278 . . . . 0.0 111.343 -178.194 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.9 p -78.81 -48.74 21.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.229 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.459 ' O ' ' O ' ' A' ' 131' ' ' VAL . . . -92.06 138.18 31.75 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.712 0.291 . . . . 0.0 111.064 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.497 ' N ' ' CD ' ' A' ' 136' ' ' PRO . 1.2 tt0 -179.69 -47.19 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.815 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 135' ' ' GLN . 55.3 Cg_exo -52.11 -33.5 53.96 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 122.326 2.017 . . . . 0.0 112.302 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 32.2 p -67.69 -42.78 81.53 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 117.941 -1.504 . . . . 0.0 109.786 -179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -66.24 -42.96 87.88 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 119.317 -0.953 . . . . 0.0 112.098 -178.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 62.5 t -64.08 -43.72 97.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -179.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 136' ' ' PRO . 72.4 t -64.89 -39.34 85.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -177.152 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 31.3 mttp -62.83 -42.01 99.56 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 118.754 -1.179 . . . . 0.0 111.325 -178.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 11.8 m -71.24 -46.33 66.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.87 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 12.8 tpp85 -65.59 -37.37 86.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.895 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -67.34 -42.0 84.26 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -177.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.3 -40.49 90.03 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 119.173 -1.011 . . . . 0.0 111.232 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.32 -35.46 81.08 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 -177.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -60.62 111.27 1.54 Allowed 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 176.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -106.12 -52.44 2.8 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.872 1.804 . . . . 0.0 115.872 -174.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.538 ' O ' ' HB3' ' A' ' 150' ' ' ALA . 10.9 mmt180 -86.9 12.14 11.78 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 121.68 2.036 . . . . 0.0 110.544 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.538 ' HB3' ' O ' ' A' ' 149' ' ' ARG . . . 72.62 -45.72 0.63 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.667 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 103.16 169.71 26.0 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.636 0 N-CA-C 111.094 -0.803 . . . . 0.0 111.094 -179.93 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.534 0.348 0 CA-C-O 120.907 0.384 . . . . 0.0 110.751 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.44 ' CD ' ' N ' ' A' ' 157' ' ' GLN . 14.8 mp0 -62.65 164.17 8.07 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.42 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.403 ' OG ' ' N ' ' A' ' 159' ' ' THR . 47.6 t -157.16 -178.02 7.05 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.457 0.646 . . . . 0.0 111.273 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.57 HG23 ' N ' ' A' ' 160' ' ' VAL . 15.1 t -63.78 -45.89 87.72 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.66 -177.171 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.57 ' N ' HG23 ' A' ' 159' ' ' THR . 94.9 t -63.95 -45.26 97.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 119.251 -0.98 . . . . 0.0 109.096 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 38.6 tp10 -67.01 -38.37 85.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.663 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.549 ' O ' HD12 ' A' ' 166' ' ' ILE . . . -60.96 -44.41 97.37 Favored 'General case' 0 C--O 1.211 -0.952 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -176.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.543 ' CE2' HD11 ' A' ' 175' ' ' LEU . 14.8 t80 -61.25 -47.62 85.19 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.662 0.744 . . . . 0.0 112.204 -177.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.402 ' NZ ' ' CB ' ' A' ' 164' ' ' LYS . 2.3 ttmp? -68.39 -45.41 72.77 Favored 'General case' 0 CA--C 1.555 1.169 0 N-CA-C 118.17 2.656 . . . . 0.0 118.17 -173.03 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 63.8 p -63.49 -45.51 90.39 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 117.381 2.363 . . . . 0.0 117.381 -175.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.741 HD13 ' H ' ' A' ' 166' ' ' ILE . 0.2 OUTLIER -64.59 -37.14 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-O 121.635 0.731 . . . . 0.0 109.233 177.082 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -58.93 -36.97 75.64 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 117.177 -1.392 . . . . 0.0 107.628 177.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 77.5 ttt-85 -62.75 -50.7 70.02 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 123.393 2.815 . . . . 0.0 111.835 -176.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -75.34 -51.22 13.69 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 123.584 0.754 . . . . 0.0 109.5 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -78.15 -36.54 47.54 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -174.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 91.9 -169.09 32.03 Favored Glycine 0 N--CA 1.464 0.509 0 N-CA-C 111.707 -0.557 . . . . 0.0 111.707 178.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.416 ' CG1' ' N ' ' A' ' 173' ' ' ARG . 7.5 pt -71.51 -42.04 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-O 121.454 0.645 . . . . 0.0 110.61 -179.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.416 ' N ' ' CG1' ' A' ' 172' ' ' ILE . 25.4 mmt180 -59.24 -34.09 71.8 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.595 -177.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -60.91 -40.67 98.68 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 118.514 -1.803 . . . . 0.0 109.035 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.543 HD11 ' CE2' ' A' ' 163' ' ' TYR . 0.5 OUTLIER -70.55 -33.48 71.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 111.239 -2.48 . . . . 0.0 116.771 -177.284 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 176' ' ' TRP . . . . . 0.484 ' CG ' ' OG1' ' A' ' 179' ' ' THR . 33.5 t-105 -77.93 -7.63 57.02 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 111.694 -2.503 . . . . 0.0 110.563 -177.004 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 51.4 mttm -43.55 -48.41 7.49 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -176.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -99.31 -25.65 9.29 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.099 0.857 . . . . 0.0 112.601 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.484 ' OG1' ' CG ' ' A' ' 176' ' ' TRP . 69.2 p -46.3 -51.9 13.71 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.99 -50.41 76.94 Favored Pre-proline 0 N--CA 1.48 1.038 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -175.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -63.34 -28.35 71.85 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 121.628 1.552 . . . . 0.0 111.42 176.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -63.88 -39.0 93.18 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.245 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 71.1 t -62.69 -42.14 94.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.0 0.429 . . . . 0.0 110.009 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.555 ' O ' HD13 ' A' ' 188' ' ' ILE . . . -61.72 -38.99 89.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.347 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -60.4 -41.97 94.99 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.71 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -61.55 -43.2 99.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.366 0.603 . . . . 0.0 110.169 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.34 -43.13 95.58 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.167 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.555 HD13 ' O ' ' A' ' 184' ' ' ALA . 1.4 mp -63.04 -45.07 99.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.2 -177.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.42 ' O ' ' OE1' ' A' ' 193' ' ' GLU . 11.8 m -60.44 -47.06 94.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 119.409 -0.916 . . . . 0.0 112.431 -178.16 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -62.68 -43.19 99.44 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 122.586 1.184 . . . . 0.0 109.868 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' CYS . . . . . . . . . . . . . 31.2 m -62.34 -46.22 89.68 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 112.565 -2.107 . . . . 0.0 110.479 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.11 -40.13 95.53 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 114.037 -1.438 . . . . 0.0 109.659 176.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 0.492 ' OE1' ' N ' ' A' ' 193' ' ' GLU . 0.0 OUTLIER -61.01 -45.64 94.0 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.63 -178.381 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 67.2 tp -64.21 -39.14 93.37 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 118.637 -1.225 . . . . 0.0 110.053 -175.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 6.9 m -64.45 -45.88 94.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 C-N-CA 116.891 -1.924 . . . . 0.0 107.907 178.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 23.4 m -63.98 -45.95 86.78 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -178.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -57.16 -39.08 74.55 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.862 0.865 . . . . 0.0 112.56 -178.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -55.86 -44.29 77.92 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.5 HD22 ' N ' ' A' ' 199' ' ' LEU . 3.8 mm? -61.34 -38.79 88.19 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 41.8 mm -62.0 -42.41 94.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 26.1 mmtm -59.57 -38.71 81.86 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.876 1.27 . . . . 0.0 113.183 178.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -67.79 -37.12 81.6 Favored 'General case' 0 C--O 1.256 1.42 0 C-N-CA 118.511 -1.276 . . . . 0.0 111.028 -175.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.433 ' O ' HG23 ' A' ' 203' ' ' THR . 5.8 t -100.96 128.82 46.82 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 121.308 1.867 . . . . 0.0 111.895 -178.334 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.508 ' CD2' ' CE1' ' A' ' 217' ' ' HIS . 6.9 mp 66.82 3.74 3.16 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 113.342 -1.754 . . . . 0.0 110.576 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 2.3 mt -126.59 29.78 5.66 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.882 0.849 . . . . 0.0 110.628 -179.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -68.78 -25.8 64.89 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.482 -1.235 . . . . 0.0 109.848 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.528 ' O ' ' ND2' ' A' ' 208' ' ' ASN . . . -161.93 39.62 0.13 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 114.363 -1.29 . . . . 0.0 109.563 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' ASN . . . . . 0.528 ' ND2' ' O ' ' A' ' 207' ' ' ALA . 0.4 OUTLIER 87.93 -18.38 0.27 Allowed 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 175.979 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.504 ' CB ' ' O ' ' A' ' 208' ' ' ASN . 1.0 OUTLIER . . . . . 0 N--CA 1.477 0.907 0 CA-C-N 119.742 1.155 . . . . 0.0 109.524 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 . . . . . 0 N--CA 1.465 0.307 0 CA-C-O 121.308 0.575 . . . . 0.0 109.683 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.412 ' N ' ' CD ' ' A' ' 215' ' ' PRO . 2.5 mm? -61.24 -43.89 91.55 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.921 -178.195 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 214' ' ' LEU . 27.3 Cg_exo -60.7 -34.45 91.92 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 CA-C-N 120.263 1.129 . . . . 0.0 111.16 -178.36 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 7.9 t -65.24 -42.43 93.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 113.085 -1.871 . . . . 0.0 111.231 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' HIS . . . . . 0.522 ' O ' ' ND1' ' A' ' 217' ' ' HIS . 1.8 t60 -66.78 -37.41 84.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.446 -0.797 . . . . 0.0 113.064 -178.134 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -62.95 -47.62 82.42 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.096 -177.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 33.5 p -60.53 -38.1 83.34 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 119.097 0.862 . . . . 0.0 110.986 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 66.0 p -59.64 -41.78 91.28 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' ALA . . . . . 0.574 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.89 -41.84 97.62 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -178.216 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -62.63 -47.82 82.08 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -176.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -61.06 -42.27 99.74 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 107.811 -2.116 . . . . 0.0 107.811 177.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' ALA . . . . . 0.788 ' O ' HG23 ' A' ' 228' ' ' THR . . . -63.31 -37.78 88.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 113.817 -1.191 . . . . 0.0 109.009 176.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' GLY . . . . . 0.574 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -61.67 -42.38 99.75 Favored Glycine 0 CA--C 1.522 0.51 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.827 -176.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 226' ' ' PHE . . . . . 0.432 ' O ' ' OG1' ' A' ' 229' ' ' THR . 0.9 OUTLIER -66.55 -38.58 87.44 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 118.28 1.04 . . . . 0.0 108.27 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 96.6 m -63.54 -41.88 98.43 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.09 0.471 . . . . 0.0 110.265 177.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' THR . . . . . 0.788 HG23 ' O ' ' A' ' 224' ' ' ALA . 80.1 p -62.5 -40.48 96.87 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.896 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' A' ' 226' ' ' PHE . 18.6 p -58.8 -39.73 81.99 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.097 -176.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 98.3 t -60.61 -41.91 89.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 118.521 -1.271 . . . . 0.0 108.839 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' ILE . . . . . 0.48 ' O ' ' HD2' ' A' ' 234' ' ' PRO . 1.3 mp -62.13 -41.29 90.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-O 121.418 0.628 . . . . 0.0 109.393 176.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -62.99 -40.09 96.7 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 -178.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.442 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 0.0 OUTLIER -59.11 -43.39 97.15 Favored Pre-proline 0 N--CA 1.476 0.84 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -173.255 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.48 ' HD2' ' O ' ' A' ' 231' ' ' ILE . 39.4 Cg_exo -60.0 -41.72 50.49 Favored 'Trans proline' 0 C--N 1.296 -2.189 0 C-N-CA 121.576 1.517 . . . . 0.0 113.781 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.408 ' H ' HG22 ' A' ' 235' ' ' VAL . 13.6 m -66.34 -37.55 79.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 119.131 -1.028 . . . . 0.0 111.303 178.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -66.0 -41.7 90.72 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -178.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.4 ' H ' HG12 ' A' ' 237' ' ' VAL . 3.0 p -65.68 -45.72 91.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -177.48 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 8.5 p . . . . . 0 C--N 1.327 -0.406 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.323 -178.627 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 73.4 p . . . . . 0 N--CA 1.465 0.302 0 CA-C-O 120.936 0.398 . . . . 0.0 111.93 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 260' ' ' MET . . . . . . . . . . . . . 51.9 ttp -60.31 -44.44 95.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.011 -176.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.522 HD13 ' O ' ' A' ' 261' ' ' LEU . 0.2 OUTLIER -62.17 -46.5 88.65 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.338 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 69.1 mmt-85 -66.41 -53.78 31.83 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.666 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -142.62 158.73 43.36 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.687 0.28 . . . . 0.0 111.23 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 264' ' ' GLU . . . . . 0.448 ' O ' ' O ' ' A' ' 265' ' ' GLY . 18.3 tp10 76.25 68.31 0.06 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.285 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 265' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 264' ' ' GLU . . . -32.09 156.59 0.01 OUTLIER Glycine 0 CA--C 1.536 1.379 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.667 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -62.82 -3.11 4.17 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 122.246 1.964 . . . . 0.0 111.836 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 80.5 mtt85 -70.0 -27.05 64.37 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 123.053 0.541 . . . . 0.0 111.805 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.441 ' O ' ' O ' ' A' ' 271' ' ' LYS . . . -58.8 -32.47 69.38 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 119.824 -0.75 . . . . 0.0 109.948 -179.137 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -62.45 -41.72 98.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.412 0.625 . . . . 0.0 110.836 178.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -66.0 -37.7 86.59 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 114.9 -1.046 . . . . 0.0 112.363 -178.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 268' ' ' ALA . 17.6 ttpp -110.65 134.37 52.49 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.73 0.3 . . . . 0.0 110.616 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 108.47 55.77 0.58 Allowed Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -147.95 29.58 0.9 Allowed 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 120.836 0.35 . . . . 0.0 110.69 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 274' ' ' MET . . . . . 0.588 ' N ' ' CD ' ' A' ' 275' ' ' PRO . 0.3 OUTLIER -63.74 -43.88 78.21 Favored Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.238 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 275' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 274' ' ' MET . 23.4 Cg_exo -63.69 -45.87 10.19 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.776 2.317 . . . . 0.0 111.908 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 86.1 p -59.72 -39.13 83.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.061 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -61.21 -41.86 97.59 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 122.884 1.326 . . . . 0.0 111.85 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -61.87 -38.31 87.81 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 111.829 -2.441 . . . . 0.0 107.78 174.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 48.4 mtp180 -62.88 -39.33 94.15 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.304 0.573 . . . . 0.0 110.26 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 30.7 tp -61.85 -36.46 81.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.121 -0.945 . . . . 0.0 112.869 -177.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -68.12 -51.18 34.94 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -178.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 282' ' ' SER . . . . . 0.614 ' O ' HG12 ' A' ' 285' ' ' VAL . 76.4 p -63.09 -44.41 95.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.422 0.63 . . . . 0.0 110.072 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 283' ' ' TRP . . . . . . . . . . . . . 75.5 t90 -60.76 -38.75 86.27 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.604 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -62.58 -39.69 94.52 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -178.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.614 HG12 ' O ' ' A' ' 282' ' ' SER . 3.7 p -61.32 -37.89 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.093 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.526 ' O ' HG12 ' A' ' 289' ' ' VAL . 95.0 t -62.02 -40.6 87.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 120.311 -0.556 . . . . 0.0 109.526 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 287' ' ' MET . . . . . 0.459 ' C ' ' SD ' ' A' ' 287' ' ' MET . 0.0 OUTLIER -61.15 -38.55 86.81 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.342 0.591 . . . . 0.0 109.893 178.606 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -58.51 -39.4 80.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.168 -0.923 . . . . 0.0 112.604 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.526 HG12 ' O ' ' A' ' 286' ' ' VAL . 1.3 p -59.85 -38.13 74.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 113.213 0.819 . . . . 0.0 113.213 -175.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 2.1 t -62.35 -40.54 96.73 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 118.892 -1.123 . . . . 0.0 109.135 178.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -60.82 -38.86 86.88 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 177.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -58.35 -40.25 81.7 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 117.664 -1.614 . . . . 0.0 109.913 -175.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 293' ' ' GLN . . . . . 0.496 ' O ' ' O ' ' A' ' 296' ' ' ARG . 56.5 tt0 -60.46 -43.3 97.02 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 122.6 1.191 . . . . 0.0 111.443 -179.011 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 11.0 mp -60.95 -40.39 93.11 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 113.313 -1.767 . . . . 0.0 109.671 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -62.68 -45.76 91.3 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.36 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 296' ' ' ARG . . . . . 0.496 ' O ' ' O ' ' A' ' 293' ' ' GLN . 43.5 ttm180 -122.53 116.33 23.72 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -119.16 -160.8 0.82 Allowed 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -178.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.493 HD23 ' OG ' ' A' ' 304' ' ' SER . 33.6 tp -71.42 114.82 9.88 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 177.289 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 28.1 ttp -96.7 64.71 2.13 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -177.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.58 101.04 0.07 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 122.047 0.927 . . . . 0.0 110.721 -178.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -64.15 -46.27 84.82 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 113.505 -1.68 . . . . 0.0 113.452 -176.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -58.73 -39.64 81.48 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.617 -0.433 . . . . 0.0 109.957 -178.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -64.68 -46.76 81.04 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.027 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 304' ' ' SER . . . . . 0.493 ' OG ' HD23 ' A' ' 298' ' ' LEU . 3.0 m -66.34 -38.1 86.85 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.404 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 59.7 mmt-85 -61.88 -42.86 99.57 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.721 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -64.94 -36.8 85.56 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -177.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 307' ' ' ALA . . . . . 0.54 ' HB3' ' HD3' ' A' ' 308' ' ' PRO . . . -60.02 -52.92 70.03 Favored Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -176.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 308' ' ' PRO . . . . . 0.54 ' HD3' ' HB3' ' A' ' 307' ' ' ALA . 73.9 Cg_endo -75.21 0.33 9.12 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.109 1.873 . . . . 0.0 111.816 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 50.4 t80 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.51 179.992 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 48.5 m . . . . . 0 N--CA 1.465 0.308 0 CA-C-O 120.824 0.345 . . . . 0.0 110.399 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 16' ' ' LYS . 16.8 t -87.05 164.19 2.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.336 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.486 ' N ' HG12 ' A' ' 15' ' ' VAL . 33.3 mtmm -64.37 -42.03 96.41 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -63.77 -41.62 97.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.386 0.612 . . . . 0.0 111.428 179.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.5 tp -79.81 -26.11 40.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.236 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.45 -41.43 94.33 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 107.472 -2.251 . . . . 0.0 107.472 177.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.531 ' HB1' HH22 ' A' ' 96' ' ' ARG . . . -71.47 -32.29 68.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 124.838 2.256 . . . . 0.0 107.061 176.377 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.56 -42.47 98.86 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-N 108.516 -3.947 . . . . 0.0 107.759 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.0 m -70.7 -27.87 64.32 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.462 0.648 . . . . 0.0 109.591 177.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.66 ' O ' HD13 ' A' ' 26' ' ' ILE . . . -65.95 -49.83 66.52 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.981 -178.413 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.05 -35.16 77.77 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 118.693 -1.203 . . . . 0.0 112.206 -177.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 78.2 m -63.29 -53.85 46.4 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -177.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.66 HD13 ' O ' ' A' ' 23' ' ' ALA . 0.2 OUTLIER -66.06 -38.16 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -177.739 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.37 -41.9 98.83 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-O 118.175 -0.917 . . . . 0.0 113.316 -172.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -77.58 -26.78 51.07 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 120.914 1.688 . . . . 0.0 110.51 -175.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.3 mp -59.56 -54.56 45.15 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 119.686 1.13 . . . . 0.0 112.27 -178.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.9 tp -74.78 -3.44 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 CA-C-O 121.692 0.758 . . . . 0.0 112.711 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -109.06 -16.19 14.17 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.39 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.495 ' N ' ' HD2' ' A' ' 33' ' ' PRO . 27.0 t80 -68.5 -46.08 36.28 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 116.654 -2.018 . . . . 0.0 111.829 -177.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 32' ' ' PHE . 24.0 Cg_endo -60.26 -15.89 37.47 Favored 'Trans proline' 0 N--CA 1.499 1.824 0 CA-C-N 120.988 1.389 . . . . 0.0 113.238 177.345 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.411 ' N ' HD12 ' A' ' 34' ' ' LEU . 10.5 mp -67.36 -35.7 79.9 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -177.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -64.64 -40.4 95.39 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.618 -178.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.9 p -58.22 -34.8 70.81 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.812 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.43 -38.85 85.2 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 119.862 -0.735 . . . . 0.0 112.231 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -62.64 -49.86 73.49 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 119.106 -1.037 . . . . 0.0 111.296 -177.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 65.6 t -64.96 -40.19 88.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -177.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.538 ' O ' ' N ' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -61.05 -41.09 95.95 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.752 -178.457 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.6 tp -62.03 38.79 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.967 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.538 ' N ' ' O ' ' A' ' 40' ' ' ARG . 6.3 pt20 -95.51 154.63 17.11 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.82 0.343 . . . . 0.0 110.603 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.701 HD12 ' N ' ' A' ' 43' ' ' ILE . 1.9 mp -69.22 -11.92 15.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.289 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 55.29 -175.71 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.374 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 57.83 38.81 90.06 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.999 -0.841 . . . . 0.0 110.999 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.405 ' O ' ' OG ' ' A' ' 47' ' ' SER . 14.7 pt-20 -61.65 -35.03 76.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.793 0.33 . . . . 0.0 110.408 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' A' ' 46' ' ' GLU . 69.1 m -168.58 -15.88 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.677 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -64.59 -40.78 96.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.655 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.51 9.57 84.61 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -177.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.1 tp -64.62 -36.8 85.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.313 -0.944 . . . . 0.0 109.929 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 95.3 t -59.69 -44.2 93.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.397 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 93.1 mtm-85 -64.46 -34.19 77.62 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.201 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.7 p -68.44 -38.09 80.83 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 178.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -134.51 93.36 3.04 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.803 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.52 -13.38 52.17 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -178.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.613 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 90.5 p -126.33 -140.06 0.27 Allowed 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.051 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.613 ' HB3' ' O ' ' A' ' 56' ' ' SER . . . 98.01 12.88 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 O-C-N 124.245 0.965 . . . . 0.0 112.04 178.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.421 ' OE1' ' O ' ' A' ' 59' ' ' TYR . 1.3 tm0? -173.59 84.17 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.562 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.421 ' O ' ' OE1' ' A' ' 58' ' ' GLN . 5.4 m-85 -65.5 148.55 51.53 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -40.23 -36.71 0.55 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.023 0.44 . . . . 0.0 110.255 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -31.85 103.38 0.01 OUTLIER Glycine 0 CA--C 1.529 0.926 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.334 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.3 p -67.14 -33.53 63.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 118.205 -0.902 . . . . 0.0 109.626 176.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -60.02 -32.3 70.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 121.397 1.908 . . . . 0.0 109.958 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.51 -48.96 67.84 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 115.262 -0.881 . . . . 0.0 114.555 -176.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.2 m -61.87 -46.3 90.03 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -178.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 28.9 mm -59.49 -36.27 63.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 40.0 tp -64.04 -35.82 81.97 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 120.252 1.387 . . . . 0.0 112.511 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 98.6 m -63.3 -40.7 98.08 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.069 -175.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 31.7 ttp -60.15 -40.19 88.97 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 114.406 1.262 . . . . 0.0 114.406 -175.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.41 ' CG1' ' N ' ' A' ' 71' ' ' ARG . 3.0 p -69.46 -40.93 80.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 119.218 -0.993 . . . . 0.0 113.16 -177.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.41 ' N ' ' CG1' ' A' ' 70' ' ' VAL . 68.1 ttt-85 -78.75 -12.92 60.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.697 0.76 . . . . 0.0 112.991 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 56.8 m -61.63 -54.85 37.33 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.682 -1.144 . . . . 0.0 111.094 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.554 ' CD ' ' H ' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -117.32 -40.81 3.03 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 118.754 -0.641 . . . . 0.0 110.472 178.064 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 155.15 159.58 9.39 Favored Glycine 0 CA--C 1.549 2.158 0 CA-C-N 120.192 1.36 . . . . 0.0 111.34 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -56.53 -34.58 95.48 Favored 'Trans proline' 0 N--CA 1.511 2.531 0 C-N-CA 122.269 1.98 . . . . 0.0 114.032 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.5 mmp_? -60.23 -10.55 4.7 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 178.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.422 ' O ' ' OD1' ' A' ' 80' ' ' ASN . 1.2 p -77.28 -31.79 55.09 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.642 -178.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 43.5 tp -74.91 -31.94 61.68 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 122.039 -0.413 . . . . 0.0 110.626 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.747 ' O ' HD12 ' A' ' 82' ' ' LEU . 97.3 m-85 -90.88 -3.86 57.01 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 122.851 1.31 . . . . 0.0 114.091 -176.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 77' ' ' SER . 0.8 OUTLIER -104.17 123.64 47.66 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 111.986 -2.37 . . . . 0.0 107.738 175.337 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.24 -16.29 49.59 Favored Glycine 0 N--CA 1.467 0.746 0 N-CA-C 108.389 -1.885 . . . . 0.0 108.389 -177.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.969 HD13 ' H ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -59.34 -34.37 72.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 113.859 -1.17 . . . . 0.0 110.559 -179.601 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.969 ' H ' HD13 ' A' ' 82' ' ' LEU . 7.5 p -70.7 -27.36 30.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.322 177.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.96 -31.96 61.6 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 119.199 -0.429 . . . . 0.0 111.35 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.84 -40.01 89.6 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 119.533 -1.317 . . . . 0.0 110.832 -177.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.691 ' O ' HD23 ' A' ' 86' ' ' LEU . 2.4 tt -62.45 -40.54 96.94 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 122.261 1.029 . . . . 0.0 113.335 -176.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -60.55 -27.48 67.69 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 113.541 -1.663 . . . . 0.0 109.815 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 64.2 mtm180 -57.81 -53.25 60.34 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 173.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 70.7 tp60 -67.06 -29.68 69.53 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 112.505 -2.134 . . . . 0.0 111.921 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.446 ' SD ' ' C ' ' A' ' 90' ' ' MET . 11.5 tmm? -61.27 -40.89 95.79 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.044 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 77.7 p -74.24 -34.5 63.66 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 119.362 -0.935 . . . . 0.0 111.402 -176.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -57.84 -44.19 86.32 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 120.951 1.705 . . . . 0.0 111.857 -177.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.38 -33.16 64.89 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 119.546 -0.862 . . . . 0.0 111.094 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.574 ' O ' HG22 ' A' ' 97' ' ' ILE . 25.3 m -64.2 -41.78 96.92 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.443 ' C ' ' H ' ' A' ' 97' ' ' ILE . 72.9 t -68.37 -28.71 41.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.485 178.339 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.531 HH22 ' HB1' ' A' ' 20' ' ' ALA . 29.6 ttp180 -77.61 10.4 2.69 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -177.054 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.574 HG22 ' O ' ' A' ' 94' ' ' SER . 10.9 tt -86.96 -15.0 9.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.859 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -140.3 -49.0 0.05 OUTLIER Glycine 0 CA--C 1.541 1.711 0 N-CA-C 117.103 1.601 . . . . 0.0 117.103 -176.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.662 HD12 ' C ' ' A' ' 99' ' ' LEU . 3.1 pp -73.28 -12.77 60.97 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 120.558 2.179 . . . . 0.0 114.515 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.626 ' N ' HD12 ' A' ' 99' ' ' LEU . 46.6 t80 -79.16 -53.04 7.38 Favored 'General case' 0 C--O 1.214 -0.797 0 C-N-CA 118.777 -1.169 . . . . 0.0 113.073 -176.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -72.3 -33.18 67.22 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 124.26 1.981 . . . . 0.0 112.403 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 67.0 m -65.47 -48.98 70.78 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 109.317 -3.583 . . . . 0.0 115.034 -178.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.405 HG22 ' O ' ' A' ' 99' ' ' LEU . 19.1 m -72.29 -23.83 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.368 0 CA-C-O 123.945 1.831 . . . . 0.0 109.437 175.147 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.565 ' HB2' ' O ' ' A' ' 100' ' ' TYR . 0.0 OUTLIER -68.03 -42.61 80.35 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 109.943 -3.299 . . . . 0.0 113.675 -179.058 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -76.56 -13.33 60.09 Favored 'General case' 0 C--O 1.211 -0.948 0 CA-C-O 125.468 2.556 . . . . 0.0 111.102 177.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.484 ' O ' ' NZ ' ' A' ' 109' ' ' LYS . 1.9 t80 -80.15 -22.08 42.42 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 109.378 -3.555 . . . . 0.0 110.711 177.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.417 ' HE2' HD21 ' A' ' 194' ' ' LEU . 0.3 OUTLIER -109.68 -28.72 8.69 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.607 0.763 . . . . 0.0 112.404 -174.137 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.753 ' C ' ' H ' ' A' ' 110' ' ' GLY . 0.8 OUTLIER -94.91 12.99 26.32 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -174.723 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.484 ' NZ ' ' O ' ' A' ' 106' ' ' PHE . 7.2 ptpp? -56.58 18.73 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 119.602 1.092 . . . . 0.0 110.825 177.287 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.753 ' H ' ' C ' ' A' ' 108' ' ' THR . . . 57.8 19.2 35.3 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-N 113.956 -1.475 . . . . 0.0 109.773 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.431 ' O ' ' O ' ' A' ' 110' ' ' GLY . 36.2 m 31.19 -160.73 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 112.47 -1.865 . . . . 0.0 114.333 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.623 ' O ' ' N ' ' A' ' 114' ' ' ALA . 39.8 tt0 -134.12 92.99 3.02 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 114.144 1.165 . . . . 0.0 114.144 -176.12 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.578 ' O ' ' HB2' ' A' ' 114' ' ' ALA . 89.4 m-70 30.63 28.68 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.082 178.341 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.623 ' N ' ' O ' ' A' ' 112' ' ' GLU . . . 159.97 -161.97 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.99 15.46 23.94 Favored Glycine 0 N--CA 1.464 0.556 0 C-N-CA 120.035 -1.079 . . . . 0.0 111.647 178.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.678 HD12 ' N ' ' A' ' 116' ' ' ILE . 2.0 mp -60.34 -40.37 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 C-N-CA 119.237 -0.985 . . . . 0.0 108.713 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.91 -41.01 95.66 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.021 175.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 38.3 t -59.33 -43.64 92.69 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 176.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 64.5 mtm180 -64.15 -37.13 86.33 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.677 -178.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.543 ' O ' HD23 ' A' ' 120' ' ' LEU . 2.4 tt -63.2 -45.5 91.41 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 62.3 mt -66.33 -44.62 82.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.406 -1.27 . . . . 0.0 110.129 178.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.09 -45.01 90.57 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 120.074 1.307 . . . . 0.0 110.82 178.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -65.96 -44.44 91.68 Favored Glycine 0 N--CA 1.458 0.155 0 C-N-CA 119.588 -1.291 . . . . 0.0 111.371 -178.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.2 m -63.99 -43.75 94.77 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.949 0.404 . . . . 0.0 110.804 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.421 ' O ' HD23 ' A' ' 129' ' ' LEU . 21.2 m -69.57 -48.7 59.39 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 119.201 -1.0 . . . . 0.0 112.333 177.463 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 13.8 m -65.93 -42.79 89.62 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 114.868 1.433 . . . . 0.0 114.868 -175.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.435 ' O ' ' OD1' ' A' ' 186' ' ' ASN . . . -64.73 -44.81 94.33 Favored Glycine 0 CA--C 1.521 0.413 0 CA-C-N 114.512 -1.222 . . . . 0.0 113.236 -177.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.32 -41.45 97.04 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 112.457 -1.871 . . . . 0.0 107.196 177.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.614 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 1.6 mm? -64.07 -42.03 97.14 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.173 -0.922 . . . . 0.0 110.207 178.299 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -62.6 -38.88 91.9 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.58 0.229 . . . . 0.0 111.053 -178.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.616 HG11 HG22 ' A' ' 183' ' ' VAL . 85.6 t -60.58 -25.37 34.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 122.262 1.03 . . . . 0.0 109.516 178.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . -57.94 -44.86 87.21 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 113.281 -1.781 . . . . 0.0 111.988 -178.196 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.487 ' CG1' ' N ' ' A' ' 134' ' ' ALA . 2.7 p -79.04 -48.87 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.536 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.487 ' N ' ' CG1' ' A' ' 133' ' ' VAL . . . -93.2 139.82 30.19 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.905 0.383 . . . . 0.0 111.23 -179.218 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.513 ' N ' ' CD ' ' A' ' 136' ' ' PRO . 1.2 tt0 178.45 -46.71 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.416 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.513 ' CD ' ' N ' ' A' ' 135' ' ' GLN . 54.3 Cg_exo -52.31 -33.45 55.75 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 122.501 2.134 . . . . 0.0 112.462 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 37.9 p -67.65 -42.39 82.29 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 118.255 -1.378 . . . . 0.0 109.394 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -66.67 -43.58 84.11 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 118.351 -1.34 . . . . 0.0 111.912 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 52.9 t -64.75 -44.89 96.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -178.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.4 p -65.48 -39.09 84.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -177.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -62.46 -41.67 98.93 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.715 -177.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 13.2 m -70.47 -45.58 74.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.108 -0.637 . . . . 0.0 110.516 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 9.6 mmt85 -65.08 -37.06 86.3 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.585 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -67.21 -42.1 84.66 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -177.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 23.8 mm100 -65.85 -40.14 91.43 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 119.203 -0.999 . . . . 0.0 110.103 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.22 -34.89 79.43 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 -178.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.441 ' O ' ' CG ' ' A' ' 147' ' ' GLN . 0.3 OUTLIER -59.89 111.07 1.33 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 177.67 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -100.39 -59.01 1.78 Allowed 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -175.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -96.46 60.69 1.92 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 122.125 2.239 . . . . 0.0 110.17 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . 54.97 -94.98 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.321 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 161.97 58.24 0.02 OUTLIER Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.716 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.911 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.743 0.306 . . . . 0.0 110.622 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -72.25 179.64 3.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.544 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.429 ' OG ' ' N ' ' A' ' 159' ' ' THR . 40.3 t -157.05 -178.14 7.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.293 0.568 . . . . 0.0 110.978 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.429 ' N ' ' OG ' ' A' ' 158' ' ' SER . 72.5 p -64.04 -46.22 85.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.591 -177.327 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.554 HG13 ' N ' ' A' ' 161' ' ' GLU . 10.3 p -64.43 -45.3 96.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 118.995 -1.082 . . . . 0.0 109.418 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.554 ' N ' HG13 ' A' ' 160' ' ' VAL . 60.6 mt-10 -67.23 -39.13 86.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.961 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -61.58 -46.0 91.75 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -177.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.478 ' CD1' ' C ' ' A' ' 163' ' ' TYR . 0.3 OUTLIER -62.77 -49.97 72.87 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 119.901 -0.719 . . . . 0.0 110.122 -179.577 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.6 mmtt -67.79 -45.62 74.29 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -174.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 19.7 m -62.82 -44.87 95.01 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 119.557 1.072 . . . . 0.0 113.385 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.525 ' N ' HD12 ' A' ' 166' ' ' ILE . 1.3 mp -64.86 -38.73 83.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 121.967 0.889 . . . . 0.0 109.165 176.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.78 -36.43 76.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 113.651 -1.613 . . . . 0.0 108.287 176.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 22.5 tpt85 -62.53 -50.88 69.61 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 122.301 2.319 . . . . 0.0 112.075 -175.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -75.29 -51.36 13.43 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 123.587 0.755 . . . . 0.0 109.231 176.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -78.57 -36.76 44.04 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 -174.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 92.89 -168.48 30.26 Favored Glycine 0 N--CA 1.468 0.81 0 O-C-N 121.995 -0.441 . . . . 0.0 112.427 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.529 HG23 ' N ' ' A' ' 173' ' ' ARG . 10.3 tp -72.99 -41.94 59.79 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.14 0 CA-C-O 121.916 0.865 . . . . 0.0 110.783 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.529 ' N ' HG23 ' A' ' 172' ' ' ILE . 36.2 ttm180 -58.69 -33.34 70.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 113.969 -1.469 . . . . 0.0 110.88 -176.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -60.76 -40.43 98.11 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 118.942 -1.599 . . . . 0.0 110.071 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 7.0 tt -70.37 -33.57 71.58 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 111.58 -2.31 . . . . 0.0 117.129 -177.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 4.9 m0 -77.88 -7.39 56.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 111.771 -2.468 . . . . 0.0 109.961 -176.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 24.8 ttpp -43.22 -48.03 6.51 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.434 -176.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -95.16 -36.29 5.5 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 124.142 0.877 . . . . 0.0 111.495 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.446 ' CG2' ' N ' ' A' ' 180' ' ' SER . 0.6 OUTLIER -45.4 -51.05 11.84 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 180' ' ' SER . . . . . 0.446 ' N ' ' CG2' ' A' ' 179' ' ' THR . 3.7 m -62.41 -50.13 80.52 Favored Pre-proline 0 N--CA 1.475 0.801 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -176.057 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 180' ' ' SER . 22.8 Cg_endo -63.95 -27.61 66.53 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 121.533 1.489 . . . . 0.0 111.652 177.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -63.43 -39.26 94.02 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.616 HG22 HG11 ' A' ' 131' ' ' VAL . 60.4 t -63.17 -42.46 96.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.067 0.461 . . . . 0.0 109.878 178.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.03 -38.98 90.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.57 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -60.23 -41.54 93.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.753 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 127' ' ' GLY . 0.5 OUTLIER -61.21 -42.99 99.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.983 0.42 . . . . 0.0 111.211 -179.471 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.73 -44.12 91.18 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.506 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 36.6 mm -64.0 -45.8 95.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.533 ' O ' ' N ' ' A' ' 193' ' ' GLU . 30.8 m -60.34 -46.11 95.48 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.373 0 C-N-CA 119.882 -0.727 . . . . 0.0 111.155 -178.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -62.62 -42.87 99.83 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.501 0.667 . . . . 0.0 110.241 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' CYS . . . . . . . . . . . . . 16.1 t -62.09 -46.09 90.62 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.365 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -63.89 -39.5 94.34 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 113.011 -1.904 . . . . 0.0 109.192 176.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 189' ' ' VAL . 49.4 tp10 -60.18 -46.49 89.53 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.065 -0.97 . . . . 0.0 111.97 -176.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.499 HD13 ' HA ' ' A' ' 194' ' ' LEU . 3.3 mm? -65.26 -38.49 90.48 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 118.17 -1.412 . . . . 0.0 110.866 -176.218 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.437 ' O ' ' CD2' ' A' ' 199' ' ' LEU . 0.3 OUTLIER -63.89 -47.02 92.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 116.345 -2.142 . . . . 0.0 107.347 -179.691 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 9.4 p -65.16 -46.54 80.43 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -179.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -57.34 -39.15 75.32 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.121 1.368 . . . . 0.0 113.473 -177.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -55.59 -44.19 76.7 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.71 HD22 ' N ' ' A' ' 199' ' ' LEU . 2.5 mm? -61.4 -39.54 91.09 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 80.0 mt -63.18 -43.78 99.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 118.485 -0.769 . . . . 0.0 111.464 -178.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 17.8 mmmt -60.52 -40.13 90.33 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 120.551 1.523 . . . . 0.0 109.511 175.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -64.34 -35.45 80.91 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 112.885 -1.961 . . . . 0.0 111.026 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 199' ' ' LEU . 0.2 OUTLIER -101.55 128.35 47.84 Favored 'General case' 0 C--N 1.357 0.894 0 O-C-N 121.0 -1.063 . . . . 0.0 111.239 -179.268 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.441 HD12 ' N ' ' A' ' 204' ' ' LEU . 10.4 mp 66.23 4.91 3.35 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.202 177.231 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 2.4 mt -129.38 35.8 4.2 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.465 0.65 . . . . 0.0 112.258 -177.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -73.83 -23.33 59.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.728 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.475 ' O ' ' CB ' ' A' ' 208' ' ' ASN . . . -131.17 -45.36 1.01 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.95 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 208' ' ' ASN . . . . . 0.557 ' CG ' ' H ' ' A' ' 209' ' ' LEU . 34.0 p-10 127.2 -72.4 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.198 1.799 . . . . 0.0 108.388 -178.207 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.557 ' H ' ' CG ' ' A' ' 208' ' ' ASN . 0.3 OUTLIER . . . . . 0 C--N 1.327 -0.406 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 . . . . . 0 N--CA 1.465 0.29 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.436 ' N ' ' CD ' ' A' ' 215' ' ' PRO . 4.1 mt -61.41 -43.52 89.56 Favored Pre-proline 0 C--N 1.33 -0.255 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 215' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 214' ' ' LEU . 26.7 Cg_exo -61.09 -33.58 91.2 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 CA-C-N 119.978 1.028 . . . . 0.0 111.107 -178.421 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 90.4 m -64.78 -42.46 95.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 113.269 -1.787 . . . . 0.0 111.807 -178.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' HIS . . . . . 0.441 ' O ' ' ND1' ' A' ' 217' ' ' HIS . 1.9 t60 -66.83 -38.32 86.2 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -177.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -63.35 -47.23 82.99 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.73 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 30.5 p -60.17 -37.86 81.43 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 118.943 0.792 . . . . 0.0 111.054 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 11.4 t -59.15 -41.16 87.7 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.3 -41.48 98.96 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -177.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -61.25 -46.98 88.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 122.172 0.987 . . . . 0.0 112.467 -176.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -60.43 -41.61 98.64 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 107.418 -2.273 . . . . 0.0 107.418 176.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' ALA . . . . . 0.454 ' O ' ' SG ' ' A' ' 227' ' ' CYS . . . -62.52 -37.73 87.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.255 -0.972 . . . . 0.0 108.479 176.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -61.65 -42.22 99.72 Favored Glycine 0 CA--C 1.525 0.679 0 CA-C-N 114.757 -1.111 . . . . 0.0 110.586 -178.19 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -66.62 -38.5 87.09 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.166 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' CYS . . . . . 0.467 ' SG ' ' N ' ' A' ' 228' ' ' THR . 0.5 OUTLIER -63.11 -40.48 97.75 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.236 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 228' ' ' THR . . . . . 0.467 ' N ' ' SG ' ' A' ' 227' ' ' CYS . 0.3 OUTLIER -61.29 -39.69 91.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.254 179.473 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.4 ' O ' ' HB3' ' A' ' 232' ' ' ALA . 20.1 m -58.39 -39.43 79.63 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 -178.214 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 92.8 t -60.25 -40.84 84.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 119.339 -0.944 . . . . 0.0 108.497 178.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' ILE . . . . . 0.596 ' O ' ' HD2' ' A' ' 234' ' ' PRO . 24.8 mm -61.29 -40.09 84.85 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.362 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.168 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 229' ' ' THR . . . -62.17 -38.4 88.92 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -178.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.451 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 0.3 OUTLIER -57.24 -40.19 82.89 Favored Pre-proline 0 N--CA 1.48 1.054 0 N-CA-C 116.107 1.891 . . . . 0.0 116.107 -173.052 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.596 ' HD2' ' O ' ' A' ' 231' ' ' ILE . 33.0 Cg_exo -58.76 -40.52 71.98 Favored 'Trans proline' 0 C--N 1.298 -2.088 0 C-N-CA 122.008 1.805 . . . . 0.0 113.516 -177.357 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 4.6 m -64.66 -36.0 76.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 119.071 -1.051 . . . . 0.0 110.243 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -64.79 -40.71 95.7 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 -177.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.439 ' H ' HG22 ' A' ' 237' ' ' VAL . 6.3 m -64.79 -45.48 94.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -176.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 5.7 p . . . . . 0 C--N 1.324 -0.519 0 C-N-CA 119.888 -0.725 . . . . 0.0 110.038 -179.851 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 96.8 m . . . . . 0 CA--C 1.534 0.348 0 CA-C-O 121.152 0.501 . . . . 0.0 109.879 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 260' ' ' MET . . . . . 0.595 ' O ' ' N ' ' A' ' 264' ' ' GLU . 0.0 OUTLIER -60.5 -41.58 94.59 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.894 -178.972 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 8.8 tp -61.2 -47.68 85.0 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 29.1 mtp85 -67.28 -53.86 26.06 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 43.6 tttp -66.51 -69.89 0.28 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.42 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 264' ' ' GLU . . . . . 0.595 ' N ' ' O ' ' A' ' 260' ' ' MET . 43.6 tp10 -88.32 110.77 21.03 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.835 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 265' ' ' GLY . . . . . 0.484 ' C ' ' H ' ' A' ' 267' ' ' ARG . . . -34.45 155.9 0.01 OUTLIER Glycine 0 CA--C 1.539 1.558 0 CA-C-N 116.3 -0.409 . . . . 0.0 112.11 -179.211 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -56.03 3.23 0.08 OUTLIER 'Trans proline' 0 N--CA 1.503 2.048 0 C-N-CA 122.131 1.888 . . . . 0.0 113.086 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 267' ' ' ARG . . . . . 0.484 ' H ' ' C ' ' A' ' 265' ' ' GLY . 99.6 mtt180 -68.95 -27.0 65.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.436 0.16 . . . . 0.0 110.768 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -58.78 -32.7 69.54 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.57 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 269' ' ' PHE . . . . . 0.408 ' CE2' ' CE ' ' A' ' 260' ' ' MET . 51.1 m-85 -62.47 -42.47 99.5 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.554 0.693 . . . . 0.0 110.683 178.192 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -66.62 -37.46 84.92 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.668 -1.151 . . . . 0.0 113.17 -178.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 272' ' ' GLY . 68.4 mttm -77.59 171.89 14.22 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.247 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 272' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 271' ' ' LYS . . . 53.69 111.79 0.01 OUTLIER Glycine 0 CA--C 1.528 0.874 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 273' ' ' PHE . . . . . 0.424 ' H ' ' H ' ' A' ' 274' ' ' MET . 48.2 p90 -172.25 3.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.616 -0.433 . . . . 0.0 111.144 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 274' ' ' MET . . . . . 0.559 ' N ' ' CD ' ' A' ' 275' ' ' PRO . 1.4 ttt -64.01 -44.13 77.12 Favored Pre-proline 0 C--N 1.329 -0.324 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.615 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 275' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' A' ' 274' ' ' MET . 19.5 Cg_exo -64.71 -47.9 4.76 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 121.852 1.701 . . . . 0.0 112.107 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 44.6 t -61.52 -40.74 95.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.664 0.745 . . . . 0.0 110.743 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -62.33 -42.62 99.53 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 123.491 1.615 . . . . 0.0 113.541 -178.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 9.2 tp -62.78 -39.24 93.6 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 110.607 -2.997 . . . . 0.0 108.887 174.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 71.5 mtp180 -63.04 -40.54 98.04 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.561 0.696 . . . . 0.0 110.713 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.855 ' O ' HD12 ' A' ' 280' ' ' LEU . 0.1 OUTLIER -62.26 -36.22 81.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.609 -1.178 . . . . 0.0 112.211 -177.446 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -68.14 -51.16 34.94 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 282' ' ' SER . . . . . 0.503 ' O ' HG22 ' A' ' 285' ' ' VAL . 71.1 m -63.19 -44.68 94.68 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 123.087 0.555 . . . . 0.0 109.84 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 283' ' ' TRP . . . . . . . . . . . . . 80.3 t90 -60.46 -38.0 82.8 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.851 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -61.75 -37.96 86.19 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.718 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.503 HG22 ' O ' ' A' ' 282' ' ' SER . 0.9 OUTLIER -60.2 -37.44 73.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 111.567 0.21 . . . . 0.0 111.567 -178.598 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.777 ' O ' HG12 ' A' ' 289' ' ' VAL . 0.8 OUTLIER -61.75 -40.15 85.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 120.505 -0.478 . . . . 0.0 109.986 -178.804 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 8.4 tpt -60.91 -39.11 88.11 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.245 0.545 . . . . 0.0 109.721 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -59.05 -41.05 86.98 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.856 -178.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.777 HG12 ' O ' ' A' ' 286' ' ' VAL . 8.1 p -61.28 -38.53 80.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 O-C-N 121.855 -0.528 . . . . 0.0 112.091 -177.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 19.4 p -62.53 -40.98 98.5 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 119.18 -1.008 . . . . 0.0 108.379 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -60.89 -38.55 86.06 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 177.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 14.9 tm-20 -57.53 -39.58 76.92 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 118.138 -1.425 . . . . 0.0 109.535 -176.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 293' ' ' GLN . . . . . 0.439 ' O ' ' O ' ' A' ' 296' ' ' ARG . 1.6 pt20 -60.17 -41.63 93.25 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 122.968 1.366 . . . . 0.0 110.11 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 65.0 mt -60.25 -39.32 86.31 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 112.206 -2.27 . . . . 0.0 109.557 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -62.16 -45.26 94.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.088 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 296' ' ' ARG . . . . . 0.439 ' O ' ' O ' ' A' ' 293' ' ' GLN . 62.3 ttm-85 -122.58 116.06 23.22 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 297' ' ' ALA . . . . . 0.445 ' HB1' HD12 ' A' ' 298' ' ' LEU . . . -109.72 -169.82 1.54 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.402 0.62 . . . . 0.0 111.76 -178.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.797 ' H ' HD12 ' A' ' 298' ' ' LEU . 0.0 OUTLIER -68.24 -8.83 42.66 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.977 -1.011 . . . . 0.0 111.471 -178.663 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 299' ' ' MET . . . . . 0.403 ' C ' ' O ' ' A' ' 298' ' ' LEU . 74.1 mtp 28.1 62.41 0.11 Allowed 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 177.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.62 100.81 0.07 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.812 0.815 . . . . 0.0 110.896 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -63.93 -46.3 85.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.131 -1.395 . . . . 0.0 113.386 -176.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 302' ' ' TYR . . . . . 0.527 ' CD2' ' OE2' ' A' ' 306' ' ' GLU . 32.8 t80 -58.68 -40.13 82.68 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.023 -0.671 . . . . 0.0 109.539 -178.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 303' ' ' GLN . . . . . 0.485 ' N ' ' OE1' ' A' ' 303' ' ' GLN . 1.3 mp0 -65.0 -46.83 79.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.186 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 304' ' ' SER . . . . . 0.446 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 77.8 p -66.23 -37.4 85.45 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.553 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -61.43 -42.82 99.35 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.057 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 306' ' ' GLU . . . . . 0.527 ' OE2' ' CD2' ' A' ' 302' ' ' TYR . 41.7 mt-10 -64.71 -36.99 86.08 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.228 1.195 . . . . 0.0 114.228 -177.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 307' ' ' ALA . . . . . 0.534 ' HB3' ' HD3' ' A' ' 308' ' ' PRO . . . -60.02 -52.95 69.88 Favored Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -176.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 308' ' ' PRO . . . . . 0.534 ' HD3' ' HB3' ' A' ' 307' ' ' ALA . 74.0 Cg_endo -75.26 0.27 9.21 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.193 1.929 . . . . 0.0 111.908 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 91.9 t80 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.609 -179.981 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.5 m . . . . . 0 C--O 1.23 0.06 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.405 HG12 ' H ' ' A' ' 17' ' ' PHE . 3.9 t -147.23 143.85 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 121.129 0.49 . . . . 0.0 111.085 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -64.21 -40.82 96.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.679 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.405 ' H ' HG12 ' A' ' 15' ' ' VAL . 74.1 t80 -63.49 -41.39 98.57 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.175 -0.921 . . . . 0.0 113.208 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 50.9 tp -79.77 -26.48 40.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.177 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.401 ' O ' ' OG1' ' A' ' 22' ' ' THR . . . -66.43 -41.44 94.37 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 107.363 -2.295 . . . . 0.0 107.363 176.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.405 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -71.26 -31.75 67.89 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 124.84 2.257 . . . . 0.0 107.316 176.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.46 -42.72 98.93 Favored Glycine 0 CA--C 1.528 0.867 1 CA-C-N 108.364 -4.016 . . . . 0.0 108.307 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' A' ' 19' ' ' GLY . 35.6 p -70.71 -27.95 64.37 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.576 0.703 . . . . 0.0 109.314 177.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -66.38 -50.18 64.34 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.946 -178.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.82 -35.82 79.33 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 118.671 -1.212 . . . . 0.0 111.2 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 75.6 m -63.71 -53.63 48.16 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.343 -178.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.9 pt -65.47 -39.77 86.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 -177.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.05 -42.02 97.19 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 119.763 -0.775 . . . . 0.0 112.845 -173.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 28' ' ' ASP . 43.1 t0 -77.71 -27.36 50.63 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 118.249 -1.38 . . . . 0.0 109.544 -176.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.1 tp -60.29 -55.67 30.86 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.714 1.143 . . . . 0.0 111.729 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.0 pt -75.4 -4.0 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 121.306 0.574 . . . . 0.0 112.368 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.429 HG22 ' O ' ' A' ' 31' ' ' THR . 30.1 m -109.12 -16.8 14.02 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.254 -178.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -69.02 -44.69 29.29 Favored Pre-proline 0 CA--C 1.544 0.731 0 CA-C-N 121.868 2.122 . . . . 0.0 111.926 -178.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -59.64 -16.25 35.67 Favored 'Trans proline' 0 N--CA 1.504 2.088 0 CA-C-N 120.897 1.356 . . . . 0.0 112.857 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 62.2 mt -67.54 -35.15 78.51 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -177.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.404 ' HA ' ' HZ3' ' A' ' 38' ' ' LYS . 1.1 m-20 -64.23 -40.52 96.2 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.128 -177.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 87.0 m -58.2 -34.84 70.81 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.14 -38.97 86.43 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 119.691 -0.804 . . . . 0.0 113.048 -179.084 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.404 ' HZ3' ' HA ' ' A' ' 35' ' ' ASP . 9.2 pttm -62.14 -47.55 84.07 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 118.995 -1.082 . . . . 0.0 111.656 -177.079 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.6 t -62.83 -38.72 82.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -177.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.504 ' O ' ' N ' ' A' ' 42' ' ' GLN . 7.9 tpm_? -59.45 -41.25 89.22 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 119.266 -0.974 . . . . 0.0 109.706 -178.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.498 ' C ' ' H ' ' A' ' 43' ' ' ILE . 9.4 mp -62.69 38.83 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.59 177.265 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.57 ' O ' ' N ' ' A' ' 44' ' ' GLN . 25.1 tp60 -72.71 23.96 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 O-C-N 121.947 -0.471 . . . . 0.0 111.385 -178.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.509 ' O ' HG23 ' A' ' 43' ' ' ILE . 9.2 tp 28.98 34.03 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 121.404 0.621 . . . . 0.0 111.534 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.57 ' N ' ' O ' ' A' ' 42' ' ' GLN . 28.2 mp0 53.79 98.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.566 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -169.19 31.74 0.17 Allowed Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -70.57 -28.68 65.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.828 0.347 . . . . 0.0 110.684 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 17.7 t 59.38 42.2 18.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.998 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -98.99 -19.64 17.18 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.1 0.476 . . . . 0.0 110.05 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.16 -23.28 30.29 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.551 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -66.1 -38.26 87.79 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.612 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.528 HG13 ' N ' ' A' ' 52' ' ' ARG . 14.3 p -61.04 -44.5 98.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.151 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.528 ' N ' HG13 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -64.24 -33.58 76.15 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.714 -178.461 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -67.93 -38.05 82.41 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -93.18 -146.25 0.23 Allowed 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.847 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -176.11 -32.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.084 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.593 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 7.9 t -128.08 -138.83 0.24 Allowed 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.593 ' HB3' ' O ' ' A' ' 56' ' ' SER . . . 99.25 12.56 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.6 0 O-C-N 124.165 0.916 . . . . 0.0 111.277 178.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.439 ' CG ' ' O ' ' A' ' 58' ' ' GLN . 4.3 pt20 -174.24 121.1 0.28 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -85.76 151.41 23.85 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 87.9 mtt180 -45.43 -33.02 2.39 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 122.453 1.121 . . . . 0.0 108.096 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -41.89 114.37 0.67 Allowed Glycine 0 CA--C 1.526 0.723 0 CA-C-N 112.86 -1.973 . . . . 0.0 113.195 -178.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.6 p -66.75 -33.02 60.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 118.124 -0.941 . . . . 0.0 108.862 176.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.407 ' O ' HD23 ' A' ' 67' ' ' LEU . 3.7 mm? -60.18 -32.3 70.94 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 121.747 2.067 . . . . 0.0 110.868 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.59 -49.07 66.59 Favored Glycine 0 CA--C 1.532 1.121 0 N-CA-C 114.965 0.746 . . . . 0.0 114.965 -176.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.401 HG22 ' H ' ' A' ' 65' ' ' THR . 1.6 t -62.04 -45.57 93.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.178 -0.511 . . . . 0.0 111.933 -179.177 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 35.2 mm -59.25 -36.25 62.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.407 HD23 ' O ' ' A' ' 63' ' ' LEU . 2.1 mm? -63.91 -35.84 81.97 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 120.764 1.62 . . . . 0.0 112.148 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 97.9 m -63.0 -39.82 95.89 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 114.002 -1.454 . . . . 0.0 111.04 -175.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.463 ' O ' ' OG1' ' A' ' 72' ' ' THR . 0.1 OUTLIER -60.03 -39.61 86.48 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -176.023 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.6 p -69.91 -40.5 78.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 113.934 1.086 . . . . 0.0 113.934 -178.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -78.3 -13.56 59.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.8 0.809 . . . . 0.0 112.883 -178.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' A' ' 69' ' ' MET . 0.0 OUTLIER -63.2 -54.62 34.61 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.069 -1.423 . . . . 0.0 111.002 178.968 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -107.79 -57.76 2.06 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.805 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 157.99 163.49 12.81 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -56.51 -35.15 96.53 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 121.987 1.792 . . . . 0.0 111.683 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.407 ' O ' ' CG ' ' A' ' 80' ' ' ASN . 91.7 mtt-85 -61.39 -11.65 11.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.654 0.74 . . . . 0.0 111.022 176.221 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.9 t -77.69 -32.42 53.04 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.089 -1.414 . . . . 0.0 111.038 -177.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.516 HD12 ' N ' ' A' ' 78' ' ' LEU . 10.2 mp -75.5 -33.09 60.74 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 122.126 -0.359 . . . . 0.0 110.783 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -91.91 -4.58 54.54 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 122.796 1.284 . . . . 0.0 113.142 -178.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.407 ' CG ' ' O ' ' A' ' 76' ' ' ARG . 5.9 m-20 -97.47 117.65 32.21 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 112.025 -2.352 . . . . 0.0 107.168 174.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.9 -13.5 56.17 Favored Glycine 0 N--CA 1.469 0.866 0 N-CA-C 108.255 -1.938 . . . . 0.0 108.255 -177.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 12.3 tp -58.85 -34.71 71.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 113.305 -1.448 . . . . 0.0 110.249 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.8 p -70.54 -26.78 29.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.364 178.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.81 -31.61 61.76 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.796 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.86 -40.42 89.4 Favored Glycine 0 N--CA 1.463 0.492 0 C-N-CA 119.677 -1.249 . . . . 0.0 111.223 -177.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.3 mp -62.34 -40.08 95.21 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 122.364 1.078 . . . . 0.0 112.5 -177.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -60.44 -27.24 67.35 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 113.071 -1.877 . . . . 0.0 109.34 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 49.4 ttp180 -57.91 -53.48 57.77 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 173.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 47.9 tp60 -67.44 -29.89 69.48 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 112.56 -2.109 . . . . 0.0 112.428 -178.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 12.2 tpt -61.02 -40.98 95.63 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.352 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 78.2 p -74.35 -34.34 63.38 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 119.509 -0.877 . . . . 0.0 111.401 -176.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -58.04 -44.48 87.43 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 120.6 1.545 . . . . 0.0 111.789 -176.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.33 -33.59 65.21 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.49 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.1 t -64.48 -41.8 96.25 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.3 t -68.41 -28.6 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.841 177.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.568 ' NH2' ' CE2' ' A' ' 100' ' ' TYR . 59.9 ttt-85 -78.05 8.79 4.29 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -177.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.492 HD13 ' O ' ' A' ' 97' ' ' ILE . 0.3 OUTLIER -87.49 -14.95 9.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.086 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -140.09 -48.13 0.06 OUTLIER Glycine 0 CA--C 1.54 1.631 0 N-CA-C 115.864 1.106 . . . . 0.0 115.864 -176.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.7 mt -71.08 -12.56 61.58 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 119.586 1.693 . . . . 0.0 112.817 -178.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.568 ' CE2' ' NH2' ' A' ' 96' ' ' ARG . 4.3 t80 -80.22 -51.32 9.08 Favored 'General case' 0 C--O 1.214 -0.778 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.438 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 1.086 ' OD1' ' CD ' ' A' ' 105' ' ' GLN . 12.7 t70 -69.48 -32.73 71.81 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 123.45 1.595 . . . . 0.0 110.561 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 31.1 m -68.82 -52.47 29.77 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 111.023 -2.808 . . . . 0.0 114.466 177.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.582 HG22 ' CE2' ' A' ' 107' ' ' TYR . 1.1 p -74.97 -27.82 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 CA-C-N 121.942 2.156 . . . . 0.0 112.479 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.521 ' HB2' ' O ' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -69.99 -41.74 73.98 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 110.849 -2.887 . . . . 0.0 112.801 -179.636 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 1.086 ' CD ' ' OD1' ' A' ' 101' ' ' ASP . 27.2 mt-30 -78.88 -11.43 60.0 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 122.972 1.368 . . . . 0.0 111.043 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.47 -21.94 48.27 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 113.924 -1.489 . . . . 0.0 111.086 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.582 ' CE2' HG22 ' A' ' 103' ' ' VAL . 47.5 m-85 -108.36 -30.57 8.25 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 120.005 1.275 . . . . 0.0 111.614 -175.47 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.1 p -98.27 9.68 42.44 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 117.972 -1.491 . . . . 0.0 112.047 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.47 ' O ' ' C ' ' A' ' 110' ' ' GLY . 16.0 ttmm -54.19 118.17 3.85 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.619 0.645 . . . . 0.0 112.453 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.511 ' O ' ' O ' ' A' ' 111' ' ' SER . . . -17.24 -89.09 0.01 OUTLIER Glycine 0 N--CA 1.48 1.585 0 CA-C-O 119.81 -0.439 . . . . 0.0 113.155 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.703 ' O ' ' O ' ' A' ' 112' ' ' GLU . 5.9 t 45.44 111.54 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 117.252 0.526 . . . . 0.0 111.797 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.703 ' O ' ' O ' ' A' ' 111' ' ' SER . 17.1 pt-20 -9.57 -148.26 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 126.481 1.913 . . . . 0.0 115.929 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.622 ' O ' ' HB2' ' A' ' 114' ' ' ALA . 0.0 OUTLIER -105.92 73.35 0.99 Allowed 'General case' 0 C--N 1.343 0.303 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -177.257 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.622 ' HB2' ' O ' ' A' ' 113' ' ' HIS . . . 160.14 -164.38 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 122.35 1.072 . . . . 0.0 108.963 175.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.03 15.6 25.72 Favored Glycine 0 C--N 1.342 0.863 0 CA-C-N 113.015 -1.902 . . . . 0.0 111.487 178.051 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.434 HG23 ' N ' ' A' ' 117' ' ' GLY . 13.3 tt -60.71 -40.33 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 C-N-CA 119.609 -0.837 . . . . 0.0 111.015 -178.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.434 ' N ' HG23 ' A' ' 116' ' ' ILE . . . -65.56 -40.39 96.05 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-O 121.716 0.62 . . . . 0.0 112.098 176.392 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 26.0 p -58.41 -42.57 87.48 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 176.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.1 tpp180 -63.55 -37.24 86.55 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 119.824 -0.75 . . . . 0.0 110.927 -177.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.669 HD21 HD22 ' A' ' 194' ' ' LEU . 2.6 mm? -63.35 -46.1 88.11 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.234 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 20.9 mt -66.51 -44.76 81.66 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 118.896 -1.122 . . . . 0.0 109.847 178.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.1 -45.21 89.67 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 119.964 1.256 . . . . 0.0 110.452 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -65.81 -44.42 92.14 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.191 -1.004 . . . . 0.0 111.262 -178.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 42.5 m -64.17 -43.75 94.2 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.742 0.306 . . . . 0.0 111.418 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 19.7 m -69.5 -48.27 61.11 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 119.346 -0.942 . . . . 0.0 112.337 177.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.475 HG23 ' N ' ' A' ' 127' ' ' GLY . 6.0 t -65.68 -42.75 90.9 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 -174.236 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.475 ' N ' HG23 ' A' ' 126' ' ' THR . . . -64.48 -44.96 94.46 Favored Glycine 0 CA--C 1.52 0.401 0 CA-C-N 114.632 -1.167 . . . . 0.0 113.138 -177.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.432 ' O ' HG22 ' A' ' 131' ' ' VAL . . . -61.81 -41.71 98.1 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 112.719 -1.741 . . . . 0.0 107.207 177.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.745 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 54.6 tp -64.7 -42.62 95.15 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.09 178.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.34 -40.09 96.33 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.099 0.778 . . . . 0.0 113.099 -177.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 128' ' ' ALA . 14.3 m -61.17 -26.55 39.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 123.521 1.629 . . . . 0.0 109.639 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.745 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . -59.29 -45.49 91.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 110.835 -2.893 . . . . 0.0 112.673 -178.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.419 ' H ' HG12 ' A' ' 133' ' ' VAL . 2.6 p -79.65 -49.03 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 -178.215 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -121.79 136.39 54.93 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.823 0.344 . . . . 0.0 111.667 -178.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.762 ' H ' ' CD ' ' A' ' 136' ' ' PRO . 3.9 pp0? 170.33 -21.36 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.723 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.79 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.762 ' CD ' ' H ' ' A' ' 135' ' ' GLN . 53.0 Cg_exo -52.84 -34.68 66.74 Favored 'Trans proline' 0 N--CA 1.499 1.85 0 CA-C-N 121.174 1.455 . . . . 0.0 113.268 -178.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.479 HG23 ' N ' ' A' ' 138' ' ' ASP . 11.5 t -67.28 -41.59 85.22 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 119.07 -1.052 . . . . 0.0 108.613 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.479 ' N ' HG23 ' A' ' 137' ' ' THR . 98.5 m-20 -64.68 -42.24 95.49 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 118.857 -1.137 . . . . 0.0 111.34 -178.02 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 55.3 t -63.85 -44.48 98.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 32.1 m -65.33 -38.17 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -177.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -61.73 -40.65 95.84 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -176.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.443 ' CG2' ' N ' ' A' ' 143' ' ' ARG . 1.5 m -69.41 -44.24 80.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.028 -0.669 . . . . 0.0 109.343 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.528 ' NH2' ' O ' ' A' ' 174' ' ' GLY . 94.8 mtt-85 -63.86 -35.41 80.56 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.288 178.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -65.89 -40.21 91.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.92 -177.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 23.8 tm0? -63.98 -39.31 93.83 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 119.335 -0.946 . . . . 0.0 108.861 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.14 -35.16 80.24 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 113.267 0.839 . . . . 0.0 113.267 -178.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.52 110.78 1.19 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 177.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -99.41 -60.58 1.5 Allowed 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -175.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -98.35 117.51 32.93 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 122.107 2.23 . . . . 0.0 109.968 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -68.14 -15.0 63.4 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.666 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 71.08 -173.85 41.68 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.692 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 179.827 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.428 ' O ' ' O ' ' A' ' 157' ' ' GLN . 79.4 t80 . . . . . 0 N--CA 1.466 0.349 0 CA-C-O 120.712 0.291 . . . . 0.0 110.979 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.428 ' O ' ' O ' ' A' ' 156' ' ' TYR . 18.1 mm100 59.4 145.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.338 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 70.5 m -157.07 -177.73 6.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.383 0.611 . . . . 0.0 111.201 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 96.8 m -63.92 -45.97 86.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.551 -177.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.539 HG23 ' N ' ' A' ' 161' ' ' GLU . 8.2 m -64.01 -44.9 97.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 118.913 -1.115 . . . . 0.0 109.008 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.539 ' N ' HG23 ' A' ' 160' ' ' VAL . 94.6 mt-10 -66.94 -39.04 87.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.859 0.361 . . . . 0.0 111.459 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -61.76 -45.62 93.14 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -177.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -62.38 -49.66 74.65 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.509 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 65.7 mmtt -68.44 -45.43 72.53 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 -175.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 35.6 p -62.79 -44.66 95.58 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 120.78 -1.2 . . . . 0.0 113.921 -177.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.419 HD12 ' N ' ' A' ' 167' ' ' ALA . 2.4 pp -64.64 -37.78 80.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 121.825 0.822 . . . . 0.0 109.632 176.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.419 ' N ' HD12 ' A' ' 166' ' ' ILE . . . -58.64 -35.87 73.2 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 113.741 -1.572 . . . . 0.0 107.829 177.361 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 7.8 tpm_? -61.94 -50.47 71.99 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 121.706 2.048 . . . . 0.0 112.726 -175.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -75.25 -51.21 13.83 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 123.684 0.793 . . . . 0.0 111.199 178.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -78.14 -36.24 48.01 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 116.169 1.914 . . . . 0.0 116.169 -172.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 93.03 -167.42 29.28 Favored Glycine 0 N--CA 1.47 0.951 0 N-CA-C 111.872 -0.491 . . . . 0.0 111.872 177.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.711 HD13 ' H ' ' A' ' 172' ' ' ILE . 0.0 OUTLIER -73.37 -44.48 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 CA-C-O 121.796 0.808 . . . . 0.0 109.871 -179.827 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -59.03 -33.9 71.28 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 114.442 -1.254 . . . . 0.0 111.424 -177.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.528 ' O ' ' NH2' ' A' ' 143' ' ' ARG . . . -61.05 -40.41 98.47 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 118.575 -1.774 . . . . 0.0 109.3 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 1.2 tp -70.54 -33.71 71.45 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 111.459 -2.371 . . . . 0.0 116.995 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 6.4 m95 -77.84 -7.56 56.83 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 111.991 -2.368 . . . . 0.0 109.796 -177.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 48.1 tttp -43.39 -48.29 7.04 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.575 -176.274 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -95.1 -40.03 4.39 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.3 0.953 . . . . 0.0 112.109 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.407 HG23 ' H ' ' A' ' 179' ' ' THR . 11.5 p -45.46 -51.44 11.57 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -179.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' SER . . . . . 0.452 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 2.6 m -62.72 -50.69 76.7 Favored Pre-proline 0 N--CA 1.472 0.659 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -176.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' A' ' 180' ' ' SER . 30.1 Cg_endo -64.5 -27.58 62.07 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 121.986 1.791 . . . . 0.0 111.928 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -63.35 -39.09 93.58 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 120.588 -0.445 . . . . 0.0 109.939 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.451 ' O ' ' OD1' ' A' ' 186' ' ' ASN . 85.2 t -62.84 -42.3 95.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.051 0.453 . . . . 0.0 109.975 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.88 -39.51 92.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.095 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 46.2 ttp85 -60.44 -40.83 92.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.923 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' ASN . . . . . 0.49 ' C ' ' ND2' ' A' ' 186' ' ' ASN . 0.0 OUTLIER -60.34 -41.67 94.08 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.136 0.493 . . . . 0.0 110.34 -179.667 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.2 -43.19 98.87 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.79 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.444 ' O ' ' SG ' ' A' ' 191' ' ' CYS . 42.9 mm -63.01 -44.8 99.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.381 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 6.3 m -59.37 -45.67 93.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 119.816 -0.754 . . . . 0.0 111.276 -178.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' ASN . . . . . 0.406 ' OD1' ' N ' ' A' ' 191' ' ' CYS . 0.9 OUTLIER -61.8 -42.51 99.1 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.876 0.846 . . . . 0.0 109.419 179.302 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 191' ' ' CYS . . . . . 0.551 ' SG ' ' N ' ' A' ' 192' ' ' ALA . 0.5 OUTLIER -62.0 -45.94 91.41 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.013 -1.449 . . . . 0.0 110.828 179.666 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.551 ' N ' ' SG ' ' A' ' 191' ' ' CYS . . . -63.71 -40.4 96.68 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 114.463 -1.244 . . . . 0.0 109.433 177.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -60.74 -44.72 96.33 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.702 -1.136 . . . . 0.0 112.579 -178.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.669 HD22 HD21 ' A' ' 120' ' ' LEU . 2.5 pp -63.0 -37.83 88.74 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 118.862 -1.135 . . . . 0.0 109.75 -174.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.47 ' N ' ' HG ' ' A' ' 194' ' ' LEU . 0.6 OUTLIER -63.99 -46.15 94.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 C-N-CA 117.206 -1.798 . . . . 0.0 107.464 179.074 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 19.2 m -63.98 -46.52 84.24 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -176.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -56.8 -39.12 73.57 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.694 0.798 . . . . 0.0 111.222 -178.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -56.06 -43.93 78.41 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.4 HD23 ' N ' ' A' ' 199' ' ' LEU . 7.7 mt -61.21 -39.39 90.06 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.599 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.1 mm -62.94 -42.04 95.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 1.8 mmmm -59.27 -38.77 80.95 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.744 1.618 . . . . 0.0 114.911 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -64.27 -42.24 96.53 Favored 'General case' 0 C--O 1.245 0.849 0 O-C-N 121.087 -1.008 . . . . 0.0 111.063 -176.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.631 HG22 HD23 ' A' ' 204' ' ' LEU . 4.0 m -102.5 129.19 48.95 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -176.15 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.631 HD23 HG22 ' A' ' 203' ' ' THR . 3.6 mm? 66.52 3.32 2.83 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 113.717 -1.583 . . . . 0.0 111.299 177.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.555 HD22 ' O ' ' A' ' 204' ' ' LEU . 2.9 mm? -122.1 24.53 9.46 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 -178.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -79.33 -18.11 53.18 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.502 0.668 . . . . 0.0 110.382 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.463 ' O ' ' CB ' ' A' ' 208' ' ' ASN . . . -167.1 25.96 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.204 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 208' ' ' ASN . . . . . 0.61 ' O ' ' O ' ' A' ' 204' ' ' LEU . 1.7 m-20 93.53 -130.83 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.39 0.676 . . . . 0.0 109.81 -178.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.682 ' O ' HD23 ' A' ' 209' ' ' LEU . 6.5 tt . . . . . 0 CA--C 1.505 -0.757 0 N-CA-C 106.719 -1.585 . . . . 0.0 106.719 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 213' ' ' ASP . 34.8 p30 . . . . . 0 N--CA 1.464 0.249 0 CA-C-O 120.963 0.411 . . . . 0.0 110.444 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.45 ' N ' ' HD2' ' A' ' 215' ' ' PRO . 2.0 pt? -61.11 -42.07 84.3 Favored Pre-proline 0 CA--C 1.548 0.877 0 N-CA-C 113.828 1.048 . . . . 0.0 113.828 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 215' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' A' ' 214' ' ' LEU . 37.5 Cg_endo -60.13 -32.19 94.27 Favored 'Trans proline' 0 N--CA 1.502 2.01 0 CA-C-N 122.419 1.9 . . . . 0.0 111.458 -178.048 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 9.9 t -63.51 -42.13 98.5 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 113.48 -1.691 . . . . 0.0 111.713 -177.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' HIS . . . . . 0.433 ' CG ' HD11 ' A' ' 209' ' ' LEU . 54.8 t60 -66.64 -37.75 85.46 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.348 -0.541 . . . . 0.0 111.933 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -63.28 -47.04 84.0 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.515 -178.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 1.5 t -60.22 -37.51 80.54 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 118.845 0.748 . . . . 0.0 111.032 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 78.7 p -59.51 -41.71 90.54 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' ALA . . . . . 0.544 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.68 -41.61 98.13 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -177.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -61.66 -47.04 87.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 122.007 0.908 . . . . 0.0 112.71 -176.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -60.42 -41.73 98.67 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 107.544 -2.223 . . . . 0.0 107.544 177.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -62.95 -38.05 89.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.33 -0.935 . . . . 0.0 109.043 177.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -61.94 -42.1 99.71 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.192 -178.091 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -66.16 -38.4 88.0 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 97.5 m -63.1 -40.8 98.69 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 176.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 11.2 m -61.59 -40.1 93.59 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.263 -1.335 . . . . 0.0 110.997 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 92.4 m -58.4 -39.13 78.86 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.371 -177.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 97.1 t -59.68 -40.46 82.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' ILE . . . . . 0.594 ' O ' ' HD2' ' A' ' 234' ' ' PRO . 23.0 mm -60.97 -40.11 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 177.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -62.32 -38.63 90.17 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.47 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 0.1 OUTLIER -57.25 -40.87 87.82 Favored Pre-proline 0 N--CA 1.482 1.173 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 -172.979 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.594 ' HD2' ' O ' ' A' ' 231' ' ' ILE . 31.6 Cg_exo -57.87 -39.22 88.53 Favored 'Trans proline' 0 C--N 1.292 -2.404 0 C-N-CA 122.021 1.814 . . . . 0.0 112.491 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 31.0 t -63.52 -36.32 75.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 118.802 -1.159 . . . . 0.0 109.398 178.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' ASP . . . . . 0.451 ' OD2' ' O ' ' A' ' 233' ' ' SER . 0.0 OUTLIER -65.23 -40.11 93.62 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.174 179.634 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 96.7 t -64.29 -45.63 95.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -176.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 25.6 m . . . . . 0 C--N 1.325 -0.478 0 C-N-CA 119.756 -0.777 . . . . 0.0 110.533 -179.044 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 31.6 m . . . . . 0 C--O 1.228 -0.069 0 CA-C-O 121.177 0.513 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 260' ' ' MET . . . . . 0.426 ' O ' ' O ' ' A' ' 264' ' ' GLU . 32.2 mtt -62.1 -43.58 98.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.945 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 11.8 tp -62.21 -46.26 89.68 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 122.685 0.394 . . . . 0.0 111.068 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 69.6 ttp85 -65.92 -53.8 34.68 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.906 -178.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 263' ' ' LYS . . . . . 0.426 ' O ' ' N ' ' A' ' 265' ' ' GLY . 0.1 OUTLIER -102.73 -107.35 0.26 Allowed 'General case' 0 N--CA 1.472 0.659 0 O-C-N 122.249 -0.282 . . . . 0.0 111.208 179.562 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 264' ' ' GLU . . . . . 0.443 ' O ' ' O ' ' A' ' 265' ' ' GLY . 71.2 mm-40 -33.47 91.92 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 265' ' ' GLY . . . . . 0.443 ' O ' ' O ' ' A' ' 264' ' ' GLU . . . -38.51 166.11 0.01 OUTLIER Glycine 0 CA--C 1.534 1.251 0 CA-C-O 121.623 0.568 . . . . 0.0 111.712 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -63.21 -3.81 5.53 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 122.807 2.338 . . . . 0.0 111.628 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 27.8 mtp180 -69.08 -25.8 64.62 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 123.043 0.537 . . . . 0.0 111.671 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -57.88 -31.84 67.12 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.253 -178.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -62.34 -41.24 98.42 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.18 0.514 . . . . 0.0 110.987 177.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -66.17 -38.37 87.88 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -176.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.439 ' O ' ' O ' ' A' ' 272' ' ' GLY . 14.5 pttm -72.09 -172.43 0.88 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 272' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 271' ' ' LYS . . . 47.05 99.23 0.01 OUTLIER Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -158.74 0.94 0.09 Allowed 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.248 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 274' ' ' MET . . . . . 0.552 ' N ' ' HD2' ' A' ' 275' ' ' PRO . 6.2 mmt -63.55 -45.44 83.2 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.581 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 275' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 274' ' ' MET . 31.9 Cg_endo -64.9 -45.9 7.35 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 121.133 1.222 . . . . 0.0 110.574 177.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 1.4 m -60.36 -39.78 88.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.246 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 277' ' ' PHE . . . . . 0.434 ' O ' ' HG ' ' A' ' 280' ' ' LEU . 34.3 t80 -61.65 -43.03 99.63 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 124.438 2.066 . . . . 0.0 112.175 -178.301 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.11 -38.81 92.67 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 110.568 -3.015 . . . . 0.0 109.569 175.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 11.3 mmm180 -63.2 -41.8 99.23 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.51 0.929 . . . . 0.0 113.51 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.68 HD12 ' N ' ' A' ' 281' ' ' GLY . 3.0 pp -63.12 -35.34 79.94 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -178.04 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 281' ' ' GLY . . . . . 0.68 ' N ' HD12 ' A' ' 280' ' ' LEU . . . -67.83 -50.88 38.51 Favored Glycine 0 CA--C 1.521 0.413 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -177.344 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 282' ' ' SER . . . . . 0.448 ' O ' HG12 ' A' ' 285' ' ' VAL . 9.5 t -62.49 -43.89 97.72 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.642 0.777 . . . . 0.0 109.387 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 283' ' ' TRP . . . . . 0.415 ' O ' HG22 ' A' ' 286' ' ' VAL . 83.0 t90 -59.54 -37.68 79.04 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 284' ' ' ASN . . . . . 0.475 ' ND2' ' O ' ' A' ' 281' ' ' GLY . 0.0 OUTLIER -61.49 -37.2 82.77 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.665 -179.845 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.448 HG12 ' O ' ' A' ' 282' ' ' SER . 0.3 OUTLIER -60.3 -39.0 79.54 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 O-C-N 121.505 -0.747 . . . . 0.0 112.184 -177.32 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.465 ' H ' HG13 ' A' ' 286' ' ' VAL . 1.0 OUTLIER -63.41 -41.94 94.49 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 119.902 -0.719 . . . . 0.0 112.585 -178.716 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 6.8 ptm -61.78 -38.47 88.18 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.192 0.52 . . . . 0.0 109.808 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -58.2 -40.31 81.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.937 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 91.5 t -60.87 -39.41 81.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.591 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 10.8 m -63.21 -40.45 97.5 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -61.21 -38.73 87.63 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 176.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -57.94 -40.17 79.87 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 118.143 -1.423 . . . . 0.0 109.272 -176.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 293' ' ' GLN . . . . . 0.446 ' O ' ' O ' ' A' ' 296' ' ' ARG . 73.9 mt-30 -60.29 -41.96 94.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 123.126 1.441 . . . . 0.0 109.764 179.089 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.41 -39.66 88.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 111.717 -2.492 . . . . 0.0 109.342 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -62.72 -45.31 93.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.537 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 296' ' ' ARG . . . . . 0.446 ' O ' ' O ' ' A' ' 293' ' ' GLN . 44.7 ttm180 -122.53 116.18 23.45 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -113.55 -164.83 0.95 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.269 0.557 . . . . 0.0 112.162 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 14.1 mt -72.74 114.89 11.38 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 79.0 mmm -97.93 63.86 1.68 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -178.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.66 100.96 0.07 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.868 0.842 . . . . 0.0 110.716 -178.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -63.95 -46.22 85.66 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 113.962 -1.472 . . . . 0.0 113.528 -176.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -58.59 -39.21 79.72 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -178.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -64.13 -46.15 85.39 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.539 -179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 304' ' ' SER . . . . . 0.432 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 40.5 t -66.19 -37.72 86.29 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.764 -0.375 . . . . 0.0 110.999 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -61.76 -43.28 99.17 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -179.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -65.19 -36.63 84.8 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.344 1.238 . . . . 0.0 114.344 -177.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 307' ' ' ALA . . . . . 0.525 ' HB3' ' HD3' ' A' ' 308' ' ' PRO . . . -60.02 -52.82 70.8 Favored Pre-proline 0 CA--C 1.544 0.738 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -176.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 308' ' ' PRO . . . . . 0.525 ' HD3' ' HB3' ' A' ' 307' ' ' ALA . 74.2 Cg_endo -75.12 0.21 9.23 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.069 1.846 . . . . 0.0 111.808 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 309' ' ' PHE . . . . . 0.472 ' CG ' ' O ' ' A' ' 308' ' ' PRO . 69.4 m-85 . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.546 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.467 0.391 0 CA-C-O 120.786 0.326 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.466 ' H ' HG22 ' A' ' 15' ' ' VAL . 3.3 m -83.15 150.61 4.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.266 0.555 . . . . 0.0 110.982 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.55 -40.74 96.14 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.241 -0.89 . . . . 0.0 112.088 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -63.32 -41.83 98.95 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -177.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.827 ' O ' HD12 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -80.06 -26.36 39.69 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.092 0.472 . . . . 0.0 111.568 -179.298 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.24 -41.54 94.7 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 107.594 -2.202 . . . . 0.0 107.594 177.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -71.55 -32.5 68.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 124.818 2.247 . . . . 0.0 107.602 176.365 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.25 -42.26 99.36 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-N 108.502 -3.954 . . . . 0.0 107.626 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.7 m -70.49 -27.68 64.39 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -66.57 -49.8 65.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.842 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.93 -35.97 79.99 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 118.077 -1.449 . . . . 0.0 111.054 -177.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 77.4 m -63.84 -53.93 42.87 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.496 -178.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.2 pp -65.79 -39.43 84.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -177.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.11 -41.96 97.05 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -174.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.519 ' OD1' ' NH2' ' A' ' 88' ' ' ARG . 10.0 t70 -77.64 -27.39 51.05 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 120.594 1.543 . . . . 0.0 109.809 -175.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 43.5 mt -60.0 -55.28 35.97 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 119.724 1.147 . . . . 0.0 112.097 -178.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.8 tp -75.42 -3.87 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-O 121.743 0.783 . . . . 0.0 112.335 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 29.7 m -108.96 -16.39 14.15 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 117.491 -1.242 . . . . 0.0 110.305 -178.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.441 ' O ' ' OD1' ' A' ' 35' ' ' ASP . 14.5 t80 -69.01 -44.3 28.25 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-N 122.784 2.538 . . . . 0.0 111.758 -177.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' A' ' 32' ' ' PHE . 32.1 Cg_exo -59.6 -15.72 32.52 Favored 'Trans proline' 0 N--CA 1.504 2.107 0 C-N-CA 121.298 1.332 . . . . 0.0 113.245 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.8 mp -67.18 -35.5 79.78 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -177.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 36' ' ' THR . 15.8 p30 -64.86 -40.53 95.3 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -178.282 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.545 ' N ' ' OD1' ' A' ' 35' ' ' ASP . 43.3 p -58.4 -34.99 71.35 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.483 ' HB3' HH22 ' A' ' 279' ' ' ARG . . . -67.59 -38.37 83.93 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 119.948 -0.701 . . . . 0.0 111.84 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -61.66 -49.09 77.94 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 119.625 -0.83 . . . . 0.0 111.266 -176.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.419 ' H ' HG22 ' A' ' 39' ' ' VAL . 10.5 m -63.69 -39.75 86.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 118.31 0.504 . . . . 0.0 111.913 -177.288 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.521 ' NH2' ' OE1' ' A' ' 42' ' ' GLN . 7.6 tpm_? -60.78 -40.99 94.66 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.411 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.0 38.85 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.589 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.521 ' OE1' ' NH2' ' A' ' 40' ' ' ARG . 2.6 pt20 -85.82 61.73 7.03 Favored 'General case' 0 N--CA 1.463 0.188 0 O-C-N 121.965 -0.459 . . . . 0.0 110.971 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.408 ' C ' ' O ' ' A' ' 42' ' ' GLN . 22.2 pt 32.06 -125.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.861 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -158.15 100.62 1.71 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.649 0.262 . . . . 0.0 110.334 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.51 ' C ' ' H ' ' A' ' 47' ' ' SER . . . -176.31 -118.59 0.54 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.089 -0.805 . . . . 0.0 111.089 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 69.22 -16.9 0.23 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.704 0.288 . . . . 0.0 110.786 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.51 ' H ' ' C ' ' A' ' 45' ' ' GLY . 29.0 t 53.66 26.41 5.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.919 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.572 ' NE2' HD23 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -44.16 -28.39 0.5 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.674 0.75 . . . . 0.0 109.789 179.727 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.72 -36.71 3.66 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -178.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.572 HD23 ' NE2' ' A' ' 48' ' ' GLN . 3.6 mm? -66.73 -38.03 85.85 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.448 0.642 . . . . 0.0 109.311 177.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 96.2 t -60.68 -44.55 97.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 114.919 -1.037 . . . . 0.0 112.604 -177.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -64.19 -33.54 76.02 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.938 -178.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.5 m -67.92 -38.06 82.45 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 177.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.409 ' C ' ' H ' ' A' ' 56' ' ' SER . . . -127.93 78.6 1.84 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.177 -0.919 . . . . 0.0 108.801 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.38 -3.42 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.635 -0.712 . . . . 0.0 112.813 -178.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.606 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 94.9 p -126.58 -140.04 0.27 Allowed 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.606 ' HB3' ' O ' ' A' ' 56' ' ' SER . . . 99.2 11.77 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 O-C-N 124.12 0.888 . . . . 0.0 111.878 178.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 177.52 70.78 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -41.12 -83.78 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.054 0.454 . . . . 0.0 110.633 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.415 ' O ' ' C ' ' A' ' 61' ' ' GLY . 30.0 ttm180 -161.01 -34.36 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.591 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 60' ' ' ARG . . . -28.61 102.74 0.01 OUTLIER Glycine 0 CA--C 1.527 0.807 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.641 -179.242 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 90.3 t -67.41 -34.6 69.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 118.451 -0.785 . . . . 0.0 109.685 176.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.493 HD22 ' N ' ' A' ' 63' ' ' LEU . 3.6 mm? -60.79 -32.65 71.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 121.011 1.732 . . . . 0.0 109.726 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.61 -49.31 65.18 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-N 114.905 -1.043 . . . . 0.0 114.398 -176.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.3 m -62.1 -46.36 89.41 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 70.6 mt -59.43 -35.95 61.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.57 ' O ' HD13 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -63.94 -35.76 81.72 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 120.919 1.69 . . . . 0.0 112.156 179.452 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 99.2 m -63.22 -40.73 98.29 Favored 'General case' 0 C--O 1.246 0.906 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.003 -174.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.402 ' C ' ' SD ' ' A' ' 69' ' ' MET . 3.2 ppp? -59.67 -40.05 86.51 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -175.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.2 p -69.49 -40.78 80.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 119.096 -1.042 . . . . 0.0 112.563 -178.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 75.0 ttt-85 -78.54 -13.3 59.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.769 0.795 . . . . 0.0 112.534 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 54.5 m -62.81 -54.65 35.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.643 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -107.44 -56.47 2.21 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.276 178.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 157.3 165.89 15.87 Favored Glycine 0 CA--C 1.535 1.325 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -56.27 -35.47 95.76 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 CA-C-N 119.508 1.654 . . . . 0.0 111.893 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.41 ' O ' ' CB ' ' A' ' 80' ' ' ASN . 12.1 tpp180 -61.42 -12.27 13.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.756 0.789 . . . . 0.0 111.007 176.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 10.4 p -78.55 -33.0 48.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.968 -178.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.59 ' O ' HD23 ' A' ' 78' ' ' LEU . 1.0 OUTLIER -75.94 -33.64 59.84 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.116 0.484 . . . . 0.0 110.535 179.754 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.746 ' O ' HD12 ' A' ' 82' ' ' LEU . 57.9 m-85 -92.74 -5.15 51.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 122.335 1.064 . . . . 0.0 113.202 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.41 ' CB ' ' O ' ' A' ' 76' ' ' ARG . 4.7 t30 -90.01 118.85 29.88 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 112.812 -1.995 . . . . 0.0 107.502 175.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.71 -7.25 57.55 Favored Glycine 0 N--CA 1.468 0.782 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 -177.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.965 HD13 ' H ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -59.42 -34.59 72.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 113.603 -1.298 . . . . 0.0 110.834 -179.687 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.965 ' H ' HD13 ' A' ' 82' ' ' LEU . 4.8 p -70.61 -26.79 29.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.94 -31.62 61.55 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.576 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -68.17 -40.34 88.01 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 119.344 -1.407 . . . . 0.0 111.206 -177.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.3 mp -62.66 -40.54 97.38 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.978 0.894 . . . . 0.0 113.099 -176.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -60.62 -27.17 67.56 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 113.799 -1.546 . . . . 0.0 109.306 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.562 ' HE ' HE22 ' A' ' 89' ' ' GLN . 37.3 ttp180 -57.89 -53.76 54.58 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 173.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.562 HE22 ' HE ' ' A' ' 88' ' ' ARG . 2.3 mp0 -67.1 -29.86 69.73 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 112.325 -2.216 . . . . 0.0 111.84 -178.17 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 33.4 tpp -61.35 -40.82 95.66 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.493 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 37.1 m -74.44 -34.6 63.24 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 118.099 -0.953 . . . . 0.0 111.302 -177.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -57.66 -43.88 85.29 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 121.324 1.874 . . . . 0.0 112.262 -176.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.56 -32.84 64.39 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.127 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.8 p -64.09 -41.31 97.34 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.499 ' CG2' HD12 ' A' ' 99' ' ' LEU . 7.9 p -68.27 -28.23 39.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.022 177.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.403 ' NH2' ' CE2' ' A' ' 100' ' ' TYR . 51.0 ttt-85 -77.44 9.22 3.42 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -176.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.517 HD13 ' O ' ' A' ' 97' ' ' ILE . 0.3 OUTLIER -87.3 -14.93 9.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.833 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -139.98 -48.2 0.06 OUTLIER Glycine 0 CA--C 1.543 1.781 0 N-CA-C 116.087 1.195 . . . . 0.0 116.087 -176.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.499 HD12 ' CG2' ' A' ' 95' ' ' VAL . 16.6 mt -71.14 -12.76 61.67 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 119.84 1.82 . . . . 0.0 113.05 -178.058 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.499 ' O ' ' CG ' ' A' ' 104' ' ' LYS . 26.2 t80 -80.57 -51.19 9.04 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 114.48 -1.236 . . . . 0.0 111.868 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.902 ' OD2' ' OE1' ' A' ' 105' ' ' GLN . 9.7 t70 -69.46 -32.29 71.11 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 123.175 1.464 . . . . 0.0 110.043 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 11.4 t -68.74 -52.54 29.48 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 111.158 -2.746 . . . . 0.0 111.89 175.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 52.3 t -74.28 -27.79 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-N 121.697 2.044 . . . . 0.0 114.131 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.499 ' CG ' ' O ' ' A' ' 100' ' ' TYR . 3.2 mmpt? -69.69 -41.68 75.12 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 112.131 -2.304 . . . . 0.0 111.518 179.238 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.902 ' OE1' ' OD2' ' A' ' 101' ' ' ASP . 27.2 mt-30 -79.69 -12.95 59.78 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 122.638 1.209 . . . . 0.0 111.011 -178.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -79.93 -22.8 42.28 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.21 178.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.619 ' CZ ' ' ND2' ' A' ' 190' ' ' ASN . 35.4 m-85 -109.81 -29.45 8.3 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 119.532 1.06 . . . . 0.0 112.721 -175.138 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.6 p -96.78 9.11 42.71 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 117.144 -1.823 . . . . 0.0 113.135 -177.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 12.4 ttpp -96.87 -154.82 0.46 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 177.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 140.42 134.58 3.11 Favored Glycine 0 N--CA 1.475 1.245 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 76.2 p -90.19 -40.29 12.29 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -177.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -116.28 174.41 6.07 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 112.899 -1.955 . . . . 0.0 113.485 -176.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.606 ' O ' ' HB2' ' A' ' 114' ' ' ALA . 85.9 m-70 -86.47 77.08 9.51 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.759 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.606 ' HB2' ' O ' ' A' ' 113' ' ' HIS . . . 159.6 -161.39 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.05 14.82 27.77 Favored Glycine 0 C--N 1.335 0.499 0 CA-C-N 115.449 -0.796 . . . . 0.0 113.213 176.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 22.6 mm -60.89 -40.83 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.0 -39.29 96.34 Favored Glycine 0 CA--C 1.525 0.713 0 CA-C-O 122.253 0.918 . . . . 0.0 110.982 175.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 5.8 t -57.93 -42.17 84.27 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 177.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 59.7 mtm180 -63.58 -37.47 87.44 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.278 -178.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 8.0 mp -64.15 -46.51 83.76 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 76.9 mt -66.83 -44.83 80.07 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 114.926 -1.033 . . . . 0.0 110.494 178.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.91 -44.77 91.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 119.532 1.06 . . . . 0.0 109.869 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -66.01 -44.1 92.21 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 119.73 -1.224 . . . . 0.0 111.295 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 71.0 m -64.07 -43.95 93.9 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.784 -0.367 . . . . 0.0 111.538 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 21.1 p -69.35 -48.43 61.36 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 119.333 -0.947 . . . . 0.0 111.954 177.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 24.0 p -65.37 -42.41 92.75 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 -174.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -63.95 -44.54 95.84 Favored Glycine 0 CA--C 1.521 0.463 0 CA-C-O 122.967 1.315 . . . . 0.0 112.916 -177.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.534 ' O ' HG22 ' A' ' 131' ' ' VAL . . . -61.35 -41.6 97.33 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 111.903 -2.148 . . . . 0.0 107.25 177.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.692 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 17.3 mt -64.41 -42.15 96.24 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.221 178.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.0 -39.77 95.74 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -177.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.534 HG22 ' O ' ' A' ' 128' ' ' ALA . 18.9 m -60.96 -26.03 37.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 122.829 1.3 . . . . 0.0 109.572 179.362 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.692 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . -58.63 -44.83 90.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 112.251 -2.25 . . . . 0.0 111.876 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.426 HG22 ' H ' ' A' ' 133' ' ' VAL . 5.1 m -79.0 -48.63 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -126.7 135.75 51.54 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.695 0.283 . . . . 0.0 111.451 -178.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.773 ' H ' ' CD ' ' A' ' 136' ' ' PRO . 22.2 pt20 175.2 -23.59 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.828 0 CA-C-N 115.47 -0.786 . . . . 0.0 113.069 178.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.773 ' CD ' ' H ' ' A' ' 135' ' ' GLN . 54.3 Cg_exo -53.03 -34.17 66.39 Favored 'Trans proline' 0 N--CA 1.5 1.894 0 CA-C-N 120.955 1.377 . . . . 0.0 113.275 -178.428 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.421 HG22 ' H ' ' A' ' 137' ' ' THR . 0.0 OUTLIER -67.43 -41.58 84.55 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 119.064 -1.055 . . . . 0.0 110.667 -178.772 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -64.38 -42.44 96.16 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 119.238 -0.985 . . . . 0.0 111.777 -177.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 14.6 m -63.6 -42.71 97.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.879 0.371 . . . . 0.0 110.977 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.423 ' O ' ' N ' ' A' ' 144' ' ' PHE . 25.3 t -63.97 -38.54 82.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.028 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.437 ' NZ ' ' CB ' ' A' ' 141' ' ' LYS . 8.8 mtmp? -62.0 -40.93 97.33 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 119.556 -0.858 . . . . 0.0 111.895 -177.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.4 p -69.56 -44.81 79.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 119.992 -0.683 . . . . 0.0 109.23 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -64.36 -35.9 82.39 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.468 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.423 ' N ' ' O ' ' A' ' 140' ' ' VAL . 93.9 t80 -66.14 -40.76 90.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.249 -177.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -64.4 -39.53 94.03 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 118.844 -1.142 . . . . 0.0 109.709 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.22 -35.03 79.79 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.519 ' NE2' ' O ' ' A' ' 147' ' ' GLN . 1.4 pp0? -59.85 111.35 1.43 Allowed 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 177.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -94.49 -64.39 1.08 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 117.396 -1.288 . . . . 0.0 112.615 -177.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -91.06 110.68 21.96 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 122.862 2.574 . . . . 0.0 110.121 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -81.41 68.69 7.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.648 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 43.28 59.37 3.52 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.697 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -179.816 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.449 ' CE2' ' O ' ' A' ' 157' ' ' GLN . 85.1 t80 . . . . . 0 N--CA 1.467 0.388 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.449 ' O ' ' CE2' ' A' ' 156' ' ' TYR . 19.7 mp0 -109.67 -155.24 0.55 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -178.492 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 83.4 p -157.22 -176.25 5.86 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 123.256 1.503 . . . . 0.0 112.936 -177.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 8.4 m -62.89 -43.53 98.56 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 111.26 -2.7 . . . . 0.0 112.002 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.5 t -61.05 -42.76 94.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -178.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.45 ' OE2' ' OG1' ' A' ' 165' ' ' THR . 0.7 OUTLIER -65.47 -38.33 89.48 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.066 179.877 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -61.4 -45.67 93.35 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -178.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.503 ' CZ ' HD23 ' A' ' 175' ' ' LEU . 13.7 t80 -62.62 -49.21 76.09 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.278 -178.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -67.83 -45.36 74.88 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -174.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.45 ' OG1' ' OE2' ' A' ' 161' ' ' GLU . 1.9 p -63.0 -43.86 97.63 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -176.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 15.0 pt -64.26 -37.93 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 CA-C-O 121.746 0.784 . . . . 0.0 109.133 177.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.89 -37.07 78.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.17 -1.377 . . . . 0.0 107.37 175.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -62.46 -50.44 71.46 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 122.211 2.278 . . . . 0.0 111.849 -176.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.524 ' N ' ' OE1' ' A' ' 169' ' ' GLU . 0.2 OUTLIER -74.93 -50.99 14.91 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.523 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -78.09 -36.28 48.32 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 116.594 2.072 . . . . 0.0 116.594 -173.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 91.14 -166.61 31.03 Favored Glycine 0 C--N 1.337 0.628 0 CA-C-N 118.841 0.746 . . . . 0.0 112.263 177.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.638 HD13 ' H ' ' A' ' 172' ' ' ILE . 0.0 OUTLIER -72.64 -38.58 59.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.903 0.859 . . . . 0.0 109.175 -179.576 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 68.1 mtp180 -58.5 -33.74 70.15 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 113.852 -1.522 . . . . 0.0 111.103 -177.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -61.48 -41.24 99.51 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 118.672 -1.728 . . . . 0.0 111.425 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.503 HD23 ' CZ ' ' A' ' 163' ' ' TYR . 7.8 mp -71.33 -34.35 70.47 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 117.717 2.488 . . . . 0.0 117.717 -177.213 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' TRP . . . . . 0.493 ' CD1' ' O ' ' A' ' 172' ' ' ILE . 63.7 m95 -78.18 -7.09 56.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 112.995 -1.912 . . . . 0.0 109.589 -177.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 16.8 ttmm -43.63 -48.64 7.75 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -175.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -90.11 -32.23 10.01 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.39 0.995 . . . . 0.0 111.815 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 90.1 m -45.31 -50.66 11.81 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' SER . . . . . 0.45 ' O ' HG12 ' A' ' 183' ' ' VAL . 0.4 OUTLIER -61.96 -50.47 80.78 Favored Pre-proline 0 N--CA 1.472 0.627 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -175.906 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 180' ' ' SER . 24.7 Cg_endo -64.64 -27.98 60.81 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 121.17 1.247 . . . . 0.0 111.704 176.135 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -64.06 -39.33 93.85 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 180' ' ' SER . 1.6 p -62.91 -41.71 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.855 -179.277 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.48 -39.28 90.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.961 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.588 HH12 ' CG1' ' A' ' 235' ' ' VAL . 48.8 ttt85 -60.6 -42.13 96.14 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 119.922 -0.711 . . . . 0.0 110.344 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -61.67 -43.86 98.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.183 0.516 . . . . 0.0 110.679 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -65.28 -44.2 88.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.617 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 24.3 mm -63.81 -45.89 95.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -177.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.503 ' O ' ' N ' ' A' ' 193' ' ' GLU . 5.9 p -60.72 -47.31 93.62 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.339 0 C-N-CA 119.237 -0.985 . . . . 0.0 111.729 -178.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' ASN . . . . . 0.619 ' ND2' ' CZ ' ' A' ' 107' ' ' TYR . 12.2 t-20 -63.54 -42.94 98.37 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 122.282 1.039 . . . . 0.0 110.868 178.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' CYS . . . . . . . . . . . . . 31.3 m -61.39 -45.53 93.98 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 113.348 -1.751 . . . . 0.0 108.389 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.27 -40.4 95.91 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 112.662 -2.063 . . . . 0.0 109.672 175.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 0.503 ' N ' ' O ' ' A' ' 189' ' ' VAL . 0.7 OUTLIER -60.81 -46.54 90.12 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.001 0.92 . . . . 0.0 113.086 -176.884 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 2.8 pp -64.31 -36.73 85.08 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 119.231 -0.988 . . . . 0.0 109.528 -175.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 1.4 m -63.18 -45.74 97.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 C-N-CA 117.01 -1.876 . . . . 0.0 107.389 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 30.3 p -64.35 -46.11 84.88 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -177.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -57.67 -39.87 78.1 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.133 -0.939 . . . . 0.0 113.338 -177.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -56.4 -44.46 80.32 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 9.7 mt -61.66 -39.45 91.41 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.803 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 1.6 mp -63.12 -42.79 97.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 118.813 -0.613 . . . . 0.0 110.115 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -59.99 -40.42 89.12 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 120.224 1.374 . . . . 0.0 111.897 178.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -66.96 -38.43 86.08 Favored 'General case' 0 C--O 1.25 1.104 0 CA-C-N 114.682 -1.145 . . . . 0.0 111.003 -176.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -101.96 128.89 48.17 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 120.804 -1.185 . . . . 0.0 112.455 -178.306 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.596 ' O ' HD22 ' A' ' 209' ' ' LEU . 4.1 tp 67.46 4.45 3.8 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 114.275 -1.33 . . . . 0.0 112.082 177.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.74 38.11 4.0 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -74.52 -21.57 59.47 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.527 0.68 . . . . 0.0 111.455 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.427 ' O ' ' CB ' ' A' ' 208' ' ' ASN . . . -130.86 -40.45 1.19 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.54 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 208' ' ' ASN . . . . . 0.427 ' CB ' ' O ' ' A' ' 207' ' ' ALA . 0.4 OUTLIER 152.13 124.43 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 -178.168 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.596 HD22 ' O ' ' A' ' 204' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.484 1.266 0 CA-C-N 110.41 -3.086 . . . . 0.0 111.954 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 . . . . . 0 N--CA 1.469 0.482 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.4 ' N ' ' CD ' ' A' ' 215' ' ' PRO . 4.4 mm? -61.28 -43.74 90.87 Favored Pre-proline 0 CA--C 1.537 0.481 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 215' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 214' ' ' LEU . 25.9 Cg_exo -60.88 -34.07 91.71 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 CA-C-N 120.59 1.246 . . . . 0.0 111.039 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 82.3 m -64.77 -42.53 95.05 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 113.173 -1.83 . . . . 0.0 111.771 -178.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -66.83 -38.13 85.82 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -63.44 -47.37 82.15 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.941 -178.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 27.1 p -60.65 -38.24 84.17 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 119.102 0.864 . . . . 0.0 110.465 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 47.8 p -59.67 -41.88 91.61 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' ALA . . . . . 0.568 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.91 -41.82 97.58 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -177.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -62.11 -47.15 85.89 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -176.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -60.74 -42.09 99.28 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 107.464 -2.254 . . . . 0.0 107.464 177.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' ALA . . . . . 0.627 ' O ' HG23 ' A' ' 228' ' ' THR . . . -63.1 -37.93 89.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.211 -0.995 . . . . 0.0 108.977 176.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 225' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -61.66 -42.28 99.73 Favored Glycine 0 CA--C 1.521 0.412 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.811 -177.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -66.57 -38.34 86.87 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' CYS . . . . . 0.432 ' O ' HG12 ' A' ' 230' ' ' VAL . 96.3 m -63.22 -41.11 99.08 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.012 0.434 . . . . 0.0 110.387 177.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 228' ' ' THR . . . . . 0.627 HG23 ' O ' ' A' ' 224' ' ' ALA . 55.9 p -61.99 -39.95 93.96 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.759 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -58.17 -38.73 77.23 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -176.027 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.432 HG12 ' O ' ' A' ' 227' ' ' CYS . 1.7 p -59.57 -40.53 82.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 119.004 -1.078 . . . . 0.0 110.02 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 231' ' ' ILE . . . . . 0.641 HD12 ' C ' ' A' ' 231' ' ' ILE . 0.3 OUTLIER -61.45 -40.16 85.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 177.615 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -62.78 -39.47 94.29 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 115.683 1.735 . . . . 0.0 115.683 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.488 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 0.2 OUTLIER -57.99 -41.72 91.39 Favored Pre-proline 0 N--CA 1.484 1.244 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 -173.525 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.528 ' HD2' ' O ' ' A' ' 231' ' ' ILE . 32.3 Cg_exo -57.7 -39.56 86.67 Favored 'Trans proline' 0 C--N 1.291 -2.461 0 C-N-CA 122.495 2.13 . . . . 0.0 113.128 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.588 ' CG1' HH12 ' A' ' 185' ' ' ARG . 59.3 t -63.69 -37.22 79.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 C-N-CA 117.8 -1.56 . . . . 0.0 108.799 178.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 236' ' ' ASP . . . . . 0.526 ' OD2' ' CE3' ' A' ' 283' ' ' TRP . 53.1 t0 -65.77 -40.37 91.94 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.266 178.326 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 59.2 t -64.6 -45.22 96.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 -176.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 84.4 t . . . . . 0 C--N 1.32 -0.693 0 C-N-CA 120.028 -0.669 . . . . 0.0 111.737 -178.064 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 19.7 m . . . . . 0 N--CA 1.467 0.403 0 N-CA-C 113.863 1.061 . . . . 0.0 113.863 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 260' ' ' MET . . . . . 0.459 ' SD ' ' N ' ' A' ' 261' ' ' LEU . 0.0 OUTLIER -61.75 -44.37 97.03 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -176.817 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.459 ' N ' ' SD ' ' A' ' 260' ' ' MET . 11.7 tp -62.36 -47.08 85.77 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 121.92 -0.487 . . . . 0.0 109.766 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 70.0 mtp180 -66.77 -53.64 30.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.976 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 263' ' ' LYS . . . . . 0.455 ' O ' ' O ' ' A' ' 260' ' ' MET . 9.6 mtpm? -130.59 179.17 6.1 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.881 0.372 . . . . 0.0 111.258 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 264' ' ' GLU . . . . . 0.456 ' O ' ' O ' ' A' ' 265' ' ' GLY . 95.1 mt-10 56.43 67.78 0.95 Allowed 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.609 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 265' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 264' ' ' GLU . . . -33.34 159.81 0.01 OUTLIER Glycine 0 CA--C 1.533 1.158 0 CA-C-O 121.789 0.661 . . . . 0.0 112.304 -179.314 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -64.91 -5.34 10.48 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.076 1.851 . . . . 0.0 111.355 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -69.73 -26.28 64.25 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.536 0.734 . . . . 0.0 111.362 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -58.02 -32.28 67.8 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.532 -178.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -62.39 -41.15 98.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.347 177.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -65.79 -37.9 87.55 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.387 -177.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.97 165.54 12.21 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 178.448 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 69.03 86.64 0.1 Allowed Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.614 -0.995 . . . . 0.0 110.614 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -168.74 22.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 121.064 -0.255 . . . . 0.0 110.784 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 274' ' ' MET . . . . . 0.568 ' N ' ' CD ' ' A' ' 275' ' ' PRO . 1.0 OUTLIER -63.7 -44.1 79.16 Favored Pre-proline 0 C--N 1.33 -0.254 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.219 -179.792 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 275' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 274' ' ' MET . 21.3 Cg_exo -64.38 -46.61 7.21 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.43 2.087 . . . . 0.0 111.54 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 1.5 p -60.66 -40.11 90.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.038 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 277' ' ' PHE . . . . . 0.411 ' CD1' ' C ' ' A' ' 277' ' ' PHE . 36.4 t80 -61.89 -42.92 99.65 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 123.289 1.519 . . . . 0.0 111.936 -178.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 12.0 tp -62.12 -38.73 90.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 111.037 -2.801 . . . . 0.0 108.159 174.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 279' ' ' ARG . . . . . 0.483 HH22 ' HB3' ' A' ' 37' ' ' ALA . 0.5 OUTLIER -62.62 -40.2 96.24 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.072 179.215 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.743 ' O ' HD12 ' A' ' 280' ' ' LEU . 0.2 OUTLIER -61.97 -36.31 81.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.145 -0.934 . . . . 0.0 113.1 -177.255 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -67.7 -50.89 39.19 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 109.146 -1.581 . . . . 0.0 109.146 -178.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 282' ' ' SER . . . . . 0.798 ' O ' HG22 ' A' ' 285' ' ' VAL . 78.0 p -61.92 -43.63 98.44 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.694 0.798 . . . . 0.0 109.538 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 283' ' ' TRP . . . . . 0.526 ' CE3' ' OD2' ' A' ' 236' ' ' ASP . 1.3 m95 -59.5 -38.09 79.99 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -61.76 -38.95 89.92 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -178.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.798 HG22 ' O ' ' A' ' 282' ' ' SER . 23.0 m -61.46 -37.26 77.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 O-C-N 121.354 -0.841 . . . . 0.0 111.339 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.407 ' O ' HG22 ' A' ' 289' ' ' VAL . 26.8 t -62.14 -41.63 92.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -177.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 11.5 ptm -62.34 -38.32 89.05 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 121.305 -0.872 . . . . 0.0 109.608 178.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -58.47 -41.22 84.73 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.13 -0.941 . . . . 0.0 113.303 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 286' ' ' VAL . 2.7 m -61.33 -38.68 80.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 121.693 -0.63 . . . . 0.0 110.846 -178.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 75.7 p -62.22 -40.43 96.1 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 177.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -61.24 -38.44 86.65 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 176.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -58.31 -40.71 82.72 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 117.915 -1.514 . . . . 0.0 109.283 -176.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 293' ' ' GLN . . . . . 0.451 ' O ' ' O ' ' A' ' 296' ' ' ARG . 83.3 mm-40 -60.72 -43.13 98.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 122.577 1.18 . . . . 0.0 110.784 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 73.5 mt -60.47 -40.52 91.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 113.027 -1.897 . . . . 0.0 109.219 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -63.18 -46.15 88.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.982 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 296' ' ' ARG . . . . . 0.451 ' O ' ' O ' ' A' ' 293' ' ' GLN . 20.1 tpt85 -123.07 116.19 23.08 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.009 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -115.52 -96.11 0.46 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.177 0.513 . . . . 0.0 110.522 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 38.9 tp -139.3 120.87 15.17 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.683 179.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 30.2 ttm -92.69 64.32 4.11 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 121.202 -0.199 . . . . 0.0 111.271 -179.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.71 101.22 0.07 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.976 0.893 . . . . 0.0 111.227 -178.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -64.12 -46.2 85.19 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 113.47 -1.695 . . . . 0.0 112.936 -176.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -58.48 -39.29 79.58 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.498 -0.481 . . . . 0.0 109.789 -178.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 303' ' ' GLN . . . . . 0.432 ' O ' ' OE2' ' A' ' 306' ' ' GLU . 86.3 mt-30 -64.56 -46.49 82.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.224 -179.151 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 304' ' ' SER . . . . . 0.439 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 74.2 p -67.09 -38.64 86.05 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.454 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -62.5 -43.87 97.75 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -178.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 306' ' ' GLU . . . . . 0.473 ' CD ' ' N ' ' A' ' 307' ' ' ALA . 2.7 pp20? -65.72 -36.76 84.51 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -177.125 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 307' ' ' ALA . . . . . 0.531 ' HB3' ' HD3' ' A' ' 308' ' ' PRO . . . -59.84 -52.6 72.57 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -176.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 308' ' ' PRO . . . . . 0.531 ' HD3' ' HB3' ' A' ' 307' ' ' ALA . 73.1 Cg_endo -74.96 0.3 9.05 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.954 1.769 . . . . 0.0 111.604 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 82.5 t80 . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.459 179.881 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.7 m . . . . . 0 N--CA 1.465 0.294 0 CA-C-O 120.829 0.347 . . . . 0.0 110.111 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.702 HG22 ' H ' ' A' ' 16' ' ' LYS . 7.2 p -91.79 176.58 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.318 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.702 ' H ' HG22 ' A' ' 15' ' ' VAL . 35.0 mtmm -64.21 -41.37 97.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.517 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -63.61 -41.42 98.3 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.548 ' H ' HG13 ' A' ' 15' ' ' VAL . 31.3 tp -79.85 -26.42 40.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.079 -179.072 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.443 ' O ' ' OG1' ' A' ' 22' ' ' THR . . . -66.26 -41.39 94.74 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 107.451 -2.259 . . . . 0.0 107.451 177.101 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.481 ' HB1' HH12 ' A' ' 96' ' ' ARG . . . -71.37 -32.0 67.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 124.77 2.224 . . . . 0.0 107.314 176.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.45 -42.57 98.98 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-N 108.469 -3.969 . . . . 0.0 108.095 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 19' ' ' GLY . 33.6 p -70.75 -28.0 64.37 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -66.28 -50.23 64.39 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.745 -178.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.406 ' O ' ' OE1' ' A' ' 89' ' ' GLN . . . -61.95 -35.96 79.98 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 118.504 -1.278 . . . . 0.0 111.234 -177.465 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.632 ' SG ' ' N ' ' A' ' 26' ' ' ILE . 5.8 p -64.15 -53.47 48.88 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.027 -179.066 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.632 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 16.0 pt -65.68 -39.68 85.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -178.05 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.68 -42.18 98.06 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 119.686 -0.806 . . . . 0.0 112.738 -173.077 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.559 ' CG ' HE22 ' A' ' 89' ' ' GLN . 1.5 m-20 -77.09 -27.13 54.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 120.739 1.608 . . . . 0.0 109.941 -174.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.478 HD13 ' O ' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -60.42 -54.26 47.71 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 118.922 0.783 . . . . 0.0 112.222 179.498 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.4 pp -72.86 -1.0 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-O 122.501 1.144 . . . . 0.0 111.906 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.71 ' O ' HD21 ' A' ' 34' ' ' LEU . 97.8 m -106.72 -12.58 15.5 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 112.588 -2.096 . . . . 0.0 112.051 -174.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.439 ' N ' ' CD ' ' A' ' 33' ' ' PRO . 8.4 t80 -70.74 -44.87 16.63 Favored Pre-proline 0 CA--C 1.551 1.011 0 CA-C-N 121.935 2.152 . . . . 0.0 113.765 -178.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.439 ' CD ' ' N ' ' A' ' 32' ' ' PHE . 33.5 Cg_exo -60.54 -17.75 50.33 Favored 'Trans proline' 0 N--CA 1.52 3.047 0 N-CA-C 119.363 2.793 . . . . 0.0 119.363 -175.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.967 HD13 ' H ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -69.11 -35.47 76.47 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 120.342 1.428 . . . . 0.0 114.067 -179.071 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.522 ' H ' HD22 ' A' ' 34' ' ' LEU . 64.1 m-20 -65.02 -41.73 95.02 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -175.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.5 p -58.33 -36.0 72.75 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 119.551 -0.86 . . . . 0.0 111.348 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.96 -38.81 83.21 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 119.782 -0.767 . . . . 0.0 111.731 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.4 ' CG ' ' N ' ' A' ' 39' ' ' VAL . 8.2 pttp -61.37 -48.24 82.18 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.28 -176.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.4 ' N ' ' CG ' ' A' ' 38' ' ' LYS . 82.2 t -63.48 -41.05 91.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 119.667 -0.813 . . . . 0.0 111.565 -176.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.465 ' C ' ' H ' ' A' ' 42' ' ' GLN . 67.9 mmt-85 -61.94 -42.09 98.7 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 119.252 -0.979 . . . . 0.0 110.064 178.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -62.81 38.85 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.685 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.465 ' H ' ' C ' ' A' ' 40' ' ' ARG . 55.1 tp60 -128.41 -76.43 0.56 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.909 0.385 . . . . 0.0 110.01 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.519 ' O ' HG23 ' A' ' 43' ' ' ILE . 21.0 tt -168.46 121.45 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.885 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.417 HE22 ' HB3' ' A' ' 59' ' ' TYR . 11.5 pt20 -71.69 57.57 0.29 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.889 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -167.24 165.87 38.87 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.137 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.6 mp0 -147.11 -160.12 1.12 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.134 -0.533 . . . . 0.0 109.574 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.7 m -81.94 -6.22 58.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.033 0.444 . . . . 0.0 110.106 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -59.42 -30.49 68.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.729 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.71 1.17 87.5 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -178.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.3 tp -64.03 -36.03 82.66 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.361 -0.92 . . . . 0.0 109.532 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.543 HG13 ' N ' ' A' ' 52' ' ' ARG . 8.6 p -58.95 -43.05 87.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.067 -178.134 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.543 ' N ' HG13 ' A' ' 51' ' ' VAL . 22.3 ptt85 -63.06 -33.07 74.65 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 119.734 -0.787 . . . . 0.0 109.658 -178.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -67.7 -37.81 82.8 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.4 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 51' ' ' VAL . . . -132.26 111.3 11.27 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.469 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.61 -8.77 59.59 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -178.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.665 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 29.4 p -130.55 -138.15 0.21 Allowed 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.665 ' HB3' ' O ' ' A' ' 56' ' ' SER . . . 91.84 -30.96 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 176.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.468 ' O ' ' N ' ' A' ' 60' ' ' ARG . 68.8 mt-30 -139.55 8.05 2.37 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.151 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.565 ' O ' ' CD2' ' A' ' 59' ' ' TYR . 20.9 p90 -46.3 87.03 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.555 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.477 ' O ' ' O ' ' A' ' 59' ' ' TYR . 75.9 mtt180 51.33 165.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.021 0.439 . . . . 0.0 110.419 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 120.01 83.87 0.82 Allowed Glycine 0 CA--C 1.519 0.298 0 N-CA-C 104.441 -3.463 . . . . 0.0 104.441 -175.04 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.6 p -67.79 -36.11 74.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 118.631 -0.699 . . . . 0.0 110.86 178.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.533 ' O ' HD13 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -61.75 -33.02 73.32 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 117.687 -1.605 . . . . 0.0 109.24 178.379 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.89 -49.9 60.85 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 113.559 -1.655 . . . . 0.0 115.126 -176.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.0 m -62.37 -46.92 86.48 Favored 'General case' 0 C--N 1.334 -0.1 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -178.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 12.0 tt -59.98 -36.04 64.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 38.6 tp -63.88 -35.57 81.07 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 120.82 1.645 . . . . 0.0 111.607 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 98.4 m -63.28 -40.13 96.52 Favored 'General case' 0 C--O 1.249 1.058 0 CA-C-N 113.729 -1.578 . . . . 0.0 111.042 -174.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 3.2 ptt? -60.63 -39.99 90.29 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 120.328 -1.482 . . . . 0.0 114.628 -175.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.8 m -69.52 -40.31 79.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 119.213 -0.995 . . . . 0.0 112.86 -178.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 62.8 ttp85 -78.78 -13.21 59.93 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.499 ' CG2' ' N ' ' A' ' 73' ' ' GLU . 0.6 OUTLIER -62.57 -54.42 40.04 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.667 179.194 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.499 ' N ' ' CG2' ' A' ' 72' ' ' THR . 19.2 mt-10 -105.24 -54.8 2.42 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.411 ' O ' ' CB ' ' A' ' 77' ' ' SER . . . 155.7 166.94 16.45 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -56.37 -35.14 95.85 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 121.329 1.352 . . . . 0.0 111.106 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.2 tpp180 -61.32 -11.93 11.77 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-O 121.985 0.897 . . . . 0.0 110.543 176.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.452 ' O ' ' OD1' ' A' ' 80' ' ' ASN . 28.9 p -77.59 -32.05 53.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 113.858 -1.519 . . . . 0.0 110.611 -177.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.0 tt -75.88 -33.93 59.98 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.539 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.49 ' C ' ' H ' ' A' ' 81' ' ' GLY . 26.2 m-85 -93.33 -5.25 50.07 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 115.003 1.482 . . . . 0.0 115.003 -178.177 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.452 ' OD1' ' O ' ' A' ' 77' ' ' SER . 50.1 p30 -84.13 32.59 0.49 Allowed 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 114.272 -1.331 . . . . 0.0 107.734 175.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.49 ' H ' ' C ' ' A' ' 79' ' ' TYR . . . -171.93 -9.46 0.02 OUTLIER Glycine 0 CA--C 1.525 0.67 0 CA-C-N 114.503 -1.226 . . . . 0.0 112.376 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.406 ' H ' ' H ' ' A' ' 81' ' ' GLY . 35.9 tp -59.13 -34.85 72.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 113.998 -1.101 . . . . 0.0 110.279 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.7 p -70.8 -27.16 29.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.284 178.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.69 -31.39 61.88 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.574 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.85 -40.03 89.54 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 119.442 -1.361 . . . . 0.0 111.051 -177.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 45.2 mt -62.21 -40.24 95.45 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 122.371 1.081 . . . . 0.0 113.179 -177.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -60.22 -26.72 66.62 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 112.993 -1.912 . . . . 0.0 108.979 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 -57.68 -53.45 58.05 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 172.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.559 HE22 ' CG ' ' A' ' 28' ' ' ASP . 1.4 tp-100 -67.95 -30.28 69.54 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 112.596 -2.093 . . . . 0.0 113.74 -177.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.53 -40.17 93.67 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 78.2 p -74.31 -34.5 63.51 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 118.409 -0.805 . . . . 0.0 111.192 -176.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -57.48 -44.05 84.58 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 120.842 1.656 . . . . 0.0 111.621 -176.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.51 -33.03 64.57 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 119.456 -0.898 . . . . 0.0 111.117 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.626 ' O ' HG22 ' A' ' 97' ' ' ILE . 38.8 t -64.08 -41.94 97.14 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.43 ' C ' ' H ' ' A' ' 97' ' ' ILE . 1.4 p -67.51 -27.47 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.755 179.152 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.499 ' CG ' ' O ' ' A' ' 96' ' ' ARG . 15.0 ttt180 -77.01 9.61 2.85 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -177.034 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.626 HG22 ' O ' ' A' ' 94' ' ' SER . 10.2 tp -86.6 -16.3 9.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 177.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -140.98 -49.0 0.05 OUTLIER Glycine 0 CA--C 1.541 1.662 0 N-CA-C 115.952 1.141 . . . . 0.0 115.952 -177.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.512 ' N ' HD12 ' A' ' 99' ' ' LEU . 10.7 mp -71.8 -13.45 61.7 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 119.453 1.627 . . . . 0.0 112.682 -177.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.479 ' O ' ' CG ' ' A' ' 104' ' ' LYS . 2.6 m-85 -80.77 -51.06 9.07 Favored 'General case' 0 C--O 1.211 -0.938 0 CA-C-N 114.293 -1.321 . . . . 0.0 110.809 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.785 ' OD2' ' OE1' ' A' ' 105' ' ' GLN . 18.3 t70 -69.18 -32.34 71.58 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 123.391 1.567 . . . . 0.0 110.071 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.5 t -68.96 -52.71 26.18 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 110.953 -2.839 . . . . 0.0 113.526 176.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 10.0 p -74.69 -27.66 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 CA-C-N 122.211 2.278 . . . . 0.0 113.146 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.479 ' CG ' ' O ' ' A' ' 100' ' ' TYR . 47.6 mtpt -69.48 -42.13 75.25 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 111.47 -2.605 . . . . 0.0 111.805 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.785 ' OE1' ' OD2' ' A' ' 101' ' ' ASP . 27.2 mt-30 -75.05 -16.37 60.59 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 122.997 1.38 . . . . 0.0 111.05 176.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.634 ' CE2' HG21 ' A' ' 126' ' ' THR . 17.3 t80 -78.7 -22.65 46.36 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 112.614 -2.085 . . . . 0.0 112.044 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -109.54 -30.83 7.74 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 119.369 0.986 . . . . 0.0 111.269 -175.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.4 m -98.1 9.06 43.78 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 118.029 -1.468 . . . . 0.0 112.105 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.521 ' O ' ' C ' ' A' ' 110' ' ' GLY . 51.4 tttm -51.97 120.8 5.74 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 118.129 -0.939 . . . . 0.0 111.564 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.544 ' O ' ' CB ' ' A' ' 111' ' ' SER . . . -20.87 -82.86 0.01 OUTLIER Glycine 0 N--CA 1.488 2.14 0 CA-C-N 119.474 1.034 . . . . 0.0 112.076 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.544 ' CB ' ' O ' ' A' ' 110' ' ' GLY . 24.2 p 103.67 -161.19 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 176.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.621 ' O ' ' N ' ' A' ' 114' ' ' ALA . 18.9 tp10 -131.49 101.56 5.57 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -177.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.641 ' O ' ' HB2' ' A' ' 114' ' ' ALA . 81.3 t60 17.36 42.41 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.924 178.142 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.641 ' HB2' ' O ' ' A' ' 113' ' ' HIS . . . 159.33 -161.48 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.205 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.51 14.9 26.53 Favored Glycine 0 C--N 1.337 0.614 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.991 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 48.6 mt -60.83 -40.5 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.0 -39.51 96.49 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-O 122.078 0.821 . . . . 0.0 111.559 175.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.6 p -57.57 -42.09 82.37 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 177.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -63.42 -37.23 86.47 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.099 -0.64 . . . . 0.0 111.377 -178.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 29.0 mt -64.18 -46.68 82.91 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.351 0.596 . . . . 0.0 110.018 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.588 ' O ' HD23 ' A' ' 121' ' ' LEU . 2.4 tt -66.63 -44.88 80.8 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.983 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.625 ' HB1' ' CE2' ' A' ' 106' ' ' PHE . . . -63.89 -44.99 91.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 119.222 0.919 . . . . 0.0 109.907 178.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -65.73 -44.04 93.08 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.568 -0.825 . . . . 0.0 111.83 -178.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 78.1 p -63.64 -43.27 97.26 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 18.9 m -68.84 -48.03 64.51 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 119.281 -0.968 . . . . 0.0 112.012 177.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.634 HG21 ' CE2' ' A' ' 106' ' ' PHE . 21.6 p -65.49 -42.63 91.95 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 -173.475 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -64.01 -44.79 95.39 Favored Glycine 0 CA--C 1.521 0.46 0 CA-C-O 122.586 1.103 . . . . 0.0 113.092 -177.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.402 ' O ' ' CG2' ' A' ' 131' ' ' VAL . . . -61.1 -41.3 96.41 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 112.54 -1.83 . . . . 0.0 106.818 177.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.662 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 51.9 mt -63.93 -41.75 97.54 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.308 178.327 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -62.64 -40.09 95.92 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -177.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.402 ' CG2' ' O ' ' A' ' 128' ' ' ALA . 5.0 m -61.22 -25.64 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 122.696 1.236 . . . . 0.0 109.5 178.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.662 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . -57.87 -44.8 86.86 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 112.49 -2.141 . . . . 0.0 111.626 -178.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.426 HG22 ' H ' ' A' ' 133' ' ' VAL . 3.6 m -78.97 -48.73 21.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.711 -179.294 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -103.59 133.19 49.03 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.786 0.326 . . . . 0.0 111.468 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.649 ' H ' ' HD2' ' A' ' 136' ' ' PRO . 5.8 tp-100 -175.88 -39.41 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.552 178.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.649 ' HD2' ' H ' ' A' ' 135' ' ' GLN . 52.9 Cg_exo -52.75 -33.56 60.66 Favored 'Trans proline' 0 N--CA 1.498 1.775 0 C-N-CA 122.009 1.806 . . . . 0.0 112.548 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 58.7 p -67.3 -41.88 84.63 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 118.309 -1.356 . . . . 0.0 109.65 -178.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -65.88 -42.48 90.26 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 118.796 -1.162 . . . . 0.0 111.903 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 59.1 t -64.04 -44.14 97.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.437 HG13 ' O ' ' A' ' 136' ' ' PRO . 33.2 m -65.08 -38.76 83.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -177.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.434 ' HB3' ' HZ2' ' A' ' 141' ' ' LYS . 14.8 mtpp -62.29 -41.86 98.86 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 119.269 -0.973 . . . . 0.0 111.823 -177.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.401 HG22 ' H ' ' A' ' 142' ' ' VAL . 12.7 m -70.44 -45.64 74.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.237 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.492 ' NH2' ' O ' ' A' ' 174' ' ' GLY . 17.6 mmt85 -65.06 -37.09 86.41 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.566 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -66.98 -42.11 85.66 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -177.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -65.52 -40.39 92.9 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 118.853 -1.139 . . . . 0.0 109.572 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.64 -35.34 80.52 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -178.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -60.2 110.51 1.24 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 176.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -98.83 -61.06 1.42 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 117.617 -1.182 . . . . 0.0 113.266 -177.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 70.8 mtp85 -71.29 -172.58 0.75 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 122.633 2.47 . . . . 0.0 110.259 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -160.79 18.61 0.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.647 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 57.57 -130.86 51.62 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.678 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -179.96 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.516 ' O ' ' CD2' ' A' ' 156' ' ' TYR . 60.8 t80 . . . . . 0 N--CA 1.463 0.185 0 CA-C-O 120.755 0.312 . . . . 0.0 110.63 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.429 ' O ' ' O ' ' A' ' 156' ' ' TYR . 35.2 tt0 58.85 146.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.811 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 88.8 p -157.06 -178.19 7.18 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.472 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 97.8 m -64.31 -45.88 86.0 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.805 -177.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 85.0 t -64.04 -45.35 96.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 119.016 -1.074 . . . . 0.0 108.898 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 -66.72 -39.55 88.05 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.833 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -62.16 -45.61 92.67 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -179.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.429 ' CD1' ' C ' ' A' ' 163' ' ' TYR . 19.3 t80 -62.4 -50.05 73.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.293 0.568 . . . . 0.0 111.075 -178.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -68.44 -45.21 73.14 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -175.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.403 ' O ' ' OE1' ' A' ' 169' ' ' GLU . 19.0 m -62.44 -44.6 96.01 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 -176.323 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 11.9 pt -64.6 -38.45 82.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-O 121.777 0.799 . . . . 0.0 109.651 176.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.91 -36.8 77.76 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 175.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 16.2 tpt85 -62.12 -49.86 74.19 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 122.095 2.225 . . . . 0.0 111.232 -176.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.403 ' OE1' ' O ' ' A' ' 165' ' ' THR . 16.4 mp0 -74.7 -51.13 15.14 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 123.561 0.744 . . . . 0.0 109.855 177.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -78.32 -36.75 45.98 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 117.033 2.235 . . . . 0.0 117.033 -172.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 91.77 -167.43 30.85 Favored Glycine 0 N--CA 1.472 1.036 0 CA-C-N 119.136 0.88 . . . . 0.0 112.597 177.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.494 HD12 ' CH2' ' A' ' 176' ' ' TRP . 9.0 pt -73.37 -41.91 57.07 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-O 122.098 0.951 . . . . 0.0 110.552 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -58.63 -32.94 69.5 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 113.661 -1.609 . . . . 0.0 110.473 -177.358 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.492 ' O ' ' NH2' ' A' ' 143' ' ' ARG . . . -60.45 -40.16 97.28 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 118.994 -1.574 . . . . 0.0 109.586 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.768 ' O ' HD23 ' A' ' 175' ' ' LEU . 2.6 tt -69.46 -34.16 73.98 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 111.883 -2.159 . . . . 0.0 116.261 -176.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' TRP . . . . . 0.494 ' CH2' HD12 ' A' ' 172' ' ' ILE . 39.2 m0 -78.36 -7.86 57.78 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 111.071 -2.786 . . . . 0.0 110.227 -178.114 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 37.6 tptt -43.45 -48.18 7.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.925 -176.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -83.75 -34.42 18.98 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 93.0 m -45.39 -51.49 11.22 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' SER . . . . . 0.416 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 1.6 t -62.9 -50.91 74.92 Favored Pre-proline 0 N--CA 1.473 0.71 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -176.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 180' ' ' SER . 30.5 Cg_endo -64.81 -28.73 59.19 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.296 1.331 . . . . 0.0 111.901 177.496 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -64.22 -39.74 94.61 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.637 179.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 94.5 t -63.28 -42.97 98.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.189 -0.459 . . . . 0.0 109.907 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.45 -39.89 94.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.014 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.407 ' O ' HG22 ' A' ' 189' ' ' VAL . 65.2 ttt180 -61.1 -42.19 98.06 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.13 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -62.24 -44.0 97.55 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.169 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -65.65 -45.95 81.03 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -178.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.437 HG23 ' N ' ' A' ' 189' ' ' VAL . 10.0 tp -65.38 -46.28 90.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.515 HG23 ' N ' ' A' ' 190' ' ' ASN . 29.6 m -60.83 -46.85 95.51 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 C-N-CA 119.837 -0.745 . . . . 0.0 111.648 -178.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' ASN . . . . . 0.515 ' N ' HG23 ' A' ' 189' ' ' VAL . 31.4 t30 -62.28 -43.46 98.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 122.169 0.985 . . . . 0.0 109.876 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 191' ' ' CYS . . . . . . . . . . . . . 28.2 t -62.7 -47.38 83.88 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 113.554 -1.657 . . . . 0.0 110.862 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -65.01 -41.19 95.58 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.253 177.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -61.37 -45.75 93.08 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 114.335 -1.302 . . . . 0.0 111.999 -178.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.554 ' O ' HD13 ' A' ' 194' ' ' LEU . 0.2 OUTLIER -63.56 -38.1 89.83 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 -176.277 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.438 ' O ' ' CD2' ' A' ' 199' ' ' LEU . 72.1 t -63.44 -46.48 95.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 C-N-CA 117.648 -1.621 . . . . 0.0 107.603 178.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 19.2 m -64.35 -45.74 86.49 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -178.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -56.78 -38.69 72.86 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.487 1.115 . . . . 0.0 112.497 -177.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -55.48 -44.13 76.18 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.698 HD22 ' N ' ' A' ' 199' ' ' LEU . 2.5 mm? -61.24 -39.95 92.24 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 40.2 mt -63.86 -44.24 98.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-O 118.65 -0.691 . . . . 0.0 112.037 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -61.13 -41.04 96.01 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 120.415 1.462 . . . . 0.0 112.182 177.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -67.32 -37.63 83.63 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.235 -1.348 . . . . 0.0 111.061 -177.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 3.4 m -101.94 129.9 48.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.269 0.557 . . . . 0.0 111.939 -177.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 22.9 mt 68.12 4.97 4.36 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 114.384 -1.28 . . . . 0.0 113.082 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.417 HD13 ' H ' ' A' ' 208' ' ' ASN . 0.2 OUTLIER -135.74 44.12 2.53 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.202 0.525 . . . . 0.0 110.889 -179.741 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.55 ' O ' ' CB ' ' A' ' 207' ' ' ALA . 56.8 pttt -88.03 49.67 1.84 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.835 -178.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.55 ' CB ' ' O ' ' A' ' 206' ' ' LYS . . . 119.96 17.83 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.155 0 O-C-N 124.494 1.121 . . . . 0.0 109.474 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 208' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' A' ' 207' ' ' ALA . 0.0 OUTLIER 77.57 116.33 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 102.31 -3.219 . . . . 0.0 102.31 -171.492 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.477 ' C ' HD23 ' A' ' 209' ' ' LEU . 2.0 tt . . . . . 0 N--CA 1.465 0.299 0 CA-C-O 120.965 0.412 . . . . 0.0 111.418 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 . . . . . 0 N--CA 1.462 0.165 0 CA-C-O 121.03 0.443 . . . . 0.0 110.712 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.487 ' N ' ' CD ' ' A' ' 215' ' ' PRO . 1.9 mt -61.34 -43.42 89.55 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.263 -178.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 215' ' ' PRO . . . . . 0.487 ' CD ' ' N ' ' A' ' 214' ' ' LEU . 33.5 Cg_exo -60.17 -32.58 94.69 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 121.602 1.534 . . . . 0.0 111.89 -178.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 97.7 m -64.08 -42.01 97.11 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 113.456 -1.702 . . . . 0.0 111.148 -179.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -66.34 -38.35 87.43 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.855 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -63.47 -46.92 84.0 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.285 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 32.7 p -59.97 -37.39 79.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 118.222 0.464 . . . . 0.0 110.785 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 14.0 t -59.29 -41.37 88.81 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.21 -41.49 99.14 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -177.185 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -61.46 -46.86 88.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 122.1 0.952 . . . . 0.0 112.59 -176.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -60.69 -41.79 99.1 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 107.725 -2.15 . . . . 0.0 107.725 176.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' ALA . . . . . 0.604 ' O ' HG23 ' A' ' 228' ' ' THR . . . -62.7 -37.87 88.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.163 -1.018 . . . . 0.0 109.218 177.28 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 225' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -61.41 -41.91 99.65 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.993 -177.414 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -66.37 -38.16 86.92 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 119.316 -0.954 . . . . 0.0 108.574 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' CYS . . . . . 0.442 ' O ' HG12 ' A' ' 230' ' ' VAL . 96.4 m -63.03 -41.23 99.47 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.081 0.467 . . . . 0.0 110.306 177.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 228' ' ' THR . . . . . 0.604 HG23 ' O ' ' A' ' 224' ' ' ALA . 60.4 p -61.85 -39.4 91.74 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.575 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 19.5 m -58.15 -39.22 78.25 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.72 -176.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 227' ' ' CYS . 1.5 p -59.66 -40.19 81.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 118.709 -1.197 . . . . 0.0 108.442 179.367 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 231' ' ' ILE . . . . . 0.599 ' O ' ' HD2' ' A' ' 234' ' ' PRO . 26.7 mt -60.88 -40.23 84.59 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.449 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 177.347 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -61.95 -38.35 88.17 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 115.454 1.649 . . . . 0.0 115.454 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.466 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 0.9 OUTLIER -56.89 -39.65 79.44 Favored Pre-proline 0 N--CA 1.481 1.093 0 N-CA-C 116.276 1.954 . . . . 0.0 116.276 -172.972 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.599 ' HD2' ' O ' ' A' ' 231' ' ' ILE . 38.1 Cg_exo -59.06 -39.94 75.35 Favored 'Trans proline' 0 C--N 1.29 -2.54 0 C-N-CA 122.097 1.865 . . . . 0.0 114.246 -176.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.8 m -64.2 -37.62 80.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 118.435 -1.306 . . . . 0.0 111.369 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 236' ' ' ASP . . . . . 0.441 ' CG ' ' O ' ' A' ' 233' ' ' SER . 0.3 OUTLIER -66.28 -40.09 89.85 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 179.003 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 99.0 t -64.54 -44.97 96.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -175.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 10.0 p . . . . . 0 C--N 1.325 -0.492 0 C-N-CA 119.423 -0.911 . . . . 0.0 110.865 -178.177 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 19.4 m . . . . . 0 CA--C 1.537 0.454 0 CA-C-O 121.25 0.548 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 260' ' ' MET . . . . . 0.575 ' O ' ' N ' ' A' ' 264' ' ' GLU . 0.0 OUTLIER -59.48 -40.87 88.36 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.074 -178.517 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 9.6 tp -59.81 -46.36 89.48 Favored 'General case' 0 C--N 1.32 -0.681 0 O-C-N 121.887 -0.508 . . . . 0.0 110.098 -177.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 262' ' ' ARG . . . . . 0.415 ' HG3' ' H ' ' A' ' 263' ' ' LYS . 9.4 ptm180 -66.36 -52.95 41.66 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 119.056 -1.058 . . . . 0.0 110.304 178.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 263' ' ' LYS . . . . . 0.415 ' H ' ' HG3' ' A' ' 262' ' ' ARG . 2.7 ptmm? -88.29 -55.45 3.73 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 264' ' ' GLU . . . . . 0.575 ' N ' ' O ' ' A' ' 260' ' ' MET . 25.0 mt-10 -90.25 102.16 14.88 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 119.673 1.124 . . . . 0.0 111.473 -179.019 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 265' ' ' GLY . . . . . 0.478 ' C ' ' H ' ' A' ' 267' ' ' ARG . . . -36.91 159.44 0.01 OUTLIER Glycine 0 CA--C 1.536 1.377 0 N-CA-C 111.424 -0.67 . . . . 0.0 111.424 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -56.96 1.13 0.16 Allowed 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 121.952 1.768 . . . . 0.0 112.412 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 267' ' ' ARG . . . . . 0.478 ' H ' ' C ' ' A' ' 265' ' ' GLY . 20.8 mmt85 -69.12 -27.33 65.47 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 110.627 -0.138 . . . . 0.0 110.627 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -59.05 -32.63 69.93 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 119.615 -0.834 . . . . 0.0 109.626 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -62.58 -42.66 99.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.172 178.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -66.94 -36.88 83.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.845 -1.07 . . . . 0.0 112.73 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.428 ' O ' ' O ' ' A' ' 272' ' ' GLY . 98.3 mttt -75.1 174.61 9.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.317 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 272' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 271' ' ' LYS . . . 47.69 101.79 0.01 OUTLIER Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -164.65 7.35 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.167 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 274' ' ' MET . . . . . 0.558 ' O ' HD13 ' A' ' 278' ' ' LEU . 65.1 mtp -63.79 -44.67 80.39 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 275' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 274' ' ' MET . 34.6 Cg_endo -64.53 -46.34 7.42 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 120.969 1.113 . . . . 0.0 112.554 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 17.4 t -60.7 -40.65 93.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.062 0.458 . . . . 0.0 111.044 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -62.05 -42.5 99.25 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 123.668 1.699 . . . . 0.0 110.445 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.558 HD13 ' O ' ' A' ' 274' ' ' MET . 7.2 mp -62.52 -38.29 89.39 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 110.288 -3.142 . . . . 0.0 108.192 174.153 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 17.5 tpt85 -62.62 -40.96 98.64 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.605 0.717 . . . . 0.0 110.613 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 9.7 mt -62.29 -36.15 81.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.586 -1.188 . . . . 0.0 112.834 -177.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -67.78 -50.73 39.85 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -178.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 282' ' ' SER . . . . . 0.518 ' O ' HG22 ' A' ' 285' ' ' VAL . 78.0 p -62.88 -44.7 95.39 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.164 0.507 . . . . 0.0 109.817 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 283' ' ' TRP . . . . . . . . . . . . . 37.8 t90 -61.32 -39.02 88.98 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.743 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -62.86 -39.73 95.31 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -178.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.518 HG22 ' O ' ' A' ' 282' ' ' SER . 9.5 m -61.12 -37.37 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.337 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.495 ' O ' HG12 ' A' ' 289' ' ' VAL . 96.9 t -61.83 -40.52 87.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 29.5 ttp -60.99 -39.18 88.68 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.453 0.645 . . . . 0.0 109.472 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -58.87 -39.52 81.62 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.906 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.495 HG12 ' O ' ' A' ' 286' ' ' VAL . 0.4 OUTLIER -60.16 -38.31 76.63 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -176.417 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -62.65 -40.19 96.25 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 119.137 -1.025 . . . . 0.0 108.642 177.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -61.23 -39.07 88.94 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 176.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -58.57 -40.59 83.53 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 117.748 -1.581 . . . . 0.0 109.737 -176.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 293' ' ' GLN . . . . . 0.445 ' O ' ' O ' ' A' ' 296' ' ' ARG . 21.9 mm100 -60.43 -42.86 96.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 122.506 1.146 . . . . 0.0 110.944 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 10.5 mt -60.2 -40.76 91.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 113.029 -1.896 . . . . 0.0 109.305 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 21.8 mtpt -63.24 -45.82 89.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.271 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 296' ' ' ARG . . . . . 0.445 ' O ' ' O ' ' A' ' 293' ' ' GLN . 80.6 mtm180 -123.02 116.51 23.65 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.443 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -117.22 -94.68 0.49 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.3 0.571 . . . . 0.0 110.862 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.477 ' C ' HD12 ' A' ' 298' ' ' LEU . 0.4 OUTLIER -135.98 -166.45 1.87 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.032 178.846 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 5.7 ptm -171.57 66.48 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.343 -0.543 . . . . 0.0 111.747 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.53 101.12 0.07 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.983 0.897 . . . . 0.0 110.343 -178.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -64.14 -46.23 85.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 113.789 -1.55 . . . . 0.0 113.436 -176.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -58.96 -40.06 83.56 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.177 -0.609 . . . . 0.0 109.613 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -64.83 -46.66 81.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.689 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 304' ' ' SER . . . . . 0.435 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 75.9 p -66.66 -37.37 84.65 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.882 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -61.55 -43.14 99.41 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -65.21 -36.73 85.07 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -177.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 307' ' ' ALA . . . . . 0.544 ' HB3' ' HD3' ' A' ' 308' ' ' PRO . . . -59.92 -52.88 70.51 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -176.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 308' ' ' PRO . . . . . 0.544 ' HD3' ' HB3' ' A' ' 307' ' ' ALA . 74.4 Cg_endo -75.26 0.37 9.09 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.048 1.832 . . . . 0.0 111.874 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 82.3 t80 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.614 179.925 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.1 t . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.748 0.309 . . . . 0.0 110.84 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.568 HG12 ' N ' ' A' ' 16' ' ' LYS . 42.1 t -135.8 164.33 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 121.031 0.443 . . . . 0.0 110.302 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.568 ' N ' HG12 ' A' ' 15' ' ' VAL . 14.2 ptpt -64.52 -41.68 96.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.434 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.535 ' CE2' ' NH1' ' A' ' 96' ' ' ARG . 32.4 t80 -63.41 -41.89 98.73 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -178.663 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.2 pp -80.1 -25.59 39.92 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.185 0.517 . . . . 0.0 112.351 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.42 ' O ' ' OG1' ' A' ' 22' ' ' THR . . . -66.14 -41.21 95.09 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 107.667 -2.173 . . . . 0.0 107.667 177.298 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.414 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -71.5 -32.07 67.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 124.787 2.232 . . . . 0.0 107.193 176.347 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.6 -42.43 98.81 Favored Glycine 0 CA--C 1.527 0.837 1 CA-C-N 108.389 -4.005 . . . . 0.0 108.19 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 19' ' ' GLY . 22.4 p -70.65 -27.74 64.27 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -66.48 -50.02 64.66 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.814 -179.113 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.94 -36.06 80.27 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 118.161 -1.416 . . . . 0.0 110.931 -177.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.2 t -63.99 -53.87 43.38 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.616 -0.433 . . . . 0.0 111.326 -179.073 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.1 tp -65.82 -39.75 85.68 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -177.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.619 ' O ' HG23 ' A' ' 31' ' ' THR . . . -63.9 -41.93 97.57 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 119.736 -0.786 . . . . 0.0 112.924 -173.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -77.69 -27.24 50.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 120.439 1.472 . . . . 0.0 109.886 -176.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.0 tp -59.86 -55.71 30.84 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 119.802 1.183 . . . . 0.0 112.553 -178.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.4 tp -75.75 -4.63 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.619 HG23 ' O ' ' A' ' 27' ' ' ALA . 28.3 p -109.84 -17.27 13.69 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 118.7 -1.2 . . . . 0.0 110.41 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.414 ' N ' ' CD ' ' A' ' 33' ' ' PRO . 66.3 t80 -67.86 -43.65 38.53 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 122.461 2.391 . . . . 0.0 110.583 -178.015 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 32' ' ' PHE . 37.6 Cg_exo -58.94 -15.32 26.72 Favored 'Trans proline' 0 N--CA 1.503 2.06 0 C-N-CA 121.343 1.362 . . . . 0.0 112.341 178.035 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.75 HD13 HH21 ' A' ' 279' ' ' ARG . 88.8 mt -67.15 -34.43 77.55 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -178.031 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -64.09 -40.64 96.67 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -177.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 75.7 p -58.29 -34.79 70.93 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.04 -38.91 86.7 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -178.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.496 ' NZ ' ' CB ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -61.17 -47.06 87.91 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 119.378 -0.929 . . . . 0.0 111.723 -176.173 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 95.0 t -62.39 -38.06 80.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 O-C-N 122.287 -0.258 . . . . 0.0 111.264 -178.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.502 ' O ' ' N ' ' A' ' 42' ' ' GLN . 25.9 mmt180 -59.58 -40.16 86.47 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.367 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 84.2 mt -61.19 38.93 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.502 ' N ' ' O ' ' A' ' 40' ' ' ARG . 2.7 pt20 -172.29 55.32 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 O-C-N 122.074 -0.391 . . . . 0.0 110.739 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.424 ' C ' ' O ' ' A' ' 42' ' ' GLN . 0.1 OUTLIER 26.68 -117.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.959 179.622 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.407 ' H ' ' CG1' ' A' ' 43' ' ' ILE . 28.0 mm100 -129.89 102.51 6.33 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.366 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -81.47 73.6 2.58 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -156.56 163.62 39.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.878 0.37 . . . . 0.0 110.45 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 63.6 p -82.18 67.21 8.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.645 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -118.34 -47.39 2.56 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.825 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.02 13.09 81.76 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -177.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.546 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -65.82 -38.12 88.07 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.435 0.636 . . . . 0.0 109.319 178.978 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.539 HG13 ' N ' ' A' ' 52' ' ' ARG . 12.5 p -60.24 -44.5 95.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.859 -178.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.539 ' N ' HG13 ' A' ' 51' ' ' VAL . 52.5 ttp180 -64.31 -33.59 76.19 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.183 -0.607 . . . . 0.0 109.474 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 95.8 m -67.71 -38.21 83.32 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.415 ' O ' ' O ' ' A' ' 51' ' ' VAL . . . -89.76 124.52 34.71 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.706 179.107 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -87.62 -7.08 57.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.949 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.441 ' C ' ' H ' ' A' ' 58' ' ' GLN . 88.1 p -174.43 -125.89 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 56' ' ' SER . . . 65.27 -19.72 0.09 Allowed 'General case' 0 N--CA 1.461 0.092 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 176.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.441 ' H ' ' C ' ' A' ' 56' ' ' SER . 71.0 mm-40 -126.01 38.76 4.08 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 177.485 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.427 ' O ' ' O ' ' A' ' 58' ' ' GLN . 75.2 m-85 -37.53 -98.37 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.132 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.428 ' O ' ' C ' ' A' ' 61' ' ' GLY . 34.4 ttm180 -154.51 -31.63 0.11 Allowed 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.442 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 60' ' ' ARG . . . -29.03 102.27 0.01 OUTLIER Glycine 0 C--N 1.34 0.774 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.914 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.1 t -66.77 -34.46 70.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 118.31 -0.852 . . . . 0.0 109.14 176.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.7 tp -60.93 -33.01 72.5 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 121.495 1.952 . . . . 0.0 111.365 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -65.05 -49.43 62.42 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 115.223 0.849 . . . . 0.0 115.223 -176.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.41 HG22 ' H ' ' A' ' 65' ' ' THR . 0.0 OUTLIER -62.21 -45.57 92.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.958 -0.621 . . . . 0.0 111.714 -179.159 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 94.5 mt -59.66 -36.37 65.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -179.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.559 ' O ' HD13 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -63.92 -36.41 83.86 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 120.561 1.528 . . . . 0.0 111.343 179.568 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.448 ' O ' ' OG1' ' A' ' 72' ' ' THR . 98.3 m -62.52 -39.35 93.24 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 113.215 -1.812 . . . . 0.0 111.084 -176.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 28.7 ttt -60.52 -39.46 87.9 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -177.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.8 t -68.92 -40.38 81.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 119.473 -0.891 . . . . 0.0 112.851 -177.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -77.71 -13.25 59.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.679 0.752 . . . . 0.0 112.947 -178.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 68' ' ' THR . 16.1 m -62.96 -55.06 29.15 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.947 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 31.9 mp0 -108.39 -58.85 1.94 Allowed 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.407 ' O ' ' CB ' ' A' ' 77' ' ' SER . . . 158.75 164.54 14.45 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -56.49 -35.14 96.39 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.762 1.642 . . . . 0.0 111.546 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.428 ' O ' ' OD1' ' A' ' 80' ' ' ASN . 48.4 ttm-85 -60.97 -11.01 6.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 122.211 1.005 . . . . 0.0 111.003 176.327 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.531 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 36.2 p -77.59 -32.19 53.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 113.285 -1.779 . . . . 0.0 110.205 -179.073 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 85.7 mt -74.8 -28.93 60.92 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.486 1.114 . . . . 0.0 111.477 178.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -86.64 -2.45 58.52 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 122.678 1.228 . . . . 0.0 113.041 -172.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.531 ' ND2' ' O ' ' A' ' 77' ' ' SER . 0.4 OUTLIER -116.33 138.23 51.5 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 112.376 -2.193 . . . . 0.0 108.542 176.847 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.8 -28.09 17.37 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -178.012 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 69.5 mt -59.34 -34.87 72.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.148 -1.026 . . . . 0.0 110.573 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.3 t -70.85 -27.47 30.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.293 -0.867 . . . . 0.0 108.969 178.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.01 -31.93 61.5 Favored 'General case' 0 C--O 1.226 -0.15 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.331 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.64 -40.33 90.42 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 119.463 -1.351 . . . . 0.0 110.802 -178.085 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.5 tp -62.22 -40.27 95.56 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 122.343 1.068 . . . . 0.0 113.243 -176.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -60.17 -27.04 66.78 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 113.285 -1.78 . . . . 0.0 109.307 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 77.0 mtt180 -57.93 -53.41 58.59 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 172.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -67.65 -30.65 70.26 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 112.061 -2.336 . . . . 0.0 113.794 -177.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 2.7 ptm -61.72 -40.09 93.83 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.925 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.5 m -74.1 -34.31 63.91 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 119.191 -1.004 . . . . 0.0 111.048 -176.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -58.0 -43.92 86.94 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 120.899 1.681 . . . . 0.0 112.416 -176.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.1 -33.07 65.36 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.921 -177.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 85.9 p -63.69 -40.74 97.56 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.446 ' C ' ' H ' ' A' ' 97' ' ' ILE . 18.7 m -67.89 -28.77 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.535 ' NH1' ' CE2' ' A' ' 17' ' ' PHE . 5.0 ptm180 -77.61 12.0 1.82 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -177.453 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.446 ' H ' ' C ' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -86.63 -15.35 9.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 179.07 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.503 ' O ' ' OD1' ' A' ' 101' ' ' ASP . . . -140.26 -47.84 0.06 OUTLIER Glycine 0 CA--C 1.536 1.344 0 CA-C-N 114.265 -1.334 . . . . 0.0 114.553 -177.349 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.4 tp -71.65 -13.52 61.77 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 119.453 1.626 . . . . 0.0 113.443 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -81.18 -52.16 7.66 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 114.595 -1.184 . . . . 0.0 112.189 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.62 ' O ' ' HG3' ' A' ' 105' ' ' GLN . 41.5 p-10 -70.15 -32.47 70.47 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 124.061 1.886 . . . . 0.0 110.591 -179.098 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.524 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 28.7 t -67.49 -50.74 57.6 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 109.695 -3.411 . . . . 0.0 111.936 176.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.466 HG22 ' CE2' ' A' ' 107' ' ' TYR . 0.5 OUTLIER -73.25 -26.42 22.58 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.185 0 CA-C-N 121.446 1.93 . . . . 0.0 111.492 178.586 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -69.29 -41.44 76.8 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 112.524 -2.126 . . . . 0.0 110.955 178.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.62 ' HG3' ' O ' ' A' ' 101' ' ' ASP . 88.1 mt-30 -76.64 -16.98 59.41 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.591 0.71 . . . . 0.0 111.073 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -79.33 -22.95 43.83 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.17 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.466 ' CE2' HG22 ' A' ' 103' ' ' VAL . 33.3 m-85 -109.34 -29.35 8.5 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 119.669 1.122 . . . . 0.0 112.855 -174.665 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 59.3 p -95.99 9.42 40.79 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 117.07 -1.852 . . . . 0.0 113.208 -176.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.0 mmmt -47.55 122.64 4.96 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.258 0.935 . . . . 0.0 108.661 176.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -119.29 85.83 0.39 Allowed Glycine 0 N--CA 1.476 1.33 0 CA-C-N 120.216 1.371 . . . . 0.0 111.624 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 34.3 t -94.55 -61.37 1.52 Allowed 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 -176.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -123.29 -176.83 3.53 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 112.749 -2.023 . . . . 0.0 111.971 -177.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.638 ' O ' ' HB2' ' A' ' 114' ' ' ALA . 0.0 OUTLIER -91.25 72.5 6.21 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -178.51 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.638 ' HB2' ' O ' ' A' ' 113' ' ' HIS . . . 159.77 -162.96 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 176.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.22 15.27 26.17 Favored Glycine 0 C--N 1.343 0.958 0 CA-C-N 114.471 -1.241 . . . . 0.0 113.15 177.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.481 HG23 ' N ' ' A' ' 117' ' ' GLY . 15.0 tt -60.87 -40.29 84.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 118.053 0.927 . . . . 0.0 110.215 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.481 ' N ' HG23 ' A' ' 116' ' ' ILE . . . -65.1 -39.68 96.44 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-O 122.029 0.794 . . . . 0.0 111.837 176.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 36.2 m -57.2 -41.68 79.85 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -63.2 -36.71 84.53 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.181 -0.607 . . . . 0.0 111.509 -178.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.649 ' C ' HD12 ' A' ' 120' ' ' LEU . 0.1 OUTLIER -63.91 -45.78 87.77 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.087 0.47 . . . . 0.0 110.407 178.387 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.423 ' N ' ' HG ' ' A' ' 120' ' ' LEU . 10.9 tp -65.7 -44.05 87.3 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 119.405 -0.918 . . . . 0.0 109.821 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.69 -44.38 96.38 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 118.922 0.783 . . . . 0.0 110.496 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -65.72 -44.23 92.76 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 119.561 -1.304 . . . . 0.0 112.021 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 10.9 t -64.15 -44.76 91.16 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 119.985 -0.686 . . . . 0.0 111.631 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.417 ' O ' HD23 ' A' ' 129' ' ' LEU . 21.3 m -69.73 -48.89 57.85 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 119.07 -1.052 . . . . 0.0 112.194 177.507 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 24.5 m -65.49 -42.81 91.78 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 -174.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -64.22 -44.65 95.3 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-O 122.802 1.223 . . . . 0.0 113.342 -177.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.426 ' O ' ' CG2' ' A' ' 131' ' ' VAL . . . -60.96 -41.31 96.09 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 112.073 -2.063 . . . . 0.0 107.075 177.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.665 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 1.6 mm? -64.3 -42.02 96.57 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.438 178.646 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.18 -39.86 95.85 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -177.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.426 ' CG2' ' O ' ' A' ' 128' ' ' ALA . 7.0 m -61.15 -25.76 37.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 122.753 1.264 . . . . 0.0 109.544 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.665 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . -58.55 -44.94 89.83 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 112.364 -2.198 . . . . 0.0 111.673 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.438 HG12 ' H ' ' A' ' 133' ' ' VAL . 2.0 p -79.07 -48.82 20.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -102.73 129.15 49.27 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.826 0.346 . . . . 0.0 111.122 -179.162 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.661 ' H ' ' CD ' ' A' ' 136' ' ' PRO . 51.2 tp60 -173.15 -38.5 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.25 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.934 179.153 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.661 ' CD ' ' H ' ' A' ' 135' ' ' GLN . 63.3 Cg_exo -52.88 -34.17 64.77 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.467 1.444 . . . . 0.0 112.002 -179.228 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 11.2 m -68.35 -42.92 78.55 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 118.082 -1.447 . . . . 0.0 110.919 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -66.91 -43.97 82.0 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 118.26 -1.376 . . . . 0.0 112.853 -178.223 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.465 HG23 ' N ' ' A' ' 140' ' ' VAL . 27.6 m -64.96 -44.6 96.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -179.166 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.465 ' N ' HG23 ' A' ' 139' ' ' VAL . 7.6 p -65.33 -38.69 83.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -177.206 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -62.16 -41.08 97.96 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -176.53 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.449 ' CG1' ' N ' ' A' ' 143' ' ' ARG . 2.4 p -70.39 -44.78 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.072 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.539 HH22 ' H ' ' A' ' 178' ' ' GLY . 81.5 mtt85 -64.26 -36.28 83.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.468 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -66.42 -41.23 89.52 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.769 -0.373 . . . . 0.0 111.572 -177.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 18.3 mm100 -64.92 -39.56 93.7 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 119.526 -0.87 . . . . 0.0 109.083 178.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.31 -34.84 79.28 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -179.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -60.27 110.47 1.24 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 176.411 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -100.91 -58.26 1.93 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 117.226 -1.368 . . . . 0.0 113.836 -176.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.528 ' O ' ' N ' ' A' ' 151' ' ' GLY . 28.9 ptt-85 -133.66 17.67 3.92 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 122.641 2.473 . . . . 0.0 110.03 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . 49.95 -86.5 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.724 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 149' ' ' ARG . . . -157.28 42.56 0.53 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.712 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 179.941 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.765 0.317 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -80.39 -164.68 0.73 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.545 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 56.7 m -156.97 -178.1 7.12 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.156 0.503 . . . . 0.0 110.843 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 98.7 m -64.25 -46.31 84.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.983 -177.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.548 HG23 ' N ' ' A' ' 161' ' ' GLU . 34.0 m -64.35 -45.36 96.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 118.946 -1.102 . . . . 0.0 109.239 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.548 ' N ' HG23 ' A' ' 160' ' ' VAL . 81.8 tt0 -67.36 -39.27 85.69 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.665 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -61.68 -45.99 91.65 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -177.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -62.73 -49.66 74.16 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.422 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -68.36 -45.41 72.87 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 -175.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.562 HG23 ' N ' ' A' ' 166' ' ' ILE . 14.1 t -62.82 -44.88 94.99 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.519 1.054 . . . . 0.0 113.689 -177.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.562 ' N ' HG23 ' A' ' 165' ' ' THR . 2.5 pp -64.84 -38.3 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 121.906 0.86 . . . . 0.0 109.337 176.328 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.451 ' N ' HD12 ' A' ' 166' ' ' ILE . . . -59.25 -35.6 73.97 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 113.992 -1.458 . . . . 0.0 107.788 176.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.407 ' HE ' ' HA ' ' A' ' 168' ' ' ARG . 0.5 OUTLIER -61.6 -49.78 75.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 122.401 2.364 . . . . 0.0 111.449 -175.475 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -74.57 -50.99 15.86 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 123.446 0.698 . . . . 0.0 109.63 177.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.487 ' CD ' ' N ' ' A' ' 170' ' ' GLU . 2.2 mp0 -77.98 -36.6 48.76 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 116.637 2.088 . . . . 0.0 116.637 -173.376 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' GLY . . . . . 0.413 ' O ' HD23 ' A' ' 175' ' ' LEU . . . 91.49 -167.23 31.03 Favored Glycine 0 N--CA 1.47 0.935 0 CA-C-N 118.842 0.746 . . . . 0.0 112.007 177.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.531 HG23 ' N ' ' A' ' 173' ' ' ARG . 19.8 tt -73.45 -42.55 56.5 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.07 0 CA-C-O 121.963 0.887 . . . . 0.0 110.885 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.531 ' N ' HG23 ' A' ' 172' ' ' ILE . 3.9 tpt180 -58.79 -33.49 70.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 113.993 -1.458 . . . . 0.0 111.261 -176.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -60.7 -40.24 97.76 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 118.965 -1.588 . . . . 0.0 110.006 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.52 ' O ' ' NH2' ' A' ' 143' ' ' ARG . 3.7 mm? -70.61 -33.27 70.86 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 111.673 -2.264 . . . . 0.0 116.922 -177.486 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 19.5 m0 -78.06 -7.65 57.2 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 112.076 -2.329 . . . . 0.0 109.845 -177.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -43.22 -47.97 6.49 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.405 -176.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.539 ' H ' HH22 ' A' ' 143' ' ' ARG . . . -91.9 -32.06 8.79 Favored Glycine 0 CA--C 1.533 1.217 0 N-CA-C 111.329 -0.708 . . . . 0.0 111.329 178.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 34.8 m -45.36 -51.52 11.09 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' SER . . . . . 0.43 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 2.8 m -62.47 -50.8 77.21 Favored Pre-proline 0 N--CA 1.471 0.581 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -176.309 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 180' ' ' SER . 28.2 Cg_endo -64.84 -28.38 59.08 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 121.482 1.455 . . . . 0.0 111.782 176.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -63.92 -39.53 94.38 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.454 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 70.9 t -63.09 -42.59 97.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.14 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.2 -39.49 92.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.048 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 33.0 ttm105 -60.59 -41.67 95.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.842 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -61.34 -42.92 99.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.063 0.459 . . . . 0.0 110.805 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.44 -43.82 93.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.092 -179.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 33.0 mm -63.56 -45.25 98.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -177.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.46 ' O ' ' N ' ' A' ' 193' ' ' GLU . 3.0 p -60.09 -46.79 93.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 119.679 -0.808 . . . . 0.0 112.027 -177.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 190' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 191' ' ' CYS . 2.6 p30 -63.13 -42.64 99.55 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 122.089 0.947 . . . . 0.0 109.983 179.103 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 191' ' ' CYS . . . . . 0.524 ' N ' ' OD1' ' A' ' 190' ' ' ASN . 27.2 m -61.2 -45.66 93.69 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 113.94 -1.482 . . . . 0.0 109.317 179.295 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -63.76 -39.56 94.56 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 112.99 -1.913 . . . . 0.0 108.638 175.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 0.46 ' N ' ' O ' ' A' ' 189' ' ' VAL . 74.6 tt0 -61.33 -46.96 88.07 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.868 -177.505 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 53.4 mt -65.15 -39.26 92.75 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 118.547 -1.261 . . . . 0.0 110.493 -175.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 7.0 m -63.97 -45.74 95.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 C-N-CA 117.078 -1.849 . . . . 0.0 107.297 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 19.9 m -63.75 -45.7 88.64 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -178.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -56.49 -38.34 71.62 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.296 1.038 . . . . 0.0 112.29 -178.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.44 -44.0 75.91 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.689 HD22 ' N ' ' A' ' 199' ' ' LEU . 2.9 mm? -61.18 -39.15 89.1 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 41.3 mm -62.78 -42.99 98.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.029 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -60.24 -39.55 87.13 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.758 1.223 . . . . 0.0 111.852 177.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -63.06 -38.53 91.56 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.119 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 35.9 m -101.56 128.19 47.93 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.855 0.835 . . . . 0.0 111.987 -179.001 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.547 ' O ' HD22 ' A' ' 205' ' ' LEU . 3.7 tp 66.84 4.73 3.61 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 114.186 -1.37 . . . . 0.0 112.147 177.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.547 HD22 ' O ' ' A' ' 204' ' ' LEU . 1.3 mm? -125.55 29.93 5.88 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.35 0.595 . . . . 0.0 112.487 -177.261 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -71.55 -24.65 61.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.806 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.547 ' O ' ' O ' ' A' ' 208' ' ' ASN . . . -165.05 33.04 0.06 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.362 179.452 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 208' ' ' ASN . . . . . 0.547 ' O ' ' O ' ' A' ' 207' ' ' ALA . 1.6 m-20 40.0 123.22 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 177.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.501 ' C ' ' O ' ' A' ' 208' ' ' ASN . 43.4 tp . . . . . 0 N--CA 1.48 1.073 0 CA-C-N 115.015 -0.993 . . . . 0.0 112.559 179.254 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 0.407 ' O ' ' OD1' ' A' ' 213' ' ' ASP . 2.5 p30 . . . . . 0 N--CA 1.464 0.24 0 CA-C-O 121.078 0.466 . . . . 0.0 110.514 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.436 ' N ' ' CD ' ' A' ' 215' ' ' PRO . 6.0 mt -61.41 -43.27 88.71 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 113.118 0.785 . . . . 0.0 113.118 -178.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 215' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 214' ' ' LEU . 27.1 Cg_exo -60.74 -33.73 92.69 Favored 'Trans proline' 0 N--CA 1.5 1.884 0 CA-C-N 120.051 1.054 . . . . 0.0 111.555 -177.746 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 84.1 m -64.01 -41.79 97.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 112.767 -2.015 . . . . 0.0 111.213 -178.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -66.18 -37.08 84.76 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.241 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -62.96 -47.41 83.31 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.252 -178.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.402 ' H ' HG22 ' A' ' 219' ' ' THR . 1.4 t -60.58 -37.94 82.97 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 119.395 0.998 . . . . 0.0 110.87 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 71.1 m -59.68 -41.89 91.71 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 221' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.9 -41.94 97.57 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.148 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -62.39 -47.5 83.86 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 119.755 -0.778 . . . . 0.0 112.953 -176.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -61.27 -42.48 99.79 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 108.199 -1.961 . . . . 0.0 108.199 177.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 224' ' ' ALA . . . . . 0.464 ' O ' ' SG ' ' A' ' 227' ' ' CYS . . . -63.25 -39.14 93.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.497 -0.851 . . . . 0.0 109.02 177.394 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 225' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -62.93 -43.05 99.49 Favored Glycine 0 CA--C 1.52 0.354 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.607 -178.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 226' ' ' PHE . . . . . 0.442 ' O ' ' OG1' ' A' ' 229' ' ' THR . 75.3 t80 -66.91 -38.95 87.19 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 119.659 -0.816 . . . . 0.0 108.855 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 227' ' ' CYS . . . . . 0.466 ' SG ' ' N ' ' A' ' 228' ' ' THR . 0.5 OUTLIER -63.41 -41.06 98.71 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 176.847 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 228' ' ' THR . . . . . 0.466 ' N ' ' SG ' ' A' ' 227' ' ' CYS . 26.8 m -62.7 -41.54 99.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.839 179.137 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.448 HG23 ' O ' ' A' ' 225' ' ' GLY . 16.1 p -59.99 -40.32 88.75 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -176.632 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.405 HG22 ' H ' ' A' ' 230' ' ' VAL . 3.3 m -60.66 -40.27 84.2 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.381 0 C-N-CA 118.455 -1.298 . . . . 0.0 108.953 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 231' ' ' ILE . . . . . 0.486 ' O ' ' HD2' ' A' ' 234' ' ' PRO . 1.7 mp -61.0 -40.85 86.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 176.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.01 -39.98 96.39 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.48 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 0.5 OUTLIER -58.47 -42.18 93.2 Favored Pre-proline 0 N--CA 1.483 1.214 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 -173.858 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.486 ' HD2' ' O ' ' A' ' 231' ' ' ILE . 31.3 Cg_exo -57.97 -39.75 83.64 Favored 'Trans proline' 0 C--N 1.293 -2.378 0 C-N-CA 122.536 2.157 . . . . 0.0 113.276 179.081 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 46.5 t -63.95 -37.26 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 118.055 -1.458 . . . . 0.0 108.922 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -65.88 -40.62 91.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.75 178.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 53.2 t -64.79 -45.51 94.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -176.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 27.6 m . . . . . 0 C--N 1.322 -0.613 0 C-N-CA 119.224 -0.991 . . . . 0.0 111.732 -178.159 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 85.8 m . . . . . 0 N--CA 1.456 -0.135 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 260' ' ' MET . . . . . 0.447 ' SD ' ' C ' ' A' ' 260' ' ' MET . 13.6 tmm? -61.62 -45.04 95.76 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -177.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.17 -47.5 82.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.102 0.477 . . . . 0.0 110.26 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 262' ' ' ARG . . . . . 0.463 ' O ' ' O ' ' A' ' 263' ' ' LYS . 61.5 ttt85 -66.66 -53.84 29.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.463 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 263' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 262' ' ' ARG . 28.0 tttp -57.81 -138.99 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.9 0.381 . . . . 0.0 111.369 -178.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -63.91 149.52 46.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.997 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 265' ' ' GLY . . . . . 0.539 ' C ' ' H ' ' A' ' 267' ' ' ARG . . . -44.04 160.19 0.1 OUTLIER Glycine 0 CA--C 1.535 1.283 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -50.85 0.07 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 122.018 1.812 . . . . 0.0 112.945 178.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 267' ' ' ARG . . . . . 0.539 ' H ' ' C ' ' A' ' 265' ' ' GLY . 89.4 mtt-85 -69.5 -26.95 64.79 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 122.696 0.398 . . . . 0.0 111.817 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -58.83 -32.63 69.57 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.404 -178.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -62.51 -41.55 98.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.376 0.608 . . . . 0.0 110.89 178.247 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -66.05 -37.46 85.91 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.284 -178.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.434 ' O ' ' O ' ' A' ' 272' ' ' GLY . 95.8 mttt -80.65 -179.72 7.37 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 272' ' ' GLY . . . . . 0.434 ' O ' ' O ' ' A' ' 271' ' ' LYS . . . 52.3 109.29 0.01 OUTLIER Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.694 -0.563 . . . . 0.0 111.694 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -178.31 8.27 0.01 OUTLIER 'General case' 0 C--O 1.232 0.151 0 C-N-CA 121.166 -0.214 . . . . 0.0 111.325 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 274' ' ' MET . . . . . 0.549 ' N ' ' CD ' ' A' ' 275' ' ' PRO . 0.1 OUTLIER -63.91 -44.53 79.11 Favored Pre-proline 0 CA--C 1.533 0.291 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.898 -179.148 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 275' ' ' PRO . . . . . 0.549 ' CD ' ' N ' ' A' ' 274' ' ' MET . 22.1 Cg_exo -64.46 -46.86 6.58 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 122.353 2.035 . . . . 0.0 111.471 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 49.2 m -60.78 -39.71 89.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.749 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 277' ' ' PHE . . . . . 0.403 ' CD1' ' C ' ' A' ' 277' ' ' PHE . 41.0 t80 -61.64 -42.67 99.21 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 122.738 1.256 . . . . 0.0 112.969 -178.24 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.514 HD13 ' O ' ' A' ' 278' ' ' LEU . 0.2 OUTLIER -62.29 -38.78 90.65 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 112.11 -2.314 . . . . 0.0 107.815 174.284 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 279' ' ' ARG . . . . . 0.75 HH21 HD13 ' A' ' 34' ' ' LEU . 4.4 mtp180 -62.81 -39.71 95.14 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.375 0.607 . . . . 0.0 110.283 178.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -62.07 -36.55 82.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.508 -178.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -68.08 -51.2 35.06 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -178.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 282' ' ' SER . . . . . 0.435 ' O ' HG12 ' A' ' 285' ' ' VAL . 74.8 m -63.0 -44.36 96.24 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 123.109 0.564 . . . . 0.0 109.91 179.348 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 283' ' ' TRP . . . . . 0.405 ' O ' HG22 ' A' ' 286' ' ' VAL . 48.7 t-105 -59.7 -38.36 81.39 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -62.2 -37.37 85.06 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.363 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.435 HG12 ' O ' ' A' ' 282' ' ' SER . 0.4 OUTLIER -59.88 -37.73 73.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.143 -178.278 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.493 ' O ' HG22 ' A' ' 289' ' ' VAL . 0.8 OUTLIER -61.61 -40.28 86.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.724 -179.23 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 30.9 mtm -60.95 -38.85 87.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.098 0.475 . . . . 0.0 110.453 178.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -58.69 -40.13 82.7 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.83 -178.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.493 HG22 ' O ' ' A' ' 286' ' ' VAL . 1.0 OUTLIER -60.31 -38.91 79.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 120.981 0.419 . . . . 0.0 110.91 -177.576 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 12.5 m -64.27 -40.04 95.17 Favored 'General case' 0 CA--C 1.549 0.925 0 O-C-N 121.574 -0.704 . . . . 0.0 111.729 177.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -61.01 -40.4 93.39 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-O 118.652 -0.69 . . . . 0.0 109.165 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 292' ' ' GLU . . . . . 0.434 ' CG ' ' O ' ' A' ' 289' ' ' VAL . 4.4 pt-20 -59.39 -39.42 83.33 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 116.552 -2.059 . . . . 0.0 109.781 -176.163 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 293' ' ' GLN . . . . . 0.471 ' O ' ' O ' ' A' ' 296' ' ' ARG . 57.4 tt0 -59.51 -42.83 93.11 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 122.38 1.086 . . . . 0.0 111.306 -178.007 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -60.52 -40.74 92.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 113.61 -1.632 . . . . 0.0 108.574 178.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -63.22 -45.97 89.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.263 178.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 296' ' ' ARG . . . . . 0.471 ' O ' ' O ' ' A' ' 293' ' ' GLN . 11.9 tpp85 -123.03 116.25 23.21 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -121.01 -163.38 1.02 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.236 0.541 . . . . 0.0 112.413 -178.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.575 HD22 ' N ' ' A' ' 298' ' ' LEU . 3.2 mm? -67.21 116.94 8.56 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 26.4 ttm -96.77 62.64 1.94 Allowed 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -178.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.65 100.84 0.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.976 0.893 . . . . 0.0 110.834 -178.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -64.1 -46.4 84.39 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 113.746 -1.57 . . . . 0.0 113.434 -176.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -58.6 -39.67 81.07 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.39 -0.524 . . . . 0.0 109.897 -178.094 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -64.9 -46.77 80.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.871 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 304' ' ' SER . . . . . 0.426 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 78.0 p -66.66 -38.04 86.04 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.711 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.04 -42.73 99.49 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.544 179.354 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 12.7 tm-20 -64.74 -37.12 86.53 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -177.241 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 307' ' ' ALA . . . . . 0.544 ' HB3' ' HD3' ' A' ' 308' ' ' PRO . . . -60.01 -52.94 69.96 Favored Pre-proline 0 CA--C 1.544 0.716 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -176.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 308' ' ' PRO . . . . . 0.544 ' HD3' ' HB3' ' A' ' 307' ' ' ALA . 74.5 Cg_endo -75.36 0.32 9.18 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.255 1.97 . . . . 0.0 112.106 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 78.7 t80 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.519 -179.895 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.3 m . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.774 0.321 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.587 HG13 ' H ' ' A' ' 18' ' ' LEU . 4.3 p -160.67 166.53 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.235 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.572 ' N ' HG22 ' A' ' 15' ' ' VAL . 30.2 mmtp -64.38 -41.65 96.58 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -178.59 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.42 ' H ' HG22 ' A' ' 15' ' ' VAL . 65.9 m-85 -63.54 -41.15 98.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.228 0.537 . . . . 0.0 112.438 -179.307 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.587 ' H ' HG13 ' A' ' 15' ' ' VAL . 9.8 tp -79.78 -25.96 40.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.276 -0.874 . . . . 0.0 112.617 -178.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.32 -41.41 94.6 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 107.768 -2.133 . . . . 0.0 107.768 177.321 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.403 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -71.53 -32.08 67.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 124.873 2.273 . . . . 0.0 107.18 176.47 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.35 -42.38 99.18 Favored Glycine 0 CA--C 1.527 0.818 1 CA-C-N 108.393 -4.003 . . . . 0.0 107.804 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 92.8 m -70.54 -27.97 64.56 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.498 0.666 . . . . 0.0 109.262 177.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -66.39 -49.94 65.13 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.851 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.96 -35.89 79.8 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 118.144 -1.422 . . . . 0.0 110.979 -177.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.446 ' O ' HD13 ' A' ' 29' ' ' LEU . 77.5 m -63.8 -54.08 40.77 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.616 -178.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.456 HD12 ' N ' ' A' ' 27' ' ' ALA . 2.6 pp -65.73 -39.39 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -176.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.456 ' N ' HD12 ' A' ' 26' ' ' ILE . . . -64.12 -41.9 97.06 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 119.831 -0.748 . . . . 0.0 112.706 -173.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.464 ' O ' ' N ' ' A' ' 32' ' ' PHE . 29.9 m-20 -77.78 -27.35 50.22 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 117.823 -1.551 . . . . 0.0 109.52 -176.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.446 HD13 ' O ' ' A' ' 25' ' ' CYS . 5.4 mp -60.23 -55.92 27.81 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 120.129 1.331 . . . . 0.0 111.731 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.521 ' O ' HD13 ' A' ' 34' ' ' LEU . 10.1 tp -75.68 -4.79 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 121.659 0.742 . . . . 0.0 112.034 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.6 m -109.83 -16.48 13.87 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 114.454 -1.248 . . . . 0.0 110.202 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.507 ' N ' ' CD ' ' A' ' 33' ' ' PRO . 0.2 OUTLIER -68.28 -44.92 38.19 Favored Pre-proline 0 C--N 1.325 -0.463 0 C-N-CA 116.156 -2.218 . . . . 0.0 109.452 -178.231 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 32' ' ' PHE . 34.0 Cg_exo -59.95 -16.67 39.99 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 121.32 1.346 . . . . 0.0 112.573 177.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.521 HD13 ' O ' ' A' ' 30' ' ' ILE . 8.6 mp -67.7 -35.41 78.74 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -178.62 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 36' ' ' THR . 1.9 p30 -64.44 -40.47 95.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.948 -177.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.545 ' N ' ' OD1' ' A' ' 35' ' ' ASP . 47.5 p -58.44 -34.97 71.41 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 120.41 -0.516 . . . . 0.0 112.176 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.52 -39.55 85.11 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 119.547 -0.861 . . . . 0.0 112.902 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.455 ' CB ' ' NH2' ' A' ' 279' ' ' ARG . 10.0 ptmt -63.09 -48.68 77.57 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 118.854 -1.138 . . . . 0.0 111.246 -177.343 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 66.4 t -63.55 -39.81 86.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -177.032 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.507 ' O ' ' N ' ' A' ' 42' ' ' GLN . 8.6 tpm_? -60.82 -41.39 95.62 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 119.19 -1.004 . . . . 0.0 109.718 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.49 38.81 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.58 178.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.507 ' N ' ' O ' ' A' ' 40' ' ' ARG . 45.1 tt0 -88.7 -112.64 0.06 Allowed 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.646 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.1 tp -154.3 8.93 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.158 0.504 . . . . 0.0 109.794 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.519 ' NE2' ' OE1' ' A' ' 58' ' ' GLN . 14.7 mm100 56.97 26.04 11.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.55 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -118.65 141.17 15.84 Favored Glycine 0 N--CA 1.466 0.683 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -149.4 -84.26 0.1 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 86.4 p -172.04 70.49 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.782 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 -156.01 -27.63 0.1 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.085 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.98 17.67 74.15 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 108.577 -1.809 . . . . 0.0 108.577 -177.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.724 HD22 ' N ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -63.92 -35.52 80.93 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.081 -1.06 . . . . 0.0 111.031 -179.089 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.724 ' N ' HD22 ' A' ' 50' ' ' LEU . 83.9 t -59.4 -43.81 91.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.217 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 71.0 ttp85 -64.01 -33.86 76.69 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.99 -38.13 82.32 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.279 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -136.36 95.39 3.17 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.236 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.92 -19.83 64.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.3 -178.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.599 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 7.9 t -125.67 -141.02 0.28 Allowed 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.62 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.599 ' HB3' ' O ' ' A' ' 56' ' ' SER . . . 99.38 12.42 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 O-C-N 124.132 0.895 . . . . 0.0 112.616 178.349 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.519 ' OE1' ' NE2' ' A' ' 44' ' ' GLN . 10.7 pt20 178.36 101.72 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.995 0.426 . . . . 0.0 111.052 179.323 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -84.88 166.95 16.43 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.44 ' O ' ' C ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER -52.29 -35.07 49.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.233 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.44 ' C ' ' O ' ' A' ' 60' ' ' ARG . . . -28.23 100.21 0.01 OUTLIER Glycine 0 CA--C 1.53 1.011 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.241 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 24.6 m -67.21 -33.99 66.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.072 176.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -60.26 -32.4 71.13 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 121.31 1.868 . . . . 0.0 109.731 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.51 -48.99 67.52 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-N 114.934 -1.03 . . . . 0.0 114.459 -176.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.41 HG23 ' H ' ' A' ' 65' ' ' THR . 12.8 p -62.14 -46.13 90.37 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -179.187 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 97.0 mt -59.68 -35.99 62.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 118.119 -0.943 . . . . 0.0 108.94 -178.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.641 HD12 ' C ' ' A' ' 67' ' ' LEU . 0.3 OUTLIER -63.84 -35.28 80.12 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 121.422 1.919 . . . . 0.0 111.993 179.525 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 98.3 m -62.19 -38.34 88.74 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 113.4 -1.727 . . . . 0.0 110.99 -176.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 58.0 mmm -59.79 -40.04 86.95 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 121.048 -1.032 . . . . 0.0 113.425 -177.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 93.3 t -69.71 -41.14 79.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 118.967 -1.093 . . . . 0.0 113.82 -177.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 36.5 mmm-85 -78.97 -13.06 60.02 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -178.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.521 ' CG2' ' N ' ' A' ' 73' ' ' GLU . 0.7 OUTLIER -62.27 -54.65 37.6 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.633 -179.215 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.521 ' N ' ' CG2' ' A' ' 72' ' ' THR . 35.2 mt-10 -106.88 -53.93 2.54 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.037 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.417 ' O ' ' CB ' ' A' ' 77' ' ' SER . . . 155.77 166.23 15.52 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -56.43 -35.32 96.32 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 121.281 1.32 . . . . 0.0 110.971 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -61.43 -12.0 12.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.983 0.897 . . . . 0.0 110.723 175.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.458 ' O ' ' OD1' ' A' ' 80' ' ' ASN . 6.5 t -77.91 -32.36 51.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 113.911 -1.495 . . . . 0.0 110.454 -178.649 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 15.3 tp -75.95 -33.41 59.82 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 121.761 -0.587 . . . . 0.0 110.823 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.43 ' C ' ' H ' ' A' ' 81' ' ' GLY . 53.5 m-85 -92.75 -5.09 51.96 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 -177.461 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.458 ' OD1' ' O ' ' A' ' 77' ' ' SER . 36.1 p-10 -92.52 26.05 2.79 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 174.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 79' ' ' TYR . . . -160.07 -19.62 0.03 OUTLIER Glycine 0 CA--C 1.526 0.732 0 CA-C-N 112.942 -1.935 . . . . 0.0 112.036 -178.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.407 ' H ' ' H ' ' A' ' 81' ' ' GLY . 42.6 tp -59.06 -35.0 72.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.091 -1.054 . . . . 0.0 110.406 -179.214 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.4 t -70.67 -27.01 29.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.29 178.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.67 -31.32 61.88 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.717 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.42 -40.06 91.43 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 119.645 -1.264 . . . . 0.0 111.46 -177.085 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -62.37 -39.92 94.75 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 122.192 0.996 . . . . 0.0 113.655 -176.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -59.68 -26.12 65.32 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 113.348 -1.751 . . . . 0.0 109.615 -179.047 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.616 ' NE ' ' NZ ' ' A' ' 141' ' ' LYS . 7.4 mmm180 -56.44 -52.35 64.99 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 173.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -67.6 -29.9 69.36 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 113.475 -1.693 . . . . 0.0 112.692 -178.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 24.8 mmt -61.08 -42.06 97.8 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 78.1 p -74.7 -34.84 62.71 Favored 'General case' 0 C--N 1.338 0.102 0 C-N-CA 119.301 -0.959 . . . . 0.0 111.864 -176.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -57.96 -43.55 86.5 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 120.496 1.498 . . . . 0.0 112.279 -176.083 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.41 -32.65 64.54 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 119.78 -0.768 . . . . 0.0 111.292 -178.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.608 ' O ' HG22 ' A' ' 97' ' ' ILE . 50.5 m -63.96 -41.53 97.55 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.448 ' C ' ' H ' ' A' ' 97' ' ' ILE . 24.2 m -68.12 -28.48 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.493 178.184 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 64.4 mtp180 -77.42 10.41 2.57 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -177.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.608 HG22 ' O ' ' A' ' 94' ' ' SER . 12.0 tt -86.78 -15.62 9.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.311 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.419 ' O ' ' OG ' ' A' ' 102' ' ' SER . . . -141.0 -48.85 0.05 OUTLIER Glycine 0 CA--C 1.534 1.252 0 CA-C-N 114.917 -1.038 . . . . 0.0 114.77 -178.282 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 60.5 mt -72.53 -14.29 61.61 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.096 1.448 . . . . 0.0 113.985 -177.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.521 ' O ' ' CD ' ' A' ' 104' ' ' LYS . 46.6 t80 -81.84 -53.12 6.44 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 114.653 -1.158 . . . . 0.0 112.542 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -72.6 -33.57 66.81 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 123.799 1.761 . . . . 0.0 114.136 -179.099 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' A' ' 98' ' ' GLY . 79.3 p -66.5 -50.6 62.71 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 110.244 -3.162 . . . . 0.0 117.068 -177.164 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.731 HG12 ' CE2' ' A' ' 107' ' ' TYR . 1.5 t -73.32 -23.37 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 CA-C-O 124.327 2.013 . . . . 0.0 109.94 175.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.521 ' CD ' ' O ' ' A' ' 100' ' ' TYR . 0.0 OUTLIER -66.8 -41.22 87.92 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 109.677 -3.42 . . . . 0.0 112.194 -178.02 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -78.81 -11.08 59.97 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 125.143 2.401 . . . . 0.0 111.05 178.049 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -79.63 -21.88 44.32 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 110.712 -2.949 . . . . 0.0 110.538 177.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.731 ' CE2' HG12 ' A' ' 103' ' ' VAL . 41.1 m-85 -109.5 -28.67 8.79 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -175.538 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.735 ' C ' ' H ' ' A' ' 110' ' ' GLY . 66.4 p -95.55 12.07 30.84 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 -174.05 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.435 ' O ' ' N ' ' A' ' 111' ' ' SER . 15.2 ttpp -54.71 22.31 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.055 0 CA-C-N 119.472 1.033 . . . . 0.0 111.239 177.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.735 ' H ' ' C ' ' A' ' 108' ' ' THR . . . 65.24 -57.06 0.11 Allowed Glycine 0 N--CA 1.472 1.053 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.544 ' CB ' ' O ' ' A' ' 110' ' ' GLY . 6.9 t 106.35 -164.67 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 177.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.537 ' OE1' ' N ' ' A' ' 112' ' ' GLU . 35.4 mp0 -120.55 -40.28 2.68 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 -175.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.608 ' O ' ' HB2' ' A' ' 114' ' ' ALA . 0.0 OUTLIER 165.05 29.97 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.503 0.668 . . . . 0.0 109.366 -179.318 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.608 ' HB2' ' O ' ' A' ' 113' ' ' HIS . . . 160.31 -161.21 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.86 14.87 25.8 Favored Glycine 0 CA--C 1.507 -0.429 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.506 HG23 ' N ' ' A' ' 117' ' ' GLY . 3.0 tp -60.77 -40.22 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.506 ' N ' HG23 ' A' ' 116' ' ' ILE . . . -65.69 -39.87 95.54 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 110.946 -0.861 . . . . 0.0 110.946 174.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 6.8 t -58.85 -43.06 90.67 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 176.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 25.9 mmm-85 -63.65 -37.48 87.49 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 119.849 -0.741 . . . . 0.0 110.38 -177.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.69 -45.91 87.89 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 6.3 tp -67.14 -45.29 77.54 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.729 178.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.29 -44.97 90.03 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 119.918 1.235 . . . . 0.0 109.803 178.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -65.85 -44.48 91.92 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 119.222 -1.466 . . . . 0.0 110.614 -178.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 65.7 m -64.48 -44.61 90.45 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.309 -0.556 . . . . 0.0 111.095 178.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 19.5 m -69.9 -49.03 56.14 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 119.419 -0.912 . . . . 0.0 112.433 177.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 42.3 p -65.82 -42.16 90.95 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 120.149 1.34 . . . . 0.0 113.775 -175.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -64.03 -44.33 96.03 Favored Glycine 0 CA--C 1.518 0.254 0 CA-C-O 122.983 1.324 . . . . 0.0 112.162 -178.176 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.417 ' O ' ' CG2' ' A' ' 131' ' ' VAL . . . -61.48 -41.45 97.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 111.386 -2.407 . . . . 0.0 107.247 177.201 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.629 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 0.2 OUTLIER -64.5 -42.33 95.89 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.25 178.928 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.23 -40.08 96.45 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -177.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.417 ' CG2' ' O ' ' A' ' 128' ' ' ALA . 5.8 m -61.15 -25.98 37.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 122.482 1.134 . . . . 0.0 109.942 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.629 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . -58.29 -44.98 88.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 112.755 -2.02 . . . . 0.0 112.425 -178.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.48 ' CG1' ' N ' ' A' ' 134' ' ' ALA . 2.7 p -79.09 -48.89 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.295 -179.039 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.48 ' N ' ' CG1' ' A' ' 133' ' ' VAL . . . -106.55 138.76 42.13 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.707 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.603 ' H ' ' HD2' ' A' ' 136' ' ' PRO . 7.8 pt20 172.23 -38.48 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.797 0 CA-C-O 118.279 -0.867 . . . . 0.0 113.132 179.043 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.603 ' HD2' ' H ' ' A' ' 135' ' ' GLN . 13.1 Cg_endo -52.66 -34.37 63.52 Favored 'Trans proline' 0 N--CA 1.498 1.785 0 CA-C-N 122.257 1.842 . . . . 0.0 112.544 -178.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 85.1 m -67.85 -42.6 81.14 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 118.683 -1.207 . . . . 0.0 110.184 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -65.82 -43.08 89.65 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 118.054 -1.458 . . . . 0.0 112.776 -177.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.423 HG23 ' N ' ' A' ' 140' ' ' VAL . 24.4 m -64.47 -44.05 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -179.262 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.423 ' N ' HG23 ' A' ' 139' ' ' VAL . 12.7 p -64.63 -37.48 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -177.644 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.616 ' NZ ' ' NE ' ' A' ' 88' ' ' ARG . 48.5 mttm -60.98 -40.55 93.88 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.16 -177.236 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 82.1 t -69.89 -44.95 78.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.57 -36.33 83.87 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.934 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -66.39 -40.69 89.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.06 -177.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 65.6 tp60 -64.35 -39.08 93.18 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 119.486 -0.886 . . . . 0.0 109.28 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.2 -35.0 79.7 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.446 ' O ' ' CG ' ' A' ' 147' ' ' GLN . 3.0 pt20 -60.31 111.06 1.4 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 177.161 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -102.5 8.81 39.87 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.246 -177.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 60.7 ttm-85 -143.71 135.99 26.85 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.848 0.356 . . . . 0.0 110.696 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -82.52 -56.36 3.92 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.617 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 168.03 -51.65 0.23 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.615 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -179.982 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 46.7 t80 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.865 0.364 . . . . 0.0 110.462 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -56.98 154.63 9.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.453 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.41 ' OG ' ' N ' ' A' ' 159' ' ' THR . 43.7 t -157.07 -178.28 7.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.211 0.529 . . . . 0.0 111.015 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.41 ' N ' ' OG ' ' A' ' 158' ' ' SER . 65.1 p -64.32 -46.1 84.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.737 -177.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 86.3 t -64.22 -45.59 95.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 119.132 -1.027 . . . . 0.0 109.438 -179.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.522 ' N ' ' OE1' ' A' ' 161' ' ' GLU . 15.1 mp0 -66.75 -39.04 87.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.873 0.368 . . . . 0.0 111.198 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -61.8 -45.54 93.41 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -178.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.607 ' CZ ' HD11 ' A' ' 175' ' ' LEU . 2.7 t80 -62.59 -50.33 71.73 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 120.372 -0.531 . . . . 0.0 110.617 -178.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 30.5 mmtm -68.84 -45.57 70.78 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 -175.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.556 HG23 ' N ' ' A' ' 166' ' ' ILE . 15.3 t -62.95 -44.73 95.27 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.198 1.185 . . . . 0.0 114.198 -177.003 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.556 ' N ' HG23 ' A' ' 165' ' ' THR . 10.0 pt -64.51 -38.44 82.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 122.032 0.92 . . . . 0.0 109.505 177.151 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.53 -36.47 76.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 113.709 -1.587 . . . . 0.0 108.074 176.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -62.54 -50.39 71.54 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 122.436 2.38 . . . . 0.0 112.164 -175.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -75.05 -51.03 14.55 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 123.903 0.881 . . . . 0.0 109.641 177.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -77.96 -36.46 49.08 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 -173.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 90.99 -167.71 32.06 Favored Glycine 0 N--CA 1.467 0.714 0 N-CA-C 111.792 -0.523 . . . . 0.0 111.792 177.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 25.2 mm -72.18 -44.72 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-O 121.679 0.752 . . . . 0.0 110.652 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -59.0 -33.96 71.32 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 114.371 -1.286 . . . . 0.0 111.529 -177.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -60.75 -40.37 98.02 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 118.783 -1.675 . . . . 0.0 109.272 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.607 HD11 ' CZ ' ' A' ' 163' ' ' TYR . 0.5 OUTLIER -70.34 -33.43 71.47 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 111.477 -2.362 . . . . 0.0 116.72 -177.136 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 176' ' ' TRP . . . . . 0.427 ' O ' ' OG1' ' A' ' 179' ' ' THR . 2.3 m95 -77.89 -7.39 56.66 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 111.564 -2.562 . . . . 0.0 109.909 -177.158 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 16.3 ttmm -43.24 -47.93 6.55 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.354 -176.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -92.04 -27.43 16.25 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 123.981 0.8 . . . . 0.0 112.216 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 176' ' ' TRP . 39.7 p -45.3 -51.17 11.3 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 180' ' ' SER . . . . . 0.419 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 3.3 m -62.4 -50.82 77.44 Favored Pre-proline 0 N--CA 1.47 0.57 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -176.186 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.419 ' HD2' ' N ' ' A' ' 180' ' ' SER . 29.2 Cg_endo -64.87 -28.61 58.68 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 121.212 1.275 . . . . 0.0 111.63 176.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -64.27 -39.73 94.52 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 120.363 -0.535 . . . . 0.0 109.809 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 82.0 t -63.32 -42.85 97.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.201 0.524 . . . . 0.0 110.026 179.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.32 -39.39 92.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.091 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 44.1 ttt85 -60.74 -42.19 96.86 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.928 -179.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -61.9 -43.89 97.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.107 0.48 . . . . 0.0 110.705 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -65.31 -44.31 88.26 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.805 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 87.4 mt -63.86 -46.04 95.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -177.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.438 HG13 ' N ' ' A' ' 190' ' ' ASN . 6.9 p -60.64 -46.96 94.88 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 C-N-CA 119.403 -0.919 . . . . 0.0 111.267 -178.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 190' ' ' ASN . . . . . 0.438 ' N ' HG13 ' A' ' 189' ' ' VAL . 58.7 m-80 -62.63 -42.62 99.7 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 122.204 1.002 . . . . 0.0 109.779 178.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 191' ' ' CYS . . . . . . . . . . . . . 41.9 t -61.63 -46.08 91.32 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 113.647 -1.615 . . . . 0.0 109.979 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.25 -40.2 95.52 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 113.317 -1.765 . . . . 0.0 109.719 176.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.81 -45.7 93.4 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.278 -177.209 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 21.1 tp -64.77 -38.89 92.51 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 118.785 -1.166 . . . . 0.0 110.972 -174.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 6.3 m -64.57 -45.97 93.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 117.275 -1.77 . . . . 0.0 108.536 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 29.0 p -63.91 -45.33 89.77 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -56.44 -38.77 72.07 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.641 0.776 . . . . 0.0 111.417 -178.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -55.95 -44.0 77.99 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.431 ' C ' HD12 ' A' ' 199' ' ' LEU . 0.2 OUTLIER -61.17 -38.69 87.38 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.908 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 37.2 mt -62.4 -41.87 93.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 15.4 mtpt -59.19 -38.2 79.24 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.958 1.303 . . . . 0.0 113.477 178.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -63.06 -42.58 99.71 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.692 -0.63 . . . . 0.0 110.986 -176.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.42 128.36 47.65 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 121.062 -1.024 . . . . 0.0 112.822 -176.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.485 HD22 ' CE1' ' A' ' 217' ' ' HIS . 11.1 mp 66.24 4.67 3.26 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 113.601 -1.636 . . . . 0.0 112.49 176.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 16.1 tp -137.1 72.02 1.41 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.117 0.484 . . . . 0.0 109.793 -178.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -112.36 -13.58 13.4 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -162.1 36.6 0.12 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.728 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' ASN . . . . . 0.443 ' O ' ' O ' ' A' ' 209' ' ' LEU . 50.2 t30 54.66 79.38 0.14 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 175.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.443 ' O ' ' O ' ' A' ' 208' ' ' ASN . 16.7 mt . . . . . 0 C--O 1.231 0.131 0 CA-C-N 115.252 -0.885 . . . . 0.0 108.795 -178.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 . . . . . 0 N--CA 1.464 0.265 0 CA-C-O 120.835 0.35 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.46 HD23 ' HD3' ' A' ' 215' ' ' PRO . 0.4 OUTLIER -61.43 -41.53 79.75 Favored Pre-proline 0 CA--C 1.538 0.487 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -179.241 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 215' ' ' PRO . . . . . 0.46 ' HD3' HD23 ' A' ' 214' ' ' LEU . 25.0 Cg_exo -61.35 -33.3 89.3 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 120.951 1.101 . . . . 0.0 112.342 -175.293 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 35.5 t -63.31 -40.27 96.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 113.085 -1.87 . . . . 0.0 108.809 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' HIS . . . . . 0.485 ' CE1' HD22 ' A' ' 204' ' ' LEU . 0.4 OUTLIER -64.94 -34.37 78.25 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.658 179.945 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.11 -46.97 86.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.908 -177.72 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -60.18 -37.1 79.2 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 119.132 0.878 . . . . 0.0 111.044 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 67.0 m -59.59 -41.62 90.7 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 221' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.7 -41.71 98.08 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -177.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 222' ' ' PHE . . . . . 0.481 ' CZ ' ' CE1' ' A' ' 226' ' ' PHE . 38.4 t80 -62.21 -47.48 84.27 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -176.418 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -60.91 -42.17 99.57 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 107.962 -2.055 . . . . 0.0 107.962 177.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -63.16 -38.18 90.14 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.068 -1.066 . . . . 0.0 109.377 177.237 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 225' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -62.05 -42.21 99.72 Favored Glycine 0 CA--C 1.522 0.491 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.513 -177.168 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 226' ' ' PHE . . . . . 0.481 ' CE1' ' CZ ' ' A' ' 222' ' ' PHE . 3.0 m-85 -66.65 -38.38 86.75 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 227' ' ' CYS . . . . . 0.415 ' O ' HG22 ' A' ' 230' ' ' VAL . 99.9 m -63.24 -40.65 98.04 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 176.374 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 15.1 m -61.61 -40.09 93.57 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 114.604 -1.18 . . . . 0.0 112.371 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.423 HG22 ' O ' ' A' ' 226' ' ' PHE . 0.6 OUTLIER -58.34 -39.13 78.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.749 -176.198 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 227' ' ' CYS . 1.0 OUTLIER -59.94 -40.38 82.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 118.907 -1.117 . . . . 0.0 109.146 179.837 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 231' ' ' ILE . . . . . 0.542 ' O ' ' HD2' ' A' ' 234' ' ' PRO . 97.2 mt -61.39 -40.72 87.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-O 121.134 0.492 . . . . 0.0 109.783 177.569 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -62.81 -39.43 94.28 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.485 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 0.0 OUTLIER -57.97 -41.54 90.49 Favored Pre-proline 0 N--CA 1.483 1.187 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -173.542 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.542 ' HD2' ' O ' ' A' ' 231' ' ' ILE . 31.8 Cg_exo -57.87 -39.58 85.55 Favored 'Trans proline' 0 C--N 1.292 -2.431 0 C-N-CA 122.357 2.038 . . . . 0.0 113.551 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 83.9 t -64.08 -37.33 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 117.514 -1.674 . . . . 0.0 109.191 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 236' ' ' ASP . . . . . 0.525 ' OD2' ' CZ2' ' A' ' 283' ' ' TRP . 94.7 m-20 -66.21 -41.09 90.61 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.41 ' CG1' ' N ' ' A' ' 238' ' ' VAL . 0.5 OUTLIER -65.37 -45.23 93.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -176.448 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.41 ' N ' ' CG1' ' A' ' 237' ' ' VAL . 94.9 t . . . . . 0 C--N 1.322 -0.595 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.441 -178.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 259' ' ' THR . . . . . 0.433 ' CG2' ' N ' ' A' ' 260' ' ' MET . 2.1 t . . . . . 0 N--CA 1.466 0.371 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 260' ' ' MET . . . . . 0.433 ' N ' ' CG2' ' A' ' 259' ' ' THR . 15.2 mmt -61.61 -44.19 97.46 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.106 -0.497 . . . . 0.0 112.051 -178.296 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 11.9 tp -62.6 -47.81 82.17 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 121.23 -0.188 . . . . 0.0 110.74 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 78.5 mtm180 -67.4 -54.03 24.05 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.078 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -76.66 -141.57 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.899 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 264' ' ' GLU . . . . . 0.616 ' CD ' ' H ' ' A' ' 264' ' ' GLU . 0.7 OUTLIER -39.87 128.47 2.1 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.083 0.468 . . . . 0.0 110.603 -179.659 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 265' ' ' GLY . . . . . 0.496 ' C ' ' H ' ' A' ' 267' ' ' ARG . . . -46.33 167.12 0.06 OUTLIER Glycine 0 CA--C 1.533 1.173 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 -179.137 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -53.79 -1.11 0.1 Allowed 'Trans proline' 0 N--CA 1.5 1.887 0 C-N-CA 122.093 1.862 . . . . 0.0 112.509 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 267' ' ' ARG . . . . . 0.496 ' H ' ' C ' ' A' ' 265' ' ' GLY . 5.1 ptp180 -69.89 -26.94 64.42 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 122.838 0.455 . . . . 0.0 111.511 178.632 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -58.67 -32.5 69.17 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 119.695 -0.802 . . . . 0.0 109.934 -178.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -62.47 -41.25 98.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.127 177.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 270' ' ' TYR . . . . . 0.428 ' O ' ' O ' ' A' ' 271' ' ' LYS . 36.7 t80 -65.87 -37.6 86.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.924 -1.035 . . . . 0.0 112.633 -178.322 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.478 ' O ' ' O ' ' A' ' 272' ' ' GLY . 54.8 mtpt -51.31 -175.36 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 272' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 271' ' ' LYS . . . 57.38 126.34 0.01 OUTLIER Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -169.37 -26.14 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 119.453 -0.899 . . . . 0.0 112.828 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 274' ' ' MET . . . . . 0.526 ' N ' ' CD ' ' A' ' 275' ' ' PRO . 1.0 OUTLIER -64.16 -45.31 79.16 Favored Pre-proline 0 CA--C 1.529 0.169 0 C-N-CA 119.274 -0.97 . . . . 0.0 110.635 -178.661 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 275' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' A' ' 274' ' ' MET . 19.7 Cg_exo -65.44 -47.78 3.94 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 121.837 1.692 . . . . 0.0 111.966 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 5.0 m -61.42 -40.22 93.61 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.018 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -61.82 -42.8 99.48 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 123.6 1.667 . . . . 0.0 113.486 -177.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 75.5 mt -62.54 -39.06 92.39 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 110.355 -3.111 . . . . 0.0 109.625 175.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 279' ' ' ARG . . . . . 0.455 ' NH2' ' CB ' ' A' ' 38' ' ' LYS . 28.7 mmt-85 -62.8 -40.67 98.08 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.099 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.759 ' O ' HD12 ' A' ' 280' ' ' LEU . 0.1 OUTLIER -62.2 -36.78 82.97 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.235 -0.893 . . . . 0.0 113.195 -177.495 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -68.01 -51.04 36.38 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -178.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 282' ' ' SER . . . . . 0.438 ' O ' HG12 ' A' ' 285' ' ' VAL . 16.4 m -62.79 -44.3 96.54 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.247 0.619 . . . . 0.0 109.68 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 283' ' ' TRP . . . . . 0.529 ' O ' HG22 ' A' ' 286' ' ' VAL . 83.5 t90 -59.94 -38.24 81.87 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -62.78 -38.4 90.5 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.695 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.438 HG12 ' O ' ' A' ' 282' ' ' SER . 0.3 OUTLIER -60.82 -38.69 79.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -177.537 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.702 ' O ' HG22 ' A' ' 289' ' ' VAL . 6.8 m -62.53 -39.52 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 120.105 -0.638 . . . . 0.0 109.674 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 76.0 mmm -60.62 -38.6 85.28 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -59.02 -41.53 87.98 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.702 HG22 ' O ' ' A' ' 286' ' ' VAL . 29.4 m -61.61 -37.99 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 120.269 -0.572 . . . . 0.0 111.16 -178.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 82.8 p -62.41 -40.43 96.49 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -60.83 -38.81 86.75 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 177.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -58.07 -40.14 80.29 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 117.77 -1.572 . . . . 0.0 109.169 -177.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 293' ' ' GLN . . . . . 0.477 ' O ' ' O ' ' A' ' 296' ' ' ARG . 14.3 mm100 -60.46 -42.42 96.15 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 123.121 1.439 . . . . 0.0 110.258 179.089 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 77.1 mt -60.43 -39.48 87.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 112.079 -2.328 . . . . 0.0 109.305 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -61.95 -45.03 95.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.41 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 296' ' ' ARG . . . . . 0.477 ' O ' ' O ' ' A' ' 293' ' ' GLN . 36.0 ttm180 -122.27 115.86 23.09 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -111.28 -163.5 0.85 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.694 0.759 . . . . 0.0 112.845 -177.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.657 ' H ' HD12 ' A' ' 298' ' ' LEU . 10.0 mp -32.98 -71.27 0.06 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.406 -1.27 . . . . 0.0 112.902 -178.163 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 299' ' ' MET . . . . . 0.526 ' SD ' ' O ' ' A' ' 299' ' ' MET . 0.0 OUTLIER 88.16 32.06 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 113.895 -1.502 . . . . 0.0 110.869 179.464 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.69 101.01 0.07 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 122.472 1.129 . . . . 0.0 111.182 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -64.34 -46.36 83.82 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 112.952 -1.931 . . . . 0.0 113.142 -176.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -58.67 -38.9 79.19 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 -177.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -64.29 -46.46 83.52 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 304' ' ' SER . . . . . 0.411 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 1.9 t -66.46 -38.18 86.78 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.672 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 -61.86 -42.64 99.3 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.919 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -64.71 -36.78 85.38 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -177.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 307' ' ' ALA . . . . . 0.546 ' HB3' ' HD3' ' A' ' 308' ' ' PRO . . . -60.04 -52.98 69.64 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -176.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 308' ' ' PRO . . . . . 0.546 ' HD3' ' HB3' ' A' ' 307' ' ' ALA . 74.3 Cg_endo -75.21 0.23 9.24 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.046 1.831 . . . . 0.0 111.862 179.307 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 29.8 t80 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.586 -179.812 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.7 p . . . . . 0 N--CA 1.462 0.133 0 CA-C-O 120.825 0.345 . . . . 0.0 110.628 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.575 HG12 ' N ' ' A' ' 16' ' ' LYS . 28.2 t -83.43 166.44 2.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.573 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.575 ' N ' HG12 ' A' ' 15' ' ' VAL . 1.1 mptm? -64.25 -41.8 96.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.095 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -63.75 -41.6 97.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.411 0.624 . . . . 0.0 111.905 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.543 HD13 ' O ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -79.83 -26.19 40.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.977 -1.011 . . . . 0.0 111.165 -179.662 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.59 -40.69 96.16 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 106.75 -2.54 . . . . 0.0 106.75 176.094 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.61 -31.26 68.17 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 124.44 2.067 . . . . 0.0 107.41 176.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.38 -43.19 97.17 Favored Glycine 0 CA--C 1.532 1.115 0 CA-C-N 109.112 -3.676 . . . . 0.0 110.726 -177.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.5 t -71.23 -27.3 63.37 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 117.567 0.684 . . . . 0.0 109.279 178.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.75 -50.64 64.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.69 -178.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.15 -35.88 80.13 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 118.109 -1.437 . . . . 0.0 110.943 -177.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 73.2 m -63.98 -54.11 39.65 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.579 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.521 HD12 ' N ' ' A' ' 27' ' ' ALA . 2.6 pp -65.74 -39.59 85.3 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -177.389 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.552 ' O ' HG23 ' A' ' 31' ' ' THR . . . -63.94 -41.8 97.52 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 119.733 -0.787 . . . . 0.0 112.861 -173.212 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.469 ' HA ' ' HG1' ' A' ' 31' ' ' THR . 2.3 m-20 -77.63 -27.07 51.01 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 120.325 1.42 . . . . 0.0 109.918 -175.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 10.8 tp -59.81 -55.83 29.41 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 119.835 1.198 . . . . 0.0 112.806 -178.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.9 pt -76.11 -4.55 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.552 HG23 ' O ' ' A' ' 27' ' ' ALA . 30.3 p -109.71 -17.08 13.77 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 118.941 -1.104 . . . . 0.0 109.549 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.479 ' N ' ' CD ' ' A' ' 33' ' ' PRO . 4.3 t80 -67.3 -44.0 45.79 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 122.296 2.316 . . . . 0.0 109.164 -178.171 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 32' ' ' PHE . 30.7 Cg_exo -59.62 -15.85 33.39 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 121.0 1.134 . . . . 0.0 111.556 177.555 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 26.9 tp -66.99 -35.47 80.03 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -177.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 36' ' ' THR . 2.0 p30 -64.61 -40.29 95.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.36 -0.837 . . . . 0.0 112.401 -177.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.532 ' N ' ' OD1' ' A' ' 35' ' ' ASP . 67.4 p -58.17 -35.01 70.95 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.03 -38.09 85.27 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.563 ' NZ ' HH22 ' A' ' 279' ' ' ARG . 11.5 ptmt -60.58 -46.99 88.18 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 120.119 -0.632 . . . . 0.0 111.855 -175.639 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.443 ' N ' ' CG ' ' A' ' 38' ' ' LYS . 93.0 t -62.16 -38.42 80.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -176.466 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.526 ' NH1' ' O ' ' A' ' 36' ' ' THR . 6.8 mmp_? -59.37 -40.47 86.57 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 119.345 -0.942 . . . . 0.0 109.611 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.58 38.96 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.3 179.115 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.508 ' N ' ' O ' ' A' ' 40' ' ' ARG . 28.3 pt20 -67.89 -159.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 O-C-N 122.136 -0.352 . . . . 0.0 110.936 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.435 HD12 ' N ' ' A' ' 43' ' ' ILE . 2.0 mp -132.07 47.81 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.562 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 46.72 29.11 0.9 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.855 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 46' ' ' GLU . . . -64.82 -116.32 0.01 OUTLIER Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.427 ' O ' ' O ' ' A' ' 45' ' ' GLY . 41.7 tt0 59.35 132.29 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.889 0.376 . . . . 0.0 110.839 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 66.9 m -115.71 -12.79 11.48 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.544 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -42.63 -27.08 0.15 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.648 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.46 -10.05 73.21 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -178.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 45.5 tp -65.89 -38.01 87.64 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.373 -0.413 . . . . 0.0 110.585 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.514 HG13 ' N ' ' A' ' 52' ' ' ARG . 7.6 p -60.74 -44.81 98.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.734 -178.311 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.514 ' N ' HG13 ' A' ' 51' ' ' VAL . 14.6 ptt180 -64.86 -33.65 76.52 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.881 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 98.0 m -67.86 -38.16 82.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.186 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.74 -152.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.207 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -166.9 -24.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.069 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.649 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 57.8 p -166.74 -127.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 179.253 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.649 ' HB3' ' O ' ' A' ' 56' ' ' SER . . . 94.33 13.8 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 177.653 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.497 ' N ' ' CD ' ' A' ' 58' ' ' GLN . 2.2 pm0 -175.29 176.81 1.97 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.867 0.365 . . . . 0.0 110.162 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.461 ' CD1' ' C ' ' A' ' 58' ' ' GLN . 84.7 m-85 -157.07 159.22 37.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.646 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 34.1 ptt-85 -48.16 -33.01 7.74 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -31.33 103.51 0.01 OUTLIER Glycine 0 CA--C 1.526 0.762 0 CA-C-N 114.875 -1.057 . . . . 0.0 112.221 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.436 HG22 ' H ' ' A' ' 62' ' ' VAL . 2.6 m -66.91 -33.61 64.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 118.229 -0.891 . . . . 0.0 109.194 176.282 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.411 HD22 ' N ' ' A' ' 63' ' ' LEU . 4.4 mm? -60.09 -32.32 70.86 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 121.25 1.841 . . . . 0.0 110.359 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -65.02 -49.3 63.2 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-N 115.243 -0.889 . . . . 0.0 114.609 -177.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.434 ' H ' HG23 ' A' ' 65' ' ' THR . 6.8 p -62.15 -46.38 89.24 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -178.239 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.482 HD12 ' N ' ' A' ' 67' ' ' LEU . 2.3 pp -58.99 -35.0 54.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -178.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.482 ' N ' HD12 ' A' ' 66' ' ' ILE . 6.8 tp -63.03 -35.29 79.73 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 120.36 1.437 . . . . 0.0 113.116 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 98.6 m -61.47 -41.52 97.37 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-N 114.316 -1.311 . . . . 0.0 111.011 -177.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 50.4 mmm -59.3 -39.31 82.61 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -176.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.7 t -68.99 -41.04 81.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 118.968 -1.093 . . . . 0.0 113.646 -177.221 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 23.0 ttp-105 -78.26 -13.54 59.81 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.503 ' CG2' ' N ' ' A' ' 73' ' ' GLU . 0.5 OUTLIER -62.85 -54.95 30.9 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 114.639 -1.164 . . . . 0.0 112.391 -179.297 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.503 ' N ' ' CG2' ' A' ' 72' ' ' THR . 13.6 tp10 -110.61 -57.36 2.23 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.283 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.41 163.21 12.08 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -56.57 -34.92 96.44 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 122.107 1.871 . . . . 0.0 112.198 -179.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.4 tpp180 -61.25 -11.84 10.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.887 0.851 . . . . 0.0 111.132 176.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.407 ' OG ' HD12 ' A' ' 78' ' ' LEU . 15.6 p -78.28 -32.86 49.69 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 113.868 -1.514 . . . . 0.0 110.95 -178.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.407 HD12 ' OG ' ' A' ' 77' ' ' SER . 6.3 mp -75.58 -31.65 60.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.017 0.437 . . . . 0.0 110.449 178.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.647 ' O ' HD12 ' A' ' 82' ' ' LEU . 75.3 m-85 -90.15 -3.69 57.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 123.644 1.688 . . . . 0.0 112.549 -176.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 -106.7 121.21 43.91 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 110.619 -2.991 . . . . 0.0 107.654 175.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.46 -18.6 50.57 Favored Glycine 0 N--CA 1.469 0.893 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 -177.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.989 HD13 ' N ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -58.91 -33.69 70.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 113.905 -1.148 . . . . 0.0 110.332 -179.096 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.989 ' N ' HD13 ' A' ' 82' ' ' LEU . 7.1 p -70.44 -26.28 28.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.265 177.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.14 -31.95 61.2 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 119.11 -0.471 . . . . 0.0 111.837 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.93 -40.0 89.18 Favored Glycine 0 N--CA 1.466 0.679 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.891 -178.004 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -62.48 -40.25 96.07 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 122.15 0.976 . . . . 0.0 112.842 -176.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.431 ' O ' ' OE1' ' A' ' 87' ' ' GLN . 0.1 OUTLIER -60.83 -28.29 68.7 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 113.431 -1.713 . . . . 0.0 110.378 -179.267 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 62.5 mtt85 -58.53 -53.7 55.36 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 173.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -66.67 -29.36 69.35 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 112.035 -2.348 . . . . 0.0 111.847 -177.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 12.3 tpt -61.27 -40.14 92.99 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.425 179.015 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 33.8 t -74.37 -34.19 63.29 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 119.366 -0.934 . . . . 0.0 111.456 -177.049 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -57.87 -43.84 86.26 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 121.04 1.745 . . . . 0.0 112.615 -176.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.49 -32.85 64.51 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 119.484 -0.886 . . . . 0.0 110.748 -178.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.597 ' O ' HG22 ' A' ' 97' ' ' ILE . 70.2 p -64.1 -41.43 97.28 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.45 ' C ' ' H ' ' A' ' 97' ' ' ILE . 29.8 m -68.79 -28.28 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.44 177.013 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 55.3 ttp85 -77.15 9.22 3.2 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -176.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.597 HG22 ' O ' ' A' ' 94' ' ' SER . 11.0 tt -86.96 -14.68 10.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.318 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.412 ' O ' ' OG ' ' A' ' 102' ' ' SER . . . -139.98 -48.14 0.06 OUTLIER Glycine 0 CA--C 1.544 1.867 0 N-CA-C 115.772 1.069 . . . . 0.0 115.772 -177.202 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.604 HD22 ' N ' ' A' ' 99' ' ' LEU . 3.4 mm? -71.79 -13.4 61.68 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 119.841 1.82 . . . . 0.0 113.925 -177.714 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.484 ' CZ ' ' NZ ' ' A' ' 104' ' ' LYS . 9.6 t80 -80.84 -51.94 8.05 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 114.63 -1.168 . . . . 0.0 112.795 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.498 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 0.4 OUTLIER -70.42 -32.23 69.74 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 124.056 1.884 . . . . 0.0 110.686 -179.738 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' A' ' 98' ' ' GLY . 67.3 m -67.32 -50.88 58.3 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 109.609 -3.451 . . . . 0.0 113.492 178.235 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 10.0 p -73.83 -26.66 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 CA-C-N 121.27 1.85 . . . . 0.0 111.79 177.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.484 ' NZ ' ' CZ ' ' A' ' 100' ' ' TYR . 39.0 mttp -69.51 -41.86 75.47 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 111.621 -2.536 . . . . 0.0 113.284 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.44 ' HG3' ' O ' ' A' ' 101' ' ' ASP . 88.1 mt-30 -76.27 -14.69 60.11 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 123.63 1.681 . . . . 0.0 111.029 178.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -79.27 -22.47 44.67 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 112.518 -2.128 . . . . 0.0 111.95 178.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.576 ' CZ ' ' ND2' ' A' ' 190' ' ' ASN . 15.4 m-85 -109.79 -27.73 9.16 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.231 1.012 . . . . 0.0 113.299 -173.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.767 ' C ' ' H ' ' A' ' 110' ' ' GLY . 14.4 t -94.53 12.68 26.54 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 -173.219 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -54.69 19.11 0.0 OUTLIER 'General case' 0 CA--C 1.57 1.747 0 CA-C-N 119.885 1.221 . . . . 0.0 110.726 177.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.767 ' H ' ' C ' ' A' ' 108' ' ' THR . . . 59.18 20.52 50.4 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.542 ' OG ' ' NH2' ' A' ' 119' ' ' ARG . 1.4 m 33.02 -163.23 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 113.23 -1.485 . . . . 0.0 113.385 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.588 ' C ' ' H ' ' A' ' 114' ' ' ALA . 3.3 tt0 -141.14 -157.3 0.75 Allowed 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 118.807 -1.157 . . . . 0.0 113.424 -177.361 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.649 ' O ' ' HB2' ' A' ' 114' ' ' ALA . 37.5 t60 -61.12 9.24 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 114.814 -1.085 . . . . 0.0 111.312 -179.104 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.649 ' HB2' ' O ' ' A' ' 113' ' ' HIS . . . 160.42 -161.01 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.26 14.58 25.74 Favored Glycine 0 N--CA 1.459 0.221 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 -179.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 25.6 mm -60.91 -39.98 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.08 -39.49 96.35 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.92 175.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 6.0 t -58.85 -43.23 90.74 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 176.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.542 ' NH2' ' OG ' ' A' ' 111' ' ' SER . 18.6 mmt85 -63.75 -37.37 87.1 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.658 -178.033 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 30.5 tp -63.58 -45.71 89.17 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 42.1 mt -66.92 -44.97 79.33 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.518 178.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.75 -45.1 87.84 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 119.903 1.229 . . . . 0.0 110.955 178.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -65.59 -44.39 92.84 Favored Glycine 0 CA--C 1.517 0.2 0 C-N-CA 119.777 -1.201 . . . . 0.0 111.148 -177.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 79.9 p -64.16 -43.07 96.32 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.83 0.348 . . . . 0.0 111.007 178.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 96.6 m -69.5 -48.82 59.39 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 119.192 -1.003 . . . . 0.0 112.687 177.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.493 HG23 ' N ' ' A' ' 127' ' ' GLY . 6.3 t -66.17 -42.7 88.56 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 115.197 1.555 . . . . 0.0 115.197 -174.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.493 ' N ' HG23 ' A' ' 126' ' ' THR . . . -64.74 -44.83 94.28 Favored Glycine 0 C--O 1.228 -0.233 0 CA-C-N 114.238 -1.347 . . . . 0.0 112.748 -177.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.57 -41.78 97.9 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 112.482 -1.859 . . . . 0.0 107.259 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.732 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 0.2 OUTLIER -64.85 -42.81 94.58 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.169 178.118 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.13 -39.67 95.36 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.894 -0.504 . . . . 0.0 111.817 -178.191 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.641 HG11 HG22 ' A' ' 183' ' ' VAL . 94.5 t -60.98 -26.25 38.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 123.342 1.544 . . . . 0.0 109.298 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.732 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . -58.93 -44.67 91.38 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 110.971 -2.832 . . . . 0.0 112.386 -178.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 61.4 t -79.07 -49.18 20.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -177.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.517 ' O ' ' CB ' ' A' ' 135' ' ' GLN . . . -107.36 -169.12 1.48 Allowed 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -177.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.527 ' N ' ' CD ' ' A' ' 136' ' ' PRO . 3.4 tt0 105.15 -23.28 0.0 OUTLIER Pre-proline 0 CA--C 1.552 1.051 0 O-C-N 124.676 1.235 . . . . 0.0 114.051 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.527 ' CD ' ' N ' ' A' ' 135' ' ' GLN . 5.2 Cg_exo -52.68 -34.64 64.93 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 CA-C-N 122.025 1.759 . . . . 0.0 112.803 -178.327 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 12.6 m -66.75 -40.72 88.39 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -64.52 -42.16 95.94 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 118.965 -1.094 . . . . 0.0 112.424 -177.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.89 -42.93 97.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -179.198 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 19.7 m -63.92 -37.3 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -177.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 16.5 mtpp -60.82 -40.13 91.61 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.981 -177.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 90.4 t -69.83 -45.11 78.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.28 0.562 . . . . 0.0 109.694 178.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.404 ' CA ' ' HE ' ' A' ' 143' ' ' ARG . 0.0 OUTLIER -64.64 -36.11 83.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.508 179.569 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -66.28 -40.4 90.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.899 -0.592 . . . . 0.0 112.312 -177.05 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -64.06 -39.07 93.28 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 119.884 -0.726 . . . . 0.0 110.185 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.16 -35.06 79.9 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.615 ' NE2' ' O ' ' A' ' 147' ' ' GLN . 0.0 OUTLIER -59.66 110.73 1.2 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 177.584 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 150' ' ' ALA . . . -43.17 93.03 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 117.33 -1.319 . . . . 0.0 111.531 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 78.8 mtm180 53.81 -89.44 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 122.64 2.473 . . . . 0.0 111.055 178.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 148' ' ' ALA . . . -154.37 -149.7 0.29 Allowed 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.405 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -158.44 31.57 0.48 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.664 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 179.98 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.514 ' CE2' ' O ' ' A' ' 157' ' ' GLN . 92.0 t80 . . . . . 0 N--CA 1.464 0.241 0 CA-C-O 120.875 0.369 . . . . 0.0 110.677 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.514 ' O ' ' CE2' ' A' ' 156' ' ' TYR . 84.1 mt-30 -81.07 166.49 20.7 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.34 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.69 ' H ' ' CG ' ' A' ' 161' ' ' GLU . 20.7 p -157.04 -178.56 7.46 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.565 0.698 . . . . 0.0 111.602 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 25.4 p -64.77 -46.64 81.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.113 -0.948 . . . . 0.0 112.335 -178.103 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.564 HG13 ' N ' ' A' ' 161' ' ' GLU . 14.9 p -65.02 -45.98 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 119.241 -0.984 . . . . 0.0 110.896 -178.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.69 ' CG ' ' H ' ' A' ' 158' ' ' SER . 2.1 pp20? -68.14 -38.54 82.27 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.921 0.391 . . . . 0.0 111.843 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.426 ' N ' ' CD ' ' A' ' 161' ' ' GLU . . . -61.14 -45.68 93.67 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -177.25 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.6 ' CZ ' HD23 ' A' ' 175' ' ' LEU . 17.0 t80 -62.54 -50.15 72.47 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.137 -179.258 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -68.68 -45.68 71.05 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 -175.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.546 HG23 ' N ' ' A' ' 166' ' ' ILE . 15.3 t -63.27 -45.1 93.05 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -177.413 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.546 ' N ' HG23 ' A' ' 165' ' ' THR . 8.4 pt -64.83 -39.08 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 CA-C-O 122.043 0.925 . . . . 0.0 108.964 177.032 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.404 ' N ' ' CG1' ' A' ' 166' ' ' ILE . . . -60.41 -37.62 81.44 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 113.704 -1.589 . . . . 0.0 109.145 177.026 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 13.4 tpp85 -63.47 -51.35 65.99 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 123.715 2.962 . . . . 0.0 112.821 -175.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -75.7 -51.4 12.82 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 123.287 0.635 . . . . 0.0 109.515 177.424 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.492 ' OE2' ' N ' ' A' ' 174' ' ' GLY . 0.0 OUTLIER -78.96 -37.19 40.17 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 119.602 1.092 . . . . 0.0 113.784 -176.204 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 171' ' ' GLY . . . . . 0.47 ' O ' ' OE2' ' A' ' 170' ' ' GLU . . . 98.31 -171.73 25.8 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 120.776 -0.726 . . . . 0.0 113.366 179.055 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.448 HG23 ' N ' ' A' ' 173' ' ' ARG . 20.8 tt -75.12 -37.84 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -177.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.448 ' N ' HG23 ' A' ' 172' ' ' ILE . 7.3 tpp180 -58.22 -34.1 70.05 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 114.298 -1.319 . . . . 0.0 112.938 -173.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.492 ' N ' ' OE2' ' A' ' 170' ' ' GLU . . . -60.56 -38.87 95.64 Favored Glycine 0 N--CA 1.464 0.51 0 CA-C-O 123.726 1.737 . . . . 0.0 111.995 -178.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.6 HD23 ' CZ ' ' A' ' 163' ' ' TYR . 5.2 mp -70.2 -34.24 72.69 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 110.153 -3.024 . . . . 0.0 116.425 -176.271 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 11.0 m95 -78.72 -7.72 58.02 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 113.481 -1.691 . . . . 0.0 109.653 -178.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -44.06 -49.28 8.86 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.756 0.651 . . . . 0.0 112.756 -175.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -87.99 -36.6 8.27 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 124.548 1.071 . . . . 0.0 111.754 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 40.3 p -45.24 -51.39 10.81 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' SER . . . . . 0.426 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 1.5 t -62.92 -50.93 74.72 Favored Pre-proline 0 N--CA 1.472 0.667 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -176.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 180' ' ' SER . 32.3 Cg_endo -65.06 -28.15 57.24 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.676 1.584 . . . . 0.0 111.257 176.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.426 ' CB ' ' OE1' ' A' ' 135' ' ' GLN . 24.5 t-20 -63.41 -39.19 93.82 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.641 HG22 HG11 ' A' ' 131' ' ' VAL . 71.8 t -62.91 -42.79 97.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.63 -39.99 95.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.18 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -60.99 -41.94 97.47 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.084 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -61.61 -43.24 99.24 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.033 0.444 . . . . 0.0 110.124 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' ALA . . . . . 0.508 ' O ' ' SG ' ' A' ' 191' ' ' CYS . . . -64.24 -43.87 93.56 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.24 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 25.2 mm -63.32 -45.17 98.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.864 -0.335 . . . . 0.0 111.309 -178.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 89.3 t -60.42 -47.22 93.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 120.265 -0.574 . . . . 0.0 111.765 -178.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' ASN . . . . . 0.576 ' ND2' ' CZ ' ' A' ' 107' ' ' TYR . 25.5 t-20 -62.61 -43.27 99.22 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 122.663 1.22 . . . . 0.0 109.873 179.175 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 191' ' ' CYS . . . . . 0.508 ' SG ' ' O ' ' A' ' 187' ' ' ALA . 94.5 m -62.43 -46.49 88.3 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 112.46 -2.155 . . . . 0.0 110.752 179.036 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.41 -40.29 95.5 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.479 176.7 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -61.54 -45.57 93.6 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.879 -178.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 7.9 tt -64.16 -38.95 92.88 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 118.623 -1.231 . . . . 0.0 110.071 -174.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 6.1 m -64.5 -45.48 95.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 116.762 -1.975 . . . . 0.0 107.808 178.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 19.8 m -63.89 -45.87 87.43 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -178.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -56.48 -38.35 71.61 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.34 1.056 . . . . 0.0 112.09 -178.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -55.19 -43.09 74.05 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 24.5 mt -60.79 -39.51 89.17 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.422 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 1.3 mp -62.98 -42.45 96.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -59.59 -38.67 81.85 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.505 1.522 . . . . 0.0 113.193 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -62.9 -40.04 96.36 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.027 -178.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 90.5 m -100.66 129.37 46.56 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.797 0.808 . . . . 0.0 111.839 -177.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.624 ' O ' HD22 ' A' ' 205' ' ' LEU . 4.6 tp 68.02 4.38 4.03 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 114.221 -1.354 . . . . 0.0 111.954 179.129 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.624 HD22 ' O ' ' A' ' 204' ' ' LEU . 1.3 mm? -128.42 28.81 5.41 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -177.115 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -72.84 -25.06 60.98 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.263 -178.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.46 ' O ' ' CG ' ' A' ' 208' ' ' ASN . . . -131.09 -38.88 1.21 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.547 0.689 . . . . 0.0 110.219 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 208' ' ' ASN . . . . . 0.617 ' CG ' ' H ' ' A' ' 209' ' ' LEU . 13.9 p30 141.25 -92.84 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 113.138 -1.846 . . . . 0.0 106.846 -177.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.617 ' H ' ' CG ' ' A' ' 208' ' ' ASN . 4.3 tt . . . . . 0 N--CA 1.463 0.185 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 177.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 0.51 ' N ' ' OD1' ' A' ' 213' ' ' ASP . 11.5 p-10 . . . . . 0 N--CA 1.46 0.051 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.491 ' N ' ' CD ' ' A' ' 215' ' ' PRO . 4.3 mm? -60.88 -42.63 88.12 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.215 -178.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 215' ' ' PRO . . . . . 0.491 ' CD ' ' N ' ' A' ' 214' ' ' LEU . 35.1 Cg_exo -59.89 -32.34 95.1 Favored 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 121.58 1.52 . . . . 0.0 112.337 -177.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 216' ' ' CYS . . . . . 0.527 ' SG ' ' N ' ' A' ' 217' ' ' HIS . 1.6 p -63.98 -42.23 97.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 113.714 -1.584 . . . . 0.0 111.422 -177.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 217' ' ' HIS . . . . . 0.527 ' N ' ' SG ' ' A' ' 216' ' ' CYS . 77.3 m80 -66.5 -37.32 84.81 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.332 0.587 . . . . 0.0 110.766 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 218' ' ' PHE . . . . . 0.524 ' CE1' HD12 ' A' ' 294' ' ' LEU . 30.7 m-85 -63.47 -46.77 84.66 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.804 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 20.8 p -60.2 -37.79 81.32 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 118.81 0.732 . . . . 0.0 110.44 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 49.7 p -59.45 -41.63 90.09 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 178.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 221' ' ' ALA . . . . . 0.566 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.74 -41.81 97.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -177.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -62.19 -47.67 83.45 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -175.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -61.15 -42.4 99.78 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 107.994 -2.042 . . . . 0.0 107.994 177.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 224' ' ' ALA . . . . . 0.541 ' O ' HG23 ' A' ' 228' ' ' THR . . . -63.48 -37.34 86.91 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 113.839 -1.18 . . . . 0.0 109.622 177.007 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 225' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -61.15 -41.96 99.64 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-N 114.364 -1.289 . . . . 0.0 112.529 -175.431 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 226' ' ' PHE . . . . . 0.443 ' O ' ' OG1' ' A' ' 229' ' ' THR . 55.1 m-85 -66.24 -38.79 88.74 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 118.767 1.283 . . . . 0.0 110.014 -178.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 227' ' ' CYS . . . . . 0.495 ' SG ' ' N ' ' A' ' 228' ' ' THR . 1.8 p -63.69 -41.91 98.07 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 119.74 -0.784 . . . . 0.0 109.873 177.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 228' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 224' ' ' ALA . 67.6 p -62.56 -40.93 98.42 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.412 179.121 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 226' ' ' PHE . 13.1 p -59.19 -39.46 82.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.266 -177.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 92.8 t -60.35 -41.26 86.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 C-N-CA 118.91 -1.116 . . . . 0.0 108.524 178.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 231' ' ' ILE . . . . . 0.505 ' O ' ' HD2' ' A' ' 234' ' ' PRO . 30.4 mm -62.08 -41.18 90.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 121.345 0.593 . . . . 0.0 109.727 176.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.1 -39.9 96.06 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 116.16 1.911 . . . . 0.0 116.16 -179.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.48 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 0.1 OUTLIER -58.1 -41.91 92.27 Favored Pre-proline 0 N--CA 1.481 1.098 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -173.271 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.505 ' HD2' ' O ' ' A' ' 231' ' ' ILE . 35.5 Cg_exo -58.39 -40.08 78.3 Favored 'Trans proline' 0 C--N 1.291 -2.483 0 C-N-CA 121.915 1.744 . . . . 0.0 112.503 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 58.9 t -64.38 -37.29 79.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 C-N-CA 118.591 -1.244 . . . . 0.0 109.004 178.372 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -66.22 -40.98 90.67 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-N 115.351 -0.841 . . . . 0.0 112.182 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 74.1 t -65.63 -45.28 92.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -176.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 C--N 1.328 -0.367 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -176.412 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 21.9 m . . . . . 0 N--CA 1.466 0.342 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 260' ' ' MET . . . . . 0.419 ' CG ' ' N ' ' A' ' 261' ' ' LEU . 17.0 ptt? -61.57 -44.45 97.01 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -177.208 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.419 ' N ' ' CG ' ' A' ' 260' ' ' MET . 11.6 tp -63.25 -48.12 79.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.787 0.327 . . . . 0.0 110.467 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 50.1 ttt85 -67.4 -54.14 23.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.582 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 3.8 ttmm -68.29 -148.45 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.954 0.407 . . . . 0.0 111.484 -178.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -51.45 136.4 25.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.399 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -41.37 166.63 0.01 OUTLIER Glycine 0 CA--C 1.527 0.834 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.809 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -60.23 -2.97 2.07 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.625 2.217 . . . . 0.0 111.7 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 -69.98 -27.01 64.36 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.193 0.597 . . . . 0.0 111.739 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -58.76 -32.31 69.16 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.006 -179.039 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -62.39 -41.19 98.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.915 177.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -65.67 -37.55 86.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.909 -1.042 . . . . 0.0 112.146 -178.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.455 ' O ' ' O ' ' A' ' 272' ' ' GLY . 42.3 mmtm -65.42 -176.7 0.35 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 272' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 271' ' ' LYS . . . 47.72 104.13 0.01 OUTLIER Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -165.26 4.26 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.611 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 274' ' ' MET . . . . . 0.583 ' N ' ' CD ' ' A' ' 275' ' ' PRO . 2.9 ttm -63.57 -44.15 80.26 Favored Pre-proline 0 C--N 1.329 -0.304 0 C-N-CA 120.268 -0.573 . . . . 0.0 109.646 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 275' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 274' ' ' MET . 22.8 Cg_exo -64.33 -46.12 8.26 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.732 2.288 . . . . 0.0 111.334 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 38.7 t -60.1 -40.04 88.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.514 -179.2 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 277' ' ' PHE . . . . . 0.464 ' O ' ' CD1' ' A' ' 280' ' ' LEU . 3.4 m-85 -61.59 -42.76 99.32 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 124.3 2.0 . . . . 0.0 111.809 -178.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 11.5 tp -62.87 -38.98 93.01 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 110.385 -3.098 . . . . 0.0 109.892 175.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 279' ' ' ARG . . . . . 0.563 HH22 ' NZ ' ' A' ' 38' ' ' LYS . 56.6 mtt-85 -63.03 -41.49 99.53 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.49 ' H ' ' HG ' ' A' ' 280' ' ' LEU . 1.3 pp -62.7 -35.37 79.49 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -177.552 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 281' ' ' GLY . . . . . 0.481 ' N ' HD12 ' A' ' 280' ' ' LEU . . . -67.67 -50.98 38.7 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -177.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 66.4 m -62.49 -43.89 97.72 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.477 0.711 . . . . 0.0 109.689 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 283' ' ' TRP . . . . . 0.463 ' O ' HG22 ' A' ' 286' ' ' VAL . 85.0 t90 -59.61 -38.16 80.55 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 284' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' A' ' 285' ' ' VAL . 0.2 OUTLIER -62.52 -38.37 89.7 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.295 179.549 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.531 ' N ' ' OD1' ' A' ' 284' ' ' ASN . 0.3 OUTLIER -61.01 -39.91 83.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -177.52 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.488 ' O ' HG22 ' A' ' 289' ' ' VAL . 10.2 m -63.31 -40.07 87.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.051 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 287' ' ' MET . . . . . 0.461 ' SD ' ' CE1' ' A' ' 291' ' ' TYR . 0.0 OUTLIER -60.83 -38.41 85.37 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.656 179.919 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -58.44 -40.1 81.63 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.846 -178.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 286' ' ' VAL . 0.9 OUTLIER -60.53 -38.24 77.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 -177.762 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 41.8 p -62.42 -40.91 98.09 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 119.558 -0.857 . . . . 0.0 108.834 177.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 291' ' ' TYR . . . . . 0.461 ' CE1' ' SD ' ' A' ' 287' ' ' MET . 16.2 m-85 -60.98 -38.34 85.6 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 177.133 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 -57.27 -39.35 75.5 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 118.163 -1.415 . . . . 0.0 109.261 -176.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 293' ' ' GLN . . . . . 0.468 ' O ' ' O ' ' A' ' 296' ' ' ARG . 17.9 mm100 -60.24 -42.08 94.53 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 122.904 1.335 . . . . 0.0 110.58 178.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.524 HD12 ' CE1' ' A' ' 218' ' ' PHE . 3.9 mm? -60.8 -39.41 88.8 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 112.404 -2.18 . . . . 0.0 110.02 178.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 45.2 mttp -61.83 -44.67 96.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.226 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 296' ' ' ARG . . . . . 0.468 ' O ' ' O ' ' A' ' 293' ' ' GLN . 89.1 mtm180 -121.89 115.7 23.06 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -112.13 -163.24 0.84 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.349 0.595 . . . . 0.0 112.276 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.59 HD12 ' N ' ' A' ' 298' ' ' LEU . 9.9 mp -74.79 109.72 8.49 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 176.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 299' ' ' MET . . . . . 0.5 ' SD ' ' O ' ' A' ' 299' ' ' MET . 0.1 OUTLIER -94.59 63.97 2.97 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.755 0.312 . . . . 0.0 111.651 -178.302 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.49 100.86 0.08 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 122.233 1.016 . . . . 0.0 110.647 -178.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -64.2 -46.47 83.8 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 113.16 -1.837 . . . . 0.0 113.265 -176.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -59.06 -39.92 83.56 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.161 -177.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 62.7 tp60 -65.01 -47.0 79.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.846 0.355 . . . . 0.0 110.351 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 304' ' ' SER . . . . . 0.453 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 39.2 t -67.11 -38.33 85.44 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.776 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 34.7 mmm-85 -62.25 -43.76 98.09 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -179.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -65.35 -36.82 85.18 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -177.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 307' ' ' ALA . . . . . 0.537 ' HB3' ' HD3' ' A' ' 308' ' ' PRO . . . -60.13 -52.87 70.26 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -176.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 308' ' ' PRO . . . . . 0.537 ' HD3' ' HB3' ' A' ' 307' ' ' ALA . 72.5 Cg_endo -75.07 0.38 9.0 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.374 2.049 . . . . 0.0 112.995 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 309' ' ' PHE . . . . . 0.49 ' C ' ' O ' ' A' ' 308' ' ' PRO . 36.3 p90 . . . . . 0 N--CA 1.481 1.078 0 O-C-N 123.894 0.746 . . . . 0.0 112.923 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.2 p . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.842 0.353 . . . . 0.0 110.516 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.6 t -84.36 155.8 3.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.846 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -64.51 -41.7 96.26 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.287 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -63.67 -41.74 98.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.497 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 45.3 tp -79.6 -26.44 41.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.089 -178.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.26 -41.25 94.81 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 107.714 -2.154 . . . . 0.0 107.714 177.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.422 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -71.66 -32.15 67.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 124.856 2.265 . . . . 0.0 107.625 176.584 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.43 -42.24 99.11 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-N 108.492 -3.958 . . . . 0.0 108.092 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -70.52 -27.62 64.31 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.098 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -66.46 -49.97 64.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.965 -179.259 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.02 -35.87 79.88 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 118.157 -1.417 . . . . 0.0 110.995 -177.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.463 ' O ' HD23 ' A' ' 29' ' ' LEU . 78.7 m -63.85 -53.94 42.69 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.245 -179.021 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.682 HD12 ' N ' ' A' ' 27' ' ' ALA . 2.7 pp -65.54 -39.58 85.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -177.235 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.682 ' N ' HD12 ' A' ' 26' ' ' ILE . . . -63.92 -41.65 97.6 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -173.07 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 32' ' ' PHE . 8.4 p-10 -77.67 -27.11 50.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 120.464 1.483 . . . . 0.0 109.89 -176.015 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.463 HD23 ' O ' ' A' ' 25' ' ' CYS . 3.0 mm? -60.33 -55.71 30.3 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 119.531 1.06 . . . . 0.0 111.77 -178.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.6 pt -75.89 -4.84 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 121.188 0.518 . . . . 0.0 112.363 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.478 ' HA ' HD12 ' A' ' 34' ' ' LEU . 53.5 m -109.91 -17.02 13.72 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 117.319 -1.324 . . . . 0.0 109.95 -179.473 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.443 ' N ' ' O ' ' A' ' 28' ' ' ASP . 10.3 t80 -68.38 -44.88 36.95 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-N 122.67 2.486 . . . . 0.0 110.977 -177.568 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -60.21 -16.69 41.88 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 CA-C-N 121.05 1.411 . . . . 0.0 112.74 177.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.478 HD12 ' HA ' ' A' ' 31' ' ' THR . 82.9 mt -67.65 -35.08 78.22 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -177.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.555 ' HA ' ' HZ3' ' A' ' 38' ' ' LYS . 5.3 p30 -63.98 -39.56 94.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.133 -178.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.532 ' N ' ' OD1' ' A' ' 35' ' ' ASP . 44.4 p -58.11 -34.02 69.75 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.29 -38.76 85.58 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.555 ' HZ3' ' HA ' ' A' ' 35' ' ' ASP . 12.1 pttm -62.0 -47.7 83.61 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 119.049 -1.06 . . . . 0.0 111.93 -177.037 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.425 HG23 ' NH1' ' A' ' 40' ' ' ARG . 4.9 m -62.8 -38.98 83.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -176.147 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.527 ' O ' ' N ' ' A' ' 42' ' ' GLN . 13.0 mmp_? -60.24 -41.08 92.41 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 118.986 -1.085 . . . . 0.0 109.909 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 12.8 tp -62.48 38.98 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.236 178.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.619 HE22 ' CA ' ' A' ' 44' ' ' GLN . 5.1 pp0? -53.0 176.02 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.078 0.466 . . . . 0.0 111.436 -178.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 90.9 mt -45.29 -84.01 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.688 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.619 ' CA ' HE22 ' A' ' 42' ' ' GLN . 10.6 tm0? -150.64 -33.93 0.16 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.439 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -163.69 155.61 27.05 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.412 ' OE1' ' CG1' ' A' ' 51' ' ' VAL . 16.8 mp0 -87.27 168.8 12.87 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.815 0.34 . . . . 0.0 110.532 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.5 t -91.26 1.18 57.29 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -63.34 -25.49 68.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.436 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.03 -6.05 84.04 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.02 -1.632 . . . . 0.0 109.02 -177.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.612 ' O ' HD23 ' A' ' 50' ' ' LEU . 1.3 tt -65.31 -37.66 87.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.583 -0.809 . . . . 0.0 109.638 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.414 HG23 ' N ' ' A' ' 52' ' ' ARG . 16.5 m -60.38 -44.04 95.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.411 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.414 ' N ' HG23 ' A' ' 51' ' ' VAL . 23.7 ttm105 -64.16 -34.04 77.15 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 19.3 m -67.97 -38.26 82.52 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.094 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -131.5 78.82 1.85 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.227 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -48.13 -14.91 0.06 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.39 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.62 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 23.1 t -126.23 -140.54 0.28 Allowed 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.62 ' HB3' ' O ' ' A' ' 56' ' ' SER . . . 96.66 13.96 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.706 0 O-C-N 124.062 0.851 . . . . 0.0 111.909 178.621 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -175.32 69.99 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.653 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -52.36 155.44 2.07 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.402 ' O ' ' C ' ' A' ' 61' ' ' GLY . 75.4 mtp180 -45.35 -37.0 4.54 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 60' ' ' ARG . . . -30.33 103.05 0.01 OUTLIER Glycine 0 CA--C 1.529 0.95 0 CA-C-N 114.993 -1.003 . . . . 0.0 112.478 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 31.0 m -67.42 -33.79 64.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 118.268 -0.872 . . . . 0.0 109.888 176.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.494 ' H ' HD12 ' A' ' 63' ' ' LEU . 6.0 mp -60.27 -32.28 71.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 121.239 1.836 . . . . 0.0 109.881 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.42 -49.2 66.74 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 114.975 -1.011 . . . . 0.0 114.671 -176.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.6 m -62.1 -46.41 89.19 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -178.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 29.0 pt -59.89 -35.97 63.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.638 ' O ' HD23 ' A' ' 67' ' ' LEU . 1.3 tt -63.84 -35.83 81.92 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 121.04 1.745 . . . . 0.0 111.651 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 98.6 m -62.79 -39.47 94.31 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-N 113.674 -1.603 . . . . 0.0 111.049 -175.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 7.6 ptt? -60.39 -39.8 88.6 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 120.648 -1.283 . . . . 0.0 113.819 -176.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.2 p -69.36 -40.7 80.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 119.244 -0.982 . . . . 0.0 113.015 -178.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 55.6 ttm-85 -77.86 -13.44 59.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.979 0.895 . . . . 0.0 112.173 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 71.3 m -63.14 -54.77 32.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.137 -1.392 . . . . 0.0 111.154 178.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -106.29 -59.85 1.73 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.473 178.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 160.98 166.34 19.51 Favored Glycine 0 CA--C 1.535 1.34 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -56.17 -35.15 94.9 Favored 'Trans proline' 0 N--CA 1.5 1.91 0 CA-C-N 119.33 1.565 . . . . 0.0 111.721 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -61.36 -11.15 8.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.739 0.78 . . . . 0.0 111.071 176.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.8 t -77.79 -32.77 52.67 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.248 -1.342 . . . . 0.0 110.876 -178.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.48 HD12 ' N ' ' A' ' 78' ' ' LEU . 9.6 mp -75.86 -33.64 60.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 118.271 0.487 . . . . 0.0 110.958 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -92.53 -4.95 52.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 122.796 1.284 . . . . 0.0 112.76 -178.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -90.69 118.31 30.02 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 112.487 -2.142 . . . . 0.0 107.228 175.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.89 -7.58 57.42 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -178.011 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.674 HD12 ' C ' ' A' ' 82' ' ' LEU . 0.4 OUTLIER -59.25 -34.51 72.32 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 113.949 -1.125 . . . . 0.0 110.541 -179.092 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.1 p -70.46 -26.67 29.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.525 178.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.73 -31.58 61.87 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.748 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.427 ' O ' ' OE1' ' A' ' 89' ' ' GLN . . . -67.84 -40.26 89.52 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 119.701 -1.238 . . . . 0.0 111.241 -177.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.3 mp -62.0 -40.05 94.34 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 122.598 1.189 . . . . 0.0 112.203 -177.121 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 49.9 tp60 -60.41 -26.99 67.1 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 112.657 -2.065 . . . . 0.0 108.992 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 46.8 ttt180 -57.56 -53.41 58.42 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 173.037 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.427 ' OE1' ' O ' ' A' ' 85' ' ' GLY . 13.7 mp0 -67.82 -29.8 69.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 113.437 -1.71 . . . . 0.0 112.196 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 8.8 tpt -60.94 -41.97 97.28 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.044 -179.214 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 77.9 p -74.9 -35.08 62.25 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 119.225 -0.99 . . . . 0.0 111.729 -177.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -57.93 -43.4 86.24 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 121.293 1.861 . . . . 0.0 113.051 -176.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.41 -32.42 64.42 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.322 -177.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 97.1 p -63.68 -40.55 97.11 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 179.139 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.415 ' C ' ' H ' ' A' ' 97' ' ' ILE . 18.4 m -67.94 -28.3 40.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.829 177.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -77.63 10.12 2.9 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -177.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.415 ' H ' ' C ' ' A' ' 95' ' ' VAL . 38.8 mm -86.69 -15.39 9.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 177.145 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -140.45 -48.0 0.05 OUTLIER Glycine 0 CA--C 1.537 1.415 0 CA-C-N 114.569 -1.196 . . . . 0.0 114.267 -177.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.573 ' N ' HD12 ' A' ' 99' ' ' LEU . 8.5 mp -70.76 -13.26 61.99 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 118.586 1.193 . . . . 0.0 112.776 -177.437 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.486 ' O ' ' CG ' ' A' ' 104' ' ' LYS . 91.8 t80 -81.53 -51.19 8.52 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.234 178.518 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 1.008 ' OD2' ' OE1' ' A' ' 105' ' ' GLN . 18.4 t70 -69.4 -31.55 69.99 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 113.332 -1.758 . . . . 0.0 111.512 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 51.2 m -68.17 -52.48 34.13 Favored 'General case' 0 CA--C 1.556 1.185 0 CA-C-N 111.138 -2.755 . . . . 0.0 115.918 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.505 ' O ' ' CD2' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -74.66 -26.26 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-N 122.015 2.189 . . . . 0.0 111.505 177.547 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.486 ' CG ' ' O ' ' A' ' 100' ' ' TYR . 16.7 mmtt -68.8 -42.17 77.67 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 111.875 -2.42 . . . . 0.0 112.334 -179.11 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 1.008 ' OE1' ' OD2' ' A' ' 101' ' ' ASP . 27.2 mt-30 -76.74 -15.95 59.62 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 122.677 1.227 . . . . 0.0 111.056 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -79.44 -23.43 43.15 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 114.105 -1.407 . . . . 0.0 112.202 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.505 ' CD2' ' O ' ' A' ' 103' ' ' VAL . 45.2 m-85 -110.22 -30.27 7.8 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 119.871 1.214 . . . . 0.0 113.278 -175.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.0 t -97.77 9.35 42.84 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 117.257 -1.777 . . . . 0.0 112.844 -178.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.528 ' CD ' HH22 ' A' ' 119' ' ' ARG . 0.0 OUTLIER -52.13 124.2 12.43 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 117.827 -1.082 . . . . 0.0 110.497 179.054 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.549 ' O ' ' CB ' ' A' ' 111' ' ' SER . . . -21.04 -83.33 0.01 OUTLIER Glycine 0 N--CA 1.491 2.352 0 CA-C-N 119.79 1.177 . . . . 0.0 111.699 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.549 ' CB ' ' O ' ' A' ' 110' ' ' GLY . 7.2 t 106.35 -162.28 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 115.424 1.638 . . . . 0.0 115.424 176.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.542 ' O ' ' CG ' ' A' ' 113' ' ' HIS . 33.4 tp10 -108.97 -46.12 3.66 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -176.491 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.618 ' O ' ' HB2' ' A' ' 114' ' ' ALA . 0.3 OUTLIER 150.44 51.07 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -179.611 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.618 ' HB2' ' O ' ' A' ' 113' ' ' HIS . . . 159.57 -161.36 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 179.56 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.15 14.79 27.62 Favored Glycine 0 C--O 1.227 -0.314 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.733 177.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 59.9 mt -60.47 -40.56 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.54 -39.97 95.86 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 175.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 34.6 t -58.78 -42.89 90.07 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 176.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.528 HH22 ' CD ' ' A' ' 109' ' ' LYS . 2.4 mpt_? -63.75 -37.3 86.86 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.249 -178.009 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 62.5 tp -63.49 -46.27 86.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.587 0.708 . . . . 0.0 109.145 178.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 59.8 mt -66.83 -44.7 80.43 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.342 178.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.96 -44.94 91.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 119.433 1.015 . . . . 0.0 109.434 177.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -66.15 -44.26 91.51 Favored Glycine 0 CA--C 1.517 0.172 0 C-N-CA 119.806 -1.187 . . . . 0.0 111.244 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 14.6 t -64.05 -44.0 93.8 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.875 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.437 ' O ' HD23 ' A' ' 129' ' ' LEU . 21.7 p -69.53 -48.53 60.14 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 119.22 -0.992 . . . . 0.0 112.054 177.456 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 25.3 m -65.53 -42.72 91.66 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -174.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -64.19 -44.38 95.73 Favored Glycine 0 N--CA 1.461 0.365 0 CA-C-O 122.945 1.303 . . . . 0.0 112.975 -177.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.413 ' O ' ' CG1' ' A' ' 131' ' ' VAL . . . -60.8 -40.93 94.48 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 111.763 -2.219 . . . . 0.0 106.627 177.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.615 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 1.5 mm? -64.24 -42.23 96.61 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.538 178.446 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.19 -39.92 96.02 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -177.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.494 HG21 HG22 ' A' ' 183' ' ' VAL . 2.4 p -60.88 -24.74 33.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 122.383 1.087 . . . . 0.0 109.366 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . -57.32 -44.49 84.25 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 113.096 -1.866 . . . . 0.0 111.685 -178.308 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.492 ' CG1' ' N ' ' A' ' 134' ' ' ALA . 2.6 p -78.91 -48.68 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.785 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.492 ' N ' ' CG1' ' A' ' 133' ' ' VAL . . . -86.52 126.07 34.2 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.527 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.459 ' N ' ' HD2' ' A' ' 136' ' ' PRO . 12.0 tp-100 -171.29 -53.25 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.686 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' A' ' 135' ' ' GLN . 10.9 Cg_endo -51.67 -32.9 46.95 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 121.706 1.604 . . . . 0.0 111.852 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.408 ' CG2' ' NZ ' ' A' ' 141' ' ' LYS . 12.2 m -67.46 -42.44 83.04 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 117.759 -1.576 . . . . 0.0 109.736 -179.067 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -66.89 -43.57 83.11 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -178.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.458 HG23 ' N ' ' A' ' 140' ' ' VAL . 3.2 m -64.73 -44.22 96.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -178.215 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.458 ' N ' HG23 ' A' ' 139' ' ' VAL . 31.6 m -65.16 -39.03 84.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -177.378 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.408 ' NZ ' ' CG2' ' A' ' 137' ' ' THR . 33.0 mttp -62.53 -42.15 99.33 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 119.38 -0.928 . . . . 0.0 111.98 -177.463 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 14.4 m -70.42 -45.41 75.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 120.104 -0.638 . . . . 0.0 110.036 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.02 -36.84 85.68 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.624 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -66.91 -42.02 86.14 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -177.183 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 95.3 mm-40 -65.67 -40.03 91.97 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 118.987 -1.085 . . . . 0.0 110.093 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.32 -34.98 79.61 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -178.291 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.411 ' O ' ' CG ' ' A' ' 147' ' ' GLN . 0.0 OUTLIER -59.89 111.1 1.34 Allowed 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 177.769 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -98.62 -60.88 1.46 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 117.6 -1.191 . . . . 0.0 113.919 -175.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 96.6 mtt-85 -90.67 130.42 36.68 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 122.476 2.398 . . . . 0.0 110.357 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -65.21 -14.21 60.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.436 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 72.41 23.95 77.09 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.691 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 -179.878 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.428 ' CD2' ' O ' ' A' ' 157' ' ' GLN . 49.8 t80 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.888 0.375 . . . . 0.0 110.627 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.428 ' O ' ' CD2' ' A' ' 156' ' ' TYR . 88.8 mt-30 -84.3 172.37 11.87 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.954 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.66 ' H ' ' CG ' ' A' ' 161' ' ' GLU . 37.0 m -157.05 -178.52 7.43 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.253 0.549 . . . . 0.0 111.054 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.425 ' H ' HG23 ' A' ' 159' ' ' THR . 9.4 p -64.88 -46.55 81.33 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 120.149 -0.62 . . . . 0.0 112.39 -178.138 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.53 HG13 ' N ' ' A' ' 161' ' ' GLU . 8.3 p -64.72 -45.92 93.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 119.305 -0.958 . . . . 0.0 110.777 -178.275 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.66 ' CG ' ' H ' ' A' ' 158' ' ' SER . 1.5 pp20? -67.55 -38.74 84.58 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.219 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.527 ' N ' ' OE2' ' A' ' 161' ' ' GLU . . . -61.36 -45.65 93.51 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -178.186 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.4 ' CD1' ' C ' ' A' ' 163' ' ' TYR . 21.4 t80 -62.5 -50.19 72.36 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.286 -179.202 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 4.7 mtpm? -69.15 -45.48 69.96 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 -176.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.567 HG23 ' N ' ' A' ' 166' ' ' ILE . 14.4 t -62.69 -44.64 95.72 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -176.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.567 ' N ' HG23 ' A' ' 165' ' ' THR . 20.9 tt -64.65 -38.36 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-O 121.997 0.904 . . . . 0.0 109.559 176.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.45 ' N ' HG23 ' A' ' 166' ' ' ILE . . . -59.73 -36.54 76.78 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 113.834 -1.53 . . . . 0.0 107.821 176.378 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 13.1 tpp85 -62.26 -50.25 72.47 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 122.393 2.36 . . . . 0.0 111.89 -175.674 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -74.9 -51.06 14.82 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 123.486 0.715 . . . . 0.0 109.392 177.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -78.1 -36.42 48.06 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 -173.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 91.52 -166.91 30.75 Favored Glycine 0 N--CA 1.468 0.767 0 O-C-N 121.704 -0.622 . . . . 0.0 112.088 177.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.578 HD12 ' N ' ' A' ' 173' ' ' ARG . 2.5 pp -72.97 -43.67 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-O 121.908 0.861 . . . . 0.0 110.469 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.578 ' N ' HD12 ' A' ' 172' ' ' ILE . 24.9 tpt85 -58.89 -33.86 70.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.199 -1.364 . . . . 0.0 111.0 -177.183 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -60.9 -40.64 98.61 Favored Glycine 0 CA--C 1.522 0.511 0 C-N-CA 118.619 -1.753 . . . . 0.0 109.646 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 17.8 tp -70.34 -33.77 71.88 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 111.319 -2.44 . . . . 0.0 116.803 -177.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 7.3 m0 -78.01 -7.44 56.88 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 111.845 -2.434 . . . . 0.0 109.783 -177.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -43.39 -47.99 6.99 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.529 -0.759 . . . . 0.0 112.521 -176.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -91.51 -34.31 7.5 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 123.978 0.799 . . . . 0.0 111.81 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 44.7 p -45.19 -51.21 10.85 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' SER . . . . . 0.41 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 1.6 t -62.44 -50.8 77.33 Favored Pre-proline 0 N--CA 1.47 0.562 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -176.447 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' A' ' 180' ' ' SER . 29.5 Cg_endo -64.96 -28.32 57.99 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.402 1.402 . . . . 0.0 111.377 176.686 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -63.95 -39.13 93.43 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.494 HG22 HG21 ' A' ' 131' ' ' VAL . 56.4 t -63.01 -43.15 98.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.219 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.75 -40.01 95.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.762 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 9.1 tmm_? -61.31 -42.39 98.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.422 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -61.81 -43.69 98.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.081 0.467 . . . . 0.0 110.53 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.62 -43.84 92.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.952 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 79.4 mt -63.35 -45.35 98.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.856 -178.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 84.7 t -60.09 -47.4 92.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 119.465 -0.894 . . . . 0.0 111.033 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -62.91 -42.99 99.98 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 122.311 1.053 . . . . 0.0 110.194 178.581 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 191' ' ' CYS . . . . . . . . . . . . . 37.5 t -61.86 -45.63 92.93 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 113.422 -1.717 . . . . 0.0 109.685 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -63.91 -39.57 94.48 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 113.193 -1.822 . . . . 0.0 109.94 176.436 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.5 -44.95 92.97 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.557 0.743 . . . . 0.0 111.522 -176.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 37.6 tp -64.87 -38.23 90.28 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.971 -176.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 92.1 t -64.47 -47.43 89.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 117.893 -1.523 . . . . 0.0 110.508 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 3.1 t -64.55 -44.24 91.41 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.057 0.943 . . . . 0.0 113.172 -177.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -54.75 -38.28 66.99 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.821 0.848 . . . . 0.0 111.372 -176.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -56.42 -44.09 80.04 Favored 'General case' 0 C--N 1.313 -0.997 0 O-C-N 121.739 -0.6 . . . . 0.0 110.451 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.677 HD22 ' N ' ' A' ' 199' ' ' LEU . 2.8 mm? -61.71 -41.09 97.15 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -177.006 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 200' ' ' ILE . 6.3 pt -64.23 -40.61 89.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.68 179.164 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -57.66 -38.54 75.27 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.461 1.904 . . . . 0.0 113.846 -178.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -65.43 -38.9 91.28 Favored 'General case' 0 C--O 1.245 0.861 0 C-N-CA 117.932 -1.507 . . . . 0.0 111.105 -177.187 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 55.1 m -102.61 128.9 49.09 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 122.369 1.081 . . . . 0.0 112.736 -178.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.519 HD22 ' CD1' ' A' ' 209' ' ' LEU . 1.2 mt 67.27 2.65 2.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 112.945 -1.934 . . . . 0.0 112.048 178.26 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.79 24.03 11.31 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.817 ' O ' ' N ' ' A' ' 208' ' ' ASN . 57.4 pttt -96.78 173.38 7.34 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 178.388 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . 48.91 -67.15 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 O-C-N 126.116 2.135 . . . . 0.0 110.658 -178.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' ASN . . . . . 0.817 ' N ' ' O ' ' A' ' 206' ' ' LYS . 9.6 p-10 164.92 109.71 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 111.976 -2.374 . . . . 0.0 106.229 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 209' ' ' LEU . 13.4 tp . . . . . 0 N--CA 1.489 1.497 0 CA-C-N 108.846 -3.797 . . . . 0.0 112.564 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.785 0.326 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.48 ' N ' ' HD2' ' A' ' 215' ' ' PRO . 12.4 mt -61.28 -44.48 93.36 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 215' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 214' ' ' LEU . 23.0 Cg_endo -61.43 -33.31 88.65 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 CA-C-N 120.944 1.373 . . . . 0.0 111.052 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 85.8 m -64.6 -42.47 95.54 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 113.487 -1.688 . . . . 0.0 111.969 -178.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' HIS . . . . . 0.628 ' NE2' ' CD2' ' A' ' 218' ' ' PHE . 1.8 p-80 -66.78 -37.9 85.49 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.192 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 218' ' ' PHE . . . . . 0.628 ' CD2' ' NE2' ' A' ' 217' ' ' HIS . 1.4 m-85 -63.14 -47.29 83.37 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.322 -178.386 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 89.7 m -60.13 -37.8 81.16 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 118.73 0.696 . . . . 0.0 110.925 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 67.9 m -59.35 -41.42 89.17 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 221' ' ' ALA . . . . . 0.569 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.62 -41.4 98.29 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -177.669 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -61.43 -46.8 88.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 122.077 0.942 . . . . 0.0 112.786 -176.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -60.1 -41.66 98.17 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 107.164 -2.374 . . . . 0.0 107.164 177.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -62.77 -37.78 87.99 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 176.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 225' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -61.82 -42.38 99.74 Favored Glycine 0 CA--C 1.523 0.584 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.843 -178.225 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 226' ' ' PHE . . . . . 0.432 ' O ' ' OG1' ' A' ' 229' ' ' THR . 55.5 t80 -66.39 -38.3 87.2 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 15.7 t -62.84 -40.7 98.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.532 0.682 . . . . 0.0 109.248 176.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 228' ' ' THR . . . . . 0.457 ' O ' HG22 ' A' ' 231' ' ' ILE . 0.4 OUTLIER -61.43 -40.09 93.19 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.589 -179.492 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' A' ' 226' ' ' PHE . 19.7 p -59.36 -39.63 83.88 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.85 -177.33 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 92.6 t -60.82 -42.61 93.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 119.006 -1.078 . . . . 0.0 111.969 -178.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 231' ' ' ILE . . . . . 0.457 HG22 ' O ' ' A' ' 228' ' ' THR . 3.8 tp -62.4 -40.22 87.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 176.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -62.1 -39.77 93.63 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.503 ' N ' ' HD2' ' A' ' 234' ' ' PRO . 66.2 m -58.71 -42.81 96.27 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 115.768 1.766 . . . . 0.0 115.768 -175.017 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 233' ' ' SER . 21.0 Cg_endo -59.89 -40.72 60.24 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 CA-C-N 121.051 1.411 . . . . 0.0 113.9 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.42 ' H ' HG22 ' A' ' 235' ' ' VAL . 11.1 m -65.14 -36.5 77.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.008 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -64.96 -41.24 95.64 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -178.105 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.42 ' H ' HG22 ' A' ' 237' ' ' VAL . 5.7 m -65.64 -45.58 91.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -177.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 57.3 t . . . . . 0 C--N 1.33 -0.243 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -177.116 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 24.8 p . . . . . 0 CA--C 1.532 0.27 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 260' ' ' MET . . . . . 0.601 ' SD ' ' N ' ' A' ' 261' ' ' LEU . 0.0 OUTLIER -61.8 -44.37 97.0 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.214 -0.594 . . . . 0.0 112.47 -177.273 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.601 ' N ' ' SD ' ' A' ' 260' ' ' MET . 12.5 tp -62.62 -46.67 87.2 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.607 0.242 . . . . 0.0 110.444 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 52.5 ttp180 -66.14 -53.76 33.71 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.805 -178.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 263' ' ' LYS . . . . . 0.442 ' HZ3' ' HB3' ' A' ' 263' ' ' LYS . 0.0 OUTLIER -123.33 160.95 25.64 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 120.938 0.399 . . . . 0.0 111.044 179.272 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 264' ' ' GLU . . . . . 0.464 ' O ' ' O ' ' A' ' 265' ' ' GLY . 72.6 mt-10 57.83 88.71 0.06 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.278 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 265' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 264' ' ' GLU . . . -38.04 166.07 0.01 OUTLIER Glycine 0 CA--C 1.531 1.058 0 N-CA-C 111.669 -0.572 . . . . 0.0 111.669 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -63.4 -5.07 7.63 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 122.817 2.344 . . . . 0.0 111.596 179.018 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 18.3 ptp180 -69.63 -26.58 64.49 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 123.086 0.554 . . . . 0.0 111.685 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -58.52 -32.49 68.88 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.895 -179.066 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -62.53 -41.87 99.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.237 0.541 . . . . 0.0 110.753 177.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -65.93 -37.77 86.92 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.84 -178.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp -77.99 -175.16 3.91 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 44.45 84.85 0.01 OUTLIER Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.371 -1.091 . . . . 0.0 110.371 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -152.78 6.79 0.4 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.558 0.218 . . . . 0.0 110.769 -179.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 274' ' ' MET . . . . . 0.587 ' N ' ' CD ' ' A' ' 275' ' ' PRO . 1.9 tpt -63.66 -43.92 78.86 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 275' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 274' ' ' MET . 23.0 Cg_exo -64.12 -46.72 7.54 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.343 2.029 . . . . 0.0 111.205 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 37.4 t -61.0 -40.67 94.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.23 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -62.41 -43.44 98.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 122.88 1.324 . . . . 0.0 113.163 -178.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 8.0 tt -62.01 -38.57 89.14 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 111.897 -2.411 . . . . 0.0 107.072 174.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.69 -40.32 96.75 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.843 178.48 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 8.2 tp -62.32 -37.24 84.82 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -178.145 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -67.95 -50.6 39.75 Favored Glycine 0 CA--C 1.52 0.399 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 -178.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.14 -44.38 96.76 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 283' ' ' TRP . . . . . 0.503 ' O ' HG22 ' A' ' 286' ' ' VAL . 57.1 t-105 -60.26 -38.67 84.2 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.191 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -63.18 -38.5 91.44 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.725 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 54.8 t -61.11 -39.24 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 -178.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.68 ' O ' HG12 ' A' ' 289' ' ' VAL . 6.9 m -62.6 -39.99 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 119.848 -0.741 . . . . 0.0 110.574 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 287' ' ' MET . . . . . 0.456 ' C ' ' SD ' ' A' ' 287' ' ' MET . 0.0 OUTLIER -60.94 -38.87 87.35 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 122.128 -0.357 . . . . 0.0 110.503 179.758 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -59.32 -41.61 89.51 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -178.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.68 HG12 ' O ' ' A' ' 286' ' ' VAL . 7.4 p -61.52 -37.72 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.027 -179.108 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 51.2 p -61.67 -39.43 91.37 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 177.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -60.37 -38.49 84.05 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 177.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.99 -39.93 79.45 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 117.948 -1.501 . . . . 0.0 109.488 -176.315 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 293' ' ' GLN . . . . . 0.45 ' O ' ' O ' ' A' ' 296' ' ' ARG . 80.3 mt-30 -60.37 -42.47 95.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 122.678 1.228 . . . . 0.0 110.641 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 8.9 mp -60.43 -40.26 90.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 112.632 -2.076 . . . . 0.0 109.003 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 17.9 tptp -63.02 -45.84 90.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.266 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 296' ' ' ARG . . . . . 0.45 ' O ' ' O ' ' A' ' 293' ' ' GLN . 64.0 ttm-85 -123.06 116.37 23.38 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.264 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -116.82 -93.2 0.51 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.125 0.488 . . . . 0.0 111.318 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.803 HD22 ' N ' ' A' ' 299' ' ' MET . 0.0 OUTLIER -137.39 -170.89 2.84 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.394 178.4 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 299' ' ' MET . . . . . 0.803 ' N ' HD22 ' A' ' 298' ' ' LEU . 34.8 ttm -169.32 65.91 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.625 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.68 101.04 0.07 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.928 0.871 . . . . 0.0 110.583 -178.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -64.0 -46.26 85.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 113.822 -1.536 . . . . 0.0 113.331 -176.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -58.65 -39.89 81.89 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.119 -0.633 . . . . 0.0 109.791 -178.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 6.6 tm0? -65.01 -47.0 79.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.487 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 304' ' ' SER . . . . . 0.429 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 50.0 m -66.71 -37.83 85.51 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.509 -0.477 . . . . 0.0 110.581 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -61.7 -43.22 99.28 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -65.04 -36.97 86.08 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -176.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 307' ' ' ALA . . . . . 0.544 ' HB3' ' HD3' ' A' ' 308' ' ' PRO . . . -60.02 -52.94 69.89 Favored Pre-proline 0 CA--C 1.545 0.76 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 -176.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 308' ' ' PRO . . . . . 0.544 ' HD3' ' HB3' ' A' ' 307' ' ' ALA . 74.0 Cg_endo -75.23 0.21 9.27 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.053 1.835 . . . . 0.0 111.793 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 52.4 t80 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.499 -179.996 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.9 m . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.768 0.318 . . . . 0.0 110.496 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.4 t -137.97 150.08 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.495 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.1 mmmm -64.41 -41.87 96.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.905 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -63.61 -41.34 98.31 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.4 tt -79.59 -26.23 41.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.443 -178.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.402 ' O ' ' OG1' ' A' ' 22' ' ' THR . . . -66.18 -41.42 94.88 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 107.761 -2.135 . . . . 0.0 107.761 177.383 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.425 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -71.6 -32.25 67.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 124.889 2.281 . . . . 0.0 107.657 176.465 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.29 -42.26 99.3 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-N 108.448 -3.978 . . . . 0.0 108.165 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.402 ' OG1' ' O ' ' A' ' 19' ' ' GLY . 32.6 p -70.62 -27.32 63.99 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 177.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -66.51 -50.04 64.55 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.775 -1.102 . . . . 0.0 112.194 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.97 -35.89 79.83 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 118.482 -1.287 . . . . 0.0 111.204 -177.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.0 t -63.78 -53.39 51.64 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.847 -178.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 71.2 mt -65.43 -39.74 86.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 -177.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.57 -42.19 95.81 Favored 'General case' 0 C--N 1.333 -0.109 0 C-N-CA 119.84 -0.744 . . . . 0.0 112.946 -174.293 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.459 ' CB ' ' OE1' ' A' ' 89' ' ' GLN . 16.7 m-20 -78.24 -27.49 47.66 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 117.964 -1.495 . . . . 0.0 109.084 -177.082 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.5 tp -59.98 -56.05 26.46 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 118.546 -1.262 . . . . 0.0 111.113 -178.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.2 pp -75.73 -5.24 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 19.1 m -110.17 -17.96 13.42 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 118.811 -1.155 . . . . 0.0 109.941 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.508 ' N ' ' HD2' ' A' ' 33' ' ' PRO . 72.7 t80 -68.27 -45.22 38.55 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 121.308 1.867 . . . . 0.0 112.235 -177.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 32' ' ' PHE . 20.8 Cg_endo -59.42 -14.73 26.49 Favored 'Trans proline' 0 N--CA 1.5 1.872 0 CA-C-N 121.147 1.445 . . . . 0.0 111.147 176.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.57 ' O ' HD23 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -66.31 -35.41 80.3 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 114.686 -1.143 . . . . 0.0 113.086 -177.139 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -64.69 -40.55 95.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.278 -178.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 52.1 p -58.39 -34.9 71.23 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.3 -38.27 84.73 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.72 -0.792 . . . . 0.0 112.534 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.446 ' CG ' ' N ' ' A' ' 39' ' ' VAL . 10.7 pttp -62.01 -48.93 78.12 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 119.576 -0.85 . . . . 0.0 111.69 -176.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.446 ' N ' ' CG ' ' A' ' 38' ' ' LYS . 8.8 p -64.8 -39.89 87.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -177.509 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.55 HH22 HE22 ' A' ' 58' ' ' GLN . 6.4 tpm_? -61.04 -42.86 99.28 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -177.437 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.423 ' CD1' ' O ' ' A' ' 38' ' ' LYS . 2.4 pp -63.15 38.73 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.799 178.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.529 ' N ' ' O ' ' A' ' 40' ' ' ARG . 42.7 tt0 -145.25 165.68 27.69 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.901 0.382 . . . . 0.0 111.273 -178.355 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.729 HD13 ' H ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -73.57 79.17 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.62 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -44.89 135.99 4.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.857 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.99 135.88 0.24 Allowed Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.502 ' O ' ' N ' ' A' ' 48' ' ' GLN . 11.1 pt-20 -94.16 150.51 20.25 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.71 0.291 . . . . 0.0 110.564 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 49.9 m 57.45 -80.55 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.571 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.502 ' N ' ' O ' ' A' ' 46' ' ' GLU . 63.7 mt-30 55.0 178.54 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.212 0.53 . . . . 0.0 111.049 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -153.3 -22.66 0.05 OUTLIER Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.58 HD22 ' N ' ' A' ' 50' ' ' LEU . 3.5 mm? -66.63 -38.5 87.05 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.539 HG23 ' N ' ' A' ' 52' ' ' ARG . 20.5 m -61.15 -44.28 98.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.992 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.539 ' N ' HG23 ' A' ' 51' ' ' VAL . 33.4 mtm-85 -64.31 -33.64 76.3 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.357 -179.081 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 19.1 m -67.6 -38.32 83.81 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.652 ' O ' ' HB2' ' A' ' 55' ' ' ALA . . . -95.44 -122.1 0.11 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.195 178.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.652 ' HB2' ' O ' ' A' ' 54' ' ' ALA . . . 162.87 -22.71 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 121.191 -0.203 . . . . 0.0 110.842 179.054 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.623 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 4.6 m -128.53 -138.31 0.24 Allowed 'General case' 0 C--N 1.334 -0.107 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.623 ' HB3' ' O ' ' A' ' 56' ' ' SER . . . 93.59 14.99 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 O-C-N 123.883 0.74 . . . . 0.0 111.937 178.293 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.55 HE22 HH22 ' A' ' 40' ' ' ARG . 27.7 mt-30 -152.92 55.99 0.78 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -41.91 132.8 3.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.187 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 63.3 mtm-85 -41.02 -42.92 2.03 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.34 0.59 . . . . 0.0 109.921 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -31.95 104.22 0.01 OUTLIER Glycine 0 CA--C 1.527 0.834 0 CA-C-N 114.853 -1.067 . . . . 0.0 112.476 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 26.2 m -67.11 -33.58 64.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 118.262 -0.875 . . . . 0.0 109.046 176.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -60.0 -32.32 70.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 121.061 1.755 . . . . 0.0 109.785 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -65.1 -49.59 61.45 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-N 115.393 -0.821 . . . . 0.0 114.534 -177.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.3 m -62.57 -46.88 86.3 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -178.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.8 pp -60.27 -35.18 60.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.548 ' O ' HD13 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -63.35 -35.56 80.81 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 120.853 1.66 . . . . 0.0 110.948 179.527 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 98.8 m -61.77 -39.19 90.78 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 113.168 -1.833 . . . . 0.0 111.034 -176.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 15.5 tpt -60.51 -39.47 87.91 Favored 'General case' 0 C--N 1.332 -0.179 0 O-C-N 121.135 -0.978 . . . . 0.0 113.531 -177.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.5 t -68.98 -40.42 80.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 119.192 -1.003 . . . . 0.0 112.652 -177.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 56.9 ttt-85 -77.63 -13.39 59.92 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.94 0.876 . . . . 0.0 112.736 -178.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 49.3 m -62.87 -55.12 28.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.17 -1.377 . . . . 0.0 112.338 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -108.74 -58.78 1.97 Allowed 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 159.37 163.81 13.78 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -56.51 -34.89 96.08 Favored 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 122.229 1.953 . . . . 0.0 111.605 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 12.3 tpp180 -61.16 -11.22 8.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.908 0.861 . . . . 0.0 111.056 176.33 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.5 t -77.36 -32.1 54.79 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 113.953 -1.476 . . . . 0.0 110.994 -177.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 19.3 mt -75.61 -33.66 60.54 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.286 -0.566 . . . . 0.0 111.156 179.15 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.427 ' C ' ' H ' ' A' ' 81' ' ' GLY . 61.6 m-85 -92.81 -5.33 51.32 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 122.305 1.05 . . . . 0.0 113.386 -178.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.433 ' CG ' ' O ' ' A' ' 80' ' ' ASN . 21.5 t30 -86.25 33.9 0.62 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 112.957 -1.929 . . . . 0.0 107.393 175.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' A' ' 79' ' ' TYR . . . -172.9 -9.78 0.02 OUTLIER Glycine 0 CA--C 1.526 0.747 0 CA-C-N 114.485 -1.234 . . . . 0.0 112.535 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.411 ' H ' ' H ' ' A' ' 81' ' ' GLY . 61.2 tp -59.48 -35.07 73.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.469 -0.866 . . . . 0.0 110.963 -178.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.2 m -70.74 -26.84 28.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.799 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.63 -31.45 61.99 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.793 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.8 -40.18 89.73 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 119.893 -1.146 . . . . 0.0 111.751 -177.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -62.63 -40.28 96.5 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 122.16 0.981 . . . . 0.0 113.094 -176.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 20.2 tm0? -60.39 -27.44 67.44 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 113.349 -1.751 . . . . 0.0 109.456 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 72.7 mtt-85 -58.07 -53.46 57.96 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 173.182 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.459 ' OE1' ' CB ' ' A' ' 28' ' ' ASP . 23.6 mm100 -67.15 -29.97 69.83 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 112.08 -2.327 . . . . 0.0 112.373 -177.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 10.4 tpp -61.2 -40.46 94.04 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.078 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 68.3 m -74.64 -34.16 62.69 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 118.346 -0.835 . . . . 0.0 111.339 -176.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -57.58 -44.11 85.1 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 120.701 1.591 . . . . 0.0 112.044 -176.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.48 -33.0 64.61 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.466 -0.893 . . . . 0.0 111.025 -178.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 59.6 p -64.03 -41.87 97.28 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.412 ' C ' ' H ' ' A' ' 97' ' ' ILE . 34.3 m -68.18 -27.81 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.988 177.374 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.415 ' HG3' ' CD1' ' A' ' 100' ' ' TYR . 47.6 ttp85 -77.21 8.54 3.9 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -176.419 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.433 HG22 ' O ' ' A' ' 97' ' ' ILE . 46.3 mm -87.71 -15.08 9.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 177.193 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -140.25 -48.3 0.05 OUTLIER Glycine 0 CA--C 1.538 1.53 0 N-CA-C 115.902 1.121 . . . . 0.0 115.902 -175.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.0 tp -71.1 -13.23 61.89 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 119.249 1.524 . . . . 0.0 112.244 -177.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.521 ' O ' ' CG ' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -80.86 -51.28 8.76 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 114.688 -1.142 . . . . 0.0 111.834 179.71 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.509 ' O ' ' HG3' ' A' ' 105' ' ' GLN . 2.4 p30 -69.23 -32.48 71.75 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 123.768 1.747 . . . . 0.0 110.47 -178.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 25.8 m -68.17 -51.79 41.83 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 110.234 -3.167 . . . . 0.0 113.327 177.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 47.0 t -73.63 -26.28 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 CA-C-N 121.405 1.911 . . . . 0.0 111.257 178.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.521 ' CG ' ' O ' ' A' ' 100' ' ' TYR . 20.7 mmtp -69.32 -41.61 76.48 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 112.523 -2.126 . . . . 0.0 111.582 179.384 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.509 ' HG3' ' O ' ' A' ' 101' ' ' ASP . 88.1 mt-30 -80.1 -15.66 56.66 Favored 'General case' 0 C--O 1.245 0.847 0 CA-C-O 122.065 0.936 . . . . 0.0 110.998 -178.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -80.48 -22.29 41.17 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 121.741 -0.6 . . . . 0.0 112.109 179.08 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.414 ' O ' ' NE ' ' A' ' 119' ' ' ARG . 13.8 m-85 -109.07 -28.62 8.97 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.692 0.797 . . . . 0.0 111.794 -174.171 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.2 m -96.12 9.49 40.73 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 116.752 -1.979 . . . . 0.0 113.639 -176.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -46.46 124.7 6.1 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.997 1.271 . . . . 0.0 109.49 176.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -131.55 40.91 1.57 Allowed Glycine 0 N--CA 1.479 1.549 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 178.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 14.8 m -67.5 -37.63 83.12 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 -176.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -125.43 162.41 24.91 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 120.759 0.314 . . . . 0.0 111.084 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.628 ' O ' ' HB2' ' A' ' 114' ' ' ALA . 6.7 p-80 -77.03 67.33 3.0 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -178.584 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.628 ' HB2' ' O ' ' A' ' 113' ' ' HIS . . . 159.06 -163.06 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 176.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 101.57 15.33 27.5 Favored Glycine 0 C--N 1.343 0.949 0 CA-C-N 113.873 -1.512 . . . . 0.0 113.238 175.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 25.4 mm -61.1 -40.99 87.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 CA-C-N 118.416 1.108 . . . . 0.0 110.31 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.33 -39.96 96.22 Favored Glycine 0 C--N 1.346 1.095 0 CA-C-O 122.237 0.909 . . . . 0.0 111.361 176.16 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.1 t -57.48 -41.72 81.23 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 177.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.481 ' CD ' HD21 ' A' ' 194' ' ' LEU . 26.9 ttm180 -63.18 -37.54 87.61 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.474 -0.491 . . . . 0.0 111.249 -177.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -64.32 -46.28 84.23 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 177.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 31.5 mt -66.64 -45.1 80.09 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 118.978 -1.089 . . . . 0.0 110.145 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.97 -45.18 90.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 119.813 1.188 . . . . 0.0 110.315 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.413 ' CA ' ' CZ ' ' A' ' 107' ' ' TYR . . . -65.79 -44.28 92.48 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.766 -178.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 59.0 m -63.83 -43.66 95.52 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 19.1 m -69.06 -48.01 63.86 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 119.526 -0.87 . . . . 0.0 112.416 177.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.48 HG23 ' N ' ' A' ' 127' ' ' GLY . 5.7 t -65.47 -42.51 92.2 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 -173.189 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.48 ' N ' HG23 ' A' ' 126' ' ' THR . . . -64.46 -44.73 94.84 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-O 122.543 1.08 . . . . 0.0 113.736 -177.528 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.03 -40.8 94.98 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 112.689 -1.756 . . . . 0.0 107.204 178.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.542 HD13 ' O ' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -62.84 -41.22 99.26 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 114.86 -1.063 . . . . 0.0 109.576 178.93 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -61.82 -38.44 88.17 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.74 -0.209 . . . . 0.0 111.38 -178.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 79.1 t -60.63 -25.91 36.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.742 0.782 . . . . 0.0 109.836 179.123 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . -57.9 -44.41 86.73 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.236 -1.347 . . . . 0.0 111.215 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 43.1 t -78.73 -49.15 20.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.563 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -99.89 124.52 45.29 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 110.248 -0.278 . . . . 0.0 110.248 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.461 ' N ' ' HD2' ' A' ' 136' ' ' PRO . 33.2 tt0 -176.62 -54.49 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 135' ' ' GLN . 11.2 Cg_endo -52.3 -34.81 61.67 Favored 'Trans proline' 0 N--CA 1.5 1.885 0 C-N-CA 121.389 1.393 . . . . 0.0 113.902 -177.313 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 81.0 p -67.54 -41.77 83.77 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 118.491 -1.284 . . . . 0.0 109.369 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -64.58 -42.43 95.63 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 118.977 -1.089 . . . . 0.0 112.746 -176.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 17.2 m -63.81 -43.35 97.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 54.3 t -64.53 -38.47 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -178.003 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -61.47 -40.33 94.14 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 119.978 -0.689 . . . . 0.0 112.106 -176.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.3 p -69.39 -44.42 80.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.535 HH21 ' CD ' ' A' ' 170' ' ' GLU . 12.4 tpt85 -63.98 -35.83 81.99 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.951 179.347 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.488 ' CD2' ' OE1' ' A' ' 147' ' ' GLN . 40.9 t80 -65.96 -40.22 91.09 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.975 -177.625 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -63.72 -38.91 92.88 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.358 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -64.86 -34.76 79.15 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -178.182 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.488 ' OE1' ' CD2' ' A' ' 144' ' ' PHE . 5.0 pt20 -59.48 111.1 1.27 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 178.047 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -97.55 -61.61 1.37 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 117.523 -1.227 . . . . 0.0 113.951 -176.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 14.1 mtp-105 -101.4 135.52 42.75 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 122.273 2.306 . . . . 0.0 109.903 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -75.35 -113.37 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.519 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 175.19 131.47 1.44 Allowed Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.638 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 179.96 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.501 ' CD2' ' O ' ' A' ' 157' ' ' GLN . 91.8 t80 . . . . . 0 N--CA 1.466 0.356 0 CA-C-O 120.72 0.295 . . . . 0.0 110.368 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.501 ' O ' ' CD2' ' A' ' 156' ' ' TYR . 95.9 mt-30 -49.51 170.46 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.552 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 45.2 p -156.94 -178.25 7.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.954 0.407 . . . . 0.0 110.789 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.555 HG23 ' N ' ' A' ' 160' ' ' VAL . 11.7 t -64.5 -46.36 83.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.792 -177.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.573 HG13 ' N ' ' A' ' 161' ' ' GLU . 12.7 p -64.63 -45.52 95.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 118.898 -1.121 . . . . 0.0 109.077 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.573 ' N ' HG13 ' A' ' 160' ' ' VAL . 74.6 tt0 -66.99 -38.95 86.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.996 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -61.41 -45.78 92.91 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -177.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.613 ' CE2' HD13 ' A' ' 175' ' ' LEU . 12.7 t80 -62.85 -50.42 71.02 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.923 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -68.77 -45.42 71.4 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 115.162 1.541 . . . . 0.0 115.162 -175.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 10.0 m -63.24 -44.44 95.19 Favored 'General case' 0 C--N 1.321 -0.658 0 O-C-N 121.137 -0.977 . . . . 0.0 113.25 -178.255 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.446 ' O ' HD13 ' A' ' 166' ' ' ILE . 0.2 OUTLIER -64.64 -38.72 83.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 122.199 0.999 . . . . 0.0 109.156 177.554 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.94 -36.64 77.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 113.201 -1.818 . . . . 0.0 109.137 177.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -62.62 -51.0 69.02 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 122.5 2.409 . . . . 0.0 112.713 -174.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -75.38 -51.07 14.01 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 177.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.535 ' CD ' HH21 ' A' ' 143' ' ' ARG . 16.3 tt0 -78.67 -36.42 43.79 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -175.016 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 95.62 -169.03 26.95 Favored Glycine 0 N--CA 1.467 0.764 0 CA-C-N 118.13 0.423 . . . . 0.0 112.57 177.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.406 HG12 ' H ' ' A' ' 172' ' ' ILE . 6.0 pt -72.92 -40.71 60.11 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.129 0 CA-C-O 121.978 0.894 . . . . 0.0 110.396 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 9.1 tpp85 -58.68 -33.63 70.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 113.859 -1.519 . . . . 0.0 110.952 -177.047 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -60.91 -40.82 98.88 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 118.676 -1.726 . . . . 0.0 110.244 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.613 HD13 ' CE2' ' A' ' 163' ' ' TYR . 6.8 mt -70.84 -33.64 70.87 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 111.286 -2.457 . . . . 0.0 116.975 -177.678 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 11.1 m0 -78.35 -7.76 57.66 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 112.456 -2.156 . . . . 0.0 109.752 -176.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -43.47 -48.49 7.27 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.535 -0.466 . . . . 0.0 112.154 -175.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.429 ' O ' ' HD2' ' A' ' 181' ' ' PRO . . . -79.11 -13.63 82.74 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 124.444 1.021 . . . . 0.0 111.933 178.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.422 ' O ' ' OD1' ' A' ' 182' ' ' ASN . 84.6 m -46.33 -51.44 14.71 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.86 -50.95 74.9 Favored Pre-proline 0 N--CA 1.475 0.789 0 N-CA-C 114.287 1.218 . . . . 0.0 114.287 -174.442 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.429 ' HD2' ' O ' ' A' ' 178' ' ' GLY . 29.1 Cg_exo -64.52 -29.96 61.58 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 CA-C-N 120.678 1.278 . . . . 0.0 113.279 177.612 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 179' ' ' THR . 0.0 OUTLIER -65.53 -40.85 93.42 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 119.366 -0.934 . . . . 0.0 109.896 178.876 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 54.9 t -64.35 -43.12 97.07 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.166 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.083 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.66 -39.79 95.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.178 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.629 HH21 ' CG1' ' A' ' 189' ' ' VAL . 0.7 OUTLIER -60.88 -43.55 98.31 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 119.789 -0.764 . . . . 0.0 110.885 -178.704 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -63.36 -45.43 91.22 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.744 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -66.59 -45.86 77.82 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.07 -46.25 91.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -177.088 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.629 ' CG1' HH21 ' A' ' 185' ' ' ARG . 35.6 m -60.86 -47.81 91.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 119.224 -0.99 . . . . 0.0 111.899 -177.473 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 190' ' ' ASN . . . . . 0.53 ' N ' HG23 ' A' ' 189' ' ' VAL . 70.7 m-80 -62.43 -44.22 96.94 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.609 0.718 . . . . 0.0 110.047 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 191' ' ' CYS . . . . . . . . . . . . . 21.9 t -63.24 -47.61 81.75 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.031 178.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.8 -39.77 94.13 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 113.742 -1.572 . . . . 0.0 110.037 177.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' A' ' 189' ' ' VAL . 3.8 tm-20 -59.63 -45.75 91.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.252 -1.34 . . . . 0.0 111.803 -176.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.481 HD21 ' CD ' ' A' ' 119' ' ' ARG . 0.1 OUTLIER -65.04 -37.64 88.26 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 118.544 -1.262 . . . . 0.0 111.229 -175.548 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 94.8 t -64.21 -47.34 90.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 117.172 -1.811 . . . . 0.0 109.414 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 196' ' ' THR . . . . . 0.413 HG23 ' N ' ' A' ' 197' ' ' TYR . 3.0 t -65.48 -45.68 82.71 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 122.075 0.94 . . . . 0.0 112.743 -179.23 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 197' ' ' TYR . . . . . 0.413 ' N ' HG23 ' A' ' 196' ' ' THR . 61.7 t80 -57.99 -39.8 79.12 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 113.611 -1.631 . . . . 0.0 113.07 -178.504 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -56.41 -44.85 80.75 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 16.4 mt -62.12 -39.64 93.22 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.185 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 80.6 mt -63.6 -42.9 97.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-O 119.252 -0.404 . . . . 0.0 111.021 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 201' ' ' LYS . . . . . 0.646 ' O ' HD12 ' A' ' 205' ' ' LEU . 0.0 OUTLIER -59.63 -37.46 78.71 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.774 2.03 . . . . 0.0 112.272 177.19 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -58.98 -34.97 72.44 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 114.135 -1.393 . . . . 0.0 110.996 -175.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.2 t -98.78 130.67 45.24 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 121.745 0.784 . . . . 0.0 111.383 -177.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.478 ' CD2' ' CE1' ' A' ' 217' ' ' HIS . 9.7 mp 70.02 6.96 6.01 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 113.417 -1.72 . . . . 0.0 115.61 -178.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.961 ' O ' HD22 ' A' ' 205' ' ' LEU . 0.0 OUTLIER -109.71 21.0 17.47 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 120.091 1.314 . . . . 0.0 112.954 179.345 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -60.44 -32.85 71.77 Favored 'General case' 0 C--N 1.332 -0.185 0 O-C-N 120.047 -1.658 . . . . 0.0 113.045 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.492 ' O ' ' CB ' ' A' ' 208' ' ' ASN . . . -165.86 32.83 0.05 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.003 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 208' ' ' ASN . . . . . 0.492 ' CB ' ' O ' ' A' ' 207' ' ' ALA . 24.8 t-20 93.19 -126.44 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 O-C-N 123.882 0.739 . . . . 0.0 110.371 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 6.6 tp . . . . . 0 C--N 1.33 -0.271 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.966 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 0.445 ' O ' ' SG ' ' A' ' 216' ' ' CYS . 71.0 m-20 . . . . . 0 N--CA 1.462 0.13 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.468 ' N ' ' CD ' ' A' ' 215' ' ' PRO . 1.8 mt -61.21 -43.39 90.01 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.63 -0.713 . . . . 0.0 112.504 -178.588 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 215' ' ' PRO . . . . . 0.468 ' CD ' ' N ' ' A' ' 214' ' ' LEU . 35.4 Cg_exo -60.29 -33.45 94.55 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 120.966 1.111 . . . . 0.0 111.715 -178.288 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 216' ' ' CYS . . . . . 0.513 ' SG ' ' N ' ' A' ' 217' ' ' HIS . 0.8 OUTLIER -64.69 -42.04 95.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 113.427 -1.715 . . . . 0.0 111.543 -178.164 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 217' ' ' HIS . . . . . 0.513 ' N ' ' SG ' ' A' ' 216' ' ' CYS . 11.6 t-160 -66.08 -37.13 85.03 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.575 -177.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -62.98 -47.94 80.99 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.051 -178.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 8.4 m -61.11 -38.81 87.66 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 120.211 1.369 . . . . 0.0 110.255 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 20.7 p -58.97 -40.94 86.28 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 221' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -62.71 -41.26 99.06 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -176.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -60.25 -46.59 89.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 122.66 1.219 . . . . 0.0 111.873 -176.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -60.9 -41.77 99.41 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-N 112.364 -2.198 . . . . 0.0 107.771 176.61 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 224' ' ' ALA . . . . . 0.89 ' O ' HG23 ' A' ' 228' ' ' THR . . . -62.37 -37.3 85.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.067 -1.067 . . . . 0.0 108.555 177.137 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 225' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -60.97 -41.99 99.59 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 -177.396 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -66.77 -38.54 86.76 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 119.294 -0.962 . . . . 0.0 108.799 178.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 227' ' ' CYS . . . . . 0.513 ' SG ' ' O ' ' A' ' 224' ' ' ALA . 0.5 OUTLIER -63.38 -40.53 97.5 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.503 0.668 . . . . 0.0 110.295 177.617 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 228' ' ' THR . . . . . 0.89 HG23 ' O ' ' A' ' 224' ' ' ALA . 75.8 p -61.34 -38.06 85.55 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 114.839 -1.073 . . . . 0.0 112.533 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.489 HG23 ' O ' ' A' ' 225' ' ' GLY . 71.6 p -56.7 -38.86 72.86 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.486 -0.485 . . . . 0.0 111.229 -174.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 227' ' ' CYS . 3.8 p -59.79 -40.81 83.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 118.026 -1.47 . . . . 0.0 108.318 178.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 24.7 mt -61.54 -40.67 87.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 176.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -62.15 -39.2 91.81 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 114.539 -1.209 . . . . 0.0 113.8 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.62 ' O ' HG13 ' A' ' 237' ' ' VAL . 8.2 t -58.74 -43.24 97.58 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 -174.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 233' ' ' SER . 20.0 Cg_endo -60.14 -41.5 51.18 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 CA-C-N 121.947 1.731 . . . . 0.0 112.705 179.065 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 2.9 p -65.97 -37.7 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 117.972 -1.491 . . . . 0.0 109.237 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -66.69 -42.0 87.14 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 -179.134 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.62 HG13 ' O ' ' A' ' 233' ' ' SER . 15.4 m -65.7 -45.43 91.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -176.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.464 ' N ' HG23 ' A' ' 237' ' ' VAL . 9.9 p . . . . . 0 C--N 1.324 -0.515 0 C-N-CA 119.444 -0.902 . . . . 0.0 111.818 -177.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 94.0 m . . . . . 0 N--CA 1.466 0.355 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 260' ' ' MET . . . . . 0.566 ' SD ' ' N ' ' A' ' 261' ' ' LEU . 0.1 OUTLIER -61.33 -43.86 98.16 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 120.134 -0.626 . . . . 0.0 110.851 -178.317 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.566 ' N ' ' SD ' ' A' ' 260' ' ' MET . 63.7 tp -63.18 -48.29 79.0 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 262' ' ' ARG . . . . . 0.447 ' O ' ' O ' ' A' ' 263' ' ' LYS . 8.6 tpt180 -67.68 -53.94 23.57 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.765 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 263' ' ' LYS . . . . . 0.447 ' O ' ' O ' ' A' ' 262' ' ' ARG . 5.4 ttpm? -56.25 -126.49 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.778 -178.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -85.89 143.11 28.4 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 121.094 0.473 . . . . 0.0 111.122 -178.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 265' ' ' GLY . . . . . 0.518 ' C ' ' H ' ' A' ' 267' ' ' ARG . . . -42.22 160.84 0.04 OUTLIER Glycine 0 CA--C 1.529 0.968 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.382 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -55.98 0.21 0.17 Allowed 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 121.798 1.666 . . . . 0.0 111.909 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 267' ' ' ARG . . . . . 0.518 ' H ' ' C ' ' A' ' 265' ' ' GLY . 82.9 mtt85 -70.25 -26.46 63.84 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.753 0.821 . . . . 0.0 112.225 178.667 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -57.98 -32.06 67.51 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.849 -178.191 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -62.1 -41.02 97.79 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.674 177.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -65.28 -37.98 88.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.372 -177.179 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.472 ' O ' ' O ' ' A' ' 272' ' ' GLY . 37.0 mmtm -67.33 -176.8 0.61 Allowed 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 178.347 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 272' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 271' ' ' LYS . . . 37.11 99.3 0.01 OUTLIER Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -156.63 -0.58 0.12 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.019 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 274' ' ' MET . . . . . 0.574 ' N ' ' CD ' ' A' ' 275' ' ' PRO . 0.1 OUTLIER -63.77 -44.62 80.39 Favored Pre-proline 0 C--N 1.328 -0.35 0 C-N-CA 120.247 -0.581 . . . . 0.0 109.565 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 275' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 274' ' ' MET . 20.9 Cg_exo -64.7 -47.22 5.58 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.093 1.862 . . . . 0.0 111.651 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 19.7 m -61.03 -40.03 92.05 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.701 0.762 . . . . 0.0 110.434 179.32 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -62.14 -41.85 98.67 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 123.528 1.633 . . . . 0.0 112.138 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 1.4 mp -62.05 -38.85 90.32 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 110.617 -2.992 . . . . 0.0 108.549 174.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 13.5 mmt85 -62.76 -40.65 97.94 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.291 0.567 . . . . 0.0 109.751 178.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.618 ' O ' HD23 ' A' ' 280' ' ' LEU . 0.9 OUTLIER -63.07 -37.2 86.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.099 -179.037 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -67.81 -50.93 38.24 Favored Glycine 0 CA--C 1.519 0.297 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -177.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 77.8 p -61.63 -44.32 97.21 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 283' ' ' TRP . . . . . 0.636 ' O ' HG22 ' A' ' 286' ' ' VAL . 87.6 t90 -61.26 -39.72 91.41 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.637 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -64.31 -40.66 96.38 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 5.3 m -62.28 -38.18 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.636 HG22 ' O ' ' A' ' 283' ' ' TRP . 27.1 m -62.02 -38.83 81.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 121.094 -0.242 . . . . 0.0 111.041 -178.022 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 287' ' ' MET . . . . . 0.453 ' C ' ' SD ' ' A' ' 287' ' ' MET . 0.0 OUTLIER -59.33 -37.31 77.49 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.643 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -57.95 -40.07 79.66 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.003 -179.093 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 286' ' ' VAL . 1.2 m -60.46 -38.16 77.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 O-C-N 121.766 -0.584 . . . . 0.0 111.018 -178.237 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 75.1 p -61.81 -38.93 89.96 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 177.199 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -60.64 -38.34 84.52 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 177.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -58.22 -40.71 82.36 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 118.089 -1.445 . . . . 0.0 109.421 -176.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 293' ' ' GLN . . . . . 0.453 ' O ' ' O ' ' A' ' 296' ' ' ARG . 36.5 tp60 -60.72 -42.74 97.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 122.823 1.296 . . . . 0.0 110.468 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 35.9 tp -60.29 -40.15 89.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 112.497 -2.138 . . . . 0.0 109.157 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -63.05 -45.71 90.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.335 179.136 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 296' ' ' ARG . . . . . 0.453 ' O ' ' O ' ' A' ' 293' ' ' GLN . 44.8 ttm180 -123.03 116.39 23.45 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.047 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -114.41 -97.25 0.44 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.069 0.461 . . . . 0.0 110.682 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.467 HD21 HE21 ' A' ' 303' ' ' GLN . 36.8 tp -140.7 121.06 14.0 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.009 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 24.3 ttt -95.59 66.15 2.73 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -178.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.52 100.82 0.07 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 122.149 0.976 . . . . 0.0 110.805 -178.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -64.28 -46.31 84.21 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 113.393 -1.73 . . . . 0.0 113.362 -176.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -58.92 -39.75 82.48 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.085 -177.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 303' ' ' GLN . . . . . 0.467 HE21 HD21 ' A' ' 298' ' ' LEU . 0.3 OUTLIER -64.51 -46.73 81.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.003 -179.61 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 304' ' ' SER . . . . . 0.44 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 15.1 m -66.56 -37.42 84.93 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.61 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -61.66 -43.25 99.22 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -178.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -65.17 -36.88 85.6 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -177.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 307' ' ' ALA . . . . . 0.523 ' HB3' ' HD3' ' A' ' 308' ' ' PRO . . . -59.86 -52.7 71.85 Favored Pre-proline 0 CA--C 1.543 0.675 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -176.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 308' ' ' PRO . . . . . 0.523 ' HD3' ' HB3' ' A' ' 307' ' ' ALA . 73.1 Cg_endo -75.2 0.39 9.04 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.038 1.825 . . . . 0.0 111.862 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 39.8 t80 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.501 179.914 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.59 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.447 HG22 ' H ' ' A' ' 14' ' ' THR . 0.0 OUTLIER -82.55 168.41 17.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.632 -179.976 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.796 HG22 ' H ' ' A' ' 16' ' ' LYS . 13.4 p -167.07 -178.98 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.898 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.796 ' H ' HG22 ' A' ' 15' ' ' VAL . 23.7 mtpp -64.32 -41.81 96.63 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.699 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -63.73 -41.5 98.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.279 0.561 . . . . 0.0 112.077 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.514 ' H ' HG13 ' A' ' 15' ' ' VAL . 12.9 tp -79.97 -26.0 40.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.046 -179.001 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.04 -41.3 95.24 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 107.601 -2.199 . . . . 0.0 107.601 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -71.47 -32.01 67.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 124.886 2.279 . . . . 0.0 107.332 176.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.76 -42.51 98.55 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-N 108.454 -3.975 . . . . 0.0 108.292 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 28.3 p -70.61 -27.48 64.11 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.541 0.686 . . . . 0.0 109.436 178.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.654 ' O ' HD13 ' A' ' 26' ' ' ILE . . . -65.76 -49.7 67.43 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.166 -178.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.98 -35.19 77.76 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 118.816 -1.154 . . . . 0.0 112.375 -177.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.4 ' HA ' HE22 ' A' ' 89' ' ' GLN . 75.7 m -63.35 -53.79 47.11 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -177.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.654 HD13 ' O ' ' A' ' 23' ' ' ALA . 0.2 OUTLIER -65.89 -38.09 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -177.117 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.449 ' O ' ' OG1' ' A' ' 31' ' ' THR . . . -63.64 -41.59 98.23 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -173.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 29' ' ' LEU . 20.0 p30 -77.6 -27.0 51.13 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 120.893 1.678 . . . . 0.0 109.93 -175.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.501 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 11.2 tp -59.8 -55.39 34.82 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 119.93 1.241 . . . . 0.0 112.148 -178.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.1 pt -75.45 -3.91 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-O 121.376 0.608 . . . . 0.0 112.61 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.573 HG23 HD12 ' A' ' 34' ' ' LEU . 7.1 m -109.3 -16.85 13.95 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.751 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.47 ' N ' ' CD ' ' A' ' 33' ' ' PRO . 1.8 t80 -68.53 -44.33 33.51 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 121.411 1.914 . . . . 0.0 110.93 -178.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.47 ' CD ' ' N ' ' A' ' 32' ' ' PHE . 36.8 Cg_exo -59.36 -15.8 31.52 Favored 'Trans proline' 0 N--CA 1.501 1.964 0 C-N-CA 121.554 1.502 . . . . 0.0 112.701 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.573 HD12 HG23 ' A' ' 31' ' ' THR . 81.6 mt -67.62 -35.36 78.79 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 114.787 1.402 . . . . 0.0 114.787 -177.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 36' ' ' THR . 45.3 p-10 -64.27 -40.53 96.16 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -177.071 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.53 ' N ' ' OD1' ' A' ' 35' ' ' ASP . 44.1 p -58.27 -35.28 71.54 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.939 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.86 -39.19 83.8 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 119.755 -0.778 . . . . 0.0 112.015 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.498 ' NZ ' ' CB ' ' A' ' 38' ' ' LYS . 8.7 mtmp? -62.12 -49.36 76.21 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 119.239 -0.984 . . . . 0.0 111.187 -176.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.1 m -64.25 -40.6 89.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -176.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.461 ' O ' ' N ' ' A' ' 42' ' ' GLN . 10.2 tpp180 -61.69 -41.87 98.16 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 119.378 -0.929 . . . . 0.0 110.08 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.54 39.06 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.768 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.498 ' C ' ' H ' ' A' ' 44' ' ' GLN . 60.2 tt0 -125.73 152.78 44.87 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.989 0.424 . . . . 0.0 110.942 -179.133 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.538 HG22 ' O ' ' A' ' 43' ' ' ILE . 73.0 mt -63.11 0.78 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.004 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.498 ' H ' ' C ' ' A' ' 42' ' ' GLN . 23.4 mt-30 64.13 78.98 0.27 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.525 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.17 -5.68 3.45 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.427 ' H ' ' C ' ' A' ' 44' ' ' GLN . 96.8 mt-10 -56.22 -42.83 77.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.912 0.387 . . . . 0.0 109.992 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.532 ' C ' ' H ' ' A' ' 49' ' ' GLY . 4.7 t 37.71 30.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.699 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.406 ' N ' ' O ' ' A' ' 46' ' ' GLU . 85.9 mt-30 -58.05 -2.8 0.19 Allowed 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.121 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.532 ' H ' ' C ' ' A' ' 47' ' ' SER . . . 87.44 -8.62 76.5 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -177.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -66.35 -37.3 85.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.665 0.745 . . . . 0.0 109.237 177.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.504 HG13 ' N ' ' A' ' 52' ' ' ARG . 13.1 p -60.76 -44.12 96.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.149 -178.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.504 ' N ' HG13 ' A' ' 51' ' ' VAL . 6.9 mmp_? -64.56 -35.14 80.02 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 119.816 -0.754 . . . . 0.0 112.31 -177.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.5 t -68.95 -38.0 79.18 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 119.24 -0.984 . . . . 0.0 108.758 177.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -138.29 97.93 3.49 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 114.798 -1.092 . . . . 0.0 108.39 178.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -80.65 9.0 6.73 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -177.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.608 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 18.7 m -125.69 -140.99 0.28 Allowed 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.608 ' HB3' ' O ' ' A' ' 56' ' ' SER . . . 97.87 12.74 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 O-C-N 124.127 0.892 . . . . 0.0 111.863 178.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -178.24 84.59 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.704 0.288 . . . . 0.0 110.36 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -63.78 163.06 12.31 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.063 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.413 ' O ' ' C ' ' A' ' 61' ' ' GLY . 78.4 mtm-85 -49.84 -36.85 28.3 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 60' ' ' ARG . . . -28.57 102.58 0.01 OUTLIER Glycine 0 CA--C 1.526 0.764 0 CA-C-N 114.955 -1.021 . . . . 0.0 112.703 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.416 HG22 ' H ' ' A' ' 62' ' ' VAL . 2.1 m -67.32 -34.37 68.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 118.41 -0.805 . . . . 0.0 109.663 176.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.439 HD22 ' N ' ' A' ' 63' ' ' LEU . 4.4 mm? -60.48 -32.5 71.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 121.077 1.762 . . . . 0.0 109.615 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.67 -49.32 64.81 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-N 114.623 -1.171 . . . . 0.0 114.781 -176.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.7 p -61.98 -46.48 89.05 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 -178.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 8.8 tt -59.8 -36.19 64.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.547 ' O ' HD13 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -64.21 -35.73 81.75 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 120.303 1.411 . . . . 0.0 111.913 179.645 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.466 ' O ' ' OG1' ' A' ' 72' ' ' THR . 98.1 m -63.56 -40.88 98.12 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.312 -1.313 . . . . 0.0 111.085 -175.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 7.3 ptm -60.59 -39.46 88.18 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -175.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.43 ' CG2' HD11 ' A' ' 78' ' ' LEU . 5.2 p -69.02 -40.01 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 119.532 -0.867 . . . . 0.0 113.05 -177.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.42 ' N ' HG13 ' A' ' 70' ' ' VAL . 56.6 ttp180 -77.78 -13.08 60.0 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.999 0.904 . . . . 0.0 112.6 -178.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.466 ' OG1' ' O ' ' A' ' 68' ' ' THR . 19.7 m -62.45 -54.65 37.08 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.025 -1.443 . . . . 0.0 111.272 179.071 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 28.2 mp0 -107.01 -57.76 2.02 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 178.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.42 ' O ' ' CB ' ' A' ' 77' ' ' SER . . . 159.36 165.49 16.46 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -56.84 -35.46 98.26 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 121.487 1.458 . . . . 0.0 111.376 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.64 -11.34 11.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.802 0.811 . . . . 0.0 110.691 175.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 74' ' ' GLY . 5.6 t -77.9 -32.49 51.8 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.098 -1.41 . . . . 0.0 110.905 -178.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.43 HD11 ' CG2' ' A' ' 70' ' ' VAL . 27.5 mt -75.45 -33.48 60.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.116 0.484 . . . . 0.0 110.61 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -92.29 -4.59 53.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 122.798 1.285 . . . . 0.0 113.243 -177.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -95.28 116.25 28.52 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 112.29 -2.232 . . . . 0.0 107.016 175.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.48 -11.38 54.16 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -177.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.674 HD12 ' C ' ' A' ' 82' ' ' LEU . 0.3 OUTLIER -59.24 -34.42 72.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 113.94 -1.13 . . . . 0.0 110.489 -179.328 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.1 m -70.49 -27.0 29.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.087 -0.961 . . . . 0.0 109.369 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.95 -31.92 61.61 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.675 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.92 -40.11 89.18 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 119.544 -1.312 . . . . 0.0 111.223 -177.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.0 mp -62.46 -40.1 95.56 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 122.29 1.043 . . . . 0.0 112.574 -177.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -60.57 -27.44 67.69 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 113.106 -1.861 . . . . 0.0 109.613 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 58.2 ttp85 -57.83 -53.55 56.97 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 173.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.4 HE22 ' HA ' ' A' ' 25' ' ' CYS . 10.3 tt0 -67.22 -29.9 69.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 112.318 -2.219 . . . . 0.0 112.512 -178.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 38.4 ttm -61.14 -40.66 94.65 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.497 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 38.2 t -74.32 -34.13 63.37 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 119.556 -0.858 . . . . 0.0 111.718 -176.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -57.75 -43.99 85.8 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 120.584 1.538 . . . . 0.0 112.308 -176.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.53 -32.85 64.44 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 119.321 -0.952 . . . . 0.0 111.015 -178.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.601 ' O ' HG22 ' A' ' 97' ' ' ILE . 48.8 m -64.35 -41.82 96.55 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.438 ' C ' ' H ' ' A' ' 97' ' ' ILE . 7.2 p -68.42 -28.41 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.221 177.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 16.9 mtp-105 -77.46 10.33 2.65 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -177.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.601 HG22 ' O ' ' A' ' 94' ' ' SER . 9.6 tp -86.87 -15.33 9.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 177.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.404 ' O ' ' OD1' ' A' ' 101' ' ' ASP . . . -140.05 -48.0 0.06 OUTLIER Glycine 0 CA--C 1.539 1.571 0 CA-C-N 114.23 -1.35 . . . . 0.0 114.383 -177.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.4 tp -70.75 -13.48 62.07 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.183 1.491 . . . . 0.0 113.37 -177.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.53 ' O ' ' HB2' ' A' ' 104' ' ' LYS . 20.6 t80 -81.21 -51.67 8.17 Favored 'General case' 0 C--O 1.211 -0.945 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.957 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.536 ' O ' ' HG3' ' A' ' 105' ' ' GLN . 9.3 p-10 -69.99 -32.73 71.07 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 123.631 1.682 . . . . 0.0 111.83 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.0 m -68.83 -52.72 26.98 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 110.81 -2.904 . . . . 0.0 116.99 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 69.2 t -74.99 -26.9 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 CA-C-N 121.121 1.782 . . . . 0.0 110.8 176.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.53 ' HB2' ' O ' ' A' ' 100' ' ' TYR . 0.4 OUTLIER -69.54 -41.53 75.84 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 110.831 -2.895 . . . . 0.0 112.974 -179.259 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.536 ' HG3' ' O ' ' A' ' 101' ' ' ASP . 88.1 mt-30 -78.65 -13.75 59.66 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 123.614 1.673 . . . . 0.0 111.025 178.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.06 -22.74 41.95 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 112.785 -2.007 . . . . 0.0 110.9 178.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -109.87 -30.62 7.75 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.833 0.742 . . . . 0.0 112.212 -175.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.646 ' O ' HG22 ' A' ' 108' ' ' THR . 50.1 m -98.46 9.06 44.01 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 118.219 -1.393 . . . . 0.0 112.579 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.444 ' O ' ' C ' ' A' ' 110' ' ' GLY . 35.3 ttmt -53.74 121.11 7.2 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.495 ' O ' ' CB ' ' A' ' 111' ' ' SER . . . -23.59 -78.79 0.01 OUTLIER Glycine 0 N--CA 1.48 1.59 0 CA-C-N 117.81 0.277 . . . . 0.0 113.12 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.525 ' O ' ' HB2' ' A' ' 112' ' ' GLU . 1.4 t 91.96 -87.26 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 177.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.525 ' HB2' ' O ' ' A' ' 111' ' ' SER . 82.7 tt0 171.64 -34.36 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 120.541 1.519 . . . . 0.0 113.915 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.637 ' O ' ' HB2' ' A' ' 114' ' ' ALA . 0.3 OUTLIER 156.87 42.46 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.201 0.524 . . . . 0.0 109.896 -179.214 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.637 ' HB2' ' O ' ' A' ' 113' ' ' HIS . . . 160.45 -162.41 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 178.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.78 15.23 25.01 Favored Glycine 0 CA--C 1.507 -0.428 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.49 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.459 HG23 ' N ' ' A' ' 117' ' ' GLY . 12.6 tt -60.43 -40.54 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.459 ' N ' HG23 ' A' ' 116' ' ' ILE . . . -65.68 -40.17 95.71 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-O 121.791 0.661 . . . . 0.0 111.685 175.079 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 10.1 p -58.65 -42.97 89.58 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 176.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.402 ' NE ' ' HA ' ' A' ' 116' ' ' ILE . 76.3 mtm180 -63.71 -37.01 85.74 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.849 -177.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.46 HD21 HD13 ' A' ' 194' ' ' LEU . 70.9 mt -63.53 -45.63 89.7 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 177.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 39.4 mt -66.52 -44.82 81.46 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 118.762 -1.175 . . . . 0.0 110.06 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.98 -45.4 89.24 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 120.22 1.373 . . . . 0.0 110.602 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -66.04 -44.16 92.0 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 120.172 -1.014 . . . . 0.0 111.289 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 59.0 m -64.14 -43.82 94.04 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.43 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 20.6 m -69.34 -48.27 61.91 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 119.365 -0.934 . . . . 0.0 111.943 177.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.449 HG23 ' N ' ' A' ' 127' ' ' GLY . 4.8 t -65.23 -42.46 93.37 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -173.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.449 ' N ' HG23 ' A' ' 126' ' ' THR . . . -63.89 -44.53 95.95 Favored Glycine 0 CA--C 1.521 0.423 0 CA-C-O 122.912 1.284 . . . . 0.0 113.196 -177.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.449 ' O ' HG22 ' A' ' 131' ' ' VAL . . . -61.12 -41.21 96.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 112.029 -2.085 . . . . 0.0 106.714 177.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.679 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 0.2 OUTLIER -63.98 -41.9 97.39 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.3 178.886 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -62.9 -39.98 96.17 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -177.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.449 HG22 ' O ' ' A' ' 128' ' ' ALA . 12.5 m -61.04 -26.12 38.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 122.628 1.204 . . . . 0.0 109.513 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.679 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . -58.31 -44.45 88.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 112.607 -2.088 . . . . 0.0 111.736 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 61.5 t -78.6 -49.02 21.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.941 -178.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -112.38 131.64 55.43 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.746 0.308 . . . . 0.0 110.805 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.596 ' H ' ' HD2' ' A' ' 136' ' ' PRO . 11.6 tt0 -175.51 -41.79 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.82 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.596 ' HD2' ' H ' ' A' ' 135' ' ' GLN . 52.6 Cg_exo -52.78 -34.52 65.35 Favored 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 121.819 1.679 . . . . 0.0 113.437 -178.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 98.6 m -67.54 -42.01 83.4 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 118.029 -1.468 . . . . 0.0 108.594 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -65.51 -43.01 91.43 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 118.159 -1.416 . . . . 0.0 112.788 -177.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.3 p -64.76 -44.22 96.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.455 ' O ' ' N ' ' A' ' 144' ' ' PHE . 21.8 m -65.26 -37.93 81.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -178.253 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -61.41 -40.72 95.44 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -176.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.453 ' CG1' ' N ' ' A' ' 143' ' ' ARG . 3.9 p -69.61 -44.7 79.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 119.399 -0.92 . . . . 0.0 108.94 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.453 ' N ' ' CG1' ' A' ' 142' ' ' VAL . 65.8 mtt180 -64.24 -35.71 81.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.701 178.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.455 ' N ' ' O ' ' A' ' 140' ' ' VAL . 85.1 t80 -65.71 -40.56 92.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.239 -178.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -64.14 -38.63 91.74 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -64.88 -35.02 79.79 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -178.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -59.75 111.18 1.35 Allowed 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 177.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -106.6 -173.12 2.22 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 117.686 2.476 . . . . 0.0 117.686 -171.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 59.0 61.13 2.21 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 110.035 -3.257 . . . . 0.0 110.899 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . 46.59 -114.79 0.54 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.806 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 170.74 113.88 0.3 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.979 -0.849 . . . . 0.0 110.979 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -99.56 -156.89 28.66 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 155' ' ' ARG . . . 81.66 56.47 2.94 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 77.8 mtp85 41.76 -90.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.733 0.301 . . . . 0.0 110.94 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.52 ' N ' ' O ' ' A' ' 153' ' ' GLY . 25.7 ttm105 -64.49 128.75 37.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.417 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.412 ' CD1' ' O ' ' A' ' 156' ' ' TYR . 28.1 p90 -70.7 132.06 44.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.516 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -54.48 175.73 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.662 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 162' ' ' ALA . 20.5 p -157.0 -178.36 7.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.657 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.57 HG23 ' N ' ' A' ' 160' ' ' VAL . 13.7 t -64.1 -46.47 84.06 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.663 -177.376 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.57 ' N ' HG23 ' A' ' 159' ' ' THR . 6.3 p -64.51 -45.43 95.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 119.06 -1.056 . . . . 0.0 109.674 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.485 ' N ' HG13 ' A' ' 160' ' ' VAL . 50.3 mm-40 -66.65 -38.34 86.67 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.162 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.556 ' O ' HD12 ' A' ' 166' ' ' ILE . . . -60.97 -44.58 97.12 Favored 'General case' 0 C--O 1.21 -0.981 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -177.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.448 ' CD1' ' C ' ' A' ' 163' ' ' TYR . 20.6 t80 -61.5 -47.84 83.79 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.527 0.565 . . . . 0.0 112.527 -178.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -67.89 -45.39 74.57 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 117.881 2.549 . . . . 0.0 117.881 -172.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 41.7 p -63.38 -45.44 91.11 Favored 'General case' 0 CA--C 1.557 1.227 0 N-CA-C 117.294 2.331 . . . . 0.0 117.294 -175.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.709 HD13 ' H ' ' A' ' 166' ' ' ILE . 0.1 OUTLIER -64.68 -37.12 79.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 CA-C-O 121.655 0.741 . . . . 0.0 109.281 176.483 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.07 -36.53 75.24 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 176.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 18.5 tpt85 -62.21 -50.09 73.16 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 122.998 2.635 . . . . 0.0 111.201 -176.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -74.77 -51.08 15.1 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 123.457 0.703 . . . . 0.0 109.593 177.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -78.24 -36.7 46.62 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 116.037 1.866 . . . . 0.0 116.037 -173.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 93.41 -168.21 29.36 Favored Glycine 0 N--CA 1.47 0.957 0 CA-C-N 118.674 0.67 . . . . 0.0 112.623 177.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 10.0 pt -73.52 -41.45 56.12 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.112 0 CA-C-O 121.944 0.878 . . . . 0.0 110.716 -179.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -58.47 -32.98 69.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 113.708 -1.587 . . . . 0.0 110.658 -176.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -60.33 -39.97 96.85 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 119.209 -1.472 . . . . 0.0 109.89 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 5.8 tp -69.49 -33.73 73.29 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 117.056 2.243 . . . . 0.0 117.056 -177.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 9.7 m0 -78.14 -7.62 57.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 111.244 -2.707 . . . . 0.0 109.826 -178.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -43.32 -47.86 6.77 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.327 -176.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -95.7 -36.33 5.35 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 123.936 0.779 . . . . 0.0 111.763 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.463 ' CG2' ' N ' ' A' ' 180' ' ' SER . 0.6 OUTLIER -45.4 -51.23 11.61 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -179.385 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.463 ' N ' ' CG2' ' A' ' 179' ' ' THR . 0.4 OUTLIER -62.9 -50.89 75.0 Favored Pre-proline 0 N--CA 1.473 0.687 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -176.666 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' A' ' 180' ' ' SER . 32.6 Cg_endo -64.8 -28.42 59.38 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 121.683 1.588 . . . . 0.0 111.992 177.326 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -63.73 -39.87 95.35 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 120.266 -0.574 . . . . 0.0 109.967 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 75.6 t -63.45 -42.43 96.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.89 -39.04 90.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.216 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.25 -41.55 93.46 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.898 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -61.61 -42.87 99.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.732 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.32 -44.27 92.06 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 -178.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 3.5 tp -63.95 -45.18 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.882 -178.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.523 ' O ' ' N ' ' A' ' 193' ' ' GLU . 15.5 m -59.83 -45.86 94.39 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.362 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.436 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -62.39 -42.62 99.57 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.843 0.83 . . . . 0.0 109.915 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' CYS . . . . . . . . . . . . . 41.4 t -61.71 -45.8 92.4 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.384 -1.28 . . . . 0.0 109.249 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -63.86 -39.61 94.61 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 113.097 -1.865 . . . . 0.0 108.501 175.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 189' ' ' VAL . 36.6 tp10 -61.01 -46.28 91.4 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.962 -178.107 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.46 HD13 HD21 ' A' ' 120' ' ' LEU . 0.6 OUTLIER -64.89 -39.64 93.84 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 118.844 -1.143 . . . . 0.0 110.225 -175.683 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 2.7 p -64.83 -46.43 91.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 116.693 -2.003 . . . . 0.0 107.853 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 96.3 m -64.11 -45.93 86.41 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.58 0.955 . . . . 0.0 113.58 -178.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -55.43 -37.99 68.4 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.716 1.606 . . . . 0.0 112.275 -176.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -55.86 -43.48 77.14 Favored 'General case' 0 C--N 1.312 -1.04 0 O-C-N 121.594 -0.691 . . . . 0.0 109.606 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 19.3 mt -61.31 -39.79 91.78 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -176.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.3 pt -63.49 -41.2 91.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-N 118.461 0.573 . . . . 0.0 111.304 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 10.3 mtpp -57.92 -37.58 74.33 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.935 1.694 . . . . 0.0 113.013 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -63.73 -38.59 91.67 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.889 -0.725 . . . . 0.0 111.039 -177.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.15 128.63 47.15 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 122.184 0.992 . . . . 0.0 111.579 -178.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.421 ' O ' HD22 ' A' ' 205' ' ' LEU . 6.4 tp 67.18 3.9 3.41 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 113.233 -1.803 . . . . 0.0 111.726 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.421 HD22 ' O ' ' A' ' 204' ' ' LEU . 0.8 OUTLIER -125.11 26.97 6.8 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.488 0.661 . . . . 0.0 111.234 -178.598 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.404 ' HD2' ' H ' ' A' ' 207' ' ' ALA . 0.1 OUTLIER -74.25 -21.58 59.71 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.527 179.658 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.476 ' O ' ' O ' ' A' ' 208' ' ' ASN . . . -163.44 33.06 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.197 -1.365 . . . . 0.0 109.078 178.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' ASN . . . . . 0.476 ' O ' ' O ' ' A' ' 207' ' ' ALA . 12.3 p30 40.54 117.93 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 177.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.473 ' O ' ' O ' ' A' ' 208' ' ' ASN . 9.0 tp 26.35 102.83 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.292 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 34.3 mtt -146.73 51.32 1.11 Allowed 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 177.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.563 HG22 ' H ' ' A' ' 213' ' ' ASP . 4.2 m -158.09 142.77 16.29 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.359 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -83.68 -14.83 50.85 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.196 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.563 ' H ' HG22 ' A' ' 211' ' ' THR . 14.9 m-20 -83.4 73.71 10.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.945 0.402 . . . . 0.0 110.696 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.511 ' N ' ' HD2' ' A' ' 215' ' ' PRO . 13.6 mt -61.39 -44.13 91.68 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 214' ' ' LEU . 29.8 Cg_endo -61.34 -32.28 89.46 Favored 'Trans proline' 0 N--CA 1.501 1.954 0 CA-C-N 120.741 1.301 . . . . 0.0 112.406 -179.104 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' CYS . . . . . 0.525 ' SG ' ' N ' ' A' ' 217' ' ' HIS . 1.1 p -63.92 -42.44 97.39 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 113.827 -1.533 . . . . 0.0 111.824 -177.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 217' ' ' HIS . . . . . 0.622 ' CE1' ' CE2' ' A' ' 218' ' ' PHE . 3.5 p-80 -66.77 -37.43 84.58 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.425 -0.51 . . . . 0.0 112.163 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' PHE . . . . . 0.622 ' CE2' ' CE1' ' A' ' 217' ' ' HIS . 25.6 m-85 -63.08 -46.88 85.35 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.069 -178.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 10.1 m -60.14 -37.46 80.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 118.271 0.487 . . . . 0.0 110.709 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 54.1 p -59.57 -41.56 90.48 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.605 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.4 -41.63 98.76 Favored 'General case' 0 C--O 1.222 -0.381 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -177.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -61.73 -46.73 88.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 122.056 0.931 . . . . 0.0 113.031 -175.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -60.28 -41.98 98.58 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 107.237 -2.345 . . . . 0.0 107.237 177.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -63.06 -36.99 85.41 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 113.898 -1.151 . . . . 0.0 108.975 176.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.605 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -61.03 -41.67 99.53 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-N 114.062 -1.426 . . . . 0.0 111.472 -176.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' PHE . . . . . 0.44 ' O ' ' OG1' ' A' ' 229' ' ' THR . 60.9 t80 -66.78 -38.26 86.19 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.347 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 94.4 m -63.27 -42.27 99.11 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.41 HG22 ' H ' ' A' ' 228' ' ' THR . 1.0 OUTLIER -62.46 -39.74 94.36 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 120.813 0.339 . . . . 0.0 111.542 179.623 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 226' ' ' PHE . 17.0 p -58.04 -38.8 76.95 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.068 -177.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 99.0 t -59.87 -40.78 83.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 119.224 -0.99 . . . . 0.0 108.635 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.64 ' O ' ' HD2' ' A' ' 234' ' ' PRO . 1.3 mp -61.32 -39.69 83.56 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.573 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 176.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 229' ' ' THR . . . -61.39 -37.5 83.66 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.257 1.423 . . . . 0.0 114.331 -179.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.468 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 1.4 m -56.31 -38.2 65.79 Favored Pre-proline 0 N--CA 1.48 1.053 0 N-CA-C 116.519 2.044 . . . . 0.0 116.519 -173.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.64 ' HD2' ' O ' ' A' ' 231' ' ' ILE . 31.5 Cg_exo -57.97 -38.69 91.1 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 C-N-CA 122.739 2.293 . . . . 0.0 114.051 -175.111 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.435 ' H ' HG22 ' A' ' 235' ' ' VAL . 3.4 m -63.02 -36.77 77.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 116.795 -1.962 . . . . 0.0 108.846 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -65.88 -40.71 91.84 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -64.9 -44.38 96.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -175.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 91.9 t -62.52 -36.46 75.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 O-C-N 121.885 -0.51 . . . . 0.0 111.97 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 22.6 mmtp -59.91 -44.14 94.47 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -177.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' THR . . . . . 0.428 HG22 ' H ' ' A' ' 240' ' ' THR . 0.6 OUTLIER -61.3 -41.91 97.77 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -178.087 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.404 ' O ' ' ND2' ' A' ' 244' ' ' ASN . 5.0 mmm180 -45.56 -45.58 13.63 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.168 0.509 . . . . 0.0 111.146 -179.123 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.612 ' O ' ' N ' ' A' ' 244' ' ' ASN . 20.4 t80 -37.34 -57.71 0.88 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.961 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 243' ' ' MET . . . . . 0.538 ' O ' ' N ' ' A' ' 245' ' ' SER . 6.9 mmt -25.82 -34.22 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' ASN . . . . . 0.612 ' N ' ' O ' ' A' ' 242' ' ' TYR . 20.5 p30 -41.0 -20.17 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.957 0.408 . . . . 0.0 110.699 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 245' ' ' SER . . . . . 0.538 ' N ' ' O ' ' A' ' 243' ' ' MET . 80.3 p -167.77 177.58 5.7 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.528 0.68 . . . . 0.0 112.76 -178.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -159.24 123.61 3.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.04 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 12.5 mt 63.2 150.09 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.041 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 163.8 -115.93 0.68 Allowed Glycine 0 CA--C 1.527 0.816 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -128.89 54.99 1.75 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.304 0.573 . . . . 0.0 109.984 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -106.9 97.43 7.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.649 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 40.9 t60 -66.39 -51.68 54.56 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -177.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 16.6 p -147.37 -173.59 4.3 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -178.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -60.09 -44.02 95.11 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -55.52 -35.17 61.05 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.167 1.365 . . . . 0.0 111.655 -171.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' HIS . . . . . 0.476 ' O ' HG23 ' A' ' 259' ' ' THR . 86.4 t60 -57.03 -33.19 66.96 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 117.44 -1.704 . . . . 0.0 111.042 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 256' ' ' CYS . . . . . . . . . . . . . 1.5 t -60.98 -44.7 97.0 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 120.838 -1.164 . . . . 0.0 111.333 179.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -60.26 -45.46 93.21 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -177.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.529 HD13 ' O ' ' A' ' 258' ' ' LEU . 0.2 OUTLIER -66.75 -43.4 84.24 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 120.064 -0.654 . . . . 0.0 110.132 -179.931 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 259' ' ' THR . . . . . 0.476 HG23 ' O ' ' A' ' 255' ' ' HIS . 60.0 p -62.99 -45.36 92.78 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.257 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 260' ' ' MET . . . . . 0.464 ' SD ' ' C ' ' A' ' 260' ' ' MET . 1.9 tmt? -60.45 -43.86 96.45 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -176.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 33.2 tp -62.21 -46.42 88.98 Favored 'General case' 0 C--N 1.322 -0.624 0 O-C-N 122.029 -0.419 . . . . 0.0 110.413 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' ARG . . . . . 0.413 ' HE ' ' HA ' ' A' ' 262' ' ' ARG . 5.2 tpm_? -66.11 -54.0 30.94 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.49 -178.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 263' ' ' LYS . . . . . 0.443 ' O ' ' O ' ' A' ' 260' ' ' MET . 23.0 pttm -115.36 162.86 16.54 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.114 0.483 . . . . 0.0 111.526 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 264' ' ' GLU . . . . . 0.498 ' O ' ' O ' ' A' ' 265' ' ' GLY . 70.0 mm-40 56.5 85.06 0.08 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.679 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.498 ' O ' ' O ' ' A' ' 264' ' ' GLU . . . -43.28 177.36 0.01 OUTLIER Glycine 0 CA--C 1.532 1.12 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -68.17 -8.79 23.83 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.301 2.001 . . . . 0.0 111.216 177.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 34.6 ptt-85 -69.72 -26.81 64.52 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 122.978 0.511 . . . . 0.0 111.853 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -58.55 -32.44 68.89 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.711 -0.796 . . . . 0.0 109.287 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -62.06 -41.55 98.27 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.157 177.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -65.66 -37.31 86.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.433 -178.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.446 ' O ' ' O ' ' A' ' 272' ' ' GLY . 54.5 tttp -82.78 171.98 13.36 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 177.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 272' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 271' ' ' LYS . . . 48.76 99.44 0.01 OUTLIER Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -171.42 12.09 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.055 0.455 . . . . 0.0 110.496 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' MET . . . . . 0.592 ' SD ' ' N ' ' A' ' 275' ' ' PRO 0.25 0.0 OUTLIER -63.49 -40.36 57.66 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.81 179.372 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 275' ' ' PRO . . . . . 0.592 ' N ' ' SD ' ' A' ' 274' ' ' MET . 16.6 Cg_exo -63.55 -46.38 9.43 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 121.453 1.435 . . . . 0.0 111.197 -176.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 3.1 m -60.43 -39.88 89.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.657 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -61.99 -42.96 99.72 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 123.079 1.418 . . . . 0.0 112.145 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 84.8 mt -62.28 -38.68 90.28 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 111.59 -2.55 . . . . 0.0 108.151 174.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 -63.01 -39.45 94.8 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.314 0.578 . . . . 0.0 110.527 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.652 ' O ' HD23 ' A' ' 280' ' ' LEU . 1.1 tt -61.76 -36.88 82.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.028 -0.987 . . . . 0.0 112.489 -177.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -68.3 -51.51 32.08 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' SER . . . . . 0.533 ' O ' HG22 ' A' ' 285' ' ' VAL . 5.6 t -63.35 -44.5 94.67 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 123.566 0.747 . . . . 0.0 110.349 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 283' ' ' TRP . . . . . 0.406 ' O ' HG22 ' A' ' 286' ' ' VAL . 79.4 t90 -59.9 -37.82 80.51 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.922 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -61.47 -37.94 85.47 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.18 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.533 HG22 ' O ' ' A' ' 282' ' ' SER . 0.9 OUTLIER -60.86 -37.69 77.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 O-C-N 121.95 -0.468 . . . . 0.0 111.778 -179.094 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.735 ' O ' HG22 ' A' ' 289' ' ' VAL . 0.9 OUTLIER -61.93 -41.14 89.72 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.661 -177.623 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -61.78 -38.16 87.0 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 121.488 -0.758 . . . . 0.0 109.757 178.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -58.49 -40.62 83.28 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.265 -0.88 . . . . 0.0 112.982 -178.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.735 HG22 ' O ' ' A' ' 286' ' ' VAL . 27.0 m -60.76 -38.53 79.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 119.974 -0.69 . . . . 0.0 110.984 -178.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 16.8 m -62.54 -40.25 96.21 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -60.85 -38.84 86.93 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 177.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.45 -40.49 82.73 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 117.706 -1.597 . . . . 0.0 109.527 -176.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 293' ' ' GLN . . . . . 0.473 ' O ' ' O ' ' A' ' 296' ' ' ARG . 56.9 tt0 -60.45 -42.9 97.08 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 122.595 1.188 . . . . 0.0 110.971 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 10.3 mp -60.32 -40.65 91.34 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 113.119 -1.855 . . . . 0.0 108.79 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -63.27 -45.91 89.25 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.322 178.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 296' ' ' ARG . . . . . 0.473 ' O ' ' O ' ' A' ' 293' ' ' GLN . 27.6 mmm-85 -123.03 116.16 23.06 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -121.41 -164.09 1.1 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.022 0.439 . . . . 0.0 112.179 -178.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.656 ' H ' HD12 ' A' ' 298' ' ' LEU . 0.0 OUTLIER -64.77 -173.96 0.12 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 177.276 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 9.2 ttt -169.15 66.99 0.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 119.236 -0.986 . . . . 0.0 112.832 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.59 100.86 0.07 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.825 0.821 . . . . 0.0 110.534 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -64.08 -46.2 85.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.107 -1.406 . . . . 0.0 113.479 -176.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 302' ' ' TYR . . . . . 0.525 ' CD2' ' OE1' ' A' ' 306' ' ' GLU . 49.0 t80 -58.8 -39.94 82.62 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 119.706 -0.798 . . . . 0.0 109.563 -178.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -65.26 -46.88 78.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.219 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 304' ' ' SER . . . . . 0.446 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 38.9 t -66.58 -37.67 85.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.796 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 -61.67 -42.8 99.42 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.525 ' OE1' ' CD2' ' A' ' 302' ' ' TYR . 41.4 mt-10 -64.87 -37.08 86.42 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -177.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 307' ' ' ALA . . . . . 0.553 ' HB3' ' HD3' ' A' ' 308' ' ' PRO . . . -60.06 -53.01 69.36 Favored Pre-proline 0 CA--C 1.544 0.743 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -176.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 308' ' ' PRO . . . . . 0.553 ' HD3' ' HB3' ' A' ' 307' ' ' ALA . 73.6 Cg_endo -75.15 0.17 9.29 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.283 1.988 . . . . 0.0 111.948 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 55.0 t80 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.574 -179.894 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.588 ' N ' ' SD ' ' A' ' 13' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.7 p 45.61 93.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.4 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.655 HG22 ' N ' ' A' ' 16' ' ' LYS . 12.4 p -148.37 171.44 2.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.002 0.43 . . . . 0.0 110.64 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.655 ' N ' HG22 ' A' ' 15' ' ' VAL . 4.6 mtmp? -64.29 -41.41 96.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.972 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -63.43 -41.56 98.68 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -178.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.525 ' H ' HG13 ' A' ' 15' ' ' VAL . 57.5 tp -79.9 -26.33 40.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.148 0.499 . . . . 0.0 111.932 -179.015 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.41 ' O ' ' OG1' ' A' ' 22' ' ' THR . . . -66.07 -41.33 95.16 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 107.595 -2.202 . . . . 0.0 107.595 177.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.419 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -71.47 -32.24 68.06 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 124.803 2.239 . . . . 0.0 107.54 176.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.5 -42.49 98.93 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-N 108.51 -3.95 . . . . 0.0 108.243 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.41 ' OG1' ' O ' ' A' ' 19' ' ' GLY . 22.2 p -70.63 -27.41 64.04 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.503 0.668 . . . . 0.0 109.248 177.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -66.51 -50.05 64.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.676 -1.147 . . . . 0.0 112.128 -179.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.78 -35.96 79.66 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 118.529 -1.268 . . . . 0.0 111.241 -177.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 68.5 m -63.64 -53.69 47.52 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.24 -178.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.4 pt -65.47 -39.63 85.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -177.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.11 -42.04 97.02 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 119.78 -0.768 . . . . 0.0 112.79 -173.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 32' ' ' PHE . 3.2 m-20 -77.89 -27.28 49.57 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 118.068 -1.453 . . . . 0.0 109.407 -176.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 15.7 mt -60.41 -56.22 24.12 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 120.159 1.345 . . . . 0.0 111.703 -178.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.71 HD12 ' N ' ' A' ' 30' ' ' ILE . 2.5 mp -76.23 -5.09 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 120.076 -0.649 . . . . 0.0 112.293 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 26.3 m -110.33 -17.98 13.37 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 117.656 -1.164 . . . . 0.0 109.71 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.517 ' N ' ' O ' ' A' ' 28' ' ' ASP . 11.4 t80 -67.88 -43.44 37.63 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 122.379 2.354 . . . . 0.0 110.009 -177.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.457 ' CD ' ' N ' ' A' ' 32' ' ' PHE . 38.1 Cg_exo -58.55 -14.68 22.0 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 121.239 1.293 . . . . 0.0 110.949 177.273 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.5 tp -66.92 -35.59 80.35 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -177.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -64.42 -40.65 96.17 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -177.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.401 ' CG2' ' O ' ' A' ' 33' ' ' PRO . 0.3 OUTLIER -58.39 -33.78 70.0 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.992 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.13 -38.77 86.12 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.455 ' NZ ' ' CB ' ' A' ' 38' ' ' LYS . 0.1 OUTLIER -61.67 -47.54 84.87 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 119.415 -0.914 . . . . 0.0 111.734 -176.768 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.2 t -62.2 -38.37 80.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -175.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.504 ' O ' ' N ' ' A' ' 42' ' ' GLN . 45.5 mtp85 -59.5 -41.08 89.05 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 119.236 -0.985 . . . . 0.0 110.049 -179.161 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -62.38 38.67 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.066 178.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.504 ' N ' ' O ' ' A' ' 40' ' ' ARG . 0.2 OUTLIER -94.57 5.11 52.81 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 121.959 -0.463 . . . . 0.0 111.187 -179.437 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.425 ' O ' ' O ' ' A' ' 42' ' ' GLN . 7.6 mm 60.28 147.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -53.14 105.25 0.12 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.873 0.368 . . . . 0.0 110.438 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.92 50.88 0.37 Allowed Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.981 -0.847 . . . . 0.0 110.981 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.51 ' H ' ' CG2' ' A' ' 51' ' ' VAL . 72.1 mm-40 -73.1 -8.68 56.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.778 0.323 . . . . 0.0 110.674 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.499 ' C ' ' H ' ' A' ' 49' ' ' GLY . 3.6 m 61.42 -159.57 0.32 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.723 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 38.7 tp60 66.4 -7.39 0.43 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.142 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.499 ' H ' ' C ' ' A' ' 47' ' ' SER . . . 84.17 3.53 88.84 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -178.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.573 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -66.61 -38.12 86.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.538 0.685 . . . . 0.0 109.769 178.487 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.51 ' CG2' ' H ' ' A' ' 46' ' ' GLU . 54.6 t -60.74 -44.97 98.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.319 -178.253 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.96 -34.72 79.09 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.275 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 19.6 p -68.68 -38.25 80.2 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.115 0.483 . . . . 0.0 110.052 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -92.88 -159.77 0.7 Allowed 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.868 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -169.78 -40.19 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.171 -0.611 . . . . 0.0 111.831 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.64 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 87.6 p -126.91 -139.58 0.26 Allowed 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.64 ' HB3' ' O ' ' A' ' 56' ' ' SER . . . 92.87 14.64 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 O-C-N 123.813 0.696 . . . . 0.0 111.81 178.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 90.6 mm-40 -155.45 52.43 0.59 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -41.39 145.43 0.26 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.381 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.418 ' O ' ' C ' ' A' ' 61' ' ' GLY . 62.7 ttp180 -49.8 -44.62 49.23 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 60' ' ' ARG . . . -28.52 101.54 0.01 OUTLIER Glycine 0 CA--C 1.53 0.995 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.7 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.5 p -67.54 -33.97 65.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.34 176.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.25 -32.37 71.08 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 121.165 1.802 . . . . 0.0 109.436 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.32 -49.22 67.14 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 114.832 -1.077 . . . . 0.0 115.062 -176.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 94.6 m -61.9 -46.32 89.87 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 33.7 mm -59.57 -35.49 59.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 76.8 mt -63.19 -35.82 81.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 121.028 1.74 . . . . 0.0 111.506 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.408 ' O ' ' OG1' ' A' ' 72' ' ' THR . 99.4 m -62.47 -38.8 91.24 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 113.219 -1.81 . . . . 0.0 111.053 -177.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 27.8 ttt -60.73 -40.02 90.79 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 -177.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.1 m -69.07 -39.81 80.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 119.612 -0.835 . . . . 0.0 112.375 -178.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -77.42 -12.76 59.99 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 122.182 0.991 . . . . 0.0 113.217 -177.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' A' ' 68' ' ' THR . 33.5 m -62.5 -55.12 30.47 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 113.927 -1.488 . . . . 0.0 112.762 -179.235 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -113.6 5.24 16.47 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 123.036 1.398 . . . . 0.0 109.466 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 96.46 170.92 34.67 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-N 111.598 -2.546 . . . . 0.0 110.783 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -56.4 -34.47 94.47 Favored 'Trans proline' 0 N--CA 1.5 1.909 0 C-N-CA 122.518 2.145 . . . . 0.0 111.682 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.425 ' O ' ' CB ' ' A' ' 80' ' ' ASN . 1.7 mpt_? -61.01 -10.53 6.03 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.796 0.807 . . . . 0.0 111.093 176.173 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 81.3 p -77.24 -32.35 55.71 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.168 -1.378 . . . . 0.0 111.231 -177.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.2 tt -75.9 -34.15 59.94 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.297 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -93.76 -5.98 47.1 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 122.022 0.915 . . . . 0.0 113.013 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.425 ' CB ' ' O ' ' A' ' 76' ' ' ARG . 4.2 t30 -81.23 124.69 29.51 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 113.802 -1.545 . . . . 0.0 107.625 176.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.99 0.67 71.12 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 109.696 -1.361 . . . . 0.0 109.696 -178.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 45.3 tp -59.43 -35.33 73.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 113.477 -1.361 . . . . 0.0 110.955 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.8 p -70.76 -26.99 29.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.563 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.8 -31.65 61.79 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.512 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -68.14 -40.79 87.97 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 119.489 -1.338 . . . . 0.0 111.389 -177.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.532 ' O ' ' SD ' ' A' ' 90' ' ' MET . 75.7 mt -62.59 -40.53 97.2 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 122.311 1.053 . . . . 0.0 112.587 -176.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -59.51 -26.22 65.13 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 113.324 -1.762 . . . . 0.0 108.944 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 18.3 ttm180 -57.06 -52.88 63.53 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 113.335 -1.757 . . . . 0.0 106.645 173.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -67.39 -30.19 69.9 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 112.857 -1.974 . . . . 0.0 113.247 -177.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.552 ' N ' ' SD ' ' A' ' 90' ' ' MET . 0.0 OUTLIER -61.02 -40.9 95.33 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.357 -179.489 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 68.7 p -74.53 -34.5 63.02 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 119.382 -0.927 . . . . 0.0 111.409 -176.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -57.86 -44.41 86.59 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-N 121.041 1.746 . . . . 0.0 111.616 -176.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.76 -33.17 64.16 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.691 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.609 ' O ' HG22 ' A' ' 97' ' ' ILE . 24.3 p -64.18 -42.07 96.84 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.432 ' C ' ' H ' ' A' ' 97' ' ' ILE . 34.5 m -68.16 -27.74 38.3 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.839 177.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.444 ' O ' ' CD1' ' A' ' 100' ' ' TYR . 49.1 ttm-85 -77.21 9.24 3.23 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 -177.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.609 HG22 ' O ' ' A' ' 94' ' ' SER . 11.0 tt -87.12 -15.58 9.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 178.256 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -140.61 -48.03 0.05 OUTLIER Glycine 0 CA--C 1.538 1.499 0 N-CA-C 115.653 1.021 . . . . 0.0 115.653 -176.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.598 ' N ' HD12 ' A' ' 99' ' ' LEU . 9.4 mp -71.18 -12.7 61.62 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.927 1.363 . . . . 0.0 112.521 -178.09 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.597 ' CD1' ' N ' ' A' ' 101' ' ' ASP . 0.1 OUTLIER -80.46 -50.76 9.64 Favored 'General case' 0 C--O 1.214 -0.792 0 CA-C-N 114.382 -1.281 . . . . 0.0 111.563 -179.623 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.941 ' OD1' ' OE1' ' A' ' 105' ' ' GLN . 28.5 t70 -68.14 -31.2 70.61 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 122.857 1.313 . . . . 0.0 109.446 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.2 t -68.61 -53.42 22.8 Favored 'General case' 0 CA--C 1.554 1.134 0 CA-C-N 112.227 -2.26 . . . . 0.0 113.393 176.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -75.59 -28.22 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 CA-C-N 123.34 2.791 . . . . 0.0 115.708 -178.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 100' ' ' TYR . 18.8 mttt -69.33 -42.3 75.52 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 111.169 -2.741 . . . . 0.0 112.888 -178.016 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.941 ' OE1' ' OD1' ' A' ' 101' ' ' ASP . 27.2 mt-30 -78.97 -10.11 59.73 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 124.225 1.964 . . . . 0.0 111.063 177.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -78.97 -22.45 45.6 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 112.273 -2.24 . . . . 0.0 111.358 177.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.467 ' CZ ' ' OD1' ' A' ' 190' ' ' ASN . 27.5 m-85 -109.3 -30.84 7.8 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 119.637 1.108 . . . . 0.0 111.995 -175.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.9 t -98.66 9.27 43.66 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 117.275 -1.77 . . . . 0.0 112.796 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.512 ' O ' ' C ' ' A' ' 110' ' ' GLY . 0.0 OUTLIER -50.49 122.06 6.58 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 118.395 -0.812 . . . . 0.0 110.948 -179.733 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.518 ' O ' ' CB ' ' A' ' 111' ' ' SER . . . -22.5 -78.83 0.01 OUTLIER Glycine 0 N--CA 1.487 2.066 0 CA-C-N 119.124 0.875 . . . . 0.0 111.73 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 110' ' ' GLY . 5.9 p 94.33 -156.36 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 175.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.496 ' O ' ' N ' ' A' ' 114' ' ' ALA . 76.6 mt-10 -120.45 172.55 7.74 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 114.398 -1.274 . . . . 0.0 111.556 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.617 ' O ' ' HB2' ' A' ' 114' ' ' ALA . 45.1 p-80 -63.81 48.59 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.498 -179.163 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' A' ' 113' ' ' HIS . . . 159.06 -162.2 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.2 14.98 27.0 Favored Glycine 0 N--CA 1.464 0.514 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.298 177.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 24.0 mm -60.72 -40.45 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.08 -39.41 96.29 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 122.066 0.814 . . . . 0.0 111.67 176.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 7.6 t -58.08 -42.09 84.82 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 177.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.559 HH12 ' NZ ' ' A' ' 201' ' ' LYS . 99.5 mtt180 -63.17 -37.23 86.41 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.227 -177.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 92.5 mt -63.59 -46.01 87.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.256 0.551 . . . . 0.0 109.823 178.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 56.2 mt -66.82 -44.79 80.24 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.391 178.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.11 -45.16 89.85 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 119.876 1.216 . . . . 0.0 110.257 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -65.75 -44.07 92.95 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 120.184 -1.008 . . . . 0.0 111.299 -179.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.4 t -63.93 -43.85 94.63 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.692 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 19.1 m -69.34 -48.32 61.72 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 119.118 -1.033 . . . . 0.0 112.075 177.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.468 HG23 ' N ' ' A' ' 127' ' ' GLY . 5.5 t -65.57 -42.74 91.45 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 -174.079 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.468 ' N ' HG23 ' A' ' 126' ' ' THR . . . -64.19 -44.48 95.58 Favored Glycine 0 CA--C 1.52 0.396 0 CA-C-O 122.73 1.183 . . . . 0.0 112.95 -177.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.484 ' O ' HG12 ' A' ' 131' ' ' VAL . . . -60.81 -41.35 95.53 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 112.178 -2.011 . . . . 0.0 106.492 177.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.646 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 15.1 tp -64.44 -42.25 96.09 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.773 178.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.11 -39.92 96.1 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -177.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.484 HG12 ' O ' ' A' ' 128' ' ' ALA . 3.3 p -60.9 -24.81 33.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 122.577 1.18 . . . . 0.0 109.265 178.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.646 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . -57.74 -44.85 86.36 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 112.709 -2.041 . . . . 0.0 111.727 -178.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.485 ' CG1' ' N ' ' A' ' 134' ' ' ALA . 3.0 p -79.17 -48.98 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.13 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.485 ' N ' ' CG1' ' A' ' 133' ' ' VAL . . . -103.29 128.78 50.23 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.257 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.503 ' N ' ' HD2' ' A' ' 136' ' ' PRO . 21.1 tt0 -179.58 -50.32 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.718 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 135' ' ' GLN . 11.2 Cg_endo -51.79 -33.89 52.38 Favored 'Trans proline' 0 N--CA 1.499 1.849 0 C-N-CA 121.545 1.497 . . . . 0.0 114.221 -177.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 41.4 p -67.36 -41.71 84.67 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 118.183 -1.407 . . . . 0.0 108.42 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -64.43 -42.26 96.11 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.104 -1.038 . . . . 0.0 111.053 -178.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 88.5 t -63.57 -43.43 98.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.176 0.513 . . . . 0.0 111.07 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 136' ' ' PRO . 53.8 t -64.32 -38.44 82.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.807 -178.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -61.55 -40.58 95.2 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.206 -0.598 . . . . 0.0 111.854 -177.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 97.6 t -69.52 -44.86 79.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.307 0.575 . . . . 0.0 109.66 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.481 HH12 ' HA ' ' A' ' 175' ' ' LEU . 0.3 OUTLIER -64.4 -35.74 81.9 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.545 179.103 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -66.13 -40.76 90.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 112.166 -177.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 4.0 tm0? -64.67 -39.52 93.82 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.08 -1.048 . . . . 0.0 109.841 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.08 -34.93 79.59 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -177.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.419 ' C ' ' OE1' ' A' ' 147' ' ' GLN . 0.0 OUTLIER -59.36 111.41 1.36 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.417 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -96.42 -62.18 1.31 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 117.777 -1.106 . . . . 0.0 113.828 -176.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -62.02 126.7 28.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 122.481 2.4 . . . . 0.0 110.474 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -55.92 -49.43 73.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.664 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.45 ' C ' ' H ' ' A' ' 153' ' ' GLY . . . 152.94 155.32 7.07 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -76.73 27.54 1.6 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.45 ' H ' ' C ' ' A' ' 151' ' ' GLY . . . -159.78 156.5 27.69 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 45.8 ttp180 -71.91 1.58 6.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.115 0.483 . . . . 0.0 110.086 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.505 ' NH1' ' OE2' ' A' ' 161' ' ' GLU . 0.0 OUTLIER -52.88 -35.59 58.1 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.021 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.423 ' O ' ' O ' ' A' ' 157' ' ' GLN . 11.0 t80 76.08 -9.32 1.47 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.01 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.423 ' O ' ' O ' ' A' ' 156' ' ' TYR . 34.3 mt-30 49.67 176.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.992 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 25.7 t -157.05 -177.66 6.78 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.307 0.575 . . . . 0.0 110.883 -179.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.551 HG23 ' N ' ' A' ' 160' ' ' VAL . 9.2 t -63.98 -45.86 87.2 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.675 -177.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.551 ' N ' HG23 ' A' ' 159' ' ' THR . 87.2 t -63.81 -45.17 97.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 119.063 -1.055 . . . . 0.0 108.721 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.505 ' OE2' ' NH1' ' A' ' 155' ' ' ARG . 92.1 mt-10 -67.28 -39.16 85.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.725 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -61.67 -45.87 92.16 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -177.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.438 ' CD1' ' C ' ' A' ' 163' ' ' TYR . 12.5 t80 -62.47 -50.12 72.69 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.06 -179.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -68.2 -45.51 73.16 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -175.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 18.8 m -62.65 -44.73 95.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 119.433 1.015 . . . . 0.0 113.142 -177.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 47.3 mm -64.63 -38.63 83.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-O 121.968 0.89 . . . . 0.0 109.6 176.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.7 -36.31 76.24 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 113.787 -1.551 . . . . 0.0 108.059 176.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 32.2 mmm-85 -62.13 -50.31 72.42 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 122.2 2.273 . . . . 0.0 111.97 -175.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -75.05 -50.92 14.89 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 123.471 0.708 . . . . 0.0 109.113 177.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -78.07 -36.51 48.19 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 -173.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 91.28 -167.32 31.36 Favored Glycine 0 N--CA 1.469 0.836 0 CA-C-N 118.29 0.496 . . . . 0.0 111.945 177.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.416 HG12 ' H ' ' A' ' 172' ' ' ILE . 6.3 pt -72.83 -43.26 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 CA-C-O 121.643 0.735 . . . . 0.0 110.414 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -58.88 -33.65 70.73 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.336 -1.302 . . . . 0.0 111.143 -177.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -60.96 -40.64 98.72 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 118.528 -1.796 . . . . 0.0 109.396 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.528 ' O ' HD13 ' A' ' 175' ' ' LEU . 0.1 OUTLIER -70.72 -34.14 71.59 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 111.134 -2.533 . . . . 0.0 117.065 -177.173 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 176' ' ' TRP . . . . . 0.528 ' CE2' ' OG ' ' A' ' 180' ' ' SER . 55.7 t90 -78.08 -8.77 58.65 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 111.779 -2.464 . . . . 0.0 110.949 -176.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.409 ' HB2' HH22 ' A' ' 143' ' ' ARG . 0.5 OUTLIER -44.57 -48.96 10.33 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 114.679 1.362 . . . . 0.0 114.679 -175.866 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -102.99 -37.96 3.02 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 124.206 0.908 . . . . 0.0 113.528 -177.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.446 ' CG2' ' N ' ' A' ' 180' ' ' SER . 0.9 OUTLIER -45.19 -50.98 11.1 Favored 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -178.925 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.528 ' OG ' ' CE2' ' A' ' 176' ' ' TRP . 0.0 OUTLIER -62.64 -50.43 78.26 Favored Pre-proline 0 N--CA 1.48 1.026 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -177.0 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 180' ' ' SER . 25.8 Cg_endo -63.83 -26.97 67.46 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.196 1.931 . . . . 0.0 111.265 177.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 18.0 t30 -62.7 -38.08 89.04 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 39.8 t -62.08 -41.34 90.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.12 -38.69 87.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.746 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 60.3 ttt85 -60.23 -41.15 92.51 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.717 -0.393 . . . . 0.0 109.944 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -60.92 -42.23 97.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.248 0.547 . . . . 0.0 110.463 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' ALA . . . . . 0.401 ' O ' ' SG ' ' A' ' 191' ' ' CYS . . . -63.8 -42.93 97.61 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.433 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 96.4 mt -62.85 -44.85 99.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -177.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 6.1 m -59.66 -45.8 93.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 119.854 -0.738 . . . . 0.0 110.875 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.467 ' OD1' ' CZ ' ' A' ' 107' ' ' TYR . 53.1 t30 -62.08 -43.55 98.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 122.069 0.937 . . . . 0.0 109.892 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' CYS . . . . . 0.401 ' SG ' ' O ' ' A' ' 187' ' ' ALA . 79.3 m -62.59 -47.02 85.62 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 113.902 -1.499 . . . . 0.0 110.625 178.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.31 -40.69 96.42 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 114.018 -1.446 . . . . 0.0 109.929 177.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -61.1 -45.49 94.51 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.337 -1.302 . . . . 0.0 112.611 -178.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 1.4 tt -63.22 -37.4 87.09 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 118.676 -1.21 . . . . 0.0 108.262 -175.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 66.1 t -62.74 -46.19 96.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 C-N-CA 117.391 -1.723 . . . . 0.0 107.076 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 14.7 m -64.27 -46.37 84.0 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 113.712 1.005 . . . . 0.0 113.712 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -57.36 -39.16 75.4 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.639 1.176 . . . . 0.0 113.27 -177.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -55.63 -44.64 77.29 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -178.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.42 HD12 ' N ' ' A' ' 199' ' ' LEU . 8.8 mp -61.46 -39.23 90.12 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.881 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 1.7 mp -63.38 -43.64 98.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-O 118.333 -0.842 . . . . 0.0 111.366 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' LYS . . . . . 0.559 ' NZ ' HH12 ' A' ' 119' ' ' ARG . 53.4 mtmt -60.59 -41.3 94.41 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 121.154 1.797 . . . . 0.0 111.237 177.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -65.33 -36.67 84.73 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 113.11 -1.859 . . . . 0.0 110.965 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 54.7 m -101.92 129.91 48.28 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.691 0.758 . . . . 0.0 111.892 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.453 HD13 HD13 ' A' ' 209' ' ' LEU . 0.3 OUTLIER 68.37 5.19 4.61 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 114.615 -1.175 . . . . 0.0 112.192 179.248 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.518 ' O ' ' O ' ' A' ' 201' ' ' LYS . 1.7 tt -148.05 74.1 1.28 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.656 0.741 . . . . 0.0 110.523 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.35 -17.97 17.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.083 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.569 ' O ' ' CG ' ' A' ' 208' ' ' ASN . . . -170.72 18.98 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.573 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' ASN . . . . . 0.572 ' OD1' ' N ' ' A' ' 209' ' ' LEU . 44.3 p30 115.46 -140.24 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.093 0 O-C-N 125.636 1.835 . . . . 0.0 109.679 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.572 ' N ' ' OD1' ' A' ' 208' ' ' ASN . 13.6 tp -176.07 53.94 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 60.9 mtm -72.42 -13.67 61.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.491 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 16.9 m -56.39 152.92 10.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.911 0.386 . . . . 0.0 111.065 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -83.86 -141.22 0.07 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.574 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 53.11 57.41 6.33 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.442 ' N ' ' CD ' ' A' ' 215' ' ' PRO . 3.3 mt -61.14 -43.74 91.53 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.158 -178.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 214' ' ' LEU . 32.3 Cg_exo -60.5 -32.97 94.29 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 121.21 1.273 . . . . 0.0 111.469 -179.155 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 76.2 m -64.05 -42.0 97.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 113.322 -1.763 . . . . 0.0 111.611 -178.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -66.53 -37.89 85.98 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.4 -0.52 . . . . 0.0 111.987 -178.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -63.42 -46.93 84.05 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.803 -178.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 1.5 t -60.13 -37.49 80.24 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 118.94 0.791 . . . . 0.0 111.064 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 82.5 p -59.38 -41.28 88.98 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.42 -41.6 98.7 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -177.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -61.46 -46.97 87.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 122.133 0.968 . . . . 0.0 112.387 -176.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -60.5 -41.65 98.76 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 107.361 -2.296 . . . . 0.0 107.361 177.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' ALA . . . . . 0.644 ' O ' HG23 ' A' ' 228' ' ' THR . . . -62.72 -38.33 90.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.45 -0.875 . . . . 0.0 108.717 177.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -62.04 -42.45 99.73 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -178.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -66.9 -38.36 86.11 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 63.5 m -63.24 -41.28 99.07 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.179 177.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.644 HG23 ' O ' ' A' ' 224' ' ' ALA . 53.2 p -61.89 -40.17 94.51 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.494 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 39.5 m -59.58 -40.46 87.47 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.644 -177.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 95.3 t -61.58 -42.73 95.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 119.245 -0.982 . . . . 0.0 112.318 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.523 ' O ' ' HD2' ' A' ' 234' ' ' PRO . 12.8 pt -62.67 -40.65 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 119.895 -0.722 . . . . 0.0 109.383 177.307 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -62.78 -39.35 93.92 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.472 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 0.0 OUTLIER -58.44 -42.45 94.7 Favored Pre-proline 0 N--CA 1.481 1.094 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -173.327 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.523 ' HD2' ' O ' ' A' ' 231' ' ' ILE . 32.5 Cg_exo -58.77 -41.05 66.99 Favored 'Trans proline' 0 C--N 1.294 -2.304 0 C-N-CA 122.059 1.84 . . . . 0.0 113.654 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.402 HG22 ' H ' ' A' ' 235' ' ' VAL . 6.9 m -65.99 -37.42 79.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 118.507 -1.277 . . . . 0.0 111.149 178.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -65.54 -41.45 93.05 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -178.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.419 ' O ' ' OG1' ' A' ' 240' ' ' THR . 16.1 m -65.24 -44.86 95.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -176.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 60.3 t -62.8 -37.3 78.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.268 -177.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -60.63 -43.97 96.9 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.486 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 237' ' ' VAL . 31.3 p -61.26 -41.72 97.4 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.238 -0.437 . . . . 0.0 112.156 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.518 ' O ' ' CB ' ' A' ' 242' ' ' TYR . 54.7 ttt-85 -39.76 142.06 0.36 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.757 -179.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.518 ' CB ' ' O ' ' A' ' 241' ' ' ARG . 0.9 OUTLIER 153.88 120.6 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 O-C-N 123.357 0.411 . . . . 0.0 111.109 179.238 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 243' ' ' MET . . . . . 0.435 ' O ' ' O ' ' A' ' 244' ' ' ASN . 12.1 ptp -178.56 -154.67 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 244' ' ' ASN . . . . . 0.584 ' O ' ' OG ' ' A' ' 245' ' ' SER . 12.1 t-20 57.2 113.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.709 -0.397 . . . . 0.0 110.874 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 245' ' ' SER . . . . . 0.584 ' OG ' ' O ' ' A' ' 244' ' ' ASN . 92.6 p 61.94 -127.84 0.73 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.647 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -178.87 -103.78 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.651 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 5.5 mt -70.41 121.67 18.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.749 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -173.3 145.66 8.47 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.962 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.663 ' HB3' ' CE1' ' A' ' 255' ' ' HIS . 25.1 mm100 51.05 -99.63 0.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.815 0.341 . . . . 0.0 110.633 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER 63.24 140.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.862 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 175.72 -46.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.633 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 252' ' ' SER . . . . . 0.656 ' O ' ' N ' ' A' ' 255' ' ' HIS . 30.8 t -178.98 130.49 0.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.632 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.603 ' C ' ' O ' ' A' ' 252' ' ' SER . . . -17.69 -56.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.241 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 254' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 252' ' ' SER . . . -42.19 -34.73 1.58 Allowed Glycine 0 N--CA 1.468 0.817 0 CA-C-O 119.394 -0.67 . . . . 0.0 112.773 178.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 255' ' ' HIS . . . . . 0.772 ' CE1' HG21 ' A' ' 259' ' ' THR . 64.7 t-80 -54.32 -36.69 64.02 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 117.545 -1.662 . . . . 0.0 111.066 -179.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 256' ' ' CYS . . . . . . . . . . . . . 17.3 t -60.59 -45.05 95.42 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 119.912 -0.715 . . . . 0.0 112.008 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -60.62 -45.66 93.2 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.446 -0.502 . . . . 0.0 112.303 -177.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.545 HD13 ' O ' ' A' ' 258' ' ' LEU . 0.2 OUTLIER -67.83 -44.58 76.9 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.356 -0.937 . . . . 0.0 110.452 179.64 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 259' ' ' THR . . . . . 0.772 HG21 ' CE1' ' A' ' 255' ' ' HIS . 70.0 p -64.03 -47.63 79.47 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -178.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 260' ' ' MET . . . . . 0.56 ' SD ' ' N ' ' A' ' 261' ' ' LEU . 0.0 OUTLIER -62.47 -43.85 97.83 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.232 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.56 ' N ' ' SD ' ' A' ' 260' ' ' MET . 7.0 tp -62.13 -46.57 88.44 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 122.792 0.437 . . . . 0.0 111.093 -178.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 13.6 tpp85 -66.0 -53.81 34.06 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.868 -178.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -91.16 -122.07 0.07 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.735 0.303 . . . . 0.0 111.595 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 264' ' ' GLU . . . . . 0.494 ' O ' ' O ' ' A' ' 265' ' ' GLY . 58.0 mt-10 -30.57 107.45 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -178.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 264' ' ' GLU . . . -41.38 175.07 0.01 OUTLIER Glycine 0 CA--C 1.533 1.173 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 178.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -68.73 -9.1 25.22 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 122.835 2.357 . . . . 0.0 111.483 177.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 82.6 mtt85 -69.43 -26.61 64.7 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.122 0.569 . . . . 0.0 112.087 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.448 ' HB1' ' NH2' ' A' ' 241' ' ' ARG . . . -58.31 -32.07 68.12 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.392 -179.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -61.99 -41.9 98.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.245 0.545 . . . . 0.0 110.547 177.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -66.15 -37.89 86.77 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.194 -178.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.444 ' O ' ' O ' ' A' ' 272' ' ' GLY . 62.7 mmtt -73.17 -173.75 1.39 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.231 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 272' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 271' ' ' LYS . . . 48.69 103.87 0.01 OUTLIER Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 273' ' ' PHE . . . . . 0.401 ' H ' ' H ' ' A' ' 274' ' ' MET . 46.0 p90 -170.46 1.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.449 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 274' ' ' MET . . . . . 0.568 ' N ' ' CD ' ' A' ' 275' ' ' PRO . 0.5 OUTLIER -63.97 -44.53 78.7 Favored Pre-proline 0 CA--C 1.532 0.268 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.869 -179.555 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 275' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 274' ' ' MET . 21.5 Cg_exo -64.68 -46.67 6.47 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.44 2.093 . . . . 0.0 110.947 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 51.0 m -60.76 -39.51 89.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.287 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -61.75 -42.76 99.4 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 122.878 1.323 . . . . 0.0 112.814 -178.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 8.5 tp -62.29 -38.79 90.73 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 111.853 -2.43 . . . . 0.0 108.138 174.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 16.2 mmm180 -62.73 -39.49 94.24 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.438 0.637 . . . . 0.0 110.326 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 22.3 tp -61.97 -36.61 81.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.974 -1.012 . . . . 0.0 113.028 -177.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -68.24 -51.34 33.34 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 282' ' ' SER . . . . . 0.442 ' O ' HG12 ' A' ' 285' ' ' VAL . 14.0 p -63.07 -44.43 95.81 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.268 0.627 . . . . 0.0 109.883 179.27 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 283' ' ' TRP . . . . . 0.421 ' O ' HG22 ' A' ' 286' ' ' VAL . 62.7 t90 -60.06 -37.99 81.52 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -61.83 -37.41 84.36 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.587 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 282' ' ' SER . 0.3 OUTLIER -59.88 -37.45 71.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.222 -178.303 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.568 ' O ' HG12 ' A' ' 289' ' ' VAL . 0.9 OUTLIER -61.86 -40.02 85.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 120.234 -0.587 . . . . 0.0 109.755 -179.27 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 16.6 mmt -61.51 -39.59 91.55 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.849 0.357 . . . . 0.0 110.66 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -59.63 -41.95 91.62 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -178.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.568 HG12 ' O ' ' A' ' 286' ' ' VAL . 3.1 p -61.82 -38.62 80.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 O-C-N 121.854 -0.529 . . . . 0.0 111.279 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 10.3 m -62.58 -40.73 97.83 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -61.27 -38.85 88.25 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 176.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -58.28 -40.45 81.95 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 117.867 -1.533 . . . . 0.0 109.616 -176.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 293' ' ' GLN . . . . . 0.48 ' O ' ' O ' ' A' ' 296' ' ' ARG . 75.7 mt-30 -60.75 -43.13 98.37 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 122.554 1.169 . . . . 0.0 111.293 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 9.3 mp -60.8 -40.66 93.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 113.382 -1.736 . . . . 0.0 109.1 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -63.39 -45.96 88.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.047 178.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 296' ' ' ARG . . . . . 0.48 ' O ' ' O ' ' A' ' 293' ' ' GLN . 16.4 tpp180 -123.22 116.02 22.7 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.299 -0.864 . . . . 0.0 108.873 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -122.24 -163.5 1.08 Allowed 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -178.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.604 HD22 ' N ' ' A' ' 298' ' ' LEU . 3.3 mm? -63.54 -175.65 0.13 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 176.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 21.8 ttt -166.55 64.47 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 119.614 -0.835 . . . . 0.0 112.371 -178.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 300' ' ' ALA . . . . . 0.428 ' CB ' ' OE1' ' A' ' 303' ' ' GLN . . . -175.6 100.85 0.07 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 122.079 0.943 . . . . 0.0 110.52 -178.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.411 ' HB1' ' HE ' ' A' ' 305' ' ' ARG . . . -64.18 -46.34 84.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 113.545 -1.661 . . . . 0.0 113.351 -176.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -58.57 -39.62 80.82 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.014 -177.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 303' ' ' GLN . . . . . 0.428 ' OE1' ' CB ' ' A' ' 300' ' ' ALA . 47.0 mt-30 -64.9 -46.93 79.65 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.71 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 304' ' ' SER . . . . . 0.433 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 15.5 m -66.79 -38.05 85.77 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.064 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 305' ' ' ARG . . . . . 0.411 ' HE ' ' HB1' ' A' ' 301' ' ' ALA . 65.2 mtt-85 -61.81 -42.61 99.23 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.017 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 10.6 tm-20 -64.75 -36.9 85.81 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -177.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 307' ' ' ALA . . . . . 0.54 ' HB3' ' HD3' ' A' ' 308' ' ' PRO . . . -60.12 -53.12 68.2 Favored Pre-proline 0 CA--C 1.544 0.717 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -176.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 308' ' ' PRO . . . . . 0.54 ' HD3' ' HB3' ' A' ' 307' ' ' ALA . 73.7 Cg_endo -75.35 0.25 9.27 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.199 1.933 . . . . 0.0 111.955 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 54.2 t80 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.558 -179.841 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 14.5 ptt? . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.5 m 44.61 85.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.617 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.684 HG22 ' H ' ' A' ' 16' ' ' LYS . 8.0 p -156.54 175.45 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.404 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.684 ' H ' HG22 ' A' ' 15' ' ' VAL . 54.3 tttp -64.3 -41.34 96.91 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.951 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -63.58 -41.77 98.34 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.519 ' H ' HG13 ' A' ' 15' ' ' VAL . 44.5 tp -79.8 -26.48 40.54 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.921 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.409 ' O ' ' OG1' ' A' ' 22' ' ' THR . . . -66.32 -41.26 94.68 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 107.615 -2.194 . . . . 0.0 107.615 177.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.42 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -71.39 -32.22 68.19 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 124.811 2.243 . . . . 0.0 107.467 176.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.55 -42.38 98.9 Favored Glycine 0 CA--C 1.528 0.845 1 CA-C-N 108.399 -4.001 . . . . 0.0 108.242 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 19' ' ' GLY . 22.2 p -70.68 -27.55 64.09 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.54 0.686 . . . . 0.0 109.225 177.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -66.48 -50.1 64.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.875 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.79 -35.98 79.76 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 118.46 -1.296 . . . . 0.0 111.253 -177.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 79.2 m -63.9 -53.77 45.25 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.339 -178.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.8 tt -65.64 -39.59 85.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 -177.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.92 -41.93 97.53 Favored 'General case' 0 C--O 1.224 -0.273 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -173.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 28' ' ' ASP . 3.8 t70 -77.78 -26.94 50.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 120.345 1.429 . . . . 0.0 110.078 -175.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 45.6 mt -59.86 -55.12 38.1 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 119.841 1.201 . . . . 0.0 112.332 -178.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.0 pt -75.47 -4.31 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -109.68 -17.59 13.66 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 118.54 -1.264 . . . . 0.0 110.253 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -68.08 -44.33 38.39 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 122.046 2.203 . . . . 0.0 110.779 -177.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -59.16 -15.63 29.47 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 CA-C-N 120.836 1.334 . . . . 0.0 111.31 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.607 ' O ' HD23 ' A' ' 34' ' ' LEU . 0.9 OUTLIER -66.8 -35.74 80.77 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.165 -0.925 . . . . 0.0 113.296 -177.293 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -64.44 -40.56 95.98 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.149 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 79.6 p -58.12 -34.87 70.69 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.34 -38.64 85.17 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 119.907 -0.717 . . . . 0.0 112.62 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.446 ' CG ' ' N ' ' A' ' 39' ' ' VAL . 12.0 pttp -61.54 -48.1 82.55 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 119.421 -0.912 . . . . 0.0 111.478 -176.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.446 ' N ' ' CG ' ' A' ' 38' ' ' LYS . 7.2 m -62.92 -38.81 82.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -176.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.508 ' O ' ' N ' ' A' ' 42' ' ' GLN . 61.7 mtp85 -59.86 -41.01 90.55 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 119.356 -0.938 . . . . 0.0 110.175 -178.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -62.59 38.75 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.866 177.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.508 ' N ' ' O ' ' A' ' 40' ' ' ARG . 5.2 pt20 -91.03 149.08 21.97 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.823 -0.548 . . . . 0.0 111.168 -179.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 7.5 mt -96.49 44.59 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.054 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 69.2 mm-40 46.62 -165.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.52 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 160.49 -72.02 0.22 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.606 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 2.6 pm0 -44.54 -24.8 0.21 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.859 0.361 . . . . 0.0 110.53 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.9 m 56.78 71.06 0.59 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.761 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -62.03 -27.96 69.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.184 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.77 -14.09 61.04 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 109.009 -1.636 . . . . 0.0 109.009 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.1 mp -65.76 -37.48 86.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.65 -0.775 . . . . 0.0 109.176 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.534 HG23 ' N ' ' A' ' 52' ' ' ARG . 20.0 m -60.87 -44.4 97.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.965 -178.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.534 ' N ' HG23 ' A' ' 51' ' ' VAL . 32.3 ttm180 -64.67 -35.44 81.05 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 119.779 -0.768 . . . . 0.0 112.35 -177.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 t -68.89 -38.01 79.37 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 119.383 -0.927 . . . . 0.0 108.778 177.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -130.63 94.39 3.63 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.571 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.21 -2.21 18.0 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -177.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.607 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 24.3 p -125.21 -141.74 0.29 Allowed 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.064 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.607 ' HB3' ' O ' ' A' ' 56' ' ' SER . . . 97.66 13.69 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 O-C-N 124.159 0.912 . . . . 0.0 111.928 178.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.445 ' O ' ' O ' ' A' ' 59' ' ' TYR . 25.0 pt20 -163.26 -39.4 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.369 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.445 ' O ' ' O ' ' A' ' 58' ' ' GLN . 39.5 m-85 54.35 166.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.979 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.408 ' O ' ' C ' ' A' ' 61' ' ' GLY . 65.3 mtm180 -57.54 -41.56 81.2 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 60' ' ' ARG . . . -29.98 102.47 0.01 OUTLIER Glycine 0 CA--C 1.527 0.833 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.567 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.3 p -67.26 -33.75 64.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 118.378 -0.82 . . . . 0.0 109.864 176.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -60.18 -32.27 70.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 121.144 1.793 . . . . 0.0 109.674 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.68 -49.4 64.32 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 115.022 -0.99 . . . . 0.0 114.564 -176.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.4 p -62.28 -46.69 87.67 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.5 tp -60.02 -35.38 60.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.606 ' O ' HD23 ' A' ' 67' ' ' LEU . 1.2 tt -63.21 -35.51 80.55 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 121.291 1.86 . . . . 0.0 110.848 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.614 ' O ' HG23 ' A' ' 72' ' ' THR . 99.9 m -62.63 -38.26 89.55 Favored 'General case' 0 C--O 1.246 0.884 0 CA-C-N 113.049 -1.887 . . . . 0.0 111.069 -175.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.512 ' O ' ' OG1' ' A' ' 72' ' ' THR . 0.4 OUTLIER -60.37 -39.14 86.17 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 120.322 -1.486 . . . . 0.0 114.283 -177.075 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.412 HG22 ' H ' ' A' ' 70' ' ' VAL . 5.7 m -69.49 -40.25 79.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 119.186 -1.005 . . . . 0.0 113.054 -178.277 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -78.4 -13.3 59.9 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -178.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.614 HG23 ' O ' ' A' ' 68' ' ' THR . 2.5 p -62.86 -54.61 36.07 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.707 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.515 ' N ' ' OE1' ' A' ' 73' ' ' GLU . 54.8 mp0 -107.36 -58.17 1.99 Allowed 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 155.45 164.19 12.89 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -56.59 -35.36 97.04 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 121.714 1.609 . . . . 0.0 111.925 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -61.65 -12.33 15.66 Favored 'General case' 0 C--O 1.226 -0.144 0 CA-C-O 121.751 0.786 . . . . 0.0 110.887 176.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.3 t -78.24 -32.9 49.95 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.247 -1.342 . . . . 0.0 110.805 -178.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 14.6 tp -75.94 -33.28 59.83 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.833 0.349 . . . . 0.0 110.963 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -92.3 -5.01 53.12 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 122.802 1.287 . . . . 0.0 112.767 -178.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -93.92 117.45 30.12 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 112.224 -2.262 . . . . 0.0 107.071 175.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.84 -10.39 57.24 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 -177.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 56.4 tp -59.05 -34.74 72.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 113.281 -1.46 . . . . 0.0 110.687 -179.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 38.2 t -70.44 -26.36 28.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.794 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.64 -31.17 61.89 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.908 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.8 -40.51 89.63 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 119.693 -1.241 . . . . 0.0 111.619 -177.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.408 ' N ' ' CD2' ' A' ' 86' ' ' LEU . 3.7 mm? -62.43 -40.36 96.32 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 122.351 1.072 . . . . 0.0 112.434 -177.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -60.32 -26.91 66.92 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 113.131 -1.85 . . . . 0.0 108.984 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 16.5 ttm-85 -57.73 -53.42 58.36 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 173.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 53.2 tp60 -67.32 -30.02 69.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 112.606 -2.088 . . . . 0.0 112.151 -178.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 11.9 tpt -61.15 -41.35 96.6 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.018 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 40.4 m -74.8 -34.86 62.47 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 119.455 -0.898 . . . . 0.0 111.304 -177.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -57.9 -44.12 86.56 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 120.966 1.712 . . . . 0.0 111.966 -176.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.48 -33.12 64.68 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.551 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.1 m -64.51 -41.69 96.26 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.429 ' CG1' HD12 ' A' ' 99' ' ' LEU . 86.0 t -68.22 -28.45 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.885 177.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.498 ' NH2' ' CE2' ' A' ' 100' ' ' TYR . 54.4 ttt-85 -77.78 9.5 3.45 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -176.334 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.454 HG22 ' O ' ' A' ' 97' ' ' ILE . 98.3 mt -86.8 -14.71 10.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.109 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -139.99 -48.38 0.06 OUTLIER Glycine 0 CA--C 1.543 1.809 0 N-CA-C 116.059 1.184 . . . . 0.0 116.059 -177.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.429 HD12 ' CG1' ' A' ' 95' ' ' VAL . 95.2 mt -71.72 -12.48 61.34 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 119.899 1.849 . . . . 0.0 113.792 -178.037 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.514 ' HE2' ' HZ1' ' A' ' 104' ' ' LYS . 2.5 t80 -80.12 -51.47 8.95 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.326 -1.306 . . . . 0.0 111.384 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -69.97 -32.35 70.53 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 123.619 1.676 . . . . 0.0 110.925 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.0 t -68.21 -51.07 49.66 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 110.455 -3.066 . . . . 0.0 113.301 177.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.684 HG22 ' CE2' ' A' ' 107' ' ' TYR . 0.3 OUTLIER -73.51 -26.41 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.359 0 CA-C-N 121.337 1.881 . . . . 0.0 111.24 179.115 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.514 ' HZ1' ' HE2' ' A' ' 100' ' ' TYR . 63.8 mttt -69.44 -41.74 75.88 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 112.385 -2.189 . . . . 0.0 112.533 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -80.16 -12.9 59.61 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 122.613 1.197 . . . . 0.0 111.047 -178.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -80.08 -23.19 41.49 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.24 178.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.684 ' CE2' HG22 ' A' ' 103' ' ' VAL . 21.4 m-85 -109.97 -28.54 8.68 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 119.53 1.059 . . . . 0.0 112.881 -175.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.11 9.38 41.06 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 116.765 -1.974 . . . . 0.0 113.962 -175.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.514 ' C ' ' H ' ' A' ' 111' ' ' SER . 62.0 mttp -45.97 130.11 9.75 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.512 1.051 . . . . 0.0 108.699 176.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -63.04 38.98 0.07 OUTLIER Glycine 0 CA--C 1.544 1.903 0 CA-C-N 119.179 0.9 . . . . 0.0 114.166 -178.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.514 ' H ' ' C ' ' A' ' 109' ' ' LYS . 10.6 m -5.29 -81.77 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 116.488 2.033 . . . . 0.0 116.488 -178.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.625 ' O ' ' CG ' ' A' ' 113' ' ' HIS . 2.9 tt0 165.79 -33.24 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 120.456 1.48 . . . . 0.0 113.446 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.655 ' O ' ' HB2' ' A' ' 114' ' ' ALA . 3.9 m-70 160.37 38.01 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.344 0.592 . . . . 0.0 109.931 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.655 ' HB2' ' O ' ' A' ' 113' ' ' HIS . . . 160.37 -162.7 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.855 0.836 . . . . 0.0 109.15 177.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.08 15.45 23.79 Favored Glycine 0 C--N 1.335 0.495 0 CA-C-N 114.104 -1.407 . . . . 0.0 110.512 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.631 HD12 HH21 ' A' ' 119' ' ' ARG . 8.7 tp -60.66 -40.36 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 C-N-CA 119.726 -0.79 . . . . 0.0 109.069 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.508 ' N ' HG23 ' A' ' 116' ' ' ILE . . . -65.99 -40.84 95.44 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-O 121.509 0.505 . . . . 0.0 111.885 175.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 42.0 p -59.11 -43.16 91.9 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 176.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.631 HH21 HD12 ' A' ' 116' ' ' ILE . 9.9 ttp-105 -64.05 -36.98 85.79 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.64 -178.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 18.3 tp -63.43 -45.73 89.61 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 36.5 mt -66.08 -44.58 84.03 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.491 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.8 -45.23 90.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 119.691 1.132 . . . . 0.0 110.27 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -66.01 -44.32 91.78 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.129 -1.034 . . . . 0.0 111.318 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 69.3 m -64.04 -44.12 93.46 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.277 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 96.7 m -69.32 -48.19 62.26 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 119.339 -0.944 . . . . 0.0 111.945 177.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 25.3 p -65.36 -42.68 92.52 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -174.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -64.11 -44.53 95.63 Favored Glycine 0 CA--C 1.521 0.424 0 CA-C-O 122.969 1.316 . . . . 0.0 112.904 -177.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.476 ' O ' HG22 ' A' ' 131' ' ' VAL . . . -61.35 -41.54 97.23 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 111.878 -2.161 . . . . 0.0 107.296 177.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.613 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 35.9 tp -64.04 -42.03 97.19 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.801 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.0 -40.03 96.55 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 113.205 0.816 . . . . 0.0 113.205 -177.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.476 HG22 ' O ' ' A' ' 128' ' ' ALA . 15.5 m -61.07 -26.05 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 122.687 1.232 . . . . 0.0 109.989 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.613 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . -58.35 -45.09 88.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 112.399 -2.182 . . . . 0.0 110.909 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 49.1 t -79.25 -49.08 20.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.449 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -97.96 135.05 40.23 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.478 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.641 ' H ' ' HD2' ' A' ' 136' ' ' PRO . 2.2 tp-100 -177.77 -39.6 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.871 179.075 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.641 ' HD2' ' H ' ' A' ' 135' ' ' GLN . 73.8 Cg_exo -52.45 -33.55 57.55 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 122.143 1.896 . . . . 0.0 112.46 -179.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 66.6 p -67.53 -42.69 82.31 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 118.725 -1.19 . . . . 0.0 109.879 -178.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -66.24 -42.81 88.11 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 119.303 -0.959 . . . . 0.0 112.136 -178.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 89.6 t -64.11 -44.28 97.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.406 HG13 ' O ' ' A' ' 136' ' ' PRO . 34.5 m -65.07 -39.49 85.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -176.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -63.08 -42.3 99.61 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 118.668 -1.213 . . . . 0.0 111.657 -178.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.421 HG13 ' N ' ' A' ' 143' ' ' ARG . 3.8 p -71.4 -46.45 64.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.678 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.421 ' N ' HG13 ' A' ' 142' ' ' VAL . 14.4 tpp180 -65.9 -38.09 87.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.693 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -68.11 -42.44 80.24 Favored 'General case' 0 C--O 1.226 -0.165 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -177.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -66.23 -40.83 90.55 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 118.819 -1.153 . . . . 0.0 110.133 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.48 -35.18 80.13 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 -178.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.466 ' O ' ' CG ' ' A' ' 147' ' ' GLN . 6.4 pt20 -59.94 111.1 1.35 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 177.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -95.19 -63.84 1.12 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 117.62 -1.181 . . . . 0.0 112.696 -177.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.462 ' O ' ' N ' ' A' ' 151' ' ' GLY . 16.2 mmm180 -77.76 0.12 24.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 122.675 2.489 . . . . 0.0 109.725 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . 62.02 -75.23 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.619 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 149' ' ' ARG . . . 157.56 -115.66 0.67 Allowed Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.46 ' O ' ' N ' ' A' ' 154' ' ' ARG . . . 165.38 -92.24 0.11 Allowed Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 46.46 15.88 0.16 Allowed Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.46 ' N ' ' O ' ' A' ' 152' ' ' GLY . 22.9 ttm-85 65.99 -177.03 0.19 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 81.6 mtt85 55.45 7.44 0.23 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.778 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.452 ' H ' ' C ' ' A' ' 154' ' ' ARG . 1.7 t80 59.48 159.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.43 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -88.21 153.69 21.03 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.946 0.403 . . . . 0.0 111.047 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.711 ' H ' ' CG ' ' A' ' 161' ' ' GLU . 19.5 m -157.12 -178.77 7.61 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 121.309 0.576 . . . . 0.0 111.007 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.548 HG23 ' N ' ' A' ' 160' ' ' VAL . 10.2 t -64.78 -46.32 82.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.442 -178.078 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.55 HG23 ' N ' ' A' ' 161' ' ' GLU . 27.4 m -64.53 -45.78 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 C-N-CA 119.354 -0.939 . . . . 0.0 110.674 -178.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.711 ' CG ' ' H ' ' A' ' 158' ' ' SER . 3.1 pp20? -67.59 -38.6 84.27 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.545 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.49 ' N ' ' CD ' ' A' ' 161' ' ' GLU . . . -61.58 -45.68 93.08 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.172 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -62.37 -49.69 74.54 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.389 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -68.45 -45.53 72.24 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 -176.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 14.5 m -62.85 -44.7 95.44 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -177.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.476 HD12 ' N ' ' A' ' 167' ' ' ALA . 2.6 pp -64.71 -38.37 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 121.955 0.884 . . . . 0.0 109.345 176.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.476 ' N ' HD12 ' A' ' 166' ' ' ILE . . . -59.58 -36.19 75.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 113.786 -1.552 . . . . 0.0 107.486 176.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 11.3 tpp85 -61.98 -49.8 74.64 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 122.266 2.303 . . . . 0.0 111.71 -175.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -74.62 -50.82 16.39 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 123.442 0.697 . . . . 0.0 109.51 177.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -77.85 -36.43 49.99 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 116.997 2.221 . . . . 0.0 116.997 -172.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 90.33 -166.16 31.82 Favored Glycine 0 N--CA 1.471 0.994 0 CA-C-N 118.779 0.718 . . . . 0.0 112.109 177.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.703 HD12 ' N ' ' A' ' 172' ' ' ILE . 2.0 mp -73.1 -44.11 56.93 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 CA-C-O 121.978 0.894 . . . . 0.0 110.251 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 -58.61 -33.47 70.06 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.632 -176.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -60.74 -40.54 98.25 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 118.896 -1.621 . . . . 0.0 110.23 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 52.4 tp -69.93 -33.94 72.8 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 116.646 2.091 . . . . 0.0 116.646 -177.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -78.41 -7.97 57.95 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 111.437 -2.62 . . . . 0.0 109.794 -178.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 38.1 tptt -43.42 -48.39 7.13 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.792 -176.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -86.02 -39.88 7.8 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.237 0.922 . . . . 0.0 110.845 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.6 m -45.44 -51.44 11.47 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.457 ' O ' HG12 ' A' ' 183' ' ' VAL . 2.7 m -63.19 -50.92 73.05 Favored Pre-proline 0 N--CA 1.474 0.739 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -176.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 180' ' ' SER . 33.6 Cg_endo -65.02 -27.32 57.9 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.278 1.985 . . . . 0.0 112.353 177.164 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -63.0 -38.63 91.96 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 121.228 -0.189 . . . . 0.0 111.102 -178.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.457 HG12 ' O ' ' A' ' 180' ' ' SER . 1.9 p -62.47 -42.02 94.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.372 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.41 ' N ' ' CG1' ' A' ' 183' ' ' VAL . . . -62.22 -39.54 93.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.95 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 72.3 ttp85 -61.08 -42.06 97.81 Favored 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.793 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ASN . . . . . 0.557 ' ND2' ' N ' ' A' ' 187' ' ' ALA . 0.1 OUTLIER -62.13 -42.67 99.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.964 0.411 . . . . 0.0 111.348 179.695 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 187' ' ' ALA . . . . . 0.557 ' N ' ' ND2' ' A' ' 186' ' ' ASN . . . -63.8 -44.24 93.9 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -177.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 7.4 tt -63.98 -45.23 97.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -178.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 12.9 m -60.18 -46.61 94.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 119.679 -0.808 . . . . 0.0 111.807 -178.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.425 ' ND2' ' HA ' ' A' ' 187' ' ' ALA . 1.4 p30 -62.41 -43.0 99.86 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 122.274 1.035 . . . . 0.0 109.602 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' CYS . . . . . . . . . . . . . 45.9 t -62.36 -47.19 85.3 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 113.538 -1.664 . . . . 0.0 111.004 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.514 ' O ' HG23 ' A' ' 196' ' ' THR . . . -64.89 -41.17 95.84 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.083 177.229 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -61.09 -45.09 96.13 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.366 -1.288 . . . . 0.0 112.087 -178.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.627 ' CD2' ' HE ' ' A' ' 119' ' ' ARG . 17.5 mt -63.21 -37.0 85.53 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 119.228 -0.989 . . . . 0.0 108.705 -175.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 92.7 t -62.69 -45.98 97.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 C-N-CA 117.074 -1.85 . . . . 0.0 107.101 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' THR . . . . . 0.514 HG23 ' O ' ' A' ' 192' ' ' ALA . 59.9 p -64.46 -45.95 85.2 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -178.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -56.92 -38.91 73.52 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.018 1.327 . . . . 0.0 113.209 -177.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -55.37 -44.12 75.76 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.53 HD12 ' N ' ' A' ' 199' ' ' LEU . 10.1 mp -60.84 -38.22 84.74 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.624 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 57.9 mt -61.37 -42.01 92.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.19 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 19.4 mmtp -59.68 -38.22 80.92 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.609 1.564 . . . . 0.0 113.329 177.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -63.27 -39.96 96.06 Favored 'General case' 0 C--N 1.316 -0.862 0 O-C-N 121.941 -0.474 . . . . 0.0 111.027 -177.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.4 t -101.26 129.04 47.14 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 122.041 0.924 . . . . 0.0 112.621 -178.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 2.2 tp 67.73 4.25 3.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 113.788 -1.551 . . . . 0.0 111.976 178.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 2.3 mt -126.71 28.78 5.82 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.718 0.771 . . . . 0.0 112.014 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 18.1 mtpp -73.86 -23.68 59.64 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.258 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -162.99 34.17 0.1 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.658 -1.155 . . . . 0.0 108.316 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 2.4 m120 42.42 54.31 4.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.354 -1.294 . . . . 0.0 113.663 177.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.826 HD13 ' H ' ' A' ' 209' ' ' LEU . 0.0 OUTLIER -115.97 142.96 46.1 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 114.777 -1.101 . . . . 0.0 108.745 178.234 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 210' ' ' MET . . . . . 0.415 ' O ' ' O ' ' A' ' 211' ' ' THR . 11.0 mmt -127.24 83.8 2.2 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.415 ' O ' ' O ' ' A' ' 210' ' ' MET . 4.4 m -33.16 154.61 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.467 -178.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ASP . . . . . 0.405 ' O ' ' OD1' ' A' ' 213' ' ' ASP . 94.3 m-20 -78.09 68.45 4.13 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.04 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 212' ' ' ASP . 25.3 m-20 -159.28 71.82 0.52 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.467 ' N ' ' CD ' ' A' ' 215' ' ' PRO . 3.4 mt -61.07 -43.48 90.96 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.871 -177.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' A' ' 214' ' ' LEU . 26.4 Cg_exo -61.2 -33.33 90.6 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 120.716 0.944 . . . . 0.0 110.701 -179.115 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 86.9 m -65.62 -43.58 89.13 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.161 -1.381 . . . . 0.0 112.579 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 38.0 t-80 -67.7 -39.29 84.42 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -177.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -64.12 -46.83 82.43 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.217 -179.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 28.6 p -60.34 -37.84 81.93 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 118.894 0.77 . . . . 0.0 110.239 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 70.7 m -59.76 -41.72 91.68 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.556 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.99 -41.67 97.44 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -177.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -62.02 -47.27 85.5 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.896 0.855 . . . . 0.0 113.111 -176.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -60.98 -42.25 99.7 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 108.0 -2.04 . . . . 0.0 108.0 177.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -63.22 -37.79 88.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.05 -1.075 . . . . 0.0 109.275 176.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -61.33 -41.78 99.61 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 114.172 -1.376 . . . . 0.0 111.59 -176.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -66.08 -38.91 89.45 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 118.168 -1.413 . . . . 0.0 107.949 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 83.6 m -64.01 -41.6 97.41 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.466 0.65 . . . . 0.0 109.778 176.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -61.81 -39.59 92.3 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.321 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 31.3 m -57.85 -39.23 77.24 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.15 -176.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 98.1 t -60.17 -40.87 84.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 118.804 -1.158 . . . . 0.0 108.302 178.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.567 ' O ' ' HD2' ' A' ' 234' ' ' PRO . 0.2 OUTLIER -61.81 -40.8 88.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 177.444 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -62.59 -38.98 92.27 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 115.686 1.736 . . . . 0.0 115.686 -178.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.449 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 0.2 OUTLIER -57.68 -40.82 86.77 Favored Pre-proline 0 N--CA 1.476 0.863 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 -172.721 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.567 ' HD2' ' O ' ' A' ' 231' ' ' ILE . 38.4 Cg_exo -58.62 -40.46 73.5 Favored 'Trans proline' 0 C--N 1.293 -2.343 0 C-N-CA 121.666 1.577 . . . . 0.0 113.78 -177.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.3 m -64.51 -37.44 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 118.395 -1.322 . . . . 0.0 109.336 178.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -65.94 -40.64 91.53 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.05 178.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.552 ' CG1' ' NH1' ' A' ' 241' ' ' ARG . 55.9 t -64.79 -45.07 96.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 115.295 -0.866 . . . . 0.0 113.073 -177.027 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 15.5 m -62.77 -37.28 78.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 119.749 -0.781 . . . . 0.0 111.299 -177.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -60.81 -44.68 96.56 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.399 -0.52 . . . . 0.0 111.532 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' THR . . . . . 0.491 ' OG1' ' NH2' ' A' ' 279' ' ' ARG . 13.5 m -61.8 -42.3 98.84 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.889 0.376 . . . . 0.0 111.56 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.586 ' O ' ' CD2' ' A' ' 242' ' ' TYR . 24.7 mtt85 -49.19 124.31 8.77 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.999 -178.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.586 ' CD2' ' O ' ' A' ' 241' ' ' ARG . 3.3 m-85 171.26 -64.72 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.6 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 243' ' ' MET . . . . . . . . . . . . . 12.2 mmt -69.84 84.99 0.49 Allowed 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.356 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' ASN . . . . . 0.458 ' ND2' ' O ' ' A' ' 244' ' ' ASN . 7.3 p-10 -157.94 99.89 1.7 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -178.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 245' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 244' ' ' ASN . 11.0 p 66.22 84.89 0.15 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.995 178.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 246' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 245' ' ' SER . . . 29.99 -145.0 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.668 178.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.68 -166.27 1.32 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.608 -179.023 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 172.05 -119.51 0.78 Allowed Glycine 0 CA--C 1.534 1.281 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.968 ' HB3' ' CD2' ' A' ' 255' ' ' HIS . 22.3 mm-40 -107.38 133.68 51.54 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 122.679 -0.307 . . . . 0.0 110.761 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.406 ' CD1' ' C ' ' A' ' 249' ' ' GLN . 35.6 m-85 -149.38 34.53 0.72 Allowed 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 118.614 -0.707 . . . . 0.0 111.606 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 251' ' ' HIS . . . . . 0.441 ' ND1' ' C ' ' A' ' 251' ' ' HIS . 10.8 t-80 -66.4 -54.45 24.22 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 115.915 -2.314 . . . . 0.0 112.166 -176.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 44.2 t -148.74 -175.1 4.81 Favored 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 178.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -62.36 -45.94 90.92 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.852 1.205 . . . . 0.0 110.028 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -58.82 -37.62 90.75 Favored Glycine 0 N--CA 1.475 1.283 0 C-N-CA 124.41 1.005 . . . . 0.0 114.387 -173.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' HIS . . . . . 0.968 ' CD2' ' HB3' ' A' ' 249' ' ' GLN . 86.4 t60 -59.45 -32.74 70.5 Favored 'General case' 0 C--N 1.367 1.328 0 C-N-CA 116.479 -2.088 . . . . 0.0 111.005 -179.26 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 256' ' ' CYS . . . . . . . . . . . . . 8.9 t -60.29 -43.93 95.83 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 117.921 0.328 . . . . 0.0 111.138 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -59.16 -44.43 92.13 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.186 -177.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.466 HD22 ' N ' ' A' ' 258' ' ' LEU . 3.6 mm? -66.32 -42.99 87.43 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 119.969 -0.692 . . . . 0.0 110.183 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 259' ' ' THR . . . . . 0.517 HG23 ' O ' ' A' ' 255' ' ' HIS . 74.7 p -62.75 -45.66 91.64 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 260' ' ' MET . . . . . . . . . . . . . 2.9 ptm -60.77 -43.48 98.0 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 121.013 -0.275 . . . . 0.0 111.505 -177.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 12.2 mt -62.53 -47.29 84.56 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 59.6 ttt85 -67.11 -54.11 24.46 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.549 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 28.1 mmtp -70.13 -156.42 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.929 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' GLU . . . . . 0.513 ' OE2' ' N ' ' A' ' 265' ' ' GLY . 1.0 OUTLIER -38.8 133.55 1.08 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.025 -179.702 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.513 ' N ' ' OE2' ' A' ' 264' ' ' GLU . . . -47.98 169.97 0.07 OUTLIER Glycine 0 CA--C 1.533 1.179 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -55.54 -0.67 0.17 Allowed 'Trans proline' 0 N--CA 1.5 1.869 0 C-N-CA 121.978 1.786 . . . . 0.0 112.326 178.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.492 ' H ' ' C ' ' A' ' 265' ' ' GLY . 91.1 mtt180 -69.77 -26.79 64.45 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.13 0.572 . . . . 0.0 112.3 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -58.37 -32.33 68.48 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.1 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 269' ' ' PHE . . . . . 0.537 ' O ' ' NH2' ' A' ' 241' ' ' ARG . 20.8 m-85 -62.42 -41.34 98.63 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.138 0.494 . . . . 0.0 111.186 177.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -65.74 -37.82 87.42 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -177.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.457 ' O ' ' O ' ' A' ' 272' ' ' GLY . 14.8 mptt -56.39 -172.33 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 272' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 271' ' ' LYS . . . 45.82 103.11 0.01 OUTLIER Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.501 -0.64 . . . . 0.0 111.501 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -158.62 -12.91 0.07 Allowed 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.346 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 274' ' ' MET . . . . . 0.541 ' N ' ' HD2' ' A' ' 275' ' ' PRO . 2.1 tpt -64.07 -45.16 79.67 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 120.39 -0.524 . . . . 0.0 111.429 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 275' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 274' ' ' MET . 36.9 Cg_endo -64.84 -45.76 7.76 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.362 1.375 . . . . 0.0 111.57 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 78.5 p -59.67 -38.88 82.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.746 -178.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -61.0 -42.55 98.65 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 122.629 1.204 . . . . 0.0 112.017 -178.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 9.4 mp -62.02 -38.45 88.69 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 112.298 -2.228 . . . . 0.0 107.678 174.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 279' ' ' ARG . . . . . 0.491 ' NH2' ' OG1' ' A' ' 240' ' ' THR . 9.9 mtm180 -62.71 -39.23 93.37 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.21 0.529 . . . . 0.0 110.184 178.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 6.8 tp -61.97 -36.96 83.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.885 -177.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -67.95 -51.23 35.65 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 282' ' ' SER . . . . . 0.425 ' O ' HG12 ' A' ' 285' ' ' VAL . 36.3 m -62.92 -44.36 96.29 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 283' ' ' TRP . . . . . 0.471 ' O ' HG22 ' A' ' 286' ' ' VAL . 91.5 t90 -60.05 -38.17 81.99 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.674 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -62.77 -38.62 91.34 Favored 'General case' 0 C--N 1.317 -0.814 0 O-C-N 122.068 -0.395 . . . . 0.0 111.181 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.425 HG12 ' O ' ' A' ' 282' ' ' SER . 0.3 OUTLIER -60.98 -39.36 81.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -177.585 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.471 HG22 ' O ' ' A' ' 283' ' ' TRP . 6.5 m -62.91 -40.08 87.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 119.98 -0.688 . . . . 0.0 109.941 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 287' ' ' MET . . . . . 0.4 ' O ' ' OG1' ' A' ' 290' ' ' THR . 10.0 tpt -60.49 -38.95 85.98 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.162 0.506 . . . . 0.0 109.695 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -58.81 -40.18 83.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.542 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.427 HG12 ' O ' ' A' ' 286' ' ' VAL . 0.3 OUTLIER -60.71 -38.72 79.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.365 -177.645 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.4 ' OG1' ' O ' ' A' ' 287' ' ' MET . 39.4 p -62.71 -40.62 97.74 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 177.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -61.56 -39.05 89.72 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 176.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -58.72 -40.96 85.25 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 117.921 -1.512 . . . . 0.0 109.506 -176.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 293' ' ' GLN . . . . . 0.45 ' O ' ' O ' ' A' ' 296' ' ' ARG . 88.4 mt-30 -60.78 -42.78 98.19 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 122.825 1.298 . . . . 0.0 110.623 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.513 ' O ' HD13 ' A' ' 294' ' ' LEU . 0.2 OUTLIER -60.41 -40.68 91.87 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 112.583 -2.099 . . . . 0.0 109.091 179.507 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 1.8 mmmm -63.48 -45.8 89.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.34 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 296' ' ' ARG . . . . . 0.45 ' O ' ' O ' ' A' ' 293' ' ' GLN . 0.5 OUTLIER -122.96 116.23 23.22 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.364 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -116.25 -95.0 0.48 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.381 0.61 . . . . 0.0 110.767 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.415 ' C ' HD12 ' A' ' 298' ' ' LEU . 3.5 pp -136.65 -166.66 1.93 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.288 178.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 12.5 ttt -170.81 66.36 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.288 -0.565 . . . . 0.0 111.489 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.6 101.01 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.849 0.833 . . . . 0.0 110.697 -178.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -64.05 -46.13 85.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 113.895 -1.502 . . . . 0.0 113.534 -176.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 302' ' ' TYR . . . . . 0.534 ' CD2' ' OE2' ' A' ' 306' ' ' GLU . 19.9 t80 -58.66 -39.82 81.72 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.643 -178.172 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -64.84 -46.53 81.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.072 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 304' ' ' SER . . . . . 0.42 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 37.8 m -66.15 -37.17 85.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.539 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -61.12 -42.48 98.61 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.186 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.534 ' OE2' ' CD2' ' A' ' 302' ' ' TYR . 52.1 mt-10 -64.66 -36.83 85.52 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 -177.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 307' ' ' ALA . . . . . 0.542 ' HB3' ' HD3' ' A' ' 308' ' ' PRO . . . -59.88 -53.0 69.68 Favored Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -176.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 308' ' ' PRO . . . . . 0.542 ' HD3' ' HB3' ' A' ' 307' ' ' ALA . 74.1 Cg_endo -75.13 0.25 9.18 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.109 1.873 . . . . 0.0 111.785 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 309' ' ' PHE . . . . . 0.491 ' CG ' ' O ' ' A' ' 308' ' ' PRO . 56.6 m-85 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.35 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 13.3 tpp . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.733 ' HA ' HD21 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -136.42 111.25 8.78 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.164 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.411 ' H ' ' HG ' ' A' ' 18' ' ' LEU . 7.6 m -114.2 178.47 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 178.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.433 ' CD ' ' N ' ' A' ' 16' ' ' LYS . 3.8 mptp? -64.53 -41.52 96.32 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.189 -0.46 . . . . 0.0 112.066 -178.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -62.94 -42.13 99.71 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -178.16 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.738 ' C ' HD12 ' A' ' 18' ' ' LEU . 1.1 pp -80.59 -24.17 39.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.428 0.632 . . . . 0.0 112.564 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.478 ' N ' HD12 ' A' ' 18' ' ' LEU . . . -65.07 -40.43 96.99 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 107.241 -2.344 . . . . 0.0 107.241 177.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.452 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -71.17 -31.34 67.55 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 124.515 2.103 . . . . 0.0 107.485 176.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.78 -42.62 98.49 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-N 108.781 -3.827 . . . . 0.0 110.315 -178.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.4 t -70.92 -26.6 63.27 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -65.8 -50.6 64.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.711 -178.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.08 -36.1 80.68 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 118.308 -1.357 . . . . 0.0 111.016 -177.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.9 t -63.97 -53.63 47.11 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.849 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 74.3 mt -65.49 -39.88 86.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -177.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.39 -42.43 96.11 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 119.516 -0.873 . . . . 0.0 112.701 -174.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.409 ' HA ' HG22 ' A' ' 31' ' ' THR . 11.1 t70 -78.13 -27.05 48.17 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 120.718 1.599 . . . . 0.0 110.111 -175.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.494 ' O ' HD23 ' A' ' 29' ' ' LEU . 1.2 tt -59.43 -55.54 33.37 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 120.033 1.288 . . . . 0.0 111.933 -177.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.432 HD13 ' O ' ' A' ' 30' ' ' ILE . 0.4 OUTLIER -75.19 -3.56 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -179.24 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.409 HG22 ' HA ' ' A' ' 28' ' ' ASP . 0.4 OUTLIER -109.5 -17.2 13.81 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.302 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.438 ' O ' ' OD1' ' A' ' 35' ' ' ASP . 1.6 t80 -67.95 -44.62 40.79 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 116.474 -2.09 . . . . 0.0 109.984 -177.152 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.421 ' CD ' ' N ' ' A' ' 32' ' ' PHE . 35.2 Cg_exo -59.45 -15.68 31.46 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 121.252 1.301 . . . . 0.0 112.291 176.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.96 -35.23 79.51 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -177.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 36' ' ' THR . 27.7 p-10 -64.53 -40.33 95.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.763 -177.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.543 ' N ' ' OD1' ' A' ' 35' ' ' ASP . 31.6 p -58.19 -34.66 70.6 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -179.116 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.11 -38.78 86.22 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.3 pttp -62.23 -48.3 80.58 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 118.877 -1.129 . . . . 0.0 111.4 -177.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.0 m -63.41 -38.23 81.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 O-C-N 122.135 -0.353 . . . . 0.0 111.927 -178.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.524 ' O ' ' NE2' ' A' ' 42' ' ' GLN . 5.5 mmp_? -59.35 -40.03 85.08 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.514 -178.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.46 38.86 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.524 ' NE2' ' O ' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -114.09 -177.2 3.07 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.407 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.786 HG23 ' H ' ' A' ' 44' ' ' GLN . 13.1 tt -63.12 -62.08 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.364 -0.535 . . . . 0.0 109.81 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.786 ' H ' HG23 ' A' ' 43' ' ' ILE . 0.3 OUTLIER 169.55 5.95 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.226 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.456 ' H ' ' H ' ' A' ' 44' ' ' GLN . . . 54.34 37.46 59.88 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.364 -1.095 . . . . 0.0 110.364 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.443 ' O ' ' CB ' ' A' ' 47' ' ' SER . 2.9 pt-20 -93.17 -95.26 0.15 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.617 0.246 . . . . 0.0 110.515 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.524 ' C ' ' H ' ' A' ' 49' ' ' GLY . 0.9 OUTLIER 82.13 -31.09 0.1 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.82 -179.833 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -65.01 8.43 0.13 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.854 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.524 ' H ' ' C ' ' A' ' 47' ' ' SER . . . 80.85 16.38 75.27 Favored Glycine 0 CA--C 1.535 1.299 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -177.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.572 ' O ' HD23 ' A' ' 50' ' ' LEU . 1.7 tt -61.44 -36.38 80.22 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 114.875 -0.662 . . . . 0.0 110.386 -176.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.499 HG13 ' N ' ' A' ' 52' ' ' ARG . 7.3 p -59.82 -44.64 94.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 C-N-CA 120.191 -0.603 . . . . 0.0 112.2 -178.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.499 ' N ' HG13 ' A' ' 51' ' ' VAL . 45.9 ttp180 -65.33 -35.95 82.54 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 119.451 -0.899 . . . . 0.0 112.793 -178.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 t -69.56 -38.48 77.46 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.628 0.728 . . . . 0.0 109.662 178.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -152.68 123.26 7.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.193 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -99.3 176.66 5.45 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -177.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.618 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 45.7 p 53.9 -141.34 0.87 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 113.993 -1.458 . . . . 0.0 108.923 -178.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.618 ' HB3' ' O ' ' A' ' 56' ' ' SER . . . 95.7 14.23 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.893 178.078 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 11.9 tp-100 -167.29 73.25 0.12 Allowed 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.547 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -61.05 142.34 56.72 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.433 ' O ' ' C ' ' A' ' 61' ' ' GLY . 84.1 mtp180 -39.41 -37.07 0.42 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.955 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 60' ' ' ARG . . . -28.8 101.44 0.01 OUTLIER Glycine 0 CA--C 1.531 1.064 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.28 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 56.2 t -66.97 -33.79 65.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 118.121 -0.943 . . . . 0.0 109.687 176.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 43.9 mt -60.56 -32.43 71.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 121.489 1.949 . . . . 0.0 111.213 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.6 -49.01 66.84 Favored Glycine 0 CA--C 1.532 1.138 0 N-CA-C 115.246 0.859 . . . . 0.0 115.246 -176.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.439 HG22 ' H ' ' A' ' 65' ' ' THR . 0.6 OUTLIER -61.99 -45.97 91.27 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.465 0.542 . . . . 0.0 112.465 -179.082 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 25.0 pt -59.75 -36.03 63.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 118.365 -0.826 . . . . 0.0 108.845 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 78.3 mt -63.84 -35.72 81.55 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 121.137 1.789 . . . . 0.0 111.749 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 97.9 m -62.91 -39.11 93.51 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 113.506 -1.679 . . . . 0.0 111.008 -175.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.457 ' C ' ' SD ' ' A' ' 69' ' ' MET . 0.0 OUTLIER -60.29 -40.39 90.31 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 120.775 -1.203 . . . . 0.0 113.835 -176.427 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.6 p -69.66 -40.56 79.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 119.211 -0.996 . . . . 0.0 113.176 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 67.9 ttp85 -78.42 -13.27 59.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.709 0.766 . . . . 0.0 112.823 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 61.0 m -62.55 -54.82 34.06 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.111 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -110.18 -54.17 2.6 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 157.03 164.11 13.22 Favored Glycine 0 CA--C 1.539 1.56 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -56.42 -35.47 96.41 Favored 'Trans proline' 0 N--CA 1.503 2.058 0 CA-C-N 119.493 1.646 . . . . 0.0 112.395 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -61.09 -11.47 8.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 122.102 0.953 . . . . 0.0 111.135 176.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.472 ' O ' ' OD1' ' A' ' 80' ' ' ASN . 3.6 t -77.72 -32.26 52.74 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 113.716 -1.583 . . . . 0.0 110.727 -178.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.45 HD22 ' N ' ' A' ' 78' ' ' LEU . 4.1 mm? -75.65 -32.5 60.23 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 122.089 -0.382 . . . . 0.0 110.843 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -91.37 -4.35 55.83 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -176.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.472 ' OD1' ' O ' ' A' ' 77' ' ' SER . 35.1 p30 -95.72 26.88 3.74 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 112.189 -2.278 . . . . 0.0 107.648 175.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -159.05 -19.72 0.03 OUTLIER Glycine 0 CA--C 1.53 1.001 0 CA-C-N 114.28 -1.327 . . . . 0.0 112.417 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.589 ' O ' HD13 ' A' ' 82' ' ' LEU . 0.2 OUTLIER -59.65 -35.16 73.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.263 -0.968 . . . . 0.0 110.502 -179.442 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.9 p -70.87 -27.44 30.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.525 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.86 -31.33 61.6 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.349 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.91 -40.54 89.15 Favored Glycine 0 C--O 1.223 -0.573 0 C-N-CA 119.69 -1.243 . . . . 0.0 111.148 -178.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 50.5 mt -62.37 -40.25 95.84 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 122.476 1.132 . . . . 0.0 112.67 -177.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -60.03 -27.01 66.55 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 112.986 -1.915 . . . . 0.0 109.025 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 36.2 ttp180 -57.31 -52.55 64.89 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 173.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -67.53 -30.32 69.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 112.853 -1.976 . . . . 0.0 112.329 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 11.8 tmm? -61.01 -41.99 97.61 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.551 -0.749 . . . . 0.0 112.484 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 21.8 t -74.81 -34.33 62.35 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.533 -176.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -57.69 -44.08 85.59 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 120.231 1.378 . . . . 0.0 111.9 -176.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.56 -32.87 64.39 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 119.402 -0.919 . . . . 0.0 110.732 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.618 ' O ' HG22 ' A' ' 97' ' ' ILE . 58.4 p -64.51 -42.2 95.96 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.457 ' C ' ' H ' ' A' ' 97' ' ' ILE . 7.1 p -68.39 -28.32 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 177.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.483 ' CG ' ' O ' ' A' ' 96' ' ' ARG . 35.3 ttt-85 -77.36 9.71 3.02 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 -176.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.618 HG22 ' O ' ' A' ' 94' ' ' SER . 3.4 tp -86.92 -15.39 9.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 177.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.498 ' O ' ' OD1' ' A' ' 101' ' ' ASP . . . -140.24 -48.17 0.06 OUTLIER Glycine 0 CA--C 1.544 1.872 0 N-CA-C 116.018 1.167 . . . . 0.0 116.018 -177.056 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.601 ' N ' HD12 ' A' ' 99' ' ' LEU . 8.6 mp -72.06 -13.06 61.49 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 120.111 1.955 . . . . 0.0 113.669 -178.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.498 ' O ' ' CG ' ' A' ' 104' ' ' LYS . 48.7 t80 -80.48 -51.85 8.32 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 114.551 -1.204 . . . . 0.0 113.025 -178.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.498 ' OD1' ' O ' ' A' ' 98' ' ' GLY . 30.9 p-10 -70.32 -32.36 70.07 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 123.663 1.696 . . . . 0.0 110.821 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.456 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 24.1 p -68.19 -51.34 46.7 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 110.284 -3.144 . . . . 0.0 112.641 176.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 59.1 t -73.51 -26.47 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 CA-C-N 121.254 1.843 . . . . 0.0 112.106 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.498 ' CG ' ' O ' ' A' ' 100' ' ' TYR . 22.7 mmtm -68.89 -41.75 77.85 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 111.914 -2.403 . . . . 0.0 110.757 178.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.487 ' HG3' ' O ' ' A' ' 101' ' ' ASP . 88.1 mt-30 -78.26 -14.64 59.35 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-O 122.772 1.272 . . . . 0.0 111.045 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -79.76 -23.16 42.41 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 114.672 -1.149 . . . . 0.0 112.462 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.463 ' CZ ' ' OD1' ' A' ' 190' ' ' ASN . 32.9 m-85 -109.66 -29.95 8.12 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 119.39 0.995 . . . . 0.0 111.735 -175.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.9 p -97.56 9.33 42.74 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 117.028 -1.869 . . . . 0.0 112.675 -178.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.532 ' O ' ' C ' ' A' ' 110' ' ' GLY . 6.1 pttp -48.06 124.41 7.58 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 117.792 -1.099 . . . . 0.0 109.835 177.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.533 ' O ' ' CB ' ' A' ' 111' ' ' SER . . . -26.46 -77.52 0.01 OUTLIER Glycine 0 N--CA 1.488 2.134 0 CA-C-N 120.46 1.482 . . . . 0.0 111.515 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 110' ' ' GLY . 24.0 p 103.35 -159.68 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 176.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.563 ' O ' ' N ' ' A' ' 114' ' ' ALA . 94.8 mt-10 -128.76 96.8 4.47 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.254 -0.885 . . . . 0.0 112.649 -178.178 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.636 ' O ' ' HB2' ' A' ' 114' ' ' ALA . 76.8 m-70 12.63 51.11 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 O-C-N 124.245 0.965 . . . . 0.0 113.138 178.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.636 ' HB2' ' O ' ' A' ' 113' ' ' HIS . . . 159.41 -161.79 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.36 14.97 26.65 Favored Glycine 0 C--N 1.338 0.687 0 CA-C-N 114.999 -1.0 . . . . 0.0 113.227 176.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.462 HG23 ' N ' ' A' ' 117' ' ' GLY . 13.0 tt -60.91 -40.35 85.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 119.167 -1.013 . . . . 0.0 109.438 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.462 ' N ' HG23 ' A' ' 116' ' ' ILE . . . -65.49 -39.56 95.72 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 122.047 0.804 . . . . 0.0 111.4 176.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 9.6 p -57.81 -42.11 83.59 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 177.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -63.42 -37.18 86.3 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.975 -178.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 30.8 tp -64.03 -46.98 82.04 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.354 0.597 . . . . 0.0 109.778 178.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 42.8 mt -67.06 -44.83 79.12 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.848 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.78 -44.7 92.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 119.281 0.946 . . . . 0.0 109.36 178.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.472 ' HA3' HD22 ' A' ' 190' ' ' ASN . . . -65.94 -44.16 92.28 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 119.691 -1.242 . . . . 0.0 111.665 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 67.1 m -63.72 -43.91 95.15 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.384 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 20.9 m -69.44 -48.53 60.65 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 119.082 -1.047 . . . . 0.0 112.023 177.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 41.5 p -65.54 -43.0 91.3 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 -174.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -64.46 -44.85 94.65 Favored Glycine 0 CA--C 1.521 0.407 0 CA-C-N 114.734 -1.121 . . . . 0.0 112.918 -177.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.448 ' O ' HG12 ' A' ' 131' ' ' VAL . . . -61.83 -41.66 98.08 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 112.395 -1.903 . . . . 0.0 107.451 177.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.682 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 24.9 tp -64.67 -42.6 95.26 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.218 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.63 -40.16 96.17 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -177.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.448 HG12 ' O ' ' A' ' 128' ' ' ALA . 2.7 p -61.27 -26.46 39.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 123.363 1.554 . . . . 0.0 109.942 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.682 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . -58.78 -45.68 89.25 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 110.787 -2.915 . . . . 0.0 112.372 -178.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.5 p -79.79 -48.65 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -178.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -102.5 86.12 2.73 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -177.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.688 ' H ' ' CD ' ' A' ' 136' ' ' PRO . 5.1 pm0 -126.77 -22.99 0.04 OUTLIER Pre-proline 0 CA--C 1.551 0.983 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 177.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.688 ' CD ' ' H ' ' A' ' 135' ' ' GLN . 6.8 Cg_endo -54.98 -33.13 81.82 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 CA-C-N 121.554 1.591 . . . . 0.0 112.214 -178.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.513 ' O ' ' NZ ' ' A' ' 141' ' ' LYS . 73.3 p -68.22 -42.87 79.14 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 117.828 -1.549 . . . . 0.0 112.286 -175.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -67.46 -44.37 78.78 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 118.438 -1.305 . . . . 0.0 113.373 -178.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.452 HG23 ' N ' ' A' ' 140' ' ' VAL . 27.9 m -65.45 -44.76 94.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -178.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.452 ' N ' HG23 ' A' ' 139' ' ' VAL . 75.2 t -65.48 -40.29 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -176.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.513 ' NZ ' ' O ' ' A' ' 137' ' ' THR . 29.3 mtmm -63.18 -41.53 99.22 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.118 -178.178 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 3.5 p -71.1 -45.57 71.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.833 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.59 HH21 ' CG2' ' A' ' 166' ' ' ILE . 61.1 mtp180 -64.73 -37.34 87.28 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.161 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.611 ' CD1' ' NE2' ' A' ' 147' ' ' GLN . 76.2 t80 -67.27 -41.76 84.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.451 -178.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 18.0 tm0? -65.92 -40.73 91.71 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.518 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -64.84 -35.96 82.81 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -176.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.611 ' NE2' ' CD1' ' A' ' 144' ' ' PHE . 5.7 pt20 -59.3 111.12 1.24 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 177.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -102.49 -174.87 2.67 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 117.469 2.396 . . . . 0.0 117.469 -171.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 90.9 mtt-85 56.02 105.39 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 110.601 -2.999 . . . . 0.0 110.376 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -44.41 -77.45 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.786 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 46.07 81.95 0.04 OUTLIER Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -75.24 42.2 1.39 Allowed Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.829 -0.909 . . . . 0.0 110.829 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 154' ' ' ARG . . . -66.09 100.08 0.49 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.436 ' O ' ' O ' ' A' ' 153' ' ' GLY . 10.1 tpp85 57.37 156.65 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.745 0.307 . . . . 0.0 110.25 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 15.2 mmt85 48.86 -138.32 0.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.491 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.489 ' O ' ' CD2' ' A' ' 156' ' ' TYR . 74.1 t80 -165.6 6.41 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.059 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.448 ' O ' ' O ' ' A' ' 156' ' ' TYR . 51.0 mt-30 58.45 144.03 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.316 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.644 ' H ' ' CG ' ' A' ' 161' ' ' GLU . 3.5 m -156.97 -178.91 7.72 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.779 0.799 . . . . 0.0 112.23 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 26.4 p -64.87 -46.48 81.61 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 114.234 -1.348 . . . . 0.0 113.063 -177.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 42.4 t -64.28 -45.48 96.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.281 -177.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.644 ' CG ' ' H ' ' A' ' 158' ' ' SER . 8.3 pt-20 -67.99 -38.89 83.21 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.401 ' O ' HG22 ' A' ' 166' ' ' ILE . . . -61.56 -45.72 92.96 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -177.04 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.451 ' CG ' ' N ' ' A' ' 164' ' ' LYS . 0.1 OUTLIER -62.45 -48.77 78.18 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.041 -179.424 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.451 ' N ' ' CG ' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -67.54 -45.08 76.74 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -174.793 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 40.6 p -62.77 -44.79 95.26 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 119.738 1.154 . . . . 0.0 113.706 -177.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.59 ' CG2' HH21 ' A' ' 143' ' ' ARG . 18.5 tt -64.94 -38.51 82.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-O 121.933 0.873 . . . . 0.0 109.454 176.447 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.441 ' N ' HG23 ' A' ' 166' ' ' ILE . . . -59.78 -36.56 76.96 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 113.825 -1.534 . . . . 0.0 108.042 176.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -62.1 -50.03 73.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 122.708 2.504 . . . . 0.0 111.51 -175.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -74.75 -51.0 15.34 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 177.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -78.18 -36.51 47.38 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 116.25 1.944 . . . . 0.0 116.25 -173.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 91.78 -167.29 30.72 Favored Glycine 0 N--CA 1.468 0.779 0 CA-C-N 118.553 0.615 . . . . 0.0 112.095 177.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 8.5 pt -72.69 -42.74 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-O 121.845 0.831 . . . . 0.0 110.551 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 53.5 ttt85 -58.94 -33.54 70.73 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 114.381 -1.282 . . . . 0.0 110.838 -177.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -61.12 -40.69 98.89 Favored Glycine 0 CA--C 1.522 0.479 0 C-N-CA 118.503 -1.808 . . . . 0.0 109.592 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.429 ' CD1' ' NH1' ' A' ' 143' ' ' ARG . 7.4 tt -70.42 -33.78 71.74 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 111.688 -2.256 . . . . 0.0 116.701 -177.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 10.1 m0 -78.21 -7.86 57.62 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 111.713 -2.494 . . . . 0.0 109.909 -177.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 16.9 tptm -43.52 -48.3 7.38 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.192 -176.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -91.05 -34.99 7.3 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.449 1.023 . . . . 0.0 111.492 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.3 m -46.29 -51.94 13.6 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.24 -50.83 73.15 Favored Pre-proline 0 N--CA 1.477 0.903 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -176.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -64.06 -28.21 65.7 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 121.666 1.577 . . . . 0.0 111.44 175.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -63.79 -38.8 92.45 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.79 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.419 ' CG1' ' N ' ' A' ' 184' ' ' ALA . 0.8 OUTLIER -62.39 -42.12 94.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.722 -178.648 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.419 ' N ' ' CG1' ' A' ' 183' ' ' VAL . . . -61.96 -39.41 92.02 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.341 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 57.3 ttp85 -60.76 -41.97 96.51 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.093 -179.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -61.58 -43.23 99.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.26 0.552 . . . . 0.0 110.596 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.37 -43.05 95.74 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.741 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 78.1 mt -62.96 -45.02 99.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -176.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.518 ' O ' ' N ' ' A' ' 193' ' ' GLU . 5.9 m -59.44 -46.34 92.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 119.546 -0.861 . . . . 0.0 111.395 -178.237 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.472 HD22 ' HA3' ' A' ' 123' ' ' GLY . 6.6 t30 -63.08 -42.98 99.76 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 122.045 0.926 . . . . 0.0 110.908 178.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' CYS . . . . . 0.591 ' SG ' ' N ' ' A' ' 192' ' ' ALA . 0.5 OUTLIER -61.6 -45.41 94.2 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.014 -1.448 . . . . 0.0 108.867 179.049 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.591 ' N ' ' SG ' ' A' ' 191' ' ' CYS . . . -63.76 -39.2 93.69 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 112.584 -2.098 . . . . 0.0 109.149 175.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 189' ' ' VAL . 44.0 tp10 -60.31 -46.38 90.09 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.004 0.922 . . . . 0.0 112.706 -176.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 75.2 mt -65.61 -37.64 87.19 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.671 -175.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 2.5 p -64.26 -46.28 93.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 117.089 -1.845 . . . . 0.0 109.569 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 2.2 t -64.48 -45.36 87.71 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -177.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -57.41 -39.45 76.19 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 114.58 -1.191 . . . . 0.0 112.305 -178.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -56.07 -44.7 79.19 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 47.3 mt -61.83 -39.42 91.73 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.891 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 42.5 mm -63.47 -43.36 98.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 118.813 -0.613 . . . . 0.0 111.257 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' LYS . . . . . 0.482 ' O ' ' O ' ' A' ' 205' ' ' LEU . 49.9 mtmt -60.27 -40.51 90.63 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 120.171 1.35 . . . . 0.0 111.613 177.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -64.81 -38.23 90.27 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 113.867 -1.515 . . . . 0.0 110.982 -176.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.481 ' O ' HG23 ' A' ' 203' ' ' THR . 13.3 t -101.89 129.16 48.07 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.706 0.765 . . . . 0.0 112.413 -178.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.763 ' O ' HD23 ' A' ' 209' ' ' LEU . 0.5 OUTLIER 68.14 5.63 4.75 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 114.323 -1.308 . . . . 0.0 112.489 178.383 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.482 ' O ' ' O ' ' A' ' 201' ' ' LYS . 0.4 OUTLIER -141.78 79.88 1.7 Allowed 'General case' 0 N--CA 1.472 0.643 0 O-C-N 122.136 -0.352 . . . . 0.0 110.214 -178.652 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.539 ' O ' ' CB ' ' A' ' 207' ' ' ALA . 3.2 mtmp? -112.03 49.3 0.92 Allowed 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.079 -1.013 . . . . 0.0 110.826 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.539 ' CB ' ' O ' ' A' ' 206' ' ' LYS . . . 122.44 34.09 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.491 1.116 . . . . 0.0 110.007 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' ASN . . . . . 0.537 ' CB ' ' O ' ' A' ' 207' ' ' ALA . 9.0 t-20 102.36 -138.17 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 O-C-N 125.05 1.469 . . . . 0.0 108.95 -177.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.763 HD23 ' O ' ' A' ' 204' ' ' LEU . 0.3 OUTLIER -176.27 58.68 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.22 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 3.4 tpt -81.52 28.04 0.41 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.549 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.529 HG22 ' N ' ' A' ' 212' ' ' ASP . 12.0 m -87.09 168.94 12.82 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.997 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ASP . . . . . 0.529 ' N ' HG22 ' A' ' 211' ' ' THR . 8.2 m-20 -104.01 -135.99 0.34 Allowed 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.258 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 212' ' ' ASP . 5.6 p-10 44.27 56.97 4.57 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.455 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.431 ' N ' ' CD ' ' A' ' 215' ' ' PRO . 3.8 mt -61.58 -43.53 88.84 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -178.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 214' ' ' LEU . 31.0 Cg_exo -60.97 -33.51 92.22 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 CA-C-O 122.811 1.088 . . . . 0.0 111.02 -178.364 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 77.6 m -64.7 -41.79 95.77 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 112.352 -2.204 . . . . 0.0 110.997 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' HIS . . . . . 0.496 ' O ' ' ND1' ' A' ' 217' ' ' HIS . 1.1 t60 -66.28 -37.52 85.63 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.514 -178.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -63.08 -48.13 79.93 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.199 -178.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 78.8 p -60.82 -38.46 85.53 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 119.79 1.177 . . . . 0.0 110.484 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 64.2 m -59.79 -42.01 92.44 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.529 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.98 -42.29 97.27 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -62.78 -48.14 80.45 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -176.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -61.88 -42.89 99.79 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 108.466 -1.854 . . . . 0.0 108.466 177.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -63.43 -38.64 91.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.112 -1.044 . . . . 0.0 109.183 177.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -62.37 -43.31 99.24 Favored Glycine 0 CA--C 1.521 0.435 0 CA-C-N 114.685 -1.143 . . . . 0.0 111.07 -177.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 226' ' ' PHE . . . . . 0.45 ' O ' ' OG1' ' A' ' 229' ' ' THR . 72.7 t80 -67.48 -39.85 85.24 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 119.274 -0.971 . . . . 0.0 109.849 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 227' ' ' CYS . . . . . 0.529 ' SG ' ' N ' ' A' ' 228' ' ' THR . 1.5 p -64.5 -41.82 96.2 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.766 0.794 . . . . 0.0 109.238 176.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.529 ' N ' ' SG ' ' A' ' 227' ' ' CYS . 91.3 m -62.35 -40.58 96.88 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 114.041 -1.436 . . . . 0.0 111.914 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 226' ' ' PHE . 5.4 p -58.73 -39.99 82.45 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.633 -176.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 58.9 t -61.05 -41.98 91.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 118.423 -1.311 . . . . 0.0 108.449 178.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.538 ' O ' ' HD2' ' A' ' 234' ' ' PRO . 47.8 mt -62.48 -41.41 91.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.485 0.659 . . . . 0.0 110.158 177.053 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.42 ' HB3' ' HA ' ' A' ' 229' ' ' THR . . . -63.06 -39.37 94.53 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 115.891 1.811 . . . . 0.0 115.891 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.444 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 0.1 OUTLIER -57.95 -41.94 92.62 Favored Pre-proline 0 N--CA 1.475 0.809 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -172.512 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.538 ' HD2' ' O ' ' A' ' 231' ' ' ILE . 30.7 Cg_exo -59.77 -41.13 57.65 Favored 'Trans proline' 0 C--N 1.295 -2.259 0 C-N-CA 121.209 1.272 . . . . 0.0 112.894 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -65.69 -37.03 79.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 118.639 -1.224 . . . . 0.0 109.246 177.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -66.01 -41.71 90.64 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.437 ' CG1' ' N ' ' A' ' 238' ' ' VAL . 1.6 p -65.88 -46.41 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -176.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.437 ' N ' ' CG1' ' A' ' 237' ' ' VAL . 9.9 p -64.17 -38.13 81.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.971 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp -61.18 -44.33 97.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.968 0.413 . . . . 0.0 111.477 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 9.2 m -61.37 -41.97 97.95 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.473 ' O ' ' HB2' ' A' ' 242' ' ' TYR . 5.6 ptm180 -50.26 145.81 5.75 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.576 -178.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.65 ' CG ' ' N ' ' A' ' 243' ' ' MET . 42.8 t80 160.91 -178.49 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 O-C-N 124.807 1.317 . . . . 0.0 109.383 -179.051 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 243' ' ' MET . . . . . 0.65 ' N ' ' CG ' ' A' ' 242' ' ' TYR . 4.7 ttt 32.28 102.23 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 O-C-N 123.242 0.339 . . . . 0.0 111.675 179.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 244' ' ' ASN . . . . . 0.443 ' O ' ' O ' ' A' ' 245' ' ' SER . 13.4 t-20 -179.59 131.77 0.11 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.874 0.369 . . . . 0.0 111.601 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 245' ' ' SER . . . . . 0.443 ' O ' ' O ' ' A' ' 244' ' ' ASN . 3.8 m 55.24 162.57 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.447 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -175.73 67.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.789 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 68.6 mt -101.99 -87.17 0.41 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.795 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.416 ' O ' ' C ' ' A' ' 249' ' ' GLN . . . -152.26 -146.42 4.35 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.416 ' C ' ' O ' ' A' ' 248' ' ' GLY . 0.0 OUTLIER 32.54 -145.0 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 122.277 0.231 . . . . 0.0 111.137 -179.744 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.647 ' CG ' ' O ' ' A' ' 250' ' ' TYR . 0.1 OUTLIER 54.15 75.06 0.3 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 120.686 -0.406 . . . . 0.0 109.949 179.268 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -67.42 -53.85 25.48 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 117.346 -1.742 . . . . 0.0 112.269 -178.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 39.2 m -148.82 -173.35 4.33 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.0 0.92 . . . . 0.0 109.338 -178.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -59.96 -43.8 94.84 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 178.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -55.8 -34.86 61.66 Favored Glycine 0 N--CA 1.464 0.521 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 -174.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -53.5 -36.57 61.85 Favored 'General case' 0 C--O 1.214 -0.777 0 C-N-CA 117.781 -1.567 . . . . 0.0 110.965 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' CYS . . . . . . . . . . . . . 43.0 t -61.31 -44.67 96.81 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.535 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -60.12 -45.91 91.41 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.405 -0.518 . . . . 0.0 112.261 -177.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.444 ' CD2' ' N ' ' A' ' 258' ' ' LEU . 3.6 mm? -67.58 -44.3 78.49 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 119.395 -0.922 . . . . 0.0 111.2 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 29.7 p -64.18 -47.92 77.93 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -178.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' MET . . . . . . . . . . . . . 10.1 ptm -62.78 -44.13 96.99 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -178.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.508 HD13 ' O ' ' A' ' 261' ' ' LEU . 0.2 OUTLIER -62.23 -47.01 86.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.858 0.361 . . . . 0.0 110.041 -178.972 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -66.49 -53.69 32.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.547 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 54.1 mttp -80.57 -124.92 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -48.92 117.21 1.97 Allowed 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.454 ' C ' ' H ' ' A' ' 267' ' ' ARG . . . -47.94 175.67 0.02 OUTLIER Glycine 0 CA--C 1.53 1.029 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 179.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.6 0.73 0.69 Allowed 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 122.237 1.958 . . . . 0.0 111.87 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.454 ' H ' ' C ' ' A' ' 265' ' ' GLY . 77.4 mtt85 -68.79 -25.92 64.94 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.195 0.598 . . . . 0.0 111.875 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -57.82 -31.97 67.14 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.127 -178.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -62.07 -42.13 98.88 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.1 0.476 . . . . 0.0 110.78 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -66.39 -38.09 86.73 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -177.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.47 ' CG ' ' N ' ' A' ' 272' ' ' GLY . 53.2 tttp -80.85 173.08 12.96 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 272' ' ' GLY . . . . . 0.47 ' N ' ' CG ' ' A' ' 271' ' ' LYS . . . 62.38 100.37 0.01 OUTLIER Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -173.85 5.67 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.53 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 274' ' ' MET . . . . . 0.578 ' N ' ' CD ' ' A' ' 275' ' ' PRO . 0.7 OUTLIER -64.03 -44.21 77.27 Favored Pre-proline 0 CA--C 1.531 0.229 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.04 -179.879 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 275' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 274' ' ' MET . 21.5 Cg_exo -64.38 -46.46 7.51 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.516 2.144 . . . . 0.0 111.253 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 20.0 m -60.41 -39.44 87.41 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.25 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -61.48 -42.59 99.02 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 122.583 1.182 . . . . 0.0 112.737 -178.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.514 HD13 ' O ' ' A' ' 278' ' ' LEU . 0.2 OUTLIER -61.96 -38.76 89.71 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 112.262 -2.244 . . . . 0.0 107.778 174.501 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 41.7 mmm-85 -62.68 -39.32 93.58 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.32 0.581 . . . . 0.0 110.511 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.66 -36.23 80.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.13 -0.941 . . . . 0.0 113.011 -177.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -67.75 -50.73 40.04 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -178.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 47.8 p -62.74 -43.94 97.5 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 283' ' ' TRP . . . . . . . . . . . . . 75.3 t90 -59.9 -37.94 80.85 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.524 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.56 -37.82 85.21 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 94.6 t -59.76 -38.3 75.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.576 -0.283 . . . . 0.0 110.397 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.438 ' O ' HG12 ' A' ' 289' ' ' VAL . 10.8 t -62.58 -41.07 90.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.845 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -61.36 -39.25 89.92 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.22 0.533 . . . . 0.0 110.378 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -59.5 -41.05 88.99 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -178.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.438 HG12 ' O ' ' A' ' 286' ' ' VAL . 0.7 OUTLIER -61.36 -40.14 85.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -175.914 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.21 -39.41 94.55 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -60.48 -38.5 84.47 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 176.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 32.9 tp10 -57.94 -40.27 80.11 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 118.157 -1.417 . . . . 0.0 109.417 -176.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 293' ' ' GLN . . . . . 0.435 ' OE1' ' O ' ' A' ' 289' ' ' VAL . 5.2 mp0 -60.35 -42.23 95.3 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 122.827 1.299 . . . . 0.0 110.032 179.018 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 78.4 mt -60.27 -39.26 86.19 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 112.268 -2.242 . . . . 0.0 109.564 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -62.3 -45.2 94.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.582 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 296' ' ' ARG . . . . . 0.433 ' O ' ' O ' ' A' ' 293' ' ' GLN . 9.0 tpm_? -122.44 116.07 23.34 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -114.22 -163.84 0.89 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.223 0.535 . . . . 0.0 112.113 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 20.1 tp -72.22 114.4 10.29 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 176.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 41.7 ttp -95.93 61.9 2.2 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.527 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.75 101.04 0.07 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.937 0.875 . . . . 0.0 111.071 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -63.94 -46.05 86.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 113.814 -1.539 . . . . 0.0 113.293 -176.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -58.14 -38.9 77.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.739 -177.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 45.3 tp60 -63.75 -46.49 85.09 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.423 -178.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 304' ' ' SER . . . . . 0.438 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 3.4 t -66.0 -37.56 86.23 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.105 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -61.78 -42.94 99.63 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.97 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 11.7 tm-20 -64.94 -37.03 86.29 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -177.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 307' ' ' ALA . . . . . 0.535 ' HB3' ' HD3' ' A' ' 308' ' ' PRO . . . -60.07 -52.87 70.38 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -176.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 308' ' ' PRO . . . . . 0.535 ' HD3' ' HB3' ' A' ' 307' ' ' ALA . 73.7 Cg_endo -75.4 0.49 9.01 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.166 1.911 . . . . 0.0 112.157 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.588 -179.852 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 10.3 ptt? . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.562 ' O ' HD13 ' A' ' 298' ' ' LEU . 69.9 m -153.25 99.11 2.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.789 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.83 HG22 ' H ' ' A' ' 16' ' ' LYS . 10.8 p -88.32 -178.6 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.28 -178.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.83 ' H ' HG22 ' A' ' 15' ' ' VAL . 12.6 mptt -63.96 -40.88 97.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.99 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -63.54 -41.26 98.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.79 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.476 ' H ' HG13 ' A' ' 15' ' ' VAL . 55.0 tp -79.96 -26.61 39.95 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.804 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.56 -41.53 94.05 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 107.215 -2.354 . . . . 0.0 107.215 176.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.18 -31.78 68.06 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 124.917 2.294 . . . . 0.0 107.286 176.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.45 -42.78 98.92 Favored Glycine 0 CA--C 1.527 0.825 1 CA-C-N 108.32 -4.037 . . . . 0.0 108.234 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 28.9 p -70.65 -28.01 64.49 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.529 0.681 . . . . 0.0 109.345 177.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.412 ' HB2' ' OE1' ' A' ' 293' ' ' GLN . . . -66.2 -50.16 64.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.866 -178.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.443 ' O ' ' OD2' ' A' ' 28' ' ' ASP . . . -62.04 -35.74 79.49 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 118.404 -1.318 . . . . 0.0 111.322 -177.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.638 ' SG ' ' N ' ' A' ' 26' ' ' ILE . 5.4 p -64.1 -53.48 48.93 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.538 -179.053 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.638 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 11.2 tp -65.59 -39.79 86.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -177.135 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.02 -41.78 97.32 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 119.775 -0.77 . . . . 0.0 112.967 -173.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.484 ' CG ' ' NE2' ' A' ' 89' ' ' GLN . 1.7 p30 -77.64 -27.14 50.95 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 118.329 -1.348 . . . . 0.0 109.636 -176.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 10.9 tp -60.16 -55.92 27.95 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 119.65 1.114 . . . . 0.0 111.929 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.8 tt -75.58 -4.63 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-O 121.382 0.61 . . . . 0.0 112.274 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.444 HG22 ' O ' ' A' ' 31' ' ' THR . 53.5 m -109.41 -16.72 13.95 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.013 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.485 ' N ' ' HD2' ' A' ' 33' ' ' PRO . 84.2 t80 -68.46 -45.89 36.72 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 121.879 2.127 . . . . 0.0 112.011 -177.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 32' ' ' PHE . 27.7 Cg_endo -60.35 -16.1 39.28 Favored 'Trans proline' 0 N--CA 1.5 1.862 0 CA-C-N 121.27 1.489 . . . . 0.0 112.858 177.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.643 HD13 ' OG ' ' A' ' 282' ' ' SER . 80.5 mt -67.08 -35.18 79.25 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.518 0.932 . . . . 0.0 113.518 -177.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -64.45 -40.07 95.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.236 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.8 m -58.33 -35.0 71.24 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.922 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.65 -37.92 83.1 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.124 -0.63 . . . . 0.0 111.615 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -61.4 -49.09 78.31 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.631 -176.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -63.28 -39.09 83.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 119.193 0.906 . . . . 0.0 112.248 -177.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.503 ' O ' ' N ' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -60.36 -40.7 91.7 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.698 -179.485 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.82 39.02 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.946 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.503 ' N ' ' O ' ' A' ' 40' ' ' ARG . 21.3 pt20 -81.11 147.11 30.24 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.748 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 14.7 mt -82.67 53.19 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.987 0.422 . . . . 0.0 110.246 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 45.01 74.83 0.12 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.742 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.52 59.95 0.31 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.405 ' O ' ' OG ' ' A' ' 47' ' ' SER . 28.3 tp10 -71.21 -7.18 45.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.836 0.35 . . . . 0.0 110.388 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' A' ' 46' ' ' GLU . 23.8 p 57.47 50.02 11.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.492 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -143.77 -18.43 0.6 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.674 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.15 -10.15 74.13 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.0 tp -65.28 -38.11 89.25 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.691 0.281 . . . . 0.0 111.554 -178.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.554 HG23 ' N ' ' A' ' 52' ' ' ARG . 14.7 m -60.88 -44.81 98.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.495 -178.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.554 ' N ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -64.92 -33.43 76.02 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.208 -179.644 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 79.7 m -67.77 -38.23 83.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.969 0.414 . . . . 0.0 110.522 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -86.82 -153.84 0.22 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.77 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -162.42 -53.38 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.89 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.639 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 8.4 t -128.32 -139.1 0.24 Allowed 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.639 ' HB3' ' O ' ' A' ' 56' ' ' SER . . . 93.82 14.63 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.659 0.6 . . . . 0.0 111.592 178.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.437 ' OE1' ' NH2' ' A' ' 40' ' ' ARG . 16.7 pt20 175.89 122.74 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.946 0.403 . . . . 0.0 109.915 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -105.83 159.46 15.99 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.402 ' O ' ' C ' ' A' ' 61' ' ' GLY . 36.2 ptt180 -43.44 -32.35 0.86 Allowed 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.505 -0.478 . . . . 0.0 109.808 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 60' ' ' ARG . . . -31.37 102.75 0.01 OUTLIER Glycine 0 CA--C 1.526 0.733 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.01 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.7 p -67.08 -33.71 64.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 118.232 -0.889 . . . . 0.0 109.639 176.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -60.32 -32.63 71.42 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 121.442 1.928 . . . . 0.0 110.288 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.49 -49.0 67.54 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-N 115.377 -0.829 . . . . 0.0 114.352 -176.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 14.1 m -61.73 -46.02 91.44 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.201 -0.5 . . . . 0.0 112.057 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 72.1 mt -59.09 -36.23 61.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 74.4 mt -63.63 -34.97 79.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 120.439 1.472 . . . . 0.0 112.602 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.416 ' O ' ' OG1' ' A' ' 72' ' ' THR . 98.9 m -63.47 -41.59 98.6 Favored 'General case' 0 C--O 1.254 1.308 0 C-N-CA 125.433 1.493 . . . . 0.0 110.983 -174.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 6.5 ptp -60.36 -38.92 85.39 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 120.018 -1.676 . . . . 0.0 113.842 -176.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.3 m -68.55 -40.77 82.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 119.025 -1.07 . . . . 0.0 113.627 -176.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 61.5 ttp85 -77.92 -13.55 59.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 122.028 0.918 . . . . 0.0 112.305 -178.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.416 ' OG1' ' O ' ' A' ' 68' ' ' THR . 70.4 m -62.92 -55.05 29.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.335 -1.302 . . . . 0.0 111.775 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -108.68 -58.22 2.04 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.794 178.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.32 164.62 13.58 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -56.59 -35.16 96.87 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 121.966 1.777 . . . . 0.0 111.775 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.465 ' O ' ' OD1' ' A' ' 80' ' ' ASN . 96.5 mtt180 -60.93 -11.19 7.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.928 0.87 . . . . 0.0 110.925 176.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.505 ' O ' ' OD1' ' A' ' 80' ' ' ASN . 7.4 t -77.64 -32.21 53.23 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 113.275 -1.784 . . . . 0.0 110.265 -178.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.9 mp -75.54 -29.34 59.37 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.224 1.01 . . . . 0.0 111.59 177.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -87.4 -2.62 58.75 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 122.896 1.331 . . . . 0.0 113.417 -172.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.505 ' OD1' ' O ' ' A' ' 77' ' ' SER . 11.9 p-10 -117.67 135.14 54.21 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 112.104 -2.316 . . . . 0.0 108.207 176.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.8 -25.9 25.89 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 -177.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.425 ' HG ' ' N ' ' A' ' 83' ' ' VAL . 0.5 OUTLIER -59.14 -34.44 72.06 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 113.834 -1.183 . . . . 0.0 110.283 -179.661 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.425 ' N ' ' HG ' ' A' ' 82' ' ' LEU . 10.6 p -70.83 -27.12 29.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.917 178.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.88 -31.86 61.7 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.408 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.8 -40.13 89.74 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 119.984 -1.103 . . . . 0.0 111.205 -177.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 86.2 mt -62.55 -40.25 96.21 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 122.285 1.04 . . . . 0.0 112.871 -176.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -60.67 -27.5 67.88 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 113.149 -1.841 . . . . 0.0 109.865 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 14.9 mmt85 -57.93 -53.32 59.54 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 173.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.484 ' NE2' ' CG ' ' A' ' 28' ' ' ASP . 60.7 mt-30 -66.83 -29.74 69.74 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 112.418 -2.174 . . . . 0.0 111.776 -177.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 33.9 ttm -61.37 -40.89 95.97 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.067 -0.97 . . . . 0.0 112.429 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.9 m -74.59 -34.65 62.91 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.453 -176.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -57.63 -43.67 84.99 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 120.794 1.633 . . . . 0.0 112.123 -176.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.47 -32.6 64.42 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 119.602 -0.839 . . . . 0.0 111.228 -178.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 38.7 t -64.11 -41.57 97.21 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.401 ' C ' ' H ' ' A' ' 97' ' ' ILE . 30.6 m -67.8 -27.94 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.005 177.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.473 ' CG ' ' O ' ' A' ' 96' ' ' ARG . 6.7 ttt85 -77.61 9.28 3.49 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -176.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.524 HD13 ' O ' ' A' ' 97' ' ' ILE . 0.3 OUTLIER -87.02 -15.95 9.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 176.538 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -140.49 -48.46 0.05 OUTLIER Glycine 0 CA--C 1.544 1.891 0 N-CA-C 115.569 0.987 . . . . 0.0 115.569 -177.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 14.9 mt -71.17 -13.12 61.83 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.2 1.5 . . . . 0.0 112.644 -177.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.494 ' O ' ' HB2' ' A' ' 104' ' ' LYS . 1.9 m-85 -81.0 -50.34 9.81 Favored 'General case' 0 C--O 1.214 -0.785 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.008 178.056 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.773 ' OD2' ' OE1' ' A' ' 105' ' ' GLN . 19.4 t70 -68.55 -31.82 71.31 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 114.059 -1.428 . . . . 0.0 110.12 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.0 t -69.33 -53.16 21.01 Favored 'General case' 0 CA--C 1.554 1.107 0 CA-C-N 112.203 -2.272 . . . . 0.0 114.544 177.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.1 t -74.9 -27.64 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 CA-C-N 122.487 2.403 . . . . 0.0 113.437 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 100' ' ' TYR . 13.4 tttp -70.16 -40.99 74.41 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 112.004 -2.362 . . . . 0.0 111.548 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.773 ' OE1' ' OD2' ' A' ' 101' ' ' ASP . 27.2 mt-30 -79.62 -13.17 59.69 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.742 0.782 . . . . 0.0 111.071 -178.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -78.79 -22.92 45.58 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.876 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 6.4 m-30 -109.04 -30.11 8.23 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 119.341 0.973 . . . . 0.0 112.068 -174.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.2 m -97.49 9.25 42.91 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 117.926 -1.509 . . . . 0.0 113.233 -178.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.466 ' O ' ' C ' ' A' ' 110' ' ' GLY . 18.7 mmtt -52.77 121.51 7.37 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-N 119.025 0.83 . . . . 0.0 111.715 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.517 ' O ' ' CB ' ' A' ' 111' ' ' SER . . . -22.91 -82.35 0.01 OUTLIER Glycine 0 N--CA 1.485 1.91 0 CA-C-N 118.665 0.666 . . . . 0.0 113.171 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.517 ' CB ' ' O ' ' A' ' 110' ' ' GLY . 1.4 m 96.53 -90.26 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 178.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.513 ' O ' ' CG ' ' A' ' 113' ' ' HIS . 0.3 OUTLIER 168.83 -35.75 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 120.725 1.602 . . . . 0.0 114.215 179.308 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.647 ' O ' ' HB2' ' A' ' 114' ' ' ALA . 1.1 p-80 155.61 46.07 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 121.103 0.477 . . . . 0.0 110.841 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.647 ' HB2' ' O ' ' A' ' 113' ' ' HIS . . . 159.91 -162.9 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.15 15.25 26.4 Favored Glycine 0 C--N 1.337 0.587 0 CA-C-N 114.114 -1.403 . . . . 0.0 111.2 178.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.549 HD13 HH21 ' A' ' 119' ' ' ARG . 31.6 mm -60.66 -41.07 86.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 C-N-CA 120.065 -0.654 . . . . 0.0 109.278 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.54 -40.12 95.94 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 121.91 0.728 . . . . 0.0 111.858 175.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 35.6 t -57.78 -41.81 82.79 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 177.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.549 HH21 HD13 ' A' ' 116' ' ' ILE . 9.5 ttm-85 -63.23 -36.78 84.78 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.984 -177.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 58.5 mt -63.73 -46.33 85.84 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.255 0.55 . . . . 0.0 109.805 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 41.5 mt -66.65 -44.77 81.02 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 119.112 -1.035 . . . . 0.0 110.459 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.69 -44.83 92.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 119.625 1.102 . . . . 0.0 109.932 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -65.73 -44.2 92.79 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 119.801 -1.19 . . . . 0.0 111.126 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 77.9 p -64.5 -44.44 90.96 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.829 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 97.2 m -69.47 -48.4 60.86 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 119.453 -0.899 . . . . 0.0 111.916 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.493 HG23 ' N ' ' A' ' 127' ' ' GLY . 6.2 t -65.26 -42.41 93.3 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -174.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.493 ' N ' HG23 ' A' ' 126' ' ' THR . . . -64.07 -44.78 95.33 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-O 122.704 1.169 . . . . 0.0 113.518 -177.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.448 ' O ' HG22 ' A' ' 131' ' ' VAL . . . -61.58 -41.62 97.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 112.358 -1.921 . . . . 0.0 107.141 177.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.68 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 1.8 mm? -64.66 -42.08 95.65 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.725 178.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.22 -39.94 96.05 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -177.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.524 ' O ' ' NE2' ' A' ' 135' ' ' GLN . 15.3 m -61.27 -25.75 37.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 123.005 1.383 . . . . 0.0 109.902 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.68 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . -58.31 -44.93 88.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 111.906 -2.406 . . . . 0.0 112.621 -178.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.493 HG13 ' N ' ' A' ' 134' ' ' ALA . 3.5 p -78.95 -48.72 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 C-N-CA 120.712 -0.395 . . . . 0.0 112.006 -178.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.493 ' N ' HG13 ' A' ' 133' ' ' VAL . . . -122.95 135.92 54.67 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.994 0.426 . . . . 0.0 111.575 -178.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.787 ' H ' ' CD ' ' A' ' 136' ' ' PRO . 24.4 pt20 177.99 -24.61 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.703 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.717 178.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.787 ' CD ' ' H ' ' A' ' 135' ' ' GLN . 52.9 Cg_exo -53.14 -33.42 63.99 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 121.437 1.425 . . . . 0.0 112.691 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.494 HG23 ' N ' ' A' ' 138' ' ' ASP . 11.1 t -66.54 -41.76 88.21 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 119.234 -0.986 . . . . 0.0 109.523 -178.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.494 ' N ' HG23 ' A' ' 137' ' ' THR . 4.5 m-20 -64.93 -42.59 94.56 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 117.876 -1.53 . . . . 0.0 111.566 -178.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 15.1 t -64.64 -44.9 96.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.0 p -65.38 -37.08 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -178.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.44 ' O ' ' OE1' ' A' ' 145' ' ' GLN . 14.0 mptt -60.42 -40.2 90.19 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.713 -176.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 70.5 t -68.54 -44.52 82.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.523 ' NH2' ' O ' ' A' ' 174' ' ' GLY . 65.6 mtt-85 -64.34 -36.09 83.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.066 178.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.414 ' CD1' ' C ' ' A' ' 144' ' ' PHE . 36.0 t80 -66.46 -41.56 88.85 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -177.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.44 ' OE1' ' O ' ' A' ' 141' ' ' LYS . 4.8 mp0 -64.83 -39.5 93.68 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 118.941 -1.104 . . . . 0.0 108.087 178.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.39 -34.59 78.66 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -60.54 110.3 1.24 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 175.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.468 ' C ' ' H ' ' A' ' 150' ' ' ALA . . . -106.1 -55.18 2.36 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 -175.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -77.24 21.47 0.24 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 122.327 2.33 . . . . 0.0 110.417 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.468 ' H ' ' C ' ' A' ' 148' ' ' ALA . . . 51.24 -94.72 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.659 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -162.78 -37.91 0.02 OUTLIER Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 55.85 -133.96 50.04 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 65.13 28.2 73.25 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 53.1 ttt85 61.74 54.9 2.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.833 0.349 . . . . 0.0 110.409 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -170.1 143.95 2.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.625 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -87.71 109.49 19.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.467 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -71.54 164.8 25.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.455 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.441 ' OG ' ' N ' ' A' ' 159' ' ' THR . 29.7 t -156.94 -177.94 7.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.878 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.441 ' N ' ' OG ' ' A' ' 158' ' ' SER . 69.5 p -63.79 -45.96 87.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.65 -177.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 77.0 t -64.04 -45.37 96.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 119.067 -1.053 . . . . 0.0 109.165 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -66.89 -38.44 86.29 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.527 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.575 ' O ' HD12 ' A' ' 166' ' ' ILE . . . -61.33 -44.27 97.48 Favored 'General case' 0 C--O 1.211 -0.969 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -177.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.436 ' O ' HD11 ' A' ' 166' ' ' ILE . 32.3 t80 -61.32 -47.85 84.04 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.67 0.747 . . . . 0.0 112.151 -177.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 17.8 tptp -68.19 -45.33 73.69 Favored 'General case' 0 CA--C 1.554 1.129 0 N-CA-C 117.841 2.534 . . . . 0.0 117.841 -172.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 17.6 m -63.1 -45.48 91.86 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 117.344 2.35 . . . . 0.0 117.344 -174.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.73 HD13 ' H ' ' A' ' 166' ' ' ILE . 0.1 OUTLIER -64.62 -37.36 79.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-O 121.524 0.678 . . . . 0.0 109.271 176.925 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.18 -37.02 76.38 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 176.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -62.57 -50.32 71.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 122.992 2.633 . . . . 0.0 111.465 -177.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -75.15 -51.24 13.91 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 123.539 0.736 . . . . 0.0 109.409 177.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -78.27 -36.8 46.32 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 115.775 1.768 . . . . 0.0 115.775 -174.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 93.71 -168.44 29.12 Favored Glycine 0 N--CA 1.468 0.788 0 CA-C-N 118.472 0.578 . . . . 0.0 112.615 177.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.6 mt -73.56 -41.62 55.78 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.067 0 CA-C-O 122.252 1.025 . . . . 0.0 110.62 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 60.5 ttt85 -58.31 -32.77 68.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 113.448 -1.706 . . . . 0.0 111.027 -176.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.523 ' O ' ' NH2' ' A' ' 143' ' ' ARG . . . -59.83 -39.37 95.33 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 119.292 -1.432 . . . . 0.0 109.579 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.403 HD22 ' OH ' ' A' ' 163' ' ' TYR . 5.5 tp -69.44 -33.39 72.88 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 117.085 2.254 . . . . 0.0 117.085 -177.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 67.3 m95 -77.58 -7.46 56.37 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 111.254 -2.703 . . . . 0.0 109.843 -177.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -43.28 -48.02 6.66 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.556 -177.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -111.24 -29.61 3.41 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.065 0.84 . . . . 0.0 112.046 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 3.9 m -46.26 -52.14 13.15 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.31 -49.75 77.83 Favored Pre-proline 0 N--CA 1.481 1.118 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -177.083 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -62.2 -27.87 78.88 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 121.973 1.782 . . . . 0.0 111.766 175.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -63.41 -39.04 93.44 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 178.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.422 HG13 HG21 ' A' ' 131' ' ' VAL . 97.0 t -63.21 -42.0 94.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.251 178.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.53 -39.21 90.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.237 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.53 -41.52 94.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.035 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -60.97 -42.38 98.22 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.265 0.555 . . . . 0.0 110.051 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.68 -43.1 97.64 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.166 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 5.6 mm -63.14 -44.78 99.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -177.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.401 ' O ' ' CD ' ' A' ' 193' ' ' GLU . 6.9 m -59.69 -45.7 94.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 120.328 -0.549 . . . . 0.0 111.472 -178.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.5 ' OD1' ' N ' ' A' ' 191' ' ' CYS . 2.0 p30 -61.84 -42.52 99.13 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 122.259 1.028 . . . . 0.0 108.91 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' CYS . . . . . 0.5 ' N ' ' OD1' ' A' ' 190' ' ' ASN . 52.2 t -62.15 -46.56 88.44 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 113.294 -1.775 . . . . 0.0 110.922 179.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.35 -40.61 96.2 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 114.296 -1.32 . . . . 0.0 109.529 176.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 0.515 ' OE1' ' N ' ' A' ' 193' ' ' GLU . 0.0 OUTLIER -61.52 -45.4 94.37 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.768 -178.701 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 4.1 tt -64.01 -39.52 94.3 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 118.331 -1.348 . . . . 0.0 110.18 -174.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 8.2 m -64.59 -45.86 94.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 116.909 -1.916 . . . . 0.0 107.775 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 98.4 m -64.16 -46.33 84.53 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -177.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -57.92 -40.11 79.61 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -178.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -56.48 -44.98 81.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.573 0.701 . . . . 0.0 109.317 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.515 ' CD2' ' N ' ' A' ' 199' ' ' LEU . 1.5 mm? -61.92 -39.89 93.6 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.51 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 45.6 mm -64.03 -43.54 97.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 118.575 -0.726 . . . . 0.0 112.893 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -59.63 -40.95 89.29 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 120.588 1.54 . . . . 0.0 110.839 178.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -66.22 -38.46 88.01 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 112.939 -1.937 . . . . 0.0 111.027 -177.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 43.8 m -102.26 130.3 48.91 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.367 -0.833 . . . . 0.0 112.446 -178.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 20.9 mt 68.08 5.58 4.7 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 114.777 -1.101 . . . . 0.0 113.402 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.403 ' CD2' ' O ' ' A' ' 205' ' ' LEU . 2.3 tt -137.37 49.58 2.0 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 178.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 4.3 tppt? -74.11 -23.55 59.33 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.718 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.483 ' O ' ' CB ' ' A' ' 208' ' ' ASN . . . -130.04 -40.22 1.34 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.776 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' ASN . . . . . 0.626 ' O ' ' N ' ' A' ' 210' ' ' MET . 41.2 p-10 130.34 76.1 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.247 1.419 . . . . 0.0 108.007 -178.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 3.1 tp 2.07 38.87 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 118.276 2.695 . . . . 0.0 118.276 178.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' MET . . . . . 0.626 ' N ' ' O ' ' A' ' 208' ' ' ASN . 41.6 ttp -78.17 -56.82 4.16 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 120.583 1.538 . . . . 0.0 112.282 -178.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.403 ' C ' ' O ' ' A' ' 210' ' ' MET . 44.3 p -34.44 126.41 0.48 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.941 0.401 . . . . 0.0 111.88 -179.046 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -60.86 114.84 3.27 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.733 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.491 ' OD1' ' SG ' ' A' ' 216' ' ' CYS . 32.9 t70 -174.17 30.58 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -61.31 -43.72 90.68 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -177.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -60.86 -34.07 91.8 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 CA-C-N 120.778 1.313 . . . . 0.0 111.514 -177.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' CYS . . . . . 0.491 ' SG ' ' OD1' ' A' ' 213' ' ' ASP . 62.4 m -66.56 -42.69 86.69 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 113.089 -1.869 . . . . 0.0 111.862 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 13.2 t-160 -66.59 -37.54 85.12 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.081 -1.418 . . . . 0.0 114.425 -176.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -62.92 -48.33 79.39 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 118.775 -0.631 . . . . 0.0 110.775 -178.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 12.9 m -61.26 -39.09 89.07 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 120.028 1.285 . . . . 0.0 110.013 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 39.5 t -59.97 -41.71 92.56 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 177.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.564 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.53 -41.79 98.45 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -177.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -61.55 -46.86 88.13 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 122.162 0.982 . . . . 0.0 112.822 -175.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -60.88 -42.11 99.51 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 107.458 -2.257 . . . . 0.0 107.458 176.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' ALA . . . . . 0.913 ' O ' HG23 ' A' ' 228' ' ' THR . . . -63.03 -37.21 86.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 113.869 -1.166 . . . . 0.0 108.934 176.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -61.06 -42.51 99.82 Favored Glycine 0 CA--C 1.52 0.383 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.626 -176.231 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' PHE . . . . . 0.419 ' O ' ' OG1' ' A' ' 229' ' ' THR . 67.3 t80 -66.88 -38.87 87.11 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 118.782 -1.167 . . . . 0.0 108.4 178.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' CYS . . . . . 0.511 ' SG ' ' O ' ' A' ' 224' ' ' ALA . 0.5 OUTLIER -63.89 -41.18 97.79 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.165 0.507 . . . . 0.0 110.251 177.445 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.913 HG23 ' O ' ' A' ' 224' ' ' ALA . 78.5 p -61.58 -40.3 94.28 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.465 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 226' ' ' PHE . 23.8 p -59.34 -40.26 85.77 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 119.802 -0.759 . . . . 0.0 111.567 -176.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 92.7 t -61.47 -43.17 96.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 118.588 -1.245 . . . . 0.0 111.919 -178.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 3.4 tp -63.08 -40.86 90.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 121.711 0.767 . . . . 0.0 109.148 176.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.418 ' O ' HG12 ' A' ' 235' ' ' VAL . . . -62.58 -39.39 93.56 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 114.331 -1.304 . . . . 0.0 113.924 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.509 ' N ' ' HD2' ' A' ' 234' ' ' PRO . 8.0 t -58.34 -42.39 94.49 Favored Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 116.04 1.867 . . . . 0.0 116.04 -174.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 233' ' ' SER . 17.9 Cg_endo -58.93 -40.9 67.34 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 CA-C-N 121.352 1.519 . . . . 0.0 113.457 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.418 HG12 ' O ' ' A' ' 232' ' ' ALA . 2.8 p -65.52 -37.63 80.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 118.357 -1.337 . . . . 0.0 110.914 178.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -66.42 -42.0 88.4 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 15.6 m -65.59 -45.66 91.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -176.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 12.9 p -63.74 -38.49 82.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 119.116 -1.034 . . . . 0.0 112.047 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -61.57 -45.91 92.11 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 119.94 -0.704 . . . . 0.0 112.591 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' THR . . . . . 0.419 ' O ' ' C ' ' A' ' 241' ' ' ARG . 1.6 t -62.5 -41.69 98.99 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 120.97 0.414 . . . . 0.0 110.864 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.419 ' C ' ' O ' ' A' ' 240' ' ' THR . 29.8 ttp180 -29.38 134.92 0.04 OUTLIER 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.328 -178.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -159.14 -76.53 0.07 Allowed 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' MET . . . . . . . . . . . . . 31.6 mmm -42.17 122.12 2.06 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.875 0.845 . . . . 0.0 112.281 -178.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' ASN . . . . . 0.975 ' ND2' ' SG ' ' A' ' 256' ' ' CYS . 0.4 OUTLIER -171.46 118.04 0.44 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.32 179.476 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 245' ' ' SER . . . . . 0.686 ' O ' ' HB2' ' A' ' 246' ' ' ALA . 15.9 m 63.44 -123.86 0.57 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.086 -177.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 246' ' ' ALA . . . . . 0.686 ' HB2' ' O ' ' A' ' 245' ' ' SER . . . 153.45 -97.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.295 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.456 ' N ' HD22 ' A' ' 247' ' ' LEU . 2.3 mm? -57.97 -161.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.85 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 1.065 ' O ' ' N ' ' A' ' 250' ' ' TYR . . . 73.04 -162.63 54.82 Favored Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 111.695 -0.562 . . . . 0.0 111.695 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.523 ' O ' ' C ' ' A' ' 250' ' ' TYR . 96.2 mm-40 -33.75 61.31 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.816 0.341 . . . . 0.0 110.773 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 1.065 ' N ' ' O ' ' A' ' 248' ' ' GLY . 66.9 t80 -26.8 -68.17 0.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.711 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 251' ' ' HIS . . . . . 0.572 ' ND1' ' NE2' ' A' ' 255' ' ' HIS . 32.5 m170 39.25 -92.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.866 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 252' ' ' SER . . . . . 0.485 ' N ' ' O ' ' A' ' 250' ' ' TYR . 23.9 m -149.52 140.11 22.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.121 -179.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.499 ' O ' ' SG ' ' A' ' 256' ' ' CYS . . . -32.73 -44.9 0.11 Allowed 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -66.24 -40.92 94.97 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.803 178.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' HIS . . . . . 0.572 ' NE2' ' ND1' ' A' ' 251' ' ' HIS . 86.4 t60 -62.92 -33.08 74.57 Favored 'General case' 0 C--N 1.367 1.332 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.033 -176.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 256' ' ' CYS . . . . . 0.975 ' SG ' ' ND2' ' A' ' 244' ' ' ASN . 3.8 p -60.46 -42.63 96.6 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.657 ' HB2' ' OD1' ' A' ' 244' ' ' ASN . . . -58.81 -43.45 90.56 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.161 -179.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.523 HD13 ' O ' ' A' ' 258' ' ' LEU . 0.3 OUTLIER -65.01 -42.91 94.0 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.558 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 259' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' A' ' 256' ' ' CYS . 67.0 p -62.29 -43.59 98.48 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.634 0.73 . . . . 0.0 109.222 177.046 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 260' ' ' MET . . . . . 0.468 ' HB2' ' OG ' ' A' ' 245' ' ' SER . 39.1 ttp -58.71 -41.6 86.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.625 -1.17 . . . . 0.0 110.066 -179.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 15.3 tp -61.06 -45.86 93.02 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.745 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 40.5 ttt-85 -65.77 -54.07 32.05 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 120.434 -0.506 . . . . 0.0 112.029 -177.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 3.4 pttt -75.34 -52.99 9.49 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 119.877 -0.729 . . . . 0.0 111.46 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 264' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' A' ' 265' ' ' GLY . 22.9 mt-10 -84.36 112.55 20.43 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.356 -179.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 264' ' ' GLU . . . -39.65 170.51 0.01 OUTLIER Glycine 0 CA--C 1.532 1.097 0 CA-C-N 115.718 -0.673 . . . . 0.0 112.564 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.3 -2.36 5.83 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.492 2.128 . . . . 0.0 112.515 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.77 -26.42 64.28 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -58.37 -32.5 68.63 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.241 -178.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -62.5 -41.46 98.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.4 0.619 . . . . 0.0 110.96 177.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -65.86 -37.18 85.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.338 -178.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.78 164.04 13.85 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.076 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 60.45 106.16 0.01 OUTLIER Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -174.68 12.32 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.441 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 274' ' ' MET . . . . . 0.478 ' N ' ' HD2' ' A' ' 275' ' ' PRO . 17.1 mtt -63.84 -44.93 80.91 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 275' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 274' ' ' MET . 38.0 Cg_endo -64.93 -47.39 4.97 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 CA-C-N 120.586 1.245 . . . . 0.0 112.436 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 89.7 p -61.32 -40.57 94.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.754 0.787 . . . . 0.0 109.926 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -62.05 -41.85 98.56 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 123.597 1.665 . . . . 0.0 112.264 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 29.4 mt -62.0 -38.5 88.87 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 110.272 -3.149 . . . . 0.0 108.513 174.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 279' ' ' ARG . . . . . 0.402 HH11 ' HB ' ' A' ' 240' ' ' THR . 21.6 ttt180 -62.67 -40.88 98.46 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.475 0.655 . . . . 0.0 110.465 179.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.8 ' O ' HD12 ' A' ' 280' ' ' LEU . 0.1 OUTLIER -62.43 -36.56 82.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.326 -177.585 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -68.04 -51.14 35.64 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -178.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 282' ' ' SER . . . . . 0.643 ' OG ' HD13 ' A' ' 34' ' ' LEU . 7.5 t -63.09 -45.04 93.99 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.226 0.61 . . . . 0.0 110.506 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 283' ' ' TRP . . . . . 0.433 ' O ' HG22 ' A' ' 286' ' ' VAL . 16.3 t90 -60.77 -38.22 84.51 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.698 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 284' ' ' ASN . . . . . 0.446 ' OD1' ' CD1' ' A' ' 280' ' ' LEU . 2.2 m120 -61.96 -37.72 85.8 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.43 0.529 . . . . 0.0 112.43 -178.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.493 HG22 ' O ' ' A' ' 282' ' ' SER . 1.0 OUTLIER -59.95 -37.67 73.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -177.447 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 283' ' ' TRP . 1.0 OUTLIER -61.95 -40.11 86.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.942 -178.682 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 4.5 ptm -60.58 -38.77 85.7 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -58.65 -40.04 82.31 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.444 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 86.0 t -60.73 -39.37 81.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.522 -178.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 71.0 m -63.03 -40.56 98.09 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 119.654 -0.819 . . . . 0.0 109.039 177.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -60.92 -38.94 87.52 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 177.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -58.34 -40.21 81.56 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 117.756 -1.578 . . . . 0.0 109.847 -176.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 293' ' ' GLN . . . . . 0.459 ' O ' ' O ' ' A' ' 296' ' ' ARG . 34.5 mt-30 -60.32 -42.67 96.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 122.893 1.33 . . . . 0.0 110.874 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 9.4 mp -60.29 -39.75 88.02 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 112.487 -2.142 . . . . 0.0 109.226 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 26.7 mmtt -62.9 -45.47 92.39 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.055 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 296' ' ' ARG . . . . . 0.459 ' O ' ' O ' ' A' ' 293' ' ' GLN . 41.4 ttm180 -122.83 116.38 23.57 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -116.97 -162.69 0.87 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.311 0.577 . . . . 0.0 112.356 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.562 HD13 ' O ' ' A' ' 14' ' ' THR . 1.9 mt -69.55 116.14 9.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.504 177.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 2.5 tpt -99.5 60.4 1.14 Allowed 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -177.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.66 100.78 0.07 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.651 0.739 . . . . 0.0 110.551 -178.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -63.96 -46.21 85.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.345 -1.298 . . . . 0.0 114.029 -176.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -58.77 -39.9 82.4 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.185 -178.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 303' ' ' GLN . . . . . 0.528 ' N ' ' OE1' ' A' ' 303' ' ' GLN . 11.0 mp0 -65.0 -46.76 80.05 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.413 -179.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 304' ' ' SER . . . . . 0.439 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 78.1 p -66.69 -37.68 85.23 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.508 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -61.83 -43.15 99.42 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -179.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -65.11 -37.09 86.37 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 -176.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 307' ' ' ALA . . . . . 0.559 ' HB3' ' HD3' ' A' ' 308' ' ' PRO . . . -60.17 -52.98 69.45 Favored Pre-proline 0 CA--C 1.544 0.738 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 -176.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 308' ' ' PRO . . . . . 0.559 ' HD3' ' HB3' ' A' ' 307' ' ' ALA . 74.2 Cg_endo -75.29 0.3 9.18 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.147 1.898 . . . . 0.0 111.929 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 86.0 t80 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.547 -179.965 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.8 mmt . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.9 m -69.63 126.51 29.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.455 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.456 HG12 ' N ' ' A' ' 16' ' ' LYS . 24.0 t -147.57 158.92 8.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.518 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.456 ' N ' HG12 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -64.41 -41.55 96.57 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.582 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.404 ' N ' ' CG ' ' A' ' 16' ' ' LYS . 4.4 t80 -63.95 -41.6 97.53 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.523 ' N ' HD22 ' A' ' 18' ' ' LEU . 3.3 mm? -79.58 -26.73 41.24 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.803 -178.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.404 ' O ' ' OG1' ' A' ' 22' ' ' THR . . . -66.2 -41.29 94.91 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 107.486 -2.245 . . . . 0.0 107.486 177.23 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.43 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -71.73 -32.21 67.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 124.79 2.233 . . . . 0.0 107.705 176.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.47 -42.4 99.01 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-N 108.501 -3.954 . . . . 0.0 108.091 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 19' ' ' GLY . 34.4 p -70.55 -27.34 64.07 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 177.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -66.39 -50.09 64.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.879 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.0 -36.17 80.72 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 118.621 -1.232 . . . . 0.0 111.502 -177.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.625 ' SG ' ' N ' ' A' ' 26' ' ' ILE . 8.7 p -63.88 -53.21 54.07 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.382 -178.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.625 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -64.84 -38.98 84.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -176.505 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.544 ' O ' HG23 ' A' ' 31' ' ' THR . . . -63.73 -41.2 98.09 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -173.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -77.18 -27.24 53.57 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 120.976 1.717 . . . . 0.0 111.714 -174.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.442 ' H ' ' HG ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -59.98 -54.09 50.12 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 121.29 1.859 . . . . 0.0 112.894 -178.395 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.5 tt -75.34 -4.2 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -179.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.544 HG23 ' O ' ' A' ' 27' ' ' ALA . 34.2 p -109.03 -16.03 14.22 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 119.369 -0.932 . . . . 0.0 109.315 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.49 ' N ' ' HD2' ' A' ' 33' ' ' PRO . 88.1 t80 -68.18 -45.77 39.86 Favored Pre-proline 0 CA--C 1.546 0.826 0 CA-C-N 121.821 2.1 . . . . 0.0 111.488 -178.047 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 32' ' ' PHE . 26.3 Cg_endo -60.33 -15.72 36.89 Favored 'Trans proline' 0 N--CA 1.504 2.122 0 CA-C-N 121.299 1.5 . . . . 0.0 113.195 176.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.414 ' N ' HD22 ' A' ' 34' ' ' LEU . 3.9 mm? -66.62 -34.94 79.0 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -177.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -64.18 -40.17 95.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.345 -178.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.3 m -58.3 -35.14 71.37 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.253 -0.43 . . . . 0.0 112.048 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.53 -38.5 84.32 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 119.926 -0.71 . . . . 0.0 111.981 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.2 ttpt -61.25 -48.44 81.42 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 119.614 -0.835 . . . . 0.0 110.938 -176.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.3 t -62.9 -38.91 83.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -177.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.528 ' NH2' ' O ' ' A' ' 59' ' ' TYR . 5.8 mmm180 -59.83 -41.1 90.62 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 119.806 -0.758 . . . . 0.0 109.948 -179.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -62.19 38.62 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.157 178.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.489 ' H ' ' C ' ' A' ' 40' ' ' ARG . 45.3 tt0 -87.18 147.87 25.41 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 121.89 -0.506 . . . . 0.0 110.972 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 29.1 pt -81.42 -177.07 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.431 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -74.48 135.48 42.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.714 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 46' ' ' GLU . . . 168.99 -114.27 0.55 Allowed Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.406 ' O ' ' O ' ' A' ' 45' ' ' GLY . 38.0 tt0 60.62 131.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.831 0.348 . . . . 0.0 110.845 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 69.5 m -74.1 -34.08 63.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.072 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -52.15 -38.88 58.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.351 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.92 9.44 85.36 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -178.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.576 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -66.62 -38.42 86.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.294 0.569 . . . . 0.0 110.241 179.004 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.432 ' O ' ' O ' ' A' ' 54' ' ' ALA . 97.2 t -60.95 -45.26 98.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.095 -177.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -65.32 -34.16 77.69 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.787 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 50' ' ' LEU . 23.3 p -68.4 -38.18 81.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.907 0.384 . . . . 0.0 110.345 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' A' ' 51' ' ' VAL . . . -95.83 122.02 38.18 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.127 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.97 -43.0 12.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.723 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.624 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 10.4 m -131.05 -137.94 0.21 Allowed 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.624 ' HB3' ' O ' ' A' ' 56' ' ' SER . . . 80.1 -27.04 0.15 Allowed 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 176.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -120.82 38.81 3.94 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.528 ' O ' ' NH2' ' A' ' 40' ' ' ARG . 16.2 m-85 -37.51 151.62 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.81 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.42 ' O ' ' C ' ' A' ' 61' ' ' GLY . 31.9 mtm105 -46.4 -33.68 4.08 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 60' ' ' ARG . . . -30.51 101.95 0.01 OUTLIER Glycine 0 CA--C 1.527 0.795 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.89 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.2 p -66.95 -33.94 66.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 118.155 -0.926 . . . . 0.0 109.44 176.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.578 ' O ' HD13 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -60.52 -33.01 72.01 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 121.263 1.847 . . . . 0.0 110.343 -179.689 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.94 -49.5 62.59 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-N 115.518 -0.765 . . . . 0.0 114.575 -176.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.488 ' OG1' ' NH2' ' A' ' 40' ' ' ARG . 4.6 m -62.18 -46.36 89.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.005 -0.598 . . . . 0.0 112.498 -178.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 11.2 tt -59.78 -35.79 62.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.87 -35.77 81.74 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 120.597 1.544 . . . . 0.0 111.488 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 99.5 m -63.08 -39.3 94.32 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 113.595 -1.639 . . . . 0.0 111.064 -175.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.492 ' SD ' ' O ' ' A' ' 69' ' ' MET . 0.0 OUTLIER -60.59 -39.99 90.12 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 120.835 -1.166 . . . . 0.0 113.912 -176.548 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.1 p -69.33 -40.34 80.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 119.256 -0.978 . . . . 0.0 112.726 -178.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -78.3 -13.37 59.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.334 0.588 . . . . 0.0 112.585 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 90.8 m -62.88 -55.02 29.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.136 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -108.01 -56.93 2.17 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 157.84 164.39 13.87 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -56.29 -34.96 95.18 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.009 1.806 . . . . 0.0 111.673 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 72.4 mtp85 -61.23 -11.55 9.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.609 0.719 . . . . 0.0 111.463 176.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.9 p -78.28 -33.07 49.76 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.853 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.485 HD12 ' N ' ' A' ' 78' ' ' LEU . 8.9 mp -76.13 -32.12 58.98 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 122.309 -0.244 . . . . 0.0 111.45 179.087 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -90.7 -3.83 57.19 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 123.485 1.612 . . . . 0.0 112.531 -176.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -94.24 37.36 1.11 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 110.748 -2.933 . . . . 0.0 108.732 176.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -168.45 -15.37 0.02 OUTLIER Glycine 0 CA--C 1.533 1.209 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.842 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 82' ' ' LEU . 59.9 mt -59.97 -34.92 73.94 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 119.163 -1.015 . . . . 0.0 111.861 -179.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.9 p -70.54 -27.67 32.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.846 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.7 -31.62 61.93 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.541 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -68.37 -40.57 86.98 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 119.472 -1.347 . . . . 0.0 111.601 -177.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 27.1 mt -63.01 -41.21 99.51 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -176.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.41 ' H ' ' HG2' ' A' ' 87' ' ' GLN . 4.3 pt20 -60.9 -26.78 67.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.405 -1.271 . . . . 0.0 108.925 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 18.7 ttm105 -57.47 -53.46 57.87 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 173.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 66.0 mm-40 -67.05 -29.58 69.42 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 112.557 -2.11 . . . . 0.0 112.089 -178.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 34.4 ttm -61.19 -40.4 93.77 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.951 -1.022 . . . . 0.0 112.682 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 78.2 p -74.22 -34.31 63.65 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 118.491 -0.766 . . . . 0.0 111.058 -176.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -57.8 -44.36 86.29 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 120.609 1.55 . . . . 0.0 110.746 -177.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.63 -33.47 64.56 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 119.075 -1.05 . . . . 0.0 110.744 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.3 p -64.82 -42.85 94.65 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.437 ' C ' ' H ' ' A' ' 97' ' ' ILE . 11.7 p -68.52 -27.91 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.666 178.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.06 9.84 2.74 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 -176.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.471 HG22 ' O ' ' A' ' 97' ' ' ILE . 99.2 mt -87.23 -15.11 9.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 177.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -140.39 -47.9 0.06 OUTLIER Glycine 0 CA--C 1.538 1.504 0 N-CA-C 115.846 1.098 . . . . 0.0 115.846 -175.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.597 HD22 ' N ' ' A' ' 99' ' ' LEU . 3.3 mm? -70.9 -12.62 61.65 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.109 1.454 . . . . 0.0 112.02 -178.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -79.78 -50.43 10.57 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.0 -1.454 . . . . 0.0 109.609 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -67.71 -32.35 72.92 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 113.768 -1.56 . . . . 0.0 109.264 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.2 p -69.84 -53.96 15.74 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 112.661 -2.063 . . . . 0.0 112.874 175.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.723 HG22 ' CE2' ' A' ' 107' ' ' TYR . 0.3 OUTLIER -75.15 -27.63 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-N 122.088 2.222 . . . . 0.0 116.182 -176.835 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.514 ' NZ ' ' CB ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -69.54 -43.5 72.85 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 112.409 -2.178 . . . . 0.0 113.412 -177.723 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.455 ' N ' ' HG3' ' A' ' 104' ' ' LYS . 88.1 mt-30 -78.27 -10.97 59.89 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 124.345 2.021 . . . . 0.0 111.039 178.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -79.23 -22.69 44.47 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 112.055 -2.339 . . . . 0.0 111.512 178.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.723 ' CE2' HG22 ' A' ' 103' ' ' VAL . 28.2 m-85 -109.38 -30.74 7.83 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 119.155 0.889 . . . . 0.0 110.831 -177.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.3 m -97.75 8.85 43.98 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 117.918 -1.513 . . . . 0.0 113.157 -178.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.494 ' O ' ' C ' ' A' ' 110' ' ' GLY . 35.4 ttpt -48.74 125.75 10.7 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 117.908 -1.044 . . . . 0.0 109.541 177.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' A' ' 111' ' ' SER . . . -29.39 -74.45 0.04 OUTLIER Glycine 0 N--CA 1.485 1.962 0 CA-C-N 120.231 1.378 . . . . 0.0 111.6 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.531 ' CB ' ' O ' ' A' ' 110' ' ' GLY . 2.7 m 104.23 -161.67 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 177.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.618 ' O ' ' N ' ' A' ' 114' ' ' ALA . 79.6 tt0 -129.95 102.3 6.22 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -178.104 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.633 ' O ' ' HB2' ' A' ' 114' ' ' ALA . 88.0 m-70 13.51 46.75 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 O-C-N 124.411 1.069 . . . . 0.0 113.135 178.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.633 ' HB2' ' O ' ' A' ' 113' ' ' HIS . . . 159.09 -161.7 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.072 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.16 15.02 26.98 Favored Glycine 0 C--N 1.337 0.626 0 CA-C-N 115.141 -0.936 . . . . 0.0 113.038 176.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 50.0 mt -60.73 -40.72 85.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 C-N-CA 119.133 -1.027 . . . . 0.0 108.576 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.6 -40.09 95.81 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 122.01 0.783 . . . . 0.0 111.362 175.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 19.4 m -58.18 -42.53 86.24 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 177.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -63.72 -37.42 87.3 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.009 -0.676 . . . . 0.0 111.058 -178.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 97.2 mt -64.16 -46.56 83.5 Favored 'General case' 0 N--CA 1.457 -0.11 0 CA-C-O 121.481 0.657 . . . . 0.0 109.352 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.568 ' O ' HD23 ' A' ' 121' ' ' LEU . 1.4 tt -66.67 -44.59 81.39 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.933 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.457 ' O ' HG22 ' A' ' 126' ' ' THR . . . -63.36 -44.69 94.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 119.457 1.026 . . . . 0.0 108.853 177.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -65.83 -44.03 92.81 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 120.034 -1.079 . . . . 0.0 111.584 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 63.9 m -64.27 -44.51 91.52 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.508 HG23 ' N ' ' A' ' 126' ' ' THR . 13.9 t -70.16 -48.02 59.11 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 118.885 -1.126 . . . . 0.0 112.077 177.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.508 ' N ' HG23 ' A' ' 125' ' ' THR . 9.4 t -65.66 -42.69 91.05 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 -174.004 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.493 ' N ' HG23 ' A' ' 126' ' ' THR . . . -64.23 -44.71 95.19 Favored Glycine 0 C--N 1.33 0.206 0 CA-C-N 114.416 -1.265 . . . . 0.0 112.253 -178.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.477 ' O ' HG12 ' A' ' 131' ' ' VAL . . . -61.01 -41.58 96.81 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 112.302 -1.949 . . . . 0.0 106.287 177.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.677 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 31.3 mt -64.91 -42.36 94.8 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.841 177.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.24 -40.01 96.23 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -177.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 128' ' ' ALA . 4.0 p -61.22 -24.84 34.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 122.932 1.348 . . . . 0.0 109.042 178.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.677 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . -57.64 -44.55 85.68 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 112.188 -2.278 . . . . 0.0 111.343 -178.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.9 p -78.81 -48.74 21.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.229 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.459 ' O ' ' O ' ' A' ' 131' ' ' VAL . . . -92.06 138.18 31.75 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.712 0.291 . . . . 0.0 111.064 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.497 ' N ' ' CD ' ' A' ' 136' ' ' PRO . 1.2 tt0 -179.69 -47.19 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.815 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 135' ' ' GLN . 55.3 Cg_exo -52.11 -33.5 53.96 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 122.326 2.017 . . . . 0.0 112.302 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 32.2 p -67.69 -42.78 81.53 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 117.941 -1.504 . . . . 0.0 109.786 -179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -66.24 -42.96 87.88 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 119.317 -0.953 . . . . 0.0 112.098 -178.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 62.5 t -64.08 -43.72 97.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -179.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 136' ' ' PRO . 72.4 t -64.89 -39.34 85.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -177.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 31.3 mttp -62.83 -42.01 99.56 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 118.754 -1.179 . . . . 0.0 111.325 -178.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 11.8 m -71.24 -46.33 66.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.87 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 12.8 tpp85 -65.59 -37.37 86.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.895 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -67.34 -42.0 84.26 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -177.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.3 -40.49 90.03 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 119.173 -1.011 . . . . 0.0 111.232 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.32 -35.46 81.08 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 -177.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -60.62 111.27 1.54 Allowed 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 176.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -106.12 -52.44 2.8 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.872 1.804 . . . . 0.0 115.872 -174.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.538 ' O ' ' HB3' ' A' ' 150' ' ' ALA . 10.9 mmt180 -86.9 12.14 11.78 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 121.68 2.036 . . . . 0.0 110.544 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.538 ' HB3' ' O ' ' A' ' 149' ' ' ARG . . . 72.62 -45.72 0.63 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.667 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 103.16 169.71 26.0 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -70.54 121.46 9.85 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.094 -0.803 . . . . 0.0 111.094 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 152.02 -162.78 29.9 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' A' ' 156' ' ' TYR . 39.4 ttp180 -160.28 -135.14 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.43 ' O ' ' O ' ' A' ' 156' ' ' TYR . 29.9 mmt180 44.89 15.5 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.831 0.348 . . . . 0.0 110.508 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.526 ' N ' ' O ' ' A' ' 154' ' ' ARG . 0.7 OUTLIER 54.29 112.52 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.751 179.758 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.44 ' CD ' ' N ' ' A' ' 157' ' ' GLN . 14.8 mp0 -62.65 164.17 8.07 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.42 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.403 ' OG ' ' N ' ' A' ' 159' ' ' THR . 47.6 t -157.16 -178.02 7.05 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.457 0.646 . . . . 0.0 111.273 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.57 HG23 ' N ' ' A' ' 160' ' ' VAL . 15.1 t -63.78 -45.89 87.72 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.66 -177.171 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.57 ' N ' HG23 ' A' ' 159' ' ' THR . 94.9 t -63.95 -45.26 97.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 119.251 -0.98 . . . . 0.0 109.096 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 38.6 tp10 -67.01 -38.37 85.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.663 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.549 ' O ' HD12 ' A' ' 166' ' ' ILE . . . -60.96 -44.41 97.37 Favored 'General case' 0 C--O 1.211 -0.952 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -176.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.543 ' CE2' HD11 ' A' ' 175' ' ' LEU . 14.8 t80 -61.25 -47.62 85.19 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.662 0.744 . . . . 0.0 112.204 -177.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.402 ' NZ ' ' CB ' ' A' ' 164' ' ' LYS . 2.3 ttmp? -68.39 -45.41 72.77 Favored 'General case' 0 CA--C 1.555 1.169 0 N-CA-C 118.17 2.656 . . . . 0.0 118.17 -173.03 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 63.8 p -63.49 -45.51 90.39 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 117.381 2.363 . . . . 0.0 117.381 -175.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.741 HD13 ' H ' ' A' ' 166' ' ' ILE . 0.2 OUTLIER -64.59 -37.14 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-O 121.635 0.731 . . . . 0.0 109.233 177.082 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -58.93 -36.97 75.64 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 117.177 -1.392 . . . . 0.0 107.628 177.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 77.5 ttt-85 -62.75 -50.7 70.02 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 123.393 2.815 . . . . 0.0 111.835 -176.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -75.34 -51.22 13.69 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 123.584 0.754 . . . . 0.0 109.5 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -78.15 -36.54 47.54 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -174.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 91.9 -169.09 32.03 Favored Glycine 0 N--CA 1.464 0.509 0 N-CA-C 111.707 -0.557 . . . . 0.0 111.707 178.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.416 ' CG1' ' N ' ' A' ' 173' ' ' ARG . 7.5 pt -71.51 -42.04 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-O 121.454 0.645 . . . . 0.0 110.61 -179.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.416 ' N ' ' CG1' ' A' ' 172' ' ' ILE . 25.4 mmt180 -59.24 -34.09 71.8 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.595 -177.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -60.91 -40.67 98.68 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 118.514 -1.803 . . . . 0.0 109.035 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.543 HD11 ' CE2' ' A' ' 163' ' ' TYR . 0.5 OUTLIER -70.55 -33.48 71.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 111.239 -2.48 . . . . 0.0 116.771 -177.284 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 176' ' ' TRP . . . . . 0.484 ' CG ' ' OG1' ' A' ' 179' ' ' THR . 33.5 t-105 -77.93 -7.63 57.02 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 111.694 -2.503 . . . . 0.0 110.563 -177.004 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 51.4 mttm -43.55 -48.41 7.49 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -176.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -99.31 -25.65 9.29 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.099 0.857 . . . . 0.0 112.601 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.484 ' OG1' ' CG ' ' A' ' 176' ' ' TRP . 69.2 p -46.3 -51.9 13.71 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.99 -50.41 76.94 Favored Pre-proline 0 N--CA 1.48 1.038 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -175.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -63.34 -28.35 71.85 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 121.628 1.552 . . . . 0.0 111.42 176.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -63.88 -39.0 93.18 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.245 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 71.1 t -62.69 -42.14 94.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.0 0.429 . . . . 0.0 110.009 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.555 ' O ' HD13 ' A' ' 188' ' ' ILE . . . -61.72 -38.99 89.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.347 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.447 ' NH1' ' O ' ' A' ' 239' ' ' LYS . 97.7 mtt180 -60.4 -41.97 94.99 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.71 -179.079 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -61.55 -43.2 99.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.366 0.603 . . . . 0.0 110.169 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.34 -43.13 95.58 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.167 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.555 HD13 ' O ' ' A' ' 184' ' ' ALA . 1.4 mp -63.04 -45.07 99.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.2 -177.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.42 ' O ' ' OE1' ' A' ' 193' ' ' GLU . 11.8 m -60.44 -47.06 94.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 119.409 -0.916 . . . . 0.0 112.431 -178.16 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -62.68 -43.19 99.44 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 122.586 1.184 . . . . 0.0 109.868 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' CYS . . . . . . . . . . . . . 31.2 m -62.34 -46.22 89.68 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 112.565 -2.107 . . . . 0.0 110.479 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.11 -40.13 95.53 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 114.037 -1.438 . . . . 0.0 109.659 176.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 0.492 ' OE1' ' N ' ' A' ' 193' ' ' GLU . 0.0 OUTLIER -61.01 -45.64 94.0 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.63 -178.381 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 67.2 tp -64.21 -39.14 93.37 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 118.637 -1.225 . . . . 0.0 110.053 -175.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 6.9 m -64.45 -45.88 94.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 C-N-CA 116.891 -1.924 . . . . 0.0 107.907 178.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 23.4 m -63.98 -45.95 86.78 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -178.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -57.16 -39.08 74.55 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.862 0.865 . . . . 0.0 112.56 -178.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -55.86 -44.29 77.92 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.5 HD22 ' N ' ' A' ' 199' ' ' LEU . 3.8 mm? -61.34 -38.79 88.19 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 41.8 mm -62.0 -42.41 94.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 26.1 mmtm -59.57 -38.71 81.86 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.876 1.27 . . . . 0.0 113.183 178.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -67.79 -37.12 81.6 Favored 'General case' 0 C--O 1.256 1.42 0 C-N-CA 118.511 -1.276 . . . . 0.0 111.028 -175.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.433 ' O ' HG23 ' A' ' 203' ' ' THR . 5.8 t -100.96 128.82 46.82 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 121.308 1.867 . . . . 0.0 111.895 -178.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.508 ' CD2' ' CE1' ' A' ' 217' ' ' HIS . 6.9 mp 66.82 3.74 3.16 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 113.342 -1.754 . . . . 0.0 110.576 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 2.3 mt -126.59 29.78 5.66 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.882 0.849 . . . . 0.0 110.628 -179.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -68.78 -25.8 64.89 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.482 -1.235 . . . . 0.0 109.848 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.432 ' O ' ' CG ' ' A' ' 208' ' ' ASN . . . -161.93 39.62 0.13 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 114.363 -1.29 . . . . 0.0 109.563 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' ASN . . . . . 0.568 ' C ' HD21 ' A' ' 208' ' ' ASN . 0.0 OUTLIER 87.93 -18.38 0.27 Allowed 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 175.979 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.504 ' CB ' ' O ' ' A' ' 208' ' ' ASN . 1.0 OUTLIER 84.85 46.33 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 119.742 1.155 . . . . 0.0 109.524 -179.874 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 210' ' ' MET . . . . . 0.474 ' O ' ' O ' ' A' ' 209' ' ' LEU . 78.1 mtm -53.04 -166.97 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.865 178.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.505 ' OG1' ' N ' ' A' ' 212' ' ' ASP . 4.4 p 61.21 -134.43 0.63 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.927 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' ASP . . . . . 0.505 ' N ' ' OG1' ' A' ' 211' ' ' THR . 4.0 p-10 -155.96 -94.12 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.551 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.486 ' H ' ' CG ' ' A' ' 212' ' ' ASP . 4.6 p-10 44.22 42.78 5.36 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.308 0.575 . . . . 0.0 109.683 -178.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.412 ' N ' ' CD ' ' A' ' 215' ' ' PRO . 2.5 mm? -61.24 -43.89 91.55 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.921 -178.195 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 214' ' ' LEU . 27.3 Cg_exo -60.7 -34.45 91.92 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 CA-C-N 120.263 1.129 . . . . 0.0 111.16 -178.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 7.9 t -65.24 -42.43 93.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 113.085 -1.871 . . . . 0.0 111.231 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' HIS . . . . . 0.522 ' O ' ' ND1' ' A' ' 217' ' ' HIS . 1.8 t60 -66.78 -37.41 84.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.446 -0.797 . . . . 0.0 113.064 -178.134 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -62.95 -47.62 82.42 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.096 -177.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 33.5 p -60.53 -38.1 83.34 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 119.097 0.862 . . . . 0.0 110.986 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 66.0 p -59.64 -41.78 91.28 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.574 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.89 -41.84 97.62 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -178.216 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -62.63 -47.82 82.08 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -176.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -61.06 -42.27 99.74 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 107.811 -2.116 . . . . 0.0 107.811 177.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' ALA . . . . . 0.788 ' O ' HG23 ' A' ' 228' ' ' THR . . . -63.31 -37.78 88.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 113.817 -1.191 . . . . 0.0 109.009 176.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.574 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -61.67 -42.38 99.75 Favored Glycine 0 CA--C 1.522 0.51 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.827 -176.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' PHE . . . . . 0.432 ' O ' ' OG1' ' A' ' 229' ' ' THR . 0.9 OUTLIER -66.55 -38.58 87.44 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 118.28 1.04 . . . . 0.0 108.27 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 96.6 m -63.54 -41.88 98.43 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.09 0.471 . . . . 0.0 110.265 177.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.788 HG23 ' O ' ' A' ' 224' ' ' ALA . 80.1 p -62.5 -40.48 96.87 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.896 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' A' ' 226' ' ' PHE . 18.6 p -58.8 -39.73 81.99 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.097 -176.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 98.3 t -60.61 -41.91 89.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 118.521 -1.271 . . . . 0.0 108.839 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.48 ' O ' ' HD2' ' A' ' 234' ' ' PRO . 1.3 mp -62.13 -41.29 90.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-O 121.418 0.628 . . . . 0.0 109.393 176.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -62.99 -40.09 96.7 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 -178.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.442 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 0.0 OUTLIER -59.11 -43.39 97.15 Favored Pre-proline 0 N--CA 1.476 0.84 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -173.255 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.48 ' HD2' ' O ' ' A' ' 231' ' ' ILE . 39.4 Cg_exo -60.0 -41.72 50.49 Favored 'Trans proline' 0 C--N 1.296 -2.189 0 C-N-CA 121.576 1.517 . . . . 0.0 113.781 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.408 ' H ' HG22 ' A' ' 235' ' ' VAL . 13.6 m -66.34 -37.55 79.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 119.131 -1.028 . . . . 0.0 111.303 178.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -66.0 -41.7 90.72 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -178.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.409 ' O ' ' OG1' ' A' ' 240' ' ' THR . 3.0 p -65.68 -45.72 91.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -177.48 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 8.5 p -63.2 -37.35 79.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.323 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' LYS . . . . . 0.447 ' O ' ' NH1' ' A' ' 185' ' ' ARG . 88.6 mttt -60.77 -45.02 95.98 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 119.786 -0.765 . . . . 0.0 110.426 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 240' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 237' ' ' VAL . 51.8 p -62.24 -42.17 99.08 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.988 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -37.57 139.52 0.28 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.533 -178.313 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.55 ' CG ' ' N ' ' A' ' 243' ' ' MET . 0.0 OUTLIER 161.88 -62.88 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 114.964 -1.016 . . . . 0.0 108.74 -179.661 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 243' ' ' MET . . . . . 0.55 ' N ' ' CG ' ' A' ' 242' ' ' TYR . 10.7 tpt -68.44 75.88 0.26 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 244' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 242' ' ' TYR . 34.4 t30 -158.97 109.1 1.99 Allowed 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 12.1 p 62.62 -178.16 0.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.857 -178.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -140.36 -70.14 0.39 Allowed 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.403 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 23.9 mt -57.88 136.78 57.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.894 0.378 . . . . 0.0 111.08 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 143.14 158.7 7.65 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.742 ' HG3' ' NE2' ' A' ' 255' ' ' HIS . 16.5 mm100 -44.74 -90.18 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER 71.49 32.81 2.0 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.021 178.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 39.9 t60 -66.83 -53.93 27.65 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 116.431 -2.108 . . . . 0.0 111.773 -177.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 69.1 m -148.53 -173.65 4.39 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -61.15 -44.88 96.63 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -57.66 -36.04 76.73 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 126.12 1.819 . . . . 0.0 115.185 -171.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' HIS . . . . . 0.742 ' NE2' ' HG3' ' A' ' 249' ' ' GLN . 86.4 t60 -57.23 -32.63 66.72 Favored 'General case' 0 C--N 1.365 1.276 0 CA-C-N 120.239 2.019 . . . . 0.0 111.019 -178.003 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 256' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -59.95 -44.8 94.17 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.327 0.512 . . . . 0.0 110.683 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -60.72 -45.41 94.35 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.823 -0.751 . . . . 0.0 111.24 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.529 ' N ' HD12 ' A' ' 258' ' ' LEU . 10.2 mp -66.97 -44.01 81.6 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.957 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 259' ' ' THR . . . . . 0.703 HG21 ' NE2' ' A' ' 255' ' ' HIS . 73.4 p -63.36 -45.09 92.79 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.93 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 260' ' ' MET . . . . . . . . . . . . . 51.9 ttp -60.31 -44.44 95.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.011 -176.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.522 HD13 ' O ' ' A' ' 261' ' ' LEU . 0.2 OUTLIER -62.17 -46.5 88.65 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.338 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 69.1 mmt-85 -66.41 -53.78 31.83 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.666 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -142.62 158.73 43.36 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.687 0.28 . . . . 0.0 111.23 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 264' ' ' GLU . . . . . 0.448 ' O ' ' O ' ' A' ' 265' ' ' GLY . 18.3 tp10 76.25 68.31 0.06 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.285 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 264' ' ' GLU . . . -32.09 156.59 0.01 OUTLIER Glycine 0 CA--C 1.536 1.379 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.667 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -62.82 -3.11 4.17 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 122.246 1.964 . . . . 0.0 111.836 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 80.5 mtt85 -70.0 -27.05 64.37 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 123.053 0.541 . . . . 0.0 111.805 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.441 ' O ' ' O ' ' A' ' 271' ' ' LYS . . . -58.8 -32.47 69.38 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 119.824 -0.75 . . . . 0.0 109.948 -179.137 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -62.45 -41.72 98.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.412 0.625 . . . . 0.0 110.836 178.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -66.0 -37.7 86.59 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 114.9 -1.046 . . . . 0.0 112.363 -178.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 268' ' ' ALA . 17.6 ttpp -110.65 134.37 52.49 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.73 0.3 . . . . 0.0 110.616 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 108.47 55.77 0.58 Allowed Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -147.95 29.58 0.9 Allowed 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 120.836 0.35 . . . . 0.0 110.69 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 274' ' ' MET . . . . . 0.588 ' N ' ' CD ' ' A' ' 275' ' ' PRO . 0.3 OUTLIER -63.74 -43.88 78.21 Favored Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.238 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 275' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 274' ' ' MET . 23.4 Cg_exo -63.69 -45.87 10.19 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.776 2.317 . . . . 0.0 111.908 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 86.1 p -59.72 -39.13 83.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.061 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -61.21 -41.86 97.59 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 122.884 1.326 . . . . 0.0 111.85 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -61.87 -38.31 87.81 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 111.829 -2.441 . . . . 0.0 107.78 174.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 48.4 mtp180 -62.88 -39.33 94.15 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.304 0.573 . . . . 0.0 110.26 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 30.7 tp -61.85 -36.46 81.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.121 -0.945 . . . . 0.0 112.869 -177.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -68.12 -51.18 34.94 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -178.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 282' ' ' SER . . . . . 0.614 ' O ' HG12 ' A' ' 285' ' ' VAL . 76.4 p -63.09 -44.41 95.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.422 0.63 . . . . 0.0 110.072 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 283' ' ' TRP . . . . . . . . . . . . . 75.5 t90 -60.76 -38.75 86.27 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.604 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -62.58 -39.69 94.52 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -178.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.614 HG12 ' O ' ' A' ' 282' ' ' SER . 3.7 p -61.32 -37.89 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.093 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.526 ' O ' HG12 ' A' ' 289' ' ' VAL . 95.0 t -62.02 -40.6 87.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 120.311 -0.556 . . . . 0.0 109.526 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 287' ' ' MET . . . . . 0.459 ' C ' ' SD ' ' A' ' 287' ' ' MET . 0.0 OUTLIER -61.15 -38.55 86.81 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.342 0.591 . . . . 0.0 109.893 178.606 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -58.51 -39.4 80.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.168 -0.923 . . . . 0.0 112.604 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.526 HG12 ' O ' ' A' ' 286' ' ' VAL . 1.3 p -59.85 -38.13 74.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 113.213 0.819 . . . . 0.0 113.213 -175.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 2.1 t -62.35 -40.54 96.73 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 118.892 -1.123 . . . . 0.0 109.135 178.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -60.82 -38.86 86.88 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 177.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -58.35 -40.25 81.7 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 117.664 -1.614 . . . . 0.0 109.913 -175.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 293' ' ' GLN . . . . . 0.496 ' O ' ' O ' ' A' ' 296' ' ' ARG . 56.5 tt0 -60.46 -43.3 97.02 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 122.6 1.191 . . . . 0.0 111.443 -179.011 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 11.0 mp -60.95 -40.39 93.11 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 113.313 -1.767 . . . . 0.0 109.671 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -62.68 -45.76 91.3 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.36 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 296' ' ' ARG . . . . . 0.496 ' O ' ' O ' ' A' ' 293' ' ' GLN . 43.5 ttm180 -122.53 116.33 23.72 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -119.16 -160.8 0.82 Allowed 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -178.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.493 HD23 ' OG ' ' A' ' 304' ' ' SER . 33.6 tp -71.42 114.82 9.88 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 177.289 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 28.1 ttp -96.7 64.71 2.13 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -177.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.58 101.04 0.07 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 122.047 0.927 . . . . 0.0 110.721 -178.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -64.15 -46.27 84.82 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 113.505 -1.68 . . . . 0.0 113.452 -176.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -58.73 -39.64 81.48 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.617 -0.433 . . . . 0.0 109.957 -178.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -64.68 -46.76 81.04 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.027 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 304' ' ' SER . . . . . 0.493 ' OG ' HD23 ' A' ' 298' ' ' LEU . 3.0 m -66.34 -38.1 86.85 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.404 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 59.7 mmt-85 -61.88 -42.86 99.57 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.721 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -64.94 -36.8 85.56 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -177.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 307' ' ' ALA . . . . . 0.54 ' HB3' ' HD3' ' A' ' 308' ' ' PRO . . . -60.02 -52.92 70.03 Favored Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -176.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 308' ' ' PRO . . . . . 0.54 ' HD3' ' HB3' ' A' ' 307' ' ' ALA . 73.9 Cg_endo -75.21 0.33 9.12 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.109 1.873 . . . . 0.0 111.816 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 50.4 t80 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.51 179.992 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.552 ' N ' ' SD ' ' A' ' 13' ' ' MET . 1.5 mpt? . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 48.5 m -106.21 88.54 2.82 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.399 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 16' ' ' LYS . 16.8 t -87.05 164.19 2.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.336 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.486 ' N ' HG12 ' A' ' 15' ' ' VAL . 33.3 mtmm -64.37 -42.03 96.41 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -63.77 -41.62 97.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.386 0.612 . . . . 0.0 111.428 179.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.5 tp -79.81 -26.11 40.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.236 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.45 -41.43 94.33 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 107.472 -2.251 . . . . 0.0 107.472 177.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.531 ' HB1' HH22 ' A' ' 96' ' ' ARG . . . -71.47 -32.29 68.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 124.838 2.256 . . . . 0.0 107.061 176.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.56 -42.47 98.86 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-N 108.516 -3.947 . . . . 0.0 107.759 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.0 m -70.7 -27.87 64.32 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.462 0.648 . . . . 0.0 109.591 177.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.66 ' O ' HD13 ' A' ' 26' ' ' ILE . . . -65.95 -49.83 66.52 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.981 -178.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.05 -35.16 77.77 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 118.693 -1.203 . . . . 0.0 112.206 -177.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 78.2 m -63.29 -53.85 46.4 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -177.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.66 HD13 ' O ' ' A' ' 23' ' ' ALA . 0.2 OUTLIER -66.06 -38.16 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -177.739 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.37 -41.9 98.83 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-O 118.175 -0.917 . . . . 0.0 113.316 -172.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -77.58 -26.78 51.07 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 120.914 1.688 . . . . 0.0 110.51 -175.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.3 mp -59.56 -54.56 45.15 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 119.686 1.13 . . . . 0.0 112.27 -178.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.9 tp -74.78 -3.44 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 CA-C-O 121.692 0.758 . . . . 0.0 112.711 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -109.06 -16.19 14.17 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.39 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.495 ' N ' ' HD2' ' A' ' 33' ' ' PRO . 27.0 t80 -68.5 -46.08 36.28 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 116.654 -2.018 . . . . 0.0 111.829 -177.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 32' ' ' PHE . 24.0 Cg_endo -60.26 -15.89 37.47 Favored 'Trans proline' 0 N--CA 1.499 1.824 0 CA-C-N 120.988 1.389 . . . . 0.0 113.238 177.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.411 ' N ' HD12 ' A' ' 34' ' ' LEU . 10.5 mp -67.36 -35.7 79.9 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -177.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -64.64 -40.4 95.39 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.618 -178.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.9 p -58.22 -34.8 70.81 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.812 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.43 -38.85 85.2 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 119.862 -0.735 . . . . 0.0 112.231 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -62.64 -49.86 73.49 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 119.106 -1.037 . . . . 0.0 111.296 -177.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 65.6 t -64.96 -40.19 88.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -177.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.538 ' O ' ' N ' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -61.05 -41.09 95.95 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.752 -178.457 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.6 tp -62.03 38.79 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.967 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.538 ' N ' ' O ' ' A' ' 40' ' ' ARG . 6.3 pt20 -95.51 154.63 17.11 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.82 0.343 . . . . 0.0 110.603 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.701 HD12 ' N ' ' A' ' 43' ' ' ILE . 1.9 mp -69.22 -11.92 15.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.289 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 55.29 -175.71 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.374 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 57.83 38.81 90.06 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.999 -0.841 . . . . 0.0 110.999 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.405 ' O ' ' OG ' ' A' ' 47' ' ' SER . 14.7 pt-20 -61.65 -35.03 76.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.793 0.33 . . . . 0.0 110.408 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' A' ' 46' ' ' GLU . 69.1 m -168.58 -15.88 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.677 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -64.59 -40.78 96.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.655 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.51 9.57 84.61 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -177.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.1 tp -64.62 -36.8 85.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.313 -0.944 . . . . 0.0 109.929 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 95.3 t -59.69 -44.2 93.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.397 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 93.1 mtm-85 -64.46 -34.19 77.62 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.201 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.7 p -68.44 -38.09 80.83 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 178.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -134.51 93.36 3.04 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.803 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.52 -13.38 52.17 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -178.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.613 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 90.5 p -126.33 -140.06 0.27 Allowed 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.051 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.613 ' HB3' ' O ' ' A' ' 56' ' ' SER . . . 98.01 12.88 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 O-C-N 124.245 0.965 . . . . 0.0 112.04 178.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.421 ' OE1' ' O ' ' A' ' 59' ' ' TYR . 1.3 tm0? -173.59 84.17 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.562 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.421 ' O ' ' OE1' ' A' ' 58' ' ' GLN . 5.4 m-85 -65.5 148.55 51.53 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -40.23 -36.71 0.55 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.023 0.44 . . . . 0.0 110.255 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -31.85 103.38 0.01 OUTLIER Glycine 0 CA--C 1.529 0.926 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.334 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.3 p -67.14 -33.53 63.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 118.205 -0.902 . . . . 0.0 109.626 176.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -60.02 -32.3 70.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 121.397 1.908 . . . . 0.0 109.958 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.51 -48.96 67.84 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 115.262 -0.881 . . . . 0.0 114.555 -176.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.2 m -61.87 -46.3 90.03 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -178.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 28.9 mm -59.49 -36.27 63.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 40.0 tp -64.04 -35.82 81.97 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 120.252 1.387 . . . . 0.0 112.511 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 98.6 m -63.3 -40.7 98.08 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.069 -175.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 31.7 ttp -60.15 -40.19 88.97 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 114.406 1.262 . . . . 0.0 114.406 -175.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.41 ' CG1' ' N ' ' A' ' 71' ' ' ARG . 3.0 p -69.46 -40.93 80.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 119.218 -0.993 . . . . 0.0 113.16 -177.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.41 ' N ' ' CG1' ' A' ' 70' ' ' VAL . 68.1 ttt-85 -78.75 -12.92 60.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.697 0.76 . . . . 0.0 112.991 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 56.8 m -61.63 -54.85 37.33 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.682 -1.144 . . . . 0.0 111.094 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.554 ' CD ' ' H ' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -117.32 -40.81 3.03 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 118.754 -0.641 . . . . 0.0 110.472 178.064 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 155.15 159.58 9.39 Favored Glycine 0 CA--C 1.549 2.158 0 CA-C-N 120.192 1.36 . . . . 0.0 111.34 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -56.53 -34.58 95.48 Favored 'Trans proline' 0 N--CA 1.511 2.531 0 C-N-CA 122.269 1.98 . . . . 0.0 114.032 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.5 mmp_? -60.23 -10.55 4.7 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 178.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.422 ' O ' ' OD1' ' A' ' 80' ' ' ASN . 1.2 p -77.28 -31.79 55.09 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.642 -178.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 43.5 tp -74.91 -31.94 61.68 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 122.039 -0.413 . . . . 0.0 110.626 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.747 ' O ' HD12 ' A' ' 82' ' ' LEU . 97.3 m-85 -90.88 -3.86 57.01 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 122.851 1.31 . . . . 0.0 114.091 -176.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 77' ' ' SER . 0.8 OUTLIER -104.17 123.64 47.66 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 111.986 -2.37 . . . . 0.0 107.738 175.337 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.24 -16.29 49.59 Favored Glycine 0 N--CA 1.467 0.746 0 N-CA-C 108.389 -1.885 . . . . 0.0 108.389 -177.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.969 HD13 ' H ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -59.34 -34.37 72.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 113.859 -1.17 . . . . 0.0 110.559 -179.601 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.969 ' H ' HD13 ' A' ' 82' ' ' LEU . 7.5 p -70.7 -27.36 30.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.322 177.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.96 -31.96 61.6 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 119.199 -0.429 . . . . 0.0 111.35 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.84 -40.01 89.6 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 119.533 -1.317 . . . . 0.0 110.832 -177.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.691 ' O ' HD23 ' A' ' 86' ' ' LEU . 2.4 tt -62.45 -40.54 96.94 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 122.261 1.029 . . . . 0.0 113.335 -176.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -60.55 -27.48 67.69 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 113.541 -1.663 . . . . 0.0 109.815 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 64.2 mtm180 -57.81 -53.25 60.34 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 173.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 70.7 tp60 -67.06 -29.68 69.53 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 112.505 -2.134 . . . . 0.0 111.921 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.446 ' SD ' ' C ' ' A' ' 90' ' ' MET . 11.5 tmm? -61.27 -40.89 95.79 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.044 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 77.7 p -74.24 -34.5 63.66 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 119.362 -0.935 . . . . 0.0 111.402 -176.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -57.84 -44.19 86.32 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 120.951 1.705 . . . . 0.0 111.857 -177.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.38 -33.16 64.89 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 119.546 -0.862 . . . . 0.0 111.094 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.574 ' O ' HG22 ' A' ' 97' ' ' ILE . 25.3 m -64.2 -41.78 96.92 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.443 ' C ' ' H ' ' A' ' 97' ' ' ILE . 72.9 t -68.37 -28.71 41.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.485 178.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.531 HH22 ' HB1' ' A' ' 20' ' ' ALA . 29.6 ttp180 -77.61 10.4 2.69 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -177.054 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.574 HG22 ' O ' ' A' ' 94' ' ' SER . 10.9 tt -86.96 -15.0 9.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.859 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -140.3 -49.0 0.05 OUTLIER Glycine 0 CA--C 1.541 1.711 0 N-CA-C 117.103 1.601 . . . . 0.0 117.103 -176.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.662 HD12 ' C ' ' A' ' 99' ' ' LEU . 3.1 pp -73.28 -12.77 60.97 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 120.558 2.179 . . . . 0.0 114.515 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.626 ' N ' HD12 ' A' ' 99' ' ' LEU . 46.6 t80 -79.16 -53.04 7.38 Favored 'General case' 0 C--O 1.214 -0.797 0 C-N-CA 118.777 -1.169 . . . . 0.0 113.073 -176.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -72.3 -33.18 67.22 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 124.26 1.981 . . . . 0.0 112.403 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 67.0 m -65.47 -48.98 70.78 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 109.317 -3.583 . . . . 0.0 115.034 -178.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.405 HG22 ' O ' ' A' ' 99' ' ' LEU . 19.1 m -72.29 -23.83 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.368 0 CA-C-O 123.945 1.831 . . . . 0.0 109.437 175.147 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.565 ' HB2' ' O ' ' A' ' 100' ' ' TYR . 0.0 OUTLIER -68.03 -42.61 80.35 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 109.943 -3.299 . . . . 0.0 113.675 -179.058 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -76.56 -13.33 60.09 Favored 'General case' 0 C--O 1.211 -0.948 0 CA-C-O 125.468 2.556 . . . . 0.0 111.102 177.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.484 ' O ' ' NZ ' ' A' ' 109' ' ' LYS . 1.9 t80 -80.15 -22.08 42.42 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 109.378 -3.555 . . . . 0.0 110.711 177.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.417 ' HE2' HD21 ' A' ' 194' ' ' LEU . 0.3 OUTLIER -109.68 -28.72 8.69 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.607 0.763 . . . . 0.0 112.404 -174.137 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.753 ' C ' ' H ' ' A' ' 110' ' ' GLY . 0.8 OUTLIER -94.91 12.99 26.32 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -174.723 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.484 ' NZ ' ' O ' ' A' ' 106' ' ' PHE . 7.2 ptpp? -56.58 18.73 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 119.602 1.092 . . . . 0.0 110.825 177.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.753 ' H ' ' C ' ' A' ' 108' ' ' THR . . . 57.8 19.2 35.3 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-N 113.956 -1.475 . . . . 0.0 109.773 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.431 ' O ' ' O ' ' A' ' 110' ' ' GLY . 36.2 m 31.19 -160.73 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 112.47 -1.865 . . . . 0.0 114.333 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.623 ' O ' ' N ' ' A' ' 114' ' ' ALA . 39.8 tt0 -134.12 92.99 3.02 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 114.144 1.165 . . . . 0.0 114.144 -176.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.578 ' O ' ' HB2' ' A' ' 114' ' ' ALA . 89.4 m-70 30.63 28.68 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.082 178.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.623 ' N ' ' O ' ' A' ' 112' ' ' GLU . . . 159.97 -161.97 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.99 15.46 23.94 Favored Glycine 0 N--CA 1.464 0.556 0 C-N-CA 120.035 -1.079 . . . . 0.0 111.647 178.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.678 HD12 ' N ' ' A' ' 116' ' ' ILE . 2.0 mp -60.34 -40.37 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 C-N-CA 119.237 -0.985 . . . . 0.0 108.713 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.91 -41.01 95.66 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.021 175.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 38.3 t -59.33 -43.64 92.69 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 176.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 64.5 mtm180 -64.15 -37.13 86.33 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.677 -178.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.543 ' O ' HD23 ' A' ' 120' ' ' LEU . 2.4 tt -63.2 -45.5 91.41 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 62.3 mt -66.33 -44.62 82.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.406 -1.27 . . . . 0.0 110.129 178.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.09 -45.01 90.57 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 120.074 1.307 . . . . 0.0 110.82 178.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -65.96 -44.44 91.68 Favored Glycine 0 N--CA 1.458 0.155 0 C-N-CA 119.588 -1.291 . . . . 0.0 111.371 -178.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.2 m -63.99 -43.75 94.77 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.949 0.404 . . . . 0.0 110.804 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.421 ' O ' HD23 ' A' ' 129' ' ' LEU . 21.2 m -69.57 -48.7 59.39 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 119.201 -1.0 . . . . 0.0 112.333 177.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 13.8 m -65.93 -42.79 89.62 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 114.868 1.433 . . . . 0.0 114.868 -175.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.435 ' O ' ' OD1' ' A' ' 186' ' ' ASN . . . -64.73 -44.81 94.33 Favored Glycine 0 CA--C 1.521 0.413 0 CA-C-N 114.512 -1.222 . . . . 0.0 113.236 -177.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.32 -41.45 97.04 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 112.457 -1.871 . . . . 0.0 107.196 177.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.614 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 1.6 mm? -64.07 -42.03 97.14 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.173 -0.922 . . . . 0.0 110.207 178.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -62.6 -38.88 91.9 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.58 0.229 . . . . 0.0 111.053 -178.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.616 HG11 HG22 ' A' ' 183' ' ' VAL . 85.6 t -60.58 -25.37 34.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 122.262 1.03 . . . . 0.0 109.516 178.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . -57.94 -44.86 87.21 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 113.281 -1.781 . . . . 0.0 111.988 -178.196 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.487 ' CG1' ' N ' ' A' ' 134' ' ' ALA . 2.7 p -79.04 -48.87 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.536 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.487 ' N ' ' CG1' ' A' ' 133' ' ' VAL . . . -93.2 139.82 30.19 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.905 0.383 . . . . 0.0 111.23 -179.218 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.513 ' N ' ' CD ' ' A' ' 136' ' ' PRO . 1.2 tt0 178.45 -46.71 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.416 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.513 ' CD ' ' N ' ' A' ' 135' ' ' GLN . 54.3 Cg_exo -52.31 -33.45 55.75 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 122.501 2.134 . . . . 0.0 112.462 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 37.9 p -67.65 -42.39 82.29 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 118.255 -1.378 . . . . 0.0 109.394 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -66.67 -43.58 84.11 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 118.351 -1.34 . . . . 0.0 111.912 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 52.9 t -64.75 -44.89 96.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -178.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.4 p -65.48 -39.09 84.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -177.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -62.46 -41.67 98.93 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.715 -177.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 13.2 m -70.47 -45.58 74.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.108 -0.637 . . . . 0.0 110.516 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 9.6 mmt85 -65.08 -37.06 86.3 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.585 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -67.21 -42.1 84.66 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -177.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 23.8 mm100 -65.85 -40.14 91.43 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 119.203 -0.999 . . . . 0.0 110.103 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.22 -34.89 79.43 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 -178.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.441 ' O ' ' CG ' ' A' ' 147' ' ' GLN . 0.3 OUTLIER -59.89 111.07 1.33 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 177.67 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -100.39 -59.01 1.78 Allowed 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -175.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -96.46 60.69 1.92 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 122.125 2.239 . . . . 0.0 110.17 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . 54.97 -94.98 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.321 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 161.97 58.24 0.02 OUTLIER Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 67.32 -80.05 0.15 Allowed Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -56.97 120.74 22.26 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 27.5 ptt-85 -79.4 -129.92 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 121.253 -0.179 . . . . 0.0 110.768 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.43 ' O ' ' O ' ' A' ' 156' ' ' TYR . 72.2 mtt85 57.34 26.31 12.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.739 0.304 . . . . 0.0 110.513 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.43 ' O ' ' O ' ' A' ' 155' ' ' ARG . 67.0 m-85 52.0 104.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.622 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -72.25 179.64 3.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.544 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.429 ' OG ' ' N ' ' A' ' 159' ' ' THR . 40.3 t -157.05 -178.14 7.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.293 0.568 . . . . 0.0 110.978 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.429 ' N ' ' OG ' ' A' ' 158' ' ' SER . 72.5 p -64.04 -46.22 85.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.591 -177.327 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.554 HG13 ' N ' ' A' ' 161' ' ' GLU . 10.3 p -64.43 -45.3 96.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 118.995 -1.082 . . . . 0.0 109.418 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.554 ' N ' HG13 ' A' ' 160' ' ' VAL . 60.6 mt-10 -67.23 -39.13 86.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.961 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -61.58 -46.0 91.75 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -177.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.478 ' CD1' ' C ' ' A' ' 163' ' ' TYR . 0.3 OUTLIER -62.77 -49.97 72.87 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 119.901 -0.719 . . . . 0.0 110.122 -179.577 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.6 mmtt -67.79 -45.62 74.29 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -174.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 19.7 m -62.82 -44.87 95.01 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 119.557 1.072 . . . . 0.0 113.385 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.525 ' N ' HD12 ' A' ' 166' ' ' ILE . 1.3 mp -64.86 -38.73 83.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 121.967 0.889 . . . . 0.0 109.165 176.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.78 -36.43 76.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 113.651 -1.613 . . . . 0.0 108.287 176.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 22.5 tpt85 -62.53 -50.88 69.61 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 122.301 2.319 . . . . 0.0 112.075 -175.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -75.29 -51.36 13.43 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 123.587 0.755 . . . . 0.0 109.231 176.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -78.57 -36.76 44.04 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 -174.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 92.89 -168.48 30.26 Favored Glycine 0 N--CA 1.468 0.81 0 O-C-N 121.995 -0.441 . . . . 0.0 112.427 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.529 HG23 ' N ' ' A' ' 173' ' ' ARG . 10.3 tp -72.99 -41.94 59.79 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.14 0 CA-C-O 121.916 0.865 . . . . 0.0 110.783 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.529 ' N ' HG23 ' A' ' 172' ' ' ILE . 36.2 ttm180 -58.69 -33.34 70.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 113.969 -1.469 . . . . 0.0 110.88 -176.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -60.76 -40.43 98.11 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 118.942 -1.599 . . . . 0.0 110.071 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 7.0 tt -70.37 -33.57 71.58 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 111.58 -2.31 . . . . 0.0 117.129 -177.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 4.9 m0 -77.88 -7.39 56.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 111.771 -2.468 . . . . 0.0 109.961 -176.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 24.8 ttpp -43.22 -48.03 6.51 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.434 -176.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -95.16 -36.29 5.5 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 124.142 0.877 . . . . 0.0 111.495 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.446 ' CG2' ' N ' ' A' ' 180' ' ' SER . 0.6 OUTLIER -45.4 -51.05 11.84 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.446 ' N ' ' CG2' ' A' ' 179' ' ' THR . 3.7 m -62.41 -50.13 80.52 Favored Pre-proline 0 N--CA 1.475 0.801 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -176.057 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 180' ' ' SER . 22.8 Cg_endo -63.95 -27.61 66.53 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 121.533 1.489 . . . . 0.0 111.652 177.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -63.43 -39.26 94.02 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.616 HG22 HG11 ' A' ' 131' ' ' VAL . 60.4 t -63.17 -42.46 96.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.067 0.461 . . . . 0.0 109.878 178.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.03 -38.98 90.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.57 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -60.23 -41.54 93.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.753 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 127' ' ' GLY . 0.5 OUTLIER -61.21 -42.99 99.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.983 0.42 . . . . 0.0 111.211 -179.471 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.73 -44.12 91.18 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.506 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 36.6 mm -64.0 -45.8 95.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.533 ' O ' ' N ' ' A' ' 193' ' ' GLU . 30.8 m -60.34 -46.11 95.48 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.373 0 C-N-CA 119.882 -0.727 . . . . 0.0 111.155 -178.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -62.62 -42.87 99.83 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.501 0.667 . . . . 0.0 110.241 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' CYS . . . . . . . . . . . . . 16.1 t -62.09 -46.09 90.62 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.365 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -63.89 -39.5 94.34 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 113.011 -1.904 . . . . 0.0 109.192 176.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 189' ' ' VAL . 49.4 tp10 -60.18 -46.49 89.53 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.065 -0.97 . . . . 0.0 111.97 -176.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.499 HD13 ' HA ' ' A' ' 194' ' ' LEU . 3.3 mm? -65.26 -38.49 90.48 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 118.17 -1.412 . . . . 0.0 110.866 -176.218 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.437 ' O ' ' CD2' ' A' ' 199' ' ' LEU . 0.3 OUTLIER -63.89 -47.02 92.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 116.345 -2.142 . . . . 0.0 107.347 -179.691 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 9.4 p -65.16 -46.54 80.43 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -179.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -57.34 -39.15 75.32 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.121 1.368 . . . . 0.0 113.473 -177.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -55.59 -44.19 76.7 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.71 HD22 ' N ' ' A' ' 199' ' ' LEU . 2.5 mm? -61.4 -39.54 91.09 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 80.0 mt -63.18 -43.78 99.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 118.485 -0.769 . . . . 0.0 111.464 -178.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 17.8 mmmt -60.52 -40.13 90.33 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 120.551 1.523 . . . . 0.0 109.511 175.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -64.34 -35.45 80.91 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 112.885 -1.961 . . . . 0.0 111.026 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 199' ' ' LEU . 0.2 OUTLIER -101.55 128.35 47.84 Favored 'General case' 0 C--N 1.357 0.894 0 O-C-N 121.0 -1.063 . . . . 0.0 111.239 -179.268 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.441 HD12 ' N ' ' A' ' 204' ' ' LEU . 10.4 mp 66.23 4.91 3.35 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.202 177.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 2.4 mt -129.38 35.8 4.2 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.465 0.65 . . . . 0.0 112.258 -177.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -73.83 -23.33 59.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.728 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.475 ' O ' ' CB ' ' A' ' 208' ' ' ASN . . . -131.17 -45.36 1.01 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.95 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' ASN . . . . . 0.557 ' CG ' ' H ' ' A' ' 209' ' ' LEU . 34.0 p-10 127.2 -72.4 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.198 1.799 . . . . 0.0 108.388 -178.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.557 ' H ' ' CG ' ' A' ' 208' ' ' ASN . 0.3 OUTLIER -160.84 104.16 1.35 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 179.139 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -139.17 29.04 2.26 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.074 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.498 ' OG1' ' N ' ' A' ' 212' ' ' ASP . 5.8 t -142.85 -162.77 1.49 Allowed 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.585 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' ASP . . . . . 0.498 ' N ' ' OG1' ' A' ' 211' ' ' THR . 43.1 m-20 -143.29 -147.2 0.2 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.152 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 63.1 72.89 0.47 Allowed 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.436 ' N ' ' CD ' ' A' ' 215' ' ' PRO . 4.1 mt -61.41 -43.52 89.56 Favored Pre-proline 0 C--N 1.33 -0.255 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 214' ' ' LEU . 26.7 Cg_exo -61.09 -33.58 91.2 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 CA-C-N 119.978 1.028 . . . . 0.0 111.107 -178.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 90.4 m -64.78 -42.46 95.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 113.269 -1.787 . . . . 0.0 111.807 -178.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' HIS . . . . . 0.441 ' O ' ' ND1' ' A' ' 217' ' ' HIS . 1.9 t60 -66.83 -38.32 86.2 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -177.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -63.35 -47.23 82.99 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.73 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 30.5 p -60.17 -37.86 81.43 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 118.943 0.792 . . . . 0.0 111.054 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 11.4 t -59.15 -41.16 87.7 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.3 -41.48 98.96 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -177.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -61.25 -46.98 88.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 122.172 0.987 . . . . 0.0 112.467 -176.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -60.43 -41.61 98.64 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 107.418 -2.273 . . . . 0.0 107.418 176.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' ALA . . . . . 0.454 ' O ' ' SG ' ' A' ' 227' ' ' CYS . . . -62.52 -37.73 87.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.255 -0.972 . . . . 0.0 108.479 176.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -61.65 -42.22 99.72 Favored Glycine 0 CA--C 1.525 0.679 0 CA-C-N 114.757 -1.111 . . . . 0.0 110.586 -178.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -66.62 -38.5 87.09 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.166 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' CYS . . . . . 0.467 ' SG ' ' N ' ' A' ' 228' ' ' THR . 0.5 OUTLIER -63.11 -40.48 97.75 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.236 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.467 ' N ' ' SG ' ' A' ' 227' ' ' CYS . 0.3 OUTLIER -61.29 -39.69 91.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.254 179.473 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.4 ' O ' ' HB3' ' A' ' 232' ' ' ALA . 20.1 m -58.39 -39.43 79.63 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 -178.214 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 92.8 t -60.25 -40.84 84.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 119.339 -0.944 . . . . 0.0 108.497 178.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.596 ' O ' ' HD2' ' A' ' 234' ' ' PRO . 24.8 mm -61.29 -40.09 84.85 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.362 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.168 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 229' ' ' THR . . . -62.17 -38.4 88.92 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -178.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.451 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 0.3 OUTLIER -57.24 -40.19 82.89 Favored Pre-proline 0 N--CA 1.48 1.054 0 N-CA-C 116.107 1.891 . . . . 0.0 116.107 -173.052 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.596 ' HD2' ' O ' ' A' ' 231' ' ' ILE . 33.0 Cg_exo -58.76 -40.52 71.98 Favored 'Trans proline' 0 C--N 1.298 -2.088 0 C-N-CA 122.008 1.805 . . . . 0.0 113.516 -177.357 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 4.6 m -64.66 -36.0 76.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 119.071 -1.051 . . . . 0.0 110.243 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -64.79 -40.71 95.7 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 -177.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.439 ' H ' HG22 ' A' ' 237' ' ' VAL . 6.3 m -64.79 -45.48 94.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -176.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 5.7 p -63.36 -36.72 77.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 119.888 -0.725 . . . . 0.0 110.038 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 30.9 mmtm -60.0 -43.66 95.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.552 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -60.59 -41.84 95.53 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -177.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.445 ' NH1' ' CE1' ' A' ' 269' ' ' PHE . 64.3 mtp180 -70.05 134.2 48.0 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.277 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.617 ' CG ' ' O ' ' A' ' 242' ' ' TYR . 22.6 t80 163.76 5.2 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 O-C-N 123.839 0.712 . . . . 0.0 112.535 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 243' ' ' MET . . . . . 0.54 ' O ' ' ND2' ' A' ' 244' ' ' ASN . 21.4 ttm -116.37 161.3 19.27 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.084 -1.01 . . . . 0.0 110.942 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 244' ' ' ASN . . . . . 0.54 ' ND2' ' O ' ' A' ' 243' ' ' MET . 2.3 m-80 81.05 -178.11 0.07 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.281 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 1.7 m 67.05 30.66 7.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.85 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -112.06 45.47 1.26 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.962 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 15.5 mt -97.64 -74.27 0.58 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.798 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.446 ' O ' ' CD2' ' A' ' 250' ' ' TYR . . . -171.19 170.09 43.0 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.61 ' O ' ' CG ' ' A' ' 250' ' ' TYR . 23.5 mt-30 65.85 -164.39 0.24 Allowed 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.61 ' CG ' ' O ' ' A' ' 249' ' ' GLN . 23.3 p90 50.52 140.12 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 O-C-N 124.133 0.896 . . . . 0.0 110.941 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 251' ' ' HIS . . . . . 0.978 ' ND1' ' NE2' ' A' ' 255' ' ' HIS . 17.8 m80 -65.37 -51.23 61.88 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 118.267 -1.373 . . . . 0.0 108.331 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 252' ' ' SER . . . . . 0.411 ' H ' ' HB3' ' A' ' 255' ' ' HIS . 55.7 m -149.09 -178.6 6.47 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 121.677 0.751 . . . . 0.0 112.031 175.436 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -65.13 -43.99 90.1 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.412 -1.267 . . . . 0.0 112.569 177.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' GLY . . . . . 0.414 ' O ' ' HB3' ' A' ' 257' ' ' ALA . . . -67.21 -43.47 89.16 Favored Glycine 0 N--CA 1.463 0.463 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.814 177.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 255' ' ' HIS . . . . . 0.978 ' NE2' ' ND1' ' A' ' 251' ' ' HIS . 86.4 t60 -63.27 -32.5 73.92 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 112.546 -1.827 . . . . 0.0 110.983 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 256' ' ' CYS . . . . . . . . . . . . . 7.5 t -61.81 -42.34 98.89 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 114.049 -1.432 . . . . 0.0 108.529 175.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 254' ' ' GLY . . . -58.06 -42.95 86.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.604 -178.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -64.43 -42.31 96.09 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 96.8 m -62.37 -45.03 95.02 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.879 177.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' MET . . . . . 0.595 ' O ' ' N ' ' A' ' 264' ' ' GLU . 0.0 OUTLIER -60.5 -41.58 94.59 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.894 -178.972 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 8.8 tp -61.2 -47.68 85.0 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 29.1 mtp85 -67.28 -53.86 26.06 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 43.6 tttp -66.51 -69.89 0.28 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.42 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 264' ' ' GLU . . . . . 0.595 ' N ' ' O ' ' A' ' 260' ' ' MET . 43.6 tp10 -88.32 110.77 21.03 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.835 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.484 ' C ' ' H ' ' A' ' 267' ' ' ARG . . . -34.45 155.9 0.01 OUTLIER Glycine 0 CA--C 1.539 1.558 0 CA-C-N 116.3 -0.409 . . . . 0.0 112.11 -179.211 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -56.03 3.23 0.08 OUTLIER 'Trans proline' 0 N--CA 1.503 2.048 0 C-N-CA 122.131 1.888 . . . . 0.0 113.086 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.484 ' H ' ' C ' ' A' ' 265' ' ' GLY . 99.6 mtt180 -68.95 -27.0 65.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.436 0.16 . . . . 0.0 110.768 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -58.78 -32.7 69.54 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.57 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 269' ' ' PHE . . . . . 0.445 ' CE1' ' NH1' ' A' ' 241' ' ' ARG . 51.1 m-85 -62.47 -42.47 99.5 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.554 0.693 . . . . 0.0 110.683 178.192 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -66.62 -37.46 84.92 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.668 -1.151 . . . . 0.0 113.17 -178.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 272' ' ' GLY . 68.4 mttm -77.59 171.89 14.22 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 272' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 271' ' ' LYS . . . 53.69 111.79 0.01 OUTLIER Glycine 0 CA--C 1.528 0.874 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 273' ' ' PHE . . . . . 0.424 ' H ' ' H ' ' A' ' 274' ' ' MET . 48.2 p90 -172.25 3.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.616 -0.433 . . . . 0.0 111.144 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 274' ' ' MET . . . . . 0.559 ' N ' ' CD ' ' A' ' 275' ' ' PRO . 1.4 ttt -64.01 -44.13 77.12 Favored Pre-proline 0 C--N 1.329 -0.324 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.615 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 275' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' A' ' 274' ' ' MET . 19.5 Cg_exo -64.71 -47.9 4.76 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 121.852 1.701 . . . . 0.0 112.107 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 44.6 t -61.52 -40.74 95.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.664 0.745 . . . . 0.0 110.743 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -62.33 -42.62 99.53 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 123.491 1.615 . . . . 0.0 113.541 -178.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 9.2 tp -62.78 -39.24 93.6 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 110.607 -2.997 . . . . 0.0 108.887 174.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 71.5 mtp180 -63.04 -40.54 98.04 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.561 0.696 . . . . 0.0 110.713 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.855 ' O ' HD12 ' A' ' 280' ' ' LEU . 0.1 OUTLIER -62.26 -36.22 81.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.609 -1.178 . . . . 0.0 112.211 -177.446 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -68.14 -51.16 34.94 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 282' ' ' SER . . . . . 0.503 ' O ' HG22 ' A' ' 285' ' ' VAL . 71.1 m -63.19 -44.68 94.68 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 123.087 0.555 . . . . 0.0 109.84 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 283' ' ' TRP . . . . . . . . . . . . . 80.3 t90 -60.46 -38.0 82.8 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.851 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -61.75 -37.96 86.19 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.718 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.503 HG22 ' O ' ' A' ' 282' ' ' SER . 0.9 OUTLIER -60.2 -37.44 73.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 111.567 0.21 . . . . 0.0 111.567 -178.598 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.777 ' O ' HG12 ' A' ' 289' ' ' VAL . 0.8 OUTLIER -61.75 -40.15 85.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 120.505 -0.478 . . . . 0.0 109.986 -178.804 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 8.4 tpt -60.91 -39.11 88.11 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.245 0.545 . . . . 0.0 109.721 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -59.05 -41.05 86.98 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.856 -178.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.777 HG12 ' O ' ' A' ' 286' ' ' VAL . 8.1 p -61.28 -38.53 80.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 O-C-N 121.855 -0.528 . . . . 0.0 112.091 -177.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 19.4 p -62.53 -40.98 98.5 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 119.18 -1.008 . . . . 0.0 108.379 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -60.89 -38.55 86.06 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 177.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 14.9 tm-20 -57.53 -39.58 76.92 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 118.138 -1.425 . . . . 0.0 109.535 -176.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 293' ' ' GLN . . . . . 0.439 ' O ' ' O ' ' A' ' 296' ' ' ARG . 1.6 pt20 -60.17 -41.63 93.25 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 122.968 1.366 . . . . 0.0 110.11 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 65.0 mt -60.25 -39.32 86.31 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 112.206 -2.27 . . . . 0.0 109.557 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -62.16 -45.26 94.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.088 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 296' ' ' ARG . . . . . 0.439 ' O ' ' O ' ' A' ' 293' ' ' GLN . 62.3 ttm-85 -122.58 116.06 23.22 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 297' ' ' ALA . . . . . 0.445 ' HB1' HD12 ' A' ' 298' ' ' LEU . . . -109.72 -169.82 1.54 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.402 0.62 . . . . 0.0 111.76 -178.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.797 ' H ' HD12 ' A' ' 298' ' ' LEU . 0.0 OUTLIER -68.24 -8.83 42.66 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.977 -1.011 . . . . 0.0 111.471 -178.663 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 299' ' ' MET . . . . . 0.403 ' C ' ' O ' ' A' ' 298' ' ' LEU . 74.1 mtp 28.1 62.41 0.11 Allowed 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 177.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.62 100.81 0.07 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.812 0.815 . . . . 0.0 110.896 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -63.93 -46.3 85.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.131 -1.395 . . . . 0.0 113.386 -176.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 302' ' ' TYR . . . . . 0.527 ' CD2' ' OE2' ' A' ' 306' ' ' GLU . 32.8 t80 -58.68 -40.13 82.68 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.023 -0.671 . . . . 0.0 109.539 -178.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 303' ' ' GLN . . . . . 0.485 ' N ' ' OE1' ' A' ' 303' ' ' GLN . 1.3 mp0 -65.0 -46.83 79.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.186 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 304' ' ' SER . . . . . 0.446 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 77.8 p -66.23 -37.4 85.45 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.553 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -61.43 -42.82 99.35 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.057 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.527 ' OE2' ' CD2' ' A' ' 302' ' ' TYR . 41.7 mt-10 -64.71 -36.99 86.08 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.228 1.195 . . . . 0.0 114.228 -177.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 307' ' ' ALA . . . . . 0.534 ' HB3' ' HD3' ' A' ' 308' ' ' PRO . . . -60.02 -52.95 69.88 Favored Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -176.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 308' ' ' PRO . . . . . 0.534 ' HD3' ' HB3' ' A' ' 307' ' ' ALA . 74.0 Cg_endo -75.26 0.27 9.21 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.193 1.929 . . . . 0.0 111.908 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 91.9 t80 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.609 -179.981 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 16.6 ptm . . . . . 0 N--CA 1.492 1.651 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.5 m -78.74 119.39 21.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.048 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.405 HG12 ' H ' ' A' ' 17' ' ' PHE . 3.9 t -147.23 143.85 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 121.129 0.49 . . . . 0.0 111.085 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -64.21 -40.82 96.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.679 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.405 ' H ' HG12 ' A' ' 15' ' ' VAL . 74.1 t80 -63.49 -41.39 98.57 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.175 -0.921 . . . . 0.0 113.208 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 50.9 tp -79.77 -26.48 40.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.177 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.401 ' O ' ' OG1' ' A' ' 22' ' ' THR . . . -66.43 -41.44 94.37 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 107.363 -2.295 . . . . 0.0 107.363 176.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.405 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -71.26 -31.75 67.89 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 124.84 2.257 . . . . 0.0 107.316 176.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.46 -42.72 98.93 Favored Glycine 0 CA--C 1.528 0.867 1 CA-C-N 108.364 -4.016 . . . . 0.0 108.307 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' A' ' 19' ' ' GLY . 35.6 p -70.71 -27.95 64.37 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.576 0.703 . . . . 0.0 109.314 177.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -66.38 -50.18 64.34 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.946 -178.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.82 -35.82 79.33 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 118.671 -1.212 . . . . 0.0 111.2 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 75.6 m -63.71 -53.63 48.16 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.343 -178.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.9 pt -65.47 -39.77 86.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 -177.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.05 -42.02 97.19 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 119.763 -0.775 . . . . 0.0 112.845 -173.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 28' ' ' ASP . 43.1 t0 -77.71 -27.36 50.63 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 118.249 -1.38 . . . . 0.0 109.544 -176.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.1 tp -60.29 -55.67 30.86 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.714 1.143 . . . . 0.0 111.729 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.0 pt -75.4 -4.0 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 121.306 0.574 . . . . 0.0 112.368 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.429 HG22 ' O ' ' A' ' 31' ' ' THR . 30.1 m -109.12 -16.8 14.02 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.254 -178.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -69.02 -44.69 29.29 Favored Pre-proline 0 CA--C 1.544 0.731 0 CA-C-N 121.868 2.122 . . . . 0.0 111.926 -178.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -59.64 -16.25 35.67 Favored 'Trans proline' 0 N--CA 1.504 2.088 0 CA-C-N 120.897 1.356 . . . . 0.0 112.857 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 62.2 mt -67.54 -35.15 78.51 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -177.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.404 ' HA ' ' HZ3' ' A' ' 38' ' ' LYS . 1.1 m-20 -64.23 -40.52 96.2 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.128 -177.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 87.0 m -58.2 -34.84 70.81 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.14 -38.97 86.43 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 119.691 -0.804 . . . . 0.0 113.048 -179.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.404 ' HZ3' ' HA ' ' A' ' 35' ' ' ASP . 9.2 pttm -62.14 -47.55 84.07 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 118.995 -1.082 . . . . 0.0 111.656 -177.079 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.6 t -62.83 -38.72 82.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -177.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.504 ' O ' ' N ' ' A' ' 42' ' ' GLN . 7.9 tpm_? -59.45 -41.25 89.22 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 119.266 -0.974 . . . . 0.0 109.706 -178.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.498 ' C ' ' H ' ' A' ' 43' ' ' ILE . 9.4 mp -62.69 38.83 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.59 177.265 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.57 ' O ' ' N ' ' A' ' 44' ' ' GLN . 3.9 tp-100 -72.71 23.96 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 O-C-N 121.947 -0.471 . . . . 0.0 111.385 -178.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.509 ' O ' HG23 ' A' ' 43' ' ' ILE . 9.2 tp 28.98 34.03 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 121.404 0.621 . . . . 0.0 111.534 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.57 ' N ' ' O ' ' A' ' 42' ' ' GLN . 28.2 mp0 53.79 98.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.566 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -169.19 31.74 0.17 Allowed Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -70.57 -28.68 65.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.828 0.347 . . . . 0.0 110.684 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 17.7 t 59.38 42.2 18.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.998 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -98.99 -19.64 17.18 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.1 0.476 . . . . 0.0 110.05 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.16 -23.28 30.29 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.551 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -66.1 -38.26 87.79 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.612 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.528 HG13 ' N ' ' A' ' 52' ' ' ARG . 14.3 p -61.04 -44.5 98.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.151 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.528 ' N ' HG13 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -64.24 -33.58 76.15 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.714 -178.461 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -67.93 -38.05 82.41 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -93.18 -146.25 0.23 Allowed 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.847 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -176.11 -32.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.084 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.593 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 7.9 t -128.08 -138.83 0.24 Allowed 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.593 ' HB3' ' O ' ' A' ' 56' ' ' SER . . . 99.25 12.56 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.6 0 O-C-N 124.165 0.916 . . . . 0.0 111.277 178.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.439 ' CG ' ' O ' ' A' ' 58' ' ' GLN . 4.3 pt20 -174.24 121.1 0.28 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -85.76 151.41 23.85 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 87.9 mtt180 -45.43 -33.02 2.39 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 122.453 1.121 . . . . 0.0 108.096 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -41.89 114.37 0.67 Allowed Glycine 0 CA--C 1.526 0.723 0 CA-C-N 112.86 -1.973 . . . . 0.0 113.195 -178.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.6 p -66.75 -33.02 60.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 118.124 -0.941 . . . . 0.0 108.862 176.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.407 ' O ' HD23 ' A' ' 67' ' ' LEU . 3.7 mm? -60.18 -32.3 70.94 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 121.747 2.067 . . . . 0.0 110.868 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.59 -49.07 66.59 Favored Glycine 0 CA--C 1.532 1.121 0 N-CA-C 114.965 0.746 . . . . 0.0 114.965 -176.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.401 HG22 ' H ' ' A' ' 65' ' ' THR . 1.6 t -62.04 -45.57 93.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.178 -0.511 . . . . 0.0 111.933 -179.177 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 35.2 mm -59.25 -36.25 62.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.407 HD23 ' O ' ' A' ' 63' ' ' LEU . 2.1 mm? -63.91 -35.84 81.97 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 120.764 1.62 . . . . 0.0 112.148 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 97.9 m -63.0 -39.82 95.89 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 114.002 -1.454 . . . . 0.0 111.04 -175.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.463 ' O ' ' OG1' ' A' ' 72' ' ' THR . 0.1 OUTLIER -60.03 -39.61 86.48 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -176.023 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.6 p -69.91 -40.5 78.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 113.934 1.086 . . . . 0.0 113.934 -178.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -78.3 -13.56 59.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.8 0.809 . . . . 0.0 112.883 -178.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' A' ' 69' ' ' MET . 0.0 OUTLIER -63.2 -54.62 34.61 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.069 -1.423 . . . . 0.0 111.002 178.968 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -107.79 -57.76 2.06 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.805 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 157.99 163.49 12.81 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -56.51 -35.15 96.53 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 121.987 1.792 . . . . 0.0 111.683 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.407 ' O ' ' CG ' ' A' ' 80' ' ' ASN . 91.7 mtt-85 -61.39 -11.65 11.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.654 0.74 . . . . 0.0 111.022 176.221 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.9 t -77.69 -32.42 53.04 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.089 -1.414 . . . . 0.0 111.038 -177.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.516 HD12 ' N ' ' A' ' 78' ' ' LEU . 10.2 mp -75.5 -33.09 60.74 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 122.126 -0.359 . . . . 0.0 110.783 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -91.91 -4.58 54.54 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 122.796 1.284 . . . . 0.0 113.142 -178.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.407 ' CG ' ' O ' ' A' ' 76' ' ' ARG . 5.9 m-20 -97.47 117.65 32.21 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 112.025 -2.352 . . . . 0.0 107.168 174.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.9 -13.5 56.17 Favored Glycine 0 N--CA 1.469 0.866 0 N-CA-C 108.255 -1.938 . . . . 0.0 108.255 -177.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 12.3 tp -58.85 -34.71 71.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 113.305 -1.448 . . . . 0.0 110.249 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.8 p -70.54 -26.78 29.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.364 178.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.81 -31.61 61.76 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.796 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.86 -40.42 89.4 Favored Glycine 0 N--CA 1.463 0.492 0 C-N-CA 119.677 -1.249 . . . . 0.0 111.223 -177.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.3 mp -62.34 -40.08 95.21 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 122.364 1.078 . . . . 0.0 112.5 -177.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -60.44 -27.24 67.35 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 113.071 -1.877 . . . . 0.0 109.34 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 49.4 ttp180 -57.91 -53.48 57.77 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 173.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 47.9 tp60 -67.44 -29.89 69.48 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 112.56 -2.109 . . . . 0.0 112.428 -178.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 12.2 tpt -61.02 -40.98 95.63 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.352 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 78.2 p -74.35 -34.34 63.38 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 119.509 -0.877 . . . . 0.0 111.401 -176.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -58.04 -44.48 87.43 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 120.6 1.545 . . . . 0.0 111.789 -176.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.33 -33.59 65.21 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.49 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.1 t -64.48 -41.8 96.25 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.3 t -68.41 -28.6 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.841 177.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.568 ' NH2' ' CE2' ' A' ' 100' ' ' TYR . 59.9 ttt-85 -78.05 8.79 4.29 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -177.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.492 HD13 ' O ' ' A' ' 97' ' ' ILE . 0.3 OUTLIER -87.49 -14.95 9.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.086 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -140.09 -48.13 0.06 OUTLIER Glycine 0 CA--C 1.54 1.631 0 N-CA-C 115.864 1.106 . . . . 0.0 115.864 -176.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.7 mt -71.08 -12.56 61.58 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 119.586 1.693 . . . . 0.0 112.817 -178.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.568 ' CE2' ' NH2' ' A' ' 96' ' ' ARG . 4.3 t80 -80.22 -51.32 9.08 Favored 'General case' 0 C--O 1.214 -0.778 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.438 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 1.086 ' OD1' ' CD ' ' A' ' 105' ' ' GLN . 12.7 t70 -69.48 -32.73 71.81 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 123.45 1.595 . . . . 0.0 110.561 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 31.1 m -68.82 -52.47 29.77 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 111.023 -2.808 . . . . 0.0 114.466 177.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.582 HG22 ' CE2' ' A' ' 107' ' ' TYR . 1.1 p -74.97 -27.82 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 CA-C-N 121.942 2.156 . . . . 0.0 112.479 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.521 ' HB2' ' O ' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -69.99 -41.74 73.98 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 110.849 -2.887 . . . . 0.0 112.801 -179.636 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 1.086 ' CD ' ' OD1' ' A' ' 101' ' ' ASP . 27.2 mt-30 -78.88 -11.43 60.0 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 122.972 1.368 . . . . 0.0 111.043 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.47 -21.94 48.27 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 113.924 -1.489 . . . . 0.0 111.086 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.582 ' CE2' HG22 ' A' ' 103' ' ' VAL . 47.5 m-85 -108.36 -30.57 8.25 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 120.005 1.275 . . . . 0.0 111.614 -175.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.1 p -98.27 9.68 42.44 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 117.972 -1.491 . . . . 0.0 112.047 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.47 ' O ' ' C ' ' A' ' 110' ' ' GLY . 16.0 ttmm -54.19 118.17 3.85 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.619 0.645 . . . . 0.0 112.453 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.511 ' O ' ' O ' ' A' ' 111' ' ' SER . . . -17.24 -89.09 0.01 OUTLIER Glycine 0 N--CA 1.48 1.585 0 CA-C-O 119.81 -0.439 . . . . 0.0 113.155 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.703 ' O ' ' O ' ' A' ' 112' ' ' GLU . 5.9 t 45.44 111.54 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 117.252 0.526 . . . . 0.0 111.797 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.703 ' O ' ' O ' ' A' ' 111' ' ' SER . 17.1 pt-20 -9.57 -148.26 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 126.481 1.913 . . . . 0.0 115.929 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.622 ' O ' ' HB2' ' A' ' 114' ' ' ALA . 0.0 OUTLIER -105.92 73.35 0.99 Allowed 'General case' 0 C--N 1.343 0.303 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -177.257 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.622 ' HB2' ' O ' ' A' ' 113' ' ' HIS . . . 160.14 -164.38 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 122.35 1.072 . . . . 0.0 108.963 175.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.03 15.6 25.72 Favored Glycine 0 C--N 1.342 0.863 0 CA-C-N 113.015 -1.902 . . . . 0.0 111.487 178.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.434 HG23 ' N ' ' A' ' 117' ' ' GLY . 13.3 tt -60.71 -40.33 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 C-N-CA 119.609 -0.837 . . . . 0.0 111.015 -178.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.434 ' N ' HG23 ' A' ' 116' ' ' ILE . . . -65.56 -40.39 96.05 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-O 121.716 0.62 . . . . 0.0 112.098 176.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 26.0 p -58.41 -42.57 87.48 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 176.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.1 tpp180 -63.55 -37.24 86.55 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 119.824 -0.75 . . . . 0.0 110.927 -177.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.669 HD21 HD22 ' A' ' 194' ' ' LEU . 2.6 mm? -63.35 -46.1 88.11 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.234 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 20.9 mt -66.51 -44.76 81.66 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 118.896 -1.122 . . . . 0.0 109.847 178.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.1 -45.21 89.67 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 119.964 1.256 . . . . 0.0 110.452 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -65.81 -44.42 92.14 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.191 -1.004 . . . . 0.0 111.262 -178.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 42.5 m -64.17 -43.75 94.2 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.742 0.306 . . . . 0.0 111.418 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 19.7 m -69.5 -48.27 61.11 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 119.346 -0.942 . . . . 0.0 112.337 177.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.475 HG23 ' N ' ' A' ' 127' ' ' GLY . 6.0 t -65.68 -42.75 90.9 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 -174.236 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.475 ' N ' HG23 ' A' ' 126' ' ' THR . . . -64.48 -44.96 94.46 Favored Glycine 0 CA--C 1.52 0.401 0 CA-C-N 114.632 -1.167 . . . . 0.0 113.138 -177.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.432 ' O ' HG22 ' A' ' 131' ' ' VAL . . . -61.81 -41.71 98.1 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 112.719 -1.741 . . . . 0.0 107.207 177.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.745 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 54.6 tp -64.7 -42.62 95.15 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.09 178.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.34 -40.09 96.33 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.099 0.778 . . . . 0.0 113.099 -177.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 128' ' ' ALA . 14.3 m -61.17 -26.55 39.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 123.521 1.629 . . . . 0.0 109.639 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.745 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . -59.29 -45.49 91.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 110.835 -2.893 . . . . 0.0 112.673 -178.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.419 ' H ' HG12 ' A' ' 133' ' ' VAL . 2.6 p -79.65 -49.03 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 -178.215 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -121.79 136.39 54.93 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.823 0.344 . . . . 0.0 111.667 -178.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.762 ' H ' ' CD ' ' A' ' 136' ' ' PRO . 3.9 pp0? 170.33 -21.36 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.723 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.79 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.762 ' CD ' ' H ' ' A' ' 135' ' ' GLN . 53.0 Cg_exo -52.84 -34.68 66.74 Favored 'Trans proline' 0 N--CA 1.499 1.85 0 CA-C-N 121.174 1.455 . . . . 0.0 113.268 -178.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.479 HG23 ' N ' ' A' ' 138' ' ' ASP . 11.5 t -67.28 -41.59 85.22 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 119.07 -1.052 . . . . 0.0 108.613 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.479 ' N ' HG23 ' A' ' 137' ' ' THR . 98.5 m-20 -64.68 -42.24 95.49 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 118.857 -1.137 . . . . 0.0 111.34 -178.02 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 55.3 t -63.85 -44.48 98.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 32.1 m -65.33 -38.17 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -177.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -61.73 -40.65 95.84 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -176.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.443 ' CG2' ' N ' ' A' ' 143' ' ' ARG . 1.5 m -69.41 -44.24 80.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.028 -0.669 . . . . 0.0 109.343 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.528 ' NH2' ' O ' ' A' ' 174' ' ' GLY . 94.8 mtt-85 -63.86 -35.41 80.56 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.288 178.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -65.89 -40.21 91.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.92 -177.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 23.8 tm0? -63.98 -39.31 93.83 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 119.335 -0.946 . . . . 0.0 108.861 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.14 -35.16 80.24 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 113.267 0.839 . . . . 0.0 113.267 -178.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.52 110.78 1.19 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 177.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -99.41 -60.58 1.5 Allowed 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -175.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -98.35 117.51 32.93 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 122.107 2.23 . . . . 0.0 109.968 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -68.14 -15.0 63.4 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.666 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 71.08 -173.85 41.68 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 153' ' ' GLY . . . -46.37 -94.5 0.01 OUTLIER Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 152' ' ' GLY . . . 48.57 101.83 0.01 OUTLIER Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -59.99 -40.41 89.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.789 0.328 . . . . 0.0 110.373 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -56.78 -169.74 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.344 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.428 ' O ' ' O ' ' A' ' 157' ' ' GLN . 79.4 t80 -108.86 -0.17 19.95 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.979 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.428 ' O ' ' O ' ' A' ' 156' ' ' TYR . 18.1 mm100 59.4 145.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.338 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 70.5 m -157.07 -177.73 6.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.383 0.611 . . . . 0.0 111.201 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 96.8 m -63.92 -45.97 86.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.551 -177.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.539 HG23 ' N ' ' A' ' 161' ' ' GLU . 8.2 m -64.01 -44.9 97.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 118.913 -1.115 . . . . 0.0 109.008 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.539 ' N ' HG23 ' A' ' 160' ' ' VAL . 94.6 mt-10 -66.94 -39.04 87.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.859 0.361 . . . . 0.0 111.459 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -61.76 -45.62 93.14 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -177.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -62.38 -49.66 74.65 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.509 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 65.7 mmtt -68.44 -45.43 72.53 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 -175.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 35.6 p -62.79 -44.66 95.58 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 120.78 -1.2 . . . . 0.0 113.921 -177.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.419 HD12 ' N ' ' A' ' 167' ' ' ALA . 2.4 pp -64.64 -37.78 80.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 121.825 0.822 . . . . 0.0 109.632 176.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.419 ' N ' HD12 ' A' ' 166' ' ' ILE . . . -58.64 -35.87 73.2 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 113.741 -1.572 . . . . 0.0 107.829 177.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 7.8 tpm_? -61.94 -50.47 71.99 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 121.706 2.048 . . . . 0.0 112.726 -175.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -75.25 -51.21 13.83 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 123.684 0.793 . . . . 0.0 111.199 178.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -78.14 -36.24 48.01 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 116.169 1.914 . . . . 0.0 116.169 -172.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 93.03 -167.42 29.28 Favored Glycine 0 N--CA 1.47 0.951 0 N-CA-C 111.872 -0.491 . . . . 0.0 111.872 177.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.711 HD13 ' H ' ' A' ' 172' ' ' ILE . 0.0 OUTLIER -73.37 -44.48 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 CA-C-O 121.796 0.808 . . . . 0.0 109.871 -179.827 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -59.03 -33.9 71.28 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 114.442 -1.254 . . . . 0.0 111.424 -177.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.528 ' O ' ' NH2' ' A' ' 143' ' ' ARG . . . -61.05 -40.41 98.47 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 118.575 -1.774 . . . . 0.0 109.3 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 1.2 tp -70.54 -33.71 71.45 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 111.459 -2.371 . . . . 0.0 116.995 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 6.4 m95 -77.84 -7.56 56.83 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 111.991 -2.368 . . . . 0.0 109.796 -177.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 48.1 tttp -43.39 -48.29 7.04 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.575 -176.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -95.1 -40.03 4.39 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.3 0.953 . . . . 0.0 112.109 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.407 HG23 ' H ' ' A' ' 179' ' ' THR . 11.5 p -45.46 -51.44 11.57 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -179.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.452 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 2.6 m -62.72 -50.69 76.7 Favored Pre-proline 0 N--CA 1.472 0.659 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -176.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' A' ' 180' ' ' SER . 30.1 Cg_endo -64.5 -27.58 62.07 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 121.986 1.791 . . . . 0.0 111.928 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -63.35 -39.09 93.58 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 120.588 -0.445 . . . . 0.0 109.939 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.451 ' O ' ' OD1' ' A' ' 186' ' ' ASN . 85.2 t -62.84 -42.3 95.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.051 0.453 . . . . 0.0 109.975 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.88 -39.51 92.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.095 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 46.2 ttp85 -60.44 -40.83 92.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.923 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ASN . . . . . 0.49 ' C ' ' ND2' ' A' ' 186' ' ' ASN . 0.0 OUTLIER -60.34 -41.67 94.08 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.136 0.493 . . . . 0.0 110.34 -179.667 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.2 -43.19 98.87 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.79 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.444 ' O ' ' SG ' ' A' ' 191' ' ' CYS . 42.9 mm -63.01 -44.8 99.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.381 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 6.3 m -59.37 -45.67 93.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 119.816 -0.754 . . . . 0.0 111.276 -178.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.406 ' OD1' ' N ' ' A' ' 191' ' ' CYS . 0.9 OUTLIER -61.8 -42.51 99.1 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.876 0.846 . . . . 0.0 109.419 179.302 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 191' ' ' CYS . . . . . 0.551 ' SG ' ' N ' ' A' ' 192' ' ' ALA . 0.5 OUTLIER -62.0 -45.94 91.41 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.013 -1.449 . . . . 0.0 110.828 179.666 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.551 ' N ' ' SG ' ' A' ' 191' ' ' CYS . . . -63.71 -40.4 96.68 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 114.463 -1.244 . . . . 0.0 109.433 177.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -60.74 -44.72 96.33 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.702 -1.136 . . . . 0.0 112.579 -178.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.669 HD22 HD21 ' A' ' 120' ' ' LEU . 2.5 pp -63.0 -37.83 88.74 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 118.862 -1.135 . . . . 0.0 109.75 -174.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.47 ' N ' ' HG ' ' A' ' 194' ' ' LEU . 0.6 OUTLIER -63.99 -46.15 94.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 C-N-CA 117.206 -1.798 . . . . 0.0 107.464 179.074 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 19.2 m -63.98 -46.52 84.24 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -176.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -56.8 -39.12 73.57 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.694 0.798 . . . . 0.0 111.222 -178.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -56.06 -43.93 78.41 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.4 HD23 ' N ' ' A' ' 199' ' ' LEU . 7.7 mt -61.21 -39.39 90.06 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.599 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.1 mm -62.94 -42.04 95.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 1.8 mmmm -59.27 -38.77 80.95 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.744 1.618 . . . . 0.0 114.911 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -64.27 -42.24 96.53 Favored 'General case' 0 C--O 1.245 0.849 0 O-C-N 121.087 -1.008 . . . . 0.0 111.063 -176.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.631 HG22 HD23 ' A' ' 204' ' ' LEU . 4.0 m -102.5 129.19 48.95 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -176.15 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.631 HD23 HG22 ' A' ' 203' ' ' THR . 3.6 mm? 66.52 3.32 2.83 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 113.717 -1.583 . . . . 0.0 111.299 177.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.555 HD22 ' O ' ' A' ' 204' ' ' LEU . 2.9 mm? -122.1 24.53 9.46 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 -178.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -79.33 -18.11 53.18 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.502 0.668 . . . . 0.0 110.382 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.463 ' O ' ' CB ' ' A' ' 208' ' ' ASN . . . -167.1 25.96 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.204 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' ASN . . . . . 0.61 ' O ' ' O ' ' A' ' 204' ' ' LEU . 1.7 m-20 93.53 -130.83 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.39 0.676 . . . . 0.0 109.81 -178.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.682 ' O ' HD23 ' A' ' 209' ' ' LEU . 6.5 tt -170.21 57.11 0.04 OUTLIER 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 106.719 -1.585 . . . . 0.0 106.719 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 8.5 mmt -99.02 42.95 1.08 Allowed 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 112.833 -1.985 . . . . 0.0 109.217 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.404 HG22 ' H ' ' A' ' 212' ' ' ASP . 2.6 m -69.48 -130.38 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.984 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 212' ' ' ASP . . . . . 0.404 ' H ' HG22 ' A' ' 211' ' ' THR . 2.7 p30 -158.57 18.89 0.21 Allowed 'General case' 0 CA--C 1.528 0.118 0 CA-C-O 120.7 0.286 . . . . 0.0 110.885 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 213' ' ' ASP . 34.8 p30 -147.44 81.42 1.52 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.963 0.411 . . . . 0.0 110.444 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.45 ' N ' ' HD2' ' A' ' 215' ' ' PRO . 2.0 pt? -61.11 -42.07 84.3 Favored Pre-proline 0 CA--C 1.548 0.877 0 N-CA-C 113.828 1.048 . . . . 0.0 113.828 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' A' ' 214' ' ' LEU . 37.5 Cg_endo -60.13 -32.19 94.27 Favored 'Trans proline' 0 N--CA 1.502 2.01 0 CA-C-N 122.419 1.9 . . . . 0.0 111.458 -178.048 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 9.9 t -63.51 -42.13 98.5 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 113.48 -1.691 . . . . 0.0 111.713 -177.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' HIS . . . . . 0.433 ' CG ' HD11 ' A' ' 209' ' ' LEU . 54.8 t60 -66.64 -37.75 85.46 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.348 -0.541 . . . . 0.0 111.933 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -63.28 -47.04 84.0 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.515 -178.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 1.5 t -60.22 -37.51 80.54 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 118.845 0.748 . . . . 0.0 111.032 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 78.7 p -59.51 -41.71 90.54 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.544 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.68 -41.61 98.13 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -177.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -61.66 -47.04 87.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 122.007 0.908 . . . . 0.0 112.71 -176.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -60.42 -41.73 98.67 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 107.544 -2.223 . . . . 0.0 107.544 177.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -62.95 -38.05 89.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.33 -0.935 . . . . 0.0 109.043 177.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -61.94 -42.1 99.71 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.192 -178.091 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -66.16 -38.4 88.0 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 97.5 m -63.1 -40.8 98.69 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 176.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 11.2 m -61.59 -40.1 93.59 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.263 -1.335 . . . . 0.0 110.997 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 92.4 m -58.4 -39.13 78.86 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.371 -177.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 97.1 t -59.68 -40.46 82.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.594 ' O ' ' HD2' ' A' ' 234' ' ' PRO . 23.0 mm -60.97 -40.11 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 177.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -62.32 -38.63 90.17 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.47 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 0.1 OUTLIER -57.25 -40.87 87.82 Favored Pre-proline 0 N--CA 1.482 1.173 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 -172.979 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.594 ' HD2' ' O ' ' A' ' 231' ' ' ILE . 31.6 Cg_exo -57.87 -39.22 88.53 Favored 'Trans proline' 0 C--N 1.292 -2.404 0 C-N-CA 122.021 1.814 . . . . 0.0 112.491 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 31.0 t -63.52 -36.32 75.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 118.802 -1.159 . . . . 0.0 109.398 178.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' ASP . . . . . 0.451 ' OD2' ' O ' ' A' ' 233' ' ' SER . 0.0 OUTLIER -65.23 -40.11 93.62 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.174 179.634 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 96.7 t -64.29 -45.63 95.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -176.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 25.6 m -63.06 -37.15 78.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 119.756 -0.777 . . . . 0.0 110.533 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 18.3 mmmt -60.49 -43.9 96.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.635 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 8.9 m -61.1 -42.2 98.07 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -177.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.491 ' O ' ' HB3' ' A' ' 242' ' ' TYR . 20.9 ptt180 -70.12 131.31 44.09 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.777 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.491 ' HB3' ' O ' ' A' ' 241' ' ' ARG . 0.1 OUTLIER 168.64 9.17 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 O-C-N 123.858 0.724 . . . . 0.0 112.525 178.155 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 243' ' ' MET . . . . . . . . . . . . . 11.2 tpt -113.17 61.73 0.64 Allowed 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.758 0.708 . . . . 0.0 111.94 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' ASN . . . . . 0.435 ' O ' ' OG ' ' A' ' 245' ' ' SER . 4.1 m120 -115.81 -27.57 6.99 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 245' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' A' ' 244' ' ' ASN . 51.1 m -171.39 175.83 4.03 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.524 -1.217 . . . . 0.0 112.926 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -165.35 152.16 10.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.215 -1.357 . . . . 0.0 108.89 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 21.7 mt 59.98 79.06 0.25 Allowed 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.304 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 249' ' ' GLN . . . 172.38 -153.05 18.24 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.605 ' CD ' ' H ' ' A' ' 249' ' ' GLN . 3.5 pm0 -56.49 -111.66 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.8 m-30 48.36 67.03 0.91 Allowed 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 17.6 t-80 -67.5 -53.8 25.61 Favored 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 117.694 2.479 . . . . 0.0 117.694 -176.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 22.6 m -148.82 -174.69 4.69 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 118.818 0.735 . . . . 0.0 109.859 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -60.54 -45.11 95.08 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 119.771 -1.831 . . . . 0.0 107.3 178.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -58.64 -36.98 88.26 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-N 118.733 0.697 . . . . 0.0 111.884 -175.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -58.46 -37.02 74.62 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 117.977 -1.489 . . . . 0.0 110.996 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 256' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -62.25 -45.52 92.94 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 121.648 -0.657 . . . . 0.0 111.65 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -60.57 -45.17 94.93 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.54 HD13 ' O ' ' A' ' 258' ' ' LEU . 0.2 OUTLIER -66.57 -43.95 83.59 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 119.869 -0.733 . . . . 0.0 110.246 -179.049 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 31.6 m -63.31 -47.14 83.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.177 0.513 . . . . 0.0 111.091 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 260' ' ' MET . . . . . 0.426 ' O ' ' O ' ' A' ' 264' ' ' GLU . 32.2 mtt -62.1 -43.58 98.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.945 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 11.8 tp -62.21 -46.26 89.68 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 122.685 0.394 . . . . 0.0 111.068 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 69.6 ttp85 -65.92 -53.8 34.68 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.906 -178.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 263' ' ' LYS . . . . . 0.426 ' O ' ' N ' ' A' ' 265' ' ' GLY . 0.1 OUTLIER -102.73 -107.35 0.26 Allowed 'General case' 0 N--CA 1.472 0.659 0 O-C-N 122.249 -0.282 . . . . 0.0 111.208 179.562 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 264' ' ' GLU . . . . . 0.443 ' O ' ' O ' ' A' ' 265' ' ' GLY . 71.2 mm-40 -33.47 91.92 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.443 ' O ' ' O ' ' A' ' 264' ' ' GLU . . . -38.51 166.11 0.01 OUTLIER Glycine 0 CA--C 1.534 1.251 0 CA-C-O 121.623 0.568 . . . . 0.0 111.712 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -63.21 -3.81 5.53 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 122.807 2.338 . . . . 0.0 111.628 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 27.8 mtp180 -69.08 -25.8 64.62 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 123.043 0.537 . . . . 0.0 111.671 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -57.88 -31.84 67.12 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.253 -178.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -62.34 -41.24 98.42 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.18 0.514 . . . . 0.0 110.987 177.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -66.17 -38.37 87.88 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -176.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.439 ' O ' ' O ' ' A' ' 272' ' ' GLY . 14.5 pttm -72.09 -172.43 0.88 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 272' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 271' ' ' LYS . . . 47.05 99.23 0.01 OUTLIER Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -158.74 0.94 0.09 Allowed 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.248 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 274' ' ' MET . . . . . 0.552 ' N ' ' HD2' ' A' ' 275' ' ' PRO . 6.2 mmt -63.55 -45.44 83.2 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.581 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 275' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 274' ' ' MET . 31.9 Cg_endo -64.9 -45.9 7.35 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 121.133 1.222 . . . . 0.0 110.574 177.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 1.4 m -60.36 -39.78 88.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.246 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 277' ' ' PHE . . . . . 0.434 ' O ' ' HG ' ' A' ' 280' ' ' LEU . 34.3 t80 -61.65 -43.03 99.63 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 124.438 2.066 . . . . 0.0 112.175 -178.301 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.11 -38.81 92.67 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 110.568 -3.015 . . . . 0.0 109.569 175.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 11.3 mmm180 -63.2 -41.8 99.23 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.51 0.929 . . . . 0.0 113.51 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.68 HD12 ' N ' ' A' ' 281' ' ' GLY . 3.0 pp -63.12 -35.34 79.94 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -178.04 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 281' ' ' GLY . . . . . 0.68 ' N ' HD12 ' A' ' 280' ' ' LEU . . . -67.83 -50.88 38.51 Favored Glycine 0 CA--C 1.521 0.413 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -177.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 282' ' ' SER . . . . . 0.448 ' O ' HG12 ' A' ' 285' ' ' VAL . 9.5 t -62.49 -43.89 97.72 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.642 0.777 . . . . 0.0 109.387 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 283' ' ' TRP . . . . . 0.415 ' O ' HG22 ' A' ' 286' ' ' VAL . 83.0 t90 -59.54 -37.68 79.04 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 284' ' ' ASN . . . . . 0.475 ' ND2' ' O ' ' A' ' 281' ' ' GLY . 0.0 OUTLIER -61.49 -37.2 82.77 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.665 -179.845 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.448 HG12 ' O ' ' A' ' 282' ' ' SER . 0.3 OUTLIER -60.3 -39.0 79.54 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 O-C-N 121.505 -0.747 . . . . 0.0 112.184 -177.32 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.465 ' H ' HG13 ' A' ' 286' ' ' VAL . 1.0 OUTLIER -63.41 -41.94 94.49 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 119.902 -0.719 . . . . 0.0 112.585 -178.716 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 6.8 ptm -61.78 -38.47 88.18 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.192 0.52 . . . . 0.0 109.808 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -58.2 -40.31 81.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.937 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 91.5 t -60.87 -39.41 81.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.591 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 10.8 m -63.21 -40.45 97.5 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -61.21 -38.73 87.63 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 176.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -57.94 -40.17 79.87 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 118.143 -1.423 . . . . 0.0 109.272 -176.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 293' ' ' GLN . . . . . 0.446 ' O ' ' O ' ' A' ' 296' ' ' ARG . 73.9 mt-30 -60.29 -41.96 94.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 123.126 1.441 . . . . 0.0 109.764 179.089 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.41 -39.66 88.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 111.717 -2.492 . . . . 0.0 109.342 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -62.72 -45.31 93.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.537 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 296' ' ' ARG . . . . . 0.446 ' O ' ' O ' ' A' ' 293' ' ' GLN . 44.7 ttm180 -122.53 116.18 23.45 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -113.55 -164.83 0.95 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.269 0.557 . . . . 0.0 112.162 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 14.1 mt -72.74 114.89 11.38 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 79.0 mmm -97.93 63.86 1.68 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -178.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.66 100.96 0.07 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.868 0.842 . . . . 0.0 110.716 -178.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -63.95 -46.22 85.66 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 113.962 -1.472 . . . . 0.0 113.528 -176.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -58.59 -39.21 79.72 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -178.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -64.13 -46.15 85.39 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.539 -179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 304' ' ' SER . . . . . 0.432 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 40.5 t -66.19 -37.72 86.29 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.764 -0.375 . . . . 0.0 110.999 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -61.76 -43.28 99.17 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -179.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -65.19 -36.63 84.8 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.344 1.238 . . . . 0.0 114.344 -177.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 307' ' ' ALA . . . . . 0.525 ' HB3' ' HD3' ' A' ' 308' ' ' PRO . . . -60.02 -52.82 70.8 Favored Pre-proline 0 CA--C 1.544 0.738 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -176.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 308' ' ' PRO . . . . . 0.525 ' HD3' ' HB3' ' A' ' 307' ' ' ALA . 74.2 Cg_endo -75.12 0.21 9.23 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.069 1.846 . . . . 0.0 111.808 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 309' ' ' PHE . . . . . 0.472 ' CG ' ' O ' ' A' ' 308' ' ' PRO . 69.4 m-85 . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.546 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.537 ' N ' ' SD ' ' A' ' 13' ' ' MET . 1.7 mpt? . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.8 t -125.47 54.96 1.44 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.221 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.466 ' H ' HG22 ' A' ' 15' ' ' VAL . 3.3 m -83.15 150.61 4.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.266 0.555 . . . . 0.0 110.982 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.55 -40.74 96.14 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.241 -0.89 . . . . 0.0 112.088 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -63.32 -41.83 98.95 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -177.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.827 ' O ' HD12 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -80.06 -26.36 39.69 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.092 0.472 . . . . 0.0 111.568 -179.298 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.24 -41.54 94.7 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 107.594 -2.202 . . . . 0.0 107.594 177.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -71.55 -32.5 68.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 124.818 2.247 . . . . 0.0 107.602 176.365 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.25 -42.26 99.36 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-N 108.502 -3.954 . . . . 0.0 107.626 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.7 m -70.49 -27.68 64.39 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -66.57 -49.8 65.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.842 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.93 -35.97 79.99 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 118.077 -1.449 . . . . 0.0 111.054 -177.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 77.4 m -63.84 -53.93 42.87 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.496 -178.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.2 pp -65.79 -39.43 84.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -177.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.11 -41.96 97.05 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -174.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.519 ' OD1' ' NH2' ' A' ' 88' ' ' ARG . 10.0 t70 -77.64 -27.39 51.05 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 120.594 1.543 . . . . 0.0 109.809 -175.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 43.5 mt -60.0 -55.28 35.97 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 119.724 1.147 . . . . 0.0 112.097 -178.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.8 tp -75.42 -3.87 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-O 121.743 0.783 . . . . 0.0 112.335 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 29.7 m -108.96 -16.39 14.15 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 117.491 -1.242 . . . . 0.0 110.305 -178.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.441 ' O ' ' OD1' ' A' ' 35' ' ' ASP . 14.5 t80 -69.01 -44.3 28.25 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-N 122.784 2.538 . . . . 0.0 111.758 -177.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' A' ' 32' ' ' PHE . 32.1 Cg_exo -59.6 -15.72 32.52 Favored 'Trans proline' 0 N--CA 1.504 2.107 0 C-N-CA 121.298 1.332 . . . . 0.0 113.245 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.8 mp -67.18 -35.5 79.78 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -177.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 36' ' ' THR . 15.8 p30 -64.86 -40.53 95.3 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -178.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.545 ' N ' ' OD1' ' A' ' 35' ' ' ASP . 43.3 p -58.4 -34.99 71.35 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.483 ' HB3' HH22 ' A' ' 279' ' ' ARG . . . -67.59 -38.37 83.93 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 119.948 -0.701 . . . . 0.0 111.84 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -61.66 -49.09 77.94 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 119.625 -0.83 . . . . 0.0 111.266 -176.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.419 ' H ' HG22 ' A' ' 39' ' ' VAL . 10.5 m -63.69 -39.75 86.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 118.31 0.504 . . . . 0.0 111.913 -177.288 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.521 ' NH2' ' OE1' ' A' ' 42' ' ' GLN . 7.6 tpm_? -60.78 -40.99 94.66 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.411 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.0 38.85 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.589 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.521 ' OE1' ' NH2' ' A' ' 40' ' ' ARG . 2.6 pt20 -85.82 61.73 7.03 Favored 'General case' 0 N--CA 1.463 0.188 0 O-C-N 121.965 -0.459 . . . . 0.0 110.971 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.408 ' C ' ' O ' ' A' ' 42' ' ' GLN . 22.2 pt 32.06 -125.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.861 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -158.15 100.62 1.71 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.649 0.262 . . . . 0.0 110.334 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.51 ' C ' ' H ' ' A' ' 47' ' ' SER . . . -176.31 -118.59 0.54 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.089 -0.805 . . . . 0.0 111.089 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 69.22 -16.9 0.23 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.704 0.288 . . . . 0.0 110.786 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.51 ' H ' ' C ' ' A' ' 45' ' ' GLY . 29.0 t 53.66 26.41 5.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.919 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.572 ' NE2' HD23 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -44.16 -28.39 0.5 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.674 0.75 . . . . 0.0 109.789 179.727 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.72 -36.71 3.66 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -178.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.572 HD23 ' NE2' ' A' ' 48' ' ' GLN . 3.6 mm? -66.73 -38.03 85.85 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.448 0.642 . . . . 0.0 109.311 177.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 96.2 t -60.68 -44.55 97.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 114.919 -1.037 . . . . 0.0 112.604 -177.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -64.19 -33.54 76.02 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.938 -178.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.5 m -67.92 -38.06 82.45 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 177.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.409 ' C ' ' H ' ' A' ' 56' ' ' SER . . . -127.93 78.6 1.84 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.177 -0.919 . . . . 0.0 108.801 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.38 -3.42 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.635 -0.712 . . . . 0.0 112.813 -178.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.606 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 94.9 p -126.58 -140.04 0.27 Allowed 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.606 ' HB3' ' O ' ' A' ' 56' ' ' SER . . . 99.2 11.77 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 O-C-N 124.12 0.888 . . . . 0.0 111.878 178.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 177.52 70.78 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -41.12 -83.78 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.054 0.454 . . . . 0.0 110.633 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.415 ' O ' ' C ' ' A' ' 61' ' ' GLY . 30.0 ttm180 -161.01 -34.36 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.591 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 60' ' ' ARG . . . -28.61 102.74 0.01 OUTLIER Glycine 0 CA--C 1.527 0.807 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.641 -179.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 90.3 t -67.41 -34.6 69.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 118.451 -0.785 . . . . 0.0 109.685 176.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.493 HD22 ' N ' ' A' ' 63' ' ' LEU . 3.6 mm? -60.79 -32.65 71.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 121.011 1.732 . . . . 0.0 109.726 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.61 -49.31 65.18 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-N 114.905 -1.043 . . . . 0.0 114.398 -176.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.3 m -62.1 -46.36 89.41 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 70.6 mt -59.43 -35.95 61.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.57 ' O ' HD13 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -63.94 -35.76 81.72 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 120.919 1.69 . . . . 0.0 112.156 179.452 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 99.2 m -63.22 -40.73 98.29 Favored 'General case' 0 C--O 1.246 0.906 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.003 -174.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.402 ' C ' ' SD ' ' A' ' 69' ' ' MET . 3.2 ppp? -59.67 -40.05 86.51 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -175.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.2 p -69.49 -40.78 80.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 119.096 -1.042 . . . . 0.0 112.563 -178.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 75.0 ttt-85 -78.54 -13.3 59.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.769 0.795 . . . . 0.0 112.534 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 54.5 m -62.81 -54.65 35.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.643 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -107.44 -56.47 2.21 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.276 178.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 157.3 165.89 15.87 Favored Glycine 0 CA--C 1.535 1.325 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -56.27 -35.47 95.76 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 CA-C-N 119.508 1.654 . . . . 0.0 111.893 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.41 ' O ' ' CB ' ' A' ' 80' ' ' ASN . 12.1 tpp180 -61.42 -12.27 13.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.756 0.789 . . . . 0.0 111.007 176.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 10.4 p -78.55 -33.0 48.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.968 -178.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.59 ' O ' HD23 ' A' ' 78' ' ' LEU . 1.0 OUTLIER -75.94 -33.64 59.84 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.116 0.484 . . . . 0.0 110.535 179.754 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.746 ' O ' HD12 ' A' ' 82' ' ' LEU . 57.9 m-85 -92.74 -5.15 51.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 122.335 1.064 . . . . 0.0 113.202 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.41 ' CB ' ' O ' ' A' ' 76' ' ' ARG . 4.7 t30 -90.01 118.85 29.88 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 112.812 -1.995 . . . . 0.0 107.502 175.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.71 -7.25 57.55 Favored Glycine 0 N--CA 1.468 0.782 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 -177.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.965 HD13 ' H ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -59.42 -34.59 72.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 113.603 -1.298 . . . . 0.0 110.834 -179.687 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.965 ' H ' HD13 ' A' ' 82' ' ' LEU . 4.8 p -70.61 -26.79 29.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.94 -31.62 61.55 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.576 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -68.17 -40.34 88.01 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 119.344 -1.407 . . . . 0.0 111.206 -177.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.3 mp -62.66 -40.54 97.38 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.978 0.894 . . . . 0.0 113.099 -176.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -60.62 -27.17 67.56 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 113.799 -1.546 . . . . 0.0 109.306 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.562 ' HE ' HE22 ' A' ' 89' ' ' GLN . 37.3 ttp180 -57.89 -53.76 54.58 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 173.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.562 HE22 ' HE ' ' A' ' 88' ' ' ARG . 2.3 mp0 -67.1 -29.86 69.73 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 112.325 -2.216 . . . . 0.0 111.84 -178.17 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 33.4 tpp -61.35 -40.82 95.66 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.493 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 37.1 m -74.44 -34.6 63.24 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 118.099 -0.953 . . . . 0.0 111.302 -177.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -57.66 -43.88 85.29 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 121.324 1.874 . . . . 0.0 112.262 -176.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.56 -32.84 64.39 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.127 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.8 p -64.09 -41.31 97.34 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.499 ' CG2' HD12 ' A' ' 99' ' ' LEU . 7.9 p -68.27 -28.23 39.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.022 177.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.403 ' NH2' ' CE2' ' A' ' 100' ' ' TYR . 51.0 ttt-85 -77.44 9.22 3.42 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -176.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.517 HD13 ' O ' ' A' ' 97' ' ' ILE . 0.3 OUTLIER -87.3 -14.93 9.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.833 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -139.98 -48.2 0.06 OUTLIER Glycine 0 CA--C 1.543 1.781 0 N-CA-C 116.087 1.195 . . . . 0.0 116.087 -176.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.499 HD12 ' CG2' ' A' ' 95' ' ' VAL . 16.6 mt -71.14 -12.76 61.67 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 119.84 1.82 . . . . 0.0 113.05 -178.058 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.499 ' O ' ' CG ' ' A' ' 104' ' ' LYS . 26.2 t80 -80.57 -51.19 9.04 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 114.48 -1.236 . . . . 0.0 111.868 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.902 ' OD2' ' OE1' ' A' ' 105' ' ' GLN . 9.7 t70 -69.46 -32.29 71.11 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 123.175 1.464 . . . . 0.0 110.043 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 11.4 t -68.74 -52.54 29.48 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 111.158 -2.746 . . . . 0.0 111.89 175.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 52.3 t -74.28 -27.79 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-N 121.697 2.044 . . . . 0.0 114.131 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.499 ' CG ' ' O ' ' A' ' 100' ' ' TYR . 3.2 mmpt? -69.69 -41.68 75.12 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 112.131 -2.304 . . . . 0.0 111.518 179.238 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.902 ' OE1' ' OD2' ' A' ' 101' ' ' ASP . 27.2 mt-30 -79.69 -12.95 59.78 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 122.638 1.209 . . . . 0.0 111.011 -178.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -79.93 -22.8 42.28 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.21 178.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.619 ' CZ ' ' ND2' ' A' ' 190' ' ' ASN . 35.4 m-85 -109.81 -29.45 8.3 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 119.532 1.06 . . . . 0.0 112.721 -175.138 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.6 p -96.78 9.11 42.71 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 117.144 -1.823 . . . . 0.0 113.135 -177.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 12.4 ttpp -96.87 -154.82 0.46 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 177.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 140.42 134.58 3.11 Favored Glycine 0 N--CA 1.475 1.245 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 76.2 p -90.19 -40.29 12.29 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -177.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -116.28 174.41 6.07 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 112.899 -1.955 . . . . 0.0 113.485 -176.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.606 ' O ' ' HB2' ' A' ' 114' ' ' ALA . 85.9 m-70 -86.47 77.08 9.51 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.759 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.606 ' HB2' ' O ' ' A' ' 113' ' ' HIS . . . 159.6 -161.39 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.05 14.82 27.77 Favored Glycine 0 C--N 1.335 0.499 0 CA-C-N 115.449 -0.796 . . . . 0.0 113.213 176.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 22.6 mm -60.89 -40.83 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.0 -39.29 96.34 Favored Glycine 0 CA--C 1.525 0.713 0 CA-C-O 122.253 0.918 . . . . 0.0 110.982 175.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 5.8 t -57.93 -42.17 84.27 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 177.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 59.7 mtm180 -63.58 -37.47 87.44 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.278 -178.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 8.0 mp -64.15 -46.51 83.76 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 76.9 mt -66.83 -44.83 80.07 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 114.926 -1.033 . . . . 0.0 110.494 178.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.91 -44.77 91.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 119.532 1.06 . . . . 0.0 109.869 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -66.01 -44.1 92.21 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 119.73 -1.224 . . . . 0.0 111.295 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 71.0 m -64.07 -43.95 93.9 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.784 -0.367 . . . . 0.0 111.538 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 21.1 p -69.35 -48.43 61.36 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 119.333 -0.947 . . . . 0.0 111.954 177.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 24.0 p -65.37 -42.41 92.75 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 -174.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -63.95 -44.54 95.84 Favored Glycine 0 CA--C 1.521 0.463 0 CA-C-O 122.967 1.315 . . . . 0.0 112.916 -177.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.534 ' O ' HG22 ' A' ' 131' ' ' VAL . . . -61.35 -41.6 97.33 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 111.903 -2.148 . . . . 0.0 107.25 177.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.692 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 17.3 mt -64.41 -42.15 96.24 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.221 178.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.0 -39.77 95.74 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -177.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.534 HG22 ' O ' ' A' ' 128' ' ' ALA . 18.9 m -60.96 -26.03 37.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 122.829 1.3 . . . . 0.0 109.572 179.362 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.692 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . -58.63 -44.83 90.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 112.251 -2.25 . . . . 0.0 111.876 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.426 HG22 ' H ' ' A' ' 133' ' ' VAL . 5.1 m -79.0 -48.63 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -126.7 135.75 51.54 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.695 0.283 . . . . 0.0 111.451 -178.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.773 ' H ' ' CD ' ' A' ' 136' ' ' PRO . 22.2 pt20 175.2 -23.59 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.828 0 CA-C-N 115.47 -0.786 . . . . 0.0 113.069 178.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.773 ' CD ' ' H ' ' A' ' 135' ' ' GLN . 54.3 Cg_exo -53.03 -34.17 66.39 Favored 'Trans proline' 0 N--CA 1.5 1.894 0 CA-C-N 120.955 1.377 . . . . 0.0 113.275 -178.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.421 HG22 ' H ' ' A' ' 137' ' ' THR . 0.0 OUTLIER -67.43 -41.58 84.55 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 119.064 -1.055 . . . . 0.0 110.667 -178.772 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -64.38 -42.44 96.16 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 119.238 -0.985 . . . . 0.0 111.777 -177.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 14.6 m -63.6 -42.71 97.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.879 0.371 . . . . 0.0 110.977 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.423 ' O ' ' N ' ' A' ' 144' ' ' PHE . 25.3 t -63.97 -38.54 82.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.028 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.437 ' NZ ' ' CB ' ' A' ' 141' ' ' LYS . 8.8 mtmp? -62.0 -40.93 97.33 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 119.556 -0.858 . . . . 0.0 111.895 -177.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.4 p -69.56 -44.81 79.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 119.992 -0.683 . . . . 0.0 109.23 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -64.36 -35.9 82.39 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.468 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.423 ' N ' ' O ' ' A' ' 140' ' ' VAL . 93.9 t80 -66.14 -40.76 90.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.249 -177.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -64.4 -39.53 94.03 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 118.844 -1.142 . . . . 0.0 109.709 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.22 -35.03 79.79 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.519 ' NE2' ' O ' ' A' ' 147' ' ' GLN . 1.4 pp0? -59.85 111.35 1.43 Allowed 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 177.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -94.49 -64.39 1.08 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 117.396 -1.288 . . . . 0.0 112.615 -177.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -91.06 110.68 21.96 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 122.862 2.574 . . . . 0.0 110.121 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -81.41 68.69 7.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.648 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 43.28 59.37 3.52 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -56.7 125.8 39.55 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.414 ' O ' ' O ' ' A' ' 154' ' ' ARG . . . 166.19 72.91 0.03 OUTLIER Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.738 HH12 ' HE ' ' A' ' 155' ' ' ARG . 54.3 ttp85 56.08 164.95 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.738 ' HE ' HH12 ' A' ' 154' ' ' ARG . 18.0 mmt85 56.97 177.48 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.881 0.372 . . . . 0.0 110.849 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.449 ' CE2' ' O ' ' A' ' 157' ' ' GLN . 85.1 t80 -138.6 145.26 40.34 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.437 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.449 ' O ' ' CE2' ' A' ' 156' ' ' TYR . 19.7 mp0 -109.67 -155.24 0.55 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -178.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 83.4 p -157.22 -176.25 5.86 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 123.256 1.503 . . . . 0.0 112.936 -177.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 8.4 m -62.89 -43.53 98.56 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 111.26 -2.7 . . . . 0.0 112.002 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.5 t -61.05 -42.76 94.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -178.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.45 ' OE2' ' OG1' ' A' ' 165' ' ' THR . 0.7 OUTLIER -65.47 -38.33 89.48 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.066 179.877 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -61.4 -45.67 93.35 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -178.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.503 ' CZ ' HD23 ' A' ' 175' ' ' LEU . 13.7 t80 -62.62 -49.21 76.09 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.278 -178.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -67.83 -45.36 74.88 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -174.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.45 ' OG1' ' OE2' ' A' ' 161' ' ' GLU . 1.9 p -63.0 -43.86 97.63 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -176.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 15.0 pt -64.26 -37.93 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 CA-C-O 121.746 0.784 . . . . 0.0 109.133 177.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.89 -37.07 78.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.17 -1.377 . . . . 0.0 107.37 175.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -62.46 -50.44 71.46 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 122.211 2.278 . . . . 0.0 111.849 -176.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.524 ' N ' ' OE1' ' A' ' 169' ' ' GLU . 0.2 OUTLIER -74.93 -50.99 14.91 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.523 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -78.09 -36.28 48.32 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 116.594 2.072 . . . . 0.0 116.594 -173.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 91.14 -166.61 31.03 Favored Glycine 0 C--N 1.337 0.628 0 CA-C-N 118.841 0.746 . . . . 0.0 112.263 177.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.638 HD13 ' H ' ' A' ' 172' ' ' ILE . 0.0 OUTLIER -72.64 -38.58 59.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.903 0.859 . . . . 0.0 109.175 -179.576 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 68.1 mtp180 -58.5 -33.74 70.15 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 113.852 -1.522 . . . . 0.0 111.103 -177.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -61.48 -41.24 99.51 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 118.672 -1.728 . . . . 0.0 111.425 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.503 HD23 ' CZ ' ' A' ' 163' ' ' TYR . 7.8 mp -71.33 -34.35 70.47 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 117.717 2.488 . . . . 0.0 117.717 -177.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' TRP . . . . . 0.493 ' CD1' ' O ' ' A' ' 172' ' ' ILE . 63.7 m95 -78.18 -7.09 56.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 112.995 -1.912 . . . . 0.0 109.589 -177.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 16.8 ttmm -43.63 -48.64 7.75 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -175.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -90.11 -32.23 10.01 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.39 0.995 . . . . 0.0 111.815 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 90.1 m -45.31 -50.66 11.81 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.45 ' O ' HG12 ' A' ' 183' ' ' VAL . 0.4 OUTLIER -61.96 -50.47 80.78 Favored Pre-proline 0 N--CA 1.472 0.627 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -175.906 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 180' ' ' SER . 24.7 Cg_endo -64.64 -27.98 60.81 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 121.17 1.247 . . . . 0.0 111.704 176.135 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -64.06 -39.33 93.85 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 180' ' ' SER . 1.6 p -62.91 -41.71 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.855 -179.277 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.48 -39.28 90.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.961 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.588 HH12 ' CG1' ' A' ' 235' ' ' VAL . 48.8 ttt85 -60.6 -42.13 96.14 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 119.922 -0.711 . . . . 0.0 110.344 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -61.67 -43.86 98.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.183 0.516 . . . . 0.0 110.679 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -65.28 -44.2 88.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.617 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 24.3 mm -63.81 -45.89 95.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -177.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.503 ' O ' ' N ' ' A' ' 193' ' ' GLU . 5.9 p -60.72 -47.31 93.62 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.339 0 C-N-CA 119.237 -0.985 . . . . 0.0 111.729 -178.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.619 ' ND2' ' CZ ' ' A' ' 107' ' ' TYR . 12.2 t-20 -63.54 -42.94 98.37 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 122.282 1.039 . . . . 0.0 110.868 178.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' CYS . . . . . . . . . . . . . 31.3 m -61.39 -45.53 93.98 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 113.348 -1.751 . . . . 0.0 108.389 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.27 -40.4 95.91 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 112.662 -2.063 . . . . 0.0 109.672 175.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 0.503 ' N ' ' O ' ' A' ' 189' ' ' VAL . 0.7 OUTLIER -60.81 -46.54 90.12 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.001 0.92 . . . . 0.0 113.086 -176.884 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 2.8 pp -64.31 -36.73 85.08 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 119.231 -0.988 . . . . 0.0 109.528 -175.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 1.4 m -63.18 -45.74 97.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 C-N-CA 117.01 -1.876 . . . . 0.0 107.389 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 30.3 p -64.35 -46.11 84.88 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -177.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -57.67 -39.87 78.1 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.133 -0.939 . . . . 0.0 113.338 -177.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -56.4 -44.46 80.32 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 9.7 mt -61.66 -39.45 91.41 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.803 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 1.6 mp -63.12 -42.79 97.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 118.813 -0.613 . . . . 0.0 110.115 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -59.99 -40.42 89.12 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 120.224 1.374 . . . . 0.0 111.897 178.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -66.96 -38.43 86.08 Favored 'General case' 0 C--O 1.25 1.104 0 CA-C-N 114.682 -1.145 . . . . 0.0 111.003 -176.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -101.96 128.89 48.17 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 120.804 -1.185 . . . . 0.0 112.455 -178.306 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.596 ' O ' HD22 ' A' ' 209' ' ' LEU . 4.1 tp 67.46 4.45 3.8 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 114.275 -1.33 . . . . 0.0 112.082 177.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.74 38.11 4.0 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -74.52 -21.57 59.47 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.527 0.68 . . . . 0.0 111.455 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.427 ' O ' ' CB ' ' A' ' 208' ' ' ASN . . . -130.86 -40.45 1.19 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.54 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' ASN . . . . . 0.67 ' C ' ' H ' ' A' ' 210' ' ' MET . 0.4 OUTLIER 152.13 124.43 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 -178.168 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.596 HD22 ' O ' ' A' ' 204' ' ' LEU . 0.2 OUTLIER -50.81 24.63 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 110.41 -3.086 . . . . 0.0 111.954 179.164 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 210' ' ' MET . . . . . 0.67 ' H ' ' C ' ' A' ' 208' ' ' ASN . 35.3 ttp -110.42 75.87 0.95 Allowed 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.789 -0.569 . . . . 0.0 110.614 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 38.4 p -98.0 -154.28 0.45 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.579 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -125.6 3.37 7.56 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.878 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -115.07 66.78 0.69 Allowed 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.4 ' N ' ' CD ' ' A' ' 215' ' ' PRO . 4.4 mm? -61.28 -43.74 90.87 Favored Pre-proline 0 CA--C 1.537 0.481 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 214' ' ' LEU . 25.9 Cg_exo -60.88 -34.07 91.71 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 CA-C-N 120.59 1.246 . . . . 0.0 111.039 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 82.3 m -64.77 -42.53 95.05 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 113.173 -1.83 . . . . 0.0 111.771 -178.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -66.83 -38.13 85.82 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -63.44 -47.37 82.15 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.941 -178.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 27.1 p -60.65 -38.24 84.17 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 119.102 0.864 . . . . 0.0 110.465 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 47.8 p -59.67 -41.88 91.61 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.568 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.91 -41.82 97.58 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -177.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -62.11 -47.15 85.89 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -176.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -60.74 -42.09 99.28 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 107.464 -2.254 . . . . 0.0 107.464 177.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' ALA . . . . . 0.627 ' O ' HG23 ' A' ' 228' ' ' THR . . . -63.1 -37.93 89.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.211 -0.995 . . . . 0.0 108.977 176.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -61.66 -42.28 99.73 Favored Glycine 0 CA--C 1.521 0.412 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.811 -177.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -66.57 -38.34 86.87 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' CYS . . . . . 0.432 ' O ' HG12 ' A' ' 230' ' ' VAL . 96.3 m -63.22 -41.11 99.08 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.012 0.434 . . . . 0.0 110.387 177.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.627 HG23 ' O ' ' A' ' 224' ' ' ALA . 55.9 p -61.99 -39.95 93.96 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.759 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -58.17 -38.73 77.23 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -176.027 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.432 HG12 ' O ' ' A' ' 227' ' ' CYS . 1.7 p -59.57 -40.53 82.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 119.004 -1.078 . . . . 0.0 110.02 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.641 HD12 ' C ' ' A' ' 231' ' ' ILE . 0.3 OUTLIER -61.45 -40.16 85.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 177.615 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -62.78 -39.47 94.29 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 115.683 1.735 . . . . 0.0 115.683 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.488 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 0.2 OUTLIER -57.99 -41.72 91.39 Favored Pre-proline 0 N--CA 1.484 1.244 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 -173.525 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.528 ' HD2' ' O ' ' A' ' 231' ' ' ILE . 32.3 Cg_exo -57.7 -39.56 86.67 Favored 'Trans proline' 0 C--N 1.291 -2.461 0 C-N-CA 122.495 2.13 . . . . 0.0 113.128 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.588 ' CG1' HH12 ' A' ' 185' ' ' ARG . 59.3 t -63.69 -37.22 79.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 C-N-CA 117.8 -1.56 . . . . 0.0 108.799 178.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 236' ' ' ASP . . . . . 0.526 ' OD2' ' CE3' ' A' ' 283' ' ' TRP . 53.1 t0 -65.77 -40.37 91.94 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.266 178.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 59.2 t -64.6 -45.22 96.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 -176.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 84.4 t -62.86 -37.13 78.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 C-N-CA 120.028 -0.669 . . . . 0.0 111.737 -178.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -60.41 -43.98 96.19 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -60.94 -41.89 97.13 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.711 -178.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.596 ' NH1' ' CZ ' ' A' ' 269' ' ' PHE . 15.8 mtt180 -44.61 -41.85 6.92 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 120.974 -0.29 . . . . 0.0 110.7 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.553 ' O ' ' N ' ' A' ' 244' ' ' ASN . 38.4 t80 -36.29 -60.25 0.58 Allowed 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 243' ' ' MET . . . . . 0.53 ' SD ' ' O ' ' A' ' 243' ' ' MET . 0.0 OUTLIER -31.65 -32.27 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 O-C-N 123.788 0.68 . . . . 0.0 110.774 179.716 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 244' ' ' ASN . . . . . 0.553 ' N ' ' O ' ' A' ' 242' ' ' TYR . 20.3 t30 -34.21 147.89 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.753 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 245' ' ' SER . . . . . 0.584 ' O ' ' HB3' ' A' ' 246' ' ' ALA . 67.1 m 12.41 -79.64 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 O-C-N 124.535 1.147 . . . . 0.0 112.767 179.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 246' ' ' ALA . . . . . 0.584 ' HB3' ' O ' ' A' ' 245' ' ' SER . . . 79.35 78.03 0.05 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.579 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 6.3 tp -173.39 106.56 0.14 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.764 0.316 . . . . 0.0 111.012 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 65.87 170.01 3.1 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.764 -0.534 . . . . 0.0 111.764 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 55.46 -164.18 0.13 Allowed 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 110.638 -0.134 . . . . 0.0 110.638 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 55.97 63.31 2.07 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.795 -0.184 . . . . 0.0 110.526 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 27.0 t60 -66.34 -52.08 50.7 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -177.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 24.5 p -147.93 -174.92 4.69 Favored 'General case' 0 C--O 1.215 -0.721 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -61.9 -45.87 91.86 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 119.774 1.17 . . . . 0.0 110.062 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -56.52 -35.42 66.53 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.705 1.622 . . . . 0.0 113.501 -171.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -55.91 -34.19 65.34 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 117.159 -1.816 . . . . 0.0 111.041 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 256' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -61.93 -44.26 97.14 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 122.03 -0.419 . . . . 0.0 110.732 178.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -59.92 -45.75 91.56 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.82 -178.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.473 HD22 ' N ' ' A' ' 258' ' ' LEU . 3.4 mm? -67.71 -44.08 78.54 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.05 178.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 19.7 m -63.68 -46.79 83.91 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 113.863 1.061 . . . . 0.0 113.863 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 260' ' ' MET . . . . . 0.459 ' SD ' ' N ' ' A' ' 261' ' ' LEU . 0.0 OUTLIER -61.75 -44.37 97.03 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -176.817 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.459 ' N ' ' SD ' ' A' ' 260' ' ' MET . 11.7 tp -62.36 -47.08 85.77 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 121.92 -0.487 . . . . 0.0 109.766 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 70.0 mtp180 -66.77 -53.64 30.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.976 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 263' ' ' LYS . . . . . 0.455 ' O ' ' O ' ' A' ' 260' ' ' MET . 9.6 mtpm? -130.59 179.17 6.1 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.881 0.372 . . . . 0.0 111.258 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 264' ' ' GLU . . . . . 0.456 ' O ' ' O ' ' A' ' 265' ' ' GLY . 95.1 mt-10 56.43 67.78 0.95 Allowed 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.609 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 264' ' ' GLU . . . -33.34 159.81 0.01 OUTLIER Glycine 0 CA--C 1.533 1.158 0 CA-C-O 121.789 0.661 . . . . 0.0 112.304 -179.314 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -64.91 -5.34 10.48 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.076 1.851 . . . . 0.0 111.355 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -69.73 -26.28 64.25 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.536 0.734 . . . . 0.0 111.362 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -58.02 -32.28 67.8 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.532 -178.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 269' ' ' PHE . . . . . 0.596 ' CZ ' ' NH1' ' A' ' 241' ' ' ARG . 29.0 m-85 -62.39 -41.15 98.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.347 177.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -65.79 -37.9 87.55 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.387 -177.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.97 165.54 12.21 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 178.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 69.03 86.64 0.1 Allowed Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.614 -0.995 . . . . 0.0 110.614 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -168.74 22.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 121.064 -0.255 . . . . 0.0 110.784 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 274' ' ' MET . . . . . 0.568 ' N ' ' CD ' ' A' ' 275' ' ' PRO . 1.0 OUTLIER -63.7 -44.1 79.16 Favored Pre-proline 0 C--N 1.33 -0.254 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.219 -179.792 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 275' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 274' ' ' MET . 21.3 Cg_exo -64.38 -46.61 7.21 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.43 2.087 . . . . 0.0 111.54 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 1.5 p -60.66 -40.11 90.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.038 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 277' ' ' PHE . . . . . 0.411 ' CD1' ' C ' ' A' ' 277' ' ' PHE . 36.4 t80 -61.89 -42.92 99.65 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 123.289 1.519 . . . . 0.0 111.936 -178.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 12.0 tp -62.12 -38.73 90.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 111.037 -2.801 . . . . 0.0 108.159 174.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 279' ' ' ARG . . . . . 0.483 HH22 ' HB3' ' A' ' 37' ' ' ALA . 0.5 OUTLIER -62.62 -40.2 96.24 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.072 179.215 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.743 ' O ' HD12 ' A' ' 280' ' ' LEU . 0.2 OUTLIER -61.97 -36.31 81.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.145 -0.934 . . . . 0.0 113.1 -177.255 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -67.7 -50.89 39.19 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 109.146 -1.581 . . . . 0.0 109.146 -178.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 282' ' ' SER . . . . . 0.798 ' O ' HG22 ' A' ' 285' ' ' VAL . 78.0 p -61.92 -43.63 98.44 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.694 0.798 . . . . 0.0 109.538 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 283' ' ' TRP . . . . . 0.526 ' CE3' ' OD2' ' A' ' 236' ' ' ASP . 1.3 m95 -59.5 -38.09 79.99 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -61.76 -38.95 89.92 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -178.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.798 HG22 ' O ' ' A' ' 282' ' ' SER . 23.0 m -61.46 -37.26 77.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 O-C-N 121.354 -0.841 . . . . 0.0 111.339 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.407 ' O ' HG22 ' A' ' 289' ' ' VAL . 26.8 t -62.14 -41.63 92.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -177.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 11.5 ptm -62.34 -38.32 89.05 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 121.305 -0.872 . . . . 0.0 109.608 178.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -58.47 -41.22 84.73 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.13 -0.941 . . . . 0.0 113.303 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 286' ' ' VAL . 2.7 m -61.33 -38.68 80.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 121.693 -0.63 . . . . 0.0 110.846 -178.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 75.7 p -62.22 -40.43 96.1 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 177.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -61.24 -38.44 86.65 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 176.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -58.31 -40.71 82.72 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 117.915 -1.514 . . . . 0.0 109.283 -176.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 293' ' ' GLN . . . . . 0.451 ' O ' ' O ' ' A' ' 296' ' ' ARG . 83.3 mm-40 -60.72 -43.13 98.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 122.577 1.18 . . . . 0.0 110.784 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 73.5 mt -60.47 -40.52 91.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 113.027 -1.897 . . . . 0.0 109.219 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -63.18 -46.15 88.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.982 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 296' ' ' ARG . . . . . 0.451 ' O ' ' O ' ' A' ' 293' ' ' GLN . 20.1 tpt85 -123.07 116.19 23.08 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.009 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -115.52 -96.11 0.46 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.177 0.513 . . . . 0.0 110.522 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 38.9 tp -139.3 120.87 15.17 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.683 179.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 30.2 ttm -92.69 64.32 4.11 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 121.202 -0.199 . . . . 0.0 111.271 -179.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.71 101.22 0.07 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.976 0.893 . . . . 0.0 111.227 -178.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -64.12 -46.2 85.19 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 113.47 -1.695 . . . . 0.0 112.936 -176.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -58.48 -39.29 79.58 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.498 -0.481 . . . . 0.0 109.789 -178.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 303' ' ' GLN . . . . . 0.432 ' O ' ' OE2' ' A' ' 306' ' ' GLU . 86.3 mt-30 -64.56 -46.49 82.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.224 -179.151 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 304' ' ' SER . . . . . 0.439 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 74.2 p -67.09 -38.64 86.05 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.454 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -62.5 -43.87 97.75 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -178.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.473 ' CD ' ' N ' ' A' ' 307' ' ' ALA . 2.7 pp20? -65.72 -36.76 84.51 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -177.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 307' ' ' ALA . . . . . 0.531 ' HB3' ' HD3' ' A' ' 308' ' ' PRO . . . -59.84 -52.6 72.57 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -176.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 308' ' ' PRO . . . . . 0.531 ' HD3' ' HB3' ' A' ' 307' ' ' ALA . 73.1 Cg_endo -74.96 0.3 9.05 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.954 1.769 . . . . 0.0 111.604 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 82.5 t80 . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.459 179.881 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.485 ' SD ' ' OG1' ' A' ' 14' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.485 ' OG1' ' SD ' ' A' ' 13' ' ' MET . 39.7 m -131.0 112.5 12.98 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.111 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.702 HG22 ' H ' ' A' ' 16' ' ' LYS . 7.2 p -91.79 176.58 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.318 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.702 ' H ' HG22 ' A' ' 15' ' ' VAL . 35.0 mtmm -64.21 -41.37 97.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.517 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -63.61 -41.42 98.3 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.548 ' H ' HG13 ' A' ' 15' ' ' VAL . 31.3 tp -79.85 -26.42 40.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.079 -179.072 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.443 ' O ' ' OG1' ' A' ' 22' ' ' THR . . . -66.26 -41.39 94.74 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 107.451 -2.259 . . . . 0.0 107.451 177.101 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.481 ' HB1' HH12 ' A' ' 96' ' ' ARG . . . -71.37 -32.0 67.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 124.77 2.224 . . . . 0.0 107.314 176.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.45 -42.57 98.98 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-N 108.469 -3.969 . . . . 0.0 108.095 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 19' ' ' GLY . 33.6 p -70.75 -28.0 64.37 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -66.28 -50.23 64.39 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.745 -178.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.406 ' O ' ' OE1' ' A' ' 89' ' ' GLN . . . -61.95 -35.96 79.98 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 118.504 -1.278 . . . . 0.0 111.234 -177.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.632 ' SG ' ' N ' ' A' ' 26' ' ' ILE . 5.8 p -64.15 -53.47 48.88 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.027 -179.066 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.632 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 16.0 pt -65.68 -39.68 85.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -178.05 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.68 -42.18 98.06 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 119.686 -0.806 . . . . 0.0 112.738 -173.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.559 ' CG ' HE22 ' A' ' 89' ' ' GLN . 1.5 m-20 -77.09 -27.13 54.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 120.739 1.608 . . . . 0.0 109.941 -174.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.478 HD13 ' O ' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -60.42 -54.26 47.71 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 118.922 0.783 . . . . 0.0 112.222 179.498 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.4 pp -72.86 -1.0 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-O 122.501 1.144 . . . . 0.0 111.906 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.71 ' O ' HD21 ' A' ' 34' ' ' LEU . 97.8 m -106.72 -12.58 15.5 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 112.588 -2.096 . . . . 0.0 112.051 -174.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.439 ' N ' ' CD ' ' A' ' 33' ' ' PRO . 8.4 t80 -70.74 -44.87 16.63 Favored Pre-proline 0 CA--C 1.551 1.011 0 CA-C-N 121.935 2.152 . . . . 0.0 113.765 -178.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.439 ' CD ' ' N ' ' A' ' 32' ' ' PHE . 33.5 Cg_exo -60.54 -17.75 50.33 Favored 'Trans proline' 0 N--CA 1.52 3.047 0 N-CA-C 119.363 2.793 . . . . 0.0 119.363 -175.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.967 HD13 ' H ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -69.11 -35.47 76.47 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 120.342 1.428 . . . . 0.0 114.067 -179.071 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.522 ' H ' HD22 ' A' ' 34' ' ' LEU . 64.1 m-20 -65.02 -41.73 95.02 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -175.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.5 p -58.33 -36.0 72.75 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 119.551 -0.86 . . . . 0.0 111.348 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.96 -38.81 83.21 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 119.782 -0.767 . . . . 0.0 111.731 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.4 ' CG ' ' N ' ' A' ' 39' ' ' VAL . 8.2 pttp -61.37 -48.24 82.18 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.28 -176.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.4 ' N ' ' CG ' ' A' ' 38' ' ' LYS . 82.2 t -63.48 -41.05 91.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 119.667 -0.813 . . . . 0.0 111.565 -176.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.465 ' C ' ' H ' ' A' ' 42' ' ' GLN . 67.9 mmt-85 -61.94 -42.09 98.7 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 119.252 -0.979 . . . . 0.0 110.064 178.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -62.81 38.85 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.685 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.465 ' H ' ' C ' ' A' ' 40' ' ' ARG . 55.1 tp60 -128.41 -76.43 0.56 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.909 0.385 . . . . 0.0 110.01 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.519 ' O ' HG23 ' A' ' 43' ' ' ILE . 21.0 tt -168.46 121.45 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.885 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.417 HE22 ' HB3' ' A' ' 59' ' ' TYR . 11.5 pt20 -71.69 57.57 0.29 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.889 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -167.24 165.87 38.87 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.137 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.6 mp0 -147.11 -160.12 1.12 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.134 -0.533 . . . . 0.0 109.574 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.7 m -81.94 -6.22 58.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.033 0.444 . . . . 0.0 110.106 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -59.42 -30.49 68.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.729 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.71 1.17 87.5 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -178.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.3 tp -64.03 -36.03 82.66 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.361 -0.92 . . . . 0.0 109.532 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.543 HG13 ' N ' ' A' ' 52' ' ' ARG . 8.6 p -58.95 -43.05 87.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.067 -178.134 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.543 ' N ' HG13 ' A' ' 51' ' ' VAL . 22.3 ptt85 -63.06 -33.07 74.65 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 119.734 -0.787 . . . . 0.0 109.658 -178.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -67.7 -37.81 82.8 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 51' ' ' VAL . . . -132.26 111.3 11.27 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.469 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.61 -8.77 59.59 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -178.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.665 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 29.4 p -130.55 -138.15 0.21 Allowed 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.665 ' HB3' ' O ' ' A' ' 56' ' ' SER . . . 91.84 -30.96 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 176.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.468 ' O ' ' N ' ' A' ' 60' ' ' ARG . 68.8 mt-30 -139.55 8.05 2.37 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.565 ' O ' ' CD2' ' A' ' 59' ' ' TYR . 20.9 p90 -46.3 87.03 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.555 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.477 ' O ' ' O ' ' A' ' 59' ' ' TYR . 75.9 mtt180 51.33 165.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.021 0.439 . . . . 0.0 110.419 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 120.01 83.87 0.82 Allowed Glycine 0 CA--C 1.519 0.298 0 N-CA-C 104.441 -3.463 . . . . 0.0 104.441 -175.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.6 p -67.79 -36.11 74.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 118.631 -0.699 . . . . 0.0 110.86 178.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.533 ' O ' HD13 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -61.75 -33.02 73.32 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 117.687 -1.605 . . . . 0.0 109.24 178.379 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.89 -49.9 60.85 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 113.559 -1.655 . . . . 0.0 115.126 -176.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.0 m -62.37 -46.92 86.48 Favored 'General case' 0 C--N 1.334 -0.1 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -178.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 12.0 tt -59.98 -36.04 64.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 38.6 tp -63.88 -35.57 81.07 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 120.82 1.645 . . . . 0.0 111.607 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 98.4 m -63.28 -40.13 96.52 Favored 'General case' 0 C--O 1.249 1.058 0 CA-C-N 113.729 -1.578 . . . . 0.0 111.042 -174.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 3.2 ptt? -60.63 -39.99 90.29 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 120.328 -1.482 . . . . 0.0 114.628 -175.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.8 m -69.52 -40.31 79.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 119.213 -0.995 . . . . 0.0 112.86 -178.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 62.8 ttp85 -78.78 -13.21 59.93 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.499 ' CG2' ' N ' ' A' ' 73' ' ' GLU . 0.6 OUTLIER -62.57 -54.42 40.04 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.667 179.194 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.499 ' N ' ' CG2' ' A' ' 72' ' ' THR . 19.2 mt-10 -105.24 -54.8 2.42 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.411 ' O ' ' CB ' ' A' ' 77' ' ' SER . . . 155.7 166.94 16.45 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -56.37 -35.14 95.85 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 121.329 1.352 . . . . 0.0 111.106 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.2 tpp180 -61.32 -11.93 11.77 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-O 121.985 0.897 . . . . 0.0 110.543 176.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.452 ' O ' ' OD1' ' A' ' 80' ' ' ASN . 28.9 p -77.59 -32.05 53.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 113.858 -1.519 . . . . 0.0 110.611 -177.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.0 tt -75.88 -33.93 59.98 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.539 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.49 ' C ' ' H ' ' A' ' 81' ' ' GLY . 26.2 m-85 -93.33 -5.25 50.07 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 115.003 1.482 . . . . 0.0 115.003 -178.177 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.452 ' OD1' ' O ' ' A' ' 77' ' ' SER . 50.1 p30 -84.13 32.59 0.49 Allowed 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 114.272 -1.331 . . . . 0.0 107.734 175.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.49 ' H ' ' C ' ' A' ' 79' ' ' TYR . . . -171.93 -9.46 0.02 OUTLIER Glycine 0 CA--C 1.525 0.67 0 CA-C-N 114.503 -1.226 . . . . 0.0 112.376 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.406 ' H ' ' H ' ' A' ' 81' ' ' GLY . 35.9 tp -59.13 -34.85 72.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 113.998 -1.101 . . . . 0.0 110.279 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.7 p -70.8 -27.16 29.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.284 178.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.69 -31.39 61.88 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.574 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.85 -40.03 89.54 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 119.442 -1.361 . . . . 0.0 111.051 -177.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 45.2 mt -62.21 -40.24 95.45 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 122.371 1.081 . . . . 0.0 113.179 -177.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -60.22 -26.72 66.62 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 112.993 -1.912 . . . . 0.0 108.979 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 -57.68 -53.45 58.05 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 172.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.559 HE22 ' CG ' ' A' ' 28' ' ' ASP . 1.4 tp-100 -67.95 -30.28 69.54 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 112.596 -2.093 . . . . 0.0 113.74 -177.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.53 -40.17 93.67 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 78.2 p -74.31 -34.5 63.51 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 118.409 -0.805 . . . . 0.0 111.192 -176.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -57.48 -44.05 84.58 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 120.842 1.656 . . . . 0.0 111.621 -176.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.51 -33.03 64.57 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 119.456 -0.898 . . . . 0.0 111.117 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.626 ' O ' HG22 ' A' ' 97' ' ' ILE . 38.8 t -64.08 -41.94 97.14 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.43 ' C ' ' H ' ' A' ' 97' ' ' ILE . 1.4 p -67.51 -27.47 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.755 179.152 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.499 ' CG ' ' O ' ' A' ' 96' ' ' ARG . 15.0 ttt180 -77.01 9.61 2.85 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -177.034 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.626 HG22 ' O ' ' A' ' 94' ' ' SER . 10.2 tp -86.6 -16.3 9.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 177.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -140.98 -49.0 0.05 OUTLIER Glycine 0 CA--C 1.541 1.662 0 N-CA-C 115.952 1.141 . . . . 0.0 115.952 -177.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.512 ' N ' HD12 ' A' ' 99' ' ' LEU . 10.7 mp -71.8 -13.45 61.7 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 119.453 1.627 . . . . 0.0 112.682 -177.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.479 ' O ' ' CG ' ' A' ' 104' ' ' LYS . 2.6 m-85 -80.77 -51.06 9.07 Favored 'General case' 0 C--O 1.211 -0.938 0 CA-C-N 114.293 -1.321 . . . . 0.0 110.809 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.785 ' OD2' ' OE1' ' A' ' 105' ' ' GLN . 18.3 t70 -69.18 -32.34 71.58 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 123.391 1.567 . . . . 0.0 110.071 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.5 t -68.96 -52.71 26.18 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 110.953 -2.839 . . . . 0.0 113.526 176.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 10.0 p -74.69 -27.66 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 CA-C-N 122.211 2.278 . . . . 0.0 113.146 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.479 ' CG ' ' O ' ' A' ' 100' ' ' TYR . 47.6 mtpt -69.48 -42.13 75.25 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 111.47 -2.605 . . . . 0.0 111.805 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.785 ' OE1' ' OD2' ' A' ' 101' ' ' ASP . 27.2 mt-30 -75.05 -16.37 60.59 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 122.997 1.38 . . . . 0.0 111.05 176.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.634 ' CE2' HG21 ' A' ' 126' ' ' THR . 17.3 t80 -78.7 -22.65 46.36 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 112.614 -2.085 . . . . 0.0 112.044 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -109.54 -30.83 7.74 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 119.369 0.986 . . . . 0.0 111.269 -175.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.4 m -98.1 9.06 43.78 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 118.029 -1.468 . . . . 0.0 112.105 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.521 ' O ' ' C ' ' A' ' 110' ' ' GLY . 51.4 tttm -51.97 120.8 5.74 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 118.129 -0.939 . . . . 0.0 111.564 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.544 ' O ' ' CB ' ' A' ' 111' ' ' SER . . . -20.87 -82.86 0.01 OUTLIER Glycine 0 N--CA 1.488 2.14 0 CA-C-N 119.474 1.034 . . . . 0.0 112.076 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.544 ' CB ' ' O ' ' A' ' 110' ' ' GLY . 24.2 p 103.67 -161.19 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 176.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.621 ' O ' ' N ' ' A' ' 114' ' ' ALA . 18.9 tp10 -131.49 101.56 5.57 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -177.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.641 ' O ' ' HB2' ' A' ' 114' ' ' ALA . 81.3 t60 17.36 42.41 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.924 178.142 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.641 ' HB2' ' O ' ' A' ' 113' ' ' HIS . . . 159.33 -161.48 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.205 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.51 14.9 26.53 Favored Glycine 0 C--N 1.337 0.614 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.991 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 48.6 mt -60.83 -40.5 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.0 -39.51 96.49 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-O 122.078 0.821 . . . . 0.0 111.559 175.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.6 p -57.57 -42.09 82.37 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 177.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -63.42 -37.23 86.47 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.099 -0.64 . . . . 0.0 111.377 -178.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 29.0 mt -64.18 -46.68 82.91 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.351 0.596 . . . . 0.0 110.018 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.588 ' O ' HD23 ' A' ' 121' ' ' LEU . 2.4 tt -66.63 -44.88 80.8 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.983 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.625 ' HB1' ' CE2' ' A' ' 106' ' ' PHE . . . -63.89 -44.99 91.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 119.222 0.919 . . . . 0.0 109.907 178.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -65.73 -44.04 93.08 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.568 -0.825 . . . . 0.0 111.83 -178.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 78.1 p -63.64 -43.27 97.26 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 18.9 m -68.84 -48.03 64.51 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 119.281 -0.968 . . . . 0.0 112.012 177.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.634 HG21 ' CE2' ' A' ' 106' ' ' PHE . 21.6 p -65.49 -42.63 91.95 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 -173.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -64.01 -44.79 95.39 Favored Glycine 0 CA--C 1.521 0.46 0 CA-C-O 122.586 1.103 . . . . 0.0 113.092 -177.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.402 ' O ' ' CG2' ' A' ' 131' ' ' VAL . . . -61.1 -41.3 96.41 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 112.54 -1.83 . . . . 0.0 106.818 177.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.662 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 51.9 mt -63.93 -41.75 97.54 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.308 178.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -62.64 -40.09 95.92 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -177.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.402 ' CG2' ' O ' ' A' ' 128' ' ' ALA . 5.0 m -61.22 -25.64 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 122.696 1.236 . . . . 0.0 109.5 178.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.662 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . -57.87 -44.8 86.86 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 112.49 -2.141 . . . . 0.0 111.626 -178.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.426 HG22 ' H ' ' A' ' 133' ' ' VAL . 3.6 m -78.97 -48.73 21.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.711 -179.294 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -103.59 133.19 49.03 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.786 0.326 . . . . 0.0 111.468 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.649 ' H ' ' HD2' ' A' ' 136' ' ' PRO . 5.8 tp-100 -175.88 -39.41 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.552 178.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.649 ' HD2' ' H ' ' A' ' 135' ' ' GLN . 52.9 Cg_exo -52.75 -33.56 60.66 Favored 'Trans proline' 0 N--CA 1.498 1.775 0 C-N-CA 122.009 1.806 . . . . 0.0 112.548 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 58.7 p -67.3 -41.88 84.63 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 118.309 -1.356 . . . . 0.0 109.65 -178.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -65.88 -42.48 90.26 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 118.796 -1.162 . . . . 0.0 111.903 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 59.1 t -64.04 -44.14 97.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.437 HG13 ' O ' ' A' ' 136' ' ' PRO . 33.2 m -65.08 -38.76 83.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -177.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.434 ' HB3' ' HZ2' ' A' ' 141' ' ' LYS . 14.8 mtpp -62.29 -41.86 98.86 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 119.269 -0.973 . . . . 0.0 111.823 -177.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.401 HG22 ' H ' ' A' ' 142' ' ' VAL . 12.7 m -70.44 -45.64 74.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.237 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.492 ' NH2' ' O ' ' A' ' 174' ' ' GLY . 17.6 mmt85 -65.06 -37.09 86.41 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.566 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -66.98 -42.11 85.66 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -177.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -65.52 -40.39 92.9 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 118.853 -1.139 . . . . 0.0 109.572 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.64 -35.34 80.52 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -178.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -60.2 110.51 1.24 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 176.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -98.83 -61.06 1.42 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 117.617 -1.182 . . . . 0.0 113.266 -177.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 70.8 mtp85 -71.29 -172.58 0.75 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 122.633 2.47 . . . . 0.0 110.259 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -160.79 18.61 0.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.647 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 57.57 -130.86 51.62 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 159.37 126.75 0.87 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 178.63 -150.94 9.98 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -62.13 -41.41 98.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.796 0.331 . . . . 0.0 110.523 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 80.4 mmt-85 -92.06 136.14 33.41 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.421 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.516 ' O ' ' CD2' ' A' ' 156' ' ' TYR . 60.8 t80 -90.96 19.89 5.28 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.63 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.429 ' O ' ' O ' ' A' ' 156' ' ' TYR . 35.2 tt0 58.85 146.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.811 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 88.8 p -157.06 -178.19 7.18 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.472 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 97.8 m -64.31 -45.88 86.0 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.805 -177.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 85.0 t -64.04 -45.35 96.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 119.016 -1.074 . . . . 0.0 108.898 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 -66.72 -39.55 88.05 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.833 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -62.16 -45.61 92.67 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -179.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.429 ' CD1' ' C ' ' A' ' 163' ' ' TYR . 19.3 t80 -62.4 -50.05 73.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.293 0.568 . . . . 0.0 111.075 -178.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -68.44 -45.21 73.14 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -175.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.403 ' O ' ' OE1' ' A' ' 169' ' ' GLU . 19.0 m -62.44 -44.6 96.01 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 -176.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 11.9 pt -64.6 -38.45 82.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-O 121.777 0.799 . . . . 0.0 109.651 176.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.91 -36.8 77.76 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 175.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 16.2 tpt85 -62.12 -49.86 74.19 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 122.095 2.225 . . . . 0.0 111.232 -176.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.403 ' OE1' ' O ' ' A' ' 165' ' ' THR . 16.4 mp0 -74.7 -51.13 15.14 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 123.561 0.744 . . . . 0.0 109.855 177.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -78.32 -36.75 45.98 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 117.033 2.235 . . . . 0.0 117.033 -172.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 91.77 -167.43 30.85 Favored Glycine 0 N--CA 1.472 1.036 0 CA-C-N 119.136 0.88 . . . . 0.0 112.597 177.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.494 HD12 ' CH2' ' A' ' 176' ' ' TRP . 9.0 pt -73.37 -41.91 57.07 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-O 122.098 0.951 . . . . 0.0 110.552 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -58.63 -32.94 69.5 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 113.661 -1.609 . . . . 0.0 110.473 -177.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.492 ' O ' ' NH2' ' A' ' 143' ' ' ARG . . . -60.45 -40.16 97.28 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 118.994 -1.574 . . . . 0.0 109.586 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.768 ' O ' HD23 ' A' ' 175' ' ' LEU . 2.6 tt -69.46 -34.16 73.98 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 111.883 -2.159 . . . . 0.0 116.261 -176.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' TRP . . . . . 0.494 ' CH2' HD12 ' A' ' 172' ' ' ILE . 39.2 m0 -78.36 -7.86 57.78 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 111.071 -2.786 . . . . 0.0 110.227 -178.114 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 37.6 tptt -43.45 -48.18 7.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.925 -176.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -83.75 -34.42 18.98 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 93.0 m -45.39 -51.49 11.22 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.416 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 1.6 t -62.9 -50.91 74.92 Favored Pre-proline 0 N--CA 1.473 0.71 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -176.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 180' ' ' SER . 30.5 Cg_endo -64.81 -28.73 59.19 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.296 1.331 . . . . 0.0 111.901 177.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -64.22 -39.74 94.61 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.637 179.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 94.5 t -63.28 -42.97 98.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.189 -0.459 . . . . 0.0 109.907 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.45 -39.89 94.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.014 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.407 ' O ' HG22 ' A' ' 189' ' ' VAL . 65.2 ttt180 -61.1 -42.19 98.06 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.13 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -62.24 -44.0 97.55 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.169 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -65.65 -45.95 81.03 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -178.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.437 HG23 ' N ' ' A' ' 189' ' ' VAL . 10.0 tp -65.38 -46.28 90.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.515 HG23 ' N ' ' A' ' 190' ' ' ASN . 29.6 m -60.83 -46.85 95.51 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 C-N-CA 119.837 -0.745 . . . . 0.0 111.648 -178.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.515 ' N ' HG23 ' A' ' 189' ' ' VAL . 31.4 t30 -62.28 -43.46 98.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 122.169 0.985 . . . . 0.0 109.876 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' CYS . . . . . . . . . . . . . 28.2 t -62.7 -47.38 83.88 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 113.554 -1.657 . . . . 0.0 110.862 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -65.01 -41.19 95.58 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.253 177.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -61.37 -45.75 93.08 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 114.335 -1.302 . . . . 0.0 111.999 -178.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.554 ' O ' HD13 ' A' ' 194' ' ' LEU . 0.2 OUTLIER -63.56 -38.1 89.83 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 -176.277 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.438 ' O ' ' CD2' ' A' ' 199' ' ' LEU . 72.1 t -63.44 -46.48 95.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 C-N-CA 117.648 -1.621 . . . . 0.0 107.603 178.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 19.2 m -64.35 -45.74 86.49 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -178.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -56.78 -38.69 72.86 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.487 1.115 . . . . 0.0 112.497 -177.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -55.48 -44.13 76.18 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.698 HD22 ' N ' ' A' ' 199' ' ' LEU . 2.5 mm? -61.24 -39.95 92.24 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 40.2 mt -63.86 -44.24 98.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-O 118.65 -0.691 . . . . 0.0 112.037 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -61.13 -41.04 96.01 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 120.415 1.462 . . . . 0.0 112.182 177.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -67.32 -37.63 83.63 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.235 -1.348 . . . . 0.0 111.061 -177.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 3.4 m -101.94 129.9 48.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.269 0.557 . . . . 0.0 111.939 -177.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 22.9 mt 68.12 4.97 4.36 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 114.384 -1.28 . . . . 0.0 113.082 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.417 HD13 ' H ' ' A' ' 208' ' ' ASN . 0.2 OUTLIER -135.74 44.12 2.53 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.202 0.525 . . . . 0.0 110.889 -179.741 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.55 ' O ' ' CB ' ' A' ' 207' ' ' ALA . 56.8 pttt -88.03 49.67 1.84 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.835 -178.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.578 ' O ' ' ND2' ' A' ' 208' ' ' ASN . . . 119.96 17.83 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.155 0 O-C-N 124.494 1.121 . . . . 0.0 109.474 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' ASN . . . . . 0.578 ' ND2' ' O ' ' A' ' 207' ' ' ALA . 0.2 OUTLIER 77.57 116.33 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 102.31 -3.219 . . . . 0.0 102.31 -171.492 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.477 ' C ' HD23 ' A' ' 209' ' ' LEU . 2.0 tt -95.48 86.6 4.52 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.965 0.412 . . . . 0.0 111.418 -178.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 37.2 ttp -135.21 136.43 41.77 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.964 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 28.0 m -167.93 -66.53 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.501 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' ASP . . . . . 0.504 ' CG ' ' H ' ' A' ' 213' ' ' ASP . 19.7 t70 -169.44 -163.23 0.38 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.306 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.504 ' H ' ' CG ' ' A' ' 212' ' ' ASP . 6.6 p-10 41.46 65.82 0.78 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.03 0.443 . . . . 0.0 110.712 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.487 ' N ' ' CD ' ' A' ' 215' ' ' PRO . 1.9 mt -61.34 -43.42 89.55 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.263 -178.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.487 ' CD ' ' N ' ' A' ' 214' ' ' LEU . 33.5 Cg_exo -60.17 -32.58 94.69 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 121.602 1.534 . . . . 0.0 111.89 -178.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 97.7 m -64.08 -42.01 97.11 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 113.456 -1.702 . . . . 0.0 111.148 -179.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -66.34 -38.35 87.43 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.855 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -63.47 -46.92 84.0 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.285 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 32.7 p -59.97 -37.39 79.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 118.222 0.464 . . . . 0.0 110.785 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 14.0 t -59.29 -41.37 88.81 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.21 -41.49 99.14 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -177.185 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -61.46 -46.86 88.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 122.1 0.952 . . . . 0.0 112.59 -176.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -60.69 -41.79 99.1 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 107.725 -2.15 . . . . 0.0 107.725 176.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' ALA . . . . . 0.604 ' O ' HG23 ' A' ' 228' ' ' THR . . . -62.7 -37.87 88.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.163 -1.018 . . . . 0.0 109.218 177.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -61.41 -41.91 99.65 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.993 -177.414 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -66.37 -38.16 86.92 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 119.316 -0.954 . . . . 0.0 108.574 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' CYS . . . . . 0.442 ' O ' HG12 ' A' ' 230' ' ' VAL . 96.4 m -63.03 -41.23 99.47 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.081 0.467 . . . . 0.0 110.306 177.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.604 HG23 ' O ' ' A' ' 224' ' ' ALA . 60.4 p -61.85 -39.4 91.74 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.575 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 19.5 m -58.15 -39.22 78.25 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.72 -176.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 227' ' ' CYS . 1.5 p -59.66 -40.19 81.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 118.709 -1.197 . . . . 0.0 108.442 179.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.599 ' O ' ' HD2' ' A' ' 234' ' ' PRO . 26.7 mt -60.88 -40.23 84.59 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.449 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 177.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -61.95 -38.35 88.17 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 115.454 1.649 . . . . 0.0 115.454 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.466 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 0.9 OUTLIER -56.89 -39.65 79.44 Favored Pre-proline 0 N--CA 1.481 1.093 0 N-CA-C 116.276 1.954 . . . . 0.0 116.276 -172.972 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.599 ' HD2' ' O ' ' A' ' 231' ' ' ILE . 38.1 Cg_exo -59.06 -39.94 75.35 Favored 'Trans proline' 0 C--N 1.29 -2.54 0 C-N-CA 122.097 1.865 . . . . 0.0 114.246 -176.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.8 m -64.2 -37.62 80.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 118.435 -1.306 . . . . 0.0 111.369 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' ASP . . . . . 0.441 ' CG ' ' O ' ' A' ' 233' ' ' SER . 0.3 OUTLIER -66.28 -40.09 89.85 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 179.003 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 99.0 t -64.54 -44.97 96.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -175.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.466 ' CG2' HH21 ' A' ' 241' ' ' ARG . 10.0 p -62.91 -36.94 77.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 119.423 -0.911 . . . . 0.0 110.865 -178.177 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 3.9 mmmm -60.83 -43.79 97.8 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.06 -42.14 97.93 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 -176.273 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.48 ' O ' ' CB ' ' A' ' 242' ' ' TYR . 12.9 ptt180 -56.56 135.69 54.58 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 119.774 -0.77 . . . . 0.0 109.727 -178.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.516 ' O ' ' ND2' ' A' ' 244' ' ' ASN . 11.9 t80 153.48 -57.94 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 O-C-N 124.009 0.818 . . . . 0.0 110.834 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 243' ' ' MET . . . . . 0.429 ' SD ' ' OE1' ' A' ' 42' ' ' GLN . 4.7 ttt -52.21 114.95 1.49 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.344 0.593 . . . . 0.0 111.248 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 244' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 242' ' ' TYR . 22.6 p30 179.21 -7.12 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 245' ' ' SER . . . . . 0.623 ' O ' ' HB2' ' A' ' 246' ' ' ALA . 54.0 m -119.05 152.62 36.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 112.661 -2.063 . . . . 0.0 113.157 -177.253 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 246' ' ' ALA . . . . . 0.623 ' HB2' ' O ' ' A' ' 245' ' ' SER . . . 157.12 -24.6 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.166 -1.379 . . . . 0.0 109.105 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 7.1 mt -137.86 101.02 4.33 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.271 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 139.81 -161.29 26.26 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 111.536 -0.625 . . . . 0.0 111.536 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.439 ' O ' ' O ' ' A' ' 250' ' ' TYR . 85.5 mm-40 -76.85 -103.34 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.623 ' CE2' ' OG ' ' A' ' 245' ' ' SER . 7.3 t80 57.0 98.67 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 119.111 -1.035 . . . . 0.0 108.934 178.302 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -65.22 -53.07 50.0 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 116.148 -2.221 . . . . 0.0 107.795 -178.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 2.8 m -151.17 -179.82 7.66 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.361 171.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.484 ' O ' ' SG ' ' A' ' 256' ' ' CYS . . . -67.49 -47.55 69.69 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 177.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 254' ' ' GLY . . . . . 0.427 ' O ' ' HB3' ' A' ' 257' ' ' ALA . . . -68.23 -43.48 79.75 Favored Glycine 0 N--CA 1.471 1.025 0 CA-C-N 124.051 3.114 . . . . 0.0 113.489 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 255' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -65.52 -31.98 73.33 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 111.894 -2.153 . . . . 0.0 111.093 -176.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 256' ' ' CYS . . . . . 0.63 ' SG ' ' N ' ' A' ' 257' ' ' ALA . 2.1 p -64.01 -43.53 95.35 Favored 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 172.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.63 ' N ' ' SG ' ' A' ' 256' ' ' CYS . . . -59.25 -43.95 92.39 Favored 'General case' 0 C--N 1.335 -0.059 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.064 -177.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 22.6 tp -65.25 -42.26 93.49 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 19.4 m -61.96 -43.78 98.13 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.891 -1.049 . . . . 0.0 109.555 177.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' MET . . . . . 0.575 ' O ' ' N ' ' A' ' 264' ' ' GLU . 0.0 OUTLIER -59.48 -40.87 88.36 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.074 -178.517 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 9.6 tp -59.81 -46.36 89.48 Favored 'General case' 0 C--N 1.32 -0.681 0 O-C-N 121.887 -0.508 . . . . 0.0 110.098 -177.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 262' ' ' ARG . . . . . 0.415 ' HG3' ' H ' ' A' ' 263' ' ' LYS . 9.4 ptm180 -66.36 -52.95 41.66 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 119.056 -1.058 . . . . 0.0 110.304 178.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 263' ' ' LYS . . . . . 0.415 ' H ' ' HG3' ' A' ' 262' ' ' ARG . 2.7 ptmm? -88.29 -55.45 3.73 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 264' ' ' GLU . . . . . 0.575 ' N ' ' O ' ' A' ' 260' ' ' MET . 25.0 mt-10 -90.25 102.16 14.88 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 119.673 1.124 . . . . 0.0 111.473 -179.019 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.478 ' C ' ' H ' ' A' ' 267' ' ' ARG . . . -36.91 159.44 0.01 OUTLIER Glycine 0 CA--C 1.536 1.377 0 N-CA-C 111.424 -0.67 . . . . 0.0 111.424 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -56.96 1.13 0.16 Allowed 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 121.952 1.768 . . . . 0.0 112.412 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.478 ' H ' ' C ' ' A' ' 265' ' ' GLY . 20.8 mmt85 -69.12 -27.33 65.47 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 110.627 -0.138 . . . . 0.0 110.627 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -59.05 -32.63 69.93 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 119.615 -0.834 . . . . 0.0 109.626 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -62.58 -42.66 99.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.172 178.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -66.94 -36.88 83.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.845 -1.07 . . . . 0.0 112.73 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.428 ' O ' ' O ' ' A' ' 272' ' ' GLY . 98.3 mttt -75.1 174.61 9.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.317 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 272' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 271' ' ' LYS . . . 47.69 101.79 0.01 OUTLIER Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -164.65 7.35 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.167 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 274' ' ' MET . . . . . 0.558 ' O ' HD13 ' A' ' 278' ' ' LEU . 65.1 mtp -63.79 -44.67 80.39 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 275' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 274' ' ' MET . 34.6 Cg_endo -64.53 -46.34 7.42 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 120.969 1.113 . . . . 0.0 112.554 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 17.4 t -60.7 -40.65 93.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.062 0.458 . . . . 0.0 111.044 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -62.05 -42.5 99.25 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 123.668 1.699 . . . . 0.0 110.445 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.558 HD13 ' O ' ' A' ' 274' ' ' MET . 7.2 mp -62.52 -38.29 89.39 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 110.288 -3.142 . . . . 0.0 108.192 174.153 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 17.5 tpt85 -62.62 -40.96 98.64 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.605 0.717 . . . . 0.0 110.613 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 9.7 mt -62.29 -36.15 81.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.586 -1.188 . . . . 0.0 112.834 -177.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -67.78 -50.73 39.85 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -178.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 282' ' ' SER . . . . . 0.518 ' O ' HG22 ' A' ' 285' ' ' VAL . 78.0 p -62.88 -44.7 95.39 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.164 0.507 . . . . 0.0 109.817 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 283' ' ' TRP . . . . . . . . . . . . . 37.8 t90 -61.32 -39.02 88.98 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.743 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -62.86 -39.73 95.31 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -178.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.518 HG22 ' O ' ' A' ' 282' ' ' SER . 9.5 m -61.12 -37.37 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.337 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.495 ' O ' HG12 ' A' ' 289' ' ' VAL . 96.9 t -61.83 -40.52 87.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 29.5 ttp -60.99 -39.18 88.68 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.453 0.645 . . . . 0.0 109.472 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -58.87 -39.52 81.62 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.906 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.495 HG12 ' O ' ' A' ' 286' ' ' VAL . 0.4 OUTLIER -60.16 -38.31 76.63 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -176.417 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -62.65 -40.19 96.25 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 119.137 -1.025 . . . . 0.0 108.642 177.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -61.23 -39.07 88.94 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 176.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -58.57 -40.59 83.53 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 117.748 -1.581 . . . . 0.0 109.737 -176.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 293' ' ' GLN . . . . . 0.445 ' O ' ' O ' ' A' ' 296' ' ' ARG . 21.9 mm100 -60.43 -42.86 96.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 122.506 1.146 . . . . 0.0 110.944 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 10.5 mt -60.2 -40.76 91.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 113.029 -1.896 . . . . 0.0 109.305 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 21.8 mtpt -63.24 -45.82 89.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.271 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 296' ' ' ARG . . . . . 0.445 ' O ' ' O ' ' A' ' 293' ' ' GLN . 80.6 mtm180 -123.02 116.51 23.65 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.443 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -117.22 -94.68 0.49 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.3 0.571 . . . . 0.0 110.862 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.477 ' C ' HD12 ' A' ' 298' ' ' LEU . 0.4 OUTLIER -135.98 -166.45 1.87 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.032 178.846 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 5.7 ptm -171.57 66.48 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.343 -0.543 . . . . 0.0 111.747 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.53 101.12 0.07 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.983 0.897 . . . . 0.0 110.343 -178.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -64.14 -46.23 85.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 113.789 -1.55 . . . . 0.0 113.436 -176.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -58.96 -40.06 83.56 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.177 -0.609 . . . . 0.0 109.613 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 303' ' ' GLN . . . . . 0.473 ' CD ' ' N ' ' A' ' 13' ' ' MET . 14.9 tt0 -64.83 -46.66 81.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.689 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 304' ' ' SER . . . . . 0.435 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 75.9 p -66.66 -37.37 84.65 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.882 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -61.55 -43.14 99.41 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -65.21 -36.73 85.07 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -177.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 307' ' ' ALA . . . . . 0.544 ' HB3' ' HD3' ' A' ' 308' ' ' PRO . . . -59.92 -52.88 70.51 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -176.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 308' ' ' PRO . . . . . 0.544 ' HD3' ' HB3' ' A' ' 307' ' ' ALA . 74.4 Cg_endo -75.26 0.37 9.09 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.048 1.832 . . . . 0.0 111.874 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 82.3 t80 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.614 179.925 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.569 ' N ' ' SD ' ' A' ' 13' ' ' MET . 4.6 mpp? . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.1 t -177.08 69.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.84 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.568 HG12 ' N ' ' A' ' 16' ' ' LYS . 42.1 t -135.8 164.33 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 121.031 0.443 . . . . 0.0 110.302 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.568 ' N ' HG12 ' A' ' 15' ' ' VAL . 14.2 ptpt -64.52 -41.68 96.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.434 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.535 ' CE2' ' NH1' ' A' ' 96' ' ' ARG . 32.4 t80 -63.41 -41.89 98.73 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -178.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.2 pp -80.1 -25.59 39.92 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.185 0.517 . . . . 0.0 112.351 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.42 ' O ' ' OG1' ' A' ' 22' ' ' THR . . . -66.14 -41.21 95.09 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 107.667 -2.173 . . . . 0.0 107.667 177.298 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.414 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -71.5 -32.07 67.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 124.787 2.232 . . . . 0.0 107.193 176.347 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.6 -42.43 98.81 Favored Glycine 0 CA--C 1.527 0.837 1 CA-C-N 108.389 -4.005 . . . . 0.0 108.19 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 19' ' ' GLY . 22.4 p -70.65 -27.74 64.27 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -66.48 -50.02 64.66 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.814 -179.113 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.94 -36.06 80.27 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 118.161 -1.416 . . . . 0.0 110.931 -177.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.2 t -63.99 -53.87 43.38 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.616 -0.433 . . . . 0.0 111.326 -179.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.1 tp -65.82 -39.75 85.68 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -177.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.619 ' O ' HG23 ' A' ' 31' ' ' THR . . . -63.9 -41.93 97.57 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 119.736 -0.786 . . . . 0.0 112.924 -173.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -77.69 -27.24 50.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 120.439 1.472 . . . . 0.0 109.886 -176.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.0 tp -59.86 -55.71 30.84 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 119.802 1.183 . . . . 0.0 112.553 -178.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.4 tp -75.75 -4.63 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.619 HG23 ' O ' ' A' ' 27' ' ' ALA . 28.3 p -109.84 -17.27 13.69 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 118.7 -1.2 . . . . 0.0 110.41 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.414 ' N ' ' CD ' ' A' ' 33' ' ' PRO . 66.3 t80 -67.86 -43.65 38.53 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 122.461 2.391 . . . . 0.0 110.583 -178.015 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 32' ' ' PHE . 37.6 Cg_exo -58.94 -15.32 26.72 Favored 'Trans proline' 0 N--CA 1.503 2.06 0 C-N-CA 121.343 1.362 . . . . 0.0 112.341 178.035 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.75 HD13 HH21 ' A' ' 279' ' ' ARG . 88.8 mt -67.15 -34.43 77.55 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -178.031 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -64.09 -40.64 96.67 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -177.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 75.7 p -58.29 -34.79 70.93 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.04 -38.91 86.7 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -178.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.496 ' NZ ' ' CB ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -61.17 -47.06 87.91 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 119.378 -0.929 . . . . 0.0 111.723 -176.173 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 95.0 t -62.39 -38.06 80.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 O-C-N 122.287 -0.258 . . . . 0.0 111.264 -178.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.502 ' O ' ' N ' ' A' ' 42' ' ' GLN . 25.9 mmt180 -59.58 -40.16 86.47 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.367 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 84.2 mt -61.19 38.93 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.502 ' N ' ' O ' ' A' ' 40' ' ' ARG . 2.7 pt20 -172.29 55.32 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 O-C-N 122.074 -0.391 . . . . 0.0 110.739 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.424 ' C ' ' O ' ' A' ' 42' ' ' GLN . 0.1 OUTLIER 26.68 -117.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.959 179.622 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.407 ' H ' ' CG1' ' A' ' 43' ' ' ILE . 28.0 mm100 -129.89 102.51 6.33 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.366 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -81.47 73.6 2.58 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -156.56 163.62 39.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.878 0.37 . . . . 0.0 110.45 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 63.6 p -82.18 67.21 8.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.645 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -118.34 -47.39 2.56 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.825 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.02 13.09 81.76 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -177.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.546 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -65.82 -38.12 88.07 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.435 0.636 . . . . 0.0 109.319 178.978 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.539 HG13 ' N ' ' A' ' 52' ' ' ARG . 12.5 p -60.24 -44.5 95.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.859 -178.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.539 ' N ' HG13 ' A' ' 51' ' ' VAL . 52.5 ttp180 -64.31 -33.59 76.19 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.183 -0.607 . . . . 0.0 109.474 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 95.8 m -67.71 -38.21 83.32 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.415 ' O ' ' O ' ' A' ' 51' ' ' VAL . . . -89.76 124.52 34.71 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.706 179.107 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -87.62 -7.08 57.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.949 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.441 ' C ' ' H ' ' A' ' 58' ' ' GLN . 88.1 p -174.43 -125.89 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 56' ' ' SER . . . 65.27 -19.72 0.09 Allowed 'General case' 0 N--CA 1.461 0.092 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 176.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.441 ' H ' ' C ' ' A' ' 56' ' ' SER . 71.0 mm-40 -126.01 38.76 4.08 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 177.485 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.427 ' O ' ' O ' ' A' ' 58' ' ' GLN . 75.2 m-85 -37.53 -98.37 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.132 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.428 ' O ' ' C ' ' A' ' 61' ' ' GLY . 34.4 ttm180 -154.51 -31.63 0.11 Allowed 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.442 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 60' ' ' ARG . . . -29.03 102.27 0.01 OUTLIER Glycine 0 C--N 1.34 0.774 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.914 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.1 t -66.77 -34.46 70.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 118.31 -0.852 . . . . 0.0 109.14 176.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.7 tp -60.93 -33.01 72.5 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 121.495 1.952 . . . . 0.0 111.365 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -65.05 -49.43 62.42 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 115.223 0.849 . . . . 0.0 115.223 -176.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.41 HG22 ' H ' ' A' ' 65' ' ' THR . 0.0 OUTLIER -62.21 -45.57 92.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.958 -0.621 . . . . 0.0 111.714 -179.159 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 94.5 mt -59.66 -36.37 65.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -179.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.559 ' O ' HD13 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -63.92 -36.41 83.86 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 120.561 1.528 . . . . 0.0 111.343 179.568 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.448 ' O ' ' OG1' ' A' ' 72' ' ' THR . 98.3 m -62.52 -39.35 93.24 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 113.215 -1.812 . . . . 0.0 111.084 -176.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 28.7 ttt -60.52 -39.46 87.9 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -177.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.8 t -68.92 -40.38 81.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 119.473 -0.891 . . . . 0.0 112.851 -177.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -77.71 -13.25 59.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.679 0.752 . . . . 0.0 112.947 -178.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 68' ' ' THR . 16.1 m -62.96 -55.06 29.15 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.947 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 31.9 mp0 -108.39 -58.85 1.94 Allowed 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.407 ' O ' ' CB ' ' A' ' 77' ' ' SER . . . 158.75 164.54 14.45 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -56.49 -35.14 96.39 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.762 1.642 . . . . 0.0 111.546 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.428 ' O ' ' OD1' ' A' ' 80' ' ' ASN . 48.4 ttm-85 -60.97 -11.01 6.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 122.211 1.005 . . . . 0.0 111.003 176.327 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.531 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 36.2 p -77.59 -32.19 53.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 113.285 -1.779 . . . . 0.0 110.205 -179.073 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 85.7 mt -74.8 -28.93 60.92 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.486 1.114 . . . . 0.0 111.477 178.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -86.64 -2.45 58.52 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 122.678 1.228 . . . . 0.0 113.041 -172.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.531 ' ND2' ' O ' ' A' ' 77' ' ' SER . 0.4 OUTLIER -116.33 138.23 51.5 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 112.376 -2.193 . . . . 0.0 108.542 176.847 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.8 -28.09 17.37 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -178.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 69.5 mt -59.34 -34.87 72.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.148 -1.026 . . . . 0.0 110.573 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.3 t -70.85 -27.47 30.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.293 -0.867 . . . . 0.0 108.969 178.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.01 -31.93 61.5 Favored 'General case' 0 C--O 1.226 -0.15 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.331 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.64 -40.33 90.42 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 119.463 -1.351 . . . . 0.0 110.802 -178.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.5 tp -62.22 -40.27 95.56 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 122.343 1.068 . . . . 0.0 113.243 -176.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -60.17 -27.04 66.78 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 113.285 -1.78 . . . . 0.0 109.307 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 77.0 mtt180 -57.93 -53.41 58.59 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 172.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -67.65 -30.65 70.26 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 112.061 -2.336 . . . . 0.0 113.794 -177.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 2.7 ptm -61.72 -40.09 93.83 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.925 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.5 m -74.1 -34.31 63.91 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 119.191 -1.004 . . . . 0.0 111.048 -176.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -58.0 -43.92 86.94 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 120.899 1.681 . . . . 0.0 112.416 -176.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.1 -33.07 65.36 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.921 -177.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 85.9 p -63.69 -40.74 97.56 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.446 ' C ' ' H ' ' A' ' 97' ' ' ILE . 18.7 m -67.89 -28.77 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.535 ' NH1' ' CE2' ' A' ' 17' ' ' PHE . 5.0 ptm180 -77.61 12.0 1.82 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -177.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.446 ' H ' ' C ' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -86.63 -15.35 9.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 179.07 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.503 ' O ' ' OD1' ' A' ' 101' ' ' ASP . . . -140.26 -47.84 0.06 OUTLIER Glycine 0 CA--C 1.536 1.344 0 CA-C-N 114.265 -1.334 . . . . 0.0 114.553 -177.349 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.4 tp -71.65 -13.52 61.77 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 119.453 1.626 . . . . 0.0 113.443 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -81.18 -52.16 7.66 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 114.595 -1.184 . . . . 0.0 112.189 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.62 ' O ' ' HG3' ' A' ' 105' ' ' GLN . 41.5 p-10 -70.15 -32.47 70.47 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 124.061 1.886 . . . . 0.0 110.591 -179.098 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.524 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 28.7 t -67.49 -50.74 57.6 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 109.695 -3.411 . . . . 0.0 111.936 176.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.466 HG22 ' CE2' ' A' ' 107' ' ' TYR . 0.5 OUTLIER -73.25 -26.42 22.58 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.185 0 CA-C-N 121.446 1.93 . . . . 0.0 111.492 178.586 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -69.29 -41.44 76.8 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 112.524 -2.126 . . . . 0.0 110.955 178.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.62 ' HG3' ' O ' ' A' ' 101' ' ' ASP . 88.1 mt-30 -76.64 -16.98 59.41 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.591 0.71 . . . . 0.0 111.073 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -79.33 -22.95 43.83 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.17 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.466 ' CE2' HG22 ' A' ' 103' ' ' VAL . 33.3 m-85 -109.34 -29.35 8.5 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 119.669 1.122 . . . . 0.0 112.855 -174.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 59.3 p -95.99 9.42 40.79 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 117.07 -1.852 . . . . 0.0 113.208 -176.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.0 mmmt -47.55 122.64 4.96 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.258 0.935 . . . . 0.0 108.661 176.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -119.29 85.83 0.39 Allowed Glycine 0 N--CA 1.476 1.33 0 CA-C-N 120.216 1.371 . . . . 0.0 111.624 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 34.3 t -94.55 -61.37 1.52 Allowed 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 -176.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -123.29 -176.83 3.53 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 112.749 -2.023 . . . . 0.0 111.971 -177.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.638 ' O ' ' HB2' ' A' ' 114' ' ' ALA . 0.0 OUTLIER -91.25 72.5 6.21 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -178.51 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.638 ' HB2' ' O ' ' A' ' 113' ' ' HIS . . . 159.77 -162.96 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 176.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.22 15.27 26.17 Favored Glycine 0 C--N 1.343 0.958 0 CA-C-N 114.471 -1.241 . . . . 0.0 113.15 177.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.481 HG23 ' N ' ' A' ' 117' ' ' GLY . 15.0 tt -60.87 -40.29 84.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 118.053 0.927 . . . . 0.0 110.215 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.481 ' N ' HG23 ' A' ' 116' ' ' ILE . . . -65.1 -39.68 96.44 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-O 122.029 0.794 . . . . 0.0 111.837 176.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 36.2 m -57.2 -41.68 79.85 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -63.2 -36.71 84.53 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.181 -0.607 . . . . 0.0 111.509 -178.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.649 ' C ' HD12 ' A' ' 120' ' ' LEU . 0.1 OUTLIER -63.91 -45.78 87.77 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.087 0.47 . . . . 0.0 110.407 178.387 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.423 ' N ' ' HG ' ' A' ' 120' ' ' LEU . 10.9 tp -65.7 -44.05 87.3 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 119.405 -0.918 . . . . 0.0 109.821 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.69 -44.38 96.38 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 118.922 0.783 . . . . 0.0 110.496 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -65.72 -44.23 92.76 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 119.561 -1.304 . . . . 0.0 112.021 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 10.9 t -64.15 -44.76 91.16 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 119.985 -0.686 . . . . 0.0 111.631 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.417 ' O ' HD23 ' A' ' 129' ' ' LEU . 21.3 m -69.73 -48.89 57.85 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 119.07 -1.052 . . . . 0.0 112.194 177.507 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 24.5 m -65.49 -42.81 91.78 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 -174.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -64.22 -44.65 95.3 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-O 122.802 1.223 . . . . 0.0 113.342 -177.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.426 ' O ' ' CG2' ' A' ' 131' ' ' VAL . . . -60.96 -41.31 96.09 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 112.073 -2.063 . . . . 0.0 107.075 177.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.665 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 1.6 mm? -64.3 -42.02 96.57 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.438 178.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.18 -39.86 95.85 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -177.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.426 ' CG2' ' O ' ' A' ' 128' ' ' ALA . 7.0 m -61.15 -25.76 37.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 122.753 1.264 . . . . 0.0 109.544 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.665 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . -58.55 -44.94 89.83 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 112.364 -2.198 . . . . 0.0 111.673 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.438 HG12 ' H ' ' A' ' 133' ' ' VAL . 2.0 p -79.07 -48.82 20.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -102.73 129.15 49.27 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.826 0.346 . . . . 0.0 111.122 -179.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.661 ' H ' ' CD ' ' A' ' 136' ' ' PRO . 51.2 tp60 -173.15 -38.5 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.25 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.934 179.153 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.661 ' CD ' ' H ' ' A' ' 135' ' ' GLN . 63.3 Cg_exo -52.88 -34.17 64.77 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.467 1.444 . . . . 0.0 112.002 -179.228 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 11.2 m -68.35 -42.92 78.55 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 118.082 -1.447 . . . . 0.0 110.919 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -66.91 -43.97 82.0 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 118.26 -1.376 . . . . 0.0 112.853 -178.223 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.465 HG23 ' N ' ' A' ' 140' ' ' VAL . 27.6 m -64.96 -44.6 96.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -179.166 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.465 ' N ' HG23 ' A' ' 139' ' ' VAL . 7.6 p -65.33 -38.69 83.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -177.206 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -62.16 -41.08 97.96 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -176.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.449 ' CG1' ' N ' ' A' ' 143' ' ' ARG . 2.4 p -70.39 -44.78 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.072 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.539 HH22 ' H ' ' A' ' 178' ' ' GLY . 81.5 mtt85 -64.26 -36.28 83.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.468 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -66.42 -41.23 89.52 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.769 -0.373 . . . . 0.0 111.572 -177.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 18.3 mm100 -64.92 -39.56 93.7 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 119.526 -0.87 . . . . 0.0 109.083 178.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.31 -34.84 79.28 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -179.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -60.27 110.47 1.24 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 176.411 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -100.91 -58.26 1.93 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 117.226 -1.368 . . . . 0.0 113.836 -176.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.528 ' O ' ' N ' ' A' ' 151' ' ' GLY . 28.9 ptt-85 -133.66 17.67 3.92 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 122.641 2.473 . . . . 0.0 110.03 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . 49.95 -86.5 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.724 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 149' ' ' ARG . . . -157.28 42.56 0.53 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 64.3 23.99 68.68 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -60.1 126.01 40.43 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 76.4 mtm-85 -62.21 -44.37 96.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.949 0.404 . . . . 0.0 110.145 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -85.4 130.69 34.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.216 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -64.64 132.43 49.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.662 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -80.39 -164.68 0.73 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.545 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 56.7 m -156.97 -178.1 7.12 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.156 0.503 . . . . 0.0 110.843 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 98.7 m -64.25 -46.31 84.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.983 -177.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.548 HG23 ' N ' ' A' ' 161' ' ' GLU . 34.0 m -64.35 -45.36 96.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 118.946 -1.102 . . . . 0.0 109.239 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.548 ' N ' HG23 ' A' ' 160' ' ' VAL . 81.8 tt0 -67.36 -39.27 85.69 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.665 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -61.68 -45.99 91.65 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -177.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -62.73 -49.66 74.16 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.422 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -68.36 -45.41 72.87 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 -175.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.562 HG23 ' N ' ' A' ' 166' ' ' ILE . 14.1 t -62.82 -44.88 94.99 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.519 1.054 . . . . 0.0 113.689 -177.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.562 ' N ' HG23 ' A' ' 165' ' ' THR . 2.5 pp -64.84 -38.3 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 121.906 0.86 . . . . 0.0 109.337 176.328 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.451 ' N ' HD12 ' A' ' 166' ' ' ILE . . . -59.25 -35.6 73.97 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 113.992 -1.458 . . . . 0.0 107.788 176.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.407 ' HE ' ' HA ' ' A' ' 168' ' ' ARG . 0.5 OUTLIER -61.6 -49.78 75.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 122.401 2.364 . . . . 0.0 111.449 -175.475 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -74.57 -50.99 15.86 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 123.446 0.698 . . . . 0.0 109.63 177.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.487 ' CD ' ' N ' ' A' ' 170' ' ' GLU . 2.2 mp0 -77.98 -36.6 48.76 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 116.637 2.088 . . . . 0.0 116.637 -173.376 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' GLY . . . . . 0.413 ' O ' HD23 ' A' ' 175' ' ' LEU . . . 91.49 -167.23 31.03 Favored Glycine 0 N--CA 1.47 0.935 0 CA-C-N 118.842 0.746 . . . . 0.0 112.007 177.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.531 HG23 ' N ' ' A' ' 173' ' ' ARG . 19.8 tt -73.45 -42.55 56.5 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.07 0 CA-C-O 121.963 0.887 . . . . 0.0 110.885 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.531 ' N ' HG23 ' A' ' 172' ' ' ILE . 3.9 tpt180 -58.79 -33.49 70.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 113.993 -1.458 . . . . 0.0 111.261 -176.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -60.7 -40.24 97.76 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 118.965 -1.588 . . . . 0.0 110.006 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.52 ' O ' ' NH2' ' A' ' 143' ' ' ARG . 3.7 mm? -70.61 -33.27 70.86 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 111.673 -2.264 . . . . 0.0 116.922 -177.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 19.5 m0 -78.06 -7.65 57.2 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 112.076 -2.329 . . . . 0.0 109.845 -177.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -43.22 -47.97 6.49 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.405 -176.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.539 ' H ' HH22 ' A' ' 143' ' ' ARG . . . -91.9 -32.06 8.79 Favored Glycine 0 CA--C 1.533 1.217 0 N-CA-C 111.329 -0.708 . . . . 0.0 111.329 178.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 34.8 m -45.36 -51.52 11.09 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.43 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 2.8 m -62.47 -50.8 77.21 Favored Pre-proline 0 N--CA 1.471 0.581 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -176.309 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 180' ' ' SER . 28.2 Cg_endo -64.84 -28.38 59.08 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 121.482 1.455 . . . . 0.0 111.782 176.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -63.92 -39.53 94.38 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.454 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 70.9 t -63.09 -42.59 97.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.14 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.2 -39.49 92.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.048 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.878 ' HE ' ' HZ1' ' A' ' 239' ' ' LYS . 33.0 ttm105 -60.59 -41.67 95.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.842 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -61.34 -42.92 99.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.063 0.459 . . . . 0.0 110.805 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.44 -43.82 93.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.092 -179.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 33.0 mm -63.56 -45.25 98.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -177.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.46 ' O ' ' N ' ' A' ' 193' ' ' GLU . 3.0 p -60.09 -46.79 93.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 119.679 -0.808 . . . . 0.0 112.027 -177.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 191' ' ' CYS . 2.6 p30 -63.13 -42.64 99.55 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 122.089 0.947 . . . . 0.0 109.983 179.103 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 191' ' ' CYS . . . . . 0.524 ' N ' ' OD1' ' A' ' 190' ' ' ASN . 27.2 m -61.2 -45.66 93.69 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 113.94 -1.482 . . . . 0.0 109.317 179.295 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -63.76 -39.56 94.56 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 112.99 -1.913 . . . . 0.0 108.638 175.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 0.46 ' N ' ' O ' ' A' ' 189' ' ' VAL . 74.6 tt0 -61.33 -46.96 88.07 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.868 -177.505 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 53.4 mt -65.15 -39.26 92.75 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 118.547 -1.261 . . . . 0.0 110.493 -175.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 7.0 m -63.97 -45.74 95.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 C-N-CA 117.078 -1.849 . . . . 0.0 107.297 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 19.9 m -63.75 -45.7 88.64 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -178.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -56.49 -38.34 71.62 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.296 1.038 . . . . 0.0 112.29 -178.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.44 -44.0 75.91 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.689 HD22 ' N ' ' A' ' 199' ' ' LEU . 2.9 mm? -61.18 -39.15 89.1 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 41.3 mm -62.78 -42.99 98.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.029 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -60.24 -39.55 87.13 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.758 1.223 . . . . 0.0 111.852 177.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -63.06 -38.53 91.56 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.119 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 35.9 m -101.56 128.19 47.93 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.855 0.835 . . . . 0.0 111.987 -179.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.547 ' O ' HD22 ' A' ' 205' ' ' LEU . 3.7 tp 66.84 4.73 3.61 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 114.186 -1.37 . . . . 0.0 112.147 177.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.547 HD22 ' O ' ' A' ' 204' ' ' LEU . 1.3 mm? -125.55 29.93 5.88 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.35 0.595 . . . . 0.0 112.487 -177.261 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -71.55 -24.65 61.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.806 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.547 ' O ' ' O ' ' A' ' 208' ' ' ASN . . . -165.05 33.04 0.06 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.362 179.452 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 208' ' ' ASN . . . . . 0.547 ' O ' ' O ' ' A' ' 207' ' ' ALA . 1.6 m-20 40.0 123.22 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 177.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.501 ' C ' ' O ' ' A' ' 208' ' ' ASN . 43.4 tp -1.28 106.32 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 115.015 -0.993 . . . . 0.0 112.559 179.254 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 5.4 tpt -143.37 25.69 1.68 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.706 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 69.2 p -123.12 -133.21 0.28 Allowed 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.542 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 25.2 p-10 -160.53 -140.47 0.07 Allowed 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.946 -0.301 . . . . 0.0 111.033 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.407 ' O ' ' OD1' ' A' ' 213' ' ' ASP . 2.5 p30 41.74 72.22 0.18 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.078 0.466 . . . . 0.0 110.514 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.436 ' N ' ' CD ' ' A' ' 215' ' ' PRO . 6.0 mt -61.41 -43.27 88.71 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 113.118 0.785 . . . . 0.0 113.118 -178.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 214' ' ' LEU . 27.1 Cg_exo -60.74 -33.73 92.69 Favored 'Trans proline' 0 N--CA 1.5 1.884 0 CA-C-N 120.051 1.054 . . . . 0.0 111.555 -177.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 84.1 m -64.01 -41.79 97.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 112.767 -2.015 . . . . 0.0 111.213 -178.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -66.18 -37.08 84.76 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.241 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -62.96 -47.41 83.31 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.252 -178.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.402 ' H ' HG22 ' A' ' 219' ' ' THR . 1.4 t -60.58 -37.94 82.97 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 119.395 0.998 . . . . 0.0 110.87 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 71.1 m -59.68 -41.89 91.71 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.9 -41.94 97.57 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.148 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -62.39 -47.5 83.86 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 119.755 -0.778 . . . . 0.0 112.953 -176.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -61.27 -42.48 99.79 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 108.199 -1.961 . . . . 0.0 108.199 177.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' ALA . . . . . 0.464 ' O ' ' SG ' ' A' ' 227' ' ' CYS . . . -63.25 -39.14 93.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.497 -0.851 . . . . 0.0 109.02 177.394 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -62.93 -43.05 99.49 Favored Glycine 0 CA--C 1.52 0.354 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.607 -178.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 226' ' ' PHE . . . . . 0.442 ' O ' ' OG1' ' A' ' 229' ' ' THR . 75.3 t80 -66.91 -38.95 87.19 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 119.659 -0.816 . . . . 0.0 108.855 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 227' ' ' CYS . . . . . 0.466 ' SG ' ' N ' ' A' ' 228' ' ' THR . 0.5 OUTLIER -63.41 -41.06 98.71 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 176.847 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.466 ' N ' ' SG ' ' A' ' 227' ' ' CYS . 26.8 m -62.7 -41.54 99.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.839 179.137 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.448 HG23 ' O ' ' A' ' 225' ' ' GLY . 16.1 p -59.99 -40.32 88.75 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -176.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.405 HG22 ' H ' ' A' ' 230' ' ' VAL . 3.3 m -60.66 -40.27 84.2 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.381 0 C-N-CA 118.455 -1.298 . . . . 0.0 108.953 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.486 ' O ' ' HD2' ' A' ' 234' ' ' PRO . 1.7 mp -61.0 -40.85 86.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 176.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.01 -39.98 96.39 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.48 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 0.5 OUTLIER -58.47 -42.18 93.2 Favored Pre-proline 0 N--CA 1.483 1.214 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 -173.858 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.486 ' HD2' ' O ' ' A' ' 231' ' ' ILE . 31.3 Cg_exo -57.97 -39.75 83.64 Favored 'Trans proline' 0 C--N 1.293 -2.378 0 C-N-CA 122.536 2.157 . . . . 0.0 113.276 179.081 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 46.5 t -63.95 -37.26 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 118.055 -1.458 . . . . 0.0 108.922 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -65.88 -40.62 91.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.75 178.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 53.2 t -64.79 -45.51 94.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -176.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 27.6 m -63.41 -37.78 80.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 119.224 -0.991 . . . . 0.0 111.732 -178.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 239' ' ' LYS . . . . . 0.878 ' HZ1' ' HE ' ' A' ' 185' ' ' ARG . 25.0 mtpp -60.98 -45.08 96.21 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -179.076 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 240' ' ' THR . . . . . 0.412 ' O ' ' C ' ' A' ' 241' ' ' ARG . 1.1 t -61.88 -41.92 98.46 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -178.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.412 ' C ' ' O ' ' A' ' 240' ' ' THR . 27.0 mtp180 -33.51 140.62 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.222 0.534 . . . . 0.0 112.438 -178.318 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.43 ' O ' ' C ' ' A' ' 243' ' ' MET . 33.7 t80 -130.71 -78.67 0.53 Allowed 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 177.265 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 243' ' ' MET . . . . . 0.43 ' C ' ' O ' ' A' ' 242' ' ' TYR . 7.1 ptp -30.92 113.58 0.11 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.969 0.414 . . . . 0.0 111.515 -179.113 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 244' ' ' ASN . . . . . 0.447 HD22 ' N ' ' A' ' 244' ' ' ASN . 0.1 OUTLIER -151.83 17.54 0.68 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.085 -179.529 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 49.0 p 42.96 67.24 0.65 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.751 0.31 . . . . 0.0 110.547 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -94.18 -99.98 0.15 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.291 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 43.9 mt 62.64 78.73 0.28 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.074 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 96.43 -6.69 65.77 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 111.977 -0.449 . . . . 0.0 111.977 179.092 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.768 ' HB3' ' NE2' ' A' ' 255' ' ' HIS . 52.9 mt-30 -131.67 107.98 9.18 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.477 ' CD1' ' N ' ' A' ' 250' ' ' TYR . 0.0 OUTLIER -176.27 53.22 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.845 -178.94 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -66.49 -53.25 37.21 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 115.929 1.825 . . . . 0.0 115.929 -175.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 12.4 p -148.56 -173.32 4.31 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -178.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -59.87 -44.21 94.29 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 178.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -57.29 -36.13 74.37 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -174.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 255' ' ' HIS . . . . . 0.768 ' NE2' ' HB3' ' A' ' 249' ' ' GLN . 86.4 t60 -55.59 -36.23 66.69 Favored 'General case' 0 CA--C 1.509 -0.599 0 C-N-CA 117.338 -1.745 . . . . 0.0 111.082 178.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 256' ' ' CYS . . . . . . . . . . . . . 11.7 t -61.87 -45.37 94.08 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.678 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -60.55 -45.22 94.68 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.767 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 11.8 tp -66.53 -43.01 86.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.151 0.501 . . . . 0.0 109.871 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 85.8 m -62.43 -46.28 89.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.868 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 260' ' ' MET . . . . . 0.447 ' SD ' ' C ' ' A' ' 260' ' ' MET . 13.6 tmm? -61.62 -45.04 95.76 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -177.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.17 -47.5 82.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.102 0.477 . . . . 0.0 110.26 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 262' ' ' ARG . . . . . 0.463 ' O ' ' O ' ' A' ' 263' ' ' LYS . 61.5 ttt85 -66.66 -53.84 29.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.463 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 263' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 262' ' ' ARG . 28.0 tttp -57.81 -138.99 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.9 0.381 . . . . 0.0 111.369 -178.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -63.91 149.52 46.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.997 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.539 ' C ' ' H ' ' A' ' 267' ' ' ARG . . . -44.04 160.19 0.1 OUTLIER Glycine 0 CA--C 1.535 1.283 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -50.85 0.07 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 122.018 1.812 . . . . 0.0 112.945 178.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.539 ' H ' ' C ' ' A' ' 265' ' ' GLY . 89.4 mtt-85 -69.5 -26.95 64.79 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 122.696 0.398 . . . . 0.0 111.817 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -58.83 -32.63 69.57 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.404 -178.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -62.51 -41.55 98.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.376 0.608 . . . . 0.0 110.89 178.247 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -66.05 -37.46 85.91 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.284 -178.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.434 ' O ' ' O ' ' A' ' 272' ' ' GLY . 95.8 mttt -80.65 -179.72 7.37 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 272' ' ' GLY . . . . . 0.434 ' O ' ' O ' ' A' ' 271' ' ' LYS . . . 52.3 109.29 0.01 OUTLIER Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.694 -0.563 . . . . 0.0 111.694 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -178.31 8.27 0.01 OUTLIER 'General case' 0 C--O 1.232 0.151 0 C-N-CA 121.166 -0.214 . . . . 0.0 111.325 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 274' ' ' MET . . . . . 0.549 ' N ' ' CD ' ' A' ' 275' ' ' PRO . 0.1 OUTLIER -63.91 -44.53 79.11 Favored Pre-proline 0 CA--C 1.533 0.291 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.898 -179.148 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 275' ' ' PRO . . . . . 0.549 ' CD ' ' N ' ' A' ' 274' ' ' MET . 22.1 Cg_exo -64.46 -46.86 6.58 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 122.353 2.035 . . . . 0.0 111.471 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 49.2 m -60.78 -39.71 89.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.749 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 277' ' ' PHE . . . . . 0.403 ' CD1' ' C ' ' A' ' 277' ' ' PHE . 41.0 t80 -61.64 -42.67 99.21 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 122.738 1.256 . . . . 0.0 112.969 -178.24 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.514 HD13 ' O ' ' A' ' 278' ' ' LEU . 0.2 OUTLIER -62.29 -38.78 90.65 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 112.11 -2.314 . . . . 0.0 107.815 174.284 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 279' ' ' ARG . . . . . 0.75 HH21 HD13 ' A' ' 34' ' ' LEU . 4.4 mtp180 -62.81 -39.71 95.14 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.375 0.607 . . . . 0.0 110.283 178.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -62.07 -36.55 82.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.508 -178.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -68.08 -51.2 35.06 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -178.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 282' ' ' SER . . . . . 0.435 ' O ' HG12 ' A' ' 285' ' ' VAL . 74.8 m -63.0 -44.36 96.24 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 123.109 0.564 . . . . 0.0 109.91 179.348 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 283' ' ' TRP . . . . . 0.405 ' O ' HG22 ' A' ' 286' ' ' VAL . 48.7 t-105 -59.7 -38.36 81.39 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -62.2 -37.37 85.06 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.363 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.435 HG12 ' O ' ' A' ' 282' ' ' SER . 0.4 OUTLIER -59.88 -37.73 73.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.143 -178.278 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.493 ' O ' HG22 ' A' ' 289' ' ' VAL . 0.8 OUTLIER -61.61 -40.28 86.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.724 -179.23 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 30.9 mtm -60.95 -38.85 87.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.098 0.475 . . . . 0.0 110.453 178.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -58.69 -40.13 82.7 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.83 -178.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.493 HG22 ' O ' ' A' ' 286' ' ' VAL . 1.0 OUTLIER -60.31 -38.91 79.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 120.981 0.419 . . . . 0.0 110.91 -177.576 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 12.5 m -64.27 -40.04 95.17 Favored 'General case' 0 CA--C 1.549 0.925 0 O-C-N 121.574 -0.704 . . . . 0.0 111.729 177.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -61.01 -40.4 93.39 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-O 118.652 -0.69 . . . . 0.0 109.165 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 292' ' ' GLU . . . . . 0.434 ' CG ' ' O ' ' A' ' 289' ' ' VAL . 4.4 pt-20 -59.39 -39.42 83.33 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 116.552 -2.059 . . . . 0.0 109.781 -176.163 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 293' ' ' GLN . . . . . 0.471 ' O ' ' O ' ' A' ' 296' ' ' ARG . 57.4 tt0 -59.51 -42.83 93.11 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 122.38 1.086 . . . . 0.0 111.306 -178.007 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -60.52 -40.74 92.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 113.61 -1.632 . . . . 0.0 108.574 178.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -63.22 -45.97 89.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.263 178.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 296' ' ' ARG . . . . . 0.471 ' O ' ' O ' ' A' ' 293' ' ' GLN . 11.9 tpp85 -123.03 116.25 23.21 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -121.01 -163.38 1.02 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.236 0.541 . . . . 0.0 112.413 -178.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.575 HD22 ' N ' ' A' ' 298' ' ' LEU . 3.2 mm? -67.21 116.94 8.56 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 26.4 ttm -96.77 62.64 1.94 Allowed 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -178.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.65 100.84 0.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.976 0.893 . . . . 0.0 110.834 -178.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -64.1 -46.4 84.39 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 113.746 -1.57 . . . . 0.0 113.434 -176.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -58.6 -39.67 81.07 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.39 -0.524 . . . . 0.0 109.897 -178.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -64.9 -46.77 80.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.871 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 304' ' ' SER . . . . . 0.426 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 78.0 p -66.66 -38.04 86.04 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.711 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.04 -42.73 99.49 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.544 179.354 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 12.7 tm-20 -64.74 -37.12 86.53 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -177.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 307' ' ' ALA . . . . . 0.544 ' HB3' ' HD3' ' A' ' 308' ' ' PRO . . . -60.01 -52.94 69.96 Favored Pre-proline 0 CA--C 1.544 0.716 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -176.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 308' ' ' PRO . . . . . 0.544 ' HD3' ' HB3' ' A' ' 307' ' ' ALA . 74.5 Cg_endo -75.36 0.32 9.18 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.255 1.97 . . . . 0.0 112.106 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 78.7 t80 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.519 -179.895 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.6 ptm . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.3 m -64.91 129.18 38.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.818 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.587 HG13 ' H ' ' A' ' 18' ' ' LEU . 4.3 p -160.67 166.53 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.235 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.572 ' N ' HG22 ' A' ' 15' ' ' VAL . 30.2 mmtp -64.38 -41.65 96.58 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -178.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.42 ' H ' HG22 ' A' ' 15' ' ' VAL . 65.9 m-85 -63.54 -41.15 98.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.228 0.537 . . . . 0.0 112.438 -179.307 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.587 ' H ' HG13 ' A' ' 15' ' ' VAL . 9.8 tp -79.78 -25.96 40.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.276 -0.874 . . . . 0.0 112.617 -178.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.32 -41.41 94.6 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 107.768 -2.133 . . . . 0.0 107.768 177.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.403 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -71.53 -32.08 67.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 124.873 2.273 . . . . 0.0 107.18 176.47 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.35 -42.38 99.18 Favored Glycine 0 CA--C 1.527 0.818 1 CA-C-N 108.393 -4.003 . . . . 0.0 107.804 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 92.8 m -70.54 -27.97 64.56 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.498 0.666 . . . . 0.0 109.262 177.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -66.39 -49.94 65.13 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.851 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.96 -35.89 79.8 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 118.144 -1.422 . . . . 0.0 110.979 -177.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.446 ' O ' HD13 ' A' ' 29' ' ' LEU . 77.5 m -63.8 -54.08 40.77 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.616 -178.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.456 HD12 ' N ' ' A' ' 27' ' ' ALA . 2.6 pp -65.73 -39.39 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -176.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.456 ' N ' HD12 ' A' ' 26' ' ' ILE . . . -64.12 -41.9 97.06 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 119.831 -0.748 . . . . 0.0 112.706 -173.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.464 ' O ' ' N ' ' A' ' 32' ' ' PHE . 29.9 m-20 -77.78 -27.35 50.22 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 117.823 -1.551 . . . . 0.0 109.52 -176.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.446 HD13 ' O ' ' A' ' 25' ' ' CYS . 5.4 mp -60.23 -55.92 27.81 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 120.129 1.331 . . . . 0.0 111.731 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.521 ' O ' HD13 ' A' ' 34' ' ' LEU . 10.1 tp -75.68 -4.79 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 121.659 0.742 . . . . 0.0 112.034 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.6 m -109.83 -16.48 13.87 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 114.454 -1.248 . . . . 0.0 110.202 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.507 ' N ' ' CD ' ' A' ' 33' ' ' PRO . 0.2 OUTLIER -68.28 -44.92 38.19 Favored Pre-proline 0 C--N 1.325 -0.463 0 C-N-CA 116.156 -2.218 . . . . 0.0 109.452 -178.231 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 32' ' ' PHE . 34.0 Cg_exo -59.95 -16.67 39.99 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 121.32 1.346 . . . . 0.0 112.573 177.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.521 HD13 ' O ' ' A' ' 30' ' ' ILE . 8.6 mp -67.7 -35.41 78.74 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -178.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 36' ' ' THR . 1.9 p30 -64.44 -40.47 95.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.948 -177.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.545 ' N ' ' OD1' ' A' ' 35' ' ' ASP . 47.5 p -58.44 -34.97 71.41 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 120.41 -0.516 . . . . 0.0 112.176 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.52 -39.55 85.11 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 119.547 -0.861 . . . . 0.0 112.902 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.455 ' CB ' ' NH2' ' A' ' 279' ' ' ARG . 10.0 ptmt -63.09 -48.68 77.57 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 118.854 -1.138 . . . . 0.0 111.246 -177.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 66.4 t -63.55 -39.81 86.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -177.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.507 ' O ' ' N ' ' A' ' 42' ' ' GLN . 8.6 tpm_? -60.82 -41.39 95.62 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 119.19 -1.004 . . . . 0.0 109.718 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.49 38.81 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.58 178.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.507 ' N ' ' O ' ' A' ' 40' ' ' ARG . 45.1 tt0 -88.7 -112.64 0.06 Allowed 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.646 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.1 tp -154.3 8.93 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.158 0.504 . . . . 0.0 109.794 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.519 ' NE2' ' OE1' ' A' ' 58' ' ' GLN . 14.7 mm100 56.97 26.04 11.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.55 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -118.65 141.17 15.84 Favored Glycine 0 N--CA 1.466 0.683 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -149.4 -84.26 0.1 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 86.4 p -172.04 70.49 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.782 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 -156.01 -27.63 0.1 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.085 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.98 17.67 74.15 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 108.577 -1.809 . . . . 0.0 108.577 -177.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.724 HD22 ' N ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -63.92 -35.52 80.93 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.081 -1.06 . . . . 0.0 111.031 -179.089 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.724 ' N ' HD22 ' A' ' 50' ' ' LEU . 83.9 t -59.4 -43.81 91.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.217 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 71.0 ttp85 -64.01 -33.86 76.69 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.99 -38.13 82.32 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.279 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -136.36 95.39 3.17 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.236 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.92 -19.83 64.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.3 -178.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.599 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 7.9 t -125.67 -141.02 0.28 Allowed 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.599 ' HB3' ' O ' ' A' ' 56' ' ' SER . . . 99.38 12.42 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 O-C-N 124.132 0.895 . . . . 0.0 112.616 178.349 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.519 ' OE1' ' NE2' ' A' ' 44' ' ' GLN . 10.7 pt20 178.36 101.72 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.995 0.426 . . . . 0.0 111.052 179.323 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -84.88 166.95 16.43 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.44 ' O ' ' C ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER -52.29 -35.07 49.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.233 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.44 ' C ' ' O ' ' A' ' 60' ' ' ARG . . . -28.23 100.21 0.01 OUTLIER Glycine 0 CA--C 1.53 1.011 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.241 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 24.6 m -67.21 -33.99 66.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.072 176.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -60.26 -32.4 71.13 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 121.31 1.868 . . . . 0.0 109.731 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.51 -48.99 67.52 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-N 114.934 -1.03 . . . . 0.0 114.459 -176.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.41 HG23 ' H ' ' A' ' 65' ' ' THR . 12.8 p -62.14 -46.13 90.37 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -179.187 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 97.0 mt -59.68 -35.99 62.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 118.119 -0.943 . . . . 0.0 108.94 -178.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.641 HD12 ' C ' ' A' ' 67' ' ' LEU . 0.3 OUTLIER -63.84 -35.28 80.12 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 121.422 1.919 . . . . 0.0 111.993 179.525 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 98.3 m -62.19 -38.34 88.74 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 113.4 -1.727 . . . . 0.0 110.99 -176.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 58.0 mmm -59.79 -40.04 86.95 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 121.048 -1.032 . . . . 0.0 113.425 -177.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 93.3 t -69.71 -41.14 79.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 118.967 -1.093 . . . . 0.0 113.82 -177.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 36.5 mmm-85 -78.97 -13.06 60.02 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -178.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.521 ' CG2' ' N ' ' A' ' 73' ' ' GLU . 0.7 OUTLIER -62.27 -54.65 37.6 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.633 -179.215 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.521 ' N ' ' CG2' ' A' ' 72' ' ' THR . 35.2 mt-10 -106.88 -53.93 2.54 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.037 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.417 ' O ' ' CB ' ' A' ' 77' ' ' SER . . . 155.77 166.23 15.52 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -56.43 -35.32 96.32 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 121.281 1.32 . . . . 0.0 110.971 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -61.43 -12.0 12.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.983 0.897 . . . . 0.0 110.723 175.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.458 ' O ' ' OD1' ' A' ' 80' ' ' ASN . 6.5 t -77.91 -32.36 51.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 113.911 -1.495 . . . . 0.0 110.454 -178.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 15.3 tp -75.95 -33.41 59.82 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 121.761 -0.587 . . . . 0.0 110.823 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.43 ' C ' ' H ' ' A' ' 81' ' ' GLY . 53.5 m-85 -92.75 -5.09 51.96 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 -177.461 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.458 ' OD1' ' O ' ' A' ' 77' ' ' SER . 36.1 p-10 -92.52 26.05 2.79 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 174.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 79' ' ' TYR . . . -160.07 -19.62 0.03 OUTLIER Glycine 0 CA--C 1.526 0.732 0 CA-C-N 112.942 -1.935 . . . . 0.0 112.036 -178.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.407 ' H ' ' H ' ' A' ' 81' ' ' GLY . 42.6 tp -59.06 -35.0 72.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.091 -1.054 . . . . 0.0 110.406 -179.214 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.4 t -70.67 -27.01 29.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.29 178.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.67 -31.32 61.88 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.717 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.42 -40.06 91.43 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 119.645 -1.264 . . . . 0.0 111.46 -177.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -62.37 -39.92 94.75 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 122.192 0.996 . . . . 0.0 113.655 -176.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -59.68 -26.12 65.32 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 113.348 -1.751 . . . . 0.0 109.615 -179.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.616 ' NE ' ' NZ ' ' A' ' 141' ' ' LYS . 7.4 mmm180 -56.44 -52.35 64.99 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 173.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -67.6 -29.9 69.36 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 113.475 -1.693 . . . . 0.0 112.692 -178.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 24.8 mmt -61.08 -42.06 97.8 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 78.1 p -74.7 -34.84 62.71 Favored 'General case' 0 C--N 1.338 0.102 0 C-N-CA 119.301 -0.959 . . . . 0.0 111.864 -176.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -57.96 -43.55 86.5 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 120.496 1.498 . . . . 0.0 112.279 -176.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.41 -32.65 64.54 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 119.78 -0.768 . . . . 0.0 111.292 -178.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.608 ' O ' HG22 ' A' ' 97' ' ' ILE . 50.5 m -63.96 -41.53 97.55 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.448 ' C ' ' H ' ' A' ' 97' ' ' ILE . 24.2 m -68.12 -28.48 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.493 178.184 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 64.4 mtp180 -77.42 10.41 2.57 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -177.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.608 HG22 ' O ' ' A' ' 94' ' ' SER . 12.0 tt -86.78 -15.62 9.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.311 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.419 ' O ' ' OG ' ' A' ' 102' ' ' SER . . . -141.0 -48.85 0.05 OUTLIER Glycine 0 CA--C 1.534 1.252 0 CA-C-N 114.917 -1.038 . . . . 0.0 114.77 -178.282 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 60.5 mt -72.53 -14.29 61.61 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.096 1.448 . . . . 0.0 113.985 -177.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.521 ' O ' ' CD ' ' A' ' 104' ' ' LYS . 46.6 t80 -81.84 -53.12 6.44 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 114.653 -1.158 . . . . 0.0 112.542 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -72.6 -33.57 66.81 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 123.799 1.761 . . . . 0.0 114.136 -179.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' A' ' 98' ' ' GLY . 79.3 p -66.5 -50.6 62.71 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 110.244 -3.162 . . . . 0.0 117.068 -177.164 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.731 HG12 ' CE2' ' A' ' 107' ' ' TYR . 1.5 t -73.32 -23.37 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 CA-C-O 124.327 2.013 . . . . 0.0 109.94 175.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.521 ' CD ' ' O ' ' A' ' 100' ' ' TYR . 0.0 OUTLIER -66.8 -41.22 87.92 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 109.677 -3.42 . . . . 0.0 112.194 -178.02 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -78.81 -11.08 59.97 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 125.143 2.401 . . . . 0.0 111.05 178.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -79.63 -21.88 44.32 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 110.712 -2.949 . . . . 0.0 110.538 177.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.731 ' CE2' HG12 ' A' ' 103' ' ' VAL . 41.1 m-85 -109.5 -28.67 8.79 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -175.538 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.735 ' C ' ' H ' ' A' ' 110' ' ' GLY . 66.4 p -95.55 12.07 30.84 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 -174.05 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.435 ' O ' ' N ' ' A' ' 111' ' ' SER . 15.2 ttpp -54.71 22.31 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.055 0 CA-C-N 119.472 1.033 . . . . 0.0 111.239 177.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.735 ' H ' ' C ' ' A' ' 108' ' ' THR . . . 65.24 -57.06 0.11 Allowed Glycine 0 N--CA 1.472 1.053 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.544 ' CB ' ' O ' ' A' ' 110' ' ' GLY . 6.9 t 106.35 -164.67 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 177.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.537 ' OE1' ' N ' ' A' ' 112' ' ' GLU . 35.4 mp0 -120.55 -40.28 2.68 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 -175.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.608 ' O ' ' HB2' ' A' ' 114' ' ' ALA . 0.0 OUTLIER 165.05 29.97 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.503 0.668 . . . . 0.0 109.366 -179.318 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.608 ' HB2' ' O ' ' A' ' 113' ' ' HIS . . . 160.31 -161.21 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.86 14.87 25.8 Favored Glycine 0 CA--C 1.507 -0.429 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.506 HG23 ' N ' ' A' ' 117' ' ' GLY . 3.0 tp -60.77 -40.22 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.506 ' N ' HG23 ' A' ' 116' ' ' ILE . . . -65.69 -39.87 95.54 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 110.946 -0.861 . . . . 0.0 110.946 174.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 6.8 t -58.85 -43.06 90.67 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 176.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 25.9 mmm-85 -63.65 -37.48 87.49 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 119.849 -0.741 . . . . 0.0 110.38 -177.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.69 -45.91 87.89 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 6.3 tp -67.14 -45.29 77.54 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.729 178.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.29 -44.97 90.03 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 119.918 1.235 . . . . 0.0 109.803 178.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -65.85 -44.48 91.92 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 119.222 -1.466 . . . . 0.0 110.614 -178.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 65.7 m -64.48 -44.61 90.45 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.309 -0.556 . . . . 0.0 111.095 178.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 19.5 m -69.9 -49.03 56.14 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 119.419 -0.912 . . . . 0.0 112.433 177.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 42.3 p -65.82 -42.16 90.95 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 120.149 1.34 . . . . 0.0 113.775 -175.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -64.03 -44.33 96.03 Favored Glycine 0 CA--C 1.518 0.254 0 CA-C-O 122.983 1.324 . . . . 0.0 112.162 -178.176 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.417 ' O ' ' CG2' ' A' ' 131' ' ' VAL . . . -61.48 -41.45 97.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 111.386 -2.407 . . . . 0.0 107.247 177.201 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.629 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 0.2 OUTLIER -64.5 -42.33 95.89 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.25 178.928 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.23 -40.08 96.45 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -177.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.417 ' CG2' ' O ' ' A' ' 128' ' ' ALA . 5.8 m -61.15 -25.98 37.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 122.482 1.134 . . . . 0.0 109.942 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.629 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . -58.29 -44.98 88.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 112.755 -2.02 . . . . 0.0 112.425 -178.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.48 ' CG1' ' N ' ' A' ' 134' ' ' ALA . 2.7 p -79.09 -48.89 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.295 -179.039 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.48 ' N ' ' CG1' ' A' ' 133' ' ' VAL . . . -106.55 138.76 42.13 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.707 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.603 ' H ' ' HD2' ' A' ' 136' ' ' PRO . 7.8 pt20 172.23 -38.48 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.797 0 CA-C-O 118.279 -0.867 . . . . 0.0 113.132 179.043 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.603 ' HD2' ' H ' ' A' ' 135' ' ' GLN . 13.1 Cg_endo -52.66 -34.37 63.52 Favored 'Trans proline' 0 N--CA 1.498 1.785 0 CA-C-N 122.257 1.842 . . . . 0.0 112.544 -178.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 85.1 m -67.85 -42.6 81.14 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 118.683 -1.207 . . . . 0.0 110.184 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -65.82 -43.08 89.65 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 118.054 -1.458 . . . . 0.0 112.776 -177.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.423 HG23 ' N ' ' A' ' 140' ' ' VAL . 24.4 m -64.47 -44.05 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -179.262 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.423 ' N ' HG23 ' A' ' 139' ' ' VAL . 12.7 p -64.63 -37.48 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -177.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.616 ' NZ ' ' NE ' ' A' ' 88' ' ' ARG . 48.5 mttm -60.98 -40.55 93.88 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.16 -177.236 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 82.1 t -69.89 -44.95 78.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.57 -36.33 83.87 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.934 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -66.39 -40.69 89.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.06 -177.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 65.6 tp60 -64.35 -39.08 93.18 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 119.486 -0.886 . . . . 0.0 109.28 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.2 -35.0 79.7 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.446 ' O ' ' CG ' ' A' ' 147' ' ' GLN . 3.0 pt20 -60.31 111.06 1.4 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 177.161 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -102.5 8.81 39.87 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.246 -177.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 60.7 ttm-85 -143.71 135.99 26.85 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.848 0.356 . . . . 0.0 110.696 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -82.52 -56.36 3.92 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.617 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 168.03 -51.65 0.23 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 73.81 65.72 2.15 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -159.0 -79.08 0.03 OUTLIER Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.602 ' NH2' ' HE ' ' A' ' 155' ' ' ARG . 44.9 ttp85 -158.43 167.94 28.3 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.602 ' HE ' ' NH2' ' A' ' 154' ' ' ARG . 1.9 mpt_? 55.96 108.88 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.456 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -58.89 128.23 36.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.462 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -56.98 154.63 9.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.453 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.41 ' OG ' ' N ' ' A' ' 159' ' ' THR . 43.7 t -157.07 -178.28 7.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.211 0.529 . . . . 0.0 111.015 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.41 ' N ' ' OG ' ' A' ' 158' ' ' SER . 65.1 p -64.32 -46.1 84.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.737 -177.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 86.3 t -64.22 -45.59 95.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 119.132 -1.027 . . . . 0.0 109.438 -179.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.522 ' N ' ' OE1' ' A' ' 161' ' ' GLU . 15.1 mp0 -66.75 -39.04 87.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.873 0.368 . . . . 0.0 111.198 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -61.8 -45.54 93.41 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -178.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.607 ' CZ ' HD11 ' A' ' 175' ' ' LEU . 2.7 t80 -62.59 -50.33 71.73 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 120.372 -0.531 . . . . 0.0 110.617 -178.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 30.5 mmtm -68.84 -45.57 70.78 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 -175.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.556 HG23 ' N ' ' A' ' 166' ' ' ILE . 15.3 t -62.95 -44.73 95.27 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.198 1.185 . . . . 0.0 114.198 -177.003 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.556 ' N ' HG23 ' A' ' 165' ' ' THR . 10.0 pt -64.51 -38.44 82.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 122.032 0.92 . . . . 0.0 109.505 177.151 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.53 -36.47 76.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 113.709 -1.587 . . . . 0.0 108.074 176.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -62.54 -50.39 71.54 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 122.436 2.38 . . . . 0.0 112.164 -175.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -75.05 -51.03 14.55 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 123.903 0.881 . . . . 0.0 109.641 177.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -77.96 -36.46 49.08 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 -173.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 90.99 -167.71 32.06 Favored Glycine 0 N--CA 1.467 0.714 0 N-CA-C 111.792 -0.523 . . . . 0.0 111.792 177.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 25.2 mm -72.18 -44.72 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-O 121.679 0.752 . . . . 0.0 110.652 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -59.0 -33.96 71.32 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 114.371 -1.286 . . . . 0.0 111.529 -177.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -60.75 -40.37 98.02 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 118.783 -1.675 . . . . 0.0 109.272 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.607 HD11 ' CZ ' ' A' ' 163' ' ' TYR . 0.5 OUTLIER -70.34 -33.43 71.47 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 111.477 -2.362 . . . . 0.0 116.72 -177.136 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 176' ' ' TRP . . . . . 0.427 ' O ' ' OG1' ' A' ' 179' ' ' THR . 2.3 m95 -77.89 -7.39 56.66 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 111.564 -2.562 . . . . 0.0 109.909 -177.158 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 16.3 ttmm -43.24 -47.93 6.55 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.354 -176.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -92.04 -27.43 16.25 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 123.981 0.8 . . . . 0.0 112.216 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 176' ' ' TRP . 39.7 p -45.3 -51.17 11.3 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.419 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 3.3 m -62.4 -50.82 77.44 Favored Pre-proline 0 N--CA 1.47 0.57 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -176.186 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.419 ' HD2' ' N ' ' A' ' 180' ' ' SER . 29.2 Cg_endo -64.87 -28.61 58.68 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 121.212 1.275 . . . . 0.0 111.63 176.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -64.27 -39.73 94.52 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 120.363 -0.535 . . . . 0.0 109.809 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 82.0 t -63.32 -42.85 97.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.201 0.524 . . . . 0.0 110.026 179.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.32 -39.39 92.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.091 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 44.1 ttt85 -60.74 -42.19 96.86 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.928 -179.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -61.9 -43.89 97.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.107 0.48 . . . . 0.0 110.705 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -65.31 -44.31 88.26 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.805 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 87.4 mt -63.86 -46.04 95.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -177.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.438 HG13 ' N ' ' A' ' 190' ' ' ASN . 6.9 p -60.64 -46.96 94.88 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 C-N-CA 119.403 -0.919 . . . . 0.0 111.267 -178.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.438 ' N ' HG13 ' A' ' 189' ' ' VAL . 58.7 m-80 -62.63 -42.62 99.7 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 122.204 1.002 . . . . 0.0 109.779 178.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 191' ' ' CYS . . . . . . . . . . . . . 41.9 t -61.63 -46.08 91.32 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 113.647 -1.615 . . . . 0.0 109.979 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.25 -40.2 95.52 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 113.317 -1.765 . . . . 0.0 109.719 176.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.81 -45.7 93.4 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.278 -177.209 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 21.1 tp -64.77 -38.89 92.51 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 118.785 -1.166 . . . . 0.0 110.972 -174.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 6.3 m -64.57 -45.97 93.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 117.275 -1.77 . . . . 0.0 108.536 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 29.0 p -63.91 -45.33 89.77 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -56.44 -38.77 72.07 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.641 0.776 . . . . 0.0 111.417 -178.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -55.95 -44.0 77.99 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.431 ' C ' HD12 ' A' ' 199' ' ' LEU . 0.2 OUTLIER -61.17 -38.69 87.38 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.908 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 37.2 mt -62.4 -41.87 93.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 15.4 mtpt -59.19 -38.2 79.24 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.958 1.303 . . . . 0.0 113.477 178.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -63.06 -42.58 99.71 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.692 -0.63 . . . . 0.0 110.986 -176.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.42 128.36 47.65 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 121.062 -1.024 . . . . 0.0 112.822 -176.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.485 HD22 ' CE1' ' A' ' 217' ' ' HIS . 11.1 mp 66.24 4.67 3.26 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 113.601 -1.636 . . . . 0.0 112.49 176.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 16.1 tp -137.1 72.02 1.41 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.117 0.484 . . . . 0.0 109.793 -178.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -112.36 -13.58 13.4 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -162.1 36.6 0.12 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.728 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' ASN . . . . . 0.443 ' O ' ' O ' ' A' ' 209' ' ' LEU . 50.2 t30 54.66 79.38 0.14 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 175.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.443 ' O ' ' O ' ' A' ' 208' ' ' ASN . 16.7 mt 56.91 110.95 0.01 OUTLIER 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.252 -0.885 . . . . 0.0 108.795 -178.529 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 20.5 ttp -140.07 15.71 2.45 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.758 HG22 ' H ' ' A' ' 212' ' ' ASP . 33.3 m -114.58 179.55 3.92 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.153 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 212' ' ' ASP . . . . . 0.758 ' H ' HG22 ' A' ' 211' ' ' THR . 25.7 t70 -131.84 -57.64 0.98 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.486 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -58.94 74.93 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.835 0.35 . . . . 0.0 110.869 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.531 ' N ' ' O ' ' A' ' 212' ' ' ASP . 0.4 OUTLIER -61.43 -41.53 79.75 Favored Pre-proline 0 CA--C 1.538 0.487 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -179.241 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.46 ' HD3' HD23 ' A' ' 214' ' ' LEU . 25.0 Cg_exo -61.35 -33.3 89.3 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 120.951 1.101 . . . . 0.0 112.342 -175.293 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 35.5 t -63.31 -40.27 96.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 113.085 -1.87 . . . . 0.0 108.809 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' HIS . . . . . 0.485 ' CE1' HD22 ' A' ' 204' ' ' LEU . 0.4 OUTLIER -64.94 -34.37 78.25 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.658 179.945 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.11 -46.97 86.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.908 -177.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -60.18 -37.1 79.2 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 119.132 0.878 . . . . 0.0 111.044 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 67.0 m -59.59 -41.62 90.7 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.7 -41.71 98.08 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -177.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 222' ' ' PHE . . . . . 0.481 ' CZ ' ' CE1' ' A' ' 226' ' ' PHE . 38.4 t80 -62.21 -47.48 84.27 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -176.418 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -60.91 -42.17 99.57 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 107.962 -2.055 . . . . 0.0 107.962 177.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -63.16 -38.18 90.14 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.068 -1.066 . . . . 0.0 109.377 177.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -62.05 -42.21 99.72 Favored Glycine 0 CA--C 1.522 0.491 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.513 -177.168 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 226' ' ' PHE . . . . . 0.481 ' CE1' ' CZ ' ' A' ' 222' ' ' PHE . 3.0 m-85 -66.65 -38.38 86.75 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 227' ' ' CYS . . . . . 0.415 ' O ' HG22 ' A' ' 230' ' ' VAL . 99.9 m -63.24 -40.65 98.04 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 176.374 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 15.1 m -61.61 -40.09 93.57 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 114.604 -1.18 . . . . 0.0 112.371 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.423 HG22 ' O ' ' A' ' 226' ' ' PHE . 0.6 OUTLIER -58.34 -39.13 78.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.749 -176.198 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 227' ' ' CYS . 1.0 OUTLIER -59.94 -40.38 82.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 118.907 -1.117 . . . . 0.0 109.146 179.837 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.542 ' O ' ' HD2' ' A' ' 234' ' ' PRO . 97.2 mt -61.39 -40.72 87.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-O 121.134 0.492 . . . . 0.0 109.783 177.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -62.81 -39.43 94.28 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.485 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 0.0 OUTLIER -57.97 -41.54 90.49 Favored Pre-proline 0 N--CA 1.483 1.187 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -173.542 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.542 ' HD2' ' O ' ' A' ' 231' ' ' ILE . 31.8 Cg_exo -57.87 -39.58 85.55 Favored 'Trans proline' 0 C--N 1.292 -2.431 0 C-N-CA 122.357 2.038 . . . . 0.0 113.551 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 83.9 t -64.08 -37.33 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 117.514 -1.674 . . . . 0.0 109.191 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' ASP . . . . . 0.525 ' OD2' ' CZ2' ' A' ' 283' ' ' TRP . 94.7 m-20 -66.21 -41.09 90.61 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.41 ' CG1' ' N ' ' A' ' 238' ' ' VAL . 0.5 OUTLIER -65.37 -45.23 93.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -176.448 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.41 ' N ' ' CG1' ' A' ' 237' ' ' VAL . 94.9 t -63.22 -37.07 78.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.441 -178.115 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 10.8 tptp -60.2 -44.48 95.09 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.64 -41.85 98.08 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.463 ' HE ' ' H ' ' A' ' 242' ' ' TYR . 8.8 tpm_? -42.21 129.41 3.76 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 121.326 -0.15 . . . . 0.0 111.166 -178.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.463 ' H ' ' HE ' ' A' ' 241' ' ' ARG . 19.8 t80 159.96 -58.81 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.813 0 O-C-N 123.865 0.728 . . . . 0.0 111.234 178.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 243' ' ' MET . . . . . 0.44 ' C ' ' O ' ' A' ' 242' ' ' TYR . 24.8 mtt -29.99 97.92 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 244' ' ' ASN . . . . . 0.552 ' ND2' ' OH ' ' A' ' 250' ' ' TYR . 50.4 p30 -168.74 -24.47 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 121.126 -0.23 . . . . 0.0 111.327 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 245' ' ' SER . . . . . 0.527 ' N ' ' OD1' ' A' ' 244' ' ' ASN . 5.2 m 150.43 -115.3 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 O-C-N 124.237 0.961 . . . . 0.0 111.679 178.073 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -179.23 -25.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.817 0.342 . . . . 0.0 110.58 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -77.45 91.08 3.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.65 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.44 ' C ' ' OE1' ' A' ' 249' ' ' GLN . . . -164.27 21.97 0.15 Allowed Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.96 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.645 ' O ' ' N ' ' A' ' 251' ' ' HIS . 12.8 mp0 63.76 28.12 14.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.797 0.332 . . . . 0.0 110.82 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.552 ' OH ' ' ND2' ' A' ' 244' ' ' ASN . 5.6 m-30 -56.1 71.11 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.267 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 251' ' ' HIS . . . . . 0.645 ' N ' ' O ' ' A' ' 249' ' ' GLN . 19.9 m-70 -75.17 -57.56 3.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.331 -178.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 26.5 t -149.55 -174.72 4.76 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -178.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.552 ' O ' ' SG ' ' A' ' 256' ' ' CYS . . . -62.14 -45.77 91.96 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.224 0.92 . . . . 0.0 110.364 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -57.41 -35.69 73.19 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.894 1.235 . . . . 0.0 112.581 -173.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 255' ' ' HIS . . . . . 0.485 ' NE2' ' HB2' ' A' ' 249' ' ' GLN . 86.4 t60 -54.32 -39.45 67.05 Favored 'General case' 0 C--O 1.215 -0.711 0 CA-C-N 118.912 1.356 . . . . 0.0 111.093 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 256' ' ' CYS . . . . . 0.552 ' SG ' ' O ' ' A' ' 253' ' ' ALA . 0.0 OUTLIER -59.17 -44.97 92.16 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 119.932 -0.707 . . . . 0.0 110.415 -178.022 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -61.31 -46.35 90.66 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 119.622 -0.831 . . . . 0.0 111.725 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.469 ' N ' HD12 ' A' ' 258' ' ' LEU . 11.2 mp -67.86 -44.58 76.79 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -179.181 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 259' ' ' THR . . . . . 0.433 ' CG2' ' N ' ' A' ' 260' ' ' MET . 2.1 t -63.42 -46.51 86.02 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -178.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 260' ' ' MET . . . . . 0.433 ' N ' ' CG2' ' A' ' 259' ' ' THR . 15.2 mmt -61.61 -44.19 97.46 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.106 -0.497 . . . . 0.0 112.051 -178.296 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 11.9 tp -62.6 -47.81 82.17 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 121.23 -0.188 . . . . 0.0 110.74 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 78.5 mtm180 -67.4 -54.03 24.05 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.078 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -76.66 -141.57 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.899 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 264' ' ' GLU . . . . . 0.616 ' CD ' ' H ' ' A' ' 264' ' ' GLU . 0.7 OUTLIER -39.87 128.47 2.1 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.083 0.468 . . . . 0.0 110.603 -179.659 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.496 ' C ' ' H ' ' A' ' 267' ' ' ARG . . . -46.33 167.12 0.06 OUTLIER Glycine 0 CA--C 1.533 1.173 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 -179.137 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -53.79 -1.11 0.1 Allowed 'Trans proline' 0 N--CA 1.5 1.887 0 C-N-CA 122.093 1.862 . . . . 0.0 112.509 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.496 ' H ' ' C ' ' A' ' 265' ' ' GLY . 5.1 ptp180 -69.89 -26.94 64.42 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 122.838 0.455 . . . . 0.0 111.511 178.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -58.67 -32.5 69.17 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 119.695 -0.802 . . . . 0.0 109.934 -178.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -62.47 -41.25 98.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.127 177.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 270' ' ' TYR . . . . . 0.428 ' O ' ' O ' ' A' ' 271' ' ' LYS . 36.7 t80 -65.87 -37.6 86.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.924 -1.035 . . . . 0.0 112.633 -178.322 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.478 ' O ' ' O ' ' A' ' 272' ' ' GLY . 54.8 mtpt -51.31 -175.36 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 272' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 271' ' ' LYS . . . 57.38 126.34 0.01 OUTLIER Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -169.37 -26.14 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 119.453 -0.899 . . . . 0.0 112.828 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 274' ' ' MET . . . . . 0.526 ' N ' ' CD ' ' A' ' 275' ' ' PRO . 1.0 OUTLIER -64.16 -45.31 79.16 Favored Pre-proline 0 CA--C 1.529 0.169 0 C-N-CA 119.274 -0.97 . . . . 0.0 110.635 -178.661 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 275' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' A' ' 274' ' ' MET . 19.7 Cg_exo -65.44 -47.78 3.94 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 121.837 1.692 . . . . 0.0 111.966 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 5.0 m -61.42 -40.22 93.61 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.018 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -61.82 -42.8 99.48 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 123.6 1.667 . . . . 0.0 113.486 -177.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 75.5 mt -62.54 -39.06 92.39 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 110.355 -3.111 . . . . 0.0 109.625 175.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 279' ' ' ARG . . . . . 0.455 ' NH2' ' CB ' ' A' ' 38' ' ' LYS . 28.7 mmt-85 -62.8 -40.67 98.08 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.099 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.759 ' O ' HD12 ' A' ' 280' ' ' LEU . 0.1 OUTLIER -62.2 -36.78 82.97 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.235 -0.893 . . . . 0.0 113.195 -177.495 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -68.01 -51.04 36.38 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -178.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 282' ' ' SER . . . . . 0.438 ' O ' HG12 ' A' ' 285' ' ' VAL . 16.4 m -62.79 -44.3 96.54 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.247 0.619 . . . . 0.0 109.68 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 283' ' ' TRP . . . . . 0.529 ' O ' HG22 ' A' ' 286' ' ' VAL . 83.5 t90 -59.94 -38.24 81.87 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -62.78 -38.4 90.5 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.695 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.438 HG12 ' O ' ' A' ' 282' ' ' SER . 0.3 OUTLIER -60.82 -38.69 79.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -177.537 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.702 ' O ' HG22 ' A' ' 289' ' ' VAL . 6.8 m -62.53 -39.52 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 120.105 -0.638 . . . . 0.0 109.674 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 76.0 mmm -60.62 -38.6 85.28 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -59.02 -41.53 87.98 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.702 HG22 ' O ' ' A' ' 286' ' ' VAL . 29.4 m -61.61 -37.99 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 120.269 -0.572 . . . . 0.0 111.16 -178.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 82.8 p -62.41 -40.43 96.49 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -60.83 -38.81 86.75 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 177.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -58.07 -40.14 80.29 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 117.77 -1.572 . . . . 0.0 109.169 -177.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 293' ' ' GLN . . . . . 0.477 ' O ' ' O ' ' A' ' 296' ' ' ARG . 14.3 mm100 -60.46 -42.42 96.15 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 123.121 1.439 . . . . 0.0 110.258 179.089 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 77.1 mt -60.43 -39.48 87.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 112.079 -2.328 . . . . 0.0 109.305 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -61.95 -45.03 95.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.41 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 296' ' ' ARG . . . . . 0.477 ' O ' ' O ' ' A' ' 293' ' ' GLN . 36.0 ttm180 -122.27 115.86 23.09 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -111.28 -163.5 0.85 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.694 0.759 . . . . 0.0 112.845 -177.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.657 ' H ' HD12 ' A' ' 298' ' ' LEU . 10.0 mp -32.98 -71.27 0.06 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.406 -1.27 . . . . 0.0 112.902 -178.163 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 299' ' ' MET . . . . . 0.526 ' SD ' ' O ' ' A' ' 299' ' ' MET . 0.0 OUTLIER 88.16 32.06 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 113.895 -1.502 . . . . 0.0 110.869 179.464 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.69 101.01 0.07 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 122.472 1.129 . . . . 0.0 111.182 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -64.34 -46.36 83.82 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 112.952 -1.931 . . . . 0.0 113.142 -176.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -58.67 -38.9 79.19 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 -177.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -64.29 -46.46 83.52 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 304' ' ' SER . . . . . 0.411 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 1.9 t -66.46 -38.18 86.78 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.672 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 -61.86 -42.64 99.3 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.919 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -64.71 -36.78 85.38 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -177.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 307' ' ' ALA . . . . . 0.546 ' HB3' ' HD3' ' A' ' 308' ' ' PRO . . . -60.04 -52.98 69.64 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -176.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 308' ' ' PRO . . . . . 0.546 ' HD3' ' HB3' ' A' ' 307' ' ' ALA . 74.3 Cg_endo -75.21 0.23 9.24 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.046 1.831 . . . . 0.0 111.862 179.307 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 29.8 t80 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.586 -179.812 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.77 ' N ' HE21 ' A' ' 303' ' ' GLN . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.7 p 43.69 73.23 0.15 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.628 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.575 HG12 ' N ' ' A' ' 16' ' ' LYS . 28.2 t -83.43 166.44 2.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.573 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.575 ' N ' HG12 ' A' ' 15' ' ' VAL . 1.1 mptm? -64.25 -41.8 96.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.095 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -63.75 -41.6 97.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.411 0.624 . . . . 0.0 111.905 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.543 HD13 ' O ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -79.83 -26.19 40.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.977 -1.011 . . . . 0.0 111.165 -179.662 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.59 -40.69 96.16 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 106.75 -2.54 . . . . 0.0 106.75 176.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.61 -31.26 68.17 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 124.44 2.067 . . . . 0.0 107.41 176.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.38 -43.19 97.17 Favored Glycine 0 CA--C 1.532 1.115 0 CA-C-N 109.112 -3.676 . . . . 0.0 110.726 -177.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.5 t -71.23 -27.3 63.37 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 117.567 0.684 . . . . 0.0 109.279 178.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.75 -50.64 64.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.69 -178.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.15 -35.88 80.13 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 118.109 -1.437 . . . . 0.0 110.943 -177.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 73.2 m -63.98 -54.11 39.65 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.579 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.521 HD12 ' N ' ' A' ' 27' ' ' ALA . 2.6 pp -65.74 -39.59 85.3 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -177.389 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.552 ' O ' HG23 ' A' ' 31' ' ' THR . . . -63.94 -41.8 97.52 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 119.733 -0.787 . . . . 0.0 112.861 -173.212 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.469 ' HA ' ' HG1' ' A' ' 31' ' ' THR . 2.3 m-20 -77.63 -27.07 51.01 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 120.325 1.42 . . . . 0.0 109.918 -175.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 10.8 tp -59.81 -55.83 29.41 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 119.835 1.198 . . . . 0.0 112.806 -178.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.9 pt -76.11 -4.55 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.552 HG23 ' O ' ' A' ' 27' ' ' ALA . 30.3 p -109.71 -17.08 13.77 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 118.941 -1.104 . . . . 0.0 109.549 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.479 ' N ' ' CD ' ' A' ' 33' ' ' PRO . 4.3 t80 -67.3 -44.0 45.79 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 122.296 2.316 . . . . 0.0 109.164 -178.171 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 32' ' ' PHE . 30.7 Cg_exo -59.62 -15.85 33.39 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 121.0 1.134 . . . . 0.0 111.556 177.555 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 26.9 tp -66.99 -35.47 80.03 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -177.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 36' ' ' THR . 2.0 p30 -64.61 -40.29 95.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.36 -0.837 . . . . 0.0 112.401 -177.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.532 ' N ' ' OD1' ' A' ' 35' ' ' ASP . 67.4 p -58.17 -35.01 70.95 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.03 -38.09 85.27 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.563 ' NZ ' HH22 ' A' ' 279' ' ' ARG . 11.5 ptmt -60.58 -46.99 88.18 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 120.119 -0.632 . . . . 0.0 111.855 -175.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.443 ' N ' ' CG ' ' A' ' 38' ' ' LYS . 93.0 t -62.16 -38.42 80.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -176.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.526 ' NH1' ' O ' ' A' ' 36' ' ' THR . 6.8 mmp_? -59.37 -40.47 86.57 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 119.345 -0.942 . . . . 0.0 109.611 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.58 38.96 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.3 179.115 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.508 ' N ' ' O ' ' A' ' 40' ' ' ARG . 28.3 pt20 -67.89 -159.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 O-C-N 122.136 -0.352 . . . . 0.0 110.936 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.435 HD12 ' N ' ' A' ' 43' ' ' ILE . 2.0 mp -132.07 47.81 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.562 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 46.72 29.11 0.9 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.855 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 46' ' ' GLU . . . -64.82 -116.32 0.01 OUTLIER Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.427 ' O ' ' O ' ' A' ' 45' ' ' GLY . 41.7 tt0 59.35 132.29 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.889 0.376 . . . . 0.0 110.839 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 66.9 m -115.71 -12.79 11.48 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.544 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -42.63 -27.08 0.15 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.648 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.46 -10.05 73.21 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -178.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 45.5 tp -65.89 -38.01 87.64 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.373 -0.413 . . . . 0.0 110.585 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.514 HG13 ' N ' ' A' ' 52' ' ' ARG . 7.6 p -60.74 -44.81 98.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.734 -178.311 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.514 ' N ' HG13 ' A' ' 51' ' ' VAL . 14.6 ptt180 -64.86 -33.65 76.52 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.881 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 98.0 m -67.86 -38.16 82.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.186 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.74 -152.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.207 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -166.9 -24.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.069 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.649 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 57.8 p -166.74 -127.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 179.253 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.649 ' HB3' ' O ' ' A' ' 56' ' ' SER . . . 94.33 13.8 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 177.653 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.497 ' N ' ' CD ' ' A' ' 58' ' ' GLN . 2.2 pm0 -175.29 176.81 1.97 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.867 0.365 . . . . 0.0 110.162 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.461 ' CD1' ' C ' ' A' ' 58' ' ' GLN . 84.7 m-85 -157.07 159.22 37.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.646 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 34.1 ptt-85 -48.16 -33.01 7.74 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -31.33 103.51 0.01 OUTLIER Glycine 0 CA--C 1.526 0.762 0 CA-C-N 114.875 -1.057 . . . . 0.0 112.221 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.436 HG22 ' H ' ' A' ' 62' ' ' VAL . 2.6 m -66.91 -33.61 64.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 118.229 -0.891 . . . . 0.0 109.194 176.282 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.411 HD22 ' N ' ' A' ' 63' ' ' LEU . 4.4 mm? -60.09 -32.32 70.86 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 121.25 1.841 . . . . 0.0 110.359 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -65.02 -49.3 63.2 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-N 115.243 -0.889 . . . . 0.0 114.609 -177.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.434 ' H ' HG23 ' A' ' 65' ' ' THR . 6.8 p -62.15 -46.38 89.24 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -178.239 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.482 HD12 ' N ' ' A' ' 67' ' ' LEU . 2.3 pp -58.99 -35.0 54.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -178.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.482 ' N ' HD12 ' A' ' 66' ' ' ILE . 6.8 tp -63.03 -35.29 79.73 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 120.36 1.437 . . . . 0.0 113.116 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 98.6 m -61.47 -41.52 97.37 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-N 114.316 -1.311 . . . . 0.0 111.011 -177.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 50.4 mmm -59.3 -39.31 82.61 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -176.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.7 t -68.99 -41.04 81.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 118.968 -1.093 . . . . 0.0 113.646 -177.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 23.0 ttp-105 -78.26 -13.54 59.81 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.503 ' CG2' ' N ' ' A' ' 73' ' ' GLU . 0.5 OUTLIER -62.85 -54.95 30.9 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 114.639 -1.164 . . . . 0.0 112.391 -179.297 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.503 ' N ' ' CG2' ' A' ' 72' ' ' THR . 13.6 tp10 -110.61 -57.36 2.23 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.283 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.41 163.21 12.08 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -56.57 -34.92 96.44 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 122.107 1.871 . . . . 0.0 112.198 -179.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.4 tpp180 -61.25 -11.84 10.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.887 0.851 . . . . 0.0 111.132 176.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.407 ' OG ' HD12 ' A' ' 78' ' ' LEU . 15.6 p -78.28 -32.86 49.69 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 113.868 -1.514 . . . . 0.0 110.95 -178.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.407 HD12 ' OG ' ' A' ' 77' ' ' SER . 6.3 mp -75.58 -31.65 60.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.017 0.437 . . . . 0.0 110.449 178.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.647 ' O ' HD12 ' A' ' 82' ' ' LEU . 75.3 m-85 -90.15 -3.69 57.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 123.644 1.688 . . . . 0.0 112.549 -176.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 -106.7 121.21 43.91 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 110.619 -2.991 . . . . 0.0 107.654 175.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.46 -18.6 50.57 Favored Glycine 0 N--CA 1.469 0.893 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 -177.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.989 HD13 ' N ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -58.91 -33.69 70.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 113.905 -1.148 . . . . 0.0 110.332 -179.096 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.989 ' N ' HD13 ' A' ' 82' ' ' LEU . 7.1 p -70.44 -26.28 28.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.265 177.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.14 -31.95 61.2 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 119.11 -0.471 . . . . 0.0 111.837 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.93 -40.0 89.18 Favored Glycine 0 N--CA 1.466 0.679 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.891 -178.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -62.48 -40.25 96.07 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 122.15 0.976 . . . . 0.0 112.842 -176.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.431 ' O ' ' OE1' ' A' ' 87' ' ' GLN . 0.1 OUTLIER -60.83 -28.29 68.7 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 113.431 -1.713 . . . . 0.0 110.378 -179.267 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 62.5 mtt85 -58.53 -53.7 55.36 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 173.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -66.67 -29.36 69.35 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 112.035 -2.348 . . . . 0.0 111.847 -177.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 12.3 tpt -61.27 -40.14 92.99 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.425 179.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 33.8 t -74.37 -34.19 63.29 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 119.366 -0.934 . . . . 0.0 111.456 -177.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -57.87 -43.84 86.26 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 121.04 1.745 . . . . 0.0 112.615 -176.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.49 -32.85 64.51 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 119.484 -0.886 . . . . 0.0 110.748 -178.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.597 ' O ' HG22 ' A' ' 97' ' ' ILE . 70.2 p -64.1 -41.43 97.28 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.45 ' C ' ' H ' ' A' ' 97' ' ' ILE . 29.8 m -68.79 -28.28 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.44 177.013 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 55.3 ttp85 -77.15 9.22 3.2 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -176.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.597 HG22 ' O ' ' A' ' 94' ' ' SER . 11.0 tt -86.96 -14.68 10.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.318 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.412 ' O ' ' OG ' ' A' ' 102' ' ' SER . . . -139.98 -48.14 0.06 OUTLIER Glycine 0 CA--C 1.544 1.867 0 N-CA-C 115.772 1.069 . . . . 0.0 115.772 -177.202 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.604 HD22 ' N ' ' A' ' 99' ' ' LEU . 3.4 mm? -71.79 -13.4 61.68 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 119.841 1.82 . . . . 0.0 113.925 -177.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.484 ' CZ ' ' NZ ' ' A' ' 104' ' ' LYS . 9.6 t80 -80.84 -51.94 8.05 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 114.63 -1.168 . . . . 0.0 112.795 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.498 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 0.4 OUTLIER -70.42 -32.23 69.74 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 124.056 1.884 . . . . 0.0 110.686 -179.738 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' A' ' 98' ' ' GLY . 67.3 m -67.32 -50.88 58.3 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 109.609 -3.451 . . . . 0.0 113.492 178.235 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 10.0 p -73.83 -26.66 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 CA-C-N 121.27 1.85 . . . . 0.0 111.79 177.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.484 ' NZ ' ' CZ ' ' A' ' 100' ' ' TYR . 39.0 mttp -69.51 -41.86 75.47 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 111.621 -2.536 . . . . 0.0 113.284 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.44 ' HG3' ' O ' ' A' ' 101' ' ' ASP . 88.1 mt-30 -76.27 -14.69 60.11 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 123.63 1.681 . . . . 0.0 111.029 178.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -79.27 -22.47 44.67 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 112.518 -2.128 . . . . 0.0 111.95 178.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.576 ' CZ ' ' ND2' ' A' ' 190' ' ' ASN . 15.4 m-85 -109.79 -27.73 9.16 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.231 1.012 . . . . 0.0 113.299 -173.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.767 ' C ' ' H ' ' A' ' 110' ' ' GLY . 14.4 t -94.53 12.68 26.54 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 -173.219 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -54.69 19.11 0.0 OUTLIER 'General case' 0 CA--C 1.57 1.747 0 CA-C-N 119.885 1.221 . . . . 0.0 110.726 177.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.767 ' H ' ' C ' ' A' ' 108' ' ' THR . . . 59.18 20.52 50.4 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.542 ' OG ' ' NH2' ' A' ' 119' ' ' ARG . 1.4 m 33.02 -163.23 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 113.23 -1.485 . . . . 0.0 113.385 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.588 ' C ' ' H ' ' A' ' 114' ' ' ALA . 3.3 tt0 -141.14 -157.3 0.75 Allowed 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 118.807 -1.157 . . . . 0.0 113.424 -177.361 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.649 ' O ' ' HB2' ' A' ' 114' ' ' ALA . 37.5 t60 -61.12 9.24 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 114.814 -1.085 . . . . 0.0 111.312 -179.104 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.649 ' HB2' ' O ' ' A' ' 113' ' ' HIS . . . 160.42 -161.01 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.26 14.58 25.74 Favored Glycine 0 N--CA 1.459 0.221 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 -179.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 25.6 mm -60.91 -39.98 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.08 -39.49 96.35 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.92 175.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 6.0 t -58.85 -43.23 90.74 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 176.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.542 ' NH2' ' OG ' ' A' ' 111' ' ' SER . 18.6 mmt85 -63.75 -37.37 87.1 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.658 -178.033 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 30.5 tp -63.58 -45.71 89.17 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 42.1 mt -66.92 -44.97 79.33 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.518 178.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.75 -45.1 87.84 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 119.903 1.229 . . . . 0.0 110.955 178.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -65.59 -44.39 92.84 Favored Glycine 0 CA--C 1.517 0.2 0 C-N-CA 119.777 -1.201 . . . . 0.0 111.148 -177.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 79.9 p -64.16 -43.07 96.32 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.83 0.348 . . . . 0.0 111.007 178.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 96.6 m -69.5 -48.82 59.39 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 119.192 -1.003 . . . . 0.0 112.687 177.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.493 HG23 ' N ' ' A' ' 127' ' ' GLY . 6.3 t -66.17 -42.7 88.56 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 115.197 1.555 . . . . 0.0 115.197 -174.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.493 ' N ' HG23 ' A' ' 126' ' ' THR . . . -64.74 -44.83 94.28 Favored Glycine 0 C--O 1.228 -0.233 0 CA-C-N 114.238 -1.347 . . . . 0.0 112.748 -177.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.57 -41.78 97.9 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 112.482 -1.859 . . . . 0.0 107.259 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.732 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 0.2 OUTLIER -64.85 -42.81 94.58 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.169 178.118 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.13 -39.67 95.36 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.894 -0.504 . . . . 0.0 111.817 -178.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.641 HG11 HG22 ' A' ' 183' ' ' VAL . 94.5 t -60.98 -26.25 38.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 123.342 1.544 . . . . 0.0 109.298 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.732 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . -58.93 -44.67 91.38 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 110.971 -2.832 . . . . 0.0 112.386 -178.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 61.4 t -79.07 -49.18 20.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -177.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.517 ' O ' ' CB ' ' A' ' 135' ' ' GLN . . . -107.36 -169.12 1.48 Allowed 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -177.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.527 ' N ' ' CD ' ' A' ' 136' ' ' PRO . 3.4 tt0 105.15 -23.28 0.0 OUTLIER Pre-proline 0 CA--C 1.552 1.051 0 O-C-N 124.676 1.235 . . . . 0.0 114.051 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.527 ' CD ' ' N ' ' A' ' 135' ' ' GLN . 5.2 Cg_exo -52.68 -34.64 64.93 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 CA-C-N 122.025 1.759 . . . . 0.0 112.803 -178.327 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 12.6 m -66.75 -40.72 88.39 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -64.52 -42.16 95.94 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 118.965 -1.094 . . . . 0.0 112.424 -177.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.89 -42.93 97.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -179.198 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 19.7 m -63.92 -37.3 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -177.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 16.5 mtpp -60.82 -40.13 91.61 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.981 -177.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 90.4 t -69.83 -45.11 78.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.28 0.562 . . . . 0.0 109.694 178.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.404 ' CA ' ' HE ' ' A' ' 143' ' ' ARG . 0.0 OUTLIER -64.64 -36.11 83.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.508 179.569 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -66.28 -40.4 90.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.899 -0.592 . . . . 0.0 112.312 -177.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -64.06 -39.07 93.28 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 119.884 -0.726 . . . . 0.0 110.185 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.16 -35.06 79.9 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.615 ' NE2' ' O ' ' A' ' 147' ' ' GLN . 0.0 OUTLIER -59.66 110.73 1.2 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 177.584 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 150' ' ' ALA . . . -43.17 93.03 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 117.33 -1.319 . . . . 0.0 111.531 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 78.8 mtm180 53.81 -89.44 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 122.64 2.473 . . . . 0.0 111.055 178.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 148' ' ' ALA . . . -154.37 -149.7 0.29 Allowed 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.405 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -158.44 31.57 0.48 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 155' ' ' ARG . . . -172.95 111.08 0.36 Allowed Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -67.57 -53.12 26.12 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -70.96 -44.89 65.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.702 0.287 . . . . 0.0 110.762 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.406 ' O ' ' O ' ' A' ' 152' ' ' GLY . 37.8 ttm180 -85.77 138.94 31.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.68 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.514 ' CE2' ' O ' ' A' ' 157' ' ' GLN . 92.0 t80 -102.4 126.69 49.5 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.677 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.514 ' O ' ' CE2' ' A' ' 156' ' ' TYR . 84.1 mt-30 -81.07 166.49 20.7 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.34 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.69 ' H ' ' CG ' ' A' ' 161' ' ' GLU . 20.7 p -157.04 -178.56 7.46 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.565 0.698 . . . . 0.0 111.602 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 25.4 p -64.77 -46.64 81.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.113 -0.948 . . . . 0.0 112.335 -178.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.564 HG13 ' N ' ' A' ' 161' ' ' GLU . 14.9 p -65.02 -45.98 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 119.241 -0.984 . . . . 0.0 110.896 -178.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.69 ' CG ' ' H ' ' A' ' 158' ' ' SER . 2.1 pp20? -68.14 -38.54 82.27 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.921 0.391 . . . . 0.0 111.843 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.426 ' N ' ' CD ' ' A' ' 161' ' ' GLU . . . -61.14 -45.68 93.67 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -177.25 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.6 ' CZ ' HD23 ' A' ' 175' ' ' LEU . 17.0 t80 -62.54 -50.15 72.47 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.137 -179.258 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -68.68 -45.68 71.05 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 -175.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.546 HG23 ' N ' ' A' ' 166' ' ' ILE . 15.3 t -63.27 -45.1 93.05 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -177.413 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.546 ' N ' HG23 ' A' ' 165' ' ' THR . 8.4 pt -64.83 -39.08 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 CA-C-O 122.043 0.925 . . . . 0.0 108.964 177.032 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.404 ' N ' ' CG1' ' A' ' 166' ' ' ILE . . . -60.41 -37.62 81.44 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 113.704 -1.589 . . . . 0.0 109.145 177.026 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 13.4 tpp85 -63.47 -51.35 65.99 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 123.715 2.962 . . . . 0.0 112.821 -175.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -75.7 -51.4 12.82 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 123.287 0.635 . . . . 0.0 109.515 177.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.492 ' OE2' ' N ' ' A' ' 174' ' ' GLY . 0.0 OUTLIER -78.96 -37.19 40.17 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 119.602 1.092 . . . . 0.0 113.784 -176.204 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 171' ' ' GLY . . . . . 0.47 ' O ' ' OE2' ' A' ' 170' ' ' GLU . . . 98.31 -171.73 25.8 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 120.776 -0.726 . . . . 0.0 113.366 179.055 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.448 HG23 ' N ' ' A' ' 173' ' ' ARG . 20.8 tt -75.12 -37.84 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -177.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.448 ' N ' HG23 ' A' ' 172' ' ' ILE . 7.3 tpp180 -58.22 -34.1 70.05 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 114.298 -1.319 . . . . 0.0 112.938 -173.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.492 ' N ' ' OE2' ' A' ' 170' ' ' GLU . . . -60.56 -38.87 95.64 Favored Glycine 0 N--CA 1.464 0.51 0 CA-C-O 123.726 1.737 . . . . 0.0 111.995 -178.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.6 HD23 ' CZ ' ' A' ' 163' ' ' TYR . 5.2 mp -70.2 -34.24 72.69 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 110.153 -3.024 . . . . 0.0 116.425 -176.271 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 11.0 m95 -78.72 -7.72 58.02 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 113.481 -1.691 . . . . 0.0 109.653 -178.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -44.06 -49.28 8.86 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.756 0.651 . . . . 0.0 112.756 -175.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -87.99 -36.6 8.27 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 124.548 1.071 . . . . 0.0 111.754 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 40.3 p -45.24 -51.39 10.81 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.426 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 1.5 t -62.92 -50.93 74.72 Favored Pre-proline 0 N--CA 1.472 0.667 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -176.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 180' ' ' SER . 32.3 Cg_endo -65.06 -28.15 57.24 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.676 1.584 . . . . 0.0 111.257 176.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.426 ' CB ' ' OE1' ' A' ' 135' ' ' GLN . 24.5 t-20 -63.41 -39.19 93.82 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.641 HG22 HG11 ' A' ' 131' ' ' VAL . 71.8 t -62.91 -42.79 97.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.63 -39.99 95.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.18 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -60.99 -41.94 97.47 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.084 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -61.61 -43.24 99.24 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.033 0.444 . . . . 0.0 110.124 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' ALA . . . . . 0.508 ' O ' ' SG ' ' A' ' 191' ' ' CYS . . . -64.24 -43.87 93.56 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.24 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 25.2 mm -63.32 -45.17 98.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.864 -0.335 . . . . 0.0 111.309 -178.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 89.3 t -60.42 -47.22 93.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 120.265 -0.574 . . . . 0.0 111.765 -178.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.576 ' ND2' ' CZ ' ' A' ' 107' ' ' TYR . 25.5 t-20 -62.61 -43.27 99.22 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 122.663 1.22 . . . . 0.0 109.873 179.175 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 191' ' ' CYS . . . . . 0.508 ' SG ' ' O ' ' A' ' 187' ' ' ALA . 94.5 m -62.43 -46.49 88.3 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 112.46 -2.155 . . . . 0.0 110.752 179.036 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.41 -40.29 95.5 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.479 176.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -61.54 -45.57 93.6 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.879 -178.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 7.9 tt -64.16 -38.95 92.88 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 118.623 -1.231 . . . . 0.0 110.071 -174.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 6.1 m -64.5 -45.48 95.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 116.762 -1.975 . . . . 0.0 107.808 178.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 19.8 m -63.89 -45.87 87.43 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -178.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -56.48 -38.35 71.61 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.34 1.056 . . . . 0.0 112.09 -178.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -55.19 -43.09 74.05 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 24.5 mt -60.79 -39.51 89.17 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.422 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 1.3 mp -62.98 -42.45 96.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -59.59 -38.67 81.85 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.505 1.522 . . . . 0.0 113.193 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -62.9 -40.04 96.36 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.027 -178.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 90.5 m -100.66 129.37 46.56 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.797 0.808 . . . . 0.0 111.839 -177.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.624 ' O ' HD22 ' A' ' 205' ' ' LEU . 4.6 tp 68.02 4.38 4.03 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 114.221 -1.354 . . . . 0.0 111.954 179.129 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.624 HD22 ' O ' ' A' ' 204' ' ' LEU . 1.3 mm? -128.42 28.81 5.41 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -177.115 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -72.84 -25.06 60.98 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.263 -178.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.46 ' O ' ' CG ' ' A' ' 208' ' ' ASN . . . -131.09 -38.88 1.21 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.547 0.689 . . . . 0.0 110.219 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 208' ' ' ASN . . . . . 0.617 ' CG ' ' H ' ' A' ' 209' ' ' LEU . 13.9 p30 141.25 -92.84 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 113.138 -1.846 . . . . 0.0 106.846 -177.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.617 ' H ' ' CG ' ' A' ' 208' ' ' ASN . 4.3 tt -101.12 114.19 27.91 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 177.096 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 210' ' ' MET . . . . . 0.528 ' N ' HD23 ' A' ' 209' ' ' LEU . 6.6 tpt -158.62 79.61 0.8 Allowed 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 120.281 -0.567 . . . . 0.0 111.692 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.527 HG23 ' O ' ' A' ' 210' ' ' MET . 24.3 p -159.42 170.88 20.81 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.627 179.226 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -133.83 -60.95 0.81 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.61 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.495 ' O ' ' SG ' ' A' ' 216' ' ' CYS . 11.5 p-10 -84.16 94.66 8.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.611 178.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.491 ' N ' ' CD ' ' A' ' 215' ' ' PRO . 4.3 mm? -60.88 -42.63 88.12 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.215 -178.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.491 ' CD ' ' N ' ' A' ' 214' ' ' LEU . 35.1 Cg_exo -59.89 -32.34 95.1 Favored 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 121.58 1.52 . . . . 0.0 112.337 -177.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 216' ' ' CYS . . . . . 0.527 ' SG ' ' N ' ' A' ' 217' ' ' HIS . 1.6 p -63.98 -42.23 97.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 113.714 -1.584 . . . . 0.0 111.422 -177.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 217' ' ' HIS . . . . . 0.527 ' N ' ' SG ' ' A' ' 216' ' ' CYS . 77.3 m80 -66.5 -37.32 84.81 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.332 0.587 . . . . 0.0 110.766 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 218' ' ' PHE . . . . . 0.524 ' CE1' HD12 ' A' ' 294' ' ' LEU . 30.7 m-85 -63.47 -46.77 84.66 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.804 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 20.8 p -60.2 -37.79 81.32 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 118.81 0.732 . . . . 0.0 110.44 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 49.7 p -59.45 -41.63 90.09 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 178.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.566 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.74 -41.81 97.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -177.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -62.19 -47.67 83.45 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -175.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -61.15 -42.4 99.78 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 107.994 -2.042 . . . . 0.0 107.994 177.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' ALA . . . . . 0.541 ' O ' HG23 ' A' ' 228' ' ' THR . . . -63.48 -37.34 86.91 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 113.839 -1.18 . . . . 0.0 109.622 177.007 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -61.15 -41.96 99.64 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-N 114.364 -1.289 . . . . 0.0 112.529 -175.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 226' ' ' PHE . . . . . 0.443 ' O ' ' OG1' ' A' ' 229' ' ' THR . 55.1 m-85 -66.24 -38.79 88.74 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 118.767 1.283 . . . . 0.0 110.014 -178.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 227' ' ' CYS . . . . . 0.495 ' SG ' ' N ' ' A' ' 228' ' ' THR . 1.8 p -63.69 -41.91 98.07 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 119.74 -0.784 . . . . 0.0 109.873 177.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 224' ' ' ALA . 67.6 p -62.56 -40.93 98.42 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.412 179.121 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 226' ' ' PHE . 13.1 p -59.19 -39.46 82.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.266 -177.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 92.8 t -60.35 -41.26 86.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 C-N-CA 118.91 -1.116 . . . . 0.0 108.524 178.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.505 ' O ' ' HD2' ' A' ' 234' ' ' PRO . 30.4 mm -62.08 -41.18 90.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 121.345 0.593 . . . . 0.0 109.727 176.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.1 -39.9 96.06 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 116.16 1.911 . . . . 0.0 116.16 -179.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.48 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 0.1 OUTLIER -58.1 -41.91 92.27 Favored Pre-proline 0 N--CA 1.481 1.098 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -173.271 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.505 ' HD2' ' O ' ' A' ' 231' ' ' ILE . 35.5 Cg_exo -58.39 -40.08 78.3 Favored 'Trans proline' 0 C--N 1.291 -2.483 0 C-N-CA 121.915 1.744 . . . . 0.0 112.503 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 58.9 t -64.38 -37.29 79.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 C-N-CA 118.591 -1.244 . . . . 0.0 109.004 178.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -66.22 -40.98 90.67 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-N 115.351 -0.841 . . . . 0.0 112.182 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 74.1 t -65.63 -45.28 92.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -176.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.19 -36.9 77.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -176.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 7.3 ptmm? -60.1 -43.56 95.46 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.632 -178.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 240' ' ' THR . . . . . 0.427 ' H ' HG23 ' A' ' 240' ' ' THR . 1.8 p -61.09 -41.94 97.58 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.093 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.509 ' O ' ' CB ' ' A' ' 242' ' ' TYR . 0.0 OUTLIER -40.25 131.56 2.09 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 121.148 -0.221 . . . . 0.0 111.165 -178.462 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.509 ' CB ' ' O ' ' A' ' 241' ' ' ARG . 2.7 t80 153.54 -59.17 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 O-C-N 123.688 0.617 . . . . 0.0 110.292 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 243' ' ' MET . . . . . 0.535 ' O ' ' ND2' ' A' ' 244' ' ' ASN . 79.6 mtp -33.25 144.68 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 O-C-N 123.147 0.279 . . . . 0.0 110.72 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 244' ' ' ASN . . . . . 0.556 ' OD1' ' N ' ' A' ' 245' ' ' SER . 0.7 OUTLIER 75.07 -175.27 0.13 Allowed 'General case' 0 N--CA 1.468 0.441 0 O-C-N 123.463 0.477 . . . . 0.0 111.259 -179.474 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 245' ' ' SER . . . . . 0.556 ' N ' ' OD1' ' A' ' 244' ' ' ASN . 41.7 t 38.47 -135.33 0.1 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.862 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 246' ' ' ALA . . . . . 0.495 ' N ' ' OG ' ' A' ' 245' ' ' SER . . . 66.35 51.44 1.2 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.173 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 39.4 mt -128.85 -19.89 3.58 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.675 -0.238 . . . . 0.0 111.149 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 249' ' ' GLN . . . -90.21 -166.81 41.58 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 -179.452 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.632 ' OE1' ' NE2' ' A' ' 255' ' ' HIS . 51.1 tt0 -46.38 -101.64 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.801 -0.2 . . . . 0.0 110.521 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.558 ' CD1' ' N ' ' A' ' 250' ' ' TYR . 0.8 OUTLIER 71.72 59.97 0.15 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.67 179.082 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -66.7 -51.4 56.47 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 114.374 1.249 . . . . 0.0 114.374 -178.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.52 -173.51 4.29 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -178.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -60.38 -44.9 95.2 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 118.921 0.782 . . . . 0.0 108.914 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -56.0 -34.94 62.58 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 125.225 1.393 . . . . 0.0 111.102 -173.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 255' ' ' HIS . . . . . 0.632 ' NE2' ' OE1' ' A' ' 249' ' ' GLN . 48.2 t-80 -55.68 -34.87 65.43 Favored 'General case' 0 C--N 1.361 1.088 0 C-N-CA 116.805 -1.958 . . . . 0.0 110.982 179.289 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 256' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -60.47 -45.04 95.18 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.984 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -60.62 -45.94 92.15 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.6 -179.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 11.5 tp -67.8 -43.72 79.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.054 0.454 . . . . 0.0 111.245 179.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 259' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 255' ' ' HIS . 21.9 m -63.11 -46.73 85.96 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -178.243 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 260' ' ' MET . . . . . 0.419 ' CG ' ' N ' ' A' ' 261' ' ' LEU . 17.0 ptt? -61.57 -44.45 97.01 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -177.208 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.419 ' N ' ' CG ' ' A' ' 260' ' ' MET . 11.6 tp -63.25 -48.12 79.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.787 0.327 . . . . 0.0 110.467 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 50.1 ttt85 -67.4 -54.14 23.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.582 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 3.8 ttmm -68.29 -148.45 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.954 0.407 . . . . 0.0 111.484 -178.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -51.45 136.4 25.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.399 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -41.37 166.63 0.01 OUTLIER Glycine 0 CA--C 1.527 0.834 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.809 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -60.23 -2.97 2.07 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.625 2.217 . . . . 0.0 111.7 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 -69.98 -27.01 64.36 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.193 0.597 . . . . 0.0 111.739 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -58.76 -32.31 69.16 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.006 -179.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -62.39 -41.19 98.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.915 177.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -65.67 -37.55 86.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.909 -1.042 . . . . 0.0 112.146 -178.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.455 ' O ' ' O ' ' A' ' 272' ' ' GLY . 42.3 mmtm -65.42 -176.7 0.35 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 272' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 271' ' ' LYS . . . 47.72 104.13 0.01 OUTLIER Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -165.26 4.26 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.611 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 274' ' ' MET . . . . . 0.583 ' N ' ' CD ' ' A' ' 275' ' ' PRO . 2.9 ttm -63.57 -44.15 80.26 Favored Pre-proline 0 C--N 1.329 -0.304 0 C-N-CA 120.268 -0.573 . . . . 0.0 109.646 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 275' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 274' ' ' MET . 22.8 Cg_exo -64.33 -46.12 8.26 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.732 2.288 . . . . 0.0 111.334 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 38.7 t -60.1 -40.04 88.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.514 -179.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 277' ' ' PHE . . . . . 0.464 ' O ' ' CD1' ' A' ' 280' ' ' LEU . 3.4 m-85 -61.59 -42.76 99.32 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 124.3 2.0 . . . . 0.0 111.809 -178.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 11.5 tp -62.87 -38.98 93.01 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 110.385 -3.098 . . . . 0.0 109.892 175.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 279' ' ' ARG . . . . . 0.563 HH22 ' NZ ' ' A' ' 38' ' ' LYS . 56.6 mtt-85 -63.03 -41.49 99.53 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.49 ' H ' ' HG ' ' A' ' 280' ' ' LEU . 1.3 pp -62.7 -35.37 79.49 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -177.552 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 281' ' ' GLY . . . . . 0.481 ' N ' HD12 ' A' ' 280' ' ' LEU . . . -67.67 -50.98 38.7 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -177.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 66.4 m -62.49 -43.89 97.72 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.477 0.711 . . . . 0.0 109.689 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 283' ' ' TRP . . . . . 0.463 ' O ' HG22 ' A' ' 286' ' ' VAL . 85.0 t90 -59.61 -38.16 80.55 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 284' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' A' ' 285' ' ' VAL . 0.2 OUTLIER -62.52 -38.37 89.7 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.295 179.549 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.531 ' N ' ' OD1' ' A' ' 284' ' ' ASN . 0.3 OUTLIER -61.01 -39.91 83.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -177.52 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.488 ' O ' HG22 ' A' ' 289' ' ' VAL . 10.2 m -63.31 -40.07 87.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.051 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 287' ' ' MET . . . . . 0.461 ' SD ' ' CE1' ' A' ' 291' ' ' TYR . 0.0 OUTLIER -60.83 -38.41 85.37 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.656 179.919 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -58.44 -40.1 81.63 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.846 -178.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 286' ' ' VAL . 0.9 OUTLIER -60.53 -38.24 77.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 -177.762 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 41.8 p -62.42 -40.91 98.09 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 119.558 -0.857 . . . . 0.0 108.834 177.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 291' ' ' TYR . . . . . 0.461 ' CE1' ' SD ' ' A' ' 287' ' ' MET . 16.2 m-85 -60.98 -38.34 85.6 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 177.133 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 -57.27 -39.35 75.5 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 118.163 -1.415 . . . . 0.0 109.261 -176.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 293' ' ' GLN . . . . . 0.468 ' O ' ' O ' ' A' ' 296' ' ' ARG . 17.9 mm100 -60.24 -42.08 94.53 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 122.904 1.335 . . . . 0.0 110.58 178.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.524 HD12 ' CE1' ' A' ' 218' ' ' PHE . 3.9 mm? -60.8 -39.41 88.8 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 112.404 -2.18 . . . . 0.0 110.02 178.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 45.2 mttp -61.83 -44.67 96.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.226 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 296' ' ' ARG . . . . . 0.468 ' O ' ' O ' ' A' ' 293' ' ' GLN . 89.1 mtm180 -121.89 115.7 23.06 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -112.13 -163.24 0.84 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.349 0.595 . . . . 0.0 112.276 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.59 HD12 ' N ' ' A' ' 298' ' ' LEU . 9.9 mp -74.79 109.72 8.49 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 176.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 299' ' ' MET . . . . . 0.5 ' SD ' ' O ' ' A' ' 299' ' ' MET . 0.1 OUTLIER -94.59 63.97 2.97 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.755 0.312 . . . . 0.0 111.651 -178.302 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.49 100.86 0.08 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 122.233 1.016 . . . . 0.0 110.647 -178.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -64.2 -46.47 83.8 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 113.16 -1.837 . . . . 0.0 113.265 -176.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -59.06 -39.92 83.56 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.161 -177.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 303' ' ' GLN . . . . . 0.77 HE21 ' N ' ' A' ' 13' ' ' MET . 62.7 tp60 -65.01 -47.0 79.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.846 0.355 . . . . 0.0 110.351 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 304' ' ' SER . . . . . 0.453 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 39.2 t -67.11 -38.33 85.44 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.776 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 34.7 mmm-85 -62.25 -43.76 98.09 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -179.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -65.35 -36.82 85.18 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -177.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 307' ' ' ALA . . . . . 0.537 ' HB3' ' HD3' ' A' ' 308' ' ' PRO . . . -60.13 -52.87 70.26 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -176.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 308' ' ' PRO . . . . . 0.537 ' HD3' ' HB3' ' A' ' 307' ' ' ALA . 72.5 Cg_endo -75.07 0.38 9.0 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.374 2.049 . . . . 0.0 112.995 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 309' ' ' PHE . . . . . 0.49 ' C ' ' O ' ' A' ' 308' ' ' PRO . 36.3 p90 . . . . . 0 N--CA 1.481 1.078 0 O-C-N 123.894 0.746 . . . . 0.0 112.923 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 39.9 ttm . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.2 p -79.65 82.93 5.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.516 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.6 t -84.36 155.8 3.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.846 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -64.51 -41.7 96.26 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.287 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -63.67 -41.74 98.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.497 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 45.3 tp -79.6 -26.44 41.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.089 -178.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.26 -41.25 94.81 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 107.714 -2.154 . . . . 0.0 107.714 177.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.422 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -71.66 -32.15 67.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 124.856 2.265 . . . . 0.0 107.625 176.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.43 -42.24 99.11 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-N 108.492 -3.958 . . . . 0.0 108.092 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -70.52 -27.62 64.31 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.098 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -66.46 -49.97 64.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.965 -179.259 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.02 -35.87 79.88 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 118.157 -1.417 . . . . 0.0 110.995 -177.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.463 ' O ' HD23 ' A' ' 29' ' ' LEU . 78.7 m -63.85 -53.94 42.69 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.245 -179.021 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.682 HD12 ' N ' ' A' ' 27' ' ' ALA . 2.7 pp -65.54 -39.58 85.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -177.235 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.682 ' N ' HD12 ' A' ' 26' ' ' ILE . . . -63.92 -41.65 97.6 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -173.07 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 32' ' ' PHE . 8.4 p-10 -77.67 -27.11 50.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 120.464 1.483 . . . . 0.0 109.89 -176.015 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.463 HD23 ' O ' ' A' ' 25' ' ' CYS . 3.0 mm? -60.33 -55.71 30.3 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 119.531 1.06 . . . . 0.0 111.77 -178.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.6 pt -75.89 -4.84 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 121.188 0.518 . . . . 0.0 112.363 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.478 ' HA ' HD12 ' A' ' 34' ' ' LEU . 53.5 m -109.91 -17.02 13.72 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 117.319 -1.324 . . . . 0.0 109.95 -179.473 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.443 ' N ' ' O ' ' A' ' 28' ' ' ASP . 10.3 t80 -68.38 -44.88 36.95 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-N 122.67 2.486 . . . . 0.0 110.977 -177.568 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -60.21 -16.69 41.88 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 CA-C-N 121.05 1.411 . . . . 0.0 112.74 177.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.478 HD12 ' HA ' ' A' ' 31' ' ' THR . 82.9 mt -67.65 -35.08 78.22 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -177.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.555 ' HA ' ' HZ3' ' A' ' 38' ' ' LYS . 5.3 p30 -63.98 -39.56 94.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.133 -178.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.532 ' N ' ' OD1' ' A' ' 35' ' ' ASP . 44.4 p -58.11 -34.02 69.75 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.29 -38.76 85.58 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.555 ' HZ3' ' HA ' ' A' ' 35' ' ' ASP . 12.1 pttm -62.0 -47.7 83.61 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 119.049 -1.06 . . . . 0.0 111.93 -177.037 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.425 HG23 ' NH1' ' A' ' 40' ' ' ARG . 4.9 m -62.8 -38.98 83.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -176.147 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.527 ' O ' ' N ' ' A' ' 42' ' ' GLN . 13.0 mmp_? -60.24 -41.08 92.41 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 118.986 -1.085 . . . . 0.0 109.909 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 12.8 tp -62.48 38.98 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.236 178.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.619 HE22 ' CA ' ' A' ' 44' ' ' GLN . 5.1 pp0? -53.0 176.02 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.078 0.466 . . . . 0.0 111.436 -178.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 90.9 mt -45.29 -84.01 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.688 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.619 ' CA ' HE22 ' A' ' 42' ' ' GLN . 10.6 tm0? -150.64 -33.93 0.16 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.439 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -163.69 155.61 27.05 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.412 ' OE1' ' CG1' ' A' ' 51' ' ' VAL . 16.8 mp0 -87.27 168.8 12.87 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.815 0.34 . . . . 0.0 110.532 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.5 t -91.26 1.18 57.29 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -63.34 -25.49 68.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.436 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.03 -6.05 84.04 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.02 -1.632 . . . . 0.0 109.02 -177.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.612 ' O ' HD23 ' A' ' 50' ' ' LEU . 1.3 tt -65.31 -37.66 87.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.583 -0.809 . . . . 0.0 109.638 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.414 HG23 ' N ' ' A' ' 52' ' ' ARG . 16.5 m -60.38 -44.04 95.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.411 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.414 ' N ' HG23 ' A' ' 51' ' ' VAL . 23.7 ttm105 -64.16 -34.04 77.15 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 19.3 m -67.97 -38.26 82.52 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.094 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -131.5 78.82 1.85 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.227 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -48.13 -14.91 0.06 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.39 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.62 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 23.1 t -126.23 -140.54 0.28 Allowed 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.62 ' HB3' ' O ' ' A' ' 56' ' ' SER . . . 96.66 13.96 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.706 0 O-C-N 124.062 0.851 . . . . 0.0 111.909 178.621 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -175.32 69.99 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.653 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -52.36 155.44 2.07 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.402 ' O ' ' C ' ' A' ' 61' ' ' GLY . 75.4 mtp180 -45.35 -37.0 4.54 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 60' ' ' ARG . . . -30.33 103.05 0.01 OUTLIER Glycine 0 CA--C 1.529 0.95 0 CA-C-N 114.993 -1.003 . . . . 0.0 112.478 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 31.0 m -67.42 -33.79 64.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 118.268 -0.872 . . . . 0.0 109.888 176.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.494 ' H ' HD12 ' A' ' 63' ' ' LEU . 6.0 mp -60.27 -32.28 71.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 121.239 1.836 . . . . 0.0 109.881 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.42 -49.2 66.74 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 114.975 -1.011 . . . . 0.0 114.671 -176.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.6 m -62.1 -46.41 89.19 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -178.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 29.0 pt -59.89 -35.97 63.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.638 ' O ' HD23 ' A' ' 67' ' ' LEU . 1.3 tt -63.84 -35.83 81.92 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 121.04 1.745 . . . . 0.0 111.651 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 98.6 m -62.79 -39.47 94.31 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-N 113.674 -1.603 . . . . 0.0 111.049 -175.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 7.6 ptt? -60.39 -39.8 88.6 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 120.648 -1.283 . . . . 0.0 113.819 -176.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.2 p -69.36 -40.7 80.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 119.244 -0.982 . . . . 0.0 113.015 -178.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 55.6 ttm-85 -77.86 -13.44 59.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.979 0.895 . . . . 0.0 112.173 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 71.3 m -63.14 -54.77 32.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.137 -1.392 . . . . 0.0 111.154 178.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -106.29 -59.85 1.73 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.473 178.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 160.98 166.34 19.51 Favored Glycine 0 CA--C 1.535 1.34 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -56.17 -35.15 94.9 Favored 'Trans proline' 0 N--CA 1.5 1.91 0 CA-C-N 119.33 1.565 . . . . 0.0 111.721 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -61.36 -11.15 8.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.739 0.78 . . . . 0.0 111.071 176.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.8 t -77.79 -32.77 52.67 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.248 -1.342 . . . . 0.0 110.876 -178.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.48 HD12 ' N ' ' A' ' 78' ' ' LEU . 9.6 mp -75.86 -33.64 60.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 118.271 0.487 . . . . 0.0 110.958 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -92.53 -4.95 52.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 122.796 1.284 . . . . 0.0 112.76 -178.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -90.69 118.31 30.02 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 112.487 -2.142 . . . . 0.0 107.228 175.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.89 -7.58 57.42 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -178.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.674 HD12 ' C ' ' A' ' 82' ' ' LEU . 0.4 OUTLIER -59.25 -34.51 72.32 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 113.949 -1.125 . . . . 0.0 110.541 -179.092 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.1 p -70.46 -26.67 29.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.525 178.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.73 -31.58 61.87 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.748 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.427 ' O ' ' OE1' ' A' ' 89' ' ' GLN . . . -67.84 -40.26 89.52 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 119.701 -1.238 . . . . 0.0 111.241 -177.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.3 mp -62.0 -40.05 94.34 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 122.598 1.189 . . . . 0.0 112.203 -177.121 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 49.9 tp60 -60.41 -26.99 67.1 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 112.657 -2.065 . . . . 0.0 108.992 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 46.8 ttt180 -57.56 -53.41 58.42 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 173.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.427 ' OE1' ' O ' ' A' ' 85' ' ' GLY . 13.7 mp0 -67.82 -29.8 69.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 113.437 -1.71 . . . . 0.0 112.196 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 8.8 tpt -60.94 -41.97 97.28 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.044 -179.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 77.9 p -74.9 -35.08 62.25 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 119.225 -0.99 . . . . 0.0 111.729 -177.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -57.93 -43.4 86.24 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 121.293 1.861 . . . . 0.0 113.051 -176.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.41 -32.42 64.42 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.322 -177.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 97.1 p -63.68 -40.55 97.11 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 179.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.415 ' C ' ' H ' ' A' ' 97' ' ' ILE . 18.4 m -67.94 -28.3 40.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.829 177.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -77.63 10.12 2.9 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -177.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.415 ' H ' ' C ' ' A' ' 95' ' ' VAL . 38.8 mm -86.69 -15.39 9.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 177.145 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -140.45 -48.0 0.05 OUTLIER Glycine 0 CA--C 1.537 1.415 0 CA-C-N 114.569 -1.196 . . . . 0.0 114.267 -177.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.573 ' N ' HD12 ' A' ' 99' ' ' LEU . 8.5 mp -70.76 -13.26 61.99 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 118.586 1.193 . . . . 0.0 112.776 -177.437 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.486 ' O ' ' CG ' ' A' ' 104' ' ' LYS . 91.8 t80 -81.53 -51.19 8.52 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.234 178.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 1.008 ' OD2' ' OE1' ' A' ' 105' ' ' GLN . 18.4 t70 -69.4 -31.55 69.99 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 113.332 -1.758 . . . . 0.0 111.512 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 51.2 m -68.17 -52.48 34.13 Favored 'General case' 0 CA--C 1.556 1.185 0 CA-C-N 111.138 -2.755 . . . . 0.0 115.918 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.505 ' O ' ' CD2' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -74.66 -26.26 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-N 122.015 2.189 . . . . 0.0 111.505 177.547 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.486 ' CG ' ' O ' ' A' ' 100' ' ' TYR . 16.7 mmtt -68.8 -42.17 77.67 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 111.875 -2.42 . . . . 0.0 112.334 -179.11 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 1.008 ' OE1' ' OD2' ' A' ' 101' ' ' ASP . 27.2 mt-30 -76.74 -15.95 59.62 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 122.677 1.227 . . . . 0.0 111.056 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -79.44 -23.43 43.15 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 114.105 -1.407 . . . . 0.0 112.202 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.505 ' CD2' ' O ' ' A' ' 103' ' ' VAL . 45.2 m-85 -110.22 -30.27 7.8 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 119.871 1.214 . . . . 0.0 113.278 -175.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.0 t -97.77 9.35 42.84 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 117.257 -1.777 . . . . 0.0 112.844 -178.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.528 ' CD ' HH22 ' A' ' 119' ' ' ARG . 0.0 OUTLIER -52.13 124.2 12.43 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 117.827 -1.082 . . . . 0.0 110.497 179.054 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.549 ' O ' ' CB ' ' A' ' 111' ' ' SER . . . -21.04 -83.33 0.01 OUTLIER Glycine 0 N--CA 1.491 2.352 0 CA-C-N 119.79 1.177 . . . . 0.0 111.699 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.549 ' CB ' ' O ' ' A' ' 110' ' ' GLY . 7.2 t 106.35 -162.28 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 115.424 1.638 . . . . 0.0 115.424 176.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.542 ' O ' ' CG ' ' A' ' 113' ' ' HIS . 33.4 tp10 -108.97 -46.12 3.66 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -176.491 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.618 ' O ' ' HB2' ' A' ' 114' ' ' ALA . 0.3 OUTLIER 150.44 51.07 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -179.611 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.618 ' HB2' ' O ' ' A' ' 113' ' ' HIS . . . 159.57 -161.36 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 179.56 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.15 14.79 27.62 Favored Glycine 0 C--O 1.227 -0.314 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.733 177.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 59.9 mt -60.47 -40.56 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.54 -39.97 95.86 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 175.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 34.6 t -58.78 -42.89 90.07 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 176.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.528 HH22 ' CD ' ' A' ' 109' ' ' LYS . 2.4 mpt_? -63.75 -37.3 86.86 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.249 -178.009 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 62.5 tp -63.49 -46.27 86.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.587 0.708 . . . . 0.0 109.145 178.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 59.8 mt -66.83 -44.7 80.43 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.342 178.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.96 -44.94 91.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 119.433 1.015 . . . . 0.0 109.434 177.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -66.15 -44.26 91.51 Favored Glycine 0 CA--C 1.517 0.172 0 C-N-CA 119.806 -1.187 . . . . 0.0 111.244 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 14.6 t -64.05 -44.0 93.8 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.875 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.437 ' O ' HD23 ' A' ' 129' ' ' LEU . 21.7 p -69.53 -48.53 60.14 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 119.22 -0.992 . . . . 0.0 112.054 177.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 25.3 m -65.53 -42.72 91.66 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -174.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -64.19 -44.38 95.73 Favored Glycine 0 N--CA 1.461 0.365 0 CA-C-O 122.945 1.303 . . . . 0.0 112.975 -177.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.413 ' O ' ' CG1' ' A' ' 131' ' ' VAL . . . -60.8 -40.93 94.48 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 111.763 -2.219 . . . . 0.0 106.627 177.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.615 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 1.5 mm? -64.24 -42.23 96.61 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.538 178.446 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.19 -39.92 96.02 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -177.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.494 HG21 HG22 ' A' ' 183' ' ' VAL . 2.4 p -60.88 -24.74 33.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 122.383 1.087 . . . . 0.0 109.366 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . -57.32 -44.49 84.25 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 113.096 -1.866 . . . . 0.0 111.685 -178.308 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.492 ' CG1' ' N ' ' A' ' 134' ' ' ALA . 2.6 p -78.91 -48.68 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.785 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.492 ' N ' ' CG1' ' A' ' 133' ' ' VAL . . . -86.52 126.07 34.2 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.527 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.459 ' N ' ' HD2' ' A' ' 136' ' ' PRO . 12.0 tp-100 -171.29 -53.25 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.686 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' A' ' 135' ' ' GLN . 10.9 Cg_endo -51.67 -32.9 46.95 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 121.706 1.604 . . . . 0.0 111.852 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.408 ' CG2' ' NZ ' ' A' ' 141' ' ' LYS . 12.2 m -67.46 -42.44 83.04 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 117.759 -1.576 . . . . 0.0 109.736 -179.067 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -66.89 -43.57 83.11 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -178.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.458 HG23 ' N ' ' A' ' 140' ' ' VAL . 3.2 m -64.73 -44.22 96.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -178.215 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.458 ' N ' HG23 ' A' ' 139' ' ' VAL . 31.6 m -65.16 -39.03 84.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -177.378 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.408 ' NZ ' ' CG2' ' A' ' 137' ' ' THR . 33.0 mttp -62.53 -42.15 99.33 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 119.38 -0.928 . . . . 0.0 111.98 -177.463 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 14.4 m -70.42 -45.41 75.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 120.104 -0.638 . . . . 0.0 110.036 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.02 -36.84 85.68 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.624 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -66.91 -42.02 86.14 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -177.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 95.3 mm-40 -65.67 -40.03 91.97 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 118.987 -1.085 . . . . 0.0 110.093 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.32 -34.98 79.61 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -178.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.411 ' O ' ' CG ' ' A' ' 147' ' ' GLN . 0.0 OUTLIER -59.89 111.1 1.34 Allowed 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 177.769 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -98.62 -60.88 1.46 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 117.6 -1.191 . . . . 0.0 113.919 -175.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 96.6 mtt-85 -90.67 130.42 36.68 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 122.476 2.398 . . . . 0.0 110.357 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -65.21 -14.21 60.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.436 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 72.41 23.95 77.09 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.488 ' C ' ' H ' ' A' ' 154' ' ' ARG . . . 80.68 -104.29 2.28 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.555 ' C ' ' H ' ' A' ' 155' ' ' ARG . . . 73.75 -33.79 0.87 Allowed Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.488 ' H ' ' C ' ' A' ' 152' ' ' GLY . 51.0 ttp85 67.01 -28.47 0.13 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.423 0.154 . . . . 0.0 111.387 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.555 ' H ' ' C ' ' A' ' 153' ' ' GLY . 28.8 ttm180 -93.67 8.72 39.82 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.87 0.367 . . . . 0.0 110.391 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.428 ' CD2' ' O ' ' A' ' 157' ' ' GLN . 49.8 t80 60.1 139.86 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.627 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.428 ' O ' ' CD2' ' A' ' 156' ' ' TYR . 88.8 mt-30 -84.3 172.37 11.87 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.954 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.66 ' H ' ' CG ' ' A' ' 161' ' ' GLU . 37.0 m -157.05 -178.52 7.43 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.253 0.549 . . . . 0.0 111.054 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.425 ' H ' HG23 ' A' ' 159' ' ' THR . 9.4 p -64.88 -46.55 81.33 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 120.149 -0.62 . . . . 0.0 112.39 -178.138 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.53 HG13 ' N ' ' A' ' 161' ' ' GLU . 8.3 p -64.72 -45.92 93.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 119.305 -0.958 . . . . 0.0 110.777 -178.275 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.66 ' CG ' ' H ' ' A' ' 158' ' ' SER . 1.5 pp20? -67.55 -38.74 84.58 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.219 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.527 ' N ' ' OE2' ' A' ' 161' ' ' GLU . . . -61.36 -45.65 93.51 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -178.186 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.4 ' CD1' ' C ' ' A' ' 163' ' ' TYR . 21.4 t80 -62.5 -50.19 72.36 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.286 -179.202 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 4.7 mtpm? -69.15 -45.48 69.96 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 -176.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.567 HG23 ' N ' ' A' ' 166' ' ' ILE . 14.4 t -62.69 -44.64 95.72 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -176.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.567 ' N ' HG23 ' A' ' 165' ' ' THR . 20.9 tt -64.65 -38.36 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-O 121.997 0.904 . . . . 0.0 109.559 176.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.45 ' N ' HG23 ' A' ' 166' ' ' ILE . . . -59.73 -36.54 76.78 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 113.834 -1.53 . . . . 0.0 107.821 176.378 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 13.1 tpp85 -62.26 -50.25 72.47 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 122.393 2.36 . . . . 0.0 111.89 -175.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -74.9 -51.06 14.82 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 123.486 0.715 . . . . 0.0 109.392 177.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -78.1 -36.42 48.06 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 -173.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 91.52 -166.91 30.75 Favored Glycine 0 N--CA 1.468 0.767 0 O-C-N 121.704 -0.622 . . . . 0.0 112.088 177.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.578 HD12 ' N ' ' A' ' 173' ' ' ARG . 2.5 pp -72.97 -43.67 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-O 121.908 0.861 . . . . 0.0 110.469 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.578 ' N ' HD12 ' A' ' 172' ' ' ILE . 24.9 tpt85 -58.89 -33.86 70.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.199 -1.364 . . . . 0.0 111.0 -177.183 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -60.9 -40.64 98.61 Favored Glycine 0 CA--C 1.522 0.511 0 C-N-CA 118.619 -1.753 . . . . 0.0 109.646 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 17.8 tp -70.34 -33.77 71.88 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 111.319 -2.44 . . . . 0.0 116.803 -177.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 7.3 m0 -78.01 -7.44 56.88 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 111.845 -2.434 . . . . 0.0 109.783 -177.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -43.39 -47.99 6.99 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.529 -0.759 . . . . 0.0 112.521 -176.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -91.51 -34.31 7.5 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 123.978 0.799 . . . . 0.0 111.81 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 44.7 p -45.19 -51.21 10.85 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.41 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 1.6 t -62.44 -50.8 77.33 Favored Pre-proline 0 N--CA 1.47 0.562 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -176.447 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' A' ' 180' ' ' SER . 29.5 Cg_endo -64.96 -28.32 57.99 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.402 1.402 . . . . 0.0 111.377 176.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -63.95 -39.13 93.43 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.494 HG22 HG21 ' A' ' 131' ' ' VAL . 56.4 t -63.01 -43.15 98.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.219 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.75 -40.01 95.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.762 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 9.1 tmm_? -61.31 -42.39 98.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.422 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -61.81 -43.69 98.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.081 0.467 . . . . 0.0 110.53 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.62 -43.84 92.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.952 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 79.4 mt -63.35 -45.35 98.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.856 -178.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 84.7 t -60.09 -47.4 92.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 119.465 -0.894 . . . . 0.0 111.033 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -62.91 -42.99 99.98 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 122.311 1.053 . . . . 0.0 110.194 178.581 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 191' ' ' CYS . . . . . . . . . . . . . 37.5 t -61.86 -45.63 92.93 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 113.422 -1.717 . . . . 0.0 109.685 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -63.91 -39.57 94.48 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 113.193 -1.822 . . . . 0.0 109.94 176.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.5 -44.95 92.97 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.557 0.743 . . . . 0.0 111.522 -176.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 37.6 tp -64.87 -38.23 90.28 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.971 -176.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 92.1 t -64.47 -47.43 89.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 117.893 -1.523 . . . . 0.0 110.508 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 3.1 t -64.55 -44.24 91.41 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.057 0.943 . . . . 0.0 113.172 -177.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -54.75 -38.28 66.99 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.821 0.848 . . . . 0.0 111.372 -176.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -56.42 -44.09 80.04 Favored 'General case' 0 C--N 1.313 -0.997 0 O-C-N 121.739 -0.6 . . . . 0.0 110.451 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.677 HD22 ' N ' ' A' ' 199' ' ' LEU . 2.8 mm? -61.71 -41.09 97.15 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -177.006 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 200' ' ' ILE . 6.3 pt -64.23 -40.61 89.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.68 179.164 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -57.66 -38.54 75.27 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.461 1.904 . . . . 0.0 113.846 -178.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -65.43 -38.9 91.28 Favored 'General case' 0 C--O 1.245 0.861 0 C-N-CA 117.932 -1.507 . . . . 0.0 111.105 -177.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 55.1 m -102.61 128.9 49.09 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 122.369 1.081 . . . . 0.0 112.736 -178.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.519 HD22 ' CD1' ' A' ' 209' ' ' LEU . 1.2 mt 67.27 2.65 2.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 112.945 -1.934 . . . . 0.0 112.048 178.26 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.79 24.03 11.31 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.817 ' O ' ' N ' ' A' ' 208' ' ' ASN . 57.4 pttt -96.78 173.38 7.34 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 178.388 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . 48.91 -67.15 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 O-C-N 126.116 2.135 . . . . 0.0 110.658 -178.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' ASN . . . . . 0.817 ' N ' ' O ' ' A' ' 206' ' ' LYS . 9.6 p-10 164.92 109.71 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 111.976 -2.374 . . . . 0.0 106.229 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 209' ' ' LEU . 13.4 tp -48.97 17.48 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 108.846 -3.797 . . . . 0.0 112.564 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 210' ' ' MET . . . . . 0.69 ' H ' ' C ' ' A' ' 208' ' ' ASN . 4.3 ptm -119.96 134.02 55.37 Favored 'General case' 0 C--N 1.314 -0.95 0 O-C-N 121.632 -0.668 . . . . 0.0 110.499 178.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.424 HG22 ' H ' ' A' ' 212' ' ' ASP . 3.9 m -154.7 -127.93 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.694 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 212' ' ' ASP . . . . . 0.424 ' H ' HG22 ' A' ' 211' ' ' THR . 73.8 m-20 -132.37 -35.37 1.17 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.356 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -79.4 68.23 5.36 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.197 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.48 ' N ' ' HD2' ' A' ' 215' ' ' PRO . 12.4 mt -61.28 -44.48 93.36 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 214' ' ' LEU . 23.0 Cg_endo -61.43 -33.31 88.65 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 CA-C-N 120.944 1.373 . . . . 0.0 111.052 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 85.8 m -64.6 -42.47 95.54 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 113.487 -1.688 . . . . 0.0 111.969 -178.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' HIS . . . . . 0.628 ' NE2' ' CD2' ' A' ' 218' ' ' PHE . 1.8 p-80 -66.78 -37.9 85.49 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.192 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 218' ' ' PHE . . . . . 0.628 ' CD2' ' NE2' ' A' ' 217' ' ' HIS . 1.4 m-85 -63.14 -47.29 83.37 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.322 -178.386 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 89.7 m -60.13 -37.8 81.16 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 118.73 0.696 . . . . 0.0 110.925 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 67.9 m -59.35 -41.42 89.17 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.569 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.62 -41.4 98.29 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -177.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -61.43 -46.8 88.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 122.077 0.942 . . . . 0.0 112.786 -176.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -60.1 -41.66 98.17 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 107.164 -2.374 . . . . 0.0 107.164 177.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -62.77 -37.78 87.99 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 176.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -61.82 -42.38 99.74 Favored Glycine 0 CA--C 1.523 0.584 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.843 -178.225 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 226' ' ' PHE . . . . . 0.432 ' O ' ' OG1' ' A' ' 229' ' ' THR . 55.5 t80 -66.39 -38.3 87.2 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 15.7 t -62.84 -40.7 98.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.532 0.682 . . . . 0.0 109.248 176.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.457 ' O ' HG22 ' A' ' 231' ' ' ILE . 0.4 OUTLIER -61.43 -40.09 93.19 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.589 -179.492 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' A' ' 226' ' ' PHE . 19.7 p -59.36 -39.63 83.88 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.85 -177.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 92.6 t -60.82 -42.61 93.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 119.006 -1.078 . . . . 0.0 111.969 -178.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.457 HG22 ' O ' ' A' ' 228' ' ' THR . 3.8 tp -62.4 -40.22 87.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 176.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -62.1 -39.77 93.63 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.503 ' N ' ' HD2' ' A' ' 234' ' ' PRO . 66.2 m -58.71 -42.81 96.27 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 115.768 1.766 . . . . 0.0 115.768 -175.017 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 233' ' ' SER . 21.0 Cg_endo -59.89 -40.72 60.24 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 CA-C-N 121.051 1.411 . . . . 0.0 113.9 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.42 ' H ' HG22 ' A' ' 235' ' ' VAL . 11.1 m -65.14 -36.5 77.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.008 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -64.96 -41.24 95.64 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -178.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.42 ' H ' HG22 ' A' ' 237' ' ' VAL . 5.7 m -65.64 -45.58 91.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -177.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 57.3 t -63.1 -38.19 81.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -177.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 5.1 ptmm? -60.73 -43.23 98.15 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.082 -0.647 . . . . 0.0 111.34 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 37.6 p -60.58 -41.87 95.52 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.304 -0.407 . . . . 0.0 112.002 -178.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.592 ' NH1' ' CD1' ' A' ' 269' ' ' PHE . 71.7 ttt180 -46.57 138.19 6.11 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.435 -0.506 . . . . 0.0 109.797 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.628 ' CG ' ' O ' ' A' ' 242' ' ' TYR . 5.0 t80 169.37 8.53 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 243' ' ' MET . . . . . 0.578 ' N ' ' SD ' ' A' ' 243' ' ' MET . 2.0 mpt? -92.86 -24.58 18.43 Favored 'General case' 0 N--CA 1.463 0.19 0 O-C-N 121.726 -0.609 . . . . 0.0 109.632 177.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 244' ' ' ASN . . . . . 0.492 ' C ' ' O ' ' A' ' 243' ' ' MET . 6.9 p30 -28.18 133.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.734 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 245' ' ' SER . . . . . 0.576 ' O ' ' O ' ' A' ' 246' ' ' ALA . 6.6 t -91.55 -147.93 0.22 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.589 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 246' ' ' ALA . . . . . 0.629 ' O ' ' C ' ' A' ' 247' ' ' LEU . . . 55.77 126.97 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 -170.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.937 ' CB ' ' HA2' ' A' ' 248' ' ' GLY . 0.3 OUTLIER -21.87 -71.17 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.2 -171.937 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.997 ' O ' ' HB2' ' A' ' 249' ' ' GLN . . . -137.84 43.13 1.22 Allowed Glycine 0 N--CA 1.451 -0.358 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 -1.425 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.997 ' HB2' ' O ' ' A' ' 248' ' ' GLY . 3.2 mt-30 102.65 118.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.703 0.287 . . . . 0.0 110.493 -178.486 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.538 ' HE1' ' CA ' ' A' ' 252' ' ' SER . 6.1 t80 -149.9 136.14 18.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.048 0.451 . . . . 0.0 111.795 -178.162 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -136.25 -23.67 1.28 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 176.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 252' ' ' SER . . . . . 0.538 ' CA ' ' HE1' ' A' ' 250' ' ' TYR . 9.6 t 179.22 -173.13 0.17 Allowed 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -59.72 -43.44 94.16 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 179.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -55.52 -34.89 60.52 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 125.21 1.386 . . . . 0.0 111.268 -172.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 255' ' ' HIS . . . . . 0.785 ' NE2' HG21 ' A' ' 259' ' ' THR . 86.4 t60 -55.92 -32.11 63.49 Favored 'General case' 0 C--N 1.369 1.441 0 C-N-CA 115.514 -2.474 . . . . 0.0 111.061 178.526 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 256' ' ' CYS . . . . . . . . . . . . . 7.1 t -60.75 -45.68 93.38 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.116 178.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -61.17 -46.0 92.3 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.194 -0.602 . . . . 0.0 111.532 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 20.2 mt -67.93 -43.97 77.93 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.691 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 259' ' ' THR . . . . . 0.785 HG21 ' NE2' ' A' ' 255' ' ' HIS . 24.8 p -63.48 -46.88 84.14 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 -178.086 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 260' ' ' MET . . . . . 0.601 ' SD ' ' N ' ' A' ' 261' ' ' LEU . 0.0 OUTLIER -61.8 -44.37 97.0 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.214 -0.594 . . . . 0.0 112.47 -177.273 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.601 ' N ' ' SD ' ' A' ' 260' ' ' MET . 12.5 tp -62.62 -46.67 87.2 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.607 0.242 . . . . 0.0 110.444 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 52.5 ttp180 -66.14 -53.76 33.71 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.805 -178.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 263' ' ' LYS . . . . . 0.442 ' HZ3' ' HB3' ' A' ' 263' ' ' LYS . 0.0 OUTLIER -123.33 160.95 25.64 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 120.938 0.399 . . . . 0.0 111.044 179.272 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 264' ' ' GLU . . . . . 0.464 ' O ' ' O ' ' A' ' 265' ' ' GLY . 72.6 mt-10 57.83 88.71 0.06 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.278 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 264' ' ' GLU . . . -38.04 166.07 0.01 OUTLIER Glycine 0 CA--C 1.531 1.058 0 N-CA-C 111.669 -0.572 . . . . 0.0 111.669 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -63.4 -5.07 7.63 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 122.817 2.344 . . . . 0.0 111.596 179.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 18.3 ptp180 -69.63 -26.58 64.49 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 123.086 0.554 . . . . 0.0 111.685 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -58.52 -32.49 68.88 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.895 -179.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 269' ' ' PHE . . . . . 0.592 ' CD1' ' NH1' ' A' ' 241' ' ' ARG . 57.2 m-85 -62.53 -41.87 99.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.237 0.541 . . . . 0.0 110.753 177.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -65.93 -37.77 86.92 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.84 -178.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp -77.99 -175.16 3.91 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 44.45 84.85 0.01 OUTLIER Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.371 -1.091 . . . . 0.0 110.371 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -152.78 6.79 0.4 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.558 0.218 . . . . 0.0 110.769 -179.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 274' ' ' MET . . . . . 0.587 ' N ' ' CD ' ' A' ' 275' ' ' PRO . 1.9 tpt -63.66 -43.92 78.86 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 275' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 274' ' ' MET . 23.0 Cg_exo -64.12 -46.72 7.54 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.343 2.029 . . . . 0.0 111.205 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 37.4 t -61.0 -40.67 94.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.23 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -62.41 -43.44 98.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 122.88 1.324 . . . . 0.0 113.163 -178.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 8.0 tt -62.01 -38.57 89.14 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 111.897 -2.411 . . . . 0.0 107.072 174.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.69 -40.32 96.75 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.843 178.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 8.2 tp -62.32 -37.24 84.82 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -178.145 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -67.95 -50.6 39.75 Favored Glycine 0 CA--C 1.52 0.399 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 -178.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.14 -44.38 96.76 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 283' ' ' TRP . . . . . 0.503 ' O ' HG22 ' A' ' 286' ' ' VAL . 57.1 t-105 -60.26 -38.67 84.2 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.191 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -63.18 -38.5 91.44 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.725 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 54.8 t -61.11 -39.24 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 -178.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.68 ' O ' HG12 ' A' ' 289' ' ' VAL . 6.9 m -62.6 -39.99 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 119.848 -0.741 . . . . 0.0 110.574 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 287' ' ' MET . . . . . 0.456 ' C ' ' SD ' ' A' ' 287' ' ' MET . 0.0 OUTLIER -60.94 -38.87 87.35 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 122.128 -0.357 . . . . 0.0 110.503 179.758 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -59.32 -41.61 89.51 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -178.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.68 HG12 ' O ' ' A' ' 286' ' ' VAL . 7.4 p -61.52 -37.72 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.027 -179.108 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 51.2 p -61.67 -39.43 91.37 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 177.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -60.37 -38.49 84.05 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 177.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.99 -39.93 79.45 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 117.948 -1.501 . . . . 0.0 109.488 -176.315 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 293' ' ' GLN . . . . . 0.45 ' O ' ' O ' ' A' ' 296' ' ' ARG . 80.3 mt-30 -60.37 -42.47 95.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 122.678 1.228 . . . . 0.0 110.641 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 8.9 mp -60.43 -40.26 90.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 112.632 -2.076 . . . . 0.0 109.003 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 17.9 tptp -63.02 -45.84 90.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.266 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 296' ' ' ARG . . . . . 0.45 ' O ' ' O ' ' A' ' 293' ' ' GLN . 64.0 ttm-85 -123.06 116.37 23.38 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.264 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -116.82 -93.2 0.51 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.125 0.488 . . . . 0.0 111.318 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.803 HD22 ' N ' ' A' ' 299' ' ' MET . 0.0 OUTLIER -137.39 -170.89 2.84 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.394 178.4 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 299' ' ' MET . . . . . 0.803 ' N ' HD22 ' A' ' 298' ' ' LEU . 34.8 ttm -169.32 65.91 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.625 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.68 101.04 0.07 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.928 0.871 . . . . 0.0 110.583 -178.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -64.0 -46.26 85.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 113.822 -1.536 . . . . 0.0 113.331 -176.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -58.65 -39.89 81.89 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.119 -0.633 . . . . 0.0 109.791 -178.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 6.6 tm0? -65.01 -47.0 79.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.487 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 304' ' ' SER . . . . . 0.429 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 50.0 m -66.71 -37.83 85.51 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.509 -0.477 . . . . 0.0 110.581 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -61.7 -43.22 99.28 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -65.04 -36.97 86.08 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -176.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 307' ' ' ALA . . . . . 0.544 ' HB3' ' HD3' ' A' ' 308' ' ' PRO . . . -60.02 -52.94 69.89 Favored Pre-proline 0 CA--C 1.545 0.76 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 -176.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 308' ' ' PRO . . . . . 0.544 ' HD3' ' HB3' ' A' ' 307' ' ' ALA . 74.0 Cg_endo -75.23 0.21 9.27 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.053 1.835 . . . . 0.0 111.793 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 52.4 t80 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.499 -179.996 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.579 ' N ' ' NE2' ' A' ' 303' ' ' GLN . 2.2 mpt? . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.9 m -159.67 104.08 1.57 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.496 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.4 t -137.97 150.08 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.495 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.1 mmmm -64.41 -41.87 96.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.905 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -63.61 -41.34 98.31 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.4 tt -79.59 -26.23 41.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.443 -178.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.402 ' O ' ' OG1' ' A' ' 22' ' ' THR . . . -66.18 -41.42 94.88 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 107.761 -2.135 . . . . 0.0 107.761 177.383 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.425 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -71.6 -32.25 67.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 124.889 2.281 . . . . 0.0 107.657 176.465 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.29 -42.26 99.3 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-N 108.448 -3.978 . . . . 0.0 108.165 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.402 ' OG1' ' O ' ' A' ' 19' ' ' GLY . 32.6 p -70.62 -27.32 63.99 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 177.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -66.51 -50.04 64.55 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.775 -1.102 . . . . 0.0 112.194 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.97 -35.89 79.83 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 118.482 -1.287 . . . . 0.0 111.204 -177.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.0 t -63.78 -53.39 51.64 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.847 -178.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 71.2 mt -65.43 -39.74 86.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 -177.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.57 -42.19 95.81 Favored 'General case' 0 C--N 1.333 -0.109 0 C-N-CA 119.84 -0.744 . . . . 0.0 112.946 -174.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.459 ' CB ' ' OE1' ' A' ' 89' ' ' GLN . 16.7 m-20 -78.24 -27.49 47.66 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 117.964 -1.495 . . . . 0.0 109.084 -177.082 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.5 tp -59.98 -56.05 26.46 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 118.546 -1.262 . . . . 0.0 111.113 -178.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.2 pp -75.73 -5.24 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 19.1 m -110.17 -17.96 13.42 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 118.811 -1.155 . . . . 0.0 109.941 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.508 ' N ' ' HD2' ' A' ' 33' ' ' PRO . 72.7 t80 -68.27 -45.22 38.55 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 121.308 1.867 . . . . 0.0 112.235 -177.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 32' ' ' PHE . 20.8 Cg_endo -59.42 -14.73 26.49 Favored 'Trans proline' 0 N--CA 1.5 1.872 0 CA-C-N 121.147 1.445 . . . . 0.0 111.147 176.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.57 ' O ' HD23 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -66.31 -35.41 80.3 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 114.686 -1.143 . . . . 0.0 113.086 -177.139 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -64.69 -40.55 95.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.278 -178.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 52.1 p -58.39 -34.9 71.23 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.3 -38.27 84.73 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.72 -0.792 . . . . 0.0 112.534 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.446 ' CG ' ' N ' ' A' ' 39' ' ' VAL . 10.7 pttp -62.01 -48.93 78.12 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 119.576 -0.85 . . . . 0.0 111.69 -176.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.446 ' N ' ' CG ' ' A' ' 38' ' ' LYS . 8.8 p -64.8 -39.89 87.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -177.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.55 HH22 HE22 ' A' ' 58' ' ' GLN . 6.4 tpm_? -61.04 -42.86 99.28 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -177.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.423 ' CD1' ' O ' ' A' ' 38' ' ' LYS . 2.4 pp -63.15 38.73 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.799 178.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.529 ' N ' ' O ' ' A' ' 40' ' ' ARG . 42.7 tt0 -145.25 165.68 27.69 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.901 0.382 . . . . 0.0 111.273 -178.355 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.729 HD13 ' H ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -73.57 79.17 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.62 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -44.89 135.99 4.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.857 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.99 135.88 0.24 Allowed Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.502 ' O ' ' N ' ' A' ' 48' ' ' GLN . 11.1 pt-20 -94.16 150.51 20.25 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.71 0.291 . . . . 0.0 110.564 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 49.9 m 57.45 -80.55 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.571 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.502 ' N ' ' O ' ' A' ' 46' ' ' GLU . 63.7 mt-30 55.0 178.54 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.212 0.53 . . . . 0.0 111.049 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -153.3 -22.66 0.05 OUTLIER Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.58 HD22 ' N ' ' A' ' 50' ' ' LEU . 3.5 mm? -66.63 -38.5 87.05 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.539 HG23 ' N ' ' A' ' 52' ' ' ARG . 20.5 m -61.15 -44.28 98.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.992 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.539 ' N ' HG23 ' A' ' 51' ' ' VAL . 33.4 mtm-85 -64.31 -33.64 76.3 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.357 -179.081 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 19.1 m -67.6 -38.32 83.81 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.652 ' O ' ' HB2' ' A' ' 55' ' ' ALA . . . -95.44 -122.1 0.11 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.195 178.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.652 ' HB2' ' O ' ' A' ' 54' ' ' ALA . . . 162.87 -22.71 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 121.191 -0.203 . . . . 0.0 110.842 179.054 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.623 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 4.6 m -128.53 -138.31 0.24 Allowed 'General case' 0 C--N 1.334 -0.107 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.623 ' HB3' ' O ' ' A' ' 56' ' ' SER . . . 93.59 14.99 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 O-C-N 123.883 0.74 . . . . 0.0 111.937 178.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.55 HE22 HH22 ' A' ' 40' ' ' ARG . 27.7 mt-30 -152.92 55.99 0.78 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -41.91 132.8 3.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.187 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 63.3 mtm-85 -41.02 -42.92 2.03 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.34 0.59 . . . . 0.0 109.921 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -31.95 104.22 0.01 OUTLIER Glycine 0 CA--C 1.527 0.834 0 CA-C-N 114.853 -1.067 . . . . 0.0 112.476 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 26.2 m -67.11 -33.58 64.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 118.262 -0.875 . . . . 0.0 109.046 176.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -60.0 -32.32 70.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 121.061 1.755 . . . . 0.0 109.785 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -65.1 -49.59 61.45 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-N 115.393 -0.821 . . . . 0.0 114.534 -177.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.3 m -62.57 -46.88 86.3 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -178.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.8 pp -60.27 -35.18 60.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.548 ' O ' HD13 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -63.35 -35.56 80.81 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 120.853 1.66 . . . . 0.0 110.948 179.527 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 98.8 m -61.77 -39.19 90.78 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 113.168 -1.833 . . . . 0.0 111.034 -176.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 15.5 tpt -60.51 -39.47 87.91 Favored 'General case' 0 C--N 1.332 -0.179 0 O-C-N 121.135 -0.978 . . . . 0.0 113.531 -177.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.5 t -68.98 -40.42 80.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 119.192 -1.003 . . . . 0.0 112.652 -177.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 56.9 ttt-85 -77.63 -13.39 59.92 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.94 0.876 . . . . 0.0 112.736 -178.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 49.3 m -62.87 -55.12 28.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.17 -1.377 . . . . 0.0 112.338 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -108.74 -58.78 1.97 Allowed 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 159.37 163.81 13.78 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -56.51 -34.89 96.08 Favored 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 122.229 1.953 . . . . 0.0 111.605 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 12.3 tpp180 -61.16 -11.22 8.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.908 0.861 . . . . 0.0 111.056 176.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.5 t -77.36 -32.1 54.79 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 113.953 -1.476 . . . . 0.0 110.994 -177.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 19.3 mt -75.61 -33.66 60.54 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.286 -0.566 . . . . 0.0 111.156 179.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.427 ' C ' ' H ' ' A' ' 81' ' ' GLY . 61.6 m-85 -92.81 -5.33 51.32 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 122.305 1.05 . . . . 0.0 113.386 -178.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.433 ' CG ' ' O ' ' A' ' 80' ' ' ASN . 21.5 t30 -86.25 33.9 0.62 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 112.957 -1.929 . . . . 0.0 107.393 175.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' A' ' 79' ' ' TYR . . . -172.9 -9.78 0.02 OUTLIER Glycine 0 CA--C 1.526 0.747 0 CA-C-N 114.485 -1.234 . . . . 0.0 112.535 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.411 ' H ' ' H ' ' A' ' 81' ' ' GLY . 61.2 tp -59.48 -35.07 73.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.469 -0.866 . . . . 0.0 110.963 -178.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.2 m -70.74 -26.84 28.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.799 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.63 -31.45 61.99 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.793 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.8 -40.18 89.73 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 119.893 -1.146 . . . . 0.0 111.751 -177.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -62.63 -40.28 96.5 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 122.16 0.981 . . . . 0.0 113.094 -176.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 20.2 tm0? -60.39 -27.44 67.44 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 113.349 -1.751 . . . . 0.0 109.456 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 72.7 mtt-85 -58.07 -53.46 57.96 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 173.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.459 ' OE1' ' CB ' ' A' ' 28' ' ' ASP . 23.6 mm100 -67.15 -29.97 69.83 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 112.08 -2.327 . . . . 0.0 112.373 -177.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 10.4 tpp -61.2 -40.46 94.04 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.078 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 68.3 m -74.64 -34.16 62.69 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 118.346 -0.835 . . . . 0.0 111.339 -176.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -57.58 -44.11 85.1 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 120.701 1.591 . . . . 0.0 112.044 -176.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.48 -33.0 64.61 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.466 -0.893 . . . . 0.0 111.025 -178.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 59.6 p -64.03 -41.87 97.28 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.412 ' C ' ' H ' ' A' ' 97' ' ' ILE . 34.3 m -68.18 -27.81 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.988 177.374 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.415 ' HG3' ' CD1' ' A' ' 100' ' ' TYR . 47.6 ttp85 -77.21 8.54 3.9 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -176.419 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.433 HG22 ' O ' ' A' ' 97' ' ' ILE . 46.3 mm -87.71 -15.08 9.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 177.193 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -140.25 -48.3 0.05 OUTLIER Glycine 0 CA--C 1.538 1.53 0 N-CA-C 115.902 1.121 . . . . 0.0 115.902 -175.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.0 tp -71.1 -13.23 61.89 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 119.249 1.524 . . . . 0.0 112.244 -177.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.521 ' O ' ' CG ' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -80.86 -51.28 8.76 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 114.688 -1.142 . . . . 0.0 111.834 179.71 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.509 ' O ' ' HG3' ' A' ' 105' ' ' GLN . 2.4 p30 -69.23 -32.48 71.75 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 123.768 1.747 . . . . 0.0 110.47 -178.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 25.8 m -68.17 -51.79 41.83 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 110.234 -3.167 . . . . 0.0 113.327 177.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 47.0 t -73.63 -26.28 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 CA-C-N 121.405 1.911 . . . . 0.0 111.257 178.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.521 ' CG ' ' O ' ' A' ' 100' ' ' TYR . 20.7 mmtp -69.32 -41.61 76.48 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 112.523 -2.126 . . . . 0.0 111.582 179.384 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.509 ' HG3' ' O ' ' A' ' 101' ' ' ASP . 88.1 mt-30 -80.1 -15.66 56.66 Favored 'General case' 0 C--O 1.245 0.847 0 CA-C-O 122.065 0.936 . . . . 0.0 110.998 -178.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -80.48 -22.29 41.17 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 121.741 -0.6 . . . . 0.0 112.109 179.08 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.414 ' O ' ' NE ' ' A' ' 119' ' ' ARG . 13.8 m-85 -109.07 -28.62 8.97 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.692 0.797 . . . . 0.0 111.794 -174.171 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.2 m -96.12 9.49 40.73 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 116.752 -1.979 . . . . 0.0 113.639 -176.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -46.46 124.7 6.1 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.997 1.271 . . . . 0.0 109.49 176.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -131.55 40.91 1.57 Allowed Glycine 0 N--CA 1.479 1.549 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 178.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 14.8 m -67.5 -37.63 83.12 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 -176.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -125.43 162.41 24.91 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 120.759 0.314 . . . . 0.0 111.084 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.628 ' O ' ' HB2' ' A' ' 114' ' ' ALA . 6.7 p-80 -77.03 67.33 3.0 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -178.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.628 ' HB2' ' O ' ' A' ' 113' ' ' HIS . . . 159.06 -163.06 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 176.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 101.57 15.33 27.5 Favored Glycine 0 C--N 1.343 0.949 0 CA-C-N 113.873 -1.512 . . . . 0.0 113.238 175.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 25.4 mm -61.1 -40.99 87.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 CA-C-N 118.416 1.108 . . . . 0.0 110.31 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.33 -39.96 96.22 Favored Glycine 0 C--N 1.346 1.095 0 CA-C-O 122.237 0.909 . . . . 0.0 111.361 176.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.1 t -57.48 -41.72 81.23 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 177.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.481 ' CD ' HD21 ' A' ' 194' ' ' LEU . 26.9 ttm180 -63.18 -37.54 87.61 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.474 -0.491 . . . . 0.0 111.249 -177.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -64.32 -46.28 84.23 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 177.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 31.5 mt -66.64 -45.1 80.09 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 118.978 -1.089 . . . . 0.0 110.145 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.97 -45.18 90.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 119.813 1.188 . . . . 0.0 110.315 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.413 ' CA ' ' CZ ' ' A' ' 107' ' ' TYR . . . -65.79 -44.28 92.48 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.766 -178.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 59.0 m -63.83 -43.66 95.52 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 19.1 m -69.06 -48.01 63.86 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 119.526 -0.87 . . . . 0.0 112.416 177.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.48 HG23 ' N ' ' A' ' 127' ' ' GLY . 5.7 t -65.47 -42.51 92.2 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 -173.189 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.48 ' N ' HG23 ' A' ' 126' ' ' THR . . . -64.46 -44.73 94.84 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-O 122.543 1.08 . . . . 0.0 113.736 -177.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.03 -40.8 94.98 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 112.689 -1.756 . . . . 0.0 107.204 178.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.542 HD13 ' O ' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -62.84 -41.22 99.26 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 114.86 -1.063 . . . . 0.0 109.576 178.93 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -61.82 -38.44 88.17 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.74 -0.209 . . . . 0.0 111.38 -178.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 79.1 t -60.63 -25.91 36.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.742 0.782 . . . . 0.0 109.836 179.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . -57.9 -44.41 86.73 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.236 -1.347 . . . . 0.0 111.215 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 43.1 t -78.73 -49.15 20.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.563 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -99.89 124.52 45.29 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 110.248 -0.278 . . . . 0.0 110.248 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.461 ' N ' ' HD2' ' A' ' 136' ' ' PRO . 33.2 tt0 -176.62 -54.49 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 135' ' ' GLN . 11.2 Cg_endo -52.3 -34.81 61.67 Favored 'Trans proline' 0 N--CA 1.5 1.885 0 C-N-CA 121.389 1.393 . . . . 0.0 113.902 -177.313 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 81.0 p -67.54 -41.77 83.77 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 118.491 -1.284 . . . . 0.0 109.369 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -64.58 -42.43 95.63 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 118.977 -1.089 . . . . 0.0 112.746 -176.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 17.2 m -63.81 -43.35 97.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 54.3 t -64.53 -38.47 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -178.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -61.47 -40.33 94.14 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 119.978 -0.689 . . . . 0.0 112.106 -176.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.3 p -69.39 -44.42 80.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.535 HH21 ' CD ' ' A' ' 170' ' ' GLU . 12.4 tpt85 -63.98 -35.83 81.99 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.951 179.347 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.488 ' CD2' ' OE1' ' A' ' 147' ' ' GLN . 40.9 t80 -65.96 -40.22 91.09 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.975 -177.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -63.72 -38.91 92.88 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.358 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -64.86 -34.76 79.15 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -178.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.488 ' OE1' ' CD2' ' A' ' 144' ' ' PHE . 5.0 pt20 -59.48 111.1 1.27 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 178.047 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -97.55 -61.61 1.37 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 117.523 -1.227 . . . . 0.0 113.951 -176.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 14.1 mtp-105 -101.4 135.52 42.75 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 122.273 2.306 . . . . 0.0 109.903 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -75.35 -113.37 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.519 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 175.19 131.47 1.44 Allowed Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -55.18 126.33 38.57 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 175.82 30.68 0.04 OUTLIER Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 49.0 mmt-85 55.45 172.2 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.786 0.327 . . . . 0.0 110.608 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 83.9 mtt85 54.12 -179.99 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.666 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.501 ' CD2' ' O ' ' A' ' 157' ' ' GLN . 91.8 t80 -123.94 127.22 47.64 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.368 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.501 ' O ' ' CD2' ' A' ' 156' ' ' TYR . 95.9 mt-30 -49.51 170.46 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.552 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 45.2 p -156.94 -178.25 7.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.954 0.407 . . . . 0.0 110.789 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.555 HG23 ' N ' ' A' ' 160' ' ' VAL . 11.7 t -64.5 -46.36 83.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.792 -177.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.573 HG13 ' N ' ' A' ' 161' ' ' GLU . 12.7 p -64.63 -45.52 95.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 118.898 -1.121 . . . . 0.0 109.077 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.573 ' N ' HG13 ' A' ' 160' ' ' VAL . 74.6 tt0 -66.99 -38.95 86.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.996 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -61.41 -45.78 92.91 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -177.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.613 ' CE2' HD13 ' A' ' 175' ' ' LEU . 12.7 t80 -62.85 -50.42 71.02 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.923 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -68.77 -45.42 71.4 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 115.162 1.541 . . . . 0.0 115.162 -175.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 10.0 m -63.24 -44.44 95.19 Favored 'General case' 0 C--N 1.321 -0.658 0 O-C-N 121.137 -0.977 . . . . 0.0 113.25 -178.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.446 ' O ' HD13 ' A' ' 166' ' ' ILE . 0.2 OUTLIER -64.64 -38.72 83.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 122.199 0.999 . . . . 0.0 109.156 177.554 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.94 -36.64 77.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 113.201 -1.818 . . . . 0.0 109.137 177.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -62.62 -51.0 69.02 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 122.5 2.409 . . . . 0.0 112.713 -174.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -75.38 -51.07 14.01 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 177.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.535 ' CD ' HH21 ' A' ' 143' ' ' ARG . 16.3 tt0 -78.67 -36.42 43.79 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -175.016 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 95.62 -169.03 26.95 Favored Glycine 0 N--CA 1.467 0.764 0 CA-C-N 118.13 0.423 . . . . 0.0 112.57 177.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.406 HG12 ' H ' ' A' ' 172' ' ' ILE . 6.0 pt -72.92 -40.71 60.11 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.129 0 CA-C-O 121.978 0.894 . . . . 0.0 110.396 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 9.1 tpp85 -58.68 -33.63 70.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 113.859 -1.519 . . . . 0.0 110.952 -177.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -60.91 -40.82 98.88 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 118.676 -1.726 . . . . 0.0 110.244 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.613 HD13 ' CE2' ' A' ' 163' ' ' TYR . 6.8 mt -70.84 -33.64 70.87 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 111.286 -2.457 . . . . 0.0 116.975 -177.678 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 11.1 m0 -78.35 -7.76 57.66 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 112.456 -2.156 . . . . 0.0 109.752 -176.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -43.47 -48.49 7.27 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.535 -0.466 . . . . 0.0 112.154 -175.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.429 ' O ' ' HD2' ' A' ' 181' ' ' PRO . . . -79.11 -13.63 82.74 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 124.444 1.021 . . . . 0.0 111.933 178.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.422 ' O ' ' OD1' ' A' ' 182' ' ' ASN . 84.6 m -46.33 -51.44 14.71 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.86 -50.95 74.9 Favored Pre-proline 0 N--CA 1.475 0.789 0 N-CA-C 114.287 1.218 . . . . 0.0 114.287 -174.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.429 ' HD2' ' O ' ' A' ' 178' ' ' GLY . 29.1 Cg_exo -64.52 -29.96 61.58 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 CA-C-N 120.678 1.278 . . . . 0.0 113.279 177.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 179' ' ' THR . 0.0 OUTLIER -65.53 -40.85 93.42 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 119.366 -0.934 . . . . 0.0 109.896 178.876 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 54.9 t -64.35 -43.12 97.07 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.166 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.083 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.66 -39.79 95.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.178 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.789 ' HE ' ' HZ2' ' A' ' 239' ' ' LYS . 0.7 OUTLIER -60.88 -43.55 98.31 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 119.789 -0.764 . . . . 0.0 110.885 -178.704 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -63.36 -45.43 91.22 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.744 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -66.59 -45.86 77.82 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.07 -46.25 91.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -177.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.629 ' CG1' HH21 ' A' ' 185' ' ' ARG . 35.6 m -60.86 -47.81 91.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 119.224 -0.99 . . . . 0.0 111.899 -177.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.53 ' N ' HG23 ' A' ' 189' ' ' VAL . 70.7 m-80 -62.43 -44.22 96.94 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.609 0.718 . . . . 0.0 110.047 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 191' ' ' CYS . . . . . . . . . . . . . 21.9 t -63.24 -47.61 81.75 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.031 178.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.8 -39.77 94.13 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 113.742 -1.572 . . . . 0.0 110.037 177.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' A' ' 189' ' ' VAL . 3.8 tm-20 -59.63 -45.75 91.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.252 -1.34 . . . . 0.0 111.803 -176.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.481 HD21 ' CD ' ' A' ' 119' ' ' ARG . 0.1 OUTLIER -65.04 -37.64 88.26 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 118.544 -1.262 . . . . 0.0 111.229 -175.548 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 94.8 t -64.21 -47.34 90.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 117.172 -1.811 . . . . 0.0 109.414 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' THR . . . . . 0.413 HG23 ' N ' ' A' ' 197' ' ' TYR . 3.0 t -65.48 -45.68 82.71 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 122.075 0.94 . . . . 0.0 112.743 -179.23 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 197' ' ' TYR . . . . . 0.413 ' N ' HG23 ' A' ' 196' ' ' THR . 61.7 t80 -57.99 -39.8 79.12 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 113.611 -1.631 . . . . 0.0 113.07 -178.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -56.41 -44.85 80.75 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 16.4 mt -62.12 -39.64 93.22 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.185 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 80.6 mt -63.6 -42.9 97.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-O 119.252 -0.404 . . . . 0.0 111.021 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' LYS . . . . . 0.646 ' O ' HD12 ' A' ' 205' ' ' LEU . 0.0 OUTLIER -59.63 -37.46 78.71 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.774 2.03 . . . . 0.0 112.272 177.19 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -58.98 -34.97 72.44 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 114.135 -1.393 . . . . 0.0 110.996 -175.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.2 t -98.78 130.67 45.24 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 121.745 0.784 . . . . 0.0 111.383 -177.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.478 ' CD2' ' CE1' ' A' ' 217' ' ' HIS . 9.7 mp 70.02 6.96 6.01 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 113.417 -1.72 . . . . 0.0 115.61 -178.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.961 ' O ' HD22 ' A' ' 205' ' ' LEU . 0.0 OUTLIER -109.71 21.0 17.47 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 120.091 1.314 . . . . 0.0 112.954 179.345 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -60.44 -32.85 71.77 Favored 'General case' 0 C--N 1.332 -0.185 0 O-C-N 120.047 -1.658 . . . . 0.0 113.045 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.492 ' O ' ' CB ' ' A' ' 208' ' ' ASN . . . -165.86 32.83 0.05 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.003 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 208' ' ' ASN . . . . . 0.492 ' CB ' ' O ' ' A' ' 207' ' ' ALA . 24.8 t-20 93.19 -126.44 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 O-C-N 123.882 0.739 . . . . 0.0 110.371 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 6.6 tp -175.85 50.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' MET . . . . . 0.447 ' SD ' ' C ' ' A' ' 210' ' ' MET . 1.5 tmt? -65.96 -21.42 66.42 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.485 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 28.4 p -62.68 -146.27 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.85 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' ASP . . . . . 0.447 ' CG ' ' N ' ' A' ' 213' ' ' ASP . 35.9 t70 -150.56 -118.0 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.564 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.447 ' N ' ' CG ' ' A' ' 212' ' ' ASP . 71.0 m-20 48.95 44.08 22.19 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.468 ' N ' ' CD ' ' A' ' 215' ' ' PRO . 1.8 mt -61.21 -43.39 90.01 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.63 -0.713 . . . . 0.0 112.504 -178.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.468 ' CD ' ' N ' ' A' ' 214' ' ' LEU . 35.4 Cg_exo -60.29 -33.45 94.55 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 120.966 1.111 . . . . 0.0 111.715 -178.288 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 216' ' ' CYS . . . . . 0.513 ' SG ' ' N ' ' A' ' 217' ' ' HIS . 0.8 OUTLIER -64.69 -42.04 95.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 113.427 -1.715 . . . . 0.0 111.543 -178.164 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 217' ' ' HIS . . . . . 0.513 ' N ' ' SG ' ' A' ' 216' ' ' CYS . 11.6 t-160 -66.08 -37.13 85.03 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.575 -177.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -62.98 -47.94 80.99 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.051 -178.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 8.4 m -61.11 -38.81 87.66 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 120.211 1.369 . . . . 0.0 110.255 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 20.7 p -58.97 -40.94 86.28 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -62.71 -41.26 99.06 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -176.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -60.25 -46.59 89.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 122.66 1.219 . . . . 0.0 111.873 -176.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -60.9 -41.77 99.41 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-N 112.364 -2.198 . . . . 0.0 107.771 176.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' ALA . . . . . 0.89 ' O ' HG23 ' A' ' 228' ' ' THR . . . -62.37 -37.3 85.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.067 -1.067 . . . . 0.0 108.555 177.137 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -60.97 -41.99 99.59 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 -177.396 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -66.77 -38.54 86.76 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 119.294 -0.962 . . . . 0.0 108.799 178.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 227' ' ' CYS . . . . . 0.513 ' SG ' ' O ' ' A' ' 224' ' ' ALA . 0.5 OUTLIER -63.38 -40.53 97.5 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.503 0.668 . . . . 0.0 110.295 177.617 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.89 HG23 ' O ' ' A' ' 224' ' ' ALA . 75.8 p -61.34 -38.06 85.55 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 114.839 -1.073 . . . . 0.0 112.533 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.489 HG23 ' O ' ' A' ' 225' ' ' GLY . 71.6 p -56.7 -38.86 72.86 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.486 -0.485 . . . . 0.0 111.229 -174.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 227' ' ' CYS . 3.8 p -59.79 -40.81 83.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 118.026 -1.47 . . . . 0.0 108.318 178.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 24.7 mt -61.54 -40.67 87.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 176.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -62.15 -39.2 91.81 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 114.539 -1.209 . . . . 0.0 113.8 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.62 ' O ' HG13 ' A' ' 237' ' ' VAL . 8.2 t -58.74 -43.24 97.58 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 -174.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 233' ' ' SER . 20.0 Cg_endo -60.14 -41.5 51.18 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 CA-C-N 121.947 1.731 . . . . 0.0 112.705 179.065 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 2.9 p -65.97 -37.7 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 117.972 -1.491 . . . . 0.0 109.237 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -66.69 -42.0 87.14 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 -179.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.62 HG13 ' O ' ' A' ' 233' ' ' SER . 15.4 m -65.7 -45.43 91.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -176.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.464 ' N ' HG23 ' A' ' 237' ' ' VAL . 9.9 p -63.54 -37.78 80.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 119.444 -0.902 . . . . 0.0 111.818 -177.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 239' ' ' LYS . . . . . 0.789 ' HZ2' ' HE ' ' A' ' 185' ' ' ARG . 63.9 mmtt -61.38 -45.72 93.18 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 240' ' ' THR . . . . . 0.41 ' H ' HG22 ' A' ' 240' ' ' THR . 1.4 t -62.58 -42.14 99.38 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.935 0.398 . . . . 0.0 111.465 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.627 ' NH2' ' CE1' ' A' ' 269' ' ' PHE . 77.1 mtt-85 -54.07 122.41 10.13 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.75 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.606 ' CG ' ' O ' ' A' ' 242' ' ' TYR . 32.7 t80 168.52 6.45 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 O-C-N 123.662 0.602 . . . . 0.0 111.456 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 243' ' ' MET . . . . . . . . . . . . . 16.5 tpt -110.26 125.43 53.1 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 244' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' A' ' 246' ' ' ALA . 1.5 p30 -179.33 141.13 0.16 Allowed 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.329 -0.548 . . . . 0.0 111.09 -179.453 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 35.5 p -65.28 68.54 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.739 178.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 246' ' ' ALA . . . . . 0.501 ' N ' ' O ' ' A' ' 244' ' ' ASN . . . -125.5 -87.59 0.6 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.277 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.401 ' CB ' ' O ' ' A' ' 246' ' ' ALA . 0.2 OUTLIER 76.41 81.64 0.09 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.829 179.783 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 250' ' ' TYR . . . 68.47 -46.47 0.39 Allowed Glycine 0 CA--C 1.526 0.753 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.387 179.126 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.502 ' HB3' ' CD2' ' A' ' 255' ' ' HIS . 79.7 mt-30 49.96 -89.78 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -178.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.857 ' HB2' ' ND1' ' A' ' 255' ' ' HIS . 5.4 t80 -103.78 -138.95 0.36 Allowed 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.898 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -67.1 -51.9 48.5 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 119.697 3.221 . . . . 0.0 119.697 -174.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 86.9 p -147.92 -170.41 3.57 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 113.267 -1.788 . . . . 0.0 112.175 -172.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -56.72 -39.0 73.14 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 179.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -54.38 -33.99 53.84 Favored Glycine 0 C--N 1.311 -0.825 0 N-CA-C 108.824 -1.711 . . . . 0.0 108.824 -173.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 255' ' ' HIS . . . . . 0.857 ' ND1' ' HB2' ' A' ' 250' ' ' TYR . 86.4 t60 -54.64 -37.66 65.93 Favored 'General case' 0 C--O 1.218 -0.601 0 C-N-CA 118.181 -1.407 . . . . 0.0 110.964 178.222 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 256' ' ' CYS . . . . . . . . . . . . . 6.7 t -59.4 -44.48 92.82 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.678 -177.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -59.92 -45.26 93.16 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.279 -0.569 . . . . 0.0 110.48 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.572 HD13 ' O ' ' A' ' 258' ' ' LEU . 0.2 OUTLIER -67.43 -43.51 81.0 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 120.134 -0.627 . . . . 0.0 110.118 178.494 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 94.0 m -62.6 -46.69 87.12 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 -177.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 260' ' ' MET . . . . . 0.566 ' SD ' ' N ' ' A' ' 261' ' ' LEU . 0.1 OUTLIER -61.33 -43.86 98.16 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 120.134 -0.626 . . . . 0.0 110.851 -178.317 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.566 ' N ' ' SD ' ' A' ' 260' ' ' MET . 63.7 tp -63.18 -48.29 79.0 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 262' ' ' ARG . . . . . 0.447 ' O ' ' O ' ' A' ' 263' ' ' LYS . 8.6 tpt180 -67.68 -53.94 23.57 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.765 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 263' ' ' LYS . . . . . 0.447 ' O ' ' O ' ' A' ' 262' ' ' ARG . 5.4 ttpm? -56.25 -126.49 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.778 -178.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -85.89 143.11 28.4 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 121.094 0.473 . . . . 0.0 111.122 -178.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.518 ' C ' ' H ' ' A' ' 267' ' ' ARG . . . -42.22 160.84 0.04 OUTLIER Glycine 0 CA--C 1.529 0.968 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.382 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -55.98 0.21 0.17 Allowed 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 121.798 1.666 . . . . 0.0 111.909 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.518 ' H ' ' C ' ' A' ' 265' ' ' GLY . 82.9 mtt85 -70.25 -26.46 63.84 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.753 0.821 . . . . 0.0 112.225 178.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -57.98 -32.06 67.51 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.849 -178.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 269' ' ' PHE . . . . . 0.627 ' CE1' ' NH2' ' A' ' 241' ' ' ARG . 10.5 t80 -62.1 -41.02 97.79 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.674 177.618 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -65.28 -37.98 88.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.372 -177.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.472 ' O ' ' O ' ' A' ' 272' ' ' GLY . 37.0 mmtm -67.33 -176.8 0.61 Allowed 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 178.347 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 272' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 271' ' ' LYS . . . 37.11 99.3 0.01 OUTLIER Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -156.63 -0.58 0.12 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.019 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 274' ' ' MET . . . . . 0.574 ' N ' ' CD ' ' A' ' 275' ' ' PRO . 0.1 OUTLIER -63.77 -44.62 80.39 Favored Pre-proline 0 C--N 1.328 -0.35 0 C-N-CA 120.247 -0.581 . . . . 0.0 109.565 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 275' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 274' ' ' MET . 20.9 Cg_exo -64.7 -47.22 5.58 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.093 1.862 . . . . 0.0 111.651 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 19.7 m -61.03 -40.03 92.05 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.701 0.762 . . . . 0.0 110.434 179.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -62.14 -41.85 98.67 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 123.528 1.633 . . . . 0.0 112.138 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 1.4 mp -62.05 -38.85 90.32 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 110.617 -2.992 . . . . 0.0 108.549 174.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 13.5 mmt85 -62.76 -40.65 97.94 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.291 0.567 . . . . 0.0 109.751 178.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.618 ' O ' HD23 ' A' ' 280' ' ' LEU . 0.9 OUTLIER -63.07 -37.2 86.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.099 -179.037 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -67.81 -50.93 38.24 Favored Glycine 0 CA--C 1.519 0.297 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -177.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 77.8 p -61.63 -44.32 97.21 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 283' ' ' TRP . . . . . 0.636 ' O ' HG22 ' A' ' 286' ' ' VAL . 87.6 t90 -61.26 -39.72 91.41 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.637 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -64.31 -40.66 96.38 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 5.3 m -62.28 -38.18 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.636 HG22 ' O ' ' A' ' 283' ' ' TRP . 27.1 m -62.02 -38.83 81.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 121.094 -0.242 . . . . 0.0 111.041 -178.022 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 287' ' ' MET . . . . . 0.453 ' C ' ' SD ' ' A' ' 287' ' ' MET . 0.0 OUTLIER -59.33 -37.31 77.49 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.643 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -57.95 -40.07 79.66 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.003 -179.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 286' ' ' VAL . 1.2 m -60.46 -38.16 77.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 O-C-N 121.766 -0.584 . . . . 0.0 111.018 -178.237 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 75.1 p -61.81 -38.93 89.96 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 177.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -60.64 -38.34 84.52 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 177.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -58.22 -40.71 82.36 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 118.089 -1.445 . . . . 0.0 109.421 -176.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 293' ' ' GLN . . . . . 0.453 ' O ' ' O ' ' A' ' 296' ' ' ARG . 36.5 tp60 -60.72 -42.74 97.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 122.823 1.296 . . . . 0.0 110.468 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 35.9 tp -60.29 -40.15 89.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 112.497 -2.138 . . . . 0.0 109.157 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -63.05 -45.71 90.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.335 179.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 296' ' ' ARG . . . . . 0.453 ' O ' ' O ' ' A' ' 293' ' ' GLN . 44.8 ttm180 -123.03 116.39 23.45 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.047 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -114.41 -97.25 0.44 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.069 0.461 . . . . 0.0 110.682 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.467 HD21 HE21 ' A' ' 303' ' ' GLN . 36.8 tp -140.7 121.06 14.0 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.009 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 24.3 ttt -95.59 66.15 2.73 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -178.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.52 100.82 0.07 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 122.149 0.976 . . . . 0.0 110.805 -178.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -64.28 -46.31 84.21 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 113.393 -1.73 . . . . 0.0 113.362 -176.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -58.92 -39.75 82.48 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.085 -177.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 303' ' ' GLN . . . . . 0.579 ' NE2' ' N ' ' A' ' 13' ' ' MET . 0.3 OUTLIER -64.51 -46.73 81.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.003 -179.61 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 304' ' ' SER . . . . . 0.44 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 15.1 m -66.56 -37.42 84.93 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.61 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -61.66 -43.25 99.22 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -178.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -65.17 -36.88 85.6 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -177.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 307' ' ' ALA . . . . . 0.523 ' HB3' ' HD3' ' A' ' 308' ' ' PRO . . . -59.86 -52.7 71.85 Favored Pre-proline 0 CA--C 1.543 0.675 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -176.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 308' ' ' PRO . . . . . 0.523 ' HD3' ' HB3' ' A' ' 307' ' ' ALA . 73.1 Cg_endo -75.2 0.39 9.04 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.038 1.825 . . . . 0.0 111.862 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 39.8 t80 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.501 179.914 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.961 0.41 . . . . 0.0 110.632 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.796 HG22 ' H ' ' A' ' 16' ' ' LYS . 13.4 p -167.07 -178.98 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.898 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.796 ' H ' HG22 ' A' ' 15' ' ' VAL . 23.7 mtpp -64.32 -41.81 96.63 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.699 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -63.73 -41.5 98.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.279 0.561 . . . . 0.0 112.077 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.514 ' H ' HG13 ' A' ' 15' ' ' VAL . 12.9 tp -79.97 -26.0 40.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.046 -179.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.04 -41.3 95.24 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 107.601 -2.199 . . . . 0.0 107.601 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -71.47 -32.01 67.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 124.886 2.279 . . . . 0.0 107.332 176.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.76 -42.51 98.55 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-N 108.454 -3.975 . . . . 0.0 108.292 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 28.3 p -70.61 -27.48 64.11 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.541 0.686 . . . . 0.0 109.436 178.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.654 ' O ' HD13 ' A' ' 26' ' ' ILE . . . -65.76 -49.7 67.43 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.166 -178.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.98 -35.19 77.76 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 118.816 -1.154 . . . . 0.0 112.375 -177.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.4 ' HA ' HE22 ' A' ' 89' ' ' GLN . 75.7 m -63.35 -53.79 47.11 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -177.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.654 HD13 ' O ' ' A' ' 23' ' ' ALA . 0.2 OUTLIER -65.89 -38.09 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -177.117 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.449 ' O ' ' OG1' ' A' ' 31' ' ' THR . . . -63.64 -41.59 98.23 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -173.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 29' ' ' LEU . 20.0 p30 -77.6 -27.0 51.13 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 120.893 1.678 . . . . 0.0 109.93 -175.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.501 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 11.2 tp -59.8 -55.39 34.82 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 119.93 1.241 . . . . 0.0 112.148 -178.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.1 pt -75.45 -3.91 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-O 121.376 0.608 . . . . 0.0 112.61 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.573 HG23 HD12 ' A' ' 34' ' ' LEU . 7.1 m -109.3 -16.85 13.95 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.751 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.47 ' N ' ' CD ' ' A' ' 33' ' ' PRO . 1.8 t80 -68.53 -44.33 33.51 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 121.411 1.914 . . . . 0.0 110.93 -178.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.47 ' CD ' ' N ' ' A' ' 32' ' ' PHE . 36.8 Cg_exo -59.36 -15.8 31.52 Favored 'Trans proline' 0 N--CA 1.501 1.964 0 C-N-CA 121.554 1.502 . . . . 0.0 112.701 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.573 HD12 HG23 ' A' ' 31' ' ' THR . 81.6 mt -67.62 -35.36 78.79 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 114.787 1.402 . . . . 0.0 114.787 -177.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 36' ' ' THR . 45.3 p-10 -64.27 -40.53 96.16 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -177.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.53 ' N ' ' OD1' ' A' ' 35' ' ' ASP . 44.1 p -58.27 -35.28 71.54 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.939 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.86 -39.19 83.8 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 119.755 -0.778 . . . . 0.0 112.015 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.498 ' CB ' ' NZ ' ' A' ' 38' ' ' LYS . 8.7 mtmp? -62.12 -49.36 76.21 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 119.239 -0.984 . . . . 0.0 111.187 -176.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.1 m -64.25 -40.6 89.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -176.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.635 ' NH1' HE21 ' A' ' 44' ' ' GLN . 10.2 tpp180 -61.69 -41.87 98.16 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 119.378 -0.929 . . . . 0.0 110.08 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.54 39.06 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.768 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.498 ' C ' ' H ' ' A' ' 44' ' ' GLN . 60.2 tt0 -125.73 152.78 44.87 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.989 0.424 . . . . 0.0 110.942 -179.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.538 HG22 ' O ' ' A' ' 43' ' ' ILE . 73.0 mt -63.11 0.78 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.004 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.635 HE21 ' NH1' ' A' ' 40' ' ' ARG . 46.0 mt-30 64.13 78.98 0.27 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.525 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.17 -5.68 3.45 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.427 ' H ' ' C ' ' A' ' 44' ' ' GLN . 96.8 mt-10 -56.22 -42.83 77.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.912 0.387 . . . . 0.0 109.992 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.532 ' C ' ' H ' ' A' ' 49' ' ' GLY . 4.7 t 37.71 30.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.699 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.406 ' N ' ' O ' ' A' ' 46' ' ' GLU . 85.9 mt-30 -58.05 -2.8 0.19 Allowed 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.121 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.532 ' H ' ' C ' ' A' ' 47' ' ' SER . . . 87.44 -8.62 76.5 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -177.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -66.35 -37.3 85.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.665 0.745 . . . . 0.0 109.237 177.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.504 HG13 ' N ' ' A' ' 52' ' ' ARG . 13.1 p -60.76 -44.12 96.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.149 -178.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.504 ' N ' HG13 ' A' ' 51' ' ' VAL . 6.9 mmp_? -64.56 -35.14 80.02 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 119.816 -0.754 . . . . 0.0 112.31 -177.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.5 t -68.95 -38.0 79.18 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 119.24 -0.984 . . . . 0.0 108.758 177.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -138.29 97.93 3.49 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 114.798 -1.092 . . . . 0.0 108.39 178.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -80.65 9.0 6.73 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -177.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.608 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 18.7 m -125.69 -140.99 0.28 Allowed 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.608 ' HB3' ' O ' ' A' ' 56' ' ' SER . . . 97.87 12.74 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 O-C-N 124.127 0.892 . . . . 0.0 111.863 178.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 41.7 tp60 -178.24 84.59 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.704 0.288 . . . . 0.0 110.36 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -63.78 163.06 12.31 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.063 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.413 ' O ' ' C ' ' A' ' 61' ' ' GLY . 78.4 mtm-85 -49.84 -36.85 28.3 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 60' ' ' ARG . . . -28.57 102.58 0.01 OUTLIER Glycine 0 CA--C 1.526 0.764 0 CA-C-N 114.955 -1.021 . . . . 0.0 112.703 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.416 HG22 ' H ' ' A' ' 62' ' ' VAL . 2.1 m -67.32 -34.37 68.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 118.41 -0.805 . . . . 0.0 109.663 176.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.439 ' N ' HD22 ' A' ' 63' ' ' LEU . 4.4 mm? -60.48 -32.5 71.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 121.077 1.762 . . . . 0.0 109.615 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.67 -49.32 64.81 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-N 114.623 -1.171 . . . . 0.0 114.781 -176.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.7 p -61.98 -46.48 89.05 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 -178.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 8.8 tt -59.8 -36.19 64.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.547 ' O ' HD13 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -64.21 -35.73 81.75 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 120.303 1.411 . . . . 0.0 111.913 179.645 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.466 ' O ' ' OG1' ' A' ' 72' ' ' THR . 98.1 m -63.56 -40.88 98.12 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.312 -1.313 . . . . 0.0 111.085 -175.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 7.3 ptm -60.59 -39.46 88.18 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -175.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.43 ' CG2' HD11 ' A' ' 78' ' ' LEU . 5.2 p -69.02 -40.01 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 119.532 -0.867 . . . . 0.0 113.05 -177.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.42 ' N ' HG13 ' A' ' 70' ' ' VAL . 56.6 ttp180 -77.78 -13.08 60.0 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.999 0.904 . . . . 0.0 112.6 -178.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.466 ' OG1' ' O ' ' A' ' 68' ' ' THR . 19.7 m -62.45 -54.65 37.08 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.025 -1.443 . . . . 0.0 111.272 179.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 28.2 mp0 -107.01 -57.76 2.02 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 178.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.42 ' O ' ' CB ' ' A' ' 77' ' ' SER . . . 159.36 165.49 16.46 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -56.84 -35.46 98.26 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 121.487 1.458 . . . . 0.0 111.376 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.64 -11.34 11.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.802 0.811 . . . . 0.0 110.691 175.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 74' ' ' GLY . 5.6 t -77.9 -32.49 51.8 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.098 -1.41 . . . . 0.0 110.905 -178.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.43 HD11 ' CG2' ' A' ' 70' ' ' VAL . 27.5 mt -75.45 -33.48 60.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.116 0.484 . . . . 0.0 110.61 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -92.29 -4.59 53.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 122.798 1.285 . . . . 0.0 113.243 -177.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -95.28 116.25 28.52 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 112.29 -2.232 . . . . 0.0 107.016 175.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.48 -11.38 54.16 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -177.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.674 ' C ' HD12 ' A' ' 82' ' ' LEU . 0.3 OUTLIER -59.24 -34.42 72.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 113.94 -1.13 . . . . 0.0 110.489 -179.328 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.1 m -70.49 -27.0 29.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.087 -0.961 . . . . 0.0 109.369 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.95 -31.92 61.61 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.675 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.92 -40.11 89.18 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 119.544 -1.312 . . . . 0.0 111.223 -177.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.0 mp -62.46 -40.1 95.56 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 122.29 1.043 . . . . 0.0 112.574 -177.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -60.57 -27.44 67.69 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 113.106 -1.861 . . . . 0.0 109.613 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 58.2 ttp85 -57.83 -53.55 56.97 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 173.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.4 HE22 ' HA ' ' A' ' 25' ' ' CYS . 10.3 tt0 -67.22 -29.9 69.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 112.318 -2.219 . . . . 0.0 112.512 -178.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 38.4 ttm -61.14 -40.66 94.65 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.497 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 38.2 t -74.32 -34.13 63.37 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 119.556 -0.858 . . . . 0.0 111.718 -176.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -57.75 -43.99 85.8 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 120.584 1.538 . . . . 0.0 112.308 -176.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.53 -32.85 64.44 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 119.321 -0.952 . . . . 0.0 111.015 -178.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.601 ' O ' HG22 ' A' ' 97' ' ' ILE . 48.8 m -64.35 -41.82 96.55 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.438 ' C ' ' H ' ' A' ' 97' ' ' ILE . 7.2 p -68.42 -28.41 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.221 177.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 16.9 mtp-105 -77.46 10.33 2.65 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -177.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.601 HG22 ' O ' ' A' ' 94' ' ' SER . 9.6 tp -86.87 -15.33 9.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 177.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.404 ' O ' ' OD1' ' A' ' 101' ' ' ASP . . . -140.05 -48.0 0.06 OUTLIER Glycine 0 CA--C 1.539 1.571 0 CA-C-N 114.23 -1.35 . . . . 0.0 114.383 -177.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.4 tp -70.75 -13.48 62.07 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.183 1.491 . . . . 0.0 113.37 -177.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.53 ' O ' ' HB2' ' A' ' 104' ' ' LYS . 20.6 t80 -81.21 -51.67 8.17 Favored 'General case' 0 C--O 1.211 -0.945 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.957 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.536 ' O ' ' HG3' ' A' ' 105' ' ' GLN . 9.3 p-10 -69.99 -32.73 71.07 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 123.631 1.682 . . . . 0.0 111.83 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.0 m -68.83 -52.72 26.98 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 110.81 -2.904 . . . . 0.0 116.99 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 69.2 t -74.99 -26.9 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 CA-C-N 121.121 1.782 . . . . 0.0 110.8 176.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.53 ' HB2' ' O ' ' A' ' 100' ' ' TYR . 0.4 OUTLIER -69.54 -41.53 75.84 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 110.831 -2.895 . . . . 0.0 112.974 -179.259 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.536 ' HG3' ' O ' ' A' ' 101' ' ' ASP . 88.1 mt-30 -78.65 -13.75 59.66 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 123.614 1.673 . . . . 0.0 111.025 178.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.06 -22.74 41.95 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 112.785 -2.007 . . . . 0.0 110.9 178.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -109.87 -30.62 7.75 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.833 0.742 . . . . 0.0 112.212 -175.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.646 HG22 ' O ' ' A' ' 108' ' ' THR . 50.1 m -98.46 9.06 44.01 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 118.219 -1.393 . . . . 0.0 112.579 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.444 ' O ' ' C ' ' A' ' 110' ' ' GLY . 35.3 ttmt -53.74 121.11 7.2 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.495 ' O ' ' CB ' ' A' ' 111' ' ' SER . . . -23.59 -78.79 0.01 OUTLIER Glycine 0 N--CA 1.48 1.59 0 CA-C-N 117.81 0.277 . . . . 0.0 113.12 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.525 ' O ' ' HB2' ' A' ' 112' ' ' GLU . 1.4 t 91.96 -87.26 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 177.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.525 ' HB2' ' O ' ' A' ' 111' ' ' SER . 82.7 tt0 171.64 -34.36 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 120.541 1.519 . . . . 0.0 113.915 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.637 ' O ' ' HB2' ' A' ' 114' ' ' ALA . 0.3 OUTLIER 156.87 42.46 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.201 0.524 . . . . 0.0 109.896 -179.214 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.637 ' HB2' ' O ' ' A' ' 113' ' ' HIS . . . 160.45 -162.41 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 178.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.78 15.23 25.01 Favored Glycine 0 CA--C 1.507 -0.428 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.49 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.459 HG23 ' N ' ' A' ' 117' ' ' GLY . 12.6 tt -60.43 -40.54 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.459 ' N ' HG23 ' A' ' 116' ' ' ILE . . . -65.68 -40.17 95.71 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-O 121.791 0.661 . . . . 0.0 111.685 175.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 10.1 p -58.65 -42.97 89.58 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 176.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.402 ' NE ' ' HA ' ' A' ' 116' ' ' ILE . 76.3 mtm180 -63.71 -37.01 85.74 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.849 -177.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.46 HD21 HD13 ' A' ' 194' ' ' LEU . 70.9 mt -63.53 -45.63 89.7 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 177.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 39.4 mt -66.52 -44.82 81.46 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 118.762 -1.175 . . . . 0.0 110.06 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.98 -45.4 89.24 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 120.22 1.373 . . . . 0.0 110.602 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -66.04 -44.16 92.0 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 120.172 -1.014 . . . . 0.0 111.289 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 59.0 m -64.14 -43.82 94.04 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.43 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 20.6 m -69.34 -48.27 61.91 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 119.365 -0.934 . . . . 0.0 111.943 177.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.449 HG23 ' N ' ' A' ' 127' ' ' GLY . 4.8 t -65.23 -42.46 93.37 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -173.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.449 ' N ' HG23 ' A' ' 126' ' ' THR . . . -63.89 -44.53 95.95 Favored Glycine 0 CA--C 1.521 0.423 0 CA-C-O 122.912 1.284 . . . . 0.0 113.196 -177.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.449 ' O ' HG22 ' A' ' 131' ' ' VAL . . . -61.12 -41.21 96.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 112.029 -2.085 . . . . 0.0 106.714 177.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.679 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 0.2 OUTLIER -63.98 -41.9 97.39 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.3 178.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -62.9 -39.98 96.17 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -177.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.449 HG22 ' O ' ' A' ' 128' ' ' ALA . 12.5 m -61.04 -26.12 38.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 122.628 1.204 . . . . 0.0 109.513 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.679 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . -58.31 -44.45 88.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 112.607 -2.088 . . . . 0.0 111.736 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 61.5 t -78.6 -49.02 21.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.941 -178.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -112.38 131.64 55.43 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.746 0.308 . . . . 0.0 110.805 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.596 ' H ' ' HD2' ' A' ' 136' ' ' PRO . 3.4 tt0 -175.51 -41.79 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.82 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.596 ' HD2' ' H ' ' A' ' 135' ' ' GLN . 52.6 Cg_exo -52.78 -34.52 65.35 Favored 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 121.819 1.679 . . . . 0.0 113.437 -178.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 98.6 m -67.54 -42.01 83.4 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 118.029 -1.468 . . . . 0.0 108.594 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -65.51 -43.01 91.43 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 118.159 -1.416 . . . . 0.0 112.788 -177.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.3 p -64.76 -44.22 96.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.455 ' O ' ' N ' ' A' ' 144' ' ' PHE . 21.8 m -65.26 -37.93 81.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -178.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -61.41 -40.72 95.44 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -176.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.453 ' CG1' ' N ' ' A' ' 143' ' ' ARG . 3.9 p -69.61 -44.7 79.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 119.399 -0.92 . . . . 0.0 108.94 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.453 ' N ' ' CG1' ' A' ' 142' ' ' VAL . 65.8 mtt180 -64.24 -35.71 81.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.701 178.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.455 ' N ' ' O ' ' A' ' 140' ' ' VAL . 85.1 t80 -65.71 -40.56 92.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.239 -178.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -64.14 -38.63 91.74 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -64.88 -35.02 79.79 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -178.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -59.75 111.18 1.35 Allowed 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 177.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -106.6 -173.12 2.22 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 117.686 2.476 . . . . 0.0 117.686 -171.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 59.0 61.13 2.21 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 110.035 -3.257 . . . . 0.0 110.899 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . 46.59 -114.79 0.54 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.806 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 170.74 113.88 0.3 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.979 -0.849 . . . . 0.0 110.979 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.708 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 179.963 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.412 ' CD1' ' O ' ' A' ' 156' ' ' TYR . 28.1 p90 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.752 0.311 . . . . 0.0 110.516 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -54.48 175.73 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.662 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 162' ' ' ALA . 20.5 p -157.0 -178.36 7.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.657 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.57 HG23 ' N ' ' A' ' 160' ' ' VAL . 13.7 t -64.1 -46.47 84.06 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.663 -177.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.57 ' N ' HG23 ' A' ' 159' ' ' THR . 6.3 p -64.51 -45.43 95.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 119.06 -1.056 . . . . 0.0 109.674 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.485 ' N ' HG13 ' A' ' 160' ' ' VAL . 50.3 mm-40 -66.65 -38.34 86.67 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.162 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.556 ' O ' HD12 ' A' ' 166' ' ' ILE . . . -60.97 -44.58 97.12 Favored 'General case' 0 C--O 1.21 -0.981 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -177.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.448 ' C ' ' CD1' ' A' ' 163' ' ' TYR . 20.6 t80 -61.5 -47.84 83.79 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.527 0.565 . . . . 0.0 112.527 -178.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -67.89 -45.39 74.57 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 117.881 2.549 . . . . 0.0 117.881 -172.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 41.7 p -63.38 -45.44 91.11 Favored 'General case' 0 CA--C 1.557 1.227 0 N-CA-C 117.294 2.331 . . . . 0.0 117.294 -175.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.709 HD13 ' H ' ' A' ' 166' ' ' ILE . 0.1 OUTLIER -64.68 -37.12 79.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 CA-C-O 121.655 0.741 . . . . 0.0 109.281 176.483 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.07 -36.53 75.24 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 176.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 18.5 tpt85 -62.21 -50.09 73.16 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 122.998 2.635 . . . . 0.0 111.201 -176.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -74.77 -51.08 15.1 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 123.457 0.703 . . . . 0.0 109.593 177.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -78.24 -36.7 46.62 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 116.037 1.866 . . . . 0.0 116.037 -173.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 93.41 -168.21 29.36 Favored Glycine 0 N--CA 1.47 0.957 0 CA-C-N 118.674 0.67 . . . . 0.0 112.623 177.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 10.0 pt -73.52 -41.45 56.12 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.112 0 CA-C-O 121.944 0.878 . . . . 0.0 110.716 -179.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -58.47 -32.98 69.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 113.708 -1.587 . . . . 0.0 110.658 -176.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -60.33 -39.97 96.85 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 119.209 -1.472 . . . . 0.0 109.89 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 5.8 tp -69.49 -33.73 73.29 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 117.056 2.243 . . . . 0.0 117.056 -177.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 9.7 m0 -78.14 -7.62 57.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 111.244 -2.707 . . . . 0.0 109.826 -178.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -43.32 -47.86 6.77 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.327 -176.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -95.7 -36.33 5.35 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 123.936 0.779 . . . . 0.0 111.763 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.463 ' CG2' ' N ' ' A' ' 180' ' ' SER . 0.6 OUTLIER -45.4 -51.23 11.61 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -179.385 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . 0.463 ' N ' ' CG2' ' A' ' 179' ' ' THR . 0.4 OUTLIER -62.9 -50.89 75.0 Favored Pre-proline 0 N--CA 1.473 0.687 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -176.666 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' A' ' 180' ' ' SER . 32.6 Cg_endo -64.8 -28.42 59.38 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 121.683 1.588 . . . . 0.0 111.992 177.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -63.73 -39.87 95.35 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 120.266 -0.574 . . . . 0.0 109.967 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 75.6 t -63.45 -42.43 96.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.89 -39.04 90.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.216 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.25 -41.55 93.46 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.898 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -61.61 -42.87 99.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.732 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.32 -44.27 92.06 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 -178.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 3.5 tp -63.95 -45.18 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.882 -178.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.523 ' O ' ' N ' ' A' ' 193' ' ' GLU . 15.5 m -59.83 -45.86 94.39 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.362 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.436 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -62.39 -42.62 99.57 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.843 0.83 . . . . 0.0 109.915 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' CYS . . . . . . . . . . . . . 41.4 t -61.71 -45.8 92.4 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.384 -1.28 . . . . 0.0 109.249 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -63.86 -39.61 94.61 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 113.097 -1.865 . . . . 0.0 108.501 175.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 189' ' ' VAL . 36.6 tp10 -61.01 -46.28 91.4 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.962 -178.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.46 HD13 HD21 ' A' ' 120' ' ' LEU . 0.6 OUTLIER -64.89 -39.64 93.84 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 118.844 -1.143 . . . . 0.0 110.225 -175.683 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 2.7 p -64.83 -46.43 91.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 116.693 -2.003 . . . . 0.0 107.853 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 96.3 m -64.11 -45.93 86.41 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.58 0.955 . . . . 0.0 113.58 -178.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -55.43 -37.99 68.4 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.716 1.606 . . . . 0.0 112.275 -176.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -55.86 -43.48 77.14 Favored 'General case' 0 C--N 1.312 -1.04 0 O-C-N 121.594 -0.691 . . . . 0.0 109.606 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 19.3 mt -61.31 -39.79 91.78 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -176.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.3 pt -63.49 -41.2 91.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-N 118.461 0.573 . . . . 0.0 111.304 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 10.3 mtpp -57.92 -37.58 74.33 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.935 1.694 . . . . 0.0 113.013 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -63.73 -38.59 91.67 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.889 -0.725 . . . . 0.0 111.039 -177.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.15 128.63 47.15 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 122.184 0.992 . . . . 0.0 111.579 -178.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.421 ' O ' HD22 ' A' ' 205' ' ' LEU . 6.4 tp 67.18 3.9 3.41 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 113.233 -1.803 . . . . 0.0 111.726 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.421 HD22 ' O ' ' A' ' 204' ' ' LEU . 0.8 OUTLIER -125.11 26.97 6.8 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.488 0.661 . . . . 0.0 111.234 -178.598 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.404 ' HD2' ' H ' ' A' ' 207' ' ' ALA . 0.1 OUTLIER -74.25 -21.58 59.71 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.527 179.658 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.476 ' O ' ' O ' ' A' ' 208' ' ' ASN . . . -163.44 33.06 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.197 -1.365 . . . . 0.0 109.078 178.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' ASN . . . . . 0.476 ' O ' ' O ' ' A' ' 207' ' ' ALA . 12.3 p30 40.54 117.93 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 177.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.473 ' O ' ' O ' ' A' ' 208' ' ' ASN . 9.0 tp . . . . . 0 N--CA 1.473 0.689 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.292 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 0.405 ' O ' ' SG ' ' A' ' 216' ' ' CYS . 14.9 m-20 . . . . . 0 N--CA 1.462 0.129 0 CA-C-O 120.945 0.402 . . . . 0.0 110.696 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.511 ' N ' ' HD2' ' A' ' 215' ' ' PRO . 13.6 mt -61.39 -44.13 91.68 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 214' ' ' LEU . 29.8 Cg_endo -61.34 -32.28 89.46 Favored 'Trans proline' 0 N--CA 1.501 1.954 0 CA-C-N 120.741 1.301 . . . . 0.0 112.406 -179.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' CYS . . . . . 0.525 ' SG ' ' N ' ' A' ' 217' ' ' HIS . 1.1 p -63.92 -42.44 97.39 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 113.827 -1.533 . . . . 0.0 111.824 -177.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' HIS . . . . . 0.622 ' CE1' ' CE2' ' A' ' 218' ' ' PHE . 3.5 p-80 -66.77 -37.43 84.58 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.425 -0.51 . . . . 0.0 112.163 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' PHE . . . . . 0.622 ' CE2' ' CE1' ' A' ' 217' ' ' HIS . 25.6 m-85 -63.08 -46.88 85.35 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.069 -178.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 10.1 m -60.14 -37.46 80.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 118.271 0.487 . . . . 0.0 110.709 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 54.1 p -59.57 -41.56 90.48 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . 0.605 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.4 -41.63 98.76 Favored 'General case' 0 C--O 1.222 -0.381 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -177.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -61.73 -46.73 88.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 122.056 0.931 . . . . 0.0 113.031 -175.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -60.28 -41.98 98.58 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 107.237 -2.345 . . . . 0.0 107.237 177.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -63.06 -36.99 85.41 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 113.898 -1.151 . . . . 0.0 108.975 176.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . 0.605 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -61.03 -41.67 99.53 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-N 114.062 -1.426 . . . . 0.0 111.472 -176.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' PHE . . . . . 0.44 ' O ' ' OG1' ' A' ' 229' ' ' THR . 60.9 t80 -66.78 -38.26 86.19 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.347 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 94.4 m -63.27 -42.27 99.11 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . 0.41 HG22 ' H ' ' A' ' 228' ' ' THR . 1.0 OUTLIER -62.46 -39.74 94.36 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 120.813 0.339 . . . . 0.0 111.542 179.623 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 226' ' ' PHE . 17.0 p -58.04 -38.8 76.95 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.068 -177.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 99.0 t -59.87 -40.78 83.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 119.224 -0.99 . . . . 0.0 108.635 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . 0.64 ' O ' ' HD2' ' A' ' 234' ' ' PRO . 1.3 mp -61.32 -39.69 83.56 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.573 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 176.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 229' ' ' THR . . . -61.39 -37.5 83.66 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.257 1.423 . . . . 0.0 114.331 -179.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.468 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 1.4 m -56.31 -38.2 65.79 Favored Pre-proline 0 N--CA 1.48 1.053 0 N-CA-C 116.519 2.044 . . . . 0.0 116.519 -173.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.64 ' HD2' ' O ' ' A' ' 231' ' ' ILE . 31.5 Cg_exo -57.97 -38.69 91.1 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 C-N-CA 122.739 2.293 . . . . 0.0 114.051 -175.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.435 ' H ' HG22 ' A' ' 235' ' ' VAL . 3.4 m -63.02 -36.77 77.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 116.795 -1.962 . . . . 0.0 108.846 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -65.88 -40.71 91.84 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -64.9 -44.38 96.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -175.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 91.9 t . . . . . 0 C--N 1.319 -0.76 0 O-C-N 121.885 -0.51 . . . . 0.0 111.97 -177.526 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 60.0 p . . . . . 0 N--CA 1.462 0.159 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' MET . . . . . 0.464 ' C ' ' SD ' ' A' ' 260' ' ' MET . 1.9 tmt? -60.45 -43.86 96.45 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -176.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 33.2 tp -62.21 -46.42 88.98 Favored 'General case' 0 C--N 1.322 -0.624 0 O-C-N 122.029 -0.419 . . . . 0.0 110.413 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' ARG . . . . . 0.413 ' HE ' ' HA ' ' A' ' 262' ' ' ARG . 5.2 tpm_? -66.11 -54.0 30.94 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.49 -178.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . 0.443 ' O ' ' O ' ' A' ' 260' ' ' MET . 23.0 pttm -115.36 162.86 16.54 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.114 0.483 . . . . 0.0 111.526 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . 0.498 ' O ' ' O ' ' A' ' 265' ' ' GLY . 70.0 mm-40 56.5 85.06 0.08 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.679 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . 0.498 ' O ' ' O ' ' A' ' 264' ' ' GLU . . . -43.28 177.36 0.01 OUTLIER Glycine 0 CA--C 1.532 1.12 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -68.17 -8.79 23.83 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.301 2.001 . . . . 0.0 111.216 177.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 34.6 ptt-85 -69.72 -26.81 64.52 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 122.978 0.511 . . . . 0.0 111.853 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -58.55 -32.44 68.89 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.711 -0.796 . . . . 0.0 109.287 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -62.06 -41.55 98.27 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.157 177.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -65.66 -37.31 86.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.433 -178.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.446 ' O ' ' O ' ' A' ' 272' ' ' GLY . 54.5 tttp -82.78 171.98 13.36 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 177.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 271' ' ' LYS . . . 48.76 99.44 0.01 OUTLIER Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -171.42 12.09 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.055 0.455 . . . . 0.0 110.496 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' MET . . . . . 0.592 ' SD ' ' N ' ' A' ' 275' ' ' PRO 0.25 0.0 OUTLIER -63.49 -40.36 57.66 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.81 179.372 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' PRO . . . . . 0.592 ' N ' ' SD ' ' A' ' 274' ' ' MET . 16.6 Cg_exo -63.55 -46.38 9.43 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 121.453 1.435 . . . . 0.0 111.197 -176.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 3.1 m -60.43 -39.88 89.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.657 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -61.99 -42.96 99.72 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 123.079 1.418 . . . . 0.0 112.145 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 84.8 mt -62.28 -38.68 90.28 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 111.59 -2.55 . . . . 0.0 108.151 174.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 -63.01 -39.45 94.8 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.314 0.578 . . . . 0.0 110.527 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.652 HD23 ' O ' ' A' ' 280' ' ' LEU . 1.1 tt -61.76 -36.88 82.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.028 -0.987 . . . . 0.0 112.489 -177.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -68.3 -51.51 32.08 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . 0.533 ' O ' HG22 ' A' ' 285' ' ' VAL . 5.6 t -63.35 -44.5 94.67 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 123.566 0.747 . . . . 0.0 110.349 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' TRP . . . . . 0.406 ' O ' HG22 ' A' ' 286' ' ' VAL . 79.4 t90 -59.9 -37.82 80.51 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.922 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . 0.472 ' ND2' ' C ' ' A' ' 284' ' ' ASN . 0.4 OUTLIER -61.47 -37.94 85.47 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.18 -179.313 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.533 HG22 ' O ' ' A' ' 282' ' ' SER . 0.9 OUTLIER -60.86 -37.69 77.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 O-C-N 121.95 -0.468 . . . . 0.0 111.778 -179.094 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.735 ' O ' HG22 ' A' ' 289' ' ' VAL . 0.9 OUTLIER -61.93 -41.14 89.72 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.661 -177.623 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -61.78 -38.16 87.0 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 121.488 -0.758 . . . . 0.0 109.757 178.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -58.49 -40.62 83.28 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.265 -0.88 . . . . 0.0 112.982 -178.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.735 HG22 ' O ' ' A' ' 286' ' ' VAL . 27.0 m -60.76 -38.53 79.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 119.974 -0.69 . . . . 0.0 110.984 -178.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 16.8 m -62.54 -40.25 96.21 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -60.85 -38.84 86.93 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 177.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.45 -40.49 82.73 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 117.706 -1.597 . . . . 0.0 109.527 -176.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' GLN . . . . . 0.473 ' O ' ' O ' ' A' ' 296' ' ' ARG . 56.9 tt0 -60.45 -42.9 97.08 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 122.595 1.188 . . . . 0.0 110.971 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 10.3 mp -60.32 -40.65 91.34 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 113.119 -1.855 . . . . 0.0 108.79 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -63.27 -45.91 89.25 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.322 178.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' ARG . . . . . 0.473 ' O ' ' O ' ' A' ' 293' ' ' GLN . 27.6 mmm-85 -123.03 116.16 23.06 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -121.41 -164.09 1.1 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.022 0.439 . . . . 0.0 112.179 -178.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.656 ' H ' HD12 ' A' ' 298' ' ' LEU . 0.0 OUTLIER -64.77 -173.96 0.12 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 177.276 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 9.2 ttt -169.15 66.99 0.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 119.236 -0.986 . . . . 0.0 112.832 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.59 100.86 0.07 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.825 0.821 . . . . 0.0 110.534 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -64.08 -46.2 85.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.107 -1.406 . . . . 0.0 113.479 -176.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . 0.525 ' CD2' ' OE1' ' A' ' 306' ' ' GLU . 49.0 t80 -58.8 -39.94 82.62 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 119.706 -0.798 . . . . 0.0 109.563 -178.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -65.26 -46.88 78.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.219 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' SER . . . . . 0.446 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 38.9 t -66.58 -37.67 85.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.796 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 -61.67 -42.8 99.42 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . 0.525 ' OE1' ' CD2' ' A' ' 302' ' ' TYR . 41.4 mt-10 -64.87 -37.08 86.42 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -177.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . 0.553 ' HB3' ' HD3' ' A' ' 308' ' ' PRO . . . -60.06 -53.01 69.36 Favored Pre-proline 0 CA--C 1.544 0.743 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -176.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' PRO . . . . . 0.553 ' HD3' ' HB3' ' A' ' 307' ' ' ALA . 73.6 Cg_endo -75.15 0.17 9.29 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.283 1.988 . . . . 0.0 111.948 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 55.0 t80 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.574 -179.894 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.7 p . . . . . 0 C--O 1.233 0.185 0 CA-C-O 120.639 0.257 . . . . 0.0 110.4 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.655 HG22 ' N ' ' A' ' 16' ' ' LYS . 12.4 p -148.37 171.44 2.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.002 0.43 . . . . 0.0 110.64 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.655 ' N ' HG22 ' A' ' 15' ' ' VAL . 4.6 mtmp? -64.29 -41.41 96.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.972 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -63.43 -41.56 98.68 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -178.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.525 ' H ' HG13 ' A' ' 15' ' ' VAL . 57.5 tp -79.9 -26.33 40.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.148 0.499 . . . . 0.0 111.932 -179.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.41 ' O ' ' OG1' ' A' ' 22' ' ' THR . . . -66.07 -41.33 95.16 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 107.595 -2.202 . . . . 0.0 107.595 177.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.419 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -71.47 -32.24 68.06 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 124.803 2.239 . . . . 0.0 107.54 176.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.5 -42.49 98.93 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-N 108.51 -3.95 . . . . 0.0 108.243 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.41 ' OG1' ' O ' ' A' ' 19' ' ' GLY . 22.2 p -70.63 -27.41 64.04 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.503 0.668 . . . . 0.0 109.248 177.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -66.51 -50.05 64.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.676 -1.147 . . . . 0.0 112.128 -179.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.78 -35.96 79.66 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 118.529 -1.268 . . . . 0.0 111.241 -177.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 68.5 m -63.64 -53.69 47.52 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.24 -178.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.4 pt -65.47 -39.63 85.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -177.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.11 -42.04 97.02 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 119.78 -0.768 . . . . 0.0 112.79 -173.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 32' ' ' PHE . 3.2 m-20 -77.89 -27.28 49.57 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 118.068 -1.453 . . . . 0.0 109.407 -176.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 15.7 mt -60.41 -56.22 24.12 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 120.159 1.345 . . . . 0.0 111.703 -178.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.71 ' N ' HD12 ' A' ' 30' ' ' ILE . 2.5 mp -76.23 -5.09 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 120.076 -0.649 . . . . 0.0 112.293 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 26.3 m -110.33 -17.98 13.37 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 117.656 -1.164 . . . . 0.0 109.71 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.517 ' N ' ' O ' ' A' ' 28' ' ' ASP . 11.4 t80 -67.88 -43.44 37.63 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 122.379 2.354 . . . . 0.0 110.009 -177.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.457 ' CD ' ' N ' ' A' ' 32' ' ' PHE . 38.1 Cg_exo -58.55 -14.68 22.0 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 121.239 1.293 . . . . 0.0 110.949 177.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.5 tp -66.92 -35.59 80.35 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -177.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -64.42 -40.65 96.17 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -177.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.401 ' CG2' ' O ' ' A' ' 33' ' ' PRO . 0.3 OUTLIER -58.39 -33.78 70.0 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.13 -38.77 86.12 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.455 ' CB ' ' NZ ' ' A' ' 38' ' ' LYS . 0.1 OUTLIER -61.67 -47.54 84.87 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 119.415 -0.914 . . . . 0.0 111.734 -176.768 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.2 t -62.2 -38.37 80.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -175.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.504 ' O ' ' N ' ' A' ' 42' ' ' GLN . 45.5 mtp85 -59.5 -41.08 89.05 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 119.236 -0.985 . . . . 0.0 110.049 -179.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -62.38 38.67 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.066 178.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.504 ' N ' ' O ' ' A' ' 40' ' ' ARG . 0.7 OUTLIER -94.57 5.11 52.81 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 121.959 -0.463 . . . . 0.0 111.187 -179.437 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.425 ' O ' ' O ' ' A' ' 42' ' ' GLN . 7.6 mm 60.28 147.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -53.14 105.25 0.12 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.873 0.368 . . . . 0.0 110.438 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.92 50.88 0.37 Allowed Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.981 -0.847 . . . . 0.0 110.981 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.51 ' H ' ' CG2' ' A' ' 51' ' ' VAL . 72.1 mm-40 -73.1 -8.68 56.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.778 0.323 . . . . 0.0 110.674 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.499 ' C ' ' H ' ' A' ' 49' ' ' GLY . 3.6 m 61.42 -159.57 0.32 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.723 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 38.7 tp60 66.4 -7.39 0.43 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.142 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.499 ' H ' ' C ' ' A' ' 47' ' ' SER . . . 84.17 3.53 88.84 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -178.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.573 ' O ' HD13 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -66.61 -38.12 86.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.538 0.685 . . . . 0.0 109.769 178.487 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.51 ' CG2' ' H ' ' A' ' 46' ' ' GLU . 54.6 t -60.74 -44.97 98.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.319 -178.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.96 -34.72 79.09 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.275 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 19.6 p -68.68 -38.25 80.2 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.115 0.483 . . . . 0.0 110.052 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -92.88 -159.77 0.7 Allowed 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.868 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -169.78 -40.19 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.171 -0.611 . . . . 0.0 111.831 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.64 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 87.6 p -126.91 -139.58 0.26 Allowed 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.64 ' HB3' ' O ' ' A' ' 56' ' ' SER . . . 92.87 14.64 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 O-C-N 123.813 0.696 . . . . 0.0 111.81 178.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 90.6 mm-40 -155.45 52.43 0.59 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -41.39 145.43 0.26 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.381 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.418 ' O ' ' C ' ' A' ' 61' ' ' GLY . 62.7 ttp180 -49.8 -44.62 49.23 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 60' ' ' ARG . . . -28.52 101.54 0.01 OUTLIER Glycine 0 CA--C 1.53 0.995 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.7 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.5 p -67.54 -33.97 65.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.34 176.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.25 -32.37 71.08 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 121.165 1.802 . . . . 0.0 109.436 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.32 -49.22 67.14 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 114.832 -1.077 . . . . 0.0 115.062 -176.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 94.6 m -61.9 -46.32 89.87 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 33.7 mm -59.57 -35.49 59.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 76.8 mt -63.19 -35.82 81.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 121.028 1.74 . . . . 0.0 111.506 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.408 ' O ' ' OG1' ' A' ' 72' ' ' THR . 99.4 m -62.47 -38.8 91.24 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 113.219 -1.81 . . . . 0.0 111.053 -177.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 27.8 ttt -60.73 -40.02 90.79 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 -177.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.1 m -69.07 -39.81 80.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 119.612 -0.835 . . . . 0.0 112.375 -178.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -77.42 -12.76 59.99 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 122.182 0.991 . . . . 0.0 113.217 -177.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' A' ' 68' ' ' THR . 33.5 m -62.5 -55.12 30.47 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 113.927 -1.488 . . . . 0.0 112.762 -179.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -113.6 5.24 16.47 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 123.036 1.398 . . . . 0.0 109.466 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 96.46 170.92 34.67 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-N 111.598 -2.546 . . . . 0.0 110.783 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -56.4 -34.47 94.47 Favored 'Trans proline' 0 N--CA 1.5 1.909 0 C-N-CA 122.518 2.145 . . . . 0.0 111.682 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.425 ' O ' ' CB ' ' A' ' 80' ' ' ASN . 1.7 mpt_? -61.01 -10.53 6.03 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.796 0.807 . . . . 0.0 111.093 176.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 81.3 p -77.24 -32.35 55.71 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.168 -1.378 . . . . 0.0 111.231 -177.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.2 tt -75.9 -34.15 59.94 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.297 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -93.76 -5.98 47.1 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 122.022 0.915 . . . . 0.0 113.013 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.425 ' CB ' ' O ' ' A' ' 76' ' ' ARG . 4.2 t30 -81.23 124.69 29.51 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 113.802 -1.545 . . . . 0.0 107.625 176.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.99 0.67 71.12 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 109.696 -1.361 . . . . 0.0 109.696 -178.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 45.3 tp -59.43 -35.33 73.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 113.477 -1.361 . . . . 0.0 110.955 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.8 p -70.76 -26.99 29.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.563 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.8 -31.65 61.79 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.512 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -68.14 -40.79 87.97 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 119.489 -1.338 . . . . 0.0 111.389 -177.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.532 ' O ' ' SD ' ' A' ' 90' ' ' MET . 75.7 mt -62.59 -40.53 97.2 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 122.311 1.053 . . . . 0.0 112.587 -176.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -59.51 -26.22 65.13 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 113.324 -1.762 . . . . 0.0 108.944 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 18.3 ttm180 -57.06 -52.88 63.53 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 113.335 -1.757 . . . . 0.0 106.645 173.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.439 HE22 ' CG ' ' A' ' 28' ' ' ASP . 9.8 tp-100 -67.39 -30.19 69.9 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 112.857 -1.974 . . . . 0.0 113.247 -177.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.552 ' N ' ' SD ' ' A' ' 90' ' ' MET . 0.0 OUTLIER -61.02 -40.9 95.33 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.357 -179.489 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 68.7 p -74.53 -34.5 63.02 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 119.382 -0.927 . . . . 0.0 111.409 -176.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -57.86 -44.41 86.59 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-N 121.041 1.746 . . . . 0.0 111.616 -176.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.76 -33.17 64.16 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.691 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.609 ' O ' HG22 ' A' ' 97' ' ' ILE . 24.3 p -64.18 -42.07 96.84 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.432 ' C ' ' H ' ' A' ' 97' ' ' ILE . 34.5 m -68.16 -27.74 38.3 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.839 177.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.444 ' O ' ' CD1' ' A' ' 100' ' ' TYR . 49.1 ttm-85 -77.21 9.24 3.23 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 -177.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.609 HG22 ' O ' ' A' ' 94' ' ' SER . 11.0 tt -87.12 -15.58 9.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 178.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -140.61 -48.03 0.05 OUTLIER Glycine 0 CA--C 1.538 1.499 0 N-CA-C 115.653 1.021 . . . . 0.0 115.653 -176.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.598 ' N ' HD12 ' A' ' 99' ' ' LEU . 9.4 mp -71.18 -12.7 61.62 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.927 1.363 . . . . 0.0 112.521 -178.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.597 ' CD1' ' N ' ' A' ' 101' ' ' ASP . 0.1 OUTLIER -80.46 -50.76 9.64 Favored 'General case' 0 C--O 1.214 -0.792 0 CA-C-N 114.382 -1.281 . . . . 0.0 111.563 -179.623 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 1.072 ' OD1' ' NE2' ' A' ' 105' ' ' GLN . 28.5 t70 -68.14 -31.2 70.61 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 122.857 1.313 . . . . 0.0 109.446 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.2 t -68.61 -53.42 22.8 Favored 'General case' 0 CA--C 1.554 1.134 0 CA-C-N 112.227 -2.26 . . . . 0.0 113.393 176.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -75.59 -28.22 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 CA-C-N 123.34 2.791 . . . . 0.0 115.708 -178.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 100' ' ' TYR . 18.8 mttt -69.33 -42.3 75.52 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 111.169 -2.741 . . . . 0.0 112.888 -178.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 1.072 ' NE2' ' OD1' ' A' ' 101' ' ' ASP . 88.1 mt-30 -78.97 -10.11 59.73 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 124.225 1.964 . . . . 0.0 111.063 177.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -78.97 -22.45 45.6 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 112.273 -2.24 . . . . 0.0 111.358 177.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.467 ' CZ ' ' OD1' ' A' ' 190' ' ' ASN . 27.5 m-85 -109.3 -30.84 7.8 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 119.637 1.108 . . . . 0.0 111.995 -175.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.9 t -98.66 9.27 43.66 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 117.275 -1.77 . . . . 0.0 112.796 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.512 ' O ' ' C ' ' A' ' 110' ' ' GLY . 0.0 OUTLIER -50.49 122.06 6.58 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 118.395 -0.812 . . . . 0.0 110.948 -179.733 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.518 ' O ' ' CB ' ' A' ' 111' ' ' SER . . . -22.5 -78.83 0.01 OUTLIER Glycine 0 N--CA 1.487 2.066 0 CA-C-N 119.124 0.875 . . . . 0.0 111.73 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 110' ' ' GLY . 5.9 p 94.33 -156.36 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 175.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.496 ' O ' ' N ' ' A' ' 114' ' ' ALA . 76.6 mt-10 -120.45 172.55 7.74 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 114.398 -1.274 . . . . 0.0 111.556 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.617 ' O ' ' HB2' ' A' ' 114' ' ' ALA . 45.1 p-80 -63.81 48.59 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.498 -179.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' A' ' 113' ' ' HIS . . . 159.06 -162.2 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.2 14.98 27.0 Favored Glycine 0 N--CA 1.464 0.514 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.298 177.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 24.0 mm -60.72 -40.45 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.08 -39.41 96.29 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 122.066 0.814 . . . . 0.0 111.67 176.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 7.6 t -58.08 -42.09 84.82 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 177.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.559 HH12 ' NZ ' ' A' ' 201' ' ' LYS . 99.5 mtt180 -63.17 -37.23 86.41 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.227 -177.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 92.5 mt -63.59 -46.01 87.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.256 0.551 . . . . 0.0 109.823 178.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 56.2 mt -66.82 -44.79 80.24 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.391 178.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.11 -45.16 89.85 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 119.876 1.216 . . . . 0.0 110.257 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -65.75 -44.07 92.95 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 120.184 -1.008 . . . . 0.0 111.299 -179.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.4 t -63.93 -43.85 94.63 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.692 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 19.1 m -69.34 -48.32 61.72 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 119.118 -1.033 . . . . 0.0 112.075 177.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.468 HG23 ' N ' ' A' ' 127' ' ' GLY . 5.5 t -65.57 -42.74 91.45 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 -174.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.468 ' N ' HG23 ' A' ' 126' ' ' THR . . . -64.19 -44.48 95.58 Favored Glycine 0 CA--C 1.52 0.396 0 CA-C-O 122.73 1.183 . . . . 0.0 112.95 -177.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.484 ' O ' HG12 ' A' ' 131' ' ' VAL . . . -60.81 -41.35 95.53 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 112.178 -2.011 . . . . 0.0 106.492 177.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.646 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 15.1 tp -64.44 -42.25 96.09 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.773 178.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.11 -39.92 96.1 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -177.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.484 HG12 ' O ' ' A' ' 128' ' ' ALA . 3.3 p -60.9 -24.81 33.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 122.577 1.18 . . . . 0.0 109.265 178.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.646 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . -57.74 -44.85 86.36 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 112.709 -2.041 . . . . 0.0 111.727 -178.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.485 ' CG1' ' N ' ' A' ' 134' ' ' ALA . 3.0 p -79.17 -48.98 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.13 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.485 ' N ' ' CG1' ' A' ' 133' ' ' VAL . . . -103.29 128.78 50.23 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.257 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.503 ' N ' ' HD2' ' A' ' 136' ' ' PRO . 27.3 tt0 -179.58 -50.32 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.718 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 135' ' ' GLN . 11.2 Cg_endo -51.79 -33.89 52.38 Favored 'Trans proline' 0 N--CA 1.499 1.849 0 C-N-CA 121.545 1.497 . . . . 0.0 114.221 -177.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 41.4 p -67.36 -41.71 84.67 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 118.183 -1.407 . . . . 0.0 108.42 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -64.43 -42.26 96.11 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.104 -1.038 . . . . 0.0 111.053 -178.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 88.5 t -63.57 -43.43 98.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.176 0.513 . . . . 0.0 111.07 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 136' ' ' PRO . 53.8 t -64.32 -38.44 82.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.807 -178.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -61.55 -40.58 95.2 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.206 -0.598 . . . . 0.0 111.854 -177.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 97.6 t -69.52 -44.86 79.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.307 0.575 . . . . 0.0 109.66 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.481 HH12 ' HA ' ' A' ' 175' ' ' LEU . 0.3 OUTLIER -64.4 -35.74 81.9 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.545 179.103 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -66.13 -40.76 90.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 112.166 -177.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 4.0 tm0? -64.67 -39.52 93.82 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.08 -1.048 . . . . 0.0 109.841 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.08 -34.93 79.59 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -177.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.419 ' C ' ' OE1' ' A' ' 147' ' ' GLN . 0.0 OUTLIER -59.36 111.41 1.36 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.417 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -96.42 -62.18 1.31 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 117.777 -1.106 . . . . 0.0 113.828 -176.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -62.02 126.7 28.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 122.481 2.4 . . . . 0.0 110.474 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -55.92 -49.43 73.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.664 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 152.94 155.32 7.07 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.666 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -179.963 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.423 ' O ' ' O ' ' A' ' 157' ' ' GLN . 11.0 t80 . . . . . 0 N--CA 1.463 0.196 0 CA-C-O 120.735 0.302 . . . . 0.0 111.01 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.423 ' O ' ' O ' ' A' ' 156' ' ' TYR . 34.3 mt-30 49.67 176.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.992 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 25.7 t -157.05 -177.66 6.78 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.307 0.575 . . . . 0.0 110.883 -179.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.551 HG23 ' N ' ' A' ' 160' ' ' VAL . 9.2 t -63.98 -45.86 87.2 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.675 -177.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.551 ' N ' HG23 ' A' ' 159' ' ' THR . 87.2 t -63.81 -45.17 97.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 119.063 -1.055 . . . . 0.0 108.721 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -67.28 -39.16 85.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.725 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -61.67 -45.87 92.16 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -177.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.438 ' CD1' ' C ' ' A' ' 163' ' ' TYR . 12.5 t80 -62.47 -50.12 72.69 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.06 -179.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -68.2 -45.51 73.16 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -175.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 18.8 m -62.65 -44.73 95.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 119.433 1.015 . . . . 0.0 113.142 -177.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 47.3 mm -64.63 -38.63 83.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-O 121.968 0.89 . . . . 0.0 109.6 176.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.7 -36.31 76.24 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 113.787 -1.551 . . . . 0.0 108.059 176.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 32.2 mmm-85 -62.13 -50.31 72.42 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 122.2 2.273 . . . . 0.0 111.97 -175.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -75.05 -50.92 14.89 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 123.471 0.708 . . . . 0.0 109.113 177.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -78.07 -36.51 48.19 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 -173.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 91.28 -167.32 31.36 Favored Glycine 0 N--CA 1.469 0.836 0 CA-C-N 118.29 0.496 . . . . 0.0 111.945 177.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.416 HG12 ' H ' ' A' ' 172' ' ' ILE . 6.3 pt -72.83 -43.26 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 CA-C-O 121.643 0.735 . . . . 0.0 110.414 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -58.88 -33.65 70.73 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.336 -1.302 . . . . 0.0 111.143 -177.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -60.96 -40.64 98.72 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 118.528 -1.796 . . . . 0.0 109.396 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.528 HD13 ' O ' ' A' ' 175' ' ' LEU . 0.1 OUTLIER -70.72 -34.14 71.59 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 111.134 -2.533 . . . . 0.0 117.065 -177.173 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . 0.528 ' CE2' ' OG ' ' A' ' 180' ' ' SER . 55.7 t90 -78.08 -8.77 58.65 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 111.779 -2.464 . . . . 0.0 110.949 -176.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.409 ' HB2' HH22 ' A' ' 143' ' ' ARG . 0.5 OUTLIER -44.57 -48.96 10.33 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 114.679 1.362 . . . . 0.0 114.679 -175.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -102.99 -37.96 3.02 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 124.206 0.908 . . . . 0.0 113.528 -177.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.446 ' CG2' ' N ' ' A' ' 180' ' ' SER . 0.9 OUTLIER -45.19 -50.98 11.1 Favored 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -178.925 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . 0.528 ' OG ' ' CE2' ' A' ' 176' ' ' TRP . 0.0 OUTLIER -62.64 -50.43 78.26 Favored Pre-proline 0 N--CA 1.48 1.026 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -177.0 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 180' ' ' SER . 25.8 Cg_endo -63.83 -26.97 67.46 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.196 1.931 . . . . 0.0 111.265 177.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 18.0 t30 -62.7 -38.08 89.04 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 39.8 t -62.08 -41.34 90.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.12 -38.69 87.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.746 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 60.3 ttt85 -60.23 -41.15 92.51 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.717 -0.393 . . . . 0.0 109.944 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -60.92 -42.23 97.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.248 0.547 . . . . 0.0 110.463 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . 0.401 ' O ' ' SG ' ' A' ' 191' ' ' CYS . . . -63.8 -42.93 97.61 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.433 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 96.4 mt -62.85 -44.85 99.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -177.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 6.1 m -59.66 -45.8 93.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 119.854 -0.738 . . . . 0.0 110.875 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.467 ' OD1' ' CZ ' ' A' ' 107' ' ' TYR . 53.1 t30 -62.08 -43.55 98.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 122.069 0.937 . . . . 0.0 109.892 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' CYS . . . . . 0.401 ' SG ' ' O ' ' A' ' 187' ' ' ALA . 79.3 m -62.59 -47.02 85.62 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 113.902 -1.499 . . . . 0.0 110.625 178.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.31 -40.69 96.42 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 114.018 -1.446 . . . . 0.0 109.929 177.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -61.1 -45.49 94.51 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.337 -1.302 . . . . 0.0 112.611 -178.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 1.4 tt -63.22 -37.4 87.09 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 118.676 -1.21 . . . . 0.0 108.262 -175.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 66.1 t -62.74 -46.19 96.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 C-N-CA 117.391 -1.723 . . . . 0.0 107.076 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 14.7 m -64.27 -46.37 84.0 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 113.712 1.005 . . . . 0.0 113.712 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -57.36 -39.16 75.4 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.639 1.176 . . . . 0.0 113.27 -177.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -55.63 -44.64 77.29 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -178.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.42 HD12 ' N ' ' A' ' 199' ' ' LEU . 8.8 mp -61.46 -39.23 90.12 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.881 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 1.7 mp -63.38 -43.64 98.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-O 118.333 -0.842 . . . . 0.0 111.366 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . 0.559 ' NZ ' HH12 ' A' ' 119' ' ' ARG . 53.4 mtmt -60.59 -41.3 94.41 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 121.154 1.797 . . . . 0.0 111.237 177.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -65.33 -36.67 84.73 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 113.11 -1.859 . . . . 0.0 110.965 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 54.7 m -101.92 129.91 48.28 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.691 0.758 . . . . 0.0 111.892 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.453 HD13 HD13 ' A' ' 209' ' ' LEU . 0.3 OUTLIER 68.37 5.19 4.61 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 114.615 -1.175 . . . . 0.0 112.192 179.248 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.518 ' O ' ' O ' ' A' ' 201' ' ' LYS . 1.7 tt -148.05 74.1 1.28 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.656 0.741 . . . . 0.0 110.523 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.35 -17.97 17.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.083 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.569 ' O ' ' CG ' ' A' ' 208' ' ' ASN . . . -170.72 18.98 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.573 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' ASN . . . . . 0.572 ' OD1' ' N ' ' A' ' 209' ' ' LEU . 44.3 p30 115.46 -140.24 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.093 0 O-C-N 125.636 1.835 . . . . 0.0 109.679 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.572 ' N ' ' OD1' ' A' ' 208' ' ' ASN . 13.6 tp . . . . . 0 C--N 1.331 -0.223 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 . . . . . 0 N--CA 1.459 -0.017 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.442 ' N ' ' CD ' ' A' ' 215' ' ' PRO . 3.3 mt -61.14 -43.74 91.53 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.158 -178.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 214' ' ' LEU . 32.3 Cg_exo -60.5 -32.97 94.29 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 121.21 1.273 . . . . 0.0 111.469 -179.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 76.2 m -64.05 -42.0 97.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 113.322 -1.763 . . . . 0.0 111.611 -178.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -66.53 -37.89 85.98 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.4 -0.52 . . . . 0.0 111.987 -178.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -63.42 -46.93 84.05 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.803 -178.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 1.5 t -60.13 -37.49 80.24 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 118.94 0.791 . . . . 0.0 111.064 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 82.5 p -59.38 -41.28 88.98 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.42 -41.6 98.7 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -177.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -61.46 -46.97 87.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 122.133 0.968 . . . . 0.0 112.387 -176.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -60.5 -41.65 98.76 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 107.361 -2.296 . . . . 0.0 107.361 177.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . 0.644 ' O ' HG23 ' A' ' 228' ' ' THR . . . -62.72 -38.33 90.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.45 -0.875 . . . . 0.0 108.717 177.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -62.04 -42.45 99.73 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -178.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -66.9 -38.36 86.11 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 63.5 m -63.24 -41.28 99.07 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.179 177.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . 0.644 HG23 ' O ' ' A' ' 224' ' ' ALA . 53.2 p -61.89 -40.17 94.51 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.494 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 39.5 m -59.58 -40.46 87.47 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.644 -177.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 95.3 t -61.58 -42.73 95.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 119.245 -0.982 . . . . 0.0 112.318 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . 0.523 ' O ' ' HD2' ' A' ' 234' ' ' PRO . 12.8 pt -62.67 -40.65 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 119.895 -0.722 . . . . 0.0 109.383 177.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -62.78 -39.35 93.92 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.472 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 0.0 OUTLIER -58.44 -42.45 94.7 Favored Pre-proline 0 N--CA 1.481 1.094 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -173.327 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.523 ' HD2' ' O ' ' A' ' 231' ' ' ILE . 32.5 Cg_exo -58.77 -41.05 66.99 Favored 'Trans proline' 0 C--N 1.294 -2.304 0 C-N-CA 122.059 1.84 . . . . 0.0 113.654 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.402 HG22 ' H ' ' A' ' 235' ' ' VAL . 6.9 m -65.99 -37.42 79.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 118.507 -1.277 . . . . 0.0 111.149 178.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -65.54 -41.45 93.05 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -178.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 16.1 m -65.24 -44.86 95.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -176.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 60.3 t . . . . . 0 C--N 1.327 -0.403 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.268 -177.334 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 70.0 p . . . . . 0 N--CA 1.466 0.34 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' MET . . . . . 0.56 ' SD ' ' N ' ' A' ' 261' ' ' LEU . 0.0 OUTLIER -62.47 -43.85 97.83 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.232 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.56 ' N ' ' SD ' ' A' ' 260' ' ' MET . 7.0 tp -62.13 -46.57 88.44 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 122.792 0.437 . . . . 0.0 111.093 -178.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 13.6 tpp85 -66.0 -53.81 34.06 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.868 -178.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -91.16 -122.07 0.07 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.735 0.303 . . . . 0.0 111.595 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . 0.494 ' O ' ' O ' ' A' ' 265' ' ' GLY . 58.0 mt-10 -30.57 107.45 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -178.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 264' ' ' GLU . . . -41.38 175.07 0.01 OUTLIER Glycine 0 CA--C 1.533 1.173 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 178.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -68.73 -9.1 25.22 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 122.835 2.357 . . . . 0.0 111.483 177.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 82.6 mtt85 -69.43 -26.61 64.7 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.122 0.569 . . . . 0.0 112.087 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -58.31 -32.07 68.12 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.392 -179.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -61.99 -41.9 98.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.245 0.545 . . . . 0.0 110.547 177.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -66.15 -37.89 86.77 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.194 -178.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.444 ' O ' ' O ' ' A' ' 272' ' ' GLY . 62.7 mmtt -73.17 -173.75 1.39 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 271' ' ' LYS . . . 48.69 103.87 0.01 OUTLIER Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . 0.401 ' H ' ' H ' ' A' ' 274' ' ' MET . 46.0 p90 -170.46 1.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.449 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' MET . . . . . 0.568 ' N ' ' CD ' ' A' ' 275' ' ' PRO . 0.5 OUTLIER -63.97 -44.53 78.7 Favored Pre-proline 0 CA--C 1.532 0.268 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.869 -179.555 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 274' ' ' MET . 21.5 Cg_exo -64.68 -46.67 6.47 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.44 2.093 . . . . 0.0 110.947 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 51.0 m -60.76 -39.51 89.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.287 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -61.75 -42.76 99.4 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 122.878 1.323 . . . . 0.0 112.814 -178.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 8.5 tp -62.29 -38.79 90.73 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 111.853 -2.43 . . . . 0.0 108.138 174.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 16.2 mmm180 -62.73 -39.49 94.24 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.438 0.637 . . . . 0.0 110.326 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 22.3 tp -61.97 -36.61 81.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.974 -1.012 . . . . 0.0 113.028 -177.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -68.24 -51.34 33.34 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . 0.442 ' O ' HG12 ' A' ' 285' ' ' VAL . 14.0 p -63.07 -44.43 95.81 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.268 0.627 . . . . 0.0 109.883 179.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' TRP . . . . . 0.421 ' O ' HG22 ' A' ' 286' ' ' VAL . 62.7 t90 -60.06 -37.99 81.52 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -61.83 -37.41 84.36 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.587 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 282' ' ' SER . 0.3 OUTLIER -59.88 -37.45 71.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.222 -178.303 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.568 ' O ' HG12 ' A' ' 289' ' ' VAL . 0.9 OUTLIER -61.86 -40.02 85.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 120.234 -0.587 . . . . 0.0 109.755 -179.27 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 16.6 mmt -61.51 -39.59 91.55 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.849 0.357 . . . . 0.0 110.66 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -59.63 -41.95 91.62 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -178.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.568 HG12 ' O ' ' A' ' 286' ' ' VAL . 3.1 p -61.82 -38.62 80.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 O-C-N 121.854 -0.529 . . . . 0.0 111.279 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 10.3 m -62.58 -40.73 97.83 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -61.27 -38.85 88.25 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 176.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -58.28 -40.45 81.95 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 117.867 -1.533 . . . . 0.0 109.616 -176.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' GLN . . . . . 0.48 ' O ' ' O ' ' A' ' 296' ' ' ARG . 75.7 mt-30 -60.75 -43.13 98.37 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 122.554 1.169 . . . . 0.0 111.293 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 9.3 mp -60.8 -40.66 93.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 113.382 -1.736 . . . . 0.0 109.1 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -63.39 -45.96 88.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.047 178.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' ARG . . . . . 0.48 ' O ' ' O ' ' A' ' 293' ' ' GLN . 16.4 tpp180 -123.22 116.02 22.7 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.299 -0.864 . . . . 0.0 108.873 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -122.24 -163.5 1.08 Allowed 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -178.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.604 ' N ' HD22 ' A' ' 298' ' ' LEU . 3.3 mm? -63.54 -175.65 0.13 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 176.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 21.8 ttt -166.55 64.47 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 119.614 -0.835 . . . . 0.0 112.371 -178.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . 0.428 ' CB ' ' OE1' ' A' ' 303' ' ' GLN . . . -175.6 100.85 0.07 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 122.079 0.943 . . . . 0.0 110.52 -178.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.411 ' HB1' ' HE ' ' A' ' 305' ' ' ARG . . . -64.18 -46.34 84.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 113.545 -1.661 . . . . 0.0 113.351 -176.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -58.57 -39.62 80.82 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.014 -177.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' GLN . . . . . 0.428 ' OE1' ' CB ' ' A' ' 300' ' ' ALA . 47.0 mt-30 -64.9 -46.93 79.65 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.71 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' SER . . . . . 0.433 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 15.5 m -66.79 -38.05 85.77 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.064 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' ARG . . . . . 0.411 ' HE ' ' HB1' ' A' ' 301' ' ' ALA . 65.2 mtt-85 -61.81 -42.61 99.23 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.017 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 10.6 tm-20 -64.75 -36.9 85.81 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -177.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . 0.54 ' HB3' ' HD3' ' A' ' 308' ' ' PRO . . . -60.12 -53.12 68.2 Favored Pre-proline 0 CA--C 1.544 0.717 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -176.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' PRO . . . . . 0.54 ' HD3' ' HB3' ' A' ' 307' ' ' ALA . 73.7 Cg_endo -75.35 0.25 9.27 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.199 1.933 . . . . 0.0 111.955 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 54.2 t80 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.558 -179.841 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.5 m . . . . . 0 C--O 1.23 0.042 0 CA-C-O 120.773 0.32 . . . . 0.0 110.617 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.684 HG22 ' H ' ' A' ' 16' ' ' LYS . 8.0 p -156.54 175.45 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.404 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.684 ' H ' HG22 ' A' ' 15' ' ' VAL . 54.3 tttp -64.3 -41.34 96.91 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.951 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -63.58 -41.77 98.34 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.519 ' H ' HG13 ' A' ' 15' ' ' VAL . 44.5 tp -79.8 -26.48 40.54 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.921 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.409 ' O ' ' OG1' ' A' ' 22' ' ' THR . . . -66.32 -41.26 94.68 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 107.615 -2.194 . . . . 0.0 107.615 177.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.42 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -71.39 -32.22 68.19 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 124.811 2.243 . . . . 0.0 107.467 176.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.55 -42.38 98.9 Favored Glycine 0 CA--C 1.528 0.845 1 CA-C-N 108.399 -4.001 . . . . 0.0 108.242 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 19' ' ' GLY . 22.2 p -70.68 -27.55 64.09 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.54 0.686 . . . . 0.0 109.225 177.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -66.48 -50.1 64.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.875 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.79 -35.98 79.76 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 118.46 -1.296 . . . . 0.0 111.253 -177.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 79.2 m -63.9 -53.77 45.25 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.339 -178.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.8 tt -65.64 -39.59 85.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 -177.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.92 -41.93 97.53 Favored 'General case' 0 C--O 1.224 -0.273 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -173.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.412 ' O ' ' OD1' ' A' ' 28' ' ' ASP . 3.8 t70 -77.78 -26.94 50.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 120.345 1.429 . . . . 0.0 110.078 -175.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 45.6 mt -59.86 -55.12 38.1 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 119.841 1.201 . . . . 0.0 112.332 -178.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.0 pt -75.47 -4.31 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -109.68 -17.59 13.66 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 118.54 -1.264 . . . . 0.0 110.253 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -68.08 -44.33 38.39 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 122.046 2.203 . . . . 0.0 110.779 -177.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -59.16 -15.63 29.47 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 CA-C-N 120.836 1.334 . . . . 0.0 111.31 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.607 HD23 ' O ' ' A' ' 34' ' ' LEU . 0.9 OUTLIER -66.8 -35.74 80.77 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.165 -0.925 . . . . 0.0 113.296 -177.293 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -64.44 -40.56 95.98 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.149 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 79.6 p -58.12 -34.87 70.69 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.34 -38.64 85.17 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 119.907 -0.717 . . . . 0.0 112.62 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.446 ' CG ' ' N ' ' A' ' 39' ' ' VAL . 12.0 pttp -61.54 -48.1 82.55 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 119.421 -0.912 . . . . 0.0 111.478 -176.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.446 ' N ' ' CG ' ' A' ' 38' ' ' LYS . 7.2 m -62.92 -38.81 82.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -176.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.508 ' O ' ' N ' ' A' ' 42' ' ' GLN . 61.7 mtp85 -59.86 -41.01 90.55 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 119.356 -0.938 . . . . 0.0 110.175 -178.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -62.59 38.75 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.866 177.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.508 ' N ' ' O ' ' A' ' 40' ' ' ARG . 15.7 pt20 -91.03 149.08 21.97 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.823 -0.548 . . . . 0.0 111.168 -179.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 7.5 mt -96.49 44.59 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.054 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 21.5 mm100 46.62 -165.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.52 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 160.49 -72.02 0.22 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.606 ' H ' ' CD ' ' A' ' 46' ' ' GLU . 2.6 pm0 -44.54 -24.8 0.21 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.859 0.361 . . . . 0.0 110.53 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.9 m 56.78 71.06 0.59 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.761 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -62.03 -27.96 69.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.184 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.77 -14.09 61.04 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 109.009 -1.636 . . . . 0.0 109.009 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.1 mp -65.76 -37.48 86.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.65 -0.775 . . . . 0.0 109.176 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.534 HG23 ' N ' ' A' ' 52' ' ' ARG . 20.0 m -60.87 -44.4 97.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.965 -178.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.534 ' N ' HG23 ' A' ' 51' ' ' VAL . 32.3 ttm180 -64.67 -35.44 81.05 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 119.779 -0.768 . . . . 0.0 112.35 -177.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 t -68.89 -38.01 79.37 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 119.383 -0.927 . . . . 0.0 108.778 177.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -130.63 94.39 3.63 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.571 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.21 -2.21 18.0 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -177.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.607 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 24.3 p -125.21 -141.74 0.29 Allowed 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.607 ' HB3' ' O ' ' A' ' 56' ' ' SER . . . 97.66 13.69 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 O-C-N 124.159 0.912 . . . . 0.0 111.928 178.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.445 ' O ' ' O ' ' A' ' 59' ' ' TYR . 25.0 pt20 -163.26 -39.4 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.369 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.445 ' O ' ' O ' ' A' ' 58' ' ' GLN . 39.5 m-85 54.35 166.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.979 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.408 ' O ' ' C ' ' A' ' 61' ' ' GLY . 65.3 mtm180 -57.54 -41.56 81.2 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 60' ' ' ARG . . . -29.98 102.47 0.01 OUTLIER Glycine 0 CA--C 1.527 0.833 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.567 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.3 p -67.26 -33.75 64.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 118.378 -0.82 . . . . 0.0 109.864 176.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -60.18 -32.27 70.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 121.144 1.793 . . . . 0.0 109.674 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.68 -49.4 64.32 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 115.022 -0.99 . . . . 0.0 114.564 -176.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.4 p -62.28 -46.69 87.67 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.5 tp -60.02 -35.38 60.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.606 HD23 ' O ' ' A' ' 67' ' ' LEU . 1.2 tt -63.21 -35.51 80.55 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 121.291 1.86 . . . . 0.0 110.848 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.614 ' O ' HG23 ' A' ' 72' ' ' THR . 99.9 m -62.63 -38.26 89.55 Favored 'General case' 0 C--O 1.246 0.884 0 CA-C-N 113.049 -1.887 . . . . 0.0 111.069 -175.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.512 ' O ' ' OG1' ' A' ' 72' ' ' THR . 0.4 OUTLIER -60.37 -39.14 86.17 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 120.322 -1.486 . . . . 0.0 114.283 -177.075 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.412 HG22 ' H ' ' A' ' 70' ' ' VAL . 5.7 m -69.49 -40.25 79.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 119.186 -1.005 . . . . 0.0 113.054 -178.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -78.4 -13.3 59.9 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -178.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.614 HG23 ' O ' ' A' ' 68' ' ' THR . 2.5 p -62.86 -54.61 36.07 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.707 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.515 ' N ' ' OE1' ' A' ' 73' ' ' GLU . 54.8 mp0 -107.36 -58.17 1.99 Allowed 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 155.45 164.19 12.89 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -56.59 -35.36 97.04 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 121.714 1.609 . . . . 0.0 111.925 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -61.65 -12.33 15.66 Favored 'General case' 0 C--O 1.226 -0.144 0 CA-C-O 121.751 0.786 . . . . 0.0 110.887 176.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.3 t -78.24 -32.9 49.95 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.247 -1.342 . . . . 0.0 110.805 -178.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 14.6 tp -75.94 -33.28 59.83 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.833 0.349 . . . . 0.0 110.963 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -92.3 -5.01 53.12 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 122.802 1.287 . . . . 0.0 112.767 -178.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -93.92 117.45 30.12 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 112.224 -2.262 . . . . 0.0 107.071 175.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.84 -10.39 57.24 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 -177.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 56.4 tp -59.05 -34.74 72.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 113.281 -1.46 . . . . 0.0 110.687 -179.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 38.2 t -70.44 -26.36 28.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.794 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.64 -31.17 61.89 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.908 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.8 -40.51 89.63 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 119.693 -1.241 . . . . 0.0 111.619 -177.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.408 ' N ' ' CD2' ' A' ' 86' ' ' LEU . 3.7 mm? -62.43 -40.36 96.32 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 122.351 1.072 . . . . 0.0 112.434 -177.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -60.32 -26.91 66.92 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 113.131 -1.85 . . . . 0.0 108.984 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 16.5 ttm-85 -57.73 -53.42 58.36 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 173.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 53.2 tp60 -67.32 -30.02 69.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 112.606 -2.088 . . . . 0.0 112.151 -178.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 11.9 tpt -61.15 -41.35 96.6 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.018 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 40.4 m -74.8 -34.86 62.47 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 119.455 -0.898 . . . . 0.0 111.304 -177.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -57.9 -44.12 86.56 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 120.966 1.712 . . . . 0.0 111.966 -176.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.48 -33.12 64.68 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.551 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.1 m -64.51 -41.69 96.26 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.429 ' CG1' HD12 ' A' ' 99' ' ' LEU . 86.0 t -68.22 -28.45 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.885 177.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.498 ' NH2' ' CE2' ' A' ' 100' ' ' TYR . 54.4 ttt-85 -77.78 9.5 3.45 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -176.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.454 ' O ' HG22 ' A' ' 97' ' ' ILE . 98.3 mt -86.8 -14.71 10.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -139.99 -48.38 0.06 OUTLIER Glycine 0 CA--C 1.543 1.809 0 N-CA-C 116.059 1.184 . . . . 0.0 116.059 -177.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.429 HD12 ' CG1' ' A' ' 95' ' ' VAL . 95.2 mt -71.72 -12.48 61.34 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 119.899 1.849 . . . . 0.0 113.792 -178.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.514 ' HE2' ' HZ1' ' A' ' 104' ' ' LYS . 2.5 t80 -80.12 -51.47 8.95 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.326 -1.306 . . . . 0.0 111.384 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -69.97 -32.35 70.53 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 123.619 1.676 . . . . 0.0 110.925 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.0 t -68.21 -51.07 49.66 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 110.455 -3.066 . . . . 0.0 113.301 177.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.684 HG22 ' CE2' ' A' ' 107' ' ' TYR . 0.3 OUTLIER -73.51 -26.41 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.359 0 CA-C-N 121.337 1.881 . . . . 0.0 111.24 179.115 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.514 ' HZ1' ' HE2' ' A' ' 100' ' ' TYR . 63.8 mttt -69.44 -41.74 75.88 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 112.385 -2.189 . . . . 0.0 112.533 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -80.16 -12.9 59.61 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 122.613 1.197 . . . . 0.0 111.047 -178.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -80.08 -23.19 41.49 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.24 178.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.684 ' CE2' HG22 ' A' ' 103' ' ' VAL . 21.4 m-85 -109.97 -28.54 8.68 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 119.53 1.059 . . . . 0.0 112.881 -175.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.11 9.38 41.06 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 116.765 -1.974 . . . . 0.0 113.962 -175.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.514 ' C ' ' H ' ' A' ' 111' ' ' SER . 62.0 mttp -45.97 130.11 9.75 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.512 1.051 . . . . 0.0 108.699 176.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -63.04 38.98 0.07 OUTLIER Glycine 0 CA--C 1.544 1.903 0 CA-C-N 119.179 0.9 . . . . 0.0 114.166 -178.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.514 ' H ' ' C ' ' A' ' 109' ' ' LYS . 10.6 m -5.29 -81.77 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 116.488 2.033 . . . . 0.0 116.488 -178.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.625 ' O ' ' CG ' ' A' ' 113' ' ' HIS . 2.9 tt0 165.79 -33.24 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 120.456 1.48 . . . . 0.0 113.446 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.655 ' O ' ' HB2' ' A' ' 114' ' ' ALA . 3.9 m-70 160.37 38.01 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.344 0.592 . . . . 0.0 109.931 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.655 ' HB2' ' O ' ' A' ' 113' ' ' HIS . . . 160.37 -162.7 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.855 0.836 . . . . 0.0 109.15 177.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.08 15.45 23.79 Favored Glycine 0 C--N 1.335 0.495 0 CA-C-N 114.104 -1.407 . . . . 0.0 110.512 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.631 HD12 HH21 ' A' ' 119' ' ' ARG . 8.7 tp -60.66 -40.36 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 C-N-CA 119.726 -0.79 . . . . 0.0 109.069 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.508 ' N ' HG23 ' A' ' 116' ' ' ILE . . . -65.99 -40.84 95.44 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-O 121.509 0.505 . . . . 0.0 111.885 175.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 42.0 p -59.11 -43.16 91.9 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 176.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.631 HH21 HD12 ' A' ' 116' ' ' ILE . 9.9 ttp-105 -64.05 -36.98 85.79 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.64 -178.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 18.3 tp -63.43 -45.73 89.61 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 36.5 mt -66.08 -44.58 84.03 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.491 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.8 -45.23 90.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 119.691 1.132 . . . . 0.0 110.27 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -66.01 -44.32 91.78 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.129 -1.034 . . . . 0.0 111.318 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 69.3 m -64.04 -44.12 93.46 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.277 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 96.7 m -69.32 -48.19 62.26 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 119.339 -0.944 . . . . 0.0 111.945 177.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 25.3 p -65.36 -42.68 92.52 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -174.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -64.11 -44.53 95.63 Favored Glycine 0 CA--C 1.521 0.424 0 CA-C-O 122.969 1.316 . . . . 0.0 112.904 -177.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.476 ' O ' HG22 ' A' ' 131' ' ' VAL . . . -61.35 -41.54 97.23 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 111.878 -2.161 . . . . 0.0 107.296 177.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.613 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 35.9 tp -64.04 -42.03 97.19 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.801 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.0 -40.03 96.55 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 113.205 0.816 . . . . 0.0 113.205 -177.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.476 HG22 ' O ' ' A' ' 128' ' ' ALA . 15.5 m -61.07 -26.05 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 122.687 1.232 . . . . 0.0 109.989 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.613 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . -58.35 -45.09 88.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 112.399 -2.182 . . . . 0.0 110.909 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 49.1 t -79.25 -49.08 20.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.449 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -97.96 135.05 40.23 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.478 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.641 ' H ' ' HD2' ' A' ' 136' ' ' PRO . 2.2 tp-100 -177.77 -39.6 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.871 179.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.641 ' HD2' ' H ' ' A' ' 135' ' ' GLN . 73.8 Cg_exo -52.45 -33.55 57.55 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 122.143 1.896 . . . . 0.0 112.46 -179.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 66.6 p -67.53 -42.69 82.31 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 118.725 -1.19 . . . . 0.0 109.879 -178.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -66.24 -42.81 88.11 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 119.303 -0.959 . . . . 0.0 112.136 -178.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 89.6 t -64.11 -44.28 97.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.406 HG13 ' O ' ' A' ' 136' ' ' PRO . 34.5 m -65.07 -39.49 85.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -176.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -63.08 -42.3 99.61 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 118.668 -1.213 . . . . 0.0 111.657 -178.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.421 HG13 ' N ' ' A' ' 143' ' ' ARG . 3.8 p -71.4 -46.45 64.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.678 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.421 ' N ' HG13 ' A' ' 142' ' ' VAL . 14.4 tpp180 -65.9 -38.09 87.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.693 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -68.11 -42.44 80.24 Favored 'General case' 0 C--O 1.226 -0.165 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -177.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -66.23 -40.83 90.55 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 118.819 -1.153 . . . . 0.0 110.133 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.48 -35.18 80.13 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 -178.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.466 ' CG ' ' O ' ' A' ' 147' ' ' GLN . 6.4 pt20 -59.94 111.1 1.35 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 177.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -95.19 -63.84 1.12 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 117.62 -1.181 . . . . 0.0 112.696 -177.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.462 ' O ' ' N ' ' A' ' 151' ' ' GLY . 16.2 mmm180 -77.76 0.12 24.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 122.675 2.489 . . . . 0.0 109.725 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . 62.02 -75.23 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.619 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 149' ' ' ARG . . . 157.56 -115.66 0.67 Allowed Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.679 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 179.962 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 1.7 t80 . . . . . 0 CA--C 1.531 0.23 0 CA-C-O 120.712 0.291 . . . . 0.0 110.43 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -88.21 153.69 21.03 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.946 0.403 . . . . 0.0 111.047 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.711 ' H ' ' CG ' ' A' ' 161' ' ' GLU . 19.5 m -157.12 -178.77 7.61 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 121.309 0.576 . . . . 0.0 111.007 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.548 HG23 ' N ' ' A' ' 160' ' ' VAL . 10.2 t -64.78 -46.32 82.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.442 -178.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.55 HG23 ' N ' ' A' ' 161' ' ' GLU . 27.4 m -64.53 -45.78 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 C-N-CA 119.354 -0.939 . . . . 0.0 110.674 -178.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.711 ' CG ' ' H ' ' A' ' 158' ' ' SER . 3.1 pp20? -67.59 -38.6 84.27 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.545 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.49 ' N ' ' CD ' ' A' ' 161' ' ' GLU . . . -61.58 -45.68 93.08 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -62.37 -49.69 74.54 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.389 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -68.45 -45.53 72.24 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 -176.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 14.5 m -62.85 -44.7 95.44 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -177.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.476 HD12 ' N ' ' A' ' 167' ' ' ALA . 2.6 pp -64.71 -38.37 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 121.955 0.884 . . . . 0.0 109.345 176.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.476 ' N ' HD12 ' A' ' 166' ' ' ILE . . . -59.58 -36.19 75.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 113.786 -1.552 . . . . 0.0 107.486 176.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 11.3 tpp85 -61.98 -49.8 74.64 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 122.266 2.303 . . . . 0.0 111.71 -175.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -74.62 -50.82 16.39 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 123.442 0.697 . . . . 0.0 109.51 177.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -77.85 -36.43 49.99 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 116.997 2.221 . . . . 0.0 116.997 -172.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 90.33 -166.16 31.82 Favored Glycine 0 N--CA 1.471 0.994 0 CA-C-N 118.779 0.718 . . . . 0.0 112.109 177.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.703 ' N ' HD12 ' A' ' 172' ' ' ILE . 2.0 mp -73.1 -44.11 56.93 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 CA-C-O 121.978 0.894 . . . . 0.0 110.251 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 -58.61 -33.47 70.06 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.632 -176.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -60.74 -40.54 98.25 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 118.896 -1.621 . . . . 0.0 110.23 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 52.4 tp -69.93 -33.94 72.8 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 116.646 2.091 . . . . 0.0 116.646 -177.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -78.41 -7.97 57.95 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 111.437 -2.62 . . . . 0.0 109.794 -178.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 38.1 tptt -43.42 -48.39 7.13 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.792 -176.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -86.02 -39.88 7.8 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.237 0.922 . . . . 0.0 110.845 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.6 m -45.44 -51.44 11.47 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . 0.457 ' O ' HG12 ' A' ' 183' ' ' VAL . 2.7 m -63.19 -50.92 73.05 Favored Pre-proline 0 N--CA 1.474 0.739 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -176.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 180' ' ' SER . 33.6 Cg_endo -65.02 -27.32 57.9 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.278 1.985 . . . . 0.0 112.353 177.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -63.0 -38.63 91.96 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 121.228 -0.189 . . . . 0.0 111.102 -178.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.457 HG12 ' O ' ' A' ' 180' ' ' SER . 1.9 p -62.47 -42.02 94.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.372 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.41 ' N ' ' CG1' ' A' ' 183' ' ' VAL . . . -62.22 -39.54 93.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.95 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 72.3 ttp85 -61.08 -42.06 97.81 Favored 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.793 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . 0.557 ' ND2' ' N ' ' A' ' 187' ' ' ALA . 0.1 OUTLIER -62.13 -42.67 99.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.964 0.411 . . . . 0.0 111.348 179.695 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . 0.557 ' N ' ' ND2' ' A' ' 186' ' ' ASN . . . -63.8 -44.24 93.9 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -177.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 7.4 tt -63.98 -45.23 97.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -178.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 12.9 m -60.18 -46.61 94.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 119.679 -0.808 . . . . 0.0 111.807 -178.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.501 ' ND2' ' N ' ' A' ' 191' ' ' CYS . 0.1 OUTLIER -62.41 -43.0 99.86 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 122.274 1.035 . . . . 0.0 109.602 179.414 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' CYS . . . . . 0.501 ' N ' ' ND2' ' A' ' 190' ' ' ASN . 45.9 t -62.36 -47.19 85.3 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 113.538 -1.664 . . . . 0.0 111.004 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.514 ' O ' HG23 ' A' ' 196' ' ' THR . . . -64.89 -41.17 95.84 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.083 177.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -61.09 -45.09 96.13 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.366 -1.288 . . . . 0.0 112.087 -178.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.627 ' CD2' ' HE ' ' A' ' 119' ' ' ARG . 17.5 mt -63.21 -37.0 85.53 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 119.228 -0.989 . . . . 0.0 108.705 -175.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 92.7 t -62.69 -45.98 97.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 C-N-CA 117.074 -1.85 . . . . 0.0 107.101 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . 0.514 HG23 ' O ' ' A' ' 192' ' ' ALA . 59.9 p -64.46 -45.95 85.2 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -178.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -56.92 -38.91 73.52 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.018 1.327 . . . . 0.0 113.209 -177.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -55.37 -44.12 75.76 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.53 HD12 ' N ' ' A' ' 199' ' ' LEU . 10.1 mp -60.84 -38.22 84.74 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.624 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 57.9 mt -61.37 -42.01 92.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.19 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 19.4 mmtp -59.68 -38.22 80.92 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.609 1.564 . . . . 0.0 113.329 177.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -63.27 -39.96 96.06 Favored 'General case' 0 C--N 1.316 -0.862 0 O-C-N 121.941 -0.474 . . . . 0.0 111.027 -177.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.4 t -101.26 129.04 47.14 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 122.041 0.924 . . . . 0.0 112.621 -178.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 2.2 tp 67.73 4.25 3.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 113.788 -1.551 . . . . 0.0 111.976 178.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 2.3 mt -126.71 28.78 5.82 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.718 0.771 . . . . 0.0 112.014 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 18.1 mtpp -73.86 -23.68 59.64 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.258 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -162.99 34.17 0.1 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.658 -1.155 . . . . 0.0 108.316 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 2.4 m120 42.42 54.31 4.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.354 -1.294 . . . . 0.0 113.663 177.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.826 ' H ' HD13 ' A' ' 209' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.463 0.18 0 CA-C-N 114.777 -1.101 . . . . 0.0 108.745 178.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 . . . . . 0 CA--C 1.521 -0.172 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.467 ' N ' ' CD ' ' A' ' 215' ' ' PRO . 3.4 mt -61.07 -43.48 90.96 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.871 -177.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' A' ' 214' ' ' LEU . 26.4 Cg_exo -61.2 -33.33 90.6 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 120.716 0.944 . . . . 0.0 110.701 -179.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 86.9 m -65.62 -43.58 89.13 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.161 -1.381 . . . . 0.0 112.579 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 38.0 t-80 -67.7 -39.29 84.42 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -177.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -64.12 -46.83 82.43 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.217 -179.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 28.6 p -60.34 -37.84 81.93 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 118.894 0.77 . . . . 0.0 110.239 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 70.7 m -59.76 -41.72 91.68 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . 0.556 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.99 -41.67 97.44 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -177.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -62.02 -47.27 85.5 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.896 0.855 . . . . 0.0 113.111 -176.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -60.98 -42.25 99.7 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 108.0 -2.04 . . . . 0.0 108.0 177.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -63.22 -37.79 88.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.05 -1.075 . . . . 0.0 109.275 176.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -61.33 -41.78 99.61 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 114.172 -1.376 . . . . 0.0 111.59 -176.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -66.08 -38.91 89.45 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 118.168 -1.413 . . . . 0.0 107.949 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 83.6 m -64.01 -41.6 97.41 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.466 0.65 . . . . 0.0 109.778 176.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -61.81 -39.59 92.3 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.321 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 31.3 m -57.85 -39.23 77.24 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.15 -176.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 98.1 t -60.17 -40.87 84.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 118.804 -1.158 . . . . 0.0 108.302 178.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . 0.567 ' O ' ' HD2' ' A' ' 234' ' ' PRO . 0.2 OUTLIER -61.81 -40.8 88.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 177.444 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -62.59 -38.98 92.27 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 115.686 1.736 . . . . 0.0 115.686 -178.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.449 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 0.2 OUTLIER -57.68 -40.82 86.77 Favored Pre-proline 0 N--CA 1.476 0.863 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 -172.721 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.567 ' HD2' ' O ' ' A' ' 231' ' ' ILE . 38.4 Cg_exo -58.62 -40.46 73.5 Favored 'Trans proline' 0 C--N 1.293 -2.343 0 C-N-CA 121.666 1.577 . . . . 0.0 113.78 -177.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.3 m -64.51 -37.44 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 118.395 -1.322 . . . . 0.0 109.336 178.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -65.94 -40.64 91.53 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.05 178.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 233' ' ' SER . 55.9 t -64.79 -45.07 96.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 115.295 -0.866 . . . . 0.0 113.073 -177.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 15.5 m . . . . . 0 C--N 1.324 -0.533 0 C-N-CA 119.749 -0.781 . . . . 0.0 111.299 -177.718 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 74.7 p . . . . . 0 N--CA 1.467 0.423 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' MET . . . . . . . . . . . . . 2.9 ptm -60.77 -43.48 98.0 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 121.013 -0.275 . . . . 0.0 111.505 -177.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 12.2 mt -62.53 -47.29 84.56 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 59.6 ttt85 -67.11 -54.11 24.46 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.549 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 28.1 mmtp -70.13 -156.42 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.929 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . 0.513 ' OE2' ' N ' ' A' ' 265' ' ' GLY . 1.0 OUTLIER -38.8 133.55 1.08 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.025 -179.702 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . 0.513 ' N ' ' OE2' ' A' ' 264' ' ' GLU . . . -47.98 169.97 0.07 OUTLIER Glycine 0 CA--C 1.533 1.179 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -55.54 -0.67 0.17 Allowed 'Trans proline' 0 N--CA 1.5 1.869 0 C-N-CA 121.978 1.786 . . . . 0.0 112.326 178.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . 0.492 ' H ' ' C ' ' A' ' 265' ' ' GLY . 91.1 mtt180 -69.77 -26.79 64.45 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.13 0.572 . . . . 0.0 112.3 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -58.37 -32.33 68.48 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.1 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -62.42 -41.34 98.63 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.138 0.494 . . . . 0.0 111.186 177.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -65.74 -37.82 87.42 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -177.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.457 ' O ' ' O ' ' A' ' 272' ' ' GLY . 14.8 mptt -56.39 -172.33 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 271' ' ' LYS . . . 45.82 103.11 0.01 OUTLIER Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.501 -0.64 . . . . 0.0 111.501 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -158.62 -12.91 0.07 Allowed 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.346 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' MET . . . . . 0.541 ' N ' ' HD2' ' A' ' 275' ' ' PRO . 2.1 tpt -64.07 -45.16 79.67 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 120.39 -0.524 . . . . 0.0 111.429 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 274' ' ' MET . 36.9 Cg_endo -64.84 -45.76 7.76 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.362 1.375 . . . . 0.0 111.57 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 78.5 p -59.67 -38.88 82.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.746 -178.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -61.0 -42.55 98.65 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 122.629 1.204 . . . . 0.0 112.017 -178.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 9.4 mp -62.02 -38.45 88.69 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 112.298 -2.228 . . . . 0.0 107.678 174.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 9.9 mtm180 -62.71 -39.23 93.37 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.21 0.529 . . . . 0.0 110.184 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 6.8 tp -61.97 -36.96 83.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.885 -177.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -67.95 -51.23 35.65 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . 0.425 ' O ' HG12 ' A' ' 285' ' ' VAL . 36.3 m -62.92 -44.36 96.29 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' TRP . . . . . 0.471 ' O ' HG22 ' A' ' 286' ' ' VAL . 91.5 t90 -60.05 -38.17 81.99 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.674 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -62.77 -38.62 91.34 Favored 'General case' 0 C--N 1.317 -0.814 0 O-C-N 122.068 -0.395 . . . . 0.0 111.181 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.425 HG12 ' O ' ' A' ' 282' ' ' SER . 0.3 OUTLIER -60.98 -39.36 81.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -177.585 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.471 HG22 ' O ' ' A' ' 283' ' ' TRP . 6.5 m -62.91 -40.08 87.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 119.98 -0.688 . . . . 0.0 109.941 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' MET . . . . . 0.4 ' O ' ' OG1' ' A' ' 290' ' ' THR . 10.0 tpt -60.49 -38.95 85.98 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.162 0.506 . . . . 0.0 109.695 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -58.81 -40.18 83.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.542 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.427 HG12 ' O ' ' A' ' 286' ' ' VAL . 0.3 OUTLIER -60.71 -38.72 79.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.365 -177.645 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.4 ' OG1' ' O ' ' A' ' 287' ' ' MET . 39.4 p -62.71 -40.62 97.74 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 177.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -61.56 -39.05 89.72 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 176.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -58.72 -40.96 85.25 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 117.921 -1.512 . . . . 0.0 109.506 -176.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' GLN . . . . . 0.45 ' O ' ' O ' ' A' ' 296' ' ' ARG . 88.4 mt-30 -60.78 -42.78 98.19 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 122.825 1.298 . . . . 0.0 110.623 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.513 HD13 ' O ' ' A' ' 294' ' ' LEU . 0.2 OUTLIER -60.41 -40.68 91.87 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 112.583 -2.099 . . . . 0.0 109.091 179.507 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 1.8 mmmm -63.48 -45.8 89.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.34 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' ARG . . . . . 0.45 ' O ' ' O ' ' A' ' 293' ' ' GLN . 0.5 OUTLIER -122.96 116.23 23.22 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.364 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -116.25 -95.0 0.48 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.381 0.61 . . . . 0.0 110.767 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.415 ' C ' HD12 ' A' ' 298' ' ' LEU . 3.5 pp -136.65 -166.66 1.93 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.288 178.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 12.5 ttt -170.81 66.36 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.288 -0.565 . . . . 0.0 111.489 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.6 101.01 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.849 0.833 . . . . 0.0 110.697 -178.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -64.05 -46.13 85.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 113.895 -1.502 . . . . 0.0 113.534 -176.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . 0.534 ' CD2' ' OE2' ' A' ' 306' ' ' GLU . 19.9 t80 -58.66 -39.82 81.72 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.643 -178.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -64.84 -46.53 81.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.072 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' SER . . . . . 0.42 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 37.8 m -66.15 -37.17 85.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.539 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -61.12 -42.48 98.61 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.186 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . 0.534 ' OE2' ' CD2' ' A' ' 302' ' ' TYR . 52.1 mt-10 -64.66 -36.83 85.52 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 -177.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . 0.542 ' HB3' ' HD3' ' A' ' 308' ' ' PRO . . . -59.88 -53.0 69.68 Favored Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -176.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' PRO . . . . . 0.542 ' HD3' ' HB3' ' A' ' 307' ' ' ALA . 74.1 Cg_endo -75.13 0.25 9.18 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.109 1.873 . . . . 0.0 111.785 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' PHE . . . . . 0.491 ' CG ' ' O ' ' A' ' 308' ' ' PRO . 56.6 m-85 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.35 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.733 ' HA ' HD21 ' A' ' 18' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.431 0 CA-C-O 120.771 0.319 . . . . 0.0 111.164 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.411 ' H ' ' HG ' ' A' ' 18' ' ' LEU . 7.6 m -114.2 178.47 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 178.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.433 ' CD ' ' N ' ' A' ' 16' ' ' LYS . 3.8 mptp? -64.53 -41.52 96.32 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.189 -0.46 . . . . 0.0 112.066 -178.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -62.94 -42.13 99.71 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -178.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.738 ' C ' HD12 ' A' ' 18' ' ' LEU . 1.1 pp -80.59 -24.17 39.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.428 0.632 . . . . 0.0 112.564 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.478 ' N ' HD12 ' A' ' 18' ' ' LEU . . . -65.07 -40.43 96.99 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 107.241 -2.344 . . . . 0.0 107.241 177.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.452 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -71.17 -31.34 67.55 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 124.515 2.103 . . . . 0.0 107.485 176.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.78 -42.62 98.49 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-N 108.781 -3.827 . . . . 0.0 110.315 -178.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.4 t -70.92 -26.6 63.27 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -65.8 -50.6 64.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.711 -178.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.08 -36.1 80.68 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 118.308 -1.357 . . . . 0.0 111.016 -177.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.9 t -63.97 -53.63 47.11 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.849 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 74.3 mt -65.49 -39.88 86.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -177.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.39 -42.43 96.11 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 119.516 -0.873 . . . . 0.0 112.701 -174.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.409 ' HA ' HG22 ' A' ' 31' ' ' THR . 11.1 t70 -78.13 -27.05 48.17 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 120.718 1.599 . . . . 0.0 110.111 -175.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.494 HD23 ' O ' ' A' ' 29' ' ' LEU . 1.2 tt -59.43 -55.54 33.37 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 120.033 1.288 . . . . 0.0 111.933 -177.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.432 ' O ' HD13 ' A' ' 30' ' ' ILE . 0.4 OUTLIER -75.19 -3.56 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -179.24 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.409 HG22 ' HA ' ' A' ' 28' ' ' ASP . 0.4 OUTLIER -109.5 -17.2 13.81 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.302 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.438 ' O ' ' OD1' ' A' ' 35' ' ' ASP . 1.6 t80 -67.95 -44.62 40.79 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 116.474 -2.09 . . . . 0.0 109.984 -177.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.421 ' CD ' ' N ' ' A' ' 32' ' ' PHE . 35.2 Cg_exo -59.45 -15.68 31.46 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 121.252 1.301 . . . . 0.0 112.291 176.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.96 -35.23 79.51 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -177.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 36' ' ' THR . 27.7 p-10 -64.53 -40.33 95.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.763 -177.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.543 ' N ' ' OD1' ' A' ' 35' ' ' ASP . 31.6 p -58.19 -34.66 70.6 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -179.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.11 -38.78 86.22 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.3 pttp -62.23 -48.3 80.58 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 118.877 -1.129 . . . . 0.0 111.4 -177.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.0 m -63.41 -38.23 81.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 O-C-N 122.135 -0.353 . . . . 0.0 111.927 -178.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.524 ' O ' ' NE2' ' A' ' 42' ' ' GLN . 5.5 mmp_? -59.35 -40.03 85.08 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.514 -178.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.46 38.86 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.524 ' NE2' ' O ' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -114.09 -177.2 3.07 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.407 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.786 HG23 ' H ' ' A' ' 44' ' ' GLN . 13.1 tt -63.12 -62.08 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.364 -0.535 . . . . 0.0 109.81 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.786 ' H ' HG23 ' A' ' 43' ' ' ILE . 3.3 mt-30 169.55 5.95 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.456 ' H ' ' H ' ' A' ' 44' ' ' GLN . . . 54.34 37.46 59.88 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.364 -1.095 . . . . 0.0 110.364 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.443 ' O ' ' CB ' ' A' ' 47' ' ' SER . 2.9 pt-20 -93.17 -95.26 0.15 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.617 0.246 . . . . 0.0 110.515 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.524 ' C ' ' H ' ' A' ' 49' ' ' GLY . 0.9 OUTLIER 82.13 -31.09 0.1 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.82 -179.833 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -65.01 8.43 0.13 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.854 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.524 ' H ' ' C ' ' A' ' 47' ' ' SER . . . 80.85 16.38 75.27 Favored Glycine 0 CA--C 1.535 1.299 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -177.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.572 HD23 ' O ' ' A' ' 50' ' ' LEU . 1.7 tt -61.44 -36.38 80.22 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 114.875 -0.662 . . . . 0.0 110.386 -176.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.499 HG13 ' N ' ' A' ' 52' ' ' ARG . 7.3 p -59.82 -44.64 94.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 C-N-CA 120.191 -0.603 . . . . 0.0 112.2 -178.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.499 ' N ' HG13 ' A' ' 51' ' ' VAL . 45.9 ttp180 -65.33 -35.95 82.54 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 119.451 -0.899 . . . . 0.0 112.793 -178.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 t -69.56 -38.48 77.46 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.628 0.728 . . . . 0.0 109.662 178.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -152.68 123.26 7.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.193 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -99.3 176.66 5.45 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -177.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.618 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 45.7 p 53.9 -141.34 0.87 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 113.993 -1.458 . . . . 0.0 108.923 -178.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.618 ' HB3' ' O ' ' A' ' 56' ' ' SER . . . 95.7 14.23 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.893 178.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 11.9 tp-100 -167.29 73.25 0.12 Allowed 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.547 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -61.05 142.34 56.72 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.433 ' O ' ' C ' ' A' ' 61' ' ' GLY . 84.1 mtp180 -39.41 -37.07 0.42 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.955 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 60' ' ' ARG . . . -28.8 101.44 0.01 OUTLIER Glycine 0 CA--C 1.531 1.064 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.28 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 56.2 t -66.97 -33.79 65.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 118.121 -0.943 . . . . 0.0 109.687 176.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 43.9 mt -60.56 -32.43 71.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 121.489 1.949 . . . . 0.0 111.213 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.6 -49.01 66.84 Favored Glycine 0 CA--C 1.532 1.138 0 N-CA-C 115.246 0.859 . . . . 0.0 115.246 -176.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.439 ' H ' HG22 ' A' ' 65' ' ' THR . 0.6 OUTLIER -61.99 -45.97 91.27 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.465 0.542 . . . . 0.0 112.465 -179.082 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 25.0 pt -59.75 -36.03 63.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 118.365 -0.826 . . . . 0.0 108.845 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 78.3 mt -63.84 -35.72 81.55 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 121.137 1.789 . . . . 0.0 111.749 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 97.9 m -62.91 -39.11 93.51 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 113.506 -1.679 . . . . 0.0 111.008 -175.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.457 ' C ' ' SD ' ' A' ' 69' ' ' MET . 0.0 OUTLIER -60.29 -40.39 90.31 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 120.775 -1.203 . . . . 0.0 113.835 -176.427 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.6 p -69.66 -40.56 79.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 119.211 -0.996 . . . . 0.0 113.176 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 67.9 ttp85 -78.42 -13.27 59.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.709 0.766 . . . . 0.0 112.823 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 61.0 m -62.55 -54.82 34.06 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.111 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -110.18 -54.17 2.6 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 157.03 164.11 13.22 Favored Glycine 0 CA--C 1.539 1.56 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -56.42 -35.47 96.41 Favored 'Trans proline' 0 N--CA 1.503 2.058 0 CA-C-N 119.493 1.646 . . . . 0.0 112.395 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -61.09 -11.47 8.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 122.102 0.953 . . . . 0.0 111.135 176.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.472 ' O ' ' OD1' ' A' ' 80' ' ' ASN . 3.6 t -77.72 -32.26 52.74 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 113.716 -1.583 . . . . 0.0 110.727 -178.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.45 HD22 ' N ' ' A' ' 78' ' ' LEU . 4.1 mm? -75.65 -32.5 60.23 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 122.089 -0.382 . . . . 0.0 110.843 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -91.37 -4.35 55.83 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -176.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.472 ' OD1' ' O ' ' A' ' 77' ' ' SER . 35.1 p30 -95.72 26.88 3.74 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 112.189 -2.278 . . . . 0.0 107.648 175.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -159.05 -19.72 0.03 OUTLIER Glycine 0 CA--C 1.53 1.001 0 CA-C-N 114.28 -1.327 . . . . 0.0 112.417 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.589 HD13 ' O ' ' A' ' 82' ' ' LEU . 0.2 OUTLIER -59.65 -35.16 73.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.263 -0.968 . . . . 0.0 110.502 -179.442 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.9 p -70.87 -27.44 30.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.525 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.86 -31.33 61.6 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.349 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.91 -40.54 89.15 Favored Glycine 0 C--O 1.223 -0.573 0 C-N-CA 119.69 -1.243 . . . . 0.0 111.148 -178.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 50.5 mt -62.37 -40.25 95.84 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 122.476 1.132 . . . . 0.0 112.67 -177.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -60.03 -27.01 66.55 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 112.986 -1.915 . . . . 0.0 109.025 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 36.2 ttp180 -57.31 -52.55 64.89 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 173.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -67.53 -30.32 69.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 112.853 -1.976 . . . . 0.0 112.329 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 11.8 tmm? -61.01 -41.99 97.61 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.551 -0.749 . . . . 0.0 112.484 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 21.8 t -74.81 -34.33 62.35 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.533 -176.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -57.69 -44.08 85.59 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 120.231 1.378 . . . . 0.0 111.9 -176.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.56 -32.87 64.39 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 119.402 -0.919 . . . . 0.0 110.732 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.618 ' O ' HG22 ' A' ' 97' ' ' ILE . 58.4 p -64.51 -42.2 95.96 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.457 ' C ' ' H ' ' A' ' 97' ' ' ILE . 7.1 p -68.39 -28.32 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 177.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.483 ' O ' ' CG ' ' A' ' 96' ' ' ARG . 35.3 ttt-85 -77.36 9.71 3.02 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 -176.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.618 HG22 ' O ' ' A' ' 94' ' ' SER . 3.4 tp -86.92 -15.39 9.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 177.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.498 ' O ' ' OD1' ' A' ' 101' ' ' ASP . . . -140.24 -48.17 0.06 OUTLIER Glycine 0 CA--C 1.544 1.872 0 N-CA-C 116.018 1.167 . . . . 0.0 116.018 -177.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.601 ' N ' HD12 ' A' ' 99' ' ' LEU . 8.6 mp -72.06 -13.06 61.49 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 120.111 1.955 . . . . 0.0 113.669 -178.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.498 ' O ' ' CG ' ' A' ' 104' ' ' LYS . 48.7 t80 -80.48 -51.85 8.32 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 114.551 -1.204 . . . . 0.0 113.025 -178.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.498 ' OD1' ' O ' ' A' ' 98' ' ' GLY . 30.9 p-10 -70.32 -32.36 70.07 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 123.663 1.696 . . . . 0.0 110.821 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.456 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 24.1 p -68.19 -51.34 46.7 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 110.284 -3.144 . . . . 0.0 112.641 176.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 59.1 t -73.51 -26.47 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 CA-C-N 121.254 1.843 . . . . 0.0 112.106 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.498 ' CG ' ' O ' ' A' ' 100' ' ' TYR . 22.7 mmtm -68.89 -41.75 77.85 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 111.914 -2.403 . . . . 0.0 110.757 178.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.487 ' HG3' ' O ' ' A' ' 101' ' ' ASP . 88.1 mt-30 -78.26 -14.64 59.35 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-O 122.772 1.272 . . . . 0.0 111.045 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -79.76 -23.16 42.41 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 114.672 -1.149 . . . . 0.0 112.462 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.622 ' CZ ' ' ND2' ' A' ' 190' ' ' ASN . 32.9 m-85 -109.66 -29.95 8.12 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 119.39 0.995 . . . . 0.0 111.735 -175.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.9 p -97.56 9.33 42.74 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 117.028 -1.869 . . . . 0.0 112.675 -178.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.532 ' O ' ' C ' ' A' ' 110' ' ' GLY . 6.1 pttp -48.06 124.41 7.58 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 117.792 -1.099 . . . . 0.0 109.835 177.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.533 ' O ' ' CB ' ' A' ' 111' ' ' SER . . . -26.46 -77.52 0.01 OUTLIER Glycine 0 N--CA 1.488 2.134 0 CA-C-N 120.46 1.482 . . . . 0.0 111.515 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 110' ' ' GLY . 24.0 p 103.35 -159.68 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 176.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.563 ' O ' ' N ' ' A' ' 114' ' ' ALA . 94.8 mt-10 -128.76 96.8 4.47 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.254 -0.885 . . . . 0.0 112.649 -178.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.636 ' O ' ' HB2' ' A' ' 114' ' ' ALA . 76.8 m-70 12.63 51.11 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 O-C-N 124.245 0.965 . . . . 0.0 113.138 178.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.636 ' HB2' ' O ' ' A' ' 113' ' ' HIS . . . 159.41 -161.79 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.36 14.97 26.65 Favored Glycine 0 C--N 1.338 0.687 0 CA-C-N 114.999 -1.0 . . . . 0.0 113.227 176.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.462 HG23 ' N ' ' A' ' 117' ' ' GLY . 13.0 tt -60.91 -40.35 85.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 119.167 -1.013 . . . . 0.0 109.438 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.462 ' N ' HG23 ' A' ' 116' ' ' ILE . . . -65.49 -39.56 95.72 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 122.047 0.804 . . . . 0.0 111.4 176.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 9.6 p -57.81 -42.11 83.59 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 177.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -63.42 -37.18 86.3 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.975 -178.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 30.8 tp -64.03 -46.98 82.04 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.354 0.597 . . . . 0.0 109.778 178.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 42.8 mt -67.06 -44.83 79.12 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.848 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.78 -44.7 92.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 119.281 0.946 . . . . 0.0 109.36 178.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -65.94 -44.16 92.28 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 119.691 -1.242 . . . . 0.0 111.665 -179.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 67.1 m -63.72 -43.91 95.15 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.384 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 20.9 m -69.44 -48.53 60.65 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 119.082 -1.047 . . . . 0.0 112.023 177.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 41.5 p -65.54 -43.0 91.3 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 -174.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -64.46 -44.85 94.65 Favored Glycine 0 CA--C 1.521 0.407 0 CA-C-N 114.734 -1.121 . . . . 0.0 112.918 -177.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.448 ' O ' HG12 ' A' ' 131' ' ' VAL . . . -61.83 -41.66 98.08 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 112.395 -1.903 . . . . 0.0 107.451 177.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.682 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 24.9 tp -64.67 -42.6 95.26 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.218 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.63 -40.16 96.17 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -177.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.448 HG12 ' O ' ' A' ' 128' ' ' ALA . 2.7 p -61.27 -26.46 39.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 123.363 1.554 . . . . 0.0 109.942 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.682 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . -58.78 -45.68 89.25 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 110.787 -2.915 . . . . 0.0 112.372 -178.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.59 ' C ' HE22 ' A' ' 135' ' ' GLN . 2.5 p -79.79 -48.65 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -178.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -102.5 86.12 2.73 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -177.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.688 ' H ' ' CD ' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -126.77 -22.99 0.04 OUTLIER Pre-proline 0 CA--C 1.551 0.983 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 177.6 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.688 ' CD ' ' H ' ' A' ' 135' ' ' GLN . 6.8 Cg_endo -54.98 -33.13 81.82 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 CA-C-N 121.554 1.591 . . . . 0.0 112.214 -178.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.513 ' O ' ' NZ ' ' A' ' 141' ' ' LYS . 73.3 p -68.22 -42.87 79.14 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 117.828 -1.549 . . . . 0.0 112.286 -175.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -67.46 -44.37 78.78 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 118.438 -1.305 . . . . 0.0 113.373 -178.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.452 HG23 ' N ' ' A' ' 140' ' ' VAL . 27.9 m -65.45 -44.76 94.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -178.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.452 ' N ' HG23 ' A' ' 139' ' ' VAL . 75.2 t -65.48 -40.29 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -176.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.513 ' NZ ' ' O ' ' A' ' 137' ' ' THR . 29.3 mtmm -63.18 -41.53 99.22 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.118 -178.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 3.5 p -71.1 -45.57 71.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.833 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.59 HH21 ' CG2' ' A' ' 166' ' ' ILE . 61.1 mtp180 -64.73 -37.34 87.28 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.161 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.611 ' CD1' ' NE2' ' A' ' 147' ' ' GLN . 76.2 t80 -67.27 -41.76 84.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.451 -178.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 18.0 tm0? -65.92 -40.73 91.71 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.518 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -64.84 -35.96 82.81 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -176.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.611 ' NE2' ' CD1' ' A' ' 144' ' ' PHE . 5.7 pt20 -59.3 111.12 1.24 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 177.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -102.49 -174.87 2.67 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 117.469 2.396 . . . . 0.0 117.469 -171.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 90.9 mtt-85 56.02 105.39 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 110.601 -2.999 . . . . 0.0 110.376 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -44.41 -77.45 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.786 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 46.07 81.95 0.04 OUTLIER Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.622 0 N-CA-C 110.829 -0.909 . . . . 0.0 110.829 179.898 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.489 ' O ' ' CD2' ' A' ' 156' ' ' TYR . 74.1 t80 . . . . . 0 C--O 1.23 0.044 0 CA-C-O 120.347 0.118 . . . . 0.0 111.059 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.448 ' O ' ' O ' ' A' ' 156' ' ' TYR . 51.0 mt-30 58.45 144.03 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.316 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.644 ' H ' ' CG ' ' A' ' 161' ' ' GLU . 3.5 m -156.97 -178.91 7.72 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.779 0.799 . . . . 0.0 112.23 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 26.4 p -64.87 -46.48 81.61 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 114.234 -1.348 . . . . 0.0 113.063 -177.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 42.4 t -64.28 -45.48 96.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.281 -177.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.644 ' CG ' ' H ' ' A' ' 158' ' ' SER . 8.3 pt-20 -67.99 -38.89 83.21 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.401 ' O ' HG22 ' A' ' 166' ' ' ILE . . . -61.56 -45.72 92.96 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -177.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.451 ' CG ' ' N ' ' A' ' 164' ' ' LYS . 0.1 OUTLIER -62.45 -48.77 78.18 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.041 -179.424 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.451 ' N ' ' CG ' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -67.54 -45.08 76.74 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -174.793 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 40.6 p -62.77 -44.79 95.26 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 119.738 1.154 . . . . 0.0 113.706 -177.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.59 ' CG2' HH21 ' A' ' 143' ' ' ARG . 18.5 tt -64.94 -38.51 82.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-O 121.933 0.873 . . . . 0.0 109.454 176.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.441 ' N ' HG23 ' A' ' 166' ' ' ILE . . . -59.78 -36.56 76.96 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 113.825 -1.534 . . . . 0.0 108.042 176.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -62.1 -50.03 73.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 122.708 2.504 . . . . 0.0 111.51 -175.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -74.75 -51.0 15.34 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 177.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -78.18 -36.51 47.38 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 116.25 1.944 . . . . 0.0 116.25 -173.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 91.78 -167.29 30.72 Favored Glycine 0 N--CA 1.468 0.779 0 CA-C-N 118.553 0.615 . . . . 0.0 112.095 177.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 8.5 pt -72.69 -42.74 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-O 121.845 0.831 . . . . 0.0 110.551 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 53.5 ttt85 -58.94 -33.54 70.73 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 114.381 -1.282 . . . . 0.0 110.838 -177.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -61.12 -40.69 98.89 Favored Glycine 0 CA--C 1.522 0.479 0 C-N-CA 118.503 -1.808 . . . . 0.0 109.592 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.429 ' CD1' ' NH1' ' A' ' 143' ' ' ARG . 7.4 tt -70.42 -33.78 71.74 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 111.688 -2.256 . . . . 0.0 116.701 -177.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 10.1 m0 -78.21 -7.86 57.62 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 111.713 -2.494 . . . . 0.0 109.909 -177.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 16.9 tptm -43.52 -48.3 7.38 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.192 -176.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -91.05 -34.99 7.3 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.449 1.023 . . . . 0.0 111.492 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.3 m -46.29 -51.94 13.6 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.24 -50.83 73.15 Favored Pre-proline 0 N--CA 1.477 0.903 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -176.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -64.06 -28.21 65.7 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 121.666 1.577 . . . . 0.0 111.44 175.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -63.79 -38.8 92.45 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.79 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.419 ' CG1' ' N ' ' A' ' 184' ' ' ALA . 0.8 OUTLIER -62.39 -42.12 94.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.722 -178.648 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.419 ' N ' ' CG1' ' A' ' 183' ' ' VAL . . . -61.96 -39.41 92.02 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.341 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 57.3 ttp85 -60.76 -41.97 96.51 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.093 -179.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -61.58 -43.23 99.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.26 0.552 . . . . 0.0 110.596 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.37 -43.05 95.74 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.741 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 78.1 mt -62.96 -45.02 99.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -176.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.518 ' O ' ' N ' ' A' ' 193' ' ' GLU . 5.9 m -59.44 -46.34 92.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 119.546 -0.861 . . . . 0.0 111.395 -178.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.622 ' ND2' ' CZ ' ' A' ' 107' ' ' TYR . 26.6 t-20 -63.08 -42.98 99.76 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 122.045 0.926 . . . . 0.0 110.908 178.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' CYS . . . . . 0.591 ' SG ' ' N ' ' A' ' 192' ' ' ALA . 0.5 OUTLIER -61.6 -45.41 94.2 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.014 -1.448 . . . . 0.0 108.867 179.049 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.591 ' N ' ' SG ' ' A' ' 191' ' ' CYS . . . -63.76 -39.2 93.69 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 112.584 -2.098 . . . . 0.0 109.149 175.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 189' ' ' VAL . 44.0 tp10 -60.31 -46.38 90.09 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.004 0.922 . . . . 0.0 112.706 -176.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 75.2 mt -65.61 -37.64 87.19 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.671 -175.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 2.5 p -64.26 -46.28 93.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 117.089 -1.845 . . . . 0.0 109.569 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 2.2 t -64.48 -45.36 87.71 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -177.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -57.41 -39.45 76.19 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 114.58 -1.191 . . . . 0.0 112.305 -178.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -56.07 -44.7 79.19 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 47.3 mt -61.83 -39.42 91.73 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.891 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 42.5 mm -63.47 -43.36 98.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 118.813 -0.613 . . . . 0.0 111.257 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . 0.482 ' O ' ' O ' ' A' ' 205' ' ' LEU . 49.9 mtmt -60.27 -40.51 90.63 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 120.171 1.35 . . . . 0.0 111.613 177.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -64.81 -38.23 90.27 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 113.867 -1.515 . . . . 0.0 110.982 -176.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.481 HG23 ' O ' ' A' ' 203' ' ' THR . 13.3 t -101.89 129.16 48.07 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.706 0.765 . . . . 0.0 112.413 -178.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.763 ' O ' HD23 ' A' ' 209' ' ' LEU . 0.5 OUTLIER 68.14 5.63 4.75 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 114.323 -1.308 . . . . 0.0 112.489 178.383 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.482 ' O ' ' O ' ' A' ' 201' ' ' LYS . 0.4 OUTLIER -141.78 79.88 1.7 Allowed 'General case' 0 N--CA 1.472 0.643 0 O-C-N 122.136 -0.352 . . . . 0.0 110.214 -178.652 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.539 ' O ' ' CB ' ' A' ' 207' ' ' ALA . 3.2 mtmp? -112.03 49.3 0.92 Allowed 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.079 -1.013 . . . . 0.0 110.826 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.539 ' CB ' ' O ' ' A' ' 206' ' ' LYS . . . 122.44 34.09 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.491 1.116 . . . . 0.0 110.007 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' ASN . . . . . 0.537 ' CB ' ' O ' ' A' ' 207' ' ' ALA . 9.0 t-20 102.36 -138.17 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 O-C-N 125.05 1.469 . . . . 0.0 108.95 -177.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.763 HD23 ' O ' ' A' ' 204' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.465 0.303 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 0.409 ' O ' ' OD2' ' A' ' 213' ' ' ASP . 5.6 p-10 . . . . . 0 N--CA 1.465 0.278 0 CA-C-O 120.964 0.411 . . . . 0.0 110.455 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.431 ' N ' ' CD ' ' A' ' 215' ' ' PRO . 3.8 mt -61.58 -43.53 88.84 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -178.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 214' ' ' LEU . 31.0 Cg_exo -60.97 -33.51 92.22 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 CA-C-O 122.811 1.088 . . . . 0.0 111.02 -178.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 77.6 m -64.7 -41.79 95.77 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 112.352 -2.204 . . . . 0.0 110.997 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' HIS . . . . . 0.496 ' O ' ' ND1' ' A' ' 217' ' ' HIS . 1.1 t60 -66.28 -37.52 85.63 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.514 -178.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -63.08 -48.13 79.93 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.199 -178.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 78.8 p -60.82 -38.46 85.53 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 119.79 1.177 . . . . 0.0 110.484 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 64.2 m -59.79 -42.01 92.44 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . 0.529 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.98 -42.29 97.27 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -62.78 -48.14 80.45 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -176.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -61.88 -42.89 99.79 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 108.466 -1.854 . . . . 0.0 108.466 177.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -63.43 -38.64 91.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.112 -1.044 . . . . 0.0 109.183 177.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -62.37 -43.31 99.24 Favored Glycine 0 CA--C 1.521 0.435 0 CA-C-N 114.685 -1.143 . . . . 0.0 111.07 -177.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' PHE . . . . . 0.45 ' O ' ' OG1' ' A' ' 229' ' ' THR . 72.7 t80 -67.48 -39.85 85.24 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 119.274 -0.971 . . . . 0.0 109.849 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . 0.529 ' SG ' ' N ' ' A' ' 228' ' ' THR . 1.5 p -64.5 -41.82 96.2 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.766 0.794 . . . . 0.0 109.238 176.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . 0.529 ' N ' ' SG ' ' A' ' 227' ' ' CYS . 91.3 m -62.35 -40.58 96.88 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 114.041 -1.436 . . . . 0.0 111.914 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 226' ' ' PHE . 5.4 p -58.73 -39.99 82.45 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.633 -176.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 58.9 t -61.05 -41.98 91.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 118.423 -1.311 . . . . 0.0 108.449 178.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . 0.538 ' O ' ' HD2' ' A' ' 234' ' ' PRO . 47.8 mt -62.48 -41.41 91.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.485 0.659 . . . . 0.0 110.158 177.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.42 ' HB3' ' HA ' ' A' ' 229' ' ' THR . . . -63.06 -39.37 94.53 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 115.891 1.811 . . . . 0.0 115.891 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.444 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 0.1 OUTLIER -57.95 -41.94 92.62 Favored Pre-proline 0 N--CA 1.475 0.809 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -172.512 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.538 ' HD2' ' O ' ' A' ' 231' ' ' ILE . 30.7 Cg_exo -59.77 -41.13 57.65 Favored 'Trans proline' 0 C--N 1.295 -2.259 0 C-N-CA 121.209 1.272 . . . . 0.0 112.894 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -65.69 -37.03 79.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 118.639 -1.224 . . . . 0.0 109.246 177.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -66.01 -41.71 90.64 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.437 ' CG1' ' N ' ' A' ' 238' ' ' VAL . 1.6 p -65.88 -46.41 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -176.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.437 ' N ' ' CG1' ' A' ' 237' ' ' VAL . 9.9 p . . . . . 0 C--N 1.33 -0.247 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.971 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 29.7 p . . . . . 0 CA--C 1.532 0.279 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' MET . . . . . . . . . . . . . 10.1 ptm -62.78 -44.13 96.99 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -178.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.508 HD13 ' O ' ' A' ' 261' ' ' LEU . 0.2 OUTLIER -62.23 -47.01 86.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.858 0.361 . . . . 0.0 110.041 -178.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -66.49 -53.69 32.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.547 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 54.1 mttp -80.57 -124.92 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -48.92 117.21 1.97 Allowed 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . 0.454 ' C ' ' H ' ' A' ' 267' ' ' ARG . . . -47.94 175.67 0.02 OUTLIER Glycine 0 CA--C 1.53 1.029 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 179.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.6 0.73 0.69 Allowed 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 122.237 1.958 . . . . 0.0 111.87 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . 0.454 ' H ' ' C ' ' A' ' 265' ' ' GLY . 77.4 mtt85 -68.79 -25.92 64.94 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.195 0.598 . . . . 0.0 111.875 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -57.82 -31.97 67.14 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.127 -178.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -62.07 -42.13 98.88 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.1 0.476 . . . . 0.0 110.78 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -66.39 -38.09 86.73 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -177.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.47 ' CG ' ' N ' ' A' ' 272' ' ' GLY . 53.2 tttp -80.85 173.08 12.96 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . 0.47 ' N ' ' CG ' ' A' ' 271' ' ' LYS . . . 62.38 100.37 0.01 OUTLIER Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -173.85 5.67 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.53 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' MET . . . . . 0.578 ' N ' ' CD ' ' A' ' 275' ' ' PRO . 0.7 OUTLIER -64.03 -44.21 77.27 Favored Pre-proline 0 CA--C 1.531 0.229 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.04 -179.879 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 274' ' ' MET . 21.5 Cg_exo -64.38 -46.46 7.51 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.516 2.144 . . . . 0.0 111.253 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 20.0 m -60.41 -39.44 87.41 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.25 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -61.48 -42.59 99.02 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 122.583 1.182 . . . . 0.0 112.737 -178.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.514 HD13 ' O ' ' A' ' 278' ' ' LEU . 0.2 OUTLIER -61.96 -38.76 89.71 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 112.262 -2.244 . . . . 0.0 107.778 174.501 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 41.7 mmm-85 -62.68 -39.32 93.58 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.32 0.581 . . . . 0.0 110.511 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.66 -36.23 80.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.13 -0.941 . . . . 0.0 113.011 -177.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -67.75 -50.73 40.04 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -178.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 47.8 p -62.74 -43.94 97.5 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' TRP . . . . . . . . . . . . . 75.3 t90 -59.9 -37.94 80.85 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.524 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . 0.405 ' ND2' ' N ' ' A' ' 285' ' ' VAL . 0.0 OUTLIER -61.56 -37.82 85.21 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.559 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.405 ' N ' ' ND2' ' A' ' 284' ' ' ASN . 94.6 t -59.76 -38.3 75.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.576 -0.283 . . . . 0.0 110.397 -179.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.438 ' O ' HG12 ' A' ' 289' ' ' VAL . 10.8 t -62.58 -41.07 90.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.845 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -61.36 -39.25 89.92 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.22 0.533 . . . . 0.0 110.378 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -59.5 -41.05 88.99 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -178.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.438 HG12 ' O ' ' A' ' 286' ' ' VAL . 0.7 OUTLIER -61.36 -40.14 85.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -175.914 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.21 -39.41 94.55 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -60.48 -38.5 84.47 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 176.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 32.9 tp10 -57.94 -40.27 80.11 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 118.157 -1.417 . . . . 0.0 109.417 -176.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' GLN . . . . . 0.435 ' OE1' ' O ' ' A' ' 289' ' ' VAL . 5.2 mp0 -60.35 -42.23 95.3 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 122.827 1.299 . . . . 0.0 110.032 179.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 78.4 mt -60.27 -39.26 86.19 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 112.268 -2.242 . . . . 0.0 109.564 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -62.3 -45.2 94.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.582 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' ARG . . . . . 0.433 ' O ' ' O ' ' A' ' 293' ' ' GLN . 9.0 tpm_? -122.44 116.07 23.34 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -114.22 -163.84 0.89 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.223 0.535 . . . . 0.0 112.113 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 20.1 tp -72.22 114.4 10.29 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 176.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 41.7 ttp -95.93 61.9 2.2 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.527 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.75 101.04 0.07 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.937 0.875 . . . . 0.0 111.071 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -63.94 -46.05 86.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 113.814 -1.539 . . . . 0.0 113.293 -176.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -58.14 -38.9 77.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.739 -177.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 45.3 tp60 -63.75 -46.49 85.09 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.423 -178.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' SER . . . . . 0.438 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 3.4 t -66.0 -37.56 86.23 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.105 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -61.78 -42.94 99.63 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.97 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 11.7 tm-20 -64.94 -37.03 86.29 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -177.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . 0.535 ' HB3' ' HD3' ' A' ' 308' ' ' PRO . . . -60.07 -52.87 70.38 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -176.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' PRO . . . . . 0.535 ' HD3' ' HB3' ' A' ' 307' ' ' ALA . 73.7 Cg_endo -75.4 0.49 9.01 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.166 1.911 . . . . 0.0 112.157 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.588 -179.852 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.562 ' O ' HD13 ' A' ' 298' ' ' LEU . 69.9 m . . . . . 0 N--CA 1.46 0.031 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.83 HG22 ' H ' ' A' ' 16' ' ' LYS . 10.8 p -88.32 -178.6 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.28 -178.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.83 ' H ' HG22 ' A' ' 15' ' ' VAL . 12.6 mptt -63.96 -40.88 97.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.99 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -63.54 -41.26 98.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.79 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.476 ' H ' HG13 ' A' ' 15' ' ' VAL . 55.0 tp -79.96 -26.61 39.95 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.804 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.56 -41.53 94.05 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 107.215 -2.354 . . . . 0.0 107.215 176.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.18 -31.78 68.06 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 124.917 2.294 . . . . 0.0 107.286 176.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.45 -42.78 98.92 Favored Glycine 0 CA--C 1.527 0.825 1 CA-C-N 108.32 -4.037 . . . . 0.0 108.234 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 28.9 p -70.65 -28.01 64.49 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.529 0.681 . . . . 0.0 109.345 177.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.562 ' HB2' ' NE2' ' A' ' 293' ' ' GLN . . . -66.2 -50.16 64.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.866 -178.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.443 ' O ' ' OD2' ' A' ' 28' ' ' ASP . . . -62.04 -35.74 79.49 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 118.404 -1.318 . . . . 0.0 111.322 -177.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.638 ' SG ' ' N ' ' A' ' 26' ' ' ILE . 5.4 p -64.1 -53.48 48.93 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.538 -179.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.638 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 11.2 tp -65.59 -39.79 86.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -177.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.02 -41.78 97.32 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 119.775 -0.77 . . . . 0.0 112.967 -173.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.484 ' CG ' ' NE2' ' A' ' 89' ' ' GLN . 1.7 p30 -77.64 -27.14 50.95 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 118.329 -1.348 . . . . 0.0 109.636 -176.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 10.9 tp -60.16 -55.92 27.95 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 119.65 1.114 . . . . 0.0 111.929 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.8 tt -75.58 -4.63 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-O 121.382 0.61 . . . . 0.0 112.274 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.444 ' O ' HG22 ' A' ' 31' ' ' THR . 53.5 m -109.41 -16.72 13.95 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.013 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.485 ' N ' ' HD2' ' A' ' 33' ' ' PRO . 84.2 t80 -68.46 -45.89 36.72 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 121.879 2.127 . . . . 0.0 112.011 -177.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 32' ' ' PHE . 27.7 Cg_endo -60.35 -16.1 39.28 Favored 'Trans proline' 0 N--CA 1.5 1.862 0 CA-C-N 121.27 1.489 . . . . 0.0 112.858 177.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.643 HD13 ' OG ' ' A' ' 282' ' ' SER . 80.5 mt -67.08 -35.18 79.25 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.518 0.932 . . . . 0.0 113.518 -177.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -64.45 -40.07 95.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.236 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.8 m -58.33 -35.0 71.24 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.922 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.65 -37.92 83.1 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.124 -0.63 . . . . 0.0 111.615 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -61.4 -49.09 78.31 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.631 -176.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -63.28 -39.09 83.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 119.193 0.906 . . . . 0.0 112.248 -177.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.61 ' NH2' HE22 ' A' ' 58' ' ' GLN . 0.0 OUTLIER -60.36 -40.7 91.7 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.698 -179.485 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.82 39.02 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.946 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.503 ' N ' ' O ' ' A' ' 40' ' ' ARG . 21.3 pt20 -81.11 147.11 30.24 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.748 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 14.7 mt -82.67 53.19 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.987 0.422 . . . . 0.0 110.246 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 45.01 74.83 0.12 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.742 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.52 59.95 0.31 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.405 ' O ' ' OG ' ' A' ' 47' ' ' SER . 28.3 tp10 -71.21 -7.18 45.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.836 0.35 . . . . 0.0 110.388 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' A' ' 46' ' ' GLU . 23.8 p 57.47 50.02 11.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.492 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -143.77 -18.43 0.6 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.674 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.15 -10.15 74.13 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.0 tp -65.28 -38.11 89.25 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.691 0.281 . . . . 0.0 111.554 -178.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.554 HG23 ' N ' ' A' ' 52' ' ' ARG . 14.7 m -60.88 -44.81 98.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.495 -178.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.554 ' N ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -64.92 -33.43 76.02 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.208 -179.644 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 79.7 m -67.77 -38.23 83.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.969 0.414 . . . . 0.0 110.522 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -86.82 -153.84 0.22 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.77 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -162.42 -53.38 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.89 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.639 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 8.4 t -128.32 -139.1 0.24 Allowed 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.639 ' HB3' ' O ' ' A' ' 56' ' ' SER . . . 93.82 14.63 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.659 0.6 . . . . 0.0 111.592 178.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.61 HE22 ' NH2' ' A' ' 40' ' ' ARG . 6.4 pt20 175.89 122.74 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.946 0.403 . . . . 0.0 109.915 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -105.83 159.46 15.99 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.402 ' O ' ' C ' ' A' ' 61' ' ' GLY . 36.2 ptt180 -43.44 -32.35 0.86 Allowed 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.505 -0.478 . . . . 0.0 109.808 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 60' ' ' ARG . . . -31.37 102.75 0.01 OUTLIER Glycine 0 CA--C 1.526 0.733 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.01 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.7 p -67.08 -33.71 64.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 118.232 -0.889 . . . . 0.0 109.639 176.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -60.32 -32.63 71.42 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 121.442 1.928 . . . . 0.0 110.288 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.49 -49.0 67.54 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-N 115.377 -0.829 . . . . 0.0 114.352 -176.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 14.1 m -61.73 -46.02 91.44 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.201 -0.5 . . . . 0.0 112.057 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 72.1 mt -59.09 -36.23 61.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 74.4 mt -63.63 -34.97 79.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 120.439 1.472 . . . . 0.0 112.602 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.416 ' O ' ' OG1' ' A' ' 72' ' ' THR . 98.9 m -63.47 -41.59 98.6 Favored 'General case' 0 C--O 1.254 1.308 0 C-N-CA 125.433 1.493 . . . . 0.0 110.983 -174.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 6.5 ptp -60.36 -38.92 85.39 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 120.018 -1.676 . . . . 0.0 113.842 -176.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.3 m -68.55 -40.77 82.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 119.025 -1.07 . . . . 0.0 113.627 -176.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 61.5 ttp85 -77.92 -13.55 59.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 122.028 0.918 . . . . 0.0 112.305 -178.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.416 ' OG1' ' O ' ' A' ' 68' ' ' THR . 70.4 m -62.92 -55.05 29.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.335 -1.302 . . . . 0.0 111.775 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -108.68 -58.22 2.04 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.794 178.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.32 164.62 13.58 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -56.59 -35.16 96.87 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 121.966 1.777 . . . . 0.0 111.775 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.465 ' O ' ' OD1' ' A' ' 80' ' ' ASN . 96.5 mtt180 -60.93 -11.19 7.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.928 0.87 . . . . 0.0 110.925 176.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.505 ' O ' ' OD1' ' A' ' 80' ' ' ASN . 7.4 t -77.64 -32.21 53.23 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 113.275 -1.784 . . . . 0.0 110.265 -178.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.9 mp -75.54 -29.34 59.37 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.224 1.01 . . . . 0.0 111.59 177.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -87.4 -2.62 58.75 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 122.896 1.331 . . . . 0.0 113.417 -172.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.505 ' OD1' ' O ' ' A' ' 77' ' ' SER . 11.9 p-10 -117.67 135.14 54.21 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 112.104 -2.316 . . . . 0.0 108.207 176.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.8 -25.9 25.89 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 -177.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.425 ' HG ' ' N ' ' A' ' 83' ' ' VAL . 0.5 OUTLIER -59.14 -34.44 72.06 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 113.834 -1.183 . . . . 0.0 110.283 -179.661 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.425 ' N ' ' HG ' ' A' ' 82' ' ' LEU . 10.6 p -70.83 -27.12 29.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.917 178.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.88 -31.86 61.7 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.408 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.8 -40.13 89.74 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 119.984 -1.103 . . . . 0.0 111.205 -177.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 86.2 mt -62.55 -40.25 96.21 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 122.285 1.04 . . . . 0.0 112.871 -176.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -60.67 -27.5 67.88 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 113.149 -1.841 . . . . 0.0 109.865 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 14.9 mmt85 -57.93 -53.32 59.54 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 173.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.484 ' NE2' ' CG ' ' A' ' 28' ' ' ASP . 60.7 mt-30 -66.83 -29.74 69.74 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 112.418 -2.174 . . . . 0.0 111.776 -177.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 33.9 ttm -61.37 -40.89 95.97 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.067 -0.97 . . . . 0.0 112.429 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.9 m -74.59 -34.65 62.91 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.453 -176.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -57.63 -43.67 84.99 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 120.794 1.633 . . . . 0.0 112.123 -176.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.47 -32.6 64.42 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 119.602 -0.839 . . . . 0.0 111.228 -178.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 38.7 t -64.11 -41.57 97.21 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.401 ' C ' ' H ' ' A' ' 97' ' ' ILE . 30.6 m -67.8 -27.94 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.005 177.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.473 ' O ' ' CG ' ' A' ' 96' ' ' ARG . 6.7 ttt85 -77.61 9.28 3.49 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -176.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.524 HD13 ' O ' ' A' ' 97' ' ' ILE . 0.3 OUTLIER -87.02 -15.95 9.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 176.538 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -140.49 -48.46 0.05 OUTLIER Glycine 0 CA--C 1.544 1.891 0 N-CA-C 115.569 0.987 . . . . 0.0 115.569 -177.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 14.9 mt -71.17 -13.12 61.83 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.2 1.5 . . . . 0.0 112.644 -177.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.494 ' O ' ' HB2' ' A' ' 104' ' ' LYS . 1.9 m-85 -81.0 -50.34 9.81 Favored 'General case' 0 C--O 1.214 -0.785 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.008 178.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.922 ' OD2' ' NE2' ' A' ' 105' ' ' GLN . 19.4 t70 -68.55 -31.82 71.31 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 114.059 -1.428 . . . . 0.0 110.12 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.0 t -69.33 -53.16 21.01 Favored 'General case' 0 CA--C 1.554 1.107 0 CA-C-N 112.203 -2.272 . . . . 0.0 114.544 177.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.1 t -74.9 -27.64 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 CA-C-N 122.487 2.403 . . . . 0.0 113.437 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 100' ' ' TYR . 13.4 tttp -70.16 -40.99 74.41 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 112.004 -2.362 . . . . 0.0 111.548 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.922 ' NE2' ' OD2' ' A' ' 101' ' ' ASP . 88.1 mt-30 -79.62 -13.17 59.69 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.742 0.782 . . . . 0.0 111.071 -178.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -78.79 -22.92 45.58 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.876 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 6.4 m-30 -109.04 -30.11 8.23 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 119.341 0.973 . . . . 0.0 112.068 -174.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.2 m -97.49 9.25 42.91 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 117.926 -1.509 . . . . 0.0 113.233 -178.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.466 ' O ' ' C ' ' A' ' 110' ' ' GLY . 18.7 mmtt -52.77 121.51 7.37 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-N 119.025 0.83 . . . . 0.0 111.715 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.517 ' O ' ' CB ' ' A' ' 111' ' ' SER . . . -22.91 -82.35 0.01 OUTLIER Glycine 0 N--CA 1.485 1.91 0 CA-C-N 118.665 0.666 . . . . 0.0 113.171 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.517 ' CB ' ' O ' ' A' ' 110' ' ' GLY . 1.4 m 96.53 -90.26 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 178.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.513 ' O ' ' CG ' ' A' ' 113' ' ' HIS . 0.3 OUTLIER 168.83 -35.75 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 120.725 1.602 . . . . 0.0 114.215 179.308 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.647 ' O ' ' HB2' ' A' ' 114' ' ' ALA . 1.1 p-80 155.61 46.07 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 121.103 0.477 . . . . 0.0 110.841 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.647 ' HB2' ' O ' ' A' ' 113' ' ' HIS . . . 159.91 -162.9 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.15 15.25 26.4 Favored Glycine 0 C--N 1.337 0.587 0 CA-C-N 114.114 -1.403 . . . . 0.0 111.2 178.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.549 HD13 HH21 ' A' ' 119' ' ' ARG . 31.6 mm -60.66 -41.07 86.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 C-N-CA 120.065 -0.654 . . . . 0.0 109.278 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.54 -40.12 95.94 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 121.91 0.728 . . . . 0.0 111.858 175.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 35.6 t -57.78 -41.81 82.79 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 177.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.549 HH21 HD13 ' A' ' 116' ' ' ILE . 9.5 ttm-85 -63.23 -36.78 84.78 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.984 -177.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 58.5 mt -63.73 -46.33 85.84 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.255 0.55 . . . . 0.0 109.805 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 41.5 mt -66.65 -44.77 81.02 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 119.112 -1.035 . . . . 0.0 110.459 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.69 -44.83 92.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 119.625 1.102 . . . . 0.0 109.932 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -65.73 -44.2 92.79 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 119.801 -1.19 . . . . 0.0 111.126 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 77.9 p -64.5 -44.44 90.96 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.829 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 97.2 m -69.47 -48.4 60.86 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 119.453 -0.899 . . . . 0.0 111.916 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.493 HG23 ' N ' ' A' ' 127' ' ' GLY . 6.2 t -65.26 -42.41 93.3 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -174.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.493 ' N ' HG23 ' A' ' 126' ' ' THR . . . -64.07 -44.78 95.33 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-O 122.704 1.169 . . . . 0.0 113.518 -177.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.448 ' O ' HG22 ' A' ' 131' ' ' VAL . . . -61.58 -41.62 97.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 112.358 -1.921 . . . . 0.0 107.141 177.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.68 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 1.8 mm? -64.66 -42.08 95.65 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.725 178.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.22 -39.94 96.05 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -177.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.524 ' O ' ' NE2' ' A' ' 135' ' ' GLN . 15.3 m -61.27 -25.75 37.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 123.005 1.383 . . . . 0.0 109.902 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.68 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . -58.31 -44.93 88.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 111.906 -2.406 . . . . 0.0 112.621 -178.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.493 HG13 ' N ' ' A' ' 134' ' ' ALA . 3.5 p -78.95 -48.72 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 C-N-CA 120.712 -0.395 . . . . 0.0 112.006 -178.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.493 ' N ' HG13 ' A' ' 133' ' ' VAL . . . -122.95 135.92 54.67 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.994 0.426 . . . . 0.0 111.575 -178.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.787 ' H ' ' CD ' ' A' ' 136' ' ' PRO . 24.4 pt20 177.99 -24.61 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.703 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.717 178.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.787 ' CD ' ' H ' ' A' ' 135' ' ' GLN . 52.9 Cg_exo -53.14 -33.42 63.99 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 121.437 1.425 . . . . 0.0 112.691 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.494 HG23 ' N ' ' A' ' 138' ' ' ASP . 11.1 t -66.54 -41.76 88.21 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 119.234 -0.986 . . . . 0.0 109.523 -178.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.494 ' N ' HG23 ' A' ' 137' ' ' THR . 4.5 m-20 -64.93 -42.59 94.56 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 117.876 -1.53 . . . . 0.0 111.566 -178.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 15.1 t -64.64 -44.9 96.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.0 p -65.38 -37.08 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -178.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.44 ' O ' ' OE1' ' A' ' 145' ' ' GLN . 14.0 mptt -60.42 -40.2 90.19 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.713 -176.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 70.5 t -68.54 -44.52 82.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.523 ' NH2' ' O ' ' A' ' 174' ' ' GLY . 65.6 mtt-85 -64.34 -36.09 83.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.066 178.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.414 ' CD1' ' C ' ' A' ' 144' ' ' PHE . 36.0 t80 -66.46 -41.56 88.85 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -177.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.44 ' OE1' ' O ' ' A' ' 141' ' ' LYS . 4.8 mp0 -64.83 -39.5 93.68 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 118.941 -1.104 . . . . 0.0 108.087 178.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.39 -34.59 78.66 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.732 HE22 HE21 ' A' ' 157' ' ' GLN . 32.9 tt0 -60.54 110.3 1.24 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 175.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.468 ' C ' ' H ' ' A' ' 150' ' ' ALA . . . -106.1 -55.18 2.36 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 -175.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -77.24 21.47 0.24 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 122.327 2.33 . . . . 0.0 110.417 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.468 ' H ' ' C ' ' A' ' 148' ' ' ALA . . . 51.24 -94.72 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.659 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -162.78 -37.91 0.02 OUTLIER Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.638 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 179.913 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 74.3 t80 . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.772 0.32 . . . . 0.0 110.467 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.732 HE21 HE22 ' A' ' 147' ' ' GLN . 19.0 tt0 -71.54 164.8 25.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.455 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.441 ' OG ' ' N ' ' A' ' 159' ' ' THR . 29.7 t -156.94 -177.94 7.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.878 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.441 ' N ' ' OG ' ' A' ' 158' ' ' SER . 69.5 p -63.79 -45.96 87.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.65 -177.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 77.0 t -64.04 -45.37 96.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 119.067 -1.053 . . . . 0.0 109.165 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -66.89 -38.44 86.29 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.527 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.575 ' O ' HD12 ' A' ' 166' ' ' ILE . . . -61.33 -44.27 97.48 Favored 'General case' 0 C--O 1.211 -0.969 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -177.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.436 ' O ' HD11 ' A' ' 166' ' ' ILE . 32.3 t80 -61.32 -47.85 84.04 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.67 0.747 . . . . 0.0 112.151 -177.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 17.8 tptp -68.19 -45.33 73.69 Favored 'General case' 0 CA--C 1.554 1.129 0 N-CA-C 117.841 2.534 . . . . 0.0 117.841 -172.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 17.6 m -63.1 -45.48 91.86 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 117.344 2.35 . . . . 0.0 117.344 -174.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.73 HD13 ' H ' ' A' ' 166' ' ' ILE . 0.1 OUTLIER -64.62 -37.36 79.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-O 121.524 0.678 . . . . 0.0 109.271 176.925 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.18 -37.02 76.38 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 176.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -62.57 -50.32 71.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 122.992 2.633 . . . . 0.0 111.465 -177.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -75.15 -51.24 13.91 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 123.539 0.736 . . . . 0.0 109.409 177.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -78.27 -36.8 46.32 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 115.775 1.768 . . . . 0.0 115.775 -174.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 93.71 -168.44 29.12 Favored Glycine 0 N--CA 1.468 0.788 0 CA-C-N 118.472 0.578 . . . . 0.0 112.615 177.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.6 mt -73.56 -41.62 55.78 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.067 0 CA-C-O 122.252 1.025 . . . . 0.0 110.62 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 60.5 ttt85 -58.31 -32.77 68.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 113.448 -1.706 . . . . 0.0 111.027 -176.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.523 ' O ' ' NH2' ' A' ' 143' ' ' ARG . . . -59.83 -39.37 95.33 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 119.292 -1.432 . . . . 0.0 109.579 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.403 HD22 ' OH ' ' A' ' 163' ' ' TYR . 5.5 tp -69.44 -33.39 72.88 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 117.085 2.254 . . . . 0.0 117.085 -177.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 67.3 m95 -77.58 -7.46 56.37 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 111.254 -2.703 . . . . 0.0 109.843 -177.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -43.28 -48.02 6.66 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.556 -177.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -111.24 -29.61 3.41 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.065 0.84 . . . . 0.0 112.046 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 3.9 m -46.26 -52.14 13.15 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.31 -49.75 77.83 Favored Pre-proline 0 N--CA 1.481 1.118 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -177.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -62.2 -27.87 78.88 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 121.973 1.782 . . . . 0.0 111.766 175.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -63.41 -39.04 93.44 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 178.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.422 HG13 HG21 ' A' ' 131' ' ' VAL . 97.0 t -63.21 -42.0 94.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.251 178.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.53 -39.21 90.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.237 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.53 -41.52 94.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.035 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -60.97 -42.38 98.22 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.265 0.555 . . . . 0.0 110.051 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.68 -43.1 97.64 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.166 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 5.6 mm -63.14 -44.78 99.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -177.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.401 ' O ' ' CD ' ' A' ' 193' ' ' GLU . 6.9 m -59.69 -45.7 94.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 120.328 -0.549 . . . . 0.0 111.472 -178.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.5 ' OD1' ' N ' ' A' ' 191' ' ' CYS . 2.0 p30 -61.84 -42.52 99.13 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 122.259 1.028 . . . . 0.0 108.91 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' CYS . . . . . 0.5 ' N ' ' OD1' ' A' ' 190' ' ' ASN . 52.2 t -62.15 -46.56 88.44 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 113.294 -1.775 . . . . 0.0 110.922 179.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.35 -40.61 96.2 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 114.296 -1.32 . . . . 0.0 109.529 176.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 0.515 ' N ' ' OE1' ' A' ' 193' ' ' GLU . 0.0 OUTLIER -61.52 -45.4 94.37 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.768 -178.701 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 4.1 tt -64.01 -39.52 94.3 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 118.331 -1.348 . . . . 0.0 110.18 -174.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 8.2 m -64.59 -45.86 94.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 116.909 -1.916 . . . . 0.0 107.775 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 98.4 m -64.16 -46.33 84.53 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -177.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -57.92 -40.11 79.61 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -178.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -56.48 -44.98 81.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.573 0.701 . . . . 0.0 109.317 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.515 ' N ' ' CD2' ' A' ' 199' ' ' LEU . 1.5 mm? -61.92 -39.89 93.6 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.51 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 45.6 mm -64.03 -43.54 97.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 118.575 -0.726 . . . . 0.0 112.893 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -59.63 -40.95 89.29 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 120.588 1.54 . . . . 0.0 110.839 178.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -66.22 -38.46 88.01 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 112.939 -1.937 . . . . 0.0 111.027 -177.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 43.8 m -102.26 130.3 48.91 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.367 -0.833 . . . . 0.0 112.446 -178.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 20.9 mt 68.08 5.58 4.7 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 114.777 -1.101 . . . . 0.0 113.402 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.403 ' CD2' ' O ' ' A' ' 205' ' ' LEU . 2.3 tt -137.37 49.58 2.0 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 178.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 4.3 tppt? -74.11 -23.55 59.33 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.718 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.483 ' O ' ' CB ' ' A' ' 208' ' ' ASN . . . -130.04 -40.22 1.34 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.776 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' ASN . . . . . 0.483 ' CB ' ' O ' ' A' ' 207' ' ' ALA . 41.2 p-10 130.34 76.1 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.247 1.419 . . . . 0.0 108.007 -178.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 3.1 tp . . . . . 0 N--CA 1.474 0.772 0 N-CA-C 118.276 2.695 . . . . 0.0 118.276 178.261 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 0.491 ' OD1' ' SG ' ' A' ' 216' ' ' CYS . 32.9 t70 . . . . . 0 C--O 1.232 0.141 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -61.31 -43.72 90.68 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -177.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -60.86 -34.07 91.8 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 CA-C-N 120.778 1.313 . . . . 0.0 111.514 -177.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' CYS . . . . . 0.491 ' SG ' ' OD1' ' A' ' 213' ' ' ASP . 62.4 m -66.56 -42.69 86.69 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 113.089 -1.869 . . . . 0.0 111.862 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 13.2 t-160 -66.59 -37.54 85.12 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.081 -1.418 . . . . 0.0 114.425 -176.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -62.92 -48.33 79.39 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 118.775 -0.631 . . . . 0.0 110.775 -178.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 12.9 m -61.26 -39.09 89.07 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 120.028 1.285 . . . . 0.0 110.013 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 39.5 t -59.97 -41.71 92.56 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 177.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . 0.564 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.53 -41.79 98.45 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -177.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -61.55 -46.86 88.13 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 122.162 0.982 . . . . 0.0 112.822 -175.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -60.88 -42.11 99.51 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 107.458 -2.257 . . . . 0.0 107.458 176.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . 0.913 ' O ' HG23 ' A' ' 228' ' ' THR . . . -63.03 -37.21 86.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 113.869 -1.166 . . . . 0.0 108.934 176.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -61.06 -42.51 99.82 Favored Glycine 0 CA--C 1.52 0.383 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.626 -176.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' PHE . . . . . 0.419 ' O ' ' OG1' ' A' ' 229' ' ' THR . 67.3 t80 -66.88 -38.87 87.11 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 118.782 -1.167 . . . . 0.0 108.4 178.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . 0.511 ' SG ' ' O ' ' A' ' 224' ' ' ALA . 0.5 OUTLIER -63.89 -41.18 97.79 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.165 0.507 . . . . 0.0 110.251 177.445 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . 0.913 HG23 ' O ' ' A' ' 224' ' ' ALA . 78.5 p -61.58 -40.3 94.28 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.465 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 226' ' ' PHE . 23.8 p -59.34 -40.26 85.77 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 119.802 -0.759 . . . . 0.0 111.567 -176.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 92.7 t -61.47 -43.17 96.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 118.588 -1.245 . . . . 0.0 111.919 -178.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 3.4 tp -63.08 -40.86 90.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 121.711 0.767 . . . . 0.0 109.148 176.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.418 ' O ' HG12 ' A' ' 235' ' ' VAL . . . -62.58 -39.39 93.56 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 114.331 -1.304 . . . . 0.0 113.924 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.509 ' N ' ' HD2' ' A' ' 234' ' ' PRO . 8.0 t -58.34 -42.39 94.49 Favored Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 116.04 1.867 . . . . 0.0 116.04 -174.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 233' ' ' SER . 17.9 Cg_endo -58.93 -40.9 67.34 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 CA-C-N 121.352 1.519 . . . . 0.0 113.457 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.418 HG12 ' O ' ' A' ' 232' ' ' ALA . 2.8 p -65.52 -37.63 80.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 118.357 -1.337 . . . . 0.0 110.914 178.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -66.42 -42.0 88.4 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 15.6 m -65.59 -45.66 91.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -176.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 12.9 p . . . . . 0 C--N 1.323 -0.58 0 C-N-CA 119.116 -1.034 . . . . 0.0 112.047 -177.683 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 67.0 p . . . . . 0 CA--C 1.529 0.137 0 CA-C-O 121.634 0.73 . . . . 0.0 109.222 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' MET . . . . . . . . . . . . . 39.1 ttp -58.71 -41.6 86.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.625 -1.17 . . . . 0.0 110.066 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 15.3 tp -61.06 -45.86 93.02 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.745 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 40.5 ttt-85 -65.77 -54.07 32.05 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 120.434 -0.506 . . . . 0.0 112.029 -177.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 3.4 pttt -75.34 -52.99 9.49 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 119.877 -0.729 . . . . 0.0 111.46 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' A' ' 265' ' ' GLY . 22.9 mt-10 -84.36 112.55 20.43 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.356 -179.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 264' ' ' GLU . . . -39.65 170.51 0.01 OUTLIER Glycine 0 CA--C 1.532 1.097 0 CA-C-N 115.718 -0.673 . . . . 0.0 112.564 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.3 -2.36 5.83 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.492 2.128 . . . . 0.0 112.515 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.77 -26.42 64.28 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -58.37 -32.5 68.63 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.241 -178.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -62.5 -41.46 98.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.4 0.619 . . . . 0.0 110.96 177.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -65.86 -37.18 85.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.338 -178.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.78 164.04 13.85 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 60.45 106.16 0.01 OUTLIER Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -174.68 12.32 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.441 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' MET . . . . . 0.478 ' N ' ' HD2' ' A' ' 275' ' ' PRO . 17.1 mtt -63.84 -44.93 80.91 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 274' ' ' MET . 38.0 Cg_endo -64.93 -47.39 4.97 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 CA-C-N 120.586 1.245 . . . . 0.0 112.436 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 89.7 p -61.32 -40.57 94.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.754 0.787 . . . . 0.0 109.926 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -62.05 -41.85 98.56 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 123.597 1.665 . . . . 0.0 112.264 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 29.4 mt -62.0 -38.5 88.87 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 110.272 -3.149 . . . . 0.0 108.513 174.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -62.67 -40.88 98.46 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.475 0.655 . . . . 0.0 110.465 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.8 ' O ' HD12 ' A' ' 280' ' ' LEU . 0.1 OUTLIER -62.43 -36.56 82.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.326 -177.585 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -68.04 -51.14 35.64 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -178.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . 0.643 ' OG ' HD13 ' A' ' 34' ' ' LEU . 7.5 t -63.09 -45.04 93.99 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.226 0.61 . . . . 0.0 110.506 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' TRP . . . . . 0.433 ' O ' HG22 ' A' ' 286' ' ' VAL . 16.3 t90 -60.77 -38.22 84.51 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.698 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . 0.446 ' OD1' ' CD1' ' A' ' 280' ' ' LEU . 2.2 m120 -61.96 -37.72 85.8 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.43 0.529 . . . . 0.0 112.43 -178.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.493 HG22 ' O ' ' A' ' 282' ' ' SER . 1.0 OUTLIER -59.95 -37.67 73.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -177.447 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 283' ' ' TRP . 1.0 OUTLIER -61.95 -40.11 86.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.942 -178.682 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 4.5 ptm -60.58 -38.77 85.7 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -58.65 -40.04 82.31 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.444 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 86.0 t -60.73 -39.37 81.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.522 -178.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 71.0 m -63.03 -40.56 98.09 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 119.654 -0.819 . . . . 0.0 109.039 177.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -60.92 -38.94 87.52 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 177.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -58.34 -40.21 81.56 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 117.756 -1.578 . . . . 0.0 109.847 -176.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' GLN . . . . . 0.562 ' NE2' ' HB2' ' A' ' 23' ' ' ALA . 76.6 mt-30 -60.32 -42.67 96.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 122.893 1.33 . . . . 0.0 110.874 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 9.4 mp -60.29 -39.75 88.02 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 112.487 -2.142 . . . . 0.0 109.226 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 26.7 mmtt -62.9 -45.47 92.39 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.055 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' ARG . . . . . 0.459 ' O ' ' O ' ' A' ' 293' ' ' GLN . 41.4 ttm180 -122.83 116.38 23.57 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -116.97 -162.69 0.87 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.311 0.577 . . . . 0.0 112.356 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.562 HD13 ' O ' ' A' ' 14' ' ' THR . 1.9 mt -69.55 116.14 9.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.504 177.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 2.5 tpt -99.5 60.4 1.14 Allowed 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -177.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.66 100.78 0.07 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.651 0.739 . . . . 0.0 110.551 -178.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -63.96 -46.21 85.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.345 -1.298 . . . . 0.0 114.029 -176.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -58.77 -39.9 82.4 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.185 -178.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' GLN . . . . . 0.528 ' OE1' ' N ' ' A' ' 303' ' ' GLN . 11.0 mp0 -65.0 -46.76 80.05 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.413 -179.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' SER . . . . . 0.439 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 78.1 p -66.69 -37.68 85.23 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.508 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -61.83 -43.15 99.42 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -179.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -65.11 -37.09 86.37 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 -176.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . 0.559 ' HB3' ' HD3' ' A' ' 308' ' ' PRO . . . -60.17 -52.98 69.45 Favored Pre-proline 0 CA--C 1.544 0.738 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 -176.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' PRO . . . . . 0.559 ' HD3' ' HB3' ' A' ' 307' ' ' ALA . 74.2 Cg_endo -75.29 0.3 9.18 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.147 1.898 . . . . 0.0 111.929 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 86.0 t80 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.547 -179.965 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.9 m . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.779 0.324 . . . . 0.0 110.455 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.456 HG12 ' N ' ' A' ' 16' ' ' LYS . 24.0 t -147.57 158.92 8.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.518 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.456 ' N ' HG12 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -64.41 -41.55 96.57 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.582 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.404 ' N ' ' CG ' ' A' ' 16' ' ' LYS . 4.4 t80 -63.95 -41.6 97.53 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.523 ' N ' HD22 ' A' ' 18' ' ' LEU . 3.3 mm? -79.58 -26.73 41.24 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.803 -178.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.404 ' O ' ' OG1' ' A' ' 22' ' ' THR . . . -66.2 -41.29 94.91 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 107.486 -2.245 . . . . 0.0 107.486 177.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.43 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -71.73 -32.21 67.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 124.79 2.233 . . . . 0.0 107.705 176.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.47 -42.4 99.01 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-N 108.501 -3.954 . . . . 0.0 108.091 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 19' ' ' GLY . 34.4 p -70.55 -27.34 64.07 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 177.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -66.39 -50.09 64.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.879 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.0 -36.17 80.72 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 118.621 -1.232 . . . . 0.0 111.502 -177.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.625 ' SG ' ' N ' ' A' ' 26' ' ' ILE . 8.7 p -63.88 -53.21 54.07 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.382 -178.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.625 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -64.84 -38.98 84.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -176.505 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.544 ' O ' HG23 ' A' ' 31' ' ' THR . . . -63.73 -41.2 98.09 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -173.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.524 ' OD1' ' NE2' ' A' ' 89' ' ' GLN . 6.7 m-20 -77.18 -27.24 53.57 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 120.976 1.717 . . . . 0.0 111.714 -174.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.442 ' H ' ' HG ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -59.98 -54.09 50.12 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 121.29 1.859 . . . . 0.0 112.894 -178.395 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.5 tt -75.34 -4.2 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -179.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.544 HG23 ' O ' ' A' ' 27' ' ' ALA . 34.2 p -109.03 -16.03 14.22 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 119.369 -0.932 . . . . 0.0 109.315 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.49 ' N ' ' HD2' ' A' ' 33' ' ' PRO . 88.1 t80 -68.18 -45.77 39.86 Favored Pre-proline 0 CA--C 1.546 0.826 0 CA-C-N 121.821 2.1 . . . . 0.0 111.488 -178.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 32' ' ' PHE . 26.3 Cg_endo -60.33 -15.72 36.89 Favored 'Trans proline' 0 N--CA 1.504 2.122 0 CA-C-N 121.299 1.5 . . . . 0.0 113.195 176.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.414 ' N ' HD22 ' A' ' 34' ' ' LEU . 3.9 mm? -66.62 -34.94 79.0 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -177.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -64.18 -40.17 95.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.345 -178.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.3 m -58.3 -35.14 71.37 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.253 -0.43 . . . . 0.0 112.048 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.53 -38.5 84.32 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 119.926 -0.71 . . . . 0.0 111.981 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.2 ttpt -61.25 -48.44 81.42 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 119.614 -0.835 . . . . 0.0 110.938 -176.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.3 t -62.9 -38.91 83.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -177.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.528 ' NH2' ' O ' ' A' ' 59' ' ' TYR . 5.8 mmm180 -59.83 -41.1 90.62 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 119.806 -0.758 . . . . 0.0 109.948 -179.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -62.19 38.62 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.157 178.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.489 ' H ' ' C ' ' A' ' 40' ' ' ARG . 45.3 tt0 -87.18 147.87 25.41 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 121.89 -0.506 . . . . 0.0 110.972 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 29.1 pt -81.42 -177.07 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.431 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -74.48 135.48 42.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.714 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 46' ' ' GLU . . . 168.99 -114.27 0.55 Allowed Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.406 ' O ' ' O ' ' A' ' 45' ' ' GLY . 38.0 tt0 60.62 131.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.831 0.348 . . . . 0.0 110.845 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 69.5 m -74.1 -34.08 63.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.072 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -52.15 -38.88 58.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.351 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.92 9.44 85.36 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -178.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.576 ' O ' HD13 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -66.62 -38.42 86.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.294 0.569 . . . . 0.0 110.241 179.004 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.432 ' O ' ' O ' ' A' ' 54' ' ' ALA . 97.2 t -60.95 -45.26 98.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.095 -177.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -65.32 -34.16 77.69 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.787 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 50' ' ' LEU . 23.3 p -68.4 -38.18 81.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.907 0.384 . . . . 0.0 110.345 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' A' ' 51' ' ' VAL . . . -95.83 122.02 38.18 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.127 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.97 -43.0 12.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.723 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.624 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 10.4 m -131.05 -137.94 0.21 Allowed 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.624 ' HB3' ' O ' ' A' ' 56' ' ' SER . . . 80.1 -27.04 0.15 Allowed 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 176.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -120.82 38.81 3.94 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.528 ' O ' ' NH2' ' A' ' 40' ' ' ARG . 16.2 m-85 -37.51 151.62 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.81 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.42 ' O ' ' C ' ' A' ' 61' ' ' GLY . 31.9 mtm105 -46.4 -33.68 4.08 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 60' ' ' ARG . . . -30.51 101.95 0.01 OUTLIER Glycine 0 CA--C 1.527 0.795 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.89 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.2 p -66.95 -33.94 66.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 118.155 -0.926 . . . . 0.0 109.44 176.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.578 HD13 ' O ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -60.52 -33.01 72.01 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 121.263 1.847 . . . . 0.0 110.343 -179.689 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.94 -49.5 62.59 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-N 115.518 -0.765 . . . . 0.0 114.575 -176.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.488 ' OG1' ' NH2' ' A' ' 40' ' ' ARG . 4.6 m -62.18 -46.36 89.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.005 -0.598 . . . . 0.0 112.498 -178.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 11.2 tt -59.78 -35.79 62.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.87 -35.77 81.74 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 120.597 1.544 . . . . 0.0 111.488 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 99.5 m -63.08 -39.3 94.32 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 113.595 -1.639 . . . . 0.0 111.064 -175.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.492 ' O ' ' SD ' ' A' ' 69' ' ' MET . 0.0 OUTLIER -60.59 -39.99 90.12 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 120.835 -1.166 . . . . 0.0 113.912 -176.548 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.1 p -69.33 -40.34 80.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 119.256 -0.978 . . . . 0.0 112.726 -178.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -78.3 -13.37 59.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.334 0.588 . . . . 0.0 112.585 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 90.8 m -62.88 -55.02 29.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.136 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -108.01 -56.93 2.17 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 157.84 164.39 13.87 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -56.29 -34.96 95.18 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.009 1.806 . . . . 0.0 111.673 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 72.4 mtp85 -61.23 -11.55 9.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.609 0.719 . . . . 0.0 111.463 176.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.9 p -78.28 -33.07 49.76 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.853 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.485 ' N ' HD12 ' A' ' 78' ' ' LEU . 8.9 mp -76.13 -32.12 58.98 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 122.309 -0.244 . . . . 0.0 111.45 179.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -90.7 -3.83 57.19 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 123.485 1.612 . . . . 0.0 112.531 -176.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.524 ' ND2' ' OH ' ' A' ' 156' ' ' TYR . 28.0 t30 -94.24 37.36 1.11 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 110.748 -2.933 . . . . 0.0 108.732 176.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -168.45 -15.37 0.02 OUTLIER Glycine 0 CA--C 1.533 1.209 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.842 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 82' ' ' LEU . 59.9 mt -59.97 -34.92 73.94 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 119.163 -1.015 . . . . 0.0 111.861 -179.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.9 p -70.54 -27.67 32.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.846 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.7 -31.62 61.93 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.541 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -68.37 -40.57 86.98 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 119.472 -1.347 . . . . 0.0 111.601 -177.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 27.1 mt -63.01 -41.21 99.51 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -176.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.41 ' H ' ' HG2' ' A' ' 87' ' ' GLN . 4.3 pt20 -60.9 -26.78 67.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.405 -1.271 . . . . 0.0 108.925 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 18.7 ttm105 -57.47 -53.46 57.87 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 173.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.524 ' NE2' ' OD1' ' A' ' 28' ' ' ASP . 10.7 mm100 -67.05 -29.58 69.42 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 112.557 -2.11 . . . . 0.0 112.089 -178.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 34.4 ttm -61.19 -40.4 93.77 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.951 -1.022 . . . . 0.0 112.682 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 78.2 p -74.22 -34.31 63.65 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 118.491 -0.766 . . . . 0.0 111.058 -176.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -57.8 -44.36 86.29 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 120.609 1.55 . . . . 0.0 110.746 -177.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.63 -33.47 64.56 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 119.075 -1.05 . . . . 0.0 110.744 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.3 p -64.82 -42.85 94.65 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.437 ' C ' ' H ' ' A' ' 97' ' ' ILE . 11.7 p -68.52 -27.91 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.666 178.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.06 9.84 2.74 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 -176.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.471 ' O ' HG22 ' A' ' 97' ' ' ILE . 99.2 mt -87.23 -15.11 9.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 177.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -140.39 -47.9 0.06 OUTLIER Glycine 0 CA--C 1.538 1.504 0 N-CA-C 115.846 1.098 . . . . 0.0 115.846 -175.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.597 HD22 ' N ' ' A' ' 99' ' ' LEU . 3.3 mm? -70.9 -12.62 61.65 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.109 1.454 . . . . 0.0 112.02 -178.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -79.78 -50.43 10.57 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.0 -1.454 . . . . 0.0 109.609 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -67.71 -32.35 72.92 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 113.768 -1.56 . . . . 0.0 109.264 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.2 p -69.84 -53.96 15.74 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 112.661 -2.063 . . . . 0.0 112.874 175.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.723 HG22 ' CE2' ' A' ' 107' ' ' TYR . 0.3 OUTLIER -75.15 -27.63 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-N 122.088 2.222 . . . . 0.0 116.182 -176.835 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.514 ' CB ' ' NZ ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -69.54 -43.5 72.85 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 112.409 -2.178 . . . . 0.0 113.412 -177.723 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.455 ' N ' ' HG3' ' A' ' 104' ' ' LYS . 88.1 mt-30 -78.27 -10.97 59.89 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 124.345 2.021 . . . . 0.0 111.039 178.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -79.23 -22.69 44.47 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 112.055 -2.339 . . . . 0.0 111.512 178.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.723 ' CE2' HG22 ' A' ' 103' ' ' VAL . 28.2 m-85 -109.38 -30.74 7.83 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 119.155 0.889 . . . . 0.0 110.831 -177.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.3 m -97.75 8.85 43.98 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 117.918 -1.513 . . . . 0.0 113.157 -178.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.494 ' O ' ' C ' ' A' ' 110' ' ' GLY . 35.4 ttpt -48.74 125.75 10.7 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 117.908 -1.044 . . . . 0.0 109.541 177.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' A' ' 111' ' ' SER . . . -29.39 -74.45 0.04 OUTLIER Glycine 0 N--CA 1.485 1.962 0 CA-C-N 120.231 1.378 . . . . 0.0 111.6 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.531 ' CB ' ' O ' ' A' ' 110' ' ' GLY . 2.7 m 104.23 -161.67 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 177.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.618 ' O ' ' N ' ' A' ' 114' ' ' ALA . 79.6 tt0 -129.95 102.3 6.22 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -178.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.633 ' O ' ' HB2' ' A' ' 114' ' ' ALA . 88.0 m-70 13.51 46.75 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 O-C-N 124.411 1.069 . . . . 0.0 113.135 178.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.633 ' HB2' ' O ' ' A' ' 113' ' ' HIS . . . 159.09 -161.7 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.16 15.02 26.98 Favored Glycine 0 C--N 1.337 0.626 0 CA-C-N 115.141 -0.936 . . . . 0.0 113.038 176.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 50.0 mt -60.73 -40.72 85.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 C-N-CA 119.133 -1.027 . . . . 0.0 108.576 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.6 -40.09 95.81 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 122.01 0.783 . . . . 0.0 111.362 175.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 19.4 m -58.18 -42.53 86.24 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 177.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -63.72 -37.42 87.3 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.009 -0.676 . . . . 0.0 111.058 -178.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 97.2 mt -64.16 -46.56 83.5 Favored 'General case' 0 N--CA 1.457 -0.11 0 CA-C-O 121.481 0.657 . . . . 0.0 109.352 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.568 HD23 ' O ' ' A' ' 121' ' ' LEU . 1.4 tt -66.67 -44.59 81.39 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.933 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.457 ' O ' HG22 ' A' ' 126' ' ' THR . . . -63.36 -44.69 94.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 119.457 1.026 . . . . 0.0 108.853 177.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -65.83 -44.03 92.81 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 120.034 -1.079 . . . . 0.0 111.584 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 63.9 m -64.27 -44.51 91.52 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.508 HG23 ' N ' ' A' ' 126' ' ' THR . 13.9 t -70.16 -48.02 59.11 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 118.885 -1.126 . . . . 0.0 112.077 177.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.508 ' N ' HG23 ' A' ' 125' ' ' THR . 9.4 t -65.66 -42.69 91.05 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 -174.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.493 ' N ' HG23 ' A' ' 126' ' ' THR . . . -64.23 -44.71 95.19 Favored Glycine 0 C--N 1.33 0.206 0 CA-C-N 114.416 -1.265 . . . . 0.0 112.253 -178.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.477 ' O ' HG12 ' A' ' 131' ' ' VAL . . . -61.01 -41.58 96.81 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 112.302 -1.949 . . . . 0.0 106.287 177.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.677 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 31.3 mt -64.91 -42.36 94.8 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.841 177.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.24 -40.01 96.23 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -177.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 128' ' ' ALA . 4.0 p -61.22 -24.84 34.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 122.932 1.348 . . . . 0.0 109.042 178.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.677 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . -57.64 -44.55 85.68 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 112.188 -2.278 . . . . 0.0 111.343 -178.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.9 p -78.81 -48.74 21.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.229 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.459 ' O ' ' O ' ' A' ' 131' ' ' VAL . . . -92.06 138.18 31.75 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.712 0.291 . . . . 0.0 111.064 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.497 ' N ' ' CD ' ' A' ' 136' ' ' PRO . 1.2 tt0 -179.69 -47.19 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.815 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 135' ' ' GLN . 55.3 Cg_exo -52.11 -33.5 53.96 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 122.326 2.017 . . . . 0.0 112.302 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 32.2 p -67.69 -42.78 81.53 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 117.941 -1.504 . . . . 0.0 109.786 -179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -66.24 -42.96 87.88 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 119.317 -0.953 . . . . 0.0 112.098 -178.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 62.5 t -64.08 -43.72 97.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -179.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 136' ' ' PRO . 72.4 t -64.89 -39.34 85.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -177.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 31.3 mttp -62.83 -42.01 99.56 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 118.754 -1.179 . . . . 0.0 111.325 -178.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 11.8 m -71.24 -46.33 66.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.87 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 12.8 tpp85 -65.59 -37.37 86.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.895 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -67.34 -42.0 84.26 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -177.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.3 -40.49 90.03 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 119.173 -1.011 . . . . 0.0 111.232 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.32 -35.46 81.08 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 -177.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -60.62 111.27 1.54 Allowed 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 176.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -106.12 -52.44 2.8 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.872 1.804 . . . . 0.0 115.872 -174.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.538 ' O ' ' HB3' ' A' ' 150' ' ' ALA . 10.9 mmt180 -86.9 12.14 11.78 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 121.68 2.036 . . . . 0.0 110.544 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.538 ' HB3' ' O ' ' A' ' 149' ' ' ARG . . . 72.62 -45.72 0.63 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.667 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 103.16 169.71 26.0 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.636 0 N-CA-C 111.094 -0.803 . . . . 0.0 111.094 -179.93 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.524 ' OH ' ' ND2' ' A' ' 80' ' ' ASN . 0.7 OUTLIER . . . . . 0 CA--C 1.534 0.348 0 CA-C-O 120.907 0.384 . . . . 0.0 110.751 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.566 ' NE2' ' H ' ' A' ' 157' ' ' GLN . 4.1 mp0 -62.65 164.17 8.07 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.42 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.403 ' OG ' ' N ' ' A' ' 159' ' ' THR . 47.6 t -157.16 -178.02 7.05 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.457 0.646 . . . . 0.0 111.273 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.57 HG23 ' N ' ' A' ' 160' ' ' VAL . 15.1 t -63.78 -45.89 87.72 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.66 -177.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.57 ' N ' HG23 ' A' ' 159' ' ' THR . 94.9 t -63.95 -45.26 97.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 119.251 -0.98 . . . . 0.0 109.096 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 38.6 tp10 -67.01 -38.37 85.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.663 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.549 ' O ' HD12 ' A' ' 166' ' ' ILE . . . -60.96 -44.41 97.37 Favored 'General case' 0 C--O 1.211 -0.952 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -176.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.543 ' CE2' HD11 ' A' ' 175' ' ' LEU . 14.8 t80 -61.25 -47.62 85.19 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.662 0.744 . . . . 0.0 112.204 -177.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.402 ' NZ ' ' CB ' ' A' ' 164' ' ' LYS . 2.3 ttmp? -68.39 -45.41 72.77 Favored 'General case' 0 CA--C 1.555 1.169 0 N-CA-C 118.17 2.656 . . . . 0.0 118.17 -173.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 63.8 p -63.49 -45.51 90.39 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 117.381 2.363 . . . . 0.0 117.381 -175.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.741 HD13 ' H ' ' A' ' 166' ' ' ILE . 0.2 OUTLIER -64.59 -37.14 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-O 121.635 0.731 . . . . 0.0 109.233 177.082 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -58.93 -36.97 75.64 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 117.177 -1.392 . . . . 0.0 107.628 177.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 77.5 ttt-85 -62.75 -50.7 70.02 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 123.393 2.815 . . . . 0.0 111.835 -176.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -75.34 -51.22 13.69 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 123.584 0.754 . . . . 0.0 109.5 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -78.15 -36.54 47.54 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -174.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 91.9 -169.09 32.03 Favored Glycine 0 N--CA 1.464 0.509 0 N-CA-C 111.707 -0.557 . . . . 0.0 111.707 178.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.416 ' CG1' ' N ' ' A' ' 173' ' ' ARG . 7.5 pt -71.51 -42.04 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-O 121.454 0.645 . . . . 0.0 110.61 -179.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.416 ' N ' ' CG1' ' A' ' 172' ' ' ILE . 25.4 mmt180 -59.24 -34.09 71.8 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.595 -177.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -60.91 -40.67 98.68 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 118.514 -1.803 . . . . 0.0 109.035 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.543 HD11 ' CE2' ' A' ' 163' ' ' TYR . 0.5 OUTLIER -70.55 -33.48 71.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 111.239 -2.48 . . . . 0.0 116.771 -177.284 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . 0.484 ' CG ' ' OG1' ' A' ' 179' ' ' THR . 33.5 t-105 -77.93 -7.63 57.02 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 111.694 -2.503 . . . . 0.0 110.563 -177.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 51.4 mttm -43.55 -48.41 7.49 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -176.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -99.31 -25.65 9.29 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.099 0.857 . . . . 0.0 112.601 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.484 ' OG1' ' CG ' ' A' ' 176' ' ' TRP . 69.2 p -46.3 -51.9 13.71 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.99 -50.41 76.94 Favored Pre-proline 0 N--CA 1.48 1.038 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -175.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -63.34 -28.35 71.85 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 121.628 1.552 . . . . 0.0 111.42 176.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -63.88 -39.0 93.18 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.245 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 71.1 t -62.69 -42.14 94.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.0 0.429 . . . . 0.0 110.009 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.555 ' O ' HD13 ' A' ' 188' ' ' ILE . . . -61.72 -38.99 89.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.347 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -60.4 -41.97 94.99 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.71 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -61.55 -43.2 99.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.366 0.603 . . . . 0.0 110.169 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.34 -43.13 95.58 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.167 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.555 HD13 ' O ' ' A' ' 184' ' ' ALA . 1.4 mp -63.04 -45.07 99.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.2 -177.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.42 ' O ' ' OE1' ' A' ' 193' ' ' GLU . 11.8 m -60.44 -47.06 94.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 119.409 -0.916 . . . . 0.0 112.431 -178.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -62.68 -43.19 99.44 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 122.586 1.184 . . . . 0.0 109.868 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' CYS . . . . . . . . . . . . . 31.2 m -62.34 -46.22 89.68 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 112.565 -2.107 . . . . 0.0 110.479 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.11 -40.13 95.53 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 114.037 -1.438 . . . . 0.0 109.659 176.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 0.492 ' N ' ' OE1' ' A' ' 193' ' ' GLU . 0.0 OUTLIER -61.01 -45.64 94.0 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.63 -178.381 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 67.2 tp -64.21 -39.14 93.37 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 118.637 -1.225 . . . . 0.0 110.053 -175.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 6.9 m -64.45 -45.88 94.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 C-N-CA 116.891 -1.924 . . . . 0.0 107.907 178.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 23.4 m -63.98 -45.95 86.78 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -178.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -57.16 -39.08 74.55 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.862 0.865 . . . . 0.0 112.56 -178.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -55.86 -44.29 77.92 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.5 ' N ' HD22 ' A' ' 199' ' ' LEU . 3.8 mm? -61.34 -38.79 88.19 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 41.8 mm -62.0 -42.41 94.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 26.1 mmtm -59.57 -38.71 81.86 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.876 1.27 . . . . 0.0 113.183 178.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -67.79 -37.12 81.6 Favored 'General case' 0 C--O 1.256 1.42 0 C-N-CA 118.511 -1.276 . . . . 0.0 111.028 -175.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.433 HG23 ' O ' ' A' ' 203' ' ' THR . 5.8 t -100.96 128.82 46.82 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 121.308 1.867 . . . . 0.0 111.895 -178.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.508 ' CD2' ' CE1' ' A' ' 217' ' ' HIS . 6.9 mp 66.82 3.74 3.16 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 113.342 -1.754 . . . . 0.0 110.576 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 2.3 mt -126.59 29.78 5.66 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.882 0.849 . . . . 0.0 110.628 -179.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -68.78 -25.8 64.89 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.482 -1.235 . . . . 0.0 109.848 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.528 ' O ' ' ND2' ' A' ' 208' ' ' ASN . . . -161.93 39.62 0.13 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 114.363 -1.29 . . . . 0.0 109.563 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' ASN . . . . . 0.528 ' ND2' ' O ' ' A' ' 207' ' ' ALA . 0.4 OUTLIER 87.93 -18.38 0.27 Allowed 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 175.979 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.504 ' CB ' ' O ' ' A' ' 208' ' ' ASN . 1.0 OUTLIER . . . . . 0 N--CA 1.477 0.907 0 CA-C-N 119.742 1.155 . . . . 0.0 109.524 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 . . . . . 0 N--CA 1.465 0.307 0 CA-C-O 121.308 0.575 . . . . 0.0 109.683 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.412 ' N ' ' CD ' ' A' ' 215' ' ' PRO . 2.5 mm? -61.24 -43.89 91.55 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.921 -178.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 214' ' ' LEU . 27.3 Cg_exo -60.7 -34.45 91.92 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 CA-C-N 120.263 1.129 . . . . 0.0 111.16 -178.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 7.9 t -65.24 -42.43 93.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 113.085 -1.871 . . . . 0.0 111.231 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' HIS . . . . . 0.522 ' O ' ' ND1' ' A' ' 217' ' ' HIS . 1.8 t60 -66.78 -37.41 84.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.446 -0.797 . . . . 0.0 113.064 -178.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -62.95 -47.62 82.42 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.096 -177.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 33.5 p -60.53 -38.1 83.34 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 119.097 0.862 . . . . 0.0 110.986 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 66.0 p -59.64 -41.78 91.28 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . 0.574 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.89 -41.84 97.62 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -178.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -62.63 -47.82 82.08 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -176.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -61.06 -42.27 99.74 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 107.811 -2.116 . . . . 0.0 107.811 177.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . 0.788 ' O ' HG23 ' A' ' 228' ' ' THR . . . -63.31 -37.78 88.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 113.817 -1.191 . . . . 0.0 109.009 176.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . 0.574 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -61.67 -42.38 99.75 Favored Glycine 0 CA--C 1.522 0.51 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.827 -176.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' PHE . . . . . 0.432 ' O ' ' OG1' ' A' ' 229' ' ' THR . 0.9 OUTLIER -66.55 -38.58 87.44 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 118.28 1.04 . . . . 0.0 108.27 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 96.6 m -63.54 -41.88 98.43 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.09 0.471 . . . . 0.0 110.265 177.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . 0.788 HG23 ' O ' ' A' ' 224' ' ' ALA . 80.1 p -62.5 -40.48 96.87 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.896 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' A' ' 226' ' ' PHE . 18.6 p -58.8 -39.73 81.99 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.097 -176.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 98.3 t -60.61 -41.91 89.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 118.521 -1.271 . . . . 0.0 108.839 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . 0.48 ' O ' ' HD2' ' A' ' 234' ' ' PRO . 1.3 mp -62.13 -41.29 90.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-O 121.418 0.628 . . . . 0.0 109.393 176.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -62.99 -40.09 96.7 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 -178.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.442 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 0.0 OUTLIER -59.11 -43.39 97.15 Favored Pre-proline 0 N--CA 1.476 0.84 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -173.255 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.48 ' HD2' ' O ' ' A' ' 231' ' ' ILE . 39.4 Cg_exo -60.0 -41.72 50.49 Favored 'Trans proline' 0 C--N 1.296 -2.189 0 C-N-CA 121.576 1.517 . . . . 0.0 113.781 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.408 ' H ' HG22 ' A' ' 235' ' ' VAL . 13.6 m -66.34 -37.55 79.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 119.131 -1.028 . . . . 0.0 111.303 178.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -66.0 -41.7 90.72 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -178.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.4 ' H ' HG12 ' A' ' 237' ' ' VAL . 3.0 p -65.68 -45.72 91.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -177.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 8.5 p . . . . . 0 C--N 1.327 -0.406 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.323 -178.627 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 73.4 p . . . . . 0 N--CA 1.465 0.302 0 CA-C-O 120.936 0.398 . . . . 0.0 111.93 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' MET . . . . . . . . . . . . . 51.9 ttp -60.31 -44.44 95.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.011 -176.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.522 HD13 ' O ' ' A' ' 261' ' ' LEU . 0.2 OUTLIER -62.17 -46.5 88.65 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.338 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 69.1 mmt-85 -66.41 -53.78 31.83 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.666 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -142.62 158.73 43.36 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.687 0.28 . . . . 0.0 111.23 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . 0.448 ' O ' ' O ' ' A' ' 265' ' ' GLY . 18.3 tp10 76.25 68.31 0.06 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.285 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 264' ' ' GLU . . . -32.09 156.59 0.01 OUTLIER Glycine 0 CA--C 1.536 1.379 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.667 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -62.82 -3.11 4.17 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 122.246 1.964 . . . . 0.0 111.836 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 80.5 mtt85 -70.0 -27.05 64.37 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 123.053 0.541 . . . . 0.0 111.805 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.441 ' O ' ' O ' ' A' ' 271' ' ' LYS . . . -58.8 -32.47 69.38 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 119.824 -0.75 . . . . 0.0 109.948 -179.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -62.45 -41.72 98.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.412 0.625 . . . . 0.0 110.836 178.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -66.0 -37.7 86.59 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 114.9 -1.046 . . . . 0.0 112.363 -178.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 268' ' ' ALA . 17.6 ttpp -110.65 134.37 52.49 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.73 0.3 . . . . 0.0 110.616 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 108.47 55.77 0.58 Allowed Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -147.95 29.58 0.9 Allowed 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 120.836 0.35 . . . . 0.0 110.69 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' MET . . . . . 0.588 ' N ' ' CD ' ' A' ' 275' ' ' PRO . 0.3 OUTLIER -63.74 -43.88 78.21 Favored Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.238 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 274' ' ' MET . 23.4 Cg_exo -63.69 -45.87 10.19 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.776 2.317 . . . . 0.0 111.908 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 86.1 p -59.72 -39.13 83.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.061 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -61.21 -41.86 97.59 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 122.884 1.326 . . . . 0.0 111.85 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -61.87 -38.31 87.81 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 111.829 -2.441 . . . . 0.0 107.78 174.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 48.4 mtp180 -62.88 -39.33 94.15 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.304 0.573 . . . . 0.0 110.26 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 30.7 tp -61.85 -36.46 81.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.121 -0.945 . . . . 0.0 112.869 -177.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -68.12 -51.18 34.94 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -178.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . 0.614 ' O ' HG12 ' A' ' 285' ' ' VAL . 76.4 p -63.09 -44.41 95.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.422 0.63 . . . . 0.0 110.072 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' TRP . . . . . . . . . . . . . 75.5 t90 -60.76 -38.75 86.27 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.604 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -62.58 -39.69 94.52 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -178.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.614 HG12 ' O ' ' A' ' 282' ' ' SER . 3.7 p -61.32 -37.89 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.093 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.526 ' O ' HG12 ' A' ' 289' ' ' VAL . 95.0 t -62.02 -40.6 87.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 120.311 -0.556 . . . . 0.0 109.526 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' MET . . . . . 0.459 ' C ' ' SD ' ' A' ' 287' ' ' MET . 0.0 OUTLIER -61.15 -38.55 86.81 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.342 0.591 . . . . 0.0 109.893 178.606 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -58.51 -39.4 80.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.168 -0.923 . . . . 0.0 112.604 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.526 HG12 ' O ' ' A' ' 286' ' ' VAL . 1.3 p -59.85 -38.13 74.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 113.213 0.819 . . . . 0.0 113.213 -175.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 2.1 t -62.35 -40.54 96.73 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 118.892 -1.123 . . . . 0.0 109.135 178.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -60.82 -38.86 86.88 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 177.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -58.35 -40.25 81.7 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 117.664 -1.614 . . . . 0.0 109.913 -175.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' GLN . . . . . 0.496 ' O ' ' O ' ' A' ' 296' ' ' ARG . 56.5 tt0 -60.46 -43.3 97.02 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 122.6 1.191 . . . . 0.0 111.443 -179.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 11.0 mp -60.95 -40.39 93.11 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 113.313 -1.767 . . . . 0.0 109.671 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -62.68 -45.76 91.3 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.36 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' ARG . . . . . 0.496 ' O ' ' O ' ' A' ' 293' ' ' GLN . 43.5 ttm180 -122.53 116.33 23.72 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -119.16 -160.8 0.82 Allowed 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -178.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.493 HD23 ' OG ' ' A' ' 304' ' ' SER . 33.6 tp -71.42 114.82 9.88 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 177.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 28.1 ttp -96.7 64.71 2.13 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -177.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.58 101.04 0.07 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 122.047 0.927 . . . . 0.0 110.721 -178.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -64.15 -46.27 84.82 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 113.505 -1.68 . . . . 0.0 113.452 -176.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -58.73 -39.64 81.48 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.617 -0.433 . . . . 0.0 109.957 -178.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -64.68 -46.76 81.04 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.027 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' SER . . . . . 0.493 ' OG ' HD23 ' A' ' 298' ' ' LEU . 3.0 m -66.34 -38.1 86.85 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.404 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 59.7 mmt-85 -61.88 -42.86 99.57 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.721 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -64.94 -36.8 85.56 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -177.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . 0.54 ' HB3' ' HD3' ' A' ' 308' ' ' PRO . . . -60.02 -52.92 70.03 Favored Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -176.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' PRO . . . . . 0.54 ' HD3' ' HB3' ' A' ' 307' ' ' ALA . 73.9 Cg_endo -75.21 0.33 9.12 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.109 1.873 . . . . 0.0 111.816 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 50.4 t80 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.51 179.992 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 48.5 m . . . . . 0 N--CA 1.465 0.308 0 CA-C-O 120.824 0.345 . . . . 0.0 110.399 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 16' ' ' LYS . 16.8 t -87.05 164.19 2.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.336 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.486 ' N ' HG12 ' A' ' 15' ' ' VAL . 33.3 mtmm -64.37 -42.03 96.41 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -63.77 -41.62 97.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.386 0.612 . . . . 0.0 111.428 179.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.5 tp -79.81 -26.11 40.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.236 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.45 -41.43 94.33 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 107.472 -2.251 . . . . 0.0 107.472 177.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.531 ' HB1' HH22 ' A' ' 96' ' ' ARG . . . -71.47 -32.29 68.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 124.838 2.256 . . . . 0.0 107.061 176.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.56 -42.47 98.86 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-N 108.516 -3.947 . . . . 0.0 107.759 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.0 m -70.7 -27.87 64.32 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.462 0.648 . . . . 0.0 109.591 177.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.66 ' O ' HD13 ' A' ' 26' ' ' ILE . . . -65.95 -49.83 66.52 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.981 -178.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.05 -35.16 77.77 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 118.693 -1.203 . . . . 0.0 112.206 -177.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 78.2 m -63.29 -53.85 46.4 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -177.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.66 HD13 ' O ' ' A' ' 23' ' ' ALA . 0.2 OUTLIER -66.06 -38.16 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -177.739 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.37 -41.9 98.83 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-O 118.175 -0.917 . . . . 0.0 113.316 -172.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -77.58 -26.78 51.07 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 120.914 1.688 . . . . 0.0 110.51 -175.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.3 mp -59.56 -54.56 45.15 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 119.686 1.13 . . . . 0.0 112.27 -178.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.9 tp -74.78 -3.44 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 CA-C-O 121.692 0.758 . . . . 0.0 112.711 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -109.06 -16.19 14.17 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.39 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.495 ' N ' ' HD2' ' A' ' 33' ' ' PRO . 27.0 t80 -68.5 -46.08 36.28 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 116.654 -2.018 . . . . 0.0 111.829 -177.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 32' ' ' PHE . 24.0 Cg_endo -60.26 -15.89 37.47 Favored 'Trans proline' 0 N--CA 1.499 1.824 0 CA-C-N 120.988 1.389 . . . . 0.0 113.238 177.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.411 ' N ' HD12 ' A' ' 34' ' ' LEU . 10.5 mp -67.36 -35.7 79.9 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -177.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -64.64 -40.4 95.39 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.618 -178.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.9 p -58.22 -34.8 70.81 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.812 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.43 -38.85 85.2 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 119.862 -0.735 . . . . 0.0 112.231 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -62.64 -49.86 73.49 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 119.106 -1.037 . . . . 0.0 111.296 -177.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 65.6 t -64.96 -40.19 88.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -177.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.538 ' O ' ' N ' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -61.05 -41.09 95.95 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.752 -178.457 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.6 tp -62.03 38.79 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.967 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.538 ' N ' ' O ' ' A' ' 40' ' ' ARG . 6.3 pt20 -95.51 154.63 17.11 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.82 0.343 . . . . 0.0 110.603 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.701 ' N ' HD12 ' A' ' 43' ' ' ILE . 1.9 mp -69.22 -11.92 15.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.289 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 55.29 -175.71 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.374 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 57.83 38.81 90.06 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.999 -0.841 . . . . 0.0 110.999 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.405 ' O ' ' OG ' ' A' ' 47' ' ' SER . 14.7 pt-20 -61.65 -35.03 76.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.793 0.33 . . . . 0.0 110.408 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' A' ' 46' ' ' GLU . 69.1 m -168.58 -15.88 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.677 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -64.59 -40.78 96.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.655 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.51 9.57 84.61 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -177.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.1 tp -64.62 -36.8 85.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.313 -0.944 . . . . 0.0 109.929 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 95.3 t -59.69 -44.2 93.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.397 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 93.1 mtm-85 -64.46 -34.19 77.62 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.201 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.7 p -68.44 -38.09 80.83 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 178.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -134.51 93.36 3.04 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.803 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.52 -13.38 52.17 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -178.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.613 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 90.5 p -126.33 -140.06 0.27 Allowed 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.613 ' HB3' ' O ' ' A' ' 56' ' ' SER . . . 98.01 12.88 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 O-C-N 124.245 0.965 . . . . 0.0 112.04 178.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.421 ' OE1' ' O ' ' A' ' 59' ' ' TYR . 1.3 tm0? -173.59 84.17 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.562 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.421 ' O ' ' OE1' ' A' ' 58' ' ' GLN . 5.4 m-85 -65.5 148.55 51.53 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -40.23 -36.71 0.55 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.023 0.44 . . . . 0.0 110.255 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -31.85 103.38 0.01 OUTLIER Glycine 0 CA--C 1.529 0.926 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.334 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.3 p -67.14 -33.53 63.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 118.205 -0.902 . . . . 0.0 109.626 176.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -60.02 -32.3 70.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 121.397 1.908 . . . . 0.0 109.958 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.51 -48.96 67.84 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 115.262 -0.881 . . . . 0.0 114.555 -176.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.2 m -61.87 -46.3 90.03 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -178.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 28.9 mm -59.49 -36.27 63.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 40.0 tp -64.04 -35.82 81.97 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 120.252 1.387 . . . . 0.0 112.511 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 98.6 m -63.3 -40.7 98.08 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.069 -175.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 31.7 ttp -60.15 -40.19 88.97 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 114.406 1.262 . . . . 0.0 114.406 -175.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.41 ' CG1' ' N ' ' A' ' 71' ' ' ARG . 3.0 p -69.46 -40.93 80.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 119.218 -0.993 . . . . 0.0 113.16 -177.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.41 ' N ' ' CG1' ' A' ' 70' ' ' VAL . 68.1 ttt-85 -78.75 -12.92 60.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.697 0.76 . . . . 0.0 112.991 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 56.8 m -61.63 -54.85 37.33 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.682 -1.144 . . . . 0.0 111.094 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.554 ' H ' ' CD ' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -117.32 -40.81 3.03 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 118.754 -0.641 . . . . 0.0 110.472 178.064 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 155.15 159.58 9.39 Favored Glycine 0 CA--C 1.549 2.158 0 CA-C-N 120.192 1.36 . . . . 0.0 111.34 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -56.53 -34.58 95.48 Favored 'Trans proline' 0 N--CA 1.511 2.531 0 C-N-CA 122.269 1.98 . . . . 0.0 114.032 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.5 mmp_? -60.23 -10.55 4.7 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 178.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.568 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 1.2 p -77.28 -31.79 55.09 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.642 -178.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 43.5 tp -74.91 -31.94 61.68 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 122.039 -0.413 . . . . 0.0 110.626 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.747 ' O ' HD12 ' A' ' 82' ' ' LEU . 97.3 m-85 -90.88 -3.86 57.01 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 122.851 1.31 . . . . 0.0 114.091 -176.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.568 ' ND2' ' O ' ' A' ' 77' ' ' SER . 0.0 OUTLIER -104.17 123.64 47.66 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 111.986 -2.37 . . . . 0.0 107.738 175.337 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.24 -16.29 49.59 Favored Glycine 0 N--CA 1.467 0.746 0 N-CA-C 108.389 -1.885 . . . . 0.0 108.389 -177.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.969 HD13 ' H ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -59.34 -34.37 72.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 113.859 -1.17 . . . . 0.0 110.559 -179.601 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.969 ' H ' HD13 ' A' ' 82' ' ' LEU . 7.5 p -70.7 -27.36 30.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.322 177.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.96 -31.96 61.6 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 119.199 -0.429 . . . . 0.0 111.35 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.84 -40.01 89.6 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 119.533 -1.317 . . . . 0.0 110.832 -177.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.691 HD23 ' O ' ' A' ' 86' ' ' LEU . 2.4 tt -62.45 -40.54 96.94 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 122.261 1.029 . . . . 0.0 113.335 -176.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -60.55 -27.48 67.69 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 113.541 -1.663 . . . . 0.0 109.815 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 64.2 mtm180 -57.81 -53.25 60.34 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 173.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 70.7 tp60 -67.06 -29.68 69.53 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 112.505 -2.134 . . . . 0.0 111.921 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.446 ' C ' ' SD ' ' A' ' 90' ' ' MET . 11.5 tmm? -61.27 -40.89 95.79 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.044 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 77.7 p -74.24 -34.5 63.66 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 119.362 -0.935 . . . . 0.0 111.402 -176.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -57.84 -44.19 86.32 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 120.951 1.705 . . . . 0.0 111.857 -177.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.38 -33.16 64.89 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 119.546 -0.862 . . . . 0.0 111.094 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.574 ' O ' HG22 ' A' ' 97' ' ' ILE . 25.3 m -64.2 -41.78 96.92 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.443 ' C ' ' H ' ' A' ' 97' ' ' ILE . 72.9 t -68.37 -28.71 41.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.485 178.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.531 HH22 ' HB1' ' A' ' 20' ' ' ALA . 29.6 ttp180 -77.61 10.4 2.69 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -177.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.574 HG22 ' O ' ' A' ' 94' ' ' SER . 10.9 tt -86.96 -15.0 9.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.859 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -140.3 -49.0 0.05 OUTLIER Glycine 0 CA--C 1.541 1.711 0 N-CA-C 117.103 1.601 . . . . 0.0 117.103 -176.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.662 ' C ' HD12 ' A' ' 99' ' ' LEU . 3.1 pp -73.28 -12.77 60.97 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 120.558 2.179 . . . . 0.0 114.515 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.626 ' N ' HD12 ' A' ' 99' ' ' LEU . 46.6 t80 -79.16 -53.04 7.38 Favored 'General case' 0 C--O 1.214 -0.797 0 C-N-CA 118.777 -1.169 . . . . 0.0 113.073 -176.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.451 ' OD1' ' NE2' ' A' ' 105' ' ' GLN . 6.0 t70 -72.3 -33.18 67.22 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 124.26 1.981 . . . . 0.0 112.403 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 67.0 m -65.47 -48.98 70.78 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 109.317 -3.583 . . . . 0.0 115.034 -178.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.405 HG22 ' O ' ' A' ' 99' ' ' LEU . 19.1 m -72.29 -23.83 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.368 0 CA-C-O 123.945 1.831 . . . . 0.0 109.437 175.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.565 ' HB2' ' O ' ' A' ' 100' ' ' TYR . 0.0 OUTLIER -68.03 -42.61 80.35 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 109.943 -3.299 . . . . 0.0 113.675 -179.058 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.451 ' NE2' ' OD1' ' A' ' 101' ' ' ASP . 88.1 mt-30 -76.56 -13.33 60.09 Favored 'General case' 0 C--O 1.211 -0.948 0 CA-C-O 125.468 2.556 . . . . 0.0 111.102 177.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.484 ' O ' ' NZ ' ' A' ' 109' ' ' LYS . 1.9 t80 -80.15 -22.08 42.42 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 109.378 -3.555 . . . . 0.0 110.711 177.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.417 ' HE2' HD21 ' A' ' 194' ' ' LEU . 0.3 OUTLIER -109.68 -28.72 8.69 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.607 0.763 . . . . 0.0 112.404 -174.137 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.753 ' C ' ' H ' ' A' ' 110' ' ' GLY . 0.8 OUTLIER -94.91 12.99 26.32 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -174.723 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.484 ' NZ ' ' O ' ' A' ' 106' ' ' PHE . 7.2 ptpp? -56.58 18.73 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 119.602 1.092 . . . . 0.0 110.825 177.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.753 ' H ' ' C ' ' A' ' 108' ' ' THR . . . 57.8 19.2 35.3 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-N 113.956 -1.475 . . . . 0.0 109.773 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.431 ' O ' ' O ' ' A' ' 110' ' ' GLY . 36.2 m 31.19 -160.73 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 112.47 -1.865 . . . . 0.0 114.333 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.623 ' O ' ' N ' ' A' ' 114' ' ' ALA . 39.8 tt0 -134.12 92.99 3.02 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 114.144 1.165 . . . . 0.0 114.144 -176.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.578 ' O ' ' HB2' ' A' ' 114' ' ' ALA . 89.4 m-70 30.63 28.68 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.082 178.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.623 ' N ' ' O ' ' A' ' 112' ' ' GLU . . . 159.97 -161.97 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.99 15.46 23.94 Favored Glycine 0 N--CA 1.464 0.556 0 C-N-CA 120.035 -1.079 . . . . 0.0 111.647 178.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.678 ' N ' HD12 ' A' ' 116' ' ' ILE . 2.0 mp -60.34 -40.37 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 C-N-CA 119.237 -0.985 . . . . 0.0 108.713 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.91 -41.01 95.66 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.021 175.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 38.3 t -59.33 -43.64 92.69 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 176.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 64.5 mtm180 -64.15 -37.13 86.33 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.677 -178.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.543 HD23 ' O ' ' A' ' 120' ' ' LEU . 2.4 tt -63.2 -45.5 91.41 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 62.3 mt -66.33 -44.62 82.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.406 -1.27 . . . . 0.0 110.129 178.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.09 -45.01 90.57 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 120.074 1.307 . . . . 0.0 110.82 178.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -65.96 -44.44 91.68 Favored Glycine 0 N--CA 1.458 0.155 0 C-N-CA 119.588 -1.291 . . . . 0.0 111.371 -178.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.2 m -63.99 -43.75 94.77 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.949 0.404 . . . . 0.0 110.804 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.421 ' O ' HD23 ' A' ' 129' ' ' LEU . 21.2 m -69.57 -48.7 59.39 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 119.201 -1.0 . . . . 0.0 112.333 177.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 13.8 m -65.93 -42.79 89.62 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 114.868 1.433 . . . . 0.0 114.868 -175.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.435 ' O ' ' OD1' ' A' ' 186' ' ' ASN . . . -64.73 -44.81 94.33 Favored Glycine 0 CA--C 1.521 0.413 0 CA-C-N 114.512 -1.222 . . . . 0.0 113.236 -177.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.32 -41.45 97.04 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 112.457 -1.871 . . . . 0.0 107.196 177.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.614 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 1.6 mm? -64.07 -42.03 97.14 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.173 -0.922 . . . . 0.0 110.207 178.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -62.6 -38.88 91.9 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.58 0.229 . . . . 0.0 111.053 -178.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.616 HG11 HG22 ' A' ' 183' ' ' VAL . 85.6 t -60.58 -25.37 34.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 122.262 1.03 . . . . 0.0 109.516 178.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . -57.94 -44.86 87.21 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 113.281 -1.781 . . . . 0.0 111.988 -178.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.487 ' CG1' ' N ' ' A' ' 134' ' ' ALA . 2.7 p -79.04 -48.87 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.536 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.487 ' N ' ' CG1' ' A' ' 133' ' ' VAL . . . -93.2 139.82 30.19 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.905 0.383 . . . . 0.0 111.23 -179.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.513 ' N ' ' CD ' ' A' ' 136' ' ' PRO . 1.2 tt0 178.45 -46.71 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.416 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.513 ' CD ' ' N ' ' A' ' 135' ' ' GLN . 54.3 Cg_exo -52.31 -33.45 55.75 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 122.501 2.134 . . . . 0.0 112.462 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 37.9 p -67.65 -42.39 82.29 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 118.255 -1.378 . . . . 0.0 109.394 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -66.67 -43.58 84.11 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 118.351 -1.34 . . . . 0.0 111.912 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 52.9 t -64.75 -44.89 96.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -178.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.4 p -65.48 -39.09 84.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -177.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -62.46 -41.67 98.93 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.715 -177.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 13.2 m -70.47 -45.58 74.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.108 -0.637 . . . . 0.0 110.516 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 9.6 mmt85 -65.08 -37.06 86.3 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.585 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.538 ' CD1' ' NE2' ' A' ' 147' ' ' GLN . 76.9 t80 -67.21 -42.1 84.66 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -177.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 23.8 mm100 -65.85 -40.14 91.43 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 119.203 -0.999 . . . . 0.0 110.103 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.22 -34.89 79.43 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 -178.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.538 ' NE2' ' CD1' ' A' ' 144' ' ' PHE . 6.5 pt20 -59.89 111.07 1.33 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 177.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -100.39 -59.01 1.78 Allowed 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -175.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -96.46 60.69 1.92 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 122.125 2.239 . . . . 0.0 110.17 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . 54.97 -94.98 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.321 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 161.97 58.24 0.02 OUTLIER Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.716 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.911 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.743 0.306 . . . . 0.0 110.622 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -72.25 179.64 3.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.544 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.429 ' OG ' ' N ' ' A' ' 159' ' ' THR . 40.3 t -157.05 -178.14 7.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.293 0.568 . . . . 0.0 110.978 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.429 ' N ' ' OG ' ' A' ' 158' ' ' SER . 72.5 p -64.04 -46.22 85.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.591 -177.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.554 HG13 ' N ' ' A' ' 161' ' ' GLU . 10.3 p -64.43 -45.3 96.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 118.995 -1.082 . . . . 0.0 109.418 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.554 ' N ' HG13 ' A' ' 160' ' ' VAL . 60.6 mt-10 -67.23 -39.13 86.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.961 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -61.58 -46.0 91.75 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -177.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.478 ' C ' ' CD1' ' A' ' 163' ' ' TYR . 0.3 OUTLIER -62.77 -49.97 72.87 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 119.901 -0.719 . . . . 0.0 110.122 -179.577 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.6 mmtt -67.79 -45.62 74.29 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -174.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 19.7 m -62.82 -44.87 95.01 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 119.557 1.072 . . . . 0.0 113.385 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.525 ' N ' HD12 ' A' ' 166' ' ' ILE . 1.3 mp -64.86 -38.73 83.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 121.967 0.889 . . . . 0.0 109.165 176.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.78 -36.43 76.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 113.651 -1.613 . . . . 0.0 108.287 176.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 22.5 tpt85 -62.53 -50.88 69.61 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 122.301 2.319 . . . . 0.0 112.075 -175.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -75.29 -51.36 13.43 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 123.587 0.755 . . . . 0.0 109.231 176.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -78.57 -36.76 44.04 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 -174.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 92.89 -168.48 30.26 Favored Glycine 0 N--CA 1.468 0.81 0 O-C-N 121.995 -0.441 . . . . 0.0 112.427 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.529 HG23 ' N ' ' A' ' 173' ' ' ARG . 10.3 tp -72.99 -41.94 59.79 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.14 0 CA-C-O 121.916 0.865 . . . . 0.0 110.783 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.529 ' N ' HG23 ' A' ' 172' ' ' ILE . 36.2 ttm180 -58.69 -33.34 70.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 113.969 -1.469 . . . . 0.0 110.88 -176.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -60.76 -40.43 98.11 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 118.942 -1.599 . . . . 0.0 110.071 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 7.0 tt -70.37 -33.57 71.58 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 111.58 -2.31 . . . . 0.0 117.129 -177.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 4.9 m0 -77.88 -7.39 56.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 111.771 -2.468 . . . . 0.0 109.961 -176.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 24.8 ttpp -43.22 -48.03 6.51 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.434 -176.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -95.16 -36.29 5.5 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 124.142 0.877 . . . . 0.0 111.495 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.446 ' CG2' ' N ' ' A' ' 180' ' ' SER . 0.6 OUTLIER -45.4 -51.05 11.84 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . 0.446 ' N ' ' CG2' ' A' ' 179' ' ' THR . 3.7 m -62.41 -50.13 80.52 Favored Pre-proline 0 N--CA 1.475 0.801 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -176.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 180' ' ' SER . 22.8 Cg_endo -63.95 -27.61 66.53 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 121.533 1.489 . . . . 0.0 111.652 177.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -63.43 -39.26 94.02 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.616 HG22 HG11 ' A' ' 131' ' ' VAL . 60.4 t -63.17 -42.46 96.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.067 0.461 . . . . 0.0 109.878 178.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.03 -38.98 90.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.57 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -60.23 -41.54 93.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.753 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 127' ' ' GLY . 0.5 OUTLIER -61.21 -42.99 99.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.983 0.42 . . . . 0.0 111.211 -179.471 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.73 -44.12 91.18 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.506 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 36.6 mm -64.0 -45.8 95.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.533 ' O ' ' N ' ' A' ' 193' ' ' GLU . 30.8 m -60.34 -46.11 95.48 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.373 0 C-N-CA 119.882 -0.727 . . . . 0.0 111.155 -178.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -62.62 -42.87 99.83 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.501 0.667 . . . . 0.0 110.241 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' CYS . . . . . . . . . . . . . 16.1 t -62.09 -46.09 90.62 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.365 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -63.89 -39.5 94.34 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 113.011 -1.904 . . . . 0.0 109.192 176.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 189' ' ' VAL . 49.4 tp10 -60.18 -46.49 89.53 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.065 -0.97 . . . . 0.0 111.97 -176.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.499 ' HA ' HD13 ' A' ' 194' ' ' LEU . 3.3 mm? -65.26 -38.49 90.48 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 118.17 -1.412 . . . . 0.0 110.866 -176.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.437 ' O ' ' CD2' ' A' ' 199' ' ' LEU . 0.3 OUTLIER -63.89 -47.02 92.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 116.345 -2.142 . . . . 0.0 107.347 -179.691 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 9.4 p -65.16 -46.54 80.43 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -179.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -57.34 -39.15 75.32 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.121 1.368 . . . . 0.0 113.473 -177.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -55.59 -44.19 76.7 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.71 ' N ' HD22 ' A' ' 199' ' ' LEU . 2.5 mm? -61.4 -39.54 91.09 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 80.0 mt -63.18 -43.78 99.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 118.485 -0.769 . . . . 0.0 111.464 -178.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 17.8 mmmt -60.52 -40.13 90.33 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 120.551 1.523 . . . . 0.0 109.511 175.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -64.34 -35.45 80.91 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 112.885 -1.961 . . . . 0.0 111.026 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 199' ' ' LEU . 0.2 OUTLIER -101.55 128.35 47.84 Favored 'General case' 0 C--N 1.357 0.894 0 O-C-N 121.0 -1.063 . . . . 0.0 111.239 -179.268 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.441 ' N ' HD12 ' A' ' 204' ' ' LEU . 10.4 mp 66.23 4.91 3.35 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.202 177.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 2.4 mt -129.38 35.8 4.2 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.465 0.65 . . . . 0.0 112.258 -177.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -73.83 -23.33 59.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.728 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.653 ' C ' HD22 ' A' ' 208' ' ' ASN . . . -131.17 -45.36 1.01 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.95 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' ASN . . . . . 0.969 ' ND2' ' H ' ' A' ' 209' ' ' LEU . 0.0 OUTLIER 127.2 -72.4 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.198 1.799 . . . . 0.0 108.388 -178.207 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.969 ' H ' ' ND2' ' A' ' 208' ' ' ASN . 0.3 OUTLIER . . . . . 0 C--N 1.327 -0.406 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 . . . . . 0 N--CA 1.465 0.29 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.436 ' N ' ' CD ' ' A' ' 215' ' ' PRO . 4.1 mt -61.41 -43.52 89.56 Favored Pre-proline 0 C--N 1.33 -0.255 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 214' ' ' LEU . 26.7 Cg_exo -61.09 -33.58 91.2 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 CA-C-N 119.978 1.028 . . . . 0.0 111.107 -178.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 90.4 m -64.78 -42.46 95.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 113.269 -1.787 . . . . 0.0 111.807 -178.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' HIS . . . . . 0.441 ' O ' ' ND1' ' A' ' 217' ' ' HIS . 1.9 t60 -66.83 -38.32 86.2 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -177.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -63.35 -47.23 82.99 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.73 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 30.5 p -60.17 -37.86 81.43 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 118.943 0.792 . . . . 0.0 111.054 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 11.4 t -59.15 -41.16 87.7 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.3 -41.48 98.96 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -177.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -61.25 -46.98 88.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 122.172 0.987 . . . . 0.0 112.467 -176.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -60.43 -41.61 98.64 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 107.418 -2.273 . . . . 0.0 107.418 176.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . 0.454 ' O ' ' SG ' ' A' ' 227' ' ' CYS . . . -62.52 -37.73 87.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.255 -0.972 . . . . 0.0 108.479 176.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -61.65 -42.22 99.72 Favored Glycine 0 CA--C 1.525 0.679 0 CA-C-N 114.757 -1.111 . . . . 0.0 110.586 -178.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -66.62 -38.5 87.09 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.166 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . 0.467 ' SG ' ' N ' ' A' ' 228' ' ' THR . 0.5 OUTLIER -63.11 -40.48 97.75 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.236 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . 0.467 ' N ' ' SG ' ' A' ' 227' ' ' CYS . 0.3 OUTLIER -61.29 -39.69 91.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.254 179.473 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.4 ' O ' ' HB3' ' A' ' 232' ' ' ALA . 20.1 m -58.39 -39.43 79.63 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 -178.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 92.8 t -60.25 -40.84 84.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 119.339 -0.944 . . . . 0.0 108.497 178.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . 0.596 ' O ' ' HD2' ' A' ' 234' ' ' PRO . 24.8 mm -61.29 -40.09 84.85 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.362 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 229' ' ' THR . . . -62.17 -38.4 88.92 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -178.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.451 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 0.3 OUTLIER -57.24 -40.19 82.89 Favored Pre-proline 0 N--CA 1.48 1.054 0 N-CA-C 116.107 1.891 . . . . 0.0 116.107 -173.052 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.596 ' HD2' ' O ' ' A' ' 231' ' ' ILE . 33.0 Cg_exo -58.76 -40.52 71.98 Favored 'Trans proline' 0 C--N 1.298 -2.088 0 C-N-CA 122.008 1.805 . . . . 0.0 113.516 -177.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 4.6 m -64.66 -36.0 76.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 119.071 -1.051 . . . . 0.0 110.243 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -64.79 -40.71 95.7 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 -177.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.439 ' H ' HG22 ' A' ' 237' ' ' VAL . 6.3 m -64.79 -45.48 94.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -176.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 5.7 p . . . . . 0 C--N 1.324 -0.519 0 C-N-CA 119.888 -0.725 . . . . 0.0 110.038 -179.851 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 96.8 m . . . . . 0 CA--C 1.534 0.348 0 CA-C-O 121.152 0.501 . . . . 0.0 109.879 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' MET . . . . . 0.595 ' O ' ' N ' ' A' ' 264' ' ' GLU . 0.0 OUTLIER -60.5 -41.58 94.59 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.894 -178.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 8.8 tp -61.2 -47.68 85.0 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 29.1 mtp85 -67.28 -53.86 26.06 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 43.6 tttp -66.51 -69.89 0.28 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.42 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . 0.595 ' N ' ' O ' ' A' ' 260' ' ' MET . 43.6 tp10 -88.32 110.77 21.03 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.835 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . 0.484 ' C ' ' H ' ' A' ' 267' ' ' ARG . . . -34.45 155.9 0.01 OUTLIER Glycine 0 CA--C 1.539 1.558 0 CA-C-N 116.3 -0.409 . . . . 0.0 112.11 -179.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -56.03 3.23 0.08 OUTLIER 'Trans proline' 0 N--CA 1.503 2.048 0 C-N-CA 122.131 1.888 . . . . 0.0 113.086 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . 0.484 ' H ' ' C ' ' A' ' 265' ' ' GLY . 99.6 mtt180 -68.95 -27.0 65.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.436 0.16 . . . . 0.0 110.768 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -58.78 -32.7 69.54 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.57 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' PHE . . . . . 0.408 ' CE2' ' CE ' ' A' ' 260' ' ' MET . 51.1 m-85 -62.47 -42.47 99.5 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.554 0.693 . . . . 0.0 110.683 178.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -66.62 -37.46 84.92 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.668 -1.151 . . . . 0.0 113.17 -178.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 272' ' ' GLY . 68.4 mttm -77.59 171.89 14.22 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 271' ' ' LYS . . . 53.69 111.79 0.01 OUTLIER Glycine 0 CA--C 1.528 0.874 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . 0.424 ' H ' ' H ' ' A' ' 274' ' ' MET . 48.2 p90 -172.25 3.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.616 -0.433 . . . . 0.0 111.144 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' MET . . . . . 0.559 ' N ' ' CD ' ' A' ' 275' ' ' PRO . 1.4 ttt -64.01 -44.13 77.12 Favored Pre-proline 0 C--N 1.329 -0.324 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.615 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' A' ' 274' ' ' MET . 19.5 Cg_exo -64.71 -47.9 4.76 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 121.852 1.701 . . . . 0.0 112.107 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 44.6 t -61.52 -40.74 95.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.664 0.745 . . . . 0.0 110.743 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -62.33 -42.62 99.53 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 123.491 1.615 . . . . 0.0 113.541 -178.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 9.2 tp -62.78 -39.24 93.6 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 110.607 -2.997 . . . . 0.0 108.887 174.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 71.5 mtp180 -63.04 -40.54 98.04 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.561 0.696 . . . . 0.0 110.713 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.855 ' O ' HD12 ' A' ' 280' ' ' LEU . 0.1 OUTLIER -62.26 -36.22 81.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.609 -1.178 . . . . 0.0 112.211 -177.446 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -68.14 -51.16 34.94 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . 0.503 ' O ' HG22 ' A' ' 285' ' ' VAL . 71.1 m -63.19 -44.68 94.68 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 123.087 0.555 . . . . 0.0 109.84 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' TRP . . . . . . . . . . . . . 80.3 t90 -60.46 -38.0 82.8 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.851 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -61.75 -37.96 86.19 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.718 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.503 HG22 ' O ' ' A' ' 282' ' ' SER . 0.9 OUTLIER -60.2 -37.44 73.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 111.567 0.21 . . . . 0.0 111.567 -178.598 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.777 ' O ' HG12 ' A' ' 289' ' ' VAL . 0.8 OUTLIER -61.75 -40.15 85.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 120.505 -0.478 . . . . 0.0 109.986 -178.804 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 8.4 tpt -60.91 -39.11 88.11 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.245 0.545 . . . . 0.0 109.721 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -59.05 -41.05 86.98 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.856 -178.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.777 HG12 ' O ' ' A' ' 286' ' ' VAL . 8.1 p -61.28 -38.53 80.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 O-C-N 121.855 -0.528 . . . . 0.0 112.091 -177.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 19.4 p -62.53 -40.98 98.5 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 119.18 -1.008 . . . . 0.0 108.379 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -60.89 -38.55 86.06 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 177.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 14.9 tm-20 -57.53 -39.58 76.92 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 118.138 -1.425 . . . . 0.0 109.535 -176.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' GLN . . . . . 0.439 ' O ' ' O ' ' A' ' 296' ' ' ARG . 0.0 OUTLIER -60.17 -41.63 93.25 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 122.968 1.366 . . . . 0.0 110.11 179.197 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 65.0 mt -60.25 -39.32 86.31 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 112.206 -2.27 . . . . 0.0 109.557 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -62.16 -45.26 94.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.088 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' ARG . . . . . 0.439 ' O ' ' O ' ' A' ' 293' ' ' GLN . 62.3 ttm-85 -122.58 116.06 23.22 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . 0.445 ' HB1' HD12 ' A' ' 298' ' ' LEU . . . -109.72 -169.82 1.54 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.402 0.62 . . . . 0.0 111.76 -178.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.797 ' H ' HD12 ' A' ' 298' ' ' LEU . 0.0 OUTLIER -68.24 -8.83 42.66 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.977 -1.011 . . . . 0.0 111.471 -178.663 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . 0.403 ' C ' ' O ' ' A' ' 298' ' ' LEU . 74.1 mtp 28.1 62.41 0.11 Allowed 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 177.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.62 100.81 0.07 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.812 0.815 . . . . 0.0 110.896 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -63.93 -46.3 85.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.131 -1.395 . . . . 0.0 113.386 -176.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . 0.527 ' CD2' ' OE2' ' A' ' 306' ' ' GLU . 32.8 t80 -58.68 -40.13 82.68 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.023 -0.671 . . . . 0.0 109.539 -178.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' GLN . . . . . 0.485 ' OE1' ' N ' ' A' ' 303' ' ' GLN . 1.3 mp0 -65.0 -46.83 79.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.186 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' SER . . . . . 0.446 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 77.8 p -66.23 -37.4 85.45 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.553 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -61.43 -42.82 99.35 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.057 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . 0.527 ' OE2' ' CD2' ' A' ' 302' ' ' TYR . 41.7 mt-10 -64.71 -36.99 86.08 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.228 1.195 . . . . 0.0 114.228 -177.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . 0.534 ' HB3' ' HD3' ' A' ' 308' ' ' PRO . . . -60.02 -52.95 69.88 Favored Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -176.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' PRO . . . . . 0.534 ' HD3' ' HB3' ' A' ' 307' ' ' ALA . 74.0 Cg_endo -75.26 0.27 9.21 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.193 1.929 . . . . 0.0 111.908 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 91.9 t80 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.609 -179.981 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.5 m . . . . . 0 C--O 1.23 0.06 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.405 HG12 ' H ' ' A' ' 17' ' ' PHE . 3.9 t -147.23 143.85 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 121.129 0.49 . . . . 0.0 111.085 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -64.21 -40.82 96.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.679 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.405 ' H ' HG12 ' A' ' 15' ' ' VAL . 74.1 t80 -63.49 -41.39 98.57 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.175 -0.921 . . . . 0.0 113.208 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 50.9 tp -79.77 -26.48 40.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.177 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.401 ' O ' ' OG1' ' A' ' 22' ' ' THR . . . -66.43 -41.44 94.37 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 107.363 -2.295 . . . . 0.0 107.363 176.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.405 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -71.26 -31.75 67.89 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 124.84 2.257 . . . . 0.0 107.316 176.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.46 -42.72 98.93 Favored Glycine 0 CA--C 1.528 0.867 1 CA-C-N 108.364 -4.016 . . . . 0.0 108.307 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' A' ' 19' ' ' GLY . 35.6 p -70.71 -27.95 64.37 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.576 0.703 . . . . 0.0 109.314 177.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -66.38 -50.18 64.34 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.946 -178.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.82 -35.82 79.33 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 118.671 -1.212 . . . . 0.0 111.2 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 75.6 m -63.71 -53.63 48.16 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.343 -178.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.9 pt -65.47 -39.77 86.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 -177.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.05 -42.02 97.19 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 119.763 -0.775 . . . . 0.0 112.845 -173.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.455 ' HB2' HE21 ' A' ' 89' ' ' GLN . 43.1 t0 -77.71 -27.36 50.63 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 118.249 -1.38 . . . . 0.0 109.544 -176.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.1 tp -60.29 -55.67 30.86 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.714 1.143 . . . . 0.0 111.729 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.0 pt -75.4 -4.0 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 121.306 0.574 . . . . 0.0 112.368 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.429 ' O ' HG22 ' A' ' 31' ' ' THR . 30.1 m -109.12 -16.8 14.02 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.254 -178.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -69.02 -44.69 29.29 Favored Pre-proline 0 CA--C 1.544 0.731 0 CA-C-N 121.868 2.122 . . . . 0.0 111.926 -178.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -59.64 -16.25 35.67 Favored 'Trans proline' 0 N--CA 1.504 2.088 0 CA-C-N 120.897 1.356 . . . . 0.0 112.857 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 62.2 mt -67.54 -35.15 78.51 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -177.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.404 ' HA ' ' HZ3' ' A' ' 38' ' ' LYS . 1.1 m-20 -64.23 -40.52 96.2 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.128 -177.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 87.0 m -58.2 -34.84 70.81 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.14 -38.97 86.43 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 119.691 -0.804 . . . . 0.0 113.048 -179.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.404 ' HZ3' ' HA ' ' A' ' 35' ' ' ASP . 9.2 pttm -62.14 -47.55 84.07 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 118.995 -1.082 . . . . 0.0 111.656 -177.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.6 t -62.83 -38.72 82.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -177.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.504 ' O ' ' N ' ' A' ' 42' ' ' GLN . 7.9 tpm_? -59.45 -41.25 89.22 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 119.266 -0.974 . . . . 0.0 109.706 -178.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.498 ' C ' ' H ' ' A' ' 43' ' ' ILE . 9.4 mp -62.69 38.83 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.59 177.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.57 ' O ' ' N ' ' A' ' 44' ' ' GLN . 25.1 tp60 -72.71 23.96 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 O-C-N 121.947 -0.471 . . . . 0.0 111.385 -178.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.509 HG23 ' O ' ' A' ' 43' ' ' ILE . 9.2 tp 28.98 34.03 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 121.404 0.621 . . . . 0.0 111.534 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.57 ' N ' ' O ' ' A' ' 42' ' ' GLN . 3.1 mp0 53.79 98.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.566 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -169.19 31.74 0.17 Allowed Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -70.57 -28.68 65.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.828 0.347 . . . . 0.0 110.684 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 17.7 t 59.38 42.2 18.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.998 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -98.99 -19.64 17.18 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.1 0.476 . . . . 0.0 110.05 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.16 -23.28 30.29 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.551 ' O ' HD13 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -66.1 -38.26 87.79 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.612 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.528 HG13 ' N ' ' A' ' 52' ' ' ARG . 14.3 p -61.04 -44.5 98.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.151 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.528 ' N ' HG13 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -64.24 -33.58 76.15 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.714 -178.461 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -67.93 -38.05 82.41 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -93.18 -146.25 0.23 Allowed 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.847 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -176.11 -32.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.084 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.593 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 7.9 t -128.08 -138.83 0.24 Allowed 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.593 ' HB3' ' O ' ' A' ' 56' ' ' SER . . . 99.25 12.56 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.6 0 O-C-N 124.165 0.916 . . . . 0.0 111.277 178.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.439 ' CG ' ' O ' ' A' ' 58' ' ' GLN . 4.3 pt20 -174.24 121.1 0.28 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -85.76 151.41 23.85 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 87.9 mtt180 -45.43 -33.02 2.39 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 122.453 1.121 . . . . 0.0 108.096 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -41.89 114.37 0.67 Allowed Glycine 0 CA--C 1.526 0.723 0 CA-C-N 112.86 -1.973 . . . . 0.0 113.195 -178.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.6 p -66.75 -33.02 60.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 118.124 -0.941 . . . . 0.0 108.862 176.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.407 ' O ' HD23 ' A' ' 67' ' ' LEU . 3.7 mm? -60.18 -32.3 70.94 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 121.747 2.067 . . . . 0.0 110.868 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.59 -49.07 66.59 Favored Glycine 0 CA--C 1.532 1.121 0 N-CA-C 114.965 0.746 . . . . 0.0 114.965 -176.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.401 HG22 ' H ' ' A' ' 65' ' ' THR . 1.6 t -62.04 -45.57 93.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.178 -0.511 . . . . 0.0 111.933 -179.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 35.2 mm -59.25 -36.25 62.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.407 HD23 ' O ' ' A' ' 63' ' ' LEU . 2.1 mm? -63.91 -35.84 81.97 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 120.764 1.62 . . . . 0.0 112.148 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 97.9 m -63.0 -39.82 95.89 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 114.002 -1.454 . . . . 0.0 111.04 -175.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.463 ' O ' ' OG1' ' A' ' 72' ' ' THR . 0.1 OUTLIER -60.03 -39.61 86.48 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -176.023 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.6 p -69.91 -40.5 78.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 113.934 1.086 . . . . 0.0 113.934 -178.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -78.3 -13.56 59.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.8 0.809 . . . . 0.0 112.883 -178.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' A' ' 69' ' ' MET . 0.0 OUTLIER -63.2 -54.62 34.61 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.069 -1.423 . . . . 0.0 111.002 178.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -107.79 -57.76 2.06 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.805 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 157.99 163.49 12.81 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -56.51 -35.15 96.53 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 121.987 1.792 . . . . 0.0 111.683 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.433 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 91.7 mtt-85 -61.39 -11.65 11.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.654 0.74 . . . . 0.0 111.022 176.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.9 t -77.69 -32.42 53.04 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.089 -1.414 . . . . 0.0 111.038 -177.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.516 ' N ' HD12 ' A' ' 78' ' ' LEU . 10.2 mp -75.5 -33.09 60.74 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 122.126 -0.359 . . . . 0.0 110.783 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -91.91 -4.58 54.54 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 122.796 1.284 . . . . 0.0 113.142 -178.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.433 ' ND2' ' O ' ' A' ' 76' ' ' ARG . 0.9 OUTLIER -97.47 117.65 32.21 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 112.025 -2.352 . . . . 0.0 107.168 174.903 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.9 -13.5 56.17 Favored Glycine 0 N--CA 1.469 0.866 0 N-CA-C 108.255 -1.938 . . . . 0.0 108.255 -177.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 12.3 tp -58.85 -34.71 71.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 113.305 -1.448 . . . . 0.0 110.249 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.8 p -70.54 -26.78 29.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.364 178.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.81 -31.61 61.76 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.796 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.86 -40.42 89.4 Favored Glycine 0 N--CA 1.463 0.492 0 C-N-CA 119.677 -1.249 . . . . 0.0 111.223 -177.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.3 mp -62.34 -40.08 95.21 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 122.364 1.078 . . . . 0.0 112.5 -177.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -60.44 -27.24 67.35 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 113.071 -1.877 . . . . 0.0 109.34 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 49.4 ttp180 -57.91 -53.48 57.77 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 173.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.455 HE21 ' HB2' ' A' ' 28' ' ' ASP . 9.8 tp-100 -67.44 -29.89 69.48 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 112.56 -2.109 . . . . 0.0 112.428 -178.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 12.2 tpt -61.02 -40.98 95.63 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.352 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 78.2 p -74.35 -34.34 63.38 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 119.509 -0.877 . . . . 0.0 111.401 -176.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -58.04 -44.48 87.43 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 120.6 1.545 . . . . 0.0 111.789 -176.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.33 -33.59 65.21 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.49 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.1 t -64.48 -41.8 96.25 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.3 t -68.41 -28.6 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.841 177.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.568 ' NH2' ' CE2' ' A' ' 100' ' ' TYR . 59.9 ttt-85 -78.05 8.79 4.29 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -177.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.492 HD13 ' O ' ' A' ' 97' ' ' ILE . 0.3 OUTLIER -87.49 -14.95 9.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.086 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -140.09 -48.13 0.06 OUTLIER Glycine 0 CA--C 1.54 1.631 0 N-CA-C 115.864 1.106 . . . . 0.0 115.864 -176.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.7 mt -71.08 -12.56 61.58 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 119.586 1.693 . . . . 0.0 112.817 -178.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.568 ' CE2' ' NH2' ' A' ' 96' ' ' ARG . 4.3 t80 -80.22 -51.32 9.08 Favored 'General case' 0 C--O 1.214 -0.778 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.438 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 1.162 ' OD1' ' NE2' ' A' ' 105' ' ' GLN . 12.7 t70 -69.48 -32.73 71.81 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 123.45 1.595 . . . . 0.0 110.561 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 31.1 m -68.82 -52.47 29.77 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 111.023 -2.808 . . . . 0.0 114.466 177.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.582 HG22 ' CE2' ' A' ' 107' ' ' TYR . 1.1 p -74.97 -27.82 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 CA-C-N 121.942 2.156 . . . . 0.0 112.479 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.521 ' HB2' ' O ' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -69.99 -41.74 73.98 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 110.849 -2.887 . . . . 0.0 112.801 -179.636 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 1.162 ' NE2' ' OD1' ' A' ' 101' ' ' ASP . 88.1 mt-30 -78.88 -11.43 60.0 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 122.972 1.368 . . . . 0.0 111.043 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.47 -21.94 48.27 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 113.924 -1.489 . . . . 0.0 111.086 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.582 ' CE2' HG22 ' A' ' 103' ' ' VAL . 47.5 m-85 -108.36 -30.57 8.25 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 120.005 1.275 . . . . 0.0 111.614 -175.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.1 p -98.27 9.68 42.44 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 117.972 -1.491 . . . . 0.0 112.047 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.47 ' O ' ' C ' ' A' ' 110' ' ' GLY . 16.0 ttmm -54.19 118.17 3.85 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.619 0.645 . . . . 0.0 112.453 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.511 ' O ' ' O ' ' A' ' 111' ' ' SER . . . -17.24 -89.09 0.01 OUTLIER Glycine 0 N--CA 1.48 1.585 0 CA-C-O 119.81 -0.439 . . . . 0.0 113.155 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.703 ' O ' ' O ' ' A' ' 112' ' ' GLU . 5.9 t 45.44 111.54 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 117.252 0.526 . . . . 0.0 111.797 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.703 ' O ' ' O ' ' A' ' 111' ' ' SER . 17.1 pt-20 -9.57 -148.26 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 126.481 1.913 . . . . 0.0 115.929 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.622 ' O ' ' HB2' ' A' ' 114' ' ' ALA . 0.0 OUTLIER -105.92 73.35 0.99 Allowed 'General case' 0 C--N 1.343 0.303 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -177.257 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.622 ' HB2' ' O ' ' A' ' 113' ' ' HIS . . . 160.14 -164.38 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 122.35 1.072 . . . . 0.0 108.963 175.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.03 15.6 25.72 Favored Glycine 0 C--N 1.342 0.863 0 CA-C-N 113.015 -1.902 . . . . 0.0 111.487 178.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.434 HG23 ' N ' ' A' ' 117' ' ' GLY . 13.3 tt -60.71 -40.33 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 C-N-CA 119.609 -0.837 . . . . 0.0 111.015 -178.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.434 ' N ' HG23 ' A' ' 116' ' ' ILE . . . -65.56 -40.39 96.05 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-O 121.716 0.62 . . . . 0.0 112.098 176.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 26.0 p -58.41 -42.57 87.48 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 176.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.1 tpp180 -63.55 -37.24 86.55 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 119.824 -0.75 . . . . 0.0 110.927 -177.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.669 HD21 HD22 ' A' ' 194' ' ' LEU . 2.6 mm? -63.35 -46.1 88.11 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 20.9 mt -66.51 -44.76 81.66 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 118.896 -1.122 . . . . 0.0 109.847 178.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.1 -45.21 89.67 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 119.964 1.256 . . . . 0.0 110.452 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -65.81 -44.42 92.14 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.191 -1.004 . . . . 0.0 111.262 -178.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 42.5 m -64.17 -43.75 94.2 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.742 0.306 . . . . 0.0 111.418 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 19.7 m -69.5 -48.27 61.11 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 119.346 -0.942 . . . . 0.0 112.337 177.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.475 HG23 ' N ' ' A' ' 127' ' ' GLY . 6.0 t -65.68 -42.75 90.9 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 -174.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.475 ' N ' HG23 ' A' ' 126' ' ' THR . . . -64.48 -44.96 94.46 Favored Glycine 0 CA--C 1.52 0.401 0 CA-C-N 114.632 -1.167 . . . . 0.0 113.138 -177.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.432 ' O ' HG22 ' A' ' 131' ' ' VAL . . . -61.81 -41.71 98.1 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 112.719 -1.741 . . . . 0.0 107.207 177.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.745 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 54.6 tp -64.7 -42.62 95.15 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.09 178.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.34 -40.09 96.33 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.099 0.778 . . . . 0.0 113.099 -177.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 128' ' ' ALA . 14.3 m -61.17 -26.55 39.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 123.521 1.629 . . . . 0.0 109.639 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.745 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . -59.29 -45.49 91.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 110.835 -2.893 . . . . 0.0 112.673 -178.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.419 ' H ' HG12 ' A' ' 133' ' ' VAL . 2.6 p -79.65 -49.03 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 -178.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -121.79 136.39 54.93 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.823 0.344 . . . . 0.0 111.667 -178.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.762 ' H ' ' CD ' ' A' ' 136' ' ' PRO . 0.0 OUTLIER 170.33 -21.36 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.723 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.79 178.669 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.762 ' CD ' ' H ' ' A' ' 135' ' ' GLN . 53.0 Cg_exo -52.84 -34.68 66.74 Favored 'Trans proline' 0 N--CA 1.499 1.85 0 CA-C-N 121.174 1.455 . . . . 0.0 113.268 -178.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.479 HG23 ' N ' ' A' ' 138' ' ' ASP . 11.5 t -67.28 -41.59 85.22 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 119.07 -1.052 . . . . 0.0 108.613 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.479 ' N ' HG23 ' A' ' 137' ' ' THR . 98.5 m-20 -64.68 -42.24 95.49 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 118.857 -1.137 . . . . 0.0 111.34 -178.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 55.3 t -63.85 -44.48 98.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 32.1 m -65.33 -38.17 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -177.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -61.73 -40.65 95.84 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -176.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.443 ' CG2' ' N ' ' A' ' 143' ' ' ARG . 1.5 m -69.41 -44.24 80.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.028 -0.669 . . . . 0.0 109.343 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.528 ' NH2' ' O ' ' A' ' 174' ' ' GLY . 94.8 mtt-85 -63.86 -35.41 80.56 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.288 178.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -65.89 -40.21 91.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.92 -177.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 23.8 tm0? -63.98 -39.31 93.83 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 119.335 -0.946 . . . . 0.0 108.861 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.14 -35.16 80.24 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 113.267 0.839 . . . . 0.0 113.267 -178.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.52 110.78 1.19 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 177.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -99.41 -60.58 1.5 Allowed 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -175.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -98.35 117.51 32.93 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 122.107 2.23 . . . . 0.0 109.968 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -68.14 -15.0 63.4 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.666 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 71.08 -173.85 41.68 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.692 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 179.827 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.428 ' O ' ' O ' ' A' ' 157' ' ' GLN . 79.4 t80 . . . . . 0 N--CA 1.466 0.349 0 CA-C-O 120.712 0.291 . . . . 0.0 110.979 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.428 ' O ' ' O ' ' A' ' 156' ' ' TYR . 18.1 mm100 59.4 145.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.338 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 70.5 m -157.07 -177.73 6.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.383 0.611 . . . . 0.0 111.201 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 96.8 m -63.92 -45.97 86.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.551 -177.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.539 HG23 ' N ' ' A' ' 161' ' ' GLU . 8.2 m -64.01 -44.9 97.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 118.913 -1.115 . . . . 0.0 109.008 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.539 ' N ' HG23 ' A' ' 160' ' ' VAL . 94.6 mt-10 -66.94 -39.04 87.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.859 0.361 . . . . 0.0 111.459 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -61.76 -45.62 93.14 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -177.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -62.38 -49.66 74.65 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.509 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 65.7 mmtt -68.44 -45.43 72.53 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 -175.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 35.6 p -62.79 -44.66 95.58 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 120.78 -1.2 . . . . 0.0 113.921 -177.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.419 HD12 ' N ' ' A' ' 167' ' ' ALA . 2.4 pp -64.64 -37.78 80.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 121.825 0.822 . . . . 0.0 109.632 176.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.419 ' N ' HD12 ' A' ' 166' ' ' ILE . . . -58.64 -35.87 73.2 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 113.741 -1.572 . . . . 0.0 107.829 177.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 7.8 tpm_? -61.94 -50.47 71.99 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 121.706 2.048 . . . . 0.0 112.726 -175.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -75.25 -51.21 13.83 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 123.684 0.793 . . . . 0.0 111.199 178.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -78.14 -36.24 48.01 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 116.169 1.914 . . . . 0.0 116.169 -172.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 93.03 -167.42 29.28 Favored Glycine 0 N--CA 1.47 0.951 0 N-CA-C 111.872 -0.491 . . . . 0.0 111.872 177.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.711 ' H ' HD13 ' A' ' 172' ' ' ILE . 0.0 OUTLIER -73.37 -44.48 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 CA-C-O 121.796 0.808 . . . . 0.0 109.871 -179.827 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -59.03 -33.9 71.28 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 114.442 -1.254 . . . . 0.0 111.424 -177.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.528 ' O ' ' NH2' ' A' ' 143' ' ' ARG . . . -61.05 -40.41 98.47 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 118.575 -1.774 . . . . 0.0 109.3 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 1.2 tp -70.54 -33.71 71.45 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 111.459 -2.371 . . . . 0.0 116.995 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 6.4 m95 -77.84 -7.56 56.83 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 111.991 -2.368 . . . . 0.0 109.796 -177.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 48.1 tttp -43.39 -48.29 7.04 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.575 -176.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -95.1 -40.03 4.39 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.3 0.953 . . . . 0.0 112.109 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.407 HG23 ' H ' ' A' ' 179' ' ' THR . 11.5 p -45.46 -51.44 11.57 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -179.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . 0.452 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 2.6 m -62.72 -50.69 76.7 Favored Pre-proline 0 N--CA 1.472 0.659 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -176.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' A' ' 180' ' ' SER . 30.1 Cg_endo -64.5 -27.58 62.07 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 121.986 1.791 . . . . 0.0 111.928 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -63.35 -39.09 93.58 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 120.588 -0.445 . . . . 0.0 109.939 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.451 ' O ' ' OD1' ' A' ' 186' ' ' ASN . 85.2 t -62.84 -42.3 95.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.051 0.453 . . . . 0.0 109.975 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.88 -39.51 92.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.095 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 46.2 ttp85 -60.44 -40.83 92.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.923 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . 0.49 ' C ' ' ND2' ' A' ' 186' ' ' ASN . 0.0 OUTLIER -60.34 -41.67 94.08 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.136 0.493 . . . . 0.0 110.34 -179.667 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.2 -43.19 98.87 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.79 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.444 ' O ' ' SG ' ' A' ' 191' ' ' CYS . 42.9 mm -63.01 -44.8 99.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 6.3 m -59.37 -45.67 93.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 119.816 -0.754 . . . . 0.0 111.276 -178.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.406 ' OD1' ' N ' ' A' ' 191' ' ' CYS . 0.9 OUTLIER -61.8 -42.51 99.1 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.876 0.846 . . . . 0.0 109.419 179.302 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' CYS . . . . . 0.551 ' SG ' ' N ' ' A' ' 192' ' ' ALA . 0.5 OUTLIER -62.0 -45.94 91.41 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.013 -1.449 . . . . 0.0 110.828 179.666 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.551 ' N ' ' SG ' ' A' ' 191' ' ' CYS . . . -63.71 -40.4 96.68 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 114.463 -1.244 . . . . 0.0 109.433 177.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -60.74 -44.72 96.33 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.702 -1.136 . . . . 0.0 112.579 -178.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.669 HD22 HD21 ' A' ' 120' ' ' LEU . 2.5 pp -63.0 -37.83 88.74 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 118.862 -1.135 . . . . 0.0 109.75 -174.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.47 ' N ' ' HG ' ' A' ' 194' ' ' LEU . 0.6 OUTLIER -63.99 -46.15 94.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 C-N-CA 117.206 -1.798 . . . . 0.0 107.464 179.074 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 19.2 m -63.98 -46.52 84.24 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -176.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -56.8 -39.12 73.57 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.694 0.798 . . . . 0.0 111.222 -178.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -56.06 -43.93 78.41 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.4 HD23 ' N ' ' A' ' 199' ' ' LEU . 7.7 mt -61.21 -39.39 90.06 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.599 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.1 mm -62.94 -42.04 95.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 1.8 mmmm -59.27 -38.77 80.95 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.744 1.618 . . . . 0.0 114.911 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -64.27 -42.24 96.53 Favored 'General case' 0 C--O 1.245 0.849 0 O-C-N 121.087 -1.008 . . . . 0.0 111.063 -176.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.631 HG22 HD23 ' A' ' 204' ' ' LEU . 4.0 m -102.5 129.19 48.95 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -176.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.631 HD23 HG22 ' A' ' 203' ' ' THR . 3.6 mm? 66.52 3.32 2.83 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 113.717 -1.583 . . . . 0.0 111.299 177.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.555 HD22 ' O ' ' A' ' 204' ' ' LEU . 2.9 mm? -122.1 24.53 9.46 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 -178.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -79.33 -18.11 53.18 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.502 0.668 . . . . 0.0 110.382 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.463 ' O ' ' CB ' ' A' ' 208' ' ' ASN . . . -167.1 25.96 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.204 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' ASN . . . . . 0.61 ' O ' ' O ' ' A' ' 204' ' ' LEU . 0.7 OUTLIER 93.53 -130.83 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.39 0.676 . . . . 0.0 109.81 -178.729 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.682 ' O ' HD23 ' A' ' 209' ' ' LEU . 6.5 tt . . . . . 0 CA--C 1.505 -0.757 0 N-CA-C 106.719 -1.585 . . . . 0.0 106.719 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 213' ' ' ASP . 34.8 p30 . . . . . 0 N--CA 1.464 0.249 0 CA-C-O 120.963 0.411 . . . . 0.0 110.444 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.45 ' N ' ' HD2' ' A' ' 215' ' ' PRO . 2.0 pt? -61.11 -42.07 84.3 Favored Pre-proline 0 CA--C 1.548 0.877 0 N-CA-C 113.828 1.048 . . . . 0.0 113.828 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' A' ' 214' ' ' LEU . 37.5 Cg_endo -60.13 -32.19 94.27 Favored 'Trans proline' 0 N--CA 1.502 2.01 0 CA-C-N 122.419 1.9 . . . . 0.0 111.458 -178.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 9.9 t -63.51 -42.13 98.5 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 113.48 -1.691 . . . . 0.0 111.713 -177.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' HIS . . . . . 0.433 ' CG ' HD11 ' A' ' 209' ' ' LEU . 54.8 t60 -66.64 -37.75 85.46 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.348 -0.541 . . . . 0.0 111.933 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -63.28 -47.04 84.0 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.515 -178.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 1.5 t -60.22 -37.51 80.54 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 118.845 0.748 . . . . 0.0 111.032 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 78.7 p -59.51 -41.71 90.54 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . 0.544 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.68 -41.61 98.13 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -177.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -61.66 -47.04 87.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 122.007 0.908 . . . . 0.0 112.71 -176.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -60.42 -41.73 98.67 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 107.544 -2.223 . . . . 0.0 107.544 177.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -62.95 -38.05 89.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.33 -0.935 . . . . 0.0 109.043 177.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -61.94 -42.1 99.71 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.192 -178.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -66.16 -38.4 88.0 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 97.5 m -63.1 -40.8 98.69 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 176.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 11.2 m -61.59 -40.1 93.59 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.263 -1.335 . . . . 0.0 110.997 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 92.4 m -58.4 -39.13 78.86 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.371 -177.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 97.1 t -59.68 -40.46 82.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . 0.594 ' O ' ' HD2' ' A' ' 234' ' ' PRO . 23.0 mm -60.97 -40.11 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 177.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -62.32 -38.63 90.17 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.47 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 0.1 OUTLIER -57.25 -40.87 87.82 Favored Pre-proline 0 N--CA 1.482 1.173 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 -172.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.594 ' HD2' ' O ' ' A' ' 231' ' ' ILE . 31.6 Cg_exo -57.87 -39.22 88.53 Favored 'Trans proline' 0 C--N 1.292 -2.404 0 C-N-CA 122.021 1.814 . . . . 0.0 112.491 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 31.0 t -63.52 -36.32 75.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 118.802 -1.159 . . . . 0.0 109.398 178.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . 0.451 ' OD2' ' O ' ' A' ' 233' ' ' SER . 0.0 OUTLIER -65.23 -40.11 93.62 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.174 179.634 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 96.7 t -64.29 -45.63 95.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -176.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 25.6 m . . . . . 0 C--N 1.325 -0.478 0 C-N-CA 119.756 -0.777 . . . . 0.0 110.533 -179.044 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 31.6 m . . . . . 0 C--O 1.228 -0.069 0 CA-C-O 121.177 0.513 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' MET . . . . . 0.426 ' O ' ' O ' ' A' ' 264' ' ' GLU . 32.2 mtt -62.1 -43.58 98.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.945 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 11.8 tp -62.21 -46.26 89.68 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 122.685 0.394 . . . . 0.0 111.068 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 69.6 ttp85 -65.92 -53.8 34.68 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.906 -178.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . 0.426 ' O ' ' N ' ' A' ' 265' ' ' GLY . 0.1 OUTLIER -102.73 -107.35 0.26 Allowed 'General case' 0 N--CA 1.472 0.659 0 O-C-N 122.249 -0.282 . . . . 0.0 111.208 179.562 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . 0.443 ' O ' ' O ' ' A' ' 265' ' ' GLY . 71.2 mm-40 -33.47 91.92 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . 0.443 ' O ' ' O ' ' A' ' 264' ' ' GLU . . . -38.51 166.11 0.01 OUTLIER Glycine 0 CA--C 1.534 1.251 0 CA-C-O 121.623 0.568 . . . . 0.0 111.712 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -63.21 -3.81 5.53 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 122.807 2.338 . . . . 0.0 111.628 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 27.8 mtp180 -69.08 -25.8 64.62 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 123.043 0.537 . . . . 0.0 111.671 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -57.88 -31.84 67.12 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.253 -178.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -62.34 -41.24 98.42 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.18 0.514 . . . . 0.0 110.987 177.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -66.17 -38.37 87.88 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -176.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.439 ' O ' ' O ' ' A' ' 272' ' ' GLY . 14.5 pttm -72.09 -172.43 0.88 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 271' ' ' LYS . . . 47.05 99.23 0.01 OUTLIER Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -158.74 0.94 0.09 Allowed 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.248 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' MET . . . . . 0.552 ' N ' ' HD2' ' A' ' 275' ' ' PRO . 6.2 mmt -63.55 -45.44 83.2 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.581 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 274' ' ' MET . 31.9 Cg_endo -64.9 -45.9 7.35 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 121.133 1.222 . . . . 0.0 110.574 177.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 1.4 m -60.36 -39.78 88.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.246 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . 0.434 ' O ' ' HG ' ' A' ' 280' ' ' LEU . 34.3 t80 -61.65 -43.03 99.63 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 124.438 2.066 . . . . 0.0 112.175 -178.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.11 -38.81 92.67 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 110.568 -3.015 . . . . 0.0 109.569 175.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 11.3 mmm180 -63.2 -41.8 99.23 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.51 0.929 . . . . 0.0 113.51 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.68 HD12 ' N ' ' A' ' 281' ' ' GLY . 3.0 pp -63.12 -35.34 79.94 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -178.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . 0.68 ' N ' HD12 ' A' ' 280' ' ' LEU . . . -67.83 -50.88 38.51 Favored Glycine 0 CA--C 1.521 0.413 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -177.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . 0.448 ' O ' HG12 ' A' ' 285' ' ' VAL . 9.5 t -62.49 -43.89 97.72 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.642 0.777 . . . . 0.0 109.387 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' TRP . . . . . 0.415 ' O ' HG22 ' A' ' 286' ' ' VAL . 83.0 t90 -59.54 -37.68 79.04 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 281' ' ' GLY . 0.1 OUTLIER -61.49 -37.2 82.77 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.665 -179.845 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.448 HG12 ' O ' ' A' ' 282' ' ' SER . 0.3 OUTLIER -60.3 -39.0 79.54 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 O-C-N 121.505 -0.747 . . . . 0.0 112.184 -177.32 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.465 ' H ' HG13 ' A' ' 286' ' ' VAL . 1.0 OUTLIER -63.41 -41.94 94.49 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 119.902 -0.719 . . . . 0.0 112.585 -178.716 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 6.8 ptm -61.78 -38.47 88.18 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.192 0.52 . . . . 0.0 109.808 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -58.2 -40.31 81.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.937 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 91.5 t -60.87 -39.41 81.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.591 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 10.8 m -63.21 -40.45 97.5 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -61.21 -38.73 87.63 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 176.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -57.94 -40.17 79.87 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 118.143 -1.423 . . . . 0.0 109.272 -176.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' GLN . . . . . 0.446 ' O ' ' O ' ' A' ' 296' ' ' ARG . 73.9 mt-30 -60.29 -41.96 94.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 123.126 1.441 . . . . 0.0 109.764 179.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.41 -39.66 88.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 111.717 -2.492 . . . . 0.0 109.342 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -62.72 -45.31 93.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.537 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' ARG . . . . . 0.446 ' O ' ' O ' ' A' ' 293' ' ' GLN . 44.7 ttm180 -122.53 116.18 23.45 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -113.55 -164.83 0.95 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.269 0.557 . . . . 0.0 112.162 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 14.1 mt -72.74 114.89 11.38 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 79.0 mmm -97.93 63.86 1.68 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -178.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.66 100.96 0.07 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.868 0.842 . . . . 0.0 110.716 -178.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -63.95 -46.22 85.66 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 113.962 -1.472 . . . . 0.0 113.528 -176.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -58.59 -39.21 79.72 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -178.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -64.13 -46.15 85.39 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.539 -179.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' SER . . . . . 0.432 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 40.5 t -66.19 -37.72 86.29 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.764 -0.375 . . . . 0.0 110.999 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -61.76 -43.28 99.17 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -179.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -65.19 -36.63 84.8 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.344 1.238 . . . . 0.0 114.344 -177.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . 0.525 ' HB3' ' HD3' ' A' ' 308' ' ' PRO . . . -60.02 -52.82 70.8 Favored Pre-proline 0 CA--C 1.544 0.738 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -176.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' PRO . . . . . 0.525 ' HD3' ' HB3' ' A' ' 307' ' ' ALA . 74.2 Cg_endo -75.12 0.21 9.23 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.069 1.846 . . . . 0.0 111.808 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' PHE . . . . . 0.472 ' CG ' ' O ' ' A' ' 308' ' ' PRO . 69.4 m-85 . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.546 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.467 0.391 0 CA-C-O 120.786 0.326 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.466 ' H ' HG22 ' A' ' 15' ' ' VAL . 3.3 m -83.15 150.61 4.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.266 0.555 . . . . 0.0 110.982 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.55 -40.74 96.14 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.241 -0.89 . . . . 0.0 112.088 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -63.32 -41.83 98.95 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -177.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.827 ' O ' HD12 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -80.06 -26.36 39.69 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.092 0.472 . . . . 0.0 111.568 -179.298 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.24 -41.54 94.7 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 107.594 -2.202 . . . . 0.0 107.594 177.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -71.55 -32.5 68.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 124.818 2.247 . . . . 0.0 107.602 176.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.25 -42.26 99.36 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-N 108.502 -3.954 . . . . 0.0 107.626 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.7 m -70.49 -27.68 64.39 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -66.57 -49.8 65.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.842 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.93 -35.97 79.99 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 118.077 -1.449 . . . . 0.0 111.054 -177.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 77.4 m -63.84 -53.93 42.87 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.496 -178.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.2 pp -65.79 -39.43 84.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -177.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.11 -41.96 97.05 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -174.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.519 ' OD1' ' NH2' ' A' ' 88' ' ' ARG . 10.0 t70 -77.64 -27.39 51.05 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 120.594 1.543 . . . . 0.0 109.809 -175.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 43.5 mt -60.0 -55.28 35.97 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 119.724 1.147 . . . . 0.0 112.097 -178.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.8 tp -75.42 -3.87 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-O 121.743 0.783 . . . . 0.0 112.335 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 29.7 m -108.96 -16.39 14.15 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 117.491 -1.242 . . . . 0.0 110.305 -178.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.441 ' O ' ' OD1' ' A' ' 35' ' ' ASP . 14.5 t80 -69.01 -44.3 28.25 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-N 122.784 2.538 . . . . 0.0 111.758 -177.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' A' ' 32' ' ' PHE . 32.1 Cg_exo -59.6 -15.72 32.52 Favored 'Trans proline' 0 N--CA 1.504 2.107 0 C-N-CA 121.298 1.332 . . . . 0.0 113.245 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.8 mp -67.18 -35.5 79.78 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -177.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 36' ' ' THR . 15.8 p30 -64.86 -40.53 95.3 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -178.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.545 ' N ' ' OD1' ' A' ' 35' ' ' ASP . 43.3 p -58.4 -34.99 71.35 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.483 ' HB3' HH22 ' A' ' 279' ' ' ARG . . . -67.59 -38.37 83.93 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 119.948 -0.701 . . . . 0.0 111.84 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -61.66 -49.09 77.94 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 119.625 -0.83 . . . . 0.0 111.266 -176.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.419 ' H ' HG22 ' A' ' 39' ' ' VAL . 10.5 m -63.69 -39.75 86.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 118.31 0.504 . . . . 0.0 111.913 -177.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.521 ' NH2' ' OE1' ' A' ' 42' ' ' GLN . 7.6 tpm_? -60.78 -40.99 94.66 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.411 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.0 38.85 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.589 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.521 ' OE1' ' NH2' ' A' ' 40' ' ' ARG . 2.6 pt20 -85.82 61.73 7.03 Favored 'General case' 0 N--CA 1.463 0.188 0 O-C-N 121.965 -0.459 . . . . 0.0 110.971 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.408 ' C ' ' O ' ' A' ' 42' ' ' GLN . 22.2 pt 32.06 -125.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.861 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -158.15 100.62 1.71 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.649 0.262 . . . . 0.0 110.334 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.51 ' C ' ' H ' ' A' ' 47' ' ' SER . . . -176.31 -118.59 0.54 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.089 -0.805 . . . . 0.0 111.089 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 69.22 -16.9 0.23 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.704 0.288 . . . . 0.0 110.786 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.51 ' H ' ' C ' ' A' ' 45' ' ' GLY . 29.0 t 53.66 26.41 5.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.919 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.519 ' NE2' ' O ' ' A' ' 48' ' ' GLN . 0.0 OUTLIER -44.16 -28.39 0.5 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.674 0.75 . . . . 0.0 109.789 179.727 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.72 -36.71 3.66 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -178.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.422 HD23 ' OE1' ' A' ' 48' ' ' GLN . 3.6 mm? -66.73 -38.03 85.85 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.448 0.642 . . . . 0.0 109.311 177.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 96.2 t -60.68 -44.55 97.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 114.919 -1.037 . . . . 0.0 112.604 -177.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -64.19 -33.54 76.02 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.938 -178.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.5 m -67.92 -38.06 82.45 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 177.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.409 ' C ' ' H ' ' A' ' 56' ' ' SER . . . -127.93 78.6 1.84 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.177 -0.919 . . . . 0.0 108.801 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.38 -3.42 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.635 -0.712 . . . . 0.0 112.813 -178.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.606 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 94.9 p -126.58 -140.04 0.27 Allowed 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.606 ' HB3' ' O ' ' A' ' 56' ' ' SER . . . 99.2 11.77 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 O-C-N 124.12 0.888 . . . . 0.0 111.878 178.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 177.52 70.78 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -41.12 -83.78 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.054 0.454 . . . . 0.0 110.633 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.415 ' O ' ' C ' ' A' ' 61' ' ' GLY . 30.0 ttm180 -161.01 -34.36 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.591 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 60' ' ' ARG . . . -28.61 102.74 0.01 OUTLIER Glycine 0 CA--C 1.527 0.807 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.641 -179.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 90.3 t -67.41 -34.6 69.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 118.451 -0.785 . . . . 0.0 109.685 176.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.493 ' N ' HD22 ' A' ' 63' ' ' LEU . 3.6 mm? -60.79 -32.65 71.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 121.011 1.732 . . . . 0.0 109.726 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.61 -49.31 65.18 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-N 114.905 -1.043 . . . . 0.0 114.398 -176.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.3 m -62.1 -46.36 89.41 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 70.6 mt -59.43 -35.95 61.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.57 ' O ' HD13 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -63.94 -35.76 81.72 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 120.919 1.69 . . . . 0.0 112.156 179.452 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 99.2 m -63.22 -40.73 98.29 Favored 'General case' 0 C--O 1.246 0.906 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.003 -174.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.402 ' C ' ' SD ' ' A' ' 69' ' ' MET . 3.2 ppp? -59.67 -40.05 86.51 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -175.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.2 p -69.49 -40.78 80.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 119.096 -1.042 . . . . 0.0 112.563 -178.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 75.0 ttt-85 -78.54 -13.3 59.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.769 0.795 . . . . 0.0 112.534 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 54.5 m -62.81 -54.65 35.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.643 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -107.44 -56.47 2.21 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.276 178.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 157.3 165.89 15.87 Favored Glycine 0 CA--C 1.535 1.325 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -56.27 -35.47 95.76 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 CA-C-N 119.508 1.654 . . . . 0.0 111.893 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.41 ' O ' ' CB ' ' A' ' 80' ' ' ASN . 12.1 tpp180 -61.42 -12.27 13.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.756 0.789 . . . . 0.0 111.007 176.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 10.4 p -78.55 -33.0 48.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.968 -178.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.59 HD23 ' O ' ' A' ' 78' ' ' LEU . 1.0 OUTLIER -75.94 -33.64 59.84 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.116 0.484 . . . . 0.0 110.535 179.754 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.746 ' O ' HD12 ' A' ' 82' ' ' LEU . 57.9 m-85 -92.74 -5.15 51.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 122.335 1.064 . . . . 0.0 113.202 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.41 ' CB ' ' O ' ' A' ' 76' ' ' ARG . 4.7 t30 -90.01 118.85 29.88 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 112.812 -1.995 . . . . 0.0 107.502 175.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.71 -7.25 57.55 Favored Glycine 0 N--CA 1.468 0.782 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 -177.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.965 HD13 ' H ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -59.42 -34.59 72.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 113.603 -1.298 . . . . 0.0 110.834 -179.687 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.965 ' H ' HD13 ' A' ' 82' ' ' LEU . 4.8 p -70.61 -26.79 29.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.94 -31.62 61.55 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.576 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -68.17 -40.34 88.01 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 119.344 -1.407 . . . . 0.0 111.206 -177.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.3 mp -62.66 -40.54 97.38 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.978 0.894 . . . . 0.0 113.099 -176.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -60.62 -27.17 67.56 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 113.799 -1.546 . . . . 0.0 109.306 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.747 ' HE ' HE22 ' A' ' 89' ' ' GLN . 37.3 ttp180 -57.89 -53.76 54.58 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 173.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.747 HE22 ' HE ' ' A' ' 88' ' ' ARG . 0.9 OUTLIER -67.1 -29.86 69.73 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 112.325 -2.216 . . . . 0.0 111.84 -178.17 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 33.4 tpp -61.35 -40.82 95.66 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.493 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 37.1 m -74.44 -34.6 63.24 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 118.099 -0.953 . . . . 0.0 111.302 -177.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -57.66 -43.88 85.29 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 121.324 1.874 . . . . 0.0 112.262 -176.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.56 -32.84 64.39 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.127 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.8 p -64.09 -41.31 97.34 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.499 ' CG2' HD12 ' A' ' 99' ' ' LEU . 7.9 p -68.27 -28.23 39.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.022 177.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.403 ' NH2' ' CE2' ' A' ' 100' ' ' TYR . 51.0 ttt-85 -77.44 9.22 3.42 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -176.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.517 HD13 ' O ' ' A' ' 97' ' ' ILE . 0.3 OUTLIER -87.3 -14.93 9.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.833 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -139.98 -48.2 0.06 OUTLIER Glycine 0 CA--C 1.543 1.781 0 N-CA-C 116.087 1.195 . . . . 0.0 116.087 -176.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.499 HD12 ' CG2' ' A' ' 95' ' ' VAL . 16.6 mt -71.14 -12.76 61.67 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 119.84 1.82 . . . . 0.0 113.05 -178.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.499 ' O ' ' CG ' ' A' ' 104' ' ' LYS . 26.2 t80 -80.57 -51.19 9.04 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 114.48 -1.236 . . . . 0.0 111.868 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 1.051 ' OD2' ' NE2' ' A' ' 105' ' ' GLN . 9.7 t70 -69.46 -32.29 71.11 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 123.175 1.464 . . . . 0.0 110.043 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 11.4 t -68.74 -52.54 29.48 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 111.158 -2.746 . . . . 0.0 111.89 175.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 52.3 t -74.28 -27.79 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-N 121.697 2.044 . . . . 0.0 114.131 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.499 ' CG ' ' O ' ' A' ' 100' ' ' TYR . 3.2 mmpt? -69.69 -41.68 75.12 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 112.131 -2.304 . . . . 0.0 111.518 179.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 1.051 ' NE2' ' OD2' ' A' ' 101' ' ' ASP . 88.1 mt-30 -79.69 -12.95 59.78 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 122.638 1.209 . . . . 0.0 111.011 -178.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -79.93 -22.8 42.28 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.21 178.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.619 ' CZ ' ' ND2' ' A' ' 190' ' ' ASN . 35.4 m-85 -109.81 -29.45 8.3 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 119.532 1.06 . . . . 0.0 112.721 -175.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.6 p -96.78 9.11 42.71 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 117.144 -1.823 . . . . 0.0 113.135 -177.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 12.4 ttpp -96.87 -154.82 0.46 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 177.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 140.42 134.58 3.11 Favored Glycine 0 N--CA 1.475 1.245 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 76.2 p -90.19 -40.29 12.29 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -177.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -116.28 174.41 6.07 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 112.899 -1.955 . . . . 0.0 113.485 -176.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.606 ' O ' ' HB2' ' A' ' 114' ' ' ALA . 85.9 m-70 -86.47 77.08 9.51 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.759 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.606 ' HB2' ' O ' ' A' ' 113' ' ' HIS . . . 159.6 -161.39 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.05 14.82 27.77 Favored Glycine 0 C--N 1.335 0.499 0 CA-C-N 115.449 -0.796 . . . . 0.0 113.213 176.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 22.6 mm -60.89 -40.83 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.0 -39.29 96.34 Favored Glycine 0 CA--C 1.525 0.713 0 CA-C-O 122.253 0.918 . . . . 0.0 110.982 175.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 5.8 t -57.93 -42.17 84.27 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 177.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 59.7 mtm180 -63.58 -37.47 87.44 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.278 -178.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 8.0 mp -64.15 -46.51 83.76 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 76.9 mt -66.83 -44.83 80.07 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 114.926 -1.033 . . . . 0.0 110.494 178.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.91 -44.77 91.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 119.532 1.06 . . . . 0.0 109.869 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -66.01 -44.1 92.21 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 119.73 -1.224 . . . . 0.0 111.295 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 71.0 m -64.07 -43.95 93.9 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.784 -0.367 . . . . 0.0 111.538 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 21.1 p -69.35 -48.43 61.36 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 119.333 -0.947 . . . . 0.0 111.954 177.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 24.0 p -65.37 -42.41 92.75 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 -174.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -63.95 -44.54 95.84 Favored Glycine 0 CA--C 1.521 0.463 0 CA-C-O 122.967 1.315 . . . . 0.0 112.916 -177.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.534 ' O ' HG22 ' A' ' 131' ' ' VAL . . . -61.35 -41.6 97.33 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 111.903 -2.148 . . . . 0.0 107.25 177.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.692 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 17.3 mt -64.41 -42.15 96.24 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.221 178.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.0 -39.77 95.74 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -177.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.534 HG22 ' O ' ' A' ' 128' ' ' ALA . 18.9 m -60.96 -26.03 37.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 122.829 1.3 . . . . 0.0 109.572 179.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.692 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . -58.63 -44.83 90.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 112.251 -2.25 . . . . 0.0 111.876 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.426 HG22 ' H ' ' A' ' 133' ' ' VAL . 5.1 m -79.0 -48.63 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -126.7 135.75 51.54 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.695 0.283 . . . . 0.0 111.451 -178.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.773 ' H ' ' CD ' ' A' ' 136' ' ' PRO . 2.1 pt20 175.2 -23.59 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.828 0 CA-C-N 115.47 -0.786 . . . . 0.0 113.069 178.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.773 ' CD ' ' H ' ' A' ' 135' ' ' GLN . 54.3 Cg_exo -53.03 -34.17 66.39 Favored 'Trans proline' 0 N--CA 1.5 1.894 0 CA-C-N 120.955 1.377 . . . . 0.0 113.275 -178.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.421 ' H ' HG22 ' A' ' 137' ' ' THR . 0.0 OUTLIER -67.43 -41.58 84.55 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 119.064 -1.055 . . . . 0.0 110.667 -178.772 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -64.38 -42.44 96.16 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 119.238 -0.985 . . . . 0.0 111.777 -177.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 14.6 m -63.6 -42.71 97.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.879 0.371 . . . . 0.0 110.977 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.423 ' O ' ' N ' ' A' ' 144' ' ' PHE . 25.3 t -63.97 -38.54 82.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.437 ' CB ' ' NZ ' ' A' ' 141' ' ' LYS . 8.8 mtmp? -62.0 -40.93 97.33 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 119.556 -0.858 . . . . 0.0 111.895 -177.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.4 p -69.56 -44.81 79.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 119.992 -0.683 . . . . 0.0 109.23 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -64.36 -35.9 82.39 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.468 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.423 ' N ' ' O ' ' A' ' 140' ' ' VAL . 93.9 t80 -66.14 -40.76 90.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.249 -177.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -64.4 -39.53 94.03 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 118.844 -1.142 . . . . 0.0 109.709 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.22 -35.03 79.79 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.413 ' CG ' ' O ' ' A' ' 147' ' ' GLN . 0.0 OUTLIER -59.85 111.35 1.43 Allowed 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 177.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -94.49 -64.39 1.08 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 117.396 -1.288 . . . . 0.0 112.615 -177.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -91.06 110.68 21.96 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 122.862 2.574 . . . . 0.0 110.121 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -81.41 68.69 7.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.648 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 43.28 59.37 3.52 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.697 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -179.816 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.449 ' CE2' ' O ' ' A' ' 157' ' ' GLN . 85.1 t80 . . . . . 0 N--CA 1.467 0.388 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.449 ' O ' ' CE2' ' A' ' 156' ' ' TYR . 19.7 mp0 -109.67 -155.24 0.55 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -178.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 83.4 p -157.22 -176.25 5.86 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 123.256 1.503 . . . . 0.0 112.936 -177.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 8.4 m -62.89 -43.53 98.56 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 111.26 -2.7 . . . . 0.0 112.002 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.5 t -61.05 -42.76 94.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -178.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.45 ' OE2' ' OG1' ' A' ' 165' ' ' THR . 0.7 OUTLIER -65.47 -38.33 89.48 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.066 179.877 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -61.4 -45.67 93.35 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -178.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.503 ' CZ ' HD23 ' A' ' 175' ' ' LEU . 13.7 t80 -62.62 -49.21 76.09 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.278 -178.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -67.83 -45.36 74.88 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -174.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.45 ' OG1' ' OE2' ' A' ' 161' ' ' GLU . 1.9 p -63.0 -43.86 97.63 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -176.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 15.0 pt -64.26 -37.93 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 CA-C-O 121.746 0.784 . . . . 0.0 109.133 177.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.89 -37.07 78.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.17 -1.377 . . . . 0.0 107.37 175.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -62.46 -50.44 71.46 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 122.211 2.278 . . . . 0.0 111.849 -176.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.524 ' N ' ' OE1' ' A' ' 169' ' ' GLU . 0.2 OUTLIER -74.93 -50.99 14.91 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.523 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -78.09 -36.28 48.32 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 116.594 2.072 . . . . 0.0 116.594 -173.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 91.14 -166.61 31.03 Favored Glycine 0 C--N 1.337 0.628 0 CA-C-N 118.841 0.746 . . . . 0.0 112.263 177.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.638 ' H ' HD13 ' A' ' 172' ' ' ILE . 0.0 OUTLIER -72.64 -38.58 59.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.903 0.859 . . . . 0.0 109.175 -179.576 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 68.1 mtp180 -58.5 -33.74 70.15 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 113.852 -1.522 . . . . 0.0 111.103 -177.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -61.48 -41.24 99.51 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 118.672 -1.728 . . . . 0.0 111.425 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.503 HD23 ' CZ ' ' A' ' 163' ' ' TYR . 7.8 mp -71.33 -34.35 70.47 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 117.717 2.488 . . . . 0.0 117.717 -177.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . 0.493 ' CD1' ' O ' ' A' ' 172' ' ' ILE . 63.7 m95 -78.18 -7.09 56.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 112.995 -1.912 . . . . 0.0 109.589 -177.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 16.8 ttmm -43.63 -48.64 7.75 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -175.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -90.11 -32.23 10.01 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.39 0.995 . . . . 0.0 111.815 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 90.1 m -45.31 -50.66 11.81 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . 0.45 ' O ' HG12 ' A' ' 183' ' ' VAL . 0.4 OUTLIER -61.96 -50.47 80.78 Favored Pre-proline 0 N--CA 1.472 0.627 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -175.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 180' ' ' SER . 24.7 Cg_endo -64.64 -27.98 60.81 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 121.17 1.247 . . . . 0.0 111.704 176.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -64.06 -39.33 93.85 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 180' ' ' SER . 1.6 p -62.91 -41.71 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.855 -179.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.48 -39.28 90.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.961 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.588 HH12 ' CG1' ' A' ' 235' ' ' VAL . 48.8 ttt85 -60.6 -42.13 96.14 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 119.922 -0.711 . . . . 0.0 110.344 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -61.67 -43.86 98.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.183 0.516 . . . . 0.0 110.679 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -65.28 -44.2 88.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.617 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 24.3 mm -63.81 -45.89 95.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -177.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.503 ' O ' ' N ' ' A' ' 193' ' ' GLU . 5.9 p -60.72 -47.31 93.62 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.339 0 C-N-CA 119.237 -0.985 . . . . 0.0 111.729 -178.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.619 ' ND2' ' CZ ' ' A' ' 107' ' ' TYR . 12.2 t-20 -63.54 -42.94 98.37 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 122.282 1.039 . . . . 0.0 110.868 178.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' CYS . . . . . . . . . . . . . 31.3 m -61.39 -45.53 93.98 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 113.348 -1.751 . . . . 0.0 108.389 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.27 -40.4 95.91 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 112.662 -2.063 . . . . 0.0 109.672 175.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 0.503 ' N ' ' O ' ' A' ' 189' ' ' VAL . 0.7 OUTLIER -60.81 -46.54 90.12 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.001 0.92 . . . . 0.0 113.086 -176.884 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 2.8 pp -64.31 -36.73 85.08 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 119.231 -0.988 . . . . 0.0 109.528 -175.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 1.4 m -63.18 -45.74 97.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 C-N-CA 117.01 -1.876 . . . . 0.0 107.389 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 30.3 p -64.35 -46.11 84.88 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -177.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -57.67 -39.87 78.1 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.133 -0.939 . . . . 0.0 113.338 -177.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -56.4 -44.46 80.32 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 9.7 mt -61.66 -39.45 91.41 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.803 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 1.6 mp -63.12 -42.79 97.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 118.813 -0.613 . . . . 0.0 110.115 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -59.99 -40.42 89.12 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 120.224 1.374 . . . . 0.0 111.897 178.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -66.96 -38.43 86.08 Favored 'General case' 0 C--O 1.25 1.104 0 CA-C-N 114.682 -1.145 . . . . 0.0 111.003 -176.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -101.96 128.89 48.17 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 120.804 -1.185 . . . . 0.0 112.455 -178.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.596 ' O ' HD22 ' A' ' 209' ' ' LEU . 4.1 tp 67.46 4.45 3.8 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 114.275 -1.33 . . . . 0.0 112.082 177.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.74 38.11 4.0 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -74.52 -21.57 59.47 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.527 0.68 . . . . 0.0 111.455 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.427 ' O ' ' CB ' ' A' ' 208' ' ' ASN . . . -130.86 -40.45 1.19 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.54 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' ASN . . . . . 0.427 ' CB ' ' O ' ' A' ' 207' ' ' ALA . 6.4 p30 152.13 124.43 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 -178.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.596 HD22 ' O ' ' A' ' 204' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.484 1.266 0 CA-C-N 110.41 -3.086 . . . . 0.0 111.954 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 . . . . . 0 N--CA 1.469 0.482 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.4 ' N ' ' CD ' ' A' ' 215' ' ' PRO . 4.4 mm? -61.28 -43.74 90.87 Favored Pre-proline 0 CA--C 1.537 0.481 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 214' ' ' LEU . 25.9 Cg_exo -60.88 -34.07 91.71 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 CA-C-N 120.59 1.246 . . . . 0.0 111.039 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 82.3 m -64.77 -42.53 95.05 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 113.173 -1.83 . . . . 0.0 111.771 -178.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -66.83 -38.13 85.82 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -63.44 -47.37 82.15 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.941 -178.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 27.1 p -60.65 -38.24 84.17 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 119.102 0.864 . . . . 0.0 110.465 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 47.8 p -59.67 -41.88 91.61 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . 0.568 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.91 -41.82 97.58 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -177.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -62.11 -47.15 85.89 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -176.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -60.74 -42.09 99.28 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 107.464 -2.254 . . . . 0.0 107.464 177.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . 0.627 ' O ' HG23 ' A' ' 228' ' ' THR . . . -63.1 -37.93 89.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.211 -0.995 . . . . 0.0 108.977 176.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -61.66 -42.28 99.73 Favored Glycine 0 CA--C 1.521 0.412 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.811 -177.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -66.57 -38.34 86.87 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . 0.432 ' O ' HG12 ' A' ' 230' ' ' VAL . 96.3 m -63.22 -41.11 99.08 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.012 0.434 . . . . 0.0 110.387 177.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . 0.627 HG23 ' O ' ' A' ' 224' ' ' ALA . 55.9 p -61.99 -39.95 93.96 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.759 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -58.17 -38.73 77.23 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -176.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.432 HG12 ' O ' ' A' ' 227' ' ' CYS . 1.7 p -59.57 -40.53 82.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 119.004 -1.078 . . . . 0.0 110.02 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . 0.641 ' C ' HD12 ' A' ' 231' ' ' ILE . 0.3 OUTLIER -61.45 -40.16 85.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 177.615 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -62.78 -39.47 94.29 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 115.683 1.735 . . . . 0.0 115.683 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.488 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 0.2 OUTLIER -57.99 -41.72 91.39 Favored Pre-proline 0 N--CA 1.484 1.244 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 -173.525 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.528 ' HD2' ' O ' ' A' ' 231' ' ' ILE . 32.3 Cg_exo -57.7 -39.56 86.67 Favored 'Trans proline' 0 C--N 1.291 -2.461 0 C-N-CA 122.495 2.13 . . . . 0.0 113.128 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.588 ' CG1' HH12 ' A' ' 185' ' ' ARG . 59.3 t -63.69 -37.22 79.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 C-N-CA 117.8 -1.56 . . . . 0.0 108.799 178.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . 0.526 ' OD2' ' CE3' ' A' ' 283' ' ' TRP . 53.1 t0 -65.77 -40.37 91.94 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.266 178.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 59.2 t -64.6 -45.22 96.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 -176.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 84.4 t . . . . . 0 C--N 1.32 -0.693 0 C-N-CA 120.028 -0.669 . . . . 0.0 111.737 -178.064 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 19.7 m . . . . . 0 N--CA 1.467 0.403 0 N-CA-C 113.863 1.061 . . . . 0.0 113.863 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' MET . . . . . 0.459 ' SD ' ' N ' ' A' ' 261' ' ' LEU . 0.0 OUTLIER -61.75 -44.37 97.03 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -176.817 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.459 ' N ' ' SD ' ' A' ' 260' ' ' MET . 11.7 tp -62.36 -47.08 85.77 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 121.92 -0.487 . . . . 0.0 109.766 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 70.0 mtp180 -66.77 -53.64 30.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.976 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . 0.455 ' O ' ' O ' ' A' ' 260' ' ' MET . 9.6 mtpm? -130.59 179.17 6.1 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.881 0.372 . . . . 0.0 111.258 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . 0.456 ' O ' ' O ' ' A' ' 265' ' ' GLY . 95.1 mt-10 56.43 67.78 0.95 Allowed 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.609 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 264' ' ' GLU . . . -33.34 159.81 0.01 OUTLIER Glycine 0 CA--C 1.533 1.158 0 CA-C-O 121.789 0.661 . . . . 0.0 112.304 -179.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -64.91 -5.34 10.48 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.076 1.851 . . . . 0.0 111.355 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -69.73 -26.28 64.25 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.536 0.734 . . . . 0.0 111.362 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -58.02 -32.28 67.8 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.532 -178.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -62.39 -41.15 98.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.347 177.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -65.79 -37.9 87.55 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.387 -177.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.97 165.54 12.21 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 178.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 69.03 86.64 0.1 Allowed Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.614 -0.995 . . . . 0.0 110.614 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -168.74 22.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 121.064 -0.255 . . . . 0.0 110.784 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' MET . . . . . 0.568 ' N ' ' CD ' ' A' ' 275' ' ' PRO . 1.0 OUTLIER -63.7 -44.1 79.16 Favored Pre-proline 0 C--N 1.33 -0.254 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.219 -179.792 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 274' ' ' MET . 21.3 Cg_exo -64.38 -46.61 7.21 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.43 2.087 . . . . 0.0 111.54 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 1.5 p -60.66 -40.11 90.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.038 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . 0.411 ' CD1' ' C ' ' A' ' 277' ' ' PHE . 36.4 t80 -61.89 -42.92 99.65 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 123.289 1.519 . . . . 0.0 111.936 -178.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 12.0 tp -62.12 -38.73 90.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 111.037 -2.801 . . . . 0.0 108.159 174.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . 0.483 HH22 ' HB3' ' A' ' 37' ' ' ALA . 0.5 OUTLIER -62.62 -40.2 96.24 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.072 179.215 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.743 ' O ' HD12 ' A' ' 280' ' ' LEU . 0.2 OUTLIER -61.97 -36.31 81.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.145 -0.934 . . . . 0.0 113.1 -177.255 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -67.7 -50.89 39.19 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 109.146 -1.581 . . . . 0.0 109.146 -178.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . 0.798 ' O ' HG22 ' A' ' 285' ' ' VAL . 78.0 p -61.92 -43.63 98.44 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.694 0.798 . . . . 0.0 109.538 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' TRP . . . . . 0.526 ' CE3' ' OD2' ' A' ' 236' ' ' ASP . 1.3 m95 -59.5 -38.09 79.99 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . 0.426 HD21 ' CD1' ' A' ' 280' ' ' LEU . 85.2 m-20 -61.76 -38.95 89.92 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -178.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.798 HG22 ' O ' ' A' ' 282' ' ' SER . 23.0 m -61.46 -37.26 77.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 O-C-N 121.354 -0.841 . . . . 0.0 111.339 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.407 ' O ' HG22 ' A' ' 289' ' ' VAL . 26.8 t -62.14 -41.63 92.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -177.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 11.5 ptm -62.34 -38.32 89.05 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 121.305 -0.872 . . . . 0.0 109.608 178.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -58.47 -41.22 84.73 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.13 -0.941 . . . . 0.0 113.303 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 286' ' ' VAL . 2.7 m -61.33 -38.68 80.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 121.693 -0.63 . . . . 0.0 110.846 -178.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 75.7 p -62.22 -40.43 96.1 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 177.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -61.24 -38.44 86.65 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 176.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -58.31 -40.71 82.72 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 117.915 -1.514 . . . . 0.0 109.283 -176.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' GLN . . . . . 0.451 ' O ' ' O ' ' A' ' 296' ' ' ARG . 83.3 mm-40 -60.72 -43.13 98.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 122.577 1.18 . . . . 0.0 110.784 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 73.5 mt -60.47 -40.52 91.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 113.027 -1.897 . . . . 0.0 109.219 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -63.18 -46.15 88.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.982 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' ARG . . . . . 0.451 ' O ' ' O ' ' A' ' 293' ' ' GLN . 20.1 tpt85 -123.07 116.19 23.08 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.009 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -115.52 -96.11 0.46 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.177 0.513 . . . . 0.0 110.522 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 38.9 tp -139.3 120.87 15.17 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.683 179.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 30.2 ttm -92.69 64.32 4.11 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 121.202 -0.199 . . . . 0.0 111.271 -179.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.71 101.22 0.07 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.976 0.893 . . . . 0.0 111.227 -178.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -64.12 -46.2 85.19 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 113.47 -1.695 . . . . 0.0 112.936 -176.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -58.48 -39.29 79.58 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.498 -0.481 . . . . 0.0 109.789 -178.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' GLN . . . . . 0.432 ' O ' ' OE2' ' A' ' 306' ' ' GLU . 86.3 mt-30 -64.56 -46.49 82.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.224 -179.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' SER . . . . . 0.439 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 74.2 p -67.09 -38.64 86.05 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.454 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -62.5 -43.87 97.75 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -178.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . 0.473 ' CD ' ' N ' ' A' ' 307' ' ' ALA . 2.7 pp20? -65.72 -36.76 84.51 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -177.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . 0.531 ' HB3' ' HD3' ' A' ' 308' ' ' PRO . . . -59.84 -52.6 72.57 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -176.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' PRO . . . . . 0.531 ' HD3' ' HB3' ' A' ' 307' ' ' ALA . 73.1 Cg_endo -74.96 0.3 9.05 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.954 1.769 . . . . 0.0 111.604 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 82.5 t80 . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.459 179.881 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.7 m . . . . . 0 N--CA 1.465 0.294 0 CA-C-O 120.829 0.347 . . . . 0.0 110.111 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.702 HG22 ' H ' ' A' ' 16' ' ' LYS . 7.2 p -91.79 176.58 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.318 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.702 ' H ' HG22 ' A' ' 15' ' ' VAL . 35.0 mtmm -64.21 -41.37 97.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.517 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -63.61 -41.42 98.3 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.548 ' H ' HG13 ' A' ' 15' ' ' VAL . 31.3 tp -79.85 -26.42 40.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.079 -179.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.443 ' O ' ' OG1' ' A' ' 22' ' ' THR . . . -66.26 -41.39 94.74 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 107.451 -2.259 . . . . 0.0 107.451 177.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.481 ' HB1' HH12 ' A' ' 96' ' ' ARG . . . -71.37 -32.0 67.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 124.77 2.224 . . . . 0.0 107.314 176.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.45 -42.57 98.98 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-N 108.469 -3.969 . . . . 0.0 108.095 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 19' ' ' GLY . 33.6 p -70.75 -28.0 64.37 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -66.28 -50.23 64.39 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.745 -178.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.406 ' O ' ' OE1' ' A' ' 89' ' ' GLN . . . -61.95 -35.96 79.98 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 118.504 -1.278 . . . . 0.0 111.234 -177.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.632 ' SG ' ' N ' ' A' ' 26' ' ' ILE . 5.8 p -64.15 -53.47 48.88 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.027 -179.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.632 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 16.0 pt -65.68 -39.68 85.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -178.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.68 -42.18 98.06 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 119.686 -0.806 . . . . 0.0 112.738 -173.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.559 ' CG ' HE22 ' A' ' 89' ' ' GLN . 1.5 m-20 -77.09 -27.13 54.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 120.739 1.608 . . . . 0.0 109.941 -174.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.478 ' O ' HD13 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -60.42 -54.26 47.71 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 118.922 0.783 . . . . 0.0 112.222 179.498 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.4 pp -72.86 -1.0 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-O 122.501 1.144 . . . . 0.0 111.906 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.71 ' O ' HD21 ' A' ' 34' ' ' LEU . 97.8 m -106.72 -12.58 15.5 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 112.588 -2.096 . . . . 0.0 112.051 -174.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.439 ' N ' ' CD ' ' A' ' 33' ' ' PRO . 8.4 t80 -70.74 -44.87 16.63 Favored Pre-proline 0 CA--C 1.551 1.011 0 CA-C-N 121.935 2.152 . . . . 0.0 113.765 -178.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.439 ' CD ' ' N ' ' A' ' 32' ' ' PHE . 33.5 Cg_exo -60.54 -17.75 50.33 Favored 'Trans proline' 0 N--CA 1.52 3.047 0 N-CA-C 119.363 2.793 . . . . 0.0 119.363 -175.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.967 HD13 ' H ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -69.11 -35.47 76.47 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 120.342 1.428 . . . . 0.0 114.067 -179.071 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.522 ' H ' HD22 ' A' ' 34' ' ' LEU . 64.1 m-20 -65.02 -41.73 95.02 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -175.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.5 p -58.33 -36.0 72.75 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 119.551 -0.86 . . . . 0.0 111.348 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.96 -38.81 83.21 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 119.782 -0.767 . . . . 0.0 111.731 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.4 ' CG ' ' N ' ' A' ' 39' ' ' VAL . 8.2 pttp -61.37 -48.24 82.18 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.28 -176.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.4 ' N ' ' CG ' ' A' ' 38' ' ' LYS . 82.2 t -63.48 -41.05 91.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 119.667 -0.813 . . . . 0.0 111.565 -176.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.465 ' C ' ' H ' ' A' ' 42' ' ' GLN . 67.9 mmt-85 -61.94 -42.09 98.7 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 119.252 -0.979 . . . . 0.0 110.064 178.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -62.81 38.85 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.685 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.465 ' H ' ' C ' ' A' ' 40' ' ' ARG . 8.1 tp-100 -128.41 -76.43 0.56 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.909 0.385 . . . . 0.0 110.01 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.519 HG23 ' O ' ' A' ' 43' ' ' ILE . 21.0 tt -168.46 121.45 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.885 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.417 HE22 ' HB3' ' A' ' 59' ' ' TYR . 11.5 pt20 -71.69 57.57 0.29 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.889 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -167.24 165.87 38.87 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.137 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.6 mp0 -147.11 -160.12 1.12 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.134 -0.533 . . . . 0.0 109.574 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.7 m -81.94 -6.22 58.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.033 0.444 . . . . 0.0 110.106 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -59.42 -30.49 68.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.729 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.71 1.17 87.5 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -178.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.3 tp -64.03 -36.03 82.66 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.361 -0.92 . . . . 0.0 109.532 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.543 HG13 ' N ' ' A' ' 52' ' ' ARG . 8.6 p -58.95 -43.05 87.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.067 -178.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.543 ' N ' HG13 ' A' ' 51' ' ' VAL . 22.3 ptt85 -63.06 -33.07 74.65 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 119.734 -0.787 . . . . 0.0 109.658 -178.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -67.7 -37.81 82.8 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 51' ' ' VAL . . . -132.26 111.3 11.27 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.469 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.61 -8.77 59.59 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -178.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.665 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 29.4 p -130.55 -138.15 0.21 Allowed 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.665 ' HB3' ' O ' ' A' ' 56' ' ' SER . . . 91.84 -30.96 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 176.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.468 ' O ' ' N ' ' A' ' 60' ' ' ARG . 68.8 mt-30 -139.55 8.05 2.37 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.565 ' CD2' ' O ' ' A' ' 59' ' ' TYR . 20.9 p90 -46.3 87.03 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.555 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.477 ' O ' ' O ' ' A' ' 59' ' ' TYR . 75.9 mtt180 51.33 165.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.021 0.439 . . . . 0.0 110.419 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 120.01 83.87 0.82 Allowed Glycine 0 CA--C 1.519 0.298 0 N-CA-C 104.441 -3.463 . . . . 0.0 104.441 -175.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.6 p -67.79 -36.11 74.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 118.631 -0.699 . . . . 0.0 110.86 178.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.533 HD13 ' O ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -61.75 -33.02 73.32 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 117.687 -1.605 . . . . 0.0 109.24 178.379 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.89 -49.9 60.85 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 113.559 -1.655 . . . . 0.0 115.126 -176.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.0 m -62.37 -46.92 86.48 Favored 'General case' 0 C--N 1.334 -0.1 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -178.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 12.0 tt -59.98 -36.04 64.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 38.6 tp -63.88 -35.57 81.07 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 120.82 1.645 . . . . 0.0 111.607 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 98.4 m -63.28 -40.13 96.52 Favored 'General case' 0 C--O 1.249 1.058 0 CA-C-N 113.729 -1.578 . . . . 0.0 111.042 -174.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 3.2 ptt? -60.63 -39.99 90.29 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 120.328 -1.482 . . . . 0.0 114.628 -175.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.8 m -69.52 -40.31 79.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 119.213 -0.995 . . . . 0.0 112.86 -178.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 62.8 ttp85 -78.78 -13.21 59.93 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.499 ' CG2' ' N ' ' A' ' 73' ' ' GLU . 0.6 OUTLIER -62.57 -54.42 40.04 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.667 179.194 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.499 ' N ' ' CG2' ' A' ' 72' ' ' THR . 19.2 mt-10 -105.24 -54.8 2.42 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.411 ' O ' ' CB ' ' A' ' 77' ' ' SER . . . 155.7 166.94 16.45 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -56.37 -35.14 95.85 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 121.329 1.352 . . . . 0.0 111.106 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.2 tpp180 -61.32 -11.93 11.77 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-O 121.985 0.897 . . . . 0.0 110.543 176.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.452 ' O ' ' OD1' ' A' ' 80' ' ' ASN . 28.9 p -77.59 -32.05 53.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 113.858 -1.519 . . . . 0.0 110.611 -177.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.0 tt -75.88 -33.93 59.98 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.539 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.49 ' C ' ' H ' ' A' ' 81' ' ' GLY . 26.2 m-85 -93.33 -5.25 50.07 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 115.003 1.482 . . . . 0.0 115.003 -178.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.452 ' OD1' ' O ' ' A' ' 77' ' ' SER . 50.1 p30 -84.13 32.59 0.49 Allowed 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 114.272 -1.331 . . . . 0.0 107.734 175.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.49 ' H ' ' C ' ' A' ' 79' ' ' TYR . . . -171.93 -9.46 0.02 OUTLIER Glycine 0 CA--C 1.525 0.67 0 CA-C-N 114.503 -1.226 . . . . 0.0 112.376 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.406 ' H ' ' H ' ' A' ' 81' ' ' GLY . 35.9 tp -59.13 -34.85 72.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 113.998 -1.101 . . . . 0.0 110.279 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.7 p -70.8 -27.16 29.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.284 178.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.69 -31.39 61.88 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.574 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.85 -40.03 89.54 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 119.442 -1.361 . . . . 0.0 111.051 -177.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 45.2 mt -62.21 -40.24 95.45 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 122.371 1.081 . . . . 0.0 113.179 -177.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -60.22 -26.72 66.62 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 112.993 -1.912 . . . . 0.0 108.979 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 -57.68 -53.45 58.05 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 172.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.559 HE22 ' CG ' ' A' ' 28' ' ' ASP . 1.4 tp-100 -67.95 -30.28 69.54 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 112.596 -2.093 . . . . 0.0 113.74 -177.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.53 -40.17 93.67 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 78.2 p -74.31 -34.5 63.51 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 118.409 -0.805 . . . . 0.0 111.192 -176.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -57.48 -44.05 84.58 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 120.842 1.656 . . . . 0.0 111.621 -176.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.51 -33.03 64.57 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 119.456 -0.898 . . . . 0.0 111.117 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.626 ' O ' HG22 ' A' ' 97' ' ' ILE . 38.8 t -64.08 -41.94 97.14 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.43 ' C ' ' H ' ' A' ' 97' ' ' ILE . 1.4 p -67.51 -27.47 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.755 179.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.499 ' O ' ' CG ' ' A' ' 96' ' ' ARG . 15.0 ttt180 -77.01 9.61 2.85 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -177.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.626 HG22 ' O ' ' A' ' 94' ' ' SER . 10.2 tp -86.6 -16.3 9.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 177.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -140.98 -49.0 0.05 OUTLIER Glycine 0 CA--C 1.541 1.662 0 N-CA-C 115.952 1.141 . . . . 0.0 115.952 -177.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.512 ' N ' HD12 ' A' ' 99' ' ' LEU . 10.7 mp -71.8 -13.45 61.7 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 119.453 1.627 . . . . 0.0 112.682 -177.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.479 ' O ' ' CG ' ' A' ' 104' ' ' LYS . 2.6 m-85 -80.77 -51.06 9.07 Favored 'General case' 0 C--O 1.211 -0.938 0 CA-C-N 114.293 -1.321 . . . . 0.0 110.809 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.936 ' OD2' ' NE2' ' A' ' 105' ' ' GLN . 18.3 t70 -69.18 -32.34 71.58 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 123.391 1.567 . . . . 0.0 110.071 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.5 t -68.96 -52.71 26.18 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 110.953 -2.839 . . . . 0.0 113.526 176.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 10.0 p -74.69 -27.66 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 CA-C-N 122.211 2.278 . . . . 0.0 113.146 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.479 ' CG ' ' O ' ' A' ' 100' ' ' TYR . 47.6 mtpt -69.48 -42.13 75.25 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 111.47 -2.605 . . . . 0.0 111.805 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.936 ' NE2' ' OD2' ' A' ' 101' ' ' ASP . 88.1 mt-30 -75.05 -16.37 60.59 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 122.997 1.38 . . . . 0.0 111.05 176.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.634 ' CE2' HG21 ' A' ' 126' ' ' THR . 17.3 t80 -78.7 -22.65 46.36 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 112.614 -2.085 . . . . 0.0 112.044 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.486 ' OH ' ' ND2' ' A' ' 190' ' ' ASN . 16.7 m-85 -109.54 -30.83 7.74 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 119.369 0.986 . . . . 0.0 111.269 -175.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.4 m -98.1 9.06 43.78 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 118.029 -1.468 . . . . 0.0 112.105 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.521 ' O ' ' C ' ' A' ' 110' ' ' GLY . 51.4 tttm -51.97 120.8 5.74 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 118.129 -0.939 . . . . 0.0 111.564 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.544 ' O ' ' CB ' ' A' ' 111' ' ' SER . . . -20.87 -82.86 0.01 OUTLIER Glycine 0 N--CA 1.488 2.14 0 CA-C-N 119.474 1.034 . . . . 0.0 112.076 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.544 ' CB ' ' O ' ' A' ' 110' ' ' GLY . 24.2 p 103.67 -161.19 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 176.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.621 ' O ' ' N ' ' A' ' 114' ' ' ALA . 18.9 tp10 -131.49 101.56 5.57 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -177.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.641 ' O ' ' HB2' ' A' ' 114' ' ' ALA . 81.3 t60 17.36 42.41 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.924 178.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.641 ' HB2' ' O ' ' A' ' 113' ' ' HIS . . . 159.33 -161.48 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.51 14.9 26.53 Favored Glycine 0 C--N 1.337 0.614 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.991 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 48.6 mt -60.83 -40.5 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.0 -39.51 96.49 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-O 122.078 0.821 . . . . 0.0 111.559 175.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.6 p -57.57 -42.09 82.37 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 177.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -63.42 -37.23 86.47 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.099 -0.64 . . . . 0.0 111.377 -178.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 29.0 mt -64.18 -46.68 82.91 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.351 0.596 . . . . 0.0 110.018 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.588 HD23 ' O ' ' A' ' 121' ' ' LEU . 2.4 tt -66.63 -44.88 80.8 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.983 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.625 ' HB1' ' CE2' ' A' ' 106' ' ' PHE . . . -63.89 -44.99 91.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 119.222 0.919 . . . . 0.0 109.907 178.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -65.73 -44.04 93.08 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.568 -0.825 . . . . 0.0 111.83 -178.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 78.1 p -63.64 -43.27 97.26 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 18.9 m -68.84 -48.03 64.51 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 119.281 -0.968 . . . . 0.0 112.012 177.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.634 HG21 ' CE2' ' A' ' 106' ' ' PHE . 21.6 p -65.49 -42.63 91.95 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 -173.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -64.01 -44.79 95.39 Favored Glycine 0 CA--C 1.521 0.46 0 CA-C-O 122.586 1.103 . . . . 0.0 113.092 -177.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.402 ' O ' ' CG2' ' A' ' 131' ' ' VAL . . . -61.1 -41.3 96.41 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 112.54 -1.83 . . . . 0.0 106.818 177.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.662 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 51.9 mt -63.93 -41.75 97.54 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.308 178.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -62.64 -40.09 95.92 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -177.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.402 ' CG2' ' O ' ' A' ' 128' ' ' ALA . 5.0 m -61.22 -25.64 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 122.696 1.236 . . . . 0.0 109.5 178.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.662 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . -57.87 -44.8 86.86 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 112.49 -2.141 . . . . 0.0 111.626 -178.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.426 HG22 ' H ' ' A' ' 133' ' ' VAL . 3.6 m -78.97 -48.73 21.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.711 -179.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -103.59 133.19 49.03 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.786 0.326 . . . . 0.0 111.468 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.649 ' H ' ' HD2' ' A' ' 136' ' ' PRO . 33.8 tp60 -175.88 -39.41 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.552 178.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.649 ' HD2' ' H ' ' A' ' 135' ' ' GLN . 52.9 Cg_exo -52.75 -33.56 60.66 Favored 'Trans proline' 0 N--CA 1.498 1.775 0 C-N-CA 122.009 1.806 . . . . 0.0 112.548 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 58.7 p -67.3 -41.88 84.63 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 118.309 -1.356 . . . . 0.0 109.65 -178.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -65.88 -42.48 90.26 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 118.796 -1.162 . . . . 0.0 111.903 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 59.1 t -64.04 -44.14 97.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.437 HG13 ' O ' ' A' ' 136' ' ' PRO . 33.2 m -65.08 -38.76 83.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -177.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.434 ' HZ2' ' HB3' ' A' ' 141' ' ' LYS . 14.8 mtpp -62.29 -41.86 98.86 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 119.269 -0.973 . . . . 0.0 111.823 -177.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.401 HG22 ' H ' ' A' ' 142' ' ' VAL . 12.7 m -70.44 -45.64 74.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.237 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.492 ' NH2' ' O ' ' A' ' 174' ' ' GLY . 17.6 mmt85 -65.06 -37.09 86.41 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.566 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -66.98 -42.11 85.66 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -177.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -65.52 -40.39 92.9 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 118.853 -1.139 . . . . 0.0 109.572 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.64 -35.34 80.52 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -178.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.624 HE21 HE22 ' A' ' 157' ' ' GLN . 46.3 tt0 -60.2 110.51 1.24 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 176.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -98.83 -61.06 1.42 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 117.617 -1.182 . . . . 0.0 113.266 -177.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 70.8 mtp85 -71.29 -172.58 0.75 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 122.633 2.47 . . . . 0.0 110.259 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -160.79 18.61 0.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.647 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 57.57 -130.86 51.62 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.678 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -179.96 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.516 ' O ' ' CD2' ' A' ' 156' ' ' TYR . 60.8 t80 . . . . . 0 N--CA 1.463 0.185 0 CA-C-O 120.755 0.312 . . . . 0.0 110.63 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.624 HE22 HE21 ' A' ' 147' ' ' GLN . 27.6 tt0 58.85 146.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.811 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 88.8 p -157.06 -178.19 7.18 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.472 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 97.8 m -64.31 -45.88 86.0 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.805 -177.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 85.0 t -64.04 -45.35 96.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 119.016 -1.074 . . . . 0.0 108.898 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 -66.72 -39.55 88.05 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.833 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -62.16 -45.61 92.67 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -179.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.429 ' CD1' ' C ' ' A' ' 163' ' ' TYR . 19.3 t80 -62.4 -50.05 73.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.293 0.568 . . . . 0.0 111.075 -178.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -68.44 -45.21 73.14 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -175.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.403 ' O ' ' OE1' ' A' ' 169' ' ' GLU . 19.0 m -62.44 -44.6 96.01 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 -176.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 11.9 pt -64.6 -38.45 82.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-O 121.777 0.799 . . . . 0.0 109.651 176.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.91 -36.8 77.76 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 175.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 16.2 tpt85 -62.12 -49.86 74.19 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 122.095 2.225 . . . . 0.0 111.232 -176.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.403 ' OE1' ' O ' ' A' ' 165' ' ' THR . 16.4 mp0 -74.7 -51.13 15.14 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 123.561 0.744 . . . . 0.0 109.855 177.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -78.32 -36.75 45.98 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 117.033 2.235 . . . . 0.0 117.033 -172.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 91.77 -167.43 30.85 Favored Glycine 0 N--CA 1.472 1.036 0 CA-C-N 119.136 0.88 . . . . 0.0 112.597 177.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.494 HD12 ' CH2' ' A' ' 176' ' ' TRP . 9.0 pt -73.37 -41.91 57.07 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-O 122.098 0.951 . . . . 0.0 110.552 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -58.63 -32.94 69.5 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 113.661 -1.609 . . . . 0.0 110.473 -177.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.492 ' O ' ' NH2' ' A' ' 143' ' ' ARG . . . -60.45 -40.16 97.28 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 118.994 -1.574 . . . . 0.0 109.586 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.768 HD23 ' O ' ' A' ' 175' ' ' LEU . 2.6 tt -69.46 -34.16 73.98 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 111.883 -2.159 . . . . 0.0 116.261 -176.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . 0.494 ' CH2' HD12 ' A' ' 172' ' ' ILE . 39.2 m0 -78.36 -7.86 57.78 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 111.071 -2.786 . . . . 0.0 110.227 -178.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 37.6 tptt -43.45 -48.18 7.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.925 -176.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -83.75 -34.42 18.98 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 93.0 m -45.39 -51.49 11.22 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . 0.416 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 1.6 t -62.9 -50.91 74.92 Favored Pre-proline 0 N--CA 1.473 0.71 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -176.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 180' ' ' SER . 30.5 Cg_endo -64.81 -28.73 59.19 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.296 1.331 . . . . 0.0 111.901 177.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.557 ' CG ' HE22 ' A' ' 135' ' ' GLN . 14.8 t-20 -64.22 -39.74 94.61 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.637 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 94.5 t -63.28 -42.97 98.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.189 -0.459 . . . . 0.0 109.907 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.45 -39.89 94.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.014 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.407 ' O ' HG22 ' A' ' 189' ' ' VAL . 65.2 ttt180 -61.1 -42.19 98.06 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.13 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -62.24 -44.0 97.55 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.169 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -65.65 -45.95 81.03 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -178.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.437 HG23 ' N ' ' A' ' 189' ' ' VAL . 10.0 tp -65.38 -46.28 90.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.515 HG23 ' N ' ' A' ' 190' ' ' ASN . 29.6 m -60.83 -46.85 95.51 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 C-N-CA 119.837 -0.745 . . . . 0.0 111.648 -178.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.515 ' N ' HG23 ' A' ' 189' ' ' VAL . 19.6 t-20 -62.28 -43.46 98.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 122.169 0.985 . . . . 0.0 109.876 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' CYS . . . . . . . . . . . . . 28.2 t -62.7 -47.38 83.88 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 113.554 -1.657 . . . . 0.0 110.862 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -65.01 -41.19 95.58 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.253 177.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -61.37 -45.75 93.08 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 114.335 -1.302 . . . . 0.0 111.999 -178.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.554 HD13 ' O ' ' A' ' 194' ' ' LEU . 0.2 OUTLIER -63.56 -38.1 89.83 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 -176.277 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.438 ' O ' ' CD2' ' A' ' 199' ' ' LEU . 72.1 t -63.44 -46.48 95.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 C-N-CA 117.648 -1.621 . . . . 0.0 107.603 178.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 19.2 m -64.35 -45.74 86.49 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -178.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -56.78 -38.69 72.86 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.487 1.115 . . . . 0.0 112.497 -177.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -55.48 -44.13 76.18 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.698 ' N ' HD22 ' A' ' 199' ' ' LEU . 2.5 mm? -61.24 -39.95 92.24 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 40.2 mt -63.86 -44.24 98.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-O 118.65 -0.691 . . . . 0.0 112.037 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -61.13 -41.04 96.01 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 120.415 1.462 . . . . 0.0 112.182 177.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -67.32 -37.63 83.63 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.235 -1.348 . . . . 0.0 111.061 -177.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 3.4 m -101.94 129.9 48.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.269 0.557 . . . . 0.0 111.939 -177.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 22.9 mt 68.12 4.97 4.36 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 114.384 -1.28 . . . . 0.0 113.082 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.417 HD13 ' H ' ' A' ' 208' ' ' ASN . 0.2 OUTLIER -135.74 44.12 2.53 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.202 0.525 . . . . 0.0 110.889 -179.741 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.55 ' O ' ' CB ' ' A' ' 207' ' ' ALA . 56.8 pttt -88.03 49.67 1.84 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.835 -178.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.55 ' CB ' ' O ' ' A' ' 206' ' ' LYS . . . 119.96 17.83 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.155 0 O-C-N 124.494 1.121 . . . . 0.0 109.474 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' A' ' 207' ' ' ALA . 0.0 OUTLIER 77.57 116.33 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 102.31 -3.219 . . . . 0.0 102.31 -171.492 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.477 HD23 ' C ' ' A' ' 209' ' ' LEU . 2.0 tt . . . . . 0 N--CA 1.465 0.299 0 CA-C-O 120.965 0.412 . . . . 0.0 111.418 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 . . . . . 0 N--CA 1.462 0.165 0 CA-C-O 121.03 0.443 . . . . 0.0 110.712 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.487 ' N ' ' CD ' ' A' ' 215' ' ' PRO . 1.9 mt -61.34 -43.42 89.55 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.263 -178.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . 0.487 ' CD ' ' N ' ' A' ' 214' ' ' LEU . 33.5 Cg_exo -60.17 -32.58 94.69 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 121.602 1.534 . . . . 0.0 111.89 -178.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 97.7 m -64.08 -42.01 97.11 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 113.456 -1.702 . . . . 0.0 111.148 -179.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -66.34 -38.35 87.43 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.855 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -63.47 -46.92 84.0 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.285 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 32.7 p -59.97 -37.39 79.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 118.222 0.464 . . . . 0.0 110.785 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 14.0 t -59.29 -41.37 88.81 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.21 -41.49 99.14 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -177.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -61.46 -46.86 88.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 122.1 0.952 . . . . 0.0 112.59 -176.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -60.69 -41.79 99.1 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 107.725 -2.15 . . . . 0.0 107.725 176.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . 0.604 ' O ' HG23 ' A' ' 228' ' ' THR . . . -62.7 -37.87 88.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.163 -1.018 . . . . 0.0 109.218 177.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -61.41 -41.91 99.65 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.993 -177.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -66.37 -38.16 86.92 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 119.316 -0.954 . . . . 0.0 108.574 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . 0.442 ' O ' HG12 ' A' ' 230' ' ' VAL . 96.4 m -63.03 -41.23 99.47 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.081 0.467 . . . . 0.0 110.306 177.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . 0.604 HG23 ' O ' ' A' ' 224' ' ' ALA . 60.4 p -61.85 -39.4 91.74 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.575 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 19.5 m -58.15 -39.22 78.25 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.72 -176.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 227' ' ' CYS . 1.5 p -59.66 -40.19 81.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 118.709 -1.197 . . . . 0.0 108.442 179.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . 0.599 ' O ' ' HD2' ' A' ' 234' ' ' PRO . 26.7 mt -60.88 -40.23 84.59 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.449 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 177.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -61.95 -38.35 88.17 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 115.454 1.649 . . . . 0.0 115.454 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.466 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 0.9 OUTLIER -56.89 -39.65 79.44 Favored Pre-proline 0 N--CA 1.481 1.093 0 N-CA-C 116.276 1.954 . . . . 0.0 116.276 -172.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.599 ' HD2' ' O ' ' A' ' 231' ' ' ILE . 38.1 Cg_exo -59.06 -39.94 75.35 Favored 'Trans proline' 0 C--N 1.29 -2.54 0 C-N-CA 122.097 1.865 . . . . 0.0 114.246 -176.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.8 m -64.2 -37.62 80.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 118.435 -1.306 . . . . 0.0 111.369 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . 0.441 ' CG ' ' O ' ' A' ' 233' ' ' SER . 0.3 OUTLIER -66.28 -40.09 89.85 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 179.003 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 99.0 t -64.54 -44.97 96.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -175.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 10.0 p . . . . . 0 C--N 1.325 -0.492 0 C-N-CA 119.423 -0.911 . . . . 0.0 110.865 -178.177 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 19.4 m . . . . . 0 CA--C 1.537 0.454 0 CA-C-O 121.25 0.548 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' MET . . . . . 0.575 ' O ' ' N ' ' A' ' 264' ' ' GLU . 0.0 OUTLIER -59.48 -40.87 88.36 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.074 -178.517 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 9.6 tp -59.81 -46.36 89.48 Favored 'General case' 0 C--N 1.32 -0.681 0 O-C-N 121.887 -0.508 . . . . 0.0 110.098 -177.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' ARG . . . . . 0.415 ' HG3' ' H ' ' A' ' 263' ' ' LYS . 9.4 ptm180 -66.36 -52.95 41.66 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 119.056 -1.058 . . . . 0.0 110.304 178.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . 0.415 ' H ' ' HG3' ' A' ' 262' ' ' ARG . 2.7 ptmm? -88.29 -55.45 3.73 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . 0.575 ' N ' ' O ' ' A' ' 260' ' ' MET . 25.0 mt-10 -90.25 102.16 14.88 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 119.673 1.124 . . . . 0.0 111.473 -179.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . 0.478 ' C ' ' H ' ' A' ' 267' ' ' ARG . . . -36.91 159.44 0.01 OUTLIER Glycine 0 CA--C 1.536 1.377 0 N-CA-C 111.424 -0.67 . . . . 0.0 111.424 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -56.96 1.13 0.16 Allowed 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 121.952 1.768 . . . . 0.0 112.412 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . 0.478 ' H ' ' C ' ' A' ' 265' ' ' GLY . 20.8 mmt85 -69.12 -27.33 65.47 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 110.627 -0.138 . . . . 0.0 110.627 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -59.05 -32.63 69.93 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 119.615 -0.834 . . . . 0.0 109.626 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -62.58 -42.66 99.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.172 178.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -66.94 -36.88 83.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.845 -1.07 . . . . 0.0 112.73 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.428 ' O ' ' O ' ' A' ' 272' ' ' GLY . 98.3 mttt -75.1 174.61 9.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.317 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 271' ' ' LYS . . . 47.69 101.79 0.01 OUTLIER Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -164.65 7.35 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.167 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' MET . . . . . 0.558 ' O ' HD13 ' A' ' 278' ' ' LEU . 65.1 mtp -63.79 -44.67 80.39 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 274' ' ' MET . 34.6 Cg_endo -64.53 -46.34 7.42 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 120.969 1.113 . . . . 0.0 112.554 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 17.4 t -60.7 -40.65 93.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.062 0.458 . . . . 0.0 111.044 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -62.05 -42.5 99.25 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 123.668 1.699 . . . . 0.0 110.445 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.558 HD13 ' O ' ' A' ' 274' ' ' MET . 7.2 mp -62.52 -38.29 89.39 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 110.288 -3.142 . . . . 0.0 108.192 174.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 17.5 tpt85 -62.62 -40.96 98.64 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.605 0.717 . . . . 0.0 110.613 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 9.7 mt -62.29 -36.15 81.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.586 -1.188 . . . . 0.0 112.834 -177.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -67.78 -50.73 39.85 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -178.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . 0.518 ' O ' HG22 ' A' ' 285' ' ' VAL . 78.0 p -62.88 -44.7 95.39 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.164 0.507 . . . . 0.0 109.817 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' TRP . . . . . . . . . . . . . 37.8 t90 -61.32 -39.02 88.98 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.743 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -62.86 -39.73 95.31 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -178.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.518 HG22 ' O ' ' A' ' 282' ' ' SER . 9.5 m -61.12 -37.37 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.337 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.495 ' O ' HG12 ' A' ' 289' ' ' VAL . 96.9 t -61.83 -40.52 87.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 29.5 ttp -60.99 -39.18 88.68 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.453 0.645 . . . . 0.0 109.472 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -58.87 -39.52 81.62 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.906 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.495 HG12 ' O ' ' A' ' 286' ' ' VAL . 0.4 OUTLIER -60.16 -38.31 76.63 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -176.417 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -62.65 -40.19 96.25 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 119.137 -1.025 . . . . 0.0 108.642 177.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -61.23 -39.07 88.94 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 176.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -58.57 -40.59 83.53 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 117.748 -1.581 . . . . 0.0 109.737 -176.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' GLN . . . . . 0.445 ' O ' ' O ' ' A' ' 296' ' ' ARG . 21.9 mm100 -60.43 -42.86 96.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 122.506 1.146 . . . . 0.0 110.944 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 10.5 mt -60.2 -40.76 91.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 113.029 -1.896 . . . . 0.0 109.305 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 21.8 mtpt -63.24 -45.82 89.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.271 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' ARG . . . . . 0.445 ' O ' ' O ' ' A' ' 293' ' ' GLN . 80.6 mtm180 -123.02 116.51 23.65 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.443 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -117.22 -94.68 0.49 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.3 0.571 . . . . 0.0 110.862 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.477 ' C ' HD12 ' A' ' 298' ' ' LEU . 0.4 OUTLIER -135.98 -166.45 1.87 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.032 178.846 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 5.7 ptm -171.57 66.48 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.343 -0.543 . . . . 0.0 111.747 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.53 101.12 0.07 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.983 0.897 . . . . 0.0 110.343 -178.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -64.14 -46.23 85.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 113.789 -1.55 . . . . 0.0 113.436 -176.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -58.96 -40.06 83.56 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.177 -0.609 . . . . 0.0 109.613 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -64.83 -46.66 81.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.689 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' SER . . . . . 0.435 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 75.9 p -66.66 -37.37 84.65 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.882 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -61.55 -43.14 99.41 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -65.21 -36.73 85.07 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -177.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . 0.544 ' HB3' ' HD3' ' A' ' 308' ' ' PRO . . . -59.92 -52.88 70.51 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -176.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' PRO . . . . . 0.544 ' HD3' ' HB3' ' A' ' 307' ' ' ALA . 74.4 Cg_endo -75.26 0.37 9.09 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.048 1.832 . . . . 0.0 111.874 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 82.3 t80 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.614 179.925 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.1 t . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.748 0.309 . . . . 0.0 110.84 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.568 HG12 ' N ' ' A' ' 16' ' ' LYS . 42.1 t -135.8 164.33 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 121.031 0.443 . . . . 0.0 110.302 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.568 ' N ' HG12 ' A' ' 15' ' ' VAL . 14.2 ptpt -64.52 -41.68 96.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.434 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.535 ' CE2' ' NH1' ' A' ' 96' ' ' ARG . 32.4 t80 -63.41 -41.89 98.73 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -178.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.2 pp -80.1 -25.59 39.92 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.185 0.517 . . . . 0.0 112.351 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.42 ' O ' ' OG1' ' A' ' 22' ' ' THR . . . -66.14 -41.21 95.09 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 107.667 -2.173 . . . . 0.0 107.667 177.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.414 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -71.5 -32.07 67.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 124.787 2.232 . . . . 0.0 107.193 176.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.6 -42.43 98.81 Favored Glycine 0 CA--C 1.527 0.837 1 CA-C-N 108.389 -4.005 . . . . 0.0 108.19 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 19' ' ' GLY . 22.4 p -70.65 -27.74 64.27 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -66.48 -50.02 64.66 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.814 -179.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.94 -36.06 80.27 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 118.161 -1.416 . . . . 0.0 110.931 -177.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.2 t -63.99 -53.87 43.38 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.616 -0.433 . . . . 0.0 111.326 -179.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.1 tp -65.82 -39.75 85.68 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -177.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.619 ' O ' HG23 ' A' ' 31' ' ' THR . . . -63.9 -41.93 97.57 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 119.736 -0.786 . . . . 0.0 112.924 -173.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -77.69 -27.24 50.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 120.439 1.472 . . . . 0.0 109.886 -176.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.0 tp -59.86 -55.71 30.84 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 119.802 1.183 . . . . 0.0 112.553 -178.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.4 tp -75.75 -4.63 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.619 HG23 ' O ' ' A' ' 27' ' ' ALA . 28.3 p -109.84 -17.27 13.69 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 118.7 -1.2 . . . . 0.0 110.41 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.414 ' N ' ' CD ' ' A' ' 33' ' ' PRO . 66.3 t80 -67.86 -43.65 38.53 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 122.461 2.391 . . . . 0.0 110.583 -178.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 32' ' ' PHE . 37.6 Cg_exo -58.94 -15.32 26.72 Favored 'Trans proline' 0 N--CA 1.503 2.06 0 C-N-CA 121.343 1.362 . . . . 0.0 112.341 178.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.75 HD13 HH21 ' A' ' 279' ' ' ARG . 88.8 mt -67.15 -34.43 77.55 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -178.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -64.09 -40.64 96.67 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -177.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 75.7 p -58.29 -34.79 70.93 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.04 -38.91 86.7 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -178.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.496 ' CB ' ' NZ ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -61.17 -47.06 87.91 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 119.378 -0.929 . . . . 0.0 111.723 -176.173 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 95.0 t -62.39 -38.06 80.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 O-C-N 122.287 -0.258 . . . . 0.0 111.264 -178.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.502 ' O ' ' N ' ' A' ' 42' ' ' GLN . 25.9 mmt180 -59.58 -40.16 86.47 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.367 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 84.2 mt -61.19 38.93 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.502 ' N ' ' O ' ' A' ' 40' ' ' ARG . 2.7 pt20 -172.29 55.32 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 O-C-N 122.074 -0.391 . . . . 0.0 110.739 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.424 ' C ' ' O ' ' A' ' 42' ' ' GLN . 0.1 OUTLIER 26.68 -117.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.959 179.622 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.407 ' H ' ' CG1' ' A' ' 43' ' ' ILE . 95.9 mm-40 -129.89 102.51 6.33 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.366 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -81.47 73.6 2.58 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -156.56 163.62 39.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.878 0.37 . . . . 0.0 110.45 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 63.6 p -82.18 67.21 8.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.645 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.675 HE21 ' N ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -118.34 -47.39 2.56 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.825 179.805 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.02 13.09 81.76 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -177.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.675 ' N ' HE21 ' A' ' 48' ' ' GLN . 0.2 OUTLIER -65.82 -38.12 88.07 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.435 0.636 . . . . 0.0 109.319 178.978 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.539 HG13 ' N ' ' A' ' 52' ' ' ARG . 12.5 p -60.24 -44.5 95.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.859 -178.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.539 ' N ' HG13 ' A' ' 51' ' ' VAL . 52.5 ttp180 -64.31 -33.59 76.19 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.183 -0.607 . . . . 0.0 109.474 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 95.8 m -67.71 -38.21 83.32 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.415 ' O ' ' O ' ' A' ' 51' ' ' VAL . . . -89.76 124.52 34.71 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.706 179.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -87.62 -7.08 57.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.949 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.441 ' C ' ' H ' ' A' ' 58' ' ' GLN . 88.1 p -174.43 -125.89 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 56' ' ' SER . . . 65.27 -19.72 0.09 Allowed 'General case' 0 N--CA 1.461 0.092 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 176.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.453 ' NE2' ' NH1' ' A' ' 40' ' ' ARG . 7.6 mm100 -126.01 38.76 4.08 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 177.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.427 ' O ' ' O ' ' A' ' 58' ' ' GLN . 75.2 m-85 -37.53 -98.37 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.132 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.428 ' O ' ' C ' ' A' ' 61' ' ' GLY . 34.4 ttm180 -154.51 -31.63 0.11 Allowed 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.442 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 60' ' ' ARG . . . -29.03 102.27 0.01 OUTLIER Glycine 0 C--N 1.34 0.774 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.914 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.1 t -66.77 -34.46 70.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 118.31 -0.852 . . . . 0.0 109.14 176.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.7 tp -60.93 -33.01 72.5 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 121.495 1.952 . . . . 0.0 111.365 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -65.05 -49.43 62.42 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 115.223 0.849 . . . . 0.0 115.223 -176.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.41 ' H ' HG22 ' A' ' 65' ' ' THR . 0.0 OUTLIER -62.21 -45.57 92.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.958 -0.621 . . . . 0.0 111.714 -179.159 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 94.5 mt -59.66 -36.37 65.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -179.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.559 ' O ' HD13 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -63.92 -36.41 83.86 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 120.561 1.528 . . . . 0.0 111.343 179.568 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.448 ' O ' ' OG1' ' A' ' 72' ' ' THR . 98.3 m -62.52 -39.35 93.24 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 113.215 -1.812 . . . . 0.0 111.084 -176.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 28.7 ttt -60.52 -39.46 87.9 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -177.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.8 t -68.92 -40.38 81.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 119.473 -0.891 . . . . 0.0 112.851 -177.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -77.71 -13.25 59.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.679 0.752 . . . . 0.0 112.947 -178.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 68' ' ' THR . 16.1 m -62.96 -55.06 29.15 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.947 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 31.9 mp0 -108.39 -58.85 1.94 Allowed 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.407 ' O ' ' CB ' ' A' ' 77' ' ' SER . . . 158.75 164.54 14.45 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -56.49 -35.14 96.39 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.762 1.642 . . . . 0.0 111.546 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.428 ' O ' ' OD1' ' A' ' 80' ' ' ASN . 48.4 ttm-85 -60.97 -11.01 6.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 122.211 1.005 . . . . 0.0 111.003 176.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.531 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 36.2 p -77.59 -32.19 53.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 113.285 -1.779 . . . . 0.0 110.205 -179.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 85.7 mt -74.8 -28.93 60.92 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.486 1.114 . . . . 0.0 111.477 178.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -86.64 -2.45 58.52 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 122.678 1.228 . . . . 0.0 113.041 -172.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.531 ' ND2' ' O ' ' A' ' 77' ' ' SER . 0.4 OUTLIER -116.33 138.23 51.5 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 112.376 -2.193 . . . . 0.0 108.542 176.847 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.8 -28.09 17.37 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -178.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 69.5 mt -59.34 -34.87 72.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.148 -1.026 . . . . 0.0 110.573 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.3 t -70.85 -27.47 30.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.293 -0.867 . . . . 0.0 108.969 178.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.01 -31.93 61.5 Favored 'General case' 0 C--O 1.226 -0.15 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.331 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.64 -40.33 90.42 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 119.463 -1.351 . . . . 0.0 110.802 -178.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.5 tp -62.22 -40.27 95.56 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 122.343 1.068 . . . . 0.0 113.243 -176.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -60.17 -27.04 66.78 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 113.285 -1.78 . . . . 0.0 109.307 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.631 HH22 HE21 ' A' ' 145' ' ' GLN . 77.0 mtt180 -57.93 -53.41 58.59 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 172.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 11.5 tm0? -67.65 -30.65 70.26 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 112.061 -2.336 . . . . 0.0 113.794 -177.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 2.7 ptm -61.72 -40.09 93.83 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.925 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.5 m -74.1 -34.31 63.91 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 119.191 -1.004 . . . . 0.0 111.048 -176.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -58.0 -43.92 86.94 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 120.899 1.681 . . . . 0.0 112.416 -176.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.1 -33.07 65.36 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.921 -177.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 85.9 p -63.69 -40.74 97.56 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.446 ' C ' ' H ' ' A' ' 97' ' ' ILE . 18.7 m -67.89 -28.77 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.535 ' NH1' ' CE2' ' A' ' 17' ' ' PHE . 5.0 ptm180 -77.61 12.0 1.82 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -177.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.446 ' H ' ' C ' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -86.63 -15.35 9.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 179.07 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.503 ' O ' ' OD1' ' A' ' 101' ' ' ASP . . . -140.26 -47.84 0.06 OUTLIER Glycine 0 CA--C 1.536 1.344 0 CA-C-N 114.265 -1.334 . . . . 0.0 114.553 -177.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.4 tp -71.65 -13.52 61.77 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 119.453 1.626 . . . . 0.0 113.443 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -81.18 -52.16 7.66 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 114.595 -1.184 . . . . 0.0 112.189 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.62 ' O ' ' HG3' ' A' ' 105' ' ' GLN . 41.5 p-10 -70.15 -32.47 70.47 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 124.061 1.886 . . . . 0.0 110.591 -179.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.524 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 28.7 t -67.49 -50.74 57.6 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 109.695 -3.411 . . . . 0.0 111.936 176.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.466 HG22 ' CE2' ' A' ' 107' ' ' TYR . 0.5 OUTLIER -73.25 -26.42 22.58 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.185 0 CA-C-N 121.446 1.93 . . . . 0.0 111.492 178.586 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -69.29 -41.44 76.8 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 112.524 -2.126 . . . . 0.0 110.955 178.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.62 ' HG3' ' O ' ' A' ' 101' ' ' ASP . 88.1 mt-30 -76.64 -16.98 59.41 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.591 0.71 . . . . 0.0 111.073 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -79.33 -22.95 43.83 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.17 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.466 ' CE2' HG22 ' A' ' 103' ' ' VAL . 33.3 m-85 -109.34 -29.35 8.5 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 119.669 1.122 . . . . 0.0 112.855 -174.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 59.3 p -95.99 9.42 40.79 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 117.07 -1.852 . . . . 0.0 113.208 -176.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.0 mmmt -47.55 122.64 4.96 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.258 0.935 . . . . 0.0 108.661 176.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -119.29 85.83 0.39 Allowed Glycine 0 N--CA 1.476 1.33 0 CA-C-N 120.216 1.371 . . . . 0.0 111.624 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 34.3 t -94.55 -61.37 1.52 Allowed 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 -176.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -123.29 -176.83 3.53 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 112.749 -2.023 . . . . 0.0 111.971 -177.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.638 ' O ' ' HB2' ' A' ' 114' ' ' ALA . 0.0 OUTLIER -91.25 72.5 6.21 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -178.51 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.638 ' HB2' ' O ' ' A' ' 113' ' ' HIS . . . 159.77 -162.96 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 176.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.22 15.27 26.17 Favored Glycine 0 C--N 1.343 0.958 0 CA-C-N 114.471 -1.241 . . . . 0.0 113.15 177.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.481 HG23 ' N ' ' A' ' 117' ' ' GLY . 15.0 tt -60.87 -40.29 84.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 118.053 0.927 . . . . 0.0 110.215 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.481 ' N ' HG23 ' A' ' 116' ' ' ILE . . . -65.1 -39.68 96.44 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-O 122.029 0.794 . . . . 0.0 111.837 176.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 36.2 m -57.2 -41.68 79.85 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -63.2 -36.71 84.53 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.181 -0.607 . . . . 0.0 111.509 -178.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.649 ' C ' HD12 ' A' ' 120' ' ' LEU . 0.1 OUTLIER -63.91 -45.78 87.77 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.087 0.47 . . . . 0.0 110.407 178.387 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.423 ' N ' ' HG ' ' A' ' 120' ' ' LEU . 10.9 tp -65.7 -44.05 87.3 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 119.405 -0.918 . . . . 0.0 109.821 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.69 -44.38 96.38 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 118.922 0.783 . . . . 0.0 110.496 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -65.72 -44.23 92.76 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 119.561 -1.304 . . . . 0.0 112.021 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 10.9 t -64.15 -44.76 91.16 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 119.985 -0.686 . . . . 0.0 111.631 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.417 ' O ' HD23 ' A' ' 129' ' ' LEU . 21.3 m -69.73 -48.89 57.85 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 119.07 -1.052 . . . . 0.0 112.194 177.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 24.5 m -65.49 -42.81 91.78 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 -174.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -64.22 -44.65 95.3 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-O 122.802 1.223 . . . . 0.0 113.342 -177.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.426 ' O ' ' CG2' ' A' ' 131' ' ' VAL . . . -60.96 -41.31 96.09 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 112.073 -2.063 . . . . 0.0 107.075 177.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.665 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 1.6 mm? -64.3 -42.02 96.57 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.438 178.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.18 -39.86 95.85 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -177.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.426 ' CG2' ' O ' ' A' ' 128' ' ' ALA . 7.0 m -61.15 -25.76 37.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 122.753 1.264 . . . . 0.0 109.544 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.665 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . -58.55 -44.94 89.83 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 112.364 -2.198 . . . . 0.0 111.673 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.438 HG12 ' H ' ' A' ' 133' ' ' VAL . 2.0 p -79.07 -48.82 20.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -102.73 129.15 49.27 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.826 0.346 . . . . 0.0 111.122 -179.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.661 ' H ' ' CD ' ' A' ' 136' ' ' PRO . 8.1 tp-100 -173.15 -38.5 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.25 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.934 179.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.661 ' CD ' ' H ' ' A' ' 135' ' ' GLN . 63.3 Cg_exo -52.88 -34.17 64.77 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.467 1.444 . . . . 0.0 112.002 -179.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 11.2 m -68.35 -42.92 78.55 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 118.082 -1.447 . . . . 0.0 110.919 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -66.91 -43.97 82.0 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 118.26 -1.376 . . . . 0.0 112.853 -178.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.465 HG23 ' N ' ' A' ' 140' ' ' VAL . 27.6 m -64.96 -44.6 96.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -179.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.465 ' N ' HG23 ' A' ' 139' ' ' VAL . 7.6 p -65.33 -38.69 83.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -177.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -62.16 -41.08 97.96 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -176.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.449 ' CG1' ' N ' ' A' ' 143' ' ' ARG . 2.4 p -70.39 -44.78 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.072 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.539 HH22 ' H ' ' A' ' 178' ' ' GLY . 81.5 mtt85 -64.26 -36.28 83.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.468 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -66.42 -41.23 89.52 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.769 -0.373 . . . . 0.0 111.572 -177.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.631 HE21 HH22 ' A' ' 88' ' ' ARG . 76.5 mm-40 -64.92 -39.56 93.7 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 119.526 -0.87 . . . . 0.0 109.083 178.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.31 -34.84 79.28 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -179.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -60.27 110.47 1.24 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 176.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -100.91 -58.26 1.93 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 117.226 -1.368 . . . . 0.0 113.836 -176.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.528 ' O ' ' N ' ' A' ' 151' ' ' GLY . 28.9 ptt-85 -133.66 17.67 3.92 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 122.641 2.473 . . . . 0.0 110.03 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . 49.95 -86.5 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.724 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 149' ' ' ARG . . . -157.28 42.56 0.53 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.712 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 179.941 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.765 0.317 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -80.39 -164.68 0.73 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.545 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 56.7 m -156.97 -178.1 7.12 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.156 0.503 . . . . 0.0 110.843 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 98.7 m -64.25 -46.31 84.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.983 -177.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.548 HG23 ' N ' ' A' ' 161' ' ' GLU . 34.0 m -64.35 -45.36 96.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 118.946 -1.102 . . . . 0.0 109.239 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.548 ' N ' HG23 ' A' ' 160' ' ' VAL . 81.8 tt0 -67.36 -39.27 85.69 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.665 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -61.68 -45.99 91.65 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -177.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -62.73 -49.66 74.16 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.422 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -68.36 -45.41 72.87 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 -175.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.562 HG23 ' N ' ' A' ' 166' ' ' ILE . 14.1 t -62.82 -44.88 94.99 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.519 1.054 . . . . 0.0 113.689 -177.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.562 ' N ' HG23 ' A' ' 165' ' ' THR . 2.5 pp -64.84 -38.3 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 121.906 0.86 . . . . 0.0 109.337 176.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.451 ' N ' HD12 ' A' ' 166' ' ' ILE . . . -59.25 -35.6 73.97 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 113.992 -1.458 . . . . 0.0 107.788 176.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.407 ' HE ' ' HA ' ' A' ' 168' ' ' ARG . 0.5 OUTLIER -61.6 -49.78 75.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 122.401 2.364 . . . . 0.0 111.449 -175.475 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -74.57 -50.99 15.86 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 123.446 0.698 . . . . 0.0 109.63 177.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.487 ' N ' ' CD ' ' A' ' 170' ' ' GLU . 2.2 mp0 -77.98 -36.6 48.76 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 116.637 2.088 . . . . 0.0 116.637 -173.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . 0.413 ' O ' HD23 ' A' ' 175' ' ' LEU . . . 91.49 -167.23 31.03 Favored Glycine 0 N--CA 1.47 0.935 0 CA-C-N 118.842 0.746 . . . . 0.0 112.007 177.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.531 HG23 ' N ' ' A' ' 173' ' ' ARG . 19.8 tt -73.45 -42.55 56.5 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.07 0 CA-C-O 121.963 0.887 . . . . 0.0 110.885 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.531 ' N ' HG23 ' A' ' 172' ' ' ILE . 3.9 tpt180 -58.79 -33.49 70.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 113.993 -1.458 . . . . 0.0 111.261 -176.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -60.7 -40.24 97.76 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 118.965 -1.588 . . . . 0.0 110.006 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.52 ' O ' ' NH2' ' A' ' 143' ' ' ARG . 3.7 mm? -70.61 -33.27 70.86 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 111.673 -2.264 . . . . 0.0 116.922 -177.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 19.5 m0 -78.06 -7.65 57.2 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 112.076 -2.329 . . . . 0.0 109.845 -177.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -43.22 -47.97 6.49 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.405 -176.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.539 ' H ' HH22 ' A' ' 143' ' ' ARG . . . -91.9 -32.06 8.79 Favored Glycine 0 CA--C 1.533 1.217 0 N-CA-C 111.329 -0.708 . . . . 0.0 111.329 178.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 34.8 m -45.36 -51.52 11.09 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . 0.43 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 2.8 m -62.47 -50.8 77.21 Favored Pre-proline 0 N--CA 1.471 0.581 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -176.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 180' ' ' SER . 28.2 Cg_endo -64.84 -28.38 59.08 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 121.482 1.455 . . . . 0.0 111.782 176.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.528 ' ND2' ' OE1' ' A' ' 135' ' ' GLN . 45.5 t30 -63.92 -39.53 94.38 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.454 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 70.9 t -63.09 -42.59 97.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.14 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.2 -39.49 92.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.048 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 33.0 ttm105 -60.59 -41.67 95.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.842 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -61.34 -42.92 99.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.063 0.459 . . . . 0.0 110.805 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.44 -43.82 93.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.092 -179.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 33.0 mm -63.56 -45.25 98.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -177.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.46 ' O ' ' N ' ' A' ' 193' ' ' GLU . 3.0 p -60.09 -46.79 93.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 119.679 -0.808 . . . . 0.0 112.027 -177.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 191' ' ' CYS . 2.6 p30 -63.13 -42.64 99.55 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 122.089 0.947 . . . . 0.0 109.983 179.103 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' CYS . . . . . 0.524 ' N ' ' OD1' ' A' ' 190' ' ' ASN . 27.2 m -61.2 -45.66 93.69 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 113.94 -1.482 . . . . 0.0 109.317 179.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -63.76 -39.56 94.56 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 112.99 -1.913 . . . . 0.0 108.638 175.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 0.46 ' N ' ' O ' ' A' ' 189' ' ' VAL . 74.6 tt0 -61.33 -46.96 88.07 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.868 -177.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 53.4 mt -65.15 -39.26 92.75 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 118.547 -1.261 . . . . 0.0 110.493 -175.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 7.0 m -63.97 -45.74 95.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 C-N-CA 117.078 -1.849 . . . . 0.0 107.297 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 19.9 m -63.75 -45.7 88.64 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -178.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -56.49 -38.34 71.62 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.296 1.038 . . . . 0.0 112.29 -178.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.44 -44.0 75.91 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.689 ' N ' HD22 ' A' ' 199' ' ' LEU . 2.9 mm? -61.18 -39.15 89.1 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 41.3 mm -62.78 -42.99 98.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.029 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -60.24 -39.55 87.13 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.758 1.223 . . . . 0.0 111.852 177.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -63.06 -38.53 91.56 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.119 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 35.9 m -101.56 128.19 47.93 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.855 0.835 . . . . 0.0 111.987 -179.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.547 ' O ' HD22 ' A' ' 205' ' ' LEU . 3.7 tp 66.84 4.73 3.61 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 114.186 -1.37 . . . . 0.0 112.147 177.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.547 HD22 ' O ' ' A' ' 204' ' ' LEU . 1.3 mm? -125.55 29.93 5.88 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.35 0.595 . . . . 0.0 112.487 -177.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -71.55 -24.65 61.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.806 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.547 ' O ' ' O ' ' A' ' 208' ' ' ASN . . . -165.05 33.04 0.06 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.362 179.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' ASN . . . . . 0.547 ' O ' ' O ' ' A' ' 207' ' ' ALA . 1.6 m-20 40.0 123.22 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 177.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.501 ' C ' ' O ' ' A' ' 208' ' ' ASN . 43.4 tp . . . . . 0 N--CA 1.48 1.073 0 CA-C-N 115.015 -0.993 . . . . 0.0 112.559 179.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 0.407 ' O ' ' OD1' ' A' ' 213' ' ' ASP . 2.5 p30 . . . . . 0 N--CA 1.464 0.24 0 CA-C-O 121.078 0.466 . . . . 0.0 110.514 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.436 ' N ' ' CD ' ' A' ' 215' ' ' PRO . 6.0 mt -61.41 -43.27 88.71 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 113.118 0.785 . . . . 0.0 113.118 -178.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 214' ' ' LEU . 27.1 Cg_exo -60.74 -33.73 92.69 Favored 'Trans proline' 0 N--CA 1.5 1.884 0 CA-C-N 120.051 1.054 . . . . 0.0 111.555 -177.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 84.1 m -64.01 -41.79 97.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 112.767 -2.015 . . . . 0.0 111.213 -178.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -66.18 -37.08 84.76 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.241 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -62.96 -47.41 83.31 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.252 -178.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.402 ' H ' HG22 ' A' ' 219' ' ' THR . 1.4 t -60.58 -37.94 82.97 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 119.395 0.998 . . . . 0.0 110.87 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 71.1 m -59.68 -41.89 91.71 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.9 -41.94 97.57 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -62.39 -47.5 83.86 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 119.755 -0.778 . . . . 0.0 112.953 -176.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -61.27 -42.48 99.79 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 108.199 -1.961 . . . . 0.0 108.199 177.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . 0.464 ' O ' ' SG ' ' A' ' 227' ' ' CYS . . . -63.25 -39.14 93.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.497 -0.851 . . . . 0.0 109.02 177.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -62.93 -43.05 99.49 Favored Glycine 0 CA--C 1.52 0.354 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.607 -178.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' PHE . . . . . 0.442 ' O ' ' OG1' ' A' ' 229' ' ' THR . 75.3 t80 -66.91 -38.95 87.19 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 119.659 -0.816 . . . . 0.0 108.855 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . 0.466 ' SG ' ' N ' ' A' ' 228' ' ' THR . 0.5 OUTLIER -63.41 -41.06 98.71 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 176.847 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . 0.466 ' N ' ' SG ' ' A' ' 227' ' ' CYS . 26.8 m -62.7 -41.54 99.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.839 179.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.448 HG23 ' O ' ' A' ' 225' ' ' GLY . 16.1 p -59.99 -40.32 88.75 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -176.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.405 HG22 ' H ' ' A' ' 230' ' ' VAL . 3.3 m -60.66 -40.27 84.2 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.381 0 C-N-CA 118.455 -1.298 . . . . 0.0 108.953 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . 0.486 ' O ' ' HD2' ' A' ' 234' ' ' PRO . 1.7 mp -61.0 -40.85 86.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 176.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.01 -39.98 96.39 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.48 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 0.5 OUTLIER -58.47 -42.18 93.2 Favored Pre-proline 0 N--CA 1.483 1.214 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 -173.858 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.486 ' HD2' ' O ' ' A' ' 231' ' ' ILE . 31.3 Cg_exo -57.97 -39.75 83.64 Favored 'Trans proline' 0 C--N 1.293 -2.378 0 C-N-CA 122.536 2.157 . . . . 0.0 113.276 179.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 46.5 t -63.95 -37.26 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 118.055 -1.458 . . . . 0.0 108.922 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -65.88 -40.62 91.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.75 178.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 53.2 t -64.79 -45.51 94.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -176.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 27.6 m . . . . . 0 C--N 1.322 -0.613 0 C-N-CA 119.224 -0.991 . . . . 0.0 111.732 -178.159 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 85.8 m . . . . . 0 N--CA 1.456 -0.135 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' MET . . . . . 0.447 ' C ' ' SD ' ' A' ' 260' ' ' MET . 13.6 tmm? -61.62 -45.04 95.76 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -177.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.17 -47.5 82.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.102 0.477 . . . . 0.0 110.26 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' ARG . . . . . 0.463 ' O ' ' O ' ' A' ' 263' ' ' LYS . 61.5 ttt85 -66.66 -53.84 29.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.463 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 262' ' ' ARG . 28.0 tttp -57.81 -138.99 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.9 0.381 . . . . 0.0 111.369 -178.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -63.91 149.52 46.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.997 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . 0.539 ' C ' ' H ' ' A' ' 267' ' ' ARG . . . -44.04 160.19 0.1 OUTLIER Glycine 0 CA--C 1.535 1.283 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -50.85 0.07 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 122.018 1.812 . . . . 0.0 112.945 178.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . 0.539 ' H ' ' C ' ' A' ' 265' ' ' GLY . 89.4 mtt-85 -69.5 -26.95 64.79 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 122.696 0.398 . . . . 0.0 111.817 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -58.83 -32.63 69.57 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.404 -178.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -62.51 -41.55 98.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.376 0.608 . . . . 0.0 110.89 178.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -66.05 -37.46 85.91 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.284 -178.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.434 ' O ' ' O ' ' A' ' 272' ' ' GLY . 95.8 mttt -80.65 -179.72 7.37 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . 0.434 ' O ' ' O ' ' A' ' 271' ' ' LYS . . . 52.3 109.29 0.01 OUTLIER Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.694 -0.563 . . . . 0.0 111.694 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -178.31 8.27 0.01 OUTLIER 'General case' 0 C--O 1.232 0.151 0 C-N-CA 121.166 -0.214 . . . . 0.0 111.325 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 274' ' ' MET . . . . . 0.549 ' N ' ' CD ' ' A' ' 275' ' ' PRO . 0.1 OUTLIER -63.91 -44.53 79.11 Favored Pre-proline 0 CA--C 1.533 0.291 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.898 -179.148 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 275' ' ' PRO . . . . . 0.549 ' CD ' ' N ' ' A' ' 274' ' ' MET . 22.1 Cg_exo -64.46 -46.86 6.58 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 122.353 2.035 . . . . 0.0 111.471 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 49.2 m -60.78 -39.71 89.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.749 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . 0.403 ' CD1' ' C ' ' A' ' 277' ' ' PHE . 41.0 t80 -61.64 -42.67 99.21 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 122.738 1.256 . . . . 0.0 112.969 -178.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.514 HD13 ' O ' ' A' ' 278' ' ' LEU . 0.2 OUTLIER -62.29 -38.78 90.65 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 112.11 -2.314 . . . . 0.0 107.815 174.284 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . 0.75 HH21 HD13 ' A' ' 34' ' ' LEU . 4.4 mtp180 -62.81 -39.71 95.14 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.375 0.607 . . . . 0.0 110.283 178.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -62.07 -36.55 82.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.508 -178.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -68.08 -51.2 35.06 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -178.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . 0.435 ' O ' HG12 ' A' ' 285' ' ' VAL . 74.8 m -63.0 -44.36 96.24 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 123.109 0.564 . . . . 0.0 109.91 179.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 283' ' ' TRP . . . . . 0.405 ' O ' HG22 ' A' ' 286' ' ' VAL . 48.7 t-105 -59.7 -38.36 81.39 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -62.2 -37.37 85.06 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.363 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.435 HG12 ' O ' ' A' ' 282' ' ' SER . 0.4 OUTLIER -59.88 -37.73 73.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.143 -178.278 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.493 ' O ' HG22 ' A' ' 289' ' ' VAL . 0.8 OUTLIER -61.61 -40.28 86.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.724 -179.23 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 30.9 mtm -60.95 -38.85 87.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.098 0.475 . . . . 0.0 110.453 178.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -58.69 -40.13 82.7 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.83 -178.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.493 HG22 ' O ' ' A' ' 286' ' ' VAL . 1.0 OUTLIER -60.31 -38.91 79.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 120.981 0.419 . . . . 0.0 110.91 -177.576 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 12.5 m -64.27 -40.04 95.17 Favored 'General case' 0 CA--C 1.549 0.925 0 O-C-N 121.574 -0.704 . . . . 0.0 111.729 177.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -61.01 -40.4 93.39 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-O 118.652 -0.69 . . . . 0.0 109.165 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . 0.434 ' CG ' ' O ' ' A' ' 289' ' ' VAL . 4.4 pt-20 -59.39 -39.42 83.33 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 116.552 -2.059 . . . . 0.0 109.781 -176.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 293' ' ' GLN . . . . . 0.471 ' O ' ' O ' ' A' ' 296' ' ' ARG . 57.4 tt0 -59.51 -42.83 93.11 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 122.38 1.086 . . . . 0.0 111.306 -178.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -60.52 -40.74 92.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 113.61 -1.632 . . . . 0.0 108.574 178.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -63.22 -45.97 89.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.263 178.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 296' ' ' ARG . . . . . 0.471 ' O ' ' O ' ' A' ' 293' ' ' GLN . 11.9 tpp85 -123.03 116.25 23.21 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -121.01 -163.38 1.02 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.236 0.541 . . . . 0.0 112.413 -178.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.575 ' N ' HD22 ' A' ' 298' ' ' LEU . 3.2 mm? -67.21 116.94 8.56 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 26.4 ttm -96.77 62.64 1.94 Allowed 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -178.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.65 100.84 0.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.976 0.893 . . . . 0.0 110.834 -178.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -64.1 -46.4 84.39 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 113.746 -1.57 . . . . 0.0 113.434 -176.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -58.6 -39.67 81.07 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.39 -0.524 . . . . 0.0 109.897 -178.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -64.9 -46.77 80.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.871 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 304' ' ' SER . . . . . 0.426 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 78.0 p -66.66 -38.04 86.04 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.711 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.04 -42.73 99.49 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.544 179.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 12.7 tm-20 -64.74 -37.12 86.53 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -177.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . 0.544 ' HB3' ' HD3' ' A' ' 308' ' ' PRO . . . -60.01 -52.94 69.96 Favored Pre-proline 0 CA--C 1.544 0.716 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -176.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 308' ' ' PRO . . . . . 0.544 ' HD3' ' HB3' ' A' ' 307' ' ' ALA . 74.5 Cg_endo -75.36 0.32 9.18 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.255 1.97 . . . . 0.0 112.106 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 78.7 t80 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.519 -179.895 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.3 m . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.774 0.321 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.587 HG13 ' H ' ' A' ' 18' ' ' LEU . 4.3 p -160.67 166.53 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.235 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.572 ' N ' HG22 ' A' ' 15' ' ' VAL . 30.2 mmtp -64.38 -41.65 96.58 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -178.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.42 ' H ' HG22 ' A' ' 15' ' ' VAL . 65.9 m-85 -63.54 -41.15 98.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.228 0.537 . . . . 0.0 112.438 -179.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.587 ' H ' HG13 ' A' ' 15' ' ' VAL . 9.8 tp -79.78 -25.96 40.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.276 -0.874 . . . . 0.0 112.617 -178.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.32 -41.41 94.6 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 107.768 -2.133 . . . . 0.0 107.768 177.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.403 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -71.53 -32.08 67.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 124.873 2.273 . . . . 0.0 107.18 176.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.35 -42.38 99.18 Favored Glycine 0 CA--C 1.527 0.818 1 CA-C-N 108.393 -4.003 . . . . 0.0 107.804 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 92.8 m -70.54 -27.97 64.56 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.498 0.666 . . . . 0.0 109.262 177.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -66.39 -49.94 65.13 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.851 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.96 -35.89 79.8 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 118.144 -1.422 . . . . 0.0 110.979 -177.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.446 ' O ' HD13 ' A' ' 29' ' ' LEU . 77.5 m -63.8 -54.08 40.77 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.616 -178.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.456 HD12 ' N ' ' A' ' 27' ' ' ALA . 2.6 pp -65.73 -39.39 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -176.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.456 ' N ' HD12 ' A' ' 26' ' ' ILE . . . -64.12 -41.9 97.06 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 119.831 -0.748 . . . . 0.0 112.706 -173.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.464 ' O ' ' N ' ' A' ' 32' ' ' PHE . 29.9 m-20 -77.78 -27.35 50.22 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 117.823 -1.551 . . . . 0.0 109.52 -176.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.507 HD12 HE22 ' A' ' 89' ' ' GLN . 5.4 mp -60.23 -55.92 27.81 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 120.129 1.331 . . . . 0.0 111.731 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.521 ' O ' HD13 ' A' ' 34' ' ' LEU . 10.1 tp -75.68 -4.79 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 121.659 0.742 . . . . 0.0 112.034 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.6 m -109.83 -16.48 13.87 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 114.454 -1.248 . . . . 0.0 110.202 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.507 ' N ' ' CD ' ' A' ' 33' ' ' PRO . 0.2 OUTLIER -68.28 -44.92 38.19 Favored Pre-proline 0 C--N 1.325 -0.463 0 C-N-CA 116.156 -2.218 . . . . 0.0 109.452 -178.231 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 32' ' ' PHE . 34.0 Cg_exo -59.95 -16.67 39.99 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 121.32 1.346 . . . . 0.0 112.573 177.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.521 HD13 ' O ' ' A' ' 30' ' ' ILE . 8.6 mp -67.7 -35.41 78.74 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -178.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 36' ' ' THR . 1.9 p30 -64.44 -40.47 95.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.948 -177.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.545 ' N ' ' OD1' ' A' ' 35' ' ' ASP . 47.5 p -58.44 -34.97 71.41 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 120.41 -0.516 . . . . 0.0 112.176 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.52 -39.55 85.11 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 119.547 -0.861 . . . . 0.0 112.902 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.455 ' CB ' ' NH2' ' A' ' 279' ' ' ARG . 10.0 ptmt -63.09 -48.68 77.57 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 118.854 -1.138 . . . . 0.0 111.246 -177.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 66.4 t -63.55 -39.81 86.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -177.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.507 ' O ' ' N ' ' A' ' 42' ' ' GLN . 8.6 tpm_? -60.82 -41.39 95.62 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 119.19 -1.004 . . . . 0.0 109.718 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.49 38.81 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.58 178.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.507 ' N ' ' O ' ' A' ' 40' ' ' ARG . 45.1 tt0 -88.7 -112.64 0.06 Allowed 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.646 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.1 tp -154.3 8.93 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.158 0.504 . . . . 0.0 109.794 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.519 ' NE2' ' OE1' ' A' ' 58' ' ' GLN . 14.7 mm100 56.97 26.04 11.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.55 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -118.65 141.17 15.84 Favored Glycine 0 N--CA 1.466 0.683 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -149.4 -84.26 0.1 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 86.4 p -172.04 70.49 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.782 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 -156.01 -27.63 0.1 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.085 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.98 17.67 74.15 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 108.577 -1.809 . . . . 0.0 108.577 -177.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.724 HD22 ' N ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -63.92 -35.52 80.93 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.081 -1.06 . . . . 0.0 111.031 -179.089 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.724 ' N ' HD22 ' A' ' 50' ' ' LEU . 83.9 t -59.4 -43.81 91.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 71.0 ttp85 -64.01 -33.86 76.69 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.99 -38.13 82.32 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -136.36 95.39 3.17 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.236 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.92 -19.83 64.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.3 -178.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.599 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 7.9 t -125.67 -141.02 0.28 Allowed 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.599 ' HB3' ' O ' ' A' ' 56' ' ' SER . . . 99.38 12.42 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 O-C-N 124.132 0.895 . . . . 0.0 112.616 178.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.519 ' OE1' ' NE2' ' A' ' 44' ' ' GLN . 10.7 pt20 178.36 101.72 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.995 0.426 . . . . 0.0 111.052 179.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -84.88 166.95 16.43 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.44 ' O ' ' C ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER -52.29 -35.07 49.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.233 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.44 ' C ' ' O ' ' A' ' 60' ' ' ARG . . . -28.23 100.21 0.01 OUTLIER Glycine 0 CA--C 1.53 1.011 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.241 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 24.6 m -67.21 -33.99 66.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.072 176.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -60.26 -32.4 71.13 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 121.31 1.868 . . . . 0.0 109.731 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.51 -48.99 67.52 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-N 114.934 -1.03 . . . . 0.0 114.459 -176.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.41 HG23 ' H ' ' A' ' 65' ' ' THR . 12.8 p -62.14 -46.13 90.37 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -179.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 97.0 mt -59.68 -35.99 62.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 118.119 -0.943 . . . . 0.0 108.94 -178.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.641 ' C ' HD12 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -63.84 -35.28 80.12 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 121.422 1.919 . . . . 0.0 111.993 179.525 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 98.3 m -62.19 -38.34 88.74 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 113.4 -1.727 . . . . 0.0 110.99 -176.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 58.0 mmm -59.79 -40.04 86.95 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 121.048 -1.032 . . . . 0.0 113.425 -177.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 93.3 t -69.71 -41.14 79.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 118.967 -1.093 . . . . 0.0 113.82 -177.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 36.5 mmm-85 -78.97 -13.06 60.02 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -178.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.521 ' CG2' ' N ' ' A' ' 73' ' ' GLU . 0.7 OUTLIER -62.27 -54.65 37.6 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.633 -179.215 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.521 ' N ' ' CG2' ' A' ' 72' ' ' THR . 35.2 mt-10 -106.88 -53.93 2.54 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.417 ' O ' ' CB ' ' A' ' 77' ' ' SER . . . 155.77 166.23 15.52 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -56.43 -35.32 96.32 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 121.281 1.32 . . . . 0.0 110.971 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -61.43 -12.0 12.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.983 0.897 . . . . 0.0 110.723 175.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.617 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 6.5 t -77.91 -32.36 51.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 113.911 -1.495 . . . . 0.0 110.454 -178.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 15.3 tp -75.95 -33.41 59.82 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 121.761 -0.587 . . . . 0.0 110.823 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.43 ' C ' ' H ' ' A' ' 81' ' ' GLY . 53.5 m-85 -92.75 -5.09 51.96 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 -177.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.617 ' ND2' ' O ' ' A' ' 77' ' ' SER . 0.0 OUTLIER -92.52 26.05 2.79 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 174.55 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 79' ' ' TYR . . . -160.07 -19.62 0.03 OUTLIER Glycine 0 CA--C 1.526 0.732 0 CA-C-N 112.942 -1.935 . . . . 0.0 112.036 -178.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.407 ' H ' ' H ' ' A' ' 81' ' ' GLY . 42.6 tp -59.06 -35.0 72.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.091 -1.054 . . . . 0.0 110.406 -179.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.4 t -70.67 -27.01 29.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.29 178.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.67 -31.32 61.88 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.717 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.42 -40.06 91.43 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 119.645 -1.264 . . . . 0.0 111.46 -177.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -62.37 -39.92 94.75 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 122.192 0.996 . . . . 0.0 113.655 -176.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -59.68 -26.12 65.32 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 113.348 -1.751 . . . . 0.0 109.615 -179.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.616 ' NE ' ' NZ ' ' A' ' 141' ' ' LYS . 7.4 mmm180 -56.44 -52.35 64.99 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 173.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.507 HE22 HD12 ' A' ' 29' ' ' LEU . 72.1 mt-30 -67.6 -29.9 69.36 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 113.475 -1.693 . . . . 0.0 112.692 -178.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 24.8 mmt -61.08 -42.06 97.8 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 78.1 p -74.7 -34.84 62.71 Favored 'General case' 0 C--N 1.338 0.102 0 C-N-CA 119.301 -0.959 . . . . 0.0 111.864 -176.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -57.96 -43.55 86.5 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 120.496 1.498 . . . . 0.0 112.279 -176.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.41 -32.65 64.54 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 119.78 -0.768 . . . . 0.0 111.292 -178.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.608 ' O ' HG22 ' A' ' 97' ' ' ILE . 50.5 m -63.96 -41.53 97.55 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.448 ' C ' ' H ' ' A' ' 97' ' ' ILE . 24.2 m -68.12 -28.48 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.493 178.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 64.4 mtp180 -77.42 10.41 2.57 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -177.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.608 HG22 ' O ' ' A' ' 94' ' ' SER . 12.0 tt -86.78 -15.62 9.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.419 ' O ' ' OG ' ' A' ' 102' ' ' SER . . . -141.0 -48.85 0.05 OUTLIER Glycine 0 CA--C 1.534 1.252 0 CA-C-N 114.917 -1.038 . . . . 0.0 114.77 -178.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 60.5 mt -72.53 -14.29 61.61 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.096 1.448 . . . . 0.0 113.985 -177.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.521 ' O ' ' CD ' ' A' ' 104' ' ' LYS . 46.6 t80 -81.84 -53.12 6.44 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 114.653 -1.158 . . . . 0.0 112.542 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -72.6 -33.57 66.81 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 123.799 1.761 . . . . 0.0 114.136 -179.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' A' ' 98' ' ' GLY . 79.3 p -66.5 -50.6 62.71 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 110.244 -3.162 . . . . 0.0 117.068 -177.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.731 HG12 ' CE2' ' A' ' 107' ' ' TYR . 1.5 t -73.32 -23.37 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 CA-C-O 124.327 2.013 . . . . 0.0 109.94 175.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.521 ' CD ' ' O ' ' A' ' 100' ' ' TYR . 0.0 OUTLIER -66.8 -41.22 87.92 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 109.677 -3.42 . . . . 0.0 112.194 -178.02 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -78.81 -11.08 59.97 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 125.143 2.401 . . . . 0.0 111.05 178.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -79.63 -21.88 44.32 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 110.712 -2.949 . . . . 0.0 110.538 177.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.731 ' CE2' HG12 ' A' ' 103' ' ' VAL . 41.1 m-85 -109.5 -28.67 8.79 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -175.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.735 ' C ' ' H ' ' A' ' 110' ' ' GLY . 66.4 p -95.55 12.07 30.84 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 -174.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.435 ' O ' ' N ' ' A' ' 111' ' ' SER . 15.2 ttpp -54.71 22.31 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.055 0 CA-C-N 119.472 1.033 . . . . 0.0 111.239 177.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.735 ' H ' ' C ' ' A' ' 108' ' ' THR . . . 65.24 -57.06 0.11 Allowed Glycine 0 N--CA 1.472 1.053 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.544 ' CB ' ' O ' ' A' ' 110' ' ' GLY . 6.9 t 106.35 -164.67 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 177.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.537 ' OE1' ' N ' ' A' ' 112' ' ' GLU . 35.4 mp0 -120.55 -40.28 2.68 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 -175.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.608 ' O ' ' HB2' ' A' ' 114' ' ' ALA . 0.0 OUTLIER 165.05 29.97 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.503 0.668 . . . . 0.0 109.366 -179.318 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.608 ' HB2' ' O ' ' A' ' 113' ' ' HIS . . . 160.31 -161.21 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.86 14.87 25.8 Favored Glycine 0 CA--C 1.507 -0.429 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.506 HG23 ' N ' ' A' ' 117' ' ' GLY . 3.0 tp -60.77 -40.22 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.506 ' N ' HG23 ' A' ' 116' ' ' ILE . . . -65.69 -39.87 95.54 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 110.946 -0.861 . . . . 0.0 110.946 174.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 6.8 t -58.85 -43.06 90.67 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 176.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 25.9 mmm-85 -63.65 -37.48 87.49 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 119.849 -0.741 . . . . 0.0 110.38 -177.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.69 -45.91 87.89 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 6.3 tp -67.14 -45.29 77.54 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.729 178.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.29 -44.97 90.03 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 119.918 1.235 . . . . 0.0 109.803 178.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -65.85 -44.48 91.92 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 119.222 -1.466 . . . . 0.0 110.614 -178.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 65.7 m -64.48 -44.61 90.45 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.309 -0.556 . . . . 0.0 111.095 178.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 19.5 m -69.9 -49.03 56.14 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 119.419 -0.912 . . . . 0.0 112.433 177.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 42.3 p -65.82 -42.16 90.95 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 120.149 1.34 . . . . 0.0 113.775 -175.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.641 ' CA ' HD21 ' A' ' 186' ' ' ASN . . . -64.03 -44.33 96.03 Favored Glycine 0 CA--C 1.518 0.254 0 CA-C-O 122.983 1.324 . . . . 0.0 112.162 -178.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.417 ' O ' ' CG2' ' A' ' 131' ' ' VAL . . . -61.48 -41.45 97.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 111.386 -2.407 . . . . 0.0 107.247 177.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.629 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 0.2 OUTLIER -64.5 -42.33 95.89 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.25 178.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.23 -40.08 96.45 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -177.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.417 ' CG2' ' O ' ' A' ' 128' ' ' ALA . 5.8 m -61.15 -25.98 37.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 122.482 1.134 . . . . 0.0 109.942 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.629 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . -58.29 -44.98 88.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 112.755 -2.02 . . . . 0.0 112.425 -178.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.48 ' CG1' ' N ' ' A' ' 134' ' ' ALA . 2.7 p -79.09 -48.89 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.295 -179.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.48 ' N ' ' CG1' ' A' ' 133' ' ' VAL . . . -106.55 138.76 42.13 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.707 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.603 ' H ' ' HD2' ' A' ' 136' ' ' PRO . 7.8 pt20 172.23 -38.48 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.797 0 CA-C-O 118.279 -0.867 . . . . 0.0 113.132 179.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.603 ' HD2' ' H ' ' A' ' 135' ' ' GLN . 13.1 Cg_endo -52.66 -34.37 63.52 Favored 'Trans proline' 0 N--CA 1.498 1.785 0 CA-C-N 122.257 1.842 . . . . 0.0 112.544 -178.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 85.1 m -67.85 -42.6 81.14 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 118.683 -1.207 . . . . 0.0 110.184 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -65.82 -43.08 89.65 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 118.054 -1.458 . . . . 0.0 112.776 -177.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.423 HG23 ' N ' ' A' ' 140' ' ' VAL . 24.4 m -64.47 -44.05 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -179.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.423 ' N ' HG23 ' A' ' 139' ' ' VAL . 12.7 p -64.63 -37.48 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -177.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.616 ' NZ ' ' NE ' ' A' ' 88' ' ' ARG . 48.5 mttm -60.98 -40.55 93.88 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.16 -177.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 82.1 t -69.89 -44.95 78.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.57 -36.33 83.87 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.934 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -66.39 -40.69 89.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.06 -177.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 65.6 tp60 -64.35 -39.08 93.18 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 119.486 -0.886 . . . . 0.0 109.28 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.2 -35.0 79.7 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.446 ' CG ' ' O ' ' A' ' 147' ' ' GLN . 3.0 pt20 -60.31 111.06 1.4 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 177.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -102.5 8.81 39.87 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.246 -177.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 60.7 ttm-85 -143.71 135.99 26.85 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.848 0.356 . . . . 0.0 110.696 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -82.52 -56.36 3.92 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.617 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 168.03 -51.65 0.23 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.615 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -179.982 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 46.7 t80 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.865 0.364 . . . . 0.0 110.462 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -56.98 154.63 9.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.453 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.41 ' OG ' ' N ' ' A' ' 159' ' ' THR . 43.7 t -157.07 -178.28 7.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.211 0.529 . . . . 0.0 111.015 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.41 ' N ' ' OG ' ' A' ' 158' ' ' SER . 65.1 p -64.32 -46.1 84.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.737 -177.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 86.3 t -64.22 -45.59 95.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 119.132 -1.027 . . . . 0.0 109.438 -179.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.522 ' OE1' ' N ' ' A' ' 161' ' ' GLU . 15.1 mp0 -66.75 -39.04 87.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.873 0.368 . . . . 0.0 111.198 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -61.8 -45.54 93.41 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -178.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.607 ' CZ ' HD11 ' A' ' 175' ' ' LEU . 2.7 t80 -62.59 -50.33 71.73 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 120.372 -0.531 . . . . 0.0 110.617 -178.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 30.5 mmtm -68.84 -45.57 70.78 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 -175.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.556 HG23 ' N ' ' A' ' 166' ' ' ILE . 15.3 t -62.95 -44.73 95.27 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.198 1.185 . . . . 0.0 114.198 -177.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.556 ' N ' HG23 ' A' ' 165' ' ' THR . 10.0 pt -64.51 -38.44 82.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 122.032 0.92 . . . . 0.0 109.505 177.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.53 -36.47 76.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 113.709 -1.587 . . . . 0.0 108.074 176.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -62.54 -50.39 71.54 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 122.436 2.38 . . . . 0.0 112.164 -175.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -75.05 -51.03 14.55 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 123.903 0.881 . . . . 0.0 109.641 177.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -77.96 -36.46 49.08 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 -173.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 90.99 -167.71 32.06 Favored Glycine 0 N--CA 1.467 0.714 0 N-CA-C 111.792 -0.523 . . . . 0.0 111.792 177.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 25.2 mm -72.18 -44.72 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-O 121.679 0.752 . . . . 0.0 110.652 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -59.0 -33.96 71.32 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 114.371 -1.286 . . . . 0.0 111.529 -177.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -60.75 -40.37 98.02 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 118.783 -1.675 . . . . 0.0 109.272 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.607 HD11 ' CZ ' ' A' ' 163' ' ' TYR . 0.5 OUTLIER -70.34 -33.43 71.47 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 111.477 -2.362 . . . . 0.0 116.72 -177.136 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . 0.427 ' O ' ' OG1' ' A' ' 179' ' ' THR . 2.3 m95 -77.89 -7.39 56.66 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 111.564 -2.562 . . . . 0.0 109.909 -177.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 16.3 ttmm -43.24 -47.93 6.55 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.354 -176.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -92.04 -27.43 16.25 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 123.981 0.8 . . . . 0.0 112.216 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 176' ' ' TRP . 39.7 p -45.3 -51.17 11.3 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . 0.419 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 3.3 m -62.4 -50.82 77.44 Favored Pre-proline 0 N--CA 1.47 0.57 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -176.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.419 ' HD2' ' N ' ' A' ' 180' ' ' SER . 29.2 Cg_endo -64.87 -28.61 58.68 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 121.212 1.275 . . . . 0.0 111.63 176.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -64.27 -39.73 94.52 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 120.363 -0.535 . . . . 0.0 109.809 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 82.0 t -63.32 -42.85 97.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.201 0.524 . . . . 0.0 110.026 179.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.32 -39.39 92.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.091 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 44.1 ttt85 -60.74 -42.19 96.86 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.928 -179.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . 0.641 HD21 ' CA ' ' A' ' 127' ' ' GLY . 40.5 t30 -61.9 -43.89 97.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.107 0.48 . . . . 0.0 110.705 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -65.31 -44.31 88.26 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.805 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 87.4 mt -63.86 -46.04 95.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -177.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.438 HG13 ' N ' ' A' ' 190' ' ' ASN . 6.9 p -60.64 -46.96 94.88 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 C-N-CA 119.403 -0.919 . . . . 0.0 111.267 -178.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.438 ' N ' HG13 ' A' ' 189' ' ' VAL . 19.5 m120 -62.63 -42.62 99.7 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 122.204 1.002 . . . . 0.0 109.779 178.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' CYS . . . . . . . . . . . . . 41.9 t -61.63 -46.08 91.32 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 113.647 -1.615 . . . . 0.0 109.979 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.25 -40.2 95.52 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 113.317 -1.765 . . . . 0.0 109.719 176.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.81 -45.7 93.4 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.278 -177.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 21.1 tp -64.77 -38.89 92.51 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 118.785 -1.166 . . . . 0.0 110.972 -174.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 6.3 m -64.57 -45.97 93.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 117.275 -1.77 . . . . 0.0 108.536 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 29.0 p -63.91 -45.33 89.77 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -56.44 -38.77 72.07 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.641 0.776 . . . . 0.0 111.417 -178.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -55.95 -44.0 77.99 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.431 ' C ' HD12 ' A' ' 199' ' ' LEU . 0.2 OUTLIER -61.17 -38.69 87.38 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.908 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 37.2 mt -62.4 -41.87 93.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 15.4 mtpt -59.19 -38.2 79.24 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.958 1.303 . . . . 0.0 113.477 178.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -63.06 -42.58 99.71 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.692 -0.63 . . . . 0.0 110.986 -176.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.42 128.36 47.65 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 121.062 -1.024 . . . . 0.0 112.822 -176.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.524 ' CD2' ' CD2' ' A' ' 217' ' ' HIS . 11.1 mp 66.24 4.67 3.26 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 113.601 -1.636 . . . . 0.0 112.49 176.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 16.1 tp -137.1 72.02 1.41 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.117 0.484 . . . . 0.0 109.793 -178.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -112.36 -13.58 13.4 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -162.1 36.6 0.12 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.728 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' ASN . . . . . 0.443 ' O ' ' O ' ' A' ' 209' ' ' LEU . 50.2 t30 54.66 79.38 0.14 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 175.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.443 ' O ' ' O ' ' A' ' 208' ' ' ASN . 16.7 mt . . . . . 0 C--O 1.231 0.131 0 CA-C-N 115.252 -0.885 . . . . 0.0 108.795 -178.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 . . . . . 0 N--CA 1.464 0.265 0 CA-C-O 120.835 0.35 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.46 HD23 ' HD3' ' A' ' 215' ' ' PRO . 0.4 OUTLIER -61.43 -41.53 79.75 Favored Pre-proline 0 CA--C 1.538 0.487 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -179.241 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . 0.46 ' HD3' HD23 ' A' ' 214' ' ' LEU . 25.0 Cg_exo -61.35 -33.3 89.3 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 120.951 1.101 . . . . 0.0 112.342 -175.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 35.5 t -63.31 -40.27 96.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 113.085 -1.87 . . . . 0.0 108.809 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' HIS . . . . . 0.524 ' CD2' ' CD2' ' A' ' 204' ' ' LEU . 2.0 t-160 -64.94 -34.37 78.25 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.658 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.11 -46.97 86.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.908 -177.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -60.18 -37.1 79.2 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 119.132 0.878 . . . . 0.0 111.044 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 67.0 m -59.59 -41.62 90.7 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.7 -41.71 98.08 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -177.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . 0.481 ' CZ ' ' CE1' ' A' ' 226' ' ' PHE . 38.4 t80 -62.21 -47.48 84.27 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -176.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -60.91 -42.17 99.57 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 107.962 -2.055 . . . . 0.0 107.962 177.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -63.16 -38.18 90.14 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.068 -1.066 . . . . 0.0 109.377 177.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -62.05 -42.21 99.72 Favored Glycine 0 CA--C 1.522 0.491 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.513 -177.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' PHE . . . . . 0.481 ' CE1' ' CZ ' ' A' ' 222' ' ' PHE . 3.0 m-85 -66.65 -38.38 86.75 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . 0.415 ' O ' HG22 ' A' ' 230' ' ' VAL . 99.9 m -63.24 -40.65 98.04 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 176.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 15.1 m -61.61 -40.09 93.57 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 114.604 -1.18 . . . . 0.0 112.371 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.423 HG22 ' O ' ' A' ' 226' ' ' PHE . 0.6 OUTLIER -58.34 -39.13 78.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.749 -176.198 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 227' ' ' CYS . 1.0 OUTLIER -59.94 -40.38 82.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 118.907 -1.117 . . . . 0.0 109.146 179.837 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . 0.542 ' O ' ' HD2' ' A' ' 234' ' ' PRO . 97.2 mt -61.39 -40.72 87.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-O 121.134 0.492 . . . . 0.0 109.783 177.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -62.81 -39.43 94.28 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.485 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 0.0 OUTLIER -57.97 -41.54 90.49 Favored Pre-proline 0 N--CA 1.483 1.187 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -173.542 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.542 ' HD2' ' O ' ' A' ' 231' ' ' ILE . 31.8 Cg_exo -57.87 -39.58 85.55 Favored 'Trans proline' 0 C--N 1.292 -2.431 0 C-N-CA 122.357 2.038 . . . . 0.0 113.551 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 83.9 t -64.08 -37.33 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 117.514 -1.674 . . . . 0.0 109.191 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . 0.525 ' OD2' ' CZ2' ' A' ' 283' ' ' TRP . 94.7 m-20 -66.21 -41.09 90.61 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.41 ' CG1' ' N ' ' A' ' 238' ' ' VAL . 0.5 OUTLIER -65.37 -45.23 93.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -176.448 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.41 ' N ' ' CG1' ' A' ' 237' ' ' VAL . 94.9 t . . . . . 0 C--N 1.322 -0.595 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.441 -178.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . 0.433 ' CG2' ' N ' ' A' ' 260' ' ' MET . 2.1 t . . . . . 0 N--CA 1.466 0.371 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' MET . . . . . 0.433 ' N ' ' CG2' ' A' ' 259' ' ' THR . 15.2 mmt -61.61 -44.19 97.46 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.106 -0.497 . . . . 0.0 112.051 -178.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 11.9 tp -62.6 -47.81 82.17 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 121.23 -0.188 . . . . 0.0 110.74 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 78.5 mtm180 -67.4 -54.03 24.05 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.078 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -76.66 -141.57 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.899 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . 0.616 ' H ' ' CD ' ' A' ' 264' ' ' GLU . 0.7 OUTLIER -39.87 128.47 2.1 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.083 0.468 . . . . 0.0 110.603 -179.659 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . 0.496 ' C ' ' H ' ' A' ' 267' ' ' ARG . . . -46.33 167.12 0.06 OUTLIER Glycine 0 CA--C 1.533 1.173 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 -179.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -53.79 -1.11 0.1 Allowed 'Trans proline' 0 N--CA 1.5 1.887 0 C-N-CA 122.093 1.862 . . . . 0.0 112.509 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . 0.496 ' H ' ' C ' ' A' ' 265' ' ' GLY . 5.1 ptp180 -69.89 -26.94 64.42 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 122.838 0.455 . . . . 0.0 111.511 178.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -58.67 -32.5 69.17 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 119.695 -0.802 . . . . 0.0 109.934 -178.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -62.47 -41.25 98.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.127 177.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 270' ' ' TYR . . . . . 0.428 ' O ' ' O ' ' A' ' 271' ' ' LYS . 36.7 t80 -65.87 -37.6 86.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.924 -1.035 . . . . 0.0 112.633 -178.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.478 ' O ' ' O ' ' A' ' 272' ' ' GLY . 54.8 mtpt -51.31 -175.36 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 271' ' ' LYS . . . 57.38 126.34 0.01 OUTLIER Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -169.37 -26.14 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 119.453 -0.899 . . . . 0.0 112.828 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 274' ' ' MET . . . . . 0.526 ' N ' ' CD ' ' A' ' 275' ' ' PRO . 1.0 OUTLIER -64.16 -45.31 79.16 Favored Pre-proline 0 CA--C 1.529 0.169 0 C-N-CA 119.274 -0.97 . . . . 0.0 110.635 -178.661 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 275' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' A' ' 274' ' ' MET . 19.7 Cg_exo -65.44 -47.78 3.94 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 121.837 1.692 . . . . 0.0 111.966 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 5.0 m -61.42 -40.22 93.61 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.018 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -61.82 -42.8 99.48 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 123.6 1.667 . . . . 0.0 113.486 -177.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 75.5 mt -62.54 -39.06 92.39 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 110.355 -3.111 . . . . 0.0 109.625 175.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . 0.455 ' NH2' ' CB ' ' A' ' 38' ' ' LYS . 28.7 mmt-85 -62.8 -40.67 98.08 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.099 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.759 ' O ' HD12 ' A' ' 280' ' ' LEU . 0.1 OUTLIER -62.2 -36.78 82.97 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.235 -0.893 . . . . 0.0 113.195 -177.495 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -68.01 -51.04 36.38 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -178.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . 0.438 ' O ' HG12 ' A' ' 285' ' ' VAL . 16.4 m -62.79 -44.3 96.54 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.247 0.619 . . . . 0.0 109.68 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 283' ' ' TRP . . . . . 0.529 ' O ' HG22 ' A' ' 286' ' ' VAL . 83.5 t90 -59.94 -38.24 81.87 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -62.78 -38.4 90.5 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.695 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.438 HG12 ' O ' ' A' ' 282' ' ' SER . 0.3 OUTLIER -60.82 -38.69 79.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -177.537 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.702 ' O ' HG22 ' A' ' 289' ' ' VAL . 6.8 m -62.53 -39.52 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 120.105 -0.638 . . . . 0.0 109.674 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 76.0 mmm -60.62 -38.6 85.28 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -59.02 -41.53 87.98 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.702 HG22 ' O ' ' A' ' 286' ' ' VAL . 29.4 m -61.61 -37.99 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 120.269 -0.572 . . . . 0.0 111.16 -178.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 82.8 p -62.41 -40.43 96.49 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -60.83 -38.81 86.75 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 177.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -58.07 -40.14 80.29 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 117.77 -1.572 . . . . 0.0 109.169 -177.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 293' ' ' GLN . . . . . 0.477 ' O ' ' O ' ' A' ' 296' ' ' ARG . 14.3 mm100 -60.46 -42.42 96.15 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 123.121 1.439 . . . . 0.0 110.258 179.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 77.1 mt -60.43 -39.48 87.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 112.079 -2.328 . . . . 0.0 109.305 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -61.95 -45.03 95.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.41 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 296' ' ' ARG . . . . . 0.477 ' O ' ' O ' ' A' ' 293' ' ' GLN . 36.0 ttm180 -122.27 115.86 23.09 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -111.28 -163.5 0.85 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.694 0.759 . . . . 0.0 112.845 -177.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.657 ' H ' HD12 ' A' ' 298' ' ' LEU . 10.0 mp -32.98 -71.27 0.06 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.406 -1.27 . . . . 0.0 112.902 -178.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . 0.526 ' O ' ' SD ' ' A' ' 299' ' ' MET . 0.0 OUTLIER 88.16 32.06 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 113.895 -1.502 . . . . 0.0 110.869 179.464 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.69 101.01 0.07 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 122.472 1.129 . . . . 0.0 111.182 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -64.34 -46.36 83.82 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 112.952 -1.931 . . . . 0.0 113.142 -176.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -58.67 -38.9 79.19 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 -177.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -64.29 -46.46 83.52 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 304' ' ' SER . . . . . 0.411 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 1.9 t -66.46 -38.18 86.78 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.672 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 -61.86 -42.64 99.3 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.919 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -64.71 -36.78 85.38 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -177.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . 0.546 ' HB3' ' HD3' ' A' ' 308' ' ' PRO . . . -60.04 -52.98 69.64 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -176.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 308' ' ' PRO . . . . . 0.546 ' HD3' ' HB3' ' A' ' 307' ' ' ALA . 74.3 Cg_endo -75.21 0.23 9.24 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.046 1.831 . . . . 0.0 111.862 179.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 29.8 t80 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.586 -179.812 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.7 p . . . . . 0 N--CA 1.462 0.133 0 CA-C-O 120.825 0.345 . . . . 0.0 110.628 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.575 HG12 ' N ' ' A' ' 16' ' ' LYS . 28.2 t -83.43 166.44 2.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.573 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.575 ' N ' HG12 ' A' ' 15' ' ' VAL . 1.1 mptm? -64.25 -41.8 96.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.095 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -63.75 -41.6 97.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.411 0.624 . . . . 0.0 111.905 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.543 HD13 ' O ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -79.83 -26.19 40.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.977 -1.011 . . . . 0.0 111.165 -179.662 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.59 -40.69 96.16 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 106.75 -2.54 . . . . 0.0 106.75 176.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.61 -31.26 68.17 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 124.44 2.067 . . . . 0.0 107.41 176.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.38 -43.19 97.17 Favored Glycine 0 CA--C 1.532 1.115 0 CA-C-N 109.112 -3.676 . . . . 0.0 110.726 -177.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.5 t -71.23 -27.3 63.37 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 117.567 0.684 . . . . 0.0 109.279 178.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.75 -50.64 64.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.69 -178.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.15 -35.88 80.13 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 118.109 -1.437 . . . . 0.0 110.943 -177.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 73.2 m -63.98 -54.11 39.65 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.579 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.521 HD12 ' N ' ' A' ' 27' ' ' ALA . 2.6 pp -65.74 -39.59 85.3 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -177.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.552 ' O ' HG23 ' A' ' 31' ' ' THR . . . -63.94 -41.8 97.52 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 119.733 -0.787 . . . . 0.0 112.861 -173.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.469 ' HA ' ' HG1' ' A' ' 31' ' ' THR . 2.3 m-20 -77.63 -27.07 51.01 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 120.325 1.42 . . . . 0.0 109.918 -175.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 10.8 tp -59.81 -55.83 29.41 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 119.835 1.198 . . . . 0.0 112.806 -178.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.9 pt -76.11 -4.55 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.552 HG23 ' O ' ' A' ' 27' ' ' ALA . 30.3 p -109.71 -17.08 13.77 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 118.941 -1.104 . . . . 0.0 109.549 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.479 ' N ' ' CD ' ' A' ' 33' ' ' PRO . 4.3 t80 -67.3 -44.0 45.79 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 122.296 2.316 . . . . 0.0 109.164 -178.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 32' ' ' PHE . 30.7 Cg_exo -59.62 -15.85 33.39 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 121.0 1.134 . . . . 0.0 111.556 177.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 26.9 tp -66.99 -35.47 80.03 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -177.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 36' ' ' THR . 2.0 p30 -64.61 -40.29 95.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.36 -0.837 . . . . 0.0 112.401 -177.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.532 ' N ' ' OD1' ' A' ' 35' ' ' ASP . 67.4 p -58.17 -35.01 70.95 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.03 -38.09 85.27 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.563 ' NZ ' HH22 ' A' ' 279' ' ' ARG . 11.5 ptmt -60.58 -46.99 88.18 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 120.119 -0.632 . . . . 0.0 111.855 -175.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.443 ' N ' ' CG ' ' A' ' 38' ' ' LYS . 93.0 t -62.16 -38.42 80.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -176.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.526 ' NH1' ' O ' ' A' ' 36' ' ' THR . 6.8 mmp_? -59.37 -40.47 86.57 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 119.345 -0.942 . . . . 0.0 109.611 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.58 38.96 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.3 179.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.508 ' N ' ' O ' ' A' ' 40' ' ' ARG . 3.1 pt20 -67.89 -159.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 O-C-N 122.136 -0.352 . . . . 0.0 110.936 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.435 ' N ' HD12 ' A' ' 43' ' ' ILE . 2.0 mp -132.07 47.81 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.562 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 46.72 29.11 0.9 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.855 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 46' ' ' GLU . . . -64.82 -116.32 0.01 OUTLIER Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.427 ' O ' ' O ' ' A' ' 45' ' ' GLY . 41.7 tt0 59.35 132.29 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.889 0.376 . . . . 0.0 110.839 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 66.9 m -115.71 -12.79 11.48 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.544 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -42.63 -27.08 0.15 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.648 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.46 -10.05 73.21 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -178.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 45.5 tp -65.89 -38.01 87.64 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.373 -0.413 . . . . 0.0 110.585 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.514 HG13 ' N ' ' A' ' 52' ' ' ARG . 7.6 p -60.74 -44.81 98.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.734 -178.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.514 ' N ' HG13 ' A' ' 51' ' ' VAL . 14.6 ptt180 -64.86 -33.65 76.52 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.881 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 98.0 m -67.86 -38.16 82.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.186 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.74 -152.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.207 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -166.9 -24.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.069 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.649 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 57.8 p -166.74 -127.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 179.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.649 ' HB3' ' O ' ' A' ' 56' ' ' SER . . . 94.33 13.8 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 177.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.497 ' N ' ' CD ' ' A' ' 58' ' ' GLN . 2.2 pm0 -175.29 176.81 1.97 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.867 0.365 . . . . 0.0 110.162 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.461 ' CD1' ' C ' ' A' ' 58' ' ' GLN . 84.7 m-85 -157.07 159.22 37.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.646 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 34.1 ptt-85 -48.16 -33.01 7.74 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -31.33 103.51 0.01 OUTLIER Glycine 0 CA--C 1.526 0.762 0 CA-C-N 114.875 -1.057 . . . . 0.0 112.221 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.436 HG22 ' H ' ' A' ' 62' ' ' VAL . 2.6 m -66.91 -33.61 64.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 118.229 -0.891 . . . . 0.0 109.194 176.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.411 ' N ' HD22 ' A' ' 63' ' ' LEU . 4.4 mm? -60.09 -32.32 70.86 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 121.25 1.841 . . . . 0.0 110.359 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -65.02 -49.3 63.2 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-N 115.243 -0.889 . . . . 0.0 114.609 -177.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.434 ' H ' HG23 ' A' ' 65' ' ' THR . 6.8 p -62.15 -46.38 89.24 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -178.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.482 HD12 ' N ' ' A' ' 67' ' ' LEU . 2.3 pp -58.99 -35.0 54.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -178.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.482 ' N ' HD12 ' A' ' 66' ' ' ILE . 6.8 tp -63.03 -35.29 79.73 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 120.36 1.437 . . . . 0.0 113.116 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 98.6 m -61.47 -41.52 97.37 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-N 114.316 -1.311 . . . . 0.0 111.011 -177.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 50.4 mmm -59.3 -39.31 82.61 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -176.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.7 t -68.99 -41.04 81.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 118.968 -1.093 . . . . 0.0 113.646 -177.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 23.0 ttp-105 -78.26 -13.54 59.81 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.503 ' CG2' ' N ' ' A' ' 73' ' ' GLU . 0.5 OUTLIER -62.85 -54.95 30.9 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 114.639 -1.164 . . . . 0.0 112.391 -179.297 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.503 ' N ' ' CG2' ' A' ' 72' ' ' THR . 13.6 tp10 -110.61 -57.36 2.23 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.41 163.21 12.08 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -56.57 -34.92 96.44 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 122.107 1.871 . . . . 0.0 112.198 -179.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.4 tpp180 -61.25 -11.84 10.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.887 0.851 . . . . 0.0 111.132 176.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.407 ' OG ' HD12 ' A' ' 78' ' ' LEU . 15.6 p -78.28 -32.86 49.69 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 113.868 -1.514 . . . . 0.0 110.95 -178.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.407 HD12 ' OG ' ' A' ' 77' ' ' SER . 6.3 mp -75.58 -31.65 60.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.017 0.437 . . . . 0.0 110.449 178.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.647 ' O ' HD12 ' A' ' 82' ' ' LEU . 75.3 m-85 -90.15 -3.69 57.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 123.644 1.688 . . . . 0.0 112.549 -176.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 -106.7 121.21 43.91 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 110.619 -2.991 . . . . 0.0 107.654 175.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.46 -18.6 50.57 Favored Glycine 0 N--CA 1.469 0.893 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 -177.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.989 HD13 ' N ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -58.91 -33.69 70.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 113.905 -1.148 . . . . 0.0 110.332 -179.096 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.989 ' N ' HD13 ' A' ' 82' ' ' LEU . 7.1 p -70.44 -26.28 28.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.265 177.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.14 -31.95 61.2 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 119.11 -0.471 . . . . 0.0 111.837 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.93 -40.0 89.18 Favored Glycine 0 N--CA 1.466 0.679 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.891 -178.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -62.48 -40.25 96.07 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 122.15 0.976 . . . . 0.0 112.842 -176.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.431 ' O ' ' OE1' ' A' ' 87' ' ' GLN . 0.1 OUTLIER -60.83 -28.29 68.7 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 113.431 -1.713 . . . . 0.0 110.378 -179.267 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 62.5 mtt85 -58.53 -53.7 55.36 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 173.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -66.67 -29.36 69.35 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 112.035 -2.348 . . . . 0.0 111.847 -177.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 12.3 tpt -61.27 -40.14 92.99 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.425 179.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 33.8 t -74.37 -34.19 63.29 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 119.366 -0.934 . . . . 0.0 111.456 -177.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -57.87 -43.84 86.26 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 121.04 1.745 . . . . 0.0 112.615 -176.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.49 -32.85 64.51 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 119.484 -0.886 . . . . 0.0 110.748 -178.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.597 ' O ' HG22 ' A' ' 97' ' ' ILE . 70.2 p -64.1 -41.43 97.28 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.45 ' C ' ' H ' ' A' ' 97' ' ' ILE . 29.8 m -68.79 -28.28 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.44 177.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 55.3 ttp85 -77.15 9.22 3.2 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -176.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.597 HG22 ' O ' ' A' ' 94' ' ' SER . 11.0 tt -86.96 -14.68 10.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.412 ' O ' ' OG ' ' A' ' 102' ' ' SER . . . -139.98 -48.14 0.06 OUTLIER Glycine 0 CA--C 1.544 1.867 0 N-CA-C 115.772 1.069 . . . . 0.0 115.772 -177.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.604 HD22 ' N ' ' A' ' 99' ' ' LEU . 3.4 mm? -71.79 -13.4 61.68 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 119.841 1.82 . . . . 0.0 113.925 -177.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.484 ' CZ ' ' NZ ' ' A' ' 104' ' ' LYS . 9.6 t80 -80.84 -51.94 8.05 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 114.63 -1.168 . . . . 0.0 112.795 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.498 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 0.4 OUTLIER -70.42 -32.23 69.74 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 124.056 1.884 . . . . 0.0 110.686 -179.738 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' A' ' 98' ' ' GLY . 67.3 m -67.32 -50.88 58.3 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 109.609 -3.451 . . . . 0.0 113.492 178.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 10.0 p -73.83 -26.66 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 CA-C-N 121.27 1.85 . . . . 0.0 111.79 177.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.484 ' NZ ' ' CZ ' ' A' ' 100' ' ' TYR . 39.0 mttp -69.51 -41.86 75.47 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 111.621 -2.536 . . . . 0.0 113.284 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.44 ' HG3' ' O ' ' A' ' 101' ' ' ASP . 88.1 mt-30 -76.27 -14.69 60.11 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 123.63 1.681 . . . . 0.0 111.029 178.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -79.27 -22.47 44.67 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 112.518 -2.128 . . . . 0.0 111.95 178.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.49 ' O ' ' NH2' ' A' ' 119' ' ' ARG . 15.4 m-85 -109.79 -27.73 9.16 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.231 1.012 . . . . 0.0 113.299 -173.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.767 ' C ' ' H ' ' A' ' 110' ' ' GLY . 14.4 t -94.53 12.68 26.54 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 -173.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -54.69 19.11 0.0 OUTLIER 'General case' 0 CA--C 1.57 1.747 0 CA-C-N 119.885 1.221 . . . . 0.0 110.726 177.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.767 ' H ' ' C ' ' A' ' 108' ' ' THR . . . 59.18 20.52 50.4 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.542 ' OG ' ' NH2' ' A' ' 119' ' ' ARG . 1.4 m 33.02 -163.23 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 113.23 -1.485 . . . . 0.0 113.385 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.588 ' C ' ' H ' ' A' ' 114' ' ' ALA . 3.3 tt0 -141.14 -157.3 0.75 Allowed 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 118.807 -1.157 . . . . 0.0 113.424 -177.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.649 ' O ' ' HB2' ' A' ' 114' ' ' ALA . 37.5 t60 -61.12 9.24 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 114.814 -1.085 . . . . 0.0 111.312 -179.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.649 ' HB2' ' O ' ' A' ' 113' ' ' HIS . . . 160.42 -161.01 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.26 14.58 25.74 Favored Glycine 0 N--CA 1.459 0.221 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 -179.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 25.6 mm -60.91 -39.98 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.08 -39.49 96.35 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.92 175.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 6.0 t -58.85 -43.23 90.74 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 176.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.542 ' NH2' ' OG ' ' A' ' 111' ' ' SER . 18.6 mmt85 -63.75 -37.37 87.1 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.658 -178.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 30.5 tp -63.58 -45.71 89.17 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 42.1 mt -66.92 -44.97 79.33 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.518 178.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.75 -45.1 87.84 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 119.903 1.229 . . . . 0.0 110.955 178.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -65.59 -44.39 92.84 Favored Glycine 0 CA--C 1.517 0.2 0 C-N-CA 119.777 -1.201 . . . . 0.0 111.148 -177.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 79.9 p -64.16 -43.07 96.32 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.83 0.348 . . . . 0.0 111.007 178.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 96.6 m -69.5 -48.82 59.39 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 119.192 -1.003 . . . . 0.0 112.687 177.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.493 HG23 ' N ' ' A' ' 127' ' ' GLY . 6.3 t -66.17 -42.7 88.56 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 115.197 1.555 . . . . 0.0 115.197 -174.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.493 ' N ' HG23 ' A' ' 126' ' ' THR . . . -64.74 -44.83 94.28 Favored Glycine 0 C--O 1.228 -0.233 0 CA-C-N 114.238 -1.347 . . . . 0.0 112.748 -177.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.57 -41.78 97.9 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 112.482 -1.859 . . . . 0.0 107.259 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.732 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 0.2 OUTLIER -64.85 -42.81 94.58 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.169 178.118 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.13 -39.67 95.36 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.894 -0.504 . . . . 0.0 111.817 -178.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.641 HG11 HG22 ' A' ' 183' ' ' VAL . 94.5 t -60.98 -26.25 38.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 123.342 1.544 . . . . 0.0 109.298 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.732 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . -58.93 -44.67 91.38 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 110.971 -2.832 . . . . 0.0 112.386 -178.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 61.4 t -79.07 -49.18 20.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -177.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.517 ' O ' ' CB ' ' A' ' 135' ' ' GLN . . . -107.36 -169.12 1.48 Allowed 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -177.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.527 ' N ' ' CD ' ' A' ' 136' ' ' PRO . 3.4 tt0 105.15 -23.28 0.0 OUTLIER Pre-proline 0 CA--C 1.552 1.051 0 O-C-N 124.676 1.235 . . . . 0.0 114.051 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.527 ' CD ' ' N ' ' A' ' 135' ' ' GLN . 5.2 Cg_exo -52.68 -34.64 64.93 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 CA-C-N 122.025 1.759 . . . . 0.0 112.803 -178.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 12.6 m -66.75 -40.72 88.39 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -64.52 -42.16 95.94 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 118.965 -1.094 . . . . 0.0 112.424 -177.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.89 -42.93 97.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -179.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 19.7 m -63.92 -37.3 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -177.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 16.5 mtpp -60.82 -40.13 91.61 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.981 -177.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 90.4 t -69.83 -45.11 78.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.28 0.562 . . . . 0.0 109.694 178.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.404 ' CA ' ' HE ' ' A' ' 143' ' ' ARG . 0.0 OUTLIER -64.64 -36.11 83.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.508 179.569 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -66.28 -40.4 90.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.899 -0.592 . . . . 0.0 112.312 -177.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -64.06 -39.07 93.28 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 119.884 -0.726 . . . . 0.0 110.185 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.16 -35.06 79.9 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.521 ' NE2' ' O ' ' A' ' 149' ' ' ARG . 0.0 OUTLIER -59.66 110.73 1.2 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 177.584 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 150' ' ' ALA . . . -43.17 93.03 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 117.33 -1.319 . . . . 0.0 111.531 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.521 ' O ' ' NE2' ' A' ' 147' ' ' GLN . 78.8 mtm180 53.81 -89.44 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 122.64 2.473 . . . . 0.0 111.055 178.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 148' ' ' ALA . . . -154.37 -149.7 0.29 Allowed 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.405 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -158.44 31.57 0.48 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.664 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 179.98 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.514 ' CE2' ' O ' ' A' ' 157' ' ' GLN . 92.0 t80 . . . . . 0 N--CA 1.464 0.241 0 CA-C-O 120.875 0.369 . . . . 0.0 110.677 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.514 ' O ' ' CE2' ' A' ' 156' ' ' TYR . 84.1 mt-30 -81.07 166.49 20.7 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.34 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.69 ' H ' ' CG ' ' A' ' 161' ' ' GLU . 20.7 p -157.04 -178.56 7.46 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.565 0.698 . . . . 0.0 111.602 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 25.4 p -64.77 -46.64 81.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.113 -0.948 . . . . 0.0 112.335 -178.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.564 HG13 ' N ' ' A' ' 161' ' ' GLU . 14.9 p -65.02 -45.98 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 119.241 -0.984 . . . . 0.0 110.896 -178.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.69 ' CG ' ' H ' ' A' ' 158' ' ' SER . 2.1 pp20? -68.14 -38.54 82.27 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.921 0.391 . . . . 0.0 111.843 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.426 ' N ' ' CD ' ' A' ' 161' ' ' GLU . . . -61.14 -45.68 93.67 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -177.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.6 ' CZ ' HD23 ' A' ' 175' ' ' LEU . 17.0 t80 -62.54 -50.15 72.47 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.137 -179.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -68.68 -45.68 71.05 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 -175.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.546 HG23 ' N ' ' A' ' 166' ' ' ILE . 15.3 t -63.27 -45.1 93.05 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -177.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.546 ' N ' HG23 ' A' ' 165' ' ' THR . 8.4 pt -64.83 -39.08 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 CA-C-O 122.043 0.925 . . . . 0.0 108.964 177.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.404 ' N ' ' CG1' ' A' ' 166' ' ' ILE . . . -60.41 -37.62 81.44 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 113.704 -1.589 . . . . 0.0 109.145 177.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 13.4 tpp85 -63.47 -51.35 65.99 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 123.715 2.962 . . . . 0.0 112.821 -175.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -75.7 -51.4 12.82 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 123.287 0.635 . . . . 0.0 109.515 177.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.492 ' OE2' ' N ' ' A' ' 174' ' ' GLY . 0.0 OUTLIER -78.96 -37.19 40.17 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 119.602 1.092 . . . . 0.0 113.784 -176.204 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . 0.47 ' O ' ' OE2' ' A' ' 170' ' ' GLU . . . 98.31 -171.73 25.8 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 120.776 -0.726 . . . . 0.0 113.366 179.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.448 HG23 ' N ' ' A' ' 173' ' ' ARG . 20.8 tt -75.12 -37.84 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -177.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.448 ' N ' HG23 ' A' ' 172' ' ' ILE . 7.3 tpp180 -58.22 -34.1 70.05 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 114.298 -1.319 . . . . 0.0 112.938 -173.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.492 ' N ' ' OE2' ' A' ' 170' ' ' GLU . . . -60.56 -38.87 95.64 Favored Glycine 0 N--CA 1.464 0.51 0 CA-C-O 123.726 1.737 . . . . 0.0 111.995 -178.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.6 HD23 ' CZ ' ' A' ' 163' ' ' TYR . 5.2 mp -70.2 -34.24 72.69 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 110.153 -3.024 . . . . 0.0 116.425 -176.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 11.0 m95 -78.72 -7.72 58.02 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 113.481 -1.691 . . . . 0.0 109.653 -178.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -44.06 -49.28 8.86 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.756 0.651 . . . . 0.0 112.756 -175.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -87.99 -36.6 8.27 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 124.548 1.071 . . . . 0.0 111.754 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 40.3 p -45.24 -51.39 10.81 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . 0.426 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 1.5 t -62.92 -50.93 74.72 Favored Pre-proline 0 N--CA 1.472 0.667 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -176.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 180' ' ' SER . 32.3 Cg_endo -65.06 -28.15 57.24 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.676 1.584 . . . . 0.0 111.257 176.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.426 ' CB ' ' OE1' ' A' ' 135' ' ' GLN . 24.5 t-20 -63.41 -39.19 93.82 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.641 HG22 HG11 ' A' ' 131' ' ' VAL . 71.8 t -62.91 -42.79 97.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.63 -39.99 95.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.18 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -60.99 -41.94 97.47 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.084 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -61.61 -43.24 99.24 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.033 0.444 . . . . 0.0 110.124 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . 0.508 ' O ' ' SG ' ' A' ' 191' ' ' CYS . . . -64.24 -43.87 93.56 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.24 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 25.2 mm -63.32 -45.17 98.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.864 -0.335 . . . . 0.0 111.309 -178.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 89.3 t -60.42 -47.22 93.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 120.265 -0.574 . . . . 0.0 111.765 -178.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.445 ' OD1' ' CZ ' ' A' ' 107' ' ' TYR . 16.6 t30 -62.61 -43.27 99.22 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 122.663 1.22 . . . . 0.0 109.873 179.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' CYS . . . . . 0.508 ' SG ' ' O ' ' A' ' 187' ' ' ALA . 94.5 m -62.43 -46.49 88.3 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 112.46 -2.155 . . . . 0.0 110.752 179.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.41 -40.29 95.5 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.479 176.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -61.54 -45.57 93.6 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.879 -178.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 7.9 tt -64.16 -38.95 92.88 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 118.623 -1.231 . . . . 0.0 110.071 -174.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 6.1 m -64.5 -45.48 95.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 116.762 -1.975 . . . . 0.0 107.808 178.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 19.8 m -63.89 -45.87 87.43 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -178.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -56.48 -38.35 71.61 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.34 1.056 . . . . 0.0 112.09 -178.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -55.19 -43.09 74.05 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 24.5 mt -60.79 -39.51 89.17 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.422 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 1.3 mp -62.98 -42.45 96.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -59.59 -38.67 81.85 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.505 1.522 . . . . 0.0 113.193 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -62.9 -40.04 96.36 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.027 -178.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 90.5 m -100.66 129.37 46.56 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.797 0.808 . . . . 0.0 111.839 -177.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.624 ' O ' HD22 ' A' ' 205' ' ' LEU . 4.6 tp 68.02 4.38 4.03 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 114.221 -1.354 . . . . 0.0 111.954 179.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.624 HD22 ' O ' ' A' ' 204' ' ' LEU . 1.3 mm? -128.42 28.81 5.41 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -177.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -72.84 -25.06 60.98 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.263 -178.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.46 ' O ' ' CG ' ' A' ' 208' ' ' ASN . . . -131.09 -38.88 1.21 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.547 0.689 . . . . 0.0 110.219 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' ASN . . . . . 0.617 ' CG ' ' H ' ' A' ' 209' ' ' LEU . 13.9 p30 141.25 -92.84 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 113.138 -1.846 . . . . 0.0 106.846 -177.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.617 ' H ' ' CG ' ' A' ' 208' ' ' ASN . 4.3 tt . . . . . 0 N--CA 1.463 0.185 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 177.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 0.51 ' N ' ' OD1' ' A' ' 213' ' ' ASP . 11.5 p-10 . . . . . 0 N--CA 1.46 0.051 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.491 ' N ' ' CD ' ' A' ' 215' ' ' PRO . 4.3 mm? -60.88 -42.63 88.12 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.215 -178.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . 0.491 ' CD ' ' N ' ' A' ' 214' ' ' LEU . 35.1 Cg_exo -59.89 -32.34 95.1 Favored 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 121.58 1.52 . . . . 0.0 112.337 -177.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' CYS . . . . . 0.527 ' SG ' ' N ' ' A' ' 217' ' ' HIS . 1.6 p -63.98 -42.23 97.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 113.714 -1.584 . . . . 0.0 111.422 -177.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' HIS . . . . . 0.527 ' N ' ' SG ' ' A' ' 216' ' ' CYS . 77.3 m80 -66.5 -37.32 84.81 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.332 0.587 . . . . 0.0 110.766 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' PHE . . . . . 0.524 ' CE1' HD12 ' A' ' 294' ' ' LEU . 30.7 m-85 -63.47 -46.77 84.66 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.804 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 20.8 p -60.2 -37.79 81.32 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 118.81 0.732 . . . . 0.0 110.44 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 49.7 p -59.45 -41.63 90.09 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 178.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . 0.566 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.74 -41.81 97.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -177.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -62.19 -47.67 83.45 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -175.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -61.15 -42.4 99.78 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 107.994 -2.042 . . . . 0.0 107.994 177.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . 0.541 ' O ' HG23 ' A' ' 228' ' ' THR . . . -63.48 -37.34 86.91 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 113.839 -1.18 . . . . 0.0 109.622 177.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -61.15 -41.96 99.64 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-N 114.364 -1.289 . . . . 0.0 112.529 -175.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' PHE . . . . . 0.443 ' O ' ' OG1' ' A' ' 229' ' ' THR . 55.1 m-85 -66.24 -38.79 88.74 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 118.767 1.283 . . . . 0.0 110.014 -178.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . 0.495 ' SG ' ' N ' ' A' ' 228' ' ' THR . 1.8 p -63.69 -41.91 98.07 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 119.74 -0.784 . . . . 0.0 109.873 177.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 224' ' ' ALA . 67.6 p -62.56 -40.93 98.42 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.412 179.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 226' ' ' PHE . 13.1 p -59.19 -39.46 82.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.266 -177.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 92.8 t -60.35 -41.26 86.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 C-N-CA 118.91 -1.116 . . . . 0.0 108.524 178.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . 0.505 ' O ' ' HD2' ' A' ' 234' ' ' PRO . 30.4 mm -62.08 -41.18 90.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 121.345 0.593 . . . . 0.0 109.727 176.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.1 -39.9 96.06 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 116.16 1.911 . . . . 0.0 116.16 -179.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.48 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 0.1 OUTLIER -58.1 -41.91 92.27 Favored Pre-proline 0 N--CA 1.481 1.098 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -173.271 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.505 ' HD2' ' O ' ' A' ' 231' ' ' ILE . 35.5 Cg_exo -58.39 -40.08 78.3 Favored 'Trans proline' 0 C--N 1.291 -2.483 0 C-N-CA 121.915 1.744 . . . . 0.0 112.503 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 58.9 t -64.38 -37.29 79.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 C-N-CA 118.591 -1.244 . . . . 0.0 109.004 178.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -66.22 -40.98 90.67 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-N 115.351 -0.841 . . . . 0.0 112.182 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 74.1 t -65.63 -45.28 92.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -176.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 C--N 1.328 -0.367 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -176.412 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 21.9 m . . . . . 0 N--CA 1.466 0.342 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' MET . . . . . 0.419 ' CG ' ' N ' ' A' ' 261' ' ' LEU . 17.0 ptt? -61.57 -44.45 97.01 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -177.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.419 ' N ' ' CG ' ' A' ' 260' ' ' MET . 11.6 tp -63.25 -48.12 79.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.787 0.327 . . . . 0.0 110.467 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 50.1 ttt85 -67.4 -54.14 23.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.582 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 3.8 ttmm -68.29 -148.45 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.954 0.407 . . . . 0.0 111.484 -178.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -51.45 136.4 25.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.399 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -41.37 166.63 0.01 OUTLIER Glycine 0 CA--C 1.527 0.834 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.809 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -60.23 -2.97 2.07 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.625 2.217 . . . . 0.0 111.7 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 -69.98 -27.01 64.36 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.193 0.597 . . . . 0.0 111.739 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -58.76 -32.31 69.16 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.006 -179.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -62.39 -41.19 98.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.915 177.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -65.67 -37.55 86.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.909 -1.042 . . . . 0.0 112.146 -178.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.455 ' O ' ' O ' ' A' ' 272' ' ' GLY . 42.3 mmtm -65.42 -176.7 0.35 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 271' ' ' LYS . . . 47.72 104.13 0.01 OUTLIER Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -165.26 4.26 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.611 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 274' ' ' MET . . . . . 0.583 ' N ' ' CD ' ' A' ' 275' ' ' PRO . 2.9 ttm -63.57 -44.15 80.26 Favored Pre-proline 0 C--N 1.329 -0.304 0 C-N-CA 120.268 -0.573 . . . . 0.0 109.646 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 275' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 274' ' ' MET . 22.8 Cg_exo -64.33 -46.12 8.26 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.732 2.288 . . . . 0.0 111.334 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 38.7 t -60.1 -40.04 88.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.514 -179.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . 0.464 ' O ' ' CD1' ' A' ' 280' ' ' LEU . 3.4 m-85 -61.59 -42.76 99.32 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 124.3 2.0 . . . . 0.0 111.809 -178.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 11.5 tp -62.87 -38.98 93.01 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 110.385 -3.098 . . . . 0.0 109.892 175.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . 0.563 HH22 ' NZ ' ' A' ' 38' ' ' LYS . 56.6 mtt-85 -63.03 -41.49 99.53 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.49 ' H ' ' HG ' ' A' ' 280' ' ' LEU . 1.3 pp -62.7 -35.37 79.49 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -177.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . 0.481 ' N ' HD12 ' A' ' 280' ' ' LEU . . . -67.67 -50.98 38.7 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -177.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 66.4 m -62.49 -43.89 97.72 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.477 0.711 . . . . 0.0 109.689 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 283' ' ' TRP . . . . . 0.463 ' O ' HG22 ' A' ' 286' ' ' VAL . 85.0 t90 -59.61 -38.16 80.55 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' A' ' 285' ' ' VAL . 0.2 OUTLIER -62.52 -38.37 89.7 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.295 179.549 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.531 ' N ' ' OD1' ' A' ' 284' ' ' ASN . 0.3 OUTLIER -61.01 -39.91 83.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -177.52 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.488 ' O ' HG22 ' A' ' 289' ' ' VAL . 10.2 m -63.31 -40.07 87.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.051 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 287' ' ' MET . . . . . 0.461 ' SD ' ' CE1' ' A' ' 291' ' ' TYR . 0.0 OUTLIER -60.83 -38.41 85.37 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.656 179.919 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -58.44 -40.1 81.63 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.846 -178.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 286' ' ' VAL . 0.9 OUTLIER -60.53 -38.24 77.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 -177.762 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 41.8 p -62.42 -40.91 98.09 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 119.558 -0.857 . . . . 0.0 108.834 177.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 291' ' ' TYR . . . . . 0.461 ' CE1' ' SD ' ' A' ' 287' ' ' MET . 16.2 m-85 -60.98 -38.34 85.6 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 177.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 -57.27 -39.35 75.5 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 118.163 -1.415 . . . . 0.0 109.261 -176.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 293' ' ' GLN . . . . . 0.468 ' O ' ' O ' ' A' ' 296' ' ' ARG . 17.9 mm100 -60.24 -42.08 94.53 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 122.904 1.335 . . . . 0.0 110.58 178.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.524 HD12 ' CE1' ' A' ' 218' ' ' PHE . 3.9 mm? -60.8 -39.41 88.8 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 112.404 -2.18 . . . . 0.0 110.02 178.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 45.2 mttp -61.83 -44.67 96.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.226 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 296' ' ' ARG . . . . . 0.468 ' O ' ' O ' ' A' ' 293' ' ' GLN . 89.1 mtm180 -121.89 115.7 23.06 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -112.13 -163.24 0.84 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.349 0.595 . . . . 0.0 112.276 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.59 HD12 ' N ' ' A' ' 298' ' ' LEU . 9.9 mp -74.79 109.72 8.49 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 176.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . 0.5 ' O ' ' SD ' ' A' ' 299' ' ' MET . 0.1 OUTLIER -94.59 63.97 2.97 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.755 0.312 . . . . 0.0 111.651 -178.302 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.49 100.86 0.08 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 122.233 1.016 . . . . 0.0 110.647 -178.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -64.2 -46.47 83.8 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 113.16 -1.837 . . . . 0.0 113.265 -176.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -59.06 -39.92 83.56 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.161 -177.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -65.01 -47.0 79.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.846 0.355 . . . . 0.0 110.351 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 304' ' ' SER . . . . . 0.453 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 39.2 t -67.11 -38.33 85.44 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.776 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 34.7 mmm-85 -62.25 -43.76 98.09 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -179.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -65.35 -36.82 85.18 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -177.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . 0.537 ' HB3' ' HD3' ' A' ' 308' ' ' PRO . . . -60.13 -52.87 70.26 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -176.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 308' ' ' PRO . . . . . 0.537 ' HD3' ' HB3' ' A' ' 307' ' ' ALA . 72.5 Cg_endo -75.07 0.38 9.0 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.374 2.049 . . . . 0.0 112.995 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 309' ' ' PHE . . . . . 0.49 ' C ' ' O ' ' A' ' 308' ' ' PRO . 36.3 p90 . . . . . 0 N--CA 1.481 1.078 0 O-C-N 123.894 0.746 . . . . 0.0 112.923 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.2 p . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.842 0.353 . . . . 0.0 110.516 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.6 t -84.36 155.8 3.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.846 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -64.51 -41.7 96.26 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.287 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -63.67 -41.74 98.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.497 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 45.3 tp -79.6 -26.44 41.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.089 -178.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.26 -41.25 94.81 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 107.714 -2.154 . . . . 0.0 107.714 177.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.422 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -71.66 -32.15 67.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 124.856 2.265 . . . . 0.0 107.625 176.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.43 -42.24 99.11 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-N 108.492 -3.958 . . . . 0.0 108.092 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -70.52 -27.62 64.31 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -66.46 -49.97 64.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.965 -179.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.02 -35.87 79.88 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 118.157 -1.417 . . . . 0.0 110.995 -177.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.463 ' O ' HD23 ' A' ' 29' ' ' LEU . 78.7 m -63.85 -53.94 42.69 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.245 -179.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.682 HD12 ' N ' ' A' ' 27' ' ' ALA . 2.7 pp -65.54 -39.58 85.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -177.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.682 ' N ' HD12 ' A' ' 26' ' ' ILE . . . -63.92 -41.65 97.6 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -173.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 32' ' ' PHE . 8.4 p-10 -77.67 -27.11 50.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 120.464 1.483 . . . . 0.0 109.89 -176.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.463 HD23 ' O ' ' A' ' 25' ' ' CYS . 3.0 mm? -60.33 -55.71 30.3 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 119.531 1.06 . . . . 0.0 111.77 -178.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.6 pt -75.89 -4.84 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 121.188 0.518 . . . . 0.0 112.363 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.478 ' HA ' HD12 ' A' ' 34' ' ' LEU . 53.5 m -109.91 -17.02 13.72 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 117.319 -1.324 . . . . 0.0 109.95 -179.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.443 ' N ' ' O ' ' A' ' 28' ' ' ASP . 10.3 t80 -68.38 -44.88 36.95 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-N 122.67 2.486 . . . . 0.0 110.977 -177.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -60.21 -16.69 41.88 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 CA-C-N 121.05 1.411 . . . . 0.0 112.74 177.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.478 HD12 ' HA ' ' A' ' 31' ' ' THR . 82.9 mt -67.65 -35.08 78.22 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -177.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.555 ' HA ' ' HZ3' ' A' ' 38' ' ' LYS . 5.3 p30 -63.98 -39.56 94.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.133 -178.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.532 ' N ' ' OD1' ' A' ' 35' ' ' ASP . 44.4 p -58.11 -34.02 69.75 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.29 -38.76 85.58 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.555 ' HZ3' ' HA ' ' A' ' 35' ' ' ASP . 12.1 pttm -62.0 -47.7 83.61 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 119.049 -1.06 . . . . 0.0 111.93 -177.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.425 HG23 ' NH1' ' A' ' 40' ' ' ARG . 4.9 m -62.8 -38.98 83.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -176.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.527 ' O ' ' N ' ' A' ' 42' ' ' GLN . 13.0 mmp_? -60.24 -41.08 92.41 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 118.986 -1.085 . . . . 0.0 109.909 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 12.8 tp -62.48 38.98 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.236 178.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.619 HE22 ' CA ' ' A' ' 44' ' ' GLN . 5.1 pp0? -53.0 176.02 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.078 0.466 . . . . 0.0 111.436 -178.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 90.9 mt -45.29 -84.01 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.688 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.619 ' CA ' HE22 ' A' ' 42' ' ' GLN . 10.6 tm0? -150.64 -33.93 0.16 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.439 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -163.69 155.61 27.05 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.412 ' OE1' ' CG1' ' A' ' 51' ' ' VAL . 16.8 mp0 -87.27 168.8 12.87 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.815 0.34 . . . . 0.0 110.532 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.5 t -91.26 1.18 57.29 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -63.34 -25.49 68.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.436 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.03 -6.05 84.04 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.02 -1.632 . . . . 0.0 109.02 -177.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.612 HD23 ' O ' ' A' ' 50' ' ' LEU . 1.3 tt -65.31 -37.66 87.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.583 -0.809 . . . . 0.0 109.638 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.414 HG23 ' N ' ' A' ' 52' ' ' ARG . 16.5 m -60.38 -44.04 95.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.411 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.414 ' N ' HG23 ' A' ' 51' ' ' VAL . 23.7 ttm105 -64.16 -34.04 77.15 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 19.3 m -67.97 -38.26 82.52 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -131.5 78.82 1.85 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.227 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -48.13 -14.91 0.06 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.39 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.62 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 23.1 t -126.23 -140.54 0.28 Allowed 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.62 ' HB3' ' O ' ' A' ' 56' ' ' SER . . . 96.66 13.96 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.706 0 O-C-N 124.062 0.851 . . . . 0.0 111.909 178.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -175.32 69.99 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.653 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -52.36 155.44 2.07 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.402 ' O ' ' C ' ' A' ' 61' ' ' GLY . 75.4 mtp180 -45.35 -37.0 4.54 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 60' ' ' ARG . . . -30.33 103.05 0.01 OUTLIER Glycine 0 CA--C 1.529 0.95 0 CA-C-N 114.993 -1.003 . . . . 0.0 112.478 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 31.0 m -67.42 -33.79 64.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 118.268 -0.872 . . . . 0.0 109.888 176.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.494 ' H ' HD12 ' A' ' 63' ' ' LEU . 6.0 mp -60.27 -32.28 71.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 121.239 1.836 . . . . 0.0 109.881 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.42 -49.2 66.74 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 114.975 -1.011 . . . . 0.0 114.671 -176.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.6 m -62.1 -46.41 89.19 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -178.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 29.0 pt -59.89 -35.97 63.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.638 HD23 ' O ' ' A' ' 67' ' ' LEU . 1.3 tt -63.84 -35.83 81.92 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 121.04 1.745 . . . . 0.0 111.651 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 98.6 m -62.79 -39.47 94.31 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-N 113.674 -1.603 . . . . 0.0 111.049 -175.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 7.6 ptt? -60.39 -39.8 88.6 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 120.648 -1.283 . . . . 0.0 113.819 -176.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.2 p -69.36 -40.7 80.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 119.244 -0.982 . . . . 0.0 113.015 -178.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 55.6 ttm-85 -77.86 -13.44 59.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.979 0.895 . . . . 0.0 112.173 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 71.3 m -63.14 -54.77 32.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.137 -1.392 . . . . 0.0 111.154 178.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -106.29 -59.85 1.73 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.473 178.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 160.98 166.34 19.51 Favored Glycine 0 CA--C 1.535 1.34 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -56.17 -35.15 94.9 Favored 'Trans proline' 0 N--CA 1.5 1.91 0 CA-C-N 119.33 1.565 . . . . 0.0 111.721 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -61.36 -11.15 8.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.739 0.78 . . . . 0.0 111.071 176.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.8 t -77.79 -32.77 52.67 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.248 -1.342 . . . . 0.0 110.876 -178.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.48 ' N ' HD12 ' A' ' 78' ' ' LEU . 9.6 mp -75.86 -33.64 60.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 118.271 0.487 . . . . 0.0 110.958 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -92.53 -4.95 52.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 122.796 1.284 . . . . 0.0 112.76 -178.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -90.69 118.31 30.02 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 112.487 -2.142 . . . . 0.0 107.228 175.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.89 -7.58 57.42 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -178.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.674 ' C ' HD12 ' A' ' 82' ' ' LEU . 0.4 OUTLIER -59.25 -34.51 72.32 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 113.949 -1.125 . . . . 0.0 110.541 -179.092 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.1 p -70.46 -26.67 29.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.525 178.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.73 -31.58 61.87 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.748 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.427 ' O ' ' OE1' ' A' ' 89' ' ' GLN . . . -67.84 -40.26 89.52 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 119.701 -1.238 . . . . 0.0 111.241 -177.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.3 mp -62.0 -40.05 94.34 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 122.598 1.189 . . . . 0.0 112.203 -177.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 49.9 tp60 -60.41 -26.99 67.1 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 112.657 -2.065 . . . . 0.0 108.992 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 46.8 ttt180 -57.56 -53.41 58.42 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 173.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.427 ' OE1' ' O ' ' A' ' 85' ' ' GLY . 13.7 mp0 -67.82 -29.8 69.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 113.437 -1.71 . . . . 0.0 112.196 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 8.8 tpt -60.94 -41.97 97.28 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.044 -179.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 77.9 p -74.9 -35.08 62.25 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 119.225 -0.99 . . . . 0.0 111.729 -177.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -57.93 -43.4 86.24 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 121.293 1.861 . . . . 0.0 113.051 -176.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.41 -32.42 64.42 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.322 -177.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 97.1 p -63.68 -40.55 97.11 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 179.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.415 ' C ' ' H ' ' A' ' 97' ' ' ILE . 18.4 m -67.94 -28.3 40.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.829 177.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -77.63 10.12 2.9 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -177.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.415 ' H ' ' C ' ' A' ' 95' ' ' VAL . 38.8 mm -86.69 -15.39 9.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 177.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -140.45 -48.0 0.05 OUTLIER Glycine 0 CA--C 1.537 1.415 0 CA-C-N 114.569 -1.196 . . . . 0.0 114.267 -177.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.573 ' N ' HD12 ' A' ' 99' ' ' LEU . 8.5 mp -70.76 -13.26 61.99 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 118.586 1.193 . . . . 0.0 112.776 -177.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.486 ' O ' ' CG ' ' A' ' 104' ' ' LYS . 91.8 t80 -81.53 -51.19 8.52 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.234 178.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 1.159 ' OD2' ' NE2' ' A' ' 105' ' ' GLN . 18.4 t70 -69.4 -31.55 69.99 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 113.332 -1.758 . . . . 0.0 111.512 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 51.2 m -68.17 -52.48 34.13 Favored 'General case' 0 CA--C 1.556 1.185 0 CA-C-N 111.138 -2.755 . . . . 0.0 115.918 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.505 ' O ' ' CD2' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -74.66 -26.26 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-N 122.015 2.189 . . . . 0.0 111.505 177.547 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.486 ' CG ' ' O ' ' A' ' 100' ' ' TYR . 16.7 mmtt -68.8 -42.17 77.67 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 111.875 -2.42 . . . . 0.0 112.334 -179.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 1.159 ' NE2' ' OD2' ' A' ' 101' ' ' ASP . 88.1 mt-30 -76.74 -15.95 59.62 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 122.677 1.227 . . . . 0.0 111.056 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -79.44 -23.43 43.15 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 114.105 -1.407 . . . . 0.0 112.202 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.505 ' CD2' ' O ' ' A' ' 103' ' ' VAL . 45.2 m-85 -110.22 -30.27 7.8 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 119.871 1.214 . . . . 0.0 113.278 -175.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.0 t -97.77 9.35 42.84 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 117.257 -1.777 . . . . 0.0 112.844 -178.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.528 ' CD ' HH22 ' A' ' 119' ' ' ARG . 0.0 OUTLIER -52.13 124.2 12.43 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 117.827 -1.082 . . . . 0.0 110.497 179.054 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.549 ' O ' ' CB ' ' A' ' 111' ' ' SER . . . -21.04 -83.33 0.01 OUTLIER Glycine 0 N--CA 1.491 2.352 0 CA-C-N 119.79 1.177 . . . . 0.0 111.699 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.549 ' CB ' ' O ' ' A' ' 110' ' ' GLY . 7.2 t 106.35 -162.28 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 115.424 1.638 . . . . 0.0 115.424 176.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.542 ' O ' ' CG ' ' A' ' 113' ' ' HIS . 33.4 tp10 -108.97 -46.12 3.66 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -176.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.618 ' O ' ' HB2' ' A' ' 114' ' ' ALA . 0.3 OUTLIER 150.44 51.07 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -179.611 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.618 ' HB2' ' O ' ' A' ' 113' ' ' HIS . . . 159.57 -161.36 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 179.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.15 14.79 27.62 Favored Glycine 0 C--O 1.227 -0.314 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.733 177.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 59.9 mt -60.47 -40.56 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.54 -39.97 95.86 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 175.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 34.6 t -58.78 -42.89 90.07 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 176.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.528 HH22 ' CD ' ' A' ' 109' ' ' LYS . 2.4 mpt_? -63.75 -37.3 86.86 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.249 -178.009 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 62.5 tp -63.49 -46.27 86.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.587 0.708 . . . . 0.0 109.145 178.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 59.8 mt -66.83 -44.7 80.43 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.342 178.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.96 -44.94 91.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 119.433 1.015 . . . . 0.0 109.434 177.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -66.15 -44.26 91.51 Favored Glycine 0 CA--C 1.517 0.172 0 C-N-CA 119.806 -1.187 . . . . 0.0 111.244 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 14.6 t -64.05 -44.0 93.8 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.875 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.437 ' O ' HD23 ' A' ' 129' ' ' LEU . 21.7 p -69.53 -48.53 60.14 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 119.22 -0.992 . . . . 0.0 112.054 177.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 25.3 m -65.53 -42.72 91.66 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -174.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -64.19 -44.38 95.73 Favored Glycine 0 N--CA 1.461 0.365 0 CA-C-O 122.945 1.303 . . . . 0.0 112.975 -177.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.413 ' O ' ' CG1' ' A' ' 131' ' ' VAL . . . -60.8 -40.93 94.48 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 111.763 -2.219 . . . . 0.0 106.627 177.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.615 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 1.5 mm? -64.24 -42.23 96.61 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.538 178.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.19 -39.92 96.02 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -177.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.494 HG21 HG22 ' A' ' 183' ' ' VAL . 2.4 p -60.88 -24.74 33.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 122.383 1.087 . . . . 0.0 109.366 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . -57.32 -44.49 84.25 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 113.096 -1.866 . . . . 0.0 111.685 -178.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.492 ' CG1' ' N ' ' A' ' 134' ' ' ALA . 2.6 p -78.91 -48.68 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.785 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.492 ' N ' ' CG1' ' A' ' 133' ' ' VAL . . . -86.52 126.07 34.2 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.527 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.459 ' N ' ' HD2' ' A' ' 136' ' ' PRO . 12.0 tp-100 -171.29 -53.25 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.686 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' A' ' 135' ' ' GLN . 10.9 Cg_endo -51.67 -32.9 46.95 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 121.706 1.604 . . . . 0.0 111.852 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.408 ' CG2' ' NZ ' ' A' ' 141' ' ' LYS . 12.2 m -67.46 -42.44 83.04 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 117.759 -1.576 . . . . 0.0 109.736 -179.067 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -66.89 -43.57 83.11 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -178.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.458 HG23 ' N ' ' A' ' 140' ' ' VAL . 3.2 m -64.73 -44.22 96.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -178.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.458 ' N ' HG23 ' A' ' 139' ' ' VAL . 31.6 m -65.16 -39.03 84.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -177.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.408 ' NZ ' ' CG2' ' A' ' 137' ' ' THR . 33.0 mttp -62.53 -42.15 99.33 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 119.38 -0.928 . . . . 0.0 111.98 -177.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 14.4 m -70.42 -45.41 75.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 120.104 -0.638 . . . . 0.0 110.036 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.02 -36.84 85.68 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.624 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -66.91 -42.02 86.14 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -177.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 24.6 mm100 -65.67 -40.03 91.97 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 118.987 -1.085 . . . . 0.0 110.093 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.32 -34.98 79.61 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -178.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.507 ' NE2' ' O ' ' A' ' 147' ' ' GLN . 2.0 pp0? -59.89 111.1 1.34 Allowed 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 177.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -98.62 -60.88 1.46 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 117.6 -1.191 . . . . 0.0 113.919 -175.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 96.6 mtt-85 -90.67 130.42 36.68 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 122.476 2.398 . . . . 0.0 110.357 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -65.21 -14.21 60.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.436 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 72.41 23.95 77.09 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.691 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 -179.878 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.428 ' CD2' ' O ' ' A' ' 157' ' ' GLN . 49.8 t80 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.888 0.375 . . . . 0.0 110.627 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.428 ' O ' ' CD2' ' A' ' 156' ' ' TYR . 26.4 mt-30 -84.3 172.37 11.87 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.954 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.66 ' H ' ' CG ' ' A' ' 161' ' ' GLU . 37.0 m -157.05 -178.52 7.43 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.253 0.549 . . . . 0.0 111.054 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.425 ' H ' HG23 ' A' ' 159' ' ' THR . 9.4 p -64.88 -46.55 81.33 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 120.149 -0.62 . . . . 0.0 112.39 -178.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.53 HG13 ' N ' ' A' ' 161' ' ' GLU . 8.3 p -64.72 -45.92 93.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 119.305 -0.958 . . . . 0.0 110.777 -178.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.66 ' CG ' ' H ' ' A' ' 158' ' ' SER . 1.5 pp20? -67.55 -38.74 84.58 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.219 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.527 ' N ' ' OE2' ' A' ' 161' ' ' GLU . . . -61.36 -45.65 93.51 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -178.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.4 ' CD1' ' C ' ' A' ' 163' ' ' TYR . 21.4 t80 -62.5 -50.19 72.36 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.286 -179.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 4.7 mtpm? -69.15 -45.48 69.96 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 -176.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.567 HG23 ' N ' ' A' ' 166' ' ' ILE . 14.4 t -62.69 -44.64 95.72 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -176.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.567 ' N ' HG23 ' A' ' 165' ' ' THR . 20.9 tt -64.65 -38.36 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-O 121.997 0.904 . . . . 0.0 109.559 176.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.45 ' N ' HG23 ' A' ' 166' ' ' ILE . . . -59.73 -36.54 76.78 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 113.834 -1.53 . . . . 0.0 107.821 176.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 13.1 tpp85 -62.26 -50.25 72.47 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 122.393 2.36 . . . . 0.0 111.89 -175.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -74.9 -51.06 14.82 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 123.486 0.715 . . . . 0.0 109.392 177.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -78.1 -36.42 48.06 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 -173.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 91.52 -166.91 30.75 Favored Glycine 0 N--CA 1.468 0.767 0 O-C-N 121.704 -0.622 . . . . 0.0 112.088 177.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.578 HD12 ' N ' ' A' ' 173' ' ' ARG . 2.5 pp -72.97 -43.67 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-O 121.908 0.861 . . . . 0.0 110.469 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.578 ' N ' HD12 ' A' ' 172' ' ' ILE . 24.9 tpt85 -58.89 -33.86 70.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.199 -1.364 . . . . 0.0 111.0 -177.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -60.9 -40.64 98.61 Favored Glycine 0 CA--C 1.522 0.511 0 C-N-CA 118.619 -1.753 . . . . 0.0 109.646 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 17.8 tp -70.34 -33.77 71.88 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 111.319 -2.44 . . . . 0.0 116.803 -177.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 7.3 m0 -78.01 -7.44 56.88 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 111.845 -2.434 . . . . 0.0 109.783 -177.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -43.39 -47.99 6.99 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.529 -0.759 . . . . 0.0 112.521 -176.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -91.51 -34.31 7.5 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 123.978 0.799 . . . . 0.0 111.81 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 44.7 p -45.19 -51.21 10.85 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . 0.41 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 1.6 t -62.44 -50.8 77.33 Favored Pre-proline 0 N--CA 1.47 0.562 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -176.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' A' ' 180' ' ' SER . 29.5 Cg_endo -64.96 -28.32 57.99 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.402 1.402 . . . . 0.0 111.377 176.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -63.95 -39.13 93.43 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.494 HG22 HG21 ' A' ' 131' ' ' VAL . 56.4 t -63.01 -43.15 98.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.219 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.75 -40.01 95.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.762 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 9.1 tmm_? -61.31 -42.39 98.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.422 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -61.81 -43.69 98.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.081 0.467 . . . . 0.0 110.53 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.62 -43.84 92.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.952 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 79.4 mt -63.35 -45.35 98.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.856 -178.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 84.7 t -60.09 -47.4 92.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 119.465 -0.894 . . . . 0.0 111.033 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -62.91 -42.99 99.98 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 122.311 1.053 . . . . 0.0 110.194 178.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' CYS . . . . . . . . . . . . . 37.5 t -61.86 -45.63 92.93 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 113.422 -1.717 . . . . 0.0 109.685 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -63.91 -39.57 94.48 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 113.193 -1.822 . . . . 0.0 109.94 176.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.5 -44.95 92.97 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.557 0.743 . . . . 0.0 111.522 -176.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 37.6 tp -64.87 -38.23 90.28 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.971 -176.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 92.1 t -64.47 -47.43 89.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 117.893 -1.523 . . . . 0.0 110.508 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 3.1 t -64.55 -44.24 91.41 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.057 0.943 . . . . 0.0 113.172 -177.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -54.75 -38.28 66.99 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.821 0.848 . . . . 0.0 111.372 -176.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -56.42 -44.09 80.04 Favored 'General case' 0 C--N 1.313 -0.997 0 O-C-N 121.739 -0.6 . . . . 0.0 110.451 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.677 ' N ' HD22 ' A' ' 199' ' ' LEU . 2.8 mm? -61.71 -41.09 97.15 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -177.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 200' ' ' ILE . 6.3 pt -64.23 -40.61 89.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.68 179.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -57.66 -38.54 75.27 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.461 1.904 . . . . 0.0 113.846 -178.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -65.43 -38.9 91.28 Favored 'General case' 0 C--O 1.245 0.861 0 C-N-CA 117.932 -1.507 . . . . 0.0 111.105 -177.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 55.1 m -102.61 128.9 49.09 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 122.369 1.081 . . . . 0.0 112.736 -178.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.519 HD22 ' CD1' ' A' ' 209' ' ' LEU . 1.2 mt 67.27 2.65 2.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 112.945 -1.934 . . . . 0.0 112.048 178.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.79 24.03 11.31 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.817 ' O ' ' N ' ' A' ' 208' ' ' ASN . 57.4 pttt -96.78 173.38 7.34 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 178.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . 48.91 -67.15 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 O-C-N 126.116 2.135 . . . . 0.0 110.658 -178.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' ASN . . . . . 0.817 ' N ' ' O ' ' A' ' 206' ' ' LYS . 9.6 p-10 164.92 109.71 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 111.976 -2.374 . . . . 0.0 106.229 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.522 ' O ' ' HG ' ' A' ' 209' ' ' LEU . 13.4 tp . . . . . 0 N--CA 1.489 1.497 0 CA-C-N 108.846 -3.797 . . . . 0.0 112.564 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.785 0.326 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.48 ' N ' ' HD2' ' A' ' 215' ' ' PRO . 12.4 mt -61.28 -44.48 93.36 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 214' ' ' LEU . 23.0 Cg_endo -61.43 -33.31 88.65 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 CA-C-N 120.944 1.373 . . . . 0.0 111.052 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 85.8 m -64.6 -42.47 95.54 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 113.487 -1.688 . . . . 0.0 111.969 -178.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' HIS . . . . . 0.628 ' NE2' ' CD2' ' A' ' 218' ' ' PHE . 1.8 p-80 -66.78 -37.9 85.49 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' PHE . . . . . 0.628 ' CD2' ' NE2' ' A' ' 217' ' ' HIS . 1.4 m-85 -63.14 -47.29 83.37 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.322 -178.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 89.7 m -60.13 -37.8 81.16 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 118.73 0.696 . . . . 0.0 110.925 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 67.9 m -59.35 -41.42 89.17 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . 0.569 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.62 -41.4 98.29 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -177.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -61.43 -46.8 88.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 122.077 0.942 . . . . 0.0 112.786 -176.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -60.1 -41.66 98.17 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 107.164 -2.374 . . . . 0.0 107.164 177.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -62.77 -37.78 87.99 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 176.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -61.82 -42.38 99.74 Favored Glycine 0 CA--C 1.523 0.584 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.843 -178.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' PHE . . . . . 0.432 ' O ' ' OG1' ' A' ' 229' ' ' THR . 55.5 t80 -66.39 -38.3 87.2 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 15.7 t -62.84 -40.7 98.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.532 0.682 . . . . 0.0 109.248 176.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . 0.457 ' O ' HG22 ' A' ' 231' ' ' ILE . 0.4 OUTLIER -61.43 -40.09 93.19 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.589 -179.492 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' A' ' 226' ' ' PHE . 19.7 p -59.36 -39.63 83.88 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.85 -177.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 92.6 t -60.82 -42.61 93.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 119.006 -1.078 . . . . 0.0 111.969 -178.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . 0.457 HG22 ' O ' ' A' ' 228' ' ' THR . 3.8 tp -62.4 -40.22 87.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 176.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -62.1 -39.77 93.63 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.503 ' N ' ' HD2' ' A' ' 234' ' ' PRO . 66.2 m -58.71 -42.81 96.27 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 115.768 1.766 . . . . 0.0 115.768 -175.017 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 233' ' ' SER . 21.0 Cg_endo -59.89 -40.72 60.24 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 CA-C-N 121.051 1.411 . . . . 0.0 113.9 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.42 ' H ' HG22 ' A' ' 235' ' ' VAL . 11.1 m -65.14 -36.5 77.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.008 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -64.96 -41.24 95.64 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -178.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.42 ' H ' HG22 ' A' ' 237' ' ' VAL . 5.7 m -65.64 -45.58 91.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -177.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 57.3 t . . . . . 0 C--N 1.33 -0.243 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -177.116 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 24.8 p . . . . . 0 CA--C 1.532 0.27 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' MET . . . . . 0.601 ' SD ' ' N ' ' A' ' 261' ' ' LEU . 0.0 OUTLIER -61.8 -44.37 97.0 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.214 -0.594 . . . . 0.0 112.47 -177.273 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.601 ' N ' ' SD ' ' A' ' 260' ' ' MET . 12.5 tp -62.62 -46.67 87.2 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.607 0.242 . . . . 0.0 110.444 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 52.5 ttp180 -66.14 -53.76 33.71 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.805 -178.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . 0.442 ' HB3' ' HZ3' ' A' ' 263' ' ' LYS . 0.0 OUTLIER -123.33 160.95 25.64 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 120.938 0.399 . . . . 0.0 111.044 179.272 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . 0.464 ' O ' ' O ' ' A' ' 265' ' ' GLY . 72.6 mt-10 57.83 88.71 0.06 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.278 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 264' ' ' GLU . . . -38.04 166.07 0.01 OUTLIER Glycine 0 CA--C 1.531 1.058 0 N-CA-C 111.669 -0.572 . . . . 0.0 111.669 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -63.4 -5.07 7.63 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 122.817 2.344 . . . . 0.0 111.596 179.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 18.3 ptp180 -69.63 -26.58 64.49 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 123.086 0.554 . . . . 0.0 111.685 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -58.52 -32.49 68.88 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.895 -179.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -62.53 -41.87 99.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.237 0.541 . . . . 0.0 110.753 177.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -65.93 -37.77 86.92 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.84 -178.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp -77.99 -175.16 3.91 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 44.45 84.85 0.01 OUTLIER Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.371 -1.091 . . . . 0.0 110.371 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -152.78 6.79 0.4 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.558 0.218 . . . . 0.0 110.769 -179.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 274' ' ' MET . . . . . 0.587 ' N ' ' CD ' ' A' ' 275' ' ' PRO . 1.9 tpt -63.66 -43.92 78.86 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 275' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 274' ' ' MET . 23.0 Cg_exo -64.12 -46.72 7.54 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.343 2.029 . . . . 0.0 111.205 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 37.4 t -61.0 -40.67 94.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.23 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -62.41 -43.44 98.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 122.88 1.324 . . . . 0.0 113.163 -178.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 8.0 tt -62.01 -38.57 89.14 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 111.897 -2.411 . . . . 0.0 107.072 174.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.69 -40.32 96.75 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.843 178.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 8.2 tp -62.32 -37.24 84.82 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -178.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -67.95 -50.6 39.75 Favored Glycine 0 CA--C 1.52 0.399 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 -178.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.14 -44.38 96.76 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 283' ' ' TRP . . . . . 0.503 ' O ' HG22 ' A' ' 286' ' ' VAL . 57.1 t-105 -60.26 -38.67 84.2 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -63.18 -38.5 91.44 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.725 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 54.8 t -61.11 -39.24 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 -178.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.68 ' O ' HG12 ' A' ' 289' ' ' VAL . 6.9 m -62.6 -39.99 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 119.848 -0.741 . . . . 0.0 110.574 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 287' ' ' MET . . . . . 0.456 ' C ' ' SD ' ' A' ' 287' ' ' MET . 0.0 OUTLIER -60.94 -38.87 87.35 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 122.128 -0.357 . . . . 0.0 110.503 179.758 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -59.32 -41.61 89.51 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -178.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.68 HG12 ' O ' ' A' ' 286' ' ' VAL . 7.4 p -61.52 -37.72 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.027 -179.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 51.2 p -61.67 -39.43 91.37 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 177.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -60.37 -38.49 84.05 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 177.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.99 -39.93 79.45 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 117.948 -1.501 . . . . 0.0 109.488 -176.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 293' ' ' GLN . . . . . 0.45 ' O ' ' O ' ' A' ' 296' ' ' ARG . 80.3 mt-30 -60.37 -42.47 95.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 122.678 1.228 . . . . 0.0 110.641 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 8.9 mp -60.43 -40.26 90.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 112.632 -2.076 . . . . 0.0 109.003 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 17.9 tptp -63.02 -45.84 90.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.266 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 296' ' ' ARG . . . . . 0.45 ' O ' ' O ' ' A' ' 293' ' ' GLN . 64.0 ttm-85 -123.06 116.37 23.38 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.264 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -116.82 -93.2 0.51 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.125 0.488 . . . . 0.0 111.318 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.803 HD22 ' N ' ' A' ' 299' ' ' MET . 0.0 OUTLIER -137.39 -170.89 2.84 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.394 178.4 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . 0.803 ' N ' HD22 ' A' ' 298' ' ' LEU . 34.8 ttm -169.32 65.91 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.625 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.68 101.04 0.07 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.928 0.871 . . . . 0.0 110.583 -178.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -64.0 -46.26 85.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 113.822 -1.536 . . . . 0.0 113.331 -176.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -58.65 -39.89 81.89 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.119 -0.633 . . . . 0.0 109.791 -178.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 6.6 tm0? -65.01 -47.0 79.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.487 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 304' ' ' SER . . . . . 0.429 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 50.0 m -66.71 -37.83 85.51 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.509 -0.477 . . . . 0.0 110.581 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -61.7 -43.22 99.28 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -65.04 -36.97 86.08 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -176.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . 0.544 ' HB3' ' HD3' ' A' ' 308' ' ' PRO . . . -60.02 -52.94 69.89 Favored Pre-proline 0 CA--C 1.545 0.76 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 -176.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 308' ' ' PRO . . . . . 0.544 ' HD3' ' HB3' ' A' ' 307' ' ' ALA . 74.0 Cg_endo -75.23 0.21 9.27 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.053 1.835 . . . . 0.0 111.793 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 52.4 t80 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.499 -179.996 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.9 m . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.768 0.318 . . . . 0.0 110.496 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.4 t -137.97 150.08 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.495 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.1 mmmm -64.41 -41.87 96.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.905 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -63.61 -41.34 98.31 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.4 tt -79.59 -26.23 41.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.443 -178.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.402 ' O ' ' OG1' ' A' ' 22' ' ' THR . . . -66.18 -41.42 94.88 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 107.761 -2.135 . . . . 0.0 107.761 177.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.425 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -71.6 -32.25 67.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 124.889 2.281 . . . . 0.0 107.657 176.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.29 -42.26 99.3 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-N 108.448 -3.978 . . . . 0.0 108.165 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.402 ' OG1' ' O ' ' A' ' 19' ' ' GLY . 32.6 p -70.62 -27.32 63.99 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 177.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -66.51 -50.04 64.55 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.775 -1.102 . . . . 0.0 112.194 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.97 -35.89 79.83 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 118.482 -1.287 . . . . 0.0 111.204 -177.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.0 t -63.78 -53.39 51.64 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.847 -178.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 71.2 mt -65.43 -39.74 86.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 -177.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.57 -42.19 95.81 Favored 'General case' 0 C--N 1.333 -0.109 0 C-N-CA 119.84 -0.744 . . . . 0.0 112.946 -174.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.459 ' CB ' ' OE1' ' A' ' 89' ' ' GLN . 16.7 m-20 -78.24 -27.49 47.66 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 117.964 -1.495 . . . . 0.0 109.084 -177.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.5 tp -59.98 -56.05 26.46 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 118.546 -1.262 . . . . 0.0 111.113 -178.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.2 pp -75.73 -5.24 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 19.1 m -110.17 -17.96 13.42 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 118.811 -1.155 . . . . 0.0 109.941 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.508 ' N ' ' HD2' ' A' ' 33' ' ' PRO . 72.7 t80 -68.27 -45.22 38.55 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 121.308 1.867 . . . . 0.0 112.235 -177.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 32' ' ' PHE . 20.8 Cg_endo -59.42 -14.73 26.49 Favored 'Trans proline' 0 N--CA 1.5 1.872 0 CA-C-N 121.147 1.445 . . . . 0.0 111.147 176.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.57 HD23 ' O ' ' A' ' 34' ' ' LEU . 0.7 OUTLIER -66.31 -35.41 80.3 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 114.686 -1.143 . . . . 0.0 113.086 -177.139 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -64.69 -40.55 95.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.278 -178.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 52.1 p -58.39 -34.9 71.23 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.3 -38.27 84.73 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.72 -0.792 . . . . 0.0 112.534 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.446 ' CG ' ' N ' ' A' ' 39' ' ' VAL . 10.7 pttp -62.01 -48.93 78.12 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 119.576 -0.85 . . . . 0.0 111.69 -176.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.446 ' N ' ' CG ' ' A' ' 38' ' ' LYS . 8.8 p -64.8 -39.89 87.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -177.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.55 HH22 HE22 ' A' ' 58' ' ' GLN . 6.4 tpm_? -61.04 -42.86 99.28 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -177.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.423 ' CD1' ' O ' ' A' ' 38' ' ' LYS . 2.4 pp -63.15 38.73 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.799 178.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.529 ' N ' ' O ' ' A' ' 40' ' ' ARG . 42.7 tt0 -145.25 165.68 27.69 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.901 0.382 . . . . 0.0 111.273 -178.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.729 ' H ' HD13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -73.57 79.17 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.62 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -44.89 135.99 4.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.857 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.99 135.88 0.24 Allowed Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.502 ' O ' ' N ' ' A' ' 48' ' ' GLN . 11.1 pt-20 -94.16 150.51 20.25 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.71 0.291 . . . . 0.0 110.564 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 49.9 m 57.45 -80.55 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.571 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.502 ' N ' ' O ' ' A' ' 46' ' ' GLU . 63.7 mt-30 55.0 178.54 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.212 0.53 . . . . 0.0 111.049 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -153.3 -22.66 0.05 OUTLIER Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.58 HD22 ' N ' ' A' ' 50' ' ' LEU . 3.5 mm? -66.63 -38.5 87.05 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.539 HG23 ' N ' ' A' ' 52' ' ' ARG . 20.5 m -61.15 -44.28 98.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.992 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.539 ' N ' HG23 ' A' ' 51' ' ' VAL . 33.4 mtm-85 -64.31 -33.64 76.3 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.357 -179.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 19.1 m -67.6 -38.32 83.81 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.652 ' O ' ' HB2' ' A' ' 55' ' ' ALA . . . -95.44 -122.1 0.11 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.195 178.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.652 ' HB2' ' O ' ' A' ' 54' ' ' ALA . . . 162.87 -22.71 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 121.191 -0.203 . . . . 0.0 110.842 179.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.623 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 4.6 m -128.53 -138.31 0.24 Allowed 'General case' 0 C--N 1.334 -0.107 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.623 ' HB3' ' O ' ' A' ' 56' ' ' SER . . . 93.59 14.99 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 O-C-N 123.883 0.74 . . . . 0.0 111.937 178.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.55 HE22 HH22 ' A' ' 40' ' ' ARG . 27.7 mt-30 -152.92 55.99 0.78 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -41.91 132.8 3.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.187 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 63.3 mtm-85 -41.02 -42.92 2.03 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.34 0.59 . . . . 0.0 109.921 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -31.95 104.22 0.01 OUTLIER Glycine 0 CA--C 1.527 0.834 0 CA-C-N 114.853 -1.067 . . . . 0.0 112.476 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 26.2 m -67.11 -33.58 64.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 118.262 -0.875 . . . . 0.0 109.046 176.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -60.0 -32.32 70.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 121.061 1.755 . . . . 0.0 109.785 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -65.1 -49.59 61.45 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-N 115.393 -0.821 . . . . 0.0 114.534 -177.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.3 m -62.57 -46.88 86.3 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -178.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.8 pp -60.27 -35.18 60.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.548 ' O ' HD13 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -63.35 -35.56 80.81 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 120.853 1.66 . . . . 0.0 110.948 179.527 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 98.8 m -61.77 -39.19 90.78 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 113.168 -1.833 . . . . 0.0 111.034 -176.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 15.5 tpt -60.51 -39.47 87.91 Favored 'General case' 0 C--N 1.332 -0.179 0 O-C-N 121.135 -0.978 . . . . 0.0 113.531 -177.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.5 t -68.98 -40.42 80.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 119.192 -1.003 . . . . 0.0 112.652 -177.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 56.9 ttt-85 -77.63 -13.39 59.92 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.94 0.876 . . . . 0.0 112.736 -178.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 49.3 m -62.87 -55.12 28.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.17 -1.377 . . . . 0.0 112.338 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -108.74 -58.78 1.97 Allowed 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 159.37 163.81 13.78 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -56.51 -34.89 96.08 Favored 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 122.229 1.953 . . . . 0.0 111.605 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 12.3 tpp180 -61.16 -11.22 8.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.908 0.861 . . . . 0.0 111.056 176.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.5 t -77.36 -32.1 54.79 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 113.953 -1.476 . . . . 0.0 110.994 -177.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 19.3 mt -75.61 -33.66 60.54 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.286 -0.566 . . . . 0.0 111.156 179.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.427 ' C ' ' H ' ' A' ' 81' ' ' GLY . 61.6 m-85 -92.81 -5.33 51.32 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 122.305 1.05 . . . . 0.0 113.386 -178.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.433 ' CG ' ' O ' ' A' ' 80' ' ' ASN . 21.5 t30 -86.25 33.9 0.62 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 112.957 -1.929 . . . . 0.0 107.393 175.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' A' ' 79' ' ' TYR . . . -172.9 -9.78 0.02 OUTLIER Glycine 0 CA--C 1.526 0.747 0 CA-C-N 114.485 -1.234 . . . . 0.0 112.535 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.411 ' H ' ' H ' ' A' ' 81' ' ' GLY . 61.2 tp -59.48 -35.07 73.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.469 -0.866 . . . . 0.0 110.963 -178.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.2 m -70.74 -26.84 28.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.799 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.63 -31.45 61.99 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.793 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.8 -40.18 89.73 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 119.893 -1.146 . . . . 0.0 111.751 -177.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -62.63 -40.28 96.5 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 122.16 0.981 . . . . 0.0 113.094 -176.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 20.2 tm0? -60.39 -27.44 67.44 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 113.349 -1.751 . . . . 0.0 109.456 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 72.7 mtt-85 -58.07 -53.46 57.96 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 173.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.459 ' OE1' ' CB ' ' A' ' 28' ' ' ASP . 23.6 mm100 -67.15 -29.97 69.83 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 112.08 -2.327 . . . . 0.0 112.373 -177.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 10.4 tpp -61.2 -40.46 94.04 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.078 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 68.3 m -74.64 -34.16 62.69 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 118.346 -0.835 . . . . 0.0 111.339 -176.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -57.58 -44.11 85.1 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 120.701 1.591 . . . . 0.0 112.044 -176.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.48 -33.0 64.61 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.466 -0.893 . . . . 0.0 111.025 -178.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 59.6 p -64.03 -41.87 97.28 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.412 ' C ' ' H ' ' A' ' 97' ' ' ILE . 34.3 m -68.18 -27.81 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.988 177.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.415 ' HG3' ' CD1' ' A' ' 100' ' ' TYR . 47.6 ttp85 -77.21 8.54 3.9 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -176.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.433 ' O ' HG22 ' A' ' 97' ' ' ILE . 46.3 mm -87.71 -15.08 9.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 177.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -140.25 -48.3 0.05 OUTLIER Glycine 0 CA--C 1.538 1.53 0 N-CA-C 115.902 1.121 . . . . 0.0 115.902 -175.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.0 tp -71.1 -13.23 61.89 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 119.249 1.524 . . . . 0.0 112.244 -177.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.521 ' O ' ' CG ' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -80.86 -51.28 8.76 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 114.688 -1.142 . . . . 0.0 111.834 179.71 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.509 ' O ' ' HG3' ' A' ' 105' ' ' GLN . 2.4 p30 -69.23 -32.48 71.75 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 123.768 1.747 . . . . 0.0 110.47 -178.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 25.8 m -68.17 -51.79 41.83 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 110.234 -3.167 . . . . 0.0 113.327 177.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 47.0 t -73.63 -26.28 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 CA-C-N 121.405 1.911 . . . . 0.0 111.257 178.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.521 ' CG ' ' O ' ' A' ' 100' ' ' TYR . 20.7 mmtp -69.32 -41.61 76.48 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 112.523 -2.126 . . . . 0.0 111.582 179.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.509 ' HG3' ' O ' ' A' ' 101' ' ' ASP . 88.1 mt-30 -80.1 -15.66 56.66 Favored 'General case' 0 C--O 1.245 0.847 0 CA-C-O 122.065 0.936 . . . . 0.0 110.998 -178.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -80.48 -22.29 41.17 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 121.741 -0.6 . . . . 0.0 112.109 179.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.414 ' O ' ' NE ' ' A' ' 119' ' ' ARG . 13.8 m-85 -109.07 -28.62 8.97 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.692 0.797 . . . . 0.0 111.794 -174.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.2 m -96.12 9.49 40.73 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 116.752 -1.979 . . . . 0.0 113.639 -176.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -46.46 124.7 6.1 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.997 1.271 . . . . 0.0 109.49 176.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -131.55 40.91 1.57 Allowed Glycine 0 N--CA 1.479 1.549 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 178.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 14.8 m -67.5 -37.63 83.12 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 -176.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -125.43 162.41 24.91 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 120.759 0.314 . . . . 0.0 111.084 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.628 ' O ' ' HB2' ' A' ' 114' ' ' ALA . 6.7 p-80 -77.03 67.33 3.0 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -178.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.628 ' HB2' ' O ' ' A' ' 113' ' ' HIS . . . 159.06 -163.06 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 176.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 101.57 15.33 27.5 Favored Glycine 0 C--N 1.343 0.949 0 CA-C-N 113.873 -1.512 . . . . 0.0 113.238 175.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 25.4 mm -61.1 -40.99 87.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 CA-C-N 118.416 1.108 . . . . 0.0 110.31 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.33 -39.96 96.22 Favored Glycine 0 C--N 1.346 1.095 0 CA-C-O 122.237 0.909 . . . . 0.0 111.361 176.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.1 t -57.48 -41.72 81.23 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 177.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.481 ' CD ' HD21 ' A' ' 194' ' ' LEU . 26.9 ttm180 -63.18 -37.54 87.61 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.474 -0.491 . . . . 0.0 111.249 -177.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -64.32 -46.28 84.23 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 177.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 31.5 mt -66.64 -45.1 80.09 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 118.978 -1.089 . . . . 0.0 110.145 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.97 -45.18 90.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 119.813 1.188 . . . . 0.0 110.315 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.413 ' CA ' ' CZ ' ' A' ' 107' ' ' TYR . . . -65.79 -44.28 92.48 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.766 -178.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 59.0 m -63.83 -43.66 95.52 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 19.1 m -69.06 -48.01 63.86 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 119.526 -0.87 . . . . 0.0 112.416 177.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.48 HG23 ' N ' ' A' ' 127' ' ' GLY . 5.7 t -65.47 -42.51 92.2 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 -173.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.572 ' C ' HD21 ' A' ' 186' ' ' ASN . . . -64.46 -44.73 94.84 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-O 122.543 1.08 . . . . 0.0 113.736 -177.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.03 -40.8 94.98 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 112.689 -1.756 . . . . 0.0 107.204 178.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.542 HD13 ' O ' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -62.84 -41.22 99.26 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 114.86 -1.063 . . . . 0.0 109.576 178.93 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -61.82 -38.44 88.17 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.74 -0.209 . . . . 0.0 111.38 -178.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 79.1 t -60.63 -25.91 36.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.742 0.782 . . . . 0.0 109.836 179.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . -57.9 -44.41 86.73 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.236 -1.347 . . . . 0.0 111.215 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 43.1 t -78.73 -49.15 20.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.563 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -99.89 124.52 45.29 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 110.248 -0.278 . . . . 0.0 110.248 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.461 ' N ' ' HD2' ' A' ' 136' ' ' PRO . 33.2 tt0 -176.62 -54.49 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 135' ' ' GLN . 11.2 Cg_endo -52.3 -34.81 61.67 Favored 'Trans proline' 0 N--CA 1.5 1.885 0 C-N-CA 121.389 1.393 . . . . 0.0 113.902 -177.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 81.0 p -67.54 -41.77 83.77 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 118.491 -1.284 . . . . 0.0 109.369 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -64.58 -42.43 95.63 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 118.977 -1.089 . . . . 0.0 112.746 -176.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 17.2 m -63.81 -43.35 97.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 54.3 t -64.53 -38.47 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -178.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -61.47 -40.33 94.14 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 119.978 -0.689 . . . . 0.0 112.106 -176.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.3 p -69.39 -44.42 80.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.535 HH21 ' CD ' ' A' ' 170' ' ' GLU . 12.4 tpt85 -63.98 -35.83 81.99 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.951 179.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.488 ' CD2' ' OE1' ' A' ' 147' ' ' GLN . 40.9 t80 -65.96 -40.22 91.09 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.975 -177.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -63.72 -38.91 92.88 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.358 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -64.86 -34.76 79.15 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -178.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.488 ' OE1' ' CD2' ' A' ' 144' ' ' PHE . 5.0 pt20 -59.48 111.1 1.27 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 178.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -97.55 -61.61 1.37 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 117.523 -1.227 . . . . 0.0 113.951 -176.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 14.1 mtp-105 -101.4 135.52 42.75 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 122.273 2.306 . . . . 0.0 109.903 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -75.35 -113.37 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.519 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 175.19 131.47 1.44 Allowed Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.638 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 179.96 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.501 ' CD2' ' O ' ' A' ' 157' ' ' GLN . 91.8 t80 . . . . . 0 N--CA 1.466 0.356 0 CA-C-O 120.72 0.295 . . . . 0.0 110.368 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.501 ' O ' ' CD2' ' A' ' 156' ' ' TYR . 24.0 mt-30 -49.51 170.46 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.552 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 45.2 p -156.94 -178.25 7.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.954 0.407 . . . . 0.0 110.789 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.555 HG23 ' N ' ' A' ' 160' ' ' VAL . 11.7 t -64.5 -46.36 83.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.792 -177.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.573 HG13 ' N ' ' A' ' 161' ' ' GLU . 12.7 p -64.63 -45.52 95.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 118.898 -1.121 . . . . 0.0 109.077 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.573 ' N ' HG13 ' A' ' 160' ' ' VAL . 74.6 tt0 -66.99 -38.95 86.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.996 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -61.41 -45.78 92.91 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -177.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.613 ' CE2' HD13 ' A' ' 175' ' ' LEU . 12.7 t80 -62.85 -50.42 71.02 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.923 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -68.77 -45.42 71.4 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 115.162 1.541 . . . . 0.0 115.162 -175.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 10.0 m -63.24 -44.44 95.19 Favored 'General case' 0 C--N 1.321 -0.658 0 O-C-N 121.137 -0.977 . . . . 0.0 113.25 -178.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.446 ' O ' HD13 ' A' ' 166' ' ' ILE . 0.2 OUTLIER -64.64 -38.72 83.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 122.199 0.999 . . . . 0.0 109.156 177.554 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.94 -36.64 77.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 113.201 -1.818 . . . . 0.0 109.137 177.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -62.62 -51.0 69.02 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 122.5 2.409 . . . . 0.0 112.713 -174.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -75.38 -51.07 14.01 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 177.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.535 ' CD ' HH21 ' A' ' 143' ' ' ARG . 16.3 tt0 -78.67 -36.42 43.79 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -175.016 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 95.62 -169.03 26.95 Favored Glycine 0 N--CA 1.467 0.764 0 CA-C-N 118.13 0.423 . . . . 0.0 112.57 177.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.406 HG12 ' H ' ' A' ' 172' ' ' ILE . 6.0 pt -72.92 -40.71 60.11 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.129 0 CA-C-O 121.978 0.894 . . . . 0.0 110.396 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 9.1 tpp85 -58.68 -33.63 70.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 113.859 -1.519 . . . . 0.0 110.952 -177.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -60.91 -40.82 98.88 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 118.676 -1.726 . . . . 0.0 110.244 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.613 HD13 ' CE2' ' A' ' 163' ' ' TYR . 6.8 mt -70.84 -33.64 70.87 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 111.286 -2.457 . . . . 0.0 116.975 -177.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 11.1 m0 -78.35 -7.76 57.66 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 112.456 -2.156 . . . . 0.0 109.752 -176.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -43.47 -48.49 7.27 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.535 -0.466 . . . . 0.0 112.154 -175.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.429 ' O ' ' HD2' ' A' ' 181' ' ' PRO . . . -79.11 -13.63 82.74 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 124.444 1.021 . . . . 0.0 111.933 178.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.422 ' O ' ' OD1' ' A' ' 182' ' ' ASN . 84.6 m -46.33 -51.44 14.71 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.86 -50.95 74.9 Favored Pre-proline 0 N--CA 1.475 0.789 0 N-CA-C 114.287 1.218 . . . . 0.0 114.287 -174.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.429 ' HD2' ' O ' ' A' ' 178' ' ' GLY . 29.1 Cg_exo -64.52 -29.96 61.58 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 CA-C-N 120.678 1.278 . . . . 0.0 113.279 177.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 179' ' ' THR . 0.0 OUTLIER -65.53 -40.85 93.42 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 119.366 -0.934 . . . . 0.0 109.896 178.876 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 54.9 t -64.35 -43.12 97.07 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.166 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.083 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.66 -39.79 95.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.178 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.629 HH21 ' CG1' ' A' ' 189' ' ' VAL . 0.7 OUTLIER -60.88 -43.55 98.31 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 119.789 -0.764 . . . . 0.0 110.885 -178.704 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . 0.572 HD21 ' C ' ' A' ' 127' ' ' GLY . 35.3 t30 -63.36 -45.43 91.22 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.744 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -66.59 -45.86 77.82 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.07 -46.25 91.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -177.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.629 ' CG1' HH21 ' A' ' 185' ' ' ARG . 35.6 m -60.86 -47.81 91.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 119.224 -0.99 . . . . 0.0 111.899 -177.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.53 ' N ' HG23 ' A' ' 189' ' ' VAL . 32.2 m120 -62.43 -44.22 96.94 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.609 0.718 . . . . 0.0 110.047 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' CYS . . . . . . . . . . . . . 21.9 t -63.24 -47.61 81.75 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.031 178.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.8 -39.77 94.13 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 113.742 -1.572 . . . . 0.0 110.037 177.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' A' ' 189' ' ' VAL . 3.8 tm-20 -59.63 -45.75 91.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.252 -1.34 . . . . 0.0 111.803 -176.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.481 HD21 ' CD ' ' A' ' 119' ' ' ARG . 0.1 OUTLIER -65.04 -37.64 88.26 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 118.544 -1.262 . . . . 0.0 111.229 -175.548 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 94.8 t -64.21 -47.34 90.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 117.172 -1.811 . . . . 0.0 109.414 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . 0.413 HG23 ' N ' ' A' ' 197' ' ' TYR . 3.0 t -65.48 -45.68 82.71 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 122.075 0.94 . . . . 0.0 112.743 -179.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . 0.413 ' N ' HG23 ' A' ' 196' ' ' THR . 61.7 t80 -57.99 -39.8 79.12 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 113.611 -1.631 . . . . 0.0 113.07 -178.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -56.41 -44.85 80.75 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 16.4 mt -62.12 -39.64 93.22 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.185 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 80.6 mt -63.6 -42.9 97.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-O 119.252 -0.404 . . . . 0.0 111.021 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . 0.646 ' O ' HD12 ' A' ' 205' ' ' LEU . 0.0 OUTLIER -59.63 -37.46 78.71 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.774 2.03 . . . . 0.0 112.272 177.19 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -58.98 -34.97 72.44 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 114.135 -1.393 . . . . 0.0 110.996 -175.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.2 t -98.78 130.67 45.24 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 121.745 0.784 . . . . 0.0 111.383 -177.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.478 ' CD2' ' CE1' ' A' ' 217' ' ' HIS . 9.7 mp 70.02 6.96 6.01 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 113.417 -1.72 . . . . 0.0 115.61 -178.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.961 HD22 ' O ' ' A' ' 205' ' ' LEU . 0.0 OUTLIER -109.71 21.0 17.47 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 120.091 1.314 . . . . 0.0 112.954 179.345 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -60.44 -32.85 71.77 Favored 'General case' 0 C--N 1.332 -0.185 0 O-C-N 120.047 -1.658 . . . . 0.0 113.045 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.492 ' O ' ' CB ' ' A' ' 208' ' ' ASN . . . -165.86 32.83 0.05 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.003 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' ASN . . . . . 0.492 ' CB ' ' O ' ' A' ' 207' ' ' ALA . 0.3 OUTLIER 93.19 -126.44 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 O-C-N 123.882 0.739 . . . . 0.0 110.371 -179.574 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 6.6 tp . . . . . 0 C--N 1.33 -0.271 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.966 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 0.445 ' O ' ' SG ' ' A' ' 216' ' ' CYS . 71.0 m-20 . . . . . 0 N--CA 1.462 0.13 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.468 ' N ' ' CD ' ' A' ' 215' ' ' PRO . 1.8 mt -61.21 -43.39 90.01 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.63 -0.713 . . . . 0.0 112.504 -178.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . 0.468 ' CD ' ' N ' ' A' ' 214' ' ' LEU . 35.4 Cg_exo -60.29 -33.45 94.55 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 120.966 1.111 . . . . 0.0 111.715 -178.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' CYS . . . . . 0.513 ' SG ' ' N ' ' A' ' 217' ' ' HIS . 0.8 OUTLIER -64.69 -42.04 95.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 113.427 -1.715 . . . . 0.0 111.543 -178.164 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' HIS . . . . . 0.513 ' N ' ' SG ' ' A' ' 216' ' ' CYS . 11.6 t-160 -66.08 -37.13 85.03 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.575 -177.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -62.98 -47.94 80.99 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.051 -178.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 8.4 m -61.11 -38.81 87.66 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 120.211 1.369 . . . . 0.0 110.255 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 20.7 p -58.97 -40.94 86.28 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -62.71 -41.26 99.06 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -176.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -60.25 -46.59 89.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 122.66 1.219 . . . . 0.0 111.873 -176.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -60.9 -41.77 99.41 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-N 112.364 -2.198 . . . . 0.0 107.771 176.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . 0.89 ' O ' HG23 ' A' ' 228' ' ' THR . . . -62.37 -37.3 85.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.067 -1.067 . . . . 0.0 108.555 177.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -60.97 -41.99 99.59 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 -177.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -66.77 -38.54 86.76 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 119.294 -0.962 . . . . 0.0 108.799 178.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . 0.513 ' SG ' ' O ' ' A' ' 224' ' ' ALA . 0.5 OUTLIER -63.38 -40.53 97.5 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.503 0.668 . . . . 0.0 110.295 177.617 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . 0.89 HG23 ' O ' ' A' ' 224' ' ' ALA . 75.8 p -61.34 -38.06 85.55 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 114.839 -1.073 . . . . 0.0 112.533 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.489 HG23 ' O ' ' A' ' 225' ' ' GLY . 71.6 p -56.7 -38.86 72.86 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.486 -0.485 . . . . 0.0 111.229 -174.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 227' ' ' CYS . 3.8 p -59.79 -40.81 83.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 118.026 -1.47 . . . . 0.0 108.318 178.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 24.7 mt -61.54 -40.67 87.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 176.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -62.15 -39.2 91.81 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 114.539 -1.209 . . . . 0.0 113.8 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.62 ' O ' HG13 ' A' ' 237' ' ' VAL . 8.2 t -58.74 -43.24 97.58 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 -174.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 233' ' ' SER . 20.0 Cg_endo -60.14 -41.5 51.18 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 CA-C-N 121.947 1.731 . . . . 0.0 112.705 179.065 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 2.9 p -65.97 -37.7 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 117.972 -1.491 . . . . 0.0 109.237 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -66.69 -42.0 87.14 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 -179.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.62 HG13 ' O ' ' A' ' 233' ' ' SER . 15.4 m -65.7 -45.43 91.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -176.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.464 ' N ' HG23 ' A' ' 237' ' ' VAL . 9.9 p . . . . . 0 C--N 1.324 -0.515 0 C-N-CA 119.444 -0.902 . . . . 0.0 111.818 -177.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 94.0 m . . . . . 0 N--CA 1.466 0.355 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' MET . . . . . 0.566 ' SD ' ' N ' ' A' ' 261' ' ' LEU . 0.1 OUTLIER -61.33 -43.86 98.16 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 120.134 -0.626 . . . . 0.0 110.851 -178.317 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.566 ' N ' ' SD ' ' A' ' 260' ' ' MET . 63.7 tp -63.18 -48.29 79.0 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' ARG . . . . . 0.447 ' O ' ' O ' ' A' ' 263' ' ' LYS . 8.6 tpt180 -67.68 -53.94 23.57 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.765 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . 0.447 ' O ' ' O ' ' A' ' 262' ' ' ARG . 5.4 ttpm? -56.25 -126.49 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.778 -178.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -85.89 143.11 28.4 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 121.094 0.473 . . . . 0.0 111.122 -178.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . 0.518 ' C ' ' H ' ' A' ' 267' ' ' ARG . . . -42.22 160.84 0.04 OUTLIER Glycine 0 CA--C 1.529 0.968 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.382 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -55.98 0.21 0.17 Allowed 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 121.798 1.666 . . . . 0.0 111.909 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . 0.518 ' H ' ' C ' ' A' ' 265' ' ' GLY . 82.9 mtt85 -70.25 -26.46 63.84 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.753 0.821 . . . . 0.0 112.225 178.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -57.98 -32.06 67.51 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.849 -178.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -62.1 -41.02 97.79 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.674 177.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -65.28 -37.98 88.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.372 -177.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.472 ' O ' ' O ' ' A' ' 272' ' ' GLY . 37.0 mmtm -67.33 -176.8 0.61 Allowed 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 178.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 271' ' ' LYS . . . 37.11 99.3 0.01 OUTLIER Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -156.63 -0.58 0.12 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.019 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 274' ' ' MET . . . . . 0.574 ' N ' ' CD ' ' A' ' 275' ' ' PRO . 0.1 OUTLIER -63.77 -44.62 80.39 Favored Pre-proline 0 C--N 1.328 -0.35 0 C-N-CA 120.247 -0.581 . . . . 0.0 109.565 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 275' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 274' ' ' MET . 20.9 Cg_exo -64.7 -47.22 5.58 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.093 1.862 . . . . 0.0 111.651 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 19.7 m -61.03 -40.03 92.05 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.701 0.762 . . . . 0.0 110.434 179.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -62.14 -41.85 98.67 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 123.528 1.633 . . . . 0.0 112.138 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 1.4 mp -62.05 -38.85 90.32 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 110.617 -2.992 . . . . 0.0 108.549 174.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 13.5 mmt85 -62.76 -40.65 97.94 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.291 0.567 . . . . 0.0 109.751 178.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.618 HD23 ' O ' ' A' ' 280' ' ' LEU . 0.9 OUTLIER -63.07 -37.2 86.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.099 -179.037 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -67.81 -50.93 38.24 Favored Glycine 0 CA--C 1.519 0.297 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -177.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 77.8 p -61.63 -44.32 97.21 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 283' ' ' TRP . . . . . 0.636 ' O ' HG22 ' A' ' 286' ' ' VAL . 87.6 t90 -61.26 -39.72 91.41 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.637 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -64.31 -40.66 96.38 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 5.3 m -62.28 -38.18 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.636 HG22 ' O ' ' A' ' 283' ' ' TRP . 27.1 m -62.02 -38.83 81.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 121.094 -0.242 . . . . 0.0 111.041 -178.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 287' ' ' MET . . . . . 0.453 ' C ' ' SD ' ' A' ' 287' ' ' MET . 0.0 OUTLIER -59.33 -37.31 77.49 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.643 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -57.95 -40.07 79.66 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.003 -179.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 286' ' ' VAL . 1.2 m -60.46 -38.16 77.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 O-C-N 121.766 -0.584 . . . . 0.0 111.018 -178.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 75.1 p -61.81 -38.93 89.96 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 177.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -60.64 -38.34 84.52 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 177.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -58.22 -40.71 82.36 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 118.089 -1.445 . . . . 0.0 109.421 -176.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 293' ' ' GLN . . . . . 0.453 ' O ' ' O ' ' A' ' 296' ' ' ARG . 36.5 tp60 -60.72 -42.74 97.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 122.823 1.296 . . . . 0.0 110.468 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 35.9 tp -60.29 -40.15 89.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 112.497 -2.138 . . . . 0.0 109.157 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -63.05 -45.71 90.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.335 179.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 296' ' ' ARG . . . . . 0.453 ' O ' ' O ' ' A' ' 293' ' ' GLN . 44.8 ttm180 -123.03 116.39 23.45 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.047 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -114.41 -97.25 0.44 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.069 0.461 . . . . 0.0 110.682 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.467 HD21 HE21 ' A' ' 303' ' ' GLN . 36.8 tp -140.7 121.06 14.0 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.009 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 24.3 ttt -95.59 66.15 2.73 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -178.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.52 100.82 0.07 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 122.149 0.976 . . . . 0.0 110.805 -178.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -64.28 -46.31 84.21 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 113.393 -1.73 . . . . 0.0 113.362 -176.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -58.92 -39.75 82.48 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.085 -177.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 303' ' ' GLN . . . . . 0.467 HE21 HD21 ' A' ' 298' ' ' LEU . 0.3 OUTLIER -64.51 -46.73 81.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.003 -179.61 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 304' ' ' SER . . . . . 0.44 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 15.1 m -66.56 -37.42 84.93 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.61 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -61.66 -43.25 99.22 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -178.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -65.17 -36.88 85.6 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -177.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . 0.523 ' HB3' ' HD3' ' A' ' 308' ' ' PRO . . . -59.86 -52.7 71.85 Favored Pre-proline 0 CA--C 1.543 0.675 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -176.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 308' ' ' PRO . . . . . 0.523 ' HD3' ' HB3' ' A' ' 307' ' ' ALA . 73.1 Cg_endo -75.2 0.39 9.04 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.038 1.825 . . . . 0.0 111.862 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 39.8 t80 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.501 179.914 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.59 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.447 HG22 ' H ' ' A' ' 14' ' ' THR . 0.0 OUTLIER -82.55 168.41 17.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.632 -179.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.796 HG22 ' H ' ' A' ' 16' ' ' LYS . 13.4 p -167.07 -178.98 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.898 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.796 ' H ' HG22 ' A' ' 15' ' ' VAL . 23.7 mtpp -64.32 -41.81 96.63 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.699 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -63.73 -41.5 98.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.279 0.561 . . . . 0.0 112.077 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.514 ' H ' HG13 ' A' ' 15' ' ' VAL . 12.9 tp -79.97 -26.0 40.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.046 -179.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.04 -41.3 95.24 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 107.601 -2.199 . . . . 0.0 107.601 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -71.47 -32.01 67.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 124.886 2.279 . . . . 0.0 107.332 176.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.76 -42.51 98.55 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-N 108.454 -3.975 . . . . 0.0 108.292 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 28.3 p -70.61 -27.48 64.11 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.541 0.686 . . . . 0.0 109.436 178.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.654 ' O ' HD13 ' A' ' 26' ' ' ILE . . . -65.76 -49.7 67.43 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.166 -178.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.98 -35.19 77.76 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 118.816 -1.154 . . . . 0.0 112.375 -177.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.4 ' HA ' HE22 ' A' ' 89' ' ' GLN . 75.7 m -63.35 -53.79 47.11 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -177.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.654 HD13 ' O ' ' A' ' 23' ' ' ALA . 0.2 OUTLIER -65.89 -38.09 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -177.117 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.449 ' O ' ' OG1' ' A' ' 31' ' ' THR . . . -63.64 -41.59 98.23 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -173.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 29' ' ' LEU . 20.0 p30 -77.6 -27.0 51.13 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 120.893 1.678 . . . . 0.0 109.93 -175.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.501 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 11.2 tp -59.8 -55.39 34.82 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 119.93 1.241 . . . . 0.0 112.148 -178.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.1 pt -75.45 -3.91 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-O 121.376 0.608 . . . . 0.0 112.61 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.573 HG23 HD12 ' A' ' 34' ' ' LEU . 7.1 m -109.3 -16.85 13.95 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.751 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.47 ' N ' ' CD ' ' A' ' 33' ' ' PRO . 1.8 t80 -68.53 -44.33 33.51 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 121.411 1.914 . . . . 0.0 110.93 -178.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.47 ' CD ' ' N ' ' A' ' 32' ' ' PHE . 36.8 Cg_exo -59.36 -15.8 31.52 Favored 'Trans proline' 0 N--CA 1.501 1.964 0 C-N-CA 121.554 1.502 . . . . 0.0 112.701 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.573 HD12 HG23 ' A' ' 31' ' ' THR . 81.6 mt -67.62 -35.36 78.79 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 114.787 1.402 . . . . 0.0 114.787 -177.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 36' ' ' THR . 45.3 p-10 -64.27 -40.53 96.16 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -177.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.53 ' N ' ' OD1' ' A' ' 35' ' ' ASP . 44.1 p -58.27 -35.28 71.54 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.939 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.86 -39.19 83.8 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 119.755 -0.778 . . . . 0.0 112.015 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.498 ' CB ' ' NZ ' ' A' ' 38' ' ' LYS . 8.7 mtmp? -62.12 -49.36 76.21 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 119.239 -0.984 . . . . 0.0 111.187 -176.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.1 m -64.25 -40.6 89.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -176.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.635 ' NH1' HE21 ' A' ' 44' ' ' GLN . 10.2 tpp180 -61.69 -41.87 98.16 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 119.378 -0.929 . . . . 0.0 110.08 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.54 39.06 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.768 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.498 ' C ' ' H ' ' A' ' 44' ' ' GLN . 60.2 tt0 -125.73 152.78 44.87 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.989 0.424 . . . . 0.0 110.942 -179.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.538 HG22 ' O ' ' A' ' 43' ' ' ILE . 73.0 mt -63.11 0.78 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.004 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.635 HE21 ' NH1' ' A' ' 40' ' ' ARG . 46.0 mt-30 64.13 78.98 0.27 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.525 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.17 -5.68 3.45 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.427 ' H ' ' C ' ' A' ' 44' ' ' GLN . 96.8 mt-10 -56.22 -42.83 77.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.912 0.387 . . . . 0.0 109.992 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.532 ' C ' ' H ' ' A' ' 49' ' ' GLY . 4.7 t 37.71 30.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.699 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.406 ' N ' ' O ' ' A' ' 46' ' ' GLU . 85.9 mt-30 -58.05 -2.8 0.19 Allowed 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.121 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.532 ' H ' ' C ' ' A' ' 47' ' ' SER . . . 87.44 -8.62 76.5 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -177.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -66.35 -37.3 85.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.665 0.745 . . . . 0.0 109.237 177.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.504 HG13 ' N ' ' A' ' 52' ' ' ARG . 13.1 p -60.76 -44.12 96.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.149 -178.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.504 ' N ' HG13 ' A' ' 51' ' ' VAL . 6.9 mmp_? -64.56 -35.14 80.02 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 119.816 -0.754 . . . . 0.0 112.31 -177.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.5 t -68.95 -38.0 79.18 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 119.24 -0.984 . . . . 0.0 108.758 177.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -138.29 97.93 3.49 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 114.798 -1.092 . . . . 0.0 108.39 178.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -80.65 9.0 6.73 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -177.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.608 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 18.7 m -125.69 -140.99 0.28 Allowed 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.608 ' HB3' ' O ' ' A' ' 56' ' ' SER . . . 97.87 12.74 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 O-C-N 124.127 0.892 . . . . 0.0 111.863 178.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 41.7 tp60 -178.24 84.59 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.704 0.288 . . . . 0.0 110.36 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -63.78 163.06 12.31 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.063 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.413 ' O ' ' C ' ' A' ' 61' ' ' GLY . 78.4 mtm-85 -49.84 -36.85 28.3 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 60' ' ' ARG . . . -28.57 102.58 0.01 OUTLIER Glycine 0 CA--C 1.526 0.764 0 CA-C-N 114.955 -1.021 . . . . 0.0 112.703 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.416 HG22 ' H ' ' A' ' 62' ' ' VAL . 2.1 m -67.32 -34.37 68.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 118.41 -0.805 . . . . 0.0 109.663 176.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.439 ' N ' HD22 ' A' ' 63' ' ' LEU . 4.4 mm? -60.48 -32.5 71.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 121.077 1.762 . . . . 0.0 109.615 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.67 -49.32 64.81 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-N 114.623 -1.171 . . . . 0.0 114.781 -176.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.7 p -61.98 -46.48 89.05 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 -178.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 8.8 tt -59.8 -36.19 64.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.547 ' O ' HD13 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -64.21 -35.73 81.75 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 120.303 1.411 . . . . 0.0 111.913 179.645 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.466 ' O ' ' OG1' ' A' ' 72' ' ' THR . 98.1 m -63.56 -40.88 98.12 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.312 -1.313 . . . . 0.0 111.085 -175.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 7.3 ptm -60.59 -39.46 88.18 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -175.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.43 ' CG2' HD11 ' A' ' 78' ' ' LEU . 5.2 p -69.02 -40.01 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 119.532 -0.867 . . . . 0.0 113.05 -177.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.42 ' N ' HG13 ' A' ' 70' ' ' VAL . 56.6 ttp180 -77.78 -13.08 60.0 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.999 0.904 . . . . 0.0 112.6 -178.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.466 ' OG1' ' O ' ' A' ' 68' ' ' THR . 19.7 m -62.45 -54.65 37.08 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.025 -1.443 . . . . 0.0 111.272 179.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 28.2 mp0 -107.01 -57.76 2.02 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 178.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.42 ' O ' ' CB ' ' A' ' 77' ' ' SER . . . 159.36 165.49 16.46 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -56.84 -35.46 98.26 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 121.487 1.458 . . . . 0.0 111.376 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.64 -11.34 11.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.802 0.811 . . . . 0.0 110.691 175.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 74' ' ' GLY . 5.6 t -77.9 -32.49 51.8 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.098 -1.41 . . . . 0.0 110.905 -178.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.43 HD11 ' CG2' ' A' ' 70' ' ' VAL . 27.5 mt -75.45 -33.48 60.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.116 0.484 . . . . 0.0 110.61 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -92.29 -4.59 53.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 122.798 1.285 . . . . 0.0 113.243 -177.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -95.28 116.25 28.52 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 112.29 -2.232 . . . . 0.0 107.016 175.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.48 -11.38 54.16 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -177.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.674 ' C ' HD12 ' A' ' 82' ' ' LEU . 0.3 OUTLIER -59.24 -34.42 72.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 113.94 -1.13 . . . . 0.0 110.489 -179.328 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.1 m -70.49 -27.0 29.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.087 -0.961 . . . . 0.0 109.369 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.95 -31.92 61.61 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.675 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.92 -40.11 89.18 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 119.544 -1.312 . . . . 0.0 111.223 -177.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.0 mp -62.46 -40.1 95.56 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 122.29 1.043 . . . . 0.0 112.574 -177.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -60.57 -27.44 67.69 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 113.106 -1.861 . . . . 0.0 109.613 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 58.2 ttp85 -57.83 -53.55 56.97 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 173.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.4 HE22 ' HA ' ' A' ' 25' ' ' CYS . 10.3 tt0 -67.22 -29.9 69.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 112.318 -2.219 . . . . 0.0 112.512 -178.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 38.4 ttm -61.14 -40.66 94.65 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.497 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 38.2 t -74.32 -34.13 63.37 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 119.556 -0.858 . . . . 0.0 111.718 -176.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -57.75 -43.99 85.8 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 120.584 1.538 . . . . 0.0 112.308 -176.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.53 -32.85 64.44 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 119.321 -0.952 . . . . 0.0 111.015 -178.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.601 ' O ' HG22 ' A' ' 97' ' ' ILE . 48.8 m -64.35 -41.82 96.55 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.438 ' C ' ' H ' ' A' ' 97' ' ' ILE . 7.2 p -68.42 -28.41 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.221 177.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 16.9 mtp-105 -77.46 10.33 2.65 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -177.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.601 HG22 ' O ' ' A' ' 94' ' ' SER . 9.6 tp -86.87 -15.33 9.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 177.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.404 ' O ' ' OD1' ' A' ' 101' ' ' ASP . . . -140.05 -48.0 0.06 OUTLIER Glycine 0 CA--C 1.539 1.571 0 CA-C-N 114.23 -1.35 . . . . 0.0 114.383 -177.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.4 tp -70.75 -13.48 62.07 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.183 1.491 . . . . 0.0 113.37 -177.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.53 ' O ' ' HB2' ' A' ' 104' ' ' LYS . 20.6 t80 -81.21 -51.67 8.17 Favored 'General case' 0 C--O 1.211 -0.945 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.957 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.536 ' O ' ' HG3' ' A' ' 105' ' ' GLN . 9.3 p-10 -69.99 -32.73 71.07 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 123.631 1.682 . . . . 0.0 111.83 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.0 m -68.83 -52.72 26.98 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 110.81 -2.904 . . . . 0.0 116.99 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 69.2 t -74.99 -26.9 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 CA-C-N 121.121 1.782 . . . . 0.0 110.8 176.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.53 ' HB2' ' O ' ' A' ' 100' ' ' TYR . 0.4 OUTLIER -69.54 -41.53 75.84 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 110.831 -2.895 . . . . 0.0 112.974 -179.259 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.536 ' HG3' ' O ' ' A' ' 101' ' ' ASP . 88.1 mt-30 -78.65 -13.75 59.66 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 123.614 1.673 . . . . 0.0 111.025 178.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.06 -22.74 41.95 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 112.785 -2.007 . . . . 0.0 110.9 178.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -109.87 -30.62 7.75 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.833 0.742 . . . . 0.0 112.212 -175.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.646 HG22 ' O ' ' A' ' 108' ' ' THR . 50.1 m -98.46 9.06 44.01 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 118.219 -1.393 . . . . 0.0 112.579 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.444 ' O ' ' C ' ' A' ' 110' ' ' GLY . 35.3 ttmt -53.74 121.11 7.2 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.495 ' O ' ' CB ' ' A' ' 111' ' ' SER . . . -23.59 -78.79 0.01 OUTLIER Glycine 0 N--CA 1.48 1.59 0 CA-C-N 117.81 0.277 . . . . 0.0 113.12 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.525 ' O ' ' HB2' ' A' ' 112' ' ' GLU . 1.4 t 91.96 -87.26 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 177.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.525 ' HB2' ' O ' ' A' ' 111' ' ' SER . 82.7 tt0 171.64 -34.36 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 120.541 1.519 . . . . 0.0 113.915 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.637 ' O ' ' HB2' ' A' ' 114' ' ' ALA . 0.3 OUTLIER 156.87 42.46 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.201 0.524 . . . . 0.0 109.896 -179.214 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.637 ' HB2' ' O ' ' A' ' 113' ' ' HIS . . . 160.45 -162.41 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 178.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.78 15.23 25.01 Favored Glycine 0 CA--C 1.507 -0.428 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.49 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.459 HG23 ' N ' ' A' ' 117' ' ' GLY . 12.6 tt -60.43 -40.54 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.459 ' N ' HG23 ' A' ' 116' ' ' ILE . . . -65.68 -40.17 95.71 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-O 121.791 0.661 . . . . 0.0 111.685 175.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 10.1 p -58.65 -42.97 89.58 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 176.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.402 ' NE ' ' HA ' ' A' ' 116' ' ' ILE . 76.3 mtm180 -63.71 -37.01 85.74 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.849 -177.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.46 HD21 HD13 ' A' ' 194' ' ' LEU . 70.9 mt -63.53 -45.63 89.7 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 177.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 39.4 mt -66.52 -44.82 81.46 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 118.762 -1.175 . . . . 0.0 110.06 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.98 -45.4 89.24 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 120.22 1.373 . . . . 0.0 110.602 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -66.04 -44.16 92.0 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 120.172 -1.014 . . . . 0.0 111.289 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 59.0 m -64.14 -43.82 94.04 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.43 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 20.6 m -69.34 -48.27 61.91 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 119.365 -0.934 . . . . 0.0 111.943 177.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.449 HG23 ' N ' ' A' ' 127' ' ' GLY . 4.8 t -65.23 -42.46 93.37 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -173.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.449 ' N ' HG23 ' A' ' 126' ' ' THR . . . -63.89 -44.53 95.95 Favored Glycine 0 CA--C 1.521 0.423 0 CA-C-O 122.912 1.284 . . . . 0.0 113.196 -177.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.449 ' O ' HG22 ' A' ' 131' ' ' VAL . . . -61.12 -41.21 96.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 112.029 -2.085 . . . . 0.0 106.714 177.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.679 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 0.2 OUTLIER -63.98 -41.9 97.39 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.3 178.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -62.9 -39.98 96.17 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -177.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.449 HG22 ' O ' ' A' ' 128' ' ' ALA . 12.5 m -61.04 -26.12 38.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 122.628 1.204 . . . . 0.0 109.513 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.679 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . -58.31 -44.45 88.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 112.607 -2.088 . . . . 0.0 111.736 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 61.5 t -78.6 -49.02 21.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.941 -178.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -112.38 131.64 55.43 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.746 0.308 . . . . 0.0 110.805 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.596 ' H ' ' HD2' ' A' ' 136' ' ' PRO . 3.4 tt0 -175.51 -41.79 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.82 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.596 ' HD2' ' H ' ' A' ' 135' ' ' GLN . 52.6 Cg_exo -52.78 -34.52 65.35 Favored 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 121.819 1.679 . . . . 0.0 113.437 -178.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 98.6 m -67.54 -42.01 83.4 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 118.029 -1.468 . . . . 0.0 108.594 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -65.51 -43.01 91.43 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 118.159 -1.416 . . . . 0.0 112.788 -177.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.3 p -64.76 -44.22 96.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.455 ' O ' ' N ' ' A' ' 144' ' ' PHE . 21.8 m -65.26 -37.93 81.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -178.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -61.41 -40.72 95.44 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -176.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.453 ' CG1' ' N ' ' A' ' 143' ' ' ARG . 3.9 p -69.61 -44.7 79.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 119.399 -0.92 . . . . 0.0 108.94 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.453 ' N ' ' CG1' ' A' ' 142' ' ' VAL . 65.8 mtt180 -64.24 -35.71 81.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.701 178.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.455 ' N ' ' O ' ' A' ' 140' ' ' VAL . 85.1 t80 -65.71 -40.56 92.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.239 -178.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -64.14 -38.63 91.74 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -64.88 -35.02 79.79 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -178.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -59.75 111.18 1.35 Allowed 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 177.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -106.6 -173.12 2.22 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 117.686 2.476 . . . . 0.0 117.686 -171.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 59.0 61.13 2.21 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 110.035 -3.257 . . . . 0.0 110.899 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . 46.59 -114.79 0.54 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.806 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 170.74 113.88 0.3 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.979 -0.849 . . . . 0.0 110.979 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -99.56 -156.89 28.66 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 155' ' ' ARG . . . 81.66 56.47 2.94 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 77.8 mtp85 41.76 -90.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.733 0.301 . . . . 0.0 110.94 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.52 ' N ' ' O ' ' A' ' 153' ' ' GLY . 25.7 ttm105 -64.49 128.75 37.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.417 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.412 ' CD1' ' O ' ' A' ' 156' ' ' TYR . 28.1 p90 -70.7 132.06 44.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.516 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -54.48 175.73 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.662 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 162' ' ' ALA . 20.5 p -157.0 -178.36 7.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.657 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.57 HG23 ' N ' ' A' ' 160' ' ' VAL . 13.7 t -64.1 -46.47 84.06 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.663 -177.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.57 ' N ' HG23 ' A' ' 159' ' ' THR . 6.3 p -64.51 -45.43 95.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 119.06 -1.056 . . . . 0.0 109.674 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.485 ' N ' HG13 ' A' ' 160' ' ' VAL . 50.3 mm-40 -66.65 -38.34 86.67 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.162 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.556 ' O ' HD12 ' A' ' 166' ' ' ILE . . . -60.97 -44.58 97.12 Favored 'General case' 0 C--O 1.21 -0.981 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -177.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.448 ' C ' ' CD1' ' A' ' 163' ' ' TYR . 20.6 t80 -61.5 -47.84 83.79 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.527 0.565 . . . . 0.0 112.527 -178.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -67.89 -45.39 74.57 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 117.881 2.549 . . . . 0.0 117.881 -172.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 41.7 p -63.38 -45.44 91.11 Favored 'General case' 0 CA--C 1.557 1.227 0 N-CA-C 117.294 2.331 . . . . 0.0 117.294 -175.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.709 HD13 ' H ' ' A' ' 166' ' ' ILE . 0.1 OUTLIER -64.68 -37.12 79.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 CA-C-O 121.655 0.741 . . . . 0.0 109.281 176.483 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.07 -36.53 75.24 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 176.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 18.5 tpt85 -62.21 -50.09 73.16 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 122.998 2.635 . . . . 0.0 111.201 -176.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -74.77 -51.08 15.1 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 123.457 0.703 . . . . 0.0 109.593 177.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -78.24 -36.7 46.62 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 116.037 1.866 . . . . 0.0 116.037 -173.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 93.41 -168.21 29.36 Favored Glycine 0 N--CA 1.47 0.957 0 CA-C-N 118.674 0.67 . . . . 0.0 112.623 177.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 10.0 pt -73.52 -41.45 56.12 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.112 0 CA-C-O 121.944 0.878 . . . . 0.0 110.716 -179.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -58.47 -32.98 69.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 113.708 -1.587 . . . . 0.0 110.658 -176.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -60.33 -39.97 96.85 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 119.209 -1.472 . . . . 0.0 109.89 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 5.8 tp -69.49 -33.73 73.29 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 117.056 2.243 . . . . 0.0 117.056 -177.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 9.7 m0 -78.14 -7.62 57.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 111.244 -2.707 . . . . 0.0 109.826 -178.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -43.32 -47.86 6.77 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.327 -176.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -95.7 -36.33 5.35 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 123.936 0.779 . . . . 0.0 111.763 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.463 ' CG2' ' N ' ' A' ' 180' ' ' SER . 0.6 OUTLIER -45.4 -51.23 11.61 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -179.385 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.463 ' N ' ' CG2' ' A' ' 179' ' ' THR . 0.4 OUTLIER -62.9 -50.89 75.0 Favored Pre-proline 0 N--CA 1.473 0.687 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -176.666 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' A' ' 180' ' ' SER . 32.6 Cg_endo -64.8 -28.42 59.38 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 121.683 1.588 . . . . 0.0 111.992 177.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -63.73 -39.87 95.35 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 120.266 -0.574 . . . . 0.0 109.967 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 75.6 t -63.45 -42.43 96.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.89 -39.04 90.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.216 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.25 -41.55 93.46 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.898 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -61.61 -42.87 99.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.732 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.32 -44.27 92.06 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 -178.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 3.5 tp -63.95 -45.18 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.882 -178.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.523 ' O ' ' N ' ' A' ' 193' ' ' GLU . 15.5 m -59.83 -45.86 94.39 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.362 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.436 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -62.39 -42.62 99.57 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.843 0.83 . . . . 0.0 109.915 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' CYS . . . . . . . . . . . . . 41.4 t -61.71 -45.8 92.4 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.384 -1.28 . . . . 0.0 109.249 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -63.86 -39.61 94.61 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 113.097 -1.865 . . . . 0.0 108.501 175.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 189' ' ' VAL . 36.6 tp10 -61.01 -46.28 91.4 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.962 -178.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.46 HD13 HD21 ' A' ' 120' ' ' LEU . 0.6 OUTLIER -64.89 -39.64 93.84 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 118.844 -1.143 . . . . 0.0 110.225 -175.683 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 2.7 p -64.83 -46.43 91.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 116.693 -2.003 . . . . 0.0 107.853 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 96.3 m -64.11 -45.93 86.41 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.58 0.955 . . . . 0.0 113.58 -178.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -55.43 -37.99 68.4 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.716 1.606 . . . . 0.0 112.275 -176.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -55.86 -43.48 77.14 Favored 'General case' 0 C--N 1.312 -1.04 0 O-C-N 121.594 -0.691 . . . . 0.0 109.606 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 19.3 mt -61.31 -39.79 91.78 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -176.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.3 pt -63.49 -41.2 91.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-N 118.461 0.573 . . . . 0.0 111.304 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 10.3 mtpp -57.92 -37.58 74.33 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.935 1.694 . . . . 0.0 113.013 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -63.73 -38.59 91.67 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.889 -0.725 . . . . 0.0 111.039 -177.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.15 128.63 47.15 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 122.184 0.992 . . . . 0.0 111.579 -178.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.421 ' O ' HD22 ' A' ' 205' ' ' LEU . 6.4 tp 67.18 3.9 3.41 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 113.233 -1.803 . . . . 0.0 111.726 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.421 HD22 ' O ' ' A' ' 204' ' ' LEU . 0.8 OUTLIER -125.11 26.97 6.8 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.488 0.661 . . . . 0.0 111.234 -178.598 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.404 ' HD2' ' H ' ' A' ' 207' ' ' ALA . 0.1 OUTLIER -74.25 -21.58 59.71 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.527 179.658 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.476 ' O ' ' O ' ' A' ' 208' ' ' ASN . . . -163.44 33.06 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.197 -1.365 . . . . 0.0 109.078 178.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . 0.476 ' O ' ' O ' ' A' ' 207' ' ' ALA . 12.3 p30 40.54 117.93 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 177.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.473 ' O ' ' O ' ' A' ' 208' ' ' ASN . 9.0 tp 26.35 102.83 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.292 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 34.3 mtt -146.73 51.32 1.11 Allowed 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 177.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.563 HG22 ' H ' ' A' ' 213' ' ' ASP . 4.2 m -158.09 142.77 16.29 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.359 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -83.68 -14.83 50.85 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.196 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.563 ' H ' HG22 ' A' ' 211' ' ' THR . 14.9 m-20 -83.4 73.71 10.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.945 0.402 . . . . 0.0 110.696 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.511 ' N ' ' HD2' ' A' ' 215' ' ' PRO . 13.6 mt -61.39 -44.13 91.68 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 214' ' ' LEU . 29.8 Cg_endo -61.34 -32.28 89.46 Favored 'Trans proline' 0 N--CA 1.501 1.954 0 CA-C-N 120.741 1.301 . . . . 0.0 112.406 -179.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' CYS . . . . . 0.525 ' SG ' ' N ' ' A' ' 217' ' ' HIS . 1.1 p -63.92 -42.44 97.39 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 113.827 -1.533 . . . . 0.0 111.824 -177.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' HIS . . . . . 0.622 ' CE1' ' CE2' ' A' ' 218' ' ' PHE . 3.5 p-80 -66.77 -37.43 84.58 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.425 -0.51 . . . . 0.0 112.163 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' PHE . . . . . 0.622 ' CE2' ' CE1' ' A' ' 217' ' ' HIS . 25.6 m-85 -63.08 -46.88 85.35 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.069 -178.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 10.1 m -60.14 -37.46 80.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 118.271 0.487 . . . . 0.0 110.709 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 54.1 p -59.57 -41.56 90.48 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.605 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.4 -41.63 98.76 Favored 'General case' 0 C--O 1.222 -0.381 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -177.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -61.73 -46.73 88.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 122.056 0.931 . . . . 0.0 113.031 -175.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -60.28 -41.98 98.58 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 107.237 -2.345 . . . . 0.0 107.237 177.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -63.06 -36.99 85.41 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 113.898 -1.151 . . . . 0.0 108.975 176.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.605 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -61.03 -41.67 99.53 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-N 114.062 -1.426 . . . . 0.0 111.472 -176.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' PHE . . . . . 0.44 ' O ' ' OG1' ' A' ' 229' ' ' THR . 60.9 t80 -66.78 -38.26 86.19 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.347 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 94.4 m -63.27 -42.27 99.11 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.41 HG22 ' H ' ' A' ' 228' ' ' THR . 1.0 OUTLIER -62.46 -39.74 94.36 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 120.813 0.339 . . . . 0.0 111.542 179.623 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 226' ' ' PHE . 17.0 p -58.04 -38.8 76.95 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.068 -177.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 99.0 t -59.87 -40.78 83.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 119.224 -0.99 . . . . 0.0 108.635 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.64 ' O ' ' HD2' ' A' ' 234' ' ' PRO . 1.3 mp -61.32 -39.69 83.56 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.573 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 176.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 229' ' ' THR . . . -61.39 -37.5 83.66 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.257 1.423 . . . . 0.0 114.331 -179.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.468 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 1.4 m -56.31 -38.2 65.79 Favored Pre-proline 0 N--CA 1.48 1.053 0 N-CA-C 116.519 2.044 . . . . 0.0 116.519 -173.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.64 ' HD2' ' O ' ' A' ' 231' ' ' ILE . 31.5 Cg_exo -57.97 -38.69 91.1 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 C-N-CA 122.739 2.293 . . . . 0.0 114.051 -175.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.435 ' H ' HG22 ' A' ' 235' ' ' VAL . 3.4 m -63.02 -36.77 77.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 116.795 -1.962 . . . . 0.0 108.846 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -65.88 -40.71 91.84 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -64.9 -44.38 96.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -175.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 91.9 t -62.52 -36.46 75.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 O-C-N 121.885 -0.51 . . . . 0.0 111.97 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 22.6 mmtp -59.91 -44.14 94.47 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -177.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . 0.428 ' H ' HG22 ' A' ' 240' ' ' THR . 0.6 OUTLIER -61.3 -41.91 97.77 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -178.087 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.404 ' O ' ' ND2' ' A' ' 244' ' ' ASN . 5.0 mmm180 -45.56 -45.58 13.63 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.168 0.509 . . . . 0.0 111.146 -179.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.612 ' O ' ' N ' ' A' ' 244' ' ' ASN . 20.4 t80 -37.34 -57.71 0.88 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.961 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' MET . . . . . 0.538 ' O ' ' N ' ' A' ' 245' ' ' SER . 6.9 mmt -25.82 -34.22 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . 0.612 ' N ' ' O ' ' A' ' 242' ' ' TYR . 20.5 p30 -41.0 -20.17 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.957 0.408 . . . . 0.0 110.699 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . 0.538 ' N ' ' O ' ' A' ' 243' ' ' MET . 80.3 p -167.77 177.58 5.7 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.528 0.68 . . . . 0.0 112.76 -178.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -159.24 123.61 3.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.04 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 12.5 mt 63.2 150.09 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.041 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 163.8 -115.93 0.68 Allowed Glycine 0 CA--C 1.527 0.816 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -128.89 54.99 1.75 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.304 0.573 . . . . 0.0 109.984 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -106.9 97.43 7.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.649 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 40.9 t60 -66.39 -51.68 54.56 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -177.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 16.6 p -147.37 -173.59 4.3 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -178.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -60.09 -44.02 95.11 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -55.52 -35.17 61.05 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.167 1.365 . . . . 0.0 111.655 -171.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' HIS . . . . . 0.476 ' O ' HG23 ' A' ' 259' ' ' THR . 86.4 t60 -57.03 -33.19 66.96 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 117.44 -1.704 . . . . 0.0 111.042 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' CYS . . . . . . . . . . . . . 1.5 t -60.98 -44.7 97.0 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 120.838 -1.164 . . . . 0.0 111.333 179.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -60.26 -45.46 93.21 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -177.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.529 HD13 ' O ' ' A' ' 258' ' ' LEU . 0.2 OUTLIER -66.75 -43.4 84.24 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 120.064 -0.654 . . . . 0.0 110.132 -179.931 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . 0.476 HG23 ' O ' ' A' ' 255' ' ' HIS . 60.0 p -62.99 -45.36 92.78 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.257 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' MET . . . . . 0.464 ' C ' ' SD ' ' A' ' 260' ' ' MET . 1.9 tmt? -60.45 -43.86 96.45 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -176.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 33.2 tp -62.21 -46.42 88.98 Favored 'General case' 0 C--N 1.322 -0.624 0 O-C-N 122.029 -0.419 . . . . 0.0 110.413 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' ARG . . . . . 0.413 ' HE ' ' HA ' ' A' ' 262' ' ' ARG . 5.2 tpm_? -66.11 -54.0 30.94 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.49 -178.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . 0.443 ' O ' ' O ' ' A' ' 260' ' ' MET . 23.0 pttm -115.36 162.86 16.54 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.114 0.483 . . . . 0.0 111.526 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . 0.498 ' O ' ' O ' ' A' ' 265' ' ' GLY . 70.0 mm-40 56.5 85.06 0.08 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.679 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.498 ' O ' ' O ' ' A' ' 264' ' ' GLU . . . -43.28 177.36 0.01 OUTLIER Glycine 0 CA--C 1.532 1.12 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -68.17 -8.79 23.83 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.301 2.001 . . . . 0.0 111.216 177.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 34.6 ptt-85 -69.72 -26.81 64.52 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 122.978 0.511 . . . . 0.0 111.853 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -58.55 -32.44 68.89 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.711 -0.796 . . . . 0.0 109.287 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -62.06 -41.55 98.27 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.157 177.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -65.66 -37.31 86.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.433 -178.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.446 ' O ' ' O ' ' A' ' 272' ' ' GLY . 54.5 tttp -82.78 171.98 13.36 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 177.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 271' ' ' LYS . . . 48.76 99.44 0.01 OUTLIER Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -171.42 12.09 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.055 0.455 . . . . 0.0 110.496 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' MET . . . . . 0.592 ' SD ' ' N ' ' A' ' 275' ' ' PRO 0.25 0.0 OUTLIER -63.49 -40.36 57.66 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.81 179.372 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' PRO . . . . . 0.592 ' N ' ' SD ' ' A' ' 274' ' ' MET . 16.6 Cg_exo -63.55 -46.38 9.43 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 121.453 1.435 . . . . 0.0 111.197 -176.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 3.1 m -60.43 -39.88 89.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.657 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -61.99 -42.96 99.72 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 123.079 1.418 . . . . 0.0 112.145 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 84.8 mt -62.28 -38.68 90.28 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 111.59 -2.55 . . . . 0.0 108.151 174.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 -63.01 -39.45 94.8 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.314 0.578 . . . . 0.0 110.527 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.652 HD23 ' O ' ' A' ' 280' ' ' LEU . 1.1 tt -61.76 -36.88 82.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.028 -0.987 . . . . 0.0 112.489 -177.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -68.3 -51.51 32.08 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . 0.533 ' O ' HG22 ' A' ' 285' ' ' VAL . 5.6 t -63.35 -44.5 94.67 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 123.566 0.747 . . . . 0.0 110.349 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' TRP . . . . . 0.406 ' O ' HG22 ' A' ' 286' ' ' VAL . 79.4 t90 -59.9 -37.82 80.51 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.922 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . 0.472 ' ND2' ' C ' ' A' ' 284' ' ' ASN . 0.4 OUTLIER -61.47 -37.94 85.47 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.18 -179.313 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.533 HG22 ' O ' ' A' ' 282' ' ' SER . 0.9 OUTLIER -60.86 -37.69 77.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 O-C-N 121.95 -0.468 . . . . 0.0 111.778 -179.094 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.735 ' O ' HG22 ' A' ' 289' ' ' VAL . 0.9 OUTLIER -61.93 -41.14 89.72 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.661 -177.623 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -61.78 -38.16 87.0 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 121.488 -0.758 . . . . 0.0 109.757 178.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -58.49 -40.62 83.28 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.265 -0.88 . . . . 0.0 112.982 -178.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.735 HG22 ' O ' ' A' ' 286' ' ' VAL . 27.0 m -60.76 -38.53 79.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 119.974 -0.69 . . . . 0.0 110.984 -178.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 16.8 m -62.54 -40.25 96.21 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -60.85 -38.84 86.93 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 177.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.45 -40.49 82.73 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 117.706 -1.597 . . . . 0.0 109.527 -176.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' GLN . . . . . 0.473 ' O ' ' O ' ' A' ' 296' ' ' ARG . 56.9 tt0 -60.45 -42.9 97.08 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 122.595 1.188 . . . . 0.0 110.971 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 10.3 mp -60.32 -40.65 91.34 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 113.119 -1.855 . . . . 0.0 108.79 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -63.27 -45.91 89.25 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.322 178.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' ARG . . . . . 0.473 ' O ' ' O ' ' A' ' 293' ' ' GLN . 27.6 mmm-85 -123.03 116.16 23.06 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -121.41 -164.09 1.1 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.022 0.439 . . . . 0.0 112.179 -178.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.656 ' H ' HD12 ' A' ' 298' ' ' LEU . 0.0 OUTLIER -64.77 -173.96 0.12 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 177.276 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 9.2 ttt -169.15 66.99 0.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 119.236 -0.986 . . . . 0.0 112.832 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.59 100.86 0.07 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.825 0.821 . . . . 0.0 110.534 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -64.08 -46.2 85.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.107 -1.406 . . . . 0.0 113.479 -176.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . 0.525 ' CD2' ' OE1' ' A' ' 306' ' ' GLU . 49.0 t80 -58.8 -39.94 82.62 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 119.706 -0.798 . . . . 0.0 109.563 -178.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -65.26 -46.88 78.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.219 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' SER . . . . . 0.446 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 38.9 t -66.58 -37.67 85.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.796 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 -61.67 -42.8 99.42 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.525 ' OE1' ' CD2' ' A' ' 302' ' ' TYR . 41.4 mt-10 -64.87 -37.08 86.42 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -177.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . 0.553 ' HB3' ' HD3' ' A' ' 308' ' ' PRO . . . -60.06 -53.01 69.36 Favored Pre-proline 0 CA--C 1.544 0.743 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -176.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' PRO . . . . . 0.553 ' HD3' ' HB3' ' A' ' 307' ' ' ALA . 73.6 Cg_endo -75.15 0.17 9.29 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.283 1.988 . . . . 0.0 111.948 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 55.0 t80 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.574 -179.894 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.588 ' N ' ' SD ' ' A' ' 13' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.7 p 45.61 93.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.4 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.655 HG22 ' N ' ' A' ' 16' ' ' LYS . 12.4 p -148.37 171.44 2.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.002 0.43 . . . . 0.0 110.64 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.655 ' N ' HG22 ' A' ' 15' ' ' VAL . 4.6 mtmp? -64.29 -41.41 96.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.972 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -63.43 -41.56 98.68 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -178.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.525 ' H ' HG13 ' A' ' 15' ' ' VAL . 57.5 tp -79.9 -26.33 40.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.148 0.499 . . . . 0.0 111.932 -179.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.41 ' O ' ' OG1' ' A' ' 22' ' ' THR . . . -66.07 -41.33 95.16 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 107.595 -2.202 . . . . 0.0 107.595 177.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.419 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -71.47 -32.24 68.06 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 124.803 2.239 . . . . 0.0 107.54 176.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.5 -42.49 98.93 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-N 108.51 -3.95 . . . . 0.0 108.243 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.41 ' OG1' ' O ' ' A' ' 19' ' ' GLY . 22.2 p -70.63 -27.41 64.04 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.503 0.668 . . . . 0.0 109.248 177.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -66.51 -50.05 64.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.676 -1.147 . . . . 0.0 112.128 -179.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.78 -35.96 79.66 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 118.529 -1.268 . . . . 0.0 111.241 -177.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 68.5 m -63.64 -53.69 47.52 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.24 -178.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.4 pt -65.47 -39.63 85.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -177.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.11 -42.04 97.02 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 119.78 -0.768 . . . . 0.0 112.79 -173.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 32' ' ' PHE . 3.2 m-20 -77.89 -27.28 49.57 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 118.068 -1.453 . . . . 0.0 109.407 -176.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 15.7 mt -60.41 -56.22 24.12 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 120.159 1.345 . . . . 0.0 111.703 -178.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.71 ' N ' HD12 ' A' ' 30' ' ' ILE . 2.5 mp -76.23 -5.09 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 120.076 -0.649 . . . . 0.0 112.293 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 26.3 m -110.33 -17.98 13.37 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 117.656 -1.164 . . . . 0.0 109.71 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.517 ' N ' ' O ' ' A' ' 28' ' ' ASP . 11.4 t80 -67.88 -43.44 37.63 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 122.379 2.354 . . . . 0.0 110.009 -177.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.457 ' CD ' ' N ' ' A' ' 32' ' ' PHE . 38.1 Cg_exo -58.55 -14.68 22.0 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 121.239 1.293 . . . . 0.0 110.949 177.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.5 tp -66.92 -35.59 80.35 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -177.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -64.42 -40.65 96.17 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -177.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.401 ' CG2' ' O ' ' A' ' 33' ' ' PRO . 0.3 OUTLIER -58.39 -33.78 70.0 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.13 -38.77 86.12 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.455 ' CB ' ' NZ ' ' A' ' 38' ' ' LYS . 0.1 OUTLIER -61.67 -47.54 84.87 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 119.415 -0.914 . . . . 0.0 111.734 -176.768 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.2 t -62.2 -38.37 80.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -175.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.504 ' O ' ' N ' ' A' ' 42' ' ' GLN . 45.5 mtp85 -59.5 -41.08 89.05 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 119.236 -0.985 . . . . 0.0 110.049 -179.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -62.38 38.67 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.066 178.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.504 ' N ' ' O ' ' A' ' 40' ' ' ARG . 0.7 OUTLIER -94.57 5.11 52.81 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 121.959 -0.463 . . . . 0.0 111.187 -179.437 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.425 ' O ' ' O ' ' A' ' 42' ' ' GLN . 7.6 mm 60.28 147.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -53.14 105.25 0.12 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.873 0.368 . . . . 0.0 110.438 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.92 50.88 0.37 Allowed Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.981 -0.847 . . . . 0.0 110.981 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.51 ' H ' ' CG2' ' A' ' 51' ' ' VAL . 72.1 mm-40 -73.1 -8.68 56.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.778 0.323 . . . . 0.0 110.674 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.499 ' C ' ' H ' ' A' ' 49' ' ' GLY . 3.6 m 61.42 -159.57 0.32 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.723 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 38.7 tp60 66.4 -7.39 0.43 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.142 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.499 ' H ' ' C ' ' A' ' 47' ' ' SER . . . 84.17 3.53 88.84 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -178.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.573 ' O ' HD13 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -66.61 -38.12 86.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.538 0.685 . . . . 0.0 109.769 178.487 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.51 ' CG2' ' H ' ' A' ' 46' ' ' GLU . 54.6 t -60.74 -44.97 98.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.319 -178.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.96 -34.72 79.09 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.275 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 19.6 p -68.68 -38.25 80.2 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.115 0.483 . . . . 0.0 110.052 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -92.88 -159.77 0.7 Allowed 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.868 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -169.78 -40.19 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.171 -0.611 . . . . 0.0 111.831 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.64 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 87.6 p -126.91 -139.58 0.26 Allowed 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.64 ' HB3' ' O ' ' A' ' 56' ' ' SER . . . 92.87 14.64 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 O-C-N 123.813 0.696 . . . . 0.0 111.81 178.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 90.6 mm-40 -155.45 52.43 0.59 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -41.39 145.43 0.26 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.381 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.418 ' O ' ' C ' ' A' ' 61' ' ' GLY . 62.7 ttp180 -49.8 -44.62 49.23 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 60' ' ' ARG . . . -28.52 101.54 0.01 OUTLIER Glycine 0 CA--C 1.53 0.995 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.7 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.5 p -67.54 -33.97 65.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.34 176.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.25 -32.37 71.08 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 121.165 1.802 . . . . 0.0 109.436 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.32 -49.22 67.14 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 114.832 -1.077 . . . . 0.0 115.062 -176.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 94.6 m -61.9 -46.32 89.87 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 33.7 mm -59.57 -35.49 59.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 76.8 mt -63.19 -35.82 81.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 121.028 1.74 . . . . 0.0 111.506 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.408 ' O ' ' OG1' ' A' ' 72' ' ' THR . 99.4 m -62.47 -38.8 91.24 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 113.219 -1.81 . . . . 0.0 111.053 -177.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 27.8 ttt -60.73 -40.02 90.79 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 -177.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.1 m -69.07 -39.81 80.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 119.612 -0.835 . . . . 0.0 112.375 -178.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -77.42 -12.76 59.99 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 122.182 0.991 . . . . 0.0 113.217 -177.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' A' ' 68' ' ' THR . 33.5 m -62.5 -55.12 30.47 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 113.927 -1.488 . . . . 0.0 112.762 -179.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -113.6 5.24 16.47 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 123.036 1.398 . . . . 0.0 109.466 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 96.46 170.92 34.67 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-N 111.598 -2.546 . . . . 0.0 110.783 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -56.4 -34.47 94.47 Favored 'Trans proline' 0 N--CA 1.5 1.909 0 C-N-CA 122.518 2.145 . . . . 0.0 111.682 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.425 ' O ' ' CB ' ' A' ' 80' ' ' ASN . 1.7 mpt_? -61.01 -10.53 6.03 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.796 0.807 . . . . 0.0 111.093 176.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 81.3 p -77.24 -32.35 55.71 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.168 -1.378 . . . . 0.0 111.231 -177.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.2 tt -75.9 -34.15 59.94 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.297 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -93.76 -5.98 47.1 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 122.022 0.915 . . . . 0.0 113.013 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.425 ' CB ' ' O ' ' A' ' 76' ' ' ARG . 4.2 t30 -81.23 124.69 29.51 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 113.802 -1.545 . . . . 0.0 107.625 176.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.99 0.67 71.12 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 109.696 -1.361 . . . . 0.0 109.696 -178.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 45.3 tp -59.43 -35.33 73.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 113.477 -1.361 . . . . 0.0 110.955 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.8 p -70.76 -26.99 29.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.563 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.8 -31.65 61.79 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.512 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -68.14 -40.79 87.97 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 119.489 -1.338 . . . . 0.0 111.389 -177.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.532 ' O ' ' SD ' ' A' ' 90' ' ' MET . 75.7 mt -62.59 -40.53 97.2 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 122.311 1.053 . . . . 0.0 112.587 -176.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -59.51 -26.22 65.13 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 113.324 -1.762 . . . . 0.0 108.944 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 18.3 ttm180 -57.06 -52.88 63.53 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 113.335 -1.757 . . . . 0.0 106.645 173.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.439 HE22 ' CG ' ' A' ' 28' ' ' ASP . 9.8 tp-100 -67.39 -30.19 69.9 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 112.857 -1.974 . . . . 0.0 113.247 -177.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.552 ' N ' ' SD ' ' A' ' 90' ' ' MET . 0.0 OUTLIER -61.02 -40.9 95.33 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.357 -179.489 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 68.7 p -74.53 -34.5 63.02 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 119.382 -0.927 . . . . 0.0 111.409 -176.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -57.86 -44.41 86.59 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-N 121.041 1.746 . . . . 0.0 111.616 -176.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.76 -33.17 64.16 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.691 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.609 ' O ' HG22 ' A' ' 97' ' ' ILE . 24.3 p -64.18 -42.07 96.84 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.432 ' C ' ' H ' ' A' ' 97' ' ' ILE . 34.5 m -68.16 -27.74 38.3 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.839 177.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.444 ' O ' ' CD1' ' A' ' 100' ' ' TYR . 49.1 ttm-85 -77.21 9.24 3.23 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 -177.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.609 HG22 ' O ' ' A' ' 94' ' ' SER . 11.0 tt -87.12 -15.58 9.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 178.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -140.61 -48.03 0.05 OUTLIER Glycine 0 CA--C 1.538 1.499 0 N-CA-C 115.653 1.021 . . . . 0.0 115.653 -176.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.598 ' N ' HD12 ' A' ' 99' ' ' LEU . 9.4 mp -71.18 -12.7 61.62 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.927 1.363 . . . . 0.0 112.521 -178.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.597 ' CD1' ' N ' ' A' ' 101' ' ' ASP . 0.1 OUTLIER -80.46 -50.76 9.64 Favored 'General case' 0 C--O 1.214 -0.792 0 CA-C-N 114.382 -1.281 . . . . 0.0 111.563 -179.623 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 1.072 ' OD1' ' NE2' ' A' ' 105' ' ' GLN . 28.5 t70 -68.14 -31.2 70.61 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 122.857 1.313 . . . . 0.0 109.446 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.2 t -68.61 -53.42 22.8 Favored 'General case' 0 CA--C 1.554 1.134 0 CA-C-N 112.227 -2.26 . . . . 0.0 113.393 176.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -75.59 -28.22 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 CA-C-N 123.34 2.791 . . . . 0.0 115.708 -178.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 100' ' ' TYR . 18.8 mttt -69.33 -42.3 75.52 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 111.169 -2.741 . . . . 0.0 112.888 -178.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 1.072 ' NE2' ' OD1' ' A' ' 101' ' ' ASP . 88.1 mt-30 -78.97 -10.11 59.73 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 124.225 1.964 . . . . 0.0 111.063 177.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -78.97 -22.45 45.6 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 112.273 -2.24 . . . . 0.0 111.358 177.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.467 ' CZ ' ' OD1' ' A' ' 190' ' ' ASN . 27.5 m-85 -109.3 -30.84 7.8 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 119.637 1.108 . . . . 0.0 111.995 -175.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.9 t -98.66 9.27 43.66 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 117.275 -1.77 . . . . 0.0 112.796 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.512 ' O ' ' C ' ' A' ' 110' ' ' GLY . 0.0 OUTLIER -50.49 122.06 6.58 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 118.395 -0.812 . . . . 0.0 110.948 -179.733 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.518 ' O ' ' CB ' ' A' ' 111' ' ' SER . . . -22.5 -78.83 0.01 OUTLIER Glycine 0 N--CA 1.487 2.066 0 CA-C-N 119.124 0.875 . . . . 0.0 111.73 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 110' ' ' GLY . 5.9 p 94.33 -156.36 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 175.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.496 ' O ' ' N ' ' A' ' 114' ' ' ALA . 76.6 mt-10 -120.45 172.55 7.74 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 114.398 -1.274 . . . . 0.0 111.556 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.617 ' O ' ' HB2' ' A' ' 114' ' ' ALA . 45.1 p-80 -63.81 48.59 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.498 -179.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' A' ' 113' ' ' HIS . . . 159.06 -162.2 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.2 14.98 27.0 Favored Glycine 0 N--CA 1.464 0.514 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.298 177.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 24.0 mm -60.72 -40.45 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.08 -39.41 96.29 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 122.066 0.814 . . . . 0.0 111.67 176.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 7.6 t -58.08 -42.09 84.82 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 177.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.559 HH12 ' NZ ' ' A' ' 201' ' ' LYS . 99.5 mtt180 -63.17 -37.23 86.41 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.227 -177.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 92.5 mt -63.59 -46.01 87.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.256 0.551 . . . . 0.0 109.823 178.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 56.2 mt -66.82 -44.79 80.24 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.391 178.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.11 -45.16 89.85 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 119.876 1.216 . . . . 0.0 110.257 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -65.75 -44.07 92.95 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 120.184 -1.008 . . . . 0.0 111.299 -179.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.4 t -63.93 -43.85 94.63 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.692 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 19.1 m -69.34 -48.32 61.72 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 119.118 -1.033 . . . . 0.0 112.075 177.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.468 HG23 ' N ' ' A' ' 127' ' ' GLY . 5.5 t -65.57 -42.74 91.45 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 -174.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.468 ' N ' HG23 ' A' ' 126' ' ' THR . . . -64.19 -44.48 95.58 Favored Glycine 0 CA--C 1.52 0.396 0 CA-C-O 122.73 1.183 . . . . 0.0 112.95 -177.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.484 ' O ' HG12 ' A' ' 131' ' ' VAL . . . -60.81 -41.35 95.53 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 112.178 -2.011 . . . . 0.0 106.492 177.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.646 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 15.1 tp -64.44 -42.25 96.09 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.773 178.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.11 -39.92 96.1 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -177.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.484 HG12 ' O ' ' A' ' 128' ' ' ALA . 3.3 p -60.9 -24.81 33.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 122.577 1.18 . . . . 0.0 109.265 178.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.646 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . -57.74 -44.85 86.36 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 112.709 -2.041 . . . . 0.0 111.727 -178.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.485 ' CG1' ' N ' ' A' ' 134' ' ' ALA . 3.0 p -79.17 -48.98 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.13 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.485 ' N ' ' CG1' ' A' ' 133' ' ' VAL . . . -103.29 128.78 50.23 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.257 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.503 ' N ' ' HD2' ' A' ' 136' ' ' PRO . 27.3 tt0 -179.58 -50.32 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.718 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 135' ' ' GLN . 11.2 Cg_endo -51.79 -33.89 52.38 Favored 'Trans proline' 0 N--CA 1.499 1.849 0 C-N-CA 121.545 1.497 . . . . 0.0 114.221 -177.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 41.4 p -67.36 -41.71 84.67 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 118.183 -1.407 . . . . 0.0 108.42 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -64.43 -42.26 96.11 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.104 -1.038 . . . . 0.0 111.053 -178.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 88.5 t -63.57 -43.43 98.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.176 0.513 . . . . 0.0 111.07 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 136' ' ' PRO . 53.8 t -64.32 -38.44 82.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.807 -178.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -61.55 -40.58 95.2 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.206 -0.598 . . . . 0.0 111.854 -177.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 97.6 t -69.52 -44.86 79.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.307 0.575 . . . . 0.0 109.66 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.481 HH12 ' HA ' ' A' ' 175' ' ' LEU . 0.3 OUTLIER -64.4 -35.74 81.9 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.545 179.103 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -66.13 -40.76 90.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 112.166 -177.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 4.0 tm0? -64.67 -39.52 93.82 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.08 -1.048 . . . . 0.0 109.841 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.08 -34.93 79.59 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -177.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.419 ' C ' ' OE1' ' A' ' 147' ' ' GLN . 0.0 OUTLIER -59.36 111.41 1.36 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.417 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -96.42 -62.18 1.31 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 117.777 -1.106 . . . . 0.0 113.828 -176.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -62.02 126.7 28.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 122.481 2.4 . . . . 0.0 110.474 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -55.92 -49.43 73.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.664 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.45 ' C ' ' H ' ' A' ' 153' ' ' GLY . . . 152.94 155.32 7.07 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -76.73 27.54 1.6 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.45 ' H ' ' C ' ' A' ' 151' ' ' GLY . . . -159.78 156.5 27.69 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 45.8 ttp180 -71.91 1.58 6.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.115 0.483 . . . . 0.0 110.086 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.505 ' NH1' ' OE2' ' A' ' 161' ' ' GLU . 0.0 OUTLIER -52.88 -35.59 58.1 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.021 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.423 ' O ' ' O ' ' A' ' 157' ' ' GLN . 11.0 t80 76.08 -9.32 1.47 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.01 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.423 ' O ' ' O ' ' A' ' 156' ' ' TYR . 34.3 mt-30 49.67 176.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.992 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 25.7 t -157.05 -177.66 6.78 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.307 0.575 . . . . 0.0 110.883 -179.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.551 HG23 ' N ' ' A' ' 160' ' ' VAL . 9.2 t -63.98 -45.86 87.2 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.675 -177.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.551 ' N ' HG23 ' A' ' 159' ' ' THR . 87.2 t -63.81 -45.17 97.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 119.063 -1.055 . . . . 0.0 108.721 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.505 ' OE2' ' NH1' ' A' ' 155' ' ' ARG . 92.1 mt-10 -67.28 -39.16 85.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.725 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -61.67 -45.87 92.16 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -177.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.438 ' CD1' ' C ' ' A' ' 163' ' ' TYR . 12.5 t80 -62.47 -50.12 72.69 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.06 -179.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -68.2 -45.51 73.16 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -175.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 18.8 m -62.65 -44.73 95.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 119.433 1.015 . . . . 0.0 113.142 -177.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 47.3 mm -64.63 -38.63 83.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-O 121.968 0.89 . . . . 0.0 109.6 176.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.7 -36.31 76.24 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 113.787 -1.551 . . . . 0.0 108.059 176.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 32.2 mmm-85 -62.13 -50.31 72.42 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 122.2 2.273 . . . . 0.0 111.97 -175.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -75.05 -50.92 14.89 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 123.471 0.708 . . . . 0.0 109.113 177.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -78.07 -36.51 48.19 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 -173.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 91.28 -167.32 31.36 Favored Glycine 0 N--CA 1.469 0.836 0 CA-C-N 118.29 0.496 . . . . 0.0 111.945 177.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.416 HG12 ' H ' ' A' ' 172' ' ' ILE . 6.3 pt -72.83 -43.26 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 CA-C-O 121.643 0.735 . . . . 0.0 110.414 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -58.88 -33.65 70.73 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.336 -1.302 . . . . 0.0 111.143 -177.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -60.96 -40.64 98.72 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 118.528 -1.796 . . . . 0.0 109.396 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.528 HD13 ' O ' ' A' ' 175' ' ' LEU . 0.1 OUTLIER -70.72 -34.14 71.59 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 111.134 -2.533 . . . . 0.0 117.065 -177.173 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . 0.528 ' CE2' ' OG ' ' A' ' 180' ' ' SER . 55.7 t90 -78.08 -8.77 58.65 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 111.779 -2.464 . . . . 0.0 110.949 -176.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.409 ' HB2' HH22 ' A' ' 143' ' ' ARG . 0.5 OUTLIER -44.57 -48.96 10.33 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 114.679 1.362 . . . . 0.0 114.679 -175.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -102.99 -37.96 3.02 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 124.206 0.908 . . . . 0.0 113.528 -177.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.446 ' CG2' ' N ' ' A' ' 180' ' ' SER . 0.9 OUTLIER -45.19 -50.98 11.1 Favored 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -178.925 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.528 ' OG ' ' CE2' ' A' ' 176' ' ' TRP . 0.0 OUTLIER -62.64 -50.43 78.26 Favored Pre-proline 0 N--CA 1.48 1.026 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -177.0 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 180' ' ' SER . 25.8 Cg_endo -63.83 -26.97 67.46 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.196 1.931 . . . . 0.0 111.265 177.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 18.0 t30 -62.7 -38.08 89.04 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 39.8 t -62.08 -41.34 90.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.12 -38.69 87.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.746 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 60.3 ttt85 -60.23 -41.15 92.51 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.717 -0.393 . . . . 0.0 109.944 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -60.92 -42.23 97.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.248 0.547 . . . . 0.0 110.463 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . 0.401 ' O ' ' SG ' ' A' ' 191' ' ' CYS . . . -63.8 -42.93 97.61 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.433 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 96.4 mt -62.85 -44.85 99.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -177.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 6.1 m -59.66 -45.8 93.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 119.854 -0.738 . . . . 0.0 110.875 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.467 ' OD1' ' CZ ' ' A' ' 107' ' ' TYR . 53.1 t30 -62.08 -43.55 98.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 122.069 0.937 . . . . 0.0 109.892 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' CYS . . . . . 0.401 ' SG ' ' O ' ' A' ' 187' ' ' ALA . 79.3 m -62.59 -47.02 85.62 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 113.902 -1.499 . . . . 0.0 110.625 178.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.31 -40.69 96.42 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 114.018 -1.446 . . . . 0.0 109.929 177.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -61.1 -45.49 94.51 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.337 -1.302 . . . . 0.0 112.611 -178.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 1.4 tt -63.22 -37.4 87.09 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 118.676 -1.21 . . . . 0.0 108.262 -175.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 66.1 t -62.74 -46.19 96.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 C-N-CA 117.391 -1.723 . . . . 0.0 107.076 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 14.7 m -64.27 -46.37 84.0 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 113.712 1.005 . . . . 0.0 113.712 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -57.36 -39.16 75.4 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.639 1.176 . . . . 0.0 113.27 -177.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -55.63 -44.64 77.29 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -178.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.42 HD12 ' N ' ' A' ' 199' ' ' LEU . 8.8 mp -61.46 -39.23 90.12 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.881 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 1.7 mp -63.38 -43.64 98.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-O 118.333 -0.842 . . . . 0.0 111.366 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . 0.559 ' NZ ' HH12 ' A' ' 119' ' ' ARG . 53.4 mtmt -60.59 -41.3 94.41 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 121.154 1.797 . . . . 0.0 111.237 177.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -65.33 -36.67 84.73 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 113.11 -1.859 . . . . 0.0 110.965 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 54.7 m -101.92 129.91 48.28 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.691 0.758 . . . . 0.0 111.892 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.453 HD13 HD13 ' A' ' 209' ' ' LEU . 0.3 OUTLIER 68.37 5.19 4.61 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 114.615 -1.175 . . . . 0.0 112.192 179.248 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.518 ' O ' ' O ' ' A' ' 201' ' ' LYS . 1.7 tt -148.05 74.1 1.28 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.656 0.741 . . . . 0.0 110.523 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.35 -17.97 17.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.083 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.569 ' O ' ' CG ' ' A' ' 208' ' ' ASN . . . -170.72 18.98 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.573 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . 0.572 ' OD1' ' N ' ' A' ' 209' ' ' LEU . 44.3 p30 115.46 -140.24 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.093 0 O-C-N 125.636 1.835 . . . . 0.0 109.679 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.572 ' N ' ' OD1' ' A' ' 208' ' ' ASN . 13.6 tp -176.07 53.94 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 60.9 mtm -72.42 -13.67 61.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.491 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 16.9 m -56.39 152.92 10.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.911 0.386 . . . . 0.0 111.065 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -83.86 -141.22 0.07 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.574 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 53.11 57.41 6.33 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.442 ' N ' ' CD ' ' A' ' 215' ' ' PRO . 3.3 mt -61.14 -43.74 91.53 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.158 -178.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 214' ' ' LEU . 32.3 Cg_exo -60.5 -32.97 94.29 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 121.21 1.273 . . . . 0.0 111.469 -179.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 76.2 m -64.05 -42.0 97.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 113.322 -1.763 . . . . 0.0 111.611 -178.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -66.53 -37.89 85.98 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.4 -0.52 . . . . 0.0 111.987 -178.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -63.42 -46.93 84.05 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.803 -178.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 1.5 t -60.13 -37.49 80.24 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 118.94 0.791 . . . . 0.0 111.064 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 82.5 p -59.38 -41.28 88.98 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.42 -41.6 98.7 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -177.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -61.46 -46.97 87.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 122.133 0.968 . . . . 0.0 112.387 -176.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -60.5 -41.65 98.76 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 107.361 -2.296 . . . . 0.0 107.361 177.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.644 ' O ' HG23 ' A' ' 228' ' ' THR . . . -62.72 -38.33 90.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.45 -0.875 . . . . 0.0 108.717 177.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -62.04 -42.45 99.73 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -178.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -66.9 -38.36 86.11 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 63.5 m -63.24 -41.28 99.07 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.179 177.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.644 HG23 ' O ' ' A' ' 224' ' ' ALA . 53.2 p -61.89 -40.17 94.51 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.494 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 39.5 m -59.58 -40.46 87.47 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.644 -177.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 95.3 t -61.58 -42.73 95.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 119.245 -0.982 . . . . 0.0 112.318 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.523 ' O ' ' HD2' ' A' ' 234' ' ' PRO . 12.8 pt -62.67 -40.65 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 119.895 -0.722 . . . . 0.0 109.383 177.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -62.78 -39.35 93.92 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.472 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 0.0 OUTLIER -58.44 -42.45 94.7 Favored Pre-proline 0 N--CA 1.481 1.094 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -173.327 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.523 ' HD2' ' O ' ' A' ' 231' ' ' ILE . 32.5 Cg_exo -58.77 -41.05 66.99 Favored 'Trans proline' 0 C--N 1.294 -2.304 0 C-N-CA 122.059 1.84 . . . . 0.0 113.654 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.402 HG22 ' H ' ' A' ' 235' ' ' VAL . 6.9 m -65.99 -37.42 79.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 118.507 -1.277 . . . . 0.0 111.149 178.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -65.54 -41.45 93.05 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -178.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.419 ' O ' ' OG1' ' A' ' 240' ' ' THR . 16.1 m -65.24 -44.86 95.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -176.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 60.3 t -62.8 -37.3 78.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.268 -177.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -60.63 -43.97 96.9 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.486 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 237' ' ' VAL . 31.3 p -61.26 -41.72 97.4 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.238 -0.437 . . . . 0.0 112.156 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.518 ' O ' ' CB ' ' A' ' 242' ' ' TYR . 54.7 ttt-85 -39.76 142.06 0.36 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.757 -179.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.518 ' CB ' ' O ' ' A' ' 241' ' ' ARG . 0.9 OUTLIER 153.88 120.6 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 O-C-N 123.357 0.411 . . . . 0.0 111.109 179.238 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' MET . . . . . 0.435 ' O ' ' O ' ' A' ' 244' ' ' ASN . 12.1 ptp -178.56 -154.67 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . 0.584 ' O ' ' OG ' ' A' ' 245' ' ' SER . 12.1 t-20 57.2 113.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.709 -0.397 . . . . 0.0 110.874 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . 0.584 ' OG ' ' O ' ' A' ' 244' ' ' ASN . 92.6 p 61.94 -127.84 0.73 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.647 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -178.87 -103.78 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.651 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 5.5 mt -70.41 121.67 18.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.749 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -173.3 145.66 8.47 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.962 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.663 ' HB3' ' CE1' ' A' ' 255' ' ' HIS . 96.2 mm-40 51.05 -99.63 0.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.815 0.341 . . . . 0.0 110.633 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER 63.24 140.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.862 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 175.72 -46.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.633 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . 0.656 ' O ' ' N ' ' A' ' 255' ' ' HIS . 30.8 t -178.98 130.49 0.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.632 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.603 ' C ' ' O ' ' A' ' 252' ' ' SER . . . -17.69 -56.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.241 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 252' ' ' SER . . . -42.19 -34.73 1.58 Allowed Glycine 0 N--CA 1.468 0.817 0 CA-C-O 119.394 -0.67 . . . . 0.0 112.773 178.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' HIS . . . . . 0.772 ' CE1' HG21 ' A' ' 259' ' ' THR . 64.7 t-80 -54.32 -36.69 64.02 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 117.545 -1.662 . . . . 0.0 111.066 -179.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' CYS . . . . . . . . . . . . . 17.3 t -60.59 -45.05 95.42 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 119.912 -0.715 . . . . 0.0 112.008 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -60.62 -45.66 93.2 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.446 -0.502 . . . . 0.0 112.303 -177.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.545 HD13 ' O ' ' A' ' 258' ' ' LEU . 0.2 OUTLIER -67.83 -44.58 76.9 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.356 -0.937 . . . . 0.0 110.452 179.64 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . 0.772 HG21 ' CE1' ' A' ' 255' ' ' HIS . 70.0 p -64.03 -47.63 79.47 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -178.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' MET . . . . . 0.56 ' SD ' ' N ' ' A' ' 261' ' ' LEU . 0.0 OUTLIER -62.47 -43.85 97.83 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.232 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.56 ' N ' ' SD ' ' A' ' 260' ' ' MET . 7.0 tp -62.13 -46.57 88.44 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 122.792 0.437 . . . . 0.0 111.093 -178.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 13.6 tpp85 -66.0 -53.81 34.06 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.868 -178.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -91.16 -122.07 0.07 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.735 0.303 . . . . 0.0 111.595 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . 0.494 ' O ' ' O ' ' A' ' 265' ' ' GLY . 58.0 mt-10 -30.57 107.45 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -178.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 264' ' ' GLU . . . -41.38 175.07 0.01 OUTLIER Glycine 0 CA--C 1.533 1.173 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 178.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -68.73 -9.1 25.22 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 122.835 2.357 . . . . 0.0 111.483 177.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 82.6 mtt85 -69.43 -26.61 64.7 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.122 0.569 . . . . 0.0 112.087 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.448 ' HB1' ' NH2' ' A' ' 241' ' ' ARG . . . -58.31 -32.07 68.12 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.392 -179.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -61.99 -41.9 98.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.245 0.545 . . . . 0.0 110.547 177.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -66.15 -37.89 86.77 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.194 -178.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.444 ' O ' ' O ' ' A' ' 272' ' ' GLY . 62.7 mmtt -73.17 -173.75 1.39 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 271' ' ' LYS . . . 48.69 103.87 0.01 OUTLIER Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . 0.401 ' H ' ' H ' ' A' ' 274' ' ' MET . 46.0 p90 -170.46 1.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.449 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' MET . . . . . 0.568 ' N ' ' CD ' ' A' ' 275' ' ' PRO . 0.5 OUTLIER -63.97 -44.53 78.7 Favored Pre-proline 0 CA--C 1.532 0.268 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.869 -179.555 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 274' ' ' MET . 21.5 Cg_exo -64.68 -46.67 6.47 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.44 2.093 . . . . 0.0 110.947 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 51.0 m -60.76 -39.51 89.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.287 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -61.75 -42.76 99.4 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 122.878 1.323 . . . . 0.0 112.814 -178.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 8.5 tp -62.29 -38.79 90.73 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 111.853 -2.43 . . . . 0.0 108.138 174.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 16.2 mmm180 -62.73 -39.49 94.24 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.438 0.637 . . . . 0.0 110.326 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 22.3 tp -61.97 -36.61 81.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.974 -1.012 . . . . 0.0 113.028 -177.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -68.24 -51.34 33.34 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . 0.442 ' O ' HG12 ' A' ' 285' ' ' VAL . 14.0 p -63.07 -44.43 95.81 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.268 0.627 . . . . 0.0 109.883 179.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' TRP . . . . . 0.421 ' O ' HG22 ' A' ' 286' ' ' VAL . 62.7 t90 -60.06 -37.99 81.52 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -61.83 -37.41 84.36 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.587 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 282' ' ' SER . 0.3 OUTLIER -59.88 -37.45 71.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.222 -178.303 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.568 ' O ' HG12 ' A' ' 289' ' ' VAL . 0.9 OUTLIER -61.86 -40.02 85.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 120.234 -0.587 . . . . 0.0 109.755 -179.27 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 16.6 mmt -61.51 -39.59 91.55 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.849 0.357 . . . . 0.0 110.66 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -59.63 -41.95 91.62 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -178.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.568 HG12 ' O ' ' A' ' 286' ' ' VAL . 3.1 p -61.82 -38.62 80.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 O-C-N 121.854 -0.529 . . . . 0.0 111.279 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 10.3 m -62.58 -40.73 97.83 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -61.27 -38.85 88.25 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 176.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -58.28 -40.45 81.95 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 117.867 -1.533 . . . . 0.0 109.616 -176.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' GLN . . . . . 0.48 ' O ' ' O ' ' A' ' 296' ' ' ARG . 75.7 mt-30 -60.75 -43.13 98.37 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 122.554 1.169 . . . . 0.0 111.293 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 9.3 mp -60.8 -40.66 93.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 113.382 -1.736 . . . . 0.0 109.1 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -63.39 -45.96 88.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.047 178.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' ARG . . . . . 0.48 ' O ' ' O ' ' A' ' 293' ' ' GLN . 16.4 tpp180 -123.22 116.02 22.7 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.299 -0.864 . . . . 0.0 108.873 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -122.24 -163.5 1.08 Allowed 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -178.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.604 ' N ' HD22 ' A' ' 298' ' ' LEU . 3.3 mm? -63.54 -175.65 0.13 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 176.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 21.8 ttt -166.55 64.47 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 119.614 -0.835 . . . . 0.0 112.371 -178.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . 0.428 ' CB ' ' OE1' ' A' ' 303' ' ' GLN . . . -175.6 100.85 0.07 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 122.079 0.943 . . . . 0.0 110.52 -178.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.411 ' HB1' ' HE ' ' A' ' 305' ' ' ARG . . . -64.18 -46.34 84.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 113.545 -1.661 . . . . 0.0 113.351 -176.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -58.57 -39.62 80.82 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.014 -177.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . 0.428 ' OE1' ' CB ' ' A' ' 300' ' ' ALA . 47.0 mt-30 -64.9 -46.93 79.65 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.71 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' SER . . . . . 0.433 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 15.5 m -66.79 -38.05 85.77 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.064 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' ARG . . . . . 0.411 ' HE ' ' HB1' ' A' ' 301' ' ' ALA . 65.2 mtt-85 -61.81 -42.61 99.23 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.017 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 10.6 tm-20 -64.75 -36.9 85.81 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -177.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . 0.54 ' HB3' ' HD3' ' A' ' 308' ' ' PRO . . . -60.12 -53.12 68.2 Favored Pre-proline 0 CA--C 1.544 0.717 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -176.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' PRO . . . . . 0.54 ' HD3' ' HB3' ' A' ' 307' ' ' ALA . 73.7 Cg_endo -75.35 0.25 9.27 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.199 1.933 . . . . 0.0 111.955 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 54.2 t80 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.558 -179.841 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 14.5 ptt? . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.5 m 44.61 85.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.617 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.684 HG22 ' H ' ' A' ' 16' ' ' LYS . 8.0 p -156.54 175.45 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.404 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.684 ' H ' HG22 ' A' ' 15' ' ' VAL . 54.3 tttp -64.3 -41.34 96.91 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.951 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -63.58 -41.77 98.34 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.519 ' H ' HG13 ' A' ' 15' ' ' VAL . 44.5 tp -79.8 -26.48 40.54 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.921 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.409 ' O ' ' OG1' ' A' ' 22' ' ' THR . . . -66.32 -41.26 94.68 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 107.615 -2.194 . . . . 0.0 107.615 177.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.42 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -71.39 -32.22 68.19 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 124.811 2.243 . . . . 0.0 107.467 176.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.55 -42.38 98.9 Favored Glycine 0 CA--C 1.528 0.845 1 CA-C-N 108.399 -4.001 . . . . 0.0 108.242 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 19' ' ' GLY . 22.2 p -70.68 -27.55 64.09 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.54 0.686 . . . . 0.0 109.225 177.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -66.48 -50.1 64.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.875 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.79 -35.98 79.76 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 118.46 -1.296 . . . . 0.0 111.253 -177.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 79.2 m -63.9 -53.77 45.25 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.339 -178.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.8 tt -65.64 -39.59 85.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 -177.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.92 -41.93 97.53 Favored 'General case' 0 C--O 1.224 -0.273 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -173.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.412 ' O ' ' OD1' ' A' ' 28' ' ' ASP . 3.8 t70 -77.78 -26.94 50.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 120.345 1.429 . . . . 0.0 110.078 -175.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 45.6 mt -59.86 -55.12 38.1 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 119.841 1.201 . . . . 0.0 112.332 -178.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.0 pt -75.47 -4.31 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -109.68 -17.59 13.66 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 118.54 -1.264 . . . . 0.0 110.253 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -68.08 -44.33 38.39 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 122.046 2.203 . . . . 0.0 110.779 -177.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -59.16 -15.63 29.47 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 CA-C-N 120.836 1.334 . . . . 0.0 111.31 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.607 HD23 ' O ' ' A' ' 34' ' ' LEU . 0.9 OUTLIER -66.8 -35.74 80.77 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.165 -0.925 . . . . 0.0 113.296 -177.293 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -64.44 -40.56 95.98 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.149 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 79.6 p -58.12 -34.87 70.69 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.34 -38.64 85.17 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 119.907 -0.717 . . . . 0.0 112.62 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.446 ' CG ' ' N ' ' A' ' 39' ' ' VAL . 12.0 pttp -61.54 -48.1 82.55 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 119.421 -0.912 . . . . 0.0 111.478 -176.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.446 ' N ' ' CG ' ' A' ' 38' ' ' LYS . 7.2 m -62.92 -38.81 82.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -176.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.508 ' O ' ' N ' ' A' ' 42' ' ' GLN . 61.7 mtp85 -59.86 -41.01 90.55 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 119.356 -0.938 . . . . 0.0 110.175 -178.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -62.59 38.75 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.866 177.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.508 ' N ' ' O ' ' A' ' 40' ' ' ARG . 15.7 pt20 -91.03 149.08 21.97 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.823 -0.548 . . . . 0.0 111.168 -179.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 7.5 mt -96.49 44.59 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.054 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 21.5 mm100 46.62 -165.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.52 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 160.49 -72.02 0.22 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.606 ' H ' ' CD ' ' A' ' 46' ' ' GLU . 2.6 pm0 -44.54 -24.8 0.21 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.859 0.361 . . . . 0.0 110.53 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.9 m 56.78 71.06 0.59 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.761 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -62.03 -27.96 69.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.184 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.77 -14.09 61.04 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 109.009 -1.636 . . . . 0.0 109.009 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.1 mp -65.76 -37.48 86.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.65 -0.775 . . . . 0.0 109.176 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.534 HG23 ' N ' ' A' ' 52' ' ' ARG . 20.0 m -60.87 -44.4 97.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.965 -178.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.534 ' N ' HG23 ' A' ' 51' ' ' VAL . 32.3 ttm180 -64.67 -35.44 81.05 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 119.779 -0.768 . . . . 0.0 112.35 -177.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 t -68.89 -38.01 79.37 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 119.383 -0.927 . . . . 0.0 108.778 177.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -130.63 94.39 3.63 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.571 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.21 -2.21 18.0 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -177.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.607 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 24.3 p -125.21 -141.74 0.29 Allowed 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.607 ' HB3' ' O ' ' A' ' 56' ' ' SER . . . 97.66 13.69 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 O-C-N 124.159 0.912 . . . . 0.0 111.928 178.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.445 ' O ' ' O ' ' A' ' 59' ' ' TYR . 25.0 pt20 -163.26 -39.4 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.369 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.445 ' O ' ' O ' ' A' ' 58' ' ' GLN . 39.5 m-85 54.35 166.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.979 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.408 ' O ' ' C ' ' A' ' 61' ' ' GLY . 65.3 mtm180 -57.54 -41.56 81.2 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 60' ' ' ARG . . . -29.98 102.47 0.01 OUTLIER Glycine 0 CA--C 1.527 0.833 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.567 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.3 p -67.26 -33.75 64.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 118.378 -0.82 . . . . 0.0 109.864 176.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -60.18 -32.27 70.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 121.144 1.793 . . . . 0.0 109.674 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.68 -49.4 64.32 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 115.022 -0.99 . . . . 0.0 114.564 -176.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.4 p -62.28 -46.69 87.67 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.5 tp -60.02 -35.38 60.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.606 HD23 ' O ' ' A' ' 67' ' ' LEU . 1.2 tt -63.21 -35.51 80.55 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 121.291 1.86 . . . . 0.0 110.848 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.614 ' O ' HG23 ' A' ' 72' ' ' THR . 99.9 m -62.63 -38.26 89.55 Favored 'General case' 0 C--O 1.246 0.884 0 CA-C-N 113.049 -1.887 . . . . 0.0 111.069 -175.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.512 ' O ' ' OG1' ' A' ' 72' ' ' THR . 0.4 OUTLIER -60.37 -39.14 86.17 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 120.322 -1.486 . . . . 0.0 114.283 -177.075 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.412 HG22 ' H ' ' A' ' 70' ' ' VAL . 5.7 m -69.49 -40.25 79.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 119.186 -1.005 . . . . 0.0 113.054 -178.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -78.4 -13.3 59.9 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -178.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.614 HG23 ' O ' ' A' ' 68' ' ' THR . 2.5 p -62.86 -54.61 36.07 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.707 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.515 ' N ' ' OE1' ' A' ' 73' ' ' GLU . 54.8 mp0 -107.36 -58.17 1.99 Allowed 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 155.45 164.19 12.89 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -56.59 -35.36 97.04 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 121.714 1.609 . . . . 0.0 111.925 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -61.65 -12.33 15.66 Favored 'General case' 0 C--O 1.226 -0.144 0 CA-C-O 121.751 0.786 . . . . 0.0 110.887 176.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.3 t -78.24 -32.9 49.95 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.247 -1.342 . . . . 0.0 110.805 -178.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 14.6 tp -75.94 -33.28 59.83 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.833 0.349 . . . . 0.0 110.963 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -92.3 -5.01 53.12 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 122.802 1.287 . . . . 0.0 112.767 -178.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -93.92 117.45 30.12 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 112.224 -2.262 . . . . 0.0 107.071 175.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.84 -10.39 57.24 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 -177.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 56.4 tp -59.05 -34.74 72.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 113.281 -1.46 . . . . 0.0 110.687 -179.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 38.2 t -70.44 -26.36 28.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.794 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.64 -31.17 61.89 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.908 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.8 -40.51 89.63 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 119.693 -1.241 . . . . 0.0 111.619 -177.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.408 ' N ' ' CD2' ' A' ' 86' ' ' LEU . 3.7 mm? -62.43 -40.36 96.32 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 122.351 1.072 . . . . 0.0 112.434 -177.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -60.32 -26.91 66.92 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 113.131 -1.85 . . . . 0.0 108.984 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 16.5 ttm-85 -57.73 -53.42 58.36 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 173.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 53.2 tp60 -67.32 -30.02 69.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 112.606 -2.088 . . . . 0.0 112.151 -178.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 11.9 tpt -61.15 -41.35 96.6 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.018 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 40.4 m -74.8 -34.86 62.47 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 119.455 -0.898 . . . . 0.0 111.304 -177.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -57.9 -44.12 86.56 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 120.966 1.712 . . . . 0.0 111.966 -176.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.48 -33.12 64.68 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.551 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.1 m -64.51 -41.69 96.26 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.429 ' CG1' HD12 ' A' ' 99' ' ' LEU . 86.0 t -68.22 -28.45 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.885 177.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.498 ' NH2' ' CE2' ' A' ' 100' ' ' TYR . 54.4 ttt-85 -77.78 9.5 3.45 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -176.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.454 ' O ' HG22 ' A' ' 97' ' ' ILE . 98.3 mt -86.8 -14.71 10.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -139.99 -48.38 0.06 OUTLIER Glycine 0 CA--C 1.543 1.809 0 N-CA-C 116.059 1.184 . . . . 0.0 116.059 -177.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.429 HD12 ' CG1' ' A' ' 95' ' ' VAL . 95.2 mt -71.72 -12.48 61.34 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 119.899 1.849 . . . . 0.0 113.792 -178.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.514 ' HE2' ' HZ1' ' A' ' 104' ' ' LYS . 2.5 t80 -80.12 -51.47 8.95 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.326 -1.306 . . . . 0.0 111.384 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -69.97 -32.35 70.53 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 123.619 1.676 . . . . 0.0 110.925 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.0 t -68.21 -51.07 49.66 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 110.455 -3.066 . . . . 0.0 113.301 177.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.684 HG22 ' CE2' ' A' ' 107' ' ' TYR . 0.3 OUTLIER -73.51 -26.41 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.359 0 CA-C-N 121.337 1.881 . . . . 0.0 111.24 179.115 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.514 ' HZ1' ' HE2' ' A' ' 100' ' ' TYR . 63.8 mttt -69.44 -41.74 75.88 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 112.385 -2.189 . . . . 0.0 112.533 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -80.16 -12.9 59.61 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 122.613 1.197 . . . . 0.0 111.047 -178.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -80.08 -23.19 41.49 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.24 178.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.684 ' CE2' HG22 ' A' ' 103' ' ' VAL . 21.4 m-85 -109.97 -28.54 8.68 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 119.53 1.059 . . . . 0.0 112.881 -175.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.11 9.38 41.06 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 116.765 -1.974 . . . . 0.0 113.962 -175.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.514 ' C ' ' H ' ' A' ' 111' ' ' SER . 62.0 mttp -45.97 130.11 9.75 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.512 1.051 . . . . 0.0 108.699 176.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -63.04 38.98 0.07 OUTLIER Glycine 0 CA--C 1.544 1.903 0 CA-C-N 119.179 0.9 . . . . 0.0 114.166 -178.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.514 ' H ' ' C ' ' A' ' 109' ' ' LYS . 10.6 m -5.29 -81.77 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 116.488 2.033 . . . . 0.0 116.488 -178.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.625 ' O ' ' CG ' ' A' ' 113' ' ' HIS . 2.9 tt0 165.79 -33.24 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 120.456 1.48 . . . . 0.0 113.446 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.655 ' O ' ' HB2' ' A' ' 114' ' ' ALA . 3.9 m-70 160.37 38.01 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.344 0.592 . . . . 0.0 109.931 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.655 ' HB2' ' O ' ' A' ' 113' ' ' HIS . . . 160.37 -162.7 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.855 0.836 . . . . 0.0 109.15 177.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.08 15.45 23.79 Favored Glycine 0 C--N 1.335 0.495 0 CA-C-N 114.104 -1.407 . . . . 0.0 110.512 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.631 HD12 HH21 ' A' ' 119' ' ' ARG . 8.7 tp -60.66 -40.36 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 C-N-CA 119.726 -0.79 . . . . 0.0 109.069 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.508 ' N ' HG23 ' A' ' 116' ' ' ILE . . . -65.99 -40.84 95.44 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-O 121.509 0.505 . . . . 0.0 111.885 175.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 42.0 p -59.11 -43.16 91.9 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 176.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.631 HH21 HD12 ' A' ' 116' ' ' ILE . 9.9 ttp-105 -64.05 -36.98 85.79 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.64 -178.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 18.3 tp -63.43 -45.73 89.61 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 36.5 mt -66.08 -44.58 84.03 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.491 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.8 -45.23 90.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 119.691 1.132 . . . . 0.0 110.27 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -66.01 -44.32 91.78 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.129 -1.034 . . . . 0.0 111.318 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 69.3 m -64.04 -44.12 93.46 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.277 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 96.7 m -69.32 -48.19 62.26 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 119.339 -0.944 . . . . 0.0 111.945 177.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 25.3 p -65.36 -42.68 92.52 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -174.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -64.11 -44.53 95.63 Favored Glycine 0 CA--C 1.521 0.424 0 CA-C-O 122.969 1.316 . . . . 0.0 112.904 -177.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.476 ' O ' HG22 ' A' ' 131' ' ' VAL . . . -61.35 -41.54 97.23 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 111.878 -2.161 . . . . 0.0 107.296 177.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.613 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 35.9 tp -64.04 -42.03 97.19 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.801 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.0 -40.03 96.55 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 113.205 0.816 . . . . 0.0 113.205 -177.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.476 HG22 ' O ' ' A' ' 128' ' ' ALA . 15.5 m -61.07 -26.05 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 122.687 1.232 . . . . 0.0 109.989 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.613 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . -58.35 -45.09 88.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 112.399 -2.182 . . . . 0.0 110.909 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 49.1 t -79.25 -49.08 20.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.449 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -97.96 135.05 40.23 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.478 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.641 ' H ' ' HD2' ' A' ' 136' ' ' PRO . 2.2 tp-100 -177.77 -39.6 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.871 179.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.641 ' HD2' ' H ' ' A' ' 135' ' ' GLN . 73.8 Cg_exo -52.45 -33.55 57.55 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 122.143 1.896 . . . . 0.0 112.46 -179.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 66.6 p -67.53 -42.69 82.31 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 118.725 -1.19 . . . . 0.0 109.879 -178.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -66.24 -42.81 88.11 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 119.303 -0.959 . . . . 0.0 112.136 -178.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 89.6 t -64.11 -44.28 97.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.406 HG13 ' O ' ' A' ' 136' ' ' PRO . 34.5 m -65.07 -39.49 85.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -176.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -63.08 -42.3 99.61 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 118.668 -1.213 . . . . 0.0 111.657 -178.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.421 HG13 ' N ' ' A' ' 143' ' ' ARG . 3.8 p -71.4 -46.45 64.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.678 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.421 ' N ' HG13 ' A' ' 142' ' ' VAL . 14.4 tpp180 -65.9 -38.09 87.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.693 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -68.11 -42.44 80.24 Favored 'General case' 0 C--O 1.226 -0.165 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -177.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -66.23 -40.83 90.55 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 118.819 -1.153 . . . . 0.0 110.133 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.48 -35.18 80.13 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 -178.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.466 ' CG ' ' O ' ' A' ' 147' ' ' GLN . 6.4 pt20 -59.94 111.1 1.35 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 177.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -95.19 -63.84 1.12 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 117.62 -1.181 . . . . 0.0 112.696 -177.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.462 ' O ' ' N ' ' A' ' 151' ' ' GLY . 16.2 mmm180 -77.76 0.12 24.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 122.675 2.489 . . . . 0.0 109.725 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . 62.02 -75.23 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.619 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 149' ' ' ARG . . . 157.56 -115.66 0.67 Allowed Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.46 ' O ' ' N ' ' A' ' 154' ' ' ARG . . . 165.38 -92.24 0.11 Allowed Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 46.46 15.88 0.16 Allowed Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.46 ' N ' ' O ' ' A' ' 152' ' ' GLY . 22.9 ttm-85 65.99 -177.03 0.19 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 81.6 mtt85 55.45 7.44 0.23 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.778 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.452 ' H ' ' C ' ' A' ' 154' ' ' ARG . 1.7 t80 59.48 159.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.43 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -88.21 153.69 21.03 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.946 0.403 . . . . 0.0 111.047 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.711 ' H ' ' CG ' ' A' ' 161' ' ' GLU . 19.5 m -157.12 -178.77 7.61 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 121.309 0.576 . . . . 0.0 111.007 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.548 HG23 ' N ' ' A' ' 160' ' ' VAL . 10.2 t -64.78 -46.32 82.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.442 -178.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.55 HG23 ' N ' ' A' ' 161' ' ' GLU . 27.4 m -64.53 -45.78 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 C-N-CA 119.354 -0.939 . . . . 0.0 110.674 -178.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.711 ' CG ' ' H ' ' A' ' 158' ' ' SER . 3.1 pp20? -67.59 -38.6 84.27 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.545 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.49 ' N ' ' CD ' ' A' ' 161' ' ' GLU . . . -61.58 -45.68 93.08 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -62.37 -49.69 74.54 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.389 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -68.45 -45.53 72.24 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 -176.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 14.5 m -62.85 -44.7 95.44 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -177.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.476 HD12 ' N ' ' A' ' 167' ' ' ALA . 2.6 pp -64.71 -38.37 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 121.955 0.884 . . . . 0.0 109.345 176.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.476 ' N ' HD12 ' A' ' 166' ' ' ILE . . . -59.58 -36.19 75.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 113.786 -1.552 . . . . 0.0 107.486 176.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 11.3 tpp85 -61.98 -49.8 74.64 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 122.266 2.303 . . . . 0.0 111.71 -175.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -74.62 -50.82 16.39 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 123.442 0.697 . . . . 0.0 109.51 177.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -77.85 -36.43 49.99 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 116.997 2.221 . . . . 0.0 116.997 -172.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 90.33 -166.16 31.82 Favored Glycine 0 N--CA 1.471 0.994 0 CA-C-N 118.779 0.718 . . . . 0.0 112.109 177.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.703 ' N ' HD12 ' A' ' 172' ' ' ILE . 2.0 mp -73.1 -44.11 56.93 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 CA-C-O 121.978 0.894 . . . . 0.0 110.251 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 -58.61 -33.47 70.06 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.632 -176.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -60.74 -40.54 98.25 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 118.896 -1.621 . . . . 0.0 110.23 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 52.4 tp -69.93 -33.94 72.8 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 116.646 2.091 . . . . 0.0 116.646 -177.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -78.41 -7.97 57.95 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 111.437 -2.62 . . . . 0.0 109.794 -178.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 38.1 tptt -43.42 -48.39 7.13 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.792 -176.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -86.02 -39.88 7.8 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.237 0.922 . . . . 0.0 110.845 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.6 m -45.44 -51.44 11.47 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.457 ' O ' HG12 ' A' ' 183' ' ' VAL . 2.7 m -63.19 -50.92 73.05 Favored Pre-proline 0 N--CA 1.474 0.739 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -176.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 180' ' ' SER . 33.6 Cg_endo -65.02 -27.32 57.9 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.278 1.985 . . . . 0.0 112.353 177.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -63.0 -38.63 91.96 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 121.228 -0.189 . . . . 0.0 111.102 -178.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.457 HG12 ' O ' ' A' ' 180' ' ' SER . 1.9 p -62.47 -42.02 94.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.372 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.41 ' N ' ' CG1' ' A' ' 183' ' ' VAL . . . -62.22 -39.54 93.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.95 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 72.3 ttp85 -61.08 -42.06 97.81 Favored 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.793 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . 0.557 ' ND2' ' N ' ' A' ' 187' ' ' ALA . 0.1 OUTLIER -62.13 -42.67 99.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.964 0.411 . . . . 0.0 111.348 179.695 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . 0.557 ' N ' ' ND2' ' A' ' 186' ' ' ASN . . . -63.8 -44.24 93.9 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -177.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 7.4 tt -63.98 -45.23 97.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -178.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 12.9 m -60.18 -46.61 94.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 119.679 -0.808 . . . . 0.0 111.807 -178.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.501 ' ND2' ' N ' ' A' ' 191' ' ' CYS . 0.1 OUTLIER -62.41 -43.0 99.86 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 122.274 1.035 . . . . 0.0 109.602 179.414 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' CYS . . . . . 0.501 ' N ' ' ND2' ' A' ' 190' ' ' ASN . 45.9 t -62.36 -47.19 85.3 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 113.538 -1.664 . . . . 0.0 111.004 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.514 ' O ' HG23 ' A' ' 196' ' ' THR . . . -64.89 -41.17 95.84 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.083 177.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -61.09 -45.09 96.13 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.366 -1.288 . . . . 0.0 112.087 -178.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.627 ' CD2' ' HE ' ' A' ' 119' ' ' ARG . 17.5 mt -63.21 -37.0 85.53 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 119.228 -0.989 . . . . 0.0 108.705 -175.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 92.7 t -62.69 -45.98 97.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 C-N-CA 117.074 -1.85 . . . . 0.0 107.101 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . 0.514 HG23 ' O ' ' A' ' 192' ' ' ALA . 59.9 p -64.46 -45.95 85.2 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -178.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -56.92 -38.91 73.52 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.018 1.327 . . . . 0.0 113.209 -177.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -55.37 -44.12 75.76 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.53 HD12 ' N ' ' A' ' 199' ' ' LEU . 10.1 mp -60.84 -38.22 84.74 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.624 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 57.9 mt -61.37 -42.01 92.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.19 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 19.4 mmtp -59.68 -38.22 80.92 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.609 1.564 . . . . 0.0 113.329 177.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -63.27 -39.96 96.06 Favored 'General case' 0 C--N 1.316 -0.862 0 O-C-N 121.941 -0.474 . . . . 0.0 111.027 -177.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.4 t -101.26 129.04 47.14 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 122.041 0.924 . . . . 0.0 112.621 -178.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 2.2 tp 67.73 4.25 3.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 113.788 -1.551 . . . . 0.0 111.976 178.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 2.3 mt -126.71 28.78 5.82 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.718 0.771 . . . . 0.0 112.014 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 18.1 mtpp -73.86 -23.68 59.64 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.258 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -162.99 34.17 0.1 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.658 -1.155 . . . . 0.0 108.316 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 2.4 m120 42.42 54.31 4.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.354 -1.294 . . . . 0.0 113.663 177.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.826 ' H ' HD13 ' A' ' 209' ' ' LEU . 0.0 OUTLIER -115.97 142.96 46.1 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 114.777 -1.101 . . . . 0.0 108.745 178.234 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . 0.415 ' O ' ' O ' ' A' ' 211' ' ' THR . 11.0 mmt -127.24 83.8 2.2 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.415 ' O ' ' O ' ' A' ' 210' ' ' MET . 4.4 m -33.16 154.61 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.467 -178.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . 0.405 ' O ' ' OD1' ' A' ' 213' ' ' ASP . 94.3 m-20 -78.09 68.45 4.13 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.04 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 212' ' ' ASP . 25.3 m-20 -159.28 71.82 0.52 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.467 ' N ' ' CD ' ' A' ' 215' ' ' PRO . 3.4 mt -61.07 -43.48 90.96 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.871 -177.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' A' ' 214' ' ' LEU . 26.4 Cg_exo -61.2 -33.33 90.6 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 120.716 0.944 . . . . 0.0 110.701 -179.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 86.9 m -65.62 -43.58 89.13 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.161 -1.381 . . . . 0.0 112.579 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 38.0 t-80 -67.7 -39.29 84.42 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -177.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -64.12 -46.83 82.43 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.217 -179.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 28.6 p -60.34 -37.84 81.93 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 118.894 0.77 . . . . 0.0 110.239 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 70.7 m -59.76 -41.72 91.68 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.556 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.99 -41.67 97.44 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -177.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -62.02 -47.27 85.5 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.896 0.855 . . . . 0.0 113.111 -176.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -60.98 -42.25 99.7 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 108.0 -2.04 . . . . 0.0 108.0 177.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -63.22 -37.79 88.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.05 -1.075 . . . . 0.0 109.275 176.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -61.33 -41.78 99.61 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 114.172 -1.376 . . . . 0.0 111.59 -176.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -66.08 -38.91 89.45 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 118.168 -1.413 . . . . 0.0 107.949 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 83.6 m -64.01 -41.6 97.41 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.466 0.65 . . . . 0.0 109.778 176.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -61.81 -39.59 92.3 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.321 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 31.3 m -57.85 -39.23 77.24 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.15 -176.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 98.1 t -60.17 -40.87 84.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 118.804 -1.158 . . . . 0.0 108.302 178.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.567 ' O ' ' HD2' ' A' ' 234' ' ' PRO . 0.2 OUTLIER -61.81 -40.8 88.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 177.444 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -62.59 -38.98 92.27 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 115.686 1.736 . . . . 0.0 115.686 -178.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.449 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 0.2 OUTLIER -57.68 -40.82 86.77 Favored Pre-proline 0 N--CA 1.476 0.863 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 -172.721 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.567 ' HD2' ' O ' ' A' ' 231' ' ' ILE . 38.4 Cg_exo -58.62 -40.46 73.5 Favored 'Trans proline' 0 C--N 1.293 -2.343 0 C-N-CA 121.666 1.577 . . . . 0.0 113.78 -177.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.3 m -64.51 -37.44 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 118.395 -1.322 . . . . 0.0 109.336 178.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -65.94 -40.64 91.53 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.05 178.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.552 ' CG1' ' NH1' ' A' ' 241' ' ' ARG . 55.9 t -64.79 -45.07 96.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 115.295 -0.866 . . . . 0.0 113.073 -177.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 15.5 m -62.77 -37.28 78.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 119.749 -0.781 . . . . 0.0 111.299 -177.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -60.81 -44.68 96.56 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.399 -0.52 . . . . 0.0 111.532 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . 0.491 ' OG1' ' NH2' ' A' ' 279' ' ' ARG . 13.5 m -61.8 -42.3 98.84 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.889 0.376 . . . . 0.0 111.56 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.586 ' O ' ' CD2' ' A' ' 242' ' ' TYR . 24.7 mtt85 -49.19 124.31 8.77 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.999 -178.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.586 ' CD2' ' O ' ' A' ' 241' ' ' ARG . 3.3 m-85 171.26 -64.72 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.6 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' MET . . . . . . . . . . . . . 12.2 mmt -69.84 84.99 0.49 Allowed 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.356 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . 0.443 ' O ' ' OG ' ' A' ' 245' ' ' SER . 4.7 p30 -157.94 99.89 1.7 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -178.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 244' ' ' ASN . 11.0 p 66.22 84.89 0.15 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.995 178.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 245' ' ' SER . . . 29.99 -145.0 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.668 178.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.68 -166.27 1.32 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.608 -179.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 172.05 -119.51 0.78 Allowed Glycine 0 CA--C 1.534 1.281 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 1.094 HE21 ' CE1' ' A' ' 255' ' ' HIS . 14.6 mm100 -107.38 133.68 51.54 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 122.679 -0.307 . . . . 0.0 110.761 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.406 ' CD1' ' C ' ' A' ' 249' ' ' GLN . 35.6 m-85 -149.38 34.53 0.72 Allowed 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 118.614 -0.707 . . . . 0.0 111.606 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . 0.441 ' ND1' ' C ' ' A' ' 251' ' ' HIS . 10.8 t-80 -66.4 -54.45 24.22 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 115.915 -2.314 . . . . 0.0 112.166 -176.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 44.2 t -148.74 -175.1 4.81 Favored 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 178.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -62.36 -45.94 90.92 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.852 1.205 . . . . 0.0 110.028 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -58.82 -37.62 90.75 Favored Glycine 0 N--CA 1.475 1.283 0 C-N-CA 124.41 1.005 . . . . 0.0 114.387 -173.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' HIS . . . . . 1.094 ' CE1' HE21 ' A' ' 249' ' ' GLN . 86.4 t60 -59.45 -32.74 70.5 Favored 'General case' 0 C--N 1.367 1.328 0 C-N-CA 116.479 -2.088 . . . . 0.0 111.005 -179.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' CYS . . . . . . . . . . . . . 8.9 t -60.29 -43.93 95.83 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 117.921 0.328 . . . . 0.0 111.138 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -59.16 -44.43 92.13 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.186 -177.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.466 ' N ' HD22 ' A' ' 258' ' ' LEU . 3.6 mm? -66.32 -42.99 87.43 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 119.969 -0.692 . . . . 0.0 110.183 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . 0.517 HG23 ' O ' ' A' ' 255' ' ' HIS . 74.7 p -62.75 -45.66 91.64 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' MET . . . . . . . . . . . . . 2.9 ptm -60.77 -43.48 98.0 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 121.013 -0.275 . . . . 0.0 111.505 -177.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 12.2 mt -62.53 -47.29 84.56 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 59.6 ttt85 -67.11 -54.11 24.46 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.549 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 28.1 mmtp -70.13 -156.42 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.929 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . 0.513 ' OE2' ' N ' ' A' ' 265' ' ' GLY . 1.0 OUTLIER -38.8 133.55 1.08 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.025 -179.702 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.513 ' N ' ' OE2' ' A' ' 264' ' ' GLU . . . -47.98 169.97 0.07 OUTLIER Glycine 0 CA--C 1.533 1.179 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -55.54 -0.67 0.17 Allowed 'Trans proline' 0 N--CA 1.5 1.869 0 C-N-CA 121.978 1.786 . . . . 0.0 112.326 178.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.492 ' H ' ' C ' ' A' ' 265' ' ' GLY . 91.1 mtt180 -69.77 -26.79 64.45 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.13 0.572 . . . . 0.0 112.3 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -58.37 -32.33 68.48 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.1 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . 0.537 ' O ' ' NH2' ' A' ' 241' ' ' ARG . 20.8 m-85 -62.42 -41.34 98.63 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.138 0.494 . . . . 0.0 111.186 177.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -65.74 -37.82 87.42 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -177.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.457 ' O ' ' O ' ' A' ' 272' ' ' GLY . 14.8 mptt -56.39 -172.33 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 271' ' ' LYS . . . 45.82 103.11 0.01 OUTLIER Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.501 -0.64 . . . . 0.0 111.501 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -158.62 -12.91 0.07 Allowed 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.346 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' MET . . . . . 0.541 ' N ' ' HD2' ' A' ' 275' ' ' PRO . 2.1 tpt -64.07 -45.16 79.67 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 120.39 -0.524 . . . . 0.0 111.429 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 274' ' ' MET . 36.9 Cg_endo -64.84 -45.76 7.76 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.362 1.375 . . . . 0.0 111.57 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 78.5 p -59.67 -38.88 82.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.746 -178.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -61.0 -42.55 98.65 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 122.629 1.204 . . . . 0.0 112.017 -178.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 9.4 mp -62.02 -38.45 88.69 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 112.298 -2.228 . . . . 0.0 107.678 174.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . 0.491 ' NH2' ' OG1' ' A' ' 240' ' ' THR . 9.9 mtm180 -62.71 -39.23 93.37 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.21 0.529 . . . . 0.0 110.184 178.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 6.8 tp -61.97 -36.96 83.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.885 -177.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -67.95 -51.23 35.65 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . 0.425 ' O ' HG12 ' A' ' 285' ' ' VAL . 36.3 m -62.92 -44.36 96.29 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' TRP . . . . . 0.471 ' O ' HG22 ' A' ' 286' ' ' VAL . 91.5 t90 -60.05 -38.17 81.99 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.674 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -62.77 -38.62 91.34 Favored 'General case' 0 C--N 1.317 -0.814 0 O-C-N 122.068 -0.395 . . . . 0.0 111.181 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.425 HG12 ' O ' ' A' ' 282' ' ' SER . 0.3 OUTLIER -60.98 -39.36 81.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -177.585 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.471 HG22 ' O ' ' A' ' 283' ' ' TRP . 6.5 m -62.91 -40.08 87.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 119.98 -0.688 . . . . 0.0 109.941 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' MET . . . . . 0.4 ' O ' ' OG1' ' A' ' 290' ' ' THR . 10.0 tpt -60.49 -38.95 85.98 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.162 0.506 . . . . 0.0 109.695 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -58.81 -40.18 83.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.542 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.427 HG12 ' O ' ' A' ' 286' ' ' VAL . 0.3 OUTLIER -60.71 -38.72 79.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.365 -177.645 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.4 ' OG1' ' O ' ' A' ' 287' ' ' MET . 39.4 p -62.71 -40.62 97.74 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 177.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -61.56 -39.05 89.72 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 176.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -58.72 -40.96 85.25 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 117.921 -1.512 . . . . 0.0 109.506 -176.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' GLN . . . . . 0.45 ' O ' ' O ' ' A' ' 296' ' ' ARG . 88.4 mt-30 -60.78 -42.78 98.19 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 122.825 1.298 . . . . 0.0 110.623 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.513 HD13 ' O ' ' A' ' 294' ' ' LEU . 0.2 OUTLIER -60.41 -40.68 91.87 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 112.583 -2.099 . . . . 0.0 109.091 179.507 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 1.8 mmmm -63.48 -45.8 89.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.34 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' ARG . . . . . 0.45 ' O ' ' O ' ' A' ' 293' ' ' GLN . 0.5 OUTLIER -122.96 116.23 23.22 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.364 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -116.25 -95.0 0.48 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.381 0.61 . . . . 0.0 110.767 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.415 ' C ' HD12 ' A' ' 298' ' ' LEU . 3.5 pp -136.65 -166.66 1.93 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.288 178.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 12.5 ttt -170.81 66.36 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.288 -0.565 . . . . 0.0 111.489 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.6 101.01 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.849 0.833 . . . . 0.0 110.697 -178.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -64.05 -46.13 85.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 113.895 -1.502 . . . . 0.0 113.534 -176.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . 0.534 ' CD2' ' OE2' ' A' ' 306' ' ' GLU . 19.9 t80 -58.66 -39.82 81.72 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.643 -178.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -64.84 -46.53 81.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.072 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' SER . . . . . 0.42 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 37.8 m -66.15 -37.17 85.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.539 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -61.12 -42.48 98.61 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.186 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.534 ' OE2' ' CD2' ' A' ' 302' ' ' TYR . 52.1 mt-10 -64.66 -36.83 85.52 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 -177.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . 0.542 ' HB3' ' HD3' ' A' ' 308' ' ' PRO . . . -59.88 -53.0 69.68 Favored Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -176.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' PRO . . . . . 0.542 ' HD3' ' HB3' ' A' ' 307' ' ' ALA . 74.1 Cg_endo -75.13 0.25 9.18 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.109 1.873 . . . . 0.0 111.785 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' PHE . . . . . 0.491 ' CG ' ' O ' ' A' ' 308' ' ' PRO . 56.6 m-85 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.35 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 13.3 tpp . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.733 ' HA ' HD21 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -136.42 111.25 8.78 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.164 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.411 ' H ' ' HG ' ' A' ' 18' ' ' LEU . 7.6 m -114.2 178.47 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 178.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.433 ' CD ' ' N ' ' A' ' 16' ' ' LYS . 3.8 mptp? -64.53 -41.52 96.32 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.189 -0.46 . . . . 0.0 112.066 -178.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -62.94 -42.13 99.71 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -178.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.738 ' C ' HD12 ' A' ' 18' ' ' LEU . 1.1 pp -80.59 -24.17 39.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.428 0.632 . . . . 0.0 112.564 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.478 ' N ' HD12 ' A' ' 18' ' ' LEU . . . -65.07 -40.43 96.99 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 107.241 -2.344 . . . . 0.0 107.241 177.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.452 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -71.17 -31.34 67.55 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 124.515 2.103 . . . . 0.0 107.485 176.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.78 -42.62 98.49 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-N 108.781 -3.827 . . . . 0.0 110.315 -178.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.4 t -70.92 -26.6 63.27 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -65.8 -50.6 64.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.711 -178.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.08 -36.1 80.68 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 118.308 -1.357 . . . . 0.0 111.016 -177.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.9 t -63.97 -53.63 47.11 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.849 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 74.3 mt -65.49 -39.88 86.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -177.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.39 -42.43 96.11 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 119.516 -0.873 . . . . 0.0 112.701 -174.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.409 ' HA ' HG22 ' A' ' 31' ' ' THR . 11.1 t70 -78.13 -27.05 48.17 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 120.718 1.599 . . . . 0.0 110.111 -175.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.494 HD23 ' O ' ' A' ' 29' ' ' LEU . 1.2 tt -59.43 -55.54 33.37 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 120.033 1.288 . . . . 0.0 111.933 -177.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.432 ' O ' HD13 ' A' ' 30' ' ' ILE . 0.4 OUTLIER -75.19 -3.56 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -179.24 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.409 HG22 ' HA ' ' A' ' 28' ' ' ASP . 0.4 OUTLIER -109.5 -17.2 13.81 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.302 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.438 ' O ' ' OD1' ' A' ' 35' ' ' ASP . 1.6 t80 -67.95 -44.62 40.79 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 116.474 -2.09 . . . . 0.0 109.984 -177.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.421 ' CD ' ' N ' ' A' ' 32' ' ' PHE . 35.2 Cg_exo -59.45 -15.68 31.46 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 121.252 1.301 . . . . 0.0 112.291 176.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.96 -35.23 79.51 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -177.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 36' ' ' THR . 27.7 p-10 -64.53 -40.33 95.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.763 -177.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.543 ' N ' ' OD1' ' A' ' 35' ' ' ASP . 31.6 p -58.19 -34.66 70.6 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -179.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.11 -38.78 86.22 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.3 pttp -62.23 -48.3 80.58 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 118.877 -1.129 . . . . 0.0 111.4 -177.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.0 m -63.41 -38.23 81.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 O-C-N 122.135 -0.353 . . . . 0.0 111.927 -178.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.524 ' O ' ' NE2' ' A' ' 42' ' ' GLN . 5.5 mmp_? -59.35 -40.03 85.08 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.514 -178.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.46 38.86 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.524 ' NE2' ' O ' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -114.09 -177.2 3.07 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.407 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.786 HG23 ' H ' ' A' ' 44' ' ' GLN . 13.1 tt -63.12 -62.08 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.364 -0.535 . . . . 0.0 109.81 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.786 ' H ' HG23 ' A' ' 43' ' ' ILE . 3.3 mt-30 169.55 5.95 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.456 ' H ' ' H ' ' A' ' 44' ' ' GLN . . . 54.34 37.46 59.88 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.364 -1.095 . . . . 0.0 110.364 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.443 ' O ' ' CB ' ' A' ' 47' ' ' SER . 2.9 pt-20 -93.17 -95.26 0.15 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.617 0.246 . . . . 0.0 110.515 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.524 ' C ' ' H ' ' A' ' 49' ' ' GLY . 0.9 OUTLIER 82.13 -31.09 0.1 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.82 -179.833 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -65.01 8.43 0.13 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.854 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.524 ' H ' ' C ' ' A' ' 47' ' ' SER . . . 80.85 16.38 75.27 Favored Glycine 0 CA--C 1.535 1.299 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -177.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.572 HD23 ' O ' ' A' ' 50' ' ' LEU . 1.7 tt -61.44 -36.38 80.22 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 114.875 -0.662 . . . . 0.0 110.386 -176.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.499 HG13 ' N ' ' A' ' 52' ' ' ARG . 7.3 p -59.82 -44.64 94.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 C-N-CA 120.191 -0.603 . . . . 0.0 112.2 -178.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.499 ' N ' HG13 ' A' ' 51' ' ' VAL . 45.9 ttp180 -65.33 -35.95 82.54 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 119.451 -0.899 . . . . 0.0 112.793 -178.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 t -69.56 -38.48 77.46 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.628 0.728 . . . . 0.0 109.662 178.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -152.68 123.26 7.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.193 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -99.3 176.66 5.45 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -177.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.618 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 45.7 p 53.9 -141.34 0.87 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 113.993 -1.458 . . . . 0.0 108.923 -178.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.618 ' HB3' ' O ' ' A' ' 56' ' ' SER . . . 95.7 14.23 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.893 178.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 11.9 tp-100 -167.29 73.25 0.12 Allowed 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.547 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -61.05 142.34 56.72 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.433 ' O ' ' C ' ' A' ' 61' ' ' GLY . 84.1 mtp180 -39.41 -37.07 0.42 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.955 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 60' ' ' ARG . . . -28.8 101.44 0.01 OUTLIER Glycine 0 CA--C 1.531 1.064 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.28 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 56.2 t -66.97 -33.79 65.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 118.121 -0.943 . . . . 0.0 109.687 176.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 43.9 mt -60.56 -32.43 71.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 121.489 1.949 . . . . 0.0 111.213 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.6 -49.01 66.84 Favored Glycine 0 CA--C 1.532 1.138 0 N-CA-C 115.246 0.859 . . . . 0.0 115.246 -176.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.439 ' H ' HG22 ' A' ' 65' ' ' THR . 0.6 OUTLIER -61.99 -45.97 91.27 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.465 0.542 . . . . 0.0 112.465 -179.082 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 25.0 pt -59.75 -36.03 63.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 118.365 -0.826 . . . . 0.0 108.845 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 78.3 mt -63.84 -35.72 81.55 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 121.137 1.789 . . . . 0.0 111.749 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 97.9 m -62.91 -39.11 93.51 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 113.506 -1.679 . . . . 0.0 111.008 -175.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.457 ' C ' ' SD ' ' A' ' 69' ' ' MET . 0.0 OUTLIER -60.29 -40.39 90.31 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 120.775 -1.203 . . . . 0.0 113.835 -176.427 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.6 p -69.66 -40.56 79.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 119.211 -0.996 . . . . 0.0 113.176 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 67.9 ttp85 -78.42 -13.27 59.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.709 0.766 . . . . 0.0 112.823 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 61.0 m -62.55 -54.82 34.06 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.111 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -110.18 -54.17 2.6 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 157.03 164.11 13.22 Favored Glycine 0 CA--C 1.539 1.56 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -56.42 -35.47 96.41 Favored 'Trans proline' 0 N--CA 1.503 2.058 0 CA-C-N 119.493 1.646 . . . . 0.0 112.395 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -61.09 -11.47 8.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 122.102 0.953 . . . . 0.0 111.135 176.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.472 ' O ' ' OD1' ' A' ' 80' ' ' ASN . 3.6 t -77.72 -32.26 52.74 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 113.716 -1.583 . . . . 0.0 110.727 -178.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.45 HD22 ' N ' ' A' ' 78' ' ' LEU . 4.1 mm? -75.65 -32.5 60.23 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 122.089 -0.382 . . . . 0.0 110.843 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -91.37 -4.35 55.83 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -176.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.472 ' OD1' ' O ' ' A' ' 77' ' ' SER . 35.1 p30 -95.72 26.88 3.74 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 112.189 -2.278 . . . . 0.0 107.648 175.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -159.05 -19.72 0.03 OUTLIER Glycine 0 CA--C 1.53 1.001 0 CA-C-N 114.28 -1.327 . . . . 0.0 112.417 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.589 HD13 ' O ' ' A' ' 82' ' ' LEU . 0.2 OUTLIER -59.65 -35.16 73.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.263 -0.968 . . . . 0.0 110.502 -179.442 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.9 p -70.87 -27.44 30.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.525 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.86 -31.33 61.6 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.349 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.91 -40.54 89.15 Favored Glycine 0 C--O 1.223 -0.573 0 C-N-CA 119.69 -1.243 . . . . 0.0 111.148 -178.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 50.5 mt -62.37 -40.25 95.84 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 122.476 1.132 . . . . 0.0 112.67 -177.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -60.03 -27.01 66.55 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 112.986 -1.915 . . . . 0.0 109.025 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 36.2 ttp180 -57.31 -52.55 64.89 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 173.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -67.53 -30.32 69.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 112.853 -1.976 . . . . 0.0 112.329 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 11.8 tmm? -61.01 -41.99 97.61 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.551 -0.749 . . . . 0.0 112.484 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 21.8 t -74.81 -34.33 62.35 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.533 -176.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -57.69 -44.08 85.59 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 120.231 1.378 . . . . 0.0 111.9 -176.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.56 -32.87 64.39 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 119.402 -0.919 . . . . 0.0 110.732 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.618 ' O ' HG22 ' A' ' 97' ' ' ILE . 58.4 p -64.51 -42.2 95.96 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.457 ' C ' ' H ' ' A' ' 97' ' ' ILE . 7.1 p -68.39 -28.32 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 177.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.483 ' O ' ' CG ' ' A' ' 96' ' ' ARG . 35.3 ttt-85 -77.36 9.71 3.02 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 -176.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.618 HG22 ' O ' ' A' ' 94' ' ' SER . 3.4 tp -86.92 -15.39 9.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 177.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.498 ' O ' ' OD1' ' A' ' 101' ' ' ASP . . . -140.24 -48.17 0.06 OUTLIER Glycine 0 CA--C 1.544 1.872 0 N-CA-C 116.018 1.167 . . . . 0.0 116.018 -177.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.601 ' N ' HD12 ' A' ' 99' ' ' LEU . 8.6 mp -72.06 -13.06 61.49 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 120.111 1.955 . . . . 0.0 113.669 -178.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.498 ' O ' ' CG ' ' A' ' 104' ' ' LYS . 48.7 t80 -80.48 -51.85 8.32 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 114.551 -1.204 . . . . 0.0 113.025 -178.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.498 ' OD1' ' O ' ' A' ' 98' ' ' GLY . 30.9 p-10 -70.32 -32.36 70.07 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 123.663 1.696 . . . . 0.0 110.821 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.456 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 24.1 p -68.19 -51.34 46.7 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 110.284 -3.144 . . . . 0.0 112.641 176.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 59.1 t -73.51 -26.47 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 CA-C-N 121.254 1.843 . . . . 0.0 112.106 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.498 ' CG ' ' O ' ' A' ' 100' ' ' TYR . 22.7 mmtm -68.89 -41.75 77.85 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 111.914 -2.403 . . . . 0.0 110.757 178.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.487 ' HG3' ' O ' ' A' ' 101' ' ' ASP . 88.1 mt-30 -78.26 -14.64 59.35 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-O 122.772 1.272 . . . . 0.0 111.045 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -79.76 -23.16 42.41 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 114.672 -1.149 . . . . 0.0 112.462 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.622 ' CZ ' ' ND2' ' A' ' 190' ' ' ASN . 32.9 m-85 -109.66 -29.95 8.12 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 119.39 0.995 . . . . 0.0 111.735 -175.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.9 p -97.56 9.33 42.74 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 117.028 -1.869 . . . . 0.0 112.675 -178.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.532 ' O ' ' C ' ' A' ' 110' ' ' GLY . 6.1 pttp -48.06 124.41 7.58 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 117.792 -1.099 . . . . 0.0 109.835 177.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.533 ' O ' ' CB ' ' A' ' 111' ' ' SER . . . -26.46 -77.52 0.01 OUTLIER Glycine 0 N--CA 1.488 2.134 0 CA-C-N 120.46 1.482 . . . . 0.0 111.515 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 110' ' ' GLY . 24.0 p 103.35 -159.68 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 176.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.563 ' O ' ' N ' ' A' ' 114' ' ' ALA . 94.8 mt-10 -128.76 96.8 4.47 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.254 -0.885 . . . . 0.0 112.649 -178.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.636 ' O ' ' HB2' ' A' ' 114' ' ' ALA . 76.8 m-70 12.63 51.11 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 O-C-N 124.245 0.965 . . . . 0.0 113.138 178.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.636 ' HB2' ' O ' ' A' ' 113' ' ' HIS . . . 159.41 -161.79 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.36 14.97 26.65 Favored Glycine 0 C--N 1.338 0.687 0 CA-C-N 114.999 -1.0 . . . . 0.0 113.227 176.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.462 HG23 ' N ' ' A' ' 117' ' ' GLY . 13.0 tt -60.91 -40.35 85.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 119.167 -1.013 . . . . 0.0 109.438 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.462 ' N ' HG23 ' A' ' 116' ' ' ILE . . . -65.49 -39.56 95.72 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 122.047 0.804 . . . . 0.0 111.4 176.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 9.6 p -57.81 -42.11 83.59 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 177.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -63.42 -37.18 86.3 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.975 -178.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 30.8 tp -64.03 -46.98 82.04 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.354 0.597 . . . . 0.0 109.778 178.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 42.8 mt -67.06 -44.83 79.12 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.848 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.78 -44.7 92.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 119.281 0.946 . . . . 0.0 109.36 178.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -65.94 -44.16 92.28 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 119.691 -1.242 . . . . 0.0 111.665 -179.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 67.1 m -63.72 -43.91 95.15 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.384 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 20.9 m -69.44 -48.53 60.65 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 119.082 -1.047 . . . . 0.0 112.023 177.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 41.5 p -65.54 -43.0 91.3 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 -174.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -64.46 -44.85 94.65 Favored Glycine 0 CA--C 1.521 0.407 0 CA-C-N 114.734 -1.121 . . . . 0.0 112.918 -177.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.448 ' O ' HG12 ' A' ' 131' ' ' VAL . . . -61.83 -41.66 98.08 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 112.395 -1.903 . . . . 0.0 107.451 177.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.682 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 24.9 tp -64.67 -42.6 95.26 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.218 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.63 -40.16 96.17 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -177.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.448 HG12 ' O ' ' A' ' 128' ' ' ALA . 2.7 p -61.27 -26.46 39.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 123.363 1.554 . . . . 0.0 109.942 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.682 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . -58.78 -45.68 89.25 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 110.787 -2.915 . . . . 0.0 112.372 -178.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.59 ' C ' HE22 ' A' ' 135' ' ' GLN . 2.5 p -79.79 -48.65 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -178.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -102.5 86.12 2.73 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -177.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.688 ' H ' ' CD ' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -126.77 -22.99 0.04 OUTLIER Pre-proline 0 CA--C 1.551 0.983 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 177.6 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.688 ' CD ' ' H ' ' A' ' 135' ' ' GLN . 6.8 Cg_endo -54.98 -33.13 81.82 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 CA-C-N 121.554 1.591 . . . . 0.0 112.214 -178.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.513 ' O ' ' NZ ' ' A' ' 141' ' ' LYS . 73.3 p -68.22 -42.87 79.14 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 117.828 -1.549 . . . . 0.0 112.286 -175.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -67.46 -44.37 78.78 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 118.438 -1.305 . . . . 0.0 113.373 -178.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.452 HG23 ' N ' ' A' ' 140' ' ' VAL . 27.9 m -65.45 -44.76 94.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -178.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.452 ' N ' HG23 ' A' ' 139' ' ' VAL . 75.2 t -65.48 -40.29 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -176.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.513 ' NZ ' ' O ' ' A' ' 137' ' ' THR . 29.3 mtmm -63.18 -41.53 99.22 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.118 -178.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 3.5 p -71.1 -45.57 71.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.833 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.59 HH21 ' CG2' ' A' ' 166' ' ' ILE . 61.1 mtp180 -64.73 -37.34 87.28 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.161 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.611 ' CD1' ' NE2' ' A' ' 147' ' ' GLN . 76.2 t80 -67.27 -41.76 84.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.451 -178.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 18.0 tm0? -65.92 -40.73 91.71 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.518 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -64.84 -35.96 82.81 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -176.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.611 ' NE2' ' CD1' ' A' ' 144' ' ' PHE . 5.7 pt20 -59.3 111.12 1.24 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 177.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -102.49 -174.87 2.67 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 117.469 2.396 . . . . 0.0 117.469 -171.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 90.9 mtt-85 56.02 105.39 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 110.601 -2.999 . . . . 0.0 110.376 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -44.41 -77.45 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.786 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 46.07 81.95 0.04 OUTLIER Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -75.24 42.2 1.39 Allowed Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.829 -0.909 . . . . 0.0 110.829 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 154' ' ' ARG . . . -66.09 100.08 0.49 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.436 ' O ' ' O ' ' A' ' 153' ' ' GLY . 10.1 tpp85 57.37 156.65 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.745 0.307 . . . . 0.0 110.25 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 15.2 mmt85 48.86 -138.32 0.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.491 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.489 ' O ' ' CD2' ' A' ' 156' ' ' TYR . 74.1 t80 -165.6 6.41 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.059 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.448 ' O ' ' O ' ' A' ' 156' ' ' TYR . 51.0 mt-30 58.45 144.03 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.316 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.644 ' H ' ' CG ' ' A' ' 161' ' ' GLU . 3.5 m -156.97 -178.91 7.72 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.779 0.799 . . . . 0.0 112.23 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 26.4 p -64.87 -46.48 81.61 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 114.234 -1.348 . . . . 0.0 113.063 -177.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 42.4 t -64.28 -45.48 96.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.281 -177.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.644 ' CG ' ' H ' ' A' ' 158' ' ' SER . 8.3 pt-20 -67.99 -38.89 83.21 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.401 ' O ' HG22 ' A' ' 166' ' ' ILE . . . -61.56 -45.72 92.96 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -177.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.451 ' CG ' ' N ' ' A' ' 164' ' ' LYS . 0.1 OUTLIER -62.45 -48.77 78.18 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.041 -179.424 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.451 ' N ' ' CG ' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -67.54 -45.08 76.74 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -174.793 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 40.6 p -62.77 -44.79 95.26 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 119.738 1.154 . . . . 0.0 113.706 -177.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.59 ' CG2' HH21 ' A' ' 143' ' ' ARG . 18.5 tt -64.94 -38.51 82.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-O 121.933 0.873 . . . . 0.0 109.454 176.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.441 ' N ' HG23 ' A' ' 166' ' ' ILE . . . -59.78 -36.56 76.96 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 113.825 -1.534 . . . . 0.0 108.042 176.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -62.1 -50.03 73.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 122.708 2.504 . . . . 0.0 111.51 -175.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -74.75 -51.0 15.34 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 177.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -78.18 -36.51 47.38 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 116.25 1.944 . . . . 0.0 116.25 -173.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 91.78 -167.29 30.72 Favored Glycine 0 N--CA 1.468 0.779 0 CA-C-N 118.553 0.615 . . . . 0.0 112.095 177.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 8.5 pt -72.69 -42.74 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-O 121.845 0.831 . . . . 0.0 110.551 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 53.5 ttt85 -58.94 -33.54 70.73 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 114.381 -1.282 . . . . 0.0 110.838 -177.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -61.12 -40.69 98.89 Favored Glycine 0 CA--C 1.522 0.479 0 C-N-CA 118.503 -1.808 . . . . 0.0 109.592 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.429 ' CD1' ' NH1' ' A' ' 143' ' ' ARG . 7.4 tt -70.42 -33.78 71.74 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 111.688 -2.256 . . . . 0.0 116.701 -177.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 10.1 m0 -78.21 -7.86 57.62 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 111.713 -2.494 . . . . 0.0 109.909 -177.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 16.9 tptm -43.52 -48.3 7.38 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.192 -176.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -91.05 -34.99 7.3 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.449 1.023 . . . . 0.0 111.492 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.3 m -46.29 -51.94 13.6 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.24 -50.83 73.15 Favored Pre-proline 0 N--CA 1.477 0.903 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -176.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -64.06 -28.21 65.7 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 121.666 1.577 . . . . 0.0 111.44 175.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -63.79 -38.8 92.45 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.79 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.419 ' CG1' ' N ' ' A' ' 184' ' ' ALA . 0.8 OUTLIER -62.39 -42.12 94.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.722 -178.648 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.419 ' N ' ' CG1' ' A' ' 183' ' ' VAL . . . -61.96 -39.41 92.02 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.341 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 57.3 ttp85 -60.76 -41.97 96.51 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.093 -179.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -61.58 -43.23 99.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.26 0.552 . . . . 0.0 110.596 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.37 -43.05 95.74 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.741 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 78.1 mt -62.96 -45.02 99.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -176.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.518 ' O ' ' N ' ' A' ' 193' ' ' GLU . 5.9 m -59.44 -46.34 92.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 119.546 -0.861 . . . . 0.0 111.395 -178.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.622 ' ND2' ' CZ ' ' A' ' 107' ' ' TYR . 26.6 t-20 -63.08 -42.98 99.76 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 122.045 0.926 . . . . 0.0 110.908 178.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' CYS . . . . . 0.591 ' SG ' ' N ' ' A' ' 192' ' ' ALA . 0.5 OUTLIER -61.6 -45.41 94.2 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.014 -1.448 . . . . 0.0 108.867 179.049 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.591 ' N ' ' SG ' ' A' ' 191' ' ' CYS . . . -63.76 -39.2 93.69 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 112.584 -2.098 . . . . 0.0 109.149 175.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 189' ' ' VAL . 44.0 tp10 -60.31 -46.38 90.09 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.004 0.922 . . . . 0.0 112.706 -176.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 75.2 mt -65.61 -37.64 87.19 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.671 -175.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 2.5 p -64.26 -46.28 93.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 117.089 -1.845 . . . . 0.0 109.569 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 2.2 t -64.48 -45.36 87.71 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -177.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -57.41 -39.45 76.19 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 114.58 -1.191 . . . . 0.0 112.305 -178.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -56.07 -44.7 79.19 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 47.3 mt -61.83 -39.42 91.73 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.891 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 42.5 mm -63.47 -43.36 98.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 118.813 -0.613 . . . . 0.0 111.257 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . 0.482 ' O ' ' O ' ' A' ' 205' ' ' LEU . 49.9 mtmt -60.27 -40.51 90.63 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 120.171 1.35 . . . . 0.0 111.613 177.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -64.81 -38.23 90.27 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 113.867 -1.515 . . . . 0.0 110.982 -176.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.481 HG23 ' O ' ' A' ' 203' ' ' THR . 13.3 t -101.89 129.16 48.07 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.706 0.765 . . . . 0.0 112.413 -178.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.763 ' O ' HD23 ' A' ' 209' ' ' LEU . 0.5 OUTLIER 68.14 5.63 4.75 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 114.323 -1.308 . . . . 0.0 112.489 178.383 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.482 ' O ' ' O ' ' A' ' 201' ' ' LYS . 0.4 OUTLIER -141.78 79.88 1.7 Allowed 'General case' 0 N--CA 1.472 0.643 0 O-C-N 122.136 -0.352 . . . . 0.0 110.214 -178.652 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.539 ' O ' ' CB ' ' A' ' 207' ' ' ALA . 3.2 mtmp? -112.03 49.3 0.92 Allowed 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.079 -1.013 . . . . 0.0 110.826 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.539 ' CB ' ' O ' ' A' ' 206' ' ' LYS . . . 122.44 34.09 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.491 1.116 . . . . 0.0 110.007 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . 0.537 ' CB ' ' O ' ' A' ' 207' ' ' ALA . 9.0 t-20 102.36 -138.17 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 O-C-N 125.05 1.469 . . . . 0.0 108.95 -177.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.763 HD23 ' O ' ' A' ' 204' ' ' LEU . 0.3 OUTLIER -176.27 58.68 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.22 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 3.4 tpt -81.52 28.04 0.41 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.549 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.529 HG22 ' N ' ' A' ' 212' ' ' ASP . 12.0 m -87.09 168.94 12.82 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.997 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . 0.529 ' N ' HG22 ' A' ' 211' ' ' THR . 8.2 m-20 -104.01 -135.99 0.34 Allowed 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.258 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 212' ' ' ASP . 5.6 p-10 44.27 56.97 4.57 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.455 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.431 ' N ' ' CD ' ' A' ' 215' ' ' PRO . 3.8 mt -61.58 -43.53 88.84 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -178.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 214' ' ' LEU . 31.0 Cg_exo -60.97 -33.51 92.22 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 CA-C-O 122.811 1.088 . . . . 0.0 111.02 -178.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 77.6 m -64.7 -41.79 95.77 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 112.352 -2.204 . . . . 0.0 110.997 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' HIS . . . . . 0.496 ' O ' ' ND1' ' A' ' 217' ' ' HIS . 1.1 t60 -66.28 -37.52 85.63 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.514 -178.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -63.08 -48.13 79.93 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.199 -178.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 78.8 p -60.82 -38.46 85.53 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 119.79 1.177 . . . . 0.0 110.484 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 64.2 m -59.79 -42.01 92.44 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.529 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.98 -42.29 97.27 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -62.78 -48.14 80.45 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -176.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -61.88 -42.89 99.79 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 108.466 -1.854 . . . . 0.0 108.466 177.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -63.43 -38.64 91.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.112 -1.044 . . . . 0.0 109.183 177.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -62.37 -43.31 99.24 Favored Glycine 0 CA--C 1.521 0.435 0 CA-C-N 114.685 -1.143 . . . . 0.0 111.07 -177.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' PHE . . . . . 0.45 ' O ' ' OG1' ' A' ' 229' ' ' THR . 72.7 t80 -67.48 -39.85 85.24 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 119.274 -0.971 . . . . 0.0 109.849 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . 0.529 ' SG ' ' N ' ' A' ' 228' ' ' THR . 1.5 p -64.5 -41.82 96.2 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.766 0.794 . . . . 0.0 109.238 176.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.529 ' N ' ' SG ' ' A' ' 227' ' ' CYS . 91.3 m -62.35 -40.58 96.88 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 114.041 -1.436 . . . . 0.0 111.914 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 226' ' ' PHE . 5.4 p -58.73 -39.99 82.45 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.633 -176.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 58.9 t -61.05 -41.98 91.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 118.423 -1.311 . . . . 0.0 108.449 178.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.538 ' O ' ' HD2' ' A' ' 234' ' ' PRO . 47.8 mt -62.48 -41.41 91.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.485 0.659 . . . . 0.0 110.158 177.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.42 ' HB3' ' HA ' ' A' ' 229' ' ' THR . . . -63.06 -39.37 94.53 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 115.891 1.811 . . . . 0.0 115.891 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.444 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 0.1 OUTLIER -57.95 -41.94 92.62 Favored Pre-proline 0 N--CA 1.475 0.809 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -172.512 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.538 ' HD2' ' O ' ' A' ' 231' ' ' ILE . 30.7 Cg_exo -59.77 -41.13 57.65 Favored 'Trans proline' 0 C--N 1.295 -2.259 0 C-N-CA 121.209 1.272 . . . . 0.0 112.894 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -65.69 -37.03 79.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 118.639 -1.224 . . . . 0.0 109.246 177.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -66.01 -41.71 90.64 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.437 ' CG1' ' N ' ' A' ' 238' ' ' VAL . 1.6 p -65.88 -46.41 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -176.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.437 ' N ' ' CG1' ' A' ' 237' ' ' VAL . 9.9 p -64.17 -38.13 81.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.971 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp -61.18 -44.33 97.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.968 0.413 . . . . 0.0 111.477 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 9.2 m -61.37 -41.97 97.95 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.473 ' O ' ' HB2' ' A' ' 242' ' ' TYR . 5.6 ptm180 -50.26 145.81 5.75 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.576 -178.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.65 ' CG ' ' N ' ' A' ' 243' ' ' MET . 42.8 t80 160.91 -178.49 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 O-C-N 124.807 1.317 . . . . 0.0 109.383 -179.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' MET . . . . . 0.65 ' N ' ' CG ' ' A' ' 242' ' ' TYR . 4.7 ttt 32.28 102.23 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 O-C-N 123.242 0.339 . . . . 0.0 111.675 179.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . 0.512 ' ND2' ' OG ' ' A' ' 245' ' ' SER . 2.9 t30 -179.59 131.77 0.11 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.874 0.369 . . . . 0.0 111.601 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . 0.512 ' OG ' ' ND2' ' A' ' 244' ' ' ASN . 3.8 m 55.24 162.57 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.447 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -175.73 67.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.789 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 68.6 mt -101.99 -87.17 0.41 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.795 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.493 ' H ' ' NE2' ' A' ' 249' ' ' GLN . . . -152.26 -146.42 4.35 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.493 ' NE2' ' H ' ' A' ' 248' ' ' GLY . 3.7 pm0 32.54 -145.0 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 122.277 0.231 . . . . 0.0 111.137 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.647 ' O ' ' CG ' ' A' ' 250' ' ' TYR . 0.1 OUTLIER 54.15 75.06 0.3 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 120.686 -0.406 . . . . 0.0 109.949 179.268 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -67.42 -53.85 25.48 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 117.346 -1.742 . . . . 0.0 112.269 -178.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 39.2 m -148.82 -173.35 4.33 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.0 0.92 . . . . 0.0 109.338 -178.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -59.96 -43.8 94.84 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 178.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -55.8 -34.86 61.66 Favored Glycine 0 N--CA 1.464 0.521 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 -174.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -53.5 -36.57 61.85 Favored 'General case' 0 C--O 1.214 -0.777 0 C-N-CA 117.781 -1.567 . . . . 0.0 110.965 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' CYS . . . . . . . . . . . . . 43.0 t -61.31 -44.67 96.81 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.535 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -60.12 -45.91 91.41 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.405 -0.518 . . . . 0.0 112.261 -177.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.444 ' N ' ' CD2' ' A' ' 258' ' ' LEU . 3.6 mm? -67.58 -44.3 78.49 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 119.395 -0.922 . . . . 0.0 111.2 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 29.7 p -64.18 -47.92 77.93 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -178.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' MET . . . . . . . . . . . . . 10.1 ptm -62.78 -44.13 96.99 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -178.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.508 HD13 ' O ' ' A' ' 261' ' ' LEU . 0.2 OUTLIER -62.23 -47.01 86.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.858 0.361 . . . . 0.0 110.041 -178.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -66.49 -53.69 32.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.547 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 54.1 mttp -80.57 -124.92 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -48.92 117.21 1.97 Allowed 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.454 ' C ' ' H ' ' A' ' 267' ' ' ARG . . . -47.94 175.67 0.02 OUTLIER Glycine 0 CA--C 1.53 1.029 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 179.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.6 0.73 0.69 Allowed 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 122.237 1.958 . . . . 0.0 111.87 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.454 ' H ' ' C ' ' A' ' 265' ' ' GLY . 77.4 mtt85 -68.79 -25.92 64.94 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.195 0.598 . . . . 0.0 111.875 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -57.82 -31.97 67.14 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.127 -178.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -62.07 -42.13 98.88 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.1 0.476 . . . . 0.0 110.78 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -66.39 -38.09 86.73 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -177.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.47 ' CG ' ' N ' ' A' ' 272' ' ' GLY . 53.2 tttp -80.85 173.08 12.96 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . 0.47 ' N ' ' CG ' ' A' ' 271' ' ' LYS . . . 62.38 100.37 0.01 OUTLIER Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -173.85 5.67 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.53 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' MET . . . . . 0.578 ' N ' ' CD ' ' A' ' 275' ' ' PRO . 0.7 OUTLIER -64.03 -44.21 77.27 Favored Pre-proline 0 CA--C 1.531 0.229 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.04 -179.879 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 274' ' ' MET . 21.5 Cg_exo -64.38 -46.46 7.51 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.516 2.144 . . . . 0.0 111.253 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 20.0 m -60.41 -39.44 87.41 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.25 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -61.48 -42.59 99.02 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 122.583 1.182 . . . . 0.0 112.737 -178.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.514 HD13 ' O ' ' A' ' 278' ' ' LEU . 0.2 OUTLIER -61.96 -38.76 89.71 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 112.262 -2.244 . . . . 0.0 107.778 174.501 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 41.7 mmm-85 -62.68 -39.32 93.58 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.32 0.581 . . . . 0.0 110.511 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.66 -36.23 80.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.13 -0.941 . . . . 0.0 113.011 -177.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -67.75 -50.73 40.04 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -178.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 47.8 p -62.74 -43.94 97.5 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' TRP . . . . . . . . . . . . . 75.3 t90 -59.9 -37.94 80.85 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.524 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . 0.405 ' ND2' ' N ' ' A' ' 285' ' ' VAL . 0.0 OUTLIER -61.56 -37.82 85.21 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.559 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.405 ' N ' ' ND2' ' A' ' 284' ' ' ASN . 94.6 t -59.76 -38.3 75.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.576 -0.283 . . . . 0.0 110.397 -179.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.438 ' O ' HG12 ' A' ' 289' ' ' VAL . 10.8 t -62.58 -41.07 90.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.845 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -61.36 -39.25 89.92 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.22 0.533 . . . . 0.0 110.378 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -59.5 -41.05 88.99 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -178.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.438 HG12 ' O ' ' A' ' 286' ' ' VAL . 0.7 OUTLIER -61.36 -40.14 85.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -175.914 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.21 -39.41 94.55 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -60.48 -38.5 84.47 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 176.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 32.9 tp10 -57.94 -40.27 80.11 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 118.157 -1.417 . . . . 0.0 109.417 -176.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' GLN . . . . . 0.435 ' OE1' ' O ' ' A' ' 289' ' ' VAL . 5.2 mp0 -60.35 -42.23 95.3 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 122.827 1.299 . . . . 0.0 110.032 179.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 78.4 mt -60.27 -39.26 86.19 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 112.268 -2.242 . . . . 0.0 109.564 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -62.3 -45.2 94.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.582 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' ARG . . . . . 0.433 ' O ' ' O ' ' A' ' 293' ' ' GLN . 9.0 tpm_? -122.44 116.07 23.34 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -114.22 -163.84 0.89 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.223 0.535 . . . . 0.0 112.113 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 20.1 tp -72.22 114.4 10.29 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 176.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 41.7 ttp -95.93 61.9 2.2 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.527 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.75 101.04 0.07 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.937 0.875 . . . . 0.0 111.071 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -63.94 -46.05 86.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 113.814 -1.539 . . . . 0.0 113.293 -176.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -58.14 -38.9 77.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.739 -177.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 45.3 tp60 -63.75 -46.49 85.09 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.423 -178.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' SER . . . . . 0.438 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 3.4 t -66.0 -37.56 86.23 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.105 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -61.78 -42.94 99.63 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.97 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 11.7 tm-20 -64.94 -37.03 86.29 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -177.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . 0.535 ' HB3' ' HD3' ' A' ' 308' ' ' PRO . . . -60.07 -52.87 70.38 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -176.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' PRO . . . . . 0.535 ' HD3' ' HB3' ' A' ' 307' ' ' ALA . 73.7 Cg_endo -75.4 0.49 9.01 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.166 1.911 . . . . 0.0 112.157 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.588 -179.852 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 10.3 ptt? . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.562 ' O ' HD13 ' A' ' 298' ' ' LEU . 69.9 m -153.25 99.11 2.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.789 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.83 HG22 ' H ' ' A' ' 16' ' ' LYS . 10.8 p -88.32 -178.6 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.28 -178.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.83 ' H ' HG22 ' A' ' 15' ' ' VAL . 12.6 mptt -63.96 -40.88 97.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.99 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -63.54 -41.26 98.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.79 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.476 ' H ' HG13 ' A' ' 15' ' ' VAL . 55.0 tp -79.96 -26.61 39.95 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.804 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.56 -41.53 94.05 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 107.215 -2.354 . . . . 0.0 107.215 176.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.18 -31.78 68.06 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 124.917 2.294 . . . . 0.0 107.286 176.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.45 -42.78 98.92 Favored Glycine 0 CA--C 1.527 0.825 1 CA-C-N 108.32 -4.037 . . . . 0.0 108.234 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 28.9 p -70.65 -28.01 64.49 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.529 0.681 . . . . 0.0 109.345 177.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.562 ' HB2' ' NE2' ' A' ' 293' ' ' GLN . . . -66.2 -50.16 64.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.866 -178.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.443 ' O ' ' OD2' ' A' ' 28' ' ' ASP . . . -62.04 -35.74 79.49 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 118.404 -1.318 . . . . 0.0 111.322 -177.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.638 ' SG ' ' N ' ' A' ' 26' ' ' ILE . 5.4 p -64.1 -53.48 48.93 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.538 -179.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.638 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 11.2 tp -65.59 -39.79 86.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -177.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.02 -41.78 97.32 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 119.775 -0.77 . . . . 0.0 112.967 -173.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.484 ' CG ' ' NE2' ' A' ' 89' ' ' GLN . 1.7 p30 -77.64 -27.14 50.95 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 118.329 -1.348 . . . . 0.0 109.636 -176.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 10.9 tp -60.16 -55.92 27.95 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 119.65 1.114 . . . . 0.0 111.929 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.8 tt -75.58 -4.63 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-O 121.382 0.61 . . . . 0.0 112.274 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.444 ' O ' HG22 ' A' ' 31' ' ' THR . 53.5 m -109.41 -16.72 13.95 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.013 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.485 ' N ' ' HD2' ' A' ' 33' ' ' PRO . 84.2 t80 -68.46 -45.89 36.72 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 121.879 2.127 . . . . 0.0 112.011 -177.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 32' ' ' PHE . 27.7 Cg_endo -60.35 -16.1 39.28 Favored 'Trans proline' 0 N--CA 1.5 1.862 0 CA-C-N 121.27 1.489 . . . . 0.0 112.858 177.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.643 HD13 ' OG ' ' A' ' 282' ' ' SER . 80.5 mt -67.08 -35.18 79.25 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.518 0.932 . . . . 0.0 113.518 -177.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -64.45 -40.07 95.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.236 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.8 m -58.33 -35.0 71.24 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.922 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.65 -37.92 83.1 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.124 -0.63 . . . . 0.0 111.615 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -61.4 -49.09 78.31 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.631 -176.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -63.28 -39.09 83.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 119.193 0.906 . . . . 0.0 112.248 -177.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.61 ' NH2' HE22 ' A' ' 58' ' ' GLN . 0.0 OUTLIER -60.36 -40.7 91.7 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.698 -179.485 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.82 39.02 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.946 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.503 ' N ' ' O ' ' A' ' 40' ' ' ARG . 21.3 pt20 -81.11 147.11 30.24 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.748 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 14.7 mt -82.67 53.19 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.987 0.422 . . . . 0.0 110.246 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 45.01 74.83 0.12 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.742 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.52 59.95 0.31 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.405 ' O ' ' OG ' ' A' ' 47' ' ' SER . 28.3 tp10 -71.21 -7.18 45.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.836 0.35 . . . . 0.0 110.388 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' A' ' 46' ' ' GLU . 23.8 p 57.47 50.02 11.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.492 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -143.77 -18.43 0.6 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.674 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.15 -10.15 74.13 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.0 tp -65.28 -38.11 89.25 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.691 0.281 . . . . 0.0 111.554 -178.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.554 HG23 ' N ' ' A' ' 52' ' ' ARG . 14.7 m -60.88 -44.81 98.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.495 -178.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.554 ' N ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -64.92 -33.43 76.02 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.208 -179.644 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 79.7 m -67.77 -38.23 83.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.969 0.414 . . . . 0.0 110.522 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -86.82 -153.84 0.22 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.77 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -162.42 -53.38 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.89 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.639 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 8.4 t -128.32 -139.1 0.24 Allowed 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.639 ' HB3' ' O ' ' A' ' 56' ' ' SER . . . 93.82 14.63 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.659 0.6 . . . . 0.0 111.592 178.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.61 HE22 ' NH2' ' A' ' 40' ' ' ARG . 6.4 pt20 175.89 122.74 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.946 0.403 . . . . 0.0 109.915 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -105.83 159.46 15.99 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.402 ' O ' ' C ' ' A' ' 61' ' ' GLY . 36.2 ptt180 -43.44 -32.35 0.86 Allowed 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.505 -0.478 . . . . 0.0 109.808 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 60' ' ' ARG . . . -31.37 102.75 0.01 OUTLIER Glycine 0 CA--C 1.526 0.733 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.01 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.7 p -67.08 -33.71 64.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 118.232 -0.889 . . . . 0.0 109.639 176.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -60.32 -32.63 71.42 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 121.442 1.928 . . . . 0.0 110.288 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.49 -49.0 67.54 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-N 115.377 -0.829 . . . . 0.0 114.352 -176.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 14.1 m -61.73 -46.02 91.44 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.201 -0.5 . . . . 0.0 112.057 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 72.1 mt -59.09 -36.23 61.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 74.4 mt -63.63 -34.97 79.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 120.439 1.472 . . . . 0.0 112.602 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.416 ' O ' ' OG1' ' A' ' 72' ' ' THR . 98.9 m -63.47 -41.59 98.6 Favored 'General case' 0 C--O 1.254 1.308 0 C-N-CA 125.433 1.493 . . . . 0.0 110.983 -174.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 6.5 ptp -60.36 -38.92 85.39 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 120.018 -1.676 . . . . 0.0 113.842 -176.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.3 m -68.55 -40.77 82.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 119.025 -1.07 . . . . 0.0 113.627 -176.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 61.5 ttp85 -77.92 -13.55 59.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 122.028 0.918 . . . . 0.0 112.305 -178.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.416 ' OG1' ' O ' ' A' ' 68' ' ' THR . 70.4 m -62.92 -55.05 29.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.335 -1.302 . . . . 0.0 111.775 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -108.68 -58.22 2.04 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.794 178.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.32 164.62 13.58 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -56.59 -35.16 96.87 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 121.966 1.777 . . . . 0.0 111.775 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.465 ' O ' ' OD1' ' A' ' 80' ' ' ASN . 96.5 mtt180 -60.93 -11.19 7.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.928 0.87 . . . . 0.0 110.925 176.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.505 ' O ' ' OD1' ' A' ' 80' ' ' ASN . 7.4 t -77.64 -32.21 53.23 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 113.275 -1.784 . . . . 0.0 110.265 -178.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.9 mp -75.54 -29.34 59.37 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.224 1.01 . . . . 0.0 111.59 177.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -87.4 -2.62 58.75 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 122.896 1.331 . . . . 0.0 113.417 -172.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.505 ' OD1' ' O ' ' A' ' 77' ' ' SER . 11.9 p-10 -117.67 135.14 54.21 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 112.104 -2.316 . . . . 0.0 108.207 176.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.8 -25.9 25.89 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 -177.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.425 ' HG ' ' N ' ' A' ' 83' ' ' VAL . 0.5 OUTLIER -59.14 -34.44 72.06 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 113.834 -1.183 . . . . 0.0 110.283 -179.661 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.425 ' N ' ' HG ' ' A' ' 82' ' ' LEU . 10.6 p -70.83 -27.12 29.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.917 178.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.88 -31.86 61.7 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.408 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.8 -40.13 89.74 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 119.984 -1.103 . . . . 0.0 111.205 -177.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 86.2 mt -62.55 -40.25 96.21 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 122.285 1.04 . . . . 0.0 112.871 -176.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -60.67 -27.5 67.88 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 113.149 -1.841 . . . . 0.0 109.865 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 14.9 mmt85 -57.93 -53.32 59.54 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 173.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.484 ' NE2' ' CG ' ' A' ' 28' ' ' ASP . 60.7 mt-30 -66.83 -29.74 69.74 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 112.418 -2.174 . . . . 0.0 111.776 -177.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 33.9 ttm -61.37 -40.89 95.97 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.067 -0.97 . . . . 0.0 112.429 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.9 m -74.59 -34.65 62.91 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.453 -176.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -57.63 -43.67 84.99 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 120.794 1.633 . . . . 0.0 112.123 -176.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.47 -32.6 64.42 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 119.602 -0.839 . . . . 0.0 111.228 -178.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 38.7 t -64.11 -41.57 97.21 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.401 ' C ' ' H ' ' A' ' 97' ' ' ILE . 30.6 m -67.8 -27.94 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.005 177.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.473 ' O ' ' CG ' ' A' ' 96' ' ' ARG . 6.7 ttt85 -77.61 9.28 3.49 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -176.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.524 HD13 ' O ' ' A' ' 97' ' ' ILE . 0.3 OUTLIER -87.02 -15.95 9.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 176.538 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -140.49 -48.46 0.05 OUTLIER Glycine 0 CA--C 1.544 1.891 0 N-CA-C 115.569 0.987 . . . . 0.0 115.569 -177.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 14.9 mt -71.17 -13.12 61.83 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.2 1.5 . . . . 0.0 112.644 -177.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.494 ' O ' ' HB2' ' A' ' 104' ' ' LYS . 1.9 m-85 -81.0 -50.34 9.81 Favored 'General case' 0 C--O 1.214 -0.785 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.008 178.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.922 ' OD2' ' NE2' ' A' ' 105' ' ' GLN . 19.4 t70 -68.55 -31.82 71.31 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 114.059 -1.428 . . . . 0.0 110.12 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.0 t -69.33 -53.16 21.01 Favored 'General case' 0 CA--C 1.554 1.107 0 CA-C-N 112.203 -2.272 . . . . 0.0 114.544 177.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.1 t -74.9 -27.64 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 CA-C-N 122.487 2.403 . . . . 0.0 113.437 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 100' ' ' TYR . 13.4 tttp -70.16 -40.99 74.41 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 112.004 -2.362 . . . . 0.0 111.548 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.922 ' NE2' ' OD2' ' A' ' 101' ' ' ASP . 88.1 mt-30 -79.62 -13.17 59.69 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.742 0.782 . . . . 0.0 111.071 -178.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -78.79 -22.92 45.58 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.876 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 6.4 m-30 -109.04 -30.11 8.23 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 119.341 0.973 . . . . 0.0 112.068 -174.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.2 m -97.49 9.25 42.91 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 117.926 -1.509 . . . . 0.0 113.233 -178.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.466 ' O ' ' C ' ' A' ' 110' ' ' GLY . 18.7 mmtt -52.77 121.51 7.37 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-N 119.025 0.83 . . . . 0.0 111.715 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.517 ' O ' ' CB ' ' A' ' 111' ' ' SER . . . -22.91 -82.35 0.01 OUTLIER Glycine 0 N--CA 1.485 1.91 0 CA-C-N 118.665 0.666 . . . . 0.0 113.171 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.517 ' CB ' ' O ' ' A' ' 110' ' ' GLY . 1.4 m 96.53 -90.26 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 178.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.513 ' O ' ' CG ' ' A' ' 113' ' ' HIS . 0.3 OUTLIER 168.83 -35.75 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 120.725 1.602 . . . . 0.0 114.215 179.308 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.647 ' O ' ' HB2' ' A' ' 114' ' ' ALA . 1.1 p-80 155.61 46.07 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 121.103 0.477 . . . . 0.0 110.841 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.647 ' HB2' ' O ' ' A' ' 113' ' ' HIS . . . 159.91 -162.9 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.15 15.25 26.4 Favored Glycine 0 C--N 1.337 0.587 0 CA-C-N 114.114 -1.403 . . . . 0.0 111.2 178.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.549 HD13 HH21 ' A' ' 119' ' ' ARG . 31.6 mm -60.66 -41.07 86.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 C-N-CA 120.065 -0.654 . . . . 0.0 109.278 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.54 -40.12 95.94 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 121.91 0.728 . . . . 0.0 111.858 175.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 35.6 t -57.78 -41.81 82.79 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 177.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.549 HH21 HD13 ' A' ' 116' ' ' ILE . 9.5 ttm-85 -63.23 -36.78 84.78 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.984 -177.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 58.5 mt -63.73 -46.33 85.84 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.255 0.55 . . . . 0.0 109.805 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 41.5 mt -66.65 -44.77 81.02 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 119.112 -1.035 . . . . 0.0 110.459 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.69 -44.83 92.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 119.625 1.102 . . . . 0.0 109.932 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -65.73 -44.2 92.79 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 119.801 -1.19 . . . . 0.0 111.126 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 77.9 p -64.5 -44.44 90.96 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.829 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 97.2 m -69.47 -48.4 60.86 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 119.453 -0.899 . . . . 0.0 111.916 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.493 HG23 ' N ' ' A' ' 127' ' ' GLY . 6.2 t -65.26 -42.41 93.3 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -174.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.493 ' N ' HG23 ' A' ' 126' ' ' THR . . . -64.07 -44.78 95.33 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-O 122.704 1.169 . . . . 0.0 113.518 -177.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.448 ' O ' HG22 ' A' ' 131' ' ' VAL . . . -61.58 -41.62 97.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 112.358 -1.921 . . . . 0.0 107.141 177.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.68 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 1.8 mm? -64.66 -42.08 95.65 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.725 178.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.22 -39.94 96.05 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -177.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.524 ' O ' ' NE2' ' A' ' 135' ' ' GLN . 15.3 m -61.27 -25.75 37.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 123.005 1.383 . . . . 0.0 109.902 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.68 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . -58.31 -44.93 88.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 111.906 -2.406 . . . . 0.0 112.621 -178.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.493 HG13 ' N ' ' A' ' 134' ' ' ALA . 3.5 p -78.95 -48.72 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 C-N-CA 120.712 -0.395 . . . . 0.0 112.006 -178.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.493 ' N ' HG13 ' A' ' 133' ' ' VAL . . . -122.95 135.92 54.67 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.994 0.426 . . . . 0.0 111.575 -178.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.787 ' H ' ' CD ' ' A' ' 136' ' ' PRO . 24.4 pt20 177.99 -24.61 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.703 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.717 178.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.787 ' CD ' ' H ' ' A' ' 135' ' ' GLN . 52.9 Cg_exo -53.14 -33.42 63.99 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 121.437 1.425 . . . . 0.0 112.691 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.494 HG23 ' N ' ' A' ' 138' ' ' ASP . 11.1 t -66.54 -41.76 88.21 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 119.234 -0.986 . . . . 0.0 109.523 -178.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.494 ' N ' HG23 ' A' ' 137' ' ' THR . 4.5 m-20 -64.93 -42.59 94.56 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 117.876 -1.53 . . . . 0.0 111.566 -178.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 15.1 t -64.64 -44.9 96.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.0 p -65.38 -37.08 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -178.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.44 ' O ' ' OE1' ' A' ' 145' ' ' GLN . 14.0 mptt -60.42 -40.2 90.19 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.713 -176.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 70.5 t -68.54 -44.52 82.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.523 ' NH2' ' O ' ' A' ' 174' ' ' GLY . 65.6 mtt-85 -64.34 -36.09 83.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.066 178.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.414 ' CD1' ' C ' ' A' ' 144' ' ' PHE . 36.0 t80 -66.46 -41.56 88.85 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -177.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.44 ' OE1' ' O ' ' A' ' 141' ' ' LYS . 4.8 mp0 -64.83 -39.5 93.68 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 118.941 -1.104 . . . . 0.0 108.087 178.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.39 -34.59 78.66 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.732 HE22 HE21 ' A' ' 157' ' ' GLN . 32.9 tt0 -60.54 110.3 1.24 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 175.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.468 ' C ' ' H ' ' A' ' 150' ' ' ALA . . . -106.1 -55.18 2.36 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 -175.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -77.24 21.47 0.24 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 122.327 2.33 . . . . 0.0 110.417 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.468 ' H ' ' C ' ' A' ' 148' ' ' ALA . . . 51.24 -94.72 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.659 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -162.78 -37.91 0.02 OUTLIER Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 55.85 -133.96 50.04 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 65.13 28.2 73.25 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 53.1 ttt85 61.74 54.9 2.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.833 0.349 . . . . 0.0 110.409 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -170.1 143.95 2.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.625 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -87.71 109.49 19.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.467 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.732 HE21 HE22 ' A' ' 147' ' ' GLN . 19.0 tt0 -71.54 164.8 25.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.455 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.441 ' OG ' ' N ' ' A' ' 159' ' ' THR . 29.7 t -156.94 -177.94 7.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.878 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.441 ' N ' ' OG ' ' A' ' 158' ' ' SER . 69.5 p -63.79 -45.96 87.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.65 -177.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 77.0 t -64.04 -45.37 96.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 119.067 -1.053 . . . . 0.0 109.165 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -66.89 -38.44 86.29 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.527 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.575 ' O ' HD12 ' A' ' 166' ' ' ILE . . . -61.33 -44.27 97.48 Favored 'General case' 0 C--O 1.211 -0.969 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -177.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.436 ' O ' HD11 ' A' ' 166' ' ' ILE . 32.3 t80 -61.32 -47.85 84.04 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.67 0.747 . . . . 0.0 112.151 -177.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 17.8 tptp -68.19 -45.33 73.69 Favored 'General case' 0 CA--C 1.554 1.129 0 N-CA-C 117.841 2.534 . . . . 0.0 117.841 -172.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 17.6 m -63.1 -45.48 91.86 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 117.344 2.35 . . . . 0.0 117.344 -174.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.73 HD13 ' H ' ' A' ' 166' ' ' ILE . 0.1 OUTLIER -64.62 -37.36 79.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-O 121.524 0.678 . . . . 0.0 109.271 176.925 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.18 -37.02 76.38 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 176.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -62.57 -50.32 71.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 122.992 2.633 . . . . 0.0 111.465 -177.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -75.15 -51.24 13.91 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 123.539 0.736 . . . . 0.0 109.409 177.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -78.27 -36.8 46.32 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 115.775 1.768 . . . . 0.0 115.775 -174.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 93.71 -168.44 29.12 Favored Glycine 0 N--CA 1.468 0.788 0 CA-C-N 118.472 0.578 . . . . 0.0 112.615 177.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.6 mt -73.56 -41.62 55.78 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.067 0 CA-C-O 122.252 1.025 . . . . 0.0 110.62 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 60.5 ttt85 -58.31 -32.77 68.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 113.448 -1.706 . . . . 0.0 111.027 -176.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.523 ' O ' ' NH2' ' A' ' 143' ' ' ARG . . . -59.83 -39.37 95.33 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 119.292 -1.432 . . . . 0.0 109.579 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.403 HD22 ' OH ' ' A' ' 163' ' ' TYR . 5.5 tp -69.44 -33.39 72.88 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 117.085 2.254 . . . . 0.0 117.085 -177.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 67.3 m95 -77.58 -7.46 56.37 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 111.254 -2.703 . . . . 0.0 109.843 -177.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -43.28 -48.02 6.66 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.556 -177.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -111.24 -29.61 3.41 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.065 0.84 . . . . 0.0 112.046 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 3.9 m -46.26 -52.14 13.15 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.31 -49.75 77.83 Favored Pre-proline 0 N--CA 1.481 1.118 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -177.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -62.2 -27.87 78.88 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 121.973 1.782 . . . . 0.0 111.766 175.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -63.41 -39.04 93.44 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 178.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.422 HG13 HG21 ' A' ' 131' ' ' VAL . 97.0 t -63.21 -42.0 94.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.251 178.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.53 -39.21 90.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.237 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.53 -41.52 94.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.035 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -60.97 -42.38 98.22 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.265 0.555 . . . . 0.0 110.051 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.68 -43.1 97.64 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.166 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 5.6 mm -63.14 -44.78 99.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -177.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.401 ' O ' ' CD ' ' A' ' 193' ' ' GLU . 6.9 m -59.69 -45.7 94.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 120.328 -0.549 . . . . 0.0 111.472 -178.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.5 ' OD1' ' N ' ' A' ' 191' ' ' CYS . 2.0 p30 -61.84 -42.52 99.13 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 122.259 1.028 . . . . 0.0 108.91 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' CYS . . . . . 0.5 ' N ' ' OD1' ' A' ' 190' ' ' ASN . 52.2 t -62.15 -46.56 88.44 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 113.294 -1.775 . . . . 0.0 110.922 179.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.35 -40.61 96.2 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 114.296 -1.32 . . . . 0.0 109.529 176.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 0.515 ' N ' ' OE1' ' A' ' 193' ' ' GLU . 0.0 OUTLIER -61.52 -45.4 94.37 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.768 -178.701 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 4.1 tt -64.01 -39.52 94.3 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 118.331 -1.348 . . . . 0.0 110.18 -174.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 8.2 m -64.59 -45.86 94.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 116.909 -1.916 . . . . 0.0 107.775 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 98.4 m -64.16 -46.33 84.53 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -177.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -57.92 -40.11 79.61 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -178.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -56.48 -44.98 81.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.573 0.701 . . . . 0.0 109.317 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.515 ' N ' ' CD2' ' A' ' 199' ' ' LEU . 1.5 mm? -61.92 -39.89 93.6 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.51 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 45.6 mm -64.03 -43.54 97.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 118.575 -0.726 . . . . 0.0 112.893 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -59.63 -40.95 89.29 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 120.588 1.54 . . . . 0.0 110.839 178.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -66.22 -38.46 88.01 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 112.939 -1.937 . . . . 0.0 111.027 -177.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 43.8 m -102.26 130.3 48.91 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.367 -0.833 . . . . 0.0 112.446 -178.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 20.9 mt 68.08 5.58 4.7 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 114.777 -1.101 . . . . 0.0 113.402 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.403 ' CD2' ' O ' ' A' ' 205' ' ' LEU . 2.3 tt -137.37 49.58 2.0 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 178.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 4.3 tppt? -74.11 -23.55 59.33 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.718 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.483 ' O ' ' CB ' ' A' ' 208' ' ' ASN . . . -130.04 -40.22 1.34 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.776 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . 0.626 ' O ' ' N ' ' A' ' 210' ' ' MET . 41.2 p-10 130.34 76.1 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.247 1.419 . . . . 0.0 108.007 -178.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 3.1 tp 2.07 38.87 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 118.276 2.695 . . . . 0.0 118.276 178.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . 0.626 ' N ' ' O ' ' A' ' 208' ' ' ASN . 41.6 ttp -78.17 -56.82 4.16 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 120.583 1.538 . . . . 0.0 112.282 -178.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.403 ' C ' ' O ' ' A' ' 210' ' ' MET . 44.3 p -34.44 126.41 0.48 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.941 0.401 . . . . 0.0 111.88 -179.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -60.86 114.84 3.27 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.733 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.491 ' OD1' ' SG ' ' A' ' 216' ' ' CYS . 32.9 t70 -174.17 30.58 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -61.31 -43.72 90.68 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -177.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -60.86 -34.07 91.8 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 CA-C-N 120.778 1.313 . . . . 0.0 111.514 -177.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' CYS . . . . . 0.491 ' SG ' ' OD1' ' A' ' 213' ' ' ASP . 62.4 m -66.56 -42.69 86.69 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 113.089 -1.869 . . . . 0.0 111.862 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 13.2 t-160 -66.59 -37.54 85.12 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.081 -1.418 . . . . 0.0 114.425 -176.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -62.92 -48.33 79.39 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 118.775 -0.631 . . . . 0.0 110.775 -178.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 12.9 m -61.26 -39.09 89.07 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 120.028 1.285 . . . . 0.0 110.013 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 39.5 t -59.97 -41.71 92.56 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 177.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.564 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.53 -41.79 98.45 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -177.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -61.55 -46.86 88.13 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 122.162 0.982 . . . . 0.0 112.822 -175.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -60.88 -42.11 99.51 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 107.458 -2.257 . . . . 0.0 107.458 176.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.913 ' O ' HG23 ' A' ' 228' ' ' THR . . . -63.03 -37.21 86.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 113.869 -1.166 . . . . 0.0 108.934 176.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -61.06 -42.51 99.82 Favored Glycine 0 CA--C 1.52 0.383 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.626 -176.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' PHE . . . . . 0.419 ' O ' ' OG1' ' A' ' 229' ' ' THR . 67.3 t80 -66.88 -38.87 87.11 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 118.782 -1.167 . . . . 0.0 108.4 178.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . 0.511 ' SG ' ' O ' ' A' ' 224' ' ' ALA . 0.5 OUTLIER -63.89 -41.18 97.79 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.165 0.507 . . . . 0.0 110.251 177.445 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.913 HG23 ' O ' ' A' ' 224' ' ' ALA . 78.5 p -61.58 -40.3 94.28 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.465 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 226' ' ' PHE . 23.8 p -59.34 -40.26 85.77 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 119.802 -0.759 . . . . 0.0 111.567 -176.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 92.7 t -61.47 -43.17 96.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 118.588 -1.245 . . . . 0.0 111.919 -178.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 3.4 tp -63.08 -40.86 90.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 121.711 0.767 . . . . 0.0 109.148 176.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.418 ' O ' HG12 ' A' ' 235' ' ' VAL . . . -62.58 -39.39 93.56 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 114.331 -1.304 . . . . 0.0 113.924 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.509 ' N ' ' HD2' ' A' ' 234' ' ' PRO . 8.0 t -58.34 -42.39 94.49 Favored Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 116.04 1.867 . . . . 0.0 116.04 -174.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 233' ' ' SER . 17.9 Cg_endo -58.93 -40.9 67.34 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 CA-C-N 121.352 1.519 . . . . 0.0 113.457 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.418 HG12 ' O ' ' A' ' 232' ' ' ALA . 2.8 p -65.52 -37.63 80.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 118.357 -1.337 . . . . 0.0 110.914 178.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -66.42 -42.0 88.4 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 15.6 m -65.59 -45.66 91.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -176.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 12.9 p -63.74 -38.49 82.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 119.116 -1.034 . . . . 0.0 112.047 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -61.57 -45.91 92.11 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 119.94 -0.704 . . . . 0.0 112.591 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . 0.419 ' O ' ' C ' ' A' ' 241' ' ' ARG . 1.6 t -62.5 -41.69 98.99 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 120.97 0.414 . . . . 0.0 110.864 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.419 ' C ' ' O ' ' A' ' 240' ' ' THR . 29.8 ttp180 -29.38 134.92 0.04 OUTLIER 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.328 -178.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -159.14 -76.53 0.07 Allowed 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' MET . . . . . . . . . . . . . 31.6 mmm -42.17 122.12 2.06 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.875 0.845 . . . . 0.0 112.281 -178.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . 0.827 ' OD1' ' SG ' ' A' ' 256' ' ' CYS . 19.0 p30 -171.46 118.04 0.44 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.32 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . 0.686 ' O ' ' HB2' ' A' ' 246' ' ' ALA . 15.9 m 63.44 -123.86 0.57 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.086 -177.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . 0.686 ' HB2' ' O ' ' A' ' 245' ' ' SER . . . 153.45 -97.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.295 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.456 HD22 ' N ' ' A' ' 247' ' ' LEU . 2.3 mm? -57.97 -161.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.85 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 1.065 ' O ' ' N ' ' A' ' 250' ' ' TYR . . . 73.04 -162.63 54.82 Favored Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 111.695 -0.562 . . . . 0.0 111.695 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.523 ' O ' ' C ' ' A' ' 250' ' ' TYR . 96.2 mm-40 -33.75 61.31 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.816 0.341 . . . . 0.0 110.773 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 1.065 ' N ' ' O ' ' A' ' 248' ' ' GLY . 66.9 t80 -26.8 -68.17 0.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.711 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . 0.572 ' ND1' ' NE2' ' A' ' 255' ' ' HIS . 32.5 m170 39.25 -92.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.866 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . 0.485 ' N ' ' O ' ' A' ' 250' ' ' TYR . 23.9 m -149.52 140.11 22.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.121 -179.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.499 ' O ' ' SG ' ' A' ' 256' ' ' CYS . . . -32.73 -44.9 0.11 Allowed 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -66.24 -40.92 94.97 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.803 178.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' HIS . . . . . 0.572 ' NE2' ' ND1' ' A' ' 251' ' ' HIS . 86.4 t60 -62.92 -33.08 74.57 Favored 'General case' 0 C--N 1.367 1.332 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.033 -176.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' CYS . . . . . 0.827 ' SG ' ' OD1' ' A' ' 244' ' ' ASN . 3.8 p -60.46 -42.63 96.6 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.807 ' HB2' ' ND2' ' A' ' 244' ' ' ASN . . . -58.81 -43.45 90.56 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.161 -179.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.523 HD13 ' O ' ' A' ' 258' ' ' LEU . 0.3 OUTLIER -65.01 -42.91 94.0 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.558 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' A' ' 256' ' ' CYS . 67.0 p -62.29 -43.59 98.48 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.634 0.73 . . . . 0.0 109.222 177.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' MET . . . . . 0.468 ' HB2' ' OG ' ' A' ' 245' ' ' SER . 39.1 ttp -58.71 -41.6 86.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.625 -1.17 . . . . 0.0 110.066 -179.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 15.3 tp -61.06 -45.86 93.02 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.745 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 40.5 ttt-85 -65.77 -54.07 32.05 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 120.434 -0.506 . . . . 0.0 112.029 -177.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 3.4 pttt -75.34 -52.99 9.49 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 119.877 -0.729 . . . . 0.0 111.46 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' A' ' 265' ' ' GLY . 22.9 mt-10 -84.36 112.55 20.43 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.356 -179.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 264' ' ' GLU . . . -39.65 170.51 0.01 OUTLIER Glycine 0 CA--C 1.532 1.097 0 CA-C-N 115.718 -0.673 . . . . 0.0 112.564 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.3 -2.36 5.83 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.492 2.128 . . . . 0.0 112.515 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.77 -26.42 64.28 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -58.37 -32.5 68.63 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.241 -178.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -62.5 -41.46 98.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.4 0.619 . . . . 0.0 110.96 177.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -65.86 -37.18 85.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.338 -178.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.78 164.04 13.85 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 60.45 106.16 0.01 OUTLIER Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -174.68 12.32 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.441 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' MET . . . . . 0.478 ' N ' ' HD2' ' A' ' 275' ' ' PRO . 17.1 mtt -63.84 -44.93 80.91 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 274' ' ' MET . 38.0 Cg_endo -64.93 -47.39 4.97 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 CA-C-N 120.586 1.245 . . . . 0.0 112.436 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 89.7 p -61.32 -40.57 94.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.754 0.787 . . . . 0.0 109.926 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -62.05 -41.85 98.56 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 123.597 1.665 . . . . 0.0 112.264 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 29.4 mt -62.0 -38.5 88.87 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 110.272 -3.149 . . . . 0.0 108.513 174.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . 0.402 HH11 ' HB ' ' A' ' 240' ' ' THR . 21.6 ttt180 -62.67 -40.88 98.46 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.475 0.655 . . . . 0.0 110.465 179.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.8 ' O ' HD12 ' A' ' 280' ' ' LEU . 0.1 OUTLIER -62.43 -36.56 82.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.326 -177.585 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -68.04 -51.14 35.64 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -178.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . 0.643 ' OG ' HD13 ' A' ' 34' ' ' LEU . 7.5 t -63.09 -45.04 93.99 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.226 0.61 . . . . 0.0 110.506 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' TRP . . . . . 0.433 ' O ' HG22 ' A' ' 286' ' ' VAL . 16.3 t90 -60.77 -38.22 84.51 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.698 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . 0.446 ' OD1' ' CD1' ' A' ' 280' ' ' LEU . 2.2 m120 -61.96 -37.72 85.8 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.43 0.529 . . . . 0.0 112.43 -178.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.493 HG22 ' O ' ' A' ' 282' ' ' SER . 1.0 OUTLIER -59.95 -37.67 73.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -177.447 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 283' ' ' TRP . 1.0 OUTLIER -61.95 -40.11 86.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.942 -178.682 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 4.5 ptm -60.58 -38.77 85.7 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -58.65 -40.04 82.31 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.444 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 86.0 t -60.73 -39.37 81.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.522 -178.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 71.0 m -63.03 -40.56 98.09 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 119.654 -0.819 . . . . 0.0 109.039 177.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -60.92 -38.94 87.52 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 177.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -58.34 -40.21 81.56 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 117.756 -1.578 . . . . 0.0 109.847 -176.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' GLN . . . . . 0.562 ' NE2' ' HB2' ' A' ' 23' ' ' ALA . 76.6 mt-30 -60.32 -42.67 96.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 122.893 1.33 . . . . 0.0 110.874 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 9.4 mp -60.29 -39.75 88.02 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 112.487 -2.142 . . . . 0.0 109.226 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 26.7 mmtt -62.9 -45.47 92.39 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.055 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' ARG . . . . . 0.459 ' O ' ' O ' ' A' ' 293' ' ' GLN . 41.4 ttm180 -122.83 116.38 23.57 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -116.97 -162.69 0.87 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.311 0.577 . . . . 0.0 112.356 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.562 HD13 ' O ' ' A' ' 14' ' ' THR . 1.9 mt -69.55 116.14 9.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.504 177.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 2.5 tpt -99.5 60.4 1.14 Allowed 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -177.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.66 100.78 0.07 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.651 0.739 . . . . 0.0 110.551 -178.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -63.96 -46.21 85.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.345 -1.298 . . . . 0.0 114.029 -176.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -58.77 -39.9 82.4 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.185 -178.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . 0.528 ' OE1' ' N ' ' A' ' 303' ' ' GLN . 11.0 mp0 -65.0 -46.76 80.05 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.413 -179.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' SER . . . . . 0.439 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 78.1 p -66.69 -37.68 85.23 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.508 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -61.83 -43.15 99.42 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -179.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -65.11 -37.09 86.37 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 -176.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . 0.559 ' HB3' ' HD3' ' A' ' 308' ' ' PRO . . . -60.17 -52.98 69.45 Favored Pre-proline 0 CA--C 1.544 0.738 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 -176.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' PRO . . . . . 0.559 ' HD3' ' HB3' ' A' ' 307' ' ' ALA . 74.2 Cg_endo -75.29 0.3 9.18 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.147 1.898 . . . . 0.0 111.929 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 86.0 t80 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.547 -179.965 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.8 mmt . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.9 m -69.63 126.51 29.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.455 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.456 HG12 ' N ' ' A' ' 16' ' ' LYS . 24.0 t -147.57 158.92 8.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.518 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.456 ' N ' HG12 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -64.41 -41.55 96.57 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.582 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.404 ' N ' ' CG ' ' A' ' 16' ' ' LYS . 4.4 t80 -63.95 -41.6 97.53 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.523 ' N ' HD22 ' A' ' 18' ' ' LEU . 3.3 mm? -79.58 -26.73 41.24 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.803 -178.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.404 ' O ' ' OG1' ' A' ' 22' ' ' THR . . . -66.2 -41.29 94.91 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 107.486 -2.245 . . . . 0.0 107.486 177.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.43 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -71.73 -32.21 67.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 124.79 2.233 . . . . 0.0 107.705 176.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.47 -42.4 99.01 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-N 108.501 -3.954 . . . . 0.0 108.091 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 19' ' ' GLY . 34.4 p -70.55 -27.34 64.07 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 177.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -66.39 -50.09 64.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.879 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.0 -36.17 80.72 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 118.621 -1.232 . . . . 0.0 111.502 -177.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.625 ' SG ' ' N ' ' A' ' 26' ' ' ILE . 8.7 p -63.88 -53.21 54.07 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.382 -178.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.625 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -64.84 -38.98 84.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -176.505 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.544 ' O ' HG23 ' A' ' 31' ' ' THR . . . -63.73 -41.2 98.09 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -173.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.524 ' OD1' ' NE2' ' A' ' 89' ' ' GLN . 6.7 m-20 -77.18 -27.24 53.57 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 120.976 1.717 . . . . 0.0 111.714 -174.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.442 ' H ' ' HG ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -59.98 -54.09 50.12 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 121.29 1.859 . . . . 0.0 112.894 -178.395 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.5 tt -75.34 -4.2 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -179.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.544 HG23 ' O ' ' A' ' 27' ' ' ALA . 34.2 p -109.03 -16.03 14.22 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 119.369 -0.932 . . . . 0.0 109.315 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.49 ' N ' ' HD2' ' A' ' 33' ' ' PRO . 88.1 t80 -68.18 -45.77 39.86 Favored Pre-proline 0 CA--C 1.546 0.826 0 CA-C-N 121.821 2.1 . . . . 0.0 111.488 -178.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 32' ' ' PHE . 26.3 Cg_endo -60.33 -15.72 36.89 Favored 'Trans proline' 0 N--CA 1.504 2.122 0 CA-C-N 121.299 1.5 . . . . 0.0 113.195 176.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.414 ' N ' HD22 ' A' ' 34' ' ' LEU . 3.9 mm? -66.62 -34.94 79.0 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -177.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -64.18 -40.17 95.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.345 -178.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.3 m -58.3 -35.14 71.37 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.253 -0.43 . . . . 0.0 112.048 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.53 -38.5 84.32 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 119.926 -0.71 . . . . 0.0 111.981 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.2 ttpt -61.25 -48.44 81.42 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 119.614 -0.835 . . . . 0.0 110.938 -176.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.3 t -62.9 -38.91 83.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -177.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.528 ' NH2' ' O ' ' A' ' 59' ' ' TYR . 5.8 mmm180 -59.83 -41.1 90.62 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 119.806 -0.758 . . . . 0.0 109.948 -179.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -62.19 38.62 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.157 178.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.489 ' H ' ' C ' ' A' ' 40' ' ' ARG . 45.3 tt0 -87.18 147.87 25.41 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 121.89 -0.506 . . . . 0.0 110.972 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 29.1 pt -81.42 -177.07 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.431 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -74.48 135.48 42.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.714 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 46' ' ' GLU . . . 168.99 -114.27 0.55 Allowed Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.406 ' O ' ' O ' ' A' ' 45' ' ' GLY . 38.0 tt0 60.62 131.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.831 0.348 . . . . 0.0 110.845 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 69.5 m -74.1 -34.08 63.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.072 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -52.15 -38.88 58.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.351 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.92 9.44 85.36 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -178.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.576 ' O ' HD13 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -66.62 -38.42 86.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.294 0.569 . . . . 0.0 110.241 179.004 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.432 ' O ' ' O ' ' A' ' 54' ' ' ALA . 97.2 t -60.95 -45.26 98.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.095 -177.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -65.32 -34.16 77.69 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.787 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 50' ' ' LEU . 23.3 p -68.4 -38.18 81.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.907 0.384 . . . . 0.0 110.345 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' A' ' 51' ' ' VAL . . . -95.83 122.02 38.18 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.127 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.97 -43.0 12.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.723 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.624 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 10.4 m -131.05 -137.94 0.21 Allowed 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.624 ' HB3' ' O ' ' A' ' 56' ' ' SER . . . 80.1 -27.04 0.15 Allowed 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 176.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -120.82 38.81 3.94 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.528 ' O ' ' NH2' ' A' ' 40' ' ' ARG . 16.2 m-85 -37.51 151.62 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.81 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.42 ' O ' ' C ' ' A' ' 61' ' ' GLY . 31.9 mtm105 -46.4 -33.68 4.08 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 60' ' ' ARG . . . -30.51 101.95 0.01 OUTLIER Glycine 0 CA--C 1.527 0.795 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.89 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.2 p -66.95 -33.94 66.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 118.155 -0.926 . . . . 0.0 109.44 176.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.578 HD13 ' O ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -60.52 -33.01 72.01 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 121.263 1.847 . . . . 0.0 110.343 -179.689 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.94 -49.5 62.59 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-N 115.518 -0.765 . . . . 0.0 114.575 -176.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.488 ' OG1' ' NH2' ' A' ' 40' ' ' ARG . 4.6 m -62.18 -46.36 89.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.005 -0.598 . . . . 0.0 112.498 -178.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 11.2 tt -59.78 -35.79 62.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.87 -35.77 81.74 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 120.597 1.544 . . . . 0.0 111.488 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 99.5 m -63.08 -39.3 94.32 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 113.595 -1.639 . . . . 0.0 111.064 -175.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.492 ' O ' ' SD ' ' A' ' 69' ' ' MET . 0.0 OUTLIER -60.59 -39.99 90.12 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 120.835 -1.166 . . . . 0.0 113.912 -176.548 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.1 p -69.33 -40.34 80.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 119.256 -0.978 . . . . 0.0 112.726 -178.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -78.3 -13.37 59.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.334 0.588 . . . . 0.0 112.585 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 90.8 m -62.88 -55.02 29.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.136 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -108.01 -56.93 2.17 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 157.84 164.39 13.87 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -56.29 -34.96 95.18 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.009 1.806 . . . . 0.0 111.673 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 72.4 mtp85 -61.23 -11.55 9.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.609 0.719 . . . . 0.0 111.463 176.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.9 p -78.28 -33.07 49.76 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.853 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.485 ' N ' HD12 ' A' ' 78' ' ' LEU . 8.9 mp -76.13 -32.12 58.98 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 122.309 -0.244 . . . . 0.0 111.45 179.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -90.7 -3.83 57.19 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 123.485 1.612 . . . . 0.0 112.531 -176.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.524 ' ND2' ' OH ' ' A' ' 156' ' ' TYR . 28.0 t30 -94.24 37.36 1.11 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 110.748 -2.933 . . . . 0.0 108.732 176.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -168.45 -15.37 0.02 OUTLIER Glycine 0 CA--C 1.533 1.209 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.842 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 82' ' ' LEU . 59.9 mt -59.97 -34.92 73.94 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 119.163 -1.015 . . . . 0.0 111.861 -179.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.9 p -70.54 -27.67 32.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.846 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.7 -31.62 61.93 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.541 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -68.37 -40.57 86.98 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 119.472 -1.347 . . . . 0.0 111.601 -177.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 27.1 mt -63.01 -41.21 99.51 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -176.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.41 ' H ' ' HG2' ' A' ' 87' ' ' GLN . 4.3 pt20 -60.9 -26.78 67.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.405 -1.271 . . . . 0.0 108.925 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 18.7 ttm105 -57.47 -53.46 57.87 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 173.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.524 ' NE2' ' OD1' ' A' ' 28' ' ' ASP . 10.7 mm100 -67.05 -29.58 69.42 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 112.557 -2.11 . . . . 0.0 112.089 -178.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 34.4 ttm -61.19 -40.4 93.77 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.951 -1.022 . . . . 0.0 112.682 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 78.2 p -74.22 -34.31 63.65 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 118.491 -0.766 . . . . 0.0 111.058 -176.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -57.8 -44.36 86.29 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 120.609 1.55 . . . . 0.0 110.746 -177.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.63 -33.47 64.56 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 119.075 -1.05 . . . . 0.0 110.744 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.3 p -64.82 -42.85 94.65 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.437 ' C ' ' H ' ' A' ' 97' ' ' ILE . 11.7 p -68.52 -27.91 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.666 178.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.06 9.84 2.74 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 -176.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.471 ' O ' HG22 ' A' ' 97' ' ' ILE . 99.2 mt -87.23 -15.11 9.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 177.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -140.39 -47.9 0.06 OUTLIER Glycine 0 CA--C 1.538 1.504 0 N-CA-C 115.846 1.098 . . . . 0.0 115.846 -175.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.597 HD22 ' N ' ' A' ' 99' ' ' LEU . 3.3 mm? -70.9 -12.62 61.65 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.109 1.454 . . . . 0.0 112.02 -178.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -79.78 -50.43 10.57 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.0 -1.454 . . . . 0.0 109.609 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -67.71 -32.35 72.92 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 113.768 -1.56 . . . . 0.0 109.264 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.2 p -69.84 -53.96 15.74 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 112.661 -2.063 . . . . 0.0 112.874 175.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.723 HG22 ' CE2' ' A' ' 107' ' ' TYR . 0.3 OUTLIER -75.15 -27.63 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-N 122.088 2.222 . . . . 0.0 116.182 -176.835 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.514 ' CB ' ' NZ ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -69.54 -43.5 72.85 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 112.409 -2.178 . . . . 0.0 113.412 -177.723 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.455 ' N ' ' HG3' ' A' ' 104' ' ' LYS . 88.1 mt-30 -78.27 -10.97 59.89 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 124.345 2.021 . . . . 0.0 111.039 178.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -79.23 -22.69 44.47 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 112.055 -2.339 . . . . 0.0 111.512 178.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.723 ' CE2' HG22 ' A' ' 103' ' ' VAL . 28.2 m-85 -109.38 -30.74 7.83 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 119.155 0.889 . . . . 0.0 110.831 -177.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.3 m -97.75 8.85 43.98 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 117.918 -1.513 . . . . 0.0 113.157 -178.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.494 ' O ' ' C ' ' A' ' 110' ' ' GLY . 35.4 ttpt -48.74 125.75 10.7 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 117.908 -1.044 . . . . 0.0 109.541 177.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' A' ' 111' ' ' SER . . . -29.39 -74.45 0.04 OUTLIER Glycine 0 N--CA 1.485 1.962 0 CA-C-N 120.231 1.378 . . . . 0.0 111.6 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.531 ' CB ' ' O ' ' A' ' 110' ' ' GLY . 2.7 m 104.23 -161.67 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 177.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.618 ' O ' ' N ' ' A' ' 114' ' ' ALA . 79.6 tt0 -129.95 102.3 6.22 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -178.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.633 ' O ' ' HB2' ' A' ' 114' ' ' ALA . 88.0 m-70 13.51 46.75 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 O-C-N 124.411 1.069 . . . . 0.0 113.135 178.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.633 ' HB2' ' O ' ' A' ' 113' ' ' HIS . . . 159.09 -161.7 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.16 15.02 26.98 Favored Glycine 0 C--N 1.337 0.626 0 CA-C-N 115.141 -0.936 . . . . 0.0 113.038 176.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 50.0 mt -60.73 -40.72 85.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 C-N-CA 119.133 -1.027 . . . . 0.0 108.576 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.6 -40.09 95.81 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 122.01 0.783 . . . . 0.0 111.362 175.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 19.4 m -58.18 -42.53 86.24 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 177.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -63.72 -37.42 87.3 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.009 -0.676 . . . . 0.0 111.058 -178.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 97.2 mt -64.16 -46.56 83.5 Favored 'General case' 0 N--CA 1.457 -0.11 0 CA-C-O 121.481 0.657 . . . . 0.0 109.352 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.568 HD23 ' O ' ' A' ' 121' ' ' LEU . 1.4 tt -66.67 -44.59 81.39 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.933 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.457 ' O ' HG22 ' A' ' 126' ' ' THR . . . -63.36 -44.69 94.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 119.457 1.026 . . . . 0.0 108.853 177.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -65.83 -44.03 92.81 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 120.034 -1.079 . . . . 0.0 111.584 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 63.9 m -64.27 -44.51 91.52 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.508 HG23 ' N ' ' A' ' 126' ' ' THR . 13.9 t -70.16 -48.02 59.11 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 118.885 -1.126 . . . . 0.0 112.077 177.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.508 ' N ' HG23 ' A' ' 125' ' ' THR . 9.4 t -65.66 -42.69 91.05 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 -174.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.493 ' N ' HG23 ' A' ' 126' ' ' THR . . . -64.23 -44.71 95.19 Favored Glycine 0 C--N 1.33 0.206 0 CA-C-N 114.416 -1.265 . . . . 0.0 112.253 -178.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.477 ' O ' HG12 ' A' ' 131' ' ' VAL . . . -61.01 -41.58 96.81 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 112.302 -1.949 . . . . 0.0 106.287 177.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.677 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 31.3 mt -64.91 -42.36 94.8 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.841 177.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.24 -40.01 96.23 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -177.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 128' ' ' ALA . 4.0 p -61.22 -24.84 34.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 122.932 1.348 . . . . 0.0 109.042 178.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.677 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . -57.64 -44.55 85.68 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 112.188 -2.278 . . . . 0.0 111.343 -178.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.9 p -78.81 -48.74 21.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.229 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.459 ' O ' ' O ' ' A' ' 131' ' ' VAL . . . -92.06 138.18 31.75 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.712 0.291 . . . . 0.0 111.064 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.497 ' N ' ' CD ' ' A' ' 136' ' ' PRO . 1.2 tt0 -179.69 -47.19 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.815 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 135' ' ' GLN . 55.3 Cg_exo -52.11 -33.5 53.96 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 122.326 2.017 . . . . 0.0 112.302 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 32.2 p -67.69 -42.78 81.53 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 117.941 -1.504 . . . . 0.0 109.786 -179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -66.24 -42.96 87.88 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 119.317 -0.953 . . . . 0.0 112.098 -178.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 62.5 t -64.08 -43.72 97.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -179.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 136' ' ' PRO . 72.4 t -64.89 -39.34 85.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -177.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 31.3 mttp -62.83 -42.01 99.56 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 118.754 -1.179 . . . . 0.0 111.325 -178.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 11.8 m -71.24 -46.33 66.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.87 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 12.8 tpp85 -65.59 -37.37 86.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.895 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -67.34 -42.0 84.26 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -177.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.3 -40.49 90.03 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 119.173 -1.011 . . . . 0.0 111.232 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.32 -35.46 81.08 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 -177.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -60.62 111.27 1.54 Allowed 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 176.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -106.12 -52.44 2.8 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.872 1.804 . . . . 0.0 115.872 -174.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.538 ' O ' ' HB3' ' A' ' 150' ' ' ALA . 10.9 mmt180 -86.9 12.14 11.78 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 121.68 2.036 . . . . 0.0 110.544 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.538 ' HB3' ' O ' ' A' ' 149' ' ' ARG . . . 72.62 -45.72 0.63 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.667 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 103.16 169.71 26.0 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -70.54 121.46 9.85 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.094 -0.803 . . . . 0.0 111.094 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 152.02 -162.78 29.9 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' A' ' 156' ' ' TYR . 39.4 ttp180 -160.28 -135.14 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.43 ' O ' ' O ' ' A' ' 156' ' ' TYR . 29.9 mmt180 44.89 15.5 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.831 0.348 . . . . 0.0 110.508 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.526 ' N ' ' O ' ' A' ' 154' ' ' ARG . 0.7 OUTLIER 54.29 112.52 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.751 179.758 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.566 ' NE2' ' H ' ' A' ' 157' ' ' GLN . 4.1 mp0 -62.65 164.17 8.07 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.42 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.403 ' OG ' ' N ' ' A' ' 159' ' ' THR . 47.6 t -157.16 -178.02 7.05 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.457 0.646 . . . . 0.0 111.273 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.57 HG23 ' N ' ' A' ' 160' ' ' VAL . 15.1 t -63.78 -45.89 87.72 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.66 -177.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.57 ' N ' HG23 ' A' ' 159' ' ' THR . 94.9 t -63.95 -45.26 97.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 119.251 -0.98 . . . . 0.0 109.096 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 38.6 tp10 -67.01 -38.37 85.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.663 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.549 ' O ' HD12 ' A' ' 166' ' ' ILE . . . -60.96 -44.41 97.37 Favored 'General case' 0 C--O 1.211 -0.952 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -176.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.543 ' CE2' HD11 ' A' ' 175' ' ' LEU . 14.8 t80 -61.25 -47.62 85.19 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.662 0.744 . . . . 0.0 112.204 -177.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.402 ' NZ ' ' CB ' ' A' ' 164' ' ' LYS . 2.3 ttmp? -68.39 -45.41 72.77 Favored 'General case' 0 CA--C 1.555 1.169 0 N-CA-C 118.17 2.656 . . . . 0.0 118.17 -173.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 63.8 p -63.49 -45.51 90.39 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 117.381 2.363 . . . . 0.0 117.381 -175.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.741 HD13 ' H ' ' A' ' 166' ' ' ILE . 0.2 OUTLIER -64.59 -37.14 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-O 121.635 0.731 . . . . 0.0 109.233 177.082 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -58.93 -36.97 75.64 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 117.177 -1.392 . . . . 0.0 107.628 177.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 77.5 ttt-85 -62.75 -50.7 70.02 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 123.393 2.815 . . . . 0.0 111.835 -176.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -75.34 -51.22 13.69 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 123.584 0.754 . . . . 0.0 109.5 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -78.15 -36.54 47.54 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -174.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 91.9 -169.09 32.03 Favored Glycine 0 N--CA 1.464 0.509 0 N-CA-C 111.707 -0.557 . . . . 0.0 111.707 178.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.416 ' CG1' ' N ' ' A' ' 173' ' ' ARG . 7.5 pt -71.51 -42.04 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-O 121.454 0.645 . . . . 0.0 110.61 -179.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.416 ' N ' ' CG1' ' A' ' 172' ' ' ILE . 25.4 mmt180 -59.24 -34.09 71.8 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.595 -177.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -60.91 -40.67 98.68 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 118.514 -1.803 . . . . 0.0 109.035 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.543 HD11 ' CE2' ' A' ' 163' ' ' TYR . 0.5 OUTLIER -70.55 -33.48 71.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 111.239 -2.48 . . . . 0.0 116.771 -177.284 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . 0.484 ' CG ' ' OG1' ' A' ' 179' ' ' THR . 33.5 t-105 -77.93 -7.63 57.02 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 111.694 -2.503 . . . . 0.0 110.563 -177.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 51.4 mttm -43.55 -48.41 7.49 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -176.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -99.31 -25.65 9.29 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.099 0.857 . . . . 0.0 112.601 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.484 ' OG1' ' CG ' ' A' ' 176' ' ' TRP . 69.2 p -46.3 -51.9 13.71 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.99 -50.41 76.94 Favored Pre-proline 0 N--CA 1.48 1.038 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -175.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -63.34 -28.35 71.85 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 121.628 1.552 . . . . 0.0 111.42 176.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -63.88 -39.0 93.18 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.245 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 71.1 t -62.69 -42.14 94.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.0 0.429 . . . . 0.0 110.009 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.555 ' O ' HD13 ' A' ' 188' ' ' ILE . . . -61.72 -38.99 89.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.347 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.447 ' NH1' ' O ' ' A' ' 239' ' ' LYS . 97.7 mtt180 -60.4 -41.97 94.99 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.71 -179.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -61.55 -43.2 99.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.366 0.603 . . . . 0.0 110.169 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.34 -43.13 95.58 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.167 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.555 HD13 ' O ' ' A' ' 184' ' ' ALA . 1.4 mp -63.04 -45.07 99.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.2 -177.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.42 ' O ' ' OE1' ' A' ' 193' ' ' GLU . 11.8 m -60.44 -47.06 94.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 119.409 -0.916 . . . . 0.0 112.431 -178.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -62.68 -43.19 99.44 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 122.586 1.184 . . . . 0.0 109.868 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' CYS . . . . . . . . . . . . . 31.2 m -62.34 -46.22 89.68 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 112.565 -2.107 . . . . 0.0 110.479 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.11 -40.13 95.53 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 114.037 -1.438 . . . . 0.0 109.659 176.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 0.492 ' N ' ' OE1' ' A' ' 193' ' ' GLU . 0.0 OUTLIER -61.01 -45.64 94.0 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.63 -178.381 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 67.2 tp -64.21 -39.14 93.37 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 118.637 -1.225 . . . . 0.0 110.053 -175.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 6.9 m -64.45 -45.88 94.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 C-N-CA 116.891 -1.924 . . . . 0.0 107.907 178.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 23.4 m -63.98 -45.95 86.78 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -178.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -57.16 -39.08 74.55 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.862 0.865 . . . . 0.0 112.56 -178.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -55.86 -44.29 77.92 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.5 ' N ' HD22 ' A' ' 199' ' ' LEU . 3.8 mm? -61.34 -38.79 88.19 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 41.8 mm -62.0 -42.41 94.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 26.1 mmtm -59.57 -38.71 81.86 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.876 1.27 . . . . 0.0 113.183 178.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -67.79 -37.12 81.6 Favored 'General case' 0 C--O 1.256 1.42 0 C-N-CA 118.511 -1.276 . . . . 0.0 111.028 -175.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.433 HG23 ' O ' ' A' ' 203' ' ' THR . 5.8 t -100.96 128.82 46.82 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 121.308 1.867 . . . . 0.0 111.895 -178.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.508 ' CD2' ' CE1' ' A' ' 217' ' ' HIS . 6.9 mp 66.82 3.74 3.16 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 113.342 -1.754 . . . . 0.0 110.576 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 2.3 mt -126.59 29.78 5.66 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.882 0.849 . . . . 0.0 110.628 -179.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -68.78 -25.8 64.89 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.482 -1.235 . . . . 0.0 109.848 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.528 ' O ' ' ND2' ' A' ' 208' ' ' ASN . . . -161.93 39.62 0.13 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 114.363 -1.29 . . . . 0.0 109.563 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . 0.56 HD21 ' CG ' ' A' ' 210' ' ' MET . 0.4 OUTLIER 87.93 -18.38 0.27 Allowed 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 175.979 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.504 ' CB ' ' O ' ' A' ' 208' ' ' ASN . 1.0 OUTLIER 84.85 46.33 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 119.742 1.155 . . . . 0.0 109.524 -179.874 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . 0.56 ' CG ' HD21 ' A' ' 208' ' ' ASN . 78.1 mtm -53.04 -166.97 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.865 178.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.505 ' OG1' ' N ' ' A' ' 212' ' ' ASP . 4.4 p 61.21 -134.43 0.63 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.927 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . 0.505 ' N ' ' OG1' ' A' ' 211' ' ' THR . 4.0 p-10 -155.96 -94.12 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.551 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.486 ' H ' ' CG ' ' A' ' 212' ' ' ASP . 4.6 p-10 44.22 42.78 5.36 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.308 0.575 . . . . 0.0 109.683 -178.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.412 ' N ' ' CD ' ' A' ' 215' ' ' PRO . 2.5 mm? -61.24 -43.89 91.55 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.921 -178.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 214' ' ' LEU . 27.3 Cg_exo -60.7 -34.45 91.92 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 CA-C-N 120.263 1.129 . . . . 0.0 111.16 -178.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 7.9 t -65.24 -42.43 93.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 113.085 -1.871 . . . . 0.0 111.231 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' HIS . . . . . 0.522 ' O ' ' ND1' ' A' ' 217' ' ' HIS . 1.8 t60 -66.78 -37.41 84.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.446 -0.797 . . . . 0.0 113.064 -178.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -62.95 -47.62 82.42 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.096 -177.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 33.5 p -60.53 -38.1 83.34 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 119.097 0.862 . . . . 0.0 110.986 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 66.0 p -59.64 -41.78 91.28 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.574 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.89 -41.84 97.62 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -178.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -62.63 -47.82 82.08 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -176.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -61.06 -42.27 99.74 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 107.811 -2.116 . . . . 0.0 107.811 177.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.788 ' O ' HG23 ' A' ' 228' ' ' THR . . . -63.31 -37.78 88.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 113.817 -1.191 . . . . 0.0 109.009 176.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.574 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -61.67 -42.38 99.75 Favored Glycine 0 CA--C 1.522 0.51 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.827 -176.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' PHE . . . . . 0.432 ' O ' ' OG1' ' A' ' 229' ' ' THR . 0.9 OUTLIER -66.55 -38.58 87.44 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 118.28 1.04 . . . . 0.0 108.27 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 96.6 m -63.54 -41.88 98.43 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.09 0.471 . . . . 0.0 110.265 177.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.788 HG23 ' O ' ' A' ' 224' ' ' ALA . 80.1 p -62.5 -40.48 96.87 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.896 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' A' ' 226' ' ' PHE . 18.6 p -58.8 -39.73 81.99 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.097 -176.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 98.3 t -60.61 -41.91 89.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 118.521 -1.271 . . . . 0.0 108.839 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.48 ' O ' ' HD2' ' A' ' 234' ' ' PRO . 1.3 mp -62.13 -41.29 90.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-O 121.418 0.628 . . . . 0.0 109.393 176.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -62.99 -40.09 96.7 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 -178.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.442 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 0.0 OUTLIER -59.11 -43.39 97.15 Favored Pre-proline 0 N--CA 1.476 0.84 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -173.255 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.48 ' HD2' ' O ' ' A' ' 231' ' ' ILE . 39.4 Cg_exo -60.0 -41.72 50.49 Favored 'Trans proline' 0 C--N 1.296 -2.189 0 C-N-CA 121.576 1.517 . . . . 0.0 113.781 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.408 ' H ' HG22 ' A' ' 235' ' ' VAL . 13.6 m -66.34 -37.55 79.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 119.131 -1.028 . . . . 0.0 111.303 178.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -66.0 -41.7 90.72 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -178.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.409 ' O ' ' OG1' ' A' ' 240' ' ' THR . 3.0 p -65.68 -45.72 91.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -177.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 8.5 p -63.2 -37.35 79.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.323 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . 0.447 ' O ' ' NH1' ' A' ' 185' ' ' ARG . 88.6 mttt -60.77 -45.02 95.98 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 119.786 -0.765 . . . . 0.0 110.426 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 237' ' ' VAL . 51.8 p -62.24 -42.17 99.08 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.988 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -37.57 139.52 0.28 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.533 -178.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.55 ' CG ' ' N ' ' A' ' 243' ' ' MET . 0.0 OUTLIER 161.88 -62.88 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 114.964 -1.016 . . . . 0.0 108.74 -179.661 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' MET . . . . . 0.55 ' N ' ' CG ' ' A' ' 242' ' ' TYR . 10.7 tpt -68.44 75.88 0.26 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 242' ' ' TYR . 34.4 t30 -158.97 109.1 1.99 Allowed 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 12.1 p 62.62 -178.16 0.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.857 -178.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -140.36 -70.14 0.39 Allowed 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.403 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 23.9 mt -57.88 136.78 57.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.894 0.378 . . . . 0.0 111.08 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 143.14 158.7 7.65 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.742 ' HG3' ' NE2' ' A' ' 255' ' ' HIS . 16.5 mm100 -44.74 -90.18 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER 71.49 32.81 2.0 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.021 178.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 39.9 t60 -66.83 -53.93 27.65 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 116.431 -2.108 . . . . 0.0 111.773 -177.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 69.1 m -148.53 -173.65 4.39 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -61.15 -44.88 96.63 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -57.66 -36.04 76.73 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 126.12 1.819 . . . . 0.0 115.185 -171.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' HIS . . . . . 0.742 ' NE2' ' HG3' ' A' ' 249' ' ' GLN . 86.4 t60 -57.23 -32.63 66.72 Favored 'General case' 0 C--N 1.365 1.276 0 CA-C-N 120.239 2.019 . . . . 0.0 111.019 -178.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -59.95 -44.8 94.17 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.327 0.512 . . . . 0.0 110.683 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -60.72 -45.41 94.35 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.823 -0.751 . . . . 0.0 111.24 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.529 ' N ' HD12 ' A' ' 258' ' ' LEU . 10.2 mp -66.97 -44.01 81.6 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.957 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . 0.703 HG21 ' NE2' ' A' ' 255' ' ' HIS . 73.4 p -63.36 -45.09 92.79 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.93 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' MET . . . . . . . . . . . . . 51.9 ttp -60.31 -44.44 95.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.011 -176.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.522 HD13 ' O ' ' A' ' 261' ' ' LEU . 0.2 OUTLIER -62.17 -46.5 88.65 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.338 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 69.1 mmt-85 -66.41 -53.78 31.83 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.666 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -142.62 158.73 43.36 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.687 0.28 . . . . 0.0 111.23 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . 0.448 ' O ' ' O ' ' A' ' 265' ' ' GLY . 18.3 tp10 76.25 68.31 0.06 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.285 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 264' ' ' GLU . . . -32.09 156.59 0.01 OUTLIER Glycine 0 CA--C 1.536 1.379 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.667 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -62.82 -3.11 4.17 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 122.246 1.964 . . . . 0.0 111.836 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 80.5 mtt85 -70.0 -27.05 64.37 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 123.053 0.541 . . . . 0.0 111.805 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.441 ' O ' ' O ' ' A' ' 271' ' ' LYS . . . -58.8 -32.47 69.38 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 119.824 -0.75 . . . . 0.0 109.948 -179.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -62.45 -41.72 98.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.412 0.625 . . . . 0.0 110.836 178.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -66.0 -37.7 86.59 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 114.9 -1.046 . . . . 0.0 112.363 -178.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 268' ' ' ALA . 17.6 ttpp -110.65 134.37 52.49 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.73 0.3 . . . . 0.0 110.616 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 108.47 55.77 0.58 Allowed Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -147.95 29.58 0.9 Allowed 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 120.836 0.35 . . . . 0.0 110.69 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' MET . . . . . 0.588 ' N ' ' CD ' ' A' ' 275' ' ' PRO . 0.3 OUTLIER -63.74 -43.88 78.21 Favored Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.238 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 274' ' ' MET . 23.4 Cg_exo -63.69 -45.87 10.19 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.776 2.317 . . . . 0.0 111.908 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 86.1 p -59.72 -39.13 83.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.061 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -61.21 -41.86 97.59 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 122.884 1.326 . . . . 0.0 111.85 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -61.87 -38.31 87.81 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 111.829 -2.441 . . . . 0.0 107.78 174.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 48.4 mtp180 -62.88 -39.33 94.15 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.304 0.573 . . . . 0.0 110.26 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 30.7 tp -61.85 -36.46 81.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.121 -0.945 . . . . 0.0 112.869 -177.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -68.12 -51.18 34.94 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -178.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . 0.614 ' O ' HG12 ' A' ' 285' ' ' VAL . 76.4 p -63.09 -44.41 95.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.422 0.63 . . . . 0.0 110.072 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' TRP . . . . . . . . . . . . . 75.5 t90 -60.76 -38.75 86.27 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.604 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -62.58 -39.69 94.52 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -178.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.614 HG12 ' O ' ' A' ' 282' ' ' SER . 3.7 p -61.32 -37.89 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.093 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.526 ' O ' HG12 ' A' ' 289' ' ' VAL . 95.0 t -62.02 -40.6 87.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 120.311 -0.556 . . . . 0.0 109.526 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' MET . . . . . 0.459 ' C ' ' SD ' ' A' ' 287' ' ' MET . 0.0 OUTLIER -61.15 -38.55 86.81 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.342 0.591 . . . . 0.0 109.893 178.606 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -58.51 -39.4 80.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.168 -0.923 . . . . 0.0 112.604 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.526 HG12 ' O ' ' A' ' 286' ' ' VAL . 1.3 p -59.85 -38.13 74.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 113.213 0.819 . . . . 0.0 113.213 -175.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 2.1 t -62.35 -40.54 96.73 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 118.892 -1.123 . . . . 0.0 109.135 178.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -60.82 -38.86 86.88 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 177.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -58.35 -40.25 81.7 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 117.664 -1.614 . . . . 0.0 109.913 -175.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' GLN . . . . . 0.496 ' O ' ' O ' ' A' ' 296' ' ' ARG . 56.5 tt0 -60.46 -43.3 97.02 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 122.6 1.191 . . . . 0.0 111.443 -179.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 11.0 mp -60.95 -40.39 93.11 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 113.313 -1.767 . . . . 0.0 109.671 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -62.68 -45.76 91.3 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.36 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' ARG . . . . . 0.496 ' O ' ' O ' ' A' ' 293' ' ' GLN . 43.5 ttm180 -122.53 116.33 23.72 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -119.16 -160.8 0.82 Allowed 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -178.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.493 HD23 ' OG ' ' A' ' 304' ' ' SER . 33.6 tp -71.42 114.82 9.88 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 177.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 28.1 ttp -96.7 64.71 2.13 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -177.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.58 101.04 0.07 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 122.047 0.927 . . . . 0.0 110.721 -178.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -64.15 -46.27 84.82 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 113.505 -1.68 . . . . 0.0 113.452 -176.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -58.73 -39.64 81.48 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.617 -0.433 . . . . 0.0 109.957 -178.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -64.68 -46.76 81.04 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.027 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' SER . . . . . 0.493 ' OG ' HD23 ' A' ' 298' ' ' LEU . 3.0 m -66.34 -38.1 86.85 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.404 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 59.7 mmt-85 -61.88 -42.86 99.57 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.721 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -64.94 -36.8 85.56 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -177.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . 0.54 ' HB3' ' HD3' ' A' ' 308' ' ' PRO . . . -60.02 -52.92 70.03 Favored Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -176.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' PRO . . . . . 0.54 ' HD3' ' HB3' ' A' ' 307' ' ' ALA . 73.9 Cg_endo -75.21 0.33 9.12 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.109 1.873 . . . . 0.0 111.816 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 50.4 t80 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.51 179.992 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.552 ' N ' ' SD ' ' A' ' 13' ' ' MET . 1.5 mpt? . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 48.5 m -106.21 88.54 2.82 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.399 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 16' ' ' LYS . 16.8 t -87.05 164.19 2.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.336 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.486 ' N ' HG12 ' A' ' 15' ' ' VAL . 33.3 mtmm -64.37 -42.03 96.41 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -63.77 -41.62 97.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.386 0.612 . . . . 0.0 111.428 179.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.5 tp -79.81 -26.11 40.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.236 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.45 -41.43 94.33 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 107.472 -2.251 . . . . 0.0 107.472 177.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.531 ' HB1' HH22 ' A' ' 96' ' ' ARG . . . -71.47 -32.29 68.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 124.838 2.256 . . . . 0.0 107.061 176.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.56 -42.47 98.86 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-N 108.516 -3.947 . . . . 0.0 107.759 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.0 m -70.7 -27.87 64.32 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.462 0.648 . . . . 0.0 109.591 177.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.66 ' O ' HD13 ' A' ' 26' ' ' ILE . . . -65.95 -49.83 66.52 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.981 -178.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.05 -35.16 77.77 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 118.693 -1.203 . . . . 0.0 112.206 -177.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 78.2 m -63.29 -53.85 46.4 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -177.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.66 HD13 ' O ' ' A' ' 23' ' ' ALA . 0.2 OUTLIER -66.06 -38.16 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -177.739 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.37 -41.9 98.83 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-O 118.175 -0.917 . . . . 0.0 113.316 -172.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -77.58 -26.78 51.07 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 120.914 1.688 . . . . 0.0 110.51 -175.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.3 mp -59.56 -54.56 45.15 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 119.686 1.13 . . . . 0.0 112.27 -178.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.9 tp -74.78 -3.44 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 CA-C-O 121.692 0.758 . . . . 0.0 112.711 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -109.06 -16.19 14.17 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.39 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.495 ' N ' ' HD2' ' A' ' 33' ' ' PRO . 27.0 t80 -68.5 -46.08 36.28 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 116.654 -2.018 . . . . 0.0 111.829 -177.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 32' ' ' PHE . 24.0 Cg_endo -60.26 -15.89 37.47 Favored 'Trans proline' 0 N--CA 1.499 1.824 0 CA-C-N 120.988 1.389 . . . . 0.0 113.238 177.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.411 ' N ' HD12 ' A' ' 34' ' ' LEU . 10.5 mp -67.36 -35.7 79.9 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -177.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -64.64 -40.4 95.39 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.618 -178.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.9 p -58.22 -34.8 70.81 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.812 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.43 -38.85 85.2 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 119.862 -0.735 . . . . 0.0 112.231 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -62.64 -49.86 73.49 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 119.106 -1.037 . . . . 0.0 111.296 -177.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 65.6 t -64.96 -40.19 88.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -177.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.538 ' O ' ' N ' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -61.05 -41.09 95.95 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.752 -178.457 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.6 tp -62.03 38.79 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.967 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.538 ' N ' ' O ' ' A' ' 40' ' ' ARG . 6.3 pt20 -95.51 154.63 17.11 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.82 0.343 . . . . 0.0 110.603 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.701 ' N ' HD12 ' A' ' 43' ' ' ILE . 1.9 mp -69.22 -11.92 15.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.289 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 55.29 -175.71 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.374 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 57.83 38.81 90.06 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.999 -0.841 . . . . 0.0 110.999 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.405 ' O ' ' OG ' ' A' ' 47' ' ' SER . 14.7 pt-20 -61.65 -35.03 76.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.793 0.33 . . . . 0.0 110.408 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' A' ' 46' ' ' GLU . 69.1 m -168.58 -15.88 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.677 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -64.59 -40.78 96.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.655 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.51 9.57 84.61 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -177.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.1 tp -64.62 -36.8 85.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.313 -0.944 . . . . 0.0 109.929 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 95.3 t -59.69 -44.2 93.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.397 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 93.1 mtm-85 -64.46 -34.19 77.62 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.201 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.7 p -68.44 -38.09 80.83 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 178.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -134.51 93.36 3.04 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.803 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.52 -13.38 52.17 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -178.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.613 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 90.5 p -126.33 -140.06 0.27 Allowed 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.613 ' HB3' ' O ' ' A' ' 56' ' ' SER . . . 98.01 12.88 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 O-C-N 124.245 0.965 . . . . 0.0 112.04 178.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.421 ' OE1' ' O ' ' A' ' 59' ' ' TYR . 1.3 tm0? -173.59 84.17 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.562 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.421 ' O ' ' OE1' ' A' ' 58' ' ' GLN . 5.4 m-85 -65.5 148.55 51.53 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -40.23 -36.71 0.55 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.023 0.44 . . . . 0.0 110.255 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -31.85 103.38 0.01 OUTLIER Glycine 0 CA--C 1.529 0.926 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.334 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.3 p -67.14 -33.53 63.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 118.205 -0.902 . . . . 0.0 109.626 176.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -60.02 -32.3 70.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 121.397 1.908 . . . . 0.0 109.958 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.51 -48.96 67.84 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 115.262 -0.881 . . . . 0.0 114.555 -176.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.2 m -61.87 -46.3 90.03 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -178.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 28.9 mm -59.49 -36.27 63.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 40.0 tp -64.04 -35.82 81.97 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 120.252 1.387 . . . . 0.0 112.511 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 98.6 m -63.3 -40.7 98.08 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.069 -175.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 31.7 ttp -60.15 -40.19 88.97 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 114.406 1.262 . . . . 0.0 114.406 -175.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.41 ' CG1' ' N ' ' A' ' 71' ' ' ARG . 3.0 p -69.46 -40.93 80.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 119.218 -0.993 . . . . 0.0 113.16 -177.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.41 ' N ' ' CG1' ' A' ' 70' ' ' VAL . 68.1 ttt-85 -78.75 -12.92 60.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.697 0.76 . . . . 0.0 112.991 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 56.8 m -61.63 -54.85 37.33 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.682 -1.144 . . . . 0.0 111.094 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.554 ' H ' ' CD ' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -117.32 -40.81 3.03 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 118.754 -0.641 . . . . 0.0 110.472 178.064 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 155.15 159.58 9.39 Favored Glycine 0 CA--C 1.549 2.158 0 CA-C-N 120.192 1.36 . . . . 0.0 111.34 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -56.53 -34.58 95.48 Favored 'Trans proline' 0 N--CA 1.511 2.531 0 C-N-CA 122.269 1.98 . . . . 0.0 114.032 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.5 mmp_? -60.23 -10.55 4.7 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 178.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.568 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 1.2 p -77.28 -31.79 55.09 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.642 -178.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 43.5 tp -74.91 -31.94 61.68 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 122.039 -0.413 . . . . 0.0 110.626 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.747 ' O ' HD12 ' A' ' 82' ' ' LEU . 97.3 m-85 -90.88 -3.86 57.01 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 122.851 1.31 . . . . 0.0 114.091 -176.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.568 ' ND2' ' O ' ' A' ' 77' ' ' SER . 0.0 OUTLIER -104.17 123.64 47.66 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 111.986 -2.37 . . . . 0.0 107.738 175.337 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.24 -16.29 49.59 Favored Glycine 0 N--CA 1.467 0.746 0 N-CA-C 108.389 -1.885 . . . . 0.0 108.389 -177.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.969 HD13 ' H ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -59.34 -34.37 72.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 113.859 -1.17 . . . . 0.0 110.559 -179.601 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.969 ' H ' HD13 ' A' ' 82' ' ' LEU . 7.5 p -70.7 -27.36 30.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.322 177.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.96 -31.96 61.6 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 119.199 -0.429 . . . . 0.0 111.35 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.84 -40.01 89.6 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 119.533 -1.317 . . . . 0.0 110.832 -177.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.691 HD23 ' O ' ' A' ' 86' ' ' LEU . 2.4 tt -62.45 -40.54 96.94 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 122.261 1.029 . . . . 0.0 113.335 -176.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -60.55 -27.48 67.69 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 113.541 -1.663 . . . . 0.0 109.815 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 64.2 mtm180 -57.81 -53.25 60.34 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 173.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 70.7 tp60 -67.06 -29.68 69.53 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 112.505 -2.134 . . . . 0.0 111.921 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.446 ' C ' ' SD ' ' A' ' 90' ' ' MET . 11.5 tmm? -61.27 -40.89 95.79 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.044 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 77.7 p -74.24 -34.5 63.66 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 119.362 -0.935 . . . . 0.0 111.402 -176.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -57.84 -44.19 86.32 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 120.951 1.705 . . . . 0.0 111.857 -177.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.38 -33.16 64.89 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 119.546 -0.862 . . . . 0.0 111.094 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.574 ' O ' HG22 ' A' ' 97' ' ' ILE . 25.3 m -64.2 -41.78 96.92 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.443 ' C ' ' H ' ' A' ' 97' ' ' ILE . 72.9 t -68.37 -28.71 41.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.485 178.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.531 HH22 ' HB1' ' A' ' 20' ' ' ALA . 29.6 ttp180 -77.61 10.4 2.69 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -177.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.574 HG22 ' O ' ' A' ' 94' ' ' SER . 10.9 tt -86.96 -15.0 9.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.859 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -140.3 -49.0 0.05 OUTLIER Glycine 0 CA--C 1.541 1.711 0 N-CA-C 117.103 1.601 . . . . 0.0 117.103 -176.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.662 ' C ' HD12 ' A' ' 99' ' ' LEU . 3.1 pp -73.28 -12.77 60.97 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 120.558 2.179 . . . . 0.0 114.515 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.626 ' N ' HD12 ' A' ' 99' ' ' LEU . 46.6 t80 -79.16 -53.04 7.38 Favored 'General case' 0 C--O 1.214 -0.797 0 C-N-CA 118.777 -1.169 . . . . 0.0 113.073 -176.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.451 ' OD1' ' NE2' ' A' ' 105' ' ' GLN . 6.0 t70 -72.3 -33.18 67.22 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 124.26 1.981 . . . . 0.0 112.403 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 67.0 m -65.47 -48.98 70.78 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 109.317 -3.583 . . . . 0.0 115.034 -178.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.405 HG22 ' O ' ' A' ' 99' ' ' LEU . 19.1 m -72.29 -23.83 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.368 0 CA-C-O 123.945 1.831 . . . . 0.0 109.437 175.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.565 ' HB2' ' O ' ' A' ' 100' ' ' TYR . 0.0 OUTLIER -68.03 -42.61 80.35 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 109.943 -3.299 . . . . 0.0 113.675 -179.058 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.451 ' NE2' ' OD1' ' A' ' 101' ' ' ASP . 88.1 mt-30 -76.56 -13.33 60.09 Favored 'General case' 0 C--O 1.211 -0.948 0 CA-C-O 125.468 2.556 . . . . 0.0 111.102 177.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.484 ' O ' ' NZ ' ' A' ' 109' ' ' LYS . 1.9 t80 -80.15 -22.08 42.42 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 109.378 -3.555 . . . . 0.0 110.711 177.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.417 ' HE2' HD21 ' A' ' 194' ' ' LEU . 0.3 OUTLIER -109.68 -28.72 8.69 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.607 0.763 . . . . 0.0 112.404 -174.137 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.753 ' C ' ' H ' ' A' ' 110' ' ' GLY . 0.8 OUTLIER -94.91 12.99 26.32 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -174.723 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.484 ' NZ ' ' O ' ' A' ' 106' ' ' PHE . 7.2 ptpp? -56.58 18.73 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 119.602 1.092 . . . . 0.0 110.825 177.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.753 ' H ' ' C ' ' A' ' 108' ' ' THR . . . 57.8 19.2 35.3 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-N 113.956 -1.475 . . . . 0.0 109.773 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.431 ' O ' ' O ' ' A' ' 110' ' ' GLY . 36.2 m 31.19 -160.73 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 112.47 -1.865 . . . . 0.0 114.333 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.623 ' O ' ' N ' ' A' ' 114' ' ' ALA . 39.8 tt0 -134.12 92.99 3.02 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 114.144 1.165 . . . . 0.0 114.144 -176.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.578 ' O ' ' HB2' ' A' ' 114' ' ' ALA . 89.4 m-70 30.63 28.68 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.082 178.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.623 ' N ' ' O ' ' A' ' 112' ' ' GLU . . . 159.97 -161.97 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.99 15.46 23.94 Favored Glycine 0 N--CA 1.464 0.556 0 C-N-CA 120.035 -1.079 . . . . 0.0 111.647 178.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.678 ' N ' HD12 ' A' ' 116' ' ' ILE . 2.0 mp -60.34 -40.37 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 C-N-CA 119.237 -0.985 . . . . 0.0 108.713 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.91 -41.01 95.66 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.021 175.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 38.3 t -59.33 -43.64 92.69 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 176.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 64.5 mtm180 -64.15 -37.13 86.33 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.677 -178.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.543 HD23 ' O ' ' A' ' 120' ' ' LEU . 2.4 tt -63.2 -45.5 91.41 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 62.3 mt -66.33 -44.62 82.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.406 -1.27 . . . . 0.0 110.129 178.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.09 -45.01 90.57 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 120.074 1.307 . . . . 0.0 110.82 178.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -65.96 -44.44 91.68 Favored Glycine 0 N--CA 1.458 0.155 0 C-N-CA 119.588 -1.291 . . . . 0.0 111.371 -178.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.2 m -63.99 -43.75 94.77 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.949 0.404 . . . . 0.0 110.804 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.421 ' O ' HD23 ' A' ' 129' ' ' LEU . 21.2 m -69.57 -48.7 59.39 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 119.201 -1.0 . . . . 0.0 112.333 177.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 13.8 m -65.93 -42.79 89.62 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 114.868 1.433 . . . . 0.0 114.868 -175.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.435 ' O ' ' OD1' ' A' ' 186' ' ' ASN . . . -64.73 -44.81 94.33 Favored Glycine 0 CA--C 1.521 0.413 0 CA-C-N 114.512 -1.222 . . . . 0.0 113.236 -177.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.32 -41.45 97.04 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 112.457 -1.871 . . . . 0.0 107.196 177.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.614 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 1.6 mm? -64.07 -42.03 97.14 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.173 -0.922 . . . . 0.0 110.207 178.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -62.6 -38.88 91.9 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.58 0.229 . . . . 0.0 111.053 -178.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.616 HG11 HG22 ' A' ' 183' ' ' VAL . 85.6 t -60.58 -25.37 34.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 122.262 1.03 . . . . 0.0 109.516 178.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . -57.94 -44.86 87.21 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 113.281 -1.781 . . . . 0.0 111.988 -178.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.487 ' CG1' ' N ' ' A' ' 134' ' ' ALA . 2.7 p -79.04 -48.87 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.536 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.487 ' N ' ' CG1' ' A' ' 133' ' ' VAL . . . -93.2 139.82 30.19 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.905 0.383 . . . . 0.0 111.23 -179.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.513 ' N ' ' CD ' ' A' ' 136' ' ' PRO . 1.2 tt0 178.45 -46.71 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.416 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.513 ' CD ' ' N ' ' A' ' 135' ' ' GLN . 54.3 Cg_exo -52.31 -33.45 55.75 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 122.501 2.134 . . . . 0.0 112.462 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 37.9 p -67.65 -42.39 82.29 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 118.255 -1.378 . . . . 0.0 109.394 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -66.67 -43.58 84.11 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 118.351 -1.34 . . . . 0.0 111.912 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 52.9 t -64.75 -44.89 96.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -178.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.4 p -65.48 -39.09 84.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -177.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -62.46 -41.67 98.93 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.715 -177.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 13.2 m -70.47 -45.58 74.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.108 -0.637 . . . . 0.0 110.516 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 9.6 mmt85 -65.08 -37.06 86.3 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.585 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.538 ' CD1' ' NE2' ' A' ' 147' ' ' GLN . 76.9 t80 -67.21 -42.1 84.66 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -177.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 23.8 mm100 -65.85 -40.14 91.43 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 119.203 -0.999 . . . . 0.0 110.103 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.22 -34.89 79.43 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 -178.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.538 ' NE2' ' CD1' ' A' ' 144' ' ' PHE . 6.5 pt20 -59.89 111.07 1.33 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 177.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -100.39 -59.01 1.78 Allowed 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -175.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -96.46 60.69 1.92 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 122.125 2.239 . . . . 0.0 110.17 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . 54.97 -94.98 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.321 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 161.97 58.24 0.02 OUTLIER Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 67.32 -80.05 0.15 Allowed Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -56.97 120.74 22.26 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 27.5 ptt-85 -79.4 -129.92 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 121.253 -0.179 . . . . 0.0 110.768 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.43 ' O ' ' O ' ' A' ' 156' ' ' TYR . 72.2 mtt85 57.34 26.31 12.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.739 0.304 . . . . 0.0 110.513 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.43 ' O ' ' O ' ' A' ' 155' ' ' ARG . 67.0 m-85 52.0 104.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.622 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -72.25 179.64 3.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.544 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.429 ' OG ' ' N ' ' A' ' 159' ' ' THR . 40.3 t -157.05 -178.14 7.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.293 0.568 . . . . 0.0 110.978 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.429 ' N ' ' OG ' ' A' ' 158' ' ' SER . 72.5 p -64.04 -46.22 85.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.591 -177.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.554 HG13 ' N ' ' A' ' 161' ' ' GLU . 10.3 p -64.43 -45.3 96.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 118.995 -1.082 . . . . 0.0 109.418 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.554 ' N ' HG13 ' A' ' 160' ' ' VAL . 60.6 mt-10 -67.23 -39.13 86.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.961 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -61.58 -46.0 91.75 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -177.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.478 ' C ' ' CD1' ' A' ' 163' ' ' TYR . 0.3 OUTLIER -62.77 -49.97 72.87 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 119.901 -0.719 . . . . 0.0 110.122 -179.577 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.6 mmtt -67.79 -45.62 74.29 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -174.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 19.7 m -62.82 -44.87 95.01 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 119.557 1.072 . . . . 0.0 113.385 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.525 ' N ' HD12 ' A' ' 166' ' ' ILE . 1.3 mp -64.86 -38.73 83.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 121.967 0.889 . . . . 0.0 109.165 176.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.78 -36.43 76.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 113.651 -1.613 . . . . 0.0 108.287 176.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 22.5 tpt85 -62.53 -50.88 69.61 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 122.301 2.319 . . . . 0.0 112.075 -175.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -75.29 -51.36 13.43 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 123.587 0.755 . . . . 0.0 109.231 176.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -78.57 -36.76 44.04 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 -174.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 92.89 -168.48 30.26 Favored Glycine 0 N--CA 1.468 0.81 0 O-C-N 121.995 -0.441 . . . . 0.0 112.427 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.529 HG23 ' N ' ' A' ' 173' ' ' ARG . 10.3 tp -72.99 -41.94 59.79 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.14 0 CA-C-O 121.916 0.865 . . . . 0.0 110.783 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.529 ' N ' HG23 ' A' ' 172' ' ' ILE . 36.2 ttm180 -58.69 -33.34 70.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 113.969 -1.469 . . . . 0.0 110.88 -176.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -60.76 -40.43 98.11 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 118.942 -1.599 . . . . 0.0 110.071 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 7.0 tt -70.37 -33.57 71.58 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 111.58 -2.31 . . . . 0.0 117.129 -177.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 4.9 m0 -77.88 -7.39 56.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 111.771 -2.468 . . . . 0.0 109.961 -176.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 24.8 ttpp -43.22 -48.03 6.51 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.434 -176.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -95.16 -36.29 5.5 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 124.142 0.877 . . . . 0.0 111.495 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.446 ' CG2' ' N ' ' A' ' 180' ' ' SER . 0.6 OUTLIER -45.4 -51.05 11.84 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.446 ' N ' ' CG2' ' A' ' 179' ' ' THR . 3.7 m -62.41 -50.13 80.52 Favored Pre-proline 0 N--CA 1.475 0.801 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -176.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 180' ' ' SER . 22.8 Cg_endo -63.95 -27.61 66.53 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 121.533 1.489 . . . . 0.0 111.652 177.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -63.43 -39.26 94.02 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.616 HG22 HG11 ' A' ' 131' ' ' VAL . 60.4 t -63.17 -42.46 96.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.067 0.461 . . . . 0.0 109.878 178.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.03 -38.98 90.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.57 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -60.23 -41.54 93.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.753 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 127' ' ' GLY . 0.5 OUTLIER -61.21 -42.99 99.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.983 0.42 . . . . 0.0 111.211 -179.471 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.73 -44.12 91.18 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.506 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 36.6 mm -64.0 -45.8 95.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.533 ' O ' ' N ' ' A' ' 193' ' ' GLU . 30.8 m -60.34 -46.11 95.48 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.373 0 C-N-CA 119.882 -0.727 . . . . 0.0 111.155 -178.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -62.62 -42.87 99.83 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.501 0.667 . . . . 0.0 110.241 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' CYS . . . . . . . . . . . . . 16.1 t -62.09 -46.09 90.62 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.365 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -63.89 -39.5 94.34 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 113.011 -1.904 . . . . 0.0 109.192 176.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 189' ' ' VAL . 49.4 tp10 -60.18 -46.49 89.53 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.065 -0.97 . . . . 0.0 111.97 -176.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.499 ' HA ' HD13 ' A' ' 194' ' ' LEU . 3.3 mm? -65.26 -38.49 90.48 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 118.17 -1.412 . . . . 0.0 110.866 -176.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.437 ' O ' ' CD2' ' A' ' 199' ' ' LEU . 0.3 OUTLIER -63.89 -47.02 92.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 116.345 -2.142 . . . . 0.0 107.347 -179.691 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 9.4 p -65.16 -46.54 80.43 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -179.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -57.34 -39.15 75.32 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.121 1.368 . . . . 0.0 113.473 -177.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -55.59 -44.19 76.7 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.71 ' N ' HD22 ' A' ' 199' ' ' LEU . 2.5 mm? -61.4 -39.54 91.09 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 80.0 mt -63.18 -43.78 99.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 118.485 -0.769 . . . . 0.0 111.464 -178.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 17.8 mmmt -60.52 -40.13 90.33 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 120.551 1.523 . . . . 0.0 109.511 175.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -64.34 -35.45 80.91 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 112.885 -1.961 . . . . 0.0 111.026 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 199' ' ' LEU . 0.2 OUTLIER -101.55 128.35 47.84 Favored 'General case' 0 C--N 1.357 0.894 0 O-C-N 121.0 -1.063 . . . . 0.0 111.239 -179.268 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.441 ' N ' HD12 ' A' ' 204' ' ' LEU . 10.4 mp 66.23 4.91 3.35 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.202 177.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 2.4 mt -129.38 35.8 4.2 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.465 0.65 . . . . 0.0 112.258 -177.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -73.83 -23.33 59.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.728 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.653 ' C ' HD22 ' A' ' 208' ' ' ASN . . . -131.17 -45.36 1.01 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.95 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . 0.969 ' ND2' ' H ' ' A' ' 209' ' ' LEU . 0.0 OUTLIER 127.2 -72.4 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.198 1.799 . . . . 0.0 108.388 -178.207 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.969 ' H ' ' ND2' ' A' ' 208' ' ' ASN . 0.3 OUTLIER -160.84 104.16 1.35 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 179.139 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -139.17 29.04 2.26 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.498 ' OG1' ' N ' ' A' ' 212' ' ' ASP . 5.8 t -142.85 -162.77 1.49 Allowed 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.585 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . 0.498 ' N ' ' OG1' ' A' ' 211' ' ' THR . 43.1 m-20 -143.29 -147.2 0.2 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.152 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 63.1 72.89 0.47 Allowed 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.436 ' N ' ' CD ' ' A' ' 215' ' ' PRO . 4.1 mt -61.41 -43.52 89.56 Favored Pre-proline 0 C--N 1.33 -0.255 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 214' ' ' LEU . 26.7 Cg_exo -61.09 -33.58 91.2 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 CA-C-N 119.978 1.028 . . . . 0.0 111.107 -178.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 90.4 m -64.78 -42.46 95.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 113.269 -1.787 . . . . 0.0 111.807 -178.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' HIS . . . . . 0.441 ' O ' ' ND1' ' A' ' 217' ' ' HIS . 1.9 t60 -66.83 -38.32 86.2 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -177.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -63.35 -47.23 82.99 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.73 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 30.5 p -60.17 -37.86 81.43 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 118.943 0.792 . . . . 0.0 111.054 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 11.4 t -59.15 -41.16 87.7 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.3 -41.48 98.96 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -177.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -61.25 -46.98 88.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 122.172 0.987 . . . . 0.0 112.467 -176.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -60.43 -41.61 98.64 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 107.418 -2.273 . . . . 0.0 107.418 176.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.454 ' O ' ' SG ' ' A' ' 227' ' ' CYS . . . -62.52 -37.73 87.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.255 -0.972 . . . . 0.0 108.479 176.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -61.65 -42.22 99.72 Favored Glycine 0 CA--C 1.525 0.679 0 CA-C-N 114.757 -1.111 . . . . 0.0 110.586 -178.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -66.62 -38.5 87.09 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.166 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . 0.467 ' SG ' ' N ' ' A' ' 228' ' ' THR . 0.5 OUTLIER -63.11 -40.48 97.75 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.236 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.467 ' N ' ' SG ' ' A' ' 227' ' ' CYS . 0.3 OUTLIER -61.29 -39.69 91.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.254 179.473 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.4 ' O ' ' HB3' ' A' ' 232' ' ' ALA . 20.1 m -58.39 -39.43 79.63 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 -178.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 92.8 t -60.25 -40.84 84.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 119.339 -0.944 . . . . 0.0 108.497 178.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.596 ' O ' ' HD2' ' A' ' 234' ' ' PRO . 24.8 mm -61.29 -40.09 84.85 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.362 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 229' ' ' THR . . . -62.17 -38.4 88.92 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -178.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.451 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 0.3 OUTLIER -57.24 -40.19 82.89 Favored Pre-proline 0 N--CA 1.48 1.054 0 N-CA-C 116.107 1.891 . . . . 0.0 116.107 -173.052 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.596 ' HD2' ' O ' ' A' ' 231' ' ' ILE . 33.0 Cg_exo -58.76 -40.52 71.98 Favored 'Trans proline' 0 C--N 1.298 -2.088 0 C-N-CA 122.008 1.805 . . . . 0.0 113.516 -177.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 4.6 m -64.66 -36.0 76.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 119.071 -1.051 . . . . 0.0 110.243 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -64.79 -40.71 95.7 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 -177.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.439 ' H ' HG22 ' A' ' 237' ' ' VAL . 6.3 m -64.79 -45.48 94.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -176.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 5.7 p -63.36 -36.72 77.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 119.888 -0.725 . . . . 0.0 110.038 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 30.9 mmtm -60.0 -43.66 95.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.552 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -60.59 -41.84 95.53 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -177.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.445 ' NH1' ' CE1' ' A' ' 269' ' ' PHE . 64.3 mtp180 -70.05 134.2 48.0 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.277 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.617 ' O ' ' CG ' ' A' ' 242' ' ' TYR . 22.6 t80 163.76 5.2 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 O-C-N 123.839 0.712 . . . . 0.0 112.535 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' MET . . . . . 0.406 ' O ' ' CB ' ' A' ' 244' ' ' ASN . 21.4 ttm -116.37 161.3 19.27 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.084 -1.01 . . . . 0.0 110.942 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . 0.406 ' CB ' ' O ' ' A' ' 243' ' ' MET . 2.6 m120 81.05 -178.11 0.07 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.281 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 1.7 m 67.05 30.66 7.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.85 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -112.06 45.47 1.26 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.962 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 15.5 mt -97.64 -74.27 0.58 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.798 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.446 ' O ' ' CD2' ' A' ' 250' ' ' TYR . . . -171.19 170.09 43.0 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.61 ' O ' ' CG ' ' A' ' 250' ' ' TYR . 23.5 mt-30 65.85 -164.39 0.24 Allowed 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.61 ' CG ' ' O ' ' A' ' 249' ' ' GLN . 23.3 p90 50.52 140.12 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 O-C-N 124.133 0.896 . . . . 0.0 110.941 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . 1.358 ' HD2' ' NE2' ' A' ' 255' ' ' HIS . 53.8 m-70 -65.37 -51.23 61.88 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 118.267 -1.373 . . . . 0.0 108.331 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . 0.411 ' H ' ' HB3' ' A' ' 255' ' ' HIS . 55.7 m -149.09 -178.6 6.47 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 121.677 0.751 . . . . 0.0 112.031 175.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -65.13 -43.99 90.1 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.412 -1.267 . . . . 0.0 112.569 177.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . 0.414 ' O ' ' HB3' ' A' ' 257' ' ' ALA . . . -67.21 -43.47 89.16 Favored Glycine 0 N--CA 1.463 0.463 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.814 177.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' HIS . . . . . 1.358 ' NE2' ' HD2' ' A' ' 251' ' ' HIS . 86.4 t60 -63.27 -32.5 73.92 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 112.546 -1.827 . . . . 0.0 110.983 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' CYS . . . . . . . . . . . . . 7.5 t -61.81 -42.34 98.89 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 114.049 -1.432 . . . . 0.0 108.529 175.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 254' ' ' GLY . . . -58.06 -42.95 86.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.604 -178.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -64.43 -42.31 96.09 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 96.8 m -62.37 -45.03 95.02 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.879 177.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' MET . . . . . 0.595 ' O ' ' N ' ' A' ' 264' ' ' GLU . 0.0 OUTLIER -60.5 -41.58 94.59 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.894 -178.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 8.8 tp -61.2 -47.68 85.0 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 29.1 mtp85 -67.28 -53.86 26.06 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 43.6 tttp -66.51 -69.89 0.28 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.42 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . 0.595 ' N ' ' O ' ' A' ' 260' ' ' MET . 43.6 tp10 -88.32 110.77 21.03 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.835 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.484 ' C ' ' H ' ' A' ' 267' ' ' ARG . . . -34.45 155.9 0.01 OUTLIER Glycine 0 CA--C 1.539 1.558 0 CA-C-N 116.3 -0.409 . . . . 0.0 112.11 -179.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -56.03 3.23 0.08 OUTLIER 'Trans proline' 0 N--CA 1.503 2.048 0 C-N-CA 122.131 1.888 . . . . 0.0 113.086 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.484 ' H ' ' C ' ' A' ' 265' ' ' GLY . 99.6 mtt180 -68.95 -27.0 65.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.436 0.16 . . . . 0.0 110.768 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -58.78 -32.7 69.54 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.57 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . 0.445 ' CE1' ' NH1' ' A' ' 241' ' ' ARG . 51.1 m-85 -62.47 -42.47 99.5 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.554 0.693 . . . . 0.0 110.683 178.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -66.62 -37.46 84.92 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.668 -1.151 . . . . 0.0 113.17 -178.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 272' ' ' GLY . 68.4 mttm -77.59 171.89 14.22 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 271' ' ' LYS . . . 53.69 111.79 0.01 OUTLIER Glycine 0 CA--C 1.528 0.874 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . 0.424 ' H ' ' H ' ' A' ' 274' ' ' MET . 48.2 p90 -172.25 3.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.616 -0.433 . . . . 0.0 111.144 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' MET . . . . . 0.559 ' N ' ' CD ' ' A' ' 275' ' ' PRO . 1.4 ttt -64.01 -44.13 77.12 Favored Pre-proline 0 C--N 1.329 -0.324 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.615 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' A' ' 274' ' ' MET . 19.5 Cg_exo -64.71 -47.9 4.76 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 121.852 1.701 . . . . 0.0 112.107 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 44.6 t -61.52 -40.74 95.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.664 0.745 . . . . 0.0 110.743 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -62.33 -42.62 99.53 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 123.491 1.615 . . . . 0.0 113.541 -178.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 9.2 tp -62.78 -39.24 93.6 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 110.607 -2.997 . . . . 0.0 108.887 174.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 71.5 mtp180 -63.04 -40.54 98.04 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.561 0.696 . . . . 0.0 110.713 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.855 ' O ' HD12 ' A' ' 280' ' ' LEU . 0.1 OUTLIER -62.26 -36.22 81.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.609 -1.178 . . . . 0.0 112.211 -177.446 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -68.14 -51.16 34.94 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . 0.503 ' O ' HG22 ' A' ' 285' ' ' VAL . 71.1 m -63.19 -44.68 94.68 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 123.087 0.555 . . . . 0.0 109.84 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' TRP . . . . . . . . . . . . . 80.3 t90 -60.46 -38.0 82.8 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.851 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -61.75 -37.96 86.19 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.718 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.503 HG22 ' O ' ' A' ' 282' ' ' SER . 0.9 OUTLIER -60.2 -37.44 73.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 111.567 0.21 . . . . 0.0 111.567 -178.598 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.777 ' O ' HG12 ' A' ' 289' ' ' VAL . 0.8 OUTLIER -61.75 -40.15 85.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 120.505 -0.478 . . . . 0.0 109.986 -178.804 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 8.4 tpt -60.91 -39.11 88.11 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.245 0.545 . . . . 0.0 109.721 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -59.05 -41.05 86.98 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.856 -178.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.777 HG12 ' O ' ' A' ' 286' ' ' VAL . 8.1 p -61.28 -38.53 80.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 O-C-N 121.855 -0.528 . . . . 0.0 112.091 -177.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 19.4 p -62.53 -40.98 98.5 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 119.18 -1.008 . . . . 0.0 108.379 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -60.89 -38.55 86.06 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 177.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 14.9 tm-20 -57.53 -39.58 76.92 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 118.138 -1.425 . . . . 0.0 109.535 -176.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' GLN . . . . . 0.439 ' O ' ' O ' ' A' ' 296' ' ' ARG . 0.0 OUTLIER -60.17 -41.63 93.25 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 122.968 1.366 . . . . 0.0 110.11 179.197 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 65.0 mt -60.25 -39.32 86.31 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 112.206 -2.27 . . . . 0.0 109.557 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -62.16 -45.26 94.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.088 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' ARG . . . . . 0.439 ' O ' ' O ' ' A' ' 293' ' ' GLN . 62.3 ttm-85 -122.58 116.06 23.22 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . 0.445 ' HB1' HD12 ' A' ' 298' ' ' LEU . . . -109.72 -169.82 1.54 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.402 0.62 . . . . 0.0 111.76 -178.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.797 ' H ' HD12 ' A' ' 298' ' ' LEU . 0.0 OUTLIER -68.24 -8.83 42.66 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.977 -1.011 . . . . 0.0 111.471 -178.663 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . 0.403 ' C ' ' O ' ' A' ' 298' ' ' LEU . 74.1 mtp 28.1 62.41 0.11 Allowed 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 177.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.62 100.81 0.07 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.812 0.815 . . . . 0.0 110.896 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -63.93 -46.3 85.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.131 -1.395 . . . . 0.0 113.386 -176.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . 0.527 ' CD2' ' OE2' ' A' ' 306' ' ' GLU . 32.8 t80 -58.68 -40.13 82.68 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.023 -0.671 . . . . 0.0 109.539 -178.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . 0.485 ' OE1' ' N ' ' A' ' 303' ' ' GLN . 1.3 mp0 -65.0 -46.83 79.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.186 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' SER . . . . . 0.446 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 77.8 p -66.23 -37.4 85.45 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.553 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -61.43 -42.82 99.35 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.057 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.527 ' OE2' ' CD2' ' A' ' 302' ' ' TYR . 41.7 mt-10 -64.71 -36.99 86.08 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.228 1.195 . . . . 0.0 114.228 -177.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . 0.534 ' HB3' ' HD3' ' A' ' 308' ' ' PRO . . . -60.02 -52.95 69.88 Favored Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -176.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' PRO . . . . . 0.534 ' HD3' ' HB3' ' A' ' 307' ' ' ALA . 74.0 Cg_endo -75.26 0.27 9.21 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.193 1.929 . . . . 0.0 111.908 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 91.9 t80 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.609 -179.981 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 16.6 ptm . . . . . 0 N--CA 1.492 1.651 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.5 m -78.74 119.39 21.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.048 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.405 HG12 ' H ' ' A' ' 17' ' ' PHE . 3.9 t -147.23 143.85 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 121.129 0.49 . . . . 0.0 111.085 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -64.21 -40.82 96.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.679 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.405 ' H ' HG12 ' A' ' 15' ' ' VAL . 74.1 t80 -63.49 -41.39 98.57 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.175 -0.921 . . . . 0.0 113.208 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 50.9 tp -79.77 -26.48 40.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.177 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.401 ' O ' ' OG1' ' A' ' 22' ' ' THR . . . -66.43 -41.44 94.37 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 107.363 -2.295 . . . . 0.0 107.363 176.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.405 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -71.26 -31.75 67.89 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 124.84 2.257 . . . . 0.0 107.316 176.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.46 -42.72 98.93 Favored Glycine 0 CA--C 1.528 0.867 1 CA-C-N 108.364 -4.016 . . . . 0.0 108.307 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' A' ' 19' ' ' GLY . 35.6 p -70.71 -27.95 64.37 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.576 0.703 . . . . 0.0 109.314 177.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -66.38 -50.18 64.34 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.946 -178.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.82 -35.82 79.33 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 118.671 -1.212 . . . . 0.0 111.2 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 75.6 m -63.71 -53.63 48.16 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.343 -178.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.9 pt -65.47 -39.77 86.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 -177.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.05 -42.02 97.19 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 119.763 -0.775 . . . . 0.0 112.845 -173.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.455 ' HB2' HE21 ' A' ' 89' ' ' GLN . 43.1 t0 -77.71 -27.36 50.63 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 118.249 -1.38 . . . . 0.0 109.544 -176.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.1 tp -60.29 -55.67 30.86 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.714 1.143 . . . . 0.0 111.729 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.0 pt -75.4 -4.0 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 121.306 0.574 . . . . 0.0 112.368 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.429 ' O ' HG22 ' A' ' 31' ' ' THR . 30.1 m -109.12 -16.8 14.02 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.254 -178.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -69.02 -44.69 29.29 Favored Pre-proline 0 CA--C 1.544 0.731 0 CA-C-N 121.868 2.122 . . . . 0.0 111.926 -178.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -59.64 -16.25 35.67 Favored 'Trans proline' 0 N--CA 1.504 2.088 0 CA-C-N 120.897 1.356 . . . . 0.0 112.857 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 62.2 mt -67.54 -35.15 78.51 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -177.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.404 ' HA ' ' HZ3' ' A' ' 38' ' ' LYS . 1.1 m-20 -64.23 -40.52 96.2 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.128 -177.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 87.0 m -58.2 -34.84 70.81 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.14 -38.97 86.43 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 119.691 -0.804 . . . . 0.0 113.048 -179.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.404 ' HZ3' ' HA ' ' A' ' 35' ' ' ASP . 9.2 pttm -62.14 -47.55 84.07 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 118.995 -1.082 . . . . 0.0 111.656 -177.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.6 t -62.83 -38.72 82.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -177.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.504 ' O ' ' N ' ' A' ' 42' ' ' GLN . 7.9 tpm_? -59.45 -41.25 89.22 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 119.266 -0.974 . . . . 0.0 109.706 -178.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.498 ' C ' ' H ' ' A' ' 43' ' ' ILE . 9.4 mp -62.69 38.83 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.59 177.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.57 ' O ' ' N ' ' A' ' 44' ' ' GLN . 25.1 tp60 -72.71 23.96 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 O-C-N 121.947 -0.471 . . . . 0.0 111.385 -178.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.509 HG23 ' O ' ' A' ' 43' ' ' ILE . 9.2 tp 28.98 34.03 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 121.404 0.621 . . . . 0.0 111.534 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.57 ' N ' ' O ' ' A' ' 42' ' ' GLN . 3.1 mp0 53.79 98.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.566 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -169.19 31.74 0.17 Allowed Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -70.57 -28.68 65.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.828 0.347 . . . . 0.0 110.684 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 17.7 t 59.38 42.2 18.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.998 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -98.99 -19.64 17.18 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.1 0.476 . . . . 0.0 110.05 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.16 -23.28 30.29 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.551 ' O ' HD13 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -66.1 -38.26 87.79 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.612 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.528 HG13 ' N ' ' A' ' 52' ' ' ARG . 14.3 p -61.04 -44.5 98.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.151 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.528 ' N ' HG13 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -64.24 -33.58 76.15 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.714 -178.461 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -67.93 -38.05 82.41 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -93.18 -146.25 0.23 Allowed 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.847 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -176.11 -32.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.084 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.593 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 7.9 t -128.08 -138.83 0.24 Allowed 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.593 ' HB3' ' O ' ' A' ' 56' ' ' SER . . . 99.25 12.56 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.6 0 O-C-N 124.165 0.916 . . . . 0.0 111.277 178.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.439 ' CG ' ' O ' ' A' ' 58' ' ' GLN . 4.3 pt20 -174.24 121.1 0.28 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -85.76 151.41 23.85 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 87.9 mtt180 -45.43 -33.02 2.39 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 122.453 1.121 . . . . 0.0 108.096 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -41.89 114.37 0.67 Allowed Glycine 0 CA--C 1.526 0.723 0 CA-C-N 112.86 -1.973 . . . . 0.0 113.195 -178.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.6 p -66.75 -33.02 60.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 118.124 -0.941 . . . . 0.0 108.862 176.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.407 ' O ' HD23 ' A' ' 67' ' ' LEU . 3.7 mm? -60.18 -32.3 70.94 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 121.747 2.067 . . . . 0.0 110.868 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.59 -49.07 66.59 Favored Glycine 0 CA--C 1.532 1.121 0 N-CA-C 114.965 0.746 . . . . 0.0 114.965 -176.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.401 HG22 ' H ' ' A' ' 65' ' ' THR . 1.6 t -62.04 -45.57 93.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.178 -0.511 . . . . 0.0 111.933 -179.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 35.2 mm -59.25 -36.25 62.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.407 HD23 ' O ' ' A' ' 63' ' ' LEU . 2.1 mm? -63.91 -35.84 81.97 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 120.764 1.62 . . . . 0.0 112.148 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 97.9 m -63.0 -39.82 95.89 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 114.002 -1.454 . . . . 0.0 111.04 -175.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.463 ' O ' ' OG1' ' A' ' 72' ' ' THR . 0.1 OUTLIER -60.03 -39.61 86.48 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -176.023 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.6 p -69.91 -40.5 78.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 113.934 1.086 . . . . 0.0 113.934 -178.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -78.3 -13.56 59.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.8 0.809 . . . . 0.0 112.883 -178.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' A' ' 69' ' ' MET . 0.0 OUTLIER -63.2 -54.62 34.61 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.069 -1.423 . . . . 0.0 111.002 178.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -107.79 -57.76 2.06 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.805 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 157.99 163.49 12.81 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -56.51 -35.15 96.53 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 121.987 1.792 . . . . 0.0 111.683 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.433 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 91.7 mtt-85 -61.39 -11.65 11.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.654 0.74 . . . . 0.0 111.022 176.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.9 t -77.69 -32.42 53.04 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.089 -1.414 . . . . 0.0 111.038 -177.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.516 ' N ' HD12 ' A' ' 78' ' ' LEU . 10.2 mp -75.5 -33.09 60.74 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 122.126 -0.359 . . . . 0.0 110.783 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -91.91 -4.58 54.54 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 122.796 1.284 . . . . 0.0 113.142 -178.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.433 ' ND2' ' O ' ' A' ' 76' ' ' ARG . 0.9 OUTLIER -97.47 117.65 32.21 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 112.025 -2.352 . . . . 0.0 107.168 174.903 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.9 -13.5 56.17 Favored Glycine 0 N--CA 1.469 0.866 0 N-CA-C 108.255 -1.938 . . . . 0.0 108.255 -177.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 12.3 tp -58.85 -34.71 71.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 113.305 -1.448 . . . . 0.0 110.249 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.8 p -70.54 -26.78 29.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.364 178.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.81 -31.61 61.76 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.796 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.86 -40.42 89.4 Favored Glycine 0 N--CA 1.463 0.492 0 C-N-CA 119.677 -1.249 . . . . 0.0 111.223 -177.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.3 mp -62.34 -40.08 95.21 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 122.364 1.078 . . . . 0.0 112.5 -177.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -60.44 -27.24 67.35 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 113.071 -1.877 . . . . 0.0 109.34 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 49.4 ttp180 -57.91 -53.48 57.77 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 173.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.455 HE21 ' HB2' ' A' ' 28' ' ' ASP . 9.8 tp-100 -67.44 -29.89 69.48 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 112.56 -2.109 . . . . 0.0 112.428 -178.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 12.2 tpt -61.02 -40.98 95.63 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.352 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 78.2 p -74.35 -34.34 63.38 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 119.509 -0.877 . . . . 0.0 111.401 -176.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -58.04 -44.48 87.43 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 120.6 1.545 . . . . 0.0 111.789 -176.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.33 -33.59 65.21 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.49 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.1 t -64.48 -41.8 96.25 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.3 t -68.41 -28.6 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.841 177.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.568 ' NH2' ' CE2' ' A' ' 100' ' ' TYR . 59.9 ttt-85 -78.05 8.79 4.29 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -177.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.492 HD13 ' O ' ' A' ' 97' ' ' ILE . 0.3 OUTLIER -87.49 -14.95 9.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.086 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -140.09 -48.13 0.06 OUTLIER Glycine 0 CA--C 1.54 1.631 0 N-CA-C 115.864 1.106 . . . . 0.0 115.864 -176.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.7 mt -71.08 -12.56 61.58 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 119.586 1.693 . . . . 0.0 112.817 -178.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.568 ' CE2' ' NH2' ' A' ' 96' ' ' ARG . 4.3 t80 -80.22 -51.32 9.08 Favored 'General case' 0 C--O 1.214 -0.778 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.438 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 1.162 ' OD1' ' NE2' ' A' ' 105' ' ' GLN . 12.7 t70 -69.48 -32.73 71.81 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 123.45 1.595 . . . . 0.0 110.561 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 31.1 m -68.82 -52.47 29.77 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 111.023 -2.808 . . . . 0.0 114.466 177.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.582 HG22 ' CE2' ' A' ' 107' ' ' TYR . 1.1 p -74.97 -27.82 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 CA-C-N 121.942 2.156 . . . . 0.0 112.479 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.521 ' HB2' ' O ' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -69.99 -41.74 73.98 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 110.849 -2.887 . . . . 0.0 112.801 -179.636 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 1.162 ' NE2' ' OD1' ' A' ' 101' ' ' ASP . 88.1 mt-30 -78.88 -11.43 60.0 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 122.972 1.368 . . . . 0.0 111.043 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.47 -21.94 48.27 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 113.924 -1.489 . . . . 0.0 111.086 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.582 ' CE2' HG22 ' A' ' 103' ' ' VAL . 47.5 m-85 -108.36 -30.57 8.25 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 120.005 1.275 . . . . 0.0 111.614 -175.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.1 p -98.27 9.68 42.44 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 117.972 -1.491 . . . . 0.0 112.047 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.47 ' O ' ' C ' ' A' ' 110' ' ' GLY . 16.0 ttmm -54.19 118.17 3.85 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.619 0.645 . . . . 0.0 112.453 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.511 ' O ' ' O ' ' A' ' 111' ' ' SER . . . -17.24 -89.09 0.01 OUTLIER Glycine 0 N--CA 1.48 1.585 0 CA-C-O 119.81 -0.439 . . . . 0.0 113.155 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.703 ' O ' ' O ' ' A' ' 112' ' ' GLU . 5.9 t 45.44 111.54 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 117.252 0.526 . . . . 0.0 111.797 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.703 ' O ' ' O ' ' A' ' 111' ' ' SER . 17.1 pt-20 -9.57 -148.26 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 126.481 1.913 . . . . 0.0 115.929 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.622 ' O ' ' HB2' ' A' ' 114' ' ' ALA . 0.0 OUTLIER -105.92 73.35 0.99 Allowed 'General case' 0 C--N 1.343 0.303 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -177.257 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.622 ' HB2' ' O ' ' A' ' 113' ' ' HIS . . . 160.14 -164.38 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 122.35 1.072 . . . . 0.0 108.963 175.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.03 15.6 25.72 Favored Glycine 0 C--N 1.342 0.863 0 CA-C-N 113.015 -1.902 . . . . 0.0 111.487 178.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.434 HG23 ' N ' ' A' ' 117' ' ' GLY . 13.3 tt -60.71 -40.33 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 C-N-CA 119.609 -0.837 . . . . 0.0 111.015 -178.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.434 ' N ' HG23 ' A' ' 116' ' ' ILE . . . -65.56 -40.39 96.05 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-O 121.716 0.62 . . . . 0.0 112.098 176.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 26.0 p -58.41 -42.57 87.48 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 176.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.1 tpp180 -63.55 -37.24 86.55 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 119.824 -0.75 . . . . 0.0 110.927 -177.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.669 HD21 HD22 ' A' ' 194' ' ' LEU . 2.6 mm? -63.35 -46.1 88.11 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 20.9 mt -66.51 -44.76 81.66 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 118.896 -1.122 . . . . 0.0 109.847 178.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.1 -45.21 89.67 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 119.964 1.256 . . . . 0.0 110.452 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -65.81 -44.42 92.14 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.191 -1.004 . . . . 0.0 111.262 -178.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 42.5 m -64.17 -43.75 94.2 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.742 0.306 . . . . 0.0 111.418 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 19.7 m -69.5 -48.27 61.11 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 119.346 -0.942 . . . . 0.0 112.337 177.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.475 HG23 ' N ' ' A' ' 127' ' ' GLY . 6.0 t -65.68 -42.75 90.9 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 -174.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.475 ' N ' HG23 ' A' ' 126' ' ' THR . . . -64.48 -44.96 94.46 Favored Glycine 0 CA--C 1.52 0.401 0 CA-C-N 114.632 -1.167 . . . . 0.0 113.138 -177.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.432 ' O ' HG22 ' A' ' 131' ' ' VAL . . . -61.81 -41.71 98.1 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 112.719 -1.741 . . . . 0.0 107.207 177.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.745 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 54.6 tp -64.7 -42.62 95.15 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.09 178.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.34 -40.09 96.33 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.099 0.778 . . . . 0.0 113.099 -177.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 128' ' ' ALA . 14.3 m -61.17 -26.55 39.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 123.521 1.629 . . . . 0.0 109.639 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.745 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . -59.29 -45.49 91.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 110.835 -2.893 . . . . 0.0 112.673 -178.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.419 ' H ' HG12 ' A' ' 133' ' ' VAL . 2.6 p -79.65 -49.03 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 -178.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -121.79 136.39 54.93 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.823 0.344 . . . . 0.0 111.667 -178.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.762 ' H ' ' CD ' ' A' ' 136' ' ' PRO . 0.0 OUTLIER 170.33 -21.36 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.723 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.79 178.669 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.762 ' CD ' ' H ' ' A' ' 135' ' ' GLN . 53.0 Cg_exo -52.84 -34.68 66.74 Favored 'Trans proline' 0 N--CA 1.499 1.85 0 CA-C-N 121.174 1.455 . . . . 0.0 113.268 -178.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.479 HG23 ' N ' ' A' ' 138' ' ' ASP . 11.5 t -67.28 -41.59 85.22 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 119.07 -1.052 . . . . 0.0 108.613 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.479 ' N ' HG23 ' A' ' 137' ' ' THR . 98.5 m-20 -64.68 -42.24 95.49 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 118.857 -1.137 . . . . 0.0 111.34 -178.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 55.3 t -63.85 -44.48 98.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 32.1 m -65.33 -38.17 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -177.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -61.73 -40.65 95.84 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -176.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.443 ' CG2' ' N ' ' A' ' 143' ' ' ARG . 1.5 m -69.41 -44.24 80.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.028 -0.669 . . . . 0.0 109.343 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.528 ' NH2' ' O ' ' A' ' 174' ' ' GLY . 94.8 mtt-85 -63.86 -35.41 80.56 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.288 178.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -65.89 -40.21 91.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.92 -177.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 23.8 tm0? -63.98 -39.31 93.83 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 119.335 -0.946 . . . . 0.0 108.861 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.14 -35.16 80.24 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 113.267 0.839 . . . . 0.0 113.267 -178.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.52 110.78 1.19 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 177.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -99.41 -60.58 1.5 Allowed 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -175.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -98.35 117.51 32.93 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 122.107 2.23 . . . . 0.0 109.968 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -68.14 -15.0 63.4 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.666 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 71.08 -173.85 41.68 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 153' ' ' GLY . . . -46.37 -94.5 0.01 OUTLIER Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 152' ' ' GLY . . . 48.57 101.83 0.01 OUTLIER Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -59.99 -40.41 89.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.789 0.328 . . . . 0.0 110.373 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -56.78 -169.74 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.344 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.428 ' O ' ' O ' ' A' ' 157' ' ' GLN . 79.4 t80 -108.86 -0.17 19.95 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.979 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.428 ' O ' ' O ' ' A' ' 156' ' ' TYR . 18.1 mm100 59.4 145.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.338 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 70.5 m -157.07 -177.73 6.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.383 0.611 . . . . 0.0 111.201 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 96.8 m -63.92 -45.97 86.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.551 -177.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.539 HG23 ' N ' ' A' ' 161' ' ' GLU . 8.2 m -64.01 -44.9 97.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 118.913 -1.115 . . . . 0.0 109.008 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.539 ' N ' HG23 ' A' ' 160' ' ' VAL . 94.6 mt-10 -66.94 -39.04 87.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.859 0.361 . . . . 0.0 111.459 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -61.76 -45.62 93.14 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -177.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -62.38 -49.66 74.65 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.509 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 65.7 mmtt -68.44 -45.43 72.53 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 -175.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 35.6 p -62.79 -44.66 95.58 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 120.78 -1.2 . . . . 0.0 113.921 -177.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.419 HD12 ' N ' ' A' ' 167' ' ' ALA . 2.4 pp -64.64 -37.78 80.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 121.825 0.822 . . . . 0.0 109.632 176.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.419 ' N ' HD12 ' A' ' 166' ' ' ILE . . . -58.64 -35.87 73.2 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 113.741 -1.572 . . . . 0.0 107.829 177.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 7.8 tpm_? -61.94 -50.47 71.99 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 121.706 2.048 . . . . 0.0 112.726 -175.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -75.25 -51.21 13.83 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 123.684 0.793 . . . . 0.0 111.199 178.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -78.14 -36.24 48.01 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 116.169 1.914 . . . . 0.0 116.169 -172.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 93.03 -167.42 29.28 Favored Glycine 0 N--CA 1.47 0.951 0 N-CA-C 111.872 -0.491 . . . . 0.0 111.872 177.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.711 ' H ' HD13 ' A' ' 172' ' ' ILE . 0.0 OUTLIER -73.37 -44.48 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 CA-C-O 121.796 0.808 . . . . 0.0 109.871 -179.827 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -59.03 -33.9 71.28 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 114.442 -1.254 . . . . 0.0 111.424 -177.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.528 ' O ' ' NH2' ' A' ' 143' ' ' ARG . . . -61.05 -40.41 98.47 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 118.575 -1.774 . . . . 0.0 109.3 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 1.2 tp -70.54 -33.71 71.45 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 111.459 -2.371 . . . . 0.0 116.995 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 6.4 m95 -77.84 -7.56 56.83 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 111.991 -2.368 . . . . 0.0 109.796 -177.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 48.1 tttp -43.39 -48.29 7.04 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.575 -176.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -95.1 -40.03 4.39 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.3 0.953 . . . . 0.0 112.109 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.407 HG23 ' H ' ' A' ' 179' ' ' THR . 11.5 p -45.46 -51.44 11.57 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -179.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.452 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 2.6 m -62.72 -50.69 76.7 Favored Pre-proline 0 N--CA 1.472 0.659 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -176.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' A' ' 180' ' ' SER . 30.1 Cg_endo -64.5 -27.58 62.07 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 121.986 1.791 . . . . 0.0 111.928 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -63.35 -39.09 93.58 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 120.588 -0.445 . . . . 0.0 109.939 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.451 ' O ' ' OD1' ' A' ' 186' ' ' ASN . 85.2 t -62.84 -42.3 95.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.051 0.453 . . . . 0.0 109.975 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.88 -39.51 92.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.095 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 46.2 ttp85 -60.44 -40.83 92.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.923 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . 0.49 ' C ' ' ND2' ' A' ' 186' ' ' ASN . 0.0 OUTLIER -60.34 -41.67 94.08 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.136 0.493 . . . . 0.0 110.34 -179.667 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.2 -43.19 98.87 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.79 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.444 ' O ' ' SG ' ' A' ' 191' ' ' CYS . 42.9 mm -63.01 -44.8 99.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 6.3 m -59.37 -45.67 93.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 119.816 -0.754 . . . . 0.0 111.276 -178.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.406 ' OD1' ' N ' ' A' ' 191' ' ' CYS . 0.9 OUTLIER -61.8 -42.51 99.1 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.876 0.846 . . . . 0.0 109.419 179.302 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' CYS . . . . . 0.551 ' SG ' ' N ' ' A' ' 192' ' ' ALA . 0.5 OUTLIER -62.0 -45.94 91.41 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.013 -1.449 . . . . 0.0 110.828 179.666 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.551 ' N ' ' SG ' ' A' ' 191' ' ' CYS . . . -63.71 -40.4 96.68 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 114.463 -1.244 . . . . 0.0 109.433 177.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -60.74 -44.72 96.33 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.702 -1.136 . . . . 0.0 112.579 -178.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.669 HD22 HD21 ' A' ' 120' ' ' LEU . 2.5 pp -63.0 -37.83 88.74 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 118.862 -1.135 . . . . 0.0 109.75 -174.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.47 ' N ' ' HG ' ' A' ' 194' ' ' LEU . 0.6 OUTLIER -63.99 -46.15 94.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 C-N-CA 117.206 -1.798 . . . . 0.0 107.464 179.074 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 19.2 m -63.98 -46.52 84.24 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -176.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -56.8 -39.12 73.57 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.694 0.798 . . . . 0.0 111.222 -178.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -56.06 -43.93 78.41 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.4 HD23 ' N ' ' A' ' 199' ' ' LEU . 7.7 mt -61.21 -39.39 90.06 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.599 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.1 mm -62.94 -42.04 95.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 1.8 mmmm -59.27 -38.77 80.95 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.744 1.618 . . . . 0.0 114.911 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -64.27 -42.24 96.53 Favored 'General case' 0 C--O 1.245 0.849 0 O-C-N 121.087 -1.008 . . . . 0.0 111.063 -176.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.631 HG22 HD23 ' A' ' 204' ' ' LEU . 4.0 m -102.5 129.19 48.95 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -176.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.631 HD23 HG22 ' A' ' 203' ' ' THR . 3.6 mm? 66.52 3.32 2.83 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 113.717 -1.583 . . . . 0.0 111.299 177.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.555 HD22 ' O ' ' A' ' 204' ' ' LEU . 2.9 mm? -122.1 24.53 9.46 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 -178.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -79.33 -18.11 53.18 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.502 0.668 . . . . 0.0 110.382 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.463 ' O ' ' CB ' ' A' ' 208' ' ' ASN . . . -167.1 25.96 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.204 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . 0.61 ' O ' ' O ' ' A' ' 204' ' ' LEU . 0.7 OUTLIER 93.53 -130.83 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.39 0.676 . . . . 0.0 109.81 -178.729 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.682 ' O ' HD23 ' A' ' 209' ' ' LEU . 6.5 tt -170.21 57.11 0.04 OUTLIER 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 106.719 -1.585 . . . . 0.0 106.719 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 8.5 mmt -99.02 42.95 1.08 Allowed 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 112.833 -1.985 . . . . 0.0 109.217 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.404 HG22 ' H ' ' A' ' 212' ' ' ASP . 2.6 m -69.48 -130.38 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.984 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . 0.404 ' H ' HG22 ' A' ' 211' ' ' THR . 2.7 p30 -158.57 18.89 0.21 Allowed 'General case' 0 CA--C 1.528 0.118 0 CA-C-O 120.7 0.286 . . . . 0.0 110.885 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 213' ' ' ASP . 34.8 p30 -147.44 81.42 1.52 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.963 0.411 . . . . 0.0 110.444 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.45 ' N ' ' HD2' ' A' ' 215' ' ' PRO . 2.0 pt? -61.11 -42.07 84.3 Favored Pre-proline 0 CA--C 1.548 0.877 0 N-CA-C 113.828 1.048 . . . . 0.0 113.828 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' A' ' 214' ' ' LEU . 37.5 Cg_endo -60.13 -32.19 94.27 Favored 'Trans proline' 0 N--CA 1.502 2.01 0 CA-C-N 122.419 1.9 . . . . 0.0 111.458 -178.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 9.9 t -63.51 -42.13 98.5 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 113.48 -1.691 . . . . 0.0 111.713 -177.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' HIS . . . . . 0.433 ' CG ' HD11 ' A' ' 209' ' ' LEU . 54.8 t60 -66.64 -37.75 85.46 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.348 -0.541 . . . . 0.0 111.933 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -63.28 -47.04 84.0 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.515 -178.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 1.5 t -60.22 -37.51 80.54 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 118.845 0.748 . . . . 0.0 111.032 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 78.7 p -59.51 -41.71 90.54 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.544 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.68 -41.61 98.13 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -177.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -61.66 -47.04 87.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 122.007 0.908 . . . . 0.0 112.71 -176.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -60.42 -41.73 98.67 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 107.544 -2.223 . . . . 0.0 107.544 177.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -62.95 -38.05 89.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.33 -0.935 . . . . 0.0 109.043 177.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -61.94 -42.1 99.71 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.192 -178.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -66.16 -38.4 88.0 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 97.5 m -63.1 -40.8 98.69 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 176.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 11.2 m -61.59 -40.1 93.59 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.263 -1.335 . . . . 0.0 110.997 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 92.4 m -58.4 -39.13 78.86 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.371 -177.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 97.1 t -59.68 -40.46 82.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.594 ' O ' ' HD2' ' A' ' 234' ' ' PRO . 23.0 mm -60.97 -40.11 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 177.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -62.32 -38.63 90.17 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.47 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 0.1 OUTLIER -57.25 -40.87 87.82 Favored Pre-proline 0 N--CA 1.482 1.173 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 -172.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.594 ' HD2' ' O ' ' A' ' 231' ' ' ILE . 31.6 Cg_exo -57.87 -39.22 88.53 Favored 'Trans proline' 0 C--N 1.292 -2.404 0 C-N-CA 122.021 1.814 . . . . 0.0 112.491 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 31.0 t -63.52 -36.32 75.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 118.802 -1.159 . . . . 0.0 109.398 178.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . 0.451 ' OD2' ' O ' ' A' ' 233' ' ' SER . 0.0 OUTLIER -65.23 -40.11 93.62 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.174 179.634 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 96.7 t -64.29 -45.63 95.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -176.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 25.6 m -63.06 -37.15 78.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 119.756 -0.777 . . . . 0.0 110.533 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 18.3 mmmt -60.49 -43.9 96.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.635 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 8.9 m -61.1 -42.2 98.07 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -177.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.491 ' O ' ' HB3' ' A' ' 242' ' ' TYR . 20.9 ptt180 -70.12 131.31 44.09 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.777 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.491 ' HB3' ' O ' ' A' ' 241' ' ' ARG . 0.1 OUTLIER 168.64 9.17 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 O-C-N 123.858 0.724 . . . . 0.0 112.525 178.155 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' MET . . . . . 0.401 ' CE ' ' NE2' ' A' ' 42' ' ' GLN . 11.2 tpt -113.17 61.73 0.64 Allowed 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.758 0.708 . . . . 0.0 111.94 -179.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . 0.435 ' O ' ' OG ' ' A' ' 245' ' ' SER . 4.1 m120 -115.81 -27.57 6.99 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' A' ' 244' ' ' ASN . 51.1 m -171.39 175.83 4.03 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.524 -1.217 . . . . 0.0 112.926 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -165.35 152.16 10.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.215 -1.357 . . . . 0.0 108.89 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 21.7 mt 59.98 79.06 0.25 Allowed 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.304 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 249' ' ' GLN . . . 172.38 -153.05 18.24 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.605 ' H ' ' CD ' ' A' ' 249' ' ' GLN . 3.5 pm0 -56.49 -111.66 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.8 m-30 48.36 67.03 0.91 Allowed 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 17.6 t-80 -67.5 -53.8 25.61 Favored 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 117.694 2.479 . . . . 0.0 117.694 -176.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 22.6 m -148.82 -174.69 4.69 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 118.818 0.735 . . . . 0.0 109.859 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -60.54 -45.11 95.08 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 119.771 -1.831 . . . . 0.0 107.3 178.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -58.64 -36.98 88.26 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-N 118.733 0.697 . . . . 0.0 111.884 -175.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -58.46 -37.02 74.62 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 117.977 -1.489 . . . . 0.0 110.996 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -62.25 -45.52 92.94 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 121.648 -0.657 . . . . 0.0 111.65 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -60.57 -45.17 94.93 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.54 HD13 ' O ' ' A' ' 258' ' ' LEU . 0.2 OUTLIER -66.57 -43.95 83.59 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 119.869 -0.733 . . . . 0.0 110.246 -179.049 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 31.6 m -63.31 -47.14 83.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.177 0.513 . . . . 0.0 111.091 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' MET . . . . . 0.426 ' O ' ' O ' ' A' ' 264' ' ' GLU . 32.2 mtt -62.1 -43.58 98.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.945 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 11.8 tp -62.21 -46.26 89.68 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 122.685 0.394 . . . . 0.0 111.068 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 69.6 ttp85 -65.92 -53.8 34.68 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.906 -178.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . 0.426 ' O ' ' N ' ' A' ' 265' ' ' GLY . 0.1 OUTLIER -102.73 -107.35 0.26 Allowed 'General case' 0 N--CA 1.472 0.659 0 O-C-N 122.249 -0.282 . . . . 0.0 111.208 179.562 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . 0.443 ' O ' ' O ' ' A' ' 265' ' ' GLY . 71.2 mm-40 -33.47 91.92 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.443 ' O ' ' O ' ' A' ' 264' ' ' GLU . . . -38.51 166.11 0.01 OUTLIER Glycine 0 CA--C 1.534 1.251 0 CA-C-O 121.623 0.568 . . . . 0.0 111.712 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -63.21 -3.81 5.53 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 122.807 2.338 . . . . 0.0 111.628 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 27.8 mtp180 -69.08 -25.8 64.62 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 123.043 0.537 . . . . 0.0 111.671 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -57.88 -31.84 67.12 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.253 -178.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -62.34 -41.24 98.42 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.18 0.514 . . . . 0.0 110.987 177.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -66.17 -38.37 87.88 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -176.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.439 ' O ' ' O ' ' A' ' 272' ' ' GLY . 14.5 pttm -72.09 -172.43 0.88 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 271' ' ' LYS . . . 47.05 99.23 0.01 OUTLIER Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -158.74 0.94 0.09 Allowed 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.248 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' MET . . . . . 0.552 ' N ' ' HD2' ' A' ' 275' ' ' PRO . 6.2 mmt -63.55 -45.44 83.2 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.581 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 274' ' ' MET . 31.9 Cg_endo -64.9 -45.9 7.35 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 121.133 1.222 . . . . 0.0 110.574 177.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 1.4 m -60.36 -39.78 88.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.246 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . 0.434 ' O ' ' HG ' ' A' ' 280' ' ' LEU . 34.3 t80 -61.65 -43.03 99.63 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 124.438 2.066 . . . . 0.0 112.175 -178.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.11 -38.81 92.67 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 110.568 -3.015 . . . . 0.0 109.569 175.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 11.3 mmm180 -63.2 -41.8 99.23 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.51 0.929 . . . . 0.0 113.51 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.68 HD12 ' N ' ' A' ' 281' ' ' GLY . 3.0 pp -63.12 -35.34 79.94 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -178.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . 0.68 ' N ' HD12 ' A' ' 280' ' ' LEU . . . -67.83 -50.88 38.51 Favored Glycine 0 CA--C 1.521 0.413 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -177.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . 0.448 ' O ' HG12 ' A' ' 285' ' ' VAL . 9.5 t -62.49 -43.89 97.72 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.642 0.777 . . . . 0.0 109.387 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' TRP . . . . . 0.415 ' O ' HG22 ' A' ' 286' ' ' VAL . 83.0 t90 -59.54 -37.68 79.04 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 281' ' ' GLY . 0.1 OUTLIER -61.49 -37.2 82.77 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.665 -179.845 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.448 HG12 ' O ' ' A' ' 282' ' ' SER . 0.3 OUTLIER -60.3 -39.0 79.54 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 O-C-N 121.505 -0.747 . . . . 0.0 112.184 -177.32 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.465 ' H ' HG13 ' A' ' 286' ' ' VAL . 1.0 OUTLIER -63.41 -41.94 94.49 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 119.902 -0.719 . . . . 0.0 112.585 -178.716 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 6.8 ptm -61.78 -38.47 88.18 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.192 0.52 . . . . 0.0 109.808 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -58.2 -40.31 81.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.937 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 91.5 t -60.87 -39.41 81.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.591 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 10.8 m -63.21 -40.45 97.5 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -61.21 -38.73 87.63 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 176.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -57.94 -40.17 79.87 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 118.143 -1.423 . . . . 0.0 109.272 -176.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' GLN . . . . . 0.446 ' O ' ' O ' ' A' ' 296' ' ' ARG . 73.9 mt-30 -60.29 -41.96 94.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 123.126 1.441 . . . . 0.0 109.764 179.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.41 -39.66 88.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 111.717 -2.492 . . . . 0.0 109.342 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -62.72 -45.31 93.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.537 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' ARG . . . . . 0.446 ' O ' ' O ' ' A' ' 293' ' ' GLN . 44.7 ttm180 -122.53 116.18 23.45 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -113.55 -164.83 0.95 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.269 0.557 . . . . 0.0 112.162 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 14.1 mt -72.74 114.89 11.38 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 79.0 mmm -97.93 63.86 1.68 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -178.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.66 100.96 0.07 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.868 0.842 . . . . 0.0 110.716 -178.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -63.95 -46.22 85.66 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 113.962 -1.472 . . . . 0.0 113.528 -176.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -58.59 -39.21 79.72 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -178.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -64.13 -46.15 85.39 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.539 -179.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' SER . . . . . 0.432 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 40.5 t -66.19 -37.72 86.29 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.764 -0.375 . . . . 0.0 110.999 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -61.76 -43.28 99.17 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -179.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -65.19 -36.63 84.8 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.344 1.238 . . . . 0.0 114.344 -177.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . 0.525 ' HB3' ' HD3' ' A' ' 308' ' ' PRO . . . -60.02 -52.82 70.8 Favored Pre-proline 0 CA--C 1.544 0.738 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -176.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' PRO . . . . . 0.525 ' HD3' ' HB3' ' A' ' 307' ' ' ALA . 74.2 Cg_endo -75.12 0.21 9.23 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.069 1.846 . . . . 0.0 111.808 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' PHE . . . . . 0.472 ' CG ' ' O ' ' A' ' 308' ' ' PRO . 69.4 m-85 . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.546 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.537 ' N ' ' SD ' ' A' ' 13' ' ' MET . 1.7 mpt? . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.8 t -125.47 54.96 1.44 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.221 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.466 ' H ' HG22 ' A' ' 15' ' ' VAL . 3.3 m -83.15 150.61 4.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.266 0.555 . . . . 0.0 110.982 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.55 -40.74 96.14 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.241 -0.89 . . . . 0.0 112.088 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -63.32 -41.83 98.95 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -177.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.827 ' O ' HD12 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -80.06 -26.36 39.69 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.092 0.472 . . . . 0.0 111.568 -179.298 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.24 -41.54 94.7 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 107.594 -2.202 . . . . 0.0 107.594 177.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -71.55 -32.5 68.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 124.818 2.247 . . . . 0.0 107.602 176.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.25 -42.26 99.36 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-N 108.502 -3.954 . . . . 0.0 107.626 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.7 m -70.49 -27.68 64.39 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -66.57 -49.8 65.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.842 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.93 -35.97 79.99 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 118.077 -1.449 . . . . 0.0 111.054 -177.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 77.4 m -63.84 -53.93 42.87 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.496 -178.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.2 pp -65.79 -39.43 84.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -177.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.11 -41.96 97.05 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -174.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.519 ' OD1' ' NH2' ' A' ' 88' ' ' ARG . 10.0 t70 -77.64 -27.39 51.05 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 120.594 1.543 . . . . 0.0 109.809 -175.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 43.5 mt -60.0 -55.28 35.97 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 119.724 1.147 . . . . 0.0 112.097 -178.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.8 tp -75.42 -3.87 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-O 121.743 0.783 . . . . 0.0 112.335 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 29.7 m -108.96 -16.39 14.15 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 117.491 -1.242 . . . . 0.0 110.305 -178.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.441 ' O ' ' OD1' ' A' ' 35' ' ' ASP . 14.5 t80 -69.01 -44.3 28.25 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-N 122.784 2.538 . . . . 0.0 111.758 -177.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' A' ' 32' ' ' PHE . 32.1 Cg_exo -59.6 -15.72 32.52 Favored 'Trans proline' 0 N--CA 1.504 2.107 0 C-N-CA 121.298 1.332 . . . . 0.0 113.245 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.8 mp -67.18 -35.5 79.78 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -177.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 36' ' ' THR . 15.8 p30 -64.86 -40.53 95.3 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -178.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.545 ' N ' ' OD1' ' A' ' 35' ' ' ASP . 43.3 p -58.4 -34.99 71.35 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.483 ' HB3' HH22 ' A' ' 279' ' ' ARG . . . -67.59 -38.37 83.93 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 119.948 -0.701 . . . . 0.0 111.84 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -61.66 -49.09 77.94 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 119.625 -0.83 . . . . 0.0 111.266 -176.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.419 ' H ' HG22 ' A' ' 39' ' ' VAL . 10.5 m -63.69 -39.75 86.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 118.31 0.504 . . . . 0.0 111.913 -177.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.521 ' NH2' ' OE1' ' A' ' 42' ' ' GLN . 7.6 tpm_? -60.78 -40.99 94.66 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.411 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.0 38.85 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.589 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.521 ' OE1' ' NH2' ' A' ' 40' ' ' ARG . 2.6 pt20 -85.82 61.73 7.03 Favored 'General case' 0 N--CA 1.463 0.188 0 O-C-N 121.965 -0.459 . . . . 0.0 110.971 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.408 ' C ' ' O ' ' A' ' 42' ' ' GLN . 22.2 pt 32.06 -125.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.861 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -158.15 100.62 1.71 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.649 0.262 . . . . 0.0 110.334 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.51 ' C ' ' H ' ' A' ' 47' ' ' SER . . . -176.31 -118.59 0.54 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.089 -0.805 . . . . 0.0 111.089 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 69.22 -16.9 0.23 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.704 0.288 . . . . 0.0 110.786 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.51 ' H ' ' C ' ' A' ' 45' ' ' GLY . 29.0 t 53.66 26.41 5.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.919 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.519 ' NE2' ' O ' ' A' ' 48' ' ' GLN . 0.0 OUTLIER -44.16 -28.39 0.5 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.674 0.75 . . . . 0.0 109.789 179.727 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.72 -36.71 3.66 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -178.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.422 HD23 ' OE1' ' A' ' 48' ' ' GLN . 3.6 mm? -66.73 -38.03 85.85 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.448 0.642 . . . . 0.0 109.311 177.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 96.2 t -60.68 -44.55 97.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 114.919 -1.037 . . . . 0.0 112.604 -177.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -64.19 -33.54 76.02 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.938 -178.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.5 m -67.92 -38.06 82.45 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 177.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.409 ' C ' ' H ' ' A' ' 56' ' ' SER . . . -127.93 78.6 1.84 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.177 -0.919 . . . . 0.0 108.801 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.38 -3.42 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.635 -0.712 . . . . 0.0 112.813 -178.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.606 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 94.9 p -126.58 -140.04 0.27 Allowed 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.606 ' HB3' ' O ' ' A' ' 56' ' ' SER . . . 99.2 11.77 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 O-C-N 124.12 0.888 . . . . 0.0 111.878 178.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 177.52 70.78 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -41.12 -83.78 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.054 0.454 . . . . 0.0 110.633 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.415 ' O ' ' C ' ' A' ' 61' ' ' GLY . 30.0 ttm180 -161.01 -34.36 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.591 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 60' ' ' ARG . . . -28.61 102.74 0.01 OUTLIER Glycine 0 CA--C 1.527 0.807 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.641 -179.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 90.3 t -67.41 -34.6 69.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 118.451 -0.785 . . . . 0.0 109.685 176.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.493 ' N ' HD22 ' A' ' 63' ' ' LEU . 3.6 mm? -60.79 -32.65 71.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 121.011 1.732 . . . . 0.0 109.726 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.61 -49.31 65.18 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-N 114.905 -1.043 . . . . 0.0 114.398 -176.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.3 m -62.1 -46.36 89.41 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 70.6 mt -59.43 -35.95 61.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.57 ' O ' HD13 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -63.94 -35.76 81.72 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 120.919 1.69 . . . . 0.0 112.156 179.452 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 99.2 m -63.22 -40.73 98.29 Favored 'General case' 0 C--O 1.246 0.906 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.003 -174.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.402 ' C ' ' SD ' ' A' ' 69' ' ' MET . 3.2 ppp? -59.67 -40.05 86.51 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -175.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.2 p -69.49 -40.78 80.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 119.096 -1.042 . . . . 0.0 112.563 -178.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 75.0 ttt-85 -78.54 -13.3 59.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.769 0.795 . . . . 0.0 112.534 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 54.5 m -62.81 -54.65 35.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.643 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -107.44 -56.47 2.21 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.276 178.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 157.3 165.89 15.87 Favored Glycine 0 CA--C 1.535 1.325 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -56.27 -35.47 95.76 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 CA-C-N 119.508 1.654 . . . . 0.0 111.893 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.41 ' O ' ' CB ' ' A' ' 80' ' ' ASN . 12.1 tpp180 -61.42 -12.27 13.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.756 0.789 . . . . 0.0 111.007 176.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 10.4 p -78.55 -33.0 48.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.968 -178.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.59 HD23 ' O ' ' A' ' 78' ' ' LEU . 1.0 OUTLIER -75.94 -33.64 59.84 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.116 0.484 . . . . 0.0 110.535 179.754 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.746 ' O ' HD12 ' A' ' 82' ' ' LEU . 57.9 m-85 -92.74 -5.15 51.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 122.335 1.064 . . . . 0.0 113.202 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.41 ' CB ' ' O ' ' A' ' 76' ' ' ARG . 4.7 t30 -90.01 118.85 29.88 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 112.812 -1.995 . . . . 0.0 107.502 175.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.71 -7.25 57.55 Favored Glycine 0 N--CA 1.468 0.782 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 -177.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.965 HD13 ' H ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -59.42 -34.59 72.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 113.603 -1.298 . . . . 0.0 110.834 -179.687 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.965 ' H ' HD13 ' A' ' 82' ' ' LEU . 4.8 p -70.61 -26.79 29.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.94 -31.62 61.55 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.576 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -68.17 -40.34 88.01 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 119.344 -1.407 . . . . 0.0 111.206 -177.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.3 mp -62.66 -40.54 97.38 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.978 0.894 . . . . 0.0 113.099 -176.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -60.62 -27.17 67.56 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 113.799 -1.546 . . . . 0.0 109.306 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.747 ' HE ' HE22 ' A' ' 89' ' ' GLN . 37.3 ttp180 -57.89 -53.76 54.58 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 173.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.747 HE22 ' HE ' ' A' ' 88' ' ' ARG . 0.9 OUTLIER -67.1 -29.86 69.73 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 112.325 -2.216 . . . . 0.0 111.84 -178.17 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 33.4 tpp -61.35 -40.82 95.66 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.493 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 37.1 m -74.44 -34.6 63.24 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 118.099 -0.953 . . . . 0.0 111.302 -177.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -57.66 -43.88 85.29 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 121.324 1.874 . . . . 0.0 112.262 -176.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.56 -32.84 64.39 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.127 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.8 p -64.09 -41.31 97.34 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.499 ' CG2' HD12 ' A' ' 99' ' ' LEU . 7.9 p -68.27 -28.23 39.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.022 177.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.403 ' NH2' ' CE2' ' A' ' 100' ' ' TYR . 51.0 ttt-85 -77.44 9.22 3.42 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -176.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.517 HD13 ' O ' ' A' ' 97' ' ' ILE . 0.3 OUTLIER -87.3 -14.93 9.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.833 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -139.98 -48.2 0.06 OUTLIER Glycine 0 CA--C 1.543 1.781 0 N-CA-C 116.087 1.195 . . . . 0.0 116.087 -176.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.499 HD12 ' CG2' ' A' ' 95' ' ' VAL . 16.6 mt -71.14 -12.76 61.67 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 119.84 1.82 . . . . 0.0 113.05 -178.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.499 ' O ' ' CG ' ' A' ' 104' ' ' LYS . 26.2 t80 -80.57 -51.19 9.04 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 114.48 -1.236 . . . . 0.0 111.868 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 1.051 ' OD2' ' NE2' ' A' ' 105' ' ' GLN . 9.7 t70 -69.46 -32.29 71.11 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 123.175 1.464 . . . . 0.0 110.043 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 11.4 t -68.74 -52.54 29.48 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 111.158 -2.746 . . . . 0.0 111.89 175.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 52.3 t -74.28 -27.79 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-N 121.697 2.044 . . . . 0.0 114.131 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.499 ' CG ' ' O ' ' A' ' 100' ' ' TYR . 3.2 mmpt? -69.69 -41.68 75.12 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 112.131 -2.304 . . . . 0.0 111.518 179.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 1.051 ' NE2' ' OD2' ' A' ' 101' ' ' ASP . 88.1 mt-30 -79.69 -12.95 59.78 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 122.638 1.209 . . . . 0.0 111.011 -178.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -79.93 -22.8 42.28 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.21 178.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.619 ' CZ ' ' ND2' ' A' ' 190' ' ' ASN . 35.4 m-85 -109.81 -29.45 8.3 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 119.532 1.06 . . . . 0.0 112.721 -175.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.6 p -96.78 9.11 42.71 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 117.144 -1.823 . . . . 0.0 113.135 -177.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 12.4 ttpp -96.87 -154.82 0.46 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 177.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 140.42 134.58 3.11 Favored Glycine 0 N--CA 1.475 1.245 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 76.2 p -90.19 -40.29 12.29 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -177.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -116.28 174.41 6.07 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 112.899 -1.955 . . . . 0.0 113.485 -176.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.606 ' O ' ' HB2' ' A' ' 114' ' ' ALA . 85.9 m-70 -86.47 77.08 9.51 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.759 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.606 ' HB2' ' O ' ' A' ' 113' ' ' HIS . . . 159.6 -161.39 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.05 14.82 27.77 Favored Glycine 0 C--N 1.335 0.499 0 CA-C-N 115.449 -0.796 . . . . 0.0 113.213 176.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 22.6 mm -60.89 -40.83 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.0 -39.29 96.34 Favored Glycine 0 CA--C 1.525 0.713 0 CA-C-O 122.253 0.918 . . . . 0.0 110.982 175.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 5.8 t -57.93 -42.17 84.27 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 177.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 59.7 mtm180 -63.58 -37.47 87.44 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.278 -178.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 8.0 mp -64.15 -46.51 83.76 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 76.9 mt -66.83 -44.83 80.07 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 114.926 -1.033 . . . . 0.0 110.494 178.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.91 -44.77 91.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 119.532 1.06 . . . . 0.0 109.869 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -66.01 -44.1 92.21 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 119.73 -1.224 . . . . 0.0 111.295 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 71.0 m -64.07 -43.95 93.9 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.784 -0.367 . . . . 0.0 111.538 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 21.1 p -69.35 -48.43 61.36 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 119.333 -0.947 . . . . 0.0 111.954 177.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 24.0 p -65.37 -42.41 92.75 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 -174.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -63.95 -44.54 95.84 Favored Glycine 0 CA--C 1.521 0.463 0 CA-C-O 122.967 1.315 . . . . 0.0 112.916 -177.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.534 ' O ' HG22 ' A' ' 131' ' ' VAL . . . -61.35 -41.6 97.33 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 111.903 -2.148 . . . . 0.0 107.25 177.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.692 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 17.3 mt -64.41 -42.15 96.24 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.221 178.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.0 -39.77 95.74 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -177.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.534 HG22 ' O ' ' A' ' 128' ' ' ALA . 18.9 m -60.96 -26.03 37.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 122.829 1.3 . . . . 0.0 109.572 179.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.692 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . -58.63 -44.83 90.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 112.251 -2.25 . . . . 0.0 111.876 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.426 HG22 ' H ' ' A' ' 133' ' ' VAL . 5.1 m -79.0 -48.63 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -126.7 135.75 51.54 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.695 0.283 . . . . 0.0 111.451 -178.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.773 ' H ' ' CD ' ' A' ' 136' ' ' PRO . 2.1 pt20 175.2 -23.59 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.828 0 CA-C-N 115.47 -0.786 . . . . 0.0 113.069 178.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.773 ' CD ' ' H ' ' A' ' 135' ' ' GLN . 54.3 Cg_exo -53.03 -34.17 66.39 Favored 'Trans proline' 0 N--CA 1.5 1.894 0 CA-C-N 120.955 1.377 . . . . 0.0 113.275 -178.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.421 ' H ' HG22 ' A' ' 137' ' ' THR . 0.0 OUTLIER -67.43 -41.58 84.55 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 119.064 -1.055 . . . . 0.0 110.667 -178.772 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -64.38 -42.44 96.16 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 119.238 -0.985 . . . . 0.0 111.777 -177.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 14.6 m -63.6 -42.71 97.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.879 0.371 . . . . 0.0 110.977 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.423 ' O ' ' N ' ' A' ' 144' ' ' PHE . 25.3 t -63.97 -38.54 82.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.437 ' CB ' ' NZ ' ' A' ' 141' ' ' LYS . 8.8 mtmp? -62.0 -40.93 97.33 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 119.556 -0.858 . . . . 0.0 111.895 -177.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.4 p -69.56 -44.81 79.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 119.992 -0.683 . . . . 0.0 109.23 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -64.36 -35.9 82.39 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.468 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.423 ' N ' ' O ' ' A' ' 140' ' ' VAL . 93.9 t80 -66.14 -40.76 90.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.249 -177.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -64.4 -39.53 94.03 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 118.844 -1.142 . . . . 0.0 109.709 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.22 -35.03 79.79 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.413 ' CG ' ' O ' ' A' ' 147' ' ' GLN . 0.0 OUTLIER -59.85 111.35 1.43 Allowed 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 177.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -94.49 -64.39 1.08 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 117.396 -1.288 . . . . 0.0 112.615 -177.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -91.06 110.68 21.96 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 122.862 2.574 . . . . 0.0 110.121 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -81.41 68.69 7.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.648 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 43.28 59.37 3.52 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -56.7 125.8 39.55 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.414 ' O ' ' O ' ' A' ' 154' ' ' ARG . . . 166.19 72.91 0.03 OUTLIER Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.738 HH12 ' HE ' ' A' ' 155' ' ' ARG . 54.3 ttp85 56.08 164.95 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.738 ' HE ' HH12 ' A' ' 154' ' ' ARG . 18.0 mmt85 56.97 177.48 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.881 0.372 . . . . 0.0 110.849 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.449 ' CE2' ' O ' ' A' ' 157' ' ' GLN . 85.1 t80 -138.6 145.26 40.34 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.437 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.449 ' O ' ' CE2' ' A' ' 156' ' ' TYR . 19.7 mp0 -109.67 -155.24 0.55 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -178.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 83.4 p -157.22 -176.25 5.86 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 123.256 1.503 . . . . 0.0 112.936 -177.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 8.4 m -62.89 -43.53 98.56 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 111.26 -2.7 . . . . 0.0 112.002 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.5 t -61.05 -42.76 94.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -178.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.45 ' OE2' ' OG1' ' A' ' 165' ' ' THR . 0.7 OUTLIER -65.47 -38.33 89.48 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.066 179.877 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -61.4 -45.67 93.35 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -178.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.503 ' CZ ' HD23 ' A' ' 175' ' ' LEU . 13.7 t80 -62.62 -49.21 76.09 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.278 -178.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -67.83 -45.36 74.88 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -174.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.45 ' OG1' ' OE2' ' A' ' 161' ' ' GLU . 1.9 p -63.0 -43.86 97.63 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -176.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 15.0 pt -64.26 -37.93 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 CA-C-O 121.746 0.784 . . . . 0.0 109.133 177.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.89 -37.07 78.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.17 -1.377 . . . . 0.0 107.37 175.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -62.46 -50.44 71.46 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 122.211 2.278 . . . . 0.0 111.849 -176.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.524 ' N ' ' OE1' ' A' ' 169' ' ' GLU . 0.2 OUTLIER -74.93 -50.99 14.91 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.523 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -78.09 -36.28 48.32 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 116.594 2.072 . . . . 0.0 116.594 -173.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 91.14 -166.61 31.03 Favored Glycine 0 C--N 1.337 0.628 0 CA-C-N 118.841 0.746 . . . . 0.0 112.263 177.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.638 ' H ' HD13 ' A' ' 172' ' ' ILE . 0.0 OUTLIER -72.64 -38.58 59.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.903 0.859 . . . . 0.0 109.175 -179.576 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 68.1 mtp180 -58.5 -33.74 70.15 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 113.852 -1.522 . . . . 0.0 111.103 -177.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -61.48 -41.24 99.51 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 118.672 -1.728 . . . . 0.0 111.425 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.503 HD23 ' CZ ' ' A' ' 163' ' ' TYR . 7.8 mp -71.33 -34.35 70.47 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 117.717 2.488 . . . . 0.0 117.717 -177.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . 0.493 ' CD1' ' O ' ' A' ' 172' ' ' ILE . 63.7 m95 -78.18 -7.09 56.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 112.995 -1.912 . . . . 0.0 109.589 -177.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 16.8 ttmm -43.63 -48.64 7.75 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -175.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -90.11 -32.23 10.01 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.39 0.995 . . . . 0.0 111.815 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 90.1 m -45.31 -50.66 11.81 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.45 ' O ' HG12 ' A' ' 183' ' ' VAL . 0.4 OUTLIER -61.96 -50.47 80.78 Favored Pre-proline 0 N--CA 1.472 0.627 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -175.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 180' ' ' SER . 24.7 Cg_endo -64.64 -27.98 60.81 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 121.17 1.247 . . . . 0.0 111.704 176.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -64.06 -39.33 93.85 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 180' ' ' SER . 1.6 p -62.91 -41.71 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.855 -179.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.48 -39.28 90.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.961 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.588 HH12 ' CG1' ' A' ' 235' ' ' VAL . 48.8 ttt85 -60.6 -42.13 96.14 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 119.922 -0.711 . . . . 0.0 110.344 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -61.67 -43.86 98.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.183 0.516 . . . . 0.0 110.679 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -65.28 -44.2 88.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.617 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 24.3 mm -63.81 -45.89 95.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -177.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.503 ' O ' ' N ' ' A' ' 193' ' ' GLU . 5.9 p -60.72 -47.31 93.62 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.339 0 C-N-CA 119.237 -0.985 . . . . 0.0 111.729 -178.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.619 ' ND2' ' CZ ' ' A' ' 107' ' ' TYR . 12.2 t-20 -63.54 -42.94 98.37 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 122.282 1.039 . . . . 0.0 110.868 178.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' CYS . . . . . . . . . . . . . 31.3 m -61.39 -45.53 93.98 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 113.348 -1.751 . . . . 0.0 108.389 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.27 -40.4 95.91 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 112.662 -2.063 . . . . 0.0 109.672 175.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 0.503 ' N ' ' O ' ' A' ' 189' ' ' VAL . 0.7 OUTLIER -60.81 -46.54 90.12 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.001 0.92 . . . . 0.0 113.086 -176.884 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 2.8 pp -64.31 -36.73 85.08 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 119.231 -0.988 . . . . 0.0 109.528 -175.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 1.4 m -63.18 -45.74 97.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 C-N-CA 117.01 -1.876 . . . . 0.0 107.389 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 30.3 p -64.35 -46.11 84.88 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -177.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -57.67 -39.87 78.1 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.133 -0.939 . . . . 0.0 113.338 -177.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -56.4 -44.46 80.32 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 9.7 mt -61.66 -39.45 91.41 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.803 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 1.6 mp -63.12 -42.79 97.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 118.813 -0.613 . . . . 0.0 110.115 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -59.99 -40.42 89.12 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 120.224 1.374 . . . . 0.0 111.897 178.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -66.96 -38.43 86.08 Favored 'General case' 0 C--O 1.25 1.104 0 CA-C-N 114.682 -1.145 . . . . 0.0 111.003 -176.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -101.96 128.89 48.17 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 120.804 -1.185 . . . . 0.0 112.455 -178.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.596 ' O ' HD22 ' A' ' 209' ' ' LEU . 4.1 tp 67.46 4.45 3.8 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 114.275 -1.33 . . . . 0.0 112.082 177.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.74 38.11 4.0 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -74.52 -21.57 59.47 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.527 0.68 . . . . 0.0 111.455 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.427 ' O ' ' CB ' ' A' ' 208' ' ' ASN . . . -130.86 -40.45 1.19 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.54 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . 0.67 ' C ' ' H ' ' A' ' 210' ' ' MET . 6.4 p30 152.13 124.43 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 -178.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.596 HD22 ' O ' ' A' ' 204' ' ' LEU . 0.2 OUTLIER -50.81 24.63 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 110.41 -3.086 . . . . 0.0 111.954 179.164 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . 0.67 ' H ' ' C ' ' A' ' 208' ' ' ASN . 35.3 ttp -110.42 75.87 0.95 Allowed 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.789 -0.569 . . . . 0.0 110.614 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 38.4 p -98.0 -154.28 0.45 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.579 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -125.6 3.37 7.56 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.878 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -115.07 66.78 0.69 Allowed 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.4 ' N ' ' CD ' ' A' ' 215' ' ' PRO . 4.4 mm? -61.28 -43.74 90.87 Favored Pre-proline 0 CA--C 1.537 0.481 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 214' ' ' LEU . 25.9 Cg_exo -60.88 -34.07 91.71 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 CA-C-N 120.59 1.246 . . . . 0.0 111.039 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 82.3 m -64.77 -42.53 95.05 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 113.173 -1.83 . . . . 0.0 111.771 -178.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -66.83 -38.13 85.82 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -63.44 -47.37 82.15 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.941 -178.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 27.1 p -60.65 -38.24 84.17 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 119.102 0.864 . . . . 0.0 110.465 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 47.8 p -59.67 -41.88 91.61 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.568 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.91 -41.82 97.58 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -177.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -62.11 -47.15 85.89 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -176.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -60.74 -42.09 99.28 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 107.464 -2.254 . . . . 0.0 107.464 177.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.627 ' O ' HG23 ' A' ' 228' ' ' THR . . . -63.1 -37.93 89.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.211 -0.995 . . . . 0.0 108.977 176.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -61.66 -42.28 99.73 Favored Glycine 0 CA--C 1.521 0.412 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.811 -177.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -66.57 -38.34 86.87 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . 0.432 ' O ' HG12 ' A' ' 230' ' ' VAL . 96.3 m -63.22 -41.11 99.08 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.012 0.434 . . . . 0.0 110.387 177.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.627 HG23 ' O ' ' A' ' 224' ' ' ALA . 55.9 p -61.99 -39.95 93.96 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.759 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -58.17 -38.73 77.23 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -176.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.432 HG12 ' O ' ' A' ' 227' ' ' CYS . 1.7 p -59.57 -40.53 82.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 119.004 -1.078 . . . . 0.0 110.02 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.641 ' C ' HD12 ' A' ' 231' ' ' ILE . 0.3 OUTLIER -61.45 -40.16 85.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 177.615 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -62.78 -39.47 94.29 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 115.683 1.735 . . . . 0.0 115.683 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.488 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 0.2 OUTLIER -57.99 -41.72 91.39 Favored Pre-proline 0 N--CA 1.484 1.244 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 -173.525 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.528 ' HD2' ' O ' ' A' ' 231' ' ' ILE . 32.3 Cg_exo -57.7 -39.56 86.67 Favored 'Trans proline' 0 C--N 1.291 -2.461 0 C-N-CA 122.495 2.13 . . . . 0.0 113.128 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.588 ' CG1' HH12 ' A' ' 185' ' ' ARG . 59.3 t -63.69 -37.22 79.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 C-N-CA 117.8 -1.56 . . . . 0.0 108.799 178.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . 0.526 ' OD2' ' CE3' ' A' ' 283' ' ' TRP . 53.1 t0 -65.77 -40.37 91.94 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.266 178.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 59.2 t -64.6 -45.22 96.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 -176.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 84.4 t -62.86 -37.13 78.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 C-N-CA 120.028 -0.669 . . . . 0.0 111.737 -178.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -60.41 -43.98 96.19 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -60.94 -41.89 97.13 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.711 -178.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.596 ' NH1' ' CZ ' ' A' ' 269' ' ' PHE . 15.8 mtt180 -44.61 -41.85 6.92 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 120.974 -0.29 . . . . 0.0 110.7 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.553 ' O ' ' N ' ' A' ' 244' ' ' ASN . 38.4 t80 -36.29 -60.25 0.58 Allowed 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' MET . . . . . 0.53 ' O ' ' SD ' ' A' ' 243' ' ' MET . 0.0 OUTLIER -31.65 -32.27 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 O-C-N 123.788 0.68 . . . . 0.0 110.774 179.716 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . 0.553 ' N ' ' O ' ' A' ' 242' ' ' TYR . 5.5 t-20 -34.21 147.89 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.753 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . 0.584 ' O ' ' HB3' ' A' ' 246' ' ' ALA . 67.1 m 12.41 -79.64 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 O-C-N 124.535 1.147 . . . . 0.0 112.767 179.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . 0.584 ' HB3' ' O ' ' A' ' 245' ' ' SER . . . 79.35 78.03 0.05 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.579 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 6.3 tp -173.39 106.56 0.14 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.764 0.316 . . . . 0.0 111.012 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 65.87 170.01 3.1 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.764 -0.534 . . . . 0.0 111.764 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 55.46 -164.18 0.13 Allowed 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 110.638 -0.134 . . . . 0.0 110.638 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 55.97 63.31 2.07 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.795 -0.184 . . . . 0.0 110.526 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 27.0 t60 -66.34 -52.08 50.7 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -177.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 24.5 p -147.93 -174.92 4.69 Favored 'General case' 0 C--O 1.215 -0.721 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -61.9 -45.87 91.86 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 119.774 1.17 . . . . 0.0 110.062 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -56.52 -35.42 66.53 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.705 1.622 . . . . 0.0 113.501 -171.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -55.91 -34.19 65.34 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 117.159 -1.816 . . . . 0.0 111.041 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -61.93 -44.26 97.14 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 122.03 -0.419 . . . . 0.0 110.732 178.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -59.92 -45.75 91.56 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.82 -178.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.473 ' N ' HD22 ' A' ' 258' ' ' LEU . 3.4 mm? -67.71 -44.08 78.54 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.05 178.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 19.7 m -63.68 -46.79 83.91 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 113.863 1.061 . . . . 0.0 113.863 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' MET . . . . . 0.459 ' SD ' ' N ' ' A' ' 261' ' ' LEU . 0.0 OUTLIER -61.75 -44.37 97.03 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -176.817 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.459 ' N ' ' SD ' ' A' ' 260' ' ' MET . 11.7 tp -62.36 -47.08 85.77 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 121.92 -0.487 . . . . 0.0 109.766 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 70.0 mtp180 -66.77 -53.64 30.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.976 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . 0.455 ' O ' ' O ' ' A' ' 260' ' ' MET . 9.6 mtpm? -130.59 179.17 6.1 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.881 0.372 . . . . 0.0 111.258 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . 0.456 ' O ' ' O ' ' A' ' 265' ' ' GLY . 95.1 mt-10 56.43 67.78 0.95 Allowed 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.609 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 264' ' ' GLU . . . -33.34 159.81 0.01 OUTLIER Glycine 0 CA--C 1.533 1.158 0 CA-C-O 121.789 0.661 . . . . 0.0 112.304 -179.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -64.91 -5.34 10.48 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.076 1.851 . . . . 0.0 111.355 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -69.73 -26.28 64.25 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.536 0.734 . . . . 0.0 111.362 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -58.02 -32.28 67.8 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.532 -178.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . 0.596 ' CZ ' ' NH1' ' A' ' 241' ' ' ARG . 29.0 m-85 -62.39 -41.15 98.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.347 177.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -65.79 -37.9 87.55 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.387 -177.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.97 165.54 12.21 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 178.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 69.03 86.64 0.1 Allowed Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.614 -0.995 . . . . 0.0 110.614 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -168.74 22.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 121.064 -0.255 . . . . 0.0 110.784 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' MET . . . . . 0.568 ' N ' ' CD ' ' A' ' 275' ' ' PRO . 1.0 OUTLIER -63.7 -44.1 79.16 Favored Pre-proline 0 C--N 1.33 -0.254 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.219 -179.792 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 274' ' ' MET . 21.3 Cg_exo -64.38 -46.61 7.21 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.43 2.087 . . . . 0.0 111.54 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 1.5 p -60.66 -40.11 90.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.038 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . 0.411 ' CD1' ' C ' ' A' ' 277' ' ' PHE . 36.4 t80 -61.89 -42.92 99.65 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 123.289 1.519 . . . . 0.0 111.936 -178.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 12.0 tp -62.12 -38.73 90.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 111.037 -2.801 . . . . 0.0 108.159 174.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . 0.483 HH22 ' HB3' ' A' ' 37' ' ' ALA . 0.5 OUTLIER -62.62 -40.2 96.24 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.072 179.215 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.743 ' O ' HD12 ' A' ' 280' ' ' LEU . 0.2 OUTLIER -61.97 -36.31 81.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.145 -0.934 . . . . 0.0 113.1 -177.255 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -67.7 -50.89 39.19 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 109.146 -1.581 . . . . 0.0 109.146 -178.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . 0.798 ' O ' HG22 ' A' ' 285' ' ' VAL . 78.0 p -61.92 -43.63 98.44 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.694 0.798 . . . . 0.0 109.538 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' TRP . . . . . 0.526 ' CE3' ' OD2' ' A' ' 236' ' ' ASP . 1.3 m95 -59.5 -38.09 79.99 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . 0.426 HD21 ' CD1' ' A' ' 280' ' ' LEU . 85.2 m-20 -61.76 -38.95 89.92 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -178.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.798 HG22 ' O ' ' A' ' 282' ' ' SER . 23.0 m -61.46 -37.26 77.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 O-C-N 121.354 -0.841 . . . . 0.0 111.339 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.407 ' O ' HG22 ' A' ' 289' ' ' VAL . 26.8 t -62.14 -41.63 92.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -177.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 11.5 ptm -62.34 -38.32 89.05 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 121.305 -0.872 . . . . 0.0 109.608 178.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -58.47 -41.22 84.73 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.13 -0.941 . . . . 0.0 113.303 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 286' ' ' VAL . 2.7 m -61.33 -38.68 80.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 121.693 -0.63 . . . . 0.0 110.846 -178.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 75.7 p -62.22 -40.43 96.1 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 177.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -61.24 -38.44 86.65 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 176.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -58.31 -40.71 82.72 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 117.915 -1.514 . . . . 0.0 109.283 -176.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' GLN . . . . . 0.451 ' O ' ' O ' ' A' ' 296' ' ' ARG . 83.3 mm-40 -60.72 -43.13 98.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 122.577 1.18 . . . . 0.0 110.784 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 73.5 mt -60.47 -40.52 91.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 113.027 -1.897 . . . . 0.0 109.219 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -63.18 -46.15 88.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.982 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' ARG . . . . . 0.451 ' O ' ' O ' ' A' ' 293' ' ' GLN . 20.1 tpt85 -123.07 116.19 23.08 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.009 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -115.52 -96.11 0.46 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.177 0.513 . . . . 0.0 110.522 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 38.9 tp -139.3 120.87 15.17 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.683 179.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 30.2 ttm -92.69 64.32 4.11 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 121.202 -0.199 . . . . 0.0 111.271 -179.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.71 101.22 0.07 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.976 0.893 . . . . 0.0 111.227 -178.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -64.12 -46.2 85.19 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 113.47 -1.695 . . . . 0.0 112.936 -176.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -58.48 -39.29 79.58 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.498 -0.481 . . . . 0.0 109.789 -178.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . 0.432 ' O ' ' OE2' ' A' ' 306' ' ' GLU . 86.3 mt-30 -64.56 -46.49 82.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.224 -179.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' SER . . . . . 0.439 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 74.2 p -67.09 -38.64 86.05 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.454 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -62.5 -43.87 97.75 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -178.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.473 ' CD ' ' N ' ' A' ' 307' ' ' ALA . 2.7 pp20? -65.72 -36.76 84.51 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -177.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . 0.531 ' HB3' ' HD3' ' A' ' 308' ' ' PRO . . . -59.84 -52.6 72.57 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -176.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' PRO . . . . . 0.531 ' HD3' ' HB3' ' A' ' 307' ' ' ALA . 73.1 Cg_endo -74.96 0.3 9.05 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.954 1.769 . . . . 0.0 111.604 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 82.5 t80 . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.459 179.881 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.485 ' SD ' ' OG1' ' A' ' 14' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.485 ' OG1' ' SD ' ' A' ' 13' ' ' MET . 39.7 m -131.0 112.5 12.98 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.111 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.702 HG22 ' H ' ' A' ' 16' ' ' LYS . 7.2 p -91.79 176.58 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.318 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.702 ' H ' HG22 ' A' ' 15' ' ' VAL . 35.0 mtmm -64.21 -41.37 97.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.517 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -63.61 -41.42 98.3 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.548 ' H ' HG13 ' A' ' 15' ' ' VAL . 31.3 tp -79.85 -26.42 40.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.079 -179.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.443 ' O ' ' OG1' ' A' ' 22' ' ' THR . . . -66.26 -41.39 94.74 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 107.451 -2.259 . . . . 0.0 107.451 177.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.481 ' HB1' HH12 ' A' ' 96' ' ' ARG . . . -71.37 -32.0 67.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 124.77 2.224 . . . . 0.0 107.314 176.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.45 -42.57 98.98 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-N 108.469 -3.969 . . . . 0.0 108.095 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 19' ' ' GLY . 33.6 p -70.75 -28.0 64.37 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -66.28 -50.23 64.39 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.745 -178.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.406 ' O ' ' OE1' ' A' ' 89' ' ' GLN . . . -61.95 -35.96 79.98 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 118.504 -1.278 . . . . 0.0 111.234 -177.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.632 ' SG ' ' N ' ' A' ' 26' ' ' ILE . 5.8 p -64.15 -53.47 48.88 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.027 -179.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.632 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 16.0 pt -65.68 -39.68 85.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -178.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.68 -42.18 98.06 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 119.686 -0.806 . . . . 0.0 112.738 -173.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.559 ' CG ' HE22 ' A' ' 89' ' ' GLN . 1.5 m-20 -77.09 -27.13 54.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 120.739 1.608 . . . . 0.0 109.941 -174.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.478 ' O ' HD13 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -60.42 -54.26 47.71 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 118.922 0.783 . . . . 0.0 112.222 179.498 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.4 pp -72.86 -1.0 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-O 122.501 1.144 . . . . 0.0 111.906 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.71 ' O ' HD21 ' A' ' 34' ' ' LEU . 97.8 m -106.72 -12.58 15.5 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 112.588 -2.096 . . . . 0.0 112.051 -174.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.439 ' N ' ' CD ' ' A' ' 33' ' ' PRO . 8.4 t80 -70.74 -44.87 16.63 Favored Pre-proline 0 CA--C 1.551 1.011 0 CA-C-N 121.935 2.152 . . . . 0.0 113.765 -178.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.439 ' CD ' ' N ' ' A' ' 32' ' ' PHE . 33.5 Cg_exo -60.54 -17.75 50.33 Favored 'Trans proline' 0 N--CA 1.52 3.047 0 N-CA-C 119.363 2.793 . . . . 0.0 119.363 -175.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.967 HD13 ' H ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -69.11 -35.47 76.47 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 120.342 1.428 . . . . 0.0 114.067 -179.071 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.522 ' H ' HD22 ' A' ' 34' ' ' LEU . 64.1 m-20 -65.02 -41.73 95.02 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -175.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.5 p -58.33 -36.0 72.75 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 119.551 -0.86 . . . . 0.0 111.348 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.96 -38.81 83.21 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 119.782 -0.767 . . . . 0.0 111.731 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.4 ' CG ' ' N ' ' A' ' 39' ' ' VAL . 8.2 pttp -61.37 -48.24 82.18 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.28 -176.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.4 ' N ' ' CG ' ' A' ' 38' ' ' LYS . 82.2 t -63.48 -41.05 91.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 119.667 -0.813 . . . . 0.0 111.565 -176.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.465 ' C ' ' H ' ' A' ' 42' ' ' GLN . 67.9 mmt-85 -61.94 -42.09 98.7 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 119.252 -0.979 . . . . 0.0 110.064 178.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -62.81 38.85 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.685 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.572 ' NE2' ' SD ' ' A' ' 243' ' ' MET . 8.1 tp-100 -128.41 -76.43 0.56 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.909 0.385 . . . . 0.0 110.01 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.519 HG23 ' O ' ' A' ' 43' ' ' ILE . 21.0 tt -168.46 121.45 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.885 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.417 HE22 ' HB3' ' A' ' 59' ' ' TYR . 11.5 pt20 -71.69 57.57 0.29 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.889 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -167.24 165.87 38.87 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.137 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.6 mp0 -147.11 -160.12 1.12 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.134 -0.533 . . . . 0.0 109.574 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.7 m -81.94 -6.22 58.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.033 0.444 . . . . 0.0 110.106 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -59.42 -30.49 68.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.729 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.71 1.17 87.5 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -178.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.3 tp -64.03 -36.03 82.66 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.361 -0.92 . . . . 0.0 109.532 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.543 HG13 ' N ' ' A' ' 52' ' ' ARG . 8.6 p -58.95 -43.05 87.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.067 -178.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.543 ' N ' HG13 ' A' ' 51' ' ' VAL . 22.3 ptt85 -63.06 -33.07 74.65 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 119.734 -0.787 . . . . 0.0 109.658 -178.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -67.7 -37.81 82.8 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 51' ' ' VAL . . . -132.26 111.3 11.27 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.469 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.61 -8.77 59.59 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -178.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.665 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 29.4 p -130.55 -138.15 0.21 Allowed 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.665 ' HB3' ' O ' ' A' ' 56' ' ' SER . . . 91.84 -30.96 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 176.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.468 ' O ' ' N ' ' A' ' 60' ' ' ARG . 68.8 mt-30 -139.55 8.05 2.37 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.565 ' CD2' ' O ' ' A' ' 59' ' ' TYR . 20.9 p90 -46.3 87.03 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.555 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.477 ' O ' ' O ' ' A' ' 59' ' ' TYR . 75.9 mtt180 51.33 165.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.021 0.439 . . . . 0.0 110.419 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 120.01 83.87 0.82 Allowed Glycine 0 CA--C 1.519 0.298 0 N-CA-C 104.441 -3.463 . . . . 0.0 104.441 -175.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.6 p -67.79 -36.11 74.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 118.631 -0.699 . . . . 0.0 110.86 178.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.533 HD13 ' O ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -61.75 -33.02 73.32 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 117.687 -1.605 . . . . 0.0 109.24 178.379 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.89 -49.9 60.85 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 113.559 -1.655 . . . . 0.0 115.126 -176.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.0 m -62.37 -46.92 86.48 Favored 'General case' 0 C--N 1.334 -0.1 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -178.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 12.0 tt -59.98 -36.04 64.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 38.6 tp -63.88 -35.57 81.07 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 120.82 1.645 . . . . 0.0 111.607 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 98.4 m -63.28 -40.13 96.52 Favored 'General case' 0 C--O 1.249 1.058 0 CA-C-N 113.729 -1.578 . . . . 0.0 111.042 -174.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 3.2 ptt? -60.63 -39.99 90.29 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 120.328 -1.482 . . . . 0.0 114.628 -175.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.8 m -69.52 -40.31 79.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 119.213 -0.995 . . . . 0.0 112.86 -178.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 62.8 ttp85 -78.78 -13.21 59.93 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.499 ' CG2' ' N ' ' A' ' 73' ' ' GLU . 0.6 OUTLIER -62.57 -54.42 40.04 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.667 179.194 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.499 ' N ' ' CG2' ' A' ' 72' ' ' THR . 19.2 mt-10 -105.24 -54.8 2.42 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.411 ' O ' ' CB ' ' A' ' 77' ' ' SER . . . 155.7 166.94 16.45 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -56.37 -35.14 95.85 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 121.329 1.352 . . . . 0.0 111.106 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.2 tpp180 -61.32 -11.93 11.77 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-O 121.985 0.897 . . . . 0.0 110.543 176.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.452 ' O ' ' OD1' ' A' ' 80' ' ' ASN . 28.9 p -77.59 -32.05 53.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 113.858 -1.519 . . . . 0.0 110.611 -177.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.0 tt -75.88 -33.93 59.98 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.539 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.49 ' C ' ' H ' ' A' ' 81' ' ' GLY . 26.2 m-85 -93.33 -5.25 50.07 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 115.003 1.482 . . . . 0.0 115.003 -178.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.452 ' OD1' ' O ' ' A' ' 77' ' ' SER . 50.1 p30 -84.13 32.59 0.49 Allowed 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 114.272 -1.331 . . . . 0.0 107.734 175.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.49 ' H ' ' C ' ' A' ' 79' ' ' TYR . . . -171.93 -9.46 0.02 OUTLIER Glycine 0 CA--C 1.525 0.67 0 CA-C-N 114.503 -1.226 . . . . 0.0 112.376 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.406 ' H ' ' H ' ' A' ' 81' ' ' GLY . 35.9 tp -59.13 -34.85 72.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 113.998 -1.101 . . . . 0.0 110.279 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.7 p -70.8 -27.16 29.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.284 178.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.69 -31.39 61.88 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.574 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.85 -40.03 89.54 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 119.442 -1.361 . . . . 0.0 111.051 -177.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 45.2 mt -62.21 -40.24 95.45 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 122.371 1.081 . . . . 0.0 113.179 -177.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -60.22 -26.72 66.62 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 112.993 -1.912 . . . . 0.0 108.979 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 -57.68 -53.45 58.05 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 172.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.559 HE22 ' CG ' ' A' ' 28' ' ' ASP . 1.4 tp-100 -67.95 -30.28 69.54 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 112.596 -2.093 . . . . 0.0 113.74 -177.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.53 -40.17 93.67 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 78.2 p -74.31 -34.5 63.51 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 118.409 -0.805 . . . . 0.0 111.192 -176.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -57.48 -44.05 84.58 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 120.842 1.656 . . . . 0.0 111.621 -176.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.51 -33.03 64.57 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 119.456 -0.898 . . . . 0.0 111.117 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.626 ' O ' HG22 ' A' ' 97' ' ' ILE . 38.8 t -64.08 -41.94 97.14 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.43 ' C ' ' H ' ' A' ' 97' ' ' ILE . 1.4 p -67.51 -27.47 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.755 179.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.499 ' O ' ' CG ' ' A' ' 96' ' ' ARG . 15.0 ttt180 -77.01 9.61 2.85 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -177.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.626 HG22 ' O ' ' A' ' 94' ' ' SER . 10.2 tp -86.6 -16.3 9.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 177.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -140.98 -49.0 0.05 OUTLIER Glycine 0 CA--C 1.541 1.662 0 N-CA-C 115.952 1.141 . . . . 0.0 115.952 -177.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.512 ' N ' HD12 ' A' ' 99' ' ' LEU . 10.7 mp -71.8 -13.45 61.7 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 119.453 1.627 . . . . 0.0 112.682 -177.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.479 ' O ' ' CG ' ' A' ' 104' ' ' LYS . 2.6 m-85 -80.77 -51.06 9.07 Favored 'General case' 0 C--O 1.211 -0.938 0 CA-C-N 114.293 -1.321 . . . . 0.0 110.809 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.936 ' OD2' ' NE2' ' A' ' 105' ' ' GLN . 18.3 t70 -69.18 -32.34 71.58 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 123.391 1.567 . . . . 0.0 110.071 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.5 t -68.96 -52.71 26.18 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 110.953 -2.839 . . . . 0.0 113.526 176.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 10.0 p -74.69 -27.66 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 CA-C-N 122.211 2.278 . . . . 0.0 113.146 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.479 ' CG ' ' O ' ' A' ' 100' ' ' TYR . 47.6 mtpt -69.48 -42.13 75.25 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 111.47 -2.605 . . . . 0.0 111.805 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.936 ' NE2' ' OD2' ' A' ' 101' ' ' ASP . 88.1 mt-30 -75.05 -16.37 60.59 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 122.997 1.38 . . . . 0.0 111.05 176.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.634 ' CE2' HG21 ' A' ' 126' ' ' THR . 17.3 t80 -78.7 -22.65 46.36 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 112.614 -2.085 . . . . 0.0 112.044 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.486 ' OH ' ' ND2' ' A' ' 190' ' ' ASN . 16.7 m-85 -109.54 -30.83 7.74 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 119.369 0.986 . . . . 0.0 111.269 -175.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.4 m -98.1 9.06 43.78 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 118.029 -1.468 . . . . 0.0 112.105 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.521 ' O ' ' C ' ' A' ' 110' ' ' GLY . 51.4 tttm -51.97 120.8 5.74 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 118.129 -0.939 . . . . 0.0 111.564 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.544 ' O ' ' CB ' ' A' ' 111' ' ' SER . . . -20.87 -82.86 0.01 OUTLIER Glycine 0 N--CA 1.488 2.14 0 CA-C-N 119.474 1.034 . . . . 0.0 112.076 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.544 ' CB ' ' O ' ' A' ' 110' ' ' GLY . 24.2 p 103.67 -161.19 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 176.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.621 ' O ' ' N ' ' A' ' 114' ' ' ALA . 18.9 tp10 -131.49 101.56 5.57 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -177.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.641 ' O ' ' HB2' ' A' ' 114' ' ' ALA . 81.3 t60 17.36 42.41 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.924 178.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.641 ' HB2' ' O ' ' A' ' 113' ' ' HIS . . . 159.33 -161.48 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.51 14.9 26.53 Favored Glycine 0 C--N 1.337 0.614 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.991 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 48.6 mt -60.83 -40.5 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.0 -39.51 96.49 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-O 122.078 0.821 . . . . 0.0 111.559 175.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.6 p -57.57 -42.09 82.37 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 177.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -63.42 -37.23 86.47 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.099 -0.64 . . . . 0.0 111.377 -178.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 29.0 mt -64.18 -46.68 82.91 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.351 0.596 . . . . 0.0 110.018 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.588 HD23 ' O ' ' A' ' 121' ' ' LEU . 2.4 tt -66.63 -44.88 80.8 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.983 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.625 ' HB1' ' CE2' ' A' ' 106' ' ' PHE . . . -63.89 -44.99 91.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 119.222 0.919 . . . . 0.0 109.907 178.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -65.73 -44.04 93.08 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.568 -0.825 . . . . 0.0 111.83 -178.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 78.1 p -63.64 -43.27 97.26 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 18.9 m -68.84 -48.03 64.51 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 119.281 -0.968 . . . . 0.0 112.012 177.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.634 HG21 ' CE2' ' A' ' 106' ' ' PHE . 21.6 p -65.49 -42.63 91.95 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 -173.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -64.01 -44.79 95.39 Favored Glycine 0 CA--C 1.521 0.46 0 CA-C-O 122.586 1.103 . . . . 0.0 113.092 -177.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.402 ' O ' ' CG2' ' A' ' 131' ' ' VAL . . . -61.1 -41.3 96.41 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 112.54 -1.83 . . . . 0.0 106.818 177.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.662 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 51.9 mt -63.93 -41.75 97.54 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.308 178.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -62.64 -40.09 95.92 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -177.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.402 ' CG2' ' O ' ' A' ' 128' ' ' ALA . 5.0 m -61.22 -25.64 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 122.696 1.236 . . . . 0.0 109.5 178.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.662 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . -57.87 -44.8 86.86 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 112.49 -2.141 . . . . 0.0 111.626 -178.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.426 HG22 ' H ' ' A' ' 133' ' ' VAL . 3.6 m -78.97 -48.73 21.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.711 -179.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -103.59 133.19 49.03 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.786 0.326 . . . . 0.0 111.468 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.649 ' H ' ' HD2' ' A' ' 136' ' ' PRO . 33.8 tp60 -175.88 -39.41 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.552 178.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.649 ' HD2' ' H ' ' A' ' 135' ' ' GLN . 52.9 Cg_exo -52.75 -33.56 60.66 Favored 'Trans proline' 0 N--CA 1.498 1.775 0 C-N-CA 122.009 1.806 . . . . 0.0 112.548 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 58.7 p -67.3 -41.88 84.63 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 118.309 -1.356 . . . . 0.0 109.65 -178.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -65.88 -42.48 90.26 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 118.796 -1.162 . . . . 0.0 111.903 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 59.1 t -64.04 -44.14 97.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.437 HG13 ' O ' ' A' ' 136' ' ' PRO . 33.2 m -65.08 -38.76 83.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -177.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.434 ' HZ2' ' HB3' ' A' ' 141' ' ' LYS . 14.8 mtpp -62.29 -41.86 98.86 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 119.269 -0.973 . . . . 0.0 111.823 -177.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.401 HG22 ' H ' ' A' ' 142' ' ' VAL . 12.7 m -70.44 -45.64 74.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.237 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.492 ' NH2' ' O ' ' A' ' 174' ' ' GLY . 17.6 mmt85 -65.06 -37.09 86.41 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.566 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -66.98 -42.11 85.66 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -177.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -65.52 -40.39 92.9 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 118.853 -1.139 . . . . 0.0 109.572 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.64 -35.34 80.52 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -178.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.624 HE21 HE22 ' A' ' 157' ' ' GLN . 46.3 tt0 -60.2 110.51 1.24 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 176.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -98.83 -61.06 1.42 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 117.617 -1.182 . . . . 0.0 113.266 -177.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 70.8 mtp85 -71.29 -172.58 0.75 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 122.633 2.47 . . . . 0.0 110.259 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -160.79 18.61 0.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.647 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 57.57 -130.86 51.62 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 159.37 126.75 0.87 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 178.63 -150.94 9.98 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -62.13 -41.41 98.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.796 0.331 . . . . 0.0 110.523 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 80.4 mmt-85 -92.06 136.14 33.41 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.421 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.516 ' O ' ' CD2' ' A' ' 156' ' ' TYR . 60.8 t80 -90.96 19.89 5.28 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.63 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.624 HE22 HE21 ' A' ' 147' ' ' GLN . 27.6 tt0 58.85 146.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.811 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 88.8 p -157.06 -178.19 7.18 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.472 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 97.8 m -64.31 -45.88 86.0 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.805 -177.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 85.0 t -64.04 -45.35 96.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 119.016 -1.074 . . . . 0.0 108.898 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 -66.72 -39.55 88.05 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.833 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -62.16 -45.61 92.67 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -179.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.429 ' CD1' ' C ' ' A' ' 163' ' ' TYR . 19.3 t80 -62.4 -50.05 73.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.293 0.568 . . . . 0.0 111.075 -178.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -68.44 -45.21 73.14 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -175.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.403 ' O ' ' OE1' ' A' ' 169' ' ' GLU . 19.0 m -62.44 -44.6 96.01 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 -176.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 11.9 pt -64.6 -38.45 82.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-O 121.777 0.799 . . . . 0.0 109.651 176.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.91 -36.8 77.76 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 175.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 16.2 tpt85 -62.12 -49.86 74.19 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 122.095 2.225 . . . . 0.0 111.232 -176.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.403 ' OE1' ' O ' ' A' ' 165' ' ' THR . 16.4 mp0 -74.7 -51.13 15.14 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 123.561 0.744 . . . . 0.0 109.855 177.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -78.32 -36.75 45.98 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 117.033 2.235 . . . . 0.0 117.033 -172.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 91.77 -167.43 30.85 Favored Glycine 0 N--CA 1.472 1.036 0 CA-C-N 119.136 0.88 . . . . 0.0 112.597 177.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.494 HD12 ' CH2' ' A' ' 176' ' ' TRP . 9.0 pt -73.37 -41.91 57.07 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-O 122.098 0.951 . . . . 0.0 110.552 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -58.63 -32.94 69.5 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 113.661 -1.609 . . . . 0.0 110.473 -177.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.492 ' O ' ' NH2' ' A' ' 143' ' ' ARG . . . -60.45 -40.16 97.28 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 118.994 -1.574 . . . . 0.0 109.586 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.768 HD23 ' O ' ' A' ' 175' ' ' LEU . 2.6 tt -69.46 -34.16 73.98 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 111.883 -2.159 . . . . 0.0 116.261 -176.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . 0.494 ' CH2' HD12 ' A' ' 172' ' ' ILE . 39.2 m0 -78.36 -7.86 57.78 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 111.071 -2.786 . . . . 0.0 110.227 -178.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 37.6 tptt -43.45 -48.18 7.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.925 -176.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -83.75 -34.42 18.98 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 93.0 m -45.39 -51.49 11.22 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.416 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 1.6 t -62.9 -50.91 74.92 Favored Pre-proline 0 N--CA 1.473 0.71 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -176.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 180' ' ' SER . 30.5 Cg_endo -64.81 -28.73 59.19 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.296 1.331 . . . . 0.0 111.901 177.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.557 ' CG ' HE22 ' A' ' 135' ' ' GLN . 14.8 t-20 -64.22 -39.74 94.61 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.637 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 94.5 t -63.28 -42.97 98.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.189 -0.459 . . . . 0.0 109.907 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.45 -39.89 94.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.014 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.407 ' O ' HG22 ' A' ' 189' ' ' VAL . 65.2 ttt180 -61.1 -42.19 98.06 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.13 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -62.24 -44.0 97.55 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.169 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -65.65 -45.95 81.03 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -178.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.437 HG23 ' N ' ' A' ' 189' ' ' VAL . 10.0 tp -65.38 -46.28 90.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.515 HG23 ' N ' ' A' ' 190' ' ' ASN . 29.6 m -60.83 -46.85 95.51 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 C-N-CA 119.837 -0.745 . . . . 0.0 111.648 -178.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.515 ' N ' HG23 ' A' ' 189' ' ' VAL . 19.6 t-20 -62.28 -43.46 98.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 122.169 0.985 . . . . 0.0 109.876 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' CYS . . . . . . . . . . . . . 28.2 t -62.7 -47.38 83.88 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 113.554 -1.657 . . . . 0.0 110.862 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -65.01 -41.19 95.58 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.253 177.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -61.37 -45.75 93.08 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 114.335 -1.302 . . . . 0.0 111.999 -178.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.554 HD13 ' O ' ' A' ' 194' ' ' LEU . 0.2 OUTLIER -63.56 -38.1 89.83 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 -176.277 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.438 ' O ' ' CD2' ' A' ' 199' ' ' LEU . 72.1 t -63.44 -46.48 95.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 C-N-CA 117.648 -1.621 . . . . 0.0 107.603 178.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 19.2 m -64.35 -45.74 86.49 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -178.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -56.78 -38.69 72.86 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.487 1.115 . . . . 0.0 112.497 -177.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -55.48 -44.13 76.18 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.698 ' N ' HD22 ' A' ' 199' ' ' LEU . 2.5 mm? -61.24 -39.95 92.24 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 40.2 mt -63.86 -44.24 98.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-O 118.65 -0.691 . . . . 0.0 112.037 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -61.13 -41.04 96.01 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 120.415 1.462 . . . . 0.0 112.182 177.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -67.32 -37.63 83.63 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.235 -1.348 . . . . 0.0 111.061 -177.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 3.4 m -101.94 129.9 48.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.269 0.557 . . . . 0.0 111.939 -177.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 22.9 mt 68.12 4.97 4.36 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 114.384 -1.28 . . . . 0.0 113.082 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.417 HD13 ' H ' ' A' ' 208' ' ' ASN . 0.2 OUTLIER -135.74 44.12 2.53 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.202 0.525 . . . . 0.0 110.889 -179.741 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.55 ' O ' ' CB ' ' A' ' 207' ' ' ALA . 56.8 pttt -88.03 49.67 1.84 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.835 -178.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.55 ' CB ' ' O ' ' A' ' 206' ' ' LYS . . . 119.96 17.83 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.155 0 O-C-N 124.494 1.121 . . . . 0.0 109.474 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' A' ' 207' ' ' ALA . 0.0 OUTLIER 77.57 116.33 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 102.31 -3.219 . . . . 0.0 102.31 -171.492 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.477 HD23 ' C ' ' A' ' 209' ' ' LEU . 2.0 tt -95.48 86.6 4.52 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.965 0.412 . . . . 0.0 111.418 -178.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 37.2 ttp -135.21 136.43 41.77 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.964 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 28.0 m -167.93 -66.53 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.501 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . 0.504 ' CG ' ' H ' ' A' ' 213' ' ' ASP . 19.7 t70 -169.44 -163.23 0.38 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.306 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.504 ' H ' ' CG ' ' A' ' 212' ' ' ASP . 6.6 p-10 41.46 65.82 0.78 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.03 0.443 . . . . 0.0 110.712 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.487 ' N ' ' CD ' ' A' ' 215' ' ' PRO . 1.9 mt -61.34 -43.42 89.55 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.263 -178.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.487 ' CD ' ' N ' ' A' ' 214' ' ' LEU . 33.5 Cg_exo -60.17 -32.58 94.69 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 121.602 1.534 . . . . 0.0 111.89 -178.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 97.7 m -64.08 -42.01 97.11 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 113.456 -1.702 . . . . 0.0 111.148 -179.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -66.34 -38.35 87.43 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.855 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -63.47 -46.92 84.0 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.285 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 32.7 p -59.97 -37.39 79.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 118.222 0.464 . . . . 0.0 110.785 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 14.0 t -59.29 -41.37 88.81 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.21 -41.49 99.14 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -177.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -61.46 -46.86 88.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 122.1 0.952 . . . . 0.0 112.59 -176.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -60.69 -41.79 99.1 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 107.725 -2.15 . . . . 0.0 107.725 176.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.604 ' O ' HG23 ' A' ' 228' ' ' THR . . . -62.7 -37.87 88.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.163 -1.018 . . . . 0.0 109.218 177.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -61.41 -41.91 99.65 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.993 -177.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -66.37 -38.16 86.92 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 119.316 -0.954 . . . . 0.0 108.574 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . 0.442 ' O ' HG12 ' A' ' 230' ' ' VAL . 96.4 m -63.03 -41.23 99.47 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.081 0.467 . . . . 0.0 110.306 177.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.604 HG23 ' O ' ' A' ' 224' ' ' ALA . 60.4 p -61.85 -39.4 91.74 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.575 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 19.5 m -58.15 -39.22 78.25 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.72 -176.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 227' ' ' CYS . 1.5 p -59.66 -40.19 81.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 118.709 -1.197 . . . . 0.0 108.442 179.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.599 ' O ' ' HD2' ' A' ' 234' ' ' PRO . 26.7 mt -60.88 -40.23 84.59 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.449 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 177.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -61.95 -38.35 88.17 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 115.454 1.649 . . . . 0.0 115.454 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.466 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 0.9 OUTLIER -56.89 -39.65 79.44 Favored Pre-proline 0 N--CA 1.481 1.093 0 N-CA-C 116.276 1.954 . . . . 0.0 116.276 -172.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.599 ' HD2' ' O ' ' A' ' 231' ' ' ILE . 38.1 Cg_exo -59.06 -39.94 75.35 Favored 'Trans proline' 0 C--N 1.29 -2.54 0 C-N-CA 122.097 1.865 . . . . 0.0 114.246 -176.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.8 m -64.2 -37.62 80.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 118.435 -1.306 . . . . 0.0 111.369 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . 0.441 ' CG ' ' O ' ' A' ' 233' ' ' SER . 0.3 OUTLIER -66.28 -40.09 89.85 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 179.003 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 99.0 t -64.54 -44.97 96.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -175.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.466 ' CG2' HH21 ' A' ' 241' ' ' ARG . 10.0 p -62.91 -36.94 77.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 119.423 -0.911 . . . . 0.0 110.865 -178.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 3.9 mmmm -60.83 -43.79 97.8 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.06 -42.14 97.93 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 -176.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.48 ' O ' ' CB ' ' A' ' 242' ' ' TYR . 12.9 ptt180 -56.56 135.69 54.58 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 119.774 -0.77 . . . . 0.0 109.727 -178.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.516 ' O ' ' ND2' ' A' ' 244' ' ' ASN . 11.9 t80 153.48 -57.94 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 O-C-N 124.009 0.818 . . . . 0.0 110.834 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' MET . . . . . 0.572 ' SD ' ' NE2' ' A' ' 42' ' ' GLN . 4.7 ttt -52.21 114.95 1.49 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.344 0.593 . . . . 0.0 111.248 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 242' ' ' TYR . 22.6 p30 179.21 -7.12 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . 0.623 ' O ' ' HB2' ' A' ' 246' ' ' ALA . 54.0 m -119.05 152.62 36.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 112.661 -2.063 . . . . 0.0 113.157 -177.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . 0.623 ' HB2' ' O ' ' A' ' 245' ' ' SER . . . 157.12 -24.6 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.166 -1.379 . . . . 0.0 109.105 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 7.1 mt -137.86 101.02 4.33 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.271 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 139.81 -161.29 26.26 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 111.536 -0.625 . . . . 0.0 111.536 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.439 ' O ' ' O ' ' A' ' 250' ' ' TYR . 85.5 mm-40 -76.85 -103.34 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.623 ' CE2' ' OG ' ' A' ' 245' ' ' SER . 7.3 t80 57.0 98.67 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 119.111 -1.035 . . . . 0.0 108.934 178.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -65.22 -53.07 50.0 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 116.148 -2.221 . . . . 0.0 107.795 -178.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 2.8 m -151.17 -179.82 7.66 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.361 171.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.484 ' O ' ' SG ' ' A' ' 256' ' ' CYS . . . -67.49 -47.55 69.69 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 177.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . 0.427 ' O ' ' HB3' ' A' ' 257' ' ' ALA . . . -68.23 -43.48 79.75 Favored Glycine 0 N--CA 1.471 1.025 0 CA-C-N 124.051 3.114 . . . . 0.0 113.489 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -65.52 -31.98 73.33 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 111.894 -2.153 . . . . 0.0 111.093 -176.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' CYS . . . . . 0.63 ' SG ' ' N ' ' A' ' 257' ' ' ALA . 2.1 p -64.01 -43.53 95.35 Favored 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 172.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.63 ' N ' ' SG ' ' A' ' 256' ' ' CYS . . . -59.25 -43.95 92.39 Favored 'General case' 0 C--N 1.335 -0.059 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.064 -177.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 22.6 tp -65.25 -42.26 93.49 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 19.4 m -61.96 -43.78 98.13 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.891 -1.049 . . . . 0.0 109.555 177.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' MET . . . . . 0.575 ' O ' ' N ' ' A' ' 264' ' ' GLU . 0.0 OUTLIER -59.48 -40.87 88.36 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.074 -178.517 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 9.6 tp -59.81 -46.36 89.48 Favored 'General case' 0 C--N 1.32 -0.681 0 O-C-N 121.887 -0.508 . . . . 0.0 110.098 -177.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' ARG . . . . . 0.415 ' HG3' ' H ' ' A' ' 263' ' ' LYS . 9.4 ptm180 -66.36 -52.95 41.66 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 119.056 -1.058 . . . . 0.0 110.304 178.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . 0.415 ' H ' ' HG3' ' A' ' 262' ' ' ARG . 2.7 ptmm? -88.29 -55.45 3.73 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . 0.575 ' N ' ' O ' ' A' ' 260' ' ' MET . 25.0 mt-10 -90.25 102.16 14.88 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 119.673 1.124 . . . . 0.0 111.473 -179.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.478 ' C ' ' H ' ' A' ' 267' ' ' ARG . . . -36.91 159.44 0.01 OUTLIER Glycine 0 CA--C 1.536 1.377 0 N-CA-C 111.424 -0.67 . . . . 0.0 111.424 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -56.96 1.13 0.16 Allowed 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 121.952 1.768 . . . . 0.0 112.412 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.478 ' H ' ' C ' ' A' ' 265' ' ' GLY . 20.8 mmt85 -69.12 -27.33 65.47 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 110.627 -0.138 . . . . 0.0 110.627 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -59.05 -32.63 69.93 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 119.615 -0.834 . . . . 0.0 109.626 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -62.58 -42.66 99.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.172 178.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -66.94 -36.88 83.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.845 -1.07 . . . . 0.0 112.73 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.428 ' O ' ' O ' ' A' ' 272' ' ' GLY . 98.3 mttt -75.1 174.61 9.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.317 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 271' ' ' LYS . . . 47.69 101.79 0.01 OUTLIER Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -164.65 7.35 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.167 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' MET . . . . . 0.558 ' O ' HD13 ' A' ' 278' ' ' LEU . 65.1 mtp -63.79 -44.67 80.39 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 274' ' ' MET . 34.6 Cg_endo -64.53 -46.34 7.42 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 120.969 1.113 . . . . 0.0 112.554 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 17.4 t -60.7 -40.65 93.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.062 0.458 . . . . 0.0 111.044 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -62.05 -42.5 99.25 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 123.668 1.699 . . . . 0.0 110.445 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.558 HD13 ' O ' ' A' ' 274' ' ' MET . 7.2 mp -62.52 -38.29 89.39 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 110.288 -3.142 . . . . 0.0 108.192 174.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 17.5 tpt85 -62.62 -40.96 98.64 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.605 0.717 . . . . 0.0 110.613 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 9.7 mt -62.29 -36.15 81.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.586 -1.188 . . . . 0.0 112.834 -177.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -67.78 -50.73 39.85 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -178.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . 0.518 ' O ' HG22 ' A' ' 285' ' ' VAL . 78.0 p -62.88 -44.7 95.39 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.164 0.507 . . . . 0.0 109.817 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' TRP . . . . . . . . . . . . . 37.8 t90 -61.32 -39.02 88.98 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.743 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -62.86 -39.73 95.31 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -178.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.518 HG22 ' O ' ' A' ' 282' ' ' SER . 9.5 m -61.12 -37.37 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.337 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.495 ' O ' HG12 ' A' ' 289' ' ' VAL . 96.9 t -61.83 -40.52 87.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 29.5 ttp -60.99 -39.18 88.68 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.453 0.645 . . . . 0.0 109.472 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -58.87 -39.52 81.62 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.906 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.495 HG12 ' O ' ' A' ' 286' ' ' VAL . 0.4 OUTLIER -60.16 -38.31 76.63 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -176.417 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -62.65 -40.19 96.25 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 119.137 -1.025 . . . . 0.0 108.642 177.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -61.23 -39.07 88.94 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 176.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -58.57 -40.59 83.53 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 117.748 -1.581 . . . . 0.0 109.737 -176.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' GLN . . . . . 0.445 ' O ' ' O ' ' A' ' 296' ' ' ARG . 21.9 mm100 -60.43 -42.86 96.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 122.506 1.146 . . . . 0.0 110.944 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 10.5 mt -60.2 -40.76 91.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 113.029 -1.896 . . . . 0.0 109.305 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 21.8 mtpt -63.24 -45.82 89.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.271 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' ARG . . . . . 0.445 ' O ' ' O ' ' A' ' 293' ' ' GLN . 80.6 mtm180 -123.02 116.51 23.65 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.443 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -117.22 -94.68 0.49 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.3 0.571 . . . . 0.0 110.862 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.477 ' C ' HD12 ' A' ' 298' ' ' LEU . 0.4 OUTLIER -135.98 -166.45 1.87 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.032 178.846 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 5.7 ptm -171.57 66.48 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.343 -0.543 . . . . 0.0 111.747 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.53 101.12 0.07 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.983 0.897 . . . . 0.0 110.343 -178.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -64.14 -46.23 85.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 113.789 -1.55 . . . . 0.0 113.436 -176.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -58.96 -40.06 83.56 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.177 -0.609 . . . . 0.0 109.613 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . 0.473 ' CD ' ' N ' ' A' ' 13' ' ' MET . 14.9 tt0 -64.83 -46.66 81.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.689 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' SER . . . . . 0.435 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 75.9 p -66.66 -37.37 84.65 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.882 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -61.55 -43.14 99.41 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -65.21 -36.73 85.07 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -177.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . 0.544 ' HB3' ' HD3' ' A' ' 308' ' ' PRO . . . -59.92 -52.88 70.51 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -176.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' PRO . . . . . 0.544 ' HD3' ' HB3' ' A' ' 307' ' ' ALA . 74.4 Cg_endo -75.26 0.37 9.09 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.048 1.832 . . . . 0.0 111.874 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 82.3 t80 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.614 179.925 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.569 ' N ' ' SD ' ' A' ' 13' ' ' MET . 4.6 mpp? . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.1 t -177.08 69.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.84 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.568 HG12 ' N ' ' A' ' 16' ' ' LYS . 42.1 t -135.8 164.33 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 121.031 0.443 . . . . 0.0 110.302 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.568 ' N ' HG12 ' A' ' 15' ' ' VAL . 14.2 ptpt -64.52 -41.68 96.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.434 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.535 ' CE2' ' NH1' ' A' ' 96' ' ' ARG . 32.4 t80 -63.41 -41.89 98.73 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -178.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.2 pp -80.1 -25.59 39.92 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.185 0.517 . . . . 0.0 112.351 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.42 ' O ' ' OG1' ' A' ' 22' ' ' THR . . . -66.14 -41.21 95.09 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 107.667 -2.173 . . . . 0.0 107.667 177.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.414 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -71.5 -32.07 67.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 124.787 2.232 . . . . 0.0 107.193 176.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.6 -42.43 98.81 Favored Glycine 0 CA--C 1.527 0.837 1 CA-C-N 108.389 -4.005 . . . . 0.0 108.19 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 19' ' ' GLY . 22.4 p -70.65 -27.74 64.27 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -66.48 -50.02 64.66 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.814 -179.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.94 -36.06 80.27 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 118.161 -1.416 . . . . 0.0 110.931 -177.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.2 t -63.99 -53.87 43.38 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.616 -0.433 . . . . 0.0 111.326 -179.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.1 tp -65.82 -39.75 85.68 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -177.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.619 ' O ' HG23 ' A' ' 31' ' ' THR . . . -63.9 -41.93 97.57 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 119.736 -0.786 . . . . 0.0 112.924 -173.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -77.69 -27.24 50.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 120.439 1.472 . . . . 0.0 109.886 -176.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.0 tp -59.86 -55.71 30.84 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 119.802 1.183 . . . . 0.0 112.553 -178.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.4 tp -75.75 -4.63 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.619 HG23 ' O ' ' A' ' 27' ' ' ALA . 28.3 p -109.84 -17.27 13.69 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 118.7 -1.2 . . . . 0.0 110.41 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.414 ' N ' ' CD ' ' A' ' 33' ' ' PRO . 66.3 t80 -67.86 -43.65 38.53 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 122.461 2.391 . . . . 0.0 110.583 -178.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 32' ' ' PHE . 37.6 Cg_exo -58.94 -15.32 26.72 Favored 'Trans proline' 0 N--CA 1.503 2.06 0 C-N-CA 121.343 1.362 . . . . 0.0 112.341 178.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.75 HD13 HH21 ' A' ' 279' ' ' ARG . 88.8 mt -67.15 -34.43 77.55 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -178.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -64.09 -40.64 96.67 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -177.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 75.7 p -58.29 -34.79 70.93 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.04 -38.91 86.7 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -178.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.496 ' CB ' ' NZ ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -61.17 -47.06 87.91 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 119.378 -0.929 . . . . 0.0 111.723 -176.173 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 95.0 t -62.39 -38.06 80.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 O-C-N 122.287 -0.258 . . . . 0.0 111.264 -178.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.502 ' O ' ' N ' ' A' ' 42' ' ' GLN . 25.9 mmt180 -59.58 -40.16 86.47 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.367 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 84.2 mt -61.19 38.93 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.502 ' N ' ' O ' ' A' ' 40' ' ' ARG . 2.7 pt20 -172.29 55.32 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 O-C-N 122.074 -0.391 . . . . 0.0 110.739 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.424 ' C ' ' O ' ' A' ' 42' ' ' GLN . 0.1 OUTLIER 26.68 -117.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.959 179.622 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.407 ' H ' ' CG1' ' A' ' 43' ' ' ILE . 95.9 mm-40 -129.89 102.51 6.33 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.366 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -81.47 73.6 2.58 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -156.56 163.62 39.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.878 0.37 . . . . 0.0 110.45 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 63.6 p -82.18 67.21 8.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.645 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.675 HE21 ' N ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -118.34 -47.39 2.56 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.825 179.805 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.02 13.09 81.76 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -177.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.675 ' N ' HE21 ' A' ' 48' ' ' GLN . 0.2 OUTLIER -65.82 -38.12 88.07 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.435 0.636 . . . . 0.0 109.319 178.978 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.539 HG13 ' N ' ' A' ' 52' ' ' ARG . 12.5 p -60.24 -44.5 95.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.859 -178.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.539 ' N ' HG13 ' A' ' 51' ' ' VAL . 52.5 ttp180 -64.31 -33.59 76.19 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.183 -0.607 . . . . 0.0 109.474 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 95.8 m -67.71 -38.21 83.32 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.415 ' O ' ' O ' ' A' ' 51' ' ' VAL . . . -89.76 124.52 34.71 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.706 179.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -87.62 -7.08 57.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.949 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.441 ' C ' ' H ' ' A' ' 58' ' ' GLN . 88.1 p -174.43 -125.89 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 56' ' ' SER . . . 65.27 -19.72 0.09 Allowed 'General case' 0 N--CA 1.461 0.092 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 176.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.453 ' NE2' ' NH1' ' A' ' 40' ' ' ARG . 7.6 mm100 -126.01 38.76 4.08 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 177.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.427 ' O ' ' O ' ' A' ' 58' ' ' GLN . 75.2 m-85 -37.53 -98.37 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.132 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.428 ' O ' ' C ' ' A' ' 61' ' ' GLY . 34.4 ttm180 -154.51 -31.63 0.11 Allowed 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.442 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 60' ' ' ARG . . . -29.03 102.27 0.01 OUTLIER Glycine 0 C--N 1.34 0.774 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.914 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.1 t -66.77 -34.46 70.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 118.31 -0.852 . . . . 0.0 109.14 176.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.7 tp -60.93 -33.01 72.5 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 121.495 1.952 . . . . 0.0 111.365 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -65.05 -49.43 62.42 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 115.223 0.849 . . . . 0.0 115.223 -176.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.41 ' H ' HG22 ' A' ' 65' ' ' THR . 0.0 OUTLIER -62.21 -45.57 92.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.958 -0.621 . . . . 0.0 111.714 -179.159 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 94.5 mt -59.66 -36.37 65.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -179.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.559 ' O ' HD13 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -63.92 -36.41 83.86 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 120.561 1.528 . . . . 0.0 111.343 179.568 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.448 ' O ' ' OG1' ' A' ' 72' ' ' THR . 98.3 m -62.52 -39.35 93.24 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 113.215 -1.812 . . . . 0.0 111.084 -176.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 28.7 ttt -60.52 -39.46 87.9 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -177.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.8 t -68.92 -40.38 81.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 119.473 -0.891 . . . . 0.0 112.851 -177.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -77.71 -13.25 59.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.679 0.752 . . . . 0.0 112.947 -178.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 68' ' ' THR . 16.1 m -62.96 -55.06 29.15 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.947 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 31.9 mp0 -108.39 -58.85 1.94 Allowed 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.407 ' O ' ' CB ' ' A' ' 77' ' ' SER . . . 158.75 164.54 14.45 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -56.49 -35.14 96.39 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.762 1.642 . . . . 0.0 111.546 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.428 ' O ' ' OD1' ' A' ' 80' ' ' ASN . 48.4 ttm-85 -60.97 -11.01 6.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 122.211 1.005 . . . . 0.0 111.003 176.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.531 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 36.2 p -77.59 -32.19 53.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 113.285 -1.779 . . . . 0.0 110.205 -179.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 85.7 mt -74.8 -28.93 60.92 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.486 1.114 . . . . 0.0 111.477 178.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -86.64 -2.45 58.52 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 122.678 1.228 . . . . 0.0 113.041 -172.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.531 ' ND2' ' O ' ' A' ' 77' ' ' SER . 0.4 OUTLIER -116.33 138.23 51.5 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 112.376 -2.193 . . . . 0.0 108.542 176.847 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.8 -28.09 17.37 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -178.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 69.5 mt -59.34 -34.87 72.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.148 -1.026 . . . . 0.0 110.573 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.3 t -70.85 -27.47 30.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.293 -0.867 . . . . 0.0 108.969 178.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.01 -31.93 61.5 Favored 'General case' 0 C--O 1.226 -0.15 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.331 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.64 -40.33 90.42 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 119.463 -1.351 . . . . 0.0 110.802 -178.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.5 tp -62.22 -40.27 95.56 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 122.343 1.068 . . . . 0.0 113.243 -176.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -60.17 -27.04 66.78 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 113.285 -1.78 . . . . 0.0 109.307 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.631 HH22 HE21 ' A' ' 145' ' ' GLN . 77.0 mtt180 -57.93 -53.41 58.59 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 172.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 11.5 tm0? -67.65 -30.65 70.26 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 112.061 -2.336 . . . . 0.0 113.794 -177.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 2.7 ptm -61.72 -40.09 93.83 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.925 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.5 m -74.1 -34.31 63.91 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 119.191 -1.004 . . . . 0.0 111.048 -176.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -58.0 -43.92 86.94 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 120.899 1.681 . . . . 0.0 112.416 -176.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.1 -33.07 65.36 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.921 -177.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 85.9 p -63.69 -40.74 97.56 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.446 ' C ' ' H ' ' A' ' 97' ' ' ILE . 18.7 m -67.89 -28.77 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.535 ' NH1' ' CE2' ' A' ' 17' ' ' PHE . 5.0 ptm180 -77.61 12.0 1.82 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -177.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.446 ' H ' ' C ' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -86.63 -15.35 9.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 179.07 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.503 ' O ' ' OD1' ' A' ' 101' ' ' ASP . . . -140.26 -47.84 0.06 OUTLIER Glycine 0 CA--C 1.536 1.344 0 CA-C-N 114.265 -1.334 . . . . 0.0 114.553 -177.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.4 tp -71.65 -13.52 61.77 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 119.453 1.626 . . . . 0.0 113.443 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -81.18 -52.16 7.66 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 114.595 -1.184 . . . . 0.0 112.189 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.62 ' O ' ' HG3' ' A' ' 105' ' ' GLN . 41.5 p-10 -70.15 -32.47 70.47 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 124.061 1.886 . . . . 0.0 110.591 -179.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.524 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 28.7 t -67.49 -50.74 57.6 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 109.695 -3.411 . . . . 0.0 111.936 176.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.466 HG22 ' CE2' ' A' ' 107' ' ' TYR . 0.5 OUTLIER -73.25 -26.42 22.58 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.185 0 CA-C-N 121.446 1.93 . . . . 0.0 111.492 178.586 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -69.29 -41.44 76.8 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 112.524 -2.126 . . . . 0.0 110.955 178.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.62 ' HG3' ' O ' ' A' ' 101' ' ' ASP . 88.1 mt-30 -76.64 -16.98 59.41 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.591 0.71 . . . . 0.0 111.073 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -79.33 -22.95 43.83 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.17 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.466 ' CE2' HG22 ' A' ' 103' ' ' VAL . 33.3 m-85 -109.34 -29.35 8.5 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 119.669 1.122 . . . . 0.0 112.855 -174.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 59.3 p -95.99 9.42 40.79 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 117.07 -1.852 . . . . 0.0 113.208 -176.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.0 mmmt -47.55 122.64 4.96 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.258 0.935 . . . . 0.0 108.661 176.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -119.29 85.83 0.39 Allowed Glycine 0 N--CA 1.476 1.33 0 CA-C-N 120.216 1.371 . . . . 0.0 111.624 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 34.3 t -94.55 -61.37 1.52 Allowed 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 -176.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -123.29 -176.83 3.53 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 112.749 -2.023 . . . . 0.0 111.971 -177.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.638 ' O ' ' HB2' ' A' ' 114' ' ' ALA . 0.0 OUTLIER -91.25 72.5 6.21 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -178.51 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.638 ' HB2' ' O ' ' A' ' 113' ' ' HIS . . . 159.77 -162.96 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 176.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.22 15.27 26.17 Favored Glycine 0 C--N 1.343 0.958 0 CA-C-N 114.471 -1.241 . . . . 0.0 113.15 177.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.481 HG23 ' N ' ' A' ' 117' ' ' GLY . 15.0 tt -60.87 -40.29 84.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 118.053 0.927 . . . . 0.0 110.215 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.481 ' N ' HG23 ' A' ' 116' ' ' ILE . . . -65.1 -39.68 96.44 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-O 122.029 0.794 . . . . 0.0 111.837 176.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 36.2 m -57.2 -41.68 79.85 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -63.2 -36.71 84.53 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.181 -0.607 . . . . 0.0 111.509 -178.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.649 ' C ' HD12 ' A' ' 120' ' ' LEU . 0.1 OUTLIER -63.91 -45.78 87.77 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.087 0.47 . . . . 0.0 110.407 178.387 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.423 ' N ' ' HG ' ' A' ' 120' ' ' LEU . 10.9 tp -65.7 -44.05 87.3 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 119.405 -0.918 . . . . 0.0 109.821 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.69 -44.38 96.38 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 118.922 0.783 . . . . 0.0 110.496 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -65.72 -44.23 92.76 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 119.561 -1.304 . . . . 0.0 112.021 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 10.9 t -64.15 -44.76 91.16 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 119.985 -0.686 . . . . 0.0 111.631 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.417 ' O ' HD23 ' A' ' 129' ' ' LEU . 21.3 m -69.73 -48.89 57.85 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 119.07 -1.052 . . . . 0.0 112.194 177.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 24.5 m -65.49 -42.81 91.78 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 -174.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -64.22 -44.65 95.3 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-O 122.802 1.223 . . . . 0.0 113.342 -177.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.426 ' O ' ' CG2' ' A' ' 131' ' ' VAL . . . -60.96 -41.31 96.09 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 112.073 -2.063 . . . . 0.0 107.075 177.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.665 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 1.6 mm? -64.3 -42.02 96.57 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.438 178.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.18 -39.86 95.85 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -177.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.426 ' CG2' ' O ' ' A' ' 128' ' ' ALA . 7.0 m -61.15 -25.76 37.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 122.753 1.264 . . . . 0.0 109.544 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.665 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . -58.55 -44.94 89.83 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 112.364 -2.198 . . . . 0.0 111.673 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.438 HG12 ' H ' ' A' ' 133' ' ' VAL . 2.0 p -79.07 -48.82 20.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -102.73 129.15 49.27 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.826 0.346 . . . . 0.0 111.122 -179.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.661 ' H ' ' CD ' ' A' ' 136' ' ' PRO . 8.1 tp-100 -173.15 -38.5 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.25 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.934 179.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.661 ' CD ' ' H ' ' A' ' 135' ' ' GLN . 63.3 Cg_exo -52.88 -34.17 64.77 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.467 1.444 . . . . 0.0 112.002 -179.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 11.2 m -68.35 -42.92 78.55 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 118.082 -1.447 . . . . 0.0 110.919 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -66.91 -43.97 82.0 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 118.26 -1.376 . . . . 0.0 112.853 -178.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.465 HG23 ' N ' ' A' ' 140' ' ' VAL . 27.6 m -64.96 -44.6 96.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -179.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.465 ' N ' HG23 ' A' ' 139' ' ' VAL . 7.6 p -65.33 -38.69 83.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -177.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -62.16 -41.08 97.96 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -176.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.449 ' CG1' ' N ' ' A' ' 143' ' ' ARG . 2.4 p -70.39 -44.78 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.072 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.539 HH22 ' H ' ' A' ' 178' ' ' GLY . 81.5 mtt85 -64.26 -36.28 83.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.468 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -66.42 -41.23 89.52 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.769 -0.373 . . . . 0.0 111.572 -177.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.631 HE21 HH22 ' A' ' 88' ' ' ARG . 76.5 mm-40 -64.92 -39.56 93.7 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 119.526 -0.87 . . . . 0.0 109.083 178.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.31 -34.84 79.28 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -179.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -60.27 110.47 1.24 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 176.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -100.91 -58.26 1.93 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 117.226 -1.368 . . . . 0.0 113.836 -176.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.528 ' O ' ' N ' ' A' ' 151' ' ' GLY . 28.9 ptt-85 -133.66 17.67 3.92 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 122.641 2.473 . . . . 0.0 110.03 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . 49.95 -86.5 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.724 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 149' ' ' ARG . . . -157.28 42.56 0.53 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 64.3 23.99 68.68 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -60.1 126.01 40.43 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 76.4 mtm-85 -62.21 -44.37 96.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.949 0.404 . . . . 0.0 110.145 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -85.4 130.69 34.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.216 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -64.64 132.43 49.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.662 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -80.39 -164.68 0.73 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.545 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 56.7 m -156.97 -178.1 7.12 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.156 0.503 . . . . 0.0 110.843 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 98.7 m -64.25 -46.31 84.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.983 -177.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.548 HG23 ' N ' ' A' ' 161' ' ' GLU . 34.0 m -64.35 -45.36 96.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 118.946 -1.102 . . . . 0.0 109.239 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.548 ' N ' HG23 ' A' ' 160' ' ' VAL . 81.8 tt0 -67.36 -39.27 85.69 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.665 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -61.68 -45.99 91.65 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -177.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -62.73 -49.66 74.16 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.422 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -68.36 -45.41 72.87 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 -175.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.562 HG23 ' N ' ' A' ' 166' ' ' ILE . 14.1 t -62.82 -44.88 94.99 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.519 1.054 . . . . 0.0 113.689 -177.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.562 ' N ' HG23 ' A' ' 165' ' ' THR . 2.5 pp -64.84 -38.3 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 121.906 0.86 . . . . 0.0 109.337 176.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.451 ' N ' HD12 ' A' ' 166' ' ' ILE . . . -59.25 -35.6 73.97 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 113.992 -1.458 . . . . 0.0 107.788 176.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.407 ' HE ' ' HA ' ' A' ' 168' ' ' ARG . 0.5 OUTLIER -61.6 -49.78 75.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 122.401 2.364 . . . . 0.0 111.449 -175.475 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -74.57 -50.99 15.86 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 123.446 0.698 . . . . 0.0 109.63 177.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.487 ' N ' ' CD ' ' A' ' 170' ' ' GLU . 2.2 mp0 -77.98 -36.6 48.76 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 116.637 2.088 . . . . 0.0 116.637 -173.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.413 ' O ' HD23 ' A' ' 175' ' ' LEU . . . 91.49 -167.23 31.03 Favored Glycine 0 N--CA 1.47 0.935 0 CA-C-N 118.842 0.746 . . . . 0.0 112.007 177.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.531 HG23 ' N ' ' A' ' 173' ' ' ARG . 19.8 tt -73.45 -42.55 56.5 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.07 0 CA-C-O 121.963 0.887 . . . . 0.0 110.885 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.531 ' N ' HG23 ' A' ' 172' ' ' ILE . 3.9 tpt180 -58.79 -33.49 70.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 113.993 -1.458 . . . . 0.0 111.261 -176.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -60.7 -40.24 97.76 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 118.965 -1.588 . . . . 0.0 110.006 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.52 ' O ' ' NH2' ' A' ' 143' ' ' ARG . 3.7 mm? -70.61 -33.27 70.86 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 111.673 -2.264 . . . . 0.0 116.922 -177.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 19.5 m0 -78.06 -7.65 57.2 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 112.076 -2.329 . . . . 0.0 109.845 -177.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -43.22 -47.97 6.49 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.405 -176.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.539 ' H ' HH22 ' A' ' 143' ' ' ARG . . . -91.9 -32.06 8.79 Favored Glycine 0 CA--C 1.533 1.217 0 N-CA-C 111.329 -0.708 . . . . 0.0 111.329 178.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 34.8 m -45.36 -51.52 11.09 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.43 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 2.8 m -62.47 -50.8 77.21 Favored Pre-proline 0 N--CA 1.471 0.581 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -176.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 180' ' ' SER . 28.2 Cg_endo -64.84 -28.38 59.08 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 121.482 1.455 . . . . 0.0 111.782 176.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.528 ' ND2' ' OE1' ' A' ' 135' ' ' GLN . 45.5 t30 -63.92 -39.53 94.38 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.454 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 70.9 t -63.09 -42.59 97.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.14 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.2 -39.49 92.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.048 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.878 ' HE ' ' HZ1' ' A' ' 239' ' ' LYS . 33.0 ttm105 -60.59 -41.67 95.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.842 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -61.34 -42.92 99.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.063 0.459 . . . . 0.0 110.805 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.44 -43.82 93.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.092 -179.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 33.0 mm -63.56 -45.25 98.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -177.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.46 ' O ' ' N ' ' A' ' 193' ' ' GLU . 3.0 p -60.09 -46.79 93.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 119.679 -0.808 . . . . 0.0 112.027 -177.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 191' ' ' CYS . 2.6 p30 -63.13 -42.64 99.55 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 122.089 0.947 . . . . 0.0 109.983 179.103 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' CYS . . . . . 0.524 ' N ' ' OD1' ' A' ' 190' ' ' ASN . 27.2 m -61.2 -45.66 93.69 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 113.94 -1.482 . . . . 0.0 109.317 179.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -63.76 -39.56 94.56 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 112.99 -1.913 . . . . 0.0 108.638 175.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 0.46 ' N ' ' O ' ' A' ' 189' ' ' VAL . 74.6 tt0 -61.33 -46.96 88.07 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.868 -177.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 53.4 mt -65.15 -39.26 92.75 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 118.547 -1.261 . . . . 0.0 110.493 -175.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 7.0 m -63.97 -45.74 95.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 C-N-CA 117.078 -1.849 . . . . 0.0 107.297 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 19.9 m -63.75 -45.7 88.64 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -178.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -56.49 -38.34 71.62 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.296 1.038 . . . . 0.0 112.29 -178.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.44 -44.0 75.91 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.689 ' N ' HD22 ' A' ' 199' ' ' LEU . 2.9 mm? -61.18 -39.15 89.1 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 41.3 mm -62.78 -42.99 98.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.029 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -60.24 -39.55 87.13 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.758 1.223 . . . . 0.0 111.852 177.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -63.06 -38.53 91.56 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.119 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 35.9 m -101.56 128.19 47.93 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.855 0.835 . . . . 0.0 111.987 -179.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.547 ' O ' HD22 ' A' ' 205' ' ' LEU . 3.7 tp 66.84 4.73 3.61 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 114.186 -1.37 . . . . 0.0 112.147 177.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.547 HD22 ' O ' ' A' ' 204' ' ' LEU . 1.3 mm? -125.55 29.93 5.88 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.35 0.595 . . . . 0.0 112.487 -177.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -71.55 -24.65 61.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.806 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.547 ' O ' ' O ' ' A' ' 208' ' ' ASN . . . -165.05 33.04 0.06 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.362 179.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . 0.547 ' O ' ' O ' ' A' ' 207' ' ' ALA . 1.6 m-20 40.0 123.22 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 177.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.501 ' C ' ' O ' ' A' ' 208' ' ' ASN . 43.4 tp -1.28 106.32 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 115.015 -0.993 . . . . 0.0 112.559 179.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 5.4 tpt -143.37 25.69 1.68 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.706 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 69.2 p -123.12 -133.21 0.28 Allowed 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.542 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 25.2 p-10 -160.53 -140.47 0.07 Allowed 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.946 -0.301 . . . . 0.0 111.033 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.407 ' O ' ' OD1' ' A' ' 213' ' ' ASP . 2.5 p30 41.74 72.22 0.18 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.078 0.466 . . . . 0.0 110.514 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.436 ' N ' ' CD ' ' A' ' 215' ' ' PRO . 6.0 mt -61.41 -43.27 88.71 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 113.118 0.785 . . . . 0.0 113.118 -178.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 214' ' ' LEU . 27.1 Cg_exo -60.74 -33.73 92.69 Favored 'Trans proline' 0 N--CA 1.5 1.884 0 CA-C-N 120.051 1.054 . . . . 0.0 111.555 -177.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 84.1 m -64.01 -41.79 97.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 112.767 -2.015 . . . . 0.0 111.213 -178.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -66.18 -37.08 84.76 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.241 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -62.96 -47.41 83.31 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.252 -178.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.402 ' H ' HG22 ' A' ' 219' ' ' THR . 1.4 t -60.58 -37.94 82.97 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 119.395 0.998 . . . . 0.0 110.87 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 71.1 m -59.68 -41.89 91.71 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.9 -41.94 97.57 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -62.39 -47.5 83.86 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 119.755 -0.778 . . . . 0.0 112.953 -176.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -61.27 -42.48 99.79 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 108.199 -1.961 . . . . 0.0 108.199 177.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.464 ' O ' ' SG ' ' A' ' 227' ' ' CYS . . . -63.25 -39.14 93.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.497 -0.851 . . . . 0.0 109.02 177.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -62.93 -43.05 99.49 Favored Glycine 0 CA--C 1.52 0.354 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.607 -178.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' PHE . . . . . 0.442 ' O ' ' OG1' ' A' ' 229' ' ' THR . 75.3 t80 -66.91 -38.95 87.19 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 119.659 -0.816 . . . . 0.0 108.855 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . 0.466 ' SG ' ' N ' ' A' ' 228' ' ' THR . 0.5 OUTLIER -63.41 -41.06 98.71 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 176.847 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.466 ' N ' ' SG ' ' A' ' 227' ' ' CYS . 26.8 m -62.7 -41.54 99.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.839 179.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.448 HG23 ' O ' ' A' ' 225' ' ' GLY . 16.1 p -59.99 -40.32 88.75 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -176.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.405 HG22 ' H ' ' A' ' 230' ' ' VAL . 3.3 m -60.66 -40.27 84.2 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.381 0 C-N-CA 118.455 -1.298 . . . . 0.0 108.953 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.486 ' O ' ' HD2' ' A' ' 234' ' ' PRO . 1.7 mp -61.0 -40.85 86.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 176.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.01 -39.98 96.39 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.48 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 0.5 OUTLIER -58.47 -42.18 93.2 Favored Pre-proline 0 N--CA 1.483 1.214 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 -173.858 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.486 ' HD2' ' O ' ' A' ' 231' ' ' ILE . 31.3 Cg_exo -57.97 -39.75 83.64 Favored 'Trans proline' 0 C--N 1.293 -2.378 0 C-N-CA 122.536 2.157 . . . . 0.0 113.276 179.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 46.5 t -63.95 -37.26 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 118.055 -1.458 . . . . 0.0 108.922 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -65.88 -40.62 91.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.75 178.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 53.2 t -64.79 -45.51 94.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -176.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 27.6 m -63.41 -37.78 80.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 119.224 -0.991 . . . . 0.0 111.732 -178.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . 0.878 ' HZ1' ' HE ' ' A' ' 185' ' ' ARG . 25.0 mtpp -60.98 -45.08 96.21 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -179.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . 0.412 ' O ' ' C ' ' A' ' 241' ' ' ARG . 1.1 t -61.88 -41.92 98.46 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -178.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.412 ' C ' ' O ' ' A' ' 240' ' ' THR . 27.0 mtp180 -33.51 140.62 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.222 0.534 . . . . 0.0 112.438 -178.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.43 ' O ' ' C ' ' A' ' 243' ' ' MET . 33.7 t80 -130.71 -78.67 0.53 Allowed 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 177.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' MET . . . . . 0.43 ' C ' ' O ' ' A' ' 242' ' ' TYR . 7.1 ptp -30.92 113.58 0.11 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.969 0.414 . . . . 0.0 111.515 -179.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . 0.447 ' N ' HD22 ' A' ' 244' ' ' ASN . 0.1 OUTLIER -151.83 17.54 0.68 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.085 -179.529 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 49.0 p 42.96 67.24 0.65 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.751 0.31 . . . . 0.0 110.547 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -94.18 -99.98 0.15 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.291 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 43.9 mt 62.64 78.73 0.28 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.074 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 96.43 -6.69 65.77 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 111.977 -0.449 . . . . 0.0 111.977 179.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.768 ' HB3' ' NE2' ' A' ' 255' ' ' HIS . 52.9 mt-30 -131.67 107.98 9.18 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.477 ' CD1' ' N ' ' A' ' 250' ' ' TYR . 0.0 OUTLIER -176.27 53.22 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.845 -178.94 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -66.49 -53.25 37.21 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 115.929 1.825 . . . . 0.0 115.929 -175.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 12.4 p -148.56 -173.32 4.31 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -178.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -59.87 -44.21 94.29 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 178.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -57.29 -36.13 74.37 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -174.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' HIS . . . . . 0.768 ' NE2' ' HB3' ' A' ' 249' ' ' GLN . 86.4 t60 -55.59 -36.23 66.69 Favored 'General case' 0 CA--C 1.509 -0.599 0 C-N-CA 117.338 -1.745 . . . . 0.0 111.082 178.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' CYS . . . . . . . . . . . . . 11.7 t -61.87 -45.37 94.08 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.678 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -60.55 -45.22 94.68 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.767 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 11.8 tp -66.53 -43.01 86.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.151 0.501 . . . . 0.0 109.871 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 85.8 m -62.43 -46.28 89.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.868 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' MET . . . . . 0.447 ' C ' ' SD ' ' A' ' 260' ' ' MET . 13.6 tmm? -61.62 -45.04 95.76 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -177.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.17 -47.5 82.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.102 0.477 . . . . 0.0 110.26 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' ARG . . . . . 0.463 ' O ' ' O ' ' A' ' 263' ' ' LYS . 61.5 ttt85 -66.66 -53.84 29.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.463 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 262' ' ' ARG . 28.0 tttp -57.81 -138.99 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.9 0.381 . . . . 0.0 111.369 -178.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -63.91 149.52 46.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.997 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.539 ' C ' ' H ' ' A' ' 267' ' ' ARG . . . -44.04 160.19 0.1 OUTLIER Glycine 0 CA--C 1.535 1.283 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -50.85 0.07 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 122.018 1.812 . . . . 0.0 112.945 178.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.539 ' H ' ' C ' ' A' ' 265' ' ' GLY . 89.4 mtt-85 -69.5 -26.95 64.79 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 122.696 0.398 . . . . 0.0 111.817 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -58.83 -32.63 69.57 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.404 -178.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -62.51 -41.55 98.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.376 0.608 . . . . 0.0 110.89 178.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -66.05 -37.46 85.91 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.284 -178.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.434 ' O ' ' O ' ' A' ' 272' ' ' GLY . 95.8 mttt -80.65 -179.72 7.37 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . 0.434 ' O ' ' O ' ' A' ' 271' ' ' LYS . . . 52.3 109.29 0.01 OUTLIER Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.694 -0.563 . . . . 0.0 111.694 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -178.31 8.27 0.01 OUTLIER 'General case' 0 C--O 1.232 0.151 0 C-N-CA 121.166 -0.214 . . . . 0.0 111.325 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' MET . . . . . 0.549 ' N ' ' CD ' ' A' ' 275' ' ' PRO . 0.1 OUTLIER -63.91 -44.53 79.11 Favored Pre-proline 0 CA--C 1.533 0.291 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.898 -179.148 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' PRO . . . . . 0.549 ' CD ' ' N ' ' A' ' 274' ' ' MET . 22.1 Cg_exo -64.46 -46.86 6.58 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 122.353 2.035 . . . . 0.0 111.471 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 49.2 m -60.78 -39.71 89.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.749 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . 0.403 ' CD1' ' C ' ' A' ' 277' ' ' PHE . 41.0 t80 -61.64 -42.67 99.21 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 122.738 1.256 . . . . 0.0 112.969 -178.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.514 HD13 ' O ' ' A' ' 278' ' ' LEU . 0.2 OUTLIER -62.29 -38.78 90.65 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 112.11 -2.314 . . . . 0.0 107.815 174.284 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . 0.75 HH21 HD13 ' A' ' 34' ' ' LEU . 4.4 mtp180 -62.81 -39.71 95.14 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.375 0.607 . . . . 0.0 110.283 178.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -62.07 -36.55 82.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.508 -178.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -68.08 -51.2 35.06 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -178.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . 0.435 ' O ' HG12 ' A' ' 285' ' ' VAL . 74.8 m -63.0 -44.36 96.24 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 123.109 0.564 . . . . 0.0 109.91 179.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' TRP . . . . . 0.405 ' O ' HG22 ' A' ' 286' ' ' VAL . 48.7 t-105 -59.7 -38.36 81.39 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -62.2 -37.37 85.06 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.363 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.435 HG12 ' O ' ' A' ' 282' ' ' SER . 0.4 OUTLIER -59.88 -37.73 73.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.143 -178.278 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.493 ' O ' HG22 ' A' ' 289' ' ' VAL . 0.8 OUTLIER -61.61 -40.28 86.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.724 -179.23 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 30.9 mtm -60.95 -38.85 87.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.098 0.475 . . . . 0.0 110.453 178.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -58.69 -40.13 82.7 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.83 -178.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.493 HG22 ' O ' ' A' ' 286' ' ' VAL . 1.0 OUTLIER -60.31 -38.91 79.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 120.981 0.419 . . . . 0.0 110.91 -177.576 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 12.5 m -64.27 -40.04 95.17 Favored 'General case' 0 CA--C 1.549 0.925 0 O-C-N 121.574 -0.704 . . . . 0.0 111.729 177.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -61.01 -40.4 93.39 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-O 118.652 -0.69 . . . . 0.0 109.165 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . 0.434 ' CG ' ' O ' ' A' ' 289' ' ' VAL . 4.4 pt-20 -59.39 -39.42 83.33 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 116.552 -2.059 . . . . 0.0 109.781 -176.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' GLN . . . . . 0.471 ' O ' ' O ' ' A' ' 296' ' ' ARG . 57.4 tt0 -59.51 -42.83 93.11 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 122.38 1.086 . . . . 0.0 111.306 -178.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -60.52 -40.74 92.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 113.61 -1.632 . . . . 0.0 108.574 178.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -63.22 -45.97 89.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.263 178.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' ARG . . . . . 0.471 ' O ' ' O ' ' A' ' 293' ' ' GLN . 11.9 tpp85 -123.03 116.25 23.21 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -121.01 -163.38 1.02 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.236 0.541 . . . . 0.0 112.413 -178.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.575 ' N ' HD22 ' A' ' 298' ' ' LEU . 3.2 mm? -67.21 116.94 8.56 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 26.4 ttm -96.77 62.64 1.94 Allowed 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -178.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.65 100.84 0.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.976 0.893 . . . . 0.0 110.834 -178.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -64.1 -46.4 84.39 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 113.746 -1.57 . . . . 0.0 113.434 -176.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -58.6 -39.67 81.07 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.39 -0.524 . . . . 0.0 109.897 -178.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -64.9 -46.77 80.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.871 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 304' ' ' SER . . . . . 0.426 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 78.0 p -66.66 -38.04 86.04 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.711 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.04 -42.73 99.49 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.544 179.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 12.7 tm-20 -64.74 -37.12 86.53 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -177.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . 0.544 ' HB3' ' HD3' ' A' ' 308' ' ' PRO . . . -60.01 -52.94 69.96 Favored Pre-proline 0 CA--C 1.544 0.716 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -176.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 308' ' ' PRO . . . . . 0.544 ' HD3' ' HB3' ' A' ' 307' ' ' ALA . 74.5 Cg_endo -75.36 0.32 9.18 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.255 1.97 . . . . 0.0 112.106 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 78.7 t80 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.519 -179.895 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.6 ptm . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.3 m -64.91 129.18 38.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.818 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.587 HG13 ' H ' ' A' ' 18' ' ' LEU . 4.3 p -160.67 166.53 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.235 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.572 ' N ' HG22 ' A' ' 15' ' ' VAL . 30.2 mmtp -64.38 -41.65 96.58 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -178.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.42 ' H ' HG22 ' A' ' 15' ' ' VAL . 65.9 m-85 -63.54 -41.15 98.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.228 0.537 . . . . 0.0 112.438 -179.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.587 ' H ' HG13 ' A' ' 15' ' ' VAL . 9.8 tp -79.78 -25.96 40.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.276 -0.874 . . . . 0.0 112.617 -178.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.32 -41.41 94.6 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 107.768 -2.133 . . . . 0.0 107.768 177.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.403 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -71.53 -32.08 67.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 124.873 2.273 . . . . 0.0 107.18 176.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.35 -42.38 99.18 Favored Glycine 0 CA--C 1.527 0.818 1 CA-C-N 108.393 -4.003 . . . . 0.0 107.804 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 92.8 m -70.54 -27.97 64.56 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.498 0.666 . . . . 0.0 109.262 177.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -66.39 -49.94 65.13 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.851 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.96 -35.89 79.8 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 118.144 -1.422 . . . . 0.0 110.979 -177.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.446 ' O ' HD13 ' A' ' 29' ' ' LEU . 77.5 m -63.8 -54.08 40.77 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.616 -178.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.456 HD12 ' N ' ' A' ' 27' ' ' ALA . 2.6 pp -65.73 -39.39 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -176.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.456 ' N ' HD12 ' A' ' 26' ' ' ILE . . . -64.12 -41.9 97.06 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 119.831 -0.748 . . . . 0.0 112.706 -173.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.464 ' O ' ' N ' ' A' ' 32' ' ' PHE . 29.9 m-20 -77.78 -27.35 50.22 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 117.823 -1.551 . . . . 0.0 109.52 -176.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.507 HD12 HE22 ' A' ' 89' ' ' GLN . 5.4 mp -60.23 -55.92 27.81 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 120.129 1.331 . . . . 0.0 111.731 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.521 ' O ' HD13 ' A' ' 34' ' ' LEU . 10.1 tp -75.68 -4.79 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 121.659 0.742 . . . . 0.0 112.034 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.6 m -109.83 -16.48 13.87 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 114.454 -1.248 . . . . 0.0 110.202 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.507 ' N ' ' CD ' ' A' ' 33' ' ' PRO . 0.2 OUTLIER -68.28 -44.92 38.19 Favored Pre-proline 0 C--N 1.325 -0.463 0 C-N-CA 116.156 -2.218 . . . . 0.0 109.452 -178.231 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 32' ' ' PHE . 34.0 Cg_exo -59.95 -16.67 39.99 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 121.32 1.346 . . . . 0.0 112.573 177.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.521 HD13 ' O ' ' A' ' 30' ' ' ILE . 8.6 mp -67.7 -35.41 78.74 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -178.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 36' ' ' THR . 1.9 p30 -64.44 -40.47 95.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.948 -177.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.545 ' N ' ' OD1' ' A' ' 35' ' ' ASP . 47.5 p -58.44 -34.97 71.41 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 120.41 -0.516 . . . . 0.0 112.176 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.52 -39.55 85.11 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 119.547 -0.861 . . . . 0.0 112.902 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.455 ' CB ' ' NH2' ' A' ' 279' ' ' ARG . 10.0 ptmt -63.09 -48.68 77.57 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 118.854 -1.138 . . . . 0.0 111.246 -177.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 66.4 t -63.55 -39.81 86.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -177.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.507 ' O ' ' N ' ' A' ' 42' ' ' GLN . 8.6 tpm_? -60.82 -41.39 95.62 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 119.19 -1.004 . . . . 0.0 109.718 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.49 38.81 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.58 178.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.507 ' N ' ' O ' ' A' ' 40' ' ' ARG . 45.1 tt0 -88.7 -112.64 0.06 Allowed 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.646 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.1 tp -154.3 8.93 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.158 0.504 . . . . 0.0 109.794 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.519 ' NE2' ' OE1' ' A' ' 58' ' ' GLN . 14.7 mm100 56.97 26.04 11.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.55 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -118.65 141.17 15.84 Favored Glycine 0 N--CA 1.466 0.683 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -149.4 -84.26 0.1 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 86.4 p -172.04 70.49 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.782 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 -156.01 -27.63 0.1 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.085 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.98 17.67 74.15 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 108.577 -1.809 . . . . 0.0 108.577 -177.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.724 HD22 ' N ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -63.92 -35.52 80.93 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.081 -1.06 . . . . 0.0 111.031 -179.089 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.724 ' N ' HD22 ' A' ' 50' ' ' LEU . 83.9 t -59.4 -43.81 91.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 71.0 ttp85 -64.01 -33.86 76.69 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.99 -38.13 82.32 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -136.36 95.39 3.17 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.236 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.92 -19.83 64.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.3 -178.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.599 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 7.9 t -125.67 -141.02 0.28 Allowed 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.599 ' HB3' ' O ' ' A' ' 56' ' ' SER . . . 99.38 12.42 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 O-C-N 124.132 0.895 . . . . 0.0 112.616 178.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.519 ' OE1' ' NE2' ' A' ' 44' ' ' GLN . 10.7 pt20 178.36 101.72 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.995 0.426 . . . . 0.0 111.052 179.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -84.88 166.95 16.43 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.44 ' O ' ' C ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER -52.29 -35.07 49.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.233 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.44 ' C ' ' O ' ' A' ' 60' ' ' ARG . . . -28.23 100.21 0.01 OUTLIER Glycine 0 CA--C 1.53 1.011 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.241 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 24.6 m -67.21 -33.99 66.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.072 176.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -60.26 -32.4 71.13 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 121.31 1.868 . . . . 0.0 109.731 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.51 -48.99 67.52 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-N 114.934 -1.03 . . . . 0.0 114.459 -176.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.41 HG23 ' H ' ' A' ' 65' ' ' THR . 12.8 p -62.14 -46.13 90.37 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -179.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 97.0 mt -59.68 -35.99 62.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 118.119 -0.943 . . . . 0.0 108.94 -178.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.641 ' C ' HD12 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -63.84 -35.28 80.12 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 121.422 1.919 . . . . 0.0 111.993 179.525 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 98.3 m -62.19 -38.34 88.74 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 113.4 -1.727 . . . . 0.0 110.99 -176.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 58.0 mmm -59.79 -40.04 86.95 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 121.048 -1.032 . . . . 0.0 113.425 -177.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 93.3 t -69.71 -41.14 79.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 118.967 -1.093 . . . . 0.0 113.82 -177.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 36.5 mmm-85 -78.97 -13.06 60.02 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -178.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.521 ' CG2' ' N ' ' A' ' 73' ' ' GLU . 0.7 OUTLIER -62.27 -54.65 37.6 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.633 -179.215 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.521 ' N ' ' CG2' ' A' ' 72' ' ' THR . 35.2 mt-10 -106.88 -53.93 2.54 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.417 ' O ' ' CB ' ' A' ' 77' ' ' SER . . . 155.77 166.23 15.52 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -56.43 -35.32 96.32 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 121.281 1.32 . . . . 0.0 110.971 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -61.43 -12.0 12.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.983 0.897 . . . . 0.0 110.723 175.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.617 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 6.5 t -77.91 -32.36 51.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 113.911 -1.495 . . . . 0.0 110.454 -178.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 15.3 tp -75.95 -33.41 59.82 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 121.761 -0.587 . . . . 0.0 110.823 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.43 ' C ' ' H ' ' A' ' 81' ' ' GLY . 53.5 m-85 -92.75 -5.09 51.96 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 -177.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.617 ' ND2' ' O ' ' A' ' 77' ' ' SER . 0.0 OUTLIER -92.52 26.05 2.79 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 174.55 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 79' ' ' TYR . . . -160.07 -19.62 0.03 OUTLIER Glycine 0 CA--C 1.526 0.732 0 CA-C-N 112.942 -1.935 . . . . 0.0 112.036 -178.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.407 ' H ' ' H ' ' A' ' 81' ' ' GLY . 42.6 tp -59.06 -35.0 72.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.091 -1.054 . . . . 0.0 110.406 -179.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.4 t -70.67 -27.01 29.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.29 178.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.67 -31.32 61.88 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.717 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.42 -40.06 91.43 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 119.645 -1.264 . . . . 0.0 111.46 -177.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -62.37 -39.92 94.75 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 122.192 0.996 . . . . 0.0 113.655 -176.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -59.68 -26.12 65.32 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 113.348 -1.751 . . . . 0.0 109.615 -179.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.616 ' NE ' ' NZ ' ' A' ' 141' ' ' LYS . 7.4 mmm180 -56.44 -52.35 64.99 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 173.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.507 HE22 HD12 ' A' ' 29' ' ' LEU . 72.1 mt-30 -67.6 -29.9 69.36 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 113.475 -1.693 . . . . 0.0 112.692 -178.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 24.8 mmt -61.08 -42.06 97.8 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 78.1 p -74.7 -34.84 62.71 Favored 'General case' 0 C--N 1.338 0.102 0 C-N-CA 119.301 -0.959 . . . . 0.0 111.864 -176.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -57.96 -43.55 86.5 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 120.496 1.498 . . . . 0.0 112.279 -176.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.41 -32.65 64.54 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 119.78 -0.768 . . . . 0.0 111.292 -178.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.608 ' O ' HG22 ' A' ' 97' ' ' ILE . 50.5 m -63.96 -41.53 97.55 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.448 ' C ' ' H ' ' A' ' 97' ' ' ILE . 24.2 m -68.12 -28.48 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.493 178.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 64.4 mtp180 -77.42 10.41 2.57 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -177.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.608 HG22 ' O ' ' A' ' 94' ' ' SER . 12.0 tt -86.78 -15.62 9.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.419 ' O ' ' OG ' ' A' ' 102' ' ' SER . . . -141.0 -48.85 0.05 OUTLIER Glycine 0 CA--C 1.534 1.252 0 CA-C-N 114.917 -1.038 . . . . 0.0 114.77 -178.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 60.5 mt -72.53 -14.29 61.61 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.096 1.448 . . . . 0.0 113.985 -177.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.521 ' O ' ' CD ' ' A' ' 104' ' ' LYS . 46.6 t80 -81.84 -53.12 6.44 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 114.653 -1.158 . . . . 0.0 112.542 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -72.6 -33.57 66.81 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 123.799 1.761 . . . . 0.0 114.136 -179.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' A' ' 98' ' ' GLY . 79.3 p -66.5 -50.6 62.71 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 110.244 -3.162 . . . . 0.0 117.068 -177.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.731 HG12 ' CE2' ' A' ' 107' ' ' TYR . 1.5 t -73.32 -23.37 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 CA-C-O 124.327 2.013 . . . . 0.0 109.94 175.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.521 ' CD ' ' O ' ' A' ' 100' ' ' TYR . 0.0 OUTLIER -66.8 -41.22 87.92 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 109.677 -3.42 . . . . 0.0 112.194 -178.02 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -78.81 -11.08 59.97 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 125.143 2.401 . . . . 0.0 111.05 178.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -79.63 -21.88 44.32 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 110.712 -2.949 . . . . 0.0 110.538 177.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.731 ' CE2' HG12 ' A' ' 103' ' ' VAL . 41.1 m-85 -109.5 -28.67 8.79 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -175.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.735 ' C ' ' H ' ' A' ' 110' ' ' GLY . 66.4 p -95.55 12.07 30.84 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 -174.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.435 ' O ' ' N ' ' A' ' 111' ' ' SER . 15.2 ttpp -54.71 22.31 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.055 0 CA-C-N 119.472 1.033 . . . . 0.0 111.239 177.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.735 ' H ' ' C ' ' A' ' 108' ' ' THR . . . 65.24 -57.06 0.11 Allowed Glycine 0 N--CA 1.472 1.053 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.544 ' CB ' ' O ' ' A' ' 110' ' ' GLY . 6.9 t 106.35 -164.67 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 177.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.537 ' OE1' ' N ' ' A' ' 112' ' ' GLU . 35.4 mp0 -120.55 -40.28 2.68 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 -175.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.608 ' O ' ' HB2' ' A' ' 114' ' ' ALA . 0.0 OUTLIER 165.05 29.97 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.503 0.668 . . . . 0.0 109.366 -179.318 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.608 ' HB2' ' O ' ' A' ' 113' ' ' HIS . . . 160.31 -161.21 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.86 14.87 25.8 Favored Glycine 0 CA--C 1.507 -0.429 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.506 HG23 ' N ' ' A' ' 117' ' ' GLY . 3.0 tp -60.77 -40.22 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.506 ' N ' HG23 ' A' ' 116' ' ' ILE . . . -65.69 -39.87 95.54 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 110.946 -0.861 . . . . 0.0 110.946 174.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 6.8 t -58.85 -43.06 90.67 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 176.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 25.9 mmm-85 -63.65 -37.48 87.49 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 119.849 -0.741 . . . . 0.0 110.38 -177.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.69 -45.91 87.89 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 6.3 tp -67.14 -45.29 77.54 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.729 178.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.29 -44.97 90.03 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 119.918 1.235 . . . . 0.0 109.803 178.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -65.85 -44.48 91.92 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 119.222 -1.466 . . . . 0.0 110.614 -178.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 65.7 m -64.48 -44.61 90.45 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.309 -0.556 . . . . 0.0 111.095 178.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 19.5 m -69.9 -49.03 56.14 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 119.419 -0.912 . . . . 0.0 112.433 177.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 42.3 p -65.82 -42.16 90.95 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 120.149 1.34 . . . . 0.0 113.775 -175.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.641 ' CA ' HD21 ' A' ' 186' ' ' ASN . . . -64.03 -44.33 96.03 Favored Glycine 0 CA--C 1.518 0.254 0 CA-C-O 122.983 1.324 . . . . 0.0 112.162 -178.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.417 ' O ' ' CG2' ' A' ' 131' ' ' VAL . . . -61.48 -41.45 97.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 111.386 -2.407 . . . . 0.0 107.247 177.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.629 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 0.2 OUTLIER -64.5 -42.33 95.89 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.25 178.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.23 -40.08 96.45 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -177.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.417 ' CG2' ' O ' ' A' ' 128' ' ' ALA . 5.8 m -61.15 -25.98 37.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 122.482 1.134 . . . . 0.0 109.942 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.629 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . -58.29 -44.98 88.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 112.755 -2.02 . . . . 0.0 112.425 -178.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.48 ' CG1' ' N ' ' A' ' 134' ' ' ALA . 2.7 p -79.09 -48.89 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.295 -179.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.48 ' N ' ' CG1' ' A' ' 133' ' ' VAL . . . -106.55 138.76 42.13 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.707 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.603 ' H ' ' HD2' ' A' ' 136' ' ' PRO . 7.8 pt20 172.23 -38.48 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.797 0 CA-C-O 118.279 -0.867 . . . . 0.0 113.132 179.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.603 ' HD2' ' H ' ' A' ' 135' ' ' GLN . 13.1 Cg_endo -52.66 -34.37 63.52 Favored 'Trans proline' 0 N--CA 1.498 1.785 0 CA-C-N 122.257 1.842 . . . . 0.0 112.544 -178.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 85.1 m -67.85 -42.6 81.14 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 118.683 -1.207 . . . . 0.0 110.184 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -65.82 -43.08 89.65 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 118.054 -1.458 . . . . 0.0 112.776 -177.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.423 HG23 ' N ' ' A' ' 140' ' ' VAL . 24.4 m -64.47 -44.05 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -179.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.423 ' N ' HG23 ' A' ' 139' ' ' VAL . 12.7 p -64.63 -37.48 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -177.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.616 ' NZ ' ' NE ' ' A' ' 88' ' ' ARG . 48.5 mttm -60.98 -40.55 93.88 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.16 -177.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 82.1 t -69.89 -44.95 78.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.57 -36.33 83.87 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.934 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -66.39 -40.69 89.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.06 -177.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 65.6 tp60 -64.35 -39.08 93.18 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 119.486 -0.886 . . . . 0.0 109.28 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.2 -35.0 79.7 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.446 ' CG ' ' O ' ' A' ' 147' ' ' GLN . 3.0 pt20 -60.31 111.06 1.4 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 177.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -102.5 8.81 39.87 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.246 -177.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 60.7 ttm-85 -143.71 135.99 26.85 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.848 0.356 . . . . 0.0 110.696 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -82.52 -56.36 3.92 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.617 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 168.03 -51.65 0.23 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 73.81 65.72 2.15 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -159.0 -79.08 0.03 OUTLIER Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.602 ' NH2' ' HE ' ' A' ' 155' ' ' ARG . 44.9 ttp85 -158.43 167.94 28.3 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.602 ' HE ' ' NH2' ' A' ' 154' ' ' ARG . 1.9 mpt_? 55.96 108.88 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -58.89 128.23 36.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.462 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -56.98 154.63 9.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.453 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.41 ' OG ' ' N ' ' A' ' 159' ' ' THR . 43.7 t -157.07 -178.28 7.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.211 0.529 . . . . 0.0 111.015 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.41 ' N ' ' OG ' ' A' ' 158' ' ' SER . 65.1 p -64.32 -46.1 84.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.737 -177.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 86.3 t -64.22 -45.59 95.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 119.132 -1.027 . . . . 0.0 109.438 -179.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.522 ' OE1' ' N ' ' A' ' 161' ' ' GLU . 15.1 mp0 -66.75 -39.04 87.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.873 0.368 . . . . 0.0 111.198 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -61.8 -45.54 93.41 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -178.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.607 ' CZ ' HD11 ' A' ' 175' ' ' LEU . 2.7 t80 -62.59 -50.33 71.73 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 120.372 -0.531 . . . . 0.0 110.617 -178.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 30.5 mmtm -68.84 -45.57 70.78 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 -175.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.556 HG23 ' N ' ' A' ' 166' ' ' ILE . 15.3 t -62.95 -44.73 95.27 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.198 1.185 . . . . 0.0 114.198 -177.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.556 ' N ' HG23 ' A' ' 165' ' ' THR . 10.0 pt -64.51 -38.44 82.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 122.032 0.92 . . . . 0.0 109.505 177.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.53 -36.47 76.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 113.709 -1.587 . . . . 0.0 108.074 176.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -62.54 -50.39 71.54 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 122.436 2.38 . . . . 0.0 112.164 -175.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -75.05 -51.03 14.55 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 123.903 0.881 . . . . 0.0 109.641 177.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -77.96 -36.46 49.08 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 -173.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 90.99 -167.71 32.06 Favored Glycine 0 N--CA 1.467 0.714 0 N-CA-C 111.792 -0.523 . . . . 0.0 111.792 177.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 25.2 mm -72.18 -44.72 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-O 121.679 0.752 . . . . 0.0 110.652 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -59.0 -33.96 71.32 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 114.371 -1.286 . . . . 0.0 111.529 -177.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -60.75 -40.37 98.02 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 118.783 -1.675 . . . . 0.0 109.272 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.607 HD11 ' CZ ' ' A' ' 163' ' ' TYR . 0.5 OUTLIER -70.34 -33.43 71.47 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 111.477 -2.362 . . . . 0.0 116.72 -177.136 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . 0.427 ' O ' ' OG1' ' A' ' 179' ' ' THR . 2.3 m95 -77.89 -7.39 56.66 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 111.564 -2.562 . . . . 0.0 109.909 -177.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 16.3 ttmm -43.24 -47.93 6.55 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.354 -176.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -92.04 -27.43 16.25 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 123.981 0.8 . . . . 0.0 112.216 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 176' ' ' TRP . 39.7 p -45.3 -51.17 11.3 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.419 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 3.3 m -62.4 -50.82 77.44 Favored Pre-proline 0 N--CA 1.47 0.57 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -176.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.419 ' HD2' ' N ' ' A' ' 180' ' ' SER . 29.2 Cg_endo -64.87 -28.61 58.68 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 121.212 1.275 . . . . 0.0 111.63 176.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -64.27 -39.73 94.52 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 120.363 -0.535 . . . . 0.0 109.809 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 82.0 t -63.32 -42.85 97.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.201 0.524 . . . . 0.0 110.026 179.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.32 -39.39 92.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.091 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 44.1 ttt85 -60.74 -42.19 96.86 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.928 -179.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . 0.641 HD21 ' CA ' ' A' ' 127' ' ' GLY . 40.5 t30 -61.9 -43.89 97.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.107 0.48 . . . . 0.0 110.705 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -65.31 -44.31 88.26 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.805 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 87.4 mt -63.86 -46.04 95.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -177.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.438 HG13 ' N ' ' A' ' 190' ' ' ASN . 6.9 p -60.64 -46.96 94.88 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 C-N-CA 119.403 -0.919 . . . . 0.0 111.267 -178.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.438 ' N ' HG13 ' A' ' 189' ' ' VAL . 19.5 m120 -62.63 -42.62 99.7 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 122.204 1.002 . . . . 0.0 109.779 178.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' CYS . . . . . . . . . . . . . 41.9 t -61.63 -46.08 91.32 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 113.647 -1.615 . . . . 0.0 109.979 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.25 -40.2 95.52 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 113.317 -1.765 . . . . 0.0 109.719 176.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.81 -45.7 93.4 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.278 -177.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 21.1 tp -64.77 -38.89 92.51 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 118.785 -1.166 . . . . 0.0 110.972 -174.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 6.3 m -64.57 -45.97 93.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 117.275 -1.77 . . . . 0.0 108.536 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 29.0 p -63.91 -45.33 89.77 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -56.44 -38.77 72.07 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.641 0.776 . . . . 0.0 111.417 -178.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -55.95 -44.0 77.99 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.431 ' C ' HD12 ' A' ' 199' ' ' LEU . 0.2 OUTLIER -61.17 -38.69 87.38 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.908 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 37.2 mt -62.4 -41.87 93.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 15.4 mtpt -59.19 -38.2 79.24 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.958 1.303 . . . . 0.0 113.477 178.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -63.06 -42.58 99.71 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.692 -0.63 . . . . 0.0 110.986 -176.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.42 128.36 47.65 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 121.062 -1.024 . . . . 0.0 112.822 -176.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.524 ' CD2' ' CD2' ' A' ' 217' ' ' HIS . 11.1 mp 66.24 4.67 3.26 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 113.601 -1.636 . . . . 0.0 112.49 176.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 16.1 tp -137.1 72.02 1.41 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.117 0.484 . . . . 0.0 109.793 -178.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -112.36 -13.58 13.4 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -162.1 36.6 0.12 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.728 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . 0.443 ' O ' ' O ' ' A' ' 209' ' ' LEU . 50.2 t30 54.66 79.38 0.14 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 175.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.443 ' O ' ' O ' ' A' ' 208' ' ' ASN . 16.7 mt 56.91 110.95 0.01 OUTLIER 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.252 -0.885 . . . . 0.0 108.795 -178.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 20.5 ttp -140.07 15.71 2.45 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.758 HG22 ' H ' ' A' ' 212' ' ' ASP . 33.3 m -114.58 179.55 3.92 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.153 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . 0.758 ' H ' HG22 ' A' ' 211' ' ' THR . 25.7 t70 -131.84 -57.64 0.98 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.486 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -58.94 74.93 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.835 0.35 . . . . 0.0 110.869 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.531 ' N ' ' O ' ' A' ' 212' ' ' ASP . 0.4 OUTLIER -61.43 -41.53 79.75 Favored Pre-proline 0 CA--C 1.538 0.487 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -179.241 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.46 ' HD3' HD23 ' A' ' 214' ' ' LEU . 25.0 Cg_exo -61.35 -33.3 89.3 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 120.951 1.101 . . . . 0.0 112.342 -175.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 35.5 t -63.31 -40.27 96.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 113.085 -1.87 . . . . 0.0 108.809 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' HIS . . . . . 0.524 ' CD2' ' CD2' ' A' ' 204' ' ' LEU . 2.0 t-160 -64.94 -34.37 78.25 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.658 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.11 -46.97 86.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.908 -177.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -60.18 -37.1 79.2 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 119.132 0.878 . . . . 0.0 111.044 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 67.0 m -59.59 -41.62 90.7 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.7 -41.71 98.08 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -177.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . 0.481 ' CZ ' ' CE1' ' A' ' 226' ' ' PHE . 38.4 t80 -62.21 -47.48 84.27 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -176.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -60.91 -42.17 99.57 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 107.962 -2.055 . . . . 0.0 107.962 177.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -63.16 -38.18 90.14 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.068 -1.066 . . . . 0.0 109.377 177.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -62.05 -42.21 99.72 Favored Glycine 0 CA--C 1.522 0.491 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.513 -177.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' PHE . . . . . 0.481 ' CE1' ' CZ ' ' A' ' 222' ' ' PHE . 3.0 m-85 -66.65 -38.38 86.75 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . 0.415 ' O ' HG22 ' A' ' 230' ' ' VAL . 99.9 m -63.24 -40.65 98.04 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 176.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 15.1 m -61.61 -40.09 93.57 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 114.604 -1.18 . . . . 0.0 112.371 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.423 HG22 ' O ' ' A' ' 226' ' ' PHE . 0.6 OUTLIER -58.34 -39.13 78.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.749 -176.198 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 227' ' ' CYS . 1.0 OUTLIER -59.94 -40.38 82.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 118.907 -1.117 . . . . 0.0 109.146 179.837 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.542 ' O ' ' HD2' ' A' ' 234' ' ' PRO . 97.2 mt -61.39 -40.72 87.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-O 121.134 0.492 . . . . 0.0 109.783 177.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -62.81 -39.43 94.28 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.485 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 0.0 OUTLIER -57.97 -41.54 90.49 Favored Pre-proline 0 N--CA 1.483 1.187 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -173.542 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.542 ' HD2' ' O ' ' A' ' 231' ' ' ILE . 31.8 Cg_exo -57.87 -39.58 85.55 Favored 'Trans proline' 0 C--N 1.292 -2.431 0 C-N-CA 122.357 2.038 . . . . 0.0 113.551 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 83.9 t -64.08 -37.33 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 117.514 -1.674 . . . . 0.0 109.191 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . 0.525 ' OD2' ' CZ2' ' A' ' 283' ' ' TRP . 94.7 m-20 -66.21 -41.09 90.61 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.41 ' CG1' ' N ' ' A' ' 238' ' ' VAL . 0.5 OUTLIER -65.37 -45.23 93.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -176.448 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.41 ' N ' ' CG1' ' A' ' 237' ' ' VAL . 94.9 t -63.22 -37.07 78.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.441 -178.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 10.8 tptp -60.2 -44.48 95.09 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.64 -41.85 98.08 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.463 ' HE ' ' H ' ' A' ' 242' ' ' TYR . 8.8 tpm_? -42.21 129.41 3.76 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 121.326 -0.15 . . . . 0.0 111.166 -178.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.463 ' H ' ' HE ' ' A' ' 241' ' ' ARG . 19.8 t80 159.96 -58.81 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.813 0 O-C-N 123.865 0.728 . . . . 0.0 111.234 178.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' MET . . . . . 0.44 ' C ' ' O ' ' A' ' 242' ' ' TYR . 24.8 mtt -29.99 97.92 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . 0.552 ' ND2' ' OH ' ' A' ' 250' ' ' TYR . 50.4 p30 -168.74 -24.47 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 121.126 -0.23 . . . . 0.0 111.327 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . 0.527 ' N ' ' OD1' ' A' ' 244' ' ' ASN . 5.2 m 150.43 -115.3 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 O-C-N 124.237 0.961 . . . . 0.0 111.679 178.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -179.23 -25.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.817 0.342 . . . . 0.0 110.58 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -77.45 91.08 3.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.65 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.44 ' C ' ' OE1' ' A' ' 249' ' ' GLN . . . -164.27 21.97 0.15 Allowed Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.96 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.645 ' O ' ' N ' ' A' ' 251' ' ' HIS . 12.8 mp0 63.76 28.12 14.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.797 0.332 . . . . 0.0 110.82 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.552 ' OH ' ' ND2' ' A' ' 244' ' ' ASN . 5.6 m-30 -56.1 71.11 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.267 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . 0.645 ' N ' ' O ' ' A' ' 249' ' ' GLN . 19.9 m-70 -75.17 -57.56 3.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.331 -178.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 26.5 t -149.55 -174.72 4.76 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -178.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.552 ' O ' ' SG ' ' A' ' 256' ' ' CYS . . . -62.14 -45.77 91.96 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.224 0.92 . . . . 0.0 110.364 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -57.41 -35.69 73.19 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.894 1.235 . . . . 0.0 112.581 -173.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' HIS . . . . . 0.485 ' NE2' ' HB2' ' A' ' 249' ' ' GLN . 86.4 t60 -54.32 -39.45 67.05 Favored 'General case' 0 C--O 1.215 -0.711 0 CA-C-N 118.912 1.356 . . . . 0.0 111.093 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' CYS . . . . . 0.552 ' SG ' ' O ' ' A' ' 253' ' ' ALA . 0.0 OUTLIER -59.17 -44.97 92.16 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 119.932 -0.707 . . . . 0.0 110.415 -178.022 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -61.31 -46.35 90.66 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 119.622 -0.831 . . . . 0.0 111.725 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.469 ' N ' HD12 ' A' ' 258' ' ' LEU . 11.2 mp -67.86 -44.58 76.79 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -179.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . 0.433 ' CG2' ' N ' ' A' ' 260' ' ' MET . 2.1 t -63.42 -46.51 86.02 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -178.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' MET . . . . . 0.433 ' N ' ' CG2' ' A' ' 259' ' ' THR . 15.2 mmt -61.61 -44.19 97.46 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.106 -0.497 . . . . 0.0 112.051 -178.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 11.9 tp -62.6 -47.81 82.17 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 121.23 -0.188 . . . . 0.0 110.74 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 78.5 mtm180 -67.4 -54.03 24.05 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.078 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -76.66 -141.57 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.899 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . 0.616 ' H ' ' CD ' ' A' ' 264' ' ' GLU . 0.7 OUTLIER -39.87 128.47 2.1 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.083 0.468 . . . . 0.0 110.603 -179.659 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.496 ' C ' ' H ' ' A' ' 267' ' ' ARG . . . -46.33 167.12 0.06 OUTLIER Glycine 0 CA--C 1.533 1.173 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 -179.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -53.79 -1.11 0.1 Allowed 'Trans proline' 0 N--CA 1.5 1.887 0 C-N-CA 122.093 1.862 . . . . 0.0 112.509 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.496 ' H ' ' C ' ' A' ' 265' ' ' GLY . 5.1 ptp180 -69.89 -26.94 64.42 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 122.838 0.455 . . . . 0.0 111.511 178.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -58.67 -32.5 69.17 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 119.695 -0.802 . . . . 0.0 109.934 -178.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -62.47 -41.25 98.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.127 177.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' TYR . . . . . 0.428 ' O ' ' O ' ' A' ' 271' ' ' LYS . 36.7 t80 -65.87 -37.6 86.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.924 -1.035 . . . . 0.0 112.633 -178.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.478 ' O ' ' O ' ' A' ' 272' ' ' GLY . 54.8 mtpt -51.31 -175.36 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 271' ' ' LYS . . . 57.38 126.34 0.01 OUTLIER Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -169.37 -26.14 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 119.453 -0.899 . . . . 0.0 112.828 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' MET . . . . . 0.526 ' N ' ' CD ' ' A' ' 275' ' ' PRO . 1.0 OUTLIER -64.16 -45.31 79.16 Favored Pre-proline 0 CA--C 1.529 0.169 0 C-N-CA 119.274 -0.97 . . . . 0.0 110.635 -178.661 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' A' ' 274' ' ' MET . 19.7 Cg_exo -65.44 -47.78 3.94 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 121.837 1.692 . . . . 0.0 111.966 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 5.0 m -61.42 -40.22 93.61 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.018 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -61.82 -42.8 99.48 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 123.6 1.667 . . . . 0.0 113.486 -177.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 75.5 mt -62.54 -39.06 92.39 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 110.355 -3.111 . . . . 0.0 109.625 175.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . 0.455 ' NH2' ' CB ' ' A' ' 38' ' ' LYS . 28.7 mmt-85 -62.8 -40.67 98.08 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.099 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.759 ' O ' HD12 ' A' ' 280' ' ' LEU . 0.1 OUTLIER -62.2 -36.78 82.97 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.235 -0.893 . . . . 0.0 113.195 -177.495 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -68.01 -51.04 36.38 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -178.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . 0.438 ' O ' HG12 ' A' ' 285' ' ' VAL . 16.4 m -62.79 -44.3 96.54 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.247 0.619 . . . . 0.0 109.68 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' TRP . . . . . 0.529 ' O ' HG22 ' A' ' 286' ' ' VAL . 83.5 t90 -59.94 -38.24 81.87 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -62.78 -38.4 90.5 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.695 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.438 HG12 ' O ' ' A' ' 282' ' ' SER . 0.3 OUTLIER -60.82 -38.69 79.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -177.537 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.702 ' O ' HG22 ' A' ' 289' ' ' VAL . 6.8 m -62.53 -39.52 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 120.105 -0.638 . . . . 0.0 109.674 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 76.0 mmm -60.62 -38.6 85.28 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -59.02 -41.53 87.98 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.702 HG22 ' O ' ' A' ' 286' ' ' VAL . 29.4 m -61.61 -37.99 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 120.269 -0.572 . . . . 0.0 111.16 -178.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 82.8 p -62.41 -40.43 96.49 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -60.83 -38.81 86.75 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 177.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -58.07 -40.14 80.29 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 117.77 -1.572 . . . . 0.0 109.169 -177.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' GLN . . . . . 0.477 ' O ' ' O ' ' A' ' 296' ' ' ARG . 14.3 mm100 -60.46 -42.42 96.15 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 123.121 1.439 . . . . 0.0 110.258 179.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 77.1 mt -60.43 -39.48 87.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 112.079 -2.328 . . . . 0.0 109.305 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -61.95 -45.03 95.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.41 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' ARG . . . . . 0.477 ' O ' ' O ' ' A' ' 293' ' ' GLN . 36.0 ttm180 -122.27 115.86 23.09 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -111.28 -163.5 0.85 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.694 0.759 . . . . 0.0 112.845 -177.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.657 ' H ' HD12 ' A' ' 298' ' ' LEU . 10.0 mp -32.98 -71.27 0.06 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.406 -1.27 . . . . 0.0 112.902 -178.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . 0.526 ' O ' ' SD ' ' A' ' 299' ' ' MET . 0.0 OUTLIER 88.16 32.06 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 113.895 -1.502 . . . . 0.0 110.869 179.464 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.69 101.01 0.07 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 122.472 1.129 . . . . 0.0 111.182 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -64.34 -46.36 83.82 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 112.952 -1.931 . . . . 0.0 113.142 -176.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -58.67 -38.9 79.19 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 -177.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -64.29 -46.46 83.52 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 304' ' ' SER . . . . . 0.411 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 1.9 t -66.46 -38.18 86.78 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.672 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 -61.86 -42.64 99.3 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.919 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -64.71 -36.78 85.38 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -177.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . 0.546 ' HB3' ' HD3' ' A' ' 308' ' ' PRO . . . -60.04 -52.98 69.64 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -176.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 308' ' ' PRO . . . . . 0.546 ' HD3' ' HB3' ' A' ' 307' ' ' ALA . 74.3 Cg_endo -75.21 0.23 9.24 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.046 1.831 . . . . 0.0 111.862 179.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 29.8 t80 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.586 -179.812 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.495 ' N ' ' SD ' ' A' ' 13' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.7 p 43.69 73.23 0.15 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.628 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.575 HG12 ' N ' ' A' ' 16' ' ' LYS . 28.2 t -83.43 166.44 2.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.573 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.575 ' N ' HG12 ' A' ' 15' ' ' VAL . 1.1 mptm? -64.25 -41.8 96.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.095 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -63.75 -41.6 97.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.411 0.624 . . . . 0.0 111.905 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.543 HD13 ' O ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -79.83 -26.19 40.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.977 -1.011 . . . . 0.0 111.165 -179.662 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.59 -40.69 96.16 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 106.75 -2.54 . . . . 0.0 106.75 176.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.61 -31.26 68.17 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 124.44 2.067 . . . . 0.0 107.41 176.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.38 -43.19 97.17 Favored Glycine 0 CA--C 1.532 1.115 0 CA-C-N 109.112 -3.676 . . . . 0.0 110.726 -177.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.5 t -71.23 -27.3 63.37 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 117.567 0.684 . . . . 0.0 109.279 178.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.75 -50.64 64.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.69 -178.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.15 -35.88 80.13 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 118.109 -1.437 . . . . 0.0 110.943 -177.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 73.2 m -63.98 -54.11 39.65 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.579 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.521 HD12 ' N ' ' A' ' 27' ' ' ALA . 2.6 pp -65.74 -39.59 85.3 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -177.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.552 ' O ' HG23 ' A' ' 31' ' ' THR . . . -63.94 -41.8 97.52 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 119.733 -0.787 . . . . 0.0 112.861 -173.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.469 ' HA ' ' HG1' ' A' ' 31' ' ' THR . 2.3 m-20 -77.63 -27.07 51.01 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 120.325 1.42 . . . . 0.0 109.918 -175.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 10.8 tp -59.81 -55.83 29.41 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 119.835 1.198 . . . . 0.0 112.806 -178.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.9 pt -76.11 -4.55 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.552 HG23 ' O ' ' A' ' 27' ' ' ALA . 30.3 p -109.71 -17.08 13.77 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 118.941 -1.104 . . . . 0.0 109.549 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.479 ' N ' ' CD ' ' A' ' 33' ' ' PRO . 4.3 t80 -67.3 -44.0 45.79 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 122.296 2.316 . . . . 0.0 109.164 -178.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 32' ' ' PHE . 30.7 Cg_exo -59.62 -15.85 33.39 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 121.0 1.134 . . . . 0.0 111.556 177.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 26.9 tp -66.99 -35.47 80.03 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -177.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 36' ' ' THR . 2.0 p30 -64.61 -40.29 95.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.36 -0.837 . . . . 0.0 112.401 -177.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.532 ' N ' ' OD1' ' A' ' 35' ' ' ASP . 67.4 p -58.17 -35.01 70.95 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.03 -38.09 85.27 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.563 ' NZ ' HH22 ' A' ' 279' ' ' ARG . 11.5 ptmt -60.58 -46.99 88.18 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 120.119 -0.632 . . . . 0.0 111.855 -175.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.443 ' N ' ' CG ' ' A' ' 38' ' ' LYS . 93.0 t -62.16 -38.42 80.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -176.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.526 ' NH1' ' O ' ' A' ' 36' ' ' THR . 6.8 mmp_? -59.37 -40.47 86.57 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 119.345 -0.942 . . . . 0.0 109.611 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.58 38.96 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.3 179.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.508 ' N ' ' O ' ' A' ' 40' ' ' ARG . 3.1 pt20 -67.89 -159.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 O-C-N 122.136 -0.352 . . . . 0.0 110.936 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.435 ' N ' HD12 ' A' ' 43' ' ' ILE . 2.0 mp -132.07 47.81 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.562 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 46.72 29.11 0.9 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.855 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 46' ' ' GLU . . . -64.82 -116.32 0.01 OUTLIER Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.427 ' O ' ' O ' ' A' ' 45' ' ' GLY . 41.7 tt0 59.35 132.29 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.889 0.376 . . . . 0.0 110.839 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 66.9 m -115.71 -12.79 11.48 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.544 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -42.63 -27.08 0.15 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.648 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.46 -10.05 73.21 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -178.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 45.5 tp -65.89 -38.01 87.64 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.373 -0.413 . . . . 0.0 110.585 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.514 HG13 ' N ' ' A' ' 52' ' ' ARG . 7.6 p -60.74 -44.81 98.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.734 -178.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.514 ' N ' HG13 ' A' ' 51' ' ' VAL . 14.6 ptt180 -64.86 -33.65 76.52 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.881 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 98.0 m -67.86 -38.16 82.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.186 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.74 -152.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.207 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -166.9 -24.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.069 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.649 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 57.8 p -166.74 -127.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 179.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.649 ' HB3' ' O ' ' A' ' 56' ' ' SER . . . 94.33 13.8 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 177.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.497 ' N ' ' CD ' ' A' ' 58' ' ' GLN . 2.2 pm0 -175.29 176.81 1.97 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.867 0.365 . . . . 0.0 110.162 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.461 ' CD1' ' C ' ' A' ' 58' ' ' GLN . 84.7 m-85 -157.07 159.22 37.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.646 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 34.1 ptt-85 -48.16 -33.01 7.74 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -31.33 103.51 0.01 OUTLIER Glycine 0 CA--C 1.526 0.762 0 CA-C-N 114.875 -1.057 . . . . 0.0 112.221 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.436 HG22 ' H ' ' A' ' 62' ' ' VAL . 2.6 m -66.91 -33.61 64.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 118.229 -0.891 . . . . 0.0 109.194 176.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.411 ' N ' HD22 ' A' ' 63' ' ' LEU . 4.4 mm? -60.09 -32.32 70.86 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 121.25 1.841 . . . . 0.0 110.359 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -65.02 -49.3 63.2 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-N 115.243 -0.889 . . . . 0.0 114.609 -177.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.434 ' H ' HG23 ' A' ' 65' ' ' THR . 6.8 p -62.15 -46.38 89.24 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -178.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.482 HD12 ' N ' ' A' ' 67' ' ' LEU . 2.3 pp -58.99 -35.0 54.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -178.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.482 ' N ' HD12 ' A' ' 66' ' ' ILE . 6.8 tp -63.03 -35.29 79.73 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 120.36 1.437 . . . . 0.0 113.116 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 98.6 m -61.47 -41.52 97.37 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-N 114.316 -1.311 . . . . 0.0 111.011 -177.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 50.4 mmm -59.3 -39.31 82.61 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -176.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.7 t -68.99 -41.04 81.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 118.968 -1.093 . . . . 0.0 113.646 -177.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 23.0 ttp-105 -78.26 -13.54 59.81 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.503 ' CG2' ' N ' ' A' ' 73' ' ' GLU . 0.5 OUTLIER -62.85 -54.95 30.9 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 114.639 -1.164 . . . . 0.0 112.391 -179.297 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.503 ' N ' ' CG2' ' A' ' 72' ' ' THR . 13.6 tp10 -110.61 -57.36 2.23 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.41 163.21 12.08 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -56.57 -34.92 96.44 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 122.107 1.871 . . . . 0.0 112.198 -179.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.4 tpp180 -61.25 -11.84 10.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.887 0.851 . . . . 0.0 111.132 176.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.407 ' OG ' HD12 ' A' ' 78' ' ' LEU . 15.6 p -78.28 -32.86 49.69 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 113.868 -1.514 . . . . 0.0 110.95 -178.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.407 HD12 ' OG ' ' A' ' 77' ' ' SER . 6.3 mp -75.58 -31.65 60.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.017 0.437 . . . . 0.0 110.449 178.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.647 ' O ' HD12 ' A' ' 82' ' ' LEU . 75.3 m-85 -90.15 -3.69 57.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 123.644 1.688 . . . . 0.0 112.549 -176.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 -106.7 121.21 43.91 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 110.619 -2.991 . . . . 0.0 107.654 175.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.46 -18.6 50.57 Favored Glycine 0 N--CA 1.469 0.893 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 -177.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.989 HD13 ' N ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -58.91 -33.69 70.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 113.905 -1.148 . . . . 0.0 110.332 -179.096 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.989 ' N ' HD13 ' A' ' 82' ' ' LEU . 7.1 p -70.44 -26.28 28.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.265 177.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.14 -31.95 61.2 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 119.11 -0.471 . . . . 0.0 111.837 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.93 -40.0 89.18 Favored Glycine 0 N--CA 1.466 0.679 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.891 -178.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -62.48 -40.25 96.07 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 122.15 0.976 . . . . 0.0 112.842 -176.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.431 ' O ' ' OE1' ' A' ' 87' ' ' GLN . 0.1 OUTLIER -60.83 -28.29 68.7 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 113.431 -1.713 . . . . 0.0 110.378 -179.267 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 62.5 mtt85 -58.53 -53.7 55.36 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 173.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -66.67 -29.36 69.35 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 112.035 -2.348 . . . . 0.0 111.847 -177.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 12.3 tpt -61.27 -40.14 92.99 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.425 179.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 33.8 t -74.37 -34.19 63.29 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 119.366 -0.934 . . . . 0.0 111.456 -177.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -57.87 -43.84 86.26 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 121.04 1.745 . . . . 0.0 112.615 -176.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.49 -32.85 64.51 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 119.484 -0.886 . . . . 0.0 110.748 -178.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.597 ' O ' HG22 ' A' ' 97' ' ' ILE . 70.2 p -64.1 -41.43 97.28 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.45 ' C ' ' H ' ' A' ' 97' ' ' ILE . 29.8 m -68.79 -28.28 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.44 177.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 55.3 ttp85 -77.15 9.22 3.2 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -176.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.597 HG22 ' O ' ' A' ' 94' ' ' SER . 11.0 tt -86.96 -14.68 10.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.412 ' O ' ' OG ' ' A' ' 102' ' ' SER . . . -139.98 -48.14 0.06 OUTLIER Glycine 0 CA--C 1.544 1.867 0 N-CA-C 115.772 1.069 . . . . 0.0 115.772 -177.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.604 HD22 ' N ' ' A' ' 99' ' ' LEU . 3.4 mm? -71.79 -13.4 61.68 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 119.841 1.82 . . . . 0.0 113.925 -177.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.484 ' CZ ' ' NZ ' ' A' ' 104' ' ' LYS . 9.6 t80 -80.84 -51.94 8.05 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 114.63 -1.168 . . . . 0.0 112.795 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.498 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 0.4 OUTLIER -70.42 -32.23 69.74 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 124.056 1.884 . . . . 0.0 110.686 -179.738 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' A' ' 98' ' ' GLY . 67.3 m -67.32 -50.88 58.3 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 109.609 -3.451 . . . . 0.0 113.492 178.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 10.0 p -73.83 -26.66 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 CA-C-N 121.27 1.85 . . . . 0.0 111.79 177.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.484 ' NZ ' ' CZ ' ' A' ' 100' ' ' TYR . 39.0 mttp -69.51 -41.86 75.47 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 111.621 -2.536 . . . . 0.0 113.284 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.44 ' HG3' ' O ' ' A' ' 101' ' ' ASP . 88.1 mt-30 -76.27 -14.69 60.11 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 123.63 1.681 . . . . 0.0 111.029 178.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -79.27 -22.47 44.67 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 112.518 -2.128 . . . . 0.0 111.95 178.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.49 ' O ' ' NH2' ' A' ' 119' ' ' ARG . 15.4 m-85 -109.79 -27.73 9.16 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.231 1.012 . . . . 0.0 113.299 -173.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.767 ' C ' ' H ' ' A' ' 110' ' ' GLY . 14.4 t -94.53 12.68 26.54 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 -173.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -54.69 19.11 0.0 OUTLIER 'General case' 0 CA--C 1.57 1.747 0 CA-C-N 119.885 1.221 . . . . 0.0 110.726 177.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.767 ' H ' ' C ' ' A' ' 108' ' ' THR . . . 59.18 20.52 50.4 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.542 ' OG ' ' NH2' ' A' ' 119' ' ' ARG . 1.4 m 33.02 -163.23 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 113.23 -1.485 . . . . 0.0 113.385 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.588 ' C ' ' H ' ' A' ' 114' ' ' ALA . 3.3 tt0 -141.14 -157.3 0.75 Allowed 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 118.807 -1.157 . . . . 0.0 113.424 -177.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.649 ' O ' ' HB2' ' A' ' 114' ' ' ALA . 37.5 t60 -61.12 9.24 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 114.814 -1.085 . . . . 0.0 111.312 -179.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.649 ' HB2' ' O ' ' A' ' 113' ' ' HIS . . . 160.42 -161.01 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.26 14.58 25.74 Favored Glycine 0 N--CA 1.459 0.221 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 -179.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 25.6 mm -60.91 -39.98 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.08 -39.49 96.35 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.92 175.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 6.0 t -58.85 -43.23 90.74 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 176.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.542 ' NH2' ' OG ' ' A' ' 111' ' ' SER . 18.6 mmt85 -63.75 -37.37 87.1 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.658 -178.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 30.5 tp -63.58 -45.71 89.17 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 42.1 mt -66.92 -44.97 79.33 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.518 178.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.75 -45.1 87.84 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 119.903 1.229 . . . . 0.0 110.955 178.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -65.59 -44.39 92.84 Favored Glycine 0 CA--C 1.517 0.2 0 C-N-CA 119.777 -1.201 . . . . 0.0 111.148 -177.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 79.9 p -64.16 -43.07 96.32 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.83 0.348 . . . . 0.0 111.007 178.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 96.6 m -69.5 -48.82 59.39 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 119.192 -1.003 . . . . 0.0 112.687 177.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.493 HG23 ' N ' ' A' ' 127' ' ' GLY . 6.3 t -66.17 -42.7 88.56 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 115.197 1.555 . . . . 0.0 115.197 -174.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.493 ' N ' HG23 ' A' ' 126' ' ' THR . . . -64.74 -44.83 94.28 Favored Glycine 0 C--O 1.228 -0.233 0 CA-C-N 114.238 -1.347 . . . . 0.0 112.748 -177.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.57 -41.78 97.9 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 112.482 -1.859 . . . . 0.0 107.259 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.732 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 0.2 OUTLIER -64.85 -42.81 94.58 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.169 178.118 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.13 -39.67 95.36 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.894 -0.504 . . . . 0.0 111.817 -178.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.641 HG11 HG22 ' A' ' 183' ' ' VAL . 94.5 t -60.98 -26.25 38.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 123.342 1.544 . . . . 0.0 109.298 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.732 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . -58.93 -44.67 91.38 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 110.971 -2.832 . . . . 0.0 112.386 -178.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 61.4 t -79.07 -49.18 20.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -177.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.517 ' O ' ' CB ' ' A' ' 135' ' ' GLN . . . -107.36 -169.12 1.48 Allowed 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -177.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.527 ' N ' ' CD ' ' A' ' 136' ' ' PRO . 3.4 tt0 105.15 -23.28 0.0 OUTLIER Pre-proline 0 CA--C 1.552 1.051 0 O-C-N 124.676 1.235 . . . . 0.0 114.051 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.527 ' CD ' ' N ' ' A' ' 135' ' ' GLN . 5.2 Cg_exo -52.68 -34.64 64.93 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 CA-C-N 122.025 1.759 . . . . 0.0 112.803 -178.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 12.6 m -66.75 -40.72 88.39 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -64.52 -42.16 95.94 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 118.965 -1.094 . . . . 0.0 112.424 -177.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.89 -42.93 97.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -179.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 19.7 m -63.92 -37.3 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -177.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 16.5 mtpp -60.82 -40.13 91.61 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.981 -177.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 90.4 t -69.83 -45.11 78.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.28 0.562 . . . . 0.0 109.694 178.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.404 ' CA ' ' HE ' ' A' ' 143' ' ' ARG . 0.0 OUTLIER -64.64 -36.11 83.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.508 179.569 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -66.28 -40.4 90.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.899 -0.592 . . . . 0.0 112.312 -177.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -64.06 -39.07 93.28 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 119.884 -0.726 . . . . 0.0 110.185 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.16 -35.06 79.9 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.521 ' NE2' ' O ' ' A' ' 149' ' ' ARG . 0.0 OUTLIER -59.66 110.73 1.2 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 177.584 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 150' ' ' ALA . . . -43.17 93.03 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 117.33 -1.319 . . . . 0.0 111.531 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.521 ' O ' ' NE2' ' A' ' 147' ' ' GLN . 78.8 mtm180 53.81 -89.44 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 122.64 2.473 . . . . 0.0 111.055 178.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 148' ' ' ALA . . . -154.37 -149.7 0.29 Allowed 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.405 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -158.44 31.57 0.48 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 155' ' ' ARG . . . -172.95 111.08 0.36 Allowed Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -67.57 -53.12 26.12 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -70.96 -44.89 65.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.702 0.287 . . . . 0.0 110.762 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.406 ' O ' ' O ' ' A' ' 152' ' ' GLY . 37.8 ttm180 -85.77 138.94 31.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.68 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.514 ' CE2' ' O ' ' A' ' 157' ' ' GLN . 92.0 t80 -102.4 126.69 49.5 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.677 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.514 ' O ' ' CE2' ' A' ' 156' ' ' TYR . 84.1 mt-30 -81.07 166.49 20.7 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.34 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.69 ' H ' ' CG ' ' A' ' 161' ' ' GLU . 20.7 p -157.04 -178.56 7.46 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.565 0.698 . . . . 0.0 111.602 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 25.4 p -64.77 -46.64 81.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.113 -0.948 . . . . 0.0 112.335 -178.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.564 HG13 ' N ' ' A' ' 161' ' ' GLU . 14.9 p -65.02 -45.98 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 119.241 -0.984 . . . . 0.0 110.896 -178.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.69 ' CG ' ' H ' ' A' ' 158' ' ' SER . 2.1 pp20? -68.14 -38.54 82.27 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.921 0.391 . . . . 0.0 111.843 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.426 ' N ' ' CD ' ' A' ' 161' ' ' GLU . . . -61.14 -45.68 93.67 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -177.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.6 ' CZ ' HD23 ' A' ' 175' ' ' LEU . 17.0 t80 -62.54 -50.15 72.47 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.137 -179.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -68.68 -45.68 71.05 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 -175.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.546 HG23 ' N ' ' A' ' 166' ' ' ILE . 15.3 t -63.27 -45.1 93.05 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -177.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.546 ' N ' HG23 ' A' ' 165' ' ' THR . 8.4 pt -64.83 -39.08 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 CA-C-O 122.043 0.925 . . . . 0.0 108.964 177.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.404 ' N ' ' CG1' ' A' ' 166' ' ' ILE . . . -60.41 -37.62 81.44 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 113.704 -1.589 . . . . 0.0 109.145 177.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 13.4 tpp85 -63.47 -51.35 65.99 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 123.715 2.962 . . . . 0.0 112.821 -175.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -75.7 -51.4 12.82 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 123.287 0.635 . . . . 0.0 109.515 177.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.492 ' OE2' ' N ' ' A' ' 174' ' ' GLY . 0.0 OUTLIER -78.96 -37.19 40.17 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 119.602 1.092 . . . . 0.0 113.784 -176.204 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.47 ' O ' ' OE2' ' A' ' 170' ' ' GLU . . . 98.31 -171.73 25.8 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 120.776 -0.726 . . . . 0.0 113.366 179.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.448 HG23 ' N ' ' A' ' 173' ' ' ARG . 20.8 tt -75.12 -37.84 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -177.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.448 ' N ' HG23 ' A' ' 172' ' ' ILE . 7.3 tpp180 -58.22 -34.1 70.05 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 114.298 -1.319 . . . . 0.0 112.938 -173.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.492 ' N ' ' OE2' ' A' ' 170' ' ' GLU . . . -60.56 -38.87 95.64 Favored Glycine 0 N--CA 1.464 0.51 0 CA-C-O 123.726 1.737 . . . . 0.0 111.995 -178.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.6 HD23 ' CZ ' ' A' ' 163' ' ' TYR . 5.2 mp -70.2 -34.24 72.69 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 110.153 -3.024 . . . . 0.0 116.425 -176.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 11.0 m95 -78.72 -7.72 58.02 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 113.481 -1.691 . . . . 0.0 109.653 -178.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -44.06 -49.28 8.86 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.756 0.651 . . . . 0.0 112.756 -175.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -87.99 -36.6 8.27 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 124.548 1.071 . . . . 0.0 111.754 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 40.3 p -45.24 -51.39 10.81 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.426 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 1.5 t -62.92 -50.93 74.72 Favored Pre-proline 0 N--CA 1.472 0.667 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -176.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 180' ' ' SER . 32.3 Cg_endo -65.06 -28.15 57.24 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.676 1.584 . . . . 0.0 111.257 176.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.426 ' CB ' ' OE1' ' A' ' 135' ' ' GLN . 24.5 t-20 -63.41 -39.19 93.82 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.641 HG22 HG11 ' A' ' 131' ' ' VAL . 71.8 t -62.91 -42.79 97.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.63 -39.99 95.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.18 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -60.99 -41.94 97.47 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.084 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -61.61 -43.24 99.24 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.033 0.444 . . . . 0.0 110.124 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . 0.508 ' O ' ' SG ' ' A' ' 191' ' ' CYS . . . -64.24 -43.87 93.56 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.24 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 25.2 mm -63.32 -45.17 98.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.864 -0.335 . . . . 0.0 111.309 -178.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 89.3 t -60.42 -47.22 93.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 120.265 -0.574 . . . . 0.0 111.765 -178.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.445 ' OD1' ' CZ ' ' A' ' 107' ' ' TYR . 16.6 t30 -62.61 -43.27 99.22 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 122.663 1.22 . . . . 0.0 109.873 179.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' CYS . . . . . 0.508 ' SG ' ' O ' ' A' ' 187' ' ' ALA . 94.5 m -62.43 -46.49 88.3 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 112.46 -2.155 . . . . 0.0 110.752 179.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.41 -40.29 95.5 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.479 176.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -61.54 -45.57 93.6 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.879 -178.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 7.9 tt -64.16 -38.95 92.88 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 118.623 -1.231 . . . . 0.0 110.071 -174.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 6.1 m -64.5 -45.48 95.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 116.762 -1.975 . . . . 0.0 107.808 178.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 19.8 m -63.89 -45.87 87.43 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -178.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -56.48 -38.35 71.61 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.34 1.056 . . . . 0.0 112.09 -178.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -55.19 -43.09 74.05 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 24.5 mt -60.79 -39.51 89.17 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.422 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 1.3 mp -62.98 -42.45 96.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -59.59 -38.67 81.85 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.505 1.522 . . . . 0.0 113.193 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -62.9 -40.04 96.36 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.027 -178.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 90.5 m -100.66 129.37 46.56 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.797 0.808 . . . . 0.0 111.839 -177.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.624 ' O ' HD22 ' A' ' 205' ' ' LEU . 4.6 tp 68.02 4.38 4.03 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 114.221 -1.354 . . . . 0.0 111.954 179.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.624 HD22 ' O ' ' A' ' 204' ' ' LEU . 1.3 mm? -128.42 28.81 5.41 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -177.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -72.84 -25.06 60.98 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.263 -178.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.46 ' O ' ' CG ' ' A' ' 208' ' ' ASN . . . -131.09 -38.88 1.21 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.547 0.689 . . . . 0.0 110.219 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . 0.617 ' CG ' ' H ' ' A' ' 209' ' ' LEU . 13.9 p30 141.25 -92.84 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 113.138 -1.846 . . . . 0.0 106.846 -177.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.617 ' H ' ' CG ' ' A' ' 208' ' ' ASN . 4.3 tt -101.12 114.19 27.91 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 177.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . 0.528 ' N ' HD23 ' A' ' 209' ' ' LEU . 6.6 tpt -158.62 79.61 0.8 Allowed 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 120.281 -0.567 . . . . 0.0 111.692 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.527 HG23 ' O ' ' A' ' 210' ' ' MET . 24.3 p -159.42 170.88 20.81 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.627 179.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -133.83 -60.95 0.81 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.61 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.495 ' O ' ' SG ' ' A' ' 216' ' ' CYS . 11.5 p-10 -84.16 94.66 8.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.611 178.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.491 ' N ' ' CD ' ' A' ' 215' ' ' PRO . 4.3 mm? -60.88 -42.63 88.12 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.215 -178.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.491 ' CD ' ' N ' ' A' ' 214' ' ' LEU . 35.1 Cg_exo -59.89 -32.34 95.1 Favored 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 121.58 1.52 . . . . 0.0 112.337 -177.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' CYS . . . . . 0.527 ' SG ' ' N ' ' A' ' 217' ' ' HIS . 1.6 p -63.98 -42.23 97.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 113.714 -1.584 . . . . 0.0 111.422 -177.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' HIS . . . . . 0.527 ' N ' ' SG ' ' A' ' 216' ' ' CYS . 77.3 m80 -66.5 -37.32 84.81 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.332 0.587 . . . . 0.0 110.766 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' PHE . . . . . 0.524 ' CE1' HD12 ' A' ' 294' ' ' LEU . 30.7 m-85 -63.47 -46.77 84.66 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.804 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 20.8 p -60.2 -37.79 81.32 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 118.81 0.732 . . . . 0.0 110.44 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 49.7 p -59.45 -41.63 90.09 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 178.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.566 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.74 -41.81 97.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -177.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -62.19 -47.67 83.45 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -175.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -61.15 -42.4 99.78 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 107.994 -2.042 . . . . 0.0 107.994 177.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.541 ' O ' HG23 ' A' ' 228' ' ' THR . . . -63.48 -37.34 86.91 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 113.839 -1.18 . . . . 0.0 109.622 177.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -61.15 -41.96 99.64 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-N 114.364 -1.289 . . . . 0.0 112.529 -175.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' PHE . . . . . 0.443 ' O ' ' OG1' ' A' ' 229' ' ' THR . 55.1 m-85 -66.24 -38.79 88.74 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 118.767 1.283 . . . . 0.0 110.014 -178.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . 0.495 ' SG ' ' N ' ' A' ' 228' ' ' THR . 1.8 p -63.69 -41.91 98.07 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 119.74 -0.784 . . . . 0.0 109.873 177.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 224' ' ' ALA . 67.6 p -62.56 -40.93 98.42 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.412 179.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 226' ' ' PHE . 13.1 p -59.19 -39.46 82.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.266 -177.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 92.8 t -60.35 -41.26 86.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 C-N-CA 118.91 -1.116 . . . . 0.0 108.524 178.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.505 ' O ' ' HD2' ' A' ' 234' ' ' PRO . 30.4 mm -62.08 -41.18 90.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 121.345 0.593 . . . . 0.0 109.727 176.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.1 -39.9 96.06 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 116.16 1.911 . . . . 0.0 116.16 -179.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.48 ' N ' ' CD ' ' A' ' 234' ' ' PRO . 0.1 OUTLIER -58.1 -41.91 92.27 Favored Pre-proline 0 N--CA 1.481 1.098 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -173.271 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.505 ' HD2' ' O ' ' A' ' 231' ' ' ILE . 35.5 Cg_exo -58.39 -40.08 78.3 Favored 'Trans proline' 0 C--N 1.291 -2.483 0 C-N-CA 121.915 1.744 . . . . 0.0 112.503 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 58.9 t -64.38 -37.29 79.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 C-N-CA 118.591 -1.244 . . . . 0.0 109.004 178.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -66.22 -40.98 90.67 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-N 115.351 -0.841 . . . . 0.0 112.182 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 74.1 t -65.63 -45.28 92.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -176.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.19 -36.9 77.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -176.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 7.3 ptmm? -60.1 -43.56 95.46 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.632 -178.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . 0.427 ' H ' HG23 ' A' ' 240' ' ' THR . 1.8 p -61.09 -41.94 97.58 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.509 ' O ' ' CB ' ' A' ' 242' ' ' TYR . 0.0 OUTLIER -40.25 131.56 2.09 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 121.148 -0.221 . . . . 0.0 111.165 -178.462 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.509 ' CB ' ' O ' ' A' ' 241' ' ' ARG . 2.7 t80 153.54 -59.17 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 O-C-N 123.688 0.617 . . . . 0.0 110.292 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' MET . . . . . 0.535 ' O ' ' ND2' ' A' ' 244' ' ' ASN . 79.6 mtp -33.25 144.68 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 O-C-N 123.147 0.279 . . . . 0.0 110.72 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . 0.556 ' OD1' ' N ' ' A' ' 245' ' ' SER . 0.7 OUTLIER 75.07 -175.27 0.13 Allowed 'General case' 0 N--CA 1.468 0.441 0 O-C-N 123.463 0.477 . . . . 0.0 111.259 -179.474 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . 0.556 ' N ' ' OD1' ' A' ' 244' ' ' ASN . 41.7 t 38.47 -135.33 0.1 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.862 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . 0.495 ' N ' ' OG ' ' A' ' 245' ' ' SER . . . 66.35 51.44 1.2 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.173 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 39.4 mt -128.85 -19.89 3.58 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.675 -0.238 . . . . 0.0 111.149 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 249' ' ' GLN . . . -90.21 -166.81 41.58 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 -179.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.972 ' NE2' ' CE1' ' A' ' 255' ' ' HIS . 6.5 tt0 -46.38 -101.64 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.801 -0.2 . . . . 0.0 110.521 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.558 ' CD1' ' N ' ' A' ' 250' ' ' TYR . 0.8 OUTLIER 71.72 59.97 0.15 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.67 179.082 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -66.7 -51.4 56.47 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 114.374 1.249 . . . . 0.0 114.374 -178.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.52 -173.51 4.29 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -178.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -60.38 -44.9 95.2 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 118.921 0.782 . . . . 0.0 108.914 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -56.0 -34.94 62.58 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 125.225 1.393 . . . . 0.0 111.102 -173.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' HIS . . . . . 0.972 ' CE1' ' NE2' ' A' ' 249' ' ' GLN . 86.4 t60 -55.68 -34.87 65.43 Favored 'General case' 0 C--N 1.361 1.088 0 C-N-CA 116.805 -1.958 . . . . 0.0 110.982 179.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -60.47 -45.04 95.18 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.984 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -60.62 -45.94 92.15 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.6 -179.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 11.5 tp -67.8 -43.72 79.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.054 0.454 . . . . 0.0 111.245 179.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 21.9 m -63.11 -46.73 85.96 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -178.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' MET . . . . . 0.419 ' CG ' ' N ' ' A' ' 261' ' ' LEU . 17.0 ptt? -61.57 -44.45 97.01 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -177.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.419 ' N ' ' CG ' ' A' ' 260' ' ' MET . 11.6 tp -63.25 -48.12 79.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.787 0.327 . . . . 0.0 110.467 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 50.1 ttt85 -67.4 -54.14 23.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.582 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 3.8 ttmm -68.29 -148.45 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.954 0.407 . . . . 0.0 111.484 -178.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -51.45 136.4 25.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.399 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -41.37 166.63 0.01 OUTLIER Glycine 0 CA--C 1.527 0.834 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.809 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -60.23 -2.97 2.07 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.625 2.217 . . . . 0.0 111.7 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 -69.98 -27.01 64.36 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.193 0.597 . . . . 0.0 111.739 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -58.76 -32.31 69.16 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.006 -179.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -62.39 -41.19 98.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.915 177.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -65.67 -37.55 86.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.909 -1.042 . . . . 0.0 112.146 -178.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.455 ' O ' ' O ' ' A' ' 272' ' ' GLY . 42.3 mmtm -65.42 -176.7 0.35 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 271' ' ' LYS . . . 47.72 104.13 0.01 OUTLIER Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -165.26 4.26 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.611 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' MET . . . . . 0.583 ' N ' ' CD ' ' A' ' 275' ' ' PRO . 2.9 ttm -63.57 -44.15 80.26 Favored Pre-proline 0 C--N 1.329 -0.304 0 C-N-CA 120.268 -0.573 . . . . 0.0 109.646 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 274' ' ' MET . 22.8 Cg_exo -64.33 -46.12 8.26 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.732 2.288 . . . . 0.0 111.334 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 38.7 t -60.1 -40.04 88.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.514 -179.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . 0.464 ' O ' ' CD1' ' A' ' 280' ' ' LEU . 3.4 m-85 -61.59 -42.76 99.32 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 124.3 2.0 . . . . 0.0 111.809 -178.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 11.5 tp -62.87 -38.98 93.01 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 110.385 -3.098 . . . . 0.0 109.892 175.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . 0.563 HH22 ' NZ ' ' A' ' 38' ' ' LYS . 56.6 mtt-85 -63.03 -41.49 99.53 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.49 ' H ' ' HG ' ' A' ' 280' ' ' LEU . 1.3 pp -62.7 -35.37 79.49 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -177.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . 0.481 ' N ' HD12 ' A' ' 280' ' ' LEU . . . -67.67 -50.98 38.7 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -177.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 66.4 m -62.49 -43.89 97.72 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.477 0.711 . . . . 0.0 109.689 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' TRP . . . . . 0.463 ' O ' HG22 ' A' ' 286' ' ' VAL . 85.0 t90 -59.61 -38.16 80.55 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' A' ' 285' ' ' VAL . 0.2 OUTLIER -62.52 -38.37 89.7 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.295 179.549 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.531 ' N ' ' OD1' ' A' ' 284' ' ' ASN . 0.3 OUTLIER -61.01 -39.91 83.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -177.52 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.488 ' O ' HG22 ' A' ' 289' ' ' VAL . 10.2 m -63.31 -40.07 87.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.051 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' MET . . . . . 0.461 ' SD ' ' CE1' ' A' ' 291' ' ' TYR . 0.0 OUTLIER -60.83 -38.41 85.37 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.656 179.919 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -58.44 -40.1 81.63 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.846 -178.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 286' ' ' VAL . 0.9 OUTLIER -60.53 -38.24 77.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 -177.762 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 41.8 p -62.42 -40.91 98.09 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 119.558 -0.857 . . . . 0.0 108.834 177.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' TYR . . . . . 0.461 ' CE1' ' SD ' ' A' ' 287' ' ' MET . 16.2 m-85 -60.98 -38.34 85.6 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 177.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 -57.27 -39.35 75.5 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 118.163 -1.415 . . . . 0.0 109.261 -176.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' GLN . . . . . 0.468 ' O ' ' O ' ' A' ' 296' ' ' ARG . 17.9 mm100 -60.24 -42.08 94.53 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 122.904 1.335 . . . . 0.0 110.58 178.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.524 HD12 ' CE1' ' A' ' 218' ' ' PHE . 3.9 mm? -60.8 -39.41 88.8 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 112.404 -2.18 . . . . 0.0 110.02 178.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 45.2 mttp -61.83 -44.67 96.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.226 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' ARG . . . . . 0.468 ' O ' ' O ' ' A' ' 293' ' ' GLN . 89.1 mtm180 -121.89 115.7 23.06 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -112.13 -163.24 0.84 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.349 0.595 . . . . 0.0 112.276 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.59 HD12 ' N ' ' A' ' 298' ' ' LEU . 9.9 mp -74.79 109.72 8.49 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 176.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . 0.5 ' O ' ' SD ' ' A' ' 299' ' ' MET . 0.1 OUTLIER -94.59 63.97 2.97 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.755 0.312 . . . . 0.0 111.651 -178.302 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.49 100.86 0.08 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 122.233 1.016 . . . . 0.0 110.647 -178.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -64.2 -46.47 83.8 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 113.16 -1.837 . . . . 0.0 113.265 -176.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -59.06 -39.92 83.56 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.161 -177.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . 0.494 ' OE1' ' SD ' ' A' ' 13' ' ' MET . 9.2 tp-100 -65.01 -47.0 79.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.846 0.355 . . . . 0.0 110.351 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 304' ' ' SER . . . . . 0.453 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 39.2 t -67.11 -38.33 85.44 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.776 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 34.7 mmm-85 -62.25 -43.76 98.09 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -179.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -65.35 -36.82 85.18 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -177.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . 0.537 ' HB3' ' HD3' ' A' ' 308' ' ' PRO . . . -60.13 -52.87 70.26 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -176.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 308' ' ' PRO . . . . . 0.537 ' HD3' ' HB3' ' A' ' 307' ' ' ALA . 72.5 Cg_endo -75.07 0.38 9.0 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.374 2.049 . . . . 0.0 112.995 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 309' ' ' PHE . . . . . 0.49 ' C ' ' O ' ' A' ' 308' ' ' PRO . 36.3 p90 . . . . . 0 N--CA 1.481 1.078 0 O-C-N 123.894 0.746 . . . . 0.0 112.923 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 39.9 ttm . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.2 p -79.65 82.93 5.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.516 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.6 t -84.36 155.8 3.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.846 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -64.51 -41.7 96.26 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.287 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -63.67 -41.74 98.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.497 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 45.3 tp -79.6 -26.44 41.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.089 -178.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.26 -41.25 94.81 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 107.714 -2.154 . . . . 0.0 107.714 177.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.422 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -71.66 -32.15 67.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 124.856 2.265 . . . . 0.0 107.625 176.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.43 -42.24 99.11 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-N 108.492 -3.958 . . . . 0.0 108.092 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -70.52 -27.62 64.31 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -66.46 -49.97 64.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.965 -179.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.02 -35.87 79.88 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 118.157 -1.417 . . . . 0.0 110.995 -177.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.463 ' O ' HD23 ' A' ' 29' ' ' LEU . 78.7 m -63.85 -53.94 42.69 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.245 -179.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.682 HD12 ' N ' ' A' ' 27' ' ' ALA . 2.7 pp -65.54 -39.58 85.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -177.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.682 ' N ' HD12 ' A' ' 26' ' ' ILE . . . -63.92 -41.65 97.6 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -173.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 32' ' ' PHE . 8.4 p-10 -77.67 -27.11 50.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 120.464 1.483 . . . . 0.0 109.89 -176.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.463 HD23 ' O ' ' A' ' 25' ' ' CYS . 3.0 mm? -60.33 -55.71 30.3 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 119.531 1.06 . . . . 0.0 111.77 -178.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.6 pt -75.89 -4.84 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 121.188 0.518 . . . . 0.0 112.363 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.478 ' HA ' HD12 ' A' ' 34' ' ' LEU . 53.5 m -109.91 -17.02 13.72 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 117.319 -1.324 . . . . 0.0 109.95 -179.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.443 ' N ' ' O ' ' A' ' 28' ' ' ASP . 10.3 t80 -68.38 -44.88 36.95 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-N 122.67 2.486 . . . . 0.0 110.977 -177.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -60.21 -16.69 41.88 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 CA-C-N 121.05 1.411 . . . . 0.0 112.74 177.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.478 HD12 ' HA ' ' A' ' 31' ' ' THR . 82.9 mt -67.65 -35.08 78.22 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -177.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.555 ' HA ' ' HZ3' ' A' ' 38' ' ' LYS . 5.3 p30 -63.98 -39.56 94.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.133 -178.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.532 ' N ' ' OD1' ' A' ' 35' ' ' ASP . 44.4 p -58.11 -34.02 69.75 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.29 -38.76 85.58 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.555 ' HZ3' ' HA ' ' A' ' 35' ' ' ASP . 12.1 pttm -62.0 -47.7 83.61 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 119.049 -1.06 . . . . 0.0 111.93 -177.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.425 HG23 ' NH1' ' A' ' 40' ' ' ARG . 4.9 m -62.8 -38.98 83.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -176.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.527 ' O ' ' N ' ' A' ' 42' ' ' GLN . 13.0 mmp_? -60.24 -41.08 92.41 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 118.986 -1.085 . . . . 0.0 109.909 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 12.8 tp -62.48 38.98 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.236 178.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.619 HE22 ' CA ' ' A' ' 44' ' ' GLN . 5.1 pp0? -53.0 176.02 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.078 0.466 . . . . 0.0 111.436 -178.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 90.9 mt -45.29 -84.01 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.688 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.619 ' CA ' HE22 ' A' ' 42' ' ' GLN . 10.6 tm0? -150.64 -33.93 0.16 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.439 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -163.69 155.61 27.05 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.412 ' OE1' ' CG1' ' A' ' 51' ' ' VAL . 16.8 mp0 -87.27 168.8 12.87 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.815 0.34 . . . . 0.0 110.532 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.5 t -91.26 1.18 57.29 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -63.34 -25.49 68.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.436 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.03 -6.05 84.04 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.02 -1.632 . . . . 0.0 109.02 -177.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.612 HD23 ' O ' ' A' ' 50' ' ' LEU . 1.3 tt -65.31 -37.66 87.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.583 -0.809 . . . . 0.0 109.638 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.414 HG23 ' N ' ' A' ' 52' ' ' ARG . 16.5 m -60.38 -44.04 95.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.411 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.414 ' N ' HG23 ' A' ' 51' ' ' VAL . 23.7 ttm105 -64.16 -34.04 77.15 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 19.3 m -67.97 -38.26 82.52 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -131.5 78.82 1.85 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.227 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -48.13 -14.91 0.06 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.39 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.62 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 23.1 t -126.23 -140.54 0.28 Allowed 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.62 ' HB3' ' O ' ' A' ' 56' ' ' SER . . . 96.66 13.96 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.706 0 O-C-N 124.062 0.851 . . . . 0.0 111.909 178.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -175.32 69.99 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.653 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -52.36 155.44 2.07 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.402 ' O ' ' C ' ' A' ' 61' ' ' GLY . 75.4 mtp180 -45.35 -37.0 4.54 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 60' ' ' ARG . . . -30.33 103.05 0.01 OUTLIER Glycine 0 CA--C 1.529 0.95 0 CA-C-N 114.993 -1.003 . . . . 0.0 112.478 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 31.0 m -67.42 -33.79 64.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 118.268 -0.872 . . . . 0.0 109.888 176.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.494 ' H ' HD12 ' A' ' 63' ' ' LEU . 6.0 mp -60.27 -32.28 71.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 121.239 1.836 . . . . 0.0 109.881 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.42 -49.2 66.74 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 114.975 -1.011 . . . . 0.0 114.671 -176.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.6 m -62.1 -46.41 89.19 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -178.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 29.0 pt -59.89 -35.97 63.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.638 HD23 ' O ' ' A' ' 67' ' ' LEU . 1.3 tt -63.84 -35.83 81.92 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 121.04 1.745 . . . . 0.0 111.651 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 98.6 m -62.79 -39.47 94.31 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-N 113.674 -1.603 . . . . 0.0 111.049 -175.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 7.6 ptt? -60.39 -39.8 88.6 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 120.648 -1.283 . . . . 0.0 113.819 -176.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.2 p -69.36 -40.7 80.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 119.244 -0.982 . . . . 0.0 113.015 -178.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 55.6 ttm-85 -77.86 -13.44 59.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.979 0.895 . . . . 0.0 112.173 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 71.3 m -63.14 -54.77 32.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.137 -1.392 . . . . 0.0 111.154 178.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -106.29 -59.85 1.73 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.473 178.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 160.98 166.34 19.51 Favored Glycine 0 CA--C 1.535 1.34 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -56.17 -35.15 94.9 Favored 'Trans proline' 0 N--CA 1.5 1.91 0 CA-C-N 119.33 1.565 . . . . 0.0 111.721 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -61.36 -11.15 8.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.739 0.78 . . . . 0.0 111.071 176.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.8 t -77.79 -32.77 52.67 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.248 -1.342 . . . . 0.0 110.876 -178.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.48 ' N ' HD12 ' A' ' 78' ' ' LEU . 9.6 mp -75.86 -33.64 60.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 118.271 0.487 . . . . 0.0 110.958 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -92.53 -4.95 52.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 122.796 1.284 . . . . 0.0 112.76 -178.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -90.69 118.31 30.02 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 112.487 -2.142 . . . . 0.0 107.228 175.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.89 -7.58 57.42 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -178.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.674 ' C ' HD12 ' A' ' 82' ' ' LEU . 0.4 OUTLIER -59.25 -34.51 72.32 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 113.949 -1.125 . . . . 0.0 110.541 -179.092 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.1 p -70.46 -26.67 29.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.525 178.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.73 -31.58 61.87 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.748 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.427 ' O ' ' OE1' ' A' ' 89' ' ' GLN . . . -67.84 -40.26 89.52 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 119.701 -1.238 . . . . 0.0 111.241 -177.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.3 mp -62.0 -40.05 94.34 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 122.598 1.189 . . . . 0.0 112.203 -177.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 49.9 tp60 -60.41 -26.99 67.1 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 112.657 -2.065 . . . . 0.0 108.992 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 46.8 ttt180 -57.56 -53.41 58.42 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 173.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.427 ' OE1' ' O ' ' A' ' 85' ' ' GLY . 13.7 mp0 -67.82 -29.8 69.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 113.437 -1.71 . . . . 0.0 112.196 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 8.8 tpt -60.94 -41.97 97.28 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.044 -179.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 77.9 p -74.9 -35.08 62.25 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 119.225 -0.99 . . . . 0.0 111.729 -177.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -57.93 -43.4 86.24 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 121.293 1.861 . . . . 0.0 113.051 -176.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.41 -32.42 64.42 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.322 -177.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 97.1 p -63.68 -40.55 97.11 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 179.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.415 ' C ' ' H ' ' A' ' 97' ' ' ILE . 18.4 m -67.94 -28.3 40.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.829 177.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -77.63 10.12 2.9 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -177.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.415 ' H ' ' C ' ' A' ' 95' ' ' VAL . 38.8 mm -86.69 -15.39 9.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 177.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -140.45 -48.0 0.05 OUTLIER Glycine 0 CA--C 1.537 1.415 0 CA-C-N 114.569 -1.196 . . . . 0.0 114.267 -177.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.573 ' N ' HD12 ' A' ' 99' ' ' LEU . 8.5 mp -70.76 -13.26 61.99 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 118.586 1.193 . . . . 0.0 112.776 -177.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.486 ' O ' ' CG ' ' A' ' 104' ' ' LYS . 91.8 t80 -81.53 -51.19 8.52 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.234 178.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 1.159 ' OD2' ' NE2' ' A' ' 105' ' ' GLN . 18.4 t70 -69.4 -31.55 69.99 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 113.332 -1.758 . . . . 0.0 111.512 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 51.2 m -68.17 -52.48 34.13 Favored 'General case' 0 CA--C 1.556 1.185 0 CA-C-N 111.138 -2.755 . . . . 0.0 115.918 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.505 ' O ' ' CD2' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -74.66 -26.26 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-N 122.015 2.189 . . . . 0.0 111.505 177.547 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.486 ' CG ' ' O ' ' A' ' 100' ' ' TYR . 16.7 mmtt -68.8 -42.17 77.67 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 111.875 -2.42 . . . . 0.0 112.334 -179.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 1.159 ' NE2' ' OD2' ' A' ' 101' ' ' ASP . 88.1 mt-30 -76.74 -15.95 59.62 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 122.677 1.227 . . . . 0.0 111.056 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -79.44 -23.43 43.15 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 114.105 -1.407 . . . . 0.0 112.202 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.505 ' CD2' ' O ' ' A' ' 103' ' ' VAL . 45.2 m-85 -110.22 -30.27 7.8 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 119.871 1.214 . . . . 0.0 113.278 -175.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.0 t -97.77 9.35 42.84 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 117.257 -1.777 . . . . 0.0 112.844 -178.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.528 ' CD ' HH22 ' A' ' 119' ' ' ARG . 0.0 OUTLIER -52.13 124.2 12.43 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 117.827 -1.082 . . . . 0.0 110.497 179.054 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.549 ' O ' ' CB ' ' A' ' 111' ' ' SER . . . -21.04 -83.33 0.01 OUTLIER Glycine 0 N--CA 1.491 2.352 0 CA-C-N 119.79 1.177 . . . . 0.0 111.699 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.549 ' CB ' ' O ' ' A' ' 110' ' ' GLY . 7.2 t 106.35 -162.28 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 115.424 1.638 . . . . 0.0 115.424 176.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.542 ' O ' ' CG ' ' A' ' 113' ' ' HIS . 33.4 tp10 -108.97 -46.12 3.66 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -176.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.618 ' O ' ' HB2' ' A' ' 114' ' ' ALA . 0.3 OUTLIER 150.44 51.07 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -179.611 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.618 ' HB2' ' O ' ' A' ' 113' ' ' HIS . . . 159.57 -161.36 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 179.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.15 14.79 27.62 Favored Glycine 0 C--O 1.227 -0.314 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.733 177.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 59.9 mt -60.47 -40.56 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.54 -39.97 95.86 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 175.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 34.6 t -58.78 -42.89 90.07 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 176.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.528 HH22 ' CD ' ' A' ' 109' ' ' LYS . 2.4 mpt_? -63.75 -37.3 86.86 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.249 -178.009 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 62.5 tp -63.49 -46.27 86.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.587 0.708 . . . . 0.0 109.145 178.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 59.8 mt -66.83 -44.7 80.43 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.342 178.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.96 -44.94 91.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 119.433 1.015 . . . . 0.0 109.434 177.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -66.15 -44.26 91.51 Favored Glycine 0 CA--C 1.517 0.172 0 C-N-CA 119.806 -1.187 . . . . 0.0 111.244 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 14.6 t -64.05 -44.0 93.8 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.875 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.437 ' O ' HD23 ' A' ' 129' ' ' LEU . 21.7 p -69.53 -48.53 60.14 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 119.22 -0.992 . . . . 0.0 112.054 177.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 25.3 m -65.53 -42.72 91.66 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -174.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -64.19 -44.38 95.73 Favored Glycine 0 N--CA 1.461 0.365 0 CA-C-O 122.945 1.303 . . . . 0.0 112.975 -177.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.413 ' O ' ' CG1' ' A' ' 131' ' ' VAL . . . -60.8 -40.93 94.48 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 111.763 -2.219 . . . . 0.0 106.627 177.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.615 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 1.5 mm? -64.24 -42.23 96.61 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.538 178.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.19 -39.92 96.02 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -177.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.494 HG21 HG22 ' A' ' 183' ' ' VAL . 2.4 p -60.88 -24.74 33.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 122.383 1.087 . . . . 0.0 109.366 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . -57.32 -44.49 84.25 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 113.096 -1.866 . . . . 0.0 111.685 -178.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.492 ' CG1' ' N ' ' A' ' 134' ' ' ALA . 2.6 p -78.91 -48.68 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.785 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.492 ' N ' ' CG1' ' A' ' 133' ' ' VAL . . . -86.52 126.07 34.2 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.527 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.459 ' N ' ' HD2' ' A' ' 136' ' ' PRO . 12.0 tp-100 -171.29 -53.25 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.686 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' A' ' 135' ' ' GLN . 10.9 Cg_endo -51.67 -32.9 46.95 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 121.706 1.604 . . . . 0.0 111.852 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.408 ' CG2' ' NZ ' ' A' ' 141' ' ' LYS . 12.2 m -67.46 -42.44 83.04 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 117.759 -1.576 . . . . 0.0 109.736 -179.067 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -66.89 -43.57 83.11 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -178.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.458 HG23 ' N ' ' A' ' 140' ' ' VAL . 3.2 m -64.73 -44.22 96.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -178.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.458 ' N ' HG23 ' A' ' 139' ' ' VAL . 31.6 m -65.16 -39.03 84.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -177.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.408 ' NZ ' ' CG2' ' A' ' 137' ' ' THR . 33.0 mttp -62.53 -42.15 99.33 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 119.38 -0.928 . . . . 0.0 111.98 -177.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 14.4 m -70.42 -45.41 75.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 120.104 -0.638 . . . . 0.0 110.036 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.02 -36.84 85.68 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.624 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -66.91 -42.02 86.14 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -177.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 24.6 mm100 -65.67 -40.03 91.97 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 118.987 -1.085 . . . . 0.0 110.093 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.32 -34.98 79.61 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -178.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.507 ' NE2' ' O ' ' A' ' 147' ' ' GLN . 2.0 pp0? -59.89 111.1 1.34 Allowed 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 177.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -98.62 -60.88 1.46 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 117.6 -1.191 . . . . 0.0 113.919 -175.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 96.6 mtt-85 -90.67 130.42 36.68 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 122.476 2.398 . . . . 0.0 110.357 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -65.21 -14.21 60.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.436 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 72.41 23.95 77.09 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.488 ' C ' ' H ' ' A' ' 154' ' ' ARG . . . 80.68 -104.29 2.28 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.555 ' C ' ' H ' ' A' ' 155' ' ' ARG . . . 73.75 -33.79 0.87 Allowed Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.488 ' H ' ' C ' ' A' ' 152' ' ' GLY . 51.0 ttp85 67.01 -28.47 0.13 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.423 0.154 . . . . 0.0 111.387 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.555 ' H ' ' C ' ' A' ' 153' ' ' GLY . 28.8 ttm180 -93.67 8.72 39.82 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.87 0.367 . . . . 0.0 110.391 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.428 ' CD2' ' O ' ' A' ' 157' ' ' GLN . 49.8 t80 60.1 139.86 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.627 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.428 ' O ' ' CD2' ' A' ' 156' ' ' TYR . 26.4 mt-30 -84.3 172.37 11.87 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.954 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.66 ' H ' ' CG ' ' A' ' 161' ' ' GLU . 37.0 m -157.05 -178.52 7.43 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.253 0.549 . . . . 0.0 111.054 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.425 ' H ' HG23 ' A' ' 159' ' ' THR . 9.4 p -64.88 -46.55 81.33 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 120.149 -0.62 . . . . 0.0 112.39 -178.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.53 HG13 ' N ' ' A' ' 161' ' ' GLU . 8.3 p -64.72 -45.92 93.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 119.305 -0.958 . . . . 0.0 110.777 -178.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.66 ' CG ' ' H ' ' A' ' 158' ' ' SER . 1.5 pp20? -67.55 -38.74 84.58 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.219 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.527 ' N ' ' OE2' ' A' ' 161' ' ' GLU . . . -61.36 -45.65 93.51 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -178.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.4 ' CD1' ' C ' ' A' ' 163' ' ' TYR . 21.4 t80 -62.5 -50.19 72.36 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.286 -179.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 4.7 mtpm? -69.15 -45.48 69.96 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 -176.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.567 HG23 ' N ' ' A' ' 166' ' ' ILE . 14.4 t -62.69 -44.64 95.72 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -176.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.567 ' N ' HG23 ' A' ' 165' ' ' THR . 20.9 tt -64.65 -38.36 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-O 121.997 0.904 . . . . 0.0 109.559 176.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.45 ' N ' HG23 ' A' ' 166' ' ' ILE . . . -59.73 -36.54 76.78 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 113.834 -1.53 . . . . 0.0 107.821 176.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 13.1 tpp85 -62.26 -50.25 72.47 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 122.393 2.36 . . . . 0.0 111.89 -175.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -74.9 -51.06 14.82 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 123.486 0.715 . . . . 0.0 109.392 177.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -78.1 -36.42 48.06 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 -173.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 91.52 -166.91 30.75 Favored Glycine 0 N--CA 1.468 0.767 0 O-C-N 121.704 -0.622 . . . . 0.0 112.088 177.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.578 HD12 ' N ' ' A' ' 173' ' ' ARG . 2.5 pp -72.97 -43.67 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-O 121.908 0.861 . . . . 0.0 110.469 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.578 ' N ' HD12 ' A' ' 172' ' ' ILE . 24.9 tpt85 -58.89 -33.86 70.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.199 -1.364 . . . . 0.0 111.0 -177.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -60.9 -40.64 98.61 Favored Glycine 0 CA--C 1.522 0.511 0 C-N-CA 118.619 -1.753 . . . . 0.0 109.646 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 17.8 tp -70.34 -33.77 71.88 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 111.319 -2.44 . . . . 0.0 116.803 -177.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 7.3 m0 -78.01 -7.44 56.88 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 111.845 -2.434 . . . . 0.0 109.783 -177.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -43.39 -47.99 6.99 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.529 -0.759 . . . . 0.0 112.521 -176.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -91.51 -34.31 7.5 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 123.978 0.799 . . . . 0.0 111.81 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 44.7 p -45.19 -51.21 10.85 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.41 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 1.6 t -62.44 -50.8 77.33 Favored Pre-proline 0 N--CA 1.47 0.562 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -176.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' A' ' 180' ' ' SER . 29.5 Cg_endo -64.96 -28.32 57.99 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.402 1.402 . . . . 0.0 111.377 176.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -63.95 -39.13 93.43 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.494 HG22 HG21 ' A' ' 131' ' ' VAL . 56.4 t -63.01 -43.15 98.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.219 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.75 -40.01 95.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.762 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 9.1 tmm_? -61.31 -42.39 98.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.422 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -61.81 -43.69 98.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.081 0.467 . . . . 0.0 110.53 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.62 -43.84 92.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.952 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 79.4 mt -63.35 -45.35 98.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.856 -178.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 84.7 t -60.09 -47.4 92.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 119.465 -0.894 . . . . 0.0 111.033 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -62.91 -42.99 99.98 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 122.311 1.053 . . . . 0.0 110.194 178.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' CYS . . . . . . . . . . . . . 37.5 t -61.86 -45.63 92.93 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 113.422 -1.717 . . . . 0.0 109.685 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -63.91 -39.57 94.48 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 113.193 -1.822 . . . . 0.0 109.94 176.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.5 -44.95 92.97 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.557 0.743 . . . . 0.0 111.522 -176.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 37.6 tp -64.87 -38.23 90.28 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.971 -176.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 92.1 t -64.47 -47.43 89.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 117.893 -1.523 . . . . 0.0 110.508 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 3.1 t -64.55 -44.24 91.41 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.057 0.943 . . . . 0.0 113.172 -177.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -54.75 -38.28 66.99 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.821 0.848 . . . . 0.0 111.372 -176.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -56.42 -44.09 80.04 Favored 'General case' 0 C--N 1.313 -0.997 0 O-C-N 121.739 -0.6 . . . . 0.0 110.451 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.677 ' N ' HD22 ' A' ' 199' ' ' LEU . 2.8 mm? -61.71 -41.09 97.15 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -177.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 200' ' ' ILE . 6.3 pt -64.23 -40.61 89.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.68 179.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -57.66 -38.54 75.27 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.461 1.904 . . . . 0.0 113.846 -178.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -65.43 -38.9 91.28 Favored 'General case' 0 C--O 1.245 0.861 0 C-N-CA 117.932 -1.507 . . . . 0.0 111.105 -177.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 55.1 m -102.61 128.9 49.09 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 122.369 1.081 . . . . 0.0 112.736 -178.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.519 HD22 ' CD1' ' A' ' 209' ' ' LEU . 1.2 mt 67.27 2.65 2.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 112.945 -1.934 . . . . 0.0 112.048 178.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.79 24.03 11.31 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.817 ' O ' ' N ' ' A' ' 208' ' ' ASN . 57.4 pttt -96.78 173.38 7.34 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 178.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . 48.91 -67.15 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 O-C-N 126.116 2.135 . . . . 0.0 110.658 -178.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . 0.817 ' N ' ' O ' ' A' ' 206' ' ' LYS . 9.6 p-10 164.92 109.71 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 111.976 -2.374 . . . . 0.0 106.229 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.522 ' O ' ' HG ' ' A' ' 209' ' ' LEU . 13.4 tp -48.97 17.48 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 108.846 -3.797 . . . . 0.0 112.564 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . 0.69 ' H ' ' C ' ' A' ' 208' ' ' ASN . 4.3 ptm -119.96 134.02 55.37 Favored 'General case' 0 C--N 1.314 -0.95 0 O-C-N 121.632 -0.668 . . . . 0.0 110.499 178.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.424 HG22 ' H ' ' A' ' 212' ' ' ASP . 3.9 m -154.7 -127.93 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.694 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . 0.424 ' H ' HG22 ' A' ' 211' ' ' THR . 73.8 m-20 -132.37 -35.37 1.17 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.356 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -79.4 68.23 5.36 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.197 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.48 ' N ' ' HD2' ' A' ' 215' ' ' PRO . 12.4 mt -61.28 -44.48 93.36 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 214' ' ' LEU . 23.0 Cg_endo -61.43 -33.31 88.65 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 CA-C-N 120.944 1.373 . . . . 0.0 111.052 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 85.8 m -64.6 -42.47 95.54 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 113.487 -1.688 . . . . 0.0 111.969 -178.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' HIS . . . . . 0.628 ' NE2' ' CD2' ' A' ' 218' ' ' PHE . 1.8 p-80 -66.78 -37.9 85.49 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' PHE . . . . . 0.628 ' CD2' ' NE2' ' A' ' 217' ' ' HIS . 1.4 m-85 -63.14 -47.29 83.37 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.322 -178.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 89.7 m -60.13 -37.8 81.16 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 118.73 0.696 . . . . 0.0 110.925 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 67.9 m -59.35 -41.42 89.17 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.569 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -63.62 -41.4 98.29 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -177.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -61.43 -46.8 88.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 122.077 0.942 . . . . 0.0 112.786 -176.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -60.1 -41.66 98.17 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 107.164 -2.374 . . . . 0.0 107.164 177.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -62.77 -37.78 87.99 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 176.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -61.82 -42.38 99.74 Favored Glycine 0 CA--C 1.523 0.584 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.843 -178.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' PHE . . . . . 0.432 ' O ' ' OG1' ' A' ' 229' ' ' THR . 55.5 t80 -66.39 -38.3 87.2 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 15.7 t -62.84 -40.7 98.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.532 0.682 . . . . 0.0 109.248 176.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.457 ' O ' HG22 ' A' ' 231' ' ' ILE . 0.4 OUTLIER -61.43 -40.09 93.19 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.589 -179.492 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' A' ' 226' ' ' PHE . 19.7 p -59.36 -39.63 83.88 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.85 -177.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 92.6 t -60.82 -42.61 93.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 119.006 -1.078 . . . . 0.0 111.969 -178.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.457 HG22 ' O ' ' A' ' 228' ' ' THR . 3.8 tp -62.4 -40.22 87.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 176.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -62.1 -39.77 93.63 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.503 ' N ' ' HD2' ' A' ' 234' ' ' PRO . 66.2 m -58.71 -42.81 96.27 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 115.768 1.766 . . . . 0.0 115.768 -175.017 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 233' ' ' SER . 21.0 Cg_endo -59.89 -40.72 60.24 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 CA-C-N 121.051 1.411 . . . . 0.0 113.9 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.42 ' H ' HG22 ' A' ' 235' ' ' VAL . 11.1 m -65.14 -36.5 77.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.008 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -64.96 -41.24 95.64 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -178.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.42 ' H ' HG22 ' A' ' 237' ' ' VAL . 5.7 m -65.64 -45.58 91.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -177.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 57.3 t -63.1 -38.19 81.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -177.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 5.1 ptmm? -60.73 -43.23 98.15 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.082 -0.647 . . . . 0.0 111.34 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 37.6 p -60.58 -41.87 95.52 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.304 -0.407 . . . . 0.0 112.002 -178.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.592 ' NH1' ' CD1' ' A' ' 269' ' ' PHE . 71.7 ttt180 -46.57 138.19 6.11 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.435 -0.506 . . . . 0.0 109.797 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.628 ' O ' ' CG ' ' A' ' 242' ' ' TYR . 5.0 t80 169.37 8.53 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' MET . . . . . 0.578 ' SD ' ' N ' ' A' ' 243' ' ' MET . 2.0 mpt? -92.86 -24.58 18.43 Favored 'General case' 0 N--CA 1.463 0.19 0 O-C-N 121.726 -0.609 . . . . 0.0 109.632 177.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . 0.492 ' C ' ' O ' ' A' ' 243' ' ' MET . 6.9 p30 -28.18 133.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.734 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . 0.576 ' O ' ' O ' ' A' ' 246' ' ' ALA . 6.6 t -91.55 -147.93 0.22 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.589 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . 0.629 ' O ' ' C ' ' A' ' 247' ' ' LEU . . . 55.77 126.97 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 -170.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.937 ' CB ' ' HA2' ' A' ' 248' ' ' GLY . 0.3 OUTLIER -21.87 -71.17 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.2 -171.937 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.997 ' O ' ' HB2' ' A' ' 249' ' ' GLN . . . -137.84 43.13 1.22 Allowed Glycine 0 N--CA 1.451 -0.358 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 -1.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.997 ' HB2' ' O ' ' A' ' 248' ' ' GLY . 3.2 mt-30 102.65 118.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.703 0.287 . . . . 0.0 110.493 -178.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.538 ' HE1' ' CA ' ' A' ' 252' ' ' SER . 6.1 t80 -149.9 136.14 18.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.048 0.451 . . . . 0.0 111.795 -178.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -136.25 -23.67 1.28 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 176.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . 0.538 ' CA ' ' HE1' ' A' ' 250' ' ' TYR . 9.6 t 179.22 -173.13 0.17 Allowed 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -59.72 -43.44 94.16 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 179.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -55.52 -34.89 60.52 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 125.21 1.386 . . . . 0.0 111.268 -172.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' HIS . . . . . 0.785 ' NE2' HG21 ' A' ' 259' ' ' THR . 86.4 t60 -55.92 -32.11 63.49 Favored 'General case' 0 C--N 1.369 1.441 0 C-N-CA 115.514 -2.474 . . . . 0.0 111.061 178.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' CYS . . . . . . . . . . . . . 7.1 t -60.75 -45.68 93.38 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.116 178.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -61.17 -46.0 92.3 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.194 -0.602 . . . . 0.0 111.532 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 20.2 mt -67.93 -43.97 77.93 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.691 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . 0.785 HG21 ' NE2' ' A' ' 255' ' ' HIS . 24.8 p -63.48 -46.88 84.14 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 -178.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' MET . . . . . 0.601 ' SD ' ' N ' ' A' ' 261' ' ' LEU . 0.0 OUTLIER -61.8 -44.37 97.0 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.214 -0.594 . . . . 0.0 112.47 -177.273 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.601 ' N ' ' SD ' ' A' ' 260' ' ' MET . 12.5 tp -62.62 -46.67 87.2 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.607 0.242 . . . . 0.0 110.444 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 52.5 ttp180 -66.14 -53.76 33.71 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.805 -178.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . 0.442 ' HB3' ' HZ3' ' A' ' 263' ' ' LYS . 0.0 OUTLIER -123.33 160.95 25.64 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 120.938 0.399 . . . . 0.0 111.044 179.272 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . 0.464 ' O ' ' O ' ' A' ' 265' ' ' GLY . 72.6 mt-10 57.83 88.71 0.06 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.278 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 264' ' ' GLU . . . -38.04 166.07 0.01 OUTLIER Glycine 0 CA--C 1.531 1.058 0 N-CA-C 111.669 -0.572 . . . . 0.0 111.669 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -63.4 -5.07 7.63 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 122.817 2.344 . . . . 0.0 111.596 179.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 18.3 ptp180 -69.63 -26.58 64.49 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 123.086 0.554 . . . . 0.0 111.685 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -58.52 -32.49 68.88 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.895 -179.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . 0.592 ' CD1' ' NH1' ' A' ' 241' ' ' ARG . 57.2 m-85 -62.53 -41.87 99.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.237 0.541 . . . . 0.0 110.753 177.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -65.93 -37.77 86.92 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.84 -178.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp -77.99 -175.16 3.91 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 44.45 84.85 0.01 OUTLIER Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.371 -1.091 . . . . 0.0 110.371 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -152.78 6.79 0.4 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.558 0.218 . . . . 0.0 110.769 -179.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' MET . . . . . 0.587 ' N ' ' CD ' ' A' ' 275' ' ' PRO . 1.9 tpt -63.66 -43.92 78.86 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 274' ' ' MET . 23.0 Cg_exo -64.12 -46.72 7.54 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.343 2.029 . . . . 0.0 111.205 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 37.4 t -61.0 -40.67 94.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.23 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -62.41 -43.44 98.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 122.88 1.324 . . . . 0.0 113.163 -178.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 8.0 tt -62.01 -38.57 89.14 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 111.897 -2.411 . . . . 0.0 107.072 174.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.69 -40.32 96.75 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.843 178.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 8.2 tp -62.32 -37.24 84.82 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -178.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -67.95 -50.6 39.75 Favored Glycine 0 CA--C 1.52 0.399 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 -178.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.14 -44.38 96.76 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' TRP . . . . . 0.503 ' O ' HG22 ' A' ' 286' ' ' VAL . 57.1 t-105 -60.26 -38.67 84.2 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -63.18 -38.5 91.44 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.725 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 54.8 t -61.11 -39.24 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 -178.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.68 ' O ' HG12 ' A' ' 289' ' ' VAL . 6.9 m -62.6 -39.99 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 119.848 -0.741 . . . . 0.0 110.574 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' MET . . . . . 0.456 ' C ' ' SD ' ' A' ' 287' ' ' MET . 0.0 OUTLIER -60.94 -38.87 87.35 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 122.128 -0.357 . . . . 0.0 110.503 179.758 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -59.32 -41.61 89.51 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -178.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.68 HG12 ' O ' ' A' ' 286' ' ' VAL . 7.4 p -61.52 -37.72 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.027 -179.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 51.2 p -61.67 -39.43 91.37 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 177.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -60.37 -38.49 84.05 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 177.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.99 -39.93 79.45 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 117.948 -1.501 . . . . 0.0 109.488 -176.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' GLN . . . . . 0.45 ' O ' ' O ' ' A' ' 296' ' ' ARG . 80.3 mt-30 -60.37 -42.47 95.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 122.678 1.228 . . . . 0.0 110.641 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 8.9 mp -60.43 -40.26 90.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 112.632 -2.076 . . . . 0.0 109.003 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 17.9 tptp -63.02 -45.84 90.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.266 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' ARG . . . . . 0.45 ' O ' ' O ' ' A' ' 293' ' ' GLN . 64.0 ttm-85 -123.06 116.37 23.38 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.264 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -116.82 -93.2 0.51 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.125 0.488 . . . . 0.0 111.318 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.803 HD22 ' N ' ' A' ' 299' ' ' MET . 0.0 OUTLIER -137.39 -170.89 2.84 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.394 178.4 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . 0.803 ' N ' HD22 ' A' ' 298' ' ' LEU . 34.8 ttm -169.32 65.91 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.625 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.68 101.04 0.07 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.928 0.871 . . . . 0.0 110.583 -178.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -64.0 -46.26 85.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 113.822 -1.536 . . . . 0.0 113.331 -176.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -58.65 -39.89 81.89 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.119 -0.633 . . . . 0.0 109.791 -178.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 6.6 tm0? -65.01 -47.0 79.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.487 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 304' ' ' SER . . . . . 0.429 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 50.0 m -66.71 -37.83 85.51 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.509 -0.477 . . . . 0.0 110.581 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -61.7 -43.22 99.28 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -65.04 -36.97 86.08 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -176.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . 0.544 ' HB3' ' HD3' ' A' ' 308' ' ' PRO . . . -60.02 -52.94 69.89 Favored Pre-proline 0 CA--C 1.545 0.76 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 -176.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 308' ' ' PRO . . . . . 0.544 ' HD3' ' HB3' ' A' ' 307' ' ' ALA . 74.0 Cg_endo -75.23 0.21 9.27 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.053 1.835 . . . . 0.0 111.793 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 52.4 t80 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.499 -179.996 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.579 ' N ' ' NE2' ' A' ' 303' ' ' GLN . 2.2 mpt? . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.9 m -159.67 104.08 1.57 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.496 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.4 t -137.97 150.08 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.495 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.1 mmmm -64.41 -41.87 96.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.905 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -63.61 -41.34 98.31 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.4 tt -79.59 -26.23 41.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.443 -178.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.402 ' O ' ' OG1' ' A' ' 22' ' ' THR . . . -66.18 -41.42 94.88 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 107.761 -2.135 . . . . 0.0 107.761 177.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.425 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -71.6 -32.25 67.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 124.889 2.281 . . . . 0.0 107.657 176.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.29 -42.26 99.3 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-N 108.448 -3.978 . . . . 0.0 108.165 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.402 ' OG1' ' O ' ' A' ' 19' ' ' GLY . 32.6 p -70.62 -27.32 63.99 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 177.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -66.51 -50.04 64.55 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.775 -1.102 . . . . 0.0 112.194 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.97 -35.89 79.83 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 118.482 -1.287 . . . . 0.0 111.204 -177.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.0 t -63.78 -53.39 51.64 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.847 -178.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 71.2 mt -65.43 -39.74 86.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 -177.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.57 -42.19 95.81 Favored 'General case' 0 C--N 1.333 -0.109 0 C-N-CA 119.84 -0.744 . . . . 0.0 112.946 -174.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.459 ' CB ' ' OE1' ' A' ' 89' ' ' GLN . 16.7 m-20 -78.24 -27.49 47.66 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 117.964 -1.495 . . . . 0.0 109.084 -177.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.5 tp -59.98 -56.05 26.46 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 118.546 -1.262 . . . . 0.0 111.113 -178.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.2 pp -75.73 -5.24 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 19.1 m -110.17 -17.96 13.42 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 118.811 -1.155 . . . . 0.0 109.941 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.508 ' N ' ' HD2' ' A' ' 33' ' ' PRO . 72.7 t80 -68.27 -45.22 38.55 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 121.308 1.867 . . . . 0.0 112.235 -177.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 32' ' ' PHE . 20.8 Cg_endo -59.42 -14.73 26.49 Favored 'Trans proline' 0 N--CA 1.5 1.872 0 CA-C-N 121.147 1.445 . . . . 0.0 111.147 176.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.57 HD23 ' O ' ' A' ' 34' ' ' LEU . 0.7 OUTLIER -66.31 -35.41 80.3 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 114.686 -1.143 . . . . 0.0 113.086 -177.139 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -64.69 -40.55 95.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.278 -178.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 52.1 p -58.39 -34.9 71.23 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.3 -38.27 84.73 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.72 -0.792 . . . . 0.0 112.534 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.446 ' CG ' ' N ' ' A' ' 39' ' ' VAL . 10.7 pttp -62.01 -48.93 78.12 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 119.576 -0.85 . . . . 0.0 111.69 -176.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.446 ' N ' ' CG ' ' A' ' 38' ' ' LYS . 8.8 p -64.8 -39.89 87.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -177.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.55 HH22 HE22 ' A' ' 58' ' ' GLN . 6.4 tpm_? -61.04 -42.86 99.28 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -177.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.423 ' CD1' ' O ' ' A' ' 38' ' ' LYS . 2.4 pp -63.15 38.73 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.799 178.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.529 ' N ' ' O ' ' A' ' 40' ' ' ARG . 42.7 tt0 -145.25 165.68 27.69 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.901 0.382 . . . . 0.0 111.273 -178.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.729 ' H ' HD13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -73.57 79.17 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.62 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -44.89 135.99 4.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.857 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.99 135.88 0.24 Allowed Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.502 ' O ' ' N ' ' A' ' 48' ' ' GLN . 11.1 pt-20 -94.16 150.51 20.25 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.71 0.291 . . . . 0.0 110.564 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 49.9 m 57.45 -80.55 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.571 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.502 ' N ' ' O ' ' A' ' 46' ' ' GLU . 63.7 mt-30 55.0 178.54 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.212 0.53 . . . . 0.0 111.049 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -153.3 -22.66 0.05 OUTLIER Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.58 HD22 ' N ' ' A' ' 50' ' ' LEU . 3.5 mm? -66.63 -38.5 87.05 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.539 HG23 ' N ' ' A' ' 52' ' ' ARG . 20.5 m -61.15 -44.28 98.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.992 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.539 ' N ' HG23 ' A' ' 51' ' ' VAL . 33.4 mtm-85 -64.31 -33.64 76.3 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.357 -179.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 19.1 m -67.6 -38.32 83.81 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.652 ' O ' ' HB2' ' A' ' 55' ' ' ALA . . . -95.44 -122.1 0.11 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.195 178.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.652 ' HB2' ' O ' ' A' ' 54' ' ' ALA . . . 162.87 -22.71 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 121.191 -0.203 . . . . 0.0 110.842 179.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.623 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 4.6 m -128.53 -138.31 0.24 Allowed 'General case' 0 C--N 1.334 -0.107 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.623 ' HB3' ' O ' ' A' ' 56' ' ' SER . . . 93.59 14.99 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 O-C-N 123.883 0.74 . . . . 0.0 111.937 178.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.55 HE22 HH22 ' A' ' 40' ' ' ARG . 27.7 mt-30 -152.92 55.99 0.78 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -41.91 132.8 3.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.187 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 63.3 mtm-85 -41.02 -42.92 2.03 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.34 0.59 . . . . 0.0 109.921 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -31.95 104.22 0.01 OUTLIER Glycine 0 CA--C 1.527 0.834 0 CA-C-N 114.853 -1.067 . . . . 0.0 112.476 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 26.2 m -67.11 -33.58 64.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 118.262 -0.875 . . . . 0.0 109.046 176.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -60.0 -32.32 70.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 121.061 1.755 . . . . 0.0 109.785 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -65.1 -49.59 61.45 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-N 115.393 -0.821 . . . . 0.0 114.534 -177.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.3 m -62.57 -46.88 86.3 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -178.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.8 pp -60.27 -35.18 60.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.548 ' O ' HD13 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -63.35 -35.56 80.81 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 120.853 1.66 . . . . 0.0 110.948 179.527 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 98.8 m -61.77 -39.19 90.78 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 113.168 -1.833 . . . . 0.0 111.034 -176.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 15.5 tpt -60.51 -39.47 87.91 Favored 'General case' 0 C--N 1.332 -0.179 0 O-C-N 121.135 -0.978 . . . . 0.0 113.531 -177.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.5 t -68.98 -40.42 80.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 119.192 -1.003 . . . . 0.0 112.652 -177.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 56.9 ttt-85 -77.63 -13.39 59.92 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.94 0.876 . . . . 0.0 112.736 -178.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 49.3 m -62.87 -55.12 28.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.17 -1.377 . . . . 0.0 112.338 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -108.74 -58.78 1.97 Allowed 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 159.37 163.81 13.78 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -56.51 -34.89 96.08 Favored 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 122.229 1.953 . . . . 0.0 111.605 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 12.3 tpp180 -61.16 -11.22 8.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.908 0.861 . . . . 0.0 111.056 176.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.5 t -77.36 -32.1 54.79 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 113.953 -1.476 . . . . 0.0 110.994 -177.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 19.3 mt -75.61 -33.66 60.54 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.286 -0.566 . . . . 0.0 111.156 179.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.427 ' C ' ' H ' ' A' ' 81' ' ' GLY . 61.6 m-85 -92.81 -5.33 51.32 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 122.305 1.05 . . . . 0.0 113.386 -178.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.433 ' CG ' ' O ' ' A' ' 80' ' ' ASN . 21.5 t30 -86.25 33.9 0.62 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 112.957 -1.929 . . . . 0.0 107.393 175.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' A' ' 79' ' ' TYR . . . -172.9 -9.78 0.02 OUTLIER Glycine 0 CA--C 1.526 0.747 0 CA-C-N 114.485 -1.234 . . . . 0.0 112.535 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.411 ' H ' ' H ' ' A' ' 81' ' ' GLY . 61.2 tp -59.48 -35.07 73.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.469 -0.866 . . . . 0.0 110.963 -178.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.2 m -70.74 -26.84 28.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.799 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.63 -31.45 61.99 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.793 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.8 -40.18 89.73 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 119.893 -1.146 . . . . 0.0 111.751 -177.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -62.63 -40.28 96.5 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 122.16 0.981 . . . . 0.0 113.094 -176.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 20.2 tm0? -60.39 -27.44 67.44 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 113.349 -1.751 . . . . 0.0 109.456 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 72.7 mtt-85 -58.07 -53.46 57.96 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 173.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.459 ' OE1' ' CB ' ' A' ' 28' ' ' ASP . 23.6 mm100 -67.15 -29.97 69.83 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 112.08 -2.327 . . . . 0.0 112.373 -177.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 10.4 tpp -61.2 -40.46 94.04 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.078 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 68.3 m -74.64 -34.16 62.69 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 118.346 -0.835 . . . . 0.0 111.339 -176.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -57.58 -44.11 85.1 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 120.701 1.591 . . . . 0.0 112.044 -176.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.48 -33.0 64.61 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.466 -0.893 . . . . 0.0 111.025 -178.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 59.6 p -64.03 -41.87 97.28 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.412 ' C ' ' H ' ' A' ' 97' ' ' ILE . 34.3 m -68.18 -27.81 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.988 177.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.415 ' HG3' ' CD1' ' A' ' 100' ' ' TYR . 47.6 ttp85 -77.21 8.54 3.9 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -176.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.433 ' O ' HG22 ' A' ' 97' ' ' ILE . 46.3 mm -87.71 -15.08 9.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 177.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -140.25 -48.3 0.05 OUTLIER Glycine 0 CA--C 1.538 1.53 0 N-CA-C 115.902 1.121 . . . . 0.0 115.902 -175.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.0 tp -71.1 -13.23 61.89 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 119.249 1.524 . . . . 0.0 112.244 -177.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.521 ' O ' ' CG ' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -80.86 -51.28 8.76 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 114.688 -1.142 . . . . 0.0 111.834 179.71 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.509 ' O ' ' HG3' ' A' ' 105' ' ' GLN . 2.4 p30 -69.23 -32.48 71.75 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 123.768 1.747 . . . . 0.0 110.47 -178.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 25.8 m -68.17 -51.79 41.83 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 110.234 -3.167 . . . . 0.0 113.327 177.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 47.0 t -73.63 -26.28 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 CA-C-N 121.405 1.911 . . . . 0.0 111.257 178.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.521 ' CG ' ' O ' ' A' ' 100' ' ' TYR . 20.7 mmtp -69.32 -41.61 76.48 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 112.523 -2.126 . . . . 0.0 111.582 179.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.509 ' HG3' ' O ' ' A' ' 101' ' ' ASP . 88.1 mt-30 -80.1 -15.66 56.66 Favored 'General case' 0 C--O 1.245 0.847 0 CA-C-O 122.065 0.936 . . . . 0.0 110.998 -178.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -80.48 -22.29 41.17 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 121.741 -0.6 . . . . 0.0 112.109 179.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.414 ' O ' ' NE ' ' A' ' 119' ' ' ARG . 13.8 m-85 -109.07 -28.62 8.97 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.692 0.797 . . . . 0.0 111.794 -174.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.2 m -96.12 9.49 40.73 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 116.752 -1.979 . . . . 0.0 113.639 -176.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -46.46 124.7 6.1 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.997 1.271 . . . . 0.0 109.49 176.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -131.55 40.91 1.57 Allowed Glycine 0 N--CA 1.479 1.549 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 178.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 14.8 m -67.5 -37.63 83.12 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 -176.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -125.43 162.41 24.91 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 120.759 0.314 . . . . 0.0 111.084 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.628 ' O ' ' HB2' ' A' ' 114' ' ' ALA . 6.7 p-80 -77.03 67.33 3.0 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -178.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.628 ' HB2' ' O ' ' A' ' 113' ' ' HIS . . . 159.06 -163.06 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 176.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 101.57 15.33 27.5 Favored Glycine 0 C--N 1.343 0.949 0 CA-C-N 113.873 -1.512 . . . . 0.0 113.238 175.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 25.4 mm -61.1 -40.99 87.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 CA-C-N 118.416 1.108 . . . . 0.0 110.31 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.33 -39.96 96.22 Favored Glycine 0 C--N 1.346 1.095 0 CA-C-O 122.237 0.909 . . . . 0.0 111.361 176.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.1 t -57.48 -41.72 81.23 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 177.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.481 ' CD ' HD21 ' A' ' 194' ' ' LEU . 26.9 ttm180 -63.18 -37.54 87.61 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.474 -0.491 . . . . 0.0 111.249 -177.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -64.32 -46.28 84.23 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 177.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 31.5 mt -66.64 -45.1 80.09 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 118.978 -1.089 . . . . 0.0 110.145 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.97 -45.18 90.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 119.813 1.188 . . . . 0.0 110.315 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.413 ' CA ' ' CZ ' ' A' ' 107' ' ' TYR . . . -65.79 -44.28 92.48 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.766 -178.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 59.0 m -63.83 -43.66 95.52 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 19.1 m -69.06 -48.01 63.86 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 119.526 -0.87 . . . . 0.0 112.416 177.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.48 HG23 ' N ' ' A' ' 127' ' ' GLY . 5.7 t -65.47 -42.51 92.2 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 -173.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.572 ' C ' HD21 ' A' ' 186' ' ' ASN . . . -64.46 -44.73 94.84 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-O 122.543 1.08 . . . . 0.0 113.736 -177.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.03 -40.8 94.98 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 112.689 -1.756 . . . . 0.0 107.204 178.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.542 HD13 ' O ' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -62.84 -41.22 99.26 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 114.86 -1.063 . . . . 0.0 109.576 178.93 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -61.82 -38.44 88.17 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.74 -0.209 . . . . 0.0 111.38 -178.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 79.1 t -60.63 -25.91 36.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.742 0.782 . . . . 0.0 109.836 179.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . -57.9 -44.41 86.73 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.236 -1.347 . . . . 0.0 111.215 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 43.1 t -78.73 -49.15 20.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.563 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -99.89 124.52 45.29 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 110.248 -0.278 . . . . 0.0 110.248 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.461 ' N ' ' HD2' ' A' ' 136' ' ' PRO . 33.2 tt0 -176.62 -54.49 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 135' ' ' GLN . 11.2 Cg_endo -52.3 -34.81 61.67 Favored 'Trans proline' 0 N--CA 1.5 1.885 0 C-N-CA 121.389 1.393 . . . . 0.0 113.902 -177.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 81.0 p -67.54 -41.77 83.77 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 118.491 -1.284 . . . . 0.0 109.369 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -64.58 -42.43 95.63 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 118.977 -1.089 . . . . 0.0 112.746 -176.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 17.2 m -63.81 -43.35 97.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 54.3 t -64.53 -38.47 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -178.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -61.47 -40.33 94.14 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 119.978 -0.689 . . . . 0.0 112.106 -176.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.3 p -69.39 -44.42 80.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.535 HH21 ' CD ' ' A' ' 170' ' ' GLU . 12.4 tpt85 -63.98 -35.83 81.99 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.951 179.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.488 ' CD2' ' OE1' ' A' ' 147' ' ' GLN . 40.9 t80 -65.96 -40.22 91.09 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.975 -177.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -63.72 -38.91 92.88 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.358 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -64.86 -34.76 79.15 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -178.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.488 ' OE1' ' CD2' ' A' ' 144' ' ' PHE . 5.0 pt20 -59.48 111.1 1.27 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 178.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -97.55 -61.61 1.37 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 117.523 -1.227 . . . . 0.0 113.951 -176.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 14.1 mtp-105 -101.4 135.52 42.75 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 122.273 2.306 . . . . 0.0 109.903 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -75.35 -113.37 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.519 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 175.19 131.47 1.44 Allowed Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -55.18 126.33 38.57 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 175.82 30.68 0.04 OUTLIER Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 49.0 mmt-85 55.45 172.2 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.786 0.327 . . . . 0.0 110.608 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 83.9 mtt85 54.12 -179.99 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.666 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.501 ' CD2' ' O ' ' A' ' 157' ' ' GLN . 91.8 t80 -123.94 127.22 47.64 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.368 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.501 ' O ' ' CD2' ' A' ' 156' ' ' TYR . 24.0 mt-30 -49.51 170.46 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.552 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 45.2 p -156.94 -178.25 7.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.954 0.407 . . . . 0.0 110.789 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.555 HG23 ' N ' ' A' ' 160' ' ' VAL . 11.7 t -64.5 -46.36 83.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.792 -177.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.573 HG13 ' N ' ' A' ' 161' ' ' GLU . 12.7 p -64.63 -45.52 95.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 118.898 -1.121 . . . . 0.0 109.077 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.573 ' N ' HG13 ' A' ' 160' ' ' VAL . 74.6 tt0 -66.99 -38.95 86.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.996 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -61.41 -45.78 92.91 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -177.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.613 ' CE2' HD13 ' A' ' 175' ' ' LEU . 12.7 t80 -62.85 -50.42 71.02 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.923 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -68.77 -45.42 71.4 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 115.162 1.541 . . . . 0.0 115.162 -175.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 10.0 m -63.24 -44.44 95.19 Favored 'General case' 0 C--N 1.321 -0.658 0 O-C-N 121.137 -0.977 . . . . 0.0 113.25 -178.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.446 ' O ' HD13 ' A' ' 166' ' ' ILE . 0.2 OUTLIER -64.64 -38.72 83.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 122.199 0.999 . . . . 0.0 109.156 177.554 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.94 -36.64 77.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 113.201 -1.818 . . . . 0.0 109.137 177.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -62.62 -51.0 69.02 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 122.5 2.409 . . . . 0.0 112.713 -174.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -75.38 -51.07 14.01 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 177.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.535 ' CD ' HH21 ' A' ' 143' ' ' ARG . 16.3 tt0 -78.67 -36.42 43.79 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -175.016 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 95.62 -169.03 26.95 Favored Glycine 0 N--CA 1.467 0.764 0 CA-C-N 118.13 0.423 . . . . 0.0 112.57 177.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.406 HG12 ' H ' ' A' ' 172' ' ' ILE . 6.0 pt -72.92 -40.71 60.11 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.129 0 CA-C-O 121.978 0.894 . . . . 0.0 110.396 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 9.1 tpp85 -58.68 -33.63 70.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 113.859 -1.519 . . . . 0.0 110.952 -177.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -60.91 -40.82 98.88 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 118.676 -1.726 . . . . 0.0 110.244 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.613 HD13 ' CE2' ' A' ' 163' ' ' TYR . 6.8 mt -70.84 -33.64 70.87 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 111.286 -2.457 . . . . 0.0 116.975 -177.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 11.1 m0 -78.35 -7.76 57.66 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 112.456 -2.156 . . . . 0.0 109.752 -176.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -43.47 -48.49 7.27 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.535 -0.466 . . . . 0.0 112.154 -175.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.429 ' O ' ' HD2' ' A' ' 181' ' ' PRO . . . -79.11 -13.63 82.74 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 124.444 1.021 . . . . 0.0 111.933 178.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.422 ' O ' ' OD1' ' A' ' 182' ' ' ASN . 84.6 m -46.33 -51.44 14.71 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.86 -50.95 74.9 Favored Pre-proline 0 N--CA 1.475 0.789 0 N-CA-C 114.287 1.218 . . . . 0.0 114.287 -174.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.429 ' HD2' ' O ' ' A' ' 178' ' ' GLY . 29.1 Cg_exo -64.52 -29.96 61.58 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 CA-C-N 120.678 1.278 . . . . 0.0 113.279 177.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 179' ' ' THR . 0.0 OUTLIER -65.53 -40.85 93.42 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 119.366 -0.934 . . . . 0.0 109.896 178.876 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 54.9 t -64.35 -43.12 97.07 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.166 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.083 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.66 -39.79 95.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.178 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.789 ' HE ' ' HZ2' ' A' ' 239' ' ' LYS . 0.7 OUTLIER -60.88 -43.55 98.31 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 119.789 -0.764 . . . . 0.0 110.885 -178.704 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . 0.572 HD21 ' C ' ' A' ' 127' ' ' GLY . 35.3 t30 -63.36 -45.43 91.22 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.744 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -66.59 -45.86 77.82 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.07 -46.25 91.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -177.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.629 ' CG1' HH21 ' A' ' 185' ' ' ARG . 35.6 m -60.86 -47.81 91.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 119.224 -0.99 . . . . 0.0 111.899 -177.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.53 ' N ' HG23 ' A' ' 189' ' ' VAL . 32.2 m120 -62.43 -44.22 96.94 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.609 0.718 . . . . 0.0 110.047 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' CYS . . . . . . . . . . . . . 21.9 t -63.24 -47.61 81.75 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.031 178.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.8 -39.77 94.13 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 113.742 -1.572 . . . . 0.0 110.037 177.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' A' ' 189' ' ' VAL . 3.8 tm-20 -59.63 -45.75 91.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.252 -1.34 . . . . 0.0 111.803 -176.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.481 HD21 ' CD ' ' A' ' 119' ' ' ARG . 0.1 OUTLIER -65.04 -37.64 88.26 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 118.544 -1.262 . . . . 0.0 111.229 -175.548 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 94.8 t -64.21 -47.34 90.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 117.172 -1.811 . . . . 0.0 109.414 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . 0.413 HG23 ' N ' ' A' ' 197' ' ' TYR . 3.0 t -65.48 -45.68 82.71 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 122.075 0.94 . . . . 0.0 112.743 -179.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . 0.413 ' N ' HG23 ' A' ' 196' ' ' THR . 61.7 t80 -57.99 -39.8 79.12 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 113.611 -1.631 . . . . 0.0 113.07 -178.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -56.41 -44.85 80.75 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 16.4 mt -62.12 -39.64 93.22 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.185 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 80.6 mt -63.6 -42.9 97.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-O 119.252 -0.404 . . . . 0.0 111.021 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . 0.646 ' O ' HD12 ' A' ' 205' ' ' LEU . 0.0 OUTLIER -59.63 -37.46 78.71 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.774 2.03 . . . . 0.0 112.272 177.19 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -58.98 -34.97 72.44 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 114.135 -1.393 . . . . 0.0 110.996 -175.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.2 t -98.78 130.67 45.24 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 121.745 0.784 . . . . 0.0 111.383 -177.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.478 ' CD2' ' CE1' ' A' ' 217' ' ' HIS . 9.7 mp 70.02 6.96 6.01 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 113.417 -1.72 . . . . 0.0 115.61 -178.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.961 HD22 ' O ' ' A' ' 205' ' ' LEU . 0.0 OUTLIER -109.71 21.0 17.47 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 120.091 1.314 . . . . 0.0 112.954 179.345 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -60.44 -32.85 71.77 Favored 'General case' 0 C--N 1.332 -0.185 0 O-C-N 120.047 -1.658 . . . . 0.0 113.045 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.492 ' O ' ' CB ' ' A' ' 208' ' ' ASN . . . -165.86 32.83 0.05 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.003 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . 0.492 ' CB ' ' O ' ' A' ' 207' ' ' ALA . 0.3 OUTLIER 93.19 -126.44 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 O-C-N 123.882 0.739 . . . . 0.0 110.371 -179.574 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 6.6 tp -175.85 50.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . 0.447 ' C ' ' SD ' ' A' ' 210' ' ' MET . 1.5 tmt? -65.96 -21.42 66.42 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.485 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 28.4 p -62.68 -146.27 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.85 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . 0.447 ' CG ' ' N ' ' A' ' 213' ' ' ASP . 35.9 t70 -150.56 -118.0 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.564 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.447 ' N ' ' CG ' ' A' ' 212' ' ' ASP . 71.0 m-20 48.95 44.08 22.19 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.468 ' N ' ' CD ' ' A' ' 215' ' ' PRO . 1.8 mt -61.21 -43.39 90.01 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.63 -0.713 . . . . 0.0 112.504 -178.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.468 ' CD ' ' N ' ' A' ' 214' ' ' LEU . 35.4 Cg_exo -60.29 -33.45 94.55 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 120.966 1.111 . . . . 0.0 111.715 -178.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' CYS . . . . . 0.513 ' SG ' ' N ' ' A' ' 217' ' ' HIS . 0.8 OUTLIER -64.69 -42.04 95.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 113.427 -1.715 . . . . 0.0 111.543 -178.164 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' HIS . . . . . 0.513 ' N ' ' SG ' ' A' ' 216' ' ' CYS . 11.6 t-160 -66.08 -37.13 85.03 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.575 -177.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -62.98 -47.94 80.99 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.051 -178.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 8.4 m -61.11 -38.81 87.66 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 120.211 1.369 . . . . 0.0 110.255 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 20.7 p -58.97 -40.94 86.28 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -62.71 -41.26 99.06 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -176.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -60.25 -46.59 89.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 122.66 1.219 . . . . 0.0 111.873 -176.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -60.9 -41.77 99.41 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-N 112.364 -2.198 . . . . 0.0 107.771 176.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.89 ' O ' HG23 ' A' ' 228' ' ' THR . . . -62.37 -37.3 85.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.067 -1.067 . . . . 0.0 108.555 177.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 221' ' ' ALA . . . -60.97 -41.99 99.59 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 -177.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -66.77 -38.54 86.76 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 119.294 -0.962 . . . . 0.0 108.799 178.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . 0.513 ' SG ' ' O ' ' A' ' 224' ' ' ALA . 0.5 OUTLIER -63.38 -40.53 97.5 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.503 0.668 . . . . 0.0 110.295 177.617 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.89 HG23 ' O ' ' A' ' 224' ' ' ALA . 75.8 p -61.34 -38.06 85.55 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 114.839 -1.073 . . . . 0.0 112.533 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.489 HG23 ' O ' ' A' ' 225' ' ' GLY . 71.6 p -56.7 -38.86 72.86 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.486 -0.485 . . . . 0.0 111.229 -174.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 227' ' ' CYS . 3.8 p -59.79 -40.81 83.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 118.026 -1.47 . . . . 0.0 108.318 178.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 24.7 mt -61.54 -40.67 87.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 176.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -62.15 -39.2 91.81 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 114.539 -1.209 . . . . 0.0 113.8 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.62 ' O ' HG13 ' A' ' 237' ' ' VAL . 8.2 t -58.74 -43.24 97.58 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 -174.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 233' ' ' SER . 20.0 Cg_endo -60.14 -41.5 51.18 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 CA-C-N 121.947 1.731 . . . . 0.0 112.705 179.065 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 2.9 p -65.97 -37.7 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 117.972 -1.491 . . . . 0.0 109.237 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -66.69 -42.0 87.14 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 -179.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.62 HG13 ' O ' ' A' ' 233' ' ' SER . 15.4 m -65.7 -45.43 91.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -176.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.464 ' N ' HG23 ' A' ' 237' ' ' VAL . 9.9 p -63.54 -37.78 80.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 119.444 -0.902 . . . . 0.0 111.818 -177.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . 0.789 ' HZ2' ' HE ' ' A' ' 185' ' ' ARG . 63.9 mmtt -61.38 -45.72 93.18 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . 0.41 ' H ' HG22 ' A' ' 240' ' ' THR . 1.4 t -62.58 -42.14 99.38 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.935 0.398 . . . . 0.0 111.465 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.627 ' NH2' ' CE1' ' A' ' 269' ' ' PHE . 77.1 mtt-85 -54.07 122.41 10.13 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.75 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.606 ' O ' ' CG ' ' A' ' 242' ' ' TYR . 32.7 t80 168.52 6.45 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 O-C-N 123.662 0.602 . . . . 0.0 111.456 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' MET . . . . . . . . . . . . . 16.5 tpt -110.26 125.43 53.1 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' A' ' 246' ' ' ALA . 1.5 p30 -179.33 141.13 0.16 Allowed 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.329 -0.548 . . . . 0.0 111.09 -179.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 35.5 p -65.28 68.54 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.739 178.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . 0.501 ' N ' ' O ' ' A' ' 244' ' ' ASN . . . -125.5 -87.59 0.6 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.277 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.401 ' CB ' ' O ' ' A' ' 246' ' ' ALA . 0.2 OUTLIER 76.41 81.64 0.09 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.829 179.783 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 250' ' ' TYR . . . 68.47 -46.47 0.39 Allowed Glycine 0 CA--C 1.526 0.753 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.387 179.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.502 ' HB3' ' CD2' ' A' ' 255' ' ' HIS . 79.7 mt-30 49.96 -89.78 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -178.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.857 ' HB2' ' ND1' ' A' ' 255' ' ' HIS . 5.4 t80 -103.78 -138.95 0.36 Allowed 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.898 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -67.1 -51.9 48.5 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 119.697 3.221 . . . . 0.0 119.697 -174.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 86.9 p -147.92 -170.41 3.57 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 113.267 -1.788 . . . . 0.0 112.175 -172.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -56.72 -39.0 73.14 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 179.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -54.38 -33.99 53.84 Favored Glycine 0 C--N 1.311 -0.825 0 N-CA-C 108.824 -1.711 . . . . 0.0 108.824 -173.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' HIS . . . . . 0.857 ' ND1' ' HB2' ' A' ' 250' ' ' TYR . 86.4 t60 -54.64 -37.66 65.93 Favored 'General case' 0 C--O 1.218 -0.601 0 C-N-CA 118.181 -1.407 . . . . 0.0 110.964 178.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' CYS . . . . . . . . . . . . . 6.7 t -59.4 -44.48 92.82 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.678 -177.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -59.92 -45.26 93.16 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.279 -0.569 . . . . 0.0 110.48 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.572 HD13 ' O ' ' A' ' 258' ' ' LEU . 0.2 OUTLIER -67.43 -43.51 81.0 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 120.134 -0.627 . . . . 0.0 110.118 178.494 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 94.0 m -62.6 -46.69 87.12 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 -177.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' MET . . . . . 0.566 ' SD ' ' N ' ' A' ' 261' ' ' LEU . 0.1 OUTLIER -61.33 -43.86 98.16 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 120.134 -0.626 . . . . 0.0 110.851 -178.317 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.566 ' N ' ' SD ' ' A' ' 260' ' ' MET . 63.7 tp -63.18 -48.29 79.0 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' ARG . . . . . 0.447 ' O ' ' O ' ' A' ' 263' ' ' LYS . 8.6 tpt180 -67.68 -53.94 23.57 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.765 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . 0.447 ' O ' ' O ' ' A' ' 262' ' ' ARG . 5.4 ttpm? -56.25 -126.49 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.778 -178.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -85.89 143.11 28.4 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 121.094 0.473 . . . . 0.0 111.122 -178.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.518 ' C ' ' H ' ' A' ' 267' ' ' ARG . . . -42.22 160.84 0.04 OUTLIER Glycine 0 CA--C 1.529 0.968 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.382 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -55.98 0.21 0.17 Allowed 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 121.798 1.666 . . . . 0.0 111.909 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.518 ' H ' ' C ' ' A' ' 265' ' ' GLY . 82.9 mtt85 -70.25 -26.46 63.84 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.753 0.821 . . . . 0.0 112.225 178.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -57.98 -32.06 67.51 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.849 -178.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . 0.627 ' CE1' ' NH2' ' A' ' 241' ' ' ARG . 10.5 t80 -62.1 -41.02 97.79 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.674 177.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -65.28 -37.98 88.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.372 -177.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.472 ' O ' ' O ' ' A' ' 272' ' ' GLY . 37.0 mmtm -67.33 -176.8 0.61 Allowed 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 178.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 271' ' ' LYS . . . 37.11 99.3 0.01 OUTLIER Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -156.63 -0.58 0.12 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.019 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' MET . . . . . 0.574 ' N ' ' CD ' ' A' ' 275' ' ' PRO . 0.1 OUTLIER -63.77 -44.62 80.39 Favored Pre-proline 0 C--N 1.328 -0.35 0 C-N-CA 120.247 -0.581 . . . . 0.0 109.565 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 274' ' ' MET . 20.9 Cg_exo -64.7 -47.22 5.58 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.093 1.862 . . . . 0.0 111.651 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 19.7 m -61.03 -40.03 92.05 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.701 0.762 . . . . 0.0 110.434 179.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -62.14 -41.85 98.67 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 123.528 1.633 . . . . 0.0 112.138 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 1.4 mp -62.05 -38.85 90.32 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 110.617 -2.992 . . . . 0.0 108.549 174.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 13.5 mmt85 -62.76 -40.65 97.94 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.291 0.567 . . . . 0.0 109.751 178.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.618 HD23 ' O ' ' A' ' 280' ' ' LEU . 0.9 OUTLIER -63.07 -37.2 86.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.099 -179.037 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -67.81 -50.93 38.24 Favored Glycine 0 CA--C 1.519 0.297 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -177.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 77.8 p -61.63 -44.32 97.21 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' TRP . . . . . 0.636 ' O ' HG22 ' A' ' 286' ' ' VAL . 87.6 t90 -61.26 -39.72 91.41 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.637 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -64.31 -40.66 96.38 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 5.3 m -62.28 -38.18 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.636 HG22 ' O ' ' A' ' 283' ' ' TRP . 27.1 m -62.02 -38.83 81.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 121.094 -0.242 . . . . 0.0 111.041 -178.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' MET . . . . . 0.453 ' C ' ' SD ' ' A' ' 287' ' ' MET . 0.0 OUTLIER -59.33 -37.31 77.49 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.643 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -57.95 -40.07 79.66 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.003 -179.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 286' ' ' VAL . 1.2 m -60.46 -38.16 77.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 O-C-N 121.766 -0.584 . . . . 0.0 111.018 -178.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 75.1 p -61.81 -38.93 89.96 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 177.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -60.64 -38.34 84.52 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 177.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -58.22 -40.71 82.36 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 118.089 -1.445 . . . . 0.0 109.421 -176.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' GLN . . . . . 0.453 ' O ' ' O ' ' A' ' 296' ' ' ARG . 36.5 tp60 -60.72 -42.74 97.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 122.823 1.296 . . . . 0.0 110.468 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 35.9 tp -60.29 -40.15 89.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 112.497 -2.138 . . . . 0.0 109.157 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -63.05 -45.71 90.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.335 179.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' ARG . . . . . 0.453 ' O ' ' O ' ' A' ' 293' ' ' GLN . 44.8 ttm180 -123.03 116.39 23.45 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.047 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -114.41 -97.25 0.44 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.069 0.461 . . . . 0.0 110.682 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.467 HD21 HE21 ' A' ' 303' ' ' GLN . 36.8 tp -140.7 121.06 14.0 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.009 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 24.3 ttt -95.59 66.15 2.73 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -178.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.52 100.82 0.07 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 122.149 0.976 . . . . 0.0 110.805 -178.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -64.28 -46.31 84.21 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 113.393 -1.73 . . . . 0.0 113.362 -176.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -58.92 -39.75 82.48 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.085 -177.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . 0.579 ' NE2' ' N ' ' A' ' 13' ' ' MET . 0.3 OUTLIER -64.51 -46.73 81.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.003 -179.61 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 304' ' ' SER . . . . . 0.44 ' O ' ' CD ' ' A' ' 308' ' ' PRO . 15.1 m -66.56 -37.42 84.93 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.61 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -61.66 -43.25 99.22 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -178.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -65.17 -36.88 85.6 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -177.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . 0.523 ' HB3' ' HD3' ' A' ' 308' ' ' PRO . . . -59.86 -52.7 71.85 Favored Pre-proline 0 CA--C 1.543 0.675 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -176.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 308' ' ' PRO . . . . . 0.523 ' HD3' ' HB3' ' A' ' 307' ' ' ALA . 73.1 Cg_endo -75.2 0.39 9.04 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.038 1.825 . . . . 0.0 111.862 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 39.8 t80 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.501 179.914 . . . . . . . . 0 0 . 1 stop_ save_